PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zito, K; Knott, G; Shepherd, GMG; Shenolikar, S; Svoboda, K				Zito, K; Knott, G; Shepherd, GMG; Shenolikar, S; Svoboda, K			Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; EXPERIENCE-DEPENDENT PLASTICITY; FILAMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; RAT BARREL CORTEX; DENDRITIC SPINES; IN-VIVO; F-ACTIN; RECEPTOR ACTIVATION; GLUTAMATE RECEPTORS	We explored the relationship between regulation of the spine actin cytoskeleton, spine morphogenesis, and synapse formation by manipulating expression of the actin binding protein Nrbl and its deletion mutants. In pyramidal neurons of cultured rat hippocampal slices, Nrbl is concentrated in dendritic spines by binding to the actin cytoskeleton. Expression of one Nrbl deletion mutant, containing the actin binding domain, dramatically increased the density and length of dendritic spines with synapses. This hyperspinogenesis was accompanied by enhanced actin polymerization and spine motility. Synaptic strengths were reduced to compensate for extra synapses, keeping total synaptic input per neuron constant. Our data support a model in which synapse formation is promoted by actin-powered motility.	Howard Hughes Med Inst, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Duke University	Svoboda, K (corresponding author), Howard Hughes Med Inst, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010	Knott, Graham W/0000-0002-2956-9052; Zito, Karen/0000-0002-0799-0460				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Allison DW, 1998, J NEUROSCI, V18, P2423; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hering H, 2003, J NEUROSCI, V23, P11759; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAllister AK, 2000, SCI STKE; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MULY EC, 2004, IN PRESS CORTEX; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	78	149	154	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					321	334		10.1016/j.neuron.2004.09.022	http://dx.doi.org/10.1016/j.neuron.2004.09.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473970	Bronze			2022-12-17	WOS:000224635800014
J	Wen, ZX; Guirland, C; Ming, GL; Zheng, JQ				Wen, ZX; Guirland, C; Ming, GL; Zheng, JQ			A CaMKII/calcineurin switch controls the direction of Ca2+-dependent growth cone guidance	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; LONG-TERM POTENTIATION; NERVE GROWTH; KINASE-II; ADENYLYL-CYCLASE; TAU-FACTOR; CALCIUM; CALCINEURIN; ATTRACTION; ACTIVATION	Axon pathfinding depends on attractive and repulsive turning of growth cones to extracellular cues. Localized cytosolic Ca2+ signals are known to mediate the bidirectional responses, but downstream mechanisms remain elusive. Here, we report that calcium-calmodulin-dependent protein kinase II (CaMKII) and calcineurin (CaN) phosphatase provide a switch-like mechanism to control the direction of Ca2+-dependent growth cone turning. A relatively large local Ca2+ elevation preferentially activates CaMKII to induce attraction, while a modest local Ca2+ signal predominately acts through CaN and phosphatase-1 (PP1) to produce repulsion. The resting level of intracellular Call concentrations also affects CaMKII/CaN operation: a normal baseline allows distinct turning responses to different local Ca2+ signals, while a low baseline favors CaN-PP1 activation for repulsion. Moreover, the CAMP pathway negatively regulates CaN-PP1 signaling to inhibit repulsion. Finally, CaMKII/CaN-PP1 also mediates netrin-1 guidance. Together, these findings establish a complex Ca2+ mechanism that targets the balance of CaMKII/CaN-PP1 activation to control distinct growth cone responses.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol, Baltimore, MD 21205 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University	Zheng, JQ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	james.zheng@umdnj.edu	Ming, Guo-li/J-7880-2013; Wen, Zhexing/L-1228-2018; Wen, Zhexing/B-9313-2014	Wen, Zhexing/0000-0002-1518-3845; Ming, Guo-li/0000-0002-2517-6075				BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; Buck KB, 2002, J NEUROSCI, V22, P9358; Chang C, 2004, SCIENCE, V305, P103, DOI 10.1126/science.1096983; CHANG HY, 1995, NATURE, V376, P686, DOI 10.1038/376686a0; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2003, J NEUROSCI, V23, P2274; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Isaac J, 2001, NEURON, V32, P963, DOI 10.1016/S0896-6273(01)00545-1; ISHIDA A, 1995, J BIOL CHEM, V270, P2163, DOI 10.1074/jbc.270.5.2163; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Uezu A, 2002, J NEUROCHEM, V82, P585, DOI 10.1046/j.1471-4159.2002.00984.x; WALAAS SI, 1983, NATURE, V301, P69; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; YAMAMOTO H, 1985, J NEUROCHEM, V44, P759, DOI 10.1111/j.1471-4159.1985.tb12880.x; YOVELL Y, 1992, J NEUROCHEM, V59, P1736, DOI 10.1111/j.1471-4159.1992.tb11005.x; Zheng JQ, 1996, PERSPECT DEV NEUROBI, V4, P205; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	53	149	150	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					835	846		10.1016/j.neuron.2004.08.037	http://dx.doi.org/10.1016/j.neuron.2004.08.037			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363394	Bronze			2022-12-17	WOS:000223992000009
J	Okazawa, H; Rich, T; Chang, A; Lin, X; Waragai, M; Kajikawa, M; Enokido, Y; Komuro, A; Kato, S; Shibata, M; Hatanaka, H; Mouradian, MM; Sudol, M; Kanazawa, I				Okazawa, H; Rich, T; Chang, A; Lin, X; Waragai, M; Kajikawa, M; Enokido, Y; Komuro, A; Kato, S; Shibata, M; Hatanaka, H; Mouradian, MM; Sudol, M; Kanazawa, I			Interaction between mutant ataxin-1 and POBP-1 affects transcription and cell death	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE PROTEIN; CREB-BINDING PROTEIN; RNA-POLYMERASE-II; NUCLEAR INCLUSIONS; TRACT-BINDING; WW DOMAIN; DISEASE; AGGREGATION; IDENTIFICATION	PQBP-1 was isolated on the basis of its interaction with polyglutamine tracts. In this study, using in vitro and in vivo assays, we show that the association between ataxin-1 and PQBP-1 is positively influenced by expanded polyglutamine sequences. In cell lines, interaction between the two molecules induces apoptotic cell death. As a possible mechanism underlying this phenomenon, we found that mutant ataxin-1 enhances binding of PQBP-1 to the C-terminal domain of RNA polymerase II large subunit (Pol II). This reduces the level of phosphorylated Pol II and transcription. Our results suggest the involvement of PQBP-1 in the pathology of spinocerebellar ataxia type 1 (SCA1) and support the idea that modified transcription underlies polyglutamine-mediated pathology.	Univ Tokyo, Grad Sch med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; MBL Co Ltd, Dept Pharmaceut Dev, Nagano 3960002, Japan; Osaka Univ, Inst Prot Res, Div Prot Biosynth, Suita, Osaka 5650871, Japan; JST, ERATO, Sagami Chem Res Ctr, Kanagawa 2290012, Japan; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Pediat Neurol Neurosci & Mol Genet, Houston, TX 77030 USA; NINCDS, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); University of Cambridge; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Okazawa, H (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Therapeut, 2-6 Musashidai, Tokyo 1838526, Japan.	okazawa@tmin.ac.jp		Mouradian, M. Maral/0000-0002-9937-412X; Enokido, Yasushi/0000-0003-3252-504X; Chang, Alex/0000-0001-8584-2984	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002826] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Berry LD, 1997, J CELL BIOL, V137, P1337, DOI 10.1083/jcb.137.6.1337; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gilman S, 1996, ANN NEUROL, V39, P241, DOI 10.1002/ana.410390214; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Hirose Y, 2000, GENE DEV, V14, P1415; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Iwamoto K, 2000, GENE, V259, P69, DOI 10.1016/S0378-1119(00)00437-6; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lunkes A, 1997, NAT MED, V3, P1201, DOI 10.1038/nm1197-1201; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okazawa H, 1996, P NATL ACAD SCI USA, V93, P11933, DOI 10.1073/pnas.93.21.11933; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wanker EE, 2000, MOL MED TODAY, V6, P387, DOI 10.1016/S1357-4310(00)01761-5; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhang JW, 2000, THIN WALL STRUCT, V38, P1, DOI 10.1016/S0263-8231(00)00027-6	56	149	156	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					701	713		10.1016/S0896-6273(02)00697-9	http://dx.doi.org/10.1016/S0896-6273(02)00697-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062018	Bronze			2022-12-17	WOS:000175951800006
J	Futatsugi, A; Kato, K; Ogura, H; Li, ST; Nagata, E; Kuwajima, G; Tanaka, K; Itohara, S; Mikoshiba, K				Futatsugi, A; Kato, K; Ogura, H; Li, ST; Nagata, E; Kuwajima, G; Tanaka, K; Itohara, S; Mikoshiba, K			Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; RAT HIPPOCAMPAL SLICES; GYRUS IN-VITRO; SYNAPTIC PLASTICITY; SKELETAL-MUSCLE; DENTATE GYRUS; CA2+ RELEASE; AUTORADIOGRAPHIC ANALYSIS	To evaluate the role in synaptic plasticity of ryanodine receptor type 3 (RyR3), which is normally enriched in hippocampal area CA1, we generated RyR3-deficient mice. Mutant mice exhibited facilitated CA1 long-term potentiation (LTP) induced by short tetanus (100 Hz, 100 ms) stimulation. Unlike LTP in wild-type mice, this LTP was not blocked by the NMDA receptor antagonist D-APS but was partially dependent on L-type voltage-dependent Ca2+ channels (VDCCs) and metabotropic glutamate receptors (mGluRs). Long-term depression (LTD) was not induced in RyR3-deficient mice. RyR3-deficient mice also exhibited improved spatial learning on a Morris water maze task. These results suggest that in wild-type mice, in contrast to the excitatory role of Ca2+ influx, RyR3-mediated intracellular Ca2+ ([Ca2+]) release from endoplasmic reticulum (ER) may inhibit hippocampal LTP and spatial learning.	Japan Sci & Technol Corp, Mikoshiba Calciosignal Net Project, Exploratory Res Adv Technol, Bunkyo Ku, Tokyo 1130021, Japan; Shionogi & Co Ltd, Shionogi Inst Med Sci, Settsu, Osaka 5660022, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3002635, Japan; Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	Japan Science & Technology Agency (JST); Shionogi & Company Limited; University of Tokyo; Eisai Co Ltd; Keio University; RIKEN; RIKEN	Kato, K (corresponding author), Japan Sci & Technol Corp, Mikoshiba Calciosignal Net Project, Exploratory Res Adv Technol, Bunkyo Ku, 2-28-8 Honkomagome, Tokyo 1130021, Japan.		Mikoshiba, Katsuhiko/N-7943-2015; Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Li, Sheng Tian/0000-0002-2836-3802				ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bertocchini F, 1997, EMBO J, V16, P6956, DOI 10.1093/emboj/16.23.6956; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; Coussens CM, 1996, SYNAPSE, V24, P97, DOI 10.1002/(SICI)1098-2396(199610)24:2<97::AID-SYN1>3.0.CO;2-9; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; CUMMINGS JA, 1994, NEUROSCI LETT, V176, P110, DOI 10.1016/0304-3940(94)90883-4; DIANA G, 1995, BRAIN RES, V686, P107, DOI 10.1016/0006-8993(95)00440-2; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FURUICHI T, 1994, J NEUROSCI, V14, P4794; Gage AT, 1997, HIPPOCAMPUS, V7, P286; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARVEY J, 1992, NEUROSCI LETT, V139, P197, DOI 10.1016/0304-3940(92)90551-H; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ikemoto T, 1997, J PHYSIOL-LONDON, V501, P305, DOI 10.1111/j.1469-7793.1997.305bn.x; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KOHDA K, 1995, J NEUROPHYSIOL, V74, P2184, DOI 10.1152/jn.1995.74.5.2184; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murayama T, 1996, J BIOL CHEM, V271, P5079; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; NAKANISHI S, 1992, NEUROSCI RES, V15, P130, DOI 10.1016/0168-0102(92)90026-9; NORI A, 1993, BIOCHEM J, V291, P199, DOI 10.1042/bj2910199; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; OMARA SM, 1995, NEUROSCIENCE, V68, P621, DOI 10.1016/0306-4522(95)00233-9; OUYANG Y, 1993, BRAIN RES, V620, P269, DOI 10.1016/0006-8993(93)90165-J; PADUA RA, 1991, BRAIN RES, V542, P135, DOI 10.1016/0006-8993(91)91007-N; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; REYNES M, 1996, J NEUROSCI, V16, P5951; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; TANAKA K, 1991, J CEREBR BLOOD F MET, V11, P283, DOI 10.1038/jcbfm.1991.60; TANAKA K, 1988, BRAIN RES BULL, V21, P693, DOI 10.1016/0361-9230(88)90210-9; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; Wang Y, 1996, J PHYSIOL-LONDON, V495, P755, DOI 10.1113/jphysiol.1996.sp021631; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918	57	149	154	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					701	713		10.1016/S0896-6273(00)81123-X	http://dx.doi.org/10.1016/S0896-6273(00)81123-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595520	Bronze			2022-12-17	WOS:000083913000024
J	Davenne, M; Maconochie, MK; Neun, R; Pattyn, A; Chambon, P; Krumlauf, R; Rijli, FM				Davenne, M; Maconochie, MK; Neun, R; Pattyn, A; Chambon, P; Krumlauf, R; Rijli, FM			Hoxa2 and Hoxb2 control dorsoventral patterns of neuronal development in the rostral hindbrain	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; DEVELOPING SPINAL-CORD; RHOMBOMERE-SPECIFIC ORIGIN; NERVOUS-SYSTEM; SEGMENTAL EXPRESSION; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; PARAXIAL MESODERM; BRANCHIAL REGION; DEVELOPING CNS	Little is known about how the generation of specific neuronal types at stereotypic positions within the hindbrain is linked to Hox gene-mediated patterning. Here, we show that during neurogenesis, Hox paralog group 2 genes control both anteroposterior (A-P) and dorsoventral (D-V) patterning. Hoxa2 and Hoxb2 differentially regulate, in a rhombomere-specific manner, the expression of several genes in broad D-V-restricted domains or narrower longitudinal columns of neuronal progenitors, immature neurons, and differentiating neuronal subtypes. Moreover, Hoxa2 and Hoxb2 can functionally synergize in controlling the development of ventral neuronal subtypes in rhombomere 3 (r3). Thus, in addition to their roles in A-P patterning, Hoxa2 and Hoxb2 have distinct and restricted functions along the D-V axis during neurogenesis, providing insights into how neuronal fates are assigned at stereotypic positions within the hindbrain.	Univ Louis Pasteur, Coll France, INSERM, CNRS,Inst Genet & Biol Molec & Cellullaire, F-67404 Strasbourg, France; Natl Inst Med Res, MRC, Lab Dev Neurobiol, London NW7 1AA, England; Univ Mediterranee, INSERM, CNRS, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Rijli, FM (corresponding author), Univ Louis Pasteur, Coll France, INSERM, CNRS,Inst Genet & Biol Molec & Cellullaire, BP 163, F-67404 Strasbourg, France.	rijli@igbmc.u-strasbg.fr	Alexandre, Pattyn/ABF-1346-2020; RIJLI, Filippo/AAP-2516-2020; Krumlauf, Robb/AAH-5012-2019	RIJLI, Filippo/0000-0003-0515-0182; Krumlauf, Robb/0000-0001-9102-7927; Pattyn, Alexandre/0000-0003-1215-1482	NICHD NIH HHS [N01-HD-7-3263] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Auclair F, 1996, J COMP NEUROL, V369, P451; Barrow JR, 1996, DEVELOPMENT, V122, P3817; Burrill JD, 1997, DEVELOPMENT, V124, P4493; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddard JM, 1996, DEVELOPMENT, V122, P3217; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GRAHAM A, 1991, DEVELOPMENT, V112, P255; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Irving C, 1996, DEV BIOL, V173, P26, DOI 10.1006/dbio.1996.0004; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; Ma QF, 1997, J NEUROSCI, V17, P3644; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; MARK M, 1993, DEVELOPMENT, V119, P319; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; McKay IJ, 1997, EUR J NEUROSCI, V9, P1499, DOI 10.1111/j.1460-9568.1997.tb01504.x; Nonchev S, 1996, DEVELOPMENT, V122, P543; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Rijli FM, 1998, INT J DEV BIOL, V42, P393; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SchneiderMaunoury S, 1997, DEVELOPMENT, V124, P1215; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; SIMON H, 1993, NEURON, V11, P209, DOI 10.1016/0896-6273(93)90179-U; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Stoykova A, 1997, DEVELOPMENT, V124, P3765; STUART ET, 1994, ANNU REV GENET, V28, P219, DOI 10.1146/annurev.ge.28.120194.001251; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Studer M, 1998, DEVELOPMENT, V125, P1025; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Theil T, 1998, DEVELOPMENT, V125, P443; Tiret L, 1998, DEVELOPMENT, V125, P279; Wizenmann A, 1997, MOL CELL NEUROSCI, V9, P448, DOI 10.1006/mcne.1997.0642; XU Q, 1995, LDEVELOPMENT, V121, P4005; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; ZHANG MB, 1994, DEVELOPMENT, V120, P2431	59	149	149	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					677	691		10.1016/S0896-6273(00)80728-X	http://dx.doi.org/10.1016/S0896-6273(00)80728-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230789	Bronze			2022-12-17	WOS:000079976200012
J	Holmes, GL; Ben-Ari, Y				Holmes, GL; Ben-Ari, Y			Seizures in the developing brain: Perhaps not so benign after all	NEURON			English	Review							DENTATE GYRUS; MOSSY FIBERS; RAT-BRAIN; NEUROGENESIS; HIPPOCAMPUS; RECEPTORS; GABA(A); NMDA; MICE		Harvard Med Sch, Childrens Hosp, Ctr Res Pediat Epilepsy, Dept Neurol, Boston, MA 02115 USA; INSERM, Lab Epilepsie & Ischem Cerebrale, Unit 29, F-75014 Paris, France	Harvard University; Boston Children's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm)	Holmes, GL (corresponding author), Harvard Med Sch, Childrens Hosp, Ctr Res Pediat Epilepsy, Dept Neurol, Boston, MA 02115 USA.	holmesg@a1.tch.harvard.edu		Ben-Ari, Yehezkel/0000-0001-6208-8480				Acsady L, 1998, J NEUROSCI, V18, P3386; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; BICKLER PE, 1993, J CEREBR BLOOD F MET, V13, P811, DOI 10.1038/jcbfm.1993.103; CATALTEPE O, 1995, PEDIATR RES, V38, P251, DOI 10.1203/00006450-199508000-00019; CRUSIO WE, 1993, EUR J NEUROSCI, V5, P1413, DOI 10.1111/j.1460-9568.1993.tb00927.x; GAIARSA JL, 1995, J NEUROPHYSIOL, V73, P246, DOI 10.1152/jn.1995.73.1.246; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Holmes GL, 1998, ANN NEUROL, V44, P845, DOI 10.1002/ana.410440602; Jensen FE, 1998, J NEUROPHYSIOL, V79, P73, DOI 10.1152/jn.1998.79.1.73; Kornblum HI, 1997, MOL BRAIN RES, V44, P219, DOI 10.1016/S0169-328X(96)00224-0; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LIPP HP, 1988, J NEUROSCI, V8, P1905; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MIKATI MA, 1994, ANN NEUROL, V36, P425, DOI 10.1002/ana.410360314; Miranda JD, 1997, DEV BRAIN RES, V99, P176, DOI 10.1016/S0165-3806(97)00016-3; Neill JC, 1996, DEV BRAIN RES, V95, P283, DOI 10.1016/0165-3806(96)00099-5; Parent JM, 1997, J NEUROSCI, V17, P3727; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; WIMER C, 1983, BEHAV NEUROSCI, V97, P844, DOI 10.1037/0735-7044.97.6.844	20	149	155	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1231	1234		10.1016/S0896-6273(00)80642-X	http://dx.doi.org/10.1016/S0896-6273(00)80642-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883716	Bronze			2022-12-17	WOS:000077910600005
J	Yu, HH; Araj, HH; Ralls, SA; Kolodkin, AL				Yu, HH; Araj, HH; Ralls, SA; Kolodkin, AL			The transmembrane semaphorin Sema I is required in Drosophila for embryonic motor and CNS axon guidance	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; GENETIC-ANALYSIS; FASCICLIN-II; TYROSINE PHOSPHATASES; EXPRESSION; PROTEIN; DEFASCICULATION; CONNECTIVITY; MELANOGASTER	The semaphorins comprise a targe family of conserved glycoproteins, several members of which have been shown to function in repulsive neuronal growth cone guidance. We show here that Drosophila Semaphorin I (Sema I), a transmembrane semaphorin expressed on embryonic motor and CNS axons, is required for correct guidance of motor axons and for the formation of CNS pathways. In mutant embryos lacking Sema I, motor axons stall and fail to defasciculate at specific choice points where normally they would project to their muscle targets. In addition, a specific CNS fascicle fails to form correctly in these embryos. Rescue and ectopic expression experiments show that Sema I is required in neurons to mediate axon guidance decisions. These studies further suggest that like secreted semaphorins, transmembrane semaphorins can function as repulsive guidance cues for specific axon guidance events during neurodevelopment.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.		Yu, Hung-Hsiang/AGP-0497-2022	Yu, Hung-Hsiang/0000-0002-2430-9251	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035165, R01NS035165] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35165] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CONDIC ML, 1989, J NEUROSCI, V10, P3935; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HE S, 1997, CELL, V90, P737; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Keynes R, 1996, NEURON, V17, P1031, DOI 10.1016/S0896-6273(00)80235-4; Kikuchi K, 1997, MOL BRAIN RES, V51, P229, DOI 10.1016/S0169-328X(97)00251-9; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mark MD, 1997, CELL TISSUE RES, V290, P299, DOI 10.1007/s004410050934; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wong JTW, 1997, DEVELOPMENT, V124, P3597; ZHOU L, 1997, MOL CELL NEUROSCI, V9, P25; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	44	149	149	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					207	220		10.1016/S0896-6273(00)80450-X	http://dx.doi.org/10.1016/S0896-6273(00)80450-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491983	hybrid			2022-12-17	WOS:000072154700007
J	Carew, TJ				Carew, TJ			Molecular enhancement of memory formation	NEURON			English	Review							APLYSIA SENSORY NEURONS; DEPENDENT PROTEIN-KINASE; LONG-TERM FACILITATION; CAMP; PHOSPHORYLATION; DYNAMICS; CREB				Carew, TJ (corresponding author), YALE UNIV,DEPT PSYCHOL,DEPT BIOL,NEW HAVEN,CT 06520, USA.							ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	24	149	152	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					5	8		10.1016/S0896-6273(00)80016-1	http://dx.doi.org/10.1016/S0896-6273(00)80016-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562090	hybrid			2022-12-17	WOS:A1996TT30700002
J	PIERCE, ME; SHESHBERADARAN, H; ZHE, Z; FOX, LE; APPLEBURY, ML; TAKAHASHI, JS				PIERCE, ME; SHESHBERADARAN, H; ZHE, Z; FOX, LE; APPLEBURY, ML; TAKAHASHI, JS			CIRCADIAN REGULATION OF IODOPSIN GENE-EXPRESSION IN EMBRYONIC PHOTORECEPTORS IN RETINAL CELL-CULTURE	NEURON			English	Article							MESSENGER-RNA; CHICK RETINA; CLOCK; TRANSCRIPTION; PROTEIN; RHYTHM; OPSIN; LEVEL; ROD	A circadian clock regulates number of diverse physiological functions in the vertebrate eye. In this study, we show that mRNA for the red-sensitive cone pigment, iodopsin, fluctuates with a circadian rhythm in chicken retina. Transcript levels increase in the late afternoon just prior to the time of cone disc shedding. Furthermore, iodopsin mRNA levels are regulated similarly by a circadian oscillator in primary cultures of dispersed embryonic chick retina. Nuclear run-on experiments show that the circadian regulation of iodopsin transcript abundance occurs at the level of gene transcription. Our results provide a demonstration of clock-regulated gene expression in a vertebrate preparation maintained in cell culture.	NORTHWESTERN UNIV,NSF,CTR BIOL TIMING,EVANSTON,IL 60208; UNIV CHICAGO,CTR VISUAL SCI,CHICAGO,IL 60637; UNIV CHICAGO,COMM NEUROBIOL,CHICAGO,IL 60637	National Science Foundation (NSF); NSF - Center for Biological Timing; Northwestern University; University of Chicago; University of Chicago			Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878	NEI NIH HHS [EY08467, EY06167, EY04801] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004801, R01EY008467] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1986, DEV BIOL, V117, P520, DOI 10.1016/0012-1606(86)90319-2; ADLER R, 1986, RETINA MODEL CELL BI, P111; [Anonymous], MOL GENETICS BIOL RH; ARAKI M, 1990, INVEST OPHTH VIS SCI, V31, P1466; BANERJI SS, 1984, MOL CELL BIOL, V4, P2437, DOI 10.1128/MCB.4.11.2437; Besharse J.C., 1988, PROGR RETINAL RES, V7, P21; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; DARNELL JE, 1982, NATURE, V297, P365, DOI 10.1038/297365a0; DUNLAP JC, 1990, TRENDS GENET, V6, P159, DOI 10.1016/0168-9525(90)90151-U; GIULIANO G, 1988, EMBO J, V7, P3635, DOI 10.1002/j.1460-2075.1988.tb03244.x; HALL JC, 1990, ANNU REV GENET, V24, P659; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; KUWATA O, 1990, FEBS LETT, V272, P128, DOI 10.1016/0014-5793(90)80465-U; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; MILLAR AJ, 1991, PLANT CELL, V3, P541, DOI 10.1105/tpc.3.5.541; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; NAGY F, 1988, GENE DEV, V2, P376, DOI 10.1101/gad.2.4.376; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; SUGARMAN BJ, 1983, J BIOL CHEM, V258, P9005; Takahashi J S, 1991, Curr Opin Neurobiol, V1, P556, DOI 10.1016/S0959-4388(05)80028-5; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105	28	149	149	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					579	584		10.1016/0896-6273(93)90161-J	http://dx.doi.org/10.1016/0896-6273(93)90161-J			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476610				2022-12-17	WOS:A1993KY50100003
J	SHAPIRO, MS; HILLE, B				SHAPIRO, MS; HILLE, B			SUBSTANCE-P AND SOMATOSTATIN INHIBIT CALCIUM CHANNELS IN RAT SYMPATHETIC NEURONS VIA DIFFERENT G-PROTEIN PATHWAYS	NEURON			English	Article							NUCLEOTIDE-BINDING-PROTEINS; PITUITARY CELL-MEMBRANES; MUSCARINIC RECEPTOR; PERIPHERAL NEURONS; NK1 RECEPTOR; K+ CHANNELS; ACTIVATION; CURRENTS; ACETYLCHOLINE; SUPPRESSION	We studied inhibition of N-type Ca2+ channels in rat superior cervical ganglion neurons by substance P (SP) and somatostatin-14 (Som). In whole-cell clamp, 70 of 82 acutely dissociated neurons showed inhibition (mean 37%) by 500 nM SP, and 54 of 61 showed inhibition by 240 nM Som (mean 57%). Pertussis toxin (PTX) blocked Som but not SP inhibition; intracellular dialysis with 2 mM GDP-beta-S attenuated inhibition with either peptide. Inhibition was voltage dependent with Som but not with SP. Neurokinin A (1 muM) or B was without effect, implicating NK1 tachykinin receptors. In cell-attached patches with bath-applied drugs, to test for a diffusible messenger, inhibition by SP or Som was only 8%. Thus, SP signaling is voltage independent and PTX insensitive; Som inhibition is voltage dependent and PTX sensitive; and both are membrane delimited.			SHAPIRO, MS (corresponding author), UNIV WASHINGTON, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 08174, NS 07332] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BERNHEIM L, 1992, P NATL ACAD SCI USA, V89, P9544, DOI 10.1073/pnas.89.20.9544; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BOHN MC, 1984, BRAIN RES, V298, P378, DOI 10.1016/0006-8993(84)91442-2; BOSMA MM, 1990, SOC GEN PHY, V45, P43; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; CASCIERI MA, 1983, J BIOL CHEM, V258, P5158; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V347, P255, DOI 10.1113/jphysiol.1984.sp015065; CONSTANTI A, 1981, NEUROSCI LETT, V24, P289, DOI 10.1016/0304-3940(81)90173-7; DEVILLIER P, 1989, EUR J PHARMACOL, V168, P53, DOI 10.1016/0014-2999(89)90632-8; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FEWTRELL CMS, 1982, J PHYSIOL-LONDON, V330, P393, DOI 10.1113/jphysiol.1982.sp014347; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANLEY MR, 1980, MOL PHARMACOL, V18, P78; HEISLER S, 1982, P NATL ACAD SCI-BIOL, V79, P6502, DOI 10.1073/pnas.79.21.6502; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; INGI T, 1991, J PHARMACOL EXP THER, V259, P968; INOUE M, 1992, PROG NEUROBIOL, V38, P203, DOI 10.1016/0301-0082(92)90040-L; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KESSLER JA, 1985, NEUROSCIENCE, V15, P827, DOI 10.1016/0306-4522(85)90081-8; KESSLER JA, 1983, SCIENCE, V221, P1059, DOI 10.1126/science.6192502; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLUXEN FW, 1992, P NATL ACAD SCI USA, V89, P4618, DOI 10.1073/pnas.89.10.4618; KOCH BD, 1984, ENDOCRINOLOGY, V114, P1784, DOI 10.1210/endo-114-5-1784; KUBA K, 1978, PROG NEUROBIOL, V11, P77, DOI 10.1016/0301-0082(78)90010-2; LAVIELLE S, 1990, FUNDAM CLIN PHARM, V4, P257, DOI 10.1111/j.1472-8206.1990.tb00493.x; LAW SF, 1991, J BIOL CHEM, V266, P17885; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; MACDONALD SG, 1989, J NEUROCHEM, V53, P264, DOI 10.1111/j.1471-4159.1989.tb07323.x; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; MAU SE, 1991, J ENDOCRINOL, V130, P63, DOI 10.1677/joe.0.1300063; MCLEAN S, 1991, SCIENCE, V251, P437, DOI 10.1126/science.1703324; MILLIGAN G, 1988, BIOCHEM J, V255, P1; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; MURRAYWHELAN R, 1992, J BIOL CHEM, V267, P2960; NAKAJIMA Y, 1988, P NATL ACAD SCI USA, V85, P3643, DOI 10.1073/pnas.85.10.3643; NAKANISHI S, 1991, ANNU REV NEUROSCI, V14, P123, DOI 10.1146/annurev.ne.14.030191.001011; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RAYNOR K, 1989, J PHARMACOL EXP THER, V251, P1988; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; ROBINSON SE, 1980, BRAIN RES, V182, P11, DOI 10.1016/0006-8993(80)90826-4; SEABROOK GR, 1992, J PHARM, V105, P925; SIMMONS LK, 1990, NEURON, V4, P393, DOI 10.1016/0896-6273(90)90051-G; SIMMONS MA, 1991, J NEUROSCI, V11, P2130; SNIDER RM, 1991, SCIENCE, V251, P435, DOI 10.1126/science.1703323; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SONG SY, 1989, BRAIN RES, V494, P383, DOI 10.1016/0006-8993(89)90609-4; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; TAYLOR CW, 1986, BIOCHEM BIOPH RES CO, V136, P362, DOI 10.1016/0006-291X(86)90919-8; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283	68	149	151	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN	1993	10	1					11	20		10.1016/0896-6273(93)90237-L	http://dx.doi.org/10.1016/0896-6273(93)90237-L			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	7678964				2022-12-17	WOS:A1993KK01200002
J	Merlini, M; Rafalski, VA; Coronado, PER; Gill, TM; Ellisman, M; Muthukumar, G; Subramanian, KS; Ryu, JK; Syme, CA; Davalos, D; Seeley, WW; Mucke, L; Nelson, RB; Akassoglou, K				Merlini, Mario; Rafalski, Victoria A.; Coronado, Pamela E. Rios; Gill, T. Michael; Ellisman, Maya; Muthukumar, Gayathri; Subramanian, Keshav S.; Ryu, Jae Kyu; Syme, Catriona A.; Davalos, Dimitrios; Seeley, William W.; Mucke, Lennart; Nelson, Robert B.; Akassoglou, Katerina			Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model	NEURON			English	Article							TRANSGENIC MICE; MATTER; ASSOCIATION; MECHANISM; DECLINE; PLAQUES	Cerebrovascular alterations are a key feature of Alzheimer's disease (AD) pathogenesis. However, whether vascular damage contributes to synaptic dysfunction and how it synergizes with amyloid pathology to cause neuroinflammation and cognitive decline remain poorly understood. Here, we show that the blood protein fibrinogen induces spine elimination and promotes cognitive deficits mediated by CD11b-CD18 microglia activation. 3D molecular labeling in cleared mouse and human AD brains combined with repetitive in vivo two-photon imaging showed focal fibrinogen deposits associated with loss of dendritic spines independent of amyloid plaques. Fibrinogen-induced spine elimination was prevented by inhibiting reactive oxygen species (ROS) generation or genetic ablation of CD11b. Genetic elimination of the fibrinogen binding motif to CD11b reduced neuroinflammation, synaptic deficits, and cognitive decline in the 5XFAD mouse model of AD. Thus, fibrinogen-induced spine elimination and cognitive decline via CD11b link cerebrovascular damage with immune-mediated neurodegeneration and may have important implications in AD and related conditions.	[Merlini, Mario; Rafalski, Victoria A.; Coronado, Pamela E. Rios; Gill, T. Michael; Ellisman, Maya; Muthukumar, Gayathri; Subramanian, Keshav S.; Ryu, Jae Kyu; Syme, Catriona A.; Davalos, Dimitrios; Mucke, Lennart; Akassoglou, Katerina] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Seeley, William W.; Mucke, Lennart; Akassoglou, Katerina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Nelson, Robert B.] Lundbeck Res USA, Paramus, NJ 07652 USA; [Davalos, Dimitrios] Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Nelson, Robert B.] Univ Rhode Isl, Ryan Inst Neurosci, MindImmune Therapeut, Kingston, RI 02881 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Cleveland Clinic Foundation; University of Rhode Island	Akassoglou, K (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Akassoglou, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	kakassoglou@gladstone.ucsf.edu	Davalos, Dimitrios/G-8627-2011; Merlini, Mario/AAJ-1542-2021	Davalos, Dimitrios/0000-0001-9038-6688; Merlini, Mario/0000-0003-4145-3025; Mucke, Lennart/0000-0001-6256-9559; RYU, JAE KYU/0000-0002-3992-4011; Akassoglou, Katerina/0000-0002-2632-1465	Conrad N. Hilton Foundation; H. Lundbeck A/S; S.D. Bechtel, Jr. Foundation; NIH [P01AG019724, P50AG023501]; Consortium for Frontotemporal Dementia Research; Tau Consortium; Swiss National Science Foundation Early Postdoc Mobility Fellowship; NIH/NINDS [F32NS096920-02, R35 NS097976]; Race to Erase MS Young Investigator Awards; American Heart Association Scientist Development Grants; Ray and Dagmar Dolby Family Fund; Conrad N. Hilton Foundation [17348]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097976, F32NS096920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019724, P50AG023501] Funding Source: NIH RePORTER	Conrad N. Hilton Foundation; H. Lundbeck A/S; S.D. Bechtel, Jr. Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Tau Consortium; Swiss National Science Foundation Early Postdoc Mobility Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Race to Erase MS Young Investigator Awards; American Heart Association Scientist Development Grants(American Heart Association); Ray and Dagmar Dolby Family Fund; Conrad N. Hilton Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Marc-Tessier Lavigne and Nicolas Renier for advice on iDISCO, Jan Egebjerg and Jeffrey B. Stavenhagen for insightful discussions, Belinda Cabriga and Rosa Meza-Acevedo for expert technical assistance, Jay L. Degen for providing us with Fgg<SUP>gamma 390-396A</SUP> and Fga<SUP>-/-</SUP> mice, and Giovanni Maki for graphics. Behavioral data were obtained by the Gladstone Institutes' Neurobehavioral Core. The Gladstone Center for In Vivo Imaging Research was supported in part by grants from the Conrad N. Hilton Foundation, H. Lundbeck A/S, and the S.D. Bechtel, Jr. Foundation. Human brain tissue was provided by the Neurodegenerative Disease Brain Bank at the University of California, San Francisco, which receives funding from NIH grants P01AG019724 and P50AG023501, the Consortium for Frontotemporal Dementia Research, and the Tau Consortium. This research was supported by a Swiss National Science Foundation Early Postdoc Mobility Fellowship to M.M.; a NIH/NINDS F32NS096920-02 to V.A.R.; Race to Erase MS Young Investigator Awards and American Heart Association Scientist Development Grants to D.D. and to J.K.R.; the Ray and Dagmar Dolby Family Fund to L.M.; and grants from H. Lundbeck A/S, the Conrad N. Hilton Foundation 17348, and NIH/NINDS R35 NS097976 to K.A.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017; Barker R, 2014, BRAIN, V137, P1524, DOI 10.1093/brain/awu040; Bien-Ly N, 2015, NEURON, V88, P289, DOI 10.1016/j.neuron.2015.09.036; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Boros BD, 2017, ANN NEUROL, V82, P602, DOI 10.1002/ana.25049; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Czirr E, 2017, J EXP MED, V214, P1081, DOI 10.1084/jem.20162011; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gowrishankar S, 2015, P NATL ACAD SCI USA, V112, pE3699, DOI 10.1073/pnas.1510329112; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Haslund-Vinding J, 2017, BRIT J PHARMACOL, V174, P1733, DOI 10.1111/bph.13425; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kirkwood CM, 2013, J NEUROPATH EXP NEUR, V72, P791, DOI 10.1097/NEN.0b013e31829ecc89; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; McLellan ME, 2003, J NEUROSCI, V23, P2212; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Petersen MA, 2017, NEURON, V96, P1003, DOI 10.1016/j.neuron.2017.10.008; Rabin JS, 2018, JAMA NEUROL, V75, P1124, DOI 10.1001/jamaneurol.2018.1123; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; SHINKAI Y, 1995, ANN NEUROL, V38, P421, DOI 10.1002/ana.410380312; Strickland S, 2018, J CLIN INVEST, V128, P556, DOI 10.1172/JCI97509; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Vemuri P, 2015, BRAIN, V138, P761, DOI 10.1093/brain/awu393; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Zamolodchikov D, 2016, BLOOD, V128, P1144, DOI 10.1182/blood-2016-03-705228	43	148	150	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2019	101	6					1099	+		10.1016/j.neuron.2019.01.014	http://dx.doi.org/10.1016/j.neuron.2019.01.014			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP7WO	30737131	Bronze, Green Accepted			2022-12-17	WOS:000461901500013
J	Green, DP; Limjunyawong, N; Gour, N; Pundir, P; Dong, XZ				Green, Dustin P.; Limjunyawong, Nathachit; Gour, Naina; Pundir, Priyanka; Dong, Xinzhong			A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain	NEURON			English	Article							MOUSE MODEL; IMMUNE	Mast cells can be found in close proximity to peripheral nerve endings where, upon activation, they release a broad range of pro-inflammatory cytokines and chemokines. However, the precise mechanism underlying this so-called neurogenic inflammation and associated pain has remained elusive. Here we report that the mast-cell-specific receptor Mrgprb2 mediates inflammatory mechanical and thermal hyperalgesia and is required for recruitment of innate immune cells at the injury site. We also found that the neuropeptide substance P (SP), an endogenous agonist of Mrgprb2, facilitates immune cells' migration via Mrgprb2. Furthermore, SP activation of the human mast cell led to the release of multiple pro-inflammatory cytokines and chemokines via the human homolog MRGPRX2. Surprisingly, the SP-mediated inflammatory responses were independent of its canonical receptor, neurokinin-1 receptor (NK-1R). These results identify Mrgprb2/X2 as an important neuroimmune modulator and a potential target for treating inflammatory pain.	[Green, Dustin P.; Limjunyawong, Nathachit; Gour, Naina; Pundir, Priyanka; Dong, Xinzhong] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Sch Med, Baltimore, MD 21218 USA; [Dong, Xinzhong] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Dong, XZ (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Sch Med, Baltimore, MD 21218 USA.; Dong, XZ (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21218 USA.	xdong2@jhmi.edu	Limjunyawong, Nathachit/GVS-1517-2022	Limjunyawong, Nathachit/0000-0002-9540-6171	US National Institutes of Health [R01NS05479, R01AI135186, T32NS070201, F32GM121030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI135186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM121030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791, T32NS070201] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Qian Xu for his assistance with the NK-1R-GFP knockin/knockout mice and Mark Sabbagh for assistance in confocal imaging. The study was supported by grants from the US National Institutes of Health to X.D. (R01NS05479 and R01AI135186) and D.P.G. (T32NS070201 and F32GM121030). X.D. is an Investigator of the Howard Hughes Medical Institute.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Azimi E, 2017, J ALLERGY CLIN IMMUN, V140, P447, DOI 10.1016/j.jaci.2016.12.980; Azimi E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89362; Barabas ME, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-9; Chatterjea D, 2012, BIOCHEM BIOPH RES CO, V425, P237, DOI 10.1016/j.bbrc.2012.07.074; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Cook AD, 2013, ANN RHEUM DIS, V72, P265, DOI 10.1136/annrheumdis-2012-201703; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; CUNHA FQ, 1991, BRIT J PHARMACOL, V104, P765, DOI 10.1111/j.1476-5381.1991.tb12502.x; Dothel G, 2015, GASTROENTEROLOGY, V148, P1002, DOI 10.1053/j.gastro.2015.01.042; Flatters SJL, 2008, PAIN, V135, P119, DOI 10.1016/j.pain.2007.05.013; Francisco-Cruz A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0774-6; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Ghasemlou N, 2015, P NATL ACAD SCI USA, V112, pE6808, DOI 10.1073/pnas.1501372112; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Heron A, 2013, J NEUROIMMUNOL, V264, P1, DOI 10.1016/j.jneuroim.2013.09.018; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; JUNG M, 1994, NEUROPHARMACOLOGY, V33, P167, DOI 10.1016/0028-3908(94)90004-3; King T, 2005, PAIN, V116, P276, DOI 10.1016/j.pain.2005.04.014; Lisowska B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146400; Liu Q, 2015, HANDB EXP PHARMACOL, V226, P71, DOI 10.1007/978-3-662-44605-8_5; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Wezel A, 2015, ATHEROSCLEROSIS, V241, P289, DOI 10.1016/j.atherosclerosis.2015.05.028; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Yasuda M, 2013, J PAIN RES, V6, P161, DOI 10.2147/JPR.S41527; Youssef S, 1998, J IMMUNOL, V161, P3870	32	148	153	8	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2019	101	3					412	+		10.1016/j.neuron.2019.01.012	http://dx.doi.org/10.1016/j.neuron.2019.01.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK3YY	30686732	Bronze, Green Accepted			2022-12-17	WOS:000457856700015
J	Seidlitz, J; Vasa, F; Shinn, M; Romero-Garcia, R; Whitaker, KJ; Vertes, PE; Wagstyl, K; Reardon, PK; Clasen, L; Liu, SY; Messinger, A; Leopold, DA; Fonagy, P; Dolan, RJ; Jones, PB; Goodyer, IM; Raznahan, A; Bullmore, ET				Seidlitz, Jakob; Vasa, Frantisek; Shinn, Maxwell; Romero-Garcia, Rafael; Whitaker, Kirstie J.; Vertes, Petra E.; Wagstyl, Konrad; Reardon, Paul Kirkpatrick; Clasen, Liv; Liu, Siyuan; Messinger, Adam; Leopold, David A.; Fonagy, Peter; Dolan, Raymond J.; Jones, Peter B.; Goodyer, Ian M.; Raznahan, Armin; Bullmore, Edward T.		NSPN Consortium	Morphometric Similarity Networks Detect Microscale Cortical Organization and Predict Inter-Individual Cognitive Variation	NEURON			English	Article							SURFACE-BASED ANALYSIS; COMMUNITY STRUCTURE; HUMAN CONNECTOME; BRAIN NETWORKS; MENTAL-HEALTH; CONNECTIVITY; ASSOCIATION; SEGMENTATION; TRACTOGRAPHY; ARCHITECTURE	Macroscopic cortical networks are important for cognitive function, but it remains challenging to construct anatomically plausible individual structural connectomes from human neuroimaging. We introduce a new technique for cortical network mapping based on inter-regional similarity of multiple morphometric parameters measured using multimodal MRI. In three cohorts (two human, one macaque), we find that the resulting morphometric similarity networks (MSNs) have a complex topological organization comprising modules and high-degree hubs. Human MSN modules recapitulate known cortical cytoarchitectonic divisions, and greater inter-regional morphometric similarity was associated with stronger inter-regional co-expression of genes enriched for neuronal terms. Comparing macaque MSNs with tract-tracing data confirmed that morphometric similarity was related to axonal connectivity. Finally, variation in the degree of human MSN nodes accounted for about 40% of between-subject variability in IQ. Morphometric similarity mapping provides a novel, robust, and biologically plausible approach to understanding how human cortical networks underpin individual differences in psychological functions.	[Seidlitz, Jakob; Vasa, Frantisek; Shinn, Maxwell; Romero-Garcia, Rafael; Whitaker, Kirstie J.; Vertes, Petra E.; Wagstyl, Konrad; Jones, Peter B.; Goodyer, Ian M.; Bullmore, Edward T.] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SZ, England; [Seidlitz, Jakob; Reardon, Paul Kirkpatrick; Clasen, Liv; Liu, Siyuan; Raznahan, Armin] NIMH, Dev Neurogen Unit, Bethesda, MD 20892 USA; [Messinger, Adam] NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA; [Leopold, David A.] NIMH, Neuropsychol Lab, Bldg 9, Bethesda, MD 20892 USA; [Leopold, David A.] NEI, Neurophysiol Imaging Facil, NIMH, NINDS, Bethesda, MD 20892 USA; [Fonagy, Peter] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Dolan, Raymond J.] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Dolan, Raymond J.] Max Planck UCL Ctr Computat Psychiat & Ageing Res, London WC1B 5EH, England; [Jones, Peter B.; Goodyer, Ian M.; Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Huntingdon PE29 3RJ, England; [Bullmore, Edward T.] GlaxoSmithKline R&D, Immunoinflammat Therapeut Area Unit, ImmunoPsychiat, Stevenage SG1 2NY, Herts, England	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); NIH National Institute of Mental Health (NIMH); NIH National Institute of Neurological Disorders & Stroke (NINDS); University of London; University College London; University of London; University College London; GlaxoSmithKline	Seidlitz, J (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge CB2 0SZ, England.; Seidlitz, J (corresponding author), NIMH, Dev Neurogen Unit, Bethesda, MD 20892 USA.	jakob.seidlitz@nih.gov	Raznahan, Armin/F-4534-2012; Seidlitz, Jakob/K-9360-2019; Whitaker, Kirstie/O-2314-2015; Bullmore, Ed/C-1706-2012; Romero Garcia, Rafael/AAT-7058-2020	Raznahan, Armin/0000-0002-5622-1190; Seidlitz, Jakob/0000-0002-8164-7476; Whitaker, Kirstie/0000-0001-8498-4059; Bullmore, Ed/0000-0002-8955-8283; Romero Garcia, Rafael/0000-0002-5199-4573; Fonagy, Peter/0000-0003-0229-0091; Vertes, Petra E./0000-0002-0992-3210; Reardon, PK/0000-0002-2461-1004	Neuroscience in Psychiatry Network; Wellcome Trust; University College London [095844/Z/11/Z]; National Institute for Health Research Cambridge Biomedical Research Centre; Medical Research Council/Wellcome Trust Behavioural and Clinical Neuroscience Institute at the University of Cambridge; intramural research program of the NIMH [NCT00001246, 89-M-0006]; NIH-Oxford/Cambridge Scholars Program; Winston Churchill Foundation of the United States; Gates Cambridge Trust; Medical Research Council [MR/K020706/1]; MRC [G1000183, MR/K020706/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002949, ZIAMH002896] Funding Source: NIH RePORTER; Medical Research Council [G0001354, G1000183B, G1000183] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051, NF-SI-0514-10157] Funding Source: researchfish; Alan Turing Institute [TU/A/000013] Funding Source: researchfish	Neuroscience in Psychiatry Network; Wellcome Trust(Wellcome Trust); University College London(General Electric); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council/Wellcome Trust Behavioural and Clinical Neuroscience Institute at the University of Cambridge(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); intramural research program of the NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH-Oxford/Cambridge Scholars Program; Winston Churchill Foundation of the United States; Gates Cambridge Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alan Turing Institute	We would like to thank the participants in the NSPN and NIH studies of human brain development. We also thank Claus Hilgetag, Alexandras Goulas, Lisa Ronan, and James Rowe for helpful comments. This study was supported by the Neuroscience in Psychiatry Network and a strategic award by the Wellcome Trust to the University of Cambridge and University College London (095844/Z/11/Z). Additional support was provided by the National Institute for Health Research Cambridge Biomedical Research Centre and the Medical Research Council/Wellcome Trust Behavioural and Clinical Neuroscience Institute at the University of Cambridge. This study was also supported in part by the intramural research program of the NIMH (NCT00001246 and 89-M-0006). J.S. was supported by the NIH-Oxford/Cambridge Scholars Program. M.S. was supported by the Winston Churchill Foundation of the United States. F.V. was supported by the Gates Cambridge Trust. P.E.V. was supported by Medical Research Council grant MR/K020706/1.	Ad-Dab'bagh Y, 2006, P 12 ANN M ORG HUM B; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baars BJ, 1997, CONSCIOUS COGN, V6, P1, DOI 10.1006/ccog.1996.0289; Barabasi AL, 2016, NETWORK SCIENCE, P1; Barbas H, 2015, ANNU REV NEUROSCI, V38, P269, DOI 10.1146/annurev-neuro-071714-033936; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.1136/QSHC.2004.010033; Batalle D, 2013, NEUROIMAGE, V83, P901, DOI 10.1016/j.neuroimage.2013.07.045; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bosnjak M., 2011, PLOS ONE, V6; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cho K. H., 2012, PLOS ONE, V7; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Crossley NA, 2013, P NATL ACAD SCI USA, V110, P11583, DOI 10.1073/pnas.1220826110; Csardi G., 2006, INTERJOURNAL COMPLEX; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Donahue CJ, 2016, J NEUROSCI, V36, P6758, DOI 10.1523/JNEUROSCI.0493-16.2016; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fan QY, 2016, NEUROIMAGE, V124, P1108, DOI 10.1016/j.neuroimage.2015.08.075; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fornito A, 2016, FUNDAMENTALS BRAIN N; Fulcher BD, 2016, P NATL ACAD SCI USA, V113, P1435, DOI 10.1073/pnas.1513302113; Giedd JN, 2015, NEUROPSYCHOPHARMACOL, V40, P43, DOI 10.1038/npp.2014.236; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Goulas A, 2016, CYTOARCHITECTONIC SI, DOI [10.1101/068254, DOI 10.1101/068254]; Goulas A, 2017, BRAIN STRUCT FUNCT, V222, P1281, DOI 10.1007/s00429-016-1277-y; Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kong XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141840; Krienen FM, 2016, P NATL ACAD SCI USA, V113, pE469, DOI 10.1073/pnas.1510903113; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kwak H, 2011, J KOREAN PHYS SOC, V59, P3128, DOI 10.3938/jkps.59.3128; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Lerch JP, 2017, NAT NEUROSCI, V20, P314, DOI 10.1038/nn.4501; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Li W, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00034; Maier-Hein K.H., 2016, BIORXIV, DOI 10.1101/084137; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Misic B, 2015, NEURON, V86, P1518, DOI 10.1016/j.neuron.2015.05.035; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Poldrack RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9885; Ritchie SJ, 2015, INTELLIGENCE, V51, P47, DOI 10.1016/j.intell.2015.05.001; Romero-Garcia R, 2012, NEUROIMAGE, V59, P3522, DOI 10.1016/j.neuroimage.2011.10.086; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sabuncu MR, 2016, P NATL ACAD SCI USA, V113, pE5749, DOI 10.1073/pnas.1604378113; Saggar M, 2015, NEUROIMAGE, V120, P274, DOI 10.1016/j.neuroimage.2015.07.006; Schroter M, 2017, NAT REV NEUROSCI, V18, P131, DOI 10.1038/nrn.2016.182; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Smith CL, 2012, MAMM GENOME, V23, P653, DOI 10.1007/s00335-012-9421-3; Solari SV, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00065; Spoma O, 2004, TRENDS COGN SCI, V8; Sponheim C., 2017, NEUROIMAGE; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Toga AW, 2005, ANNU REV NEUROSCI, V28, P1, DOI 10.1146/annurev.neuro.28.061604.135655; van den Heuvel MP, 2015, HUM BRAIN MAPP, V36, P3064, DOI 10.1002/hbm.22828; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vandekar SN, 2016, NEUROIMAGE, V133, P88, DOI 10.1016/j.neuroimage.2016.03.002; Vasa F., 2017, CEREB CORTEX, P1, DOI DOI 10.1093/CERCOR/BHX249; Vertes PE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0362; von Economo C, 1925, CYTOARCHITEKTONIK HI; Wagstyl K, 2015, NEUROIMAGE, V111, P241, DOI 10.1016/j.neuroimage.2015.02.036; Walker L, 2012, BIOL PSYCHIAT, V72, P1043, DOI 10.1016/j.biopsych.2012.08.001; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wechsler D, 1999, WECHSLER ABBREVIATED; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; Whitaker KJ, 2016, P NATL ACAD SCI USA, V113, P9105, DOI 10.1073/pnas.1601745113; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Young JT, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00029	95	148	148	8	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2018	97	1					231	+		10.1016/j.neuron.2017.11.039	http://dx.doi.org/10.1016/j.neuron.2017.11.039			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FR7CO	29276055	Green Accepted, Green Submitted, Bronze			2022-12-17	WOS:000419224100022
J	Kim, EJ; Juavinett, AL; Kyubwa, EM; Jacobs, MW; Callaway, EM				Kim, Euiseok J.; Juavinett, Ashley L.; Kyubwa, Espoir M.; Jacobs, Matthew W.; Callaway, Edward M.			Three Types of Cortical Layer 5 Neurons That Differ in Brain-wide Connectivity and Function	NEURON			English	Article							PRIMARY VISUAL-CORTEX; DORSAL LATERAL GENICULATE; PYRAMIDAL NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; SUPERIOR COLLICULUS; PROJECTION NEURONS; RECEPTIVE-FIELDS; BEHAVIORAL STATE; CRE-RECOMBINASE; CEREBRAL-CORTEX	Cortical layer 5 (L5) pyramidal neurons integrate inputs from many sources and distribute outputs to cortical and subcortical structures. Previous studies demonstrate two L5 pyramid types: cortico-cortical (CC) and cortico-subcortical (CS). We characterize connectivity and function of these cell types in mouse primary visual cortex and reveal a new subtype. Unlike previously described L5 CC and CS neurons, this new subtype does not project to striatum [cortico-cortical, non-striatal (CC-NS)] and has distinct morphology, physiology, and visual responses. Monosynaptic rabies tracing reveals that CC neurons preferentially receive input from higher visual areas, while CS neurons receive more input from structures implicated in top-down modulation of brain states. CS neurons are also more direction-selective and prefer faster stimuli than CC neurons. These differences suggest distinct roles as specialized output channels, with CS neurons integrating information and generating responses more relevant to movement control and CC neurons being more important in visual perception.	[Kim, Euiseok J.; Juavinett, Ashley L.; Kyubwa, Espoir M.; Jacobs, Matthew W.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Juavinett, Ashley L.; Callaway, Edward M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Kyubwa, Espoir M.] Univ Calif San Diego, Bioengn Grad Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	; Callaway, Edward/D-4336-2011	Juavinett, Ashley/0000-0002-4254-3009; Jacobs, Matthew/0000-0002-3004-8553; Callaway, Edward/0000-0002-6366-5267	NIH [EY022577, EY019005, MH063912]; Gatsby Charitable Foundation; National Science Foundation; Martinet Foundation; Howard Hughes Medical Institute; University of California, San Diego Medical Scientist Training Program [T32 GM007198-40]; Brain & Behavior Research Foundation; NATIONAL EYE INSTITUTE [P30EY019005, R01EY022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; National Science Foundation(National Science Foundation (NSF)); Martinet Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of California, San Diego Medical Scientist Training Program; Brain & Behavior Research Foundation(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all Callaway Lab members for discussion; B.J. Neichin, T. Ito, D. Chatterjee, and S. Gilmour for technical assistance; I. Nauhaus for Matlab programming help; C. Gerfen and E. Schmidt for BAC transgenic mice search help; and L. Luo for sharing Cav2-Cre virus. We also thank the Salk Viral Vector and Biophotonics Core staff members. This work was supported by the NIH grants EY022577, EY019005, and MH063912 and the Gatsby Charitable Foundation (E.M.C.). A.L.J. is supported by the National Science Foundation and Martinet Foundation. E.M.K. is supported by the Howard Hughes Medical Institute Gilliam Fellowship and the University of California, San Diego Medical Scientist Training Program T32 GM007198-40. E.J.K. is a Biogen-IDEC Fellow of the Life Science Research Foundation and a recipient of the 2012 NARSAD Young Investigator Award from the Brain & Behavior Research Foundation.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Bortone DS, 2014, NEURON, V82, P474, DOI 10.1016/j.neuron.2014.02.021; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Garrett ME, 2014, J NEUROSCI, V34, P12587, DOI 10.1523/JNEUROSCI.1124-14.2014; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Guan DX, 2015, J NEUROPHYSIOL, V113, P2014, DOI 10.1152/jn.00524.2014; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; HUBENER M, 1990, J COMP NEUROL, V301, P655, DOI 10.1002/cne.903010412; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; Kim J, 2014, J NEUROSCI, V34, P9656, DOI 10.1523/JNEUROSCI.1325-14.2014; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; LARKMAN AU, 1988, NEUROSCI RES, V6, P1, DOI 10.1016/0168-0102(88)90002-8; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Levesque M, 1996, BRAIN RES, V709, P311, DOI 10.1016/0006-8993(95)01333-4; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nienborg H, 2013, J NEUROSCI, V33, P11145, DOI 10.1523/JNEUROSCI.5320-12.2013; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; PALMER LA, 1974, BRAIN RES, V67, P27, DOI 10.1016/0006-8993(74)90295-9; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Sheets PL, 2011, J NEUROPHYSIOL, V106, P2216, DOI 10.1152/jn.00232.2011; Sorensen S.A., 2013, CEREB CORTEX, V25, P443; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; Van Essen DC, 2005, PROG BRAIN RES, V149, P173, DOI 10.1016/S0079-6123(05)49013-5; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Zarrinpar A., 2014, CEREB CORTEX; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126	54	148	148	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2015	88	6					1253	1267		10.1016/j.neuron.2015.11.002	http://dx.doi.org/10.1016/j.neuron.2015.11.002			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB3WM	26671462	Bronze, Green Accepted			2022-12-17	WOS:000368443900019
J	Hanoun, M; Maryanovich, M; Arnal-Estape, A; Frenette, PS				Hanoun, Maher; Maryanovich, Maria; Arnal-Estape, Anna; Frenette, Paul S.			Neural Regulation of Hematopoiesis, Inflammation, and Cancer	NEURON			English	Review							STEM-CELL NICHE; SYMPATHETIC-NERVOUS-SYSTEM; MARROW STROMAL CELLS; COLONY-STIMULATING FACTOR; BETA-BLOCKER USAGE; BONE-MARROW; BREAST-CANCER; IMMUNE-SYSTEM; VAGUS NERVE; BETA(2)-ADRENERGIC RECEPTOR	Although the function of the autonomic nervous system (ANS) in mediating the flight-or-fight response was recognized decades ago, the crucial role of peripheral innervation in regulating cell behavior and response to the microenvironment has only recently emerged. In the hematopoietic system, the ANS regulates stem cell niche homeostasis and regeneration and fine-tunes the inflammatory response. Additionally, emerging data suggest that cancer cells take advantage of innervating neural circuitry to promote their progression. These new discoveries outline the need to redesign therapeutic strategies to target this underappreciated stromal constituent. Here, we review the importance of neural signaling in hematopoietic homeostasis, inflammation, and cancer.	[Hanoun, Maher; Maryanovich, Maria; Arnal-Estape, Anna; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Hanoun, Maher; Maryanovich, Maria; Arnal-Estape, Anna; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Arnal-Estapé, Anna/A-4091-2011; Frenette, Paul S/J-8272-2012	Arnal-Estapé, Anna/0000-0003-0490-7040; Frenette, Paul S/0000-0003-0862-9922	NIH [DK056638, HL069438, HL116340]; New York State Department of Health (NYSTEM program) [C029154]; Leukemia and Lymphoma Society; German Research Foundation (DFG) [Ha 6731/1-1]; EMBO European Commission [GA-2012-600394, ALTF 447-2014]; National Postdoctoral Award for Advancing Women in Science (Weizmann Institute of Science, Israel); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL116340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSTEM program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); German Research Foundation (DFG)(German Research Foundation (DFG)); EMBO European Commission; National Postdoctoral Award for Advancing Women in Science (Weizmann Institute of Science, Israel); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the NIH (R01 grants DK056638, HL069438, and HL116340), the New York State Department of Health (NYSTEM program; C029154), and the Leukemia and Lymphoma Society for supporting our research program. M.H. was supported by a fellowship of the German Research Foundation (DFG; Ha 6731/1-1); M.M. is supported by the EMBO European Commission FP7 (Marie Curie Actions; EMBOCOFUND2012, GA-2012-600394, ALTF 447-2014) and is a recipient of the National Postdoctoral Award for Advancing Women in Science (Weizmann Institute of Science, Israel, 2013).	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Ayala GE, 2006, CANCER RES, V66, P5159, DOI 10.1158/0008-5472.CAN-05-1847; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; BAERWALD C, 1992, EUR J CLIN INVEST, V22, P42; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bellinger DL, 2008, CELL IMMUNOL, V252, P27, DOI 10.1016/j.cellimm.2007.09.005; Bloom AP, 2011, J PAIN, V12, P698, DOI 10.1016/j.jpain.2010.12.016; BOCKMAN DE, 1994, GASTROENTEROLOGY, V107, P219, DOI 10.1016/0016-5085(94)90080-9; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cannon W. B., 1929, BODILY CHANGES PAIN; Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cruveilheir J., 1835, MALADIES NERFS ANATO; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Geldof AA, 1997, J CANCER RES CLIN, V123, P107, DOI 10.1007/BF01269888; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Goldstein RS, 2007, MOL MED, V13, P210, DOI 10.2119/2006-00108.Goldstein; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Gratwohl A, 2013, CURR OPIN HEMATOL, V20, P485, DOI 10.1097/MOH.0b013e328364f573; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Grytli HH, 2013, PROSTATE, V73, P250, DOI 10.1002/pros.22564; Halvorson KG, 2005, CANCER RES, V65, P9426, DOI 10.1158/0008-5472.CAN-05-0826; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; Harle P, 2005, ARTHRITIS RHEUM-US, V52, P1305, DOI 10.1002/art.20987; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heijnen CJ, 1996, J NEUROIMMUNOL, V71, P223, DOI 10.1016/S0165-5728(96)00125-7; Hicks BM, 2013, ANN ONCOL, V24, P3100, DOI 10.1093/annonc/mdt381; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jimenez-Andrade JM, 2011, PAIN, V152, P2564, DOI 10.1016/j.pain.2011.07.020; Katayama Y, 2003, IMMUNITY, V18, P789, DOI 10.1016/S1074-7613(03)00150-X; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiba T, 2004, PANCREAS, V29, pE51, DOI 10.1097/00006676-200408000-00019; Kiba T, 2002, DIGESTION, V66, P79, DOI 10.1159/000065594; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Kuis W, 1996, BRAIN BEHAV IMMUN, V10, P387, DOI 10.1006/brbi.1996.0034; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Lillberg K, 2003, AM J EPIDEMIOL, V157, P415, DOI 10.1093/aje/kwg002; Liu K, 2007, CLIN CHIM ACTA, V385, P28, DOI 10.1016/j.cca.2007.07.008; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Lujan M, 1998, J UROLOGY, V160, P1919, DOI 10.1016/S0022-5347(01)62444-3; Lutgendorf SK, 2008, CLIN CANCER RES, V14, P6839, DOI 10.1158/1078-0432.CCR-08-0230; Maestroni GJM, 2003, J NEUROIMMUNOL, V144, P91, DOI 10.1016/j.jneuroim.2003.08.039; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Maestroni GJM, 2000, J IMMUNOL, V165, P6743, DOI 10.4049/jimmunol.165.12.6743; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mantyh WG, 2010, NEUROSCIENCE, V171, P588, DOI 10.1016/j.neuroscience.2010.08.056; McCourt C, 2014, BRIT J DERMATOL, V170, P930, DOI 10.1111/bjd.12894; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Miller LE, 2000, FASEB J, V14, P2097, DOI 10.1096/fj.99-1082com; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Norton W.T., 1984, ISOLATION CHARACTERI; Nowicki M, 2007, J CLIN PATHOL, V60, P749, DOI 10.1136/jcp.2006.041475; Okada Y, 1999, INT J CANCER, V81, P67, DOI 10.1002/(SICI)1097-0215(19990331)81:1<67::AID-IJC13>3.0.CO;2-V; Padro CJ, 2014, SEMIN IMMUNOL, V26, P357, DOI 10.1016/j.smim.2014.01.003; Palm D, 2007, PROG EXP TUMOR RES, V39, P91, DOI 10.1159/000100049; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Penninx BWJH, 1998, J NATL CANCER I, V90, P1888, DOI 10.1093/jnci/90.24.1888; Perron L, 2004, CANCER CAUSE CONTROL, V15, P535, DOI 10.1023/B:CACO.0000036152.58271.5e; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pongratz G, 2013, NAT REV RHEUMATOL, V9, P117, DOI 10.1038/nrrheum.2012.181; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Prasad SM, 2014, J CLIN ONCOL, V32, P2471, DOI 10.1200/JCO.2013.51.1048; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; REYNOLDS ML, 1995, J COMP NEUROL, V358, P487, DOI 10.1002/cne.903580403; Robinson SN, 2000, EXP HEMATOL, V28, P1325, DOI 10.1016/S0301-472X(00)00547-6; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sanders VM, 1997, J IMMUNOL, V158, P4200; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Sweeney EA, 2000, P NATL ACAD SCI USA, V97, P6544, DOI 10.1073/pnas.97.12.6544; Szumilas P, 2005, CELL PROLIFERAT, V38, P47, DOI 10.1111/j.1365-2184.2005.00329.x; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; Ventura S, 2002, PHARMACOL THERAPEUT, V94, P93, DOI 10.1016/S0163-7258(02)00174-2; Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007; Viswanathan K, 2005, P NATL ACAD SCI USA, V102, P5808, DOI 10.1073/pnas.0501650102; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	151	148	152	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2015	86	2					360	373		10.1016/j.neuron.2015.01.026	http://dx.doi.org/10.1016/j.neuron.2015.01.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG6KS	25905810	Bronze, Green Accepted			2022-12-17	WOS:000353410000007
J	Schwenk, J; Baehrens, D; Haupt, A; Bildl, W; Boudkkazi, S; Roeper, J; Fakler, B; Schulte, U				Schwenk, Jochen; Baehrens, David; Haupt, Alexander; Bildl, Wolfgang; Boudkkazi, Sami; Roeper, Jochen; Fakler, Bernd; Schulte, Uwe			Regional Diversity and Developmental Dynamics of the AMPA-Receptor Proteome in the Mammalian Brain	NEURON			English	Article							SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; CORNICHON PROTEINS; TIME-COURSE; GLUTAMATE; TARP; TRAFFICKING; STARGAZIN; IDENTIFICATION; MECHANISMS	Native AMPA receptors (AMPARs) in the mammalian brain are macromolecular complexes whose functional characteristics vary across the different brain regions and change during postnatal development or in response to neuronal activity. The structural and functional properties of the AMPARs are determined by their proteome, the ensemble of their protein building blocks. Here we use high-resolution quantitative mass spectrometry to analyze the entire pool of AMPARs affinity-isolated from distinct brain regions, selected sets of neurons, and whole brains at distinct stages of postnatal development. These analyses show that the AMPAR proteome is dynamic in both space and time: AMPARs exhibit profound region specificity in their architecture and the constituents building their core and periphery. Likewise, AMPARs exchange many of their building blocks during postnatal development. These results provide a unique resource and detailed contextual data sets for the analysis of native AMPAR complexes and their role in excitatory neurotransmission.	[Schwenk, Jochen; Baehrens, David; Haupt, Alexander; Bildl, Wolfgang; Boudkkazi, Sami; Fakler, Bernd; Schulte, Uwe] Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; [Schwenk, Jochen; Fakler, Bernd; Schulte, Uwe] Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Roeper, Jochen] Goethe Univ Frankfurt, Inst Neurophysiol, D-60590 Frankfurt, Germany	University of Freiburg; Goethe University Frankfurt	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de; uwe.schulte@physiologie.uni-freiburg.de		Haupt, Alexander/0000-0001-5647-5724; Schwenk, Jochen/0000-0003-3664-9795; Roeper, Jochen/0000-0003-2145-8742	Deutsche Forschungsgemeinschaft [SFB 746, TP16, Fa 332/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J.P. Adelman for thoughtful discussions and critical reading of the manuscript. The mass spectrometry data have been deposited to the ProteomeXchange Consortium via the PRIDE repository (identifier, PXD001195). This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB 746, TP16, and Fa 332/9-1) to B.F.	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bildl W, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.007955; Boudkkazi S, 2014, NEURON, V82, P848, DOI 10.1016/j.neuron.2014.03.031; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brill J, 2008, J NEUROSCI, V28, P13918, DOI 10.1523/JNEUROSCI.3229-08.2008; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Coombs ID, 2012, J NEUROSCI, V32, P9796, DOI 10.1523/JNEUROSCI.0345-12.2012; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hanley JG, 2010, BIOCHEM SOC T, V38, P460, DOI 10.1042/BST0380460; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hussain NK, 2010, J NEUROSCI, V30, P14786, DOI 10.1523/JNEUROSCI.4124-10.2010; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Pratt JM, 2006, NAT PROTOC, V1, P1029, DOI 10.1038/nprot.2006.129; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Schulte U, 2011, SEMIN CELL DEV BIOL, V22, P132, DOI 10.1016/j.semcdb.2010.09.015; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Straub C, 2012, CURR OPIN NEUROBIOL, V22, P488, DOI 10.1016/j.conb.2011.09.005; Studniarczyk D, 2013, NAT NEUROSCI, V16, P1266, DOI 10.1038/nn.3473; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Turecek R, 2014, NEURON, V82, P1032, DOI 10.1016/j.neuron.2014.04.015; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Zhang L, 2008, J NEUROSCI, V28, P9953, DOI 10.1523/JNEUROSCI.0880-08.2008; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	52	148	149	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 1	2014	84	1					41	54		10.1016/j.neuron.2014.08.044	http://dx.doi.org/10.1016/j.neuron.2014.08.044			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ0WG	25242221	Bronze			2022-12-17	WOS:000342502800009
J	Specht, CG; Izeddin, I; Rodriguez, PC; El Beheiry, M; Rostaing, P; Darzacq, X; Dahan, M; Triller, A				Specht, Christian G.; Izeddin, Ignacio; Rodriguez, Pamela C.; El Beheiry, Mohamed; Rostaing, Philippe; Darzacq, Xavier; Dahan, Maxime; Triller, Antoine			Quantitative Nanoscopy of Inhibitory Synapses: Counting Gephyrin Molecules and Receptor Binding Sites	NEURON			English	Article							GLYCINE RECEPTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION; SUBUNIT; NUMBER; KINASE; DYNAMICS; MOBILITY; SIZE	The strength of synaptic transmission is controlled by the number and activity of neurotransmitter receptors. However, little is known about absolute numbers and densities of receptor and scaffold proteins and the stoichiometry of molecular interactions at synapses. Here, we conducted three-dimensional and quantitative nanoscopic imaging based on single-molecule detections to characterize the ultrastructure of inhibitory synapses and to count scaffold proteins and receptor binding sites. We observed a close correspondence between the spatial organization of gephyrin scaffolds and glycine receptors at spinal cord synapses. Endogenous gephyrin was clustered at densities of 5,00010,000 molecules/mu m(2). The stoichiometry between gephyrin molecules and receptor binding sites was approximately 1:1, consistent with a two-dimensional scaffold in which all gephyrin molecules can contribute to receptor binding. The competition of glycine and GABA(A) receptor complexes for synaptic binding sites highlights the potential of single-molecule imaging to quantify synaptic plasticity on the nanoscopic scale.	[Specht, Christian G.; Rodriguez, Pamela C.; Rostaing, Philippe; Triller, Antoine] ENS, INSERM, U1024, Inst Biol, F-75005 Paris, France; [Izeddin, Ignacio; El Beheiry, Mohamed; Dahan, Maxime] Univ Paris 06, ENS, Lab Kastler Brossel, CNRS,UMR 8552,Dept Phys, F-75005 Paris, France; [Izeddin, Ignacio; El Beheiry, Mohamed; Dahan, Maxime] Univ Paris 06, ENS, Inst Biol, F-75005 Paris, France; [Izeddin, Ignacio; Darzacq, Xavier] ENS, CNRS, UMR 8197, Inst Biol, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Triller, A (corresponding author), ENS, INSERM, U1024, Inst Biol, 46 Rue Ulm, F-75005 Paris, France.	triller@biologie.ens.fr	Dahan, Maxime/F-1740-2010; Izeddin, Ignacio/H-2628-2013	Izeddin, Ignacio/0000-0002-8476-3915; Specht, Christian G/0000-0001-6038-7735; Dahan, Maxime/0000-0002-4943-2491; Darzacq, Xavier/0000-0003-2537-8395; TRILLER, Antoine/0000-0002-7530-1233; Rodriguez, Pamela/0000-0002-7529-0992	Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale; Agence Nationale pour la Recherche; Lamonica; Netherlands Organisation for Scientific Research; Marie Curie International Incoming Fellowship; European Community	Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Lamonica; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie International Incoming Fellowship(European Commission); European Community(European Commission)	The authors thank Alain Bessis, Yasmine Cantaut-Belarif, and Andrea Dumoulin (Institut de Biologie de l'Ecole Normale Superieure) as well as Christophe Zimmer and Mickael Lelek (Institut Pasteur) for technical help. This project was funded by the Fondation Pierre-Gilles de Gennes through a research contract with Nikon France, the Institut pour la Recherche sur la Moelle Epiniere et l'Encephale, and by grants TRIDIMIC and MorphoSynDiff from the Agence Nationale pour la Recherche. C.G.S. acknowledges grant Lamonica, and l.l. acknowledges the Netherlands Organisation for Scientific Research for financial support. P.C.R. was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme. C.G.S., l.l., M.D., and A.T. designed the experiments; C.G.S., l.l., P.C.R., P.R., and M.E.B. conducted the experiments and analyzed the data; C.G.S. and l.l. wrote the manuscript.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; BEHEIRY ME, 2013, NAT METHODS, V10, P689, DOI DOI 10.1038/NMETH.2566; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Hoyer P, 2011, NANO LETT, V11, P245, DOI 10.1021/nl103639f; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Izeddin I, 2012, OPT EXPRESS, V20, P4957, DOI 10.1364/OE.20.004957; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Lushnikova I, 2011, NEUROPHARMACOLOGY, V60, P757, DOI 10.1016/j.neuropharm.2010.12.014; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Rigo JM, 2003, J PHYSIOL-LONDON, V553, P819, DOI 10.1113/jphysiol.2003.049577; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; TRILLER A, 1982, J NEUROPHYSIOL, V48, P708, DOI 10.1152/jn.1982.48.3.708; TRILLER A, 1986, P101; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vlachos A, 2013, CEREB CORTEX, V23, P2700, DOI 10.1093/cercor/bhs260; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	49	148	148	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 24	2013	79	2					308	321		10.1016/j.neuron.2013.05.013	http://dx.doi.org/10.1016/j.neuron.2013.05.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889935	Bronze			2022-12-17	WOS:000322426200010
J	Viader, A; Sasaki, Y; Kim, S; Strickland, A; Workman, CS; Yang, K; Gross, RW; Milbrandt, J				Viader, Andreu; Sasaki, Yo; Kim, Sungsu; Strickland, Amy; Workman, Cayce S.; Yang, Kui; Gross, Richard W.; Milbrandt, Jeffrey			Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits Leads to Axon Degeneration and Neuropathy	NEURON			English	Article							MULTIDIMENSIONAL MASS-SPECTROMETRY; LONG-CHAIN ACYLCARNITINE; TRANSCRIPTION FACTOR; STRESS; MYELIN; IDENTIFICATION; ACID; MICE; MOLECULES	Mitochondrial dysfunction is a common cause of peripheral neuropathy. Much effort has been devoted to examining the role played by neuronal/axonal mitochondria, but how mitochondrial deficits in peripheral nerve glia (Schwann cells [SCs]) contribute to peripheral nerve diseases remains unclear. Here, we investigate a mouse model of peripheral neuropathy secondary to SC mitochondria! dysfunction (Tfam-SCKOs). We show that disruption of SC mitochondria activates a maladaptive integrated stress response (ISR) through the actions of heme-regulated inhibitor (H RI) kinase, and causes a shift in lipid metabolism away from fatty acid synthesis toward oxidation. These alterations in SC lipid metabolism result in depletion of important myelin lipid components as well as in accumulation of acylcarnitines (ACs), an intermediate of fatty acid beta-oxidation. Importantly, we show that ACs are released from SCs and induce axonal degeneration. A maladaptive ISR as well as altered SC lipid metabolism are thus underlying pathological mechanisms in mitochondria-related peripheral neuropathies.	[Viader, Andreu; Sasaki, Yo; Kim, Sungsu; Strickland, Amy; Workman, Cayce S.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yang, Kui; Gross, Richard W.] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	NCI Cancer Center [P30 CA91842]; ICTS/CTSA from the National Center for Research Resources, a component of the National Institutes of Health (NIH) [UL1RR024992]; NIH Roadmap for Medical Research; NIH Neuroscience Blueprint Center [P30 NS057105]; HOPE Center for Neurological Disorders, National Institutes of Health [AG13730]; Muscular Dystrophy Association [237041]; Amyotrophic Lateral Sclerosis Foundation [57696]; PPG [2P01 HL057278]; LipoSpectrum; Platomics Inc.; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013730, R01AG013730] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA from the National Center for Research Resources, a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroscience Blueprint Center; HOPE Center for Neurological Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis Foundation; PPG; LipoSpectrum; Platomics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Michael A. Kiebish, Nina Pachenko, Kelli Simburger, and members of the Milbrandt laboratory for experimental assistance, comments on the manuscript, and helpful discussions; Dennis Dietzen and the St. Louis Children's Hospital Metabolic Genetics Section Core laboratory for help with AC release measurements; Nils-Goran Larsson for the Tfam<SUP>loxP</SUP> mice; Lawrence Wrabetz and Albee Messing for the P<INF>o</INF>-Cre mice; the Genome Technology Access Center (GTAC) in the Department of Genetics for help with genomic analysis; the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital (St. Louis, MO) for the use of the Biomedical Informatics Core (BMC), which provided the in silico analysis service, especially Nobish Varghese. Both GTAC and BMC are partially supported by NCI Cancer Center grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant UL1RR024992 from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This work was also supported by NIH Neuroscience Blueprint Center core grant P30 NS057105 to Washington University, the HOPE Center for Neurological Disorders, National Institutes of Health Grant AG13730 (J.M.), Muscular Dystrophy Association grant 237041 (J.M.), Amyotrophic Lateral Sclerosis Foundation grant 57696 (J.M.), and PPG 2P01 HL057278 (R.W.G). R.W.G. has financial relationships with LipoSpectrum and Platomics Inc.	Atkinson D.E., 1968, NEUROSCIENTIST, V7, P4030; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Dalton LE, 2012, PROG MOL BIOL TRANSL, V106, P189, DOI 10.1016/B978-0-12-396456-4.00003-1; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fernyhough Paul, 2010, Expert Rev Endocrinol Metab, V5, P39; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Gately DP, 1996, BRIT J CANCER, V73, P18, DOI 10.1038/bjc.1996.4; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Hoshi T, 2007, GLIA, V55, P584, DOI 10.1002/glia.20487; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; MARBACH EP, 1967, CLIN CHEM, V13, P314; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Schaefer J, 1996, ANN NEUROL, V40, P597, DOI 10.1002/ana.410400409; SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamada KA, 2000, J CARDIOVASC PHARM, V36, P14, DOI 10.1097/00005344-200007000-00002; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	40	148	153	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					886	898		10.1016/j.neuron.2013.01.012	http://dx.doi.org/10.1016/j.neuron.2013.01.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473319	Bronze, Green Accepted			2022-12-17	WOS:000316162600010
J	Franco, SJ; Muller, U				Franco, Santos J.; Mueller, Ulrich			Shaping Our Minds: Stem and Progenitor Cell Diversity in the Mammalian Neocortex	NEURON			English	Review							RADIAL GLIAL-CELLS; SUBCORTICAL PROJECTION NEURONS; DEVELOPING CEREBRAL-CORTEX; OUTER SUBVENTRICULAR ZONE; SUBTYPE-SPECIFIC GENES; NEURAL PROGENITORS; VENTRICULAR ZONE; POSTMITOTIC NEURONS; SPINDLE ORIENTATION; PRECURSOR CELLS	The neural circuits of the mammalian neocortex are crucial for perception, complex thought, cognition, and consciousness. This circuitry is assembled from many different neuronal subtypes with divergent properties and functions. Here, we review recent studies that have begun to clarify the mechanisms of cell-type specification in the neocortex, focusing on the lineage relationships between neocortical progenitors and subclasses of excitatory projection neurons. These studies reveal an unanticipated diversity in the progenitor pool that requires a revised view of prevailing models of cell-type specification in the neocortex. We propose a "sequential progenitor-diversification model" that integrates current knowledge to explain how projection neuron diversity is achieved by mechanisms acting on proliferating progenitors and their postmitotic offspring. We discuss the implications of this model for our understanding of brain evolution and pathological states of the neocortex.	[Franco, Santos J.; Mueller, Ulrich] Scripps Res Inst, Mol & Cellular Neurosci Dept, Dorris Neurosci Ctr, La Jolla, CA 92037 USA	Scripps Research Institute	Franco, SJ (corresponding author), Scripps Res Inst, Mol & Cellular Neurosci Dept, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	franco@scripps.edu; umueller@scripps.edu	Franco, Santos/V-3413-2019	Franco, Santos/0000-0002-4478-5634	NIH [NS060355, NS046456, MH078833, HD070494]; Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS060355, R01NS046456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH (S.J.F., NS060355; U.M., NS046456, MH078833, HD070494), the Dorris Neuroscience Center (U.M.), and the Skaggs Institute for Chemical Biology (U.M.).	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Ortega JA, 2010, CEREB CORTEX, V20, P2132, DOI 10.1093/cercor/bhp275; ANDERSON JC, 1994, J COMP NEUROL, V341, P16, DOI 10.1002/cne.903410103; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-30; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; BRUCKNER G, 1981, J NEUROCYTOL, V10, P749, DOI 10.1007/BF01262651; Campos LS, 2001, J NEUROSCI RES, V64, P590, DOI 10.1002/jnr.1111.abs; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Desai AR, 2000, DEVELOPMENT, V127, P2863; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; GADISSEUX JF, 1985, DEV NEUROSCI-BASEL, V7, P12, DOI 10.1159/000112273; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Garcia-Moreno F, 2012, CEREB CORTEX, V22, P482, DOI 10.1093/cercor/bhr312; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; GROVE EA, 1993, DEVELOPMENT, V117, P553; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hawrylycz M, 2010, METHODS, V50, P113, DOI 10.1016/j.ymeth.2009.09.005; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; LEVITT P, 1983, DEV BIOL, V96, P472, DOI 10.1016/0012-1606(83)90184-7; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Liu W, 2009, J NEUROSCI RES, V87, P2821, DOI 10.1002/jnr.22129; Lukaszewicz A, 2006, CEREB CORTEX, V16, pI26, DOI 10.1093/cercor/bhk011; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MCKELVIE PA, 1992, J NEUROPATH EXP NEUR, V51, P464, DOI 10.1097/00005072-199207000-00009; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Parnavelas JG, 1995, CIBA F SYMP, V193, P41; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Segklia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034088; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SMART IHM, 1973, J ANAT, V116, P67; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; Takahashi T, 1999, J NEUROSCI, V19, P10357; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Vessey JP, 2012, CELL STEM CELL, V11, P517, DOI 10.1016/j.stem.2012.06.010; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Welagen J, 2011, DEV NEUROBIOL, V71, P10, DOI 10.1002/dneu.20857; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	162	148	149	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2013	77	1					19	34		10.1016/j.neuron.2012.12.022	http://dx.doi.org/10.1016/j.neuron.2012.12.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	068ZL	23312513	Green Accepted, Bronze			2022-12-17	WOS:000313404600005
J	Chen, Q; Cichon, J; Wang, WT; Qiu, L; Lee, SJR; Campbell, NR; DeStefino, N; Goard, MJ; Fu, ZY; Yasuda, R; Looger, LL; Arenkiel, BR; Gan, WB; Feng, GP				Chen, Qian; Cichon, Joseph; Wang, Wenting; Qiu, Li; Lee, Seok-Jin R.; Campbell, Nolan R.; DeStefino, Nicholas; Goard, Michael J.; Fu, Zhanyan; Yasuda, Ryohei; Looger, Loren L.; Arenkiel, Benjamin R.; Gan, Wen-Biao; Feng, Guoping			Imaging Neural Activity Using Thy1-GCaMP Transgenic Mice	NEURON			English	Article							MOUSE OLFACTORY-BULB; ENCODED CA2+ INDICATORS; VISUAL CORTICAL AREAS; NEURONS IN-VIVO; CELLULAR RESOLUTION; CALCIUM INDICATORS; FUNCTIONAL SPECIALIZATION; ODORANT REPRESENTATIONS; FLUORESCENT PROTEIN; GLOMERULAR LAYER	The ability to chronically monitor neuronal activity in the living brain is essential for understanding the organization and function of the nervous system. The genetically encoded green fluorescent protein-based calcium sensor GCaMP provides a powerful tool for detecting calcium transients in neuronal somata, processes, and synapses that are triggered by neuronal activities. Here we report the generation and characterization of transgenic mice that express improved GCaMPs in various neuronal subpopulations under the control of the Thy1 promoter. In vitro and in vivo studies show that calcium transients induced by spontaneous and stimulus-evoked neuronal activities can be readily detected at the level of individual cells and synapses in acute brain slices, as well as chronically in awake, behaving animals. These GCaMP transgenic mice allow investigation of activity patterns in defined neuronal populations in the living brain and will greatly facilitate dissecting complex structural and functional relationships of neural networks.	[Chen, Qian; Wang, Wenting; Campbell, Nolan R.; Fu, Zhanyan; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA; [Goard, Michael J.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Cichon, Joseph; Gan, Wen-Biao] NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, New York, NY 10016 USA; [Qiu, Li; Lee, Seok-Jin R.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Fu, Zhanyan] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [DeStefino, Nicholas] Harvard Univ, Sch Med, MD PhD Program, Boston, MA 02115 USA; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Arenkiel, Benjamin R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Feng, Guoping] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; New York University; Duke University; Duke University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Feng, GP (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fengg@mit.edu	Feng, Guoping/Y-2827-2019; Chen, Qian/B-7405-2013	Arenkiel, Benjamin/0000-0001-9047-2420; Goard, Michael/0000-0002-5366-8501; Wang, Wenting/0000-0002-8344-0102; Yasuda, Ryohei/0000-0001-6263-9297	Poitras Center for Affective Disorders Research; National Institutes of Health [NS047325]; McNair Foundation; NINDS [R00NS64171]; NIH [R01NS078294]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325, R01NS078294, R00NS064171] Funding Source: NIH RePORTER	Poitras Center for Affective Disorders Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Feng laboratory for helpful discussions. We would like to give special thanks to Peimin Qi, Ethan Skowronski-Lutz, Tyler Clark Brown, Mriganka Sur, Caroline Runyan, and Holly Robertson for their intellectual input and technical help. We also thank Charles Jennings and Thomas J. Diefenbach in the McGovern Institute two-photon microscopy core facility for their technical support. This work was made possible by the support from an anonymous grant and from The Poitras Center for Affective Disorders Research to G.F, by National Institutes of Health Grant NS047325 to W.-B.G, and by The McNair Foundation and NINDS R00NS64171 and NIH grant R01NS078294 to B.R.A.	Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; De Saint Jan D, 2009, J NEUROSCI, V29, P2043, DOI 10.1523/JNEUROSCI.5317-08.2009; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 2004, METH MOLEC MED, P255; Fletcher ML, 2009, J NEUROPHYSIOL, V102, P817, DOI 10.1152/jn.00020.2009; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Varshavsky A, 2011, NAT NEUROSCI, V10, P631; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Warp E, 2012, CURR BIOL, V22, P93, DOI 10.1016/j.cub.2011.12.002; Yamada Y, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00018; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; YASUDA R, 2004, SCI STKE, P15; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	52	148	153	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 18	2012	76	2					297	308		10.1016/j.neuron.2012.07.011	http://dx.doi.org/10.1016/j.neuron.2012.07.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LV	23083733	Green Accepted, Bronze, Green Published			2022-12-17	WOS:000310424700006
J	Patel, J; Fujisawa, S; Berenyi, A; Royer, S; Buzsaki, G				Patel, Jagdish; Fujisawa, Shigeyoshi; Berenyi, Antal; Royer, Sebastien; Buzsaki, Gyoergy			Traveling Theta Waves along the Entire Septotemporal Axis of the Hippocampus	NEURON			English	Article							FREELY-MOVING RATS; VENTRAL HIPPOCAMPUS; INHIBITORY INTERNEURONS; SPATIAL REPRESENTATION; FUNCTIONAL DOMAINS; CELL ASSEMBLIES; MEDIAL SEPTUM; BEHAVING RAT; PLACE CELLS; GRID CELLS	A topographical relationship exists between the hippocampus-entorhinal cortex and the neocortex. However, it is not known how these anatomical connections are utilized during information exchange and behavior. We recorded theta oscillations along the entire extent of the septotemporal axis of the hippocampal CA1 pyramidal layer. While the frequency of theta oscillation remained same along the entire long axis, the amplitude and coherence between recording sites decreased from dorsal to ventral hippocampus (VH). Theta phase shifted monotonically with distance along the longitudinal axis, reaching similar to 180 degrees between the septal and temporal poles. The majority of concurrently recorded units were phase-locked to the local field theta at all dorsoventral segments. The power of VH theta had only a weak correlation with locomotion velocity, and its amplitude varied largely independently from theta in the dorsal part. Thus, theta oscillations can temporally combine or segregate neocortical representations along the septotemporal axis of the hippocampus.	[Patel, Jagdish; Fujisawa, Shigeyoshi; Berenyi, Antal; Royer, Sebastien; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Berenyi, Antal] Univ Szeged, Dept Physiol, H-6720 Szeged, Hungary; [Royer, Sebastien] Korea Adv Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea; [Buzsaki, Gyoergy] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Szeged University; Korea Advanced Institute of Science & Technology (KAIST); New York University	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	gyorgy.buzsaki@nyumc.org	Patel, Jagdish/P-8729-2014; Berényi, Antal/A-9174-2013; Fujisawa, Shigeyoshi/N-6439-2015	Patel, Jagdish/0000-0003-4042-2200; Berényi, Antal/0000-0003-0084-8530; Fujisawa, Shigeyoshi/0000-0003-3963-4281; Buzsaki, Gyorgy/0000-0002-3100-4800	National Institute of Health [NS34994, MH54671]; James S. McDonnell Foundation; Global Institute for Scientific Thinking; Marie Curie Fellowship; Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Global Institute for Scientific Thinking; Marie Curie Fellowship(European Commission); Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants NS34994 and MH54671, James S. McDonnell Foundation, the Global Institute for Scientific Thinking (G.B.), Marie Curie Fellowship, and the Rosztoczy Foundation (A.B.). We thank J. Csicsvari and S. Montgomery for providing valuable data and M. Bellucio, K. Mizuseki, E. Pastalkova, A. Amir, and D. Sullivan for providing critical comments and insightful suggestions.	Amaral D., 2007, HIPPOCAMPAL NEUROANA; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bast T, 2009, PLOS BIOL, V7, P730, DOI 10.1371/journal.pbio.1000089; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BILKEY DK, 1985, BRAIN RES, V361, P99, DOI 10.1016/0006-8993(85)91279-X; BULLOCK TH, 1990, NEUROSCIENCE, V38, P609, DOI 10.1016/0306-4522(90)90055-9; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; GAGE FH, 1983, BRAIN RES, V268, P27, DOI 10.1016/0006-8993(83)90387-6; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hinman JR, 2011, J NEUROPHYSIOL, V105, P2675, DOI 10.1152/jn.00837.2010; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KONOPACKI J, 1987, BRAIN RES, V417, P399, DOI 10.1016/0006-8993(87)90473-2; KOPELL N, 1986, COMMUN PUR APPL MATH, V39, P623, DOI 10.1002/cpa.3160390504; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J., 2007, HIPPOCAMPUS BOOK; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; Small SA, 2002, REV NEUROSCIENCE, V13, P183; TOTH K, 1993, J NEUROSCI, V13, P3712; Wiener SI, 1996, PROG NEUROBIOL, V49, P335, DOI 10.1016/0301-0082(96)00019-6; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	52	148	150	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 9	2012	75	3					410	417		10.1016/j.neuron.2012.07.015	http://dx.doi.org/10.1016/j.neuron.2012.07.015			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	987LF	22884325	Green Accepted, Bronze			2022-12-17	WOS:000307417700009
J	Poort, J; Raudies, F; Wannig, A; Lamme, VAF; Neumann, H; Roelfsema, PR				Poort, Jasper; Raudies, Florian; Wannig, Aurel; Lamme, Victor A. F.; Neumann, Heiko; Roelfsema, Pieter R.			The Role of Attention in Figure-Ground Segregation in Areas V1 and V4 of the Visual Cortex	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; TEXTURE SEGREGATION; STRIATE CORTEX; MACAQUE MONKEY; CONTEXTUAL MODULATION; SELECTIVE ATTENTION; SUPERIOR COLLICULUS; SCENE SEGMENTATION; CORTICAL AREAS; BOTTOM-UP	Our visual system segments images into objects and background. Figure-ground segregation relies on the detection of feature discontinuities that signal boundaries between the figures and the background and on a complementary region-filling process that groups together image regions with similar features. The neuronal mechanisms for these processes are not well understood and it is unknown how they depend on visual attention. We measured neuronal activity in V1 and V4 in a task where monkeys either made an eye movement to texture-defined figures or ignored them. Vi activity predicted the timing and the direction of the saccade if the figures were task relevant. We found that boundary detection is an early process that depends little on attention, whereas region filling occurs later and is facilitated by visual attention, which acts in an object-based manner. Our findings are explained by a model with local, bottom-up computations for boundary detection and feedback processing for region filling.	[Poort, Jasper; Wannig, Aurel; Roelfsema, Pieter R.] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Raudies, Florian] Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02115 USA; [Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, NL-1018 WB Amsterdam, Netherlands; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Boston University; University of Amsterdam; Ulm University; Vrije Universiteit Amsterdam	Roelfsema, PR (corresponding author), Netherlands Inst Neurosci, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.roelfsema@nin.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034; Poort, Jasper/0000-0001-6306-4042	European Union Sixth and Seventh Framework Programmes (EU IST Cognitive Systems [027198, 269921]; NWO-VICI grant; CELEST; National Science Foundation Science of Learning Center (NSF) [OMA-0835976]; Office of Naval Research (ONR) [N00014-11-1-0535]; advanced investigator grant from the European Research Council; Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems"; German Research Foundation (DFG)	European Union Sixth and Seventh Framework Programmes (EU IST Cognitive Systems; NWO-VICI grant(Netherlands Organization for Scientific Research (NWO)); CELEST(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Science of Learning Center (NSF)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Naval Research (ONR)(Office of Naval Research); advanced investigator grant from the European Research Council; Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems"; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank Kor Brandsma, Dave Vleesenbeek, and Anneke Ditewig for biotechnical assistance. The research leading to these results has received funding from the European Union Sixth and Seventh Framework Programmes (EU IST Cognitive Systems, project 027198 "Decisions in Motion" and project 269921 "BrainScaleS") and a NWO-VICI grant awarded to P.R.R. F.R. is supported in part by CELEST, a National Science Foundation Science of Learning Center (NSF OMA-0835976) and the Office of Naval Research (ONR N00014-11-1-0535). V.A.F.L. is supported by an advanced investigator grant from the European Research Council. H.N. is supported by the Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG).	Allen HA, 2009, J VISION, V9, DOI 10.1167/9.9.2; Bair W, 2003, J NEUROSCI, V23, P7690; Bhatt R, 2007, VISION RES, V47, P3173, DOI 10.1016/j.visres.2007.07.013; Burrows BE, 2009, J NEUROSCI, V29, P15169, DOI 10.1523/JNEUROSCI.3710-09.2009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DEWEERD P, 1994, J NEUROSCI, V14, P929, DOI 10.1523/JNEUROSCI.14-03-00929.1994; Donk M, 2008, PSYCHOL SCI, V19, P733, DOI 10.1111/j.1467-9280.2008.02149.x; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; FRIES W, 1983, PROC R SOC SER B-BIO, V219, P53, DOI 10.1098/rspb.1983.0058; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; Huang X, 2008, J NEUROPHYSIOL, V100, P539, DOI 10.1152/jn.00997.2007; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; Kanisza G., 1976, VISION ARTIFACT, P25; Kastner S, 1997, VISION RES, V37, P371, DOI 10.1016/S0042-6989(96)00184-8; Kastner S, 2000, J NEUROPHYSIOL, V83, P2453, DOI 10.1152/jn.2000.83.4.2453; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Koffka Kurt, 1999, PRINCIPLES GESTALT P; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Landman R, 2003, J COGNITIVE NEUROSCI, V15, P873, DOI 10.1162/089892903322370799; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Melcher D, 1999, VISION RES, V39, P2929, DOI 10.1016/S0042-6989(99)00029-2; Merigan WH, 1996, VISUAL NEUROSCI, V13, P51, DOI 10.1017/S0952523800007124; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; MUMFORD D, 1987, P NATL ACAD SCI USA, V84, P7354, DOI 10.1073/pnas.84.20.7354; Mumford D., 1996, PERCEPTION BAYESIAN; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Nothdurft HC, 2000, VISUAL NEUROSCI, V17, P421, DOI 10.1017/S0952523800173092; Ogawa T, 2006, EXP BRAIN RES, V173, P1, DOI 10.1007/s00221-006-0362-5; PETERSON MA, 1991, J EXP PSYCHOL HUMAN, V17, P1075, DOI 10.1037/0096-1523.17.4.1075; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Roelfsema PR, 2011, ATTEN PERCEPT PSYCHO, V73, P2542, DOI 10.3758/s13414-011-0200-0; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Rubin E., 1915, VISUELL WAHRGENOMMEN; Schira MM, 2004, J NEUROPHYSIOL, V91, P1716, DOI 10.1152/jn.00380.2003; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Super H, 2004, P NATL ACAD SCI USA, V101, P3230, DOI 10.1073/pnas.0400433101; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Super H, 2006, J PHYSIOL-PARIS, V100, P63, DOI 10.1016/j.jphysparis.2006.09.002; Theeuwes J, 2006, VIS COGN, V14, P466, DOI 10.1080/13506280500195110; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; ULLMAN S, 1984, COGNITION, V18, P97, DOI 10.1016/0010-0277(84)90023-4; Vecera SP, 2004, PSYCHOL SCI, V15, P20, DOI 10.1111/j.0963-7214.2004.01501004.x; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Zhaoping L, 2003, J PHYSIOL-PARIS, V97, P503, DOI 10.1016/j.jphysparis.2004.01.008; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	65	148	150	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 12	2012	75	1					143	156		10.1016/j.neuron.2012.04.032	http://dx.doi.org/10.1016/j.neuron.2012.04.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	975VM	22794268	Bronze			2022-12-17	WOS:000306539600016
J	Potenza, MN; Sofuoglu, M; Carroll, KM; Rounsaville, BJ				Potenza, Marc N.; Sofuoglu, Mehmet; Carroll, Kathleen M.; Rounsaville, Bruce J.			Neuroscience of Behavioral and Pharmacological Treatments for Addictions	NEURON			English	Review							SUBSTANCE-USE DISORDERS; PLACEBO-CONTROLLED TRIAL; IMPULSE CONTROL DISORDERS; WHITE-MATTER INTEGRITY; OPIOID RECEPTOR GENE; DOUBLE-BLIND; COCAINE DEPENDENCE; DRUG-USE; SMOKING-CESSATION; PREFRONTAL CORTEX	Although substantial advances have been made in behavioral and pharmacological treatments for addictions, moving treatment development to the next stage may require novel ways of approaching addictions, particularly ways based on new findings regarding the neurobiological underpinnings of addictions that also assimilate and incorporate relevant information from earlier approaches. In this review, we first briefly review theoretical and biological models of addiction and then describe existing behavioral and pharmacologic therapies for the addictions within this framework. We then propose new directions for treatment development and targets that are informed by recent evidence regarding the heterogeneity of addictions and the neurobiological contributions to these disorders.	[Potenza, Marc N.; Sofuoglu, Mehmet; Carroll, Kathleen M.; Rounsaville, Bruce J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06519 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06519 USA	Yale University; Yale University; Yale University	Potenza, MN (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA.	marc.potenza@yale.edu	Carroll, Kathleen/A-7526-2009	Carroll, Kathleen/0000-0003-3263-3374	Somaxon; National Institutes of Health; Veteran's Administration; Mohegan Sun Casino; National Center for Responsible Gaming; National Institute on Drug Abuse [P50-DA09241, P50-DA016556, P20-DA027844, R37-DA015969, K02-DA021304, R01-DA020908, RC1-DA028279, R01-DA018647, R21 DA029445, R01-DA019039]; National Institute on Alcoholism and Alcohol Abuse [RL1-AA017539]; VISN 1 Mental Illness Educational, Research, and Clinical Center (MIRECC); Center of Excellence in Gambling Research from the National Center for Responsible Gaming; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RL1AA017539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020752, R01DA019885, P50DA009241, R21DA029445, U10DA013038, R01DA029577, R01DA014537, R01DA019039, RC1DA028279, K02DA021304, P20DA027844, K05DA000457, P50DA016556, R37DA015969, R01DA015969, K05DA000089, K12DA000167, R01DA018647, R01DA020908] Funding Source: NIH RePORTER	Somaxon; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); Mohegan Sun Casino; National Center for Responsible Gaming; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); VISN 1 Mental Illness Educational, Research, and Clinical Center (MIRECC); Center of Excellence in Gambling Research from the National Center for Responsible Gaming; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors report that they have no financial conflicts of interest with respect to the content of this manuscript. Dr. Potenza has received financial support or compensation for the following: Dr. Potenza has consulted for and advised Boehringer Ingelheim; has consulted for and has financial interests in Somaxon; has received research support from the National Institutes of Health, Veteran's Administration, Mohegan Sun Casino, the National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, and Forest Laboratories, Ortho-McNeil, Oy-Control/Biotie and Glaxo-SmithKline pharmaceuticals; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for law offices and the federal public defender's office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has guest-edited journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Support was provided by National Institute on Drug Abuse grants P50-DA09241, P50-DA016556, P20-DA027844, R37-DA015969, K02-DA021304, R01-DA020908, RC1-DA028279, R01-DA018647, R21 DA029445, and R01-DA019039, the National Institute on Alcoholism and Alcohol Abuse grant RL1-AA017539, the VISN 1 Mental Illness Educational, Research, and Clinical Center (MIRECC), and a Center of Excellence in Gambling Research from the National Center for Responsible Gaming.	Achat-Mendes C, 2010, J PHARMACOL EXP THER, V334, P556, DOI 10.1124/jpet.110.167619; Adewale AS, 2006, J PHARMACOL EXP THER, V318, P922, DOI 10.1124/jpet.106.105387; Aharonovich E, 2006, DRUG ALCOHOL DEPEN, V81, P313, DOI 10.1016/j.drugalcdep.2005.08.003; *ALC AN, 1986, 12 STEPS 12 TRAD; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anderson AL, 2009, DRUG ALCOHOL DEPEN, V104, P133, DOI 10.1016/j.drugalcdep.2009.04.015; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; Arias AJ, 2008, ALCOHOL CLIN EXP RES, V32, P1159, DOI 10.1111/j.1530-0277.2008.00735.x; Baker DA, 2003, ANN NY ACAD SCI, V1003, P349, DOI 10.1196/annals.1300.023; Ball J.C., 2012, EFFECTIVENESS METHAD; Balleine BW, 2007, ANN NY ACAD SCI, V1104, pXI, DOI 10.1196/annals.1390.2226; Baptista MAS, 2004, J NEUROSCI, V24, P4723, DOI 10.1523/JNEUROSCI.0176-04.2004; Bates ME, 2006, PSYCHOL ADDICT BEHAV, V20, P241, DOI 10.1037/0893-164X.20.3.241; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bell M, 2001, ARCH GEN PSYCHIAT, V58, P763, DOI 10.1001/archpsyc.58.8.763; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Beveridge TJR, 2008, PHILOS T R SOC B, V363, P3257, DOI 10.1098/rstb.2008.0102; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Bickel WK, 2008, ADV HEALTH ECON HEAL, V20, P289, DOI 10.1016/S0731-2199(08)20012-9; Bisaga A, 2010, DRUG ALCOHOL DEPEN, V111, P97, DOI 10.1016/j.drugalcdep.2010.04.006; Blanco C, 2009, PSYCHIAT RES, V167, P161, DOI 10.1016/j.psychres.2008.04.023; Blum K, 1996, AM SCI, V84, P132; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brauer LH, 1997, PHARMACOL BIOCHEM BE, V56, P265, DOI 10.1016/S0091-3057(96)00240-7; Brewer JA, 2008, BIOCHEM PHARMACOL, V75, P63, DOI 10.1016/j.bcp.2007.06.043; Brewer JA, 2010, ADDICTION, V105, P1698, DOI 10.1111/j.1360-0443.2009.02890.x; Brewer JA, 2009, SUBST ABUS, V30, P306, DOI 10.1080/08897070903250241; Brewer JA, 2008, BIOL PSYCHIAT, V64, P998, DOI 10.1016/j.biopsych.2008.05.024; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Cahill K, 2010, COCHRANE DB SYST REV, V12; Carroll KM, 2008, AM J PSYCHIAT, V165, P881, DOI 10.1176/appi.ajp.2008.07111835; Carroll KM, 2009, DRUG ALCOHOL DEPEN, V100, P178, DOI 10.1016/j.drugalcdep.2008.09.015; CARROLL KM, 1994, ARCH GEN PSYCHIAT, V51, P989; Carroll KM, 2005, AM J PSYCHIAT, V162, P1452, DOI 10.1176/appi.ajp.162.8.1452; Carroll KM, 2004, DRUG ALCOHOL DEPEN, V75, P123, DOI 10.1016/j.drugalcdep.2004.02.007; Carroll KM, 1998, COGNITIVE BEHAV APPR, V98-4308; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Chambers RA, 2001, BIOL PSYCHIAT, V50, P71, DOI 10.1016/S0006-3223(01)01134-9; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Cheon Y, 2008, INT J NEUROPSYCHOPH, V11, P971, DOI 10.1017/S1461145708008663; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Costello MR, 2010, NEUROPSYCHOPHARMACOL, V35, P605, DOI 10.1038/npp.2009.165; Culbertson CS, 2011, ARCH GEN PSYCHIAT, V68, P505, DOI 10.1001/archgenpsychiatry.2010.193; Cutler RB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-75; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; DeRubeis RJ, 1999, AM J PSYCHIAT, V156, P1007; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Economidou D, 2011, BIOL PSYCHIAT, V69, P266, DOI 10.1016/j.biopsych.2010.09.040; Edwards S, 2010, FUTUR NEUROL, V5, P393, DOI 10.2217/FNL.10.14; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Ersche KD, 2007, NEUROPSYCHOL REV, V17, P317, DOI 10.1007/s11065-007-9033-y; Ersche KD, 2006, PSYCHOPHARMACOLOGY, V188, P364, DOI 10.1007/s00213-006-0515-z; Evans SM, 2007, ALCOHOL CLIN EXP RES, V31, P775, DOI 10.1111/j.1530-0277.2007.00360.x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faraone SV, 2005, J CHILD ADOL PSYCHOP, V15, P664, DOI 10.1089/cap.2005.15.664; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Fiore M. C., 2008, TREATING TOBACCO USE; Fong T, 2008, PHARMACOL BIOCHEM BE, V89, P298, DOI 10.1016/j.pbb.2007.12.025; Frascella J, 2010, ANN NY ACAD SCI, V1187, P294, DOI 10.1111/j.1749-6632.2009.05420.x; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P228, DOI 10.1016/j.cpr.2007.05.002; George O, 2010, NEUROSCI BIOBEHAV R, V35, P232, DOI 10.1016/j.neubiorev.2010.05.002; George TP, 2002, BIOL PSYCHIAT, V52, P53, DOI 10.1016/S0006-3223(02)01339-2; GHAHREMANI DG, 2011, NEUROPSYCHO IN PRESS, DOI DOI 10.1038/NPP.2010.233; Giacobini E, 2004, PHARMACOL RES, V50, P433, DOI 10.1016/j.phrs.2003.11.017; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grabowski J, 2004, NEUROPSYCHOPHARMACOL, V29, P969, DOI 10.1038/sj.npp.1300392; Grant JE, 2008, PSYCHOPHARMACOLOGY, V200, P521, DOI 10.1007/s00213-008-1235-3; Grant JE, 2010, PSYCHOPHARMACOLOGY, V212, P603, DOI 10.1007/s00213-010-1994-5; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Grant JE, 2009, BRIT J PSYCHIAT, V195, P266, DOI 10.1192/bjp.bp.108.062414; Grohman K, 2006, BRAIN COGNITION, V60, P203; Gual A, 2001, ALCOHOL ALCOHOLISM, V36, P413, DOI 10.1093/alcalc/36.5.413; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hall SM, 2002, ARCH GEN PSYCHIAT, V59, P930, DOI 10.1001/archpsyc.59.10.930; Haney M, 2001, PSYCHOPHARMACOLOGY, V155, P330, DOI 10.1007/s002130100725; Haney M, 2010, BIOL PSYCHIAT, V67, P59, DOI 10.1016/j.biopsych.2009.08.031; Harsan LA, 2008, J NEUROSCI, V28, P14189, DOI 10.1523/JNEUROSCI.4453-08.2008; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Havassy BE, 2004, AM J PSYCHIAT, V161, P139, DOI 10.1176/appi.ajp.161.1.139; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Herin DV, 2010, ANN NY ACAD SCI, V1187, P76, DOI 10.1111/j.1749-6632.2009.05145.x; HIGGINS ST, 1991, AM J PSYCHIAT, V148, P1218; Highfield D, 2001, NEUROPSYCHOPHARMACOL, V25, P320, DOI 10.1016/S0893-133X(01)00227-5; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Holden C, 2001, SCIENCE, V294, P980, DOI 10.1126/science.294.5544.980; Holden C, 2010, SCIENCE, V327, P935, DOI 10.1126/science.327.5968.935; Horder J, 2010, INT J NEUROPSYCHOPH, V13, P1103, DOI 10.1017/S1461145710000453; Hu J, 2010, BIOL PSYCHIAT, V67, P800, DOI 10.1016/j.biopsych.2009.12.028; Irvin JE, 1999, J CONSULT CLIN PSYCH, V67, P563, DOI 10.1037/0022-006X.67.4.563; Janes AC, 2010, BIOL PSYCHIAT, V67, P722, DOI 10.1016/j.biopsych.2009.12.034; Jentsch JD, 2009, PSYCHOPHARMACOLOGY, V202, P497, DOI 10.1007/s00213-008-1181-0; Johansson BA, 2006, ADDICTION, V101, P491, DOI 10.1111/j.1360-0443.2006.01369.x; Johnson BA, 2008, PROG NEURO-PSYCHOPH, V32, P209, DOI 10.1016/j.pnpbp.2007.07.030; Johnson MW, 2007, EXP CLIN PSYCHOPHARM, V15, P187, DOI 10.1037/1064-1297.15.2.187; Johnson MW, 2010, EXP CLIN PSYCHOPHARM, V18, P99, DOI 10.1037/a0018333; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kampman KM, 2006, DRUG ALCOHOL DEPEN, V85, P129, DOI 10.1016/j.drugalcdep.2006.04.002; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim CH, 2006, P NATL ACAD SCI USA, V103, P19164, DOI 10.1073/pnas.0510836103; Knackstedt LA, 2009, BIOL PSYCHIAT, V65, P841, DOI 10.1016/j.biopsych.2008.10.040; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kosten T, 2003, DRUG ALCOHOL DEPEN, V70, P315, DOI 10.1016/S0376-8716(03)00032-2; Kosten TR, 2006, NEUROPSYCHOPHARMACOL, V31, P644, DOI 10.1038/sj.npp.1300851; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Krishnan-Sarin S, 2007, DRUG ALCOHOL DEPEN, V88, P79, DOI 10.1016/j.drugalcdep.2006.09.006; Krupitsky EM, 2007, AM J PSYCHIAT, V164, P519, DOI 10.1176/appi.ajp.164.3.519; Lajtha A, 2010, NEUROCHEM RES, V35, P851, DOI 10.1007/s11064-009-0096-4; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Laucht M, 2009, BIOL PSYCHIAT, V66, P102, DOI 10.1016/j.biopsych.2009.02.010; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; Le Moal M, 2009, PHARMACOPSYCHIATRY, V42, pS42, DOI 10.1055/s-0029-1216355; Lehrer Jonah, 2009, New Yorker, P26; LeSage MG, 2006, AAPS J, V8, pE65, DOI 10.1208/aapsj080108; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Leyton M, 2005, BEHAV NEUROSCI, V119, P1619, DOI 10.1037/0735-7044.119.6.1619; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Longo M, 2010, ADDICTION, V105, P146, DOI 10.1111/j.1360-0443.2009.02717.x; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Maddux JF, 2000, ADDICTION, V95, P661, DOI 10.1046/j.1360-0443.2000.9556611.x; Magill M, 2009, J STUD ALCOHOL DRUGS, V70, P516, DOI 10.15288/jsad.2009.70.516; Mann K, 2004, CNS DRUGS, V18, P485, DOI 10.2165/00023210-200418080-00002; Mardikian PN, 2007, PROG NEURO-PSYCHOPH, V31, P389, DOI 10.1016/j.pnpbp.2006.10.001; Martell BA, 2005, BIOL PSYCHIAT, V58, P158, DOI 10.1016/j.biopsych.2005.04.032; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Martelle JL, 2007, J PHARMACOL EXP THER, V321, P573, DOI 10.1124/jpet.106.113571; Martinez-Raga Jose, 2008, Curr Drug Abuse Rev, V1, P213; Mason BJ, 2010, EXPERT OPIN DRUG SAF, V9, P177, DOI 10.1517/14740330903512943; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; Meda SA, 2009, BEHAV PHARMACOL, V20, P390, DOI 10.1097/FBP.0b013e32833113a3; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; National Institute on Drug Abuse, 2007, PRINC DRUG ADD TREAT; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; O'Brien CP, 2006, AM J PSYCHIAT, V163, P764, DOI 10.1176/appi.ajp.163.5.764; Olive MF, 2010, EUR J PHARMACOL, V639, P47, DOI 10.1016/j.ejphar.2010.01.029; Orson FM, 2008, ANN NY ACAD SCI, V1141, P257, DOI 10.1196/annals.1441.027; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Partilla JS, 2006, J PHARMACOL EXP THER, V319, P237, DOI 10.1124/jpet.106.103622; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Petry N. M., 2005, PATHOLOGICAL GAMBLIN; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Poling J, 2006, ARCH GEN PSYCHIAT, V63, P219, DOI 10.1001/archpsyc.63.2.219; Potenza MN, 2007, J WOMENS HEALTH, V16, P1108; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Potenza MN, 2008, PHILOS T R SOC B, V363, P3181, DOI 10.1098/rstb.2008.0100; Potenza MN, 2010, ALCOHOL CLIN EXP RES, V34, P1303, DOI 10.1111/j.1530-0277.2010.01214.x; Potenza MN, 2009, ADDICTION, V104, P1016, DOI 10.1111/j.1360-0443.2009.02619.x; Potenza MN, 2005, ARCH GEN PSYCHIAT, V62, P1015, DOI 10.1001/archpsyc.62.9.1015; Potenza MN, 2007, J DUAL DIAGN, V3, P47, DOI DOI 10.1300/J374v03n02_06; POTENZA MN, 2009, GAMBLING MAPPING AM, P175; Ray LA, 2008, AM J ADDICTION, V17, P257, DOI 10.1080/10550490802138400; Reissner KJ, 2010, BEHAV PHARMACOL, V21, P514, DOI 10.1097/FBP.0b013e32833d41b2; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; RITCHEY M, 2010, J PSYCHIAT RES; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROSS D, 2009, WHAT IS ADDICTION; Rutherford HJV, 2010, CHILD ADOL PSYCH CL, V19, P479, DOI 10.1016/j.chc.2010.03.003; Saxena S, 2009, MOL PSYCHIATR, V14, P197, DOI 10.1038/sj.mp.4002134; Schilstrom B, 2007, NEUROPSYCHOPHARMACOL, V32, P43, DOI 10.1038/sj.npp.1301087; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schultz W, 2011, NEURON, V69, P603, DOI 10.1016/j.neuron.2011.02.014; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Seu E, 2009, PSYCHOPHARMACOLOGY, V202, P505, DOI 10.1007/s00213-008-1250-4; Shaffer HJ, 1999, ADDICTION, V94, P1445, DOI 10.1046/j.1360-0443.1999.941014451.x; Shearer J, 2003, ADDICTION, V98, P1137, DOI 10.1046/j.1360-0443.2003.00447.x; Shearer J, 2001, ADDICTION, V96, P1289, DOI 10.1046/j.1360-0443.2001.96912898.x; Sidhpura N, 2010, BIOL PSYCHIAT, V67, P804, DOI 10.1016/j.biopsych.2010.01.005; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Sinha R, 2007, PSYCHOPHARMACOLOGY, V190, P569, DOI 10.1007/s00213-006-0640-8; Sinha R, 2009, BIOL PSYCHIAT, V66, P100, DOI 10.1016/j.biopsych.2009.05.003; Sofuoglu M, 2009, PSYCHOPHARMACOLOGY, V207, P153, DOI 10.1007/s00213-009-1643-z; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Srisurapanont M, 2005, INT J NEUROPSYCHOPH, V8, P267, DOI 10.1017/S1461145704004997; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Uhl GR, 2009, J NEUROGENET, V23, P272, DOI 10.1080/01677060802572929; Uhl GR, 2004, ARCH GEN PSYCHIAT, V61, P223, DOI 10.1001/archpsyc.61.3.223; VanBuskirk KA, 2010, J ADDICT MED, V4, P1, DOI 10.1097/ADM.0b013e3181ce38e7; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Vocci FJ, 2005, AM J PSYCHIAT, V162, P1432, DOI 10.1176/appi.ajp.162.8.1432; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Volkow ND, 2011, NEURON, V69, P599, DOI 10.1016/j.neuron.2011.01.027; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Walker M, 2006, ADDICTION, V101, P504, DOI 10.1111/j.1360-0443.2005.01341.x; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; West R, 2008, PSYCHOPHARMACOLOGY, V197, P371, DOI 10.1007/s00213-007-1041-3; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Wexler BE, 2011, BIOL PSYCHIAT, V69, P197, DOI 10.1016/j.biopsych.2010.11.016; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Xu JS, 2010, NEUROPSYCHOPHARMACOL, V35, P1541, DOI 10.1038/npp.2010.25; Zack M, 2007, NEUROPSYCHOPHARMACOL, V32, P1678, DOI 10.1038/sj.npp.1301295; Zhao Y, 2006, J NEUROSCI, V26, P9967, DOI 10.1523/JNEUROSCI.2384-06.2006	243	148	150	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					695	712		10.1016/j.neuron.2011.02.009	http://dx.doi.org/10.1016/j.neuron.2011.02.009			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338880	Green Accepted, Bronze			2022-12-17	WOS:000288413200012
J	Takahashi, H; Arstikaitis, P; Prasad, T; Bartlett, TE; Wang, YT; Murphy, TH; Craig, AM				Takahashi, Hideto; Arstikaitis, Pamela; Prasad, Tuhina; Bartlett, Thomas E.; Wang, Yu Tian; Murphy, Timothy H.; Craig, Ann Marie			Postsynaptic TrkC and Presynaptic PTP sigma Function as a Bidirectional Excitatory Synaptic Organizing Complex	NEURON			English	Article							TYROSINE-PHOSPHATASE-SIGMA; IMMUNOGLOBULIN-LIKE DOMAIN; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIN RECEPTORS; TRANSGENIC MICE; PDZ DOMAINS; NTRK3 GENE; IN-VIVO; NEUROLIGINS; LAR	Neurotrophin receptor tyrosine kinases (Trks) have well-defined trophic roles in nervous system development through kinase activation by neurotrophins. Yet Trks have typical cell-adhesion domains and express noncatalytic isoforms, suggesting additional functions. Here we discovered noncatalytic TrkC in an unbiased hippocampal neuron-fibroblast coculture screen for proteins that trigger differentiation of neurotransmitter release sites in axons. All TrkC isoforms, but not TrkA or TrkB, function directly in excitatory glutamatergic synaptic adhesion by neurotrophin-independent high-affinity trans binding to axonal protein tyrosine phosphatase receptor PTP sigma. PTP sigma triggers and TrkC mediates clustering of postsynaptic molecules in dendrites, indicating bidirectional synaptic organizing functions. Effects of a TrkC-neutralizing antibody that blocks TrkC-PTP sigma interaction and TrkC knockdown in culture and in vivo reveal essential roles of TrkC-PTP sigma in glutamatergic synapse formation. Thus, postsynaptic TrkC trans interaction with presynaptic PTP sigma generates bidirectional adhesion and recruitment essential for excitatory synapse development and positions these signaling molecules at the center of synaptic pathways.	[Takahashi, Hideto; Arstikaitis, Pamela; Prasad, Tuhina; Bartlett, Thomas E.; Wang, Yu Tian; Murphy, Timothy H.; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Takahashi, Hideto; Arstikaitis, Pamela; Prasad, Tuhina; Murphy, Timothy H.; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Bartlett, Thomas E.; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada.	amcraig@interchange.ubc.ca	Takahashi, Hideto/T-2650-2018; Wang, Yu Tian/J-8255-2015; Craig, Ann Marie/M-2054-2014; Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014; Wang, Yu Tian/A-4729-2008	Takahashi, Hideto/0000-0002-6473-5060; Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490; 	National Institutes of Health [MH070860]; CIHR [MOP-84241, MOP-12675]; Canada Research Chair; Michael Smith Foundation for Health Research; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Michael Linhoff for his cDNA expression library and screening method, Dr. Daisaku Yokomaku for advice and technical assistance, and Xiling Zhou for excellent preparation of neuron cultures. We thank Dr. Robert Holt and team at the Michael Smith Genome Sciences Centre for arraying the cDNA subpool and preparing DNA in 384 well format. P. A. would like to thank Dr. Hillel Adesnik for his help in learning the in utero electroporation technique. This work was supported by National Institutes of Health MH070860, CIHR MOP-84241, Canada Research Chair and Michael Smith Foundation for Health Research salary awards to A.M.C., CIHR MOP-12675 to T.H.M., and by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad to H.T.	Alonso P, 2008, GENES BRAIN BEHAV, V7, P778, DOI 10.1111/j.1601-183X.2008.00418.x; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Armengol L, 2002, MOL PSYCHIATR, V7, P928, DOI 10.1038/sj.mp.4001134; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dierssen M, 2006, NEUROBIOL DIS, V24, P403, DOI 10.1016/j.nbd.2006.07.015; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Esteban PF, 2006, J CELL BIOL, V173, P291, DOI 10.1083/jcb.200512013; Feng Y, 2008, AM J PSYCHIAT, V165, P610, DOI 10.1176/appi.ajp.2007.07050805; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Krasnoperov V, 2002, J BIOL CHEM, V277, P35887, DOI 10.1074/jbc.M205478200; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; Meathrel K, 2002, J NEUROSCI RES, V70, P24, DOI 10.1002/jnr.10382; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Sahun I, 2007, J NEUROSCI, V27, P2253, DOI 10.1523/JNEUROSCI.4055-06.2007; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; SIDDIQUI TJ, 2010, CURR OPIN N IN PRESS; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; URFER R, 1995, EMBO J, V14, P2795, DOI 10.1002/j.1460-2075.1995.tb07279.x; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	51	148	149	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					287	303		10.1016/j.neuron.2010.12.024	http://dx.doi.org/10.1016/j.neuron.2010.12.024			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262467	Bronze, Green Accepted			2022-12-17	WOS:000286792900012
J	Yassin, L; Benedetti, BL; Jouhanneau, JS; Wen, JA; Poulet, JFA; Barth, AL				Yassin, Lina; Benedetti, Brett L.; Jouhanneau, Jean-Sebastien; Wen, Jing A.; Poulet, James F. A.; Barth, Alison L.			An Embedded Subnetwork of Highly Active Neurons in the Neocortex	NEURON			English	Article							CORTICAL MAP PLASTICITY; IN-VIVO EXPERIENCE; BARREL CORTEX; SOMATOSENSORY CORTEX; SENSORY DEPRIVATION; PYRAMIDAL CELLS; BEHAVING MICE; BRAIN STATE; LAYER 2/3; RAT	Unbiased methods to assess the firing activity of individual neurons in the neocortex have revealed that a large proportion of cells fire at extremely low rates (<0.1 Hz), both in their spontaneous and evoked activity. Thus, firing in neocortical networks appears to be dominated by a small population of highly active neurons. Here, we use a fosGFP transgenic mouse to examine the properties of cells with a recent history of elevated activity. FosGFP-expressing layer 2/3 pyramidal cells fired at higher rates compared to fosGFP(-) neurons, both in vivo and in vitro. Elevated activity could be attributed to increased excitatory and decreased inhibitory drive to fosGFP(+) neurons. Paired-cell recordings indicated that fosGFP(+) neurons had a greater likelihood of being connected to each other. These findings indicate that highly active, interconnected neuronal ensembles are present in the neocortex and suggest these cells may play a role in the encoding of sensory information.	[Yassin, Lina; Benedetti, Brett L.; Wen, Jing A.; Barth, Alison L.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Yassin, Lina; Benedetti, Brett L.; Wen, Jing A.; Barth, Alison L.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Jouhanneau, Jean-Sebastien; Poulet, James F. A.] Charite, Neurosci Res Ctr, D-10115 Berlin, Germany; [Jouhanneau, Jean-Sebastien; Poulet, James F. A.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13092 Berlin, Germany	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Barth, AL (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	barth@cmu.edu	Wen, Jing/H-5557-2012	Jouhanneau, Jean-Sebastien/0000-0001-8804-5198; Benedetti, Brett/0000-0003-4608-9701; Poulet, James/0000-0003-0296-5415	NIH [DA0171-88]; Alexander von Humboldt Foundation; NeuroCure; Deutsch Forschung Gemeinshaft [Exc 257]; Swiss-German Research Unit [SNF-DFG FOR 1341]; Max-Delbruck Center-Berlin; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NeuroCure; Deutsch Forschung Gemeinshaft; Swiss-German Research Unit; Max-Delbruck Center-Berlin; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH DA0171-88 (A.L.B.), the Alexander von Humboldt Foundation (A.L.B.), NeuroCure (A.L.B. and J.F.A.P.), the Deutsch Forschung Gemeinshaft (Exc 257; J.F.A.P.), the Swiss-German Research Unit "Barrel Cortex Function" (SNF-DFG FOR 1341; J.F.A.P.) and the Max-Delbruck Center-Berlin (J.F.A.P.). Thanks to Kazuo Kitamura for help with fosGFP imaging in vivo and Rick Gerkin for custom Igor Pro macros. Thanks also to Jesse Sheehan, Jill Guy, and Joanne Steinmiller for animal care, and Michael Brecht and members of the Barth, Urban, and Crowley laboratories for helpful discussions. A.L.B. is the author of a patent covering the fosGFP transgenic mice.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Gall CM, 1998, NEUROBIOL LEARN MEM, V70, P14, DOI 10.1006/nlme.1998.3835; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gerkin RC, 2010, J CLIN NEUROPHYSIOL, V27, P425, DOI 10.1097/WNP.0b013e3181fdf8bd; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Glazewski S, 2007, J NEUROSCI, V27, P3910, DOI 10.1523/JNEUROSCI.0181-07.2007; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ikegaya Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003983; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vijayan S, 2010, J NEUROPHYSIOL, V103, P2074, DOI 10.1152/jn.00474.2009; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wolfe J, 2010, CURR OPIN NEUROBIOL, V20, P306, DOI 10.1016/j.conb.2010.03.006; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	46	148	151	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2010	68	6					1043	1050		10.1016/j.neuron.2010.11.029	http://dx.doi.org/10.1016/j.neuron.2010.11.029			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705KT	21172607	Green Accepted, Bronze			2022-12-17	WOS:000286128000005
J	Luo, WQ; Enomoto, H; Rice, FL; Milbrandt, J; Ginty, DD				Luo, Wenqin; Enomoto, Hideki; Rice, Frank L.; Milbrandt, Jeffrey; Ginty, David D.			Molecular Identification of Rapidly Adapting Mechanoreceptors and Their Developmental Dependence on Ret Signaling	NEURON			English	Article							CUTANEOUS MECHANORECEPTORS; SENSORY NEURONS; GDNF FAMILY; RAT; EXPRESSION; NEUROPEPTIDES; AFFERENTS; RECEPTORS; CORPUSCLE; NEURTURIN	In mammals, the first step in the perception of form and texture is the activation of trigeminal or dorsal root ganglion (DRG) mechanosensory neurons, which are classified as either rapidly (RA) or slowly adapting (SA) according to their rates of adaptation to sustained stimuli. The molecular identities and mechanisms of development of RA and SA mechanoreceptors are largely unknown. We found that the "early Ret(+)" DRG neurons are RA mechanoreceptors, which form Meissner corpuscles, Pacinian corpuscles, and longitudinal lanceolate endings. The central projections of these RA mechanoreceptors innervate layers III through V of the spinal cord and terminate within discrete subdomains of the dorsal column nuclei. Moreover, mice lacking Ret signaling components are devoid of Pacinian corpuscles and exhibit a dramatic disruption of RA mechanoreceptor projections to both the spinal cord and medulla. Thus, the early Re+ neurons are RA mechanoreceptors and Ret signaling is required for the assembly of neural circuits underlying touch perception.	[Luo, Wenqin; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Enomoto, Hideki] RIKEN, Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; [Rice, Frank L.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Rice, Frank L.] Integrated Tissue Dynam LLC, Rensselaer, NY 12144 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Johns Hopkins University; RIKEN; Albany Medical College; Washington University (WUSTL)	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [NS34814, AG13730]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034814, R01NS034814, R29NS034814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thanks S. Arber and G. Fishell for providing Tau<SUP>f(mGFP)</SUP> mice, F. Wang for providing Avil<SUP>AP</SUP> mice, and M. Caterina for the TRPV3 antibody. We thank X. Dong, A. Kolodkin, R. Koerber, R. Krimm, D. Molliver, M. Caterina, and members of the Ginty laboratory for helpful discussions and comments on the manuscript. We thank M. Rutlin, Y. Liu, A. Strickland, and H. Guo for reagents and technical support. This work was supported by National Institutes of Health grants NS34814 (D.D.G.) and AG13730 (J.M.). D.D.G. is an investigator of the Howard Hughes Medical Institute.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; ALBRECHT PJ, 2008, CUTANEOUS MECH TACTI, P1; Brown AG, 1981, ORG SPINAL CORD; Carpenter M., 1983, HUMAN NEUROANATOMY; CARR PA, 1989, NEUROSCIENCE, V33, P363, DOI 10.1016/0306-4522(89)90216-9; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Darian-Smith, 1984, HDB PHYSL 2 1, V3, P789; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; DYKES RW, 1983, BRAIN RES REV, V6, P47, DOI 10.1016/0165-0173(83)90004-8; DYKES RW, 1982, J NEUROPHYSIOL, V47, P389, DOI 10.1152/jn.1982.47.3.389; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Gonzalez-Martinez T, 2005, NEUROSCI LETT, V377, P12, DOI 10.1016/j.neulet.2004.11.078; Gonzalez-Martinez T, 2004, BRAIN RES, V1002, P120, DOI 10.1016/j.brainres.2004.01.003; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Hughes DI, 2007, J NEUROSCI, V27, P2035, DOI 10.1523/JNEUROSCI.5401-06.2007; Hughes DI, 2004, BRAIN RES, V1017, P69, DOI 10.1016/j.brainres.2004.05.054; IDE C, 1976, AM J ANAT, V147, P329, DOI 10.1002/aja.1001470307; IGGO A, 1977, J PHYSIOL-LONDON, V266, P275, DOI 10.1113/jphysiol.1977.sp011768; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IGGO A, 1982, ANNU REV NEUROSCI, V5, P1, DOI 10.1146/annurev.ne.05.030182.000245; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; LAWSON SN, 1974, CELL TISSUE RES, V153, P399; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Lawson SN., 1992, MORPHOLOGICAL BIOCH; LeMaster AM, 1999, J NEUROSCI, V19, P5919, DOI 10.1523/JNEUROSCI.19-14-05919.1999; Lindahl M, 2000, MOL CELL NEUROSCI, V15, P522, DOI 10.1006/mcne.2000.0845; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; McDonagh SC, 2007, AM J PHYSIOL-GASTR L, V293, pG461, DOI 10.1152/ajpgi.00424.2006; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pare M, 2002, J COMP NEUROL, V445, P347, DOI 10.1002/cne.10196; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Perez-Pinera P, 2008, NEUROSCI LETT, V433, P43, DOI 10.1016/j.neulet.2007.12.035; Rasmusson DD, 1997, J NEUROPHYSIOL, V78, P2924, DOI 10.1152/jn.1997.78.6.2924; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; WHITSEL BL, 1969, BRAIN RES, V15, P67, DOI 10.1016/0006-8993(69)90310-2; Zelena J, 1976, Prog Brain Res, V43, P59; Zelena J, 1994, NERVES MECHANORECEPT	58	148	150	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					841	856		10.1016/j.neuron.2009.11.003	http://dx.doi.org/10.1016/j.neuron.2009.11.003			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064391	Bronze, Green Accepted			2022-12-17	WOS:000273425800011
J	Rosas-Ballina, M; Tracey, KJ				Rosas-Ballina, Mauricio; Tracey, Kevin J.			The Neurology of the Immune System: Neural Reflexes Regulate Immunity	NEURON			English	Review							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TO-BRAIN COMMUNICATION; HUMAN LYMPHOCYTE-T; VAGUS NERVE; SYMPATHETIC NEURONS; NEURITE OUTGROWTH; IMPROVES SURVIVAL; INDUCED ARTHRITIS; CELL-ACTIVATION; ALPHA-7 SUBUNIT	Parallel advances in neuroscience and immunology established the anatomical and cellular basis for bidirectional interactions between the nervous and immune systems. Like other physiological systems, the immune system-and the development of immunity-is modulated by neural reflexes. A prototypical example is the inflammatory reflex, comprised of an afferent arm that senses inflammation and an efferent arm, the cholinergic anti-inflammatory pathway, that inhibits innate immune responses. This mechanism is dependent on the alpha 7 subunit of the nicotinic acetylcholine receptor, which inhibits NF-kappa B nuclear translocation and suppresses cytokine release by monocytes and macrophages. Here we summarize evidence showing that innate immunity is reflexive. Future advances will come from applying an integrative physiology approach that utilizes methods adapted from neuroscience and immunology.	[Rosas-Ballina, Mauricio; Tracey, Kevin J.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA	Northwell Health	Tracey, KJ (corresponding author), N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.	kjtracey@nshs.edu		Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM057226, R01 GM057226-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonica A, 1996, J NEUROIMMUNOL, V64, P115, DOI 10.1016/0165-5728(95)00157-3; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BELLINGER DL, 1993, BRAIN BEHAV IMMUN, V7, P191, DOI 10.1006/brbi.1993.1021; Beresford L, 2004, IMMUNOLOGY, V111, P118, DOI 10.1111/j.1365-2567.2004.01786.x; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; BESEDOVSKY H O, 1987, Brain Behavior and Immunity, V1, P185, DOI 10.1016/0889-1591(87)90020-1; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; CASTELLUCCI VF, 1986, J PHYSIOL-PARIS, V81, P349; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Esquifino AI, 2001, BRAIN RES, V888, P227, DOI 10.1016/S0006-8993(00)03060-2; Gaspar R, 1996, BIOCHEM BIOPH RES CO, V226, P303, DOI 10.1006/bbrc.1996.1351; Goehler LE, 1997, BRAIN RES BULL, V43, P357, DOI 10.1016/S0361-9230(97)00020-8; Goehler LE, 1998, BRAIN RES, V804, P306, DOI 10.1016/S0006-8993(98)00685-4; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hansen MK, 2001, AM J PHYSIOL-REG I, V280, pR929; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Kannan Y, 1996, J IMMUNOL, V157, P313; Kannan Y, 2000, NEUROIMMUNOMODULAT, V8, P132, DOI 10.1159/000054273; KANNAN Y, 1994, J NEUROSCI RES, V37, P374, DOI 10.1002/jnr.490370309; Kannan-Hayashi Y, 2008, J IMMUNOL, V180, P4227, DOI 10.4049/jimmunol.180.6.4227; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; KLEIN RL, 1982, NEUROSCIENCE, V7, P2255, DOI 10.1016/0306-4522(82)90135-X; Krasznai Z, 2005, ARCH IMMUNOL THER EX, V53, P127; LEADERS FE, 1965, J PHARMACOL EXP THER, V147, P145; Lips KS, 2006, J MOL NEUROSCI, V30, P15, DOI 10.1385/JMN:30:1:15; Lorton D, 2009, BRAIN BEHAV IMMUN, V23, P276, DOI 10.1016/j.bbi.2008.10.004; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mignini F., 2003, Autonomic & Autacoid Pharmacology, V23, P1, DOI 10.1046/j.1474-8673.2003.00280.x; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; NAGY P, 1995, IMMUNOL LETT, V44, P91, DOI 10.1016/0165-2478(94)00198-Z; NOVOTNY GEK, 1994, ANAT REC, V238, P213, DOI 10.1002/ar.1092380208; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Shepherd AJ, 2005, IMMUNOLOGY, V116, P145, DOI 10.1111/j.1365-2567.2005.02223.x; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; SOLIVEN B, 1990, J MEMBRANE BIOL, V117, P263, DOI 10.1007/BF01868456; Straub RH, 2008, ARTHRITIS RHEUM, V58, P3450, DOI 10.1002/art.24030; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WEINREICH D, 1987, J CLIN INVEST, V79, P1529, DOI 10.1172/JCI112984; Wessler IK, 2001, PULM PHARMACOL THER, V14, P423, DOI 10.1006/pupt.2001.0313; Yang H, 1998, NEUROIMMUNOMODULAT, V5, P53, DOI 10.1159/000026326	61	148	155	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 15	2009	64	1					28	32		10.1016/j.neuron.2009.09.039	http://dx.doi.org/10.1016/j.neuron.2009.09.039			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840545	Green Accepted, Bronze			2022-12-17	WOS:000271454400007
J	Atiani, S; Elhilali, M; David, SV; Fritz, JB; Shamma, SA				Atiani, Serin; Elhilali, Mounya; David, Stephen V.; Fritz, Jonathan B.; Shamma, Shihab A.			Task Difficulty and Performance Induce Diverse Adaptive Patterns in Gain and Shape of Primary Auditory Cortical Receptive Fields	NEURON			English	Article							VISUAL-CORTEX; SELECTIVE ATTENTION; AREA V4; ORGANIZATION; NEURONS; MODULATION; MECHANISMS; PLASTICITY; SHIFT	Attention is essential for navigating complex acoustic scenes, when the listener seeks to extract a foreground source while suppressing background acoustic clutter. This study explored the neural correlates of this perceptual ability by measuring rapid changes of spectrotemporal receptive fields (STRFs) in primary auditory cortex during detection of a target tone embedded in noise. Compared with responses in the passive state, STRF gain decreased during task performance in most cells. By contrast, STRF shape changes were excitatory and specific, and were strongest in cells with best frequencies near the target tone. The net effect of these adaptations was to accentuate the representation of the target tone relative to the noise by enhancing responses of near-target cells to the tone during high-signal-to-noise ratio (SNR) tasks while suppressing responses of far-from-target cells to the masking noise in low-SNR tasks. These adaptive STRF changes were largest in high-performance sessions, confirming a close correlation with behavior.	[Atiani, Serin; Fritz, Jonathan B.; Shamma, Shihab A.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [David, Stephen V.; Fritz, Jonathan B.; Shamma, Shihab A.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Elhilali, Mounya] Johns Hopkins Univ, Dept Elect Engn, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Shamma, SA (corresponding author), Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA.	sas@umd.edu	Elhilali, Mounya/A-3396-2010; Shamma, Shihab A/F-9852-2012; Fritz, Jonathan/AAK-4863-2020	Elhilali, Mounya/0000-0003-2597-738X; David, Stephen/0000-0003-4135-3104; Fritz, Jonathan/0000-0002-0625-172X	NIH [R01-DC005779, R01-DC007657]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005779, R01DC007657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Pingbo Yin for his assistance with implant surgeries and Dr. Nima Mesgarani for technical assistance with electronics and software design. The research was supported in part by NIH (R01-DC005779 and R01-DC007657).	Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Compte A, 2006, CEREB CORTEX, V16, P761, DOI 10.1093/cercor/bhj021; Conner CE, 1997, J NEUROSCI, V17, P3201; David SV, 2008, NEURON, V59, P509, DOI 10.1016/j.neuron.2008.07.001; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Efron B., 1993, INTRO BOOTSTRAP; Elhilali M, 2007, J NEUROSCI, V27, P10372, DOI 10.1523/JNEUROSCI.1462-07.2007; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; Fritz JB, 2007, J NEUROPHYSIOL, V98, P2337, DOI 10.1152/jn.00552.2007; Heffner H.E., 1995, METHODS COMP PSYCHOA, P79; KEMP S, 1984, PERCEPT PSYCHOPHYS, V36, P473, DOI 10.3758/BF03207501; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; LABERGE D, 1991, J EXP PSYCHOL HUMAN, V17, P65, DOI 10.1037/0096-1523.17.1.65; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; Sade A, 1998, SPATIAL VISION, V11, P367, DOI 10.1163/156856898X00086; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; SPITZER H, 1991, EXP BRAIN RES, V83, P340; URBACH D, 1995, VISION RES, V35, P2169, DOI 10.1016/0042-6989(94)00305-X; Womelsdorf T, 2008, J NEUROSCI, V28, P8934, DOI 10.1523/JNEUROSCI.4030-07.2008; Yantis S., 1996, CONVERGING OPERATION, P45, DOI DOI 10.1037/10187-002	30	148	148	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 12	2009	61	3					467	480		10.1016/j.neuron.2008.12.027	http://dx.doi.org/10.1016/j.neuron.2008.12.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	408BG	19217382	Green Accepted, Bronze			2022-12-17	WOS:000263407500015
J	Shimizu, H; Watanabe, E; Hiyama, TY; Nagakura, A; Fujikawa, A; Okado, H; Yanagawa, Y; Obata, K; Noda, M				Shimizu, Hidetada; Watanabe, Eiji; Hiyama, Takeshi Y.; Nagakura, Ayano; Fujikawa, Akihiro; Okado, Haruo; Yanagawa, Yuchio; Obata, Kunihiko; Noda, Masaharu			Glial Na-x channels control lactate signaling to neurons for brain [Na+] sensing	NEURON			English	Article							SENSORY CIRCUMVENTRICULAR ORGANS; NA+,K+-ATPASE ALPHA-SUBUNIT; SENSITIVE SODIUM-CHANNEL; SUBFORNICAL ORGAN; FIRING PATTERNS; GLUCOSE-UPTAKE; NA,K-ATPASE; METABOLISM; TRANSPORT; SINGLE	Sodium (Na) homeostasis is crucial for life, and Na levels in body fluids are constantly monitored in the brain. The subfornical organ (SFO) is the center of the sensing responsible for the control of salt-intake behavior, where Na-x channels are expressed in specific glial cells as the Na-level sensor. Here, we show direct interaction between Na-x channels and alpha subunits of Na+/K+-ATPase, which brings about Na-dependent activation of the metabolic state of the glial cells. The metabolic enhancement leading to extensive lactate production was observed in the SFO of wild-type mice, but not of the Na-x-knockout mice. Furthermore, lactate, as well as Na, stimulated the activity of GABAergic neurons in the SFO. These results suggest that the information on a physiological increase of the Na level in body fluids sensed by Na-x in glial cells is transmitted to neurons by lactate as a mediator to regulate neural activities of the SFO.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; Natl Inst Basic Biol, Lab Neurophysiol, Okazaki, Aichi 4448787, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; Tokyo Metropolitan Inst Neurosci, Dept Mol Physiol, Fuchu, Tokyo 1838526, Japan; Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gunma 3718511, Japan; RIKEN, Neuronal Circuit Mechanisms Res Grp, Brain Sci Inst, Wako, Saitama 3510198, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Gunma University; RIKEN	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Hiyama, Takeshi/X-4134-2018; Noda, Masaharu/D-7146-2016	Fujikawa, Akihiro/0000-0002-3950-0550; Hiyama, Takeshi/0000-0001-8612-8707; Noda, Masaharu/0000-0002-3796-524X; Watanabe, Eiji/0000-0001-9089-8122				ANDERSSON B, 1978, PHYSIOL REV, V58, P582, DOI 10.1152/physrev.1978.58.3.582; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; COX PS, 1987, AM J PHYSIOL, V252, pR1, DOI 10.1152/ajpregu.1987.252.1.R1; Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kondo S, 1998, J PHYSIOL-LONDON, V509, P233, DOI 10.1111/j.1469-7793.1998.233bo.x; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; NOSE H, 1992, J APPL PHYSIOL, V73, P1419, DOI 10.1152/jappl.1992.73.4.1419; PARK R, 1989, BRAIN RES, V493, P123, DOI 10.1016/0006-8993(89)91006-8; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; ROSENTHAL M, 1992, CAN J PHYSIOL PHARM, V70, pS165, DOI 10.1139/y92-258; SERPERSU EH, 1984, J BIOL CHEM, V259, P7155; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Wang XQ, 2005, J NEUROCHEM, V93, P1515, DOI 10.1111/j.1471-4159.2005.03147.x; Waniewski RA, 2004, NEUROCHEM RES, V29, P209, DOI 10.1023/B:NERE.0000010450.21586.a6; Washburn DLS, 2000, J PHYSIOL-LONDON, V529, P359, DOI 10.1111/j.1469-7793.2000.00359.x; Watanabe E, 2006, AM J PHYSIOL-REG I, V290, pR568, DOI 10.1152/ajpregu.00618.2005; Watanabe E, 2000, J NEUROSCI, V20, P7743; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; WEISINGER RS, 1979, NATURE, V280, P490, DOI 10.1038/280490a0; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zouzoulas A, 2006, J BIOL CHEM, V281, P8539, DOI 10.1074/jbc.M512700200	45	148	152	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					59	72		10.1016/j.neuron.2007.03.014	http://dx.doi.org/10.1016/j.neuron.2007.03.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408578	Bronze, Green Submitted			2022-12-17	WOS:000245848400010
J	Stalnaker, TA; Franz, TM; Singh, T; Schoenbaum, G				Stalnaker, Thomas A.; Franz, Theresa M.; Singh, Teghpal; Schoenbaum, Geoffrey			Basolateral amygdala lesions abolish orbitofrontal-dependent reversal impairments	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; REWARD VALUE; BEHAVIORAL FLEXIBILITY; HIPPOCAMPAL-LESIONS; OUTCOME EXPECTANCY; ANTERIOR CINGULATE; DORSAL STRIATUM; FRONTAL-CORTEX; STIMULUS	Damage to orbitofrontal cortex (OFC) has long been associated with deficits in reversal learning. OFC damage also causes inflexible associative encoding in basolateral amygdala (ABL) during reversal learning. Here we provide a critical test of the hypothesis that the reversal deficit in OFC-lesioned rats is caused by this inflexible encoding in ABL. Rats with bilateral neurotoxic lesions of OFC, ABL, or both areas were tested on a series of two-odor go/no-go discrimination problems, followed by two serial reversals of the final problem. As expected, all groups acquired the initial problems at the same rate, and rats with OFC lesions were slower to acquire the reversals than sham controls. This impairment was abolished by accompanying ABL lesions, while ABL lesions alone had no effect on reversal learning. These results are consistent with the hypothesis that OFC facilitates cognitive flexibility by promoting updating of associative encoding in downstream brain areas.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Psychol, Catonsville, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Stalnaker, TA (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	tstal002@umaryland.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER; NIDA NIH HHS [R01-DA015718] Funding Source: Medline; NIDCD NIH HHS [T32-DC00054] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Birrell JM, 2000, J NEUROSCI, V20, P4320; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; Chudasama Y, 2003, J NEUROSCI, V23, P8771; CINELLI AR, 1987, BRAIN RES BULL, V19, P651, DOI 10.1016/0361-9230(87)90051-7; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Featherstone RE, 2004, BEHAV BRAIN RES, V150, P15, DOI 10.1016/S0166-4328(03)00218-3; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2005, EUR J NEUROSCI, V22, P2341, DOI 10.1111/j.1460-9568.2005.04434.x; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kim J, 2005, NEUROBIOL LEARN MEM, V83, P125, DOI 10.1016/j.nlm.2004.10.003; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDannald MA, 2005, J NEUROSCI, V25, P4626, DOI 10.1523/JNEUROSCI.5301-04.2005; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickens CL, 2003, J NEUROSCI, V23, P11078; PRICE JL, 1991, OLFACTION, P101; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schoenbaum G, 2003, J NEUROSCI, V23, P9833; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	69	148	151	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					51	58		10.1016/j.neuron.2007.02.014	http://dx.doi.org/10.1016/j.neuron.2007.02.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408577	Bronze			2022-12-17	WOS:000245848400009
J	Suto, F; Tsuboi, M; Kamiya, H; Mizuno, H; Kiyama, Y; Komai, S; Shimizu, M; Sanbo, M; Yagi, T; Hiromi, Y; Chedotal, A; Mitchell, KJ; Manabe, T; Fujisawa, H				Suto, Fumikazu; Tsuboi, Miu; Kamiya, Haruyuki; Mizuno, Hidenobu; Kiyama, Yuji; Komai, Shoji; Shimizu, Masayuki; Sanbo, Makoto; Yagi, Takeshi; Hiromi, Yasushi; Chedotal, Alain; Mitchell, Kevin J.; Manabe, Toshiya; Fujisawa, Hajime			Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers	NEURON			English	Article							LONG-TERM POTENTIATION; SECRETED SEMAPHORINS; DENTATE GYRUS; GUIDANCE; RECEPTORS; NEURONS; MICE; NEUROPILIN-2; GROWTH; TRANSMISSION	Hippocampal mossy fibers project preferentially to the stratum lucidum, the proximal-most lamina of the suprapyramidal region of CA3. The molecular mechanisms that govern this lamina-restricted projection are still unknown. We examined the projection pattern of mossy fibers in mutant mice for semaphorin receptors plexin-A2 and plexin-A4, and their ligand, the transmembrane semaphorin Sema6A. We found that plexin-A2 deficiency causes a shift of mossy fibers from the suprapyramidal region to the infra- and intrapyramidal regions, while plexin-A4 deficiency induces inappropriate spreading of mossy fibers within CA3. We also report that the plexin-A2 loss-of-function phenotype is genetically suppressed by Sema-6A loss of function. Based on these results, we propose a model for the lamina-restricted projection of mossy fibers: the expression of plexinA4 on mossy fibers prevents them from entering the Sema6A-expressing suprapyramidal region of CA3 and restricts them to the proximal-most part, where Sema6A repulsive activity is attenuated by plexin-A2.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century COE Program, Nagoya, Aichi 4648602, Japan; Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Dev Neurobiol, Nagoya, Aichi 4648602, Japan; Hokkaido Univ, Grad Sch Med, Dept Mol Neuroanat, Sapporo, Hokkaido 0608637, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo 1088639, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kumamoto Univ, Div Cellular Interact, Inst Embryol & Genet, Kumamoto 8600811, Japan; Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 4448585, Japan; Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France; Trinity Coll Dublin, Smufit Inst Genet, Dublin 2, Ireland	Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Nagoya University; Hokkaido University; University of Tokyo; Nara Institute of Science & Technology; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University; Graduate University for Advanced Studies - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Trinity College Dublin	Fujisawa, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century COE Program, Nagoya, Aichi 4648602, Japan.	fujisawa@bio.nagoya-u.ac.jp	Chedotal, Alain/F-2750-2017; Kamiya, Haruyuki/E-7199-2010; Komai, Shoji/L-9273-2018	Chedotal, Alain/0000-0001-7577-3794; Kamiya, Haruyuki/0000-0002-2618-3146; Komai, Shoji/0000-0002-8474-7800; Mitchell, Kevin/0000-0002-3433-4530				Amaral David G., 1995, P443; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goslin K., 1998, CULTURING NERVE CELL, P339; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pozas E, 2001, MOL CELL NEUROSCI, V18, P26, DOI 10.1006/mcne.2001.0999; Sahay A, 2003, J NEUROSCI, V23, P6671; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Skutella T, 2001, TRENDS NEUROSCI, V24, P107, DOI 10.1016/S0166-2236(00)01717-3; Stein E, 1999, J NEUROSCI, V19, P8885, DOI 10.1523/JNEUROSCI.19-20-08885.1999; Steup A, 1999, EUR J NEUROSCI, V11, P729, DOI 10.1046/j.1460-9568.1999.00517.x; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhao ST, 2003, J NEUROSCI, V23, P7351; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	40	148	157	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					535	547		10.1016/j.neuron.2007.01.028	http://dx.doi.org/10.1016/j.neuron.2007.01.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296555	Bronze			2022-12-17	WOS:000245126900012
J	Pelkey, KA; Lavezzari, G; Racca, C; Roche, KW; McBain, CJ				Pelkey, KA; Lavezzari, G; Racca, C; Roche, KW; McBain, CJ			MGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; FIBER-INTERNEURON SYNAPSES; TARGET-SPECIFIC EXPRESSION; HIPPOCAMPAL INTERNEURONS; RAT HIPPOCAMPUS; SYNAPTIC PLASTICITY; TRANSMISSION; NEURONS; ACTIVATION	Plasticity of feedforward inhibition in the hippocampal mossy fiber (MF) pathway can dramatically influence dentate gyrus-CA3 dialog. Interestingly, MF inputs to CA3 stratum lucidum interneurons (SLINs) undergo long-term depression (LTD) following high-frequency stimulation (HFS), in contrast to IVIF-pyramid (PYR) synapses, where long-term potentiation (LTP) occurs. Furthermore, activity-induced potentiation of IVIF-SLIN transmission has not previously been observed. Here we report that metabotropic glutamate receptor subtype 7 (mGluR7) is a metaplastic switch at MF-SLIN synapses, whose activation and surface expression governs the direction of plasticity. In naive slices, mGIuR7 activation during HFS generates MF-SLIN LTD, depressing presynaptic release through a PKC-dependent mechanism. Following agonist exposure, mGIuR7 undergoes internalization, unmasking the ability of IVIF-SLIN synapses to undergo presynaptic potentiation in response to the same HFS that induces LTD in naive slices. Thus, selective mGIuR7 targeting to MF terminals contacting SLINs and not PYRs provides cell target-specific plasticity and bidirectional control of feedforward inhibition.	NICHHD, Lab Cellular & Synaptic Neurophysiol, NIH, Bethesda, MD 20892 USA; NINDS, NIH, Bethesda, MD 20892 USA; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Leeds	Pelkey, KA (corresponding author), NICHHD, Lab Cellular & Synaptic Neurophysiol, NIH, Bldg 35, Bethesda, MD 20892 USA.	pelkeyk2@mail.nih.gov; mcbainc@mail.nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002994, ZIANS002994] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dev KK, 2000, J NEUROSCI, V20, P7252; Doherty J, 1998, J NEUROPHYSIOL, V79, P2903, DOI 10.1152/jn.1998.79.6.2903; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hay M, 2000, J MEMBRANE BIOL, V178, P195, DOI 10.1007/s002320010027; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Losonczy A, 2003, J NEUROPHYSIOL, V89, P1910, DOI 10.1152/jn.00842.2002; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Mundell SJ, 2003, J NEUROCHEM, V84, P294, DOI 10.1046/j.1471-4159.2003.01515.x; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, J BIOL CHEM, V277, P1223, DOI 10.1074/jbc.M109141200; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Walker HC, 2002, NEURON, V35, P161, DOI 10.1016/S0896-6273(02)00734-1; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	54	148	151	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					89	102		10.1016/j.neuron.2005.02.011	http://dx.doi.org/10.1016/j.neuron.2005.02.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820696	Bronze			2022-12-17	WOS:000228228600011
J	Thoreson, WB; Rabl, K; Townes-Anderson, E; Heidelberger, R				Thoreson, WB; Rabl, K; Townes-Anderson, E; Heidelberger, R			A highly Ca2+-sensitive pool of vesicles contributes to linearity at the rod photoreceptor ribbon synapse	NEURON			English	Article							TRANSMITTER RELEASE; GLUTAMATE RELEASE; CALCIUM-DEPENDENCE; BIPOLAR CELLS; SYNAPTOTAGMIN-III; HORIZONTAL CELLS; CHROMAFFIN CELLS; INNER SEGMENTS; SALAMANDER; EXOCYTOSIS	Studies of the properties of synaptic transmission have been carried out at only a few synapses. We analyzed exocytosis from rod photoreceptors with a combination of physiological and ultrastructural techniques. As at other ribbon synapses, we found that rods exhibited rapid kinetics of release, and the number of vesicles in the releasable pool is comparable to the number of vesicles tethered at ribbon-style active zones. However, unlike other previously studied neurons, we identified a highly Call-sensitive pool of releasable vesicles with a relatively shallow relationship between the rate of exocytosis and [Ca2+], that is nearly linear over a presumed physiological range of intra-terminal [Ca2+]. The low-order [Ca2+] dependence of release promotes a linear relationship between Ca2+ entry and exocytosis that permits rods to relay information about small changes in illumination with high fidelity at the first synapse in vision.	Univ Nebraska, Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA; Univ Med & Dent New Jersey, Dept Neurol & Neurosci, Sch Med, Newark, NJ 07103 USA; Univ Texas, Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Health Science Center Houston	Thoreson, WB (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol, 600 S 42nd St, Omaha, NE 68198 USA.	wbthores@unmc.edu	Thoreson, Wallace B./F-6172-2010	Thoreson, Wallace B./0000-0001-7104-042X; Heidelberger, Ruth/0000-0002-8033-2050	NATIONAL EYE INSTITUTE [P30EY010608, R55EY010542, R29EY012128, R01EY012031, R29EY010542, R01EY010542, R01EY012128] Funding Source: NIH RePORTER; NEI NIH HHS [R29 EY010542, R01 EY010542-08, EY-12031, EY-10608, EY-12128, EY-10542, R01 EY012128, R29 EY012128, R01 EY010542, P30 EY010608, R01 EY012031] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABE H, 1984, J ULTRA MOL STRUCT R, V86, P246, DOI 10.1016/S0022-5320(84)90104-7; Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DONNELLY DF, 1994, BIOPHYS J, V66, P873, DOI 10.1016/S0006-3495(94)80863-X; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; Heidelberger R, 2003, VISUAL NEUROSCI, V20, P37, DOI 10.1017/S095252380320105X; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Heidelberger R, 2001, REV PHYSIOL BIOCH P, V143, P1, DOI 10.1007/BFb0115592; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KIM HG, 1991, BRAIN RES, V538, P141, DOI 10.1016/0006-8993(91)90388-C; KIM HG, 1993, J NEUROPHYSIOL, V69, P352, DOI 10.1152/jn.1993.69.2.352; Kits KS, 1999, BIOPHYS J, V76, P1693, DOI 10.1016/S0006-3495(99)77328-5; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Messler P, 1996, J NEUROSCI METH, V69, P137, DOI 10.1016/S0165-0270(96)00032-5; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAKA KI, 1987, J GEN PHYSIOL, V89, P321, DOI 10.1085/jgp.89.2.321; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PIERANTONI RL, 1981, PHOTORECEPTORS, P255; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROHLICEK V, 1994, PFLUG ARCH EUR J PHY, V428, P30, DOI 10.1007/BF00374749; Rouze NC, 1998, J NEUROSCI, V18, P8614; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1329, DOI 10.1152/jn.1987.58.6.1329; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Thoreson WB, 2003, NEUROSCIENCE, V122, P785, DOI 10.1016/j.neuroscience.2003.08.012; TOWNESANDERSON E, 1985, J CELL BIOL, V100, P175, DOI 10.1083/jcb.100.1.175; TOWNESANDERSON E, 1988, J NEUROSCI, V8, P320; TRANCHINA D, 1981, P NATL ACAD SCI-BIOL, V78, P6540, DOI 10.1073/pnas.78.10.6540; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wu LG, 1999, J NEUROSCI, V19, P726; WU SM, 1985, P NATL ACAD SCI USA, V82, P3944, DOI 10.1073/pnas.82.11.3944; WU SM, 1988, VISION RES, V28, P1; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	82	148	148	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					595	605		10.1016/S0896-6273(04)00254-5	http://dx.doi.org/10.1016/S0896-6273(04)00254-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157421	Green Accepted, Bronze			2022-12-17	WOS:000221708300010
J	Chen, K; Ratzliff, A; Hilgenberg, L; Gulyas, A; Freund, TF; Smith, M; Dinh, TP; Piomelli, D; Mackie, K; Soltesz, I				Chen, K; Ratzliff, A; Hilgenberg, L; Gulyas, A; Freund, TF; Smith, M; Dinh, TP; Piomelli, D; Mackie, K; Soltesz, I			Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures	NEURON			English	Article							CB1 CANNABINOID RECEPTOR; ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOIDS; HIPPOCAMPAL SYNAPSES; GABAERGIC INTERNEURONS; INVERSE AGONIST; RAT-BRAIN; INHIBITION; ANANDAMIDE; NEURONS	Febrile (fever-induced) seizures are the most common form of childhood seizures, affecting 3%-5% of infants and young children. Here we show that the activity-dependent, retrograde inhibition of GABA release by endogenous cannabinoids is persistently enhanced in the rat hippocampus following a single episode of experimental prolonged febrile seizures during early postnatal development. The potentiation of endocannabinoid signaling results from an increase in the number of presynaptic cannabinoid type 1 receptors associated with cholecystokinin-containing perisomatic inhibitory inputs, without an effect on the endocannabinoid-mediated inhibition of glutamate release. These results demonstrate a selective, long-term increase in the gain of endocannabinoid-mediated retrograde signaling at GABAergic synapses in a model of a human neurological disease.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Soltesz, I (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	isoltesz@uci.edu	Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013	Mackie, Ken/0000-0001-8501-6199; Gulyas, Attila/0000-0003-4961-636X; Ratzliff, Anna/0000-0002-6654-8007	NIDA NIH HHS [DA00286, DA11322, DA12447, DA3412] Funding Source: Medline; NINDS NIH HHS [NS33213, NS38580] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033213, R01NS038580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012447, R01DA011322] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ameri A, 1999, BRIT J PHARMACOL, V126, P1831, DOI 10.1038/sj.bjp.0702478; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Chen HM, 2000, P NATL ACAD SCI USA, V97, P12810, DOI 10.1073/pnas.230260397; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Clement AB, 2003, J NEUROSCI, V23, P3916; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; Hampson RE, 2003, J NEUROPHYSIOL, V90, P55, DOI 10.1152/jn.01161.2002; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Katona I, 1999, J NEUROSCI, V19, P4544; Kim J, 2002, J NEUROSCI, V22, P10182; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pan XH, 1998, MOL PHARMACOL, V54, P1064, DOI 10.1124/mol.54.6.1064; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; PITLER TA, 1992, J NEUROSCI, V12, P4122; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Shinnar S, 1998, ANN NEUROL, V43, P411, DOI 10.1002/ana.410430402; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Toth Z, 1998, J NEUROSCI, V18, P4285; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Varma N, 2002, NEUROPHARMACOLOGY, V43, P550, DOI 10.1016/S0028-3908(02)00168-5; Vasquez C, 1999, J NEUROSCI, V19, P9271; Walker MC, 1999, NAT MED, V5, P871, DOI 10.1038/11308; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	48	148	155	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2003	39	4					599	611		10.1016/S0896-6273(03)00499-9	http://dx.doi.org/10.1016/S0896-6273(03)00499-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925275	Green Published, Bronze			2022-12-17	WOS:000184779500006
J	Marek, KW; Davis, GW				Marek, KW; Davis, GW			Transgenically encoded protein photoinactivation (FIAsH-FALI): Acute inactivation of synaptotagmin I	NEURON			English	Article							GROWTH CONE MOTILITY; SYNAPTIC TRANSMISSION; NEUROTRANSMITTER RELEASE; NEURITE OUTGROWTH; C2B DOMAIN; DROSOPHILA; MUTANTS; VESICLES; SECRETION; MOLECULES	We demonstrate a noninvasive technique for protein photoinactivation using a transgenically encoded tag. A tetracysteine motif that binds the membrane-permeable fluorescein derivative 4',5'-bis(1,3,2-dithioarsoIan-2-yl)fluorescein (FlAsH) was engineered into synaptotagmin I (Syt 14C). Neuronally expressed Syt 14C rescues the syt I null mutation, can be visualized after FlAsH labeling, and is normally distributed at the Drosophila neuromuscular synapse. Illumination of FlAsH bound Syt 14C at 488 nm decreases evoked release in seconds demonstrating efficient fluorophore-assisted light inactivation (FlAsH-FALl) of Syt I. The inactivation of Syt I is proportional to the duration of illumination and follows first-order kinetics. In addition, Syt I FlAsH-FALl is specific and does not impair Syt I-independent vesicle fusion. We demonstrate that Syt I is required for a post-docking step during vesicle fusion but does not function to stabilize the docked vesicle state.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem, 513 Parnassus Ave, San Francisco, CA 94143 USA.				PHS HHS [44908-32374] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Buchstaller A, 2000, MICROSC RES TECHNIQ, V48, P97, DOI 10.1002/(SICI)1097-0029(20000115)48:2<97::AID-JEMT5>3.0.CO;2-G; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Liu CWA, 1999, CELL MOTIL CYTOSKEL, V43, P232, DOI 10.1002/(SICI)1097-0169(1999)43:3<232::AID-CM6>3.0.CO;2-7; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Reist NE, 1998, J NEUROSCI, V18, P7662; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Takei K, 1999, J NEUROSCI, V19, P9469; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2	35	148	153	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					805	813		10.1016/S0896-6273(02)01068-1	http://dx.doi.org/10.1016/S0896-6273(02)01068-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467585	Bronze			2022-12-17	WOS:000179667800006
J	Zenisek, D; Steyer, JA; Feldman, ME; Almers, W				Zenisek, D; Steyer, JA; Feldman, ME; Almers, W			A membrane marker leaves synaptic vesicles in milliseconds after exocytosis in retinal bipolar cells	NEURON			English	Article							NEUROTRANSMITTER RELEASE; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; FAST ENDOCYTOSIS; FUSION PORE; KINETICS; RIBBON; KISS; FLUORESCENCE; TRANSPORT	Perhaps synaptic vesicles can recycle so rapidly because they avoid complete exocytosis, and release transmitter through a fusion pore that opens transiently. This view emerges from imaging whole terminals where the fluorescent lipid FM1-43 seems unable to leave vesicles during transmitter release. Here we imaged single, FM1-43-stained synaptic vesicles by evanescent field fluorescence microscopy, and tracked the escape of dye from single vesicles by watching the increase in fluorescence after exocytosis. Dye left rapidly and completely during most or all exocytic events. We conclude that vesicles at this terminal allow lipid exchange soon after exocytosis, and lose their dye even if they connected with the plasma membrane only briefly. At the level of single vesicles, therefore, observations with FM1-43 provide no evidence that exocytosis of synaptic vesicles is incomplete.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Calif Berkeley, Dept Biol, Berkeley, CA 94720 USA; Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Oregon Health & Science University; University of California System; University of California Berkeley; Cornell University; Yale University	Almers, W (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.	almersw@ohsu.edu	Zenisek, David/C-6555-2011; 李, 应辉/A-7739-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060600] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60600] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BLOOM JA, 1983, BIOPHYS J, V42, P295, DOI 10.1016/S0006-3495(83)84397-5; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Crank J., 1970, MATH DIFFUSION; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GINGELL D, 1979, BIOPHYS J, V26, P507, DOI 10.1016/S0006-3495(79)85268-6; Gomis A, 1999, J NEUROSCI, V19, P6309; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSL, V207, P623; HELLEN EH, 1988, SPECTROSCOPIC MEMBRA, P47; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JACOBSON K, 1981, BIOCHEMISTRY-US, V20, P5268, DOI 10.1021/bi00521a027; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kavalali ET, 1999, PHILOS T ROY SOC B, V354, P337, DOI 10.1098/rstb.1999.0385; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; MELDOLESI J, 1981, PHILOS T ROY SOC B, V296, P55, DOI 10.1098/rstb.1981.0171; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TORRITARELLI F, 1985, J CELL BIOL, V101, P1386, DOI 10.1083/jcb.101.4.1386; TSE FW, 1993, J CELL BIOL, V121, P543, DOI 10.1083/jcb.121.3.543; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; VALTORTA F, 1990, NEUROSCIENCE, V35, P477, DOI 10.1016/0306-4522(90)90323-V; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	59	148	151	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1085	1097		10.1016/S0896-6273(02)00896-6	http://dx.doi.org/10.1016/S0896-6273(02)00896-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354398	Bronze			2022-12-17	WOS:000178040000009
J	Giraud, AL; Price, CJ; Graham, JM; Truy, E; Frackowiak, RSJ				Giraud, AL; Price, CJ; Graham, JM; Truy, E; Frackowiak, RSJ			Cross-modal plasticity underpins language recovery after cochlear implantation	NEURON			English	Article							AUDITORY-CORTEX; CEREBRAL-CORTEX; VISUAL AREAS; SPEECH; ACTIVATION; HUMANS; COMPENSATION; RECRUITMENT; ATTENTION; MOVEMENTS	Postlingually deaf subjects learn the meaning of sounds after cochlear implantation by forming new associations between sounds and their sources. Implants generate coarse frequency responses, preventing place-coding fine enough to discriminate sounds with similar temporal characteristics, e.g., buck/duck. This limitation imposes a dependency on visual cues, e.g., lipreading. We hypothesized that cross-modal facilitation results from engagement of the visual cortex by purely auditory tasks. In four functional neuroimaging experiments, we show recruitment of early visual cortex (V1/V2) when cochlear implant users listen to sounds with eyes closed. Activity in visual cortex evolved in a stimulus-specific manner as a function of time from implantation reflecting experience-dependent adaptations in the postimplant phase.	Goethe Univ Frankfurt, Dept Physiol, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Neurol, D-60590 Frankfurt, Germany; Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Royal Natl Throat Nose & Ear Hosp, Cochlear Implant Programme, London WC1X 8DA, England; Hop Edouard Herriot, F-69003 Lyon, France	Goethe University Frankfurt; Goethe University Frankfurt; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; CHU Lyon	Giraud, AL (corresponding author), Goethe Univ Frankfurt, Dept Physiol, D-60590 Frankfurt, Germany.	giraud@em.uni-frankfurt.de	Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; truy, eric/J-9097-2017	Frackowiak, Richard/0000-0002-3151-822X; truy, eric/0000-0002-1769-8623; Price, Catherine/0000-0001-7448-4835	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Campbell R, 1998, SCAND AUDIOL, V27, P80, DOI 10.1080/010503998420694; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Giraud AL, 2000, BRAIN, V123, P1391, DOI 10.1093/brain/123.7.1391; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; MacSweeney M, 2000, NEUROREPORT, V11, P1729, DOI 10.1097/00001756-200006050-00026; McIntosh AR, 1998, J NEUROPHYSIOL, V80, P2790, DOI 10.1152/jn.1998.80.5.2790; MIDDELWEERD MJ, 1987, J ACOUST SOC AM, V82, P2145, DOI 10.1121/1.395659; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; Nishimura H, 2000, NEUROREPORT, V11, P811, DOI 10.1097/00001756-200003200-00031; Puce A, 1998, J NEUROSCI, V18, P2188; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Tyler RS, 1997, OTOLARYNG HEAD NECK, V117, P180, DOI 10.1016/S0194-5998(97)70172-4; Tyler RS, 1997, J ACOUST SOC AM, V102, P508, DOI 10.1121/1.419724; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Weeks R, 2000, J NEUROSCI, V20, P2664	27	148	151	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					657	663		10.1016/S0896-6273(01)00318-X	http://dx.doi.org/10.1016/S0896-6273(01)00318-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430800	Bronze			2022-12-17	WOS:000169508900007
J	Delgado, R; Maureira, C; Oliva, C; Kidokoro, Y; Labarca, P				Delgado, R; Maureira, C; Oliva, C; Kidokoro, Y; Labarca, P			Size of vesicle pools, rates of mobilization, and recycling at neuromuscular synapses of a Drosophila mutant, shibire	NEURON			English	Article							SYNAPTIC VESICLES; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; JUNCTION; ENDOCYTOSIS; EXOCYTOSIS; MEMBRANE; MUSCLES; BOUTONS; LARVAE	Two vesicle pools, readily releasable (RRP) and reserve (RP) pools, are present at Drosophila neuromuscular junctions. Using a temperature-sensitive mutant, shibire(ts), we studied pool sizes and vesicle mobilization rates. In shibire(ts), due to lack of endocytosis at nonpermissive temperatures, synaptic currents continuously declined during tetanic stimulation until they ceased as the result of vesicle depletion. By then, similar to 84,000 quanta were released. Vesicles were mobilized from RP at a rate 1/7-1/10 of RRP. Cytochalasin D inhibited mobilization of vesicles from RP, allowing us to estimate the size of RRP as 14%-19% of all vesicles. Vesicle recycling supports synaptic transmission during prolonged tetanic stimulation and the maximum recycling rate was 1000 vesicles/s.	Ctr Estudios Cient, Valdivia, Chile; Univ Chile, Fac Ciencias, Escuele Postgrad, Santiago, Chile; Gunma Univ, Sch Med, Maebashi, Gumma 3718511, Japan	Universidad de Chile; Gunma University	Labarca, P (corresponding author), Ctr Estudios Cient, Arturo Prat 514, Valdivia, Chile.	plabarca@cecs.cl	Oliva, Carolina/AAF-3887-2019	Oliva, Carolina/0000-0002-5917-9856; Maureira, Carlos/0000-0002-2245-9053				Acharya JK, 1998, NEURON, V20, P1219, DOI 10.1016/S0896-6273(00)80502-4; Atwood H. L., 1997, Invertebrate Neuroscience, V3, P81, DOI 10.1007/BF02480362; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Estes PS, 1996, J NEUROSCI, V16, P5443; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 1999, J NEUROSCI, V19, P1557; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PLERIBONE VA, 1995, NATURE, V375, P493; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Smith TW, 1998, ANN BEHAV MED, V20, P243, DOI 10.1007/BF02886373; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZIMMERMANN H, 1977, NEUROSCIENCE, V2, P715, DOI 10.1016/0306-4522(77)90025-2; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	29	148	153	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					941	953		10.1016/S0896-6273(00)00165-3	http://dx.doi.org/10.1016/S0896-6273(00)00165-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163278	Bronze			2022-12-17	WOS:000166057500028
J	Zhou, C; Qiu, YH; Pereira, FA; Crair, MC; Tsai, SY; Tsai, MJ				Zhou, C; Qiu, YH; Pereira, FA; Crair, MC; Tsai, SY; Tsai, MJ			The nuclear orphan receptor COUP-TFI is required for differentiation of subplate neurons and guidance of thalamocortical axons	NEURON			English	Article							PROMOTER TRANSCRIPTION FACTOR; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; CORTICAL DEVELOPMENT; VISUAL-CORTEX; HUMAN BRAIN; CELLS; MOUSE; CONNECTIONS; EXPRESSION	Chicken ovalbumin upstream promotor-transcription factor I (COUP-TFI), an orphan member of the nuclear receptor superfamily, is highly expressed in the developing nervous systems. In the cerebral cortex of Coup-tfl mutants, cortical layer IV was absent due to excessive cell death, a consequence of the failure of thalamocortical projections. Moreover, subplate neurons underwent improper differentiation and premature cell death during corticogenesis. Our results indicate that the subplate neuron defects lead to the failure of guidance and innervation of thalamocortical projections. Thus, our findings demonstrate a critical role of the subplate in early corticothalamic connectivity and confirm the importance of afferent innervation for the survival of layer IV neurons. These results also substantiate COUP-TFI as an important regulator of neuronal development and differentiation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tsai, SY (corresponding author), RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA.	stsai@bcm.tmc.edu; mtsai@bcm.tmc.edu		Pereira, Fred/0000-0003-2100-0280				AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.ne.17.030194.001153; ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531; BERRY M, 1965, J ANAT, V99, P691; BLOOM FE, 1993, ARCH GEN PSYCHIAT, V50, P224; Brodmann K., 1909, LOKALISATIONSLEHRE G; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GHOSH A, 1993, DEVELOPMENT, V117, P1031; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Jones EG, 1995, CIBA F SYMP, V193, P277; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; KAGEYAMA GH, 1993, J COMP NEUROL, V335, P123, DOI 10.1002/cne.903350109; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; KOSTOVIC I, 1974, ANAT REC, V178, P395; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Miller B, 1991, CEREB CORTEX, V1, P241, DOI 10.1093/cercor/1.3.241; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molnar Z, 1998, J NEUROSCI, V18, P5746; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Park HT, 1997, BRAIN RES, V747, P332, DOI 10.1016/S0006-8993(96)01320-0; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Price DJ, 1996, J NEUROSCI, V16, P3247; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; Rodriguez JC, 1997, BIOCHEM J, V326, P587, DOI 10.1042/bj3260587; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Sawaya BE, 1996, J BIOL CHEM, V271, P23572, DOI 10.1074/jbc.271.38.23572; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; Windrem MS, 1991, CEREB CORTEX, V1, P230, DOI 10.1093/cercor/1.3.230; ZAHS KR, 1985, J COMP NEUROL, V241, P210, DOI 10.1002/cne.902410208	51	148	150	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1999	24	4					847	859		10.1016/S0896-6273(00)81032-6	http://dx.doi.org/10.1016/S0896-6273(00)81032-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624948	Bronze			2022-12-17	WOS:000084495300013
J	Renstrom, E; Ding, WG; Bokvist, K; Rorsman, P				Renstrom, E; Ding, WG; Bokvist, K; Rorsman, P			Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin	NEURON			English	Article							PANCREATIC B-CELLS; ADRENAL CHROMAFFIN CELLS; FREE CA-2+ CONCENTRATION; G-PROTEIN; ACTION-POTENTIALS; CALCIUM CURRENTS; CA2+ CHANNELS; OKADAIC ACID; RELEASE; MEMBRANE	Neurotransmitters and hormones such as somatostatin, galanin, and adrenalin reduce insulin secretion. Their inhibitory action involves direct interference with the exocytotic machinery. We have examined the molecular processes underlying this effect using high resolution measurements of cell capacitance. Suppression of exocytosis was maximal at concentrations that did not cause complete inhibition of glucose-stimulated electrical activity. This action was dependent on activation of G proteins but was not associated with inhibition of the voltage-dependent Ca2+ currents or adenylate cyclase activity. The molecular processes initiated by the agonists culminate in the activation of the Ca2+-dependent protein phosphatase calcineurin, and suppression of the activity of this enzyme abolishes their action on exocytosis. We propose that mechanisms similar to those we report here may contribute to adrenergic and peptidergic inhibition of secretion in other neuroendocrine cells and in nerve terminals.			Renstrom, E (corresponding author), NOVO NORDISK AS,DEPT ISLET CELL PHYSIOL,SYMB SCI PK,FRUEBJERGVEJ 3,DK-2100 COPENHAGEN,DENMARK.		Rorsman, Patrik/A-4331-2016; Tuluc, Petronel/C-2527-2011	Rorsman, Patrik/0000-0001-7578-0767; 				AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BOKVIST K, 1991, BIOSCIENCE REP, V11, P147, DOI 10.1007/BF01182483; CHEN C, 1992, GROWTH REGULAT, V2, P167; CHEN C, 1994, TRENDS ENDOCRIN MET, V5, P227, DOI 10.1016/1043-2760(94)P3080-Q; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COOK DL, 1982, DIABETES, V31, P985, DOI 10.2337/diabetes.31.11.985; DEBUYSER A, 1991, PFLUG ARCH EUR J PHY, V419, P131, DOI 10.1007/BF00372998; DREWS G, 1990, ENDOCRINOLOGY, V126, P1646, DOI 10.1210/endo-126-3-1646; DREWS G, 1994, MOL CELL ENDOCRINOL, V105, P97, DOI 10.1016/0303-7207(94)90040-X; ENAN E, 1992, PESTIC SCI, V37, P21; GALINDO E, 1992, P NATL ACAD SCI USA, V89, P7398, DOI 10.1073/pnas.89.16.7398; GILLISON SL, 1994, INSULIN SECRETION PA, P287; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOMAIDAN FR, 1991, P NATL ACAD SCI USA, V88, P8744, DOI 10.1073/pnas.88.19.8744; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWELL SL, 1991, TXB DIABETES, P72; HSU WH, 1991, J BIOL CHEM, V266, P837; ISHIBASHI H, 1995, J NEUROPHYSIOL, V74, P1028, DOI 10.1152/jn.1995.74.3.1028; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KEAHEY HH, 1990, AM J PHYSIOL, V357, pC1171; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; NILSSON T, 1989, J BIOL CHEM, V264, P973; NILSSON T, 1988, J BIOL CHEM, V263, P1855; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; RORSMAN P, 1988, J GEN PHYSIOL, V91, P223, DOI 10.1085/jgp.91.2.223; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; RORSMAN P, 1986, J PHYSIOL-LONDON, V374, P531, DOI 10.1113/jphysiol.1986.sp016096; SAKURA H, 1995, DIABETOLOGIA, V38, pA111; SEAQUIST ER, 1992, DIABETES, V41, P1390, DOI 10.2337/diabetes.41.11.1390; SHARP GWG, 1989, J BIOL CHEM, V264, P7302; SWAIN JE, 1991, J NEUROBIOL, V22, P855, DOI 10.1002/neu.480220806; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; ULLRICH S, 1989, FEBS LETT, V247, P401, DOI 10.1016/0014-5793(89)81379-1; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WAHLANDER K, 1991, WENNER GREN INT S SE, V8, P237	48	148	149	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					513	522		10.1016/S0896-6273(00)80183-X	http://dx.doi.org/10.1016/S0896-6273(00)80183-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816714	Bronze			2022-12-17	WOS:A1996VJ44000017
J	Schafer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R				Schafer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R			Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wld(s) mice	NEURON			English	Article							NERVE GROWTH-FACTOR; SCIATIC-NERVE; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; PERIPHERAL-NERVES; MESSENGER-RNA; REGENERATION; NGF; LOCALIZATION; MACROPHAGES	The myelin-associated glycoprotein (MAG) has been shown to be inhibitory for certain neurons in vitro (Mukhopadhyay et al., 1994; McKerracher et al., 1994). To investigate whether MAG is an inhibitory component in peripheral myelin in vivo, MAG-deficient mutant mice were cross-bred with C57BL/Wld(s) mice that have delayed lesion-induced myelin degeneration and axon regrowth. While in crushed nerves of C57BL/Wld(s) mice expressing MAG, only 16% of myelin sheaths were associated with regrowing axons, this number was doubled in MAG-deficient C57BL/Wld(s) mice. These observations suggest that the absence of MAG may contribute to the improved axonal regrowth in the double mutants. Therefore, degeneration of MAG-containing myelin might be an important prerequisite to optimize axonal regrowth after peripheral nerve injury.	SWISS FED INST TECHNOL, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich			Fruttiger, Marcus/C-1899-2008; Montag, Dirk/D-3925-2014	Montag, Dirk/0000-0002-4964-1330; Martini, Rudolf/0000-0002-5463-5592; Fruttiger, Marcus/0000-0002-6962-5485				ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BARTSCH U, 1995, GLIA, V14, P115, DOI 10.1002/glia.440140206; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; BROWN MC, 1991, EUR J NEUROSCI, V3, P1366, DOI 10.1111/j.1460-9568.1991.tb00069.x; DAVID S, 1995, J NEUROSCI RES, V42, P594, DOI 10.1002/jnr.490420417; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FRUTTIGER M, 1995, J NEUROCYTOL, V24, P1, DOI 10.1007/BF01370156; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; FUNAKOSHI H, 1993, BIOCHEM BIOPH RES CO, V194, P1317; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HALL SM, 1993, J NEUROCYTOL, V22, P480, DOI 10.1007/BF01181567; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; MARTINI R, 1990, J NEUROCYTOL, V19, P601, DOI 10.1007/BF01257247; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; RAIVICH G, 1991, NEURON, V7, P151, DOI 10.1016/0896-6273(91)90083-C; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202; ZHANG Y, 1995, J COMP NEUROL, V361, P210, DOI 10.1002/cne.903610203	31	148	150	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1107	1113		10.1016/S0896-6273(00)80137-3	http://dx.doi.org/10.1016/S0896-6273(00)80137-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663987	Bronze			2022-12-17	WOS:A1996UU11800008
J	DEFREITAS, MF; YOSHIDA, CK; FRAZIER, WA; MENDRICK, DL; KYPTA, RM; REICHARDT, LF				DEFREITAS, MF; YOSHIDA, CK; FRAZIER, WA; MENDRICK, DL; KYPTA, RM; REICHARDT, LF			IDENTIFICATION OF INTEGRIN ALPHA(3)BETA-1 AS A NEURONAL THROMBOSPONDIN RECEPTOR MEDIATING NEURITE OUTGROWTH	NEURON			English	Article							CELL-ADHESION RECEPTORS; ARG-GLY-ASP; BASEMENT-MEMBRANES; LAMININ RECEPTOR; GENE FAMILY; IV COLLAGEN; LINE PC12; PROTEIN; ALPHA-3-BETA-1; EXPRESSION	Thrombospondins are a family of extracellular matrix proteins expressed throughout the developing nervous system that promote neurite outgrowth in vitro and help mediate the migration of granule cells across the molecular layer in explants of neonatal cerebellum. The receptors mediating these interactions have not previously been identified. In this study, monoclonal antibodies raised to the integrin alpha(3) beta(1) heterodimer are shown to inhibit neurite outgrowth by rat sympathetic neurons on thrombospondin-1. alpha(3) beta(1) is found to be expressed on the cell body, neurites, and growth cones of sympathetic neurons in vitro and on sympathetic axons passing through the thrombospondin-rich outer sheath of the superior cervical ganglion in vivo, consistent with its role in mediating axon outgrowth. A receptor-ligand binding assay is used to demonstrate the direct binding of immunopurified alpha(3) beta(1) to thrombospondin-1. These results demonstrate a direct interaction between the integrin alpha(3) beta(1) and thrombospondin-1, which mediates neurite outgrowth in vitro and is likely to mediate the same interactions in vivo.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard Medical School			Kypta, Robert/F-7699-2011	Kypta, Robert/0000-0002-2389-310X	NATIONAL EYE INSTITUTE [T32EY007120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER; NEI NIH HHS [EY07120] Funding Source: Medline; NIGMS NIH HHS [T32 GM07449] Funding Source: Medline; NINDS NIH HHS [NS19090] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; BOTTENSTEIN JE, 1980, EXP CELL RES, V125, P183, DOI 10.1016/0014-4827(80)90202-5; CARTER WG, 1981, CELL, V65, P599; CHAN BMC, 1993, J CELL BIOL, V120, P537, DOI 10.1083/jcb.120.2.537; DECURTIS I, 1991, J CELL BIOL, V113, P405, DOI 10.1083/jcb.113.2.405; DEDHAR S, 1992, J BIOL CHEM, V267, P18908; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; DIXIT VM, 1984, J BIOL CHEM, V259, P100; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; Frazier WA, 1991, CURR OPIN CELL BIOL, V3, P792, DOI 10.1016/0955-0674(91)90052-Z; GEHLSEN KR, 1989, J BIOL CHEM, V264, P19034; GEHLSEN KR, 1988, SCIENCE, V241, P1228, DOI 10.1126/science.2970671; HARLOW E, 1988, ANTIBODIES LABORATOR; Hawrot E, 1979, Methods Enzymol, V58, P574; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; KIRCHHOFER D, 1990, J BIOL CHEM, V285, P615; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417; MENDRICK DL, 1993, LAB INVEST, V69, P690; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; PRATER CA, 1991, J CELL BIOL, V112, P1031, DOI 10.1083/jcb.112.5.1031; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; SYMINGTON BE, 1993, J CELL BIOL, V120, P525; TAMURA RN, 1991, P NATL ACAD SCI USA, V88, P10183, DOI 10.1073/pnas.88.22.10183; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TOMASELLI KJ, 1988, J CELL BIOL, V107, P1241, DOI 10.1083/jcb.107.3.1241; TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880; TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6; TURNER DC, 1989, J NEUROSCI, V9, P3287; TUSZYNSKI GP, 1989, EXP CELL RES, V182, P473, DOI 10.1016/0014-4827(89)90251-6; VOS HL, 1992, J BIOL CHEM, V267, P12192; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; YABKOWITZ R, 1993, J IMMUNOL, V151, P149	48	148	148	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1995	15	2					333	343		10.1016/0896-6273(95)90038-1	http://dx.doi.org/10.1016/0896-6273(95)90038-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR426	7544141	Bronze			2022-12-17	WOS:A1995RR42600011
J	WILLIAMS, BP; PRICE, J				WILLIAMS, BP; PRICE, J			EVIDENCE FOR MULTIPLE PRECURSOR CELL-TYPES IN THE EMBRYONIC RAT CEREBRAL-CORTEX	NEURON			English	Article							MEDIATED GENE-TRANSFER; CHICKEN OPTIC TECTUM; RECOMBINANT RETROVIRUS; LINEAGE ANALYSIS; NERVOUS-SYSTEM; DIFFERENTIATION; PROGENITOR; DISPERSION; DIVISION; INVITRO	Cell lineage studies of the rat cerebral cortex suggest that by midneurogenesis, most precursor cells of the ventricular zone are specified to produce a single cell type. Yet there is also evidence for multipotential precursor cells. We used a retroviral vector to follow the developmental potential of cortical precursor cells by labeling cortical cells in cultures from embryos between 12 and 18 days of gestation. We found specified precursor cells as early as embryonic day 12, in addition to bipotential cells that generate neurons and astrocytes. Most importantly, we discovered a type of neural precursor cell, a neuroepithelial cell, that predominates earlier in development, differs distinctly from the specified precursor cells, and as a population, appears to be multipotential. These data suggest that corticogenesis progresses from an early phase dominated by neuroepithelial cells to a rater phase characterized by multiple populations of specified precursor cells.	NATL INST MED RES,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research			Price, Jack/G-9510-2011	Williams, Brenda Patricia/0000-0003-4690-5932				BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GRAY GE, 1992, DEVELOPMENT, V114, P271; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; GROVE EA, 1993, DEVELOPMENT, V17, P553; HAJIHOSSEINI M, 1993, EMBO J, V12, P4969, DOI 10.1002/j.1460-2075.1993.tb06190.x; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; LEBER SM, 1993, J NEUROSCI, V10, P255; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PARNEVELAS JG, 1992, CEREB CORTEX, V1, P463; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAEDLER E, 1980, ANAT EMBRYOL, V7, P253; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TOHAYAMA T, 1991, J COMP NEUROL, V310, P285; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9	29	148	151	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1995	14	6					1181	1188		10.1016/0896-6273(95)90265-1	http://dx.doi.org/10.1016/0896-6273(95)90265-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RF987	7605631	Bronze			2022-12-17	WOS:A1995RF98700009
J	UMBACH, JA; ZINSMAIER, KE; EBERLE, KK; BUCHNER, E; BENZER, S; GUNDERSEN, CB				UMBACH, JA; ZINSMAIER, KE; EBERLE, KK; BUCHNER, E; BENZER, S; GUNDERSEN, CB			PRESYNAPTIC DYSFUNCTION IN DROSOPHILA CSP MUTANTS	NEURON			English	Article							LARVAL NEUROMUSCULAR-JUNCTION; ESCHERICHIA-COLI DNAJ; NEUROTRANSMITTER RELEASE; SYNAPTIC FUNCTION; SYNAPTOTAGMIN; EXOCYTOSIS; MELANOGASTER; HOMOLOGS; PROTEINS	Cysteine string proteins are synapse-specific proteins. In Drosophila, csp deletion mutants exhibit temperature-sensitive paralysis and early death. Here, we report that neuromuscular transmission is impaired presynaptically in these csp mutant larvae. At 22 degrees C, evoked transmitter release is depressed relative to wild type and rescued controls, and high frequency stimulation of the nerve leads to sporadic failures. At 30 degrees C, stimulus-evoked responses decline gradually before failing completely. When the temperature is returned to 22 degrees C, evoked responses recover. Spontaneous release events persist at both 22 degrees C and 30 degrees C. Since nerve conduction and postsynaptic sensitivity are unaffected, these data indicate that csp mutations disrupt depolarization-secretion coupling. This disruption explains the cellular basis of the temperature-sensitive paralysis of these organisms.	CALTECH,DIV BIOL,PASADENA,CA 91125; THEODOR BOVERI INST BIOWISSENSCH,D-97074 WURZBURG,GERMANY	California Institute of Technology	UMBACH, JA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT MOLEC & MED PHARMACOL,LOS ANGELES,CA 90024, USA.							ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2539; BRANTON WD, 1987, J NEUROSCI, V7, P4195; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIANTONIO WM, 1994, NEURON, V12, P909; GINSBORG BL, 1976, HDB EXPT PHARM, P229; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OHKI R, 1992, J BIOL CHEM, V267, P13180; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; SILVER PA, 1993, CELL, V74, P5, DOI 10.1016/0092-8674(93)90287-Z; SINGH S, 1990, J EXP BIOL, V152, P59; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TRIMBLE V, 1991, ANN REV NEUROSCI, V14, P93; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	32	148	148	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					899	907		10.1016/0896-6273(94)90255-0	http://dx.doi.org/10.1016/0896-6273(94)90255-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946336				2022-12-17	WOS:A1994PP53300012
J	RAYMOND, PA; BARTHEL, LK; ROUNSIFER, ME; SULLIVAN, SA; KNIGHT, JK				RAYMOND, PA; BARTHEL, LK; ROUNSIFER, ME; SULLIVAN, SA; KNIGHT, JK			EXPRESSION OF ROD AND CONE VISUAL PIGMENTS IN GOLDFISH AND ZEBRAFISH - A RHODOPSIN-LIKE GENE IS EXPRESSED IN CONES	NEURON			English	Article							COLOR-VISION; MONOCLONAL-ANTIBODIES; POECILIA-RETICULATA; BRACHYDANIO-RERIO; BOVINE RHODOPSIN; OUTER SEGMENTS; PHOTORECEPTORS; SEQUENCE; POLYMORPHISM; EVOLUTION	The primary purpose of the present study was to determine whether a rhodopsin-like gene, which has been postulated to represent the green cone pigment in several species, is in fact expressed in cone photoreceptors instead of rods. The expression patterns of rod opsin and blue and red cone opsins were also examined in both goldfish and zebrafish retinas using colorimetric in situ hybridization. The results demonstrate that the rhodopsin-like gene is expressed in green cones, as predicted. A subset of small cones that do not hybridize with these cRNA probes are tentatively identified as ultraviolet receptors. The results also demonstrate that opsin message in cones is restricted to the perinuclear region, whereas in rods, it is both perinuclear and adjacent to the ellipsoid.	UNIV MICHIGAN,NEUROSCI PROGRAM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	RAYMOND, PA (corresponding author), UNIV MICHIGAN,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109, USA.			KNIGHT, JENNY/0000-0002-0041-5500; Raymond, Pamela/0000-0003-1083-5530				APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; ARAKI M, 1984, CELL STRUCT FUNCT, V9, P1, DOI 10.1247/csf.9.1; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; BOWMAKER JK, 1987, VISION RES, V27, P2101, DOI 10.1016/0042-6989(87)90124-6; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; BRIDGES CDB, 1970, VISION RES, V10, P1315, DOI 10.1016/0042-6989(70)90084-2; COHEN AI, 1972, HDB SENSORY PHYSIOLO, V7, P63; CRESCITELLI F, 1977, J PHYSIOL-LONDON, V268, P559, DOI 10.1113/jphysiol.1977.sp011872; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; FALK JD, 1987, PROGR RETINAL RES, V7, P89; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; HASHRYSHYN CW, 1988, VIS NEUROSCI, V8, P81; HAWRYSHYN CW, 1991, VISION RES, V31, P567, DOI 10.1016/0042-6989(91)90107-G; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HISATOMI O, 1991, BIOCHEM BIOPH RES CO, V174, P1125, DOI 10.1016/0006-291X(91)91537-M; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; LEVINE JS, 1979, SENS PROCESS, V3, P95; LYALL AH, 1957, Q J MICROSC SCI, V98, P101; MARC RE, 1976, VISION RES, V16, P1211, DOI 10.1016/0042-6989(76)90044-4; MARC RE, 1976, SCIENCE, V191, P487, DOI 10.1126/science.1246634; MCGINNIS JF, 1992, J NEUROSCI RES, V31, P584, DOI 10.1002/jnr.490310325; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; NEUMEYER C, 1985, NATURWISSENSCHAFTEN, V72, P162, DOI 10.1007/BF00490410; NEUMEYER C, 1986, J COMP PHYSIOL A, V158, P203, DOI 10.1007/BF01338563; OHTSUKA T, 1990, EXP EYE RES, V50, P483, DOI 10.1016/0014-4835(90)90036-T; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; RAYMOND PA, 1985, J COMP NEUROL, V236, P90, DOI 10.1002/cne.902360108; Sambrook J., 1989, MOL CLONING LAB MANU; STELL WK, 1976, VISION RES, V16, P647, DOI 10.1016/0042-6989(76)90013-4; TABATA M, 1982, COMP BIOCHEM PHYS A, V73, P125; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; TOKUNAGA F, 1990, BIOCHEM BIOPH RES CO, V173, P1212, DOI 10.1016/S0006-291X(05)80915-5; TRAVIS DS, 1988, VISION RES, V28, P481, DOI 10.1016/0042-6989(88)90170-8; TSIN ATC, 1981, VISION RES, V21, P943, DOI 10.1016/0042-6989(81)90196-6; WALLS GL, 1967, VERTEBRATE EYE ITS A; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; YOKOYAMA R, 1990, VISION RES, V30, P807, DOI 10.1016/0042-6989(90)90049-Q; ZILLES K, 1983, CELL TISSUE RES, V229, P423; [No title captured]	53	148	150	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1161	1174		10.1016/0896-6273(93)90064-X	http://dx.doi.org/10.1016/0896-6273(93)90064-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318234	Green Submitted			2022-12-17	WOS:A1993LK37300016
J	WAGNER, KR; COHEN, JB; HUGANIR, RL				WAGNER, KR; COHEN, JB; HUGANIR, RL			THE 87K-POSTSYNAPTIC MEMBRANE-PROTEIN FROM TORPEDO IS A PROTEIN-TYROSINE KINASE SUBSTRATE HOMOLOGOUS TO DYSTROPHIN	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; POSTSYNAPTIC 43-KDA PROTEIN; MARMORATA ELECTRIC ORGAN; CULTURED MUSCLE-CELLS; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; MONOCLONAL-ANTIBODIES; ALKALINE TREATMENT; LEUCINE ZIPPER; RICH MEMBRANES	Postsynaptic peripheral membrane proteins at the neuromuscular junction have been proposed to participate in the immobilization of the nicotinic acetylcholine receptor at the synapse. An 87 kd cytoplasmic peripheral membrane protein has been demonstrated to colocalize with the nicotinic acetylcholine receptor in the Torpedo electric organ and at the mammalian neuromuscular junction. We have cloned the cDNA encoding the 87K protein from Torpedo electric organ, and the predicted protein sequence is homologous to the C-terminal domains of dystrophin, the protein product of the Duchenne muscular dystrophy gene. The 87K protein displays a restricted pattern of expression detected only in electric organ, brain, and skeletal muscle. Analysis of the in vitro and in vivo phosphorylation of the 87K protein indicates that it is multiply phosphorylated on serine, threonine, and tyrosine residues. The 87K protein is in a complex with other proteins associated with the post-synaptic membrane, including dystrophin and a 58 kd protein. These results suggest that the 87K protein is involved in the formation and stability of synapses and is regulated by protein phosphorylation.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	WAGNER, KR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NINDS NIH HHS [NS 24418, NS 29343] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024418, P01NS029343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; BALDWIN TJ, 1988, DEVELOPMENT, V104, P557; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BERG JM, 1990, J BIOL CHEM, V265, P6513; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BRIDGMAN PC, 1989, J CELL BIOL, V105, P1829; BUCKLAND R, 1989, NATURE, V338, P547, DOI 10.1038/338547a0; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; CHANG HW, 1989, J BIOL CHEM, V264, P20831; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FOX GQ, 1978, J COMP NEUROL, V179, P677, DOI 10.1002/cne.901790313; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1987, P NATL ACAD SCI USA, V84, P6302, DOI 10.1073/pnas.84.17.6302; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; FROEHNER SC, 1989, FEBS LETT, V249, P229, DOI 10.1016/0014-5793(89)80629-5; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; HARLOW E, 1988, ANTIBODIES LABORATOR; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1984, P NATL ACAD SCI USA, V81, P6963; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P5995; KRAMARCY NR, 1990, FEBS LETT, V274, P171, DOI 10.1016/0014-5793(90)81356-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEMAIRE C, 1988, EMBO J, V7, P4517; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; MUSIL LS, 1989, J CELL BIOL, V108, P1833, DOI 10.1083/jcb.108.5.1833; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1982, J NEUROSCI, V2, P1760; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; ROUSSELET A, 1981, BIOCHIM BIOPHYS ACTA, V648, P169, DOI 10.1016/0005-2736(81)90032-8; Sambrook J., 1989, MOL CLONING LAB MANU; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SEALOCK R, 1991, J CELL BIOL, V113, P1133, DOI 10.1083/jcb.113.5.1133; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER K, 1991, J BIOL CHEM, V266, P23784; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	69	148	148	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					511	522		10.1016/0896-6273(93)90338-R	http://dx.doi.org/10.1016/0896-6273(93)90338-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461138				2022-12-17	WOS:A1993KU90100015
J	ZHENG, F; GALLAGHER, JP				ZHENG, F; GALLAGHER, JP			METABOTROPIC GLUTAMATE RECEPTORS ARE REQUIRED FOR THE INDUCTION OF LONG-TERM POTENTIATION	NEURON			English	Article							DORSOLATERAL SEPTAL NEURONS; AMINO-ACID RECEPTOR; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; PHOSPHOINOSITIDE HYDROLYSIS; INDUCED HYPERPOLARIZATIONS; STRIATAL NEURONS; XENOPUS OOCYTES; LATERAL SEPTUM; TRANS-ACPD	Recent observations have led to the suggestion that the metabotropic glutamate receptor may play a role in the induction or maintenance of long-term potentiation (LTP). However, experimental evidence supporting a role for this receptor in the induction of LTP is still inconclusive and controversial. Here we report that, in rat dorsolateral septal nucleus (DLSN) neurons, which have the highest density of metabotropic receptors and show functional responses, the induction of LTP is not blocked by the NMDA receptor antagonist 2-amino-5-phosphonovalerate, but is blocked by two putative metabotropic glutamate receptor antagonists, L-2-amino-3-phosphonopropionic acid and L-2-amino-4-phosphonobutyrate. Furthermore, superfusion of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid, a selective metabotropic glutamate agonist, resulted in a long-lasting potentiation of synaptic transmission similar to that induced by tetanic stimuli. Our results demonstrated that activation of post-synaptic metabotropic receptors is both necessary and sufficient for the induction of LTP in the DLSN, and we suggest that such a mechanism may be important at other CNS synapses.			ZHENG, F (corresponding author), UNIV TEXAS, MED BRANCH, DEPT PHARMACOL & TOXICOL, GALVESTON, TX 77550 USA.		Zheng, Fang/J-1400-2016	Zheng, Fang/0000-0002-6626-1938	NIMH NIH HHS [MH39163] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039163] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CHA JHJ, 1990, NEUROSCI LETT, V113, P78, DOI 10.1016/0304-3940(90)90498-X; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; EVANS RH, 1982, BRIT J PHARMACOL, V75, P65, DOI 10.1111/j.1476-5381.1982.tb08758.x; FANG Z, 1992, EUR J PHARMACOL, V211, P281, DOI 10.1016/0014-2999(92)90542-C; GALLAGHER JP, 1989, J PHYSIOL-LONDON, V418, P367, DOI 10.1113/jphysiol.1989.sp017846; GOH JW, 1989, SCIENCE, V244, P980, DOI 10.1126/science.2543072; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HASUO H, 1990, J NEUROPHYSIOL, V64, P1838, DOI 10.1152/jn.1990.64.6.1838; HASUO H, 1988, NEUROSCI LETT, V86, P77, DOI 10.1016/0304-3940(88)90186-3; IRVING AJ, 1990, EUR J PHARMACOL, V186, P363, DOI 10.1016/0014-2999(90)90462-F; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; IZUMI Y, 1991, NEUROSCI LETT, V122, P187, DOI 10.1016/0304-3940(91)90854-M; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MAILLEUX P, 1991, BRAIN RES, V539, P203, DOI 10.1016/0006-8993(91)91622-8; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MANZONI O, 1990, MOL PHARMACOL, V38, P1; MANZONI OJJ, 1991, EUR J PHARM-MOLEC PH, V207, P231; MCGUINNESS N, 1991, EUR J PHARMACOL, V197, P231, DOI 10.1016/0014-2999(91)90529-Y; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; OTANI S, 1991, EUR J PHARMACOL, V205, P325, DOI 10.1016/0014-2999(91)90920-L; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; RACINE RJ, 1983, BRAIN RES, V260, P217, DOI 10.1016/0006-8993(83)90676-5; REYMANN KG, 1989, NEUROSCI LETT, V98, P166, DOI 10.1016/0304-3940(89)90504-1; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SCHOEPP DD, 1989, J NEUROCHEM, V53, P1865, DOI 10.1111/j.1471-4159.1989.tb09254.x; SCHOEPP DD, 1991, J NEUROCHEM, V56, P1789, DOI 10.1111/j.1471-4159.1991.tb02082.x; SCHOEPP DD, 1991, EUR J PHARM-MOLEC PH, V207, P351, DOI 10.1016/0922-4106(91)90010-F; SCHOEPP DD, 1988, J NEUROCHEM, V50, P1605, DOI 10.1111/j.1471-4159.1988.tb03050.x; SCHOEPP DD, 1990, MOL PHARMACOL, V38, P222; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; STEVENS DR, 1984, BRAIN RES, V305, P353, DOI 10.1016/0006-8993(84)90441-4; STEVENS DR, 1991, BRAIN RES, V558, P120, DOI 10.1016/0006-8993(91)90726-C; STEVENS DR, 1987, SYNAPSE, V1, P184, DOI 10.1002/syn.890010206; SWANSON LW, 1980, BRAIN RES, V197, P207, DOI 10.1016/0006-8993(80)90446-1; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; VANDENHOOFF P, 1989, BRAIN RES, V505, P181, DOI 10.1016/0006-8993(89)91440-6; WATSON GB, 1990, EUR J PHARMACOL, V179, P479, DOI 10.1016/0014-2999(90)90194-B; WONG LA, 1989, NATURE, V341, P439, DOI 10.1038/341439a0; ZHENG F, 1991, NEUROSCI LETT, V125, P147, DOI 10.1016/0304-3940(91)90013-J	51	148	153	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					163	172		10.1016/0896-6273(92)90231-2	http://dx.doi.org/10.1016/0896-6273(92)90231-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352982				2022-12-17	WOS:A1992JE75600017
J	WIMPEY, TL; CHAVKIN, C				WIMPEY, TL; CHAVKIN, C			OPIOIDS ACTIVATE BOTH AN INWARD RECTIFIER AND A NOVEL VOLTAGE-GATED POTASSIUM CONDUCTANCE IN THE HIPPOCAMPAL-FORMATION	NEURON			English	Article							RAT HIPPOCAMPUS; GUINEA-PIG; NEURONS; BINDING; OPIATE; PEPTIDES; CALCIUM; ENKEPHALINS; INHIBITION; RECEPTORS	Opioid receptors were found to activate two different types of membrane potassium conductance in acutely dissociated neurons from the CA1/subiculum regions of the adult rat hippocampal formation. Opioid-responsive neurons were distinguished based on their morphology and electrophysiological responses. In one population of neurons having a multipolar, nonpyramidal cell shape, mu-selective opioid agonists increased an inward rectifying potassium current. Opioid activation of the inward rectifying conductance resulted in small outward potassium currents at resting membrane potentials and increased inward currents at hyperpolarized potentials. In a second population of nonpyramidal neurons, mu-opioid agonists increased a novel voltage-gated potassium current. This current was blocked by internal CsCl2, unaffected by external BaCl2 or CdCl2, irreversibly activated by intracellular GTP-gamma-S, and inactivated by sustained depolarization. In contrast to the inward rectifying conductance, the voltage-gated conductance was not activated at resting membrane potentials or hyperpolarized potentials. The opioid-activated, voltage-gated conductance represents a new class of G protein-regulated potassium current in the brain.			WIMPEY, TL (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195, USA.		Chavkin, Charles/G-2797-2010		NIDA NIH HHS [DA-04123] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004123] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ATTALI B, 1989, J BIOL CHEM, V264, P347; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; CHANG KJ, 1983, J PHARMACOL EXP THER, V227, P403; CRAIN BJ, 1986, J COMP NEUROL, V246, P170, DOI 10.1002/cne.902460203; CRAIN SM, 1990, TRENDS NEUROSCI, V11, P78; DINGLEDINE R, 1980, J NEUROSCI METH, V2, P323, DOI 10.1016/0165-0270(80)90002-3; DOERNER D, 1988, J NEUROSCI, V8, P4069; FINCH DM, 1988, J NEUROSCI, V8, P2213; FINCH DM, 1983, BRAIN RES, V271, P201, DOI 10.1016/0006-8993(83)90283-4; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KOSTERLITZ HW, 1980, BRIT J PHARMACOL, V68, P333, DOI 10.1111/j.1476-5381.1980.tb10422.x; LEE HK, 1980, BRAIN RES, V184, P331, DOI 10.1016/0006-8993(80)90802-1; LOOSE MD, 1990, BRAIN RES, V513, P15, DOI 10.1016/0006-8993(90)91084-T; MACDONALD RL, 1986, J PHYSIOL-LONDON, V377, P237, DOI 10.1113/jphysiol.1986.sp016184; MADISON DV, 1988, J PHYSIOL-LONDON, V398, P123, DOI 10.1113/jphysiol.1988.sp017033; MCLEAN S, 1987, J COMP NEUROL, V255, P497, DOI 10.1002/cne.902550403; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; NEUMAIER JF, 1989, BRAIN RES, V493, P292, DOI 10.1016/0006-8993(89)91164-5; NUMANN RE, 1987, J PHYSIOL-LONDON, V393, P331, DOI 10.1113/jphysiol.1987.sp016826; SEGAL M, 1986, J NEUROPHYSIOL, V55, P751, DOI 10.1152/jn.1986.55.4.751; SURPRENANT A, 1988, PROC R SOC SER B-BIO, V234, P85, DOI 10.1098/rspb.1988.0039; TATSUMI H, 1990, J NEUROSCI, V10, P1675; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; WAGNER JJ, 1990, NEUROSCIENCE, V37, P45, DOI 10.1016/0306-4522(90)90190-F; WERZ MA, 1983, NEUROSCI LETT, V42, P173, DOI 10.1016/0304-3940(83)90402-0; WILLIAMS JT, 1988, J NEUROSCI, V8, P4299; WIMPEY TL, 1990, NEUROSCI LETT, V110, P349, DOI 10.1016/0304-3940(90)90872-7; WUARIN JP, 1990, NEUROSCIENCE, V36, P291, DOI 10.1016/0306-4522(90)90426-5; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	30	148	154	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					281	289		10.1016/0896-6273(91)90363-5	http://dx.doi.org/10.1016/0896-6273(91)90363-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1993123				2022-12-17	WOS:A1991EY70900010
J	JACOBS, JR; HIROMI, Y; PATEL, NH; GOODMAN, CS				JACOBS, JR; HIROMI, Y; PATEL, NH; GOODMAN, CS			LINEAGE, MIGRATION, AND MORPHOGENESIS OF LONGITUDINAL GLIA IN THE DROSOPHILA CNS AS REVEALED BY A MOLECULAR LINEAGE MARKER	NEURON			English	Article											JACOBS, JR (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT BIOCHEM,BERKELEY,CA 94720, USA.			jacobs, j roger/0000-0002-5878-5416; Patel, Nipam/0000-0003-4328-654X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTAVANISTSAKONAS S, 1988, TRENDS GENET, V4, P95, DOI 10.1016/0168-9525(88)90096-0; BASTIANI MJ, 1986, J NEUROSCI, V6, P3542; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CARROLL SB, 1985, CELL, V43, P47, DOI 10.1016/0092-8674(85)90011-X; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DEAROLF DR, 1989, GENES DEV, V3, P384; DOE CQ, 1985, DEV BIOL, V111, P193, DOI 10.1016/0012-1606(85)90445-2; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; JACOBS JR, 1989, IN PRESS J NEUROSCI; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; ROBERTSON HM, 1988, GENETICS, V118, P461; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHEDL P, 1978, CELL, V14, P921, DOI 10.1016/0092-8674(78)90346-X; SEIFERT HS, 1986, P NATL ACAD SCI USA, V83, P735, DOI 10.1073/pnas.83.3.735; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; Slizynska H, 1938, GENETICS, V23, P291; TECHNAU GM, 1986, ROUX ARCH DEV BIOL, V195, P445, DOI 10.1007/BF00375748; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5	26	148	148	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1989	2	6					1625	1631						7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC665	2576376				2022-12-17	WOS:A1989AC66500012
J	Francois, A; Low, SA; Sypek, EI; Christensen, AJ; Sotoudeh, C; Beier, KT; Ramakrishnan, C; Ritola, KD; Sharif-Naeini, R; Deisseroth, K; Delp, SL; Malenka, RC; Luo, LQ; Hantman, AW; Scherrer, G				Francois, Amaury; Low, Sarah A.; Sypek, Elizabeth I.; Christensen, Amelia J.; Sotoudeh, Chaudy; Beier, Kevin T.; Ramakrishnan, Charu; Ritola, Kimberly D.; Sharif-Naeini, Reza; Deisseroth, Karl; Delp, Scott L.; Malenka, Robert C.; Luo, Liqun; Hantman, Adam W.; Scherrer, Gregory			A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins	NEURON			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; SUBSTANTIA-GELATINOSA NEURONS; PREPROENKEPHALIN MESSENGER-RNA; GAMMA-AMINOBUTYRIC-ACID; SUPERFICIAL DORSAL-HORN; MU-OPIOID RECEPTORS; MET-ENKEPHALIN; IN-VIVO; PRESYNAPTIC INHIBITION; MOLECULAR-MECHANISMS	Pain thresholds are, in part, set as a function of emotional and internal states by descending modulation of nociceptive transmission in the spinal cord. Neurons of the rostral ventromedial medulla (RVM) are thought to critically contribute to this process; however, the neural circuits and synaptic mechanisms by which distinct populations of RVM neurons facilitate or diminish pain remain elusive. Here we used in vivo opto/chemogenetic manipulations and trans-synaptic tracing of genetically identified dorsal horn and RVM neurons to uncover an RVM-spinal cord-primary afferent circuit controlling pain thresholds. Unexpectedly, we found that RVM GABAergic neurons facilitate mechanical pain by inhibiting dorsal horn enkephalinergic/GABAergic interneurons. We further demonstrate that these interneurons gate sensory inputs and control pain through temporally coordinated enkephalin-and GABA-mediated presynaptic inhibition of somatosensory neurons. Our results uncover a descending disynaptic inhibitory circuit that facilitates mechanical pain, is engaged during stress, and could be targeted to establish higher pain thresholds.	[Francois, Amaury; Low, Sarah A.; Sypek, Elizabeth I.; Sotoudeh, Chaudy; Scherrer, Gregory] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Dept Mol & Cellular Physiol, Dept Neurosurg,Stanford Neurosci Inst, Stanford, CA 94305 USA; [Christensen, Amelia J.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Beier, Kevin T.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Beier, Kevin T.; Malenka, Robert C.] Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Ramakrishnan, Charu] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ritola, Kimberly D.] Howard Hughes Med Inst, Virus Serv, Janelia Res Campus, Ashburn, VA 20147 USA; [Sharif-Naeini, Reza] McGill Univ, Dept Physiol, Montreal, PQ H3G 0B1, Canada; [Sharif-Naeini, Reza] McGill Univ, Cell Informat Syst Grp, Montreal, PQ H3G 0B1, Canada; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Dept Bioengn, Howard Hughes Med Inst,CNC Program, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Dept Bioengn, Stanford, CA 94305 USA; [Hantman, Adam W.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; McGill University; McGill University; Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute	Scherrer, G (corresponding author), Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Dept Mol & Cellular Physiol, Dept Neurosurg,Stanford Neurosci Inst, Stanford, CA 94305 USA.	gs25@stanford.edu	Core, Vector/CAF-4832-2022	Delp, Scott/0000-0002-9643-7551; sypek, elizabeth/0000-0001-6904-2426; Beier, Kevin/0000-0002-4934-1338; LOW, SARAH/0000-0002-3847-2965; Francois, Amaury/0000-0003-1171-7974; Scherrer, Gregory/0000-0002-1983-5126; Christensen, Amelia/0000-0002-0082-4822; Luo, Liqun/0000-0001-5467-9264	NIH/NIDA [DA031777]; Rita Allen Foundation; American Pain Society award; Stanford Dean's fellowship; HHMI medical research fellowship; NDSEG fellowship; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Rita Allen Foundation; American Pain Society award; Stanford Dean's fellowship; HHMI medical research fellowship; NDSEG fellowship; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH/NIDA grant DA031777 (G.S.), a Rita Allen Foundation and American Pain Society award (G.S.), a Stanford Dean's fellowship (A.F.), an HHMI medical research fellowship (S.A.L.), a NDSEG fellowship (E.I.S), and HHMI (K.D.R. and A.W.H.). We thank Dr. Carmen Birchmeier for the TLX3 and PAX2 antibodies, Dr. Brigitte Kieffer for providing MOR-mCherry mice, and Dr. Peter Schiller for providing Tipp-psi.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; Baker KB, 2010, EXP NEUROL, V226, P259, DOI 10.1016/j.expneurol.2010.08.019; BARBARO NM, 1986, BRAIN RES, V366, P203, DOI 10.1016/0006-8993(86)91296-5; Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Bardoni R, 2013, ANN NY ACAD SCI, V1279, P90, DOI 10.1111/nyas.12056; BASBAUM AI, 1976, P NATL ACAD SCI USA, V73, P4685, DOI 10.1073/pnas.73.12.4685; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; BELIN MF, 1983, BRAIN RES, V275, P329, DOI 10.1016/0006-8993(83)90994-0; Bellchambers CE, 1998, NEUROSCIENCE, V83, P517, DOI 10.1016/S0306-4522(97)00399-0; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Bourane S, 2015, CELL, V160, P503, DOI 10.1016/j.cell.2015.01.011; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Budai D, 1998, J NEUROPHYSIOL, V79, P677, DOI 10.1152/jn.1998.79.2.677; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2014, NEUROSCIENCE, V260, P47, DOI 10.1016/j.neuroscience.2013.12.008; Christensen AJ, 2016, CELL REP, V17, P1699, DOI 10.1016/j.celrep.2016.10.010; COMB M, 1982, NATURE, V295, P663, DOI 10.1038/295663a0; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Eckert WA, 2002, J PAIN, V3, P115, DOI 10.1054/jpai.2002.122946; Erbs E, 2015, BRAIN STRUCT FUNCT, V220, P677, DOI 10.1007/s00429-014-0717-9; FIELDS HL, 1983, NATURE, V306, P684, DOI 10.1038/306684a0; FIELDS HL, 1983, J NEUROSCI, V3, P2545; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Goetz L, 2016, J NEUROSCI, V36, P4917, DOI 10.1523/JNEUROSCI.2514-15.2016; GREVERT P, 1978, SCIENCE, V199, P1093, DOI 10.1126/science.343250; GRUDT TJ, 1994, J NEUROSCI, V14, P1646, DOI 10.1523/JNEUROSCI.14-03-01646.1994; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; HAWKINS KN, 1989, J PHARMACOL EXP THER, V248, P73; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HEINRICHER MM, 1992, NEUROSCIENCE, V48, P533, DOI 10.1016/0306-4522(92)90400-V; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3081, DOI 10.1073/pnas.74.7.3081; Huang J, 2008, ANAT REC, V291, P1334, DOI 10.1002/ar.20755; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; Jennings EM, 2014, PROG NEUROBIOL, V121, P1, DOI 10.1016/j.pneurobio.2014.06.003; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; Katzel D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4847; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu T, 2015, NEUROSCI LETT, V584, P390, DOI 10.1016/j.neulet.2014.11.008; Lu Y, 2007, J PHYSIOL-LONDON, V582, P127, DOI 10.1113/jphysiol.2007.131565; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marinelli S, 2002, J NEUROSCI, V22, P10847; Marvizon JCG, 2009, J COMP NEUROL, V517, P51, DOI 10.1002/cne.22130; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; Mende M, 2016, NEURON, V90, P1189, DOI 10.1016/j.neuron.2016.05.008; MICZEK KA, 1987, PSYCHOPHARMACOLOGY, V92, P444; NORTH MA, 1978, LIFE SCI, V22, P295, DOI 10.1016/0024-3205(78)90136-4; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Palyo SA, 2005, PAIN, V117, P121, DOI 10.1016/j.pain.2005.05.028; Pedersen NP, 2011, J NEUROPHYSIOL, V106, P731, DOI 10.1152/jn.01062.2010; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Petitjean H, 2015, CELL REP, V13, P1246, DOI 10.1016/j.celrep.2015.09.080; POHL M, 1994, J NEUROCHEM, V63, P1226; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; POTREBIC SB, 1994, J NEUROSCI, V14, P1655, DOI 10.1523/JNEUROSCI.14-03-01655.1994; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI [10.1586/ern.09.34, 10.1586/ERN.09.34]; RALSTON HJ, 1979, J NEUROCYTOL, V8, P151, DOI 10.1007/BF01175558; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; REICHLING DB, 1990, J COMP NEUROL, V302, P370, DOI 10.1002/cne.903020213; RIBEIRODASILVA A, 1989, J COMP NEUROL, V281, P497, DOI 10.1002/cne.902810402; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; SCHILLER PW, 1993, J MED CHEM, V36, P3182, DOI 10.1021/jm00073a020; Schreiter A, 2012, FASEB J, V26, P5161, DOI 10.1096/fj.12-208678; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; SEYBOLD V, 1980, J HISTOCHEM CYTOCHEM, V28, P367, DOI 10.1177/28.4.6154731; SKAGERBERG G, 1985, NEUROSCIENCE, V15, P445, DOI 10.1016/0306-4522(85)90225-8; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; TODD AJ, 1993, PROG NEUROBIOL, V41, P609, DOI 10.1016/0301-0082(93)90045-T; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Uusisaari M, 2011, CEREBELLUM, V10, P637, DOI 10.1007/s12311-010-0240-3; Van Dort CJ, 2015, P NATL ACAD SCI USA, V112, P584, DOI 10.1073/pnas.1423136112; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0; YAKSH TL, 1977, NEUROSCIENCE, V2, P593, DOI 10.1016/0306-4522(77)90055-0; YAKSH TL, 1983, BRAIN RES, V268, P119, DOI 10.1016/0006-8993(83)90396-7; YAMAMOTO T, 1993, PAIN, V54, P79, DOI 10.1016/0304-3959(93)90102-U; YOSHIMURA M, 1983, NATURE, V305, P529, DOI 10.1038/305529a0; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; ZEMLAN FP, 1988, BRAIN RES, V453, P89, DOI 10.1016/0006-8993(88)90146-1; Zhao ZQ, 2014, NEURON, V84, P821, DOI 10.1016/j.neuron.2014.10.003; ZHUO M, 1990, PAIN, V42, P337, DOI 10.1016/0304-3959(90)91147-B; Zhuo M, 2016, TRENDS NEUROSCI, V39, P136, DOI 10.1016/j.tins.2016.01.006	94	147	155	1	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 22	2017	93	4					822	+		10.1016/j.neuron.2017.01.008	http://dx.doi.org/10.1016/j.neuron.2017.01.008			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO1AE	28162807	Green Accepted, Bronze			2022-12-17	WOS:000396429100013
J	Amunts, K; Ebell, C; Muller, J; Telefont, M; Knoll, A; Lippert, T				Amunts, Katrin; Ebell, Christoph; Muller, Jeff; Telefont, Martin; Knoll, Alois; Lippert, Thomas			The Human Brain Project: Creating a European Research Infrastructure to Decode the Human Brain	NEURON			English	Editorial Material							SIMULATION	Decoding the human brain is perhaps the most fascinating scientific challenge in the 21st century. The Human Brain Project (HBP), a 10-year European Flagship, targets the reconstruction of the brain's multiscale organization. It uses productive loops of experiments, medical, data, data analytics, and simulation on all levels that will eventually bridge the scales. The HBP IT architecture is unique, utilizing cloud-based collaboration and development platforms with databases, workflow systems, petabyte storage, and supercomputers. The HBP is developing toward a European research infrastructure advancing brain research, medicine, and brain-inspired information technology.	[Amunts, Katrin] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany; [Amunts, Katrin] Univ Dusseldorf, Univ Hosp Dusseldorf, C & O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany; [Ebell, Christoph; Muller, Jeff; Telefont, Martin] EPFL, Human Brain Project, Campus Biotech,Batiment B1,Chemin Mines 9, CH-1202 Geneva, Switzerland; [Knoll, Alois] Tech Univ Munich, Inst Informat 6, Boltzmannstr 3, D-85748 Garching, Germany; [Lippert, Thomas] Forschungszentrum Julich, Inst Adv Simulat, Julich Supercomp Ctr, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Technical University of Munich; Helmholtz Association; Research Center Julich	Amunts, K (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany.; Amunts, K (corresponding author), Univ Dusseldorf, Univ Hosp Dusseldorf, C & O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany.	k.amunts@fz-juelich.de	Knoll, Alois/AAN-8417-2021; Amunts, Katrin/I-3470-2013	Knoll, Alois/0000-0003-4840-076X; Ebell, Christoph/0000-0001-9959-3771; Amunts, Katrin/0000-0001-5828-0867				Amunts K, 2014, NEUROIMAGE, V99, P525, DOI 10.1016/j.neuroimage.2014.06.010; Christen M., 2016, AJOB NEUROSCI, V7, P5, DOI DOI 10.1080/21507740.2015.1135831; Eyal G, 2016, ELIFE, V5, DOI 10.7554/eLife.16553; Farisco M, 2015, CURR TOP BEHAV NEURO, V19, P205, DOI 10.1007/7854_2014_338; Friedmann S., 2016, IEEE T BIOMED CIRC S, P1; Furber S, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/5/051001; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Kunkel S, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00078; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Nair AG, 2015, J NEUROSCI, V35, P14017, DOI 10.1523/JNEUROSCI.0730-15.2015; Papp EA, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00011; Probst D, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00013; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Richter C., 2016, ARXIV160104862; Venetis T, 2015, LECT N BIOINFORMAT, V9162, P28, DOI 10.1007/978-3-319-21843-4_3; Vogelstein JT, 2016, NEURON, V92, P622, DOI 10.1016/j.neuron.2016.10.033; Walter F, 2015, NEURAL NETWORKS, V72, P152, DOI 10.1016/j.neunet.2015.07.004; Zehl L, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00026; Zenke F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7922	19	147	155	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 2	2016	92	3					574	581		10.1016/j.neuron.2016.10.046	http://dx.doi.org/10.1016/j.neuron.2016.10.046			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA6TU	27809997	Green Published, Bronze			2022-12-17	WOS:000386762700007
J	Mieda, M; Ono, D; Hasegawa, E; Okamoto, H; Honma, K; Honma, S; Sakurai, T				Mieda, Michihiro; Ono, Daisuke; Hasegawa, Emi; Okamoto, Hitoshi; Honma, Ken-ichi; Honma, Sato; Sakurai, Takeshi			Cellular Clocks in AVP Neurons of the SCN Are Critical for Interneuronal Coupling Regulating Circadian Behavior Rhythm	NEURON			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; MOUSE SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; IN-VITRO; PERIPHERAL-TISSUES; PERIOD GENE; MICE; CELLS; PROKINETICIN-2; VASOPRESSIN	The suprachiasmatic nucleus (SCN), the primary circadian pacemaker in mammals, is a network structure composed of multiple types of neurons. Here, we report that mice with a Bmal1 deletion specific to arginine vasopressin (AVP)-producing neurons showed marked lengthening in the free-running period and activity time of behavior rhythms. When exposed to an abrupt 8-hr advance of the light/dark cycle, these mice reentrained faster than control mice did. In these mice, the circadian expression of genes involved in intercellular communications, including Avp, Prokineticin 2, and Rgs16, was drastically reduced in the dorsal SCN, where AVP neurons predominate. In slices, dorsal SCN cells showed attenuated PER2::LUC oscillation with highly variable and lengthened periods. Thus, Bmal1-dependent oscillators of AVP neurons may modulate the coupling of the SCN network, eventually coupling morning and evening behavioral rhythms, by regulating expression of multiple factors important for the network property of these neurons.	[Mieda, Michihiro; Hasegawa, Emi; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan; [Ono, Daisuke] Hokkaido Univ, Grad Sch Med, Photon Bioimaging Sect, Res Ctr Cooperat Projects,Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Honma, Ken-ichi; Honma, Sato] Hokkaido Univ, Grad Sch Med, Dept Chronomed, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Okamoto, Hitoshi] RIKEN Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan	Kanazawa University; Hokkaido University; Hokkaido University; RIKEN	Mieda, M (corresponding author), Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	mieda@med.kanazawa-u.ac.jp	Hasegawa, Emi/L-4939-2015; Okamoto, Hitoshi/P-9767-2015	Hasegawa, Emi/0000-0003-3020-1949; Okamoto, Hitoshi/0000-0002-7512-8549; Mieda, Michihiro/0000-0002-2451-7034; Honma, Sato/0000-0003-2874-0732	JSPS [20390056, 24390052]; MEXT of Japan [25126708]; HFSP; Takeda Science Foundation; Cabinet Office, Government of Japan [LS048]; JSPS Research Fellowship for Young Scientists; Grants-in-Aid for Scientific Research [24390052] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); HFSP(Human Frontier Science Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cabinet Office, Government of Japan; JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research (B) (20390056, 24390052) and for Scientific Research on Innovative Areas (25126708) from JSPS and MEXT of Japan; by a Career Development Award from the HFSP; by the Takeda Science Foundation (M.M.); by the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers" (LS048) (T.S.); and by the JSPS Research Fellowship for Young Scientists (E.H.). We thank N.G. Copeland for recombineering reagents; R. Sprengel for iCre cDNA; J. Takeda for p23loxZeo;	Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Aschoff, 1965, CIRCADIAN CLOCKS, P95; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Aton SJ, 2004, J BIOL RHYTHM, V19, P198, DOI 10.1177/0748730404264156; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CASTEL M, 1990, J COMP NEUROL, V298, P172, DOI 10.1002/cne.902980204; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chou TC, 2003, J NEUROSCI, V23, P10691; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hallbeck M, 1999, J COMP NEUROL, V411, P181; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hasegawa E, 2014, J CLIN INVEST, V124, P604, DOI 10.1172/JCI71017; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Li JD, 2009, AM J PHYSIOL-REG I, V296, pR824, DOI 10.1152/ajpregu.90463.2008; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masumoto K, 2006, EUR J NEUROSCI, V23, P2959, DOI 10.1111/j.1460-9568.2006.04834.x; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mickman CT, 2008, AM J PHYSIOL-REG I, V295, pR1688, DOI 10.1152/ajpregu.90510.2008; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Molyneux PC, 2008, BRAIN RES, V1228, P127, DOI 10.1016/j.brainres.2008.05.091; Muschamp JW, 2014, P NATL ACAD SCI USA, V111, pE1648, DOI 10.1073/pnas.1315542111; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schone C, 2014, CELL REP, V7, P697, DOI 10.1016/j.celrep.2014.03.055; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	58	147	153	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2015	85	5					1103	1116		10.1016/j.neuron.2015.02.005	http://dx.doi.org/10.1016/j.neuron.2015.02.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD8AZ	25741730	Green Submitted, Bronze			2022-12-17	WOS:000351318900020
J	Keller, PJ; Ahrens, MB				Keller, Philipp J.; Ahrens, Misha B.			Visualizing Whole-Brain Activity and Development at the Single-Cell Level Using Light-Sheet Microscopy	NEURON			English	Review							FLUORESCENCE MICROSCOPY; NEURONAL POPULATIONS; CALCIUM; FIELD; RECONSTRUCTION; RESOLUTION; CIRCUIT; SCALE; DYNAMICS; INTERROGATION	The nature of nervous system function and development is inherently global, since all components eventually influence one another. Networks communicate through dense synaptic, electric, and modulatory connections and develop through concurrent growth and interlinking of their neurons, processes, glia, and blood vessels. These factors drive the development of techniques capable of imaging neural signaling, anatomy, and developmental processes at ever-larger scales. Here, we discuss the nature of questions benefitting from large-scale imaging techniques and introduce recent applications. We focus on emerging light-sheet microscopy approaches, which are well suited for live imaging of large systems with high spatiotemporal resolution and over long periods of time. We also discuss computational methods suitable for extracting biological information from the resulting system-level image data sets. Together with new tools for reporting and manipulating neuronal activity and gene expression, these techniques promise new insights into the large-scale function and development of neural systems.	[Keller, Philipp J.; Ahrens, Misha B.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Keller, PJ (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	kellerp@janelia.hhmi.org; ahrensm@janelia.hhmi.org		Keller, Philipp/0000-0003-2896-4920	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Timothy Dunn, Joseph Fetcho, Jeremy Freeman, Katie McDole, Minoru Koyama, Burkhard Hockendorf, James Truman, and the anonymous reviewers for valuable comments on the manuscript; the authors of Broxton et al. (2013), Dodt et al. (2007), Heckscher et al. (2014), Holekamp et al. (2008), Panier et al. (2013), Prevedel et al. (2014), Portugues et al. (2014), Quirin et al. (2014), Susaki et al. (2014), Tomer et al. (2014), and Wu et al. (2013) for kindly providing figure materials for reproduction in this work; and Logan Grosenick, Michael Broxton, and Karl Deisseroth for sharing figure materials prior to publication. This work was supported by the Howard Hughes Medical Institute.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Baumgart E, 2012, OPT EXPRESS, V20, P21805, DOI 10.1364/OE.20.021805; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bourgenot C, 2012, OPT EXPRESS, V20, P13252, DOI 10.1364/OE.20.013252; Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Broxton M, 2013, OPT EXPRESS, V21, P25418, DOI 10.1364/OE.21.025418; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chao DL, 2009, NAT REV NEUROSCI, V10, P262, DOI 10.1038/nrn2594; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; DOWSKI ER, 1995, APPL OPTICS, V34, P1859, DOI 10.1364/AO.34.001859; Fahrbach FO, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1646; Fahrbach FO, 2010, NAT PHOTONICS, V4, P780, DOI [10.1038/NPHOTON.2010.204, 10.1038/nphoton.2010.204]; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grosenick L, 2009, I S BIOMED IMAGING, P1263, DOI 10.1109/ISBI.2009.5193292; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hammen GF, 2014, NAT NEUROSCI, V17, P953, DOI 10.1038/nn.3738; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Heckscher ES, 2014, DEVELOPMENT, V141, P2524, DOI 10.1242/dev.108720; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Jorand R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035795; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/nmeth.1851, 10.1038/NMETH.1851]; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Keller PJ, 2012, CURR OPIN NEUROBIOL, V22, P138, DOI 10.1016/j.conb.2011.08.003; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Levoy M, 2009, J MICROSC-OXFORD, V235, P144, DOI 10.1111/j.1365-2818.2009.03195.x; Levoy M, 2006, ACM T GRAPHIC, V25, P924, DOI 10.1145/1141911.1141976; Lister JA, 1999, DEVELOPMENT, V126, P3757; Livneh Y, 2012, NAT NEUROSCI, V15, P26, DOI 10.1038/nn.2980; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mahou P, 2014, NAT METHODS, V11, P600, DOI 10.1038/nmeth.2963; Majoul IV, 2013, P NATL ACAD SCI USA, V110, pE4125, DOI 10.1073/pnas.1315850110; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Nykamp DQ, 2007, MATH BIOSCI, V205, P204, DOI 10.1016/j.mbs.2006.08.020; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pfau D., 2013, P ADV NEUR INF PROC, V26, P1; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/nmeth.2964, 10.1038/NMETH.2964]; Quirin S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00029; Rohrbach A, 2009, OPT LETT, V34, P3041, DOI 10.1364/OL.34.003041; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Schmid B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3207; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Siedentopf H, 1902, ANN PHYS, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Turaga D, 2013, BIOMED OPT EXPRESS, V4, P1654, DOI 10.1364/BOE.4.001654; Turaga D, 2012, J NEUROSCI, V32, P1612, DOI 10.1523/JNEUROSCI.5339-11.2012; Viadimirov N, 2014, NAT METHODS, V11, P883, DOI 10.1038/nmeth.3040; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Weber M, 2011, CURR OPIN GENET DEV, V21, P566, DOI 10.1016/j.gde.2011.09.009; Winter PW, 2014, CURR OPIN CHEM BIOL, V20, P46, DOI 10.1016/j.cbpa.2014.04.008; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	95	147	153	3	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 4	2015	85	3					462	483		10.1016/j.neuron.2014.12.039	http://dx.doi.org/10.1016/j.neuron.2014.12.039			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB9NY	25654253	Bronze			2022-12-17	WOS:000349959700006
J	Schmidt, TM; Alam, NM; Chen, S; Kofuji, P; Li, W; Prusky, GT; Hattar, S				Schmidt, Tiffany M.; Alam, Nazia M.; Chen, Shan; Kofuji, Paulo; Li, Wei; Prusky, Glen T.; Hattar, Samer			A Role for Melanopsin in Alpha Retinal Ganglion Cells and Contrast Detection	NEURON			English	Article							PROJECTIONS; ADAPTATION; IRRADIANCE; NEURONS; MICE; FORM	Distinct subclasses of retinal ganglion cells (RGCs) mediate vision and nonimage-forming functions such as circadian photoentrainment. This distinction stems from studies that ablated melanopsin-expressing intrinsically photosensitive RGCs (ipRGCs) and showed deficits in nonimage-forming behaviors, but not image vision. However, we show that the ON alpha RGC, a conventional RGC type, is intrinsically photosensitive in mammals. In addition to their classical response to fast changes in contrast through rod/cone signaling, melanopsin expression allows ON alpha RGCs to signal prior light exposure and environmental luminance over long periods of time. Consistent with the high contrast sensitivity of ON alpha RGCs, mice lacking either melanopsin or ON alpha RGCs have behavioral deficits in contrast sensitivity. These findings indicate a surprising role for melanopsin and ipRGCs in vision.	[Schmidt, Tiffany M.; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Alam, Nazia M.; Prusky, Glen T.] Weill Cornell Med Coll, Burke Med Res Inst, Dept Physiol & Biophys, White Plains, NY 10605 USA; [Chen, Shan; Li, Wei] NEI, NIH, Bethesda, MD 20892 USA; [Kofuji, Paulo] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Hattar, Samer] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University	Schmidt, TM (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	tmschmidt@jhu.edu	Schmidt, Tiffany/L-7598-2014; Hattar, Samer/W-6927-2019; Schmidt, Tiffany M/A-9660-2012; Kofuji, Paulo/AAR-7835-2021	Schmidt, Tiffany/0000-0002-4791-6775; Schmidt, Tiffany M/0000-0002-4791-6775; Kofuji, Paulo/0000-0002-4840-9986	National Institutes of Health [GM076430, EY022543]; NIH; Burke Foundation; NATIONAL EYE INSTITUTE [F32EY022543, P30EY011374, ZIAEY000488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Drs. Marnie Halpern, Rejji Kuruvilla, Haiqing Zhao, Robert F. Miller, and Stewart Hendry for comments on the manuscript. We would also like to thank Dr. Cara Altimus, Ms. Diane Vig, and Mr. Nathan Schmidt for technical assistance. This work was funded by National Institutes of Health grants GM076430 (S. H.) and EY022543 (T. M. S.), the NIH Intramural Research Program (W. L.), and the Burke Foundation (G. T. P.). G. T. P. is a principal at Cerebral Mechanics, which manufactures equipment and software used in this study.	BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; CLELAND BG, 1973, J PHYSIOL-LONDON, V228, P649, DOI 10.1113/jphysiol.1973.sp010105; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; JAKIELA HG, 1976, EXP BRAIN RES, V24, P335; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Li W, 2004, NAT NEUROSCI, V7, P751, DOI 10.1038/nn1275; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, VISION RES, V44, P3411, DOI 10.1016/j.visres.2004.09.001; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Schmidt TM, 2011, JOVE-J VIS EXP, DOI 10.3791/2367; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	33	147	148	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 21	2014	82	4					781	788		10.1016/j.neuron.2014.03.022	http://dx.doi.org/10.1016/j.neuron.2014.03.022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH8IA	24853938	Bronze, Green Accepted			2022-12-17	WOS:000336379800009
J	Cohen, MR; Maunsell, JHR				Cohen, Marlene R.; Maunsell, John H. R.			Using Neuronal Populations to Study the Mechanisms Underlying Spatial and Feature Attention	NEURON			English	Article							SELECTIVE VISUAL-ATTENTION; MACAQUE AREA V4; EFFECTIVE CONNECTIVITY; NORMALIZATION MODEL; PARIETAL CORTEX; NEURAL ACTIVITY; FRONTAL-CORTEX; BEHAVING MICE; MODULATION; RESPONSES	Visual attention affects both perception and neuronal responses. Whether the same neuronal mechanisms mediate spatial attention, which improves perception of attended locations, and nonspatial forms of attention has been a subject of considerable debate. Spatial and feature attention have similar effects on individual neurons. Because visual cortex is retinotopically organized, however, spatial attention can comodulate local neuronal populations, whereas feature attention generally requires more selective modulation. We compared the effects of feature and spatial attention on local and spatially separated populations by recording simultaneously from dozens of neurons in both hemispheres of V4. Feature and spatial attention affect the activity of local populations similarly, modulating both firing rates and correlations between pairs of nearby neurons. However, whereas spatial attention appears to act on local populations, feature attention is coordinated across hemispheres. Our results are consistent with a unified attentional mechanism that can modulate the responses of arbitrary subgroups of neurons.	[Cohen, Marlene R.; Maunsell, John H. R.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Cohen, Marlene R.; Maunsell, John H. R.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cohen, MR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cohenm@pitt.edu	Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	NIH [K99EY020844-01, R01EY005911]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY005911, K99EY020844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to Mark Histed, Adam Kohn, Amy Ni, and Douglas Ruff for helpful discussions and comments on an earlier version of the manuscript. This work was supported by NIH grants K99EY020844-01 (M.R.C.) and R01EY005911 (J.H.R.M.) and the Howard Hughes Medical Institute.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cavanaugh J, 2006, J NEUROSCI, V26, P11347, DOI 10.1523/JNEUROSCI.2376-06.2006; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Coull JT, 1998, J NEUROSCI, V18, P7426; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Cutrell EB, 2002, EXP BRAIN RES, V144, P103, DOI 10.1007/s00221-002-1032-x; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; ESPINOSA IE, 1988, BRAIN RES, V450, P39, DOI 10.1016/0006-8993(88)91542-9; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gregoriou GG, 2009, PROG BRAIN RES, V176, P35, DOI 10.1016/S0079-6123(09)17603-3; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hayden BY, 2009, VISION RES, V49, P1182, DOI 10.1016/j.visres.2008.06.011; Herrington TM, 2009, J NEUROSCI, V29, P14160, DOI 10.1523/JNEUROSCI.1916-09.2009; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Houtkamp R, 2003, PERCEPT PSYCHOPHYS, V65, P1136, DOI 10.3758/BF03194840; KEREN G, 1976, J EXP PSYCHOL GEN, V105, P349, DOI 10.1037/0096-3445.105.4.349; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; KWAK HW, 1992, PERCEPT PSYCHOPHYS, V51, P455, DOI 10.3758/BF03211641; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Liu TS, 2011, VISION RES, V51, P26, DOI 10.1016/j.visres.2010.09.023; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; NISSEN MJ, 1985, J GERONTOL, V40, P185, DOI 10.1093/geronj/40.2.185; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROSSI AF, 1995, VISION RES, V35, P621, DOI 10.1016/0042-6989(94)00156-G; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Sally SL, 2009, SPATIAL VISION, V22, P529, DOI 10.1163/156856809789822970; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; VONWRIGH.JM, 1970, ACTA PSYCHOL, V33, P280, DOI 10.1016/0001-6918(70)90140-X; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2004, VISION RES, V44, P1411, DOI 10.1016/j.visres.2003.11.024; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	78	147	148	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1192	1204		10.1016/j.neuron.2011.04.029	http://dx.doi.org/10.1016/j.neuron.2011.04.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689604	Green Accepted, Bronze			2022-12-17	WOS:000292410700016
J	Dranovsky, A; Picchini, AM; Moadel, T; Sisti, AC; Yamada, A; Kimura, S; Leonardo, ED; Hen, R				Dranovsky, Alex; Picchini, Alyssa M.; Moadel, Tiffany; Sisti, Alexander C.; Yamada, Atsushi; Kimura, Shioko; Leonardo, E. David; Hen, Rene			Experience Dictates Stem Cell Fate in the Adult Hippocampus	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; PROGENITOR CELLS; PATTERN SEPARATION; NEUROGENESIS; NEURONS; MICE; PROLIFERATION; DIVISION; MEMORY	Adult hippocampal neurogenesis has been implicated in cognitive and emotional processes, as well as in response to antidepressant treatment. However, little is known about how the adult stem cell lineage contributes to hippocampal structure and function and how this process is modulated by the animal's experience. Here we perform an indelible lineage analysis and report that neural stem cells can produce expanding and persisting populations of not only neurons, but also stem cells in the adult hippocampus. Furthermore, the ratio of stem cells to neurons depends on experiences of the animal or the location of the stem cell. Surprisingly, social isolation facilitated accumulation of stem cells, but not neurons. These results show that neural stem cells accumulate in the adult hippocampus and that the stem cell-lineage relationship is under control of anatomic and experiential niches. Our findings suggest that, in the hippocampus, fate specification may act as a form of cellular plasticity for adapting to environmental changes.	[Dranovsky, Alex; Picchini, Alyssa M.; Moadel, Tiffany; Sisti, Alexander C.; Leonardo, E. David; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Picchini, Alyssa M.; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Dranovsky, Alex; Picchini, Alyssa M.; Moadel, Tiffany; Sisti, Alexander C.; Leonardo, E. David; Hen, Rene] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Yamada, Atsushi; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dranovsky, A (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	ad722@columbia.edu	Dranovsky, Alex/P-4357-2018; Leonardo, Eduardo/AAH-1525-2020	Dranovsky, Alex/0000-0001-7896-3243; Leonardo, Eduardo/0000-0001-7426-0217	NIH [K08MH079088, R01MH068542, NIH T32HD055165]; BRAINS [R01MH0911844]; NARSAD; NYSTEM; NCI CCR [P50 MH66171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC005522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH079088, R01MH091427, R01MH091844, R01MH068542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRAINS; NARSAD(NARSAD); NYSTEM; NCI CCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Matheus Araujo for technical assistance, Eric Kandel and Harshad Vishwasrao for sharing confocal resources, Richard Josephson for providing the pNerv-SXN construct, Linda Byrd for assistance with mice, and Frank Gonzalez. We are grateful to Chris Henderson, Fiona Doetsch, Ben Samuels, and Jesse Richardson-Jones for helpful discussions and critical reading of the manuscript. This work was supported by NIH K08MH079088, BRAINS R01MH0911844, and NARSAD Young Investigator Awards (A.D.); NIH R01MH068542 and NYSTEM (R.H.); NCI CCR Intramural Research Program (S.K.), P50 MH66171 (Molecular and Cellular Core) and the NYSTEM institutional development award; A.P. was supported by NIH T32HD055165. R.H. receives compensation as a consultant for Braincells, in relation to the generation of novel antidepressants. E.D.L. receives compensation as a consultant from PGxHealth.	Abusaad I, 1999, J COMP NEUROL, V408, P560, DOI 10.1002/(SICI)1096-9861(19990614)408:4<560::AID-CNE9>3.0.CO;2-P; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; GOULD E, 1992, J NEUROSCI, V12, P3642; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lu L, 2003, EXP NEUROL, V183, P600, DOI 10.1016/S0014-4886(03)00248-6; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	62	147	151	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 9	2011	70	5					908	923		10.1016/j.neuron.2011.05.022	http://dx.doi.org/10.1016/j.neuron.2011.05.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658584	Bronze, Green Accepted			2022-12-17	WOS:000291843500011
J	Lee, Y; Kim, SH; Montell, C				Lee, Youngseok; Kim, Sang Hoon; Montell, Craig			Avoiding DEET through Insect Gustatory Receptors	NEURON			English	Article							CAFFEINE RESPONSE; REPELLENT DEET; DROSOPHILA; TASTE; NEURONS; GENES; SMELL	DEET is the most widely used insect repellent worldwide. In Drosophila olfactory receptor neurons (ORNs), DEET is detected through a mechanism employing the olfactory receptor, OR83b. However, it is controversial as to whether ORNs respond directly to DEET or whether DEET blocks the response to attractive odors. Here, we showed that DEET suppressed feeding behavior in Drosophila, and this effect was mediated by gustatory receptor neurons (GRNs). DEET was potent in suppressing feeding as <0.1% DEET elicited aversive behavior. Inhibition of feeding required multiple gustatory receptors (GRs) expressed in inhibitory GRNs. DEET stimulated action potentials in GRNs that respond to aversive compounds, and this response was lost in the Gr32a, Gr33a, and Gr66a mutants. Since 0.02% DEET elicited action potentials, we conclude that DEET directly activates of GRNs. We suggest that the effectiveness of DEET in pest control owes to its dual action in inducing avoidance simultaneously via GRNs and ORNs.	[Lee, Youngseok; Kim, Sang Hoon; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Lee, Youngseok; Kim, Sang Hoon; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Sensory Biol, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Lee, Youngseok/0000-0003-0459-1138	Samsung; NIDCD [DC007864]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	Samsung(Samsung); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs. H. Amrein and T. Tanimura for fly stocks, S.J. Moon for the unpublished Gr33a-GAL4 line, and M. Jin for the drawing in Figure 1E. S.H.K. was supported in part by a Samsung Fellowship. This work was supported by a grant to C.M. from the NIDCD (DC007864).	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Pimentel David, 2009, P83, DOI 10.1007/978-1-4020-8992-3_3; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	24	147	157	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					555	561		10.1016/j.neuron.2010.07.006	http://dx.doi.org/10.1016/j.neuron.2010.07.006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797533	Bronze, Green Accepted			2022-12-17	WOS:000281534600006
J	Maimon, G; Assad, JA				Maimon, Gaby; Assad, John A.			Beyond Poisson: Increased Spike-Time Regularity across Primate Parietal Cortex	NEURON			English	Article							MONKEY VISUAL-CORTEX; CORTICAL-NEURONS; SUPERIOR COLLICULUS; WORKING-MEMORY; MOTOR CORTEX; MACAQUE; DISCRIMINATION; RELIABILITY; CELLS; AREA	Cortical areas differ in their patterns of connectivity, cellular composition, and functional architecture. Spike trains, on the other hand, are commonly assumed to follow similarly irregular dynamics across neocortex. We examined spike-time statistics in four parietal areas using a method that accounts for non-stationarities in firing rate. We found that, whereas neurons in visual areas fire irregularly, many cells in association and motor-like parietal regions show increasingly regular spike trains by comparison. Regularity was evident both in the shape of interspike interval distributions and in spike-count variability across trials. Thus, Poisson-like randomness is not a universal feature of neocortex. Rather, many parietal cells have reduced trial-to-trial variability in spike counts that could provide for more reliable firing-rate signals. These results suggest that spiking dynamics may play different roles in different cortical areas and should not be assumed to arise from fundamentally irreducible noise sources.	[Maimon, Gaby] CALTECH, Pasadena, CA 91125 USA; [Maimon, Gaby; Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	California Institute of Technology; Harvard University; Harvard Medical School	Maimon, G (corresponding author), CALTECH, MC 138-78, Pasadena, CA 91125 USA.	maimon@caltech.edu			NEI [EY12106]; McKnight Endowment Fund for Neuroscience; NEI Vision [EY12196]; NATIONAL EYE INSTITUTE [P30EY012196, R01EY012106] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); McKnight Endowment Fund for Neuroscience; NEI Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J.H.R. Maunsell, C. Padoa-Schioppa, R. Maimon, and P. Weir for helpful comments on the manuscript and discussions. K. Irwin, T. Lafratta, M. LaFratta, J. LeBlanc, and D. Averbuch provided technical assistance. This work was supported by NEI EY12106 and the McKnight Endowment Fund for Neuroscience and an NEI Vision Core Grant, EY12196.	Amarasingham A, 2006, J NEUROSCI, V26, P801, DOI 10.1523/JNEUROSCI.2948-05.2006; Averbeck BB, 2003, J NEUROSCI, V23, P7630; BAIR W, 1994, J NEUROSCI, V14, P2870; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; BUZSAKI G, 2006, J NEUROPHYSIOL, V31, P574; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Gabbiani F., 1998, METHODS NEURONAL MOD, P313; Geisler C, 2005, J NEUROPHYSIOL, V94, P4344, DOI 10.1152/jn.00510.2004; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Joelving FC, 2007, J NEUROPHYSIOL, V97, P2254, DOI 10.1152/jn.00977.2006; KALASKA JF, 1983, EXP BRAIN RES, V51, P247; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kelly RM, 2003, J NEUROSCI, V23, P8432; KUFFLER SW, 1957, J GEN PHYSIOL, V40, P683, DOI 10.1085/jgp.40.5.683; Lee D, 1998, J NEUROSCI, V18, P1161; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maimon G, 2006, J NEUROSCI, V26, P2487, DOI 10.1523/JNEUROSCI.3590-05.2006; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Masse NY, 2008, J NEUROSCI, V28, P1343, DOI 10.1523/JNEUROSCI.2775-07.2008; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; PFEIFFER RR, 1965, BIOPHYS J, V5, P301, DOI 10.1016/S0006-3495(65)86718-2; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; SASAKI K, 1976, EXP BRAIN RES, V24, P495; SEAL J, 1985, EXP BRAIN RES, V58, P144; SEAL J, 1983, BRAIN RES, V278, P382, DOI 10.1016/0006-8993(83)90279-2; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY WR, 1993, J NEUROSCI, V13, P334; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; WERNER G, 1965, J NEUROPHYSIOL, V28, P359, DOI 10.1152/jn.1965.28.2.359	50	147	148	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 14	2009	62	3					426	440		10.1016/j.neuron.2009.03.021	http://dx.doi.org/10.1016/j.neuron.2009.03.021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446UG	19447097	Green Accepted, Bronze			2022-12-17	WOS:000266146100013
J	Lin, SC; Huck, JHJ; Roberts, JDB; Macklin, WB; Somogyi, P; Bergles, DE				Lin, SC; Huck, JHJ; Roberts, JDB; Macklin, WB; Somogyi, P; Bergles, DE			Climbing fiber innervation of NG2-expressing glia in the mammalian cerebellum	NEURON			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; CENTRAL-NERVOUS-SYSTEM; SYNAPTICALLY RELEASED GLUTAMATE; PURKINJE-CELLS; PROGENITOR CELLS; GABAERGIC INTERNEURONS; SUBVENTRICULAR ZONE; RAT CEREBELLUM; ACID RECEPTORS; DEVELOPMENTAL FATES	The molecular layer of the cerebellar cortex is populated by glial progenitors that express ionotropic glutamate receptors and extend numerous processes among Purkinje cell dendrites. Here, we show that release of glutamate from climbing fiber (CF) axons produces AMPA receptor currents with rapid kinetics in these NG2-immunoreactive glial cells (NG2(+) cells) in cerebellar slices. NG2(+) cells may receive up to 70 discrete inputs from one CF and, unlike mature Purkinje cells, are often innervated by multiple CFs. Paired Purkinje cell-NG2(+) cell recordings show that one CF can innervate both cell types. CF boutons make direct synaptic junctions with NG2(+) cell processes, indicating that this rapid neuron-glia signaling occurs at discrete sites rather than through ectopic release at CF-Purkinje cell synapses. This robust activation of Ca2+-permeable AMPA receptors in NG2+ cells expands the influence of the olivocerebellar projection to this abundant class of glial progenitors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Johns Hopkins University; Cleveland Clinic Foundation	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Huck, Jojanneke/B-1534-2013	Bergles, Dwight/0000-0002-7133-7378; Huck, Jojanneke/0000-0002-3853-8581	NINDS NIH HHS [R01 NS025304] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025304] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; DESCLIN JC, 1976, ANAT EMBRYOL, V149, P87, DOI 10.1007/BF00315087; Diamond JS, 1997, J NEUROSCI, V17, P4672; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dzubay JA, 1999, J NEUROSCI, V19, P5265; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Fortin M, 1998, NEUROSCI RES, V30, P155, DOI 10.1016/S0168-0102(97)00124-7; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; GALLO V, 1994, GLIA, V11, P94, DOI 10.1002/glia.440110204; Hall A, 1996, DEVELOPMENT, V122, P4085; HAMORI J, 1980, BRAIN RES, V186, P454, DOI 10.1016/0006-8993(80)90990-7; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Ichikawa R, 2002, J NEUROSCI, V22, P8487; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jorntell H, 2003, J NEUROSCI, V23, P9620; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LEVINE JM, 1987, J NEUROSCI, V7, P2711; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Lin SC, 2002, J NEUROCYTOL, V31, P537, DOI 10.1023/A:1025799816285; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; MARIANI J, 1981, J NEUROSCI, V1, P703, DOI 10.1523/JNEUROSCI.01-07-00703.1981; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Muller T, 1996, GLIA, V17, P274, DOI 10.1002/(SICI)1098-1136(199608)17:4<274::AID-GLIA2>3.0.CO;2-#; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Palay S.L., 1974, CEREBELLAR CORTEX CY; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Peters A, 1991, FINE STRUCTURE NERVO; RAMMES G, 1994, NEUROSCI LETT, V175, P21, DOI 10.1016/0304-3940(94)91068-5; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; Sugihara I, 1999, J COMP NEUROL, V414, P131; Tillet E, 1997, J BIOL CHEM, V272, P10769; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Ye P, 2003, J NEUROSCI, V23, P4401; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang L, 1996, J COMP NEUROL, V370, P536, DOI 10.1002/(SICI)1096-9861(19960708)370:4<536::AID-CNE9>3.0.CO;2-5	85	147	154	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					773	785		10.1016/j.neuron.2005.04.025	http://dx.doi.org/10.1016/j.neuron.2005.04.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924863	Bronze			2022-12-17	WOS:000229689800011
J	Roseberry, AG; Liu, HY; Jackson, AC; Cai, XL; Friedman, JM				Roseberry, AG; Liu, HY; Jackson, AC; Cai, XL; Friedman, JM			Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice	NEURON			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; RECEPTOR MESSENGER-RNA; AGOUTI-RELATED PROTEIN; OBESE GENE-PRODUCT; LEPTIN RECEPTOR; POTASSIUM CONDUCTANCE; MOUSE HYPOTHALAMUS; POMC NEURONS; FOOD-INTAKE; DB/DB MICE	NPY and alphaMSH are expressed in distinct neurons in the arcuate nucleus of the hypothalamus, where alphaMSH decreases and NPY increases food intake and body weight. Here we use patch-clamp electrophysiology from GFP-labeled POMC and NPY neurons to demonstrate that NPY strongly hyperpolarized POMC neurons through the Y1R-mediated activation of GIRK channels, while the alphaMSH analog, MTII, had no effect on activity of NPY neurons. While initially NPY had similar effects on POMC neurons derived from ob/ob mice, further studies revealed a significant increase in desensitization of the NPY-induced currents in POMC neurons from ob/ob mice. This increase in desensitization was specific to NPY, as GABA(B) and muOR agonists showed unaltered desensitization in POMC neurons from ob/ob mice. These data reveal an intricate and asymmetric interplay between NPY and POMC neurons in the hypothalamus and have important implications for the delineation of the neural circuits that regulate feeding behavior.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave,Box 305, New York, NY 10021 USA.	friedj@rockefeller.edu	Friedman, Jeffrey M/E-5784-2011	Roseberry, Aaron/0000-0003-0468-0333	NIDDK NIH HHS [F32 DK61176, R01 DK410096] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK061176] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bagnol D, 1999, J NEUROSCI, V19; BAI FL, 1985, BRAIN RES, V331, P172, DOI 10.1016/0006-8993(85)90730-9; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Broberger C, 1998, J COMP NEUROL, V402, P460; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; LOOSE MD, 1991, NEUROENDOCRINOLOGY, V54, P537, DOI 10.1159/000125979; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Michel MC, 1998, PHARMACOL REV, V50, P143; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; SAWCHENKO PE, 1982, BRAIN RES, V232, P365; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; STANLEY BG, 1986, PEPTIDES, V7, P1189; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	39	147	148	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					711	722		10.1016/S0896-6273(04)00074-1	http://dx.doi.org/10.1016/S0896-6273(04)00074-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003171	Bronze			2022-12-17	WOS:000221458200007
J	Grubb, MS; Rossi, FM; Changeux, JP; Thompson, ID				Grubb, MS; Rossi, FM; Changeux, JP; Thompson, ID			Abnormal functional organization in the dorsal lateral geniculate nucleus of mice lacking the beta 2 subunit of the nicotinic acetylcholine receptor	NEURON			English	Article							EYE-SPECIFIC SEGREGATION; RETINAL GANGLION-CELLS; OPTIC-NERVE TERMINALS; RETINOCOLLICULAR PROJECTION; TOPOGRAPHIC SPECIFICITY; SYNAPTIC TRANSMISSION; POSTNATAL-DEVELOPMENT; SUPERIOR COLLICULUS; BINDING-SITES; RETINOGENICULATE	Spontaneous activity patterns in the developing retina appear important for the functional organization of the visual system. We show here that an absence of early retinal waves in mice lacking the beta2 subunit of the nicotinic acetylcholine receptor (nAChR) is associated with both gain and loss of functional organization in the dorsal lateral geniculate nucleus (dLGN). Anatomical studies show normal gross retinotopy in the beta2(-/-) dLGN but suggest reduced topographic precision in the retinogeniculate projection. Physiological recordings reveal normal topography in the dorsoventral visual axis but a lack of fine-scale mapping in the nasotemporal visual plane. In contrast, unlike wildtype mice, on- and off-center cells in the beta2(-/-) dLGN are spatially segregated. The presence of the beta2 subunit of the nAChR in the CNS is therefore important for normal functional organization in the retinogeniculate projection.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Inst Pasteur, CNRS, URA 2182, Dept Biotechnol, F-75724 Paris 15, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Thompson, ID (corresponding author), Univ Oxford, Physiol Lab, Pks Rd, Oxford OX1 3PT, England.		Grubb, Matthew S/B-4939-2008; Thompson, Ian D/C-5785-2009; Rossi, Francesco Mattia/K-6544-2015	Grubb, Matthew S/0000-0002-2673-274X; Rossi, Francesco Mattia/0000-0001-9855-5925				Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bansal A, 2000, J NEUROSCI, V20, P7672; BONAVENTURE N, 1968, CR SOC BIOL, V162, P553; Butts DA, 2002, NEUROSCIENTIST, V8, P243; Chalupa LM, 1998, J COMP NEUROL, V392, P35, DOI 10.1002/(SICI)1096-9861(19980302)392:1<35::AID-CNE3>3.0.CO;2-Q; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; EYSEL UT, 1986, J PHYSIOL-LONDON, V370, P233, DOI 10.1113/jphysiol.1986.sp015932; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FRANCESCONI W, 1988, J NEUROPHYSIOL, V59, P1690, DOI 10.1152/jn.1988.59.6.1690; FRAUNFEL.FT, 1970, EXP EYE RES, V10, P19, DOI 10.1016/S0014-4835(70)80005-7; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GRANT S, 1992, EUR J NEUROSCI, V4, P37, DOI 10.1111/j.1460-9568.1992.tb00107.x; GRUBB MS, 2003, IN PRESS J NEUROPHYS, V27; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; King AJ, 1998, J NEUROSCI, V18, P9394; KING WM, 1990, BRAIN RES, V527, P150; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; Lena C, 1997, J NEUROSCI, V17, P576; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; METIN C, 1983, CR ACAD SCI III-VIE, V296, P157; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; NAEFF B, 1992, DEV BRAIN RES, V68, P163, DOI 10.1016/0165-3806(92)90058-5; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; PRUSKY GT, 1988, VISUAL NEUROSCI, V1, P245, DOI 10.1017/S0952523800001504; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SILLITO AM, 1983, BRAIN RES, V280, P299, DOI 10.1016/0006-8993(83)90059-8; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; SIMON DK, 1991, J COMP NEUROL, V307, P393, DOI 10.1002/cne.903070305; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; STRYKER MP, 1983, J NEUROSCI, V3, P1943; SWANSON LW, 1987, J NEUROSCI, V7, P3334; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Yu CJ, 2003, EUR J NEUROSCI, V17, P1253, DOI 10.1046/j.1460-9568.2003.02557.x; Zar, 2001, BIOSTAT ANAL; Zhu JJ, 1997, NEUROSCIENCE, V80, P191, DOI 10.1016/S0306-4522(97)00095-X; Zoli M, 1998, J NEUROSCI, V18, P4461	52	147	149	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1161	1172		10.1016/S0896-6273(03)00789-X	http://dx.doi.org/10.1016/S0896-6273(03)00789-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687550	Bronze			2022-12-17	WOS:000187503400014
J	Dragoi, G; Harris, KD; Buzsaki, G				Dragoi, G; Harris, KD; Buzsaki, G			Place representation within hippocampal networks is modified by long-term potentiation	NEURON			English	Article							WATER MAZE; SYNAPTIC ENHANCEMENT; PYRAMIDAL CELLS; UNIT-ACTIVITY; NEURONS; MEMORY; PLASTICITY; RAT; TASK; NEUROSCIENCE	In the brain, information is encoded by the firing patterns of neuronal ensembles and the strength of synaptic connections between individual neurons. We report here that representation of the environment by "place" cells is altered by changing synaptic weights within hippocampal networks. Long-term potentiation (LTP) of intrinsic hippocampal pathways abolished existing place fields, created new place fields, and rearranged the temporal relationship within the affected population. The effect of LTP on neuron discharge was rate and context dependent. The LTP-induced "remapping" occurred without affecting the global firing rate of the network. The findings support the view that learned place representation can be accomplished by LTP-like synaptic plasticity within intrahippocampal networks.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.		Harris, Kenneth/B-3469-2009	Harris, Kenneth/0000-0002-5930-6456; Buzsaki, Gyorgy/0000-0002-3100-4800				BARNES CA, 1994, J NEUROSCI, V14, P5793; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; BUZSAKI G, 1982, BRAIN RES, V237, P283, DOI 10.1016/0006-8993(82)90442-5; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; DEADWYLER SA, 1976, BRAIN RES BULL, V1, P1, DOI 10.1016/0361-9230(76)90043-5; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kimura A, 2000, J NEUROPHYSIOL, V84, P1894, DOI 10.1152/jn.2000.84.4.1894; KOROL DL, 1993, HIPPOCAMPUS, V3, P127, DOI 10.1002/hipo.450030204; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; Martin PD, 2000, HIPPOCAMPUS, V10, P207, DOI 10.1002/1098-1063(2000)10:3<207::AID-HIPO1>3.0.CO;2-S; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCNAMARA RK, 1993, HIPPOCAMPUS, V3, P149, DOI 10.1002/hipo.450030207; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TAUBE JS, 1988, J NEUROSCI, V8, P1632; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	46	147	152	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					843	853		10.1016/S0896-6273(03)00465-3	http://dx.doi.org/10.1016/S0896-6273(03)00465-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948450	Bronze			2022-12-17	WOS:000185079300013
J	Takahashi, M; Dore, S; Ferris, CD; Tomita, T; Sawa, A; Wolosker, H; Borchelt, DR; Iwatsubo, T; Kim, SH; Thinakaran, G; Sisodia, SS; Snyder, SH				Takahashi, M; Dore, S; Ferris, CD; Tomita, T; Sawa, A; Wolosker, H; Borchelt, DR; Iwatsubo, T; Kim, SH; Thinakaran, G; Sisodia, SS; Snyder, SH			Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease	NEURON			English	Article							TRANSGENIC MICE; OXIDATIVE STRESS; BETA-PROTEIN; IN-VITRO; MOLECULAR-CLONING; CARBON-MONOXIDE; EXPRESSION; BRAIN; IRON; TOXICITY	Amyloid precursor protein (APP) generates the beta -amyloid peptide, postulated to participate in the neurotoxicity of Alzheimer's disease. We report that APP and APLP bind to heme oxygenase (HO), an enzyme whose product, bilirubin, is antioxidant and neuroprotective. The binding of APP inhibits HO activity, and APP with mutations linked to the familiar Alzheimer's disease (FAD) provides substantially greater inhibition of HO activity than wild-type APP. Cortical cultures from transgenic mice expressing Swedish mutant APP have greatly reduced bilirubin levels, establishing that mutant APP inhibits HO activity in vivo. Oxidative neurotoxicity is markedly greater in cerebral cortical cultures from APP Swedish mutant transgenic mice than wild-type cultures. These findings indicate that augmented neurotoxicity caused by APP-HO interactions may contribute to neuronal cell death in Alzheimer's disease.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Univ Tokyo, Fac Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 113, Japan; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Tokyo; University of Chicago	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Dore, Sylvain/AAG-1470-2020; Tomita, Taisuke/L-5427-2015	Dore, Sylvain/0000-0003-3771-5109; Tomita, Taisuke/0000-0002-0075-5943; Wolosker, Herman/0000-0001-5508-9194	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266, DA 00074] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Crain BJ, 1996, AM J PATHOL, V149, P1087; Dennery PA, 1997, J BIOL CHEM, V272, P14937, DOI 10.1074/jbc.272.23.14937; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; DRUMMOND GS, 1981, P NATL ACAD SCI-BIOL, V78, P6466, DOI 10.1073/pnas.78.10.6466; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Hansen TWR, 1999, MOL GENET METAB, V68, P404, DOI 10.1006/mgme.1999.2899; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; HARROW E, 1988, ANTIBODIES LAB MANUA, V1, P522; HINO Y, 1979, BIOCHEM J, V178, P331, DOI 10.1042/bj1780331; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; McNamara MJ, 1998, BRAIN RES, V804, P45, DOI 10.1016/S0006-8993(98)00653-2; Mucke L, 1996, ANN NY ACAD SCI, V777, P82, DOI 10.1111/j.1749-6632.1996.tb34405.x; OTTO JC, 1994, J BIOL CHEM, V269, P19868; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pappolla MA, 1998, AM J PATHOL, V152, P871; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; Sawa A, 1997, MOL BRAIN RES, V48, P53, DOI 10.1016/S0169-328X(97)00078-8; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH JA, 1994, CURR PROT MOL BIOL, V1; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; SMITH MA, 1994, AM J PATHOL, V145, P42; SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; VANLENTEN BJ, 1995, J CLIN INVEST, V95, P2104, DOI 10.1172/JCI117898; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; White AR, 1998, J NEUROSCI, V18, P6207; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zakhary R, 1996, P NATL ACAD SCI USA, V93, P795, DOI 10.1073/pnas.93.2.795; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	68	147	157	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					461	473		10.1016/S0896-6273(00)00125-2	http://dx.doi.org/10.1016/S0896-6273(00)00125-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144356	Bronze			2022-12-17	WOS:000165493700021
J	Feldman, DE; Nicoll, RA; Malenka, RC; Isaac, JTR				Feldman, DE; Nicoll, RA; Malenka, RC; Isaac, JTR			Long-term depression at thalamocortical synapses in developing rat somatosensory cortex	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; VISUAL-CORTEX; CRITICAL PERIOD; BARREL CORTEX; SILENT SYNAPSES; MONOCULAR DEPRIVATION; DEVELOPMENTAL-CHANGES; VOLTAGE-DEPENDENCE; PYRAMIDAL CELLS; SENSORY CORTEX	Sensory experience during an early critical period guides the development of thalamocortical circuits in many cortical areas. This process has been hypothesized to involve long-term potentiation (LTP) end longterm depression (LTD) at thalamocortical synapses. Here, we show that thalamocortical synapses in rat barrel cortex can express LTD, and that LTD is most readily induced during a developmental period that is similar to the critical period for thalamocortical plasticity in vivo. Thalamocortical LTD is homosynaptic and dependent on activation of N-methyl-D-aspartate (NMDA) receptors. The age-related decline of LTD is not due to changes in inhibition nor to changes in NMDA receptor voltage dependence. Minimal stimulation experiments indicate that, unlike thalamocortical LTP, thalamocortical LTD is not associated with a significant change in failure rate. The existence of LTD and its developmental time course suggest that LTD, like LTP, may contribute to the refinement of thalamocortical inputs in vivo.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Bristol, Dept Anat, Bristol BS8 1TD, Avon, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bristol	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BENARI Y, 1988, NEUROSCI LETT, V94, P88, DOI 10.1016/0304-3940(88)90275-3; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BURGARD EC, 1994, DEV BRAIN RES, V80, P275, DOI 10.1016/0165-3806(94)90113-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FOX K, 1992, J NEUROSCI, V12, P1826; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FREGNAC Y, 1994, J NEUROPHYSIOL, V71, P1403, DOI 10.1152/jn.1994.71.4.1403; Gil Z, 1996, J NEUROPHYSIOL, V76, P2547, DOI 10.1152/jn.1996.76.4.2547; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KATO N, 1993, P NATL ACAD SCI USA, V90, P7114, DOI 10.1073/pnas.90.15.7114; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LUHMANN HJ, 1990, DEV BRAIN RES, V54, P287, DOI 10.1016/0165-3806(90)90152-O; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; TSUMOTO T, 1992, PROG NEUROBIOL, V39, P209, DOI 10.1016/0301-0082(92)90011-3; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	73	147	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					347	357		10.1016/S0896-6273(00)80544-9	http://dx.doi.org/10.1016/S0896-6273(00)80544-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728916	Bronze			2022-12-17	WOS:000075598300012
J	Baum, PD; Garriga, G				Baum, PD; Garriga, G			Neuronal migrations and axon fasciculation are disrupted in ina-1 integrin mutants	NEURON			English	Article							CREST CELL ATTACHMENT; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; ADHESION; OUTGROWTH; EMBRYO; MICE; FIBRONECTIN; RECEPTORS	Integrins are heterodimeric cell surface receptors implicated in cell adhesion and signaling. Our analysis of C. elegans ina-1 alpha integrin mutants provides the first genetic evidence that migrating neurons require integrins. Mosaic analysis and expression studies show that ina-1 acts autonomously in cells to promote their migrations. Although axons generally extend to their normal targets in ina-1 mutants, bundling of axons into fascicles is defective, defining a previously unrecognized role for integrins. In addition to these neuronal phenotypes, ina-1 mutants also display many morphogenetic defects. Finally, we show that the C. elegans INA-1 alpha integrin subunit associates with the PAT-3 beta subunit in vivo, suggesting that these proteins function together in cell migration, axon fasciculation, and morphogenesis.			Baum, PD (corresponding author), UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,229 STANLEY HALL,BERKELEY,CA 94720, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07127, GM07232] Funding Source: Medline; NINDS NIH HHS [NS32057] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DC, 1995, METABOLIC MOL BASES, P3955; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHISHOLM AD, 1995, NATURE, V377, P52, DOI 10.1038/377052a0; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; DECURTIS I, 1993, DEVELOPMENT, V118, P377; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DUFOUR S, 1988, EMBO J, V7, P2661, DOI 10.1002/j.1460-2075.1988.tb03119.x; ELLIS RE, 1991, GENETICS, V129, P79; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FASSLER R, 1996, CURR OPIN CELL BIOL, V8, P657; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1997, DEVELOPMENT, V124, P1831; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HEDGECOCK EM, 1995, GENETICS, V141, P989; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HERMAN RK, 1989, J NEUROGENET, V5, P1, DOI 10.3109/01677068909167261; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; JAFFREDO T, 1988, DEVELOPMENT, V103, P431; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; LALLIER T, 1993, SCIENCE, V259, P692, DOI 10.1126/science.8430321; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller LM, 1996, GENETICS, V143, P1181; OTOOLE TE, 1989, BLOOD, V74, P14; PERRIS R, 1993, J CELL SCI, V106, P1357; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Schachner M, 1993, CURR OPIN CELL BIOL, V5, P786, DOI 10.1016/0955-0674(93)90026-M; SHEPPARD AM, 1994, CELL ADHES COMMUN, V2, P27, DOI 10.3109/15419069409014200; SHIH DT, 1993, J CELL BIOL, V122, P1361, DOI 10.1083/jcb.122.6.1361; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; STEPP MA, 1994, CELL ADHES COMMUN, V2, P359, DOI 10.3109/15419069409014210; THIERY JP, 1985, ANNU REV CELL BIOL, V1, P91, DOI 10.1146/annurev.cellbio.1.1.91; TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; WEAVER CD, 1995, J NEUROSCI, V15, P5275; WEHRLI M, 1993, MECH DEVELOP, V43, P21, DOI 10.1016/0925-4773(93)90020-X; Wightman B, 1996, DEVELOPMENT, V122, P671; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; WILLIAMS BD, 1992, GENETICS, V131, P609; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YANG JT, 1995, DEVELOPMENT, V121, P549; YANG JT, 1993, DEVELOPMENT, V119, P1093; ZUSMAN S, 1993, DEVELOPMENT, V118, P737	61	147	150	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					51	62		10.1016/S0896-6273(00)80347-5	http://dx.doi.org/10.1016/S0896-6273(00)80347-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247263	Bronze			2022-12-17	WOS:A1997XN39400006
J	McMahon, LL; Kauer, JA				McMahon, LL; Kauer, JA			Hippocampal interneurons express a novel form of synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; GUINEA-PIG HIPPOCAMPUS; LACUNOSUM-MOLECULARE INTERNEURONS; EPSP SPIKE DISSOCIATION; RAT HIPPOCAMPUS; LASTING POTENTIATION; PYRAMIDAL CELLS; PERFORANT PATH; DENTATE GYRUS; INTRADENDRITIC RECORDINGS	Individual GABAergic interneurons in hippocampus can powerfully inhibit more than a thousand excitatory pyramidal neurons. Therefore, control of interneuron excitability provides control over hippocampal networks. We have identified a novel mechanism in hippocampus that weakens excitatory synapses onto GABAergic interneurons. Following stimulation that elicits long-term potentiation at neighboring synapses onto excitatory cells, excitatory synapses onto inhibitory interneurons undergo a long-term synaptic depression (interneuron LTD; iLTD). Unlike most other forms of hippocampal synaptic plasticity, iLTD is not synapse specific: stimulation of an afferent pathway triggers depression not only of activated synapses but also of inactive excitatory synapses onto the same interneuron. These results suggest that high frequency afferent activity increases hippocampal excitability through a dual mechanism, simultaneously potentiating synapses onto excitatory neurons and depressing synapses onto inhibitory neurons.			McMahon, LL (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.		McMahon, Lori/C-2922-2009	Kauer, Julie/0000-0002-3362-1642	NINDS NIH HHS [NS30500, NS09734] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009734, R29NS030500, R01NS030500] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; ANDERSEN P, 1973, Acta Physiologica Scandinavica Supplementum, V396, P34; ASHWOOD TJ, 1984, BRAIN RES, V293, P279, DOI 10.1016/0006-8993(84)91235-6; ASZETELY F, 1994, HIPPOCAMPUS, V4, P148; BABB TL, 1988, J COMP NEUROL, V278, P121, DOI 10.1002/cne.902780108; BARR DS, 1995, J NEUROSCI, V15, P5402; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bruton C., 1988, NEUROPATHOLOGY TEMPO; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1982, J NEUROPHYSIOL, V48, P597, DOI 10.1152/jn.1982.48.3.597; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHRISTIE BR, 1994, HIPPOCAMPUS, V4, P127, DOI 10.1002/hipo.450040203; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DUDEK SM, 1992, P ANTL ACAD SCI US, V89, P4367; FOX SE, 1981, EXP BRAIN RES, V41, P399; FRANCK JE, 1988, J NEUROSCI, V8, P1991; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; FROTSCHER M, 1984, NEUROSCI LETT, V46, P137, DOI 10.1016/0304-3940(84)90431-2; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KAWAGUCHI Y, 1988, EXP BRAIN RES, V72, P494; KAWAGUCHI Y, 1987, BRAIN RES, V411, P190, DOI 10.1016/0006-8993(87)90700-1; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; KNOWLES WD, 1981, J NEUROSCI, V1, P317; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LACAILLE JC, 1989, HIPPOCAMPUS, P287; LI XG, 1992, EXP BRAIN RES, V90, P519; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Maccaferri G, 1996, J NEUROSCI, V16, P5334; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nakajima S, 1991, Hippocampus, V1, P67, DOI 10.1002/hipo.450010107; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHARFMAN HE, 1990, NEUROSCIENCE, V35, P491, DOI 10.1016/0306-4522(90)90324-W; SCHWARTZKROIN PA, 1978, BRAIN RES, V157, P1, DOI 10.1016/0006-8993(78)90991-5; SCHWARTZKROIN PA, 1985, J COMP NEUROL, V232, P205, DOI 10.1002/cne.902320206; SIK A, 1995, J NEUROSCI, V15, P6651; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; TAUBE JS, 1987, BRAIN RES, V419, P32, DOI 10.1016/0006-8993(87)90565-8; TAUBE JS, 1988, J NEUROSCI, V8, P1632; TOMASULO RA, 1991, BRAIN RES, V561, P27, DOI 10.1016/0006-8993(91)90745-H; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; WILSON R C, 1981, Journal of Neurophysiology (Bethesda), V46, P339; WILSON RC, 1981, J NEUROPHYSIOL, V46, P324, DOI 10.1152/jn.1981.46.2.324; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442; WONG RKS, 1979, SCIENCE, V204, P1228, DOI 10.1126/science.451569; ZHAO DC, 1991, BRAIN RES, V564, P220, DOI 10.1016/0006-8993(91)91457-C	72	147	147	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					295	305		10.1016/S0896-6273(00)80269-X	http://dx.doi.org/10.1016/S0896-6273(00)80269-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052799	Bronze			2022-12-17	WOS:A1997WK82200012
J	PUCHALSKI, RB; LOUIS, JC; BROSE, N; TRAYNELIS, SF; EGEBJERG, J; KUKEKOV, V; WENTHOLD, RJ; ROGERS, SW; LIN, F; MORAN, T; MORRISON, JH; HEINEMANN, SF				PUCHALSKI, RB; LOUIS, JC; BROSE, N; TRAYNELIS, SF; EGEBJERG, J; KUKEKOV, V; WENTHOLD, RJ; ROGERS, SW; LIN, F; MORAN, T; MORRISON, JH; HEINEMANN, SF			SELECTIVE RNA EDITING AND SUBUNIT ASSEMBLY OF NATIVE GLUTAMATE RECEPTORS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; AMINO-ACID RECEPTORS; HIGH-AFFINITY KAINATE; NICOTINIC ACETYLCHOLINE-RECEPTORS; RAT-BRAIN; FUNCTIONAL EXPRESSION; CA2+ PERMEABILITY; STRUCTURAL DETERMINANTS; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING	RNA editing and subunit assembly of ionotropic glutamate receptors (GluRs) were examined in an oligodendrocyte progenitor cell line, CG4, which expresses GluR2-GluR4, GluR6, GluR7, KA1, and KA2. AMPA-evoked currents rapidly desensitize, whereas kainate-evoked currents contain a steady-state component with a nearly linear current-voltage relation and a fast desensitizing component that is inwardly rectifying. The Q/R site is edited >95% to the arginine codon in GluR2(Q607) mRNA, and <5% in GluR6(Q621) mRNA. Immunoprecipitation experiments demonstrate that GluR6 and/or GluR7 subunits assemble with KA2, but not with GluR2-GluR4. These results indicate that oligodendrocyte progenitor cells selectively edit and assemble glutamate receptors into at least two functionally and structurally distinct heteromeric channels.	SALK INST BIOL STUDIES, HOWARD HUGHES MED INST, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; NIDOCD, NEUROCHEM LAB, BETHESDA, MD 20892 USA; UNIV COLORADO, HLTH SCI CTR, DEPT PHARMACOL, DENVER, CO 80262 USA; CUNY MT SINAI SCH MED, FISHBERG RES CTR NEUROBIOL, NEW YORK, NY 10029 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	PUCHALSKI, RB (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.		Morrison, John/F-9229-2012		NIA NIH HHS [AG06647] Funding Source: Medline; NINDS NIH HHS [NS09029-02, NS08549-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG006647, R01AG006647] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLACKSTONE CD, 1992, ANN NEUROL, V31, P680, DOI 10.1002/ana.410310620; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BROSE N, 1990, J BIOL CHEM, V265, P10604; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; EGEBJERG J, 1994, IN PRESS P NATL ACAD; GALLO V, 1992, J NEUROSCI, V12, P1010; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MACKLER SA, 1993, MOL PHARMACOL, V44, P308; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; ROGERS SW, 1991, J NEUROSCI, V11, P2713; ROGERS SW, 1992, J NEUROSCI, V12, P4611; SAKIMURA K, 1992, NEURON, V8, P267, DOI 10.1016/0896-6273(92)90293-M; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; Thein SI., 1986, HUMAN GENETIC DIS PR, P33; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WISDEN W, 1993, J NEUROSCI, V13, P3581; WISDEN W, 1993, J NEUROSCI, V13, P582; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383	64	147	150	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					131	147		10.1016/0896-6273(94)90464-2	http://dx.doi.org/10.1016/0896-6273(94)90464-2			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	7519023				2022-12-17	WOS:A1994NZ24700010
J	WILLIAMS, JH; LI, YG; NAYAK, A; ERRINGTON, ML; MURPHY, KPSJ; BLISS, TVP				WILLIAMS, JH; LI, YG; NAYAK, A; ERRINGTON, ML; MURPHY, KPSJ; BLISS, TVP			THE SUPPRESSION OF LONG-TERM POTENTIATION IN RAT HIPPOCAMPUS BY INHIBITORS OF NITRIC-OXIDE SYNTHASE IS TEMPERATURE AND AGE-DEPENDENT	NEURON			English	Article							INDUCTION; FREQUENCY; STIMULATION; ACTIVATION; MESSENGER; BLOCKADE; RELEASE; NEURONS; INVITRO	At room temperature (23-degrees-C-25-degrees-C), the induction of long-term potentiation (LTP) in area CA1 of slices from young male Sprague-Dawley rats was depressed by preincubation with the nitric oxide synthase inhibitors N(G)-nitro-L-arginine (L-NA, 100 muM) and N(G)-nitro-L-arginine methyl ester (L-NAME, 100 muM). The D isomers were ineffective under the same conditions. Hemoglobin (20 muM) reduced but did not completely block LTP. Neither L-NA (at concentrations up to 1 mM) nor hemoglobin (20 muM) had any significant effect on LTP in slices from adult rats at room temperature, or in young rats at 29-degrees-C-30-degrees-C. These results suggest that nitric oxide is unlikely to play a role in the induction of LTP under physiological conditions.	SHANGHAI INST BRAIN RES,SHANGHAI,PEOPLES R CHINA; NATL INST MED RES,DIV NEUROPHYSIOL & NEUROPHARMACOL,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research								BLISS TVP, 1986, J PHYSIOL-LONDON, V377, P391, DOI 10.1113/jphysiol.1986.sp016193; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BON C, 1992, EUR J NEUROSCI, V4, P420, DOI 10.1111/j.1460-9568.1992.tb00891.x; CHETKOVICH DM, 1993, NEUROREPORT, V4, P919, DOI 10.1097/00001756-199307000-00020; COAN EJ, 1989, NEUROSCI LETT, V105, P205, DOI 10.1016/0304-3940(89)90038-4; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; GRIBKOFF VK, 1992, J NEUROPHYSIOL, V68, P639, DOI 10.1152/jn.1992.68.2.639; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; IZUMI Y, 1992, SCIENCE, V257, P1273, DOI 10.1126/science.1519065; KATO K, 1993, J NEUROPHYSIOL, V70, P1260, DOI 10.1152/jn.1993.70.3.1260; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LYNCH G, 1982, BRAIN RES, V244, P101, DOI 10.1016/0006-8993(82)90908-8; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; ROWLEY HL, 1993, BRAIN RES, V613, P49, DOI 10.1016/0006-8993(93)90452-S; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHUMAN EM, 1993, SEMIN NEUROSCI, V5, P207, DOI 10.1016/S1044-5765(05)80054-5; THOMPSON SM, 1985, J NEUROSCI, V5, P817; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	26	147	148	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					877	884		10.1016/0896-6273(93)90117-A	http://dx.doi.org/10.1016/0896-6273(93)90117-A			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	7694601				2022-12-17	WOS:A1993MJ04100009
J	KITAGAWA, K; SINOWAY, MP; YANG, C; GOULD, RM; COLMAN, DR				KITAGAWA, K; SINOWAY, MP; YANG, C; GOULD, RM; COLMAN, DR			A PROTEOLIPID PROTEIN GENE FAMILY - EXPRESSION IN SHARKS AND RAYS AND POSSIBLE EVOLUTION FROM AN ANCESTRAL GENE ENCODING A PORE-FORMING POLYPEPTIDE	NEURON			English	Article							PELIZAEUS-MERZBACHER DISEASE; NERVOUS-SYSTEM MYELIN; BOVINE BRAIN MYELIN; POINT MUTATION; MESSENGER-RNAS; INSITU HYBRIDIZATION; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; ESCHERICHIA-COLI; CNS MYELIN	The myelin proteolipid proteins (PLP and DM20) are believed to act as ''adhesive struts'' in the extracellular apposition of the CNS myelin sheath. These proteins have been considered late evolutionary developments, which arose de novo in the antecedents of early tetrapods. However, PCR primed with degenerate oligonucleotides corresponding to common segments of rat PLP/DM20 revealed three novel mRNAs in the brains of two elasmobranchs. These mRNAs are closely related to each other and to mammalian DM20, but lack the sequence that distinguishes PLP from DM20. We term the novel proteolipid proteins DM(alpha), DM(beta), and DM(gamma). At least DM(alpha) and DM(gamma) are highly expressed in white matter in myelinating shark brain. The DMs not only are highly homologous to each other, but also contain regions bearing similarities with segments of channel-forming regions of the nicotinic acetylcholine receptor and the glutamate receptor macromolecular complexes. Significantly, we find that across these segments, DM(alpha) and DM(gamma) are more similar to the channel proteins than the two channel proteins are to each other.	OSAKA UNIV, SCH MED, DEPT INTERNAL MED 1, FUKUSHIMA KU, OSAKA 553, JAPAN; COLUMBIA UNIV COLL PHYS & SURG, DEPT ANAT, NEW YORK, NY 10032 USA; OSAKA UNIV, SCH MED, DEPT CELL BIOL, OSAKA 553, JAPAN; NEW YORK STATE INST BASIC RES, MEMBRANE BIOL LAB, STATEN ISL, NY 10314 USA	Osaka University; Columbia University; Osaka University	KITAGAWA, K (corresponding author), CUNY MT SINAI SCH MED, BROOKDALE CTR MOLEC BIOL, NEW YORK, NY 10029 USA.				NINDS NIH HHS [NS 20147, NS 13980] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147, R01NS013980] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLBERG PE, 1992, NATURE, V358, P459, DOI 10.1038/358459a0; BALDINO F, 1989, METHOD ENZYMOL, V168, P761; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; BERNIER L, 1987, J NEUROSCI, V7, P2703; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; CAPPETTA H, 1987, HDB PALEOICHTHYOLO B, V3, P41; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DECOZAR M, 1987, BIOCHEM INT, V14, P833; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GARDINIER MV, 1988, J NEUROCHEM, V51, P360; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; GORR T, 1993, AM SCI, V81, P72; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; HUDSON LD, 1990, ANN NY ACAD SCI, V605, P155, DOI 10.1111/j.1749-6632.1990.tb42390.x; HUDSON LD, 1989, J CELL BIOL, V109, P717, DOI 10.1083/jcb.109.2.717; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kirschner D., 1984, MYELIN, P51; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LAI C, 1987, IMMUNOL REV, V100, P129, DOI 10.1111/j.1600-065X.1987.tb00530.x; LAURSEN RA, 1984, P NATL ACAD SCI-BIOL, V81, P2912, DOI 10.1073/pnas.81.9.2912; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; Maniatis T., 1982, MOL CLONING; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; NADON NL, 1990, DEVELOPMENT, V110, P529; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHIRAI S, 1992, COPEIA, P505; SIMONS R, 1987, BIOCHEM BIOPH RES CO, V146, P666, DOI 10.1016/0006-291X(87)90580-8; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Smeets W. J. A. J., 1983, CENTRAL NERVOUS SYST; SORG BA, 1987, J NEUROCHEM, V49, P1146, DOI 10.1111/j.1471-4159.1987.tb10005.x; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TINGBEALL HP, 1979, J MEMBRANE BIOL, V51, P33, DOI 10.1007/BF01869342; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x; WAEHNELDT TV, 1986, J NEUROCHEM, V46, P1387, DOI 10.1111/j.1471-4159.1986.tb01752.x; WAEHNELDT TV, 1989, J NEUROCHEM, V52, P1941, DOI 10.1111/j.1471-4159.1989.tb07281.x; WAEHNELDT TV, 1991, ENVIRON BIOL FISH, V32, P131, DOI 10.1007/BF00007449; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J	78	147	151	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					433	448		10.1016/0896-6273(93)90148-K	http://dx.doi.org/10.1016/0896-6273(93)90148-K			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398138				2022-12-17	WOS:A1993LY49800004
J	MAHANTHAPPA, NK; SCHWARTING, GA				MAHANTHAPPA, NK; SCHWARTING, GA			PEPTIDE GROWTH-FACTOR CONTROL OF OLFACTORY NEUROGENESIS AND NEURON SURVIVAL INVITRO - ROLES OF EGF AND TGF-BETA-S	NEURON			English	Article							FACTOR IMMUNOREACTIVE MATERIAL; MONOCLONAL-ANTIBODIES; RAT-BRAIN; MOUSE; EXPRESSION; DIFFERENTIATION; LOCALIZATION; CELLS; PROLIFERATION; EPITHELIUM	The Olfactory epithelium (OE) is unique in the mammalian nervous system as a site of continual neurogenesis. Though many studies have described this process in vivo and olfactory neurogenesis can be demonstrated in vitro, the specific factors that modulate this process have not been defined. Noting the common ectodermal origin and structural similarity between the OE and epidermis, peptide factors known to modulate epidermal differentiation were tested in OE cultures. Our results demonstrate that EGF acts as a mitogen for the basal cells that give rise to olfactory neurons and that transforming growth factor-betas (TGF-betas) promote neurogenesis. Using a neutralizing antibody, we show that it is likely that the endogenous neurogenic factor is TGF-beta2, or a very closely related factor.	HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	MAHANTHAPPA, NK (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, 200 TRAPELO RD, WALTHAM, MA 02254 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD005515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000953] Funding Source: NIH RePORTER; NICHD NIH HHS [HD05515] Funding Source: Medline; NIDCD NIH HHS [DC00953] Funding Source: Medline; NINDS NIH HHS [NS09167] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; Buss LW, 1987, EVOLUTION INDIVIDUAL; CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; CALOF AL, 1991, CIBA F SYMP, V160, P249; CHUAH MI, 1991, J NEUROSCI RES, V29, P172, DOI 10.1002/jnr.490290206; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; DIFIGLIA M, 1989, J NEUROSCI, V9, P4158; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; GORHAM JD, 1991, NEURON, V7, P485, DOI 10.1016/0896-6273(91)90300-O; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; GUTHRIE KM, 1991, J COMP NEUROL, V313, P95, DOI 10.1002/cne.903130107; KSANDER GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1831, DOI 10.1177/38.12.2254647; LAZAR LM, 1992, J NEUROSCI, V12, P1688; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; OLAND LA, 1990, J NEUROSCI, V10, P2096; OSBORN M, 1984, EUR J CELL BIOL, V34, P137; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; PURVES D, 1985, PRINCIPLES NEURAL DE; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; REH TA, 1989, J NEUROSCI, V9, P4179; REISS M, 1987, CANCER RES, V47, P6705; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RONNETT GV, 1991, J NEUROSCI, V11, P1243; SCHAUDIES RP, 1989, J BIOL CHEM, V264, P10447; SCHWARTING GA, 1992, J NEUROBIOL, V23, P130, DOI 10.1002/neu.480230204; SCHWARTING GA, 1991, BRAIN RES, V547, P239, DOI 10.1016/0006-8993(91)90967-Z; SUZUKI Y, 1991, CELL TISSUE RES, V266, P239, DOI 10.1007/BF00318179; WILCOX JN, 1988, MOL CELL BIOL, V8, P3415, DOI 10.1128/MCB.8.8.3415; YABE N, 1986, IN VITRO CELL DEV B, V22, P363; [No title captured]	35	147	151	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					293	305		10.1016/0896-6273(93)90319-M	http://dx.doi.org/10.1016/0896-6273(93)90319-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	7679915				2022-12-17	WOS:A1993KP68500016
J	WISDEN, W; MORRIS, BJ; DARLISON, MG; HUNT, SP; BARNARD, EA				WISDEN, W; MORRIS, BJ; DARLISON, MG; HUNT, SP; BARNARD, EA			DISTINCT GABAA RECEPTOR ALPHA-SUBUNIT MESSENGER-RNAS SHOW DIFFERENTIAL PATTERNS OF EXPRESSION IN BOVINE BRAIN	NEURON			English	Article											WISDEN, W (corresponding author), MRC,MOLEC NEUROBIOL UNIT,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		HUNT, STEPHEN P/C-1646-2008; Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Hunt, Stephen/0000-0001-9453-5505				AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BARNARD EA, 1988, GABA BENZODIAZEPINE, V2, P103; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOWERY NG, 1987, NEUROSCIENCE, V20, P365, DOI 10.1016/0306-4522(87)90098-4; BRAESTRUP C, 1981, J NEUROCHEM, V37, P333, DOI 10.1111/j.1471-4159.1981.tb00460.x; CARPENTER MB, 1983, HUMAN NEUROANATOMY, P643; CASH DJ, 1987, BIOCHEMISTRY-US, V26, P7562, DOI 10.1021/bi00398a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COOPER SJ, 1987, TRENDS PHARMACOL SCI, V8, P180, DOI 10.1016/0165-6147(87)90163-5; DEBLAS AL, 1988, J NEUROSCI, V8, P602; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENG G, 1981, NUCLEIC ACIDS RES, V9, P4173, DOI 10.1093/nar/9.16.4173; FAGG GE, 1983, NEUROSCIENCE, V9, P701, DOI 10.1016/0306-4522(83)90263-4; FAUL RLM, 1988, JNEUROSCIENCE, V26, P783; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FRY JP, 1985, NEUROSCIENCE, V14, P1091, DOI 10.1016/0306-4522(85)90279-9; GOCAYNE J, 1987, P NATL ACAD SCI USA, V84, P8296, DOI 10.1073/pnas.84.23.8296; GOLDBERG DA, 1980, P NATL ACAD SCI-BIOL, V77, P5794, DOI 10.1073/pnas.77.10.5794; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HEBEBRAND J, 1986, J NEUROCHEM, V47, P790; HOUSER CR, 1988, J NEUROSCI, V8, P1370; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LIPPA AS, 1982, LIFE SCI, V31, P1409, DOI 10.1016/0024-3205(82)90001-7; MANIATIS T, 1982, MOL CLONING LABORATO, P466; MONTMINY MR, 1984, P NATL ACAD SCI-BIOL, V81, P3337, DOI 10.1073/pnas.81.11.3337; MORRIS BJ, 1986, NEUROSCI LETT, V69, P104, DOI 10.1016/0304-3940(86)90423-4; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OLSEN RW, 1984, EUR J PHARMACOL, V99, P247, DOI 10.1016/0014-2999(84)90249-8; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RICHARDS JG, 1987, J NEUROSCI, V7, P1866; RICHARDS JG, 1986, NEUROLOGY NEUROBIOLO, V16, P629; ROBERTS R, 1986, BENZODIAZEPINE GABA, P1; SCHOCH P, 1985, NATURE, V314, P168, DOI 10.1038/314168a0; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SIEGHART W, 1988, NEUROSCI LETT, V86, P213, DOI 10.1016/0304-3940(88)90573-3; STUDY RE, 1981, P NATL ACAD SCI-BIOL, V78, P7180, DOI 10.1073/pnas.78.11.7180; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; UNNERSTALL JR, 1981, J PHARMACOL EXP THER, V218, P797; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; YOUNG WS, 1979, NATURE, V280, P393, DOI 10.1038/280393a0; YOUNG WS, 1986, NEUROSCI LETT, V70, P198	58	147	147	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1988	1	10					937	947		10.1016/0896-6273(88)90151-1	http://dx.doi.org/10.1016/0896-6273(88)90151-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R4674	2856089				2022-12-17	WOS:A1988R467400005
J	O'Connor, EC; Kremer, Y; Lefort, S; Harada, M; Pascoli, V; Rohner, C; Luscher, C				O'Connor, Eoin C.; Kremer, Yves; Lefort, Sandrine; Harada, Masaya; Pascoli, Vincent; Rohner, Clement; Luescher, Christian			Accumbal D1R Neurons Projecting to Lateral Hypothalamus Authorize Feeding	NEURON			English	Article							MELANIN-CONCENTRATING HORMONE; OPIOID RECEPTOR STIMULATION; VENTRAL TEGMENTAL AREA; MEDIUM SPINY NEURONS; NUCLEUS-ACCUMBENS; FOOD-INTAKE; ELECTRICAL-STIMULATION; SUBSTANTIA INNOMINATA; ENERGY-BALANCE; SHELL	Feeding satisfies metabolic need but is also controlled by external stimuli, like palatability or predator threat. Nucleus accumbens shell (NAcSh) projections to the lateral hypothalamus (LH) are implicated in mediating such feeding control, but the neurons involved and their mechanism of action remain elusive. We show that dopamine D1R-expressing NAcSh neurons (D1R-MSNs) provide the dominant source of accumbal inhibition to LH and provide rapid control over feeding via LH GABA neurons. In freely feeding mice, D1R-MSN activity reduced during consumption, while their optogenetic inhibition prolonged feeding, even in the face of distracting stimuli. Conversely, activation of D1R-MSN terminals in LH was sufficient to abruptly stop ongoing consumption, even during hunger. Direct inhibition of LH GABA neurons, which received input from D1R-MSNs, fully recapitulated these findings. Together, our study resolves a feeding circuit that overrides immediate metabolic need to allow rapid consumption control in response to changing external stimuli.	[O'Connor, Eoin C.; Kremer, Yves; Lefort, Sandrine; Pascoli, Vincent; Rohner, Clement; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Harada, Masaya] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, CREST Project,Sakyo Ku, Kyoto 6068509, Japan; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; Japan Science & Technology Agency (JST); Kyoto University; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Kremer, Yves/0000-0002-2319-1394; O'Connor, Eoin/0000-0002-7810-1915	Swiss National Science Foundation; National Center of Competence in Research (NCCR) SYNAPSY-The Synaptic Bases of Mental Diseases; European Research Council advanced grant (MeSSI)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) SYNAPSY-The Synaptic Bases of Mental Diseases(Swiss National Science Foundation (SNSF)); European Research Council advanced grant (MeSSI)	We thank members of the C. L. laboratory and M. T. C. Brown for discussion and comments on the manuscript; S. Startchik and the Bioimaging Platform at the University of Geneva for assistance with imaging analysis; E. Valjent for advice on immunohistochemistry; A. Holtmaat, Y. Bernardinelli, and D. Huber for providing virus constructs; and K. Deisseroth and the UNC viral vector core, Chapel Hill, for optogenetic effectors. This work was financed by a grant from the Swiss National Science Foundation, the National Center of Competence in Research (NCCR) SYNAPSY-The Synaptic Bases of Mental Diseases, and a European Research Council advanced grant (MeSSI).	Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Bocklisch C, 2013, SCIENCE, V341, P1521, DOI 10.1126/science.1237059; Brown MTC, 2012, NATURE, V492, P452, DOI 10.1038/nature11657; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; CROMWELL HC, 1993, BRAIN RES, V624, P1, DOI 10.1016/0006-8993(93)90053-P; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Faure A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011223; Fromentin G, 2012, NUTR RES REV, V25, P29, DOI 10.1017/S0954422411000175; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Hussain SS, 2013, INT J OBESITY, V37, P625, DOI 10.1038/ijo.2012.93; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Katsuura Y, 2011, AM J PHYSIOL-REG I, V301, pR244, DOI 10.1152/ajpregu.00406.2010; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Kupchik YM, 2015, NAT NEUROSCI, V18, P1230, DOI 10.1038/nn.4068; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; MOGENSON GJ, 1983, J NEUROSCI, V3, P189; MORGANE PJ, 1969, ANN NY ACAD SCI, V157, P806, DOI 10.1111/j.1749-6632.1969.tb12922.x; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Richard JM, 2011, J NEUROSCI, V31, P12866, DOI 10.1523/JNEUROSCI.1339-11.2011; Roitman MF, 2010, LEARN MEMORY, V17, P539, DOI 10.1101/lm.1869710; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sano H, 2007, J NEUROSCI, V27, P6948, DOI 10.1523/JNEUROSCI.0514-07.2007; Schoene C, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00081; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Spiegel TA, 2000, NEUROSCI BIOBEHAV R, V24, P229, DOI 10.1016/S0149-7634(99)00076-7; Stratford TR, 2012, BEHAV BRAIN RES, V226, P548, DOI 10.1016/j.bbr.2011.10.014; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Sunday SR, 1996, APPETITE, V26, P21, DOI 10.1006/appe.1996.0002; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tellez LA, 2012, J NEUROPHYSIOL, V108, P1739, DOI 10.1152/jn.00394.2012; Thompson RH, 2010, P NATL ACAD SCI USA, V107, P15235, DOI 10.1073/pnas.1009112107; Tripathi A, 2010, J COMP NEUROL, V518, P4649, DOI 10.1002/cne.22484; Urstadt KR, 2013, NEUROPHARMACOLOGY, V67, P176, DOI 10.1016/j.neuropharm.2012.10.027; van Kerkhof LWM, 2014, BRAIN STRUCT FUNCT, V219, P1181, DOI 10.1007/s00429-013-0558-y; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; WISE RA, 1974, BRAIN RES, V67, P187, DOI 10.1016/0006-8993(74)90272-8; Zhang JP, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00043; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007; Zheng HY, 2003, AM J PHYSIOL-REG I, V284, pR1436, DOI 10.1152/ajpregu.00781.2002	62	146	146	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2015	88	3					553	564		10.1016/j.neuron.2015.09.038	http://dx.doi.org/10.1016/j.neuron.2015.09.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX5TM	26593092	Bronze			2022-12-17	WOS:000365765400015
J	Williams, ME; Wilke, SA; Daggett, A; Davis, E; Otto, S; Ravi, D; Ripley, B; Bushong, EA; Ellisman, MH; Klein, G; Ghosh, A				Williams, Megan E.; Wilke, Scott A.; Daggett, Anthony; Davis, Elizabeth; Otto, Stefanie; Ravi, Deepak; Ripley, Beth; Bushong, Eric A.; Ellisman, Mark H.; Klein, Gerd; Ghosh, Anirvan			Cadherin-9 Regulates Synapse-Specific Differentiation in the Developing Hippocampus	NEURON			English	Article							LAMINA-SPECIFIC CONNECTIVITY; MOSSY FIBER BOUTONS; N-CADHERIN; CLASSIC CADHERINS; SPINE MORPHOGENESIS; TARGET RECOGNITION; DENTATE GYRUS; GRANULE CELLS; C-ELEGANS; IN-VIVO	Our understanding of mechanisms that regulate the differentiation of specific classes of synapses is limited. Here, we investigate the formation of synapses between hippocampal dentate gyrus (DG) neurons and their target CA3 neurons and find that DG neurons preferentially form synapses with CA3 rather than DG or CA1 neurons in culture, suggesting that specific interactions between DG and CA3 neurons drive synapse formation. Cadherin-9 is expressed selectively in DG and CA3 neurons, and downregulation of cadherin-9 in CA3 neurons leads to a selective decrease in the number and size of DG synapses onto CA3 neurons. In addition, loss of cadherin-9 from DG or CA3 neurons in vivo leads to striking defects in the formation and differentiation of the DG-CA3 mossy fiber synapse. These observations indicate that cadherin-9 bidirectionally regulates DG-CA3 synapse development and highlight the critical role of differentially expressed molecular cues in establishing specific connections in the mammalian brain.	[Williams, Megan E.; Wilke, Scott A.; Daggett, Anthony; Davis, Elizabeth; Otto, Stefanie; Ravi, Deepak; Ripley, Beth; Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Klein, Gerd] Univ Med Clin, Med Res Ctr, Sect Transplantat Immunol & Immunohematol, D-72072 Tubingen, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ghosh, A (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	aghosh@ucsd.edu	Klein, Gerd/C-8499-2013	ripley, beth/0000-0001-7723-169X; Williams, Megan/0000-0002-5461-4126	Autism Speaks; NIH [R01 NS052772, R01 NS067216]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216] Funding Source: NIH RePORTER	Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Webb for the PY antibody, H. Cline for the synaptophysin-GFP plasmid, P. Caroni for the membrane GFP plasmid, Y. Zou for confocal use, K. Tiglio, J. Fakhoury, and E. Kang for technical assistance, and A. Kolodkin, Y. Zou, Y. Jin, N. Spitzer, D. Berg, D. Trankner, and members of the Ghosh lab for comments and discussion. This work was supported by Autism Speaks (to M.E.W.) and NIH Grants R01 NS052772 (to A.G.) and R01 NS067216 (to A.G.).	Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Bekirov IH, 2002, NEUROSCIENCE, V115, P213, DOI 10.1016/S0306-4522(02)00375-5; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; CAMARDO J, 1983, J NEUROSCI, V3, P2614; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; GRABS D, 1994, EUR J NEUROSCI, V6, P1765, DOI 10.1111/j.1460-9568.1994.tb00569.x; Grosse G, 1998, J NEUROSCI RES, V51, P602, DOI 10.1002/(SICI)1097-4547(19980301)51:5<602::AID-JNR7>3.0.CO;2-J; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Poskanzer K, 2003, J NEUROSCI, V23, P2294; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rose D, 2000, MICROSC RES TECHNIQ, V49, P3, DOI 10.1002/(SICI)1097-0029(20000401)49:1<3::AID-JEMT2>3.0.CO;2-E; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vogt AK, 2005, NEUROSCIENCE, V134, P783, DOI 10.1016/j.neuroscience.2005.04.039; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	56	146	147	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					640	655		10.1016/j.neuron.2011.06.019	http://dx.doi.org/10.1016/j.neuron.2011.06.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867881	Green Accepted, Bronze			2022-12-17	WOS:000294521600010
J	Taverna, E; Huttner, WB				Taverna, Elena; Huttner, Wieland B.			Neural Progenitor Nuclei IN Motion	NEURON			English	Review							CELL MARKER PROMININ-1; NEUROEPITHELIAL CELLS; ASYMMETRIC DIVISION; NEURONAL MIGRATION; PROLIFERATIVE CHARACTERISTICS; CORTICAL NEUROGENESIS; DEVELOPING NEOCORTEX; VENTRICULAR ZONE; EPENDYMAL LAYER; PLASMA-MEMBRANE	Interkinetic nuclear migration (INM), the movement of neuroepithelial and radial glial cell nuclei along the apical-basal axis in concert with the cell cycle, underlies the pseudostratification of the ventricular zone (VZ). Recent studies provide insight into the molecular mechanisms of INM and its effects on neural progenitor cell fate determination. Moreover, INM not only has a key role in increasing the VZ progenitor pool, but also may have set the stage for the evolution of subventricular zone progenitors implicated in cortical expansion.	[Taverna, Elena; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	taverna, elena/O-8180-2014; Huttner, Wieland B./P-4080-2018; Taverna, Elena/AFW-4935-2022	taverna, elena/0000-0002-2430-4725; 	DFG [SFB 655, A2]; DFG-funded Center for Regenerative Therapies Dresden; Fonds der Chemischen Industrie	DFG(German Research Foundation (DFG)); DFG-funded Center for Regenerative Therapies Dresden(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank Eli Knust, Caren Norden, and Iva Tolic-Norrelykke, as well as Yoko Arai, Anne-Marie Marzesco, Felipe Mora-Bermudez, Jeremy Pulvers, and Michaela Wilsch-Brauninger from our lab, for their helpful comments on the manuscript. W.B.H. was supported by a grant from the DFG (SFB 655, A2), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie.	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bittman K, 1997, J NEUROSCI, V17, P7037; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen RW, 1998, SIAM J DISCRETE MATH, V11, P183, DOI 10.1137/S0895480195282148; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; MARSTON S, 1995, INT J BIOCHEM CELL B, V27, P97, DOI 10.1016/1357-2725(94)00080-U; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; MESSIER PE, 1978, EXPERIENTIA, V34, P289, DOI 10.1007/BF01922992; Minobe S, 2009, NEUROSCI RES, V63, P294, DOI 10.1016/j.neures.2009.01.006; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Pearson RA, 2004, EUR J NEUROSCI, V19, P2435, DOI 10.1111/j.0953-816X.2004.03338.x; Pilaz LJ, 2009, P NATL ACAD SCI USA, V106, P21924, DOI 10.1073/pnas.0909894106; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reinsch S, 1998, J CELL SCI, V111, P2283; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Saito K, 2003, DEV GROWTH DIFFER, V45, P219; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1972, J ANAT, V113, P109; SMART IHM, 1972, J ANAT, V111, P365; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2007, MOL BIOSYST, V3, P583, DOI 10.1039/b703878j; Tamai H, 2007, GENES CELLS, V12, P983, DOI 10.1111/j.1365-2443.2007.01113.x; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tolic-Norrelykke IM, 2008, EUR BIOPHYS J BIOPHY, V37, P1271, DOI 10.1007/s00249-008-0321-0; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsuda S, 2010, J CELL SCI, V123, P484, DOI 10.1242/jcs.057851; Ueno M, 2006, BRAIN RES, V1088, P57, DOI 10.1016/j.brainres.2006.03.042; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	66	146	150	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					906	914		10.1016/j.neuron.2010.08.027	http://dx.doi.org/10.1016/j.neuron.2010.08.027			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869589	Bronze			2022-12-17	WOS:000282801100004
J	Cheng, LE; Song, W; Looger, LL; Jan, LY; Jan, YN				Cheng, Li E.; Song, Wei; Looger, Loren L.; Jan, Lily Yeh; Jan, Yuh Nung			The Role of the TRP Channel NompC in Drosophila Larval and Adult Locomotion	NEURON			English	Article							MECHANOSENSORY TRANSDUCTION; STRETCH-RECEPTOR; BEHAVIOR; NEURONS; HEARING; FEEDBACK; ENCODES	The generation of coordinated body movements relies on sensory feedback from mechanosensitive proprioceptors. We have found that the proper function of NompC, a putative mechanosensitive TRP channel, is not only required for fly locomotion, but also crucial for larval crawling. Calcium imaging revealed that NompC is required for the activation of two subtypes of sensory neurons during peristaltic muscle contractions. Having isolated a full-length nompC cDNA with a protein coding sequence larger than previously predicted, we demonstrate its function by rescuing locomotion defects in nompC mutants, and further show that antibodies against the extended C terminus recognize NompC in chordotonal ciliary tips. Moreover, we show that the ankyrin repeats in NompC are required for proper localization and function of NompC in vivo and are required for association of NompC with microtubules. Taken together, our findings suggest that NompC mediates proprioception in locomotion and support its role as a mechanosensitive channel.	[Cheng, Li E.; Song, Wei; Looger, Loren L.; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Cheng, Li E.; Song, Wei; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Cheng, Li E.; Song, Wei; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Song, Wei/0000-0001-6531-8317; Jan, Lily/0000-0003-3938-8498	NINDS [R37NS040929]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ulrike Heberlein, Kazuo Emoto, Charles Zuker, and Maurice Kernan for fly stocks; Taihao Jin, Quan Yuan, James Berg, and other members of the Jan lab for experimental advice; and Jay Parrish and Peter Soba for comments on the manuscript. This work was supported by a Javits Neuroscience Investigator Award R37NS040929 from NINDS (Y.N.J). L.E.C. and W.S. are research associates and L.Y.J. and Y.N.J. are investigators of the Howard Hughes Medical Institute. L.L.L. is an HHMI Janelia Farm Research Campus group leader.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; FINLAYSON LH, 1958, PROC R SOC SER B-BIO, V148, P433, DOI 10.1098/rspb.1958.0037; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KEMAN MJ, 2007, PFLUGERS ARCH, V454, P703; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Lee E, 2008, CURR BIOL, V18, P1899, DOI 10.1016/j.cub.2008.11.020; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011012; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Martinac B, 2001, CELL PHYSIOL BIOCHEM, V11, P61, DOI 10.1159/000047793; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Schrader S, 2007, ARTHROPOD STRUCT DEV, V36, P157, DOI 10.1016/j.asd.2006.08.014; Smetacek V, 2004, NATURE, V432, P21, DOI 10.1038/432021a; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; SUKHAREV S, 2004, SCI STKE, pRE4; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang JW, 1997, J NEUROGENET, V11, P231, DOI 10.3109/01677069709115098; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010	36	146	151	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 12	2010	67	3					373	380		10.1016/j.neuron.2010.07.004	http://dx.doi.org/10.1016/j.neuron.2010.07.004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	639AJ	20696376	Green Accepted, Bronze			2022-12-17	WOS:000280942900007
J	Fernandez-Alfonso, T; Kwan, R; Ryan, TA				Fernandez-Alfonso, Tomas; Kwan, Ricky; Ryan, Timothy A.			Synaptic vesicles interchange their membrane proteins with a large surface reservoir during recycling	NEURON			English	Article							FROG NEUROMUSCULAR JUNCTION; NERVE-TERMINALS; HIPPOCAMPAL SYNAPSES; PLASMA-MEMBRANE; POOL; EXOCYTOSIS; MOBILIZATION; TRANSMITTER; ENDOCYTOSIS; RELEASE	During recycling of synaptic vesicles (SVs), the retrieval machinery faces the challenge of recapturing SV proteins in a timely and precise manner. The significant dilution factor that would result from equilibration of vesicle proteins with the much larger cell surface would make recapture by diffusional encounter with the endocytic retrieval machinery unlikely. If SV proteins exchanged with counterparts residing at steady state on the cell surface, the dilution problem would be largely avoided. In this scenario, during electrical activity, endocytosis would be driven by the concentration of a pre-existing pool of SVs residing on the axonal or synaptic surface rather than the heavily diluted postfusion vesicular pool. Using both live cell imaging of endogenous synaptotagmin la (sytla) as well as pHluorin-tagged sytla and VAMP-2, we show here that synaptic vesicle proteins interchange with a large pool on the cell axonal surface whose concentration is similar to 10-fold lower than that in SVs.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Fernandez Alfonso, Tomas/0000-0002-9339-6678; Ryan, Timothy/0000-0003-2533-9548	NINDS NIH HHS [R01 NS036942] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; FERNANDEZALFONS.T, 2006, IN PRESS TRENDS CELL; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Mitchell SJ, 2004, J NEUROSCI, V24, P4884, DOI 10.1523/JNEUROSCI.0174-04.2004; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Poskanzer KE, 2004, NEUROPHARMACOLOGY, V47, P714, DOI 10.1016/j.neuropharm.2004.07.026; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	24	146	148	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					179	186		10.1016/j.neuron.2006.06.008	http://dx.doi.org/10.1016/j.neuron.2006.06.008			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846853	Bronze			2022-12-17	WOS:000239535100006
J	Genovesio, A; Brasted, PJ; Mitz, AR; Wise, SP				Genovesio, A; Brasted, PJ; Mitz, AR; Wise, SP			Prefrontal cortex activity related to abstract response strategies	NEURON			English	Article							NEURONAL-ACTIVITY; WORKING-MEMORY; FRONTAL-CORTEX; VISUOSPATIAL ATTENTION; VISUAL CATEGORIZATION; PARKINSONS-DISEASE; TEMPORAL-ORDER; SINGLE NEURONS; BASAL GANGLIA; TASK	Many monkeys adopt abstract response strategies as they learn to map visual symbols to responses by trial and error. According to the repeat-stay strategy, if a symbol repeats from a previous, successful trial, the monkeys should stay with their most recent response choice. According to the change-shift strategy, if the symbol changes, the monkeys should shift to a different choice. We recorded the activity of prefrontal cortex neurons while monkeys chose responses according to these two strategies. Many neurons had activity selective for the strategy used. In a subsequent block of trials, the monkeys learned fixed stimulus-response mappings with the same stimuli. Some neurons had activity selective for choosing responses based on fixed mappings, others for choosing based on abstract strategies. These findings indicate that the prefrontal cortex contributes to the implementation of the abstract response strategies that monkeys use during trial-and-error learning.	NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Wise, SP (corresponding author), NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA.	stevenwise@mail.nih.gov		Genovesio, Aldo/0000-0003-2521-143X; , Andrew/0000-0002-8045-0970	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001092] Funding Source: NIH RePORTER; NIMH NIH HHS [Z01 MH001092-27] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Brass M, 2003, NEUROIMAGE, V20, P1026, DOI 10.1016/S1053-8119(03)00357-4; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; BUNGE SA, 2005, IN PRESS COGN AFFECT; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Folstein JR, 2004, J EXP PSYCHOL LEARN, V30, P1026, DOI 10.1037/0278-7393.30.5.1026; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Gaffan D, 2002, J NEUROSCI, V22, P7288; Gaffan D, 2002, PHILOS T R SOC B, V357, P1111, DOI 10.1098/rstb.2002.1110; Goldman-Rakic PS, 1987, HDB PHYSL 1, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GREEN CG, 1966, SIGNAL DETECTION THE; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Huettel SA, 2004, NEUROREPORT, V15, P1883, DOI 10.1097/00001756-200408260-00009; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; Koski L, 2002, NEUROPSYCHOLOGIA, V40, P1059, DOI 10.1016/S0028-3932(01)00140-3; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; Miller EK, 1996, J NEUROSCI, V16, P5154; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Parker A, 1998, NEUROPSYCHOLOGIA, V36, P259, DOI 10.1016/S0028-3932(97)00112-7; Pessoa L, 2003, J NEUROSCI, V23, P3990; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pinker S., 1999, WORD RULES; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; Shohamy D, 2004, BEHAV NEUROSCI, V118, P676, DOI 10.1037/0735-7044.118.4.676; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Swainson R, 2001, NEUROCASE, V7, P433, DOI 10.1076/neur.7.5.433.16248; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Zhang J, 1997, J NEUROSCI, V17, P2227	69	146	146	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					307	320		10.1016/j.neuron.2005.06.006	http://dx.doi.org/10.1016/j.neuron.2005.06.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039571	Green Accepted, Bronze			2022-12-17	WOS:000230693900016
J	Touryan, J; Felsen, G; Dan, Y				Touryan, J; Felsen, G; Dan, Y			Spatial structure of complex cell receptive fields measured with natural images	NEURON			English	Article							CAT STRIATE CORTEX; VISUAL CORTICAL-NEURONS; INFORMATION-TRANSMISSION; NEURAL RESPONSES; V1 NEURONS; STATISTICS; ORGANIZATION; SEQUENCES; STIMULI; MONKEY	Neuronal receptive fields (RFs) play crucial roles in visual processing. While the linear RFs of early neurons have been well studied, RFs of cortical complex cells are nonlinear and therefore difficult to characterize, especially in the context of natural stimuli. In this study, we used a nonlinear technique to compute the RFs of complex cells from their responses to natural images. We found that each RF is well described by a small number of subunits, which are oriented, localized, and bandpass. These subunits contribute to neuronal responses in a contrast-dependent, polarity invariant manner, and they can largely predict the orientation and spatial frequency tuning of the cell. Although the RIF structures measured with natural images were similar to those measured with random stimuli, natural images were more effective for driving complex cells, thus facilitating rapid identification of the subunits. The subunit RF model provides a useful basis for understanding cortical processing of natural stimuli.	Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Touryan, Jonathan/AAA-7108-2019	Touryan, Jonathan/0000-0001-7343-7869; Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY012561] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12561] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GASKA JP, 1994, VISUAL NEUROSCI, V11, P805, DOI 10.1017/S0952523800003102; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lau B, 2002, P NATL ACAD SCI USA, V99, P8974, DOI 10.1073/pnas.122173799; LEHKY SR, 1992, J NEUROSCI, V12, P3568; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; Mechler F, 2002, J NEUROSCI, V22, P6129; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Prenger R, 2004, NEURAL NETWORKS, V17, P663, DOI 10.1016/j.neunet.2004.03.008; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rust NC, 2004, NEUROCOMPUTING, V58, P793, DOI 10.1016/j.neucom.2004.01.128; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smyth D, 2003, J NEUROSCI, V23, P4746; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1244, DOI 10.1152/jn.1985.53.5.1244; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Touryan J, 2002, J NEUROSCI, V22, P10811; Touryan J, 2001, CURR OPIN NEUROBIOL, V11, P443, DOI 10.1016/S0959-4388(00)00232-4; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; WIENER N, 1958, NONLINEAR PROBLEMS R	50	146	146	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					781	791		10.1016/j.neuron.2005.01.029	http://dx.doi.org/10.1016/j.neuron.2005.01.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748852	Bronze			2022-12-17	WOS:000227446700016
J	Lu, HC; Gonzalez, E; Crair, MC				Lu, HC; Gonzalez, E; Crair, MC			Barrel cortex critical period plasticity is independent of changes in NMDA receptor subunit composition	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; OCULAR DOMINANCE PLASTICITY; D-ASPARTATE RECEPTOR; MICE LACKING; FUNCTIONAL-PROPERTIES; VISUAL-CORTEX; DEVELOPMENTAL REGULATION; SOMATOSENSORY CORTEX; NEURONAL PATTERNS	The regulation of NMDA receptor (NMDAR) subunit composition and expression during development is thought to control the process of thalamocortical afferent innervation, segregation, and plasticity. Thalamocortical synaptic plasticity in the mouse is dependent on NMDARs containing the NR2B subunit, which are the dominant form during the "critical period" window for plasticity. Near the end of the critical period there is a gradual increase in the contribution of NR2A subunits that happens in parallel to changes in NMDAR-mediated current kinetics. However, no extension of the critical period occurs in NR2A knockout mice, despite the fact that NMDA subunit composition and current kinetics remain immature past the end of the critical period. These data suggest that regulation of NMDAR subunit composition is not essential for closing the critical period plasticity window in mouse somatosensory barrel cortex.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Crair, MC (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza,S-603, Houston, TX 77030 USA.	mcrair@bcm.tmc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011034] Funding Source: NIH RePORTER; NIMH NIH HHS [MH62639] Funding Source: Medline; NINDS NIH HHS [F32 NS011034, NS11034] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; BEAR MF, 1990, J NEUROSCI, V10, P909; Bear MF, 1996, J PHYSIOL-PARIS, V90, P223, DOI 10.1016/S0928-4257(97)81428-3; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Cao ZP, 2000, BRAIN RES, V859, P26, DOI 10.1016/S0006-8993(99)02450-6; Cao ZP, 2000, BRAIN RES, V868, P296, DOI 10.1016/S0006-8993(00)02343-X; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Catalano SM, 1997, J NEUROSCI, V17, P8376; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FOX K, 1994, J NEUROSCI, V14, P7665; FOX K, 1989, J NEUROSCI, V9, P2443; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Glazewski S, 1999, CEREB CORTEX, V9, P249, DOI 10.1093/cercor/9.3.249; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kiyama Y, 1998, J NEUROSCI, V18, P6704; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Rema V, 1998, J NEUROSCI, V18, P10196; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHOEPFER R, 1994, PROG NEUROBIOL, V42, P353, DOI 10.1016/0301-0082(94)90076-0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; STROMINGER RN, 1987, J NEUROSCI METH, V22, P113, DOI 10.1016/0165-0270(87)90004-5; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2000, J NEUROPHYSIOL, V83, P616, DOI 10.1152/jn.2000.83.1.616; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Vallano ML, 1996, J NEUROSCI, V16, P631; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; WANG YH, 1995, J NEUROCHEM, V65, P176; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Woolsey T.A., 1990, P461; ZHONG J, 1995, J NEUROCHEM, V64, P531	86	146	150	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					619	634		10.1016/S0896-6273(01)00501-3	http://dx.doi.org/10.1016/S0896-6273(01)00501-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719203	Bronze			2022-12-17	WOS:000172363900009
J	Michikawa, T; Hirota, J; Kawano, S; Hiraoka, M; Yamada, M; Furuichi, T; Mikoshiba, K				Michikawa, T; Hirota, J; Kawano, S; Hiraoka, M; Yamada, M; Furuichi, T; Mikoshiba, K			Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,14,5-trisphosphate receptor	NEURON			English	Article							RECONSTITUTED LIPID VESICLES; LONG-TERM DEPRESSION; SMOOTH-MUSCLE CELLS; 1,4,5-TRISPHOSPHATE RECEPTOR; 1,4,5,-TRISPHOSPHATE RECEPTOR; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; PURKINJE NEURONS; MOUSE CEREBELLUM; CA2+ FLUX	The dependency of purified mouse cerebellar type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1)/Ca2+ channel function on cytoplasmic Ca2+ was examined. In contrast to the channels in crude systems, the purified IP(3)R1 reconstituted into planar lipid bilayers did not show the bell-shaped dependence on Ca2+. It was activated with increasing Ca2+ sublinearly without inhibition even up to 200 mu M. The addition of calmodulin to the cytoplasmic side inhibited the channel at high Ca2+ concentrations. Calmodulin antagonists reversed the Ca2+-dependent inactivation of the native channels in cerebellar microsomes. These results indicate that the bell-shaped dependence on cytoplasmic Ca2+ is not an intrinsic property of the IP(3)R1, and the Ca2+-dependent inactivation is directly mediated by calmodulin.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan; Japan Sci & Technol Corp, Exploratory Res Adv Technol, Mikoshiba Calciosignal Net Project, Tokyo 1130021, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Cardiovasc Dis, Tokyo 1138510, Japan; Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); RIKEN	Michikawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan.	takamich@lms.u-tokyo.ac.jp	Hirota, Junji/O-9315-2019; Mikoshiba, Katsuhiko/N-7943-2015; Hirota, Junji/G-1357-2019; Yamada, Maki/U-5251-2019; Yamada, Maki K./A-1573-2015; Furuichi, Teiichi/B-5086-2014	Hirota, Junji/0000-0002-5741-0655; Hirota, Junji/0000-0002-5741-0655; Yamada, Maki K./0000-0002-1956-6069; Furuichi, Teiichi/0000-0002-9676-1888				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ASHLEY RH, 1990, J GEN PHYSIOL, V95, P981, DOI 10.1085/jgp.95.5.981; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Colquhoun David, 1995, P483; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.ph.55.030193.002235; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HIROTA J, 1995, J BIOL CHEM, V270, P19046, DOI 10.1074/jbc.270.32.19046; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; LIN CT, 1980, J CELL BIOL, V85, P473, DOI 10.1083/jcb.85.2.473; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1993, METH NEUROSCI, V18, P247; MIKOSHIBA K, 1993, TRENDS PHARMACOL SCI, V14, P86, DOI 10.1016/0165-6147(93)90069-V; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; NAKADE S, 1994, J BIOL CHEM, V269, P6735; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; WATRAS J, 1991, J NEUROSCI, V11, P3239; WORLEY PF, 1989, J NEUROSCI, V9, P339; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083	60	146	148	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1999	23	4					799	808		10.1016/S0896-6273(01)80037-4	http://dx.doi.org/10.1016/S0896-6273(01)80037-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482245	Bronze			2022-12-17	WOS:000082280900022
J	von Gersdorff, H; Sakaba, T; Berglund, K; Tachibana, M				von Gersdorff, H; Sakaba, T; Berglund, K; Tachibana, M			Submillisecond kinetics of glutamate release from a sensory synapse	NEURON			English	Article							RETINAL BIPOLAR CELLS; ADRENAL CHROMAFFIN CELLS; FROG NEUROMUSCULAR-JUNCTION; SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; RECEPTOR DESENSITIZATION; HORIZONTAL CELLS; CALCIUM CHANNELS; TIME-COURSE; NEUROTRANSMITTER RELEASE	Exocytosis-mediated glutamate release from ribbon-type synaptic terminals of retinal bipolar cells was studied using AMPA receptors and simultaneous membrane capacitance measurements. Release onset (delay <0.8 ms) and offset were closely tied to Ca2+ channel opening and closing. Asynchronous release was not copious and we estimate that there are similar to 5 Ca2+ channels per docked synaptic vesicle. Depending on Ca2+ current amplitude, release occurred in a single fast bout or in two successive bouts with fast and slow onset kinetics. The second, slower bout may reflect a mobilization rate of reserve vesicles toward fusion sites that is accelerated by increasing Ca2+ influx. Bipolar cell synaptic ribbons thus are remarkably versatile signal transducers, capable of transmitting rapidly changing sensory input, as well as sustained stimuli, due to their large pool of releasable vesicles.	Univ Tokyo, Dept Psychol, Grad Sch Humanities & Sociol, Bunkyo Ku, Tokyo 1130033, Japan; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	University of Tokyo; Max Planck Society	Tachibana, M (corresponding author), Univ Tokyo, Dept Psychol, Grad Sch Humanities & Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	itmasao@hongo.ecc.u-tokyo.ac.jp		Sakaba, Takeshi/0000-0003-0688-7717				ADLER EM, 1991, J NEUROSCI, V11, P1496; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BAYLOR DA, 1977, J PHYSIOL-LONDON, V271, P425, DOI 10.1113/jphysiol.1977.sp012007; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; Cousin MA, 1997, J NEUROCHEM, V69, P1927; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUKADA Y, 1971, VISION RES, V11, P227, DOI 10.1016/0042-6989(71)90187-8; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GLEASON E, 1994, NEURON, V13, P1109, DOI 10.1016/0896-6273(94)90049-3; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; LUKASIEWICZ PD, 1995, J NEUROSCI, V15, P6189; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Morgans CW, 1996, J NEUROSCI, V16, P6713; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P1097, DOI 10.1152/jn.1989.61.6.1097; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAVIOLA E, 1982, J COMP NEUROL, V209, P233, DOI 10.1002/cne.902090303; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Roska B, 1998, J NEUROSCI, V18, P3451; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SAITO T, 1979, J GEN PHYSIOL, V73, P73, DOI 10.1085/jgp.73.1.73; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; SCHMIDT KF, 1994, P NATL ACAD SCI USA, V91, P8288, DOI 10.1073/pnas.91.17.8288; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SHERRY DM, 1993, J COMP NEUROL, V329, P188, DOI 10.1002/cne.903290204; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yazejian B, 1997, J NEUROSCI, V17, P2990; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	96	146	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1177	1188		10.1016/S0896-6273(00)80634-0	http://dx.doi.org/10.1016/S0896-6273(00)80634-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856472	Bronze			2022-12-17	WOS:000077386100027
J	Stoeckli, ET; Sonderegger, P; Pollerberg, GE; Landmesser, LT				Stoeckli, ET; Sonderegger, P; Pollerberg, GE; Landmesser, LT			Interference with axonin-1 and NrCAM interactions unmasks a floor-plate activity inhibitory for commissural axons	NEURON			English	Article							EMBRYO SPINAL-CORD; CHICK-EMBRYO; ADHESION MOLECULES; NERVOUS-SYSTEM; GROWTH CONES; GUIDANCE; INTERNEURONS; ORIENTATION; PROTEIN; ROLES	Axonin-1 and NrCAM were previously shown to be involved in the in vivo guidance of commissural growth cones across the floor plate of the embryonic chicken spinal cord. To further characterize their role in axon pathfinding, we developed a two-dimensional coculture system of commissural and floor-plate explants in which it was possible to study the behavior of growth cones upon floor- plate contact. Although commissural axons readily entered the floor plate under control conditions, perturbations of either axonin-1 or NrCAM interactions prevented the growth cones from entering the floor-plate explants. The presence of anti-axonin-1 resulted in the collapse of commissural growth cones upon contact with the floor plate. The perturbation of NrCAM interactions also resulted in an avoidance of the floor plate, but without inducing growth-cone collapse. Therefore, axonin-1 and NrCAM are crucial for the contact-mediated interaction between commissural growth cones and the floor plate, which in turn is required for the proper guidance of the axons across the ventral midline and their subsequent rostral turn into the longitudinal axis.	CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106; UNIV ZURICH,INST BIOCHEM,CH-8057 ZURICH,SWITZERLAND; MAX PLANCK INST DEV BIOL,D-72074 TUBINGEN,GERMANY	Case Western Reserve University; University of Zurich; Max Planck Society				Stoeckli, Esther/0000-0002-8485-0648	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019640] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 19640] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Bruemmendorf Thomas, 1993, Journal of Neurochemistry, V61, P1207; Burden-Gulley Susan M., 1995, Seminars in Developmental Biology, V6, P79, DOI 10.1016/S1044-5781(06)80017-4; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; DELAROSA EJ, 1990, J CELL BIOL, V111, P3087, DOI 10.1083/jcb.111.6.3087; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOODMAN CS, 1993, NEURON S, V10, P77; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MYERS PZ, 1993, J NEUROSCI, V13, P115; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Rathjen F. G, 1991, SEMIN NEUROSCI, V3, P297, DOI 10.1016/1044-5765(91)90047-R; Rathjen FG, 1991, CURR OPIN CELL BIOL, V3, P992, DOI 10.1016/0955-0674(91)90119-J; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHIGA T, 1990, DEV BRAIN RES, V55, P209, DOI 10.1016/0165-3806(90)90202-A; SHIGA T, 1991, J COMP NEUROL, V310, P2334; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; YAGINUMA H, 1990, DEVELOPMENT, V108, P705	30	146	146	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					209	221		10.1016/S0896-6273(00)80262-7	http://dx.doi.org/10.1016/S0896-6273(00)80262-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052792	Green Accepted, Bronze			2022-12-17	WOS:A1997WK82200005
J	SCHLIMGEN, AK; HELMS, JA; VOGEL, H; PERIN, MS				SCHLIMGEN, AK; HELMS, JA; VOGEL, H; PERIN, MS			NEURONAL PENTRAXIN, A SECRETED PROTEIN WITH HOMOLOGY TO ACUTE-PHASE PROTEINS OF THE IMMUNE-SYSTEM	NEURON			English	Article							SERUM AMYLOID-P; C-REACTIVE PROTEIN; CLASSICAL COMPLEMENT PATHWAY; COMPONENT; TAIPOXIN; SEQUENCE; EXPRESSION; ACTIVATION; COMPLEXES; BINDING	We have identified, by affinity chromatography, a binding protein for the snake venom toxin taipoxin, The sequence of this 47 kDa protein is unique, is characteristic of a secreted protein, and has homology to the acute phase proteins serum amyloid P protein and C-reactive protein of the pentraxin family, We have named this protein neuronal pentraxin (NP), as Northern analysis and in situ hybridization demonstrate high message levels in neurons of cerebellum, hippocampus, and cerebral cortex, Because NP may be released synaptically and has homology to immune proteins potentially involved in uptake of lipidic, toxic, or other antigenic material, we suggest that NP may be involved in a general uptake of synaptic macromolecules.	BAYLOR COLL MED,DEPT OTORHINOLARYNGOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	SCHLIMGEN, AK (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.			Vogel, Otto Hannes/0000-0002-0960-3508; Helms, Jill/0000-0002-0463-396X				AGRAWAL A, 1993, J BIOL CHEM, V267, P25352; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Banker G., 1991, CULTURING NERVE CELL; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; BROWN MR, 1993, J IMMUNOL, V151, P2087; CHRISTNER RB, 1994, J BIOL CHEM, V269, P9760; CULLCANDY SG, 1976, NEUROSCIENCE, V1, P175, DOI 10.1016/0306-4522(76)90074-9; DODDS D, 1995, IN PRESS J NEUROCHEM; DOWTON SB, 1989, J IMMUNOL, V143, P3776; DOWTON SB, 1990, BIOCHEM J, V270, P553, DOI 10.1042/bj2700553; DUFTON MJ, 1983, EUR J BIOCHEM, V137, P545, DOI 10.1111/j.1432-1033.1983.tb07860.x; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; FOHLMAN J, 1979, EUR J BIOCHEM, V94, P531, DOI 10.1111/j.1432-1033.1979.tb12922.x; GATES CA, 1990, TOXICON, V28, P1303, DOI 10.1016/0041-0101(90)90095-O; HICKS PS, 1992, J IMMUNOL, V149, P3689; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; KAMENSKAYA MA, 1974, ACTA PHYSIOL SCAND, V90, P716, DOI 10.1111/j.1748-1716.1974.tb05639.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Lee C-Y., 1979, HDB EXPT PHARM; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MOLD C, 1982, ANN NY ACAD SCI, V389, P251, DOI 10.1111/j.1749-6632.1982.tb22141.x; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; PERIN MS, 1988, EMBO J, V7, P2697, DOI 10.1002/j.1460-2075.1988.tb03123.x; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; STRONG PN, 1987, CELLULAR MOL BASIS C, P534; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TZENG MC, 1989, BIOCHEM BIOPH RES CO, V165, P689, DOI 10.1016/S0006-291X(89)80021-X; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; Wilkinson D.G., 1993, ESSENTIAL DEV BIOL P, P257; YING SC, 1993, J IMMUNOL, V150, P169; ZAREI MM, 1994, J GEN PHYSIOL, V103, P231, DOI 10.1085/jgp.103.2.231	40	146	151	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					519	526		10.1016/0896-6273(95)90308-9	http://dx.doi.org/10.1016/0896-6273(95)90308-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695898	Bronze			2022-12-17	WOS:A1995QP23000005
J	VOROBJEV, VS; SHARONOVA, IN; WALSH, IB; HAAS, HL				VOROBJEV, VS; SHARONOVA, IN; WALSH, IB; HAAS, HL			HISTAMINE POTENTIATES N-METHYL-D-ASPARTATE RESPONSES IN ACUTELY ISOLATED HIPPOCAMPAL-NEURONS	NEURON			English	Article							RECEPTOR DESENSITIZATION; NMDA RECEPTOR; POTASSIUM CONDUCTANCE; DIVALENT-CATIONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; XENOPUS-OOCYTES; POLYAMINES; BRAIN; GLYCINE	N-methyl-D-aspartate (NMDA-evoked currents were recorded from acutely isolated rat hippocampal neurons, using the whole-cell patch-clamp technique and a rapid perfusion system. Histamine, at concentrations from 0.5 to 100 muM, reversibly enhanced NMDA currents by up to 50%. The effect cannot be ascribed to activation of the known histamine receptors (H-1, H-2, H-3) but is occluded by spermine. These results suggest an interaction of histamine with the polyamine-binding site on the NMDA receptor complex. This modulatory action could allow the histaminergic system to determine time and loci of NMDA receptor-mediated events, such as memory formation according to behavioral state.			VOROBJEV, VS (corresponding author), HEINRICH HEINE UNIV, INST PHYSIOL 2, D-40001 DUSSELDORF, GERMANY.		Sharonova, Irina/B-5288-2012	Sharonova, Irina/0000-0001-9955-1870				ASCHER P, 1990, PROG CELL R, V1, P149; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEKKERS JM, 1993, SCIENCE, V261, P104, DOI 10.1126/science.8391168; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131, DOI 10.1113/jphysiol.1993.sp019627; BERRIDGE MJ, 1987, ANN NY ACAD SCI, V494, P39, DOI 10.1111/j.1749-6632.1987.tb29479.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; FAGE D, 1992, J NEUROCHEM, V58, P2170, DOI 10.1111/j.1471-4159.1992.tb10960.x; GREENE RW, 1990, NEUROSCIENCE, V34, P299, DOI 10.1016/0306-4522(90)90140-Y; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1984, AGENTS ACTIONS, V14, P534, DOI 10.1007/BF01973865; HAAS HL, 1992, HISTAMINE RECEPTOR, P161; HAAS HL, 1991, HISTAMINERGIC NEURON, P196; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; INAGAKI N, 1988, J COMP NEUROL, V273, P283, DOI 10.1002/cne.902730302; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KOSTOPOULOS G, 1988, EXP BRAIN RES, V72, P45, DOI 10.1007/BF00248499; KREMZNER LT, 1965, BIOCHEM PHARMACOL, V14, P1189; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCGURK JF, 1990, P NATL ACAD SCI USA, V87, P9971, DOI 10.1073/pnas.87.24.9971; Monnier M, 1970, Int Rev Neurobiol, V12, P265; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PASCHEN W, 1988, NEUROCHEM PATHOL, V9, P1; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PRELL GD, 1986, ANNU REV NEUROSCI, V9, P209; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; ROCK DM, 1992, MOL PHARMACOL, V42, P157; ROCK DM, 1992, MOL PHARMACOL, V41, P83; SCHWARTZ JC, 1986, TRENDS PHARMACOL SCI, V7, P24, DOI 10.1016/0165-6147(86)90236-1; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SPECIALE C, 1992, MOL NEUROPHARMACOL, V2, P121; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; 1992, CHEN L, V356, P521	46	146	153	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					837	844		10.1016/0896-6273(93)90113-6	http://dx.doi.org/10.1016/0896-6273(93)90113-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240807				2022-12-17	WOS:A1993MJ04100005
J	BARBOUR, B				BARBOUR, B			SYNAPTIC CURRENTS EVOKED IN PURKINJE-CELLS BY STIMULATING INDIVIDUAL GRANULE CELLS	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; CEREBELLAR GRANULE; RAT; SLICES; NEURONS; CULTURE; CORTEX; TRANSMISSION; DEPRESSION	Each cerebellar Purkinje cell receives input from about 160,000 glutamatergic granule cells. In anatomically intact preparations this input has hitherto been studied only as a compound synaptic potential or current. Presented here are simultaneous recordings in cerebellar slices of synaptically connected granule cell-Purkinje cell pairs. The mean amplitude of the excitatory synaptic currents evoked by stimulation of individual granule cells ranged from 2 to 60 pA, whereas the great majority of the spontaneous glutamatergic currents in Purkinje cells in the presence of tetrodotoxin were <40 pA. In several cases, stimulation of a single granule cell evoked a disynaptic inhibitory current. It is estimated that on the order of 50 simultaneously active granule cells are sufficient to excite a Purkinje cell.			BARBOUR, B (corresponding author), ECOLE NORMALE SUPER,NEUROBIOL LAB,46 RUE ULM,F-75230 PARIS 05,FRANCE.			Barbour, Boris/0000-0002-1911-0539				ALBUS JS, 1971, MATH BIOSCI, V10, P318; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; CREPEL F, 1978, BRAIN RES, V155, P176, DOI 10.1016/0006-8993(78)90321-9; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1966, EXP BRAIN RES, V1, P17; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Eccles JC, 1967, CEREBELLUM NEURONAL; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GAHWILER BH, 1984, NEUROSCI LETT, V45, P311, DOI 10.1016/0304-3940(84)90244-1; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; HIRANO T, 1986, P NATL ACAD SCI USA, V83, P4957, DOI 10.1073/pnas.83.13.4957; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Ito M, 1984, CEREBELLUM NEURAL CO; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1969, J NEUROPHYSIOL, V32, P847, DOI 10.1152/jn.1969.32.6.847; Llinas R., 1992, CEREBELLUM REVISITED, P167; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; NAPPER RMA, 1988, J COMP NEUROL, V274, P158, DOI 10.1002/cne.902740203; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Palay S.L., 1974, CEREBELLAR CORTEX CY; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346	32	146	146	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					759	769		10.1016/0896-6273(93)90085-6	http://dx.doi.org/10.1016/0896-6273(93)90085-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398158				2022-12-17	WOS:A1993MD06800018
J	JONES, KA; BAUGHMAN, RW				JONES, KA; BAUGHMAN, RW			BOTH NMDA AND NON-NMDA SUBTYPES OF GLUTAMATE RECEPTORS ARE CONCENTRATED AT SYNAPSES ON CEREBRAL CORTICAL-NEURONS IN CULTURE	NEURON			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; POSTSYNAPTIC DENSITY PROTEIN; RAT VISUAL-CORTEX; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; ACETYLCHOLINE-RECEPTORS; FUNCTIONAL EXPRESSION; QUISQUALATE RECEPTORS; AMINO-ACIDS	N-methy-D-aspartate (NMDA) and non-NMDA receptors play a key role in synaptic transmission and plasticity in the vertebrate central nervous system. Previous studies have suggested that although both receptor types are present at synapses, the NMDA receptors may be relatively uniformly distributed. We have combined iontophoretic mapping of NMDA and non-NMDA receptors with immunohistochemical localization of synaptic vesicles along dendrites of single neocortical neurons to determine the relationship between NMDA and non-NMDA receptor distribution and the location of synapses. We find that when corrections for glutamate diffusion are made, NMDA responses are concentrated at focal "hot spots"that coincide with non-NMDA hot spots and that there is an excellent correlation between these hot spots and synapses.	HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School			Baughman, Robert/O-9078-2014	Baughman, Robert/0000-0002-8557-9458	NEI NIH HHS [EY05810, EY3502] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY005810, R01EY003502] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BAUGHMAN RW, 1991, IN PRESS NEURONAL CE; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLAKE JF, 1988, NEUROSCI LETT, V89, P182, DOI 10.1016/0304-3940(88)90378-3; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DAVIES J, 1982, BRAIN RES, V235, P378, DOI 10.1016/0006-8993(82)91017-4; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; FAGG GE, 1984, P NATL ACAD SCI-BIOL, V81, P6876, DOI 10.1073/pnas.81.21.6876; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; GARTHWAITE J, 1985, BRIT J PHARMACOL, V85, P297, DOI 10.1111/j.1476-5381.1985.tb08860.x; Gray E G, 1969, Prog Brain Res, V31, P141; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUETTNER JE, 1988, J NEUROSCI, V8, P160; JONES KA, 1988, J NEUROSCI, V8, P3522; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KUFFLER SW, 1975, J PHYSIOL-LONDON, V244, P703, DOI 10.1113/jphysiol.1975.sp010821; LAND BR, 1980, P NATL ACAD SCI-BIOL, V77, P3736, DOI 10.1073/pnas.77.6.3736; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WITZEMANN V, 1990, EUR J BIOCHEM, V194, P437, DOI 10.1111/j.1432-1033.1990.tb15637.x; ZORUMSKI CF, 1990, NEURON, V5, P61, DOI 10.1016/0896-6273(90)90033-C	46	146	146	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					593	603		10.1016/0896-6273(91)90372-7	http://dx.doi.org/10.1016/0896-6273(91)90372-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1718334				2022-12-17	WOS:A1991GM95400008
J	COWDEN, C; STRETTON, AOW; DAVIS, RE				COWDEN, C; STRETTON, AOW; DAVIS, RE			AF1, A SEQUENCED BIOACTIVE NEUROPEPTIDE ISOLATED FROM THE NEMATODE ASCARIS SUUM	NEURON			English	Article											COWDEN, C (corresponding author), UNIV WISCONSIN,DEPT ZOOL,MADISON,WI 53706, USA.				NIAID NIH HHS [AI 15429, AI 20355] Funding Source: Medline; NINDS NIH HHS [NS 07954] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015429, R01AI020355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS007954] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACOSTAURQUIDI J, 1988, J NEUROSCI, V8, P1694; BERLARDETTI F, 1987, NATURE, V325, P153; BOYD PJ, 1985, COMP BIOCHEM PHYS C, V81, P379, DOI 10.1016/0742-8413(85)90023-4; BREZINA V, 1987, J PHYSIOL-LONDON, V388, P565, DOI 10.1113/jphysiol.1987.sp016632; BREZINA V, 1987, J PHYSIOL-LONDON, V382, P267, DOI 10.1113/jphysiol.1987.sp016367; BRUSSAARD AB, 1988, BRAIN RES, V447, P35, DOI 10.1016/0006-8993(88)90963-8; BULLOCH AGM, 1988, J NEUROSCI, V8, P3459; CAWTHORPE D, 1988, REGUL PEPTIDES, V22, P227, DOI 10.1016/0167-0115(88)90035-3; COLOMBAIONI L, 1985, J NEUROSCI, V5, P2533; COTTRELL GA, 1987, J PHYSIOL-LONDON, V382, P51, DOI 10.1113/jphysiol.1987.sp016355; COTTRELL GA, 1984, J PHYSIOL-LONDON, V356, P315, DOI 10.1113/jphysiol.1984.sp015467; COTTRELL GA, 1983, COMP BIOCHEM PHYS C, V75, P373, DOI 10.1016/0742-8413(83)90208-6; COTTRELL GA, 1982, NATURE, V296, P87, DOI 10.1038/296087a0; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DAVENPORT TRB, 1988, PARASITOLOGY, V97, P81, DOI 10.1017/S0031182000066762; DAVIS RE, 1989, J NEUROSCI, V9, P403; DOCKRAY GJ, 1983, NATURE, V305, P328, DOI 10.1038/305328a0; EBBERINK RHM, 1987, PEPTIDES, V8, P515, DOI 10.1016/0196-9781(87)90018-0; Goldschmidt R, 1908, Z WISS ZOOL ABT A, V90, P73; GRIMMELIKHUIJZEN CJP, 1986, P NATL ACAD SCI USA, V83, P9817, DOI 10.1073/pnas.83.24.9817; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P329, DOI 10.1016/0742-8413(86)90202-1; HOOPER SL, 1984, BRAIN RES, V305, P186, DOI 10.1016/0006-8993(84)91138-7; ICHINOSE M, 1988, J NEUROSCI, V8, P3891; KRIEGER DT, 1983, SCIENCE, V222, P975, DOI 10.1126/science.6139875; LEACH L, 1987, HISTOCHEM J, V19, P471, DOI 10.1007/BF01675416; LEHMAN HK, 1987, J EXP BIOL, V131, P55; MARDER E, 1987, J COMP NEUROL, V259, P150, DOI 10.1002/cne.902590111; MURPHY AD, 1985, P NATL ACAD SCI USA, V82, P7140, DOI 10.1073/pnas.82.20.7140; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V140, P357, DOI 10.1016/0006-291X(86)91098-3; NACHMAN RJ, 1986, SCIENCE, V234, P71, DOI 10.1126/science.3749893; NAMBU JR, 1988, NEURON, V1, P55, DOI 10.1016/0896-6273(88)90209-7; OSHEA M, 1985, ANNU REV NEUROSCI, V8, P171; OSHEA M, 1982, J NEUROSCI, V2, P1242; PAINTER SD, 1982, BIOL BULL, V162, P311, DOI 10.2307/1540986; PAYZA K, 1987, PEPTIDES, V8, P1065, DOI 10.1016/0196-9781(87)90138-0; PRICE DA, 1987, PEPTIDES, V8, P533, DOI 10.1016/0196-9781(87)90020-9; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; PRICE DA, 1985, BIOL BULL, V169, P256, DOI 10.2307/1541402; RUBEN P, 1986, J NEUROSCI, V6, P252; Sasaki H., 1985, SCI REP TOYO SODA, V29, P37; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; SITHIGORNGUL P, 1989, IN PRESS J COMP NEUR; SOSSIN WS, 1987, J NEUROSCI, V7, P671; STRETTON AOW, 1978, P NATL ACAD SCI USA, V75, P3493, DOI 10.1073/pnas.75.7.3493; THOMPSON S, 1988, J NEUROSCI, V8, P3200; TRIMMER BA, 1987, J COMP NEUROL, V266, P16, DOI 10.1002/cne.902660103; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757	49	146	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1989	2	5					1465	1473		10.1016/0896-6273(89)90192-X	http://dx.doi.org/10.1016/0896-6273(89)90192-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	U7512	2627377				2022-12-17	WOS:A1989U751200007
J	Belin, S; Nawabi, H; Wang, C; Tang, SJ; Latremoliere, A; Warren, P; Schorle, H; Uncu, C; Woolf, CJ; He, ZG; Steen, JA				Belin, Stephane; Nawabi, Homaira; Wang, Chen; Tang, Shaojun; Latremoliere, Alban; Warren, Peter; Schorle, Hubert; Uncu, Ceren; Woolf, Clifford J.; He, Zhigang; Steen, Judith A.			Injury-Induced Decline of Intrinsic Regenerative Ability Revealed by Quantitative Proteomics	NEURON			English	Article							SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; AXON REGENERATION; OPTIC-NERVE; C-MYC; CORTICOSPINAL TRACT; IN-VIVO; GROWTH; MTOR; PLASTICITY	Neurons differ in their responses to injury, but the underlying mechanisms remain poorly understood. Using quantitative proteomics, we characterized the injury-triggered response from purified intact and axotomized retinal ganglion cells (RGCs). Subsequent informatics analyses revealed a network of injury-response signaling hubs. In addition to confirming known players, such as mTOR, this also identified new candidates, such as c-myc, NF kappa B, and Huntingtin. Similar to mTOR, c-myc has been implicated as a key regulator of anabolic metabolism and is downregulated by axotomy. Forced expression of c-myc in RGCs, either before or after injury, promotes dramatic RGC survival and axon regeneration after optic nerve injury. Finally, in contrast to RGCs, neither c-myc nor mTOR was downregulated in injured peripheral sensory neurons. Our studies suggest that c-myc and other injury-responsive pathways are critical to the intrinsic regenerative mechanisms and might represent a novel target for developing neural repair strategies in adults.	[Belin, Stephane; Nawabi, Homaira; Wang, Chen; Latremoliere, Alban; Uncu, Ceren; Woolf, Clifford J.; He, Zhigang; Steen, Judith A.] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Belin, Stephane; Nawabi, Homaira; Wang, Chen; Latremoliere, Alban; Uncu, Ceren; Woolf, Clifford J.; He, Zhigang; Steen, Judith A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Tang, Shaojun] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Warren, Peter] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Schorle, Hubert] Univ Bonn, Dept Dev Pathol, Sch Med, D-53127 Bonn, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Bonn	He, ZG (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu; judith.steen@childrens.harvard.edu	Homaira, NAWABI/G-6145-2017; Schorle, Hubert/S-1713-2019; TANG, SHAOJUN/J-4876-2015; Woolf, Clifford/A-9784-2010; Schorle, Hubert/M-5001-2016	Schorle, Hubert/0000-0001-8272-0076; Latremoliere, Alban/0000-0002-9212-1007; NAWABI, Homaira/0000-0003-3155-2783; tang, shaojun/0000-0002-5141-0515; Belin, Stephane/0000-0001-7074-6885	William Randolph Hearst Foundation; NIH [EY021242, NS066973]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation;  [NIH P30 HD018655];  [P30EY012196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021242, R01EY021526, R01EY021342, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066973] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Katherine Zukor for reading the manuscript. This study was supported by fellowships from the William Randolph Hearst Foundation (S.B. and H.N.), NIH grants EY021242 (Z.H.) and NS066973 (J.A.S.), and a grant from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z.H.). IDDRC and viral cores supported by the grants NIH P30 HD018655 and P30EY012196 were used for this study.	Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen AS, 2009, METHODS MOL BIOL, V566, P57, DOI 10.1007/978-1-59745-562-6_4; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Dang C. V., 2013, PERSPECT MED, V3, DOI DOI 10.1101/CSHPERSPECT.A014217; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Harel NY, 2013, BRAIN RES, V1538, P17, DOI 10.1016/j.brainres.2013.07.012; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Jager R, 2004, GENESIS, V38, P145, DOI 10.1002/gene.20014; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; Magharious M, 2011, J PROTEOME RES, V10, P3344, DOI 10.1021/pr2004055; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; NEAR SL, 1992, P NATL ACAD SCI USA, V89, P11716, DOI 10.1073/pnas.89.24.11716; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Saul KE, 2010, COMP BIOCHEM PHYS A, V155, P172, DOI 10.1016/j.cbpa.2009.10.042; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Staab CA, 2007, J PROTEOME RES, V6, P3705, DOI 10.1021/pr070308q; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Tanabe K, 2003, J NEUROSCI, V23, P9675; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Toth C, 2006, NEUROSCIENCE, V139, P429, DOI 10.1016/j.neuroscience.2005.11.065; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Zhu LQ, 2010, J NEUROSCI, V30, P3839, DOI 10.1523/JNEUROSCI.5174-09.2010; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	55	145	148	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 20	2015	86	4					1000	1014		10.1016/j.neuron.2015.03.060	http://dx.doi.org/10.1016/j.neuron.2015.03.060			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI6OB	25937169	Green Accepted, Bronze			2022-12-17	WOS:000354878400014
J	Garcia-Caballero, A; Gadotti, VM; Stemkowski, P; Weiss, N; Souza, IA; Hodgkinson, V; Bladen, C; Chen, LN; Hamid, J; Pizzoccaro, A; Deage, M; Francois, A; Bourinet, E; Zamponi, GW				Garcia-Caballero, Agustin; Gadotti, Vinicius M.; Stemkowski, Patrick; Weiss, Norbert; Souza, Ivana A.; Hodgkinson, Victoria; Bladen, Chris; Chen, Lina; Hamid, Jawed; Pizzoccaro, Anne; Deage, Mickael; Francois, Amaury; Bourinet, Emmanuel; Zamponi, Gerald W.			The Deubiquitinating Enzyme USP5 Modulates Neuropathic and Inflammatory Pain by Enhancing Ca(v)3.2 Channel Activity	NEURON			English	Article							EPITHELIAL NA+ CHANNEL; CALCIUM-CHANNELS; SENSORY NEURONS; UBIQUITIN; GENE; EXCITABILITY; ALPHA(1H); NEDD4; MODEL; MICE	T-type calciumchannels are essential contributors to the transmission of nociceptive signals in the primary afferent pain pathway. Here, we show that T-type calcium channels are ubiquitinated by WWP1, a plasma-membrane- associated ubiquitin ligase that binds to the intracellular domain III-IV linker region of the Ca(v)3.2 T-type channel and modifies specific lysine residues in this region. A proteomic screen identified the deubiquitinating enzyme USP5 as a Ca(v)3.2 III-IV linker interacting partner. Knockdown of USP5 via shRNA increases Ca(v)3.2 ubiquitination, decreases Ca(v)3.2 protein levels, and reduces Ca(v)3.2 whole-cell currents. In vivo knockdown of USP5 or uncoupling USP5 from native Cav3.2 channels via intrathecal delivery of Tat peptides mediates analgesia in both inflammatory and neuropathic mouse models of mechanical hypersensitivity. Altogether, our experiments reveal a cell signaling pathway that regulates T- type channel activity and their role in nociceptive signaling.	[Garcia-Caballero, Agustin; Gadotti, Vinicius M.; Stemkowski, Patrick; Weiss, Norbert; Souza, Ivana A.; Hodgkinson, Victoria; Bladen, Chris; Chen, Lina; Hamid, Jawed; Zamponi, Gerald W.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Pizzoccaro, Anne; Deage, Mickael; Francois, Amaury; Bourinet, Emmanuel] Univ Montpellier I, Labs Excellence Ion Channel Sci & Therapeut, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661,IFR3, Montpellier, France; [Pizzoccaro, Anne; Deage, Mickael; Francois, Amaury; Bourinet, Emmanuel] Univ Montpellier 2, Labs Excellence Ion Channel Sci & Therapeut, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661,IFR3, Montpellier, France	University of Calgary; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	Zamponi@ucalgary.ca	Gadotti, Vinicius M/E-6378-2017; Weiss, Norbert/G-5330-2014; Bourinet, Emmanuel/S-4396-2017	Gadotti, Vinicius M/0000-0001-5730-5081; Weiss, Norbert/0000-0002-0040-1109; Bourinet, Emmanuel/0000-0001-8021-0419; Bladen, Christopher/0000-0003-1063-2901; Zamponi, Gerald W./0000-0002-0644-9066; PIZZOCCARO, Anne/0000-0002-9912-231X; Assis Souza, Ivana/0000-0001-6410-7622; Francois, Amaury/0000-0003-1171-7974	Canadian Institutes of Health Research; Agence Nationale de la Recherche [ANR-09-MNPS-037, ANR-08-NMPS-025]; Association Francaise contres les Myopathies (AFM); AIHS Fellowships; AFM Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contres les Myopathies (AFM)(Association Francaise contre les Myopathies); AIHS Fellowships; AFM Fellowship(Association Francaise contre les Myopathies)	This work was supported by grants to G.W.Z. from the Canadian Institutes of Health Research and to E. B. from the Agence Nationale de la Recherche (ANR-09-MNPS-037, ANR-08-NMPS-025) and the Association Francaise contres les Myopathies (AFM). G.W.Z. is an Alberta Innovates-Health Solutions (AI-HS) Scientist and a Canada Research Chair. V.G., P.S., and N.W. were supported by AIHS Fellowships. A. F. is supported by an AFM Fellowship. We would like to thank N. Daniel Berger for help with the blinded studies, S. Laffray for the SNI animals used for the immunohistochemistry, and Dr. Peter Smith (University of Alberta) for helpful discussion on the spinal cord slice recordings.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Cachemaille M, 2012, NEUROSCIENCE, V227, P370, DOI 10.1016/j.neuroscience.2012.09.044; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Duan B, 2012, J NEUROSCI, V32, P6351, DOI 10.1523/JNEUROSCI.4479-11.2012; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; FALQUET L, 1995, FEBS LETT, V376, P233, DOI 10.1016/0014-5793(95)01287-7; Francois A, 2013, PAIN, V154, P283, DOI 10.1016/j.pain.2012.10.023; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Jacus MO, 2012, J NEUROSCI, V32, P9374, DOI 10.1523/JNEUROSCI.0068-12.2012; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Marger F, 2011, P NATL ACAD SCI USA, V108, P11268, DOI 10.1073/pnas.1100869108; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oberfeld B, 2011, AM J PHYSIOL-RENAL, V301, pF189, DOI 10.1152/ajprenal.00487.2010; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Shanmugham A, 2008, CURR OPIN DRUG DISC, V11, P688; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Talley EM, 1999, J NEUROSCI, V19, P1895; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Yue J, 2013, SPINE, V38, P463, DOI 10.1097/BRS.0b013e318272fbf8; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522	39	145	148	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 3	2014	83	5					1144	1158		10.1016/j.neuron.2014.07.036	http://dx.doi.org/10.1016/j.neuron.2014.07.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5XB	25189210	Bronze			2022-12-17	WOS:000341419000016
J	Baldan, LC; Williams, KA; Gallezot, JD; Pogorelov, V; Rapanelli, M; Crowley, M; Anderson, GM; Loring, E; Gorczyca, R; Billingslea, E; Wasylink, S; Panza, KE; Ercan-Sencicek, AG; Krusong, K; Leventhal, BL; Ohtsu, H; Bloch, MH; Hughes, ZA; Krystal, JH; Mayes, L; de Araujo, I; Ding, YS; State, MW; Pittenger, C				Baldan, Lissandra Castellan; Williams, Kyle A.; Gallezot, Jean-Dominique; Pogorelov, Vladimir; Rapanelli, Maximiliano; Crowley, Michael; Anderson, George M.; Loring, Erin; Gorczyca, Roxanne; Billingslea, Eileen; Wasylink, Suzanne; Panza, Kaitlyn E.; Ercan-Sencicek, A. Gulhan; Krusong, Kuakarun; Leventhal, Bennett L.; Ohtsu, Hiroshi; Bloch, Michael H.; Hughes, Zoe A.; Krystal, John H.; Mayes, Linda; de Araujo, Ivan; Ding, Yu-Shin; State, Matthew W.; Pittenger, Christopher			Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice	NEURON			English	Article							BASAL GANGLIA; HISTAMINE H-1; INTRAVENTRICULAR-INJECTION; DIFFERENTIAL REGULATION; PREPULSE INHIBITION; TISSUE EXPRESSION; ACOUSTIC STARTLE; D3 RECEPTORS; GENE CLONING; DOPAMINE	Tourette syndrome (TS) is characterized by tics, sensorimotor gating deficiencies, and abnormalities of cortico-basal ganglia circuits. A mutation in histidine decarboxylase (Hdc), the key enzyme for the biosynthesis of histamine (HA), has been implicated as a rare genetic cause. Hdc knockout mice exhibited potentiated tic-like stereotypies, recapitulating core phenomenology of TS; these were mitigated by the dopamine (DA) D2 antagonist haloperidol, a proven pharmacotherapy, and by HA infusion into the brain. Prepulse inhibition was impaired in both mice and humans carrying Hdc mutations. HA infusion reduced striatal DA levels; in Hdc knockout mice, striatal DA was increased and the DA-regulated immediate early gene Fos was up-regulated. DA D2/D3 receptor binding was altered both in mice and in humans carrying the Hdc mutation. These data confirm histidine decarboxylase deficiency as a rare cause of IS and identify HA-DA interactions in the basal ganglia as an important locus of pathology.	[Baldan, Lissandra Castellan; Williams, Kyle A.; Pogorelov, Vladimir; Rapanelli, Maximiliano; Billingslea, Eileen; Wasylink, Suzanne; Krusong, Kuakarun; Bloch, Michael H.; Krystal, John H.; Mayes, Linda; de Araujo, Ivan; State, Matthew W.; Pittenger, Christopher] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Williams, Kyle A.; Crowley, Michael; Anderson, George M.; Loring, Erin; Panza, Kaitlyn E.; Ercan-Sencicek, A. Gulhan; Bloch, Michael H.; Mayes, Linda; State, Matthew W.; Pittenger, Christopher] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Gallezot, Jean-Dominique; Ding, Yu-Shin] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA; [Anderson, George M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Loring, Erin; Ercan-Sencicek, A. Gulhan; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Mayes, Linda] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Mayes, Linda; Pittenger, Christopher] Yale Univ, Sch Med, Dept Psychol, New Haven, CT 06520 USA; [Loring, Erin; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Program Neurogenet, New Haven, CT 06520 USA; [Pittenger, Christopher] Yale Univ, Sch Med, Integrated Neurosci Res Program, New Haven, CT 06520 USA; [Gorczyca, Roxanne; Hughes, Zoe A.] Pfizer Inc, Neurosci Res Unit, Cambridge, MA 02139 USA; [Krusong, Kuakarun] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok 10330, Thailand; [Leventhal, Bennett L.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Leventhal, Bennett L.] NYU, NYU Langone Med Ctr, Dept Child & Adolescent Psychiat, New York, NY 10016 USA; [Ohtsu, Hiroshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808577, Japan; [de Araujo, Ivan] John B Pierce Lab, New Haven, CT 06519 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Pfizer; Chulalongkorn University; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; Tohoku University; Yale University; The John B Pierce Laboratory, Inc	Pittenger, C (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	christopher.pittenger@yale.edu	Hughes, Zoe/P-5119-2019; Gallezot, Jean-Dominique/C-9938-2014; State, Matthew/W-2256-2019; Bloch, Michael/O-7845-2017; rapanelli, maximiliano/P-3141-2016; Ding, yu/GWV-1732-2022	Hughes, Zoe/0000-0001-7174-0944; Gallezot, Jean-Dominique/0000-0003-0399-8374; Bloch, Michael/0000-0003-0352-4080; rapanelli, maximiliano/0000-0001-7329-2364; State, Matthew/0000-0003-1624-8302	Allison Family foundation; National Institutes of Health [K08MH081190, R01MH091861, PL1DA024860, R01NS056276, T32MH014276, T32MH018268, 2P50AA012870, D43TW06166]; Tourette Syndrome Association; Yale Program on Neurogenetics; Yale PET Center; Brain Research Foundation, Chicago, IL; Overlook International Fund; Pfizer Global Research; State of Connecticut through the Ribicoff Research Facilities at the Connecticut Mental Health Center; National Institutes of Health (Yale Center for Clinical Investigation Pilot Award) [UL1RR024139]; FOGARTY INTERNATIONAL CENTER [D43TW006166] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823, R01MH091861, T32MH018268, T32MH014276, K08MH081190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [PL1DA024860] Funding Source: NIH RePORTER	Allison Family foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tourette Syndrome Association; Yale Program on Neurogenetics; Yale PET Center; Brain Research Foundation, Chicago, IL; Overlook International Fund; Pfizer Global Research(Pfizer); State of Connecticut through the Ribicoff Research Facilities at the Connecticut Mental Health Center; National Institutes of Health (Yale Center for Clinical Investigation Pilot Award); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Stacey Wilber for assistance with mouse genotyping; Theresa Brand for assistance with HA analysis in tissue; the staff of the Yale PET Center for support in all PET studies and analyses; Brian Pittman for statistical consultation and support; and Marina Picciotto, Ronald Duman, and Ralph DiLeone for helpful discussion and comments on the manuscript. This work was supported by The Allison Family foundation (C.P.) and National Institutes of Health grants K08MH081190 (C.P.), R01MH091861 (C.P.), PL1DA024860 (G.M.A.), R01NS056276 (M.W.S.), T32MH014276 (L.C.B.; Principal Investigator (PI), R. Duman), T32MH018268 (K.A.W.; PI, J. Leckman), UL1RR024139 (Yale Center for Clinical Investigation Pilot Award to C.P.; PI, R. Sherwin), 2P50AA012870 (J.H.K.), and D43TW06166 (K.K.; Pis, J. Gelertner and R. Malison). Additional support came from the Tourette Syndrome Association (C.P., L.C.B.); the Yale Program on Neurogenetics (AGES., M.W.S.); the Yale PET Center (Y.-S.D., J.-D.G.); the Brain Research Foundation, Chicago, IL; the Overlook International Fund; Pfizer Global Research (R.G., Z.A.H.); and the State of Connecticut through its support of the Ribicoff Research Facilities at the Connecticut Mental Health Center (C.P., L.C.B., V.P., M.R.). Z.A.H. and R.G. are employees of Pfizer, Inc.	Acevedo SF, 2006, BRAIN RES, V1071, P113, DOI 10.1016/j.brainres.2005.11.067; Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Albin Roger L, 2006, Adv Neurol, V99, P99; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bloch M, 2011, CURR OPIN NEUROL, V24, P119, DOI 10.1097/WCO.0b013e328344648c; Bloch Michael H, 2008, Curr Psychiatry Rep, V10, P323, DOI 10.1007/s11920-008-0052-z; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Carson RE, 2004, IEEE NUCL SCI CONF R, P3281, DOI 10.1109/NSSMIC.2003.1352597; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; de Leeuw AS, 2010, INT CLIN PSYCHOPHARM, V25, P232, DOI 10.1097/YIC.0b013e328338c4f0; Dere E, 2004, EUR J NEUROSCI, V20, P1051, DOI 10.1111/j.1460-9568.2004.03546.x; Dere E, 2003, LEARN MEMORY, V10, P510, DOI 10.1101/lm.67603; Du JC, 2010, PEDIATR NEONATOL, V51, P255, DOI 10.1016/S1875-9572(10)60050-2; Ellender TJ, 2011, J NEUROSCI, V31, P15340, DOI 10.1523/JNEUROSCI.3144-11.2011; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Fauchey V, 2000, EUR J NEUROSCI, V12, P19, DOI 10.1046/j.1460-9568.2000.00876.x; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Flik G, 2011, EUR J NEUROSCI, V34, P1747, DOI 10.1111/j.1460-9568.2011.07893.x; FRAY PJ, 1980, PSYCHOPHARMACOLOGY, V69, P253, DOI 10.1007/BF00433091; Graff-Guerrero A, 2008, HUM BRAIN MAPP, V29, P400, DOI 10.1002/hbm.20392; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Grillner S, 2013, J PHYSIOL-LONDON, V591, P5425, DOI 10.1113/jphysiol.2012.246660; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hoenig K, 2005, BIOL PSYCHIAT, V57, P1153, DOI 10.1016/j.biopsych.2005.01.040; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Jankovic J, 2011, MOVEMENT DISORD, V26, P1149, DOI 10.1002/mds.23618; JOSHI VV, 1981, EUR J PHARMACOL, V69, P499, DOI 10.1016/0014-2999(81)90456-8; KALIVAS PW, 1982, J PHARMACOL EXP THER, V222, P37; KAMEI C, 1984, JPN J PHARMACOL, V35, P193, DOI 10.1254/jjp.35.193; KAMEI C, 1983, JPN J PHARMACOL, V33, P1081, DOI 10.1254/jjp.33.1081; Kelley A, 2001, CURR PROTOC NEUROSCI, V8, DOI [10.1002/0471142301.ns0808s04, DOI 10.1002/0471142301.NS0808S04]; Kitanaka J, 2007, NEUROSCIENCE, V147, P765, DOI 10.1016/j.neuroscience.2007.05.006; Kitanaka J, 2010, PHARMACOL BIOCHEM BE, V94, P464, DOI 10.1016/j.pbb.2009.10.009; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Krusong K, 2011, NEUROSCI LETT, V495, P110, DOI 10.1016/j.neulet.2011.03.050; Kurlan R, 2010, NEW ENGL J MED, V363, P2332, DOI 10.1056/NEJMcp1007805; Kwak CH, 2002, MOVEMENT DISORD, V17, P821, DOI 10.1002/mds.10207; Leckman JF, 2010, J CHILD ADOL PSYCHOP, V20, P237, DOI 10.1089/cap.2009.0118; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Lipschitz DS, 2005, J AM ACAD CHILD PSY, V44, P807, DOI 10.1097/01.chi.0000166379.60769.b6; McCairn KW, 2009, BRAIN, V132, P2125, DOI 10.1093/brain/awp142; Mink J W, 2001, Adv Neurol, V85, P113; Narendran R, 2006, SYNAPSE, V60, P485, DOI 10.1002/syn.20325; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; O'Rourke JA, 2009, J PSYCHOSOM RES, V67, P533, DOI 10.1016/j.jpsychores.2009.06.006; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Onodera K., 1981, ADV HISTAMINE RES, P127; Paul Varghese N., 2000, Indian Journal of Experimental Biology, V38, P988; Payer DE, 2014, NEUROPSYCHOPHARMACOL, V39, P311, DOI 10.1038/npp.2013.192; Pittenger C, 2011, BIOL PSYCHIAT, V70, P1002, DOI 10.1016/j.biopsych.2011.10.005; Rabiner EA, 2009, SYNAPSE, V63, P782, DOI 10.1002/syn.20658; Ramsey LCB, 2011, NEUROSCIENCE, V180, P222, DOI 10.1016/j.neuroscience.2011.01.041; Scharf JM, 2013, MOL PSYCHIATR, V18, P721, DOI 10.1038/mp.2012.69; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Singer HS, 2002, AM J PSYCHIAT, V159, P1329, DOI 10.1176/appi.ajp.159.8.1329; Stanwood GD, 2000, J PHARMACOL EXP THER, V295, P1223; Stanwood GD, 2000, J PHARMACOL EXP THER, V295, P1232; State MW, 2011, CURR OPIN GENET DEV, V21, P302, DOI 10.1016/j.gde.2011.01.007; Swerdlow N.R., 2012, NEUROSCI BIOBEHAV RE; Swerdlow NR, 2001, BIOL PSYCHIAT, V50, P578, DOI 10.1016/S0006-3223(01)01164-7; TAKAGI H, 1986, BRAIN RES, V364, P114, DOI 10.1016/0006-8993(86)90992-3; Tellez LA, 2013, SCIENCE, V341, P800, DOI 10.1126/science.1239275; Terrados G, 2012, NUCLEIC ACIDS RES, V40, P7844, DOI 10.1093/nar/gks544; TRAIFFORT E, 1995, BIOCHEM BIOPH RES CO, V211, P570, DOI 10.1006/bbrc.1995.1851; TRAIFFORT E, 1994, J NEUROCHEM, V62, P507; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; WHITE FJ, 1984, LIFE SCI, V34, P1161, DOI 10.1016/0024-3205(84)90088-2; Williams K., 2013, NEUROBIOLOGY MENTAL, P1048; Wong DF, 2008, NEUROPSYCHOPHARMACOL, V33, P1239, DOI 10.1038/sj.npp.1301528; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006	83	145	148	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2014	81	1					77	90		10.1016/j.neuron.2013.10.052	http://dx.doi.org/10.1016/j.neuron.2013.10.052			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287RD	24411733	Green Accepted, Bronze			2022-12-17	WOS:000329559000010
J	Suzuki, K; Hayashi, Y; Nakahara, S; Kumazaki, H; Prox, J; Horiuchi, K; Zeng, MS; Tanimura, S; Nishiyama, Y; Osawa, S; Sehara-Fujisawa, A; Saftig, P; Yokoshima, S; Fukuyama, T; Matsuki, N; Koyama, R; Tomita, T; Iwatsubo, T				Suzuki, Kunimichi; Hayashi, Yukari; Nakahara, Soichiro; Kumazaki, Hiroshi; Prox, Johannes; Horiuchi, Keisuke; Zeng, Mingshuo; Tanimura, Shun; Nishiyama, Yoshitake; Osawa, Satoko; Sehara-Fujisawa, Atsuko; Saftig, Paul; Yokoshima, Satoshi; Fukuyama, Tohru; Matsuki, Norio; Koyama, Ryuta; Tomita, Taisuke; Iwatsubo, Takeshi			Activity-Dependent Proteolytic Cleavage of Neuroligin-1	NEURON			English	Article							AMYLOID-BETA PEPTIDES; GAMMA-SECRETASE; CELL-ADHESION; SYNAPTIC FUNCTION; ALPHA-SECRETASE; N-CADHERIN; INHIBITORY SYNAPSES; STATUS EPILEPTICUS; PILOCARPINE MODEL; SLICE CULTURES	Neuroligin (NLG), a postsynaptic adhesion molecule, is involved in the formation of synapses by binding to a cognate presynaptic ligand, neurexin. Here we report that neuroligin-1 (NLG1) undergoes ectodomain shedding at the juxtamembrane stalk region to generate a secreted form of NLG1 and a membrane-tethered C-terminal fragment (CTF) in adult rat brains in vivo as well as in neuronal cultures. Pharmacological and genetic studies identified ADAM10 as the major protease responsible for NLG1 shedding, the latter being augmented by synaptic NMDA receptor activation or interaction with soluble neurexin ligands. NLG1-CTF was subsequently cleaved by presenilin/gamma-secretase. Secretion of soluble NLG1 was significantly upregulated under a prolonged epileptic seizure condition, and inhibition of NLG1 shedding led to an increase in numbers of dendritic spines in neuronal cultures. Collectively, neuronal activity-dependent proteolytic processing of NLG1 may negatively regulate the remodeling of spines at excitatory synapses.	[Suzuki, Kunimichi; Hayashi, Yukari; Osawa, Satoko; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Nakahara, Soichiro; Matsuki, Norio; Koyama, Ryuta] Univ Tokyo, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Kumazaki, Hiroshi; Zeng, Mingshuo; Tanimura, Shun; Nishiyama, Yoshitake; Yokoshima, Satoshi; Fukuyama, Tohru] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Synthet Nat Prod Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan; [Prox, Johannes; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Sakyo Ku, Kyoto 6068507, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Kiel; Keio University; Kyoto University; Japan Science & Technology Agency (JST)	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015; Suzuki, Kunimichi/L-4819-2013; Saftig, Paul/A-7966-2010; Suzuki, Kunimichi/ABB-4501-2020; Nishiyama, Yoshitake/G-7291-2019; Horiuchi, Keisuke/L-2277-2013; Yukari, Takeo/L-5878-2013; Yokoshima, Satoshi/I-6961-2014	Tomita, Taisuke/0000-0002-0075-5943; Suzuki, Kunimichi/0000-0001-7699-2163; Nishiyama, Yoshitake/0000-0002-2935-6313; Horiuchi, Keisuke/0000-0001-7063-9609; Yokoshima, Satoshi/0000-0003-4036-0062; Zeng, Mingshuo/0000-0003-1082-1227	Japan Society for the Promotion of Science (JSPS); Challenging Exploratory Research from JSPS; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Cell Science Research Foundation; Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, Japan; Deutsche Forschungsgemeinschaft [SFB877]; Grants-in-Aid for Scientific Research [24659028, 24111511, 12J10970] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Challenging Exploratory Research from JSPS; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, Japan(Core Research for Evolutional Science and Technology (CREST)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs. C. Blobel (Hospital for Special Surgery, New York), R. Balice-Gordon (University of Pennsylvania), P. Scheiffele (University of Basel), B. De Strooper (VIB Leuven), K. Hozumi (Tokai University), F. Fahrenholtz (Johannes Gutenberg University Mainz), T. Kitamura (The University of Tokyo), and J. Takagi (Osaka University) for materials. We are also grateful to our laboratory members for helpful discussions and technical assistance. This work was supported by Grants-in-Aid for Young Scientists (S) from Japan Society for the Promotion of Science (JSPS) (for T.T.), Challenging Exploratory Research from JSPS (for T.T.), Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (for T.T. and T.I.), the Cell Science Research Foundation (for T.T.), Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency (for Y.H., T.T., and T.I.), Japan, and the Deutsche Forschungsgemeinschaft SFB877 TP:A3 (for P.S.). K.S. is a research fellow of JSPS.	Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; Bottos A, 2011, CELL MOL LIFE SCI, V68, P2655, DOI 10.1007/s00018-011-0664-z; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; Horiuchi K, 2007, J IMMUNOL, V179, P6715, DOI 10.4049/jimmunol.179.10.6715; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Isokawa M, 1998, NEUROSCI LETT, V258, P73, DOI 10.1016/S0304-3940(98)00848-9; Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kochan LD, 2000, NEUROSCIENCE, V95, P735; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Levinson JN, 2007, NEURON, V56, P937, DOI 10.1016/j.neuron.2007.12.003; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nakahara S, 2009, HIPPOCAMPUS, V19, P379, DOI 10.1002/hipo.20529; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; PATEL S, 1988, BEHAV BRAIN RES, V31, P165, DOI 10.1016/0166-4328(88)90019-8; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Thyagarajan A, 2010, CELL, V143, P456, DOI 10.1016/j.cell.2010.09.025; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	73	145	148	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 18	2012	76	2					410	422		10.1016/j.neuron.2012.10.003	http://dx.doi.org/10.1016/j.neuron.2012.10.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LV	23083742	Bronze			2022-12-17	WOS:000310424700015
J	Kullmann, DM; Moreau, AW; Bakiri, Y; Nicholsonl, E				Kullmann, Dimitri M.; Moreau, Alexandre W.; Bakiri, Yamina; Nicholsonl, Elizabeth			Plasticity of Inhibition	NEURON			English	Review							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; DEPOLARIZATION-INDUCED SUPPRESSION; CEREBELLAR PURKINJE-CELLS; NEONATAL-RAT HIPPOCAMPUS; GABA(A) RECEPTOR TRAFFICKING; OCULAR DOMINANCE PLASTICITY; NEUROTROPHIC FACTOR BDNF; CA1 PYRAMIDAL NEURONS; MOUSE VISUAL-CORTEX	Until recently, the study of plasticity of neural circuits focused almost exclusively on potentiation and depression at excitatory synapses on principal cells. Other elements in the neural circuitry, such as inhibitory synapses on principal cells and the synapses recruiting interneurons, were assumed to be relatively inflexible, as befits a role of inhibition in maintaining stable levels and accurate timing of neuronal activity. It is now evident that inhibition is highly plastic, with multiple underlying cellular mechanisms. This Review considers these recent developments, focusing mainly on functional and structural changes in GABAergic inhibition of principal cells and long-term plasticity of glutamateric recruitment of inhibitory interneurons in the mammalian forebrain. A major challenge is to identify the adaptive roles of these different forms of plasticity, taking into account the roles of inhibition in the regulation of excitability, generation of population oscillations, and precise timing of neuronal firing.	[Kullmann, Dimitri M.; Moreau, Alexandre W.; Bakiri, Yamina; Nicholsonl, Elizabeth] UCL Inst Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545	European Research Council; Wellcome Trust; MRC; Medical Research Council [G0802158, G116/147, G0501424] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish; MRC [G0802158, G0501424, G116/147] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in the authors' laboratory is supported by the European Research Council, Wellcome Trust, and MRC.	Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Alger BE, 2012, J PHYSIOL-LONDON, V590, P2203, DOI 10.1113/jphysiol.2011.220855; Ali AB, 2007, J NEUROPHYSIOL, V98, P861, DOI 10.1152/jn.00156.2007; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Balena T, 2008, EUR J NEUROSCI, V27, P2402, DOI 10.1111/j.1460-9568.2008.06194.x; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; Brumback AC, 2008, J NEUROSCI, V28, P1301, DOI 10.1523/JNEUROSCI.3378-07.2008; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; BUZSAKI G, 1982, J NEUROPHYSIOL, V48, P597, DOI 10.1152/jn.1982.48.3.597; Caillard O, 1999, J NEUROSCI, V19, P7568, DOI 10.1523/JNEUROSCI.19-17-07568.1999; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Castillo PE, 2006, NAT NEUROSCI, V9, P719, DOI 10.1038/nn0606-719; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen HX, 2009, J NEUROPHYSIOL, V102, P3251, DOI 10.1152/jn.00641.2009; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen Y, 2012, CURR OPIN NEUROBIOL, V22, P389, DOI 10.1016/j.conb.2012.03.003; Cheng Q, 2003, J PHYSIOL-LONDON, V548, P711, DOI 10.1113/jphysiol.2002.037846; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Cooke SF, 2006, J PHYSIOL-LONDON, V574, P805, DOI 10.1113/jphysiol.2006.111559; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Edwards JG, 2012, HIPPOCAMPUS, V22, P209, DOI 10.1002/hipo.20884; Evstratova A, 2011, J PHYSIOL-LONDON, V589, P1957, DOI 10.1113/jphysiol.2010.204255; Fino E, 2008, J PHYSIOL-LONDON, V586, P265, DOI 10.1113/jphysiol.2007.144501; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Galvan EJ, 2008, J NEUROSCI, V28, P14042, DOI 10.1523/JNEUROSCI.4848-08.2008; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Gubellini P, 2005, J NEUROSCI, V25, P5796, DOI 10.1523/JNEUROSCI.0824-05.2005; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Heifets BD, 2008, P NATL ACAD SCI USA, V105, P10250, DOI 10.1073/pnas.0711880105; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Houser CR, 2003, HIPPOCAMPUS, V13, P633, DOI 10.1002/hipo.10108; Inagaki T, 2008, NEUROSCI RES, V61, P192, DOI 10.1016/j.neures.2008.02.006; Jia YS, 2010, EUR J NEUROSCI, V31, P463, DOI 10.1111/j.1460-9568.2009.07058.x; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kapur J, 1995, ANN NEUROL, V38, P893, DOI 10.1002/ana.410380609; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; Katona I, 1999, J NEUROSCI, V19, P4544; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Kittler JT, 2000, J NEUROSCI, V20, P7972; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kuczewski N, 2008, J NEUROSCI, V28, P7013, DOI 10.1523/JNEUROSCI.1673-08.2008; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Kullmann DM, 2011, NEUROPHARMACOLOGY, V60, P712, DOI 10.1016/j.neuropharm.2010.12.020; Kurotani T, 2008, NEURON, V57, P905, DOI 10.1016/j.neuron.2008.01.030; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lamsa K, 2007, J PHYSIOL-LONDON, V584, P885, DOI 10.1113/jphysiol.2007.137380; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lapointe V, 2004, J PHYSIOL-LONDON, V555, P125, DOI 10.1113/jphysiol.2003.053603; Le Duigou C, 2011, NEUROPHARMACOLOGY, V60, P748, DOI 10.1016/j.neuropharm.2010.12.015; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee SH, 2010, J NEUROSCI, V30, P7993, DOI 10.1523/JNEUROSCI.6238-09.2010; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Lei SB, 2003, J NEUROSCI, V23, P9786; Lemtiri-Chlieh F, 2007, J NEUROPHYSIOL, V98, P2517, DOI 10.1152/jn.00817.2007; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Ma YY, 2012, J NEUROSCI, V32, P983, DOI 10.1523/JNEUROSCI.5007-11.2012; Maccaferri G, 1996, J NEUROSCI, V16, P5334; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Mizoguchi Y, 2003, J PHYSIOL-LONDON, V548, P703, DOI 10.1113/jphysiol.2003.038935; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Mukhtarov M, 2005, J PHYSIOL-LONDON, V569, P817, DOI 10.1113/jphysiol.2005.094862; Nissen W, 2010, J NEUROSCI, V30, P1337, DOI 10.1523/JNEUROSCI.3481-09.2010; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Oliet SHR, 2007, J NEUROSCI, V27, P1325, DOI 10.1523/JNEUROSCI.2676-06.2007; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Oren I, 2009, J NEUROSCI, V29, P939, DOI 10.1523/JNEUROSCI.3251-08.2009; Ormond J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007224; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; Palizvan MR, 2004, NEUROSCIENCE, V126, P955, DOI 10.1016/j.neuroscience.2004.03.053; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Patenaude C, 2005, EUR J NEUROSCI, V22, P179, DOI 10.1111/j.1460-9568.2005.04207.x; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; PITLER TA, 1992, J NEUROSCI, V12, P4122; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Polepalli JS, 2010, J NEUROSCI, V30, P14619, DOI 10.1523/JNEUROSCI.3252-10.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Sambandan S, 2010, J NEUROSCI, V30, P11826, DOI 10.1523/JNEUROSCI.2012-10.2010; Sanes DH, 2011, HEARING RES, V279, P140, DOI 10.1016/j.heares.2011.03.015; Sarihi A, 2008, J NEUROSCI, V28, P1224, DOI 10.1523/JNEUROSCI.4928-07.2008; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Sivakumaran S, 2009, J NEUROSCI, V29, P2637, DOI 10.1523/JNEUROSCI.5019-08.2009; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; Sudhakaran IP, 2012, J NEUROSCI, V32, P7225, DOI 10.1523/JNEUROSCI.1099-12.2012; Sun QQ, 2011, J NEUROSCI RES, V89, P73, DOI 10.1002/jnr.22530; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szabo A, 2012, J NEUROSCI, V32, P6511, DOI 10.1523/JNEUROSCI.0206-12.2012; Tanaka T, 1997, J NEUROSCI, V17, P2959; Tomasulo RA, 1996, HIPPOCAMPUS, V6, P62, DOI 10.1002/(SICI)1098-1063(1996)6:1<62::AID-HIPO11>3.0.CO;2-I; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Topolnik L, 2009, J NEUROSCI, V29, P4658, DOI 10.1523/JNEUROSCI.0493-09.2009; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wanaverbecq N, 2007, J NEUROSCI, V27, P5683, DOI 10.1523/JNEUROSCI.1732-07.2007; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wardle RA, 2003, J NEUROSCI, V23, P8722; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Xu C, 2008, NAT NEUROSCI, V11, P1410, DOI 10.1038/nn.2215; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	164	145	145	2	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 20	2012	75	6					951	962		10.1016/j.neuron.2012.07.030	http://dx.doi.org/10.1016/j.neuron.2012.07.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011XF	22998865	hybrid			2022-12-17	WOS:000309198900008
J	Marshel, JH; Mori, T; Nielsen, KJ; Callaway, EM				Marshel, James H.; Mori, Takuma; Nielsen, Kristina J.; Callaway, Edward M.			Targeting Single Neuronal Networks for Gene Expression and Cell Labeling In Vivo	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RABIES VIRUS; CEREBRAL-CORTEX; TRANSNEURONAL TRACER; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; VISUAL-CORTEX; BARREL CORTEX; PREFRONTAL CORTEX; AVIAN-LEUKOSIS	To understand fine-scale structure and function of single mammalian neuronal networks, we developed and validated a strategy to genetically target and trace monosynaptic inputs to a single neuron in vitro and in vivo. The strategy independently targets a neuron and its presynaptic network for specific gene expression and fine-scale labeling, using single-cell electroporation of DNA to target infection and monosynaptic retrograde spread of a genetically modifiable rabies virus. The technique is highly reliable, with transsynaptic labeling occurring in every electroporated neuron infected by the virus. Targeting single neocortical neuronal networks in vivo, we found clusters of both spiny and aspiny neurons surrounding the electroporated neuron in each case, in addition to intricately labeled distal cortical and subcortical inputs. This technique, broadly applicable for probing and manipulating single neuronal networks with single-cell resolution in vivo, may help shed new light on fundamental mechanisms underlying circuit development and information processing by neuronal networks throughout the brain.	[Marshel, James H.; Mori, Takuma; Nielsen, Kristina J.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; [Marshel, James H.; Callaway, Edward M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Mori, Takuma/AFS-0267-2022; Nielsen, Kristina/M-2298-2016; Callaway, Edward/D-4336-2011; Mori, Takuma/GMX-3581-2022; Marshel, James/W-2792-2019	Mori, Takuma/0000-0002-4195-2804; Nielsen, Kristina/0000-0002-9155-2972; Callaway, Edward/0000-0002-6366-5267; Mori, Takuma/0000-0002-4195-2804; Marshel, James/0000-0003-3517-8493	National Institutes of Health; Kavli Institute for Brain and Mind; Institute for Neural Computation; National Science Foundation; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Brain and Mind; Institute for Neural Computation; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for support from the National Institutes of Health, the Kavli Institute for Brain and Mind, the Institute for Neural Computation, and the National Science Foundation Bridge to the Doctorate Program. We thank D. Lyon for helpful discussions; I. Wickersham and N. Wall for reagents; M. de la Parra, K. von Bochmann, M. Garrett, and T. Lien for technical assistance; and members of the Callaway laboratory for discussions. J.M. and E.G. designed the experiments and prepared the manuscript. E.C. supervised the experiments. J.M. performed all of the experiments and analyzed the data. J.M. and T.M. set up the slice electroporation rig. J.M. and K.N. set up the in vivo electroporation and two-photon imaging rig.	Aaron G, 2006, SYNAPSE, V60, P437, DOI 10.1002/syn.20316; ASTIC L, 1993, BRAIN RES, V619, P146, DOI 10.1016/0006-8993(93)91606-S; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Boudes M, 2008, J NEUROSCI METH, V170, P204, DOI 10.1016/j.jneumeth.2008.01.018; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Dantzker JL, 1998, J NEUROSCI, V18, P4145; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; DOUGLAS R, 2003, SYNAPTIC ORG BRAIN; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lewis BC, 2001, J VIROL, V75, P9339, DOI 10.1128/JVI.75.19.9339-9344.2001; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Mebatsion T, 1996, P NATL ACAD SCI USA, V93, P7310, DOI 10.1073/pnas.93.14.7310; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Nassi JJ, 2006, J NEUROSCI, V26, P12789, DOI 10.1523/JNEUROSCI.4044-06.2006; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rae JL, 2002, PFLUG ARCH EUR J PHY, V443, P664, DOI 10.1007/s00424-001-0753-1; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tanaka M, 2009, J NEUROSCI METH, V178, P80, DOI 10.1016/j.jneumeth.2008.11.025; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993	67	145	155	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					562	574		10.1016/j.neuron.2010.08.001	http://dx.doi.org/10.1016/j.neuron.2010.08.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797534	Bronze, Green Accepted			2022-12-17	WOS:000281534600007
J	Young, L; Bechara, A; Tranel, D; Damasio, H; Hauser, M; Damasio, A				Young, Liane; Bechara, Antoine; Tranel, Daniel; Damasio, Hanna; Hauser, Marc; Damasio, Antonio			Damage to Ventromedial Prefrontal Cortex Impairs Judgment of Harmful Intent	NEURON			English	Article							MORAL COGNITION; NEURAL BASIS; DECISION-MAKING; EMOTION; FMRI; MIND; NETWORKS; PUNISHMENT	Moral judgments, whether delivered in ordinary experience or in the courtroom, depend on our ability to infer intentions. We forgive unintentional or accidental harms and condemn failed attempts to harm. Prior work demonstrates that patients with damage to the ventromedial prefrontal cortex (VMPC) deliver abnormal judgments in response to moral dilemmas and that these patients are especially impaired in triggering emotional responses to inferred or abstract events (e.g., intentions), as opposed to real or actual outcomes. We therefore predicted that VMPC patients would deliver abnormal moral judgments of harmful intentions in the absence of harmful outcomes, as in failed attempts to harm. This prediction was confirmed in the current study: VMPC patients judged attempted harms, including attempted murder, as more morally permissible relative to controls. These results highlight the critical role of the VMPC in processing harmful intent for moral judgment.	[Young, Liane] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Bechara, Antoine; Damasio, Hanna; Damasio, Antonio] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Bechara, Antoine; Damasio, Hanna; Damasio, Antonio] Univ So Calif, Dornsife Ctr Cognit Neuroimaging, Los Angeles, CA 90089 USA; [Tranel, Daniel] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Hauser, Marc] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Hauser, Marc] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); University of Southern California; University of Southern California; University of Iowa; University of Iowa; Harvard University; Harvard University	Young, L (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	lyoung@mit.edu	Damasio, Antonio/AAD-1342-2019	Bechara, Antoine/0000-0001-5127-2549; Tranel, Daniel/0000-0002-1338-1389	NSF-HSD; NINDS [P01 NS19632]; NIDA [DA022549]; NSF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	NSF-HSD; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Rebecca Saxe and Josh Greene for their helpful comments on an earlier draft of this manuscript. This research was supported in part by a grant from the NSF-HSD (A.B., A.D., M.H.), NINDS (P01 NS19632) (A.D., H.D., D.T.), gift funds from J. Epstein and S. Shuman (M.H.), by NIDA (DA022549) (D.T.), and the NSF (L.Y.).	Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Baird JA, 2004, NEW DIR CHILD ADOLES, V103, P37, DOI 10.1002/cd.96; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Casebeer WD, 2003, BIOL PHILOS, V18, P169, DOI 10.1023/A:1023380907603; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; Cushman F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006699; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; Damasio H., 2005, HUMAN BRAIN ANATOMY, V2; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Gazzaniga MS, 2005, J R SOC MED, V98, P433; Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Jenkins AC, 2010, CEREB CORTEX, V20, P404, DOI 10.1093/cercor/bhp109; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Piaget J., 1965, MORAL JUDGEMENT CHIL; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Young L, 2007, BRIT MED BULL, V84, P69, DOI 10.1093/bmb/ldm031; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137; Young L, 2009, NEUROPSYCHOLOGIA, V47, P2065, DOI 10.1016/j.neuropsychologia.2009.03.020; Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057	50	145	149	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2010	65	6					845	851		10.1016/j.neuron.2010.03.003	http://dx.doi.org/10.1016/j.neuron.2010.03.003			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576MP	20346759	Green Published, Green Accepted, Bronze			2022-12-17	WOS:000276148900012
J	Popescu, MV; Polley, DB				Popescu, Maria V.; Polley, Daniel B.			Monaural Deprivation Disrupts Development of Binaural Selectivity in Auditory Midbrain and Cortex	NEURON			English	Article							CONDUCTIVE HEARING-LOSS; CRITICAL-PERIOD PLASTICITY; RAT BARREL CORTEX; BRAIN-STEM; VISUAL-CORTEX; FREQUENCY ORGANIZATION; INFERIOR COLLICULUS; LEVEL DIFFERENCES; RECEPTIVE-FIELDS; COCHLEAR LESIONS	Degraded sensory experience during critical periods of development can have adverse effects on brain function. In the auditory system, conductive hearing loss associated with childhood ear infections can produce long-lasting deficits in auditory perceptual acuity, much like amblyopia in the visual system. Here we explore the neural mechanisms that may underlie "amblyaudio" by inducing reversible monaural deprivation (MD) in infant, juvenile, and adult rats. MD distorted tonotopic maps, weakened the deprived ear's representation, strengthened the open ear's representation, and disrupted binaural integration of interaural level differences (ILD). Bidirectional plasticity effects were strictly governed by critical periods, were more strongly expressed in primary auditory cortex than inferior colliculus, and directly impacted neural coding accuracy. These findings highlight a remarkable degree of competitive plasticity between aural representations and suggest that the enduring perceptual sequelae of childhood hearing loss might be traced to maladaptive plasticity during critical periods of auditory cortex development.	[Popescu, Maria V.; Polley, Daniel B.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Polley, Daniel B.] Vanderbilt Univ, Sch Med, Vanderbilt Bill Wilkerson Ctr Otolaryngol & Commu, Dept Hearing & Speech Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Polley, DB (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA.	daniel_polley@meei.harvard.edu		Polley, Daniel/0000-0002-5120-2409	Vanderbilt Kennedy Center; National Organization of Hearing Research Foundation; NIH [DC009836]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009836] Funding Source: NIH RePORTER	Vanderbilt Kennedy Center; National Organization of Hearing Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to Z. Barnett for his invaluable technical assistance and to Drs. D. Blake and V. Khatri for commenting on an earlier version of manuscript. D.B.P. designed the experiment, collected data, analyzed data, and wrote the manuscript. M.V.P. collected data, implemented the computational model, and analyzed data. This work is supported by development funds from the Vanderbilt Kennedy Center, a Robin and Michael Fox Grant in Auditory Science from the National Organization of Hearing Research Foundation, and NIH grant DC009836 to D.B.P.	Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CLEMENTS M, 1978, J COMP PHYSIOL PSYCH, V92, P34, DOI 10.1037/h0077424; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Davis-Gunter MJ, 2001, SCAND AUDIOL, V30, P50, DOI 10.1080/010503901750069572; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; EGGERMONT JJ, 1980, J ACOUST SOC AM, V68, P1671, DOI 10.1121/1.385199; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; FOX K, 1992, J NEUROSCI, V12, P1826; Friauf E, 2000, AUDIOL NEURO-OTOL, V5, P251, DOI 10.1159/000013889; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; GRAY L, 1982, BRAIN RES, V244, P360, DOI 10.1016/0006-8993(82)90098-1; Green JS, 2005, J NEUROPHYSIOL, V94, P3826, DOI 10.1152/jn.00601.2005; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hogan SCM, 2003, JARO, V4, P123, DOI 10.1007/s10162-002-3007-9; Hutson KA, 2007, HEARING RES, V233, P124, DOI 10.1016/j.heares.2007.08.003; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; Kamke MR, 2003, J COMP NEUROL, V459, P355, DOI 10.1002/cne.10586; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lanphear BP, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e1; Li RW, 2008, J NEUROSCI, V28, P14223, DOI 10.1523/JNEUROSCI.4271-08.2008; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MOGDANS J, 1993, BRAIN RES, V619, P29, DOI 10.1016/0006-8993(93)91593-H; MOORE DR, 1991, AUDIOLOGY, V30, P91; Moore DR, 1999, J NEUROSCI, V19, P8704; Nodal FR, 2010, J NEUROPHYSIOL, V103, P1209, DOI 10.1152/jn.00991.2009; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; PILLSBURY HC, 1991, ARCH OTOLARYNGOL, V117, P718; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2008, J AM ACAD AUDIOL, V19, P780, DOI 10.3766/jaaa.19.10.6; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; POON PWF, 1992, BRAIN RES, V585, P391, DOI 10.1016/0006-8993(92)91243-8; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Razak KA, 2007, HEARING RES, V228, P69, DOI 10.1016/j.heares.2007.01.020; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SANES DH, 1985, J NEUROSCI, V5, P1152; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SCHAPPERT S, 1992, NATL CTR HLTH CARE S, V214; SILVERMAN MS, 1977, J NEUROPHYSIOL, V40, P1266, DOI 10.1152/jn.1977.40.6.1266; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Suga N, 2008, LEARN MEMORY, V15, P198, DOI 10.1101/lm.791408; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; SUR M, 1988, J NEUROSCI, V8, P874; Tucci DL, 1999, LARYNGOSCOPE, V109, P1359, DOI 10.1097/00005537-199909000-00001; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; Weinberger NM, 2007, HEARING RES, V229, P54, DOI 10.1016/j.heares.2007.01.004; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Xu H, 2010, J NEUROSCI, V30, P331, DOI 10.1523/JNEUROSCI.4554-09.2010; Yu X, 2007, P NATL ACAD SCI USA, V104, P12193, DOI 10.1073/pnas.0700960104; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188; Zhou X, 2008, NEUROSCIENCE, V154, P390, DOI 10.1016/j.neuroscience.2008.01.026	69	145	147	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					718	731		10.1016/j.neuron.2010.02.019	http://dx.doi.org/10.1016/j.neuron.2010.02.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223206	Green Accepted, Bronze			2022-12-17	WOS:000275758000014
J	Van Der Giessen, RS; Koekkoek, SK; van Dorp, S; De Gruijl, JR; Cupido, A; Khosrovani, S; Dortland, B; Wellershaus, K; Degen, J; Deuchars, J; Fuchs, EC; Monyer, H; Willecke, K; De Jeu, MTG; De Zeeuw, CI				Van Der Giessen, Ruben S.; Koekkoek, Sebastiaan K.; van Dorp, Stijn; De Gruijl, Jornt R.; Cupido, Alexander; Khosrovani, Sara; Dortland, Bjorn; Wellershaus, Kerstin; Degen, Joachim; Deuchars, Jim; Fuchs, Elke C.; Monyer, Hannah; Willecke, Klaus; De Jeu, Marcel T. G.; De Zeeuw, Chris I.			Role of olivary electrical coupling in cerebellar motor learning	NEURON			English	Article							CONDITIONED EYELID RESPONSES; JUNCTION GENE CONNEXIN36; INFERIOR OLIVE; MAMMALIAN BRAIN; GAP-JUNCTIONS; IN-VIVO; LURCHER MICE; MOUSE; RAT; OSCILLATIONS	The level of electrotonic coupling in the inferior olive is extremely high, but its functional role in cerebellar motor control remains elusive. Here, we subjected mice that lack olivary coupling to paradigms that require learning-depend ent timing. Cx36-deficient mice showed impaired timing of both locomotion and eye-blink responses that were conditioned to a tone. The latencies of their olivary spike activities in response to the unconditioned stimulus were significantly more variable than those in wild-types. Whole-cell recordings of olivary neurons in vivo showed that these differences in spike timing result at least in part from altered interactions with their subthreshold oscillations. These results, combined with analyses of olivary activities in computer simulations at both the cellular and systems level, suggest that electrotonic coupling among olivary neurons by gap junctions is essential for proper timing of their action potentials and thereby for learning-dependent timing in cerebellar motor control.	[Van Der Giessen, Ruben S.; Koekkoek, Sebastiaan K.; De Gruijl, Jornt R.; Cupido, Alexander; Khosrovani, Sara; Dortland, Bjorn; De Jeu, Marcel T. G.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; [Wellershaus, Kerstin; Degen, Joachim; Willecke, Klaus] Univ Bonn, Div Mol Genet, Inst Genet, D-53117 Bonn, Germany; [Deuchars, Jim] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Fuchs, Elke C.; Monyer, Hannah] Interdisciplinary Ctr Neurosci, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [van Dorp, Stijn; De Gruijl, Jornt R.; De Zeeuw, Chris I.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Bonn; University of Leeds; Ruprecht Karls University Heidelberg; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	Oka, Yoshitaka/C-9670-2010; Deuchars, Jim/L-3740-2019	Oka, Yoshitaka/0000-0002-3482-3051; Deuchars, Jim/0000-0002-4445-654X	Biotechnology and Biological Sciences Research Council [BB/E001831/1] Funding Source: Medline; BBSRC [BB/E001831/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bengtsson F, 2006, CEREBELLUM, V5, P7, DOI 10.1080/14734220500462757; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Blenkinsop TA, 2006, J NEUROSCI, V26, P1739, DOI 10.1523/JNEUROSCI.3677-05.2006; Buhl DL, 2003, J NEUROSCI, V23, P1013; Bullock TH, 2005, SCIENCE, V310, P791, DOI 10.1126/science.1114394; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 2003, J NEUROSCI, V23, P4700; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Degen J, 2004, J COMP NEUROL, V473, P511, DOI 10.1002/cne.20085; DEZEEUW CI, 1995, J NEUROSCI, V15, P1587; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Gareri P, 2005, NEUROPHARMACOLOGY, V49, P551, DOI 10.1016/j.neuropharm.2005.04.012; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; HESSLOW G, 1994, J PHYSIOL-LONDON, V476, P229, DOI 10.1113/jphysiol.1994.sp020126; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Khosrovani S, 2007, P NATL ACAD SCI USA, V104, P15911, DOI 10.1073/pnas.0702727104; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; Leznik E, 2002, J NEUROSCI, V22, P2804, DOI 10.1523/JNEUROSCI.22-07-02804.2002; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Long MA, 2002, J NEUROSCI, V22, P10898; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Margineanu DG, 2006, BRAIN RES BULL, V71, P23, DOI 10.1016/j.brainresbull.2006.07.011; Marshall SP, 2007, CEREBELLUM, V6, P287, DOI 10.1080/14734220601100801; Martin FC, 2006, MOVEMENT DISORD, V21, P1641, DOI 10.1002/mds.20940; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Pijpers A, 2005, J COMP NEUROL, V492, P193, DOI 10.1002/cne.20707; Placantonakis DG, 2004, P NATL ACAD SCI USA, V101, P7164, DOI 10.1073/pnas.0400322101; Placantonakis DG, 2006, J NEUROSCI, V26, P5008, DOI 10.1523/JNEUROSCI.0146-06.2006; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Rozental R, 2001, METH MOL B, V154, P447; Ruigrok TJH, 2000, J COMP NEUROL, V426, P209, DOI 10.1002/1096-9861(20001016)426:2<209::AID-CNE4>3.0.CO;2-0; RUIGROK TJH, 1995, EUR J NEUROSCI, V7, P679, DOI 10.1111/j.1460-9568.1995.tb00672.x; RULGROK TJ, 2007, NAT PROTOC, V2, P1869; Saffitz JE, 2000, CIRC RES, V86, P723, DOI 10.1161/01.RES.86.7.723; Schweighofer N, 1999, J NEUROPHYSIOL, V82, P804, DOI 10.1152/jn.1999.82.2.804; SETOOHSHIMA A, 1989, EXP BRAIN RES, V75, P653; SIMPSON JI, 1996, BEHAV BRAIN SCI, V19, P380; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Theis M, 2000, METHODS, V20, P205, DOI 10.1006/meth.1999.0938; Van Alphen AM, 2002, ANN NY ACAD SCI, V978, P413; Van Der Giessen RS, 2006, J COMP NEUROL, V495, P173, DOI 10.1002/cne.20873; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	65	145	146	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					599	612		10.1016/j.neuron.2008.03.016	http://dx.doi.org/10.1016/j.neuron.2008.03.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498740	Bronze			2022-12-17	WOS:000256120500013
J	Chiu, PH; Kayali, MA; Kishida, KT; Tomlin, D; Klinger, LG; Klinger, MR; Montague, PR				Chiu, Pearl H.; Kayali, M. Amin; Kishida, Kenneth T.; Tomlin, Damon; Klinger, Laura G.; Klinger, Mark R.; Montague, P. Read			Self responses along cingulate cortex reveal quantitative neural phenotype for high-functioning autism	NEURON			English	Article							MINDS	Attributing behavioral outcomes correctly to oneself or to other agents is essential for all productive social exchange. We approach this issue in high-functioning males with autism spectrum disorder (ASD) using two separate fMRI paradigms. First, using a visual imagery task, we extract a basis set for responses along the cingulate cortex of control subjects that reveals an agent-specific eigenvector (self eigenmode) associated with imagining oneself executing a specific motor act. Second, we show that the same self eigenmode arises during one's own decision (the self phase) in an interpersonal exchange game (iterated trust game). Third, using this exchange game, we show that ASD males exhibit a severely diminished cingulate self response when playing the game with a human partner. This diminishment covaries parametrically with their behaviorally assessed symptom severity, suggesting its value as an objective endophenotype. These findings may provide a quantitative assessment tool for high-functioning ASD.	[Chiu, Pearl H.; Kayali, M. Amin; Kishida, Kenneth T.; Montague, P. Read] Baylor Coll Med, Comp Psychiat Unit, Houston, TX 77030 USA; [Chiu, Pearl H.; Kayali, M. Amin; Kishida, Kenneth T.; Tomlin, Damon; Montague, P. Read] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; [Chiu, Pearl H.; Montague, P. Read] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Klinger, Laura G.; Klinger, Mark R.] Univ Alabama, Dept Psychol, Tuscaloosa, AL 35487 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Tuscaloosa	Montague, PR (corresponding author), Baylor Coll Med, Comp Psychiat Unit, Houston, TX 77030 USA.	rmontague@cpu.bcm.edu			NIDA NIH HHS [R01 DA11723, R01 DA011723] Funding Source: Medline; NIMH NIH HHS [F32 MH078485, T32 MH18882, T32 MH018882] Funding Source: Medline; NINDS NIH HHS [R01 NS045790] Funding Source: Medline; Autism Speaks [AS1947] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH078485, T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; DENNETT DC, 2001, MINDS 1 FANTASIES RE; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; FRITH CD, 2006, NEURAL BASIS MENTALI, V4, P531; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Frith U., 2003, AUTISM EXPLAINING EN; GREENWALD A, 2003, GEN CLASS NO REGRET; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Kagel J., 1997, HDB EXPT EC; Kaufman A.S., 2004, KAUFMANN BRIEF INTEL, V2nd ed.; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7	48	145	153	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					463	473		10.1016/j.neuron.2007.12.020	http://dx.doi.org/10.1016/j.neuron.2007.12.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255038	Green Accepted, Bronze			2022-12-17	WOS:000253075300015
J	Philpot, BD; Cho, KKA; Bear, MF				Philpot, Benjamin D.; Cho, Kathleen K. A.; Bear, Mark F.			Obligatory role of NR2A for metaplasticity in visual cortex	NEURON			English	Article							LONG-TERM-POTENTIATION; D-ASPARTATE RECEPTORS; SYNAPTIC NMDA RECEPTORS; SUBUNIT COMPOSITION; CRITICAL PERIOD; THALAMOCORTICAL SYNAPSES; FUNCTIONAL-PROPERTIES; DEPENDENT REGULATION; HIPPOCAMPAL LTP; EXON 5	Light deprivation lowers the threshold for long-term depression (LTD) and long-term potentiation (LTP) in visual cortex by a process termed metaplasticity, but the mechanism is unknown. The decreased LTD/P threshold correlates with a decrease in the ratio of NR2A to NR2B subunits of cortical NMDA receptors (NMDARs) and a slowing of NMDAR-mediated excitatory postsynaptic currents (EPSCs). However, whether and how changes in NR2 subunit expression contribute to LTD and LTP have been controversial. In the present study, we used an NR2A knockout (KO) mouse to examine the role of this subunit in the experience-dependent modulation of NMDAR properties, LTD, and LTP. We found that deletion of NR2A abrogates the effects of visual experience on NMDAR EPSCs and prevents metaplasticity of LTP and LTD. These data support the hypothesis that experience-dependent changes in NR2A/B are functionally significant and yield a mechanism for an adjustable synaptic modification threshold in visual cortex.	MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ N Carolina, Ctr Neurosci, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bear, MF (corresponding author), MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave,46-3301, Cambridge, MA 02139 USA.	mbear@mit.edu	Cho, Kathleen/AAX-2327-2020	Cho, Kathleen/0000-0003-0215-8779; Bear, Mark/0000-0002-9903-2541	NATIONAL EYE INSTITUTE [R01EY012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY012309] Funding Source: Medline; NIMH NIH HHS [P50 MH058880] Funding Source: Medline; NINDS NIH HHS [P01 NS039321] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; CZEPITA D, 1994, J NEUROPHYSIOL, V72, P1220, DOI 10.1152/jn.1994.72.3.1220; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Flint AC, 1997, J NEUROSCI, V17, P2469; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FOX K, 1992, J NEUROSCI, V12, P2672; Fu ZY, 2005, J PHYSIOL-LONDON, V563, P867, DOI 10.1113/jphysiol.2004.079467; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morikawa E, 1998, J NEUROSCI, V18, P9727; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Prybylowski K, 2000, J NEUROCHEM, V75, P1140, DOI 10.1046/j.1471-4159.2000.0751140.x; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rumbaugh G, 2000, J NEUROPHYSIOL, V83, P1300, DOI 10.1152/jn.2000.83.3.1300; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	60	145	153	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					495	502		10.1016/j.neuron.2007.01.027	http://dx.doi.org/10.1016/j.neuron.2007.01.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296552	Green Accepted, Bronze, Green Submitted			2022-12-17	WOS:000245126900009
J	Yoshida, W; Ishii, S				Yoshida, Wako; Ishii, Shin			Resolution of uncertainty in prefrontal cortex	NEURON			English	Article							ANTERIOR CINGULATE; BASAL GANGLIA; INFORMATION; SELECTION; CONFLICT; SYSTEMS	Making optimal decisions in the face of uncertain or incomplete information arises as a common problem in everyday behavior, but the neural processes underlying this ability remain poorly understood. A typical case is navigation, in which a subject has to search for a known goal from an unknown location. Navigating under uncertain conditions requires making decisions on the basis of the current belief about location and updating that belief based on incoming information. Here, we use functional magnetic resonance imaging during a maze navigation task to study neural activity relating to the resolution of uncertainty as subjects make sequential decisions to reach a goal. We show that distinct regions of prefrontal cortex are engaged in specific computational functions that are well described by a Bayesian model of decision making. This permits efficient goal-oriented navigation and provides new insights into decision making by humans.	Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Ishii, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, 8916-5 Takayama, Nara 6300192, Japan.	ishii@is.naist.jp		Ishii, Shin/0000-0001-9385-8230				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ASTROM KJ, 1965, J MATH ANAL APPL, V10, P174, DOI 10.1016/0022-247X(65)90154-X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; CASSANDRA AR, 1994, PROCEEDINGS OF THE TWELFTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P1023; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Ishii S, 2002, NEURAL NETWORKS, V15, P665, DOI 10.1016/S0893-6080(02)00056-4; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; MacDonald I.L., 1997, HIDDEN MARKOV OTHER; MacKay David JC, 2003, INFORM THEORY INFERE; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; STANKIEWICZ BJ, 2006, IN PRESS J EXP PSYCH; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	34	145	146	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					781	789		10.1016/j.neuron.2006.05.006	http://dx.doi.org/10.1016/j.neuron.2006.05.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731515	Bronze			2022-12-17	WOS:000238165000012
J	Ng, JL; Luo, LQ				Ng, JL; Luo, LQ			Rho GTPases regulate axon growth through convergent and divergent signaling pathways	NEURON			English	Article							ACTIN-DEPOLYMERIZING FACTOR; ABL TYROSINE KINASE; LIM-KINASE; EXCHANGE FACTOR; FAMILY GTPASES; FACTOR COFILIN; CELL POLARITY; RAC; PHOSPHORYLATION; POLYMERIZATION	Rho GTPases are essential regulators of cytoskeletal reorganization, but how they do so during neuronal morphogenesis in vivo is poorly understood. Here we show that the actin depolymerization factor cofilin is essential for axon growth in Drosophila neurons. Cofilin function in axon growth is inhibited by LIM kinase and activated by Slingshot phosphatase. Dephosphorylating cofilin appears to be the major function of Slingshot in regulating axon growth in vivo. Genetic data provide evidence that Rho or Rac/Cdc42, via effector kinases Rok or Pak, respectively, activate LIM kinase to inhibit axon growth. Importantly, Rac also activates a Pak-independent pathway that promotes axon growth, and different RacGEFs regulate these distinct pathways. These genetic analyses reveal convergent and divergent pathways from Rho GTPases to the cytoskeleton during axon growth in vivo and suggest that different developmental outcomes could be achieved by biases in pathway selection.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Ng, JL (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	julian.ng@kcl.ac.uk; lluo@stanford.edu	Ng, Julian/C-5747-2009	Luo, Liqun/0000-0001-5467-9264; Ng, Julian/0000-0002-1908-4414	NINDS NIH HHS [R01-NS 36632] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fehon RG, 1997, GENETICS, V146, P245; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Mizuno T, 2002, DEVELOPMENT, V129, P1215; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	59	145	155	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					779	793		10.1016/j.neuron.2004.11.014	http://dx.doi.org/10.1016/j.neuron.2004.11.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572110	Bronze			2022-12-17	WOS:000225548400007
J	Ricci, AJ; Crawford, AC; Fettiplace, R				Ricci, AJ; Crawford, AC; Fettiplace, R			Tonotopic variation in the conductance of the hair cell mechanotransducer channel	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; JUNCTION CHANNELS; FAST ADAPTATION; CALCIUM; TURTLE; CURRENTS; COCHLEA; DROSOPHILA; KINETICS; BUNDLE	Hair cells in the vertebrate cochlea are arranged tonotopically with their characteristic frequency (CF), the sound frequency to which they are most sensitive, changing systematically with position. Single mechanotransducer channels of hair cells were characterized at different locations in the turtle cochlea. In 2.8 mM external Ca2+, the channel's chord conductance was 118 pS (range 80-163 pS), which nearly doubled (range 149-300 pS) on reducing Ca2+ to 50 muM. In both Ca2+ concentrations, the conductance was positively correlated with hair cell CF. Variation in channel conductance can largely explain the increases in size of the macroscopic transducer current and speed of adaptation with CF. It suggests diversity of transducer channel structure or environment along the cochlea that may be an important element of its tonotopic organization.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.			ricci, anthony/0000-0002-1706-8904	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362, R01DC003896] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 03896, R01 DC 01362] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashcroft FM, 2000, ION CHANNELS DIS; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bonigk W, 1999, J NEUROSCI, V19, P5332; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Fettiplace R, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P65, DOI 10.1142/9789812704931_0007; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HACKNEY CM, 1995, ACTIVE HEARING, P103; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Marty A., 1983, SINGLE CHANNEL RECOR, P107; Meyer J, 1998, J NEUROSCI, V18, P6748; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Verselis V.K., 2000, ADV MOL CEL, V30, P129; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	45	145	152	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					983	990		10.1016/S0896-6273(03)00721-9	http://dx.doi.org/10.1016/S0896-6273(03)00721-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659096	Bronze			2022-12-17	WOS:000187042200014
J	Bao, L; Jin, SX; Zhang, C; Wang, LH; Xu, ZZ; Zhang, FX; Wang, LC; Ning, FS; Cai, HJ; Guan, JS; Xiao, HS; Xu, ZQD; He, C; Hokfelt, T; Zhou, Z; Zhang, X				Bao, L; Jin, SX; Zhang, C; Wang, LH; Xu, ZZ; Zhang, FX; Wang, LC; Ning, FS; Cai, HJ; Guan, JS; Xiao, HS; Xu, ZQD; He, C; Hokfelt, T; Zhou, Z; Zhang, X			Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion	NEURON			English	Article							GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLIA; SPINAL-CORD; SUBSTANCE-P; CA2+-DEPENDENT EXOCYTOSIS; PLASMA-MEMBRANE; SENSORY NEURONS; AMPA RECEPTORS; RAT; RELEASE	Here we describe a novel mechanism for plasma membrane insertion of the delta opioid receptor (DOR). In small dorsal root ganglion neurons, only low levels of DORs are present on the cell surface, in contrast to high levels of intracellular DORs mainly associated with vesicles containing calcitonin gene-related peptide (CGRP). Activation of surface DORs caused Ca2+ release from lP(3)-sensitive stores and Ca2+ entry, resulting in a slow and long-lasting exocytosis, DOR insertion, and CGRP release. In contrast, membrane depolarization or activation of vanilloid and P2Y, receptors induced a rapid DOR insertion. Thus, DOR activation induces a Ca2+-dependent insertion of DORs that is coupled to a release of excitatory neuropeptides, suggesting that treatment of inflammatory pain should include blockade of DORs.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Sensory Syst, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Sensory Syst, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Cellular Biophys, Shanghai, Peoples R China; Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Karolinska Institutet	Zhou, Z (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Sensory Syst, Shanghai, Peoples R China.	zzhou@ion.ac.cn; xu.zhang@ion.ac.cn	zhou, zhuan/A-8285-2011; Xu, Zhi-Qing David/H-9757-2013	Guan, Ji-Song/0000-0001-5219-0289; Xu, Zhen-Zhong/0000-0001-6578-211X; Xu, Zhi-Qing David/0000-0002-0387-7559				AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHENG PY, 1995, J NEUROSCI, V15, P5976; COLLIN E, 1993, BRAIN RES, V609, P211, DOI 10.1016/0006-8993(93)90875-N; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Engisch KL, 1996, J NEUROSCI, V16, P1359; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FIELDS HL, 1980, NATURE, V284, P351, DOI 10.1038/284351a0; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3081, DOI 10.1073/pnas.74.7.3081; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; JUNG LJ, 1991, SCIENCE, V251, P1330, DOI 10.1126/science.2003219; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; LAMOTTE C, 1976, BRAIN RES, V112, P407, DOI 10.1016/0006-8993(76)90296-1; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; MERIGHI A, 1988, CELL TISSUE RES, V254, P101; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; MORTON CR, 1990, NEUROSCI LETT, V117, P319, DOI 10.1016/0304-3940(90)90684-2; Nakatsuka T, 2001, NEUROSCIENCE, V107, P293, DOI 10.1016/S0306-4522(01)00342-6; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PEI G, 1995, MOL PHARMACOL, V48, P173; POHL M, 1989, NEUROPEPTIDES, V14, P151, DOI 10.1016/0143-4179(89)90039-5; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; RINK TJ, 1990, FEBS LETT, V268, P381, DOI 10.1016/0014-5793(90)81290-5; Schiller PW, 1999, J MED CHEM, V42, P3520, DOI 10.1021/jm980724+; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; SUAREZROCA H, 1992, BRAIN RES, V579, P195, DOI 10.1016/0006-8993(92)90051-A; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Trapaidze N, 2000, DNA CELL BIOL, V19, P195, DOI 10.1089/104454900314465; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Whim MD, 2001, NEURON, V30, P37, DOI 10.1016/S0896-6273(01)00261-6; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0; YAKSH TL, 1988, PROG BRAIN RES, V77, P371; Zhang X, 1998, NEUROSCIENCE, V82, P1225; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	50	145	165	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					121	133		10.1016/S0896-6273(02)01103-0	http://dx.doi.org/10.1016/S0896-6273(02)01103-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526778	Bronze			2022-12-17	WOS:000181054700015
J	Sherman, DL; Fabrizi, C; Gillespie, CS; Brophy, PJ				Sherman, DL; Fabrizi, C; Gillespie, CS; Brophy, PJ			Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy	NEURON			English	Article							PDZ-DOMAIN PROTEIN; PERIPHERAL-NERVE; MUSCULAR-DYSTROPHY; BASAL LAMINA; EXTRACELLULAR-MATRIX; GLYCOPROTEIN-COMPLEX; AXONAL ENSHEATHMENT; BINDING DOMAIN; ANIMAL-MODELS; CHAIN GENE	Dystroglycan-dystrophin complexes are believed to have structural and signaling functions by linking extracellular matrix proteins to the cytoskeleton and cortical signaling molecules. Here we characterize a dystroglycan-dystrophin-related protein 2 (DRP2) complex at the surface of myelin-forming Schwann cells. The complex is clustered by the interaction of DRP2 with L-periaxin, a homodimeric PDZ domain-containing protein. In the absence of L-periaxin, DRP2 is mislocalized and depleted, although other dystrophin family proteins are unaffected. Disruption of the DRP2-dystroglycan complex is followed by hypermyelination and destabilization of the Schwann cell-axon unit in Prx(-/-) mice. Hence, the DRP2-dystroglycan complex likely has a distinct function in the terminal stages of PNS myelinogenesis, possibly in the regulation of myelin thickness.	Univ Edinburgh, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh	Brophy, PJ (corresponding author), Univ Edinburgh, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland.		fabrizi, cinzia/G-2379-2012					Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ARAHATA K, 1993, P JPN ACAD B-PHYS, V69, P259, DOI 10.2183/pjab.69.259; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; BUNGE MB, 1990, ANN NY ACAD SCI, V580, P281, DOI 10.1111/j.1749-6632.1990.tb17937.x; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; BUNGE RP, 1978, J CELL BIOL, V78, P943, DOI 10.1083/jcb.78.3.943; CAREY DJ, 1986, J CELL BIOL, V102, P2254, DOI 10.1083/jcb.102.6.2254; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; COMI GP, 1995, HUM MOL GENET, V4, P2171, DOI 10.1093/hmg/4.11.2171; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; di Vignano AT, 2000, FEBS LETT, V471, P229, DOI 10.1016/S0014-5793(00)01400-9; Dixon AK, 1997, J MOL BIOL, V270, P551, DOI 10.1006/jmbi.1997.1138; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; DOYU M, 1993, J NEUROCHEM, V60, P543, DOI 10.1111/j.1471-4159.1993.tb03183.x; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Dyck P, 1993, PERIPHERAL NEUROPATH; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Froehner SC, 1997, SOC GEN PHY, V52, P197; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GEE SH, 1993, J BIOL CHEM, V268, P14972; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Greenberg DS, 1996, HUM MOL GENET, V5, P1299, DOI 10.1093/hmg/5.9.1299; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Imamura M, 2000, HUM MOL GENET, V9, P3091, DOI 10.1093/hmg/9.20.3091; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; LEMKE G, 1988, DEVELOPMENT, V102, P499; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; MATSUMURA K, 1993, FEBS LETT, V334, P281, DOI 10.1016/0014-5793(93)80695-Q; Matsumura K, 1997, HISTOL HISTOPATHOL, V12, P195; Morris GE, 1998, BIOCHEMISTRY-US, V37, P11117, DOI 10.1021/bi9805137; Muller HW, 1997, NEUROBIOL DIS, V4, P215, DOI 10.1006/nbdi.1997.0148; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Roberts RG, 2000, MOL CELL NEUROSCI, V16, P674, DOI 10.1006/mcne.2000.0895; Roberts RG, 1996, NAT GENET, V13, P223, DOI 10.1038/ng0696-223; Saito F, 1999, J BIOL CHEM, V274, P8240, DOI 10.1074/jbc.274.12.8240; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Stevenson S, 1997, CIRC RES, V80, P269, DOI 10.1161/01.RES.80.2.269; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Uziyel Y, 2000, GLIA, V32, P109, DOI 10.1002/1098-1136(200011)32:2<109::AID-GLIA10>3.0.CO;2-1; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; Winder SJ, 1997, J MUSCLE RES CELL M, V18, P617, DOI 10.1023/A:1018627705273; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yamada H, 1996, J NEUROCHEM, V66, P1518; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	66	145	160	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					677	687		10.1016/S0896-6273(01)00327-0	http://dx.doi.org/10.1016/S0896-6273(01)00327-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430802	Bronze			2022-12-17	WOS:000169508900009
J	Zylka, MJ; Shearman, LP; Levine, JD; Jin, XW; Weaver, DR; Reppert, SM				Zylka, MJ; Shearman, LP; Levine, JD; Jin, XW; Weaver, DR; Reppert, SM			Molecular analysis of mammalian timeless	NEURON			English	Article							DROSOPHILA CIRCADIAN CLOCK; POSITIONAL CLONING; PERIOD GENE; PROTEIN; LIGHT; TRANSLATION; ENTRAINMENT; EXPRESSION; MECHANISM; RHYTHMS	We cloned the mouse cDNA of a mammalian homolog of the Drosophila timeless (tim) gene and designated it mTim. The mTim protein shows five homologous regions with Drosophila TIM. mTim is weakly expressed in the suprachiasmatic nuclei (SCN) but exhibits robust expression in the hypophyseal pars tuberalis (PT). mTim RNA levels do not oscillate in the SCN nor are they acutely altered by light exposure during subjective night, mTim RNA is expressed at low levels in several peripheral tissues, including eyes, and is heavily expressed in spleen and testis. Yeast two-hybrid assays revealed an array of interactions between the various mPER proteins but no mPER-mTIM interactions. The data suggest that PER-PER interactions have replaced the function of PER-TIM dimers in the molecular workings of the mammalian circadian clock.	Massachusetts Gen Hosp, Serv Pediat, Lab Dev Chronobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Serv Pediat, Lab Dev Chronobiol, Boston, MA 02114 USA.			Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011547, F32MH012067] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NIMH NIH HHS [MH12067, MH11547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1998, CURR OPIN GENET DEV, V8, P400, DOI 10.1016/S0959-437X(98)80109-3; FINLEY RL, 1995, DNA CLONING EXPRESSI, P169; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LINCOLN GA, 1994, J NEUROENDOCRINOL, V6, P251, DOI 10.1111/j.1365-2826.1994.tb00580.x; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reppert SM, 1995, CELL, V83, P1059, DOI 10.1016/0092-8674(95)90131-0; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Sharman AC, 1996, NETH J ZOOL, V46, P47, DOI 10.1163/156854295X00050; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahata S, 1998, BIOCHEM BIOPH RES CO, V248, P789, DOI 10.1006/bbrc.1998.9012; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; WEAVER DR, 1993, MOL BRAIN RES, V20, P313, DOI 10.1016/0169-328X(93)90058-W; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	43	145	148	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1115	1122		10.1016/S0896-6273(00)80628-5	http://dx.doi.org/10.1016/S0896-6273(00)80628-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856466	Bronze			2022-12-17	WOS:000077386100021
J	Giniger, E				Giniger, E			A role for abl in notch signaling	NEURON			English	Article							ABELSON TYROSINE KINASE; DROSOPHILA-ABL; NUCLEOTIDE-SEQUENCE; AXONAL OUTGROWTH; FACTOR-RECEPTOR; CELL FATES; C-SRC; PROTEIN; GENE; DIFFERENTIATION	Abl is an axonal tyrosine kinase that has yet to be clearly linked to a receptor; Notch is a receptor for which the signaling pathway remains incompletely understood. We show here that Notch and abl mutations interact synergistically to produce synthetic lethality and defects in axon extension. Surprisingly, we cannot account for these axonal aberrations on the basis of changes in cell identity. We show, moreover, that Notch is present in the growth cones of extending axons, and that the Abl accessory protein Disabled binds to a signaling domain of Notch in vitro. We therefore speculate that Disabled and Abl may play a role in Notch signaling in Drosophila axons, perhaps by binding to the Notch intracellular domain.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Giniger, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.		Giniger, Edward/C-1764-2015	Giniger, Edward/0000-0002-8340-6158				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BATE M, 1993, DEVELOPMENT, P149; BENNETT RL, 1992, DEVELOPMENT, V116, P953; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Bruno KS, 1996, P NATL ACAD SCI USA, V93, P4775, DOI 10.1073/pnas.93.10.4775; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; GINIGER E, 1993, DEVELOPMENT, V117, P431; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; GINIGER E, 1994, DEVELOPMENT, V120, P1385; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Goodman Corey S., 1993, P1131; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HIRATA T, 1993, DEVELOPMENT, V119, P49; HOFFMANN FM, 1991, TRENDS GENET, V7, P351, DOI 10.1016/0168-9525(91)90254-F; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; Larkin MK, 1996, DEVELOPMENT, V122, P3639; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shawber C, 1996, DEVELOPMENT, V122, P3765; SHELLENBARGER DL, 1978, DEV BIOL, V62, P432, DOI 10.1016/0012-1606(78)90226-9; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; WANG JYJ, 1993, CURR OPIN GENET DEV, V3, P35, DOI 10.1016/S0959-437X(05)80338-7; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wettstein DA, 1997, DEVELOPMENT, V124, P693; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	62	145	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1998	20	4					667	681		10.1016/S0896-6273(00)81007-7	http://dx.doi.org/10.1016/S0896-6273(00)81007-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581760	Bronze			2022-12-17	WOS:000073346500007
J	Haass, C				Haass, C			Presenilins: Genes for life and death	NEURON			English	Review							FAMILIAL ALZHEIMERS-DISEASE; MISSENSE MUTATIONS				Haass, C (corresponding author), CENT INST MENTAL HLTH,DEPT MOL BIOL,D-68159 MANNHEIM,GERMANY.							BAUMEISTER R, 1997, IN PRESS GENES FUNCT; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; KIM TW, 1997, IN PRESS J BIOL CHEM; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; PODLISNY MB, 1997, IN PRESS NEUROBIOL D; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SEEGER M, 1997, IN PRESS P NATL ACAD; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; TIENARI P, 1997, IN PRESS P NATL ACAD; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; WALTER J, 1997, IN PRESS P NATL ACAD; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977	27	145	150	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					687	690		10.1016/S0896-6273(00)80309-8	http://dx.doi.org/10.1016/S0896-6273(00)80309-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182794	Bronze			2022-12-17	WOS:A1997XB72200002
J	BEZPROZVANNY, I; EHRLICH, BE				BEZPROZVANNY, I; EHRLICH, BE			ATP MODULATES THE FUNCTION OF INOSITOL 1,4,5-TRISPHOSPHATE-GATED CHANNELS AT 2 SITES	NEURON			English	Article							SMOOTH-MUSCLE CELLS; RECONSTITUTED LIPID VESICLES; DEPENDENT PROTEIN-KINASE; TRISPHOSPHATE RECEPTOR; CALCIUM RELEASE; CA-2+ RELEASE; ADENINE-NUCLEOTIDES; CEREBELLUM; BINDING; PHOSPHORYLATION	The inositol 1,4,5-trisphosphate (IP3) receptor, a Ca2+-permeable channel, plays a key role in intracellular Ca2+ signaling. The effects of ATP on the IP3 receptor at the single-channel level were characterized after channel incorporation into planar lipid bilayers. ATP alone was not sufficient to open the IP3-gated channel, but addition of ATP or nonhydrolyzable ATP analogs in the presence of IP3 increased the frequency of channel openings 4.8-fold and increased the average duration of channel openings 2.5-fold; channel conductance was unchanged. High concentrations of ATP (>4 mM) decreased channel activity most probably by competing with IP3 for the IP3-binding site. Allosteric modulation of IP3-induced Ca2+ release by ATP may contribute to the maintenance of cell viability during periods of energy starvation.	MARINE BIOL LAB, WOODS HOLE, MA 02543 USA	Marine Biological Laboratory - Woods Hole	BEZPROZVANNY, I (corresponding author), UNIV CONNECTICUT, DEPT MED & PHYSIOL, FARMINGTON, CT 06030 USA.		/AAX-8408-2021	/0000-0001-9657-9704	NHLBI NIH HHS [HL 33026] Funding Source: Medline; NIGMS NIH HHS [GM 39029] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033026] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; [Anonymous], [No title captured]; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; Colquhoun D., 1973, DRUG RECEPTORS, P149, DOI [10.1007/978-1-349-00910-7_11, DOI 10.1007/978-1-349-00910-7_11]; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GUILLEMETTE G, 1987, P NATL ACAD SCI USA, V84, P8195, DOI 10.1073/pnas.84.23.8195; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Katz A. M., 1992, PHYSL HEART; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NUNN DL, 1992, MOL PHARMACOL, V41, P115; PALLOTTA BS, 1991, FASEB J, V5, P2035, DOI 10.1096/fasebj.5.7.1707020; SMITH JB, 1985, J BIOL CHEM, V260, P4413; SPAT A, 1992, BIOCHEM J, V287, P335; SPAT A, 1987, BIOCHEM J, V244, P493; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; VOLPE P, 1990, AM J PHYSIOL, V258, pC1077, DOI 10.1152/ajpcell.1990.258.6.C1077; WATRAS J, 1991, J NEUROSCI, V11, P3239; WORLEY PF, 1987, J BIOL CHEM, V262, P12132	37	145	146	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1175	1184		10.1016/0896-6273(93)90065-Y	http://dx.doi.org/10.1016/0896-6273(93)90065-Y			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	7686381				2022-12-17	WOS:A1993LK37300017
J	ELLISMAN, MH; DEERINCK, TJ; OUYANG, Y; BECK, CF; TANKSLEY, SJ; WALTON, PD; AIREY, JA; SUTKO, JL				ELLISMAN, MH; DEERINCK, TJ; OUYANG, Y; BECK, CF; TANKSLEY, SJ; WALTON, PD; AIREY, JA; SUTKO, JL			IDENTIFICATION AND LOCALIZATION OF RYANODINE BINDING-PROTEINS IN THE AVIAN CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article									UNIV IDAHO,DEPT BACTERIOL & BIOCHEM,MOSCOW,ID 83843; UNIV NEVADA,DEPT PHARMACOL,RENO,NV 89557; UNIV NEVADA,CELL & MOLEC BIOL PROGRAM,RENO,NV 89557	Idaho; University of Idaho; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	ELLISMAN, MH (corresponding author), UNIV CALIF SAN DIEGO,DEPT NEUROSCI,NEUROCYTOL LAB,LA JOLLA,CA 92093, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL027470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026739, R01NS014718] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL27470] Funding Source: Medline; NINDS NIH HHS [NS14718, NS26739] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1989, J CELL BIOL, V108, P2301, DOI 10.1083/jcb.108.6.2301; AIREY JA, 1990, IN PRESS J BIOL CHEM; ARIYASU RG, 1987, J NEUROCYTOL, V16, P511, DOI 10.1007/BF01668505; ASHLEY RH, 1989, J MEMBRANE BIOL, V111, P179, DOI 10.1007/BF01871781; BLAUSTEIN MP, 1988, HDB EXPT PHARM, V83, P275; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; CAMPBELL KP, 1987, J BIOL CHEM, V262, P6460; CARR CE, 1990, IN PRESS J NEUROSCI; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CONNOR JA, 1987, J NEUROSCI, V7, P1384; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; ENDO T, 1985, NEUROSCI LETT, V60, P279, DOI 10.1016/0304-3940(85)90590-7; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FLEISCHER S, 1985, P NATL ACAD SCI USA, V82, P7256, DOI 10.1073/pnas.82.21.7256; FRANZINIARMSTRONG C, 1975, FED PROC, V34, P1382; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GLOSSMANN H, 1985, METHOD ENZYMOL, V109, P513; Glossmann H, 1987, CIRC RES, V61, P130; GORMAN ALF, 1984, J PHYSIOL-LONDON, V353, P127, DOI 10.1113/jphysiol.1984.sp015327; HENKART M, 1980, FED PROC, V39, P2783; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; HENKART M, 1983, PHYSL EXCITABLE CELL, P371; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P441, DOI 10.1073/pnas.85.2.441; INUI M, 1987, J BIOL CHEM, V262, P1740; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; LAI FA, 1987, BIOCHEM BIOPH RES CO, V143, P704, DOI 10.1016/0006-291X(87)91411-2; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; LEVITT P, 1984, J NEUROSCI, V4, P2553; LEVRAM V, 1987, BIOPHYS J, V52, P571, DOI 10.1016/S0006-3495(87)83246-0; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MULLINS LJ, 1979, J GEN PHYSIOL, V74, P393, DOI 10.1085/jgp.74.3.393; OGAWA Y, 1971, METHOD PHARMACOL, V1, P327; PENNER R, 1989, FEBS LETT, V259, P217, DOI 10.1016/0014-5793(89)81532-7; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; ROSS WN, 1986, J NEUROSCI, V6, P1148; ROSS WN, 1990, IN PRESS P ROY SOC B; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH SJ, 1980, J PHYSIOL-LONDON, V300, P167, DOI 10.1113/jphysiol.1980.sp013157; Sternberger LA, 1979, IMMUNOCYTOCHEMISTRY, P104; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; SUTKO JL, 1985, J LABELLED COMPD RAD, V23, P215; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; THAYER SA, 1988, J NEUROSCI, V8, P4089; THAYER SA, 1988, MOL PHARMACOL, V34, P664; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; VANDENPOL AN, 1989, COLLOIDAL GOLD METHO, P451; ZORZATO F, 1988, ARCH BIOCHEM BIOPHYS, V261, P324, DOI 10.1016/0003-9861(88)90347-5	59	145	145	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1990	5	2					135	146		10.1016/0896-6273(90)90304-X	http://dx.doi.org/10.1016/0896-6273(90)90304-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU559	2200448				2022-12-17	WOS:A1990DU55900004
J	McGregor, MM; Nelson, AB				McGregor, Matthew M.; Nelson, Alexandra B.			Circuit Mechanisms of Parkinson's Disease	NEURON			English	Review							PRIMARY MOTOR CORTEX; DEEP BRAIN-STIMULATION; HIGH-FREQUENCY STIMULATION; SLEEP BEHAVIOR DISORDER; GLOBUS-PALLIDUS NEURONS; BASAL GANGLIA OUTPUT; MEDIUM SPINY NEURONS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE PRIMATE MODEL; SUBTHALAMIC NUCLEUS NEURONS; BETA-BAND OSCILLATIONS	Parkinson's disease (PD) is a complex, multi-system neurodegenerative disorder. The second most common neurodegenerative disorder after Alzheimer's disease, it affects approximately 1% of adults over age 60. Diagnosis follows the development of one or more of the core motor features of the disease, including tremor, slowing of movement (bradykinesia), and rigidity. However, there are numerous other motor and nonmotor disease manifestations. Many PD symptoms result directly from neurodegeneration; others are driven by aberrant activity patterns in surviving neurons. This latter phenomenon, PD circuit dysfunction, is an area of intense study, as it likely underlies our ability to treat many disease symptoms in the face of (currently) irreversible neurodegeneration. This Review will discuss key clinical features of PD and their basis in neural circuit dysfunction. We will first review important disease symptoms and some of the responsible neuropathology. We will then describe the basal ganglia-thalamocortical circuit, the major locus of PD-related circuit dysfunction, and some of the models that have influenced its study. We will review PD-related changes in network activity, subdividing findings into those that touch on the rate, rhythm, or synchronization of neurons. Finally, we suggest some critical remaining questions for the field and areas for new developments.	[McGregor, Matthew M.; Nelson, Alexandra B.] UCSF, Neurosci Grad Program, San Francisco, CA 94158 USA; [McGregor, Matthew M.; Nelson, Alexandra B.] UCSF, Dept Neurol, San Francisco, CA 94158 USA; [Nelson, Alexandra B.] UCSF, Weill Inst Neurosci, San Francisco, CA 94158 USA; [Nelson, Alexandra B.] UCSF, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nelson, AB (corresponding author), UCSF, Neurosci Grad Program, San Francisco, CA 94158 USA.; Nelson, AB (corresponding author), UCSF, Dept Neurol, San Francisco, CA 94158 USA.; Nelson, AB (corresponding author), UCSF, Weill Inst Neurosci, San Francisco, CA 94158 USA.; Nelson, AB (corresponding author), UCSF, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA.	alexandra.nelson@ucsf.edu			National Science Foundation Graduate Fellowship; Parkinson's Foundation [PDF-JFA-1688]; NINDS [1R01NS101354]	National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); Parkinson's Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Nelson laboratory for critical feedback on the manuscript. M.M.M. is funded by the National Science Foundation Graduate Fellowship. A.B.N. is the Richard and Shirley Cahill Endowed Professor in Parkinson's Disease Research and is funded by the Parkinson's Foundation (PDF-JFA-1688) and NINDS (1R01NS101354).	Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alcacer C, 2017, J CLIN INVEST, V127, P720, DOI 10.1172/JCI90132; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Assaf F, 2019, MOVEMENT DISORD, V34, P469, DOI 10.1002/mds.27554; Avila I, 2010, EXP NEUROL, V221, P307, DOI 10.1016/j.expneurol.2009.11.016; AZIZ TZ, 1991, MOVEMENT DISORD, V6, P288, DOI 10.1002/mds.870060404; Barbera G, 2016, NEURON, V92, P202, DOI 10.1016/j.neuron.2016.08.037; Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Bedard C, 2011, PARKINSONISM RELAT D, V17, P593, DOI 10.1016/j.parkreldis.2011.05.012; Benazzouz A, 2002, MOVEMENT DISORD, V17, pS145, DOI 10.1002/mds.10156; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Boraud T, 1998, BRAIN RES, V787, P157, DOI 10.1016/S0006-8993(97)01563-1; Boraud T, 2000, J NEUROPHYSIOL, V83, P1760, DOI 10.1152/jn.2000.83.3.1760; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brazhnik E, 2016, J NEUROSCI, V36, P4196, DOI 10.1523/JNEUROSCI.3582-15.2016; Brazhnik E, 2014, EXP NEUROL, V261, P563, DOI 10.1016/j.expneurol.2014.07.010; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Brittain JS, 2014, EUR J NEUROSCI, V39, P1951, DOI 10.1111/ejn.12574; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Calzavara R, 2007, EUR J NEUROSCI, V26, P2005, DOI 10.1111/j.1460-9568.2007.05825.x; Carriere N, 2014, MOVEMENT DISORD, V29, P897, DOI 10.1002/mds.25904; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Chen H, 2018, BEHAV BRAIN RES, V341, P135, DOI 10.1016/j.bbr.2017.12.018; Chiken S, 2016, NEUROSCIENTIST, V22, P313, DOI 10.1177/1073858415581986; Cho JW, 2002, J COMP NEUROL, V452, P24, DOI 10.1002/cne.10349; Chung JW, 2018, NEUROIMAGE-CLIN, V19, P559, DOI 10.1016/j.nicl.2018.05.021; COOPER IS, 1958, J NEUROSURG, V15, P244, DOI 10.3171/jns.1958.15.3.0244; CROSSMAN AR, 1985, NEUROPHARMACOLOGY, V24, P587, DOI 10.1016/0028-3908(85)90070-X; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Deffains M, 2018, MOVEMENT DISORD, V33, P1609, DOI 10.1002/mds.27418; Deffains M, 2016, ELIFE, V5, DOI 10.7554/eLife.16443; Delaville C, 2015, J NEUROSCI, V35, P6918, DOI 10.1523/JNEUROSCI.0587-15.2015; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; Dobbs LK, 2016, NEURON, V90, P1100, DOI 10.1016/j.neuron.2016.04.031; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Espay AJ, 2014, MOVEMENT DISORD, V29, P1710, DOI 10.1002/mds.26048; Faivre F, 2019, NEUROSCI BIOBEHAV R, V96, P335, DOI 10.1016/j.neubiorev.2018.10.004; FILION M, 1991, BRAIN RES, V547, P142; FILION M, 1991, BRAIN RES, V547, P152; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Galbiati A, 2019, SLEEP MED REV, V43, P37, DOI 10.1016/j.smrv.2018.09.008; Galvan A, 2017, J NEUROSCI, V37, P10894, DOI 10.1523/JNEUROSCI.1839-17.2017; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giannicola G, 2013, NEUROSIGNALS, V21, P89, DOI 10.1159/000336543; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heimer G, 2002, J NEUROSCI, V22, P7850; Hell F, 2018, NEUROIMAGE, V171, P222, DOI 10.1016/j.neuroimage.2018.01.001; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henderson JM, 1999, EUR J NEUROSCI, V11, P2749, DOI 10.1046/j.1460-9568.1999.00692.x; HERVE D, 1995, MOL BRAIN RES, V32, P125, DOI 10.1016/0169-328X(95)00070-9; Horvath J, 2013, PARKINSONISM RELAT D, V19, P864, DOI 10.1016/j.parkreldis.2013.05.010; HUTCHISON WD, 1994, NEUROREPORT, V5, P1533, DOI 10.1097/00001756-199407000-00031; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Jellinger KA, 2018, J NEURAL TRANSM, V125, P615, DOI 10.1007/s00702-017-1821-9; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kiss ZHT, 2003, EXP BRAIN RES, V150, P85, DOI 10.1007/s00221-003-1399-3; Kita H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00042; Klaus A, 2017, NEURON, V96, P949, DOI 10.1016/j.neuron.2017.10.031; KLOCKGETHER T, 1990, ANN NEUROL, V28, P539, DOI 10.1002/ana.410280411; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreiss DS, 1997, J NEUROSCI, V17, P6807; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Leblois A, 2007, EUR J NEUROSCI, V26, P1701, DOI 10.1111/j.1460-9568.2007.05777.x; Lee HJ, 2016, NEURON, V91, P412, DOI 10.1016/j.neuron.2016.06.010; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Levy R, 2001, J NEUROPHYSIOL, V86, P249, DOI 10.1152/jn.2001.86.1.249; Levy R, 2000, J NEUROSCI, V20, P7766; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Liang L, 2008, J NEUROSCI, V28, P7537, DOI 10.1523/JNEUROSCI.1176-08.2008; LIMOUSIN P, 1995, MOVEMENT DISORD, V10, P672, DOI 10.1002/mds.870100523; Lobb CJ, 2015, NEUROBIOL DIS, V75, P177, DOI 10.1016/j.nbd.2014.12.026; Lobb CJ, 2013, J NEUROPHYSIOL, V110, P2792, DOI 10.1152/jn.00441.2013; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2016, NEURON, V89, P308, DOI 10.1016/j.neuron.2015.12.017; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Markowitz JE, 2018, CELL, V174, P44, DOI 10.1016/j.cell.2018.04.019; Mastro KJ, 2017, NAT NEUROSCI, V20, P815, DOI 10.1038/nn.4559; McCairn KW, 2015, J NEUROPHYSIOL, V113, P2537, DOI 10.1152/jn.00701.2014; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; McCarthy MM, 2011, P NATL ACAD SCI USA, V108, P11620, DOI 10.1073/pnas.1107748108; McConnell GC, 2012, J NEUROSCI, V32, P15657, DOI 10.1523/JNEUROSCI.2824-12.2012; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; MILLER WC, 1988, ANN NY ACAD SCI, V515, P287, DOI 10.1111/j.1749-6632.1988.tb32998.x; Mink J W, 1993, Curr Opin Neurobiol, V3, P950, DOI 10.1016/0959-4388(93)90167-W; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; MITCHELL IJ, 1986, NEUROSCI LETT, V63, P61, DOI 10.1016/0304-3940(86)90013-3; Molnar GF, 2005, J NEUROPHYSIOL, V93, P3094, DOI 10.1152/jn.00881.2004; Monakow K H, 1978, Exp Brain Res, V33, P395; MOORE RY, 1978, ANNU REV NEUROSCI, V1, P129, DOI 10.1146/annurev.ne.01.030178.001021; Moran A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00021; Muralidharan A, 2016, EXP NEUROL, V279, P187, DOI 10.1016/j.expneurol.2016.03.002; Nambu A, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-4002-y; Nambu A, 2015, BASAL GANGLIA, V5, P1, DOI 10.1016/j.baga.2014.11.001; NARABAYASHI H, 1956, ARCH NEURO PSYCHIATR, V75, P36, DOI 10.1001/archneurpsyc.1956.02330190052003; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; Pagano G, 2017, ANN NEUROL, V81, P171, DOI 10.1002/ana.24859; Pagano G, 2015, J NEUROL NEUROSUR PS, V86, P767, DOI 10.1136/jnnp-2014-308764; PAN HS, 1988, SYNAPSE, V2, P650, DOI 10.1002/syn.890020612; Pan MK, 2016, J CLIN INVEST, V126, P4516, DOI 10.1172/JCI88170; Parent M, 2004, PARKINSONISM RELAT D, V10, P203, DOI 10.1016/j.parkreldis.2004.02.007; Parker JG, 2018, NATURE, V557, P177, DOI 10.1038/s41586-018-0090-6; Pasquereau B, 2016, BRAIN, V139, P127, DOI 10.1093/brain/awv312; Pasquereau B, 2011, CEREB CORTEX, V21, P1362, DOI 10.1093/cercor/bhq217; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Piallat B, 1996, EUR J NEUROSCI, V8, P1408, DOI 10.1111/j.1460-9568.1996.tb01603.x; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Polotis M, 2015, BEHAV BRAIN RES, V277, P136, DOI 10.1016/j.bbr.2014.07.037; Pontone GM, 2009, MOVEMENT DISORD, V24, P1333, DOI 10.1002/mds.22611; Postuma RB, 2009, MOVEMENT DISORD, V24, P2225, DOI 10.1002/mds.22757; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; Reese R, 2011, EXP NEUROL, V229, P517, DOI 10.1016/j.expneurol.2011.01.020; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Robbins TW, 2014, MOVEMENT DISORD, V29, P597, DOI 10.1002/mds.25853; Rothblat DS, 1995, BRAIN RES, V705, P1, DOI 10.1016/0006-8993(95)00892-6; Ryan MB, 2018, CELL REP, V23, P3438, DOI 10.1016/j.celrep.2018.05.059; Rylander D, 2010, ANN NEUROL, V68, P619, DOI 10.1002/ana.22097; Sagot B, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00057; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Schneider JS, 2013, MOVEMENT DISORD, V28, P663, DOI 10.1002/mds.25258; Schneider JS, 1996, BRAIN RES, V742, P25, DOI 10.1016/S0006-8993(96)00988-2; SCHNEIDER JS, 1990, BRAIN RES, V519, P122, DOI 10.1016/0006-8993(90)90069-N; SCHWARTZMAN RJ, 1985, BRAIN RES, V358, P137, DOI 10.1016/0006-8993(85)90957-6; Seidel K, 2015, BRAIN PATHOL, V25, P121, DOI 10.1111/bpa.12168; Sethi K, 2008, MOVEMENT DISORD, V23, pS521, DOI 10.1002/mds.22049; Shimamoto SA, 2013, J NEUROSCI, V33, P7220, DOI 10.1523/JNEUROSCI.4676-12.2013; Siegert S, 2014, CORTEX, V60, P103, DOI 10.1016/j.cortex.2013.12.008; Singh A, 2016, P NATL ACAD SCI USA, V113, P9629, DOI 10.1073/pnas.1606792113; Singh A, 2015, J NEUROPHYSIOL, V113, P1533, DOI 10.1152/jn.00910.2014; Soares J, 2004, J NEUROSCI, V24, P6417, DOI 10.1523/JNEUROSCI.0836-04.2004; St Louis EK, 2017, MOVEMENT DISORD, V32, P645, DOI 10.1002/mds.27018; Starr PA, 2005, J NEUROPHYSIOL, V93, P3165, DOI 10.1152/jn.00971.2004; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Surmeier DJ, 2010, PROG BRAIN RES, V183, P149, DOI 10.1016/S0079-6123(10)83008-0; Surmeier DJ, 2018, FEBS J, V285, P3657, DOI 10.1111/febs.14607; Swann NC, 2018, J NEUROSURG, V128, P605, DOI 10.3171/2016.11.JNS161162; Swann NC, 2016, J NEUROSCI, V36, P6445, DOI 10.1523/JNEUROSCI.1128-16.2016; Tai CH, 2012, ANN NEUROL, V72, P464, DOI 10.1002/ana.23618; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Timmermann L, 2004, MOVEMENT DISORD, V19, P1328, DOI 10.1002/mds.20198; Villalba RM, 2018, J NEURAL TRANSM, V125, P431, DOI 10.1007/s00702-017-1735-6; Wach C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00511; Wang ZY, 2017, NEUROSCI BULL, V33, P413, DOI 10.1007/s12264-017-0146-x; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; WICHMANN T, 1994, J NEUROPHYSIOL, V72, P521, DOI 10.1152/jn.1994.72.2.521; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Yoon HH, 2014, NEUROSURGERY, V74, P533, DOI 10.1227/NEU.0000000000000297	165	144	145	10	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2019	101	6					1042	1056		10.1016/j.neuron.2019.03.004	http://dx.doi.org/10.1016/j.neuron.2019.03.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP7WO	30897356	Bronze			2022-12-17	WOS:000461901500009
J	Zhao, N; Liu, CC; Van Ingelgom, AJ; Martens, YA; Linares, C; Knight, JA; Painter, MM; Sullivan, PM; Bu, GJ				Zhao, Na; Liu, Chia-Chen; Van Ingelgom, Alexandra J.; Martens, Yuka A.; Linares, Cynthia; Knight, Joshua A.; Painter, Meghan M.; Sullivan, Patrick M.; Bu, Guojun			Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; INTRANASAL INSULIN; IMPROVES COGNITION; DIABETES-MELLITUS; SKELETAL-MUSCLE; UP-REGULATION; E ISOFORMS	Diabetes and impaired brain insulin signaling are linked to the pathogenesis of Alzheimer's disease (AD). The association between diabetes and AD-associated amyloid pathology is stronger among carriers of the apolipoprotein E (APOE) epsilon 4 gene allele, the strongest genetic risk factor for late-onset AD. Here we report that apoE4 impairs neuronal insulin signaling in human apoE-targeted replacement (TR) mice in an age-dependent manner. High-fat diet (HFD) accelerates these effects in apoE4-TR mice at middle age. In primary neurons, apoE4 interacts with insulin receptor and impairs its trafficking by trapping it in the endosomes, leading to impaired insulin signaling and insulin-stimulated mitochondrial respiration and glycolysis. In aging brains, the increased apoE4 aggregation and compromised endosomal function further exacerbate the inhibitory effects of apoE4 on insulin signaling and related functions. Together, our study provides novel mechanistic insights into the pathogenic mechanisms of apoE4 and insulin resistance in AD.	[Zhao, Na; Liu, Chia-Chen; Van Ingelgom, Alexandra J.; Martens, Yuka A.; Linares, Cynthia; Knight, Joshua A.; Painter, Meghan M.; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Sullivan, Patrick M.] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; [Sullivan, Patrick M.] Durham Vet Affairs Med Ctr, GRECC, Durham, NC 27705 USA; [Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Mayo Clinic; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Xiamen University	Liu, CC; Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.; Bu, GJ (corresponding author), Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China.	liu.chiachen@mayo.edu; bu.guojun@mayo.edu		Zhao, Na/0000-0001-8648-9422	NIH [R01AG035355, R37AG027924, RF1AG051504, R01AG046205]; Cure Alzheimer's Fund; BrightFocus Foundation [A2016346F]; Alzheimer's Association [AARG-17-500335]; Mayo Clinic Alzheimer's Disease Research Center [P50AG016574]; Mayo Clinic; NATIONAL INSTITUTE ON AGING [R01AG027924, R37AG027924, R01AG046205, P50AG016574, RF1AG051504, R01AG035355, RF1AG046205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Mayo Clinic Alzheimer's Disease Research Center; Mayo Clinic; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R01AG035355, R37AG027924, RF1AG051504, and R01AG046205 (to G.B.), a grant from the Cure Alzheimer's Fund (to G.B.), a fellowship from the BrightFocus Foundation A2016346F (to C.-C.L.), a grant from Alzheimer's Association AARG-17-500335 (to C.-C.L.), a pilot project grant from Mayo Clinic Alzheimer's Disease Research Center P50AG016574 (to N.Z.), and Younkin fellowship from Mayo Clinic (to N.Z.). We thank Linda Rousseau and Monica Castanedes-Casey for helping with the preparation of mouse brain slices and the immunohistochemical staining.	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; BEITNER R, 1971, J BIOL CHEM, V246, P500; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; CARPENTIER JL, 1978, J CLIN INVEST, V61, P1057, DOI 10.1172/JCI109005; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chan ES, 2016, SCI REP-UK, V6, DOI 10.1038/srep26119; Chan ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep13842; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Cihil KM, 2013, JOVE-J VIS EXP, DOI 10.3791/50867; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Claxton A, 2013, J ALZHEIMERS DIS, V35, P789, DOI 10.3233/JAD-122308; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Craft S, 2013, J ALZHEIMERS DIS, V33, pS263, DOI 10.3233/JAD-2012-129042; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elliott DA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-23; Fu Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0099-y; Garcia-Caceres C, 2016, CELL, V166, P867, DOI 10.1016/j.cell.2016.07.028; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; GORDEN P, 1978, SCIENCE, V200, P782, DOI 10.1126/science.644321; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Hatters DM, 2006, J MOL BIOL, V361, P932, DOI 10.1016/j.jmb.2006.06.080; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Lane-Donovan C, 2016, J NEUROSCI, V36, P10141, DOI 10.1523/JNEUROSCI.1054-16.2016; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3650; Liu CC, 2015, J NEUROSCI, V35, P5851, DOI 10.1523/JNEUROSCI.5180-14.2015; Martel CL, 1997, J NEUROCHEM, V69, P1995; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Nisr RB, 2014, BBA-BIOENERGETICS, V1837, P270, DOI 10.1016/j.bbabio.2013.10.012; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ong QR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03754; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; TRISCHITTA V, 1989, J BIOL CHEM, V264, P5041; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; WEISGRABER KH, 1991, J BIOL CHEM, V266, P12029; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhao N., 2017, BIOL PSYCHIAT; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	72	144	145	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2017	96	1					115	+		10.1016/j.neuron.2017.09.003	http://dx.doi.org/10.1016/j.neuron.2017.09.003			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI3GD	28957663	Green Accepted, Bronze			2022-12-17	WOS:000411845100014
J	He, M; Tucciarone, J; Lee, S; Nigro, MJ; Kim, Y; Levine, JM; Kelly, SM; Krugikov, I; Wu, P; Chen, Y; Gong, L; Hou, YJ; Osten, P; Rudy, B; Huang, ZJ				He, Miao; Tucciarone, Jason; Lee, SooHyun; Nigro, Maximiliano Jose; Kim, Yongsoo; Levine, Jesse Maurica; Kelly, Sean Michael; Krugikov, Illya; Wu, Priscilla; Chen, Yang; Gong, Ling; Hou, Yongjie; Osten, Pavel; Rudy, Bernardo; Huang, Z. Josh			Strategies and Tools for Combinatorial Targeting of GABAergic Neurons in Mouse Cerebral Cortex	NEURON			English	Article							CELL-TYPES; INHIBITORY INTERNEURONS; CORTICAL INTERNEURONS; SOMATOSENSORY CORTEX; CIRCUIT; RAT; CONNECTIONS; DIVERSITY; SOMATOSTATIN; EXPRESSION	Systematic genetic access to GABAergic cell types will facilitate studying the function and development of inhibitory circuitry. However, single gene-driven recombinase lines mark relatively broad and heterogeneous cell populations. Although intersectional approaches improve precision, it remains unclear whether they can capture cell types defined by multiple features. Here we demonstrate that combinatorial genetic and viral approaches target restricted GABAergic subpopulations and cell types characterized by distinct laminar location, morphology, axonal projection, and electrophysiological properties. Intersectional embryonic transcription factor drivers allow finer fate mapping of progenitor pools that give rise to distinct GABAergic populations, including laminar cohorts. Conversion of progenitor fate restriction signals to constitutive recombinase expression enables viral targeting of cell types based on their lineage and birth time. Properly designed intersection, subtraction, conversion, and multicolor reporters enhance the precision and versatility of drivers and viral vectors. These strategies and tools will facilitate studying GABAergic neurons throughout the mouse brain.	[He, Miao; Tucciarone, Jason; Kim, Yongsoo; Levine, Jesse Maurica; Kelly, Sean Michael; Wu, Priscilla; Osten, Pavel; Huang, Z. Josh] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [He, Miao; Chen, Yang; Gong, Ling; Hou, Yongjie] Fudan Univ, Inst Brain Sci, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Tucciarone, Jason; Levine, Jesse Maurica; Kelly, Sean Michael] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11790 USA; [Tucciarone, Jason; Levine, Jesse Maurica; Kelly, Sean Michael] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11790 USA; [Lee, SooHyun; Nigro, Maximiliano Jose; Krugikov, Illya; Rudy, Bernardo] NYU, Sch Med, Neurosci Inst, New York, NY 10016 USA; [Kim, Yongsoo] Penn State Univ, Coll Med, Hershey, PA 17036 USA	Cold Spring Harbor Laboratory; Fudan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu	Nigro, Maximiliano Jose/AAC-5552-2021; Kruglikov, Ilya/AAC-9131-2020; He, Miao/AAQ-1044-2020; Kim, Yongsoo/AAE-4970-2020	Kruglikov, Ilya/0000-0002-1575-4636; He, Miao/0000-0003-0731-6801; Kim, Yongsoo/0000-0002-4277-0279; Tucciarone, Jason/0000-0002-6053-2952; Rudy, Bernardo/0000-0001-5748-6900; Lee, Soohyun/0000-0003-1532-7041	NIH [5U01 MH078844-05, R01NS30989, P01NS074972]; CSHL Robertson Neuroscience Fund; National Natural Science Foundation of China [31471037, 91432106, 31421091]; Shanghai Yangfan [14YF1400500]; NARSAD; NRSA F30 Medical Scientist Predoctoral Fellowships; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844, U01MH105971, R01MH102616, ZIAMH002959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, R01NS030989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSHL Robertson Neuroscience Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Yangfan; NARSAD(NARSAD); NRSA F30 Medical Scientist Predoctoral Fellowships; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Hongkui Zeng for providing Ai3 and Ai65 vectors and the Ai65 mouse line, Dawen Cai, Jeff Lichtman, and Joshua Sanes for sharing the Brainbow vector and antibodies, Sang Yong Kim for help with generation of knockin mice, and Adam Kepecs, Hiroki Taniguchi, and Dhananjay Huilgol for comments on the manuscript. This work was supported in part by NIH 5U01 MH078844-05, CSHL Robertson Neuroscience Fund to Z.J.H., National Natural Science Foundation of China 31471037, 91432106, 31421091, and Shanghai Yangfan 14YF1400500 to M.H., NARSAD Young Investigator Grant to Y.K., NIH U01MH105971 to P.O., and NIH R01NS30989 and P01NS074972 to B.R., J.T, S.M.K., and J.M.L. are supported by NRSA F30 Medical Scientist Predoctoral Fellowships.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bayraktar T, 2000, J COMP NEUROL, V420, P291; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cauli B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00052; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dehorter N, 2015, SCIENCE, V349, P1216, DOI 10.1126/science.aab3415; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Harris RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04493; Harwell CC, 2015, NEURON, V87, P999, DOI 10.1016/j.neuron.2015.07.030; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huang ZJ, 2014, NEURON, V83, P1284, DOI 10.1016/j.neuron.2014.08.041; Huang Z Josh, 2014, Cold Spring Harb Protoc, V2014, P190, DOI 10.1101/pdb.prot080382; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kessaris N, 2014, CURR OPIN NEUROBIOL, V26, P79, DOI 10.1016/j.conb.2013.12.012; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kremer EJ, 2005, CURR GENOMICS, V6, P13, DOI 10.2174/1389202053202111; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YF, 2011, CEREB CORTEX, V21, P2639, DOI 10.1093/cercor/bhr051; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Magno L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00065; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Munoz W, 2014, CELL REP, V9, P2304, DOI 10.1016/j.celrep.2014.11.042; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Perrenoud Q, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00036; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pronneke A, 2015, CEREB CORTEX, V25, P4854, DOI 10.1093/cercor/bhv202; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/NMETH.1854, 10.1038/nmeth.1854]; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tai YL, 2014, CELL REP, V6, P254, DOI 10.1016/j.celrep.2013.12.034; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; Tricoire L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00105; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wang L, 2008, NEUROBIOL DIS, V29, P400, DOI 10.1016/j.nbd.2007.10.004; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Woodruff AR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00201; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	73	144	144	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2016	91	6					1228	1243		10.1016/j.neuron.2016.08.021	http://dx.doi.org/10.1016/j.neuron.2016.08.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA6SW	27618674	Bronze, Green Accepted			2022-12-17	WOS:000386760300009
J	Gottlieb, J				Gottlieb, Jacqueline			Attention, Learning, and the Value of Information	NEURON			English	Review							NEURAL MECHANISMS; EYE-MOVEMENTS; ACCUMULATOR MODEL; PREFRONTAL CORTEX; PARIETAL CORTEX; VISUAL SALIENCE; REWARD; DOPAMINE; NEURONS; RISK	Despite many studies on selective attention, fundamental questions remain about its nature and neural mechanisms. Here I draw from the animal and machine learning fields that describe attention as a mechanism for active learning and uncertainty reduction and explore the implications of this view for understanding visual attention and eye movement control. I propose that a closer integration of these different views has the potential greatly to expand our understanding of oculomotor control and our ability to use this system as a window into high level but poorly understood cognitive functions, including the capacity for curiosity and exploration and for inferring internal models of the external world.	[Gottlieb, Jacqueline] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Gottlieb, Jacqueline] Columbia Univ, Kavli Inst Brain Res, New York, NY 10032 USA	Columbia University; Columbia University	Gottlieb, J (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	jg2141@columbia.edu			National Eye Institute; National Institute of Mental Health; National Institute for Drug Abuse; Keck Foundation; McKnight Fund for Neuroscience; Klingenstein Fund for Neuroscience; Sloan Foundation; National Alliance for Research on Schizophrenia and Depression; Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Keck Foundation(W.M. Keck Foundation); McKnight Fund for Neuroscience; Klingenstein Fund for Neuroscience(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); National Alliance for Research on Schizophrenia and Depression(NARSAD); Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	I am deeply indebted to Peter Dayan and Mary Hayhoe for their detailed comments on several rounds of this manuscript, and to Eric Kandel and Tom Albright for their guidance in the final stages of its preparation. I also thank members of my laboratory, in particular Nicholas Foley, Himanshu Mhatre, and Adrien Baranes for their comments on several versions of this paper. Work from my own laboratory that is described in this research was supported by The National Eye Institute, The National Institute of Mental Health, The National Institute for Drug Abuse, The Keck Foundation, the McKnight Fund for Neuroscience, The Klingenstein Fund for Neuroscience, the Sloan Foundation, the National Alliance for Research on Schizophrenia and Depression, and the Gatsby Charitable Foundation.	Acuna DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001003; Albright TD, 2012, NEURON, V74, P227, DOI 10.1016/j.neuron.2012.04.001; Balan PF, 2006, J NEUROSCI, V26, P9239, DOI 10.1523/JNEUROSCI.1898-06.2006; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Ballard DH, 2009, VIS COGN, V17, P1185, DOI 10.1080/13506280902978477; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Boehnke SE, 2011, EUR J NEUROSCI, V34, P766, DOI 10.1111/j.1460-9568.2011.07805.x; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Brockmole JR, 2005, PSYCHON B REV, V12, P1061, DOI 10.3758/BF03206444; Brockmole JR, 2005, J EXP PSYCHOL HUMAN, V31, P857, DOI 10.1037/0096-1523.31.5.857; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Damaraju E, 2009, NEUROPSYCHOLOGIA, V47, P2480, DOI 10.1016/j.neuropsychologia.2009.04.023; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Friston KJ, 2010, NAT REV NEUROSCI, V11, P607, DOI 10.1038/nrn2787-c2; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe MM, 2012, EXP BRAIN RES, V217, P125, DOI 10.1007/s00221-011-2979-2; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hogarth L., 2010, SELECTIVE ATTENTION; Johnson A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00216; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Karacan H, 2008, VIS COGN, V16, P356, DOI 10.1080/13506280701453854; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Le Pelley M.E., 2010, ATTENTION ASS LEARNI; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Maddux J.-M., 2010, ATTENTION ASS LEARNI; Maddux JM, 2007, BEHAV NEUROSCI, V121, P63, DOI 10.1037/0735-7044.121.1.63; Maddux JM, 2011, BEHAV NEUROSCI, V125, P383, DOI 10.1037/a0023515; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Mirabella G, 2007, NEURON, V54, P303, DOI 10.1016/j.neuron.2007.04.007; Mirpour K, 2009, J NEUROPHYSIOL, V102, P3481, DOI 10.1152/jn.00688.2009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Niv Y, 2008, TRENDS COGN SCI, V12, P265, DOI 10.1016/j.tics.2008.03.006; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Pearce J.M., 2010, 2 THEORIES ATTENTION; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Rothkopf CA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00173; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Schall JD, 2011, EUR J NEUROSCI, V33, P1991, DOI 10.1111/j.1460-9568.2011.07715.x; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sprague N, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1265957.1265960; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Thompson KA, 2005, ABA J, V91, P25; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; Vilares I, 2011, ANN NY ACAD SCI, V1224, P22, DOI 10.1111/j.1749-6632.2011.05965.x; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Walton ME, 2011, ANN NY ACAD SCI, V1239, P14, DOI 10.1111/j.1749-6632.2011.06257.x; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wilson RC, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00189; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Yakushijin R, 2011, COGNITIVE SCI, V35, P939, DOI 10.1111/j.1551-6709.2011.01176.x; Yang HJ, 2009, ATTEN PERCEPT PSYCHO, V71, P554, DOI 10.3758/APP.71.3.554; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	100	144	145	1	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 18	2012	76	2					281	295		10.1016/j.neuron.2012.09.034	http://dx.doi.org/10.1016/j.neuron.2012.09.034			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	028LV	23083732	Green Accepted, Bronze			2022-12-17	WOS:000310424700005
J	Lee, S; Kim, K; Zhou, ZJ				Lee, Seunghoon; Kim, Kyongmin; Zhou, Z. Jimmy			Role of ACh-GABA Cotransmission in Detecting Image Motion and Motion Direction	NEURON			English	Article							STARBURST AMACRINE CELLS; SELECTIVE GANGLION-CELLS; TERM SYNAPTIC PLASTICITY; GAMMA-AMINOBUTYRIC-ACID; RABBIT RETINA; CHOLINERGIC NEURONS; MOUSE RETINA; VISUAL EXPERIENCE; RECEPTIVE-FIELDS; MAMMALIAN RETINA	Starburst amacrine cells (SACs) process complex visual signals in the retina using both acetylcholine (ACh) and gamma-aminobutyric acid (GABA), but the synaptic organization and function of ACh-GABA corelease remain unclear. Here, we show that SACs make cholinergic synapses onto On-Off direction-selective ganglion cells (DSGCs) from all directions but make GABAergic synapses onto DSGCs only from the null direction. ACh and GABA were released differentially in a Ca2+ level-specific manner, suggesting the two transmitters were released from different vesicle populations. Despite the symmetric cholinergic connection, the light-evoked cholinergic input to a DSGC, detected at both light onset and offset, was motion- and direction-sensitive. This input was facilitated by two-spot apparent motion in the preferred direction but supressed in the null direction, presumably by a GABAergic mechnism. The results revealed a high level of synaptic intricacy in the starburst circuit and suggested differential, yet synergistic, roles of ACh-GABA cotransmission in motion sensitivity and direction selectivity.	[Lee, Seunghoon; Zhou, Z. Jimmy] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Zhou, Z. Jimmy] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Lee, Seunghoon; Kim, Kyongmin; Zhou, Z. Jimmy] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	Yale University; Yale University; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA.	jimmy.zhou@yale.edu			National Institutes of Health [R01EY017353, R01EY10894, P30 EY000785]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY017353, P30EY000785, R01EY010894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Jijian Zheng for scientific discussions. This work was supported in part by National Institutes of HealthGgrants R01EY017353 and R01EY10894 (ZJZ), Departmental Challenge Grant from Research to Prevent Blindness, Inc. and NIH Vision Core Grant (P30 EY000785).	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Blitz DM, 2004, NAT REV NEUROSCI, V5, P630, DOI 10.1038/nrn1475; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Burnstock G, 2004, CURR OPIN PHARMACOL, V4, P47, DOI 10.1016/j.coph.2003.08.001; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Chiao CC, 2002, J NEUROSCI, V22, P10509; Cohen ED, 2001, VISUAL NEUROSCI, V18, P799, DOI 10.1017/S0952523801185135; COHEN ED, 1995, P NATL ACAD SCI USA, V92, P1127, DOI 10.1073/pnas.92.4.1127; Dacheux RF, 2003, J COMP NEUROL, V456, P267, DOI 10.1002/cne.10521; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1992, J COMP NEUROL, V324, P322, DOI 10.1002/cne.903240303; Fried SI, 2007, CURR BIOL, V17, pR63, DOI 10.1016/j.cub.2006.12.013; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grzywacz NM, 1998, VISUAL NEUROSCI, V15, P1119, DOI 10.1017/S0952523898156109; Grzywacz NM, 1998, J PHYSIOL-LONDON, V512, P575, DOI 10.1111/j.1469-7793.1998.575be.x; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; JENSEN RJ, 1995, J NEUROPHYSIOL, V74, P12, DOI 10.1152/jn.1995.74.1.12; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kaneda M, 2007, J NEUROPHYSIOL, V97, P4225, DOI 10.1152/jn.01022.2006; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Li WC, 2004, P NATL ACAD SCI USA, V101, P15488, DOI 10.1073/pnas.0404864101; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MASSEY SC, 1979, J NEUROCHEM, V32, P1327, DOI 10.1111/j.1471-4159.1979.tb11062.x; MASSEY SC, 1979, BRIT J PHARMACOL, V65, P271, DOI 10.1111/j.1476-5381.1979.tb07828.x; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; SCHMIDT M, 1987, J NEUROPHYSIOL, V58, P997, DOI 10.1152/jn.1987.58.5.997; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Strang CE, 2007, VISUAL NEUROSCI, V24, P523, DOI 10.1017/S0952523807070435; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; VANEY DI, 1994, J NEUROSCI, V14, P6301; VARDI N, 1989, J COMP NEUROL, V288, P601, DOI 10.1002/cne.902880407; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; YANG G, 1994, J NEUROSCI, V14, P5267; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	67	144	147	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 22	2010	68	6					1159	1172		10.1016/j.neuron.2010.11.031	http://dx.doi.org/10.1016/j.neuron.2010.11.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705KT	21172616	Bronze, Green Accepted			2022-12-17	WOS:000286128000014
J	Sahara, S; O'Leary, DDM				Sahara, Setsuko; O'Leary, Dennis D. M.			Fgf10 Regulates Transition Period of Cortical Stem Cell Differentiation to Radial Glia Controlling Generation of Neurons and Basal Progenitors	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; DEVELOPING CEREBRAL-CORTEX; DEVELOPING NEOCORTEX; TELENCEPHALIC PROGENITORS; REGIONAL DIFFERENCES; FACTOR FAMILY; NEUROGENESIS; EXPRESSION; BRAIN; RECEPTORS	Radial glia (RG), the progenitors of cortical neurons and basal progenitors (BPs), differentiate from neuroepithelial cells (NCs) with stem cell properties. We show that the morphogen Fgf10 is transiently expressed by NCs coincident with the transition period of NC differentiation into RG. Targeted deletion of Fgf10 delays RG differentiation, whereas overexpression has opposing effects. Delayed RG differentiation in Fgf10 mutants occurs selectively in rostral cortex, paralleled by an extended period of symmetric NC divisions increasing progenitor number, coupled with delayed and initially diminished production of neurons and BPs. RG eventually differentiate in excess number and overproduce neurons and BPs rostrally resulting in tangential expansion of frontal areas and increased laminar thickness. Thus, transient Fgf10 expression regulates timely differentiation of RG, and through this function, determines both length of the early progenitor expansion phase and onset of neurogenesis and ultimately the number of progenitors and neurons fated to specific cortical areas.	[Sahara, Setsuko; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu		Sahara, Setsuko/0000-0002-8332-323X	NIH [R37 NS31558, R01 MH086147]; JSPS; Uehara Memorial Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Todd McLaughlin and Chuck Stevens for comments on the manuscript, Yasuhiko Kawakami and Juan Carlos Belmonte for materials, Haydee Gutierrez and Berta Higgins for technical assistance, Scott Simonet for Fgf10 mutant mice, Robert Hevner for Tbrl antibody, and Stephen Noctor and Arnold Kriegstein for sharing unpublished observations. This work was supported by NIH grants R37 NS31558 and R01 MH086147 (D.D.M.O.). S.S. was supported by fellowships from the JSPS Fellowships for Research Abroad and the Uehara Memorial Foundation.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Bishop KM, 2002, J NEUROSCI, V22, P7627; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ever L, 2008, DEV NEUROSCI-BASEL, V30, P306, DOI 10.1159/000112521; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Qian XM, 1998, DEVELOPMENT, V125, P3143; Raballo R, 2000, J NEUROSCI, V20, P5012; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takahashi T, 1999, J NEUROSCI, V19, P10357; Treier M, 2001, DEVELOPMENT, V128, P377; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004	52	144	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					48	62		10.1016/j.neuron.2009.06.006	http://dx.doi.org/10.1016/j.neuron.2009.06.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607792	Bronze, Green Accepted			2022-12-17	WOS:000268189900008
J	Kim, SJ; Linden, DJ				Kim, Sang Jeong; Linden, David J.			Ubiquitous plasticity and memory storage	NEURON			English	Review							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; HOMEOSTATIC PLASTICITY; REBOUND POTENTIATION; EXCITABILITY; DEPRESSION; NEURONS; SYNAPSES; TRANSMISSION	To date, most hypotheses of memory storage in the mammalian brain have focused upon long-term synaptic potentiation and depression (LTP and LTD) of fast glutamatergic excitatory postsynaptic currents (EPSCs). In recent years, it has become clear that many additional electrophysiological components of neurons, from electrical synapses to glutamate transporters to voltage-sensitive ion channels, can also undergo use-dependent long-term plasticity. Models of memory storage that incorporate this full range of demonstrated electrophysiological plasticity are better able to account for both the storage of memory in neuronal networks and the complexities of memory storage, indexing, and recall as measured behaviorally.	Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Seoul National University (SNU); Johns Hopkins University	Kim, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea.	sangjkim@snu.ac.kr; dlinden@jhmi.edu	Kim, Sang Jeong/J-2740-2012	Kim, Sang Jeong/0000-0001-8931-3713	NIMH NIH HHS [MH51106, MH07769] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bellamy TC, 2006, EUR J NEUROSCI, V23, P581, DOI 10.1111/j.1460-9568.2005.04588.x; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BRECSTEAD MJ, 2007, J NEUROSCI, V27, P2074; BRONS JF, 1980, J NEUROPHYSIOL, V44, P605, DOI 10.1152/jn.1980.44.3.605; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Desai NS, 2003, J PHYSIOL-PARIS, V97, P391, DOI 10.1016/j.jphysparis.2004.01.005; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Jin YJ, 2007, NEURON, V55, P277, DOI 10.1016/j.neuron.2007.06.035; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kirschstein T, 2007, J NEUROSCI, V27, P7696, DOI 10.1523/JNEUROSCI.4572-06.2007; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Minami I, 2003, EUR J NEUROSCI, V17, P1023, DOI 10.1046/j.1460-9568.2003.02499.x; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Pereda AE, 2004, BRAIN RES REV, V47, P227, DOI 10.1016/j.brainresrev.2004.06.010; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Shen Y, 2005, NEURON, V46, P715, DOI 10.1016/j.neuron.2005.04.033; Sourdet V, 2003, J NEUROSCI, V23, P10238; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; von der Malsburg C, 1973, Kybernetik, V14, P85; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wong R K, 1999, Adv Neurol, V79, P685; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	44	144	148	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					582	592		10.1016/j.neuron.2007.10.030	http://dx.doi.org/10.1016/j.neuron.2007.10.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031678	Bronze			2022-12-17	WOS:000251306600004
J	Yasuda, S; Tanaka, H; Sugiura, H; Okamura, K; Sakaguchi, T; Tran, U; Takemiya, T; Mizoguchi, A; Yagita, Y; Sakurai, T; De Robertis, EM; Yamagata, K				Yasuda, Shin; Tanaka, Hidekazu; Sugiura, Hiroko; Okamura, Ko; Sakaguchi, Taiki; Tran, Uyen; Takemiya, Takako; Mizoguchi, Akira; Yagita, Yoshiki; Sakurai, Takeshi; De Robertis, E. M.; Yamagata, Kanato			Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2 beta and p38 MAP kinases	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT REGULATION; AMPA RECEPTOR TRAFFICKING; PARAXIAL PROTOCADHERIN; HIPPOCAMPAL SYNAPSES; SYNAPTIC PLASTICITY; MOUSE DEVELOPMENT; BETA-CATENIN; ADHESION	Synaptic activity induces changes in the number of dendritic spines. Here, we report a pathway of regulated endocytosis triggered by arcadlin, a protocadherin induced by electroconvulsive and other excitatory stimuli in hippocampal neurons. The homophilic binding of extracellular arcadlin domains activates TAO2 beta, a splice variant of the thousand and one amino acid protein kinase 2, cloned here by virtue of its binding to the arcadlin intracellular domain. TAO2 beta is a MAPKKK that activates the MEK3 MAPKK, which phosphorylates the p38 MAPK Activation of p38 feeds-back on TAO2 beta, phosphorylating a key serine required for triggering endocytosis of N-cadherin at the synapse. Arcadlin knockout increases the number of dendritic spines, and the phenotype is rescued by siRNA knockdown of N-cadherin. This pathway of regulated endocytosis of N-cadherin via protocadherin/TAO2 beta/ MEK3/p38 provides a molecular mechanism for transducing neuronal activity into changes in synaptic morphologies.	Tokyo Metropolitan Inst Neurosci, Dept Neuropharmacol, Tokyo 1838526, Japan; Osaka Univ, Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; Mie Univ, Sch Med, Dept Anat, Tsu, Mie 5148507, Japan; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; CUNY Mt Sinai Sch Med, Dept Neurosci, New York, NY 10128 USA	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Osaka University; Mie University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Tanaka, H (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Neuropharmacol, Tokyo 1838526, Japan.	htanaka@pharma1.med.osaka-u.ac.jp; kyamagat@tmin.ac.jp	Yagita, Yoshiki/S-6954-2016	Sakaguchi, Taiki/0000-0002-2661-0646	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD021502-21A1, R01 HD021502] Funding Source: Medline; NINDS NIH HHS [R01 NS020147, NS20147] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Chen Z, 2003, J BIOL CHEM, V278, P22278, DOI 10.1074/jbc.M301173200; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Huber O, 1999, J CELL SCI, V112, P4415; Irie Y, 2000, J BIOL CHEM, V275, P2647, DOI 10.1074/jbc.275.4.2647; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Makarenkova H, 2005, BBA-GENE STRUCT EXPR, V1681, P150, DOI 10.1016/j.bbaexp.2004.11.001; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Strehl S, 1998, GENOMICS, V53, P81, DOI 10.1006/geno.1998.5467; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yamamoto A, 2000, GENESIS, V27, P49, DOI 10.1002/1526-968X(200006)27:2<49::AID-GENE10>3.0.CO;2-7; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	144	153	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 8	2007	56	3					456	471		10.1016/j.neuron.2007.08.020	http://dx.doi.org/10.1016/j.neuron.2007.08.020			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988630	Bronze, Green Accepted			2022-12-17	WOS:000250774600006
J	Sasaki, Y; Rajimehr, R; Kim, BW; Ekstrom, LB; Vanduffel, W; Tootell, RBH				Sasaki, Yuka; Rajimehr, Reza; Kim, Byoung Woo; Ekstrom, Leeland B.; Vanduffel, Wim; Tootell, Roger B. H.			The radial bias: A different slant on visual orientation sensitivity in human and nonhuman primates	NEURON			English	Article							SURFACE-BASED ANALYSIS; STRIATE CORTEX; PERIPHERAL-VISION; SPATIAL-FREQUENCY; RECEPTIVE-FIELDS; CONTRAST AGENT; GANGLION-CELLS; FUNCTIONAL MRI; DORSAL V4; AREAS	It is generally assumed that sensitivity to different stimulus orientations is mapped in a globally equivalent fashion across primate visual cortex, at a spatial scale larger than that of orientation columns. However, some evidence predicts instead that radial orientations should produce higher activity than other orientations, throughout visual cortex. Here, this radial orientation bias was robustly confirmed using (1) human psychophysics, plus fMRI in (2) humans and (3) behaving monkeys. In visual cortex, fMRI activity was at least 20% higher in the retinotopic representations of polar angle which corresponded to the radial stimulus orientations (relative to tangential). In a global demonstration of this, we activated complementary retinotopic quadrants of visual cortex by simply changing stimulus orientation, without changing stimulus location in the visual field. This evidence reveals a neural link between orientation sensitivity and the cortical retinotopy, which have previously been considered independent.	Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martios Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; CALTECH, ERATO Shimojo Implicit Brain Funct Project, Pasadena, CA 91125 USA; MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; California Institute of Technology; Massachusetts Institute of Technology (MIT)	Sasaki, Y (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martios Ctr Biomed Imaging, 149 13th St, Charlestown, MA 02129 USA.	yuka@nmr.mgh.harvard.edu		Sasaki, Yuka/0000-0002-0061-0250	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067529] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR 14075] Funding Source: Medline; NEI NIH HHS [R01 EY017081] Funding Source: Medline; NIBIB NIH HHS [EB 00790] Funding Source: Medline; NIMH NIH HHS [MH 67529] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBRECHT DG, 1980, SCIENCE, V207, P88, DOI 10.1126/science.6765993; Alexander DM, 2004, VISION RES, V44, P857, DOI 10.1016/j.visres.2003.11.009; BENNETT PJ, 1991, VISION RES, V31, P1759, DOI 10.1016/0042-6989(91)90025-Z; BERARDI N, 1991, VISION RES, V31, P1831, DOI 10.1016/0042-6989(91)90030-9; BERKLEY MA, 1975, VISION RES, V15, P239, DOI 10.1016/0042-6989(75)90213-8; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Durand JB, 2002, J NEUROPHYSIOL, V88, P2874, DOI 10.1152/jn.00291.2002; DURAND JB, 2004, 34 ANN M SOC NEUR SA; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FAHLE M, 1986, EXP BRAIN RES, V63, P113; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; FRISEN L, 1975, INVEST OPHTH VISUAL, V14, P528; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; GREVE DN, 2003, HUM BRAIN MAPP NY NY; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P476, DOI 10.1002/cne.902200409; LEVICK WR, 1982, J PHYSIOL-LONDON, V329, P243, DOI 10.1113/jphysiol.1982.sp014301; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; McGraw PV, 1999, EXP BRAIN RES, V125, P122, DOI 10.1007/s002210050667; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; RODIECK RW, 1985, J COMP NEUROL, V233, P115, DOI 10.1002/cne.902330107; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; SCHALL JD, 1987, J COMP NEUROL, V257, P149, DOI 10.1002/cne.902570202; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCOBEY RP, 1991, VISION RES, V31, P99, DOI 10.1016/0042-6989(91)90077-I; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 1996, J NEUROSCI, V16, P6945; SHOU T, 1989, J NEUROSCI, V9, P4287; TEMME LA, 1985, AM J OPTOM PHYS OPT, V62, P545; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Westheimer G, 2005, SPATIAL VISION, V18, P159, DOI 10.1163/1568568053320611; Westheimer G, 2003, VISION RES, V43, P53, DOI 10.1016/S0042-6989(02)00398-X; YAP YL, 1987, J OPT SOC AM A, V4, P1562, DOI 10.1364/JOSAA.4.001562	54	144	147	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					661	670		10.1016/j.neuron.2006.07.021	http://dx.doi.org/10.1016/j.neuron.2006.07.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950163	Bronze			2022-12-17	WOS:000240623400014
J	Gardner, JL; Sun, P; Waggoner, RA; Ueno, K; Tanaka, K; Cheng, K				Gardner, JL; Sun, P; Waggoner, RA; Ueno, K; Tanaka, K; Cheng, K			Contrast adaptation and representation in human early visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; STRIATE CORTICAL-NEURONS; CEREBRAL BLOOD OXYGENATION; EXTRASTRIATE AREA V4; FUNCTIONAL MRI; RESPONSE AMPLITUDE; GAIN-CONTROL; SELECTIVE ADAPTATION; SYNAPTIC DEPRESSION; SPATIAL ATTENTION	The human visual system can distinguish variations in image contrast over a much larger range than measurements of the static relationship between contrast and response in visual cortex would suggest. This discrepancy may be explained if adaptation serves to recenter contrast response functions around the ambient contrast, yet experiments on humans have yet to report such an effect. By using event-related fMRl and a data-driven analysis approach, we found that contrast response functions in V1, V2, and V3 shift to approximately center on the adapting contrast. Furthermore, we discovered that, unlike earlier areas, human V4 (hV4) responds positively to contrast changes, whether increments or decrements, suggesting that hV4 does not faithfully represent contrast, but instead responds to salient changes. These findings suggest that the visual system discounts slow uninformative changes in contrast with adaptation, yet remains exquisitely sensitive to changes that may signal important events in the environment.	RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Dept Psychol, New York, NY 10003 USA	RIKEN; New York University; New York University	Gardner, JL (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	justin@cns.nyu.edu	Cheng, Kang/A-6448-2016; Ueno, Kenichi/A-9395-2014; Sun, Pei/B-5191-2013; Waggoner, Allen/F-2654-2010; Tanaka, Keiji/N-5917-2015	Sun, Pei/0000-0003-4184-1079; Waggoner, Allen/0000-0002-4921-7521; Tanaka, Keiji/0000-0002-1910-3427; Gardner, Justin/0000-0003-2220-5050	NATIONAL EYE INSTITUTE [F32EY016260] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY016260-01, F32 EY016260] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; ANZAI A, 1995, VISUAL NEUROSCI, V12, P77, DOI 10.1017/S0952523800007331; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRAUN J, 1994, J NEUROSCI, V14, P554; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Chance FS, 1998, J NEUROSCI, V18, P4785; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEAN AF, 1983, VISION RES, V23, P249, DOI 10.1016/0042-6989(83)90113-X; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; FINLAYSON PG, 1995, EXP BRAIN RES, V106, P145; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GARDNER JL, 2005, P INT SOC MAGN RES M, V13, P25; GREENLEE MW, 1988, VISION RES, V28, P791, DOI 10.1016/0042-6989(88)90026-0; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; MCKEEFRY DJ, 1997, BRAIN, V120, P2299; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 2003, J NEUROSCI, V23, P3990; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1985, J NEUROPHYSIOL, V54, P668, DOI 10.1152/jn.1985.54.3.668; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SMIMAKIS SM, 1997, NATURE, V386, P69; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	76	144	146	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					607	620		10.1016/j.neuron.2005.07.016	http://dx.doi.org/10.1016/j.neuron.2005.07.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102542	Green Accepted, Bronze			2022-12-17	WOS:000231411100016
J	Domeniconi, M; Zampieri, N; Spencer, T; Hilaire, M; Mellado, W; Chao, MV; Filbin, MT				Domeniconi, M; Zampieri, N; Spencer, T; Hilaire, M; Mellado, W; Chao, MV; Filbin, MT			MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; GROWTH-FACTOR RECEPTOR; AXONAL REGENERATION; NOGO RECEPTOR; INTRACELLULAR DOMAIN; GAMMA-SECRETASE; FAMILY-MEMBER; RHO; COMPLEX; INTERACTS	The three known inhibitors of axonal regeneration present in myelin-MAG, Nogo, and OMgp-all interact with the same receptor complex to effect inhibition via protein kinase C (PKC)-dependent activation of the small GTPase Rho. The transducing component of this receptor complex is the p75 neurotrophin receptor. Here we show that MAG binding to cerebellar neurons induces alpha- and then gamma-secretase proteolytic cleavage of p75, in a protein kinase C-dependent manner, and that this cleavage is necessary for both activation of Rho and inhibition of neurite outgrowth.	CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Cell Biol & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA	City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Spencer, Tim/AAK-2094-2020	Chao, Moses/0000-0002-6969-3744; Zampieri, Niccolo/0000-0002-2228-9453	NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS41073, NS21072] Funding Source: Medline; DS NIH HHS [NINDS NS 37060] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, U54NS041073, R56NS021072] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DS NIH HHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Dergham P, 2002, J NEUROSCI, V22, P6570; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; GROB PM, 1985, J BIOL CHEM, V260, P8044; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Majdan M, 1997, J NEUROSCI, V17, P6988; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	37	144	151	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					849	855		10.1016/j.neuron.2005.05.029	http://dx.doi.org/10.1016/j.neuron.2005.05.029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953414	Bronze			2022-12-17	WOS:000229922500005
J	Akassoglou, K; Yu, WM; Akpinar, P; Strickland, S				Akassoglou, K; Yu, WM; Akpinar, P; Strickland, S			Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation	NEURON			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXTRACELLULAR-MATRIX MOLECULES; DEFICIENT MICE; IN-VITRO; PLASMINOGEN-ACTIVATOR; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; KINASE KINASE; BASAL LAMINA; LEWIS RATS	Remyelination is a critical step for functional nerve regeneration. Here we show that fibrin deposition in the peripheral nervous system after injury is a key regulator of remyelination. After sciatic nerve crush, fibrin is deposited and its clearance correlates with remyelination. Fibrin induces phosphorylation of ERK1/2 and production of p75 NGF low-affinity receptor in Schwann cells and maintains them in a nonmyelinating state, suppresses fibronectin production, and prevents synthesis of myelin proteins. In mice depleted of fibrin(ogen), remyelination of myelinated axons is accelerated due to the faster transition of the Schwann cells to a myelinating state. Regulation of fibrin clearance and/or deposition could be a key regulatory mechanism for Schwann differentiation after nerve damage.	Rockefeller Univ, Lab Neurobiol & Genet, New York, NY 10021 USA	Rockefeller University	Strickland, S (corresponding author), Rockefeller Univ, Lab Neurobiol & Genet, 1230 York Ave, New York, NY 10021 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Strickland, Sidney/0000-0002-3072-9244; Akassoglou, Katerina/0000-0002-2632-1465	NINDS NIH HHS [R01 NS035704] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035704] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; ANTON ES, 1994, DEV BIOL, V164, P133, DOI 10.1006/dbio.1994.1186; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BELL WR, 1978, J LAB CLIN MED, V91, P592; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Busso N, 1998, J CLIN INVEST, V102, P41, DOI 10.1172/JCI2312; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chen R, 1971, Biochemistry, V10, P4487; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; CLARK MB, 1991, GLIA, V4, P514, DOI 10.1002/glia.440040511; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; Friedmann I, 1999, FASEB J, V13, P533, DOI 10.1096/fasebj.13.3.533; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; HO MK, 1982, J IMMUNOL, V128, P2281; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; HSIEH ST, 1994, J NEUROSCI, V14, P6392; Hughes PM, 1998, BRAIN, V121, P481, DOI 10.1093/brain/121.3.481; Inoue A, 1996, J NEUROIMMUNOL, V71, P131, DOI 10.1016/S0165-5728(96)00150-6; Jessen KR, 1999, ADV EXP MED BIOL, V468, P3; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; KOH CS, 1993, J NEUROIMMUNOL, V47, P141, DOI 10.1016/0165-5728(93)90024-S; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Kuhlmann T, 2001, J NEUROSCI, V21, P3401, DOI 10.1523/JNEUROSCI.21-10-03401.2001; Lansink M, 1998, BLOOD, V92, P927; LEFCORT F, 1992, DEVELOPMENT, V116, P767; LEMKE G, 1988, DEVELOPMENT, V102, P499; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LISAK RP, 1994, J NEUROIMMUNOL, V55, P171, DOI 10.1016/0165-5728(94)90007-8; LORAND L, 1969, BIOCHEM BIOPH RES CO, V37, P219, DOI 10.1016/0006-291X(69)90722-0; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; PATERSON PY, 1976, FED PROC, V35, P2428; PEREZ RL, 1995, J IMMUNOL, V154, P1879; Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RICHARDSON PM, 1994, J NEUROL, V242, pS57, DOI 10.1007/BF00939244; Robertson AM, 1997, J ANAT, V190, P423, DOI 10.1046/j.1469-7580.1997.19030423.x; Rutkowski JL, 1999, J NEUROIMMUNOL, V101, P47, DOI 10.1016/S0165-5728(99)00132-0; SCHERER SS, 1994, J NEUROSCI RES, V38, P575, DOI 10.1002/jnr.490380510; SHAW G, 1985, EUR J CELL BIOL, V39, P205; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Sobel RA, 1998, J NEUROPATH EXP NEUR, V57, P205, DOI 10.1097/00005072-199803000-00001; Soilu-Hanninen M, 1999, J NEUROSCI, V19, P4828; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Vogelezang MG, 1999, J NEUROSCI RES, V56, P323, DOI 10.1002/(SICI)1097-4547(19990515)56:4<323::AID-JNR1>3.0.CO;2-6; WOOLF CJ, 1990, NEUROSCIENCE, V34, P465, DOI 10.1016/0306-4522(90)90155-W; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1; Zorick TS, 1999, DEVELOPMENT, V126, P1397	76	144	158	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					861	875		10.1016/S0896-6273(02)00617-7	http://dx.doi.org/10.1016/S0896-6273(02)00617-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906694	Bronze			2022-12-17	WOS:000174389600005
J	Kloss, B; Rothenfluh, A; Young, MW; Saez, L				Kloss, B; Rothenfluh, A; Young, MW; Saez, L			Phosphorylation of PERIOD is influenced by cycling physical associations of DOUBLE-TIME, PERIOD, and TIMELESS in the Drosophila clock	NEURON			English	Review							NUCLEAR ENTRY; CIRCADIAN-RHYTHMS; PROTEIN; MUTATION; GENE; ENTRAINMENT; MECHANISM; ABUNDANCE; SUGGESTS	The clock gene double-time (dbt) encodes an ortholog of casein kinase le that promotes phosphorylation and turnover of the PERIOD protein. Whereas the period (per), timeless (tim), and dClock (dClk) genes of Drosophila each contribute cycling mRNA and protein to a circadian clock, dbt RNA and DBT protein are constitutively expressed. Robust circadian changes in DBT subcellular localization are nevertheless observed in clock-containing cells of the fly head. These localization rhythms accompany formation of protein complexes that include PER, TIM, and DBT, and reflect periodic redistribution between the nucleus and the cytoplasm. Nuclear phosphorylation of PER is strongly enhanced when TIM is removed from PER/TIM/DBT complexes. The varying associations of PER, DBT and TIM appear to determine the onset and duration of nuclear PER function within the Drosophila clock.	Rockefeller Univ, Ctr Biol Timing, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn Sci & Technol, New York, NY 10021 USA	Rockefeller University; National Science Foundation (NSF); Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Ctr Biol Timing, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@rockvax.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Kloss, Brian/0000-0003-0130-8739; Rothenfluh, Adrian/0000-0002-3813-5723	NIGMS NIH HHS [GM 54339] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; MARTINEK S, 2001, IN PRESS CELL; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Rothenfluh A, 2000, GENETICS, V156, P665; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; Suri V, 2000, J NEUROSCI, V20, P7547; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zilian O, 1999, DEVELOPMENT, V126, P5409	31	144	147	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					699	706		10.1016/S0896-6273(01)00320-8	http://dx.doi.org/10.1016/S0896-6273(01)00320-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430804	Bronze			2022-12-17	WOS:000169508900011
J	Jontes, JD; Smith, SJ				Jontes, JD; Smith, SJ			Filopodia, spines, and the generation of synaptic diversity	NEURON			English	Review							DENDRITIC SPINES; CORTICORUBRAL AXONS; CELL MOTILITY; ACTIN; PLASTICITY; SYNAPTOGENESIS; PROTRUSIONS; RECEPTORS; DYNAMICS; SYNAPSES		Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Smith, SJ (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA.							Allison DW, 1998, J NEUROSCI, V18, P2423; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dailey ME, 1996, J NEUROSCI, V16, P2983; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Saito Y, 1997, J NEUROSCI, V17, P8792; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	20	144	146	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					11	14		10.1016/S0896-6273(00)00003-9	http://dx.doi.org/10.1016/S0896-6273(00)00003-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939326	Bronze			2022-12-17	WOS:000088503800006
J	Ahn, S; Ginty, DD; Linden, DJ				Ahn, S; Ginty, DD; Linden, DJ			A late phase of cerebellar long-term depression requires activation of CaMKIV and CREB	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; CAMP-RESPONSIVE ELEMENT; DEVELOPING RAT-BRAIN; GENE-EXPRESSION; CA2+/CALMODULIN KINASE; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; PURKINJE-CELLS; MUTANT MICE	Recently, it has been shown that cerebellar LTD has a late phase that may be blocked by protein synthesis inhibitors. To understand the mechanisms underlying the late phase, we interfered with the activation of transcription factors that might couple synaptic activation to protein synthesis. Particle-mediated transfection of cultured Purkinje neurons with an expression vector encoding a dominant inhibitory form of CREB resulted in a nearly complete blockade of the late phase. Kinases that activate CREB were inhibited, and LTD was assessed. Inhibition of PKA or the MAPK/RSK cascades were without effect on the late phase, while constructs designed to interfere with CaMKIV function attenuated the late phase. These results indicate that the activation of CaMKIV and ORES are necessary to establish a late phase of cerebellar LTD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051106, R01MH051106, R37MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline; NINDS NIH HHS [NS34815] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAY RN, 1989, J BIOL CHEM, V264, P431; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; ENYEART JJ, 1987, AM J PHYSIOL, V253, pC162, DOI 10.1152/ajpcell.1987.253.1.C162; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Ginty DD, 1997, NEURON, V18, P183, DOI 10.1016/S0896-6273(00)80258-5; GLASS DB, 1989, J BIOL CHEM, V264, P8802; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Heist EK, 1998, CELL CALCIUM, V23, P103; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Huang Y Y, 1994, Learn Mem, V1, P74; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; KURINO M, 1995, J NEUROCHEM, V65, P1282; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LI GD, 1992, MOL PHARMACOL, V42, P489; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Matthies H, 1990, Adv Exp Med Biol, V268, P359; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; Peavy RD, 1998, J NEUROCHEM, V71, P603; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; SAKAGAMI H, 1993, MOL BRAIN RES, V20, P51, DOI 10.1016/0169-328X(93)90109-3; SAKAGAMI H, 1992, MOL BRAIN RES, V16, P20, DOI 10.1016/0169-328X(92)90189-I; SAKAGAMI H, 1993, MOL BRAIN RES, V19, P215, DOI 10.1016/0169-328X(93)90029-O; Sawamura Y, 1996, BRAIN RES, V706, P259, DOI 10.1016/0006-8993(95)01161-7; SEGER R, 1994, J BIOL CHEM, V269, P25699; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SIRHA TS, 1995, NEUROPHARMACOLOGY, V34, P731; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vincent SR, 1998, SYNAPSE, V29, P29, DOI 10.1002/(SICI)1098-2396(199805)29:1<29::AID-SYN3>3.3.CO;2-T; WALAAS SI, 1988, MOL BRAIN RES, V4, P233, DOI 10.1016/0169-328X(88)90029-0; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	76	144	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					559	568		10.1016/S0896-6273(00)80808-9	http://dx.doi.org/10.1016/S0896-6273(00)80808-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433267	Bronze			2022-12-17	WOS:000081701000019
J	Lo, LC; Morin, X; Brunet, JF; Anderson, DJ				Lo, LC; Morin, X; Brunet, JF; Anderson, DJ			Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells	NEURON			English	Article							TYROSINE-HYDROXYLASE GENE; DEVELOPING SYMPATHETIC NEURONS; NEGATIVE REGULATORY ELEMENT; RESTRICTIVE SILENCER FACTOR; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE HOMOLOG-1; CAMP-RESPONSE ELEMENT; HOMEODOMAIN PROTEIN; TRANSGENIC MICE; CYCLIC-AMP	We have investigated the specification of noradrenergic neurotransmitter identity in neural crest stem cells (NCSCs). Retroviral expression of both wild-type and dominant-negative forms of the paired homeodomain transcription factor Phox2a indicates a crucial and direct role for this protein (and/or the closely related Phox2b) in the regulation of endogenous tyrosine hydroxylase (TH) and dopamine-beta hydroxylase (DBH) gene expression in these cells. In collaboration with cAMP, Phox2a can induce expression of TH but not of DBH or of panneuronal genes. Phox2 proteins are, moreover, necessary for the induction of both TH and DBH by bone morphogenetic protein 2 (BMP2) (which induces Phox2a/b) and forskolin. They are also necessary for neuronal differentiation. These data suggest that Phox2a/b coordinates the specification of neurotransmitter identity and neuronal fate by cooperating environmental signals in sympathetic neuroblasts.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Mediterranee, INSERM, CNRS, Inst Biol Dev Marseille,Lab Genet & Physiol Dev, Marseille, France	California Institute of Technology; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.		morin, xavier/AAI-3306-2020	Brunet, Jean-Francois/0000-0002-1985-6103; Morin, Xavier/0000-0001-9999-0355				Afar R, 1996, MOL BRAIN RES, V36, P79, DOI 10.1016/0169-328X(95)00247-P; Anderson D, 1997, MOL CELLULAR APPROAC, P26; BADIANI P, 1994, GENE DEV, V8, P770, DOI 10.1101/gad.8.7.770; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; BANERJEE SA, 1994, MOL BRAIN RES, V24, P89, DOI 10.1016/0169-328X(94)90121-X; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; CHEN ZF, 1998, IN PRESS NAT GENET, V20; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUNG BP, 1992, J NEUROCHEM, V58, P2044, DOI 10.1111/j.1471-4159.1992.tb10945.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GANDELMAN KY, 1990, J NEUROCHEM, V55, P2149, DOI 10.1111/j.1471-4159.1990.tb05811.x; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; GROVES AK, 1995, DEVELOPMENT, V121, P887; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hirsch MR, 1998, DEVELOPMENT, V125, P599; ISHIGURO H, 1993, J BIOL CHEM, V268, P17987; Ishiguro H, 1995, MOL BRAIN RES, V34, P251, DOI 10.1016/0169-328X(95)00170-W; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kim HS, 1998, J NEUROSCI, V18, P8247; KIM KS, 1993, J BIOL CHEM, V268, P15689; LAZAROFF M, 1995, J BIOL CHEM, V270, P21579, DOI 10.1074/jbc.270.37.21579; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Lindsay RM, 1996, NEURON, V17, P571, DOI 10.1016/S0896-6273(00)80189-0; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; LO LC, 1990, DEV BIOL, V145, P139; MANDEL G, 1993, ANNU REV NEUROSCI, V16, P323, DOI 10.1146/annurev.ne.16.030193.001543; Maxwell GD, 1996, P NATL ACAD SCI USA, V93, P13274, DOI 10.1073/pnas.93.23.13274; MIN N, 1994, MOL BRAIN RES, V27, P281, DOI 10.1016/0169-328X(94)90011-6; MITANI S, 1993, DEVELOPMENT, V119, P773; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Osaka H, 1997, MOL BRAIN RES, V49, P222, DOI 10.1016/S0169-328X(97)00148-4; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Quinn JP, 1996, PROG NEUROBIOL, V50, P363, DOI 10.1016/S0301-0082(96)00041-X; Reissmann E, 1996, DEVELOPMENT, V122, P2079; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHASKUS J, 1995, J NEUROCHEM, V64, P52; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMITH J, 1984, J NEUROSCI, V4, P2160; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STERN CD, 1991, DEVELOPMENT, V113, P207; STRUDEL G, 1977, CR ACAD SCI D NAT, V284, P967; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; VALARCHE I, 1993, DEVELOPMENT, V119, P881; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; WONG SC, 1995, J NEUROCHEM, V65, P23; Yang CY, 1998, J NEUROCHEM, V71, P1813; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8; Zellmer E, 1995, J NEUROSCI, V15, P8109; ZHANG JM, 1992, BRAIN RES, V570, P251, DOI 10.1016/0006-8993(92)90588-Z; Zhang JM, 1997, J NEUROBIOL, V32, P262, DOI 10.1002/(SICI)1097-4695(199703)32:3<262::AID-NEU2>3.0.CO;2-5	67	144	155	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					693	705		10.1016/S0896-6273(00)80729-1	http://dx.doi.org/10.1016/S0896-6273(00)80729-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230790	Bronze			2022-12-17	WOS:000079976200013
J	Krapivinsky, G; Medina, I; Eng, L; Krapivinsky, L; Yang, YH; Clapham, DE				Krapivinsky, G; Medina, I; Eng, L; Krapivinsky, L; Yang, YH; Clapham, DE			A novel inward rectifier K+ channel with unique pore properties	NEURON			English	Article							POTASSIUM CHANNEL; ANOMALOUS RECTIFICATION; FUNCTIONAL EXPRESSION; CLONING; MEMBRANE; CONDUCTANCE; PROTEINS; RECEPTOR; SUBUNITS; CELLS	We have cloned a novel K+-selective, inward rectifier channel that is widely expressed in brain but is especially abundant in the Purkinje cell layer of the cerebellum and pyramidal cells of the hippocampus. It is also present in a wide array of tissues, including kidney and intestine. The channel is only 38% identical to its closest relative, Kir1.3 (Kir1-ATP-regulated inward rectifier K+ [ROMK] family) and displays none of the functional properties unique to the ROMK class. Kir7.1 has several unique features, including a very low estimated single channel conductance (similar to 50 fS), low sensitivity to block by external Ba2+ and Cs+, and no dependence of its inward rectification properties on the internal blocking particle Mg2+. The unusual pore properties of Kir7.1 seem to be explained by amino acids in the pore sequence that differ from corresponding conserved residues in all other Kir channel proteins. Replacement of one of these amino acids (Met-125) with the Arg absolutely conserved in all other Kir channels dramatically increases its single channel conductance and Ba2+ sensitivity. This channel would provide a steady background K+ current to help set the membrane potential in cells in which it is expressed. We propose that the novel channel be assigned to a new Kir subfamily, Kir7.1.	Childrens Hosp, Howard Hughes Med Inst, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Div Cardiovasc, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019; Medina, Igor/O-5532-2016	Clapham, David/0000-0002-4459-9428; Medina, Igor/0000-0001-6839-5414	NHLBI NIH HHS [NHLBI 54873] Funding Source: Medline; NIDDK NIH HHS [NIDDK 09432] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009432] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov A, 1996, BIOPHYS J, V70, P2680, DOI 10.1016/S0006-3495(96)79837-5; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BREDT DS, 1995, P NATL ACAD SCI USA, V92, P6753, DOI 10.1073/pnas.92.15.6753; CIANI S, 1978, J MEMBRANE BIOL, V44, P103, DOI 10.1007/BF01976035; DEFELICE LJ, 1981, INTRO MEMBRANE NOISE, P115; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MAKHINA EN, 1994, J BIOL CHEM, V269, P20468; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Medina I, 1996, J PHYSIOL-LONDON, V495, P411, DOI 10.1113/jphysiol.1996.sp021603; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Sabirov RZ, 1997, J GEN PHYSIOL, V110, P665, DOI 10.1085/jgp.110.6.665; SAMBROOK J, 1989, MOL CLONING LAB MANU, V3; Shuck ME, 1997, J BIOL CHEM, V272, P586; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	30	144	147	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					995	1005		10.1016/S0896-6273(00)80480-8	http://dx.doi.org/10.1016/S0896-6273(00)80480-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620703	Bronze			2022-12-17	WOS:000073864700018
J	Livingstone, MS				Livingstone, MS			Mechanisms of direction selectivity in macaque V1	NEURON			English	Article							CAT STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; VISUAL-CORTEX; SIMPLE CELLS; AREA 17; RESPONSE PROPERTIES; LINEAR MECHANISMS; COMPLEX CELLS; RHESUS-MONKEY	Mechanisms underlying direction selectivity were studied in V1 of alert fixating macaque monkeys. Some direction-selective cells showed delayed asymmetric inhibition, some showed a shifting excitatory time course across the receptive field, and some showed both. Both the direction of the spatial offset of the inhibition and the direction of the shift in excitatory response time course correlated with the cells' preferred directionality. The delayed asymmetric inhibition may contribute to the shifting response time course. The data suggest that asymmetric inhibition is the major determinant for directionality in these cells, though both mechanisms could contribute. Based on this physiology, a simple, single-cell model is proposed, consistent with the known anatomy of some direction-selective cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Livingstone, MS (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Livingstone, Margaret/0000-0002-1950-0123	NEI NIH HHS [R01 EY10203] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010203] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BISHOP PO, 1973, J PHYSL, V238, P25; Clark WELG, 1942, J ANAT, V76, P369; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; FERSTER D, 1988, J NEUROSCI, V8, P1172; FREUND TF, 1983, J COMP NEUROL, V221, P263, DOI 10.1002/cne.902210303; GANZ L, 1984, J NEUROPHYSIOL, V51, P294, DOI 10.1152/jn.1984.51.2.294; GANZ L, 1984, VISION RES, P243; GASKA JP, 1994, VISUAL NEUROSCI, V11, P805, DOI 10.1017/S0952523800003102; GLEZER VD, 1982, BIOL CYBERN, V43, P35, DOI 10.1007/BF00337286; GOODWIN AW, 1975, J NEUROPHYSIOL, V38, P1500, DOI 10.1152/jn.1975.38.6.1500; HAMILTON DB, 1989, VISION RES, V29, P1285, DOI 10.1016/0042-6989(89)90186-7; HAMMOND P, 1994, P ROY SOC B-BIOL SCI, V257, P179, DOI 10.1098/rspb.1994.0113; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P293, DOI 10.1113/jphysiol.1986.sp016048; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; HUMPHREY AL, 1988, J COMP NEUROL, V268, P429, DOI 10.1002/cne.902680311; INNOCENTI GM, 1974, BRAIN RES, V80, P122, DOI 10.1016/0006-8993(74)90728-8; IRVIN GE, 1986, BRAIN RES, V362, P254, DOI 10.1016/0006-8993(86)90450-6; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LANDAU LD, 1976, MECHANICS, P99; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; LUND JS, 1973, J COMP NEUROL, V147, P455, DOI 10.1002/cne.901470404; MARTIN KAC, 1984, J PHYSIOL-LONDON, V356, P291, DOI 10.1113/jphysiol.1984.sp015465; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P357, DOI 10.1152/jn.1987.57.2.357; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Meynert T., 1872, HDB LEHRE GEWEBEN ME, V2, P694; MOTTER BC, 1984, EXP BRAIN RES, V54, P304; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 1996, J NEUROSCI, V16, P7733; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; PALMER LA, 1981, J NEUROPHYSIOL, V46, P277, DOI 10.1152/jn.1981.46.2.277; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1369, DOI 10.1152/jn.1977.40.6.1369; Rail W., 1964, NEURAL THEORY MODELI, P122; Ramo n, 1899, CORTEZA VISUAL REV T, V4, P1; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; SATO H, 1995, J NEUROPHYSIOL, V74, P1382, DOI 10.1152/jn.1995.74.4.1382; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SHAPLEY R, 1991, COMPUTATIONAL MODELS, P109; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SNODDERLY DM, 1985, VISION RES, V25, P83, DOI 10.1016/0042-6989(85)90083-5; SNODDERLY DM, 1987, VISION RES, V27, P401, DOI 10.1016/0042-6989(87)90089-7; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SPATZ WB, 1975, BRAIN RES, V92, P450, DOI 10.1016/0006-8993(75)90329-7; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; STEVENS JK, 1976, J NEUROPHYSIOL, V39, P213, DOI 10.1152/jn.1976.39.2.213; TIGGES J, 1981, J COMP NEUROL, V202, P539, DOI 10.1002/cne.902020407; TOLHURST DJ, 1991, VISUAL NEUROSCI, V6, P421, DOI 10.1017/S0952523800001280; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; WINFIELD DA, 1983, PROC R SOC SER B-BIO, V217, P129, DOI 10.1098/rspb.1983.0002	71	144	145	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					509	526		10.1016/S0896-6273(00)80991-5	http://dx.doi.org/10.1016/S0896-6273(00)80991-5			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539125	Bronze			2022-12-17	WOS:000072755600016
J	Navaratnam, DS; Bell, TJ; Tu, TD; Cohen, EL; Oberholtzer, JC				Navaratnam, DS; Bell, TJ; Tu, TD; Cohen, EL; Oberholtzer, JC			Differential distribution of Ca2+-activated K+ channel splice variants among hair cells along the tonotopic axis of the chick cochlea	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; ION-DEPENDENT CONDUCTANCES; CALCIUM-BINDING PROTEIN; BETA-SUBUNIT; ELECTRICAL RESONANCE; INNER-EAR; RANA-CATESBEIANA; BIRD COCHLEA; HUMAN BRAIN; BULL-FROG	We have cloned from the receptor epithelium of the chick cochlea a family of alternatively spliced cDNAs derived from cslo, which encodes a Ca2+-activated K+ channel like those shown to help determine the resonant frequency of electrically tuned hair cells. Our results from PCRs using template RNAs from both tonotopically subdivided receptor epithelia and single hair cells demonstrate differential exon usage along the frequency axis of the epithelium at multiple splice sites in cslo. We also show that single hair cells express more than one splice variant at a given splice site. Since channel isoforms encoded by differentially spliced slo transcripts in other species are functionally heterogeneous, these data suggest that differential processing of slo transcripts may account, at least in part, for the systematic variation in hair-cell membrane properties along the frequency axis of electrically tuned auditory receptor epithelia.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,DIV NEUROPATHOL,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002755] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02755] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; EATOCK RA, 1993, J NEUROSCI, V13, P1767; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FETTIPLACE R, 1980, HEARING RES, V2, P447, DOI 10.1016/0378-5955(80)90081-7; FETTIPLACE R, 1987, TRENDS NEUROSCI, V10, P421, DOI 10.1016/0166-2236(87)90013-0; FUCHS PA, 1992, PROG NEUROBIOL, V39, P493, DOI 10.1016/0301-0082(92)90003-W; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947; Goodman MB, 1996, J PHYSIOL-LONDON, V497, P395, DOI 10.1113/jphysiol.1996.sp021776; Goodman MB, 1996, BIOPHYS J, V71, P430, DOI 10.1016/S0006-3495(96)79245-7; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; HUNZIKER W, 1986, P NATL ACAD SCI USA, V83, P7578, DOI 10.1073/pnas.83.20.7578; Jiang GJ, 1997, P ROY SOC B-BIOL SCI, V264, P731, DOI 10.1098/rspb.1997.0104; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; NAVARATNAM DS, 1995, J BIOL CHEM, V270, P19238, DOI 10.1074/jbc.270.33.19238; OBERHOLTZER JC, 1994, DNA CELL BIOL, V13, P857, DOI 10.1089/dna.1994.13.857; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PITCHFORD S, 1987, HEARING RES, V27, P75, DOI 10.1016/0378-5955(87)90027-X; REINHART PH, 1995, J NEUROSCI, V15, P4572; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sambrok J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; SIEBERT PD, 1993, BIOTECHNIQUES, V14, P244; SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330, DOI 10.1152/jn.1989.62.6.1330; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; TILNEY LG, 1988, J CELL BIOL, V107, P2563, DOI 10.1083/jcb.107.6.2563; TILNEY LG, 1986, DEV BIOL, V116, P100, DOI 10.1016/0012-1606(86)90047-3; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Wu YC, 1996, BIOPHYS J, V70, P2557, DOI 10.1016/S0006-3495(96)79827-2; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7	59	144	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1077	1085		10.1016/S0896-6273(00)80398-0	http://dx.doi.org/10.1016/S0896-6273(00)80398-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390520	Bronze			2022-12-17	WOS:A1997YH59400014
J	Davis, GW; Schuster, CM; Goodman, CS				Davis, GW; Schuster, CM; Goodman, CS			Genetic analysis of the mechanisms controlling target selection: Target-derived fasciclin II regulates the pattern of synapse formation	NEURON			English	Article							GROWTH CONE GUIDANCE; MOTOR AXON GUIDANCE; DENERVATED SKELETAL-MUSCLE; FUNCTIONAL COMPONENTS; NEUROMUSCULAR SPECIFICITY; RECOGNITION MOLECULE; N-CAM; DROSOPHILA; MOTONEURON; EXPRESSION	In Drosophila, motoneuron growth cones initially probe many potential muscle targets but later withdraw most of these contacts to form stereotypic synapses with only one or a few muscles. Prior to synapse formation, Fasciclin II (Fas II) is expressed at low levels on muscle. During synapse formation, Fas II concentrates at the synapse and disappears from the rest of the muscle. We previously showed that Fas II is required both pre- and postsynaptically for synaptic stabilization. Here, we show that the differential expression of target derived Pas II has a profound influence on the patterning of synapse formation. A transient increase in muscle Fas II stabilizes growth cone contacts and leads to novel synapses that are functional and stable; targets that normally receive two inputs can now receive up to six inputs. Changing the relative levels of Fas II on neighboring muscles leads to dramatic shifts in target selection.	UNIV CALIF BERKELEY,DEPT CELL & MOL BIOL,HOWARD HUGHES MED INST,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALL EE, 1985, J NEUROSCI, V5, P1808; BRAND AH, 1993, DEVELOPMENT, V118, P401; CASH S, 1992, J NEUROSCI, V12, P2051; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; CHIBA A, 1993, J NEUROSCI, V13, P714; COVAULT J, 1986, J CELL BIOL, V102, P731, DOI 10.1083/jcb.102.3.731; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; COVAULT J, 1987, J CELL BIOL, V105, P2479, DOI 10.1083/jcb.105.6.2479; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Jarecki J, 1995, J NEUROSCI, V15, P8177; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; Nose A, 1997, DEVELOPMENT, V124, P1433; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SINK H, 1991, DEVELOPMENT, V114, P939; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	34	144	145	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					561	573		10.1016/S0896-6273(00)80372-4	http://dx.doi.org/10.1016/S0896-6273(00)80372-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331349	Bronze			2022-12-17	WOS:A1997XZ01600012
J	Verhage, M; deVries, KJ; Roshol, H; Burbach, JPH; Gispen, WH; Sudhof, TC				Verhage, M; deVries, KJ; Roshol, H; Burbach, JPH; Gispen, WH; Sudhof, TC			DOC2 proteins in rat brain: Complementary distribution and proposed function as vesicular adapter proteins in early stages of secretion	NEURON			English	Article							SYNAPTIC VESICLE DOCKING; MEMBRANE-PROTEINS; BINDING PROTEIN; IN-VITRO; RABPHILIN-3A; FUSION; SYNAPTOTAGMIN; INTERACTS; SYNTAXIN; COMPLEX	DOC2 proteins constitute a novel protein family that may function in secretion and contain a double C2 domain. We have cloned and characterized two DOC2 isoforms in rat brain and studied their interactions with other proteins implicated in secretion. DOC2A was virtually brain specific, DOC2B ubiquitous. Within brain, the isoforms were expressed nonuniformly and complementary within neurons, not astroglia, and copurified with synaptic vesicles. Affinity purification, yeast two-hybrid analysis, and coimmunoprecipitation revealed that DOC2 binds munc18, a protein also implicated in secretion. The first DOC2 62 domain and most of munc18 are involved in direct interactions. Munc18 may regulate formation of 'core complexes' during vesicle docking, by interacting with syntaxin. We show that DOC2 and syntaxin compete for munc18. Other core complex components shifted the equilibrium between syntaxin-munc18 versus DOC2-munc18. These data suggest that DOC2 proteins are vesicular adapter proteins regulating munc18-syntaxin complexes and herewith synaptic vesicle docking.	SW TEXAS STATE UNIV,HOWARD HUGHES MED INST,DEPT MOL GENET,DALLAS,TX	Howard Hughes Medical Institute; Texas State University System; Texas State University San Marcos	Verhage, M (corresponding author), UNIV UTRECHT,RUDOLF MAGNUS INST NEUROSCI,UNIV WEG 100,NL-3584 CG UTRECHT,NETHERLANDS.			verhage, matthijs/0000-0002-6085-7503				BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HUTTNER WB, 1983, J CELL BIOL, V96, P1684; INAGAKI N, 1994, J BIOCHEM-TOKYO, V116, P239, DOI 10.1093/oxfordjournals.jbchem.a124512; Kwon OJ, 1996, FEBS LETT, V378, P135, DOI 10.1016/0014-5793(95)01430-6; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; MCMAHON HT, 1995, CELL, V83, P1; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; ROSE MD, 1990, METHODS YEAST GENETI; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C	34	144	148	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					453	461		10.1016/S0896-6273(00)81245-3	http://dx.doi.org/10.1016/S0896-6273(00)81245-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115738	Bronze			2022-12-17	WOS:A1997WQ07400012
J	DAS, S; POTTER, H				DAS, S; POTTER, H			EXPRESSION OF THE ALZHEIMER AMYLOID-PROMOTING FACTOR ANTICHYMOTRYPSIN IS INDUCED IN HUMAN ASTROCYTES BY IL-1	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HEPARAN-SULFATE PROTEOGLYCANS; ACUTE PHASE RESPONSE; BETA-PROTEIN; SENILE PLAQUES; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; MESSENGER-RNA; INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN; NEURITIC PLAQUES	The amyloid deposits of Alzheimer's disease contain, in addition to the beta protein (Ap), lesser amounts of other proteins including the protease inhibitor alpha-antichymotrypsin (ACT). We have recently shown that ACT acts as a pathological chaperone, binding to the beta protein and strongly promoting its polymerization into amyloid filaments in vitro. The data of this paper show that ACT synthesis is induced in cultured human astrocytes by IL-1, a lymphokine whose expression is strongly up-regulated in microglial cells in affected areas of Alzheimer's disease brain. Furthermore, unfractionated glial cultures containing both astrocytes and microglia from human cortex (which develops amyloid in Alzheimer's disease) spontaneously express IL-1 and ACT as they reach confluence. In contrast, confluent mixed glial cultures similarly prepared from human cerebellum or brain stem, or from rat brain tissues not prone to amyloid formation-do not express ACT unless supplemented with exogenous IL-1. The same regional difference in IL-1 expression by microglia is seen in vivo in Alzheimer's disease. These results indicate that the IL-1-induced expression of ACT may help direct the region-specific production of mature amyloid filaments in the Alzheimer brain.			DAS, S (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA.		Das, Saumya/R-7644-2019	Das, Saumya/0000-0002-4521-4606				ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1989, NEUROSCIENCE, V32, P715, DOI 10.1016/0306-4522(89)90292-3; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ABRAHAM CR, 1989, BIO-TECHNOL, V7, P147, DOI 10.1038/nbt0289-147; ARAUJO DM, 1992, BRAIN RES, V569, P141, DOI 10.1016/0006-8993(92)90380-R; BAUMANN H, 1987, J IMMUNOL, V139, P4122; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; BENOWITZ LI, 1989, EXP NEUROL, V106, P237, DOI 10.1016/0014-4886(89)90156-8; BIRECREE E, 1988, J NEUROPATH EXP NEUR, V47, P549, DOI 10.1097/00005072-198809000-00006; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; CARD JP, 1988, NEURON, V1, P835, DOI 10.1016/0896-6273(88)90131-6; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; DUFFY PE, 1980, NEUROLOGY, V30, P778, DOI 10.1212/WNL.30.7.778; EIKELENBOOM P, 1989, VIRCHOWS ARCH B, V56, P259; ESIRI MM, 1984, J CLIN PATHOL, V37, P150, DOI 10.1136/jcp.37.2.150; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; IKEDA S, 1969, LAB INVEST, V61, P133; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JUSTICE DL, 1987, J CELL BIOCHEM, V34, P227, DOI 10.1002/jcb.240340402; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOO EH, 1991, NEUROBIOL AGING, V12, P495, DOI 10.1016/0197-4580(91)90079-Y; LEE SHC, 1992, LAB INVEST, V67, P465; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MANN DMA, 1985, NEUROPATHOL APPL NEU, V15, P317; MARTIGNONI E, 1990, ACTA NEUROL SCAND, V81, P452; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NELSON RB, 1990, J BIOL CHEM, V265, P3836; NELSON RB, 1993, J NEUROCHEM, V61, P567; NIETOSAMPEDRO M, 1988, SCIENCE, V240, P1784, DOI 10.1126/science.3289118; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PASTERNACK JM, 1989, AM J PATHOL, V135, P827; POTTER H, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P275; POTTER H, 1992, PROG BRAIN RES, V94, P447; PROBST A, 1987, ACTA NEUROPATHOL, V74, P133, DOI 10.1007/BF00692843; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROZEMULLER JM, 1990, NEUROSCI LETT, V119, P75, DOI 10.1016/0304-3940(90)90759-3; ROZEMULLER JM, 1991, ACTA NEUROPATHOL, V82, P200, DOI 10.1007/BF00294446; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHENG JG, 1994, IN PRESS J EXP NEURO; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SNOW AD, 1989, J NEUROPATH EXP NEUR, V48, P352, DOI 10.1097/00005072-198905000-00160; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1988, AM J PATHOL, V133, P456; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRUBLE RG, 1985, BRAIN RES, V361, P267, DOI 10.1016/0006-8993(85)91298-3; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; Wisniewski H M, 1973, Prog Brain Res, V40, P167; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V77, P113; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	77	144	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1995	14	2					447	456		10.1016/0896-6273(95)90300-3	http://dx.doi.org/10.1016/0896-6273(95)90300-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857652	Bronze			2022-12-17	WOS:A1995QH29400022
J	HERLITZE, S; RADITSCH, M; RUPPERSBERG, JP; JAHN, W; MONYER, H; SCHOEPFER, R; WITZEMANN, V				HERLITZE, S; RADITSCH, M; RUPPERSBERG, JP; JAHN, W; MONYER, H; SCHOEPFER, R; WITZEMANN, V			ARGIOTOXIN DETECTS MOLECULAR DIFFERENCES IN AMPA RECEPTOR CHANNELS	NEURON			English	Article							FUNCTIONAL EXPRESSION; GLUTAMATE RECEPTORS; CA2+ PERMEABILITY; SPIDER TOXINS; NMDA RECEPTOR; VENOM; ACID; CLONING; FAMILY; TRANSMISSION	Argiotoxin, a component of the spider venom from Argiope lobata, blocks AMPA receptor channels expressed in homomeric and heteromeric configuration in Xenopus oocytes. Argiotoxin acts as an open channel blocker in a voltage-dependent manner and discriminates between the functionally diverse AMPA receptors. Importantly, a transmembrane region 2 determinant for divalent cation permeability also determines argiotoxin sensitivity. Subunit-specific differences in the time courses of block and recovery demonstrate that heteromeric AMPA receptors can assemble in variable ratios. Thus, argiotoxin can be used as a tool in analyzing the subunit composition of AMPA receptors in native membranes.	MAX PLANCK INST MED RES,BIOPHYS ABT,W-6900 HEIDELBERG 1,GERMANY; UNIV HEIDELBERG,CTR MOLEC BIOL,MOLEC NEUROSCI LAB,W-6900 HEIDELBERG,GERMANY	Max Planck Society; Ruprecht Karls University Heidelberg	HERLITZE, S (corresponding author), MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,JAHNSTR 29,W-6900 HEIDELBERG 1,GERMANY.							ADAMS ME, 1987, BIOCHEM BIOPH RES CO, V148, P678, DOI 10.1016/0006-291X(87)90930-2; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; BURNASHEV N, 1992, NEURON, V256, P1566; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DRAGUHN A, 1991, NEUROSCI LETT, V132, P187, DOI 10.1016/0304-3940(91)90298-8; ELDEFRAWI AT, 1988, P NATL ACAD SCI USA, V85, P4910, DOI 10.1073/pnas.85.13.4910; GRISHIN EV, 1986, BIOORG KHIM+, V12, P1121; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JACKSON H, 1988, TRENDS NEUROSCI, V11, P278, DOI 10.1016/0166-2236(88)90112-9; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; KAWAI N, 1991, COMP BIOCHEM PHYS C, V98, P87, DOI 10.1016/0742-8413(91)90185-V; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MISHINA M, 1991, BIOCHEM BIOPH RES CO, V180, P813, DOI 10.1016/S0006-291X(05)81137-4; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MUELLER AL, 1991, SYNAPSE, V9, P244, DOI 10.1002/syn.890090403; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PARKS TN, 1991, J BIOL CHEM, V266, P21523; PRIESTLEY T, 1989, BRIT J PHARMACOL, V97, P1315, DOI 10.1111/j.1476-5381.1989.tb12594.x; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	31	144	149	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1131	1140		10.1016/0896-6273(93)90061-U	http://dx.doi.org/10.1016/0896-6273(93)90061-U			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	7686380				2022-12-17	WOS:A1993LK37300013
J	FURSHPAN, EJ; POTTER, DD				FURSHPAN, EJ; POTTER, DD			SEIZURE-LIKE ACTIVITY AND CELLULAR-DAMAGE IN RAT HIPPOCAMPAL-NEURONS IN CELL-CULTURE	NEURON			English	Article											FURSHPAN, EJ (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA.				NINDS NIH HHS [NS02253] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVOLI M, 1987, NEUROSCI LETT, V76, P249, DOI 10.1016/0304-3940(87)90724-5; BALDINO F, 1986, NEUROSCI LETT, V70, P101, DOI 10.1016/0304-3940(86)90445-3; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BOTTENSTEIN JE, 1980, EXP CELL RES, V125, P183, DOI 10.1016/0014-4827(80)90202-5; BRENNEMAN DE, 1983, DEV BRAIN RES, V9, P13, DOI 10.1016/0165-3806(83)90104-9; CHOI DW, 1987, J NEUROSCI, V7, P357; CROUCHER MJ, 1982, SCIENCE, V216, P899, DOI 10.1126/science.7079744; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; DICHTER M, 1969, J NEUROPHYSIOL, V32, P663, DOI 10.1152/jn.1969.32.5.663; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; ERECINSKA M, 1987, BIOCHEM PHARMACOL, V36, P3547, DOI 10.1016/0006-2952(87)90001-3; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; FUTAMACHI KJ, 1974, BRAIN RES, V75, P5, DOI 10.1016/0006-8993(74)90767-7; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HABLITZ JJ, 1987, J NEUROPHYSIOL, V58, P1052, DOI 10.1152/jn.1987.58.5.1052; HAGLUND MM, 1984, DEV BRAIN RES, V14, P51, DOI 10.1016/0165-3806(84)90008-7; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hawrot E, 1979, Methods Enzymol, V58, P574; HERRON CE, 1985, NEUROSCI LETT, V61, P255, DOI 10.1016/0304-3940(85)90473-2; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; JOHNSTON D, 1981, SCIENCE, V211, P294, DOI 10.1126/science.7444469; KANDEL ER, 1961, EXP NEUROL, V4, P162, DOI 10.1016/0014-4886(61)90038-3; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MATSUMOTO H, 1964, EXP NEUROL, V9, P286, DOI 10.1016/0014-4886(64)90025-1; MATSUMOTO H, 1964, EXP NEUROL, V9, P305, DOI 10.1016/0014-4886(64)90026-3; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; NEWBERRY NR, 1984, J PHYSIOL-LONDON, V348, P239, DOI 10.1113/jphysiol.1984.sp015107; Nicholson C, 1981, APPLICATION ION SELE, P217; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; Olney J W, 1986, Adv Neurol, V44, P857; OLNEY JW, 1981, NEUROSCI LETT, V25, P185, DOI 10.1016/0304-3940(81)90329-3; OLNEY JW, 1971, J NEUROPATH EXP NEUR, V30, P75, DOI 10.1097/00005072-197101000-00008; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; RUTECKI PA, 1985, J NEUROPHYSIOL, V54, P1363, DOI 10.1152/jn.1985.54.5.1363; SAGAR HJ, 1987, ANN NEUROL, V22, P334, DOI 10.1002/ana.410220309; SEGAL M, 1983, J NEUROPHYSIOL, V50, P1249, DOI 10.1152/jn.1983.50.6.1249; Siesjo B K, 1986, Adv Neurol, V44, P813; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; SOMJEN GG, 1985, J NEUROPHYSIOL, V53, P1079, DOI 10.1152/jn.1985.53.4.1079; TECOMA ES, 1989, NEUROLOGY, V39, P676, DOI 10.1212/WNL.39.5.676; THALMANN RH, 1988, J NEUROSCI, V8, P4589; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P739, DOI 10.1152/jn.1987.58.4.739; VANHARREVELD A, 1959, J NEUROCHEM, V3, P300; VANHARREVELD A, 1984, J NEUROBIOL, V15, P333, DOI 10.1002/neu.480150504	51	144	145	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1989	3	2					199	207		10.1016/0896-6273(89)90033-0	http://dx.doi.org/10.1016/0896-6273(89)90033-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM324	2560392				2022-12-17	WOS:A1989AM32400007
J	THOMPSON, MA; ZIFF, EB				THOMPSON, MA; ZIFF, EB			STRUCTURE OF THE GENE ENCODING PERIPHERIN, AN NGF-REGULATED NEURONAL-SPECIFIC TYPE-III INTERMEDIATE FILAMENT PROTEIN	NEURON			English	Article									NYU MED CTR, KAPLAN CANC CTR, NEW YORK, NY 10016 USA	New York University	THOMPSON, MA (corresponding author), NYU MED CTR, DEPT BIOCHEM, NEW YORK, NY 10016 USA.			Ziff, Edward/0000-0001-7389-8649	NATIONAL CANCER INSTITUTE [P01CA016239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM011981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH035976] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA16239] Funding Source: Medline; NIGMS NIH HHS [GM11981-02] Funding Source: Medline; NIMH NIH HHS [MH 35976] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALETTA JM, 1988, IN PRESS J NEUROCHEM; ALTMAN J, 1980, J COMP NEUROL, V194, P37, DOI 10.1002/cne.901940103; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; BAKER CC, 1981, J MOL BIOL, V149, P189, DOI 10.1016/0022-2836(81)90298-9; BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BENNETT GS, 1987, CURR TOP DEV BIOL, V21, P151; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; BLUMENBERG M, 1988, IN PRESS MOL BIOL EV; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CALABRETTA B, 1986, J BIOL CHEM, V261, P2628; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COSTA RH, 1988, P NATL ACAD SCI USA, V85, P3840, DOI 10.1073/pnas.85.11.3840; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRARI S, 1987, J BIOL CHEM, V262, P8325; FRANKE WW, 1986, J CELL BIOL, V103, P1933, DOI 10.1083/jcb.103.5.1933; FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7; GEISLER N, 1983, EMBO J, V2, P1295, DOI 10.1002/j.1460-2075.1983.tb01584.x; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P327, DOI 10.1093/nar/14.1.327; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; JULIEN JP, 1987, GENE DEV, V1, P1085, DOI 10.1101/gad.1.10.1085; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDIS SC, 1981, TRENDS NEUROSCI, V4, P172, DOI 10.1016/0166-2236(81)90056-4; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LEE VMY, 1984, J NEUROSCI, V4, P1705; LEES JF, 1988, EMBO J, V7, P1947, DOI 10.1002/j.1460-2075.1988.tb03032.x; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Levi-Montalcini R, 1976, Prog Brain Res, V45, P235, DOI 10.1016/S0079-6123(08)60993-0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LEVY E, 1987, EUR J BIOCHEM, V166, P71, DOI 10.1111/j.1432-1033.1987.tb13485.x; LEWIS SA, 1986, MOL CELL BIOL, V6, P1529, DOI 10.1128/MCB.6.5.1529; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; PARYSEK LM, 1988, J NEUROSCI, V8, P555; PIEPER FR, 1987, EMBO J, V6, P3611, DOI 10.1002/j.1460-2075.1987.tb02692.x; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P215, DOI 10.1159/000112348; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; PORTIER MM, 1983, CR ACAD SCI III-VIE, V297, P57; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; QUAX W, 1985, CELL, V43, P327, DOI 10.1016/0092-8674(85)90038-8; QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; WEBER K, 1983, COLD SPRING HARB SYM, V48, P717, DOI 10.1101/SQB.1983.048.01.075; YOSHIHARA CM, 1987, NUCLEIC ACIDS RES, V15, P753, DOI 10.1093/nar/15.2.753; ZEHNER ZE, 1987, J BIOL CHEM, V262, P8112	75	144	146	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1989	2	1					1043	1053		10.1016/0896-6273(89)90228-6	http://dx.doi.org/10.1016/0896-6273(89)90228-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R8949	2624740				2022-12-17	WOS:A1989R894900003
J	Cooper, KW; Brann, DH; Farruggia, MC; Bhutani, S; Pellegrino, R; Tsukahara, T; Weinreb, C; Joseph, PV; Larson, ED; Parma, V; Albers, MW; Barlow, LA; Datta, SR; Di Pizio, A				Cooper, Keiland W.; Brann, David H.; Farruggia, Michael C.; Bhutani, Surabhi; Pellegrino, Robert; Tsukahara, Tatsuya; Weinreb, Caleb; Joseph, Paule V.; Larson, Eric D.; Parma, Valentina; Albers, Mark W.; Barlow, Linda A.; Datta, Sandeep Robert; Di Pizio, Antonella			COVID-19 and the Chemical Senses: Supporting Players Take Center Stage	NEURON			English	Review							RESPIRATORY SYNDROME CORONAVIRUS; ANGIOTENSIN-CONVERTING ENZYME-2; MOUSE HEPATITIS-VIRUS; OLFACTORY EPITHELIUM; CHRONIC RHINOSINUSITIS; SARS CORONAVIRUS; FUNCTIONAL RECEPTOR; MURINE CORONAVIRUS; CHEMOSENSORY CELLS; SPIKE PROTEIN	The main neurological manifestation of COVID-19 is loss of smell or taste. The high incidence of smell loss without significant rhinorrhea or nasal congestion suggests that SARS-CoV-2 targets the chemical senses through mechanisms distinct from those used by endemic coronaviruses or other common cold-causing agents. Here we review recently developed hypotheses about how SARS-CoV-2 might alter the cells and cir-cuits involved in chemosensory processing and thereby change perception. Given our limited understanding of SARS-CoV-2 pathogenesis, we propose future experiments to elucidate disease mechanisms and high-light the relevance of this ongoing work to understanding how the virus might alter brain function more broadly.	[Cooper, Keiland W.] Univ Calif Irvine, Interdept Neurosci Program, Irvine, CA USA; [Brann, David H.; Tsukahara, Tatsuya; Weinreb, Caleb; Datta, Sandeep Robert] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Farruggia, Michael C.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Bhutani, Surabhi] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA; [Pellegrino, Robert] Univ Tennessee, Inst Agr, Dept Food Sci, Knoxville, TN 37901 USA; [Pellegrino, Robert] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Joseph, Paule V.] NINR, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Joseph, Paule V.] NIAAA, NIH, Bethesda, MD USA; [Larson, Eric D.] Univ Colorado, Dept Otolaryngol, Anschutz Med Campus, Aurora, CO USA; [Larson, Eric D.] Rocky Mt Taste & Smell Ctr, Aurora, CO USA; [Parma, Valentina] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Albers, Mark W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Barlow, Linda A.] Univ Colorado, Sch Med, Grad Program Cell Biol Stem Cells & Dev, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO 80045 USA; [Barlow, Linda A.] Univ Colorado, Sch Med, Rocky Mt Taste & Smell Ctr, Anschutz Med Campus, Aurora, CO 80045 USA; [Di Pizio, Antonella] Tech Univ Munich, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany	University of California System; University of California Irvine; Harvard University; Harvard Medical School; Yale University; California State University System; San Diego State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Massachusetts General Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich	Datta, SR (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Barlow, LA (corresponding author), Univ Colorado, Sch Med, Grad Program Cell Biol Stem Cells & Dev, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO 80045 USA.; Barlow, LA (corresponding author), Univ Colorado, Sch Med, Rocky Mt Taste & Smell Ctr, Anschutz Med Campus, Aurora, CO 80045 USA.; Di Pizio, A (corresponding author), Tech Univ Munich, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany.	linda.barlow@cuanschutz.edu; srdatta@hms.harvard.edu; a.dipizio.leibniz-lsb@tum.de	Cooper, Keiland/AAS-5426-2020; Bhutani, Surabhi/ABB-5063-2021; Albers, Mark/AAK-8718-2021; Di Pizio, Antonella/ABC-6792-2020; Joseph, Paule/N-2701-2013; Tsukahara, Tatsuya/AAO-1707-2021; Parma, Valentina/K-3268-2016	Cooper, Keiland/0000-0002-0358-9645; Albers, Mark/0000-0001-7855-3455; Di Pizio, Antonella/0000-0002-8520-5165; Joseph, Paule/0000-0002-1198-9622; Tsukahara, Tatsuya/0000-0002-6928-8562; Datta, Sandeep/0000-0002-8068-3862; Parma, Valentina/0000-0003-0276-7072	National Institutes of Health [R011DC016222, U19NS112953]; Simons Collaboration on the Global Brain; UCI INP; NIDCD [K23 DC014747, R01 DC012555, R01 DC017679, R01 DC014253]; Yale Medical School Fellowship; National Institute of Nursing Research [1ZIANR000035-01]; Office of Workforce Diversity, National Institutes of Health; Rockefeller University Heilbrunn Nurse Scholar Award; NSF Graduate Research Fellowship;  [R01 DC012383];  [R21 CA236480]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Collaboration on the Global Brain; UCI INP; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Yale Medical School Fellowship; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Office of Workforce Diversity, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Heilbrunn Nurse Scholar Award; NSF Graduate Research Fellowship(National Science Foundation (NSF)); ; 	The authors would like to thank the Global Consortium for Chemosensory Research (GCCR) for facilitating the collaborative environment in which this manuscript was conceived. S.R.D. is supported by grants R011DC016222 and U19NS112953 from the National Institutes of Health and by the Simons Collaboration on the Global Brain. L.A.B. is supported by grants R01 DC012383 and R21 CA236480. K.W.C. gratefully acknowledges support from UCI INP. E.D.L. is supported by NIDCD K23 DC014747 to V. Ramakrishnan, R01s DC012555 and DC017679 to S. Kinnamon, and R01 DC014253 to D. Restrepo. M.C.F. is supported by the Yale Medical School Fellowship. P.V.J. is supported by the National Institute of Nursing Research under award number 1ZIANR000035-01. P.V.J. is also supported by the Office of Workforce Diversity, National Institutes of Health, and the Rockefeller University Heilbrunn Nurse Scholar Award. D.H.B. is supported by an NSF Graduate Research Fellowship.	Adamczyk K., 2020, SENSITIVITY SPECIFIC, V2, P196, DOI [10.1101/2020.05.31.20118380, DOI 10.1101/2020.05.31.20118380]; AKERLUND A, 1995, ACTA OTO-LARYNGOL, V115, P88, DOI 10.3109/00016489509133353; Ansari MA, 2020, GENE LOCUS CONTROLS, DOI [10.1101/2020.04.26.20080408, DOI 10.1101/2020.04.26.20080408]; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Barlow LA, 2015, DEVELOPMENT, V142, P3620, DOI 10.1242/dev.120394; Barlow LA, 2015, CURR TOP DEV BIOL, V111, P401, DOI 10.1016/bs.ctdb.2014.11.012; BARNETT EM, 1993, VIROLOGY, V194, P185, DOI 10.1006/viro.1993.1248; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Baxter B Dnate', 2020, bioRxiv, DOI 10.1101/2020.05.14.096016; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Benezit F, 2020, LANCET INFECT DIS, V20, P1014, DOI 10.1016/S1473-3099(20)30297-8; Bergstrom U, 2003, TOXICOL PATHOL, V31, P379, DOI 10.1080/01926230390201101; Besser G, 2020, INT FORUM ALLERGY RH, V10, P713, DOI 10.1002/alr.22549; Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586; Bilinska K, 2020, ACS CHEM NEUROSCI, V11, P1555, DOI 10.1021/acschemneuro.0c00210; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Bryche B, 2020, BRAIN BEHAV IMMUN, V89, P579, DOI 10.1016/j.bbi.2020.06.032; Buccitelli C, 2020, NAT REV GENET, V21, P630, DOI 10.1038/s41576-020-0258-4; Butler N, 2006, VIROLOGY, V347, P410, DOI 10.1016/j.virol.2005.11.044; Cantuti-Castelvetri L., 2020, BIORXIV, DOI [10.1101/2020.06.07.137802, DOI 10.1101/2020.06.07.137802]; Cavazzana A, 2018, LARYNGOSCOPE, V128, P10, DOI 10.1002/lary.26606; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078; Chen Mengfei, 2020, bioRxiv, DOI [10.1183/13993003.01948-2020, 10.1101/2020.05.08.084996]; Chen MF, 2019, CELL STEM CELL, V25, P501, DOI 10.1016/j.stem.2019.08.011; Chen R., 2020, NEUROSCIENCE, DOI [10.1101/2020.04.07.030650, 10.1101/2020.04.07.030650., DOI 10.1101/2020.04.07.030650]; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Choi R, 2018, LARYNGOSCOPE INVEST, V3, P35, DOI 10.1002/lio2.135; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; Coolen T, 2020, NEUROLOGY, V95, pE2016, DOI 10.1212/WNL.0000000000010116; Cowley TJ, 2010, J NEUROVIROL, V16, P427, DOI 10.3109/13550284.2010.529238; Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805; Dalton P, 2004, CURR ALLERGY ASTHM R, V4, P230, DOI 10.1007/s11882-004-0031-3; Damm M, 2002, CHEM SENSES, V27, P831, DOI 10.1093/chemse/27.9.831; DEAR TN, 1991, EMBO J, V10, P2813, DOI 10.1002/j.1460-2075.1991.tb07830.x; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Dube M, 2018, J VIROL, V92, DOI 10.1128/JVI.00404-18; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Durante MA, 2020, NAT NEUROSCI, V23, P323, DOI 10.1038/s41593-020-0587-9; Durrant DM, 2016, ACS CHEM NEUROSCI, V7, P464, DOI 10.1021/acschemneuro.6b00043; Dvoryanchikov G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01095-1; Eliezer M, 2020, JAMA OTOLARYNGOL, V146, P674, DOI 10.1001/jamaoto.2020.0832; Farhadian S, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01812-2; Feng P, 2014, CHEM SENSES, V39, P3, DOI 10.1093/chemse/bjt059; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fodoulian L., 2020, BIORXIV, DOI [10.14.339259, 10.1101/2020.03.31.013268]; Fontanet A, 2020, CLUSTER COVID 19 NO, DOI [10.1101/2020.04.18.20071134, DOI 10.1101/2020.04.18.20071134]; Frasnelli J., 2017, SPRINGER HDB ODOR, P113; Gaillard D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005208; Gallagher PE, 2006, AM J PHYSIOL-CELL PH, V290, pC420, DOI 10.1152/ajpcell.00409.2004; Galougahi MK, 2020, ACAD RADIOL, V27, P892, DOI 10.1016/j.acra.2020.04.002; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Gowrisankar YV, 2016, MOL CELL ENDOCRINOL, V437, P130, DOI 10.1016/j.mce.2016.08.013; Gulbransen BD, 2008, J NEUROPHYSIOL, V99, P2929, DOI 10.1152/jn.00066.2008; Gussing F, 2004, EUR J NEUROSCI, V19, P2511, DOI 10.1111/j.0953-816X.2004.03331.x; Haehner A, 2020, ORL J OTO-RHINO-LARY, V82, P175, DOI 10.1159/000509143; Hamamichi R, 2006, NEUROSCIENCE, V141, P2129, DOI 10.1016/j.neuroscience.2006.05.061; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Han Q, 2020, TASTE CELL IS ABUNDA, DOI [10.20944/preprints202004.0424.v1, DOI 10.20944/PREPRINTS202004.0424.V1, 10.20944/ preprints202004.0424.v1]; He L., 2020, PERICYTE SPECIFIC VA, DOI [10.1101/2020.05.11.088500., 10.1101/2020.05.11.088500v2]; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Herrick DB, 2017, P NATL ACAD SCI USA, V114, pE5589, DOI 10.1073/pnas.1701333114; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hopkins C, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00423-8; HORNUSS D, 2020, CLIN MICROBIOL INFEC, V26, P1426, DOI DOI 10.1016/J.CMI.2020.05.017; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Hummel T, 1998, ANN NY ACAD SCI, V855, P616, DOI 10.1111/j.1749-6632.1998.tb10632.x; Hummel T, 1998, EUR J CLIN PHARMACOL, V54, P521, DOI 10.1007/s002280050507; Hung ECW, 2003, CLIN CHEM, V49, P2108, DOI 10.1373/clinchem.2003.025437; Hwang Chi-Shin, 2006, Acta Neurol Taiwan, V15, P26; Iravani B., 2020, RELATIONSHIP ODOR IN, DOI [10.1101/2020.05.07.20094516, DOI 10.1101/2020.05.07.20094516]; Jafek BW., 1990, AM J RHINOL, V4, P91, DOI [10.2500/105065890782009497, DOI 10.2500/105065890782009497]; Kang Yuan-Lin, 2020, Proc Natl Acad Sci U S A, V117, P20803, DOI [10.1101/2020.04.21.053058, 10.1073/pnas.2007837117]; Kaufman A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2001959; Kaye R, 2020, OTOLARYNG HEAD NECK, V163, P132, DOI 10.1177/0194599820922992; Kehoe PG, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0217-7; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035588; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Laurendon T, 2020, NEUROLOGY, V95, P224, DOI 10.1212/WNL.0000000000009850; Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Lee H, 2017, NATURE, V548, P330, DOI 10.1038/nature23299; Lemons K, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0135-17.2017; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Liang FY, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050493; Liu HX, 2013, DEV BIOL, V382, P82, DOI 10.1016/j.ydbio.2013.07.022; Lu L, 2020, EPILEPSIA, V61, pE49, DOI 10.1111/epi.16524; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Meinhardt J, 2020, OLFACTORY TRANSMUCOS, DOI 10.1101/2020.06.04.135012; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587; Morris M, 2020, AM J NEURORADIOL, V41, pE37, DOI 10.3174/ajnr.A6551; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Mygind N, 1998, ADV DRUG DELIVER REV, V29, P3, DOI 10.1016/S0169-409X(97)00058-6; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Nguyen MQ, 2019, ELIFE, V8, DOI 10.7554/eLife.49679; Nguyen MQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185543; O'Leary CE, 2019, ANNU REV IMMUNOL, V37, P47, DOI 10.1146/annurev-immunol-042718-041505; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Parma V, 2020, CHEM SENSES, V45, P609, DOI 10.1093/chemse/bjaa041; Pellegrino R, 2020, CHEM SENSES, V45, P415, DOI 10.1093/chemse/bjaa031; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; PERLMAN S, 1989, VIROLOGY, V170, P556, DOI 10.1016/0042-6822(89)90446-7; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pisco A.O., 2020, ASINGLE CELL TRANSCR, DOI 10.1101/6617828; Politi LS, 2020, JAMA NEUROL, V77, P1028, DOI 10.1001/jamaneurol.2020.2125; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Prescott SL, 2020, CELL, V181, P574, DOI 10.1016/j.cell.2020.03.004; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Qin YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007058; Qiu CH, 2020, OTOLARYNG HEAD NECK, V163, P714, DOI [10.1177/0194599820934376, 10.1101/2020.05.13.20100198]; Ramani A, 2020, EMBO J, V39, DOI 10.15252/embj.2020106230; Rodriguez Steve, 2020, medRxiv, DOI 10.1101/2020.06.14.20131128; Romanov RA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1815; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; Roper SD, 2014, HANDB EXP PHARMACOL, V223, P827, DOI 10.1007/978-3-319-05161-1_5; Rowan NR, 2015, AM J RHINOL ALLERGY, V29, pE197, DOI 10.2500/ajra.2015.29.4242; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schlosser RJ, 2016, JAMA OTOLARYNGOL, V142, P731, DOI 10.1001/jamaoto.2016.0927; Schwob JE, 2017, J COMP NEUROL, V525, P1034, DOI 10.1002/cne.24105; Schwob JE, 2001, CHEM SENSES, V26, P937, DOI 10.1093/chemse/26.8.937; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shigemura N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092251; Shoer S., 2020, WHO SHOULD WE TEST C, DOI [10.1101/2020.05.18.20105569, DOI 10.1101/2020.05.18.20105569]; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Solbu TT, 2012, CHEM SENSES, V37, P35, DOI 10.1093/chemse/bjr063; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Suzuki M, 2007, LARYNGOSCOPE, V117, P272, DOI 10.1097/01.mlg.0000249922.37381.1e; Suzuki Y, 1996, J COMP NEUROL, V376, P509, DOI 10.1002/(SICI)1096-9861(19961223)376:4<509::AID-CNE1>3.0.CO;2-5; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Torabi A, 2020, ACS CHEM NEUROSCI, V11, P1909, DOI 10.1021/acschemneuro.0c00249; Trotier D, 2007, CHEM SENSES, V32, P285, DOI 10.1093/chemse/bjl057; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Ualiyeva S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax7224; Ueha R, 2020, BIORXIV, DOI DOI 10.1101/2020.05.15.097352; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1252, DOI 10.1002/hed.26204; van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461; Vandenbeuch A, 2013, P NATL ACAD SCI USA, V110, P14789, DOI 10.1073/pnas.1309468110; Venkatakrishnan AJ, 2020, ELIFE, V9, DOI 10.7554/eLife.58040; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Victores AJ, 2018, INT FORUM ALLERGY RH, V8, P415, DOI 10.1002/alr.22053; Vogalis F, 2005, J PHYSIOL-LONDON, V562, P785, DOI 10.1113/jphysiol.2004.079228; Wagner T., 2020, AUGMENTED CURATION C, DOI [10.1101/2020.04.19, DOI 10.1101/2020.04.19.20067660, 10.1101/2020.04.19.20067660]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; Wang H, 2009, ANN NY ACAD SCI, V1170, P596, DOI 10.1111/j.1749-6632.2009.04480.x; [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1; Welge-Lussen A, 2006, ADV OTO-RHINO-LARYNG, V63, P125, DOI 10.1159/000093758; Welge-Lussen Antje, 2005, GMS Curr Top Otorhinolaryngol Head Neck Surg, V4, pDoc06; Whitcroft KL, 2020, JAMA-J AM MED ASSOC, V323, P2512, DOI 10.1001/jama.2020.8391; Wood AJ, 2011, INT FORUM ALLERGY RH, V1, P95, DOI 10.1002/alr.20030; Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-x, 10.1038/s41368-020-0074-X]; Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461; Yan CH., 2020, INT FORUM ALLERGY RH, V10, P806, DOI [10.1002/alr.22579, DOI 10.1002/alr.22579]; Yang RB, 2020, J COMP NEUROL, V528, P756, DOI 10.1002/cne.24779; Yang XH, 2007, COMPARATIVE MED, V57, P450; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zhang J, 2019, CELL, V179, P392, DOI 10.1016/j.cell.2019.08.031; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033; Zhao K, 2014, INT FORUM ALLERGY RH, V4, P298, DOI 10.1002/alr.21272; Zhao XS, 2020, J VIROL, V94, DOI 10.1128/JVI.00940-20; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37	197	143	149	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2020	107	2					219	233		10.1016/j.neuron.2020.06.032	http://dx.doi.org/10.1016/j.neuron.2020.06.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MO2RX	32640192	Green Published, Bronze			2022-12-17	WOS:000551380900008
J	Pan, BF; Akyuz, N; Liu, XP; Asai, Y; Nist-Lund, C; Kurima, K; Derfler, BH; Gyorgy, B; Limapichat, W; Walujkar, S; Wimalasena, LN; Sotomayor, M; Corey, DP; Holt, JR				Pan, Bifeng; Akyuz, Nurunisa; Liu, Xiao-Ping; Asai, Yukako; Nist-Lund, Carl; Kurima, Kiyoto; Derfler, Bruce H.; Gyorgy, Bence; Limapichat, Walrati; Walujkar, Sanket; Wimalasena, Lahiru N.; Sotomayor, Marcos; Corey, David P.; Holt, Jeffrey R.			TMC1 Forms the Pore of Mechanosensory Transduction Channels in Vertebrate Inner Ear Hair Cells	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; HIDDEN MARKOV MODEL; TIP-LINK; TOPOLOGY PREDICTION; MECHANOELECTRICAL-TRANSDUCTION; MECHANOTRANSDUCTION CHANNEL; MOLECULAR-DYNAMICS; LIGHT-SCATTERING; PROTEINS; WEB	The proteins that form the permeation pathway of mechanosensory transduction channels in inner-ear hair cells have not been definitively identified. Genetic, anatomical, and physiological evidence support a role for transmembrane channel-like protein (TMC) 1 in hair cell sensory transduction, yet the molecular function of TMC proteins remains unclear. Here, we provide biochemical evidence suggesting TMC1 assembles as a dimer, along with structural and sequence analyses suggesting similarity to dimeric TMEM16 channels. To identify the pore region of TMC1, we used cysteine mutagenesis and expressed mutant TMC1 in hair cells of Tmc1/2-null mice. Cysteine-modification reagents rapidly and irreversibly altered permeation properties of mechanosensory transduction. We propose that TMC1 is structurally similar to TMEM16 channels and includes ten transmembrane domains with four domains, S4-S7, that line the channel pore. The data provide compelling evidence that TMC1 is a pore-forming component of sensory transduction channels in auditory and vestibular hair cells.	[Pan, Bifeng; Liu, Xiao-Ping; Asai, Yukako; Nist-Lund, Carl; Holt, Jeffrey R.] Boston Childrens Hosp, Dept Otolaryngol, Boston, MA 02115 USA; [Pan, Bifeng; Liu, Xiao-Ping; Asai, Yukako; Nist-Lund, Carl; Holt, Jeffrey R.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Pan, Bifeng; Liu, Xiao-Ping; Asai, Yukako; Nist-Lund, Carl; Holt, Jeffrey R.] Harvard Med Sch, Boston, MA 02115 USA; [Akyuz, Nurunisa; Derfler, Bruce H.; Gyorgy, Bence; Limapichat, Walrati; Corey, David P.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Akyuz, Nurunisa; Derfler, Bruce H.; Gyorgy, Bence; Limapichat, Walrati; Corey, David P.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Kurima, Kiyoto] Natl Inst Deafness & Other Commun Disorders, Mol Biol & Genet Sect, NIH, Bethesda, MD 20892 USA; [Walujkar, Sanket; Wimalasena, Lahiru N.; Sotomayor, Marcos] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University System of Ohio; Ohio State University	Holt, JR (corresponding author), Boston Childrens Hosp, Dept Otolaryngol, Boston, MA 02115 USA.; Holt, JR (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.; Holt, JR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Corey, DP (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Corey, DP (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.	dcorey@hms.harvard.edu; jeffrey.holt@childrens.harvard.edu	Sotomayor, Marcos/J-4898-2012; Sotomayor, Marcos/T-2411-2019	Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805; Walujkar, Sanket/0000-0002-5892-4578; Akyuz, Nurunisa/0000-0002-6340-1915; Nist-Lund, Carl/0000-0002-0224-7387	Boston Children's Hospital (BCH) Viral Core (BCH Intellectual and Developmental Disabilities Research Center [IDDRC]) [1U54HD090255]; NIH/NIDCD (National Institute for Deafness and Communication Disorders) [R01-DC013521, R01-DC000304, R01 DC015271, F32 DC016210]; NIDCD intramural research fund [Z01-DC000060-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304, F32DC016210, R01DC015271, R01DC013521] Funding Source: NIH RePORTER	Boston Children's Hospital (BCH) Viral Core (BCH Intellectual and Developmental Disabilities Research Center [IDDRC]); NIH/NIDCD (National Institute for Deafness and Communication Disorders); NIDCD intramural research fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs. Andrew Griffith, Criss Hartzell, Jonathan Cohen, Gary Yellen, and Hiroshi Suzuki and members of Holt/Geleoc and Corey laboratories for many helpful discussions and critical review of a prior version of the manuscript. We thank the Boston Children's Hospital (BCH) Viral Core (BCH Intellectual and Developmental Disabilities Research Center [IDDRC], grant no. 1U54HD090255), Dr. Chen Xu for extensive training on electron microscopy, Dr. Kelly Arnett for SEC-MALS training and discussions, Dr. Tomaino Ross for mass spectrometry analysis, and Dr. Debora Marks for EV-coupling analysis. Molecular dynamics simulations were carried out using the Texas Advanced Computing Center (TACC)-Stampede2 (XSEDE XRAC MCB140226) and Ohio Supercomputing Center (OSC) supercomputers (PAS1037). This work was supported by NIH/NIDCD (National Institute for Deafness and Communication Disorders) grants R01-DC013521 (J.R.H.), R01-DC000304 (D.P.C.), R01 DC015271 (M.S.), and F32 DC016210 (N.A.). B.G. was an Edward R. and Anne G. Lefler Center Postdoctoral Fellow. K.K. was supported by an NIDCD intramural research fund Z01-DC000060-10 (A.J. Griffith).	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; [Anonymous], 2008, BMC BIOINFORMATICS; Askew C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1996; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Corey DP, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033506; Corey DP, 2016, J NEUROSCI, V36, P10921, DOI 10.1523/JNEUROSCI.1148-16.2016; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Corns LF, 2016, J NEUROSCI, V36, P336, DOI 10.1523/JNEUROSCI.2439-15.2016; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Davies KTJ, 2012, HEREDITY, V108, P480, DOI 10.1038/hdy.2011.119; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Erickson T, 2017, ELIFE, V6, DOI 10.7554/eLife.28474; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fasman G.D., 1989, PRACTICAL HDB BIOCH; Fettiplace R, 2016, BIOPHYS J, V111, P3, DOI 10.1016/j.bpj.2016.05.032; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Geertsma ER, 2015, NAT STRUCT MOL BIOL, V22, P803, DOI 10.1038/nsmb.3091; Gillespie PG, 2005, CURR OPIN NEUROBIOL, V15, P389, DOI 10.1016/j.conb.2005.06.007; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Gorbunov D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4622; Guo YM, 2016, P NATL ACAD SCI USA, V113, P7243, DOI 10.1073/pnas.1606537113; Hahn Y, 2009, INT J MOL MED, V24, P51, DOI 10.3892/ijmm_00000205; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hoger U, 1999, BRAIN RES, V826, P230, DOI 10.1016/S0006-8993(99)01276-7; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kawashima Y, 2015, PFLUG ARCH EUR J PHY, V467, P85, DOI 10.1007/s00424-014-1582-3; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; Maeda R, 2014, P NATL ACAD SCI USA, V111, P12907, DOI 10.1073/pnas.1402152111; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Medrano-Soto A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192851; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Nashmi R, 2003, J NEUROSCI, V23, P11554; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Park E, 2017, NATURE, V541, P500, DOI 10.1038/nature20812; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Peters C, 2016, BIOINFORMATICS, V32, P1158, DOI 10.1093/bioinformatics/btv709; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; RUSCH A, 1994, J PHYSIOL-LONDON, V474, P75; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; Whitlock JM, 2016, PFLUG ARCH EUR J PHY, V468, P455, DOI 10.1007/s00424-015-1777-2; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Wu C.S., 2004, HDB SIZE EXCLUSION C; Wu ZZ, 2016, J NEUROSCI, V36, P10927, DOI 10.1523/JNEUROSCI.1149-16.2016; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	83	143	145	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 22	2018	99	4					736	+		10.1016/j.neuron.2018.07.033	http://dx.doi.org/10.1016/j.neuron.2018.07.033			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR1YF	30138589	Green Accepted, Bronze			2022-12-17	WOS:000442351600012
J	Soukup, SF; Kuenen, S; Vanhauwaert, R; Manetsberger, J; Hernandez-Diaz, S; Swerts, J; Schoovaerts, N; Vilain, S; Gounko, NV; Vints, K; Geens, A; De Strooper, B; Verstreken, P				Soukup, Sandra-Fausia; Kuenen, Sabine; Vanhauwaert, Roeland; Manetsberger, Julia; Hernandez-Diaz, Sergio; Swerts, Jef; Schoovaerts, Nils; Vilain, Sven; Gounko, Natalia V.; Vints, Katlijn; Geens, Ann; De Strooper, Bart; Verstreken, Patrik			A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE ENDOCYTOSIS; SPORADIC PARKINSONS-DISEASE; MEMBRANE-CURVATURE; AUTOPHAGOSOME BIOGENESIS; ELECTRON-MICROSCOPY; GENE PROMOTER; PROTEINS; CLATHRIN; DOMAIN	Synapses are often far from the soma and independently cope with proteopathic stress induced by intense neuronal activity. However, how presynaptic compartments turn over proteins is poorly understood. We show that the synapse-enriched protein EndophilinA, thus far studied for its role in endocytosis, induces macroautophagy at presynaptic terminals. We find that EndophilinA executes this unexpected function at least partly independent of its role in synaptic vesicle endocytosis. EndophilinA-induced macroautophagy is activated when the kinase LRRK2 phosphorylates the EndophilinA-BAR domain and is blocked in animals where EndophilinA cannot be phosphorylated. EndophilinA-phosphorylation promotes the formation of highly curved membranes, and reconstitution experiments show these curved membranes serve as docking stations for autophagic factors, including Atg3. Functionally, deregulation of the EndophilinA phosphorylation state accelerates activity-induced neurodegeneration. Given that EndophilinA is connected to at least three Parkinson's disease genes (LRRK2, Parkin and Synaptojanin), dysfunction of EndophilinA-dependent synaptic macroautophagy may be common in this disorder.	[Soukup, Sandra-Fausia; Kuenen, Sabine; Vanhauwaert, Roeland; Manetsberger, Julia; Hernandez-Diaz, Sergio; Swerts, Jef; Schoovaerts, Nils; Vilain, Sven; Gounko, Natalia V.; Vints, Katlijn; Geens, Ann; De Strooper, Bart; Verstreken, Patrik] VIB Ctr Brain & Dis Res, Leuven Inst Neurodegenerat Dis, B-3000 Leuven, Belgium; [Soukup, Sandra-Fausia; Kuenen, Sabine; Vanhauwaert, Roeland; Manetsberger, Julia; Hernandez-Diaz, Sergio; Swerts, Jef; Schoovaerts, Nils; Vilain, Sven; Gounko, Natalia V.; Vints, Katlijn; Geens, Ann; De Strooper, Bart; Verstreken, Patrik] Katholieke Univ Leuven, Leuven Inst Neurodegenerat Dis, Dept Human Genet, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Verstreken, P (corresponding author), VIB Ctr Brain & Dis Res, Leuven Inst Neurodegenerat Dis, B-3000 Leuven, Belgium.; Verstreken, P (corresponding author), Katholieke Univ Leuven, Leuven Inst Neurodegenerat Dis, Dept Human Genet, B-3000 Leuven, Belgium.	patrik.verstreken@cme.vib-kuleuven.be	Gounko, Natalia/N-4102-2019; Vilain, Sven/AHA-7944-2022; Soukup, Sandra/ABG-2322-2021; Verstreken, Patrik/AAC-7591-2022; de+Strooper, Bart/Z-1638-2019	Gounko, Natalia/0000-0003-0791-9477; Verstreken, Patrik/0000-0002-5073-5393; Vints, Katlijn/0000-0002-2893-752X; Hernandez-Diaz, Sergio/0000-0001-9497-7119; Soukup, Sandra/0000-0003-2915-919X; Vanhauwaert, Roeland/0000-0003-0829-6128; Manetsberger, Julia/0000-0003-0787-1370	KU Leuven (CREA); KU Leuven (GOA); ERC CoG; FWO; opening the future; Hercules Foundation; IWT fellowship; BELSPO; Methusalem grant of the Flemish government; VIB	KU Leuven (CREA); KU Leuven (GOA)(KU Leuven); ERC CoG; FWO(FWO); opening the future; Hercules Foundation; IWT fellowship; BELSPO(Belgian Federal Science Policy Office); Methusalem grant of the Flemish government; VIB	We thank T. Neufeld, H. Kramer, G. Juhasz, H. Stenmark, the Bloomington Drosophila Stock Center, FlyORF, and the DSHB for reagents; and E. Lauwers and the VIB Bioimaging core Leuven for help. Support was provided by KU Leuven (CREA, GOA), ERC CoG, FWO, opening the future, the Hercules Foundation, IWT fellowship to R.V., BELSPO, a Methusalem grant of the Flemish government, and VIB.	Ambroso MR, 2014, P NATL ACAD SCI USA, V111, P6982, DOI 10.1073/pnas.1402233111; Arranz AM, 2015, J CELL SCI, V128, P541, DOI 10.1242/jcs.158196; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Cao M, 2014, J NEUROSCI, V34, P16544, DOI 10.1523/JNEUROSCI.1710-14.2014; Chen DF, 2013, NEUROSCI LETT, V538, P49, DOI 10.1016/j.neulet.2013.01.044; Chen DF, 2013, NEUROSCI LETT, V534, P193, DOI 10.1016/j.neulet.2012.12.039; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dwivedi M, 2011, MOL CELLS, V31, P477, DOI 10.1007/s10059-011-1035-1; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Hernandez D, 2012, NEURON, V74, P277, DOI 10.1016/j.neuron.2012.02.020; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kasprowicz J, 2014, J CELL BIOL, V204, P1141, DOI 10.1083/jcb.201310090; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Lauwers E, 2016, NEURON, V90, P11, DOI 10.1016/j.neuron.2016.02.033; Maday S, 2014, DEV CELL, V30, P71, DOI 10.1016/j.devcel.2014.06.001; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Newsome TP, 2000, DEVELOPMENT, V127, P851; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Soukup SF, 2013, CURR BIOL, V23, P1349, DOI 10.1016/j.cub.2013.05.060; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Titlowa JS, 2014, NEUROSCI RES, V83, P54, DOI 10.1016/j.neures.2014.04.003; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Urwyler O, 2015, DEVELOPMENT, V142, P394, DOI 10.1242/dev.115071; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Vilain S, 2014, G3-GENES GENOM GENET, V4, P2381, DOI 10.1534/g3.114.014803; Williamson WR, 2010, J CELL BIOL, V189, P885, DOI 10.1083/jcb.201003062; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	54	143	145	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2016	92	4					829	844		10.1016/j.neuron.2016.09.037	http://dx.doi.org/10.1016/j.neuron.2016.09.037			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED0ZH	27720484	Green Submitted, Bronze			2022-12-17	WOS:000388572700017
J	Buschman, TJ; Kastner, S				Buschman, Timothy J.; Kastner, Sabine			From Behavior to Neural Dynamics: An Integrated Theory of Attention	NEURON			English	Review							SELECTIVE VISUAL-ATTENTION; MACAQUE AREA V4; LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; NATURAL SCENE CATEGORIZATION; GAMMA-BAND SYNCHRONIZATION; PRIMATE PREFRONTAL CORTEX; SPATIAL ATTENTION; TOP-DOWN; NEURONAL SYNCHRONIZATION	The brain has a limited capacity and therefore needs mechanisms to selectively enhance the information most relevant to one's current behavior. We refer to these mechanisms as "attention." Attention acts by increasing the strength of selected neural representations and preferentially routing them through the brain's large-scale network. This is a critical component of cognition and therefore has been a central topic in cognitive neuroscience. Here we review a diverse literature that has studied attention at the level of behavior, networks, circuits, and neurons. We then integrate these disparate results into a unified theory of attention.	[Buschman, Timothy J.; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University	Buschman, TJ (corresponding author), Princeton Univ, Dept Psychol, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	tbuschma@princeton.edu; skastner@princeton.edu	Buschman, Timothy J/B-3056-2009	Buschman, Timothy J/0000-0003-1298-2761; Kastner, Sabine/0000-0002-9742-965X	NIH [RO1-MH64043, RO1-EY017699, R21-EY02565, R00-MH092715, DP2-EY025446]; NSF [BCS-1328270R01NS035710]; ONR [N000141410681]; NATIONAL EYE INSTITUTE [R21EY023565, DP2EY025446, R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH092715, R01MH064043] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by NIH RO1-MH64043, NIH RO1-EY017699, NIH R21-EY02565, and NSF BCS-1328270R01NS035710 to S.K. and NIH R00-MH092715, NIH DP2-EY025446, and ONR N000141410681 to T.J.B.	Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [10.1016/S0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bisiach E, 1988, HDB NEUROPSYCHOLOGY, V1, P195; Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Bressler SL, 1996, BEHAV BRAIN RES, V76, P37, DOI 10.1016/0166-4328(95)00187-5; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Conner CE, 1997, J NEUROSCI, V17, P3201; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cukur T, 2013, NAT NEUROSCI, V16, P763, DOI 10.1038/nn.3381; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; David SV, 2008, NEURON, V59, P509, DOI 10.1016/j.neuron.2008.07.001; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Fiebelkorn IC, 2013, CURR BIOL, V23, P2553, DOI 10.1016/j.cub.2013.10.063; Foley NC, 2014, J NEUROSCI, V34, P7947, DOI 10.1523/JNEUROSCI.4171-13.2014; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Gazzaley A, 2011, NEUROPSYCHOLOGIA, V49, P1410, DOI 10.1016/j.neuropsychologia.2010.12.022; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Iba M, 2003, J NEUROPHYSIOL, V89, P587, DOI 10.1152/jn.00148.2002; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; James W., 1890, PRINCIPLES PSYCHOL, V2; JANER KW, 1991, J COGNITIVE NEUROSCI, V3, P231, DOI 10.1162/jocn.1991.3.3.231; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kenzie JM, 2015, BRAIN CONNECT, V5, P413, DOI 10.1089/brain.2014.0316; Kinsbourne M, 1977, Adv Neurol, V18, P41; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kuo BC, 2012, J COGNITIVE NEUROSCI, V24, P51, DOI 10.1162/jocn_a_00087; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Li L, 2010, BRAIN RES, V1344, P173, DOI 10.1016/j.brainres.2010.05.016; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lunven M, 2015, BRAIN, V138, P746, DOI 10.1093/brain/awu389; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mirpour K, 2009, J NEUROPHYSIOL, V102, P3481, DOI 10.1152/jn.00688.2009; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nassi JJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00105; Niv Y, 2015, J NEUROSCI, V35, P8145, DOI 10.1523/JNEUROSCI.2978-14.2015; Nobre A.C., 2014, OXFORD HDB ATTENTION; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Norman D., 1986, CONSCIOUSNESS SELF R, V4, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_]; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Peelen MV, 2014, TRENDS COGN SCI, V18, P242, DOI 10.1016/j.tics.2014.02.004; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Peelena MV, 2011, P NATL ACAD SCI USA, V108, P12125, DOI 10.1073/pnas.1101042108; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Premereur E, 2015, J NEUROSCI, V35, P3446, DOI 10.1523/JNEUROSCI.3710-14.2015; Premereur E, 2012, J NEUROPHYSIOL, V108, P1392, DOI 10.1152/jn.00323.2012; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rombouts JO, 2015, VIS COGN, V23, P179, DOI 10.1080/13506285.2015.1010462; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Siegel M, 2015, SCIENCE, V348, P1352, DOI 10.1126/science.aab0551; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Soto D, 2008, TRENDS COGN SCI, V12, P342, DOI 10.1016/j.tics.2008.05.007; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Summerfield JJ, 2006, NEURON, V49, P905, DOI 10.1016/j.neuron.2006.01.021; Szczepanski SM, 2013, J NEUROSCI, V33, P5411, DOI 10.1523/JNEUROSCI.4089-12.2013; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Tiesinga PHE, 2004, NEUROCOMPUTING, V58, P641, DOI 10.1016/j.neucom.2004.01.108; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Vinck M, 2013, NEURON, V80, P1077, DOI 10.1016/j.neuron.2013.08.019; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 1996, J NEUROSCI, V16, P6402; Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wilke M, 2010, J NEUROSCI, V30, P8650, DOI 10.1523/JNEUROSCI.0953-10.2010; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126	150	143	147	4	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2015	88	1					127	144		10.1016/j.neuron.2015.09.017	http://dx.doi.org/10.1016/j.neuron.2015.09.017			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8HM	26447577	Green Accepted, Bronze			2022-12-17	WOS:000363782500010
J	Wang, L; Chen, IZ; Lin, DY				Wang, Li; Chen, Irene Z.; Lin, Dayu			Collateral Pathways from the Ventromedial Hypothalamus Mediate Defensive Behaviors	NEURON			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; EFFERENT CONNECTIONS; PERIAQUEDUCTAL GRAY; RAT; NUCLEUS; ORGANIZATION; PROJECTIONS; STIMULATION; AMYGDALA; SYSTEM	The ventromedial hypothalamus (VMH) was thought to be essential for coping with threat, although its circuit mechanism remains unclear. To investigate this, we optogenetically activated steroidogenic factor 1 (SF1)-expressing neurons in the dorsomedial and central parts of the VMH (VMHdm/c), and observed a range of context-dependent somatomotor and autonomic responses resembling animals' natural defensive behaviors. By activating independent pathways emanating from the VMHdm/c, we demonstrated that VMHdm/c projection to the dorsolateral periaqueductal gray (dlPAG) induces inflexible immobility, while the VMHdm/c to anterior hypothalamic nucleus (AHN) pathway promotes avoidance. Consistent with the behavior changes induced by VMH to AHN pathway activation, direct activation of the AHN elicited avoidance and escape jumping, but not immobility. Retrograde tracing studies revealed that nearly 50% of PAG-projecting VMHdm/c neurons send collateral projection to the AHN and vice versa. Thus, VMHdm/c neurons employ a one-to-many wiring configuration to orchestrate multiple aspects of defensive behaviors.	[Wang, Li; Chen, Irene Z.; Lin, Dayu] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA; [Lin, Dayu] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Lin, Dayu] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Lin, Dayu] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; New York University; New York University; Nathan Kline Institute for Psychiatric Research	Lin, DY (corresponding author), NYU, Sch Med, Inst Neurosci, 522 First Ave, New York, NY 10016 USA.	dayu.lin@nyumc.org		Lin, Dayu/0000-0003-2006-0791	Esther A. & Joseph Klingenstein Fund; Whitehall Foundation; Sloan Foundation; McKnight Foundation; NIH [1R01MH101377]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101377] Funding Source: NIH RePORTER	Esther A. & Joseph Klingenstein Fund; Whitehall Foundation; Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Lowell for providing the SF1-CRE mice and G. Fishell for providing the RCE:loxP mice. We also thank K. Deisseroth for ChR2-EYFP viral constructs; J.E. Feng and B.C. Chang for helping construct the optrodes; K. Ferguson for assistance with the behavioral tests; and P. Dollar for advice on optimizing the tracking program. Finally, we thank N.S. Canteras, J.E. LeDoux, A. L. Falkner, K. Hashikawa, and L.C. Wong for helpful conversations, and P. Hare and S. Tranguch for editorial comments. This work was supported by Esther A. & Joseph Klingenstein Fund (D.L.), Whitehall Foundation (D.L.), Sloan Foundation (D.L.), McKnight Foundation (D.L.), and an NIH grant (1R01MH101377 to D.L.).	AKESSON TR, 1994, J NEUROBIOL, V25, P406, DOI 10.1002/neu.480250406; Bandler R, 1996, PROG BRAIN RES, V107, P285; Bard P, 1928, AM J PHYSIOL, V84, P490, DOI 10.1152/ajplegacy.1928.84.3.490; Blanchard RJ, 1998, PHYSIOL BEHAV, V65, P201, DOI 10.1016/S0031-9384(98)00012-2; BLANCHARD RJ, 1995, AGGRESSIVE BEHAV, V21, P123, DOI 10.1002/1098-2337(1995)21:2<123::AID-AB2480210205>3.0.CO;2-E; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; Burgos-Artizzu XP, 2012, PROC CVPR IEEE, P1322, DOI 10.1109/CVPR.2012.6247817; CANTERAS NS, 1992, P NATL ACAD SCI USA, V89, P10089, DOI 10.1073/pnas.89.21.10089; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; de MOLINA A. FERNANDEZ, 1962, JOUR PHYSIOL [LONDON], V160, P200; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Dollar P, 2010, PROC CVPR IEEE, P1078, DOI 10.1109/CVPR.2010.5540094; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Franklin K. B. J., 2008, MOUSE BRAIN STEREOTA; FUCHS SAG, 1985, BRAIN RES, V330, P93, DOI 10.1016/0006-8993(85)90010-1; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hofle M., 2013, EUR J NEUROSCI; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lindberg D, 2013, J COMP NEUROL, V521, P3167, DOI 10.1002/cne.23338; LIPP HP, 1978, BRAIN BEHAV EVOLUT, V15, P260, DOI 10.1159/000123782; Martinez RCR, 2008, BEHAV BRAIN RES, V192, P185, DOI 10.1016/j.bbr.2008.03.042; McClellan KM, 2006, FRONT NEUROENDOCRIN, V27, P193, DOI 10.1016/j.yfrne.2006.02.002; Pereira M, 2009, BEHAV BRAIN RES, V205, P238, DOI 10.1016/j.bbr.2009.06.026; Petrovich GD, 1996, J COMP NEUROL, V374, P387, DOI 10.1002/(SICI)1096-9861(19961021)374:3<387::AID-CNE6>3.0.CO;2-Y; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; SAPER CB, 1978, J COMP NEUROL, V182, P575, DOI 10.1002/cne.901820402; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; SCHMITT P, 1985, EUR J PHARMACOL, V117, P149, DOI 10.1016/0014-2999(85)90599-0; Silva BA, 2013, NAT NEUROSCI, V16, P1731, DOI 10.1038/nn.3573; SILVEIRA MCL, 1988, BRAZ J MED BIOL RES, V21, P569; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Wilent WB, 2010, J NEUROSURG, V112, P1295, DOI 10.3171/2009.9.JNS09577	39	143	144	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 18	2015	85	6					1344	1358		10.1016/j.neuron.2014.12.025	http://dx.doi.org/10.1016/j.neuron.2014.12.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD8BA	25754823	Bronze, Green Accepted			2022-12-17	WOS:000351319000019
J	Nakamura, Y; Harada, H; Kamasawa, N; Matsui, K; Rothman, JS; Shigemoto, R; Silver, RA; DiGregorio, DA; Takahashi, T				Nakamura, Yukihiro; Harada, Harumi; Kamasawa, Naomi; Matsui, Ko; Rothman, Jason S.; Shigemoto, Ryuichi; Silver, R. Angus; DiGregorio, David A.; Takahashi, Tomoyuki			Nanoscale Distribution of Presynaptic Ca2+ Channels and Its Impact on Vesicular Release during Development	NEURON			English	Article							TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; CALCIUM-CHANNELS; SYNAPTIC STRENGTH; GRANULE CELL; RAT CALYX; PROTEINS; KINETICS; P/Q; DESENSITIZATION	Synaptic efficacy and precision are influenced by the coupling of voltage-gated Ca2+ channels (VGCCs) to vesicles. But because the topography of VGCCs and their proximity to vesicles is unknown, a quantitative understanding of the determinants of vesicular release at nanometer scale is lacking. To investigate this, we combined freeze-fracture replica immuno-gold labeling of Ca(v)2.1 channels, local [Ca2+] imaging, and patch pipette perfusion of EGTA at the calyx of Held. Between postnatal day 7 and 21, VGCCs formed variable sized clusters and vesicular release became less sensitive to EGTA, whereas fixed Ca2+ buffer properties remained constant. Experimentally constrained reaction-diffusion simulations suggest that Ca2+ sensors for vesicular release are located at the perimeter of VGCC clusters (<30 nm) and predict that VGCC number per cluster determines vesicular release probability without altering release time course. This "perimeter release model" provides a unifying framework accounting for developmental changes in both synaptic efficacy and time course.	[Nakamura, Yukihiro; Takahashi, Tomoyuki] Doshisha Univ, Grad Sch Brain Sci, Lab Mol Synapt Funct, Kyoto 6100394, Japan; [Nakamura, Yukihiro; Takahashi, Tomoyuki] OIST Grad Univ, Cellular & Mol Synapt Funct Unit, Onna, Okinawa 9040495, Japan; [Nakamura, Yukihiro; DiGregorio, David A.] Inst Pasteur, Lab Dynam Neuronal Imaging, F-75724 Paris 15, France; [Nakamura, Yukihiro; DiGregorio, David A.] CNRS, UMR 3571, F-75724 Paris 15, France; [Harada, Harumi; Kamasawa, Naomi; Matsui, Ko; Shigemoto, Ryuichi] Natl Inst Physiol Sci, Dept Cerebral Res, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan; [Harada, Harumi; Shigemoto, Ryuichi] IST Austria, A-3400 Klosterneuburg, Austria; [Rothman, Jason S.; Silver, R. Angus] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Doshisha University; Okinawa Institute of Science & Technology Graduate University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Institute of Science & Technology - Austria; University of London; University College London	DiGregorio, DA (corresponding author), Inst Pasteur, Lab Dynam Neuronal Imaging, 25 Rue Dr Roux, F-75724 Paris 15, France.	david.digregorio@pasteur.fr; ttakahas@mail.doshisha.ac.jp	Shigemoto, Ryuichi/E-3628-2013; Takahashi, Tomoyuki/G-5951-2015; Matsui, Ko/AAE-3687-2019	Shigemoto, Ryuichi/0000-0001-8761-9444; Takahashi, Tomoyuki/0000-0002-8771-7666; Matsui, Ko/0000-0003-1068-9705; Silver, Robin/0000-0002-5480-6638; Harada, Harumi/0000-0001-7429-7896; Nakamura, Yukihiro/0000-0002-8820-7780; Rothman, Jason/0000-0003-3036-2291	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency; Okinawa Institute of Science and Technology (OIST); JSPS Core-to-Core Program, A. Advanced Networks; Japanese Ministry of Education, Culture, Sports, Science and Technology [23700474]; Centre National de la Recherche Scientifique through Actions Thematiques et Initatives sur Programme; Fondation Fyssen; Fondation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche [ANR-2007-Neuro-008-01, ANR-2010-BLAN-1411-01]; European Commission Coordination Action ENINET [LSHM-CT-2005-19063]; Wellcome Trust [064413, 095667]; ERC [294667]	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Okinawa Institute of Science and Technology (OIST)(Okinawa Institute of Science & Technology Graduate University); JSPS Core-to-Core Program, A. Advanced Networks; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Centre National de la Recherche Scientifique through Actions Thematiques et Initatives sur Programme; Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission Coordination Action ENINET(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); ERC(European Research Council (ERC)European Commission)	We thank Taro Ishikawa, Shinichi Iwasaki, Masahiro Kimura, Florian Mueller, and Tetsuhiro Tsujimoto for their contributions during the early stage of this study. We also thank Tetsuya Hori for helping with the pipette perfusion experiments, Hee-Sup Shin for providing Ca<INF>v</INF>2.1 knockout mice, Masahiko Watanabe for providing Ca<INF>v</INF>2.1 antibodies, and Steven Aird for editing the paper. This work was supported by the Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency to T.T. and R.S.; by the funding provided by Okinawa Institute of Science and Technology (OIST) to T.T. and Y.N.; by JSPS Core-to-Core Program, A. Advanced Networks to T.T.; by the Grant-in-Aid for Young Scientists from the Japanese Ministry of Education, Culture, Sports, Science and Technology (#23700474) to Y.N.; by the Centre National de la Recherche Scientifique through the Actions Thematiques et Initatives sur Programme, Fondation Fyssen, Fondation pour la Recherche Medicale, Federation pour la Recherche sur le Cerveau, Agence Nationale de la Recherche (ANR-2007-Neuro-008-01 and ANR-2010-BLAN-1411-01) to D.D. and Y.N.; and by the European Commission Coordination Action ENINET (LSHM-CT-2005-19063) to D.D. and R.A.S. R.A.S. and J.S.R. were funded by Wellcome Trust Senior (064413) and Principal (095667) Research Fellowship and an ERC advance grant (294667) to RAS.	Atluri PP, 1996, J NEUROSCI, V16, P5661; Bennett MR, 2000, BIOPHYS J, V78, P2222, DOI 10.1016/S0006-3495(00)76770-1; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Budisantoso T, 2013, J PHYSIOL-LONDON, V591, P219, DOI 10.1113/jphysiol.2012.241398; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Hagiwara A, 2005, J COMP NEUROL, V489, P195, DOI 10.1002/cne.20633; Hallermann S, 2013, TRENDS NEUROSCI, V36, P185, DOI 10.1016/j.tins.2012.10.001; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Indriati DW, 2013, J NEUROSCI, V33, P3668, DOI 10.1523/JNEUROSCI.2921-12.2013; Ishikawa T, 2003, J NEUROSCI, V23, P10445; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kochubey O, 2009, J PHYSIOL-LONDON, V587, P3009, DOI 10.1113/jphysiol.2009.172387; Koike-Tani M, 2008, J PHYSIOL-LONDON, V586, P2263, DOI 10.1113/jphysiol.2007.142547; Kulik A, 2004, EUR J NEUROSCI, V19, P2169, DOI 10.1111/j.0953-816X.2004.03319.x; Mercer AJ, 2011, J NEUROSCI, V31, P4397, DOI 10.1523/JNEUROSCI.5921-10.2011; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Miyazaki T, 2012, J NEUROSCI, V32, P1311, DOI 10.1523/JNEUROSCI.2755-11.2012; Nadkarni S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000983; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pan B, 2009, NEURON, V62, P539, DOI 10.1016/j.neuron.2009.03.025; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Satzler K, 2002, J NEUROSCI, V22, P10567; Schmidt H, 2013, CURR BIOL, V23, P244, DOI 10.1016/j.cub.2012.12.007; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Scimemi A, 2012, J NEUROSCI, V32, P18157, DOI 10.1523/JNEUROSCI.3827-12.2012; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takahashi T., 2012, PATCH CLAMP TECHNIQU, P137; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Vyleta NP, 2014, SCIENCE, V343, P665, DOI 10.1126/science.1244811; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003	51	143	143	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 7	2015	85	1					145	158		10.1016/j.neuron.2014.11.019	http://dx.doi.org/10.1016/j.neuron.2014.11.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ5YS	25533484	Green Published, hybrid			2022-12-17	WOS:000348295100015
J	Hong, S; Ostaszewski, BL; Yang, T; O'Malley, TT; Jin, M; Yanagisawa, K; Li, SM; Bartels, T; Selkoe, DJ				Hong, Soyon; Ostaszewski, Beth L.; Yang, Ting; O'Malley, Tiernan T.; Jin, Ming; Yanagisawa, Katsuhiko; Li, Shaomin; Bartels, Tim; Selkoe, Dennis J.			Soluble A beta Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes	NEURON			English	Article							LIPID-PEPTIDE INTERACTIONS; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; TRANSGENIC MICE; CHOLERA-TOXIN; TAU PHOSPHORYLATION; PLAQUE-FORMATION; PRION PROTEIN	Soluble A beta oligomers contribute importantly to synaptotoxicity in Alzheimer's disease, but their dynamics in vivo remain unclear. Here, we found that soluble A beta oligomers were sequestered from brain interstitial fluid onto brain membranes much more rapidly than nontoxic monomers and were recovered in part as bound to GM1 ganglioside on membranes. Ab oligomers bound strongly to GM1 ganglioside, and blocking the sialic acid residue on GM1 decreased oligomer-mediated LTP impairment in mouse hippocampal slices. In a hAPP transgenic mouse model, substantial levels of GM1-bound A beta(42) were recovered from brain membrane fractions. We also detected GM1-bound Ab in human CSF, and its levels correlated with A beta(42), suggesting its potential as a biomarker of A beta-related membrane dysfunction. Together, these findings highlight a mechanism whereby hydrophobic A beta oligomers become sequestered onto GM1 ganglioside and presumably other lipids on neuronal membranes, where they may induce progressive functional and structural changes.	[Hong, Soyon; Ostaszewski, Beth L.; Yang, Ting; O'Malley, Tiernan T.; Jin, Ming; Li, Shaomin; Bartels, Tim; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Hong, Soyon; Ostaszewski, Beth L.; Yang, Ting; O'Malley, Tiernan T.; Jin, Ming; Li, Shaomin; Bartels, Tim; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hong, Soyon] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [O'Malley, Tiernan T.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Aichi 4748522, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University College Dublin; National Center for Geriatrics & Gerontology	Selkoe, DJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021; Hong, Soyon/AAE-9662-2021	Hong, Soyon/0000-0002-5744-4871; /0000-0002-3538-0731; Bartels, Tim/0000-0002-4071-5612	NIH [R01 AG027443, R01 AG06173]; PPG [P01 AG036694]; Harvard NeuroDiscovery Center Pre-doctoral Training Fellowship; Jerome L. Rappaport Fellowship at HMS; NATIONAL INSTITUTE ON AGING [R01AG006173, R01AG027443, P01AG036694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PPG; Harvard NeuroDiscovery Center Pre-doctoral Training Fellowship; Jerome L. Rappaport Fellowship at HMS; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are very grateful to R. Ledeen (NJMS) for GM2/GD2 synthase KO mice, D. Harris (BU) for PrnP KO mice, R. Sperling (BWH) for human CSF samples, L. Mucke (UCSF) for J20 mice, D. M. Walsh (BWH) for AW8 antibody, and Elan, plc (South San Francisco, CA) for 3D6, 2G3, and 21F12 antibodies. We thank D. R. Podlisny and W. T. Cavanaugh for technical assistance, M.J. LaVoie and T. L. Young-Pearse for critical reading of manuscript, and members of the Selkoe laboratory for helpful comments. Supported by NIH grants R01 AG027443 (D.J.S.), R01 AG06173 (D. J. S.), and PPG P01 AG036694 (Sperling/D.J.S.), a Harvard NeuroDiscovery Center Pre-doctoral Training Fellowship (S. H.), and a Jerome L. Rappaport Fellowship at HMS (S. H.). D. J. S. is a consultant to Elan and a director of Prothena.	Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; BLENNOW K, 1991, ARCH NEUROL-CHICAGO, V48, P1032, DOI 10.1001/archneur.1991.00530220048018; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grimm MOW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034095; HANSSON HA, 1977, P NATL ACAD SCI USA, V74, P3782, DOI 10.1073/pnas.74.9.3782; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li SM, 2013, NEURON, V77, P929, DOI 10.1016/j.neuron.2012.12.040; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Morris JC, 2011, NEUROBIOL AGING, V32, pS1, DOI 10.1016/j.neurobiolaging.2011.09.005; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pernber Z, 2012, DEMENT GERIATR COGN, V33, P174, DOI 10.1159/000338181; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Sanghera N, 2008, BBA-PROTEINS PROTEOM, V1784, P873, DOI 10.1016/j.bbapap.2008.02.017; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wu GS, 2001, P NATL ACAD SCI USA, V98, P307, DOI 10.1073/pnas.011523698; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1997, FEBS LETT, V420, P43, DOI 10.1016/S0014-5793(97)01484-1; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	69	143	145	1	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 16	2014	82	2					308	319		10.1016/j.neuron.2014.02.027	http://dx.doi.org/10.1016/j.neuron.2014.02.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF1XI	24685176	Green Accepted, Bronze			2022-12-17	WOS:000334506800008
J	Markopoulos, F; Rokni, D; Gire, DH; Murthy, VN				Markopoulos, Foivos; Rokni, Dan; Gire, David H.; Murthy, Venkatesh N.			Functional Properties of Cortical Feedback Projections to the Olfactory Bulb	NEURON			English	Article							NUCLEUS PARS EXTERNA; MITRAL CELLS; TUFTED CELLS; PIRIFORM CORTEX; CENTRIFUGAL PROJECTIONS; PRESYNAPTIC INHIBITION; ODOR; RAT; NEURONS; MODULATION	Sensory perception is not a simple feed-forward process, and higher brain areas can actively modulate information processing in "lower" areas. We used optogenetic methods to examine how cortical feedback projections affect circuits in the first olfactory processing stage, the olfactory bulb. Selective activation of back projections from the anterior olfactory nucleus/cortex (AON) revealed functional gluta-matergic synaptic connections on several types of bulbar interneurons. Unexpectedly, AON axons also directly depolarized mitral cells (MCs), enough to elicit spikes reliably in a time window of a few milliseconds. MCs received strong disynaptic inhibition, a third of which arises in the glomerular layer. Activating feedback axons in vivo suppressed spontaneous as well as odor-evoked activity of MCs, sometimes preceded by a temporally precise increase in firing probability. Our study indicates that cortical feedback can shape the activity of bulbar output neurons by enabling precisely timed spikes and enforcing broad inhibition to suppress background activity.	[Markopoulos, Foivos; Rokni, Dan; Gire, David H.; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University	Murthy, VN (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu		Rokni, Dan/0000-0002-3041-8462; Gire, David/0000-0003-4119-4270; Markopoulos, Foivos/0000-0002-5501-9249; Murthy, Venkatesh/0000-0003-2443-4252	Swiss National Foundation; Edmond and Lily Safra Center for Brain Sciences, Hebrew University; Harvard University; NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011291] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Edmond and Lily Safra Center for Brain Sciences, Hebrew University; Harvard University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	F.M. was supported by a Swiss National Foundation Fellowship and D.R. was supported by the Edmond and Lily Safra Center for Brain Sciences, Hebrew University. Work in V.N.M.'s laboratory related to this project was supported by Harvard University and by the NIH. We thank the Harvard Center for Biological Imaging and Professor Catherine Dulac for the use of microscopes to image fixed tissue.	Albeanu DF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002146; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; Balu R, 2007, J NEUROPHYSIOL, V97, P1959, DOI 10.1152/jn.01115.2006; Bardy C, 2010, J NEUROSCI, V30, P17023, DOI 10.1523/JNEUROSCI.4543-10.2010; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Carlson GC, 2000, J NEUROSCI, V20, P2011; Christie JM, 2006, J NEUROSCI, V26, P2269, DOI 10.1523/JNEUROSCI.4791-05.2006; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; DAVIS BJ, 1981, J COMP NEUROL, V203, P475, DOI 10.1002/cne.902030310; DAVIS BJ, 1978, BRAIN RES BULL, V3, P59, DOI 10.1016/0361-9230(78)90062-X; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; De Saint Jan D, 2009, J NEUROSCI, V29, P2043, DOI 10.1523/JNEUROSCI.5317-08.2009; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Fontanini A, 2009, ANN NY ACAD SCI, V1170, P403, DOI 10.1111/j.1749-6632.2009.03922.x; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Han X, 2012, PROG BRAIN RES, V196, P215, DOI 10.1016/B978-0-444-59426-6.00011-2; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Illig KR, 2009, J COMP NEUROL, V512, P115, DOI 10.1002/cne.21900; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isaacson JS, 2010, CURR OPIN NEUROBIOL, V20, P328, DOI 10.1016/j.conb.2010.02.004; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kikuta S, 2008, J NEUROSCI, V28, P11989, DOI 10.1523/JNEUROSCI.3106-08.2008; Kikuta S, 2010, P NATL ACAD SCI USA, V107, P12363, DOI 10.1073/pnas.1003999107; Kiselycznyk CL, 2006, LEARN MEMORY, V13, P575, DOI 10.1101/lm.285706; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; Pimentel DO, 2008, J PHYSIOL-LONDON, V586, P2107, DOI 10.1113/jphysiol.2007.149575; PINCHING AJ, 1972, J CELL SCI, V10, P621; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; POWELL TPS, 1965, J ANAT, V99, P791; PRICE JL, 1970, J ANAT, V107, P215; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Restrepo D, 2009, TRENDS NEUROSCI, V32, P525, DOI 10.1016/j.tins.2009.06.001; REYHER CKH, 1988, BRAIN RES BULL, V20, P549, DOI 10.1016/0361-9230(88)90214-6; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; Shao Z, 2009, J NEUROPHYSIOL, V101, P1988, DOI 10.1152/jn.91116.2008; Shao ZY, 2012, J NEUROPHYSIOL, V108, P782, DOI 10.1152/jn.00119.2012; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Strowbridge BW, 2009, ANN NY ACAD SCI, V1170, P270, DOI 10.1111/j.1749-6632.2009.04018.x; Tyler WJ, 2007, J NEUROSCI, V27, P9427, DOI 10.1523/JNEUROSCI.0664-07.2007	68	143	145	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2012	76	6					1175	1188		10.1016/j.neuron.2012.10.028	http://dx.doi.org/10.1016/j.neuron.2012.10.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	065NI	23259952	Bronze, Green Accepted			2022-12-17	WOS:000313154800014
J	Palminteri, S; Justo, D; Jauffret, C; Pavlicek, B; Dauta, A; Delmaire, C; Czernecki, V; Karachi, C; Capelle, L; Durr, A; Pessiglione, M				Palminteri, Stefano; Justo, Damian; Jauffret, Celine; Pavlicek, Beth; Dauta, Aurelie; Delmaire, Christine; Czernecki, Virginie; Karachi, Carine; Capelle, Laurent; Durr, Alexandra; Pessiglione, Mathias			Critical Roles for Anterior Insula and Dorsal Striatum in Punishment-Based Avoidance Learning	NEURON			English	Article							TEMPORAL DIFFERENCE MODELS; BASAL GANGLIA; NEURAL BASIS; REWARD; PREDICTION; SEROTONIN; CONNECTIVITY; ANTICIPATION; CORTEX; INFORMATION	The division of human learning systems into reward and punishment opponent modules is still a debated issue. While the implication of ventral prefrontostriatal circuits in reward-based learning is well established, the neural underpinnings of punishment-based learning remain unclear. To elucidate the causal implication of brain regions that were related to punishment learning in a previous functional neuroimaging study, we tested the effects of brain damage on behavioral performance, using the same task contrasting monetary gains and losses. Cortical and subcortical candidate regions, the anterior insula and dorsal striatum, were assessed in patients presenting brain tumor and Huntington disease, respectively. Both groups exhibited selective impairment of punishment-based learning. Computational modeling suggested complementary roles for these structures: the anterior insula might be involved in learning the negative value of loss-predicting cues, whereas the dorsal striatum might be involved in choosing between those cues so as to avoid the worst.	[Palminteri, Stefano; Pessiglione, Mathias] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere ICM, Motivat Brain & Behav MBB Team, F-75013 Paris, France; [Palminteri, Stefano; Justo, Damian; Jauffret, Celine; Durr, Alexandra; Pessiglione, Mathias] Univ Paris 06, CNRS UMR 7225, INSERM UMR 975, F-75013 Paris, France; [Pavlicek, Beth] INSEAD, Decis Neurosci Grp, F-77300 Fontainebleau, France; [Durr, Alexandra] Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Dept Genet, F-75013 Paris, France; [Czernecki, Virginie] Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Inst Memoire & Maladie Alzheimer IM2A, F-75013 Paris, France; [Dauta, Aurelie; Karachi, Carine; Capelle, Laurent] Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Serv Neurochirurg, F-75013 Paris, France; [Delmaire, Christine] CHU Lille, Dept Neuroradiol, F-59000 Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; INSEAD Business School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille	Pessiglione, M (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere ICM, Motivat Brain & Behav MBB Team, F-75013 Paris, France.	mathias.pessiglione@gmail.com	Pessiglione, Mathias/E-2141-2017	Pessiglione, Mathias/0000-0002-6992-3677; Palminteri, Stefano/0000-0001-5768-6646	European Research Council (ERC); Neuropole de Recherche Francilien (NERF); Ecole de Neurosciences de Paris (ENP); CHDI/HighQ Foundation Inc.	European Research Council (ERC)(European Research Council (ERC)); Neuropole de Recherche Francilien (NERF); Ecole de Neurosciences de Paris (ENP); CHDI/HighQ Foundation Inc.	The study was funded by a European Research Council (ERC) starting grant. S.P. received a PhD fellowship of the Neuropole de Recherche Francilien (NERF). B.P. received a PhD fellowship from the Ecole de Neurosciences de Paris (ENP). TRACK-HD is supported by the CHDI/HighQ Foundation Inc. a not-for-profit organization dedicated to finding treatments for Huntington disease.	Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; De Martino B, 2010, P NATL ACAD SCI USA, V107, P3788, DOI 10.1073/pnas.0910230107; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Kahnt T, 2009, J COGNITIVE NEUROSCI, V21, P1332, DOI 10.1162/jocn.2009.21092; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Palminteri S, 2012, BIOL PSYCHIAT, V72, P244, DOI 10.1016/j.biopsych.2011.12.028; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Palminteri S, 2009, J NEUROSCI, V29, P13465, DOI 10.1523/JNEUROSCI.1500-09.2009; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Petrovic P, 2008, J NEUROSCI, V28, P10509, DOI 10.1523/JNEUROSCI.2807-08.2008; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Ravel S, 2003, J NEUROSCI, V23, P8489; Rutledge RB, 2010, J NEUROSCI, V30, P13525, DOI 10.1523/JNEUROSCI.1747-10.2010; Samanez-Larkin GR, 2008, PSYCHOL SCI, V19, P320, DOI 10.1111/j.1467-9280.2008.02087.x; Schlund MW, 2010, NEUROIMAGE, V53, P769, DOI 10.1016/j.neuroimage.2010.06.058; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	50	143	143	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2012	76	5					998	1009		10.1016/j.neuron.2012.10.017	http://dx.doi.org/10.1016/j.neuron.2012.10.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	053OX	23217747	Bronze			2022-12-17	WOS:000312283400015
J	Yang, SB; Tien, AC; Boddupalli, G; Xu, AW; Jan, YN; Jan, LY				Yang, Shi-Bing; Tien, An-Chi; Boddupalli, Gayatri; Xu, Allison W.; Jan, Yuh Nung; Jan, Lily Yeh			Rapamycin Ameliorates Age-Dependent Obesity Associated with Increased mTOR Signaling in Hypothalamic POMC Neurons	NEURON			English	Article							K-ATP-CHANNELS; REGULATES GLUCOSE-HOMEOSTASIS; ARCUATE NUCLEUS; ENERGY-BALANCE; TUBEROUS SCLEROSIS; POTASSIUM CHANNELS; MAMMALIAN TARGET; UP-REGULATION; FOOD-INTAKE; LEPTIN	The prevalence of obesity in older people is the leading cause of metabolic syndromes. Central neurons serving as homeostatic sensors for body-weight control include hypothalamic neurons that express pro-opiomelanocortin (POMC) or neuropeptide-Y (NPY) and agouti-related protein (AgRP). Here, we report an age-dependent increase of mammalian target of rapamycin (mTOR) signaling in POMC neurons that elevates the ATP-sensitive potassium (K-ATP) channel activity cell-autonomously to silence POMC neurons. Systemic or intracerebral administration of the mTOR inhibitor rapamycin causes weight loss in old mice. Intracerebral rapamycin infusion into old mice enhances the excitability and neurite projection of POMC neurons, thereby causing a reduction of food intake and body weight. Conversely, young mice lacking the mTOR-negative regulator TSC1 in POMC neurons, but not those lacking TSC1 in NPY/AgRP neurons, were obese. Our study reveals that an increase in mTOR signaling in hypothalamic POMC neurons contributes to age-dependent obesity.	[Yang, Shi-Bing; Boddupalli, Gayatri; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; [Yang, Shi-Bing; Boddupalli, Gayatri; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tien, An-Chi] Univ Calif San Francisco, Howard Hughes Med Inst, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Xu, Allison W.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	lily.jan@ucsf.edu	Yang, Shi-Bing/C-8308-2011	Yang, Shi-Bing/0000-0001-8061-3963; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	American Diabetes Association [7-06-MN-29]; NIDDK; NIH [MH065334]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334, R01MH065334] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Jans, Xu, and Vaisse laboratories at UCSF for discussions, Dr. Chris Bohlen and Xiuming Wong at UCSF for confirming the rapamycin activity, Dr. James Warne at UCSF for measuring alpha-MSH in tissue explants, Dr. Grant Li at UCSF for providing the Pomc-cre, Tsc1-flox, and ZeG mouse lines, and Dr. Jeffrey Friedman at Rockefeller University for providing the POMC-GFP mouse line. This work was supported by American Diabetes Association Mentor-Based Fellowship 7-06-MN-29 (to S.-B.Y.), NIDDK summer student training grant (to G.B.), and the NIH grant MH065334 (to L.Y.J.). Y.N.J. and L.Y.J. are investigators of the Howard Hughes Medical Institute.	Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Blagosklonny MV, 2011, CELL CYCLE, V10, P4217, DOI 10.4161/cc.10.24.18595; Blagosklonny MV, 2011, AGING-US, V3, P1051, DOI 10.18632/aging.100411; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; BUNEL D T, 1990, Molecular Brain Research, V8, P167, DOI 10.1016/0169-328X(90)90061-H; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Claret M, 2011, DIABETES, V60, P735, DOI 10.2337/db10-1055; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Coupe B, 2012, CELL CYCLE, V11, P1477, DOI 10.4161/cc.20046; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dicken MS, 2012, J NEUROSCI, V32, P4042, DOI 10.1523/JNEUROSCI.6032-11.2012; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 2001, PHYSIOL BEHAV, V74, P703, DOI 10.1016/S0031-9384(01)00613-8; Forbes S, 2001, P NATL ACAD SCI USA, V98, P4233, DOI 10.1073/pnas.071054298; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Garelick MG, 2011, EXP GERONTOL, V46, P155, DOI 10.1016/j.exger.2010.08.030; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kito H, 2011, BIOCHEM BIOPH RES CO, V411, P293, DOI 10.1016/j.bbrc.2011.06.128; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Li H, 1998, AM J PHYSIOL-ENDOC M, V275, pE405, DOI 10.1152/ajpendo.1998.275.3.E405; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Lyons DJ, 2010, NEURON, V65, P217, DOI 10.1016/j.neuron.2009.12.024; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; MACHADOSALAS JP, 1979, EXP NEUROL, V63, P347, DOI 10.1016/0014-4886(79)90130-4; Marcellini F, 2009, ARCH GERONTOL GERIAT, V49, P195, DOI 10.1016/j.archger.2009.09.029; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Price CJ, 2008, BRAIN RES, V1230, P99, DOI 10.1016/j.brainres.2008.06.084; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Sandoval D, 2008, PHYSIOL BEHAV, V94, P670, DOI 10.1016/j.physbeh.2008.04.018; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Speier S, 2005, MOL CELL ENDOCRINOL, V230, P51, DOI 10.1016/j.mce.2004.11.002; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Van den Top M, 2007, NEUROSCIENCE, V144, P815, DOI 10.1016/j.neuroscience.2006.09.059; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wyttenbach A, 2008, AUTOPHAGY, V4, P542, DOI 10.4161/auto.6059; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang CZ, 2010, CELL TISSUE RES, V341, P341, DOI 10.1007/s00441-010-1016-2	65	143	147	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 9	2012	75	3					425	436		10.1016/j.neuron.2012.03.043	http://dx.doi.org/10.1016/j.neuron.2012.03.043			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	987LF	22884327	Bronze, Green Accepted, Green Submitted			2022-12-17	WOS:000307417700011
J	Gregoriou, GG; Gotts, SJ; Desimone, R				Gregoriou, Georgia G.; Gotts, Stephen J.; Desimone, Robert			Cell-Type-Specific Synchronization of Neural Activity in FEF with V4 during Attention	NEURON			English	Article							FRONTAL EYE FIELD; SACCADE TARGET SELECTION; HUMAN CORTICOSPINAL SYSTEM; COVERT SPATIAL ATTENTION; MACAQUE AREA V4; VISUAL-ATTENTION; SUPERIOR COLLICULUS; NEURONAL SYNCHRONIZATION; PREFRONTAL CORTEX; MOTOR CORTEX	Shifts of gaze and shifts of attention are closely linked and it is debated whether they result from the same neural mechanisms. Both processes involve the frontal eye fields (FEF), an area which is also a source of top-down feedback to area V4 during covert attention. To test the relative contributions of oculomotor and attention-related FEF signals to such feedback, we recorded simultaneously from both areas in a covert attention task and in a saccade task. In the attention task, only visual and visuomovement FEF neurons showed enhanced responses, whereas movement cells were unchanged. Importantly, visual, but not movement or visuomovement cells, showed enhanced gamma frequency synchronization with activity in V4 during attention. Within FEF, beta synchronization was increased for movement cells during attention but was suppressed in the saccade task. These findings support the idea that the attentional modulation of visual processing is not mediated by movement neurons.	[Gregoriou, Georgia G.] Univ Crete, Dept Basic Sci, Fac Med, Iraklion 71003, Crete, Greece; [Gregoriou, Georgia G.] Fdn Res & Technol, Inst Appl & Computat Math, Iraklion 70013, Crete, Greece; [Gotts, Stephen J.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	University of Crete; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT)	Gregoriou, GG (corresponding author), Univ Crete, Dept Basic Sci, Fac Med, Iraklion 71003, Crete, Greece.	gregoriou@med.uoc.gr	Gregoriou, Georgia/AAD-3925-2019; Desimone, Robert/G-1121-2018; Gotts, Stephen/J-4842-2012; Gregoriou, Georgia/F-7759-2011	Gregoriou, Georgia/0000-0002-4002-6657; Gregoriou, Georgia/0000-0002-4002-6657; Desimone, Robert/0000-0002-5938-4227	European Community [PIRG05-GA-2009-246761]; General Secretariat for Research and Technology [9FR27]; University of Crete [3004]; National Institutes of Health (USA) [MH64445]; National Institute of Mental Health, Division of Intramural Research;  [5R01EY017921]; NATIONAL EYE INSTITUTE [R01EY017921, R01EY017292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445] Funding Source: NIH RePORTER	European Community(European Commission); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); University of Crete; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Grant Pielli, Donovan Stock and Courtney Alfes for help with the animal training and Steve Stefanou and George Spiropoulos for help with preliminary analysis. The authors were supported by a 5R01EY017921 Grant to R.D., by the European Community's Seventh Framework Programme (Grant PIRG05-GA-2009-246761), the General Secretariat for Research and Technology (Grant 9FR27), and the Special Account of Research Funds, University of Crete (Grant 3004) to G.G.G. S.J.G. was supported initially by MH64445 from the National Institutes of Health (USA) and later by the National Institute of Mental Health, Division of Intramural Research.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Androulidakis AG, 2007, EUR J NEUROSCI, V25, P3758, DOI 10.1111/j.1460-9568.2007.05620.x; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; FISCHER B, 1981, EXP BRAIN RES, V44, P129; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Gregoriou GG, 2009, PROG BRAIN RES, V176, P35, DOI 10.1016/S0079-6123(09)17603-3; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Hunt AR, 2003, COGNITIVE BRAIN RES, V18, P102, DOI 10.1016/j.cogbrainres.2003.08.006; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Juan CH, 2004, P NATL ACAD SCI USA, V101, P15541, DOI 10.1073/pnas.0403507101; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Klein R. M., 1980, ATTENTION PERFORM, P259, DOI DOI 10.1037/E665402011-424; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget P, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.002.2009; Ray S, 2009, J NEUROPHYSIOL, V102, P3091, DOI 10.1152/jn.00270.2009; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rizzolatti G., 1983, ADV VERTEBRATE NEURO, P261, DOI [10.1007/978-1-4684-4412-4_12, DOI 10.1007/978-1-4684-4412-4_12]; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	75	143	144	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					581	594		10.1016/j.neuron.2011.12.019	http://dx.doi.org/10.1016/j.neuron.2011.12.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325208	Green Accepted, Green Published, Bronze			2022-12-17	WOS:000300140600017
J	Gu, Y; Liu, S; Fetsch, CR; Yang, Y; Fok, S; Sunkara, A; DeAngelis, GC; Angelaki, DE				Gu, Yong; Liu, Sheng; Fetsch, Christopher R.; Yang, Yun; Fok, Sam; Sunkara, Adhira; DeAngelis, Gregory C.; Angelaki, Dora E.			Perceptual Learning Reduces Interneuronal Correlations in Macaque Visual Cortex	NEURON			English	Article							SUPERIOR TEMPORAL AREA; SELF-MOTION PERCEPTION; PURSUIT EYE-MOVEMENTS; ADULT OWL MONKEYS; HEADING PERCEPTION; CORTICAL AREA; NEURONAL CORRELATION; NOISE CORRELATIONS; POPULATION CODE; ATTENTION	Responses of neurons in early visual cortex change little with training and appear insufficient to account for perceptual learning. Behavioral performance, however, relies on population activity, and the accuracy of a population code is constrained by correlated noise among neurons. We tested whether training changes interneuronal correlations in the dorsal medial superior temporal area, which is involved in multisensory heading perception. Pairs of single units were recorded simultaneously in two groups of subjects: animals trained extensively in a heading discrimination task, and "naive" animals that performed a passive fixation task. Correlated noise was significantly weaker in trained versus naive animals, which might be expected to improve coding efficiency. However, we show that the observed uniform reduction in noise correlations leads to little change in population coding efficiency when all neurons are decoded. Thus, global changes in correlated noise among sensory neurons may be insufficient to account for perceptual learning.	[Gu, Yong; Liu, Sheng; Fetsch, Christopher R.; Yang, Yun; Fok, Sam; Sunkara, Adhira; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Washington University (WUSTL); University of Rochester	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273; Liu, Sheng/0000-0002-2497-8666	National Institutes of Health [EY019087, EY016178]; NATIONAL EYE INSTITUTE [R01EY019087, R01EY016178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (EY019087 to D.E.A., and EY016178 to G.C.D.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BACH M, 1986, EXP BRAIN RES, V61, P451; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bejjanki VR, 2011, NAT NEUROSCI, V14, P642, DOI 10.1038/nn.2796; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; GU Y, 2008, SOC NEUR ABSTR; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Lee D, 1998, J NEUROSCI, V18, P1161; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Wilke SD, 2002, NEURAL COMPUT, V14, P155, DOI 10.1162/089976602753284482; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Zhang T, 2011, J NEUROSCI, V31, P2569, DOI 10.1523/JNEUROSCI.5520-10.2011; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	64	143	145	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					750	761		10.1016/j.neuron.2011.06.015	http://dx.doi.org/10.1016/j.neuron.2011.06.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867889	Green Accepted, Bronze			2022-12-17	WOS:000294521600018
J	Aboody, K; Capela, A; Niazi, N; Stern, JH; Temple, S				Aboody, Karen; Capela, Alexandra; Niazi, Nilofar; Stern, Jeffrey H.; Temple, Sally			Translating Stem Cell Studies to the Clinic for CNS Repair: Current State of the Art and the Need for a Rosetta Stone	NEURON			English	Article							PROGENITOR CELLS; FDA REGULATION; MOTOR-NEURONS; TRANSPLANTATION; RECOVERY; DISEASE; TISSUE; REMYELINATE; GRAFTS; RESCUE	Since their discovery twenty years ago and prospective isolation a decade later, neural stem cells (NSCs), their progenitors, and differentiated cell derivatives along with other stem-cell based strategies have advanced steadily toward clinical trials, spurred by the immense need to find reparative therapeutics for central nervous system (CNS) diseases and injury. Current phase I/II trials using stem cells in the CNS are the vanguard for the widely anticipated next generation of regenerative therapies and as such are pioneering the stem cell therapy process. While translation has typically been the purview of industry, academic researchers are increasingly driven to bring their findings toward treatments and face challenges in knowledge gap and resource access that are accentuated by the unique financial, manufacturing, scientific, and regulatory aspects of cell therapy. Solutions are envisioned that both address the significant unmet medical need and lead to increased funding for basic and translational research.	[Stern, Jeffrey H.; Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Niazi, Nilofar] CNS Regenerat Med Fdn, New York, NY 10069 USA; [Capela, Alexandra] StemCells Inc, Palo Alto, CA 94304 USA; [Aboody, Karen] City Hope Natl Med Ctr, Dept Neurosci, Duarte, CA 91010 USA; [Aboody, Karen] City Hope Natl Med Ctr, Div Neurosurg, Duarte, CA 91010 USA; [Aboody, Karen] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Temple, S (corresponding author), Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org						Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Alberts B, 2010, SCIENCE, V329, P1257, DOI 10.1126/science.1197077; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009414; Burger SR, 2003, CYTOTHERAPY, V5, P289, DOI 10.1080/14653240310002324; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cundiff PE, 2011, CURR OPIN GENET DEV, V21, P354, DOI 10.1016/j.gde.2011.01.008; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Gentry T, 2007, CYTOTHERAPY, V9, P259, DOI 10.1080/14653240701218516; Giannelli SG, 2011, STEM CELLS, V29, P344, DOI 10.1002/stem.579; Goldman SA, 2011, ARCH NEUROL-CHICAGO, V68, P848, DOI 10.1001/archneurol.2011.46; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Isacson O, 2010, NAT MED, V16, P960, DOI 10.1038/nm0910-960b; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keung AJ, 2010, WIRES SYST BIOL MED, V2, P49, DOI 10.1002/wsbm.46; Kim SU, 2007, BRAIN DEV-JPN, V29, P193, DOI 10.1016/j.braindev.2006.07.012; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P191, DOI 10.1111/j.1749-6632.2009.04962.x; Lindsay SL, 2010, GLIA, V58, P125, DOI 10.1002/glia.20917; LIU MB, 2010, CLIN TRIAL MANUAL DU; Lowry N, 2008, EXP NEUROL, V209, P510, DOI 10.1016/j.expneurol.2007.09.031; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Neuman T., 2009, OPEN STEM CELL J, V1, P20, DOI DOI 10.2174/1876893800901010020; *NINDS, 2011, 2012 FISC YEAR BUDG; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; PriceWaterhouseCoopers, 2008, PHARM 2020 VIRT R D; Raisman G, 2007, NAT REV NEUROSCI, V8, P312, DOI 10.1038/nrn2099; Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416; Rohn J, 2011, NATURE, V471, P7, DOI 10.1038/471007a; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Sandrock RW, 2010, REGEN MED, V5, P381, DOI 10.2217/RME.10.24; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Steiner R., 2009, 12 INT C NEUR CER LI; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Sun J, 2010, TRANSFUSION, V50, P1980, DOI 10.1111/j.1537-2995.2010.02720.x; Tamaki SJ, 2009, CELL STEM CELL, V5, P310, DOI 10.1016/j.stem.2009.05.022; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wallace VA, 2011, STEM CELLS, V29, P412, DOI 10.1002/stem.602; West EL, 2009, PROG BRAIN RES, V175, P3, DOI 10.1016/S0079-6123(09)17501-5; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; [WORLD HEALTH ORG. UNAIDS], 2006, PROGR GLOB ACC HIV A, P36; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011	65	143	149	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 26	2011	70	4					597	613		10.1016/j.neuron.2011.05.007	http://dx.doi.org/10.1016/j.neuron.2011.05.007			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	792NR	21609819	Bronze			2022-12-17	WOS:000292754300005
J	Volkow, ND; Baler, RD; Goldstein, RZ				Volkow, Nora D.; Baler, Ruben D.; Goldstein, Rita Z.			Addiction: Pulling at the Neural Threads of Social Behaviors	NEURON			English	Editorial Material							PREFRONTAL CORTEX; DRUG-ABUSE	Addiction coopts the brain's neuronal circuits necessary for insight, reward, motivation, and social behaviors. This functional overlap results in addicted individuals making poor choices despite awareness of the negative consequences; it explains why previously rewarding life situations and the threat of judicial punishment cannot stop drug taking and why a medical rather than a criminal approach is more effective in curtailing addiction.	[Volkow, Nora D.; Baler, Ruben D.] Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA; [Goldstein, Rita Z.] Brookhaven Natl Lab, Ctr Translat Neuroimaging, Dept Med Res, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ACQUAS E, 1992, J NEUROCHEM, V58, P1620, DOI 10.1111/j.1471-4159.1992.tb10033.x; Behen ME, 2009, BRAIN IMAGING BEHAV, V3, P292, DOI 10.1007/s11682-009-9071-6; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Karelina K, 2011, PSYCHOSOM MED, V73, P67, DOI 10.1097/PSY.0b013e3182002116; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Martinez D, 2010, BIOL PSYCHIAT, V67, P275, DOI 10.1016/j.biopsych.2009.07.037; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Mumola C., 2006, BUREAU JUSTICE STAT; *ONDCP, 2004, EC COSTS DRUG AB US; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Weiss F, 2001, NEUROTOX RES, V3, P145, DOI 10.1007/BF03033235	19	143	145	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 24	2011	69	4					599	602		10.1016/j.neuron.2011.01.027	http://dx.doi.org/10.1016/j.neuron.2011.01.027			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338873	Green Accepted, Bronze			2022-12-17	WOS:000288413200005
J	Yu, Y; Chen, Z; Li, WG; Cao, H; Feng, EG; Yu, F; Liu, H; Jiang, HL; Xu, TL				Yu, Ye; Chen, Zhi; Li, Wei-Guang; Cao, Hui; Feng, En-Guang; Yu, Fang; Liu, Hong; Jiang, Hualiang; Xu, Tian-Le			A Nonproton Ligand Sensor in the Acid-Sensing Ion Channel	NEURON			English	Article							TARANTULA TOXIN PSALMOTOXIN-1; DORSAL-HORN NEURONS; TRP CHANNELS; MECHANOSENSORY FUNCTION; EXTRACELLULAR DOMAIN; INFLAMMATORY PAIN; ASIC 1A; MODULATION; ISCHEMIA; CA2+	Acid-sensing ion channels (ASICs) have long been considered as extracellular proton (H+)-gated cation channels, and peripheral ASIC3 channels seem to be a natural sensor of acidic pain. Here, we report the identification of a nonproton sensor on ASIC3. We show first that 2-guanidine-4-methylquinazoline (GMQ) causes persistent ASIC3 channel activation at the normal pH. Using GMQ as a probe and combining mutagenesis and covalent modification analysis, we then uncovered a ligand sensor lined by residues around E423 and E79 of the extracellular "palm" domain of the ASIC3 channel that-is crucial for activation by nonproton activators. Furthermore, we show that GMQ activates sensory neurons and causes pain-related behaviors in an ASIC3,dependent manner, indicating the functional significance of ASIC activation by nonproton ligands. Thus, natural ligands beyond protons may activate ASICs under physiological and pathological conditions through the nonproton ligand sensor, serving for channel activation independent of abrupt and marked acidosis.	[Chen, Zhi; Feng, En-Guang; Liu, Hong; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Yu, Fang; Xu, Tian-Le] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Yu, Fang; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; tlxu@ion.ac.cn		Yu, Ye/0000-0002-4054-8543	National Natural Science Foundation of China [30830035, 30700145, 9091300]; National Basic Research Program of China [2006CB500803, 2011CB809005, 2009CB918502]; Shanghai Municipal Government [09XD1404900]; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Government; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank all groups that provided us with ASIC cDNAs and thank Drs. J.A. Wemmie, M.P Price, and M J Welsh for their kind gills of asic3 and asic1 knockout mice. We also thank Drs. M -m Poo and M.X Zhu for helpful comments on the manuscript This study was supported by grants from the National Natural Science Foundation of China (Nos. 30830035, 30700145, and 9091300), the National Basic Research Program of China (2006CB500803, 2011CB809005, and 2009CB918502), and the Shanghai Municipal Government (09XD1404900). Y.Y is a postdoctoral fellow supported by the K.C. Wong Education Foundation (Hong Kong) and China Postdoctoral Science Foundation	Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coric T, 2008, FASEB J, V22, P1914, DOI 10.1096/fj.07-100313; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Li YF, 2003, J PHYSIOL-LONDON, V552, P73, DOI 10.1113/jphysiol.2003.047324; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Otake K, 1998, BRAIN RES, V787, P1, DOI 10.1016/S0006-8993(97)01200-6; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Reis DJ, 1998, NEUROSCI LETT, V250, P185, DOI 10.1016/S0304-3940(98)00466-2; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang W, 2006, J BIOL CHEM, V281, P2497, DOI 10.1074/jbc.M507123200; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Welsh MJ, 2002, J BIOL CHEM, V277, P2369, DOI 10.1074/jbc.R100060200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu TL, 2009, PROG NEUROBIOL, V87, P171, DOI 10.1016/j.pneurobio.2009.01.004; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	62	143	150	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					61	72		10.1016/j.neuron.2010.09.001	http://dx.doi.org/10.1016/j.neuron.2010.09.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920791	Bronze			2022-12-17	WOS:000283704200008
J	Lee, MC; Yasuda, R; Ehlers, MD				Lee, Ming-Chia; Yasuda, Ryohei; Ehlers, Michael D.			Metaplasticity at Single Glutamatergic Synapses	NEURON			English	Article							LONG-TERM POTENTIATION; RECEPTOR SUBUNIT COMPOSITION; NR2B-CONTAINING NMDA RECEPTORS; BIDIRECTIONAL SYNAPTIC PLASTICITY; VISUAL-CORTEX; DENDRITIC SPINES; DEVELOPMENTAL REGULATION; POSTNATAL-DEVELOPMENT; HIPPOCAMPAL-NEURONS; DIFFERENTIAL ROLES	Optimal function of neuronal networks requires interplay between rapid forms of Hebbian plasticity and homeostatic mechanisms that adjust the threshold for plasticity, termed metaplasticity. Numerous forms of rapid synapse plasticity have been examined in detail. However, the rules that govern synaptic metaplasticity are much less clear. Here, we demonstrate a local subunit-specific switch in NMDA receptors that alternately primes or prevents potentiation at single synapses. Prolonged suppression of neurotransmitter release enhances NMDA receptor currents, increases the number of functional NMDA receptors containing NR2B, and augments calcium transients at single dendritic spines. This local switch in NMDA receptors requires spontaneous glutamate release but is independent of action potentials. Moreover, single inactivated synapses exhibit a lower induction threshold for both long-term synaptic potentiation and plasticity-induced spine growth. Thus, spontaneous glutamate release adjusts plasticity threshold at single synapses by local regulation of NMDA receptors, providing a novel spatially delimited form of synaptic metaplasticity.	[Lee, Ming-Chia; Yasuda, Ryohei; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	NINDS/NIH; NIMH/NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748, R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574, R01NS068410] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Benjamin Arenkiel, Ian Davison, David Fitzpatrick, Juliet Hernandez, Matt Kennedy, Shih-Chieh Lin, Tom Newpher, Sri Raghavachari, and Richard Weinberg for critical review of the manuscript. We thank Irina Lebedeva and Marguerita Klein for excellent technical assistance. This work was supported by grants from the NINDS/NIH and NIMH/NIH to M.D.E. and NIMH/NIH to R.Y. M.D.E. is an Investigator of the Howard Hughes Medical Institute. R.Y. is an Early Career Scientist of the Howard Hughes Medical Institute.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Capogna M, 1997, J NEUROSCI, V17, P7190; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen L, 2000, MOL BRAIN RES, V78, P196, DOI 10.1016/S0169-328X(00)00076-0; Colonnese MT, 2003, J NEUROPHYSIOL, V89, P57, DOI 10.1152/jn.00049.2002; Cormier RJ, 2001, J NEUROPHYSIOL, V85, P399, DOI 10.1152/jn.2001.85.1.399; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2007, NAT NEUROSCI, V10, P485, DOI 10.1038/nn1859; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Ito I, 2000, NEUROPHARMACOLOGY, V39, P943, DOI 10.1016/S0028-3908(99)00217-8; Ito I, 1997, J PHYSIOL-LONDON, V500, P401, DOI 10.1113/jphysiol.1997.sp022030; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Kumar SS, 2003, J NEUROSCI, V23, P10074; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; YASUDA R, 2004, SCI STKE, P15; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	78	143	144	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					859	870		10.1016/j.neuron.2010.05.015	http://dx.doi.org/10.1016/j.neuron.2010.05.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620872	Green Accepted, Bronze			2022-12-17	WOS:000279420800009
J	Scott, K				Scott, K			Taste recognition: Food for thought	NEURON			English	Review							ODORANT RECEPTOR EXPRESSION; SWEET TASTE; BITTER TASTE; SENSORY PROJECTIONS; POSITIONAL CLONING; MAMMALIAN SWEET; SOLITARY TRACT; SOUR TASTE; DROSOPHILA; GENE	The ability to identify food that is nutrient-rich and avoid toxic substances is essential for an animal's survival. Although olfaction and vision contribute to food detection, the gustatory system acts as a final checkpoint control for food acceptance or rejection behavior. Recent studies with model organisms such as mice and Drosophila have identified candidate taste receptors and examined the logic of taste coding in the periphery. Despite differences in terms of gustatory anatomy and taste-receptor families, these gustatory systems share a basic organization that is different from other sensory systems. This review will summarize our current understanding of taste recognition in mammals and Drosophila, highlighting similarities and raising several as yet unanswered questions.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 291 Life Sci Addict, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NIDCD NIH HHS [1R01DC006252-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACKERMAN D., 1991, NATURAL HIST SENSES; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2000, NEUROSCI LETT, V283, P61, DOI 10.1016/S0304-3940(00)00911-3; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Boughter JD, 1999, NEURON, V22, P213, DOI 10.1016/S0896-6273(00)81082-X; Breslin PAS, 1996, PERCEPT PSYCHOPHYS, V58, P327, DOI 10.3758/BF03206809; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; DeSimone JA, 2001, RESP PHYSIOL, V129, P231, DOI 10.1016/S0034-5687(01)00293-6; Dethier VG, 1976, HUNGRY FLY; Dotson CD, 2005, CHEM SENSES, V30, P593, DOI 10.1093/chemse/bji053; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gilbertson TA, 1998, CURR OPIN NEUROBIOL, V8, P447, DOI 10.1016/S0959-4388(98)80030-5; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Glendinning JI, 2005, CHEM SENSES, V30, P299, DOI 10.1093/chemse/bji025; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; HAMILTON RB, 1984, J COMP NEUROL, V222, P560, DOI 10.1002/cne.902220408; HAYAMA T, 1985, EXP BRAIN RES, V60, P235; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KINNAMON SC, 1988, J GEN PHYSIOL, V91, P351, DOI 10.1085/jgp.91.3.351; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kleyman TR, 1999, SEMIN NEPHROL, V19, P524; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; Lyall V, 2005, CHEM SENSES, V30, pI42, DOI 10.1093/chemse/bjh104; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/ng0501-58; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MIYAMOTO T, 1988, J PHYSIOL-LONDON, V405, P699, DOI 10.1113/jphysiol.1988.sp017356; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sclafani A, 2004, APPETITE, V43, P1, DOI 10.1016/j.appet.2004.03.007; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Smith DV, 1999, CURR OPIN NEUROBIOL, V9, P427, DOI 10.1016/S0959-4388(99)80064-6; Smith DV, 2001, SCI AM, V284, P32, DOI 10.1038/scientificamerican0301-32; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; TRAVERS JB, 1987, ANNU REV NEUROSCI, V10, P595, DOI 10.1146/annurev.ne.10.030187.003115; TRAVERS SP, 1991, J NEUROPHYSIOL, V65, P1372, DOI 10.1152/jn.1991.65.6.1372; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	103	143	146	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					455	464		10.1016/j.neuron.2005.10.015	http://dx.doi.org/10.1016/j.neuron.2005.10.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269362	Bronze			2022-12-17	WOS:000233250100006
J	Schultz, J; Friston, KJ; O'Doherty, J; Wolpert, DM; Frith, CD				Schultz, J; Friston, KJ; O'Doherty, J; Wolpert, DM; Frith, CD			Activation in posterior superior temporal sulcus parallels parameter inducing the percept of animacy	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; BIOLOGICAL MOTION; FUNCTIONAL MRI; NEURAL BASIS; HUMAN BRAIN; NEURONS; MOVEMENT; MACAQUE; OBJECT	An essential, evolutionarily stable feature of brain function is the detection of animate entities, and one of the main cues to identify them is their movement. We developed a model of a simple interaction between two objects, in which an increase of the correlation between their movements varied the amount of interactivity and animacy observers attributed to them. Functional magnetic resonance imaging revealed that activation in the posterior superior temporal sulcus and gyrus (pSTS/pSTG) increased in relation to the degree of correlated motion between the two objects. This activation increase was not different when subjects performed an explicit or implicit task while observing these interacting objects. These data suggest that the pSTS and pSTG play a role in the automatic identification of animate entities, by responding directly to an objective movement characteristic inducing the percept of animacy, such as the amount of interactivity between two moving objects.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Schultz, J (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	johannes.schultz@tuebingen.mpg.de	Schultz, Johannes/B-8613-2012; O'Doherty, John P/F-1204-2013; Frith, Chris D/A-2171-2009; Friston, Karl/D-9230-2011	Schultz, Johannes/0000-0003-4117-232X; Frith, Chris D/0000-0002-8665-0690; Friston, Karl/0000-0001-7984-8909; Wolpert, Daniel/0000-0003-2011-2790				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; BASSILI JN, 1976, J PERS SOC PSYCHOL, V33, P680; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Blythe PW., 1999, SIMPLE HEURISTICS MA, P257; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Duvernoy HM, 1999, HUMAN BRAIN; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Johnson SC, 2003, PHILOS T R SOC B, V358, P549, DOI 10.1098/rstb.2002.1237; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; Nielsen JM, 1958, MEMORY AMNESIA; Opfer JE, 2002, COGNITION, V86, P97, DOI 10.1016/S0010-0277(02)00171-3; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; PERANI D, 1995, NEUROREPORT, V6, P1637, DOI 10.1097/00001756-199508000-00012; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257	54	143	145	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					625	635		10.1016/j.neuron.2004.12.052	http://dx.doi.org/10.1016/j.neuron.2004.12.052			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721247	Bronze			2022-12-17	WOS:000227099700017
J	Carello, CD; Krauzlis, RJ				Carello, CD; Krauzlis, RJ			Manipulating intent: Evidence for a causal role of the superior colliculus in target selection	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; CHOICE REACTION-TIME; VISUAL-SEARCH TASK; NEURONAL-ACTIVITY; ELECTRICAL-STIMULATION; SPATIAL ATTENTION; PURSUIT; MONKEY; MICROSTIMULATION; DISCRIMINATION	The superior colliculus (SC) is well known for its role in the motor control of saccades. Recent work has shown that it also plays a role in the selection of saccades, but a causal role in the process of target selection has not been demonstrated. We applied subthreshold microstimulation to the SC while monkeys performed a task requiring them to select a stimulus as the target for a pursuit or saccade movement. Stimulation increased the proportion of selections toward the stimulus that appeared contralateral to the site of stimulation and also decreased their latencies. For pursuit, this stimulation-induced contralateral response bias was with respect to the initial target location and not the direction of eye movement, demonstrating a causal effect on target choice distinct from any effect on motor preparation. These results show that the SC helps decide the object of the next movement, beyond its traditional responsibility of saccade production.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego	Carello, CD (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA USA.	ccarello@ucsd.edu		Richard, Krauzlis/0000-0002-1826-0447	NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER; NEI NIH HHS [EY12212] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler SA, 2002, J VISION, V2, P627, DOI 10.1167/2.9.5; Asrress KN, 2001, VISION RES, V41, P2645, DOI 10.1016/S0042-6989(01)00107-9; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; Basso MA, 1998, J NEUROSCI, V18, P7519; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; Carpenter R. H. S., 1981, EYE MOVEMENTS COGNIT, P237; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Dorris MC, 1997, J NEUROSCI, V17, P8566; GIRVIN JP, 1979, SENS PROCESS, V3, P66; GLIMCHER PW, 1993, J NEUROPHYSIOL, V69, P953, DOI 10.1152/jn.1993.69.3.953; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Keller EL, 2003, ANN NY ACAD SCI, V1004, P29, DOI 10.1196/annals.1303.004; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2002, ANN NY ACAD SCI, V956, P409, DOI 10.1111/j.1749-6632.2002.tb02842.x; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan Gordon D., 1994, P189; Macmillan N, 1991, DETECTION THEORY USE; McGarry T, 2003, Q J EXP PSYCHOL-A, V56, P601, DOI 10.1080/02724980244000549; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; McPeek RM, 2003, J NEUROPHYSIOL, V89, P2577, DOI 10.1152/jn.00657.2002; McPeek RM, 2002, J NEUROPHYSIOL, V87, P1805, DOI 10.1152/jn.00501.2001; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SCHWARZ W, 1993, PSYCHOL RES-PSYCH FO, V55, P200, DOI 10.1007/BF00419607; SHELIGA BM, 1995, NEUROREPORT, V6, P585, DOI 10.1097/00001756-199502000-00044; SPARKS DL, 1990, ANNU REV NEUROSCI, V13, P309, DOI 10.1146/annurev.ne.13.030190.001521; SPARKS DL, 1989, NEUROBIOLOGY SACCADI, V3, P213; STRYKER MP, 1975, EXP BRAIN RES, V23, P103; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	52	143	145	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 19	2004	43	4					575	583		10.1016/j.neuron.2004.07.026	http://dx.doi.org/10.1016/j.neuron.2004.07.026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312655	Bronze			2022-12-17	WOS:000223436400015
J	Marillat, V; Sabatier, C; Failli, V; Matsunaga, E; Sotelo, C; Tessier-Lavigne, M; Chedotal, A				Marillat, V; Sabatier, C; Failli, V; Matsunaga, E; Sotelo, C; Tessier-Lavigne, M; Chedotal, A			The slit receptor Rig-1/Robo3 controls midline crossing by hindbrain precerebellar neurons and axons	NEURON			English	Article							INFERIOR OLIVARY NEURONS; FLOOR PLATE; NEURITIC DIFFERENTIATION; MOLECULAR-MECHANISMS; CEREBELLAR SYSTEM; COMMISSURAL AXONS; MIGRATORY STREAM; CAUDAL MEDULLA; RETINAL AXONS; CNS MIDLINE	During development, precerebellar neurons migrate dorsoventrally from the rhombic lip to the floor plate. Some of these neurons cross the midline while others stop. We have identified a role for the slit receptor Rig-1/Robo3 in directing this process. During their tangential migration, neurons of all major hindbrain precerebellar nuclei express high levels of Rig-1 mRNA. Rig-1 expression is rapidly downregulated as their leading process crosses the floor plate. Interestingly, most precerebellar nuclei do not develop normally in Rig-1-deficient mice, as they fail to cross the midline. In addition, inferior olivary neurons, which normally send axons into the contralateral cerebellum, project ipsilaterally in Rig-1 mutant mice. Similarly, neurons of the lateral reticular nucleus and basilar pons are unable to migrate across the floor plate and instead remain ipsilateral. These results demonstrate that Rig-1 controls the ability of both precerebellar neuron cell bodies and their axons to cross the midline.	Univ Paris 06, CNRS, UMR7102, F-75005 Paris, France; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Howard Hughes Medical Institute; Stanford University	Chedotal, A (corresponding author), Univ Paris 06, CNRS, UMR7102, Bat B,Case 12,9 Quai St Bernard, F-75005 Paris, France.	chedotal@infobiogen.fr	Sotelo, Constantino/G-3397-2015; Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794; Sotelo, Constantino/0000-0001-8051-2492				Alcantara S, 2000, DEVELOPMENT, V127, P1359; ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; ALTMAN J, 1987, J COMP NEUROL, V257, P490, DOI 10.1002/cne.902570403; ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P300; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; BOURRAT F, 1990, ARCH ITAL BIOL, V128, P151; BOURRAT F, 1991, J COMP NEUROL, V313, P509, DOI 10.1002/cne.903130311; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Causeret F, 2002, DEV BIOL, V246, P429, DOI 10.1006/dbio.2002.0681; Chedotal A, 1996, J NEUROSCI, V16, P3296; de Diego I, 2002, DEVELOPMENT, V129, P297; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Gilthorpe JD, 2002, DEVELOPMENT, V129, P4719; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kyriakopoulou K, 2002, DEVELOPMENT, V129, P287; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; ONO K, 1990, ANAT EMBRYOL, V182, P11; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Stoeckli ET, 1998, PROG BRAIN RES, V117, P105; TABERPIERCE E, 1973, PROG BRAIN RES, V40, P53; Taniguchi H, 2002, DEV BIOL, V249, P321, DOI 10.1006/dbio.2002.0763; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Wong MS, 2002, NANO LETT, V2, P583, DOI 10.1021/nl020244c; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zhu Y, 2002, DEV DYNAM, V225, P365, DOI 10.1002/dvdy.10166; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	52	143	144	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					69	79		10.1016/j.neuron.2004.06.018	http://dx.doi.org/10.1016/j.neuron.2004.06.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233918	Bronze			2022-12-17	WOS:000222549800008
J	Brody, CD; Hopfield, JJ				Brody, CD; Hopfield, JJ			Simple networks for spike-timing-based computation, with application to olfactory processing	NEURON			English	Article							BULB; REPRESENTATIONS; OSCILLATIONS; RECOGNITION; INTEGRATION; SYNCHRONY; RESPONSES; MIXTURES; ODORANTS; NEURONS	Spike synchronization across neurons can be selective for the situation where neurons are driven at similar firing rates, a "many are equal" computation. This can be achieved in the absence of synaptic interactions between neurons, through phase locking to a common underlying oscillatory potential. Based on this principle, we instantiate an algorithm for robust odor recognition into a model network of spiking neurons whose main features are taken from known properties of biological olfactory systems. Here, recognition of odors is signaled by spike synchronization of specific subsets of "mitral cells." This synchronization is highly odor selective and invariant to a wide range of odor concentrations. It is also robust to the presence of strong distractor odors, thus allowing odor segmentation within complex olfactory scenes. Information about odors is encoded in both the identity of glomeruli activated above threshold (1 bit of information per glomerulus) and in the analog degree of activation of the glomeruli (approximately 3 bits per glomerulus).	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Cold Spring Harbor Laboratory; Princeton University	Brody, CD (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC06104-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Hopfield IJ, 2000, P NATL ACAD SCI USA, V97, P13919, DOI 10.1073/pnas.250483697; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; Hopfield JJ, 1998, ADV NEUR IN, V10, P166; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Krone D, 2001, PHYTOTHER RES, V15, P135, DOI 10.1002/ptr.716; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; Laing DG, 2001, CHIMIA, V55, P413; LAVINE RA, 1971, J NEUROPHYSIOL, V34, P467, DOI 10.1152/jn.1971.34.3.467; Meister M, 2001, J NEUROSCI, V21, P1351; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2	21	143	147	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 6	2003	37	5					843	852		10.1016/S0896-6273(03)00120-X	http://dx.doi.org/10.1016/S0896-6273(03)00120-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628174	Bronze			2022-12-17	WOS:000181452800013
J	Janssen, P; Vogels, R; Orban, GA				Janssen, P; Vogels, R; Orban, GA			Three-dimensional shape coding in inferior temporal cortex	NEURON			English	Article							MACAQUE MONKEY; INFEROTEMPORAL CORTEX; RHESUS-MONKEY; VISUAL IMAGES; NEURONS; DISPARITY; SELECTIVITY; SENSITIVITY; STEREOPSIS; SURFACES	Neurons in the rostral lower bank of the superior temporal sulcus (TEs), part of the inferior temporal cortex, respond selectively to three-dimensional (3D) shapes. We have investigated how these neurons represent disparity-defined 3D structure. Most neurons were selective for either first-order (disparity gradients) or second-order (disparity curvature) disparities. The latter selectivity proved remarkably vulnerable to disparity discontinuities, such as sharp edges or steps in disparity. The majority of the neurons remained selective for small disparity variations within the stimulus. 3D shape selectivity was preserved when the fronto-parallel position or the stimulus size was altered. Thus, in TEs, 3D shape is coded by first- and second-order disparity-selective neurons, which are highly sensitive to spatial variations of disparity.	Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium	KU Leuven	Orban, GA (corresponding author), Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	guy.orban@med.kuleuven.ac.be		Orban, Guy/0000-0002-8179-9584				BAIZER JS, 1991, J NEUROSCI, V11, P168; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; Cumming BG, 1999, J NEUROSCI, V19, P5602; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1984, J NEUROSCI, V4, P2051; GATTASS R, 1988, J NEUROSCI, V8, P1831; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HARWERTH RS, 1995, VISION RES, V35, P1755, DOI 10.1016/0042-6989(94)00256-L; HARWERTH RS, 1979, VISION RES, V19, P985, DOI 10.1016/0042-6989(79)90223-2; Howard I.P., 1995, BINOCULAR VISION STE; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; IWAI E, 1969, EXP NEUROL, V25, P585, DOI 10.1016/0014-4886(69)90101-0; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Janssen P, 1998, DOC OPHTHALMOL, V95, P247, DOI 10.1023/A:1001848105993; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; KOENDERINK JJ, 1976, BIOL CYBERN, V21, P29, DOI 10.1007/BF00326670; KOMATSU H, 1992, J NEUROSCI, V12, P408; LOWE D, 1986, PERCEPTUAL ORG 3 DIM; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; NORMAN JF, 1991, PERCEPTION, V20, P789, DOI 10.1068/p200789; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Prince SJD, 1998, VISION RES, V38, P2533, DOI 10.1016/S0042-6989(98)00118-7; ROGERS B, 1989, NATURE, V339, P135, DOI 10.1038/339135a0; ROY JP, 1992, J NEUROSCI, V12, P2478; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SATO T, 1980, EXP BRAIN RES, V38, P313; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; STEVENS KA, 1988, VISION RES, V28, P371, DOI 10.1016/0042-6989(88)90180-0; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; WEISKRANTZ L, 1984, BRAIN, V107, P1033, DOI 10.1093/brain/107.4.1033	39	143	146	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	2000	27	2					385	397		10.1016/S0896-6273(00)00045-3	http://dx.doi.org/10.1016/S0896-6273(00)00045-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	347YD	10985357	Green Published, Bronze			2022-12-17	WOS:000088956000021
J	Chain, DG; Casadio, A; Schacher, S; Hegde, AN; Valbrun, M; Yamamoto, N; Goldberg, AL; Bartsch, D; Kandel, ER; Schwartz, JH				Chain, DG; Casadio, A; Schacher, S; Hegde, AN; Valbrun, M; Yamamoto, N; Goldberg, AL; Bartsch, D; Kandel, ER; Schwartz, JH			Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia	NEURON			English	Article							SIPHON-WITHDRAWAL REFLEX; SENSORY NEURONS; REGULATORY SUBUNIT; PERSISTENT ACTIVATION; TRANSMITTER RELEASE; MOLECULAR MECHANISM; CATALYTIC SUBUNIT; CELL-CULTURE; SITE-A; UBIQUITIN	The formation of a persistently active cAMP-dependent protein kinase (PKA) is critical far establishing long-term synaptic facilitation (LTF) in Aplysia. The injection of bovine catalytic (C) subunits into sensory neurons is sufficient to produce protein synthesis-dependent LTF. Early in the LTF induced by serotonin (5-HT), an autonomous PKA is generated through the ubiquitin-proteasome-mediated proteolysis of regulatory (R) subunits. The degradation of R occurs during an early time window and appears to be a key function of proteasomes in LTF. Lactacystin, a specific proteasome inhibitor, blocks the facilitation induced by 5-HT, and this block is rescued by injecting C subunits. R is degraded through an allosteric mechanism requiring an elevation of cAMP coincident with the induction of a ubiquitin carboxy-terminal hydrolase.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard Medical School	Schwartz, JH (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.	jhs6@columbia.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029255, R55NS029255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32099] Funding Source: Medline; NIMH NIH HHS [MH48850] Funding Source: Medline; NINDS NIH HHS [NS29255] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BERGOLD PJ, 1990, P NATL ACAD SCI USA, V87, P3788, DOI 10.1073/pnas.87.10.3788; BERGOLD PJ, 1992, NEURON, V8, P387, DOI 10.1016/0896-6273(92)90304-V; BERNIER L, 1982, J NEUROSCI, V2, P1682; BUBIS J, 1988, J BIOL CHEM, V263, P9668; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; Byrne JH, 1996, J NEUROSCI, V16, P425; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; DALE N, 1987, J NEUROSCI, V7, P2232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dohrman DP, 1996, P NATL ACAD SCI USA, V93, P10217, DOI 10.1073/pnas.93.19.10217; EYTAN E, 1993, J BIOL CHEM, V268, P4668; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; GREENBERG SM, 1987, J NEUROSCI, V7, P291; Haas AL, 1997, FASEB J, V11, P1257; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOFMANN F, 1977, J BIOL CHEM, V252, P1441; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; MCKNIGHT GS, 1988, RECENT PROG HORM RES, V44, P307; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Mykles DL, 1998, INT REV CYTOL, V184, P157, DOI 10.1016/S0074-7696(08)62181-6; NEITZEL JJ, 1991, BIOCHEMISTRY-US, V30, P733, DOI 10.1021/bi00217a023; OH CE, 1994, J NEUROSCI, V14, P3166; OLEARY FA, 1995, J NEUROSCI, V15, P3519; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SACKTOR TC, 1990, P NATL ACAD SCI USA, V87, P2036, DOI 10.1073/pnas.87.5.2036; SAITOH T, 1983, P NATL ACAD SCI-BIOL, V80, P6708, DOI 10.1073/pnas.80.21.6708; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; Schwartz JH, 1989, NEURAL MODELS PLASTI, P46; Sossin W S, 1994, Learn Mem, V1, P189; SQUIRES L, 1987, MEMORY BRAIN; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.biochem.59.1.971; Vanderklish P, 1996, LEARN MEMORY, V3, P209, DOI 10.1101/lm.3.2-3.209; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275	67	143	150	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1999	22	1					147	156		10.1016/S0896-6273(00)80686-8	http://dx.doi.org/10.1016/S0896-6273(00)80686-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027297	Bronze			2022-12-17	WOS:000078410300020
J	Baker, OS; Larsson, HP; Mannuzzu, LM; Isacoff, EY				Baker, OS; Larsson, HP; Mannuzzu, LM; Isacoff, EY			Three transmembrane conformations and sequence-dependent displacement of the S4 domain in shaker K+ channel gating	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; ION CHANNELS; ACTIVATION; CURRENTS; CHARGE; INACTIVATION; TRANSITIONS; MOVEMENT; SEGMENT	We have acquired structural evidence that two components evident previously in the depolarization-evoked gating currents from voltage-gated Shaker K+ channels have their origin in sequential, two-step outward movements of the S4 protein segments. A point mutation greatly destabilizes the "fully retracted" state of S4 transmembrane translocation, causing instead an intermediate state to predominate at resting potentials. This state is distinguishable topologically and fluorometrically. That a point mutation effectively excludes half the range of S4 motion from physiological voltages suggests that the diverse sensitivities among voltage-gated channels might reflect not only differences in S4 valence, but also displacement. Existence of an intermediate subunit state helps explain why modeling channel activation has required positing greater than four closed states.	Univ Calif Berkeley, Grp Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Grp Biophys, Berkeley, CA 94720 USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	NINDS NIH HHS [R01NS35549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CREIGTON TC, 1993, PROTEINS STRUCTURES; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCCORMACK K, 1994, NEURON, V12, P301, DOI 10.1016/0896-6273(94)90273-9; MCCORMACK K, 1994, NEURON, V12, P706; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; Stryer L., 1988, BIOCHEMISTRY-US; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	40	143	148	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1283	1294		10.1016/S0896-6273(00)80507-3	http://dx.doi.org/10.1016/S0896-6273(00)80507-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655514	Bronze			2022-12-17	WOS:000074627300022
J	Luthi, A; McCormick, DA				Luthi, A; McCormick, DA			Periodicity of thalamic synchronized oscillations: The role of Ca2+-mediated upregulation of I-h	NEURON			English	Article							FERRET LATERAL GENICULATE; CAT THALAMOCORTICAL CELLS; ACTIVATED INWARD CURRENT; RELAY NEURONS; INTRACELLULAR CALCIUM; ADENYLYL CYCLASES; NODE CELLS; VITRO; MODULATION; MECHANISMS	Thalamocortical networks can generate both normal and abnormal patterns of synchronized network activity, such as spindle waves and spike-and-wave seizures. These periods of synchronized discharge are often separated by a silent, refractory phase of between 5 and 20 s. In vitro investigations have demonstrated that this refractory period is due in large part to the persistent activation of the hyperpolarization-activated cation current I-h in thalamocortical cells. Here, we show that increases in [Ca2+](i) due to rebound Ca2+ bursts result in persistent activation of I-h resulting from a positive shift in the activation curve of this current. The dynamical upregulation and persistent activation of I-h is the critical determinant of the time course of the refractory period. These findings demonstrate that periodicity in neural network oscillations may be generated through an interaction between the electrophysiological properties and intracellular signaling pathways of the constituent neurons.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA.		McCormick, David A/J-2649-2015; Luthi, Anita/ABE-1411-2021; Kobelt, Liza/F-5926-2011	McCormick, David A/0000-0002-9803-8335; Luthi, Anita/0000-0002-4954-4143				[Anonymous], [No title captured]; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Budde T, 1997, J PHYSIOL-LONDON, V503, P79, DOI 10.1111/j.1469-7793.1997.079bi.x; Contreras D, 1997, J NEUROSCI, V17, P1179; COOPER DMF, 1994, CELL SIGNAL, V6, P823, DOI 10.1016/0898-6568(94)90016-7; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; HAGIWARA N, 1989, J PHYSIOL-LONDON, V409, P121, DOI 10.1113/jphysiol.1989.sp017488; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; JANDO G, 1995, NEUROSCIENCE, V64, P301, DOI 10.1016/0306-4522(94)00329-4; Jones EG, 1985, THALAMUS; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; LANCASTER B, 1994, J PHYSIOL-LONDON, V475, P229, DOI 10.1113/jphysiol.1994.sp020064; Lee KH, 1996, NEURON, V17, P309, DOI 10.1016/S0896-6273(00)80162-2; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Matsuoka I, 1997, J NEUROCHEM, V68, P498; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; NIEDERMEYER E, 1990, EPILEPSIES DIAGNOSIS; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; SCHWINDT PC, 1992, NEUROSCIENCE, V47, P571, DOI 10.1016/0306-4522(92)90166-Y; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS, VI; TERZANO MG, 1985, SLEEP, V8, P137, DOI 10.1093/sleep/8.2.137; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Williams SR, 1997, J PHYSIOL-LONDON, V505, P727, DOI 10.1111/j.1469-7793.1997.727ba.x; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZAZA A, 1991, PFLUG ARCH EUR J PHY, V419, P662, DOI 10.1007/BF00370312; Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816, DOI 10.1152/jn.1997.77.5.2816; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L; ZUFALL F, 1993, P NATL ACAD SCI USA, V90, P9335, DOI 10.1073/pnas.90.20.9335	47	143	146	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					553	563		10.1016/S0896-6273(00)80994-0	http://dx.doi.org/10.1016/S0896-6273(00)80994-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539128	hybrid			2022-12-17	WOS:000072755600019
J	Schiffer, HH; Swanson, GT; Heinemann, SF				Schiffer, HH; Swanson, GT; Heinemann, SF			Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate	NEURON			English	Article							HIGH-AFFINITY KAINATE; CULTURED HIPPOCAMPAL-NEURONS; CHANNELS; AMPA; DESENSITIZATION; CLONING; RELEASE; DOMOATE	Glutamate receptors of the kainate-preferring subtype have recently been shown to mediate synaptic transmission in the hippocampus. The low-affinity kainate receptor subunit GluR7 was found to be nonfunctional in previous studies. We report here that the GluR7 subunit and a novel carboxy-terminal splice variant, GluR7b, are functional glutamate receptors with unique pharmacological properties. In particular, glutamate exhibits a 10-fold lower potency for (non-desensitized) GluR7-mediated currents as compared to other non-NMDA receptor channels. These data will facilitate understanding of the distinct role played by GluR7 receptors in synaptic transmission.			Schiffer, HH (corresponding author), SALK INST BIOL STUDIES, MOL NEUROBIOL LAB, LA JOLLA, CA 92037 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709] Funding Source: NIH RePORTER; NIGMS NIH HHS [1 F32 GM 18717-01] Funding Source: Medline; NINDS NIH HHS [2 RO1 NS 28709-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Diamond JS, 1997, J NEUROSCI, V17, P4672; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; NUTT SL, 1994, RECEPTOR CHANNEL, V2, P315; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Sahara Y, 1997, J NEUROSCI, V17, P6611; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SPRENGEL R, 1995, LIGAND VOLTAGE GATED, P213; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Yue KT, 1995, EUR J PHARM-MOLEC PH, V291, P229, DOI 10.1016/0922-4106(95)90062-4	24	143	147	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1141	1146		10.1016/S0896-6273(00)80404-3	http://dx.doi.org/10.1016/S0896-6273(00)80404-3			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390526	Bronze			2022-12-17	WOS:A1997YH59400020
J	Pettit, DL; Wang, SSH; Gee, KR; Augustine, GJ				Pettit, DL; Wang, SSH; Gee, KR; Augustine, GJ			Chemical two-photon uncaging: a novel approach to mapping glutamate receptors	NEURON			English	Article							PHOTOLABILE PRECURSORS; CAGED COMPOUNDS; MICROSCOPY; ACTIVATION; RELEASE	Functional mapping of neurotransmitter receptors requires rapid and localized application of transmitter. The usefulness of caged glutamate for this purpose has been limited, because photolysis by unfocused light above and below the target cell limits depth resolution. This problem is eliminated by using a double-caged glutamate that requires absorption of two photons for conversion to active glutamate, resulting in a substantial improvement in spatial resolution over conventional caged glutamate. This method was used to map the distribution of glutamate receptors on hippocampal pyramidal neurons. A higher density of AMPA receptors was found on distal apical dendrites than on basal or primary apical dendrites, suggesting that synaptic efficacy is locally heterogeneous. Such ''chemical two-photon uncaging'' offers a simple, general, and economical strategy for spatially localized photolysis of caged compounds.	MOL PROBES INC,EUGENE,OR 97402		Pettit, DL (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.		Augustine, George James/J-9228-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034045, P01NS017771] Funding Source: NIH RePORTER; NIMH NIH HHS [MH15177] Funding Source: Medline; NINDS NIH HHS [NS34045, NS17771] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Crank J., 1979, MATH DIFFUSION; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk Winfried, 1995, P445; Dingledine R., 1984, BRAIN SLICES; Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESS GP, 1995, ANN NY ACAD SCI, V757, P23, DOI 10.1111/j.1749-6632.1995.tb17462.x; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Inoue S, 1986, VIDEO MICROSCOPY; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; ONEILL SC, 1990, AM J PHYSIOL, V258, pC1165, DOI 10.1152/ajpcell.1990.258.6.C1165; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; Siegman A. E., 1971, INTRO LASERS MASERS; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752	24	143	148	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					465	471		10.1016/S0896-6273(00)80361-X	http://dx.doi.org/10.1016/S0896-6273(00)80361-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331338	Bronze			2022-12-17	WOS:A1997XZ01600001
J	Song, HJ; Ming, GL; Fon, E; Bellocchio, E; Edwards, RH; Poo, MM				Song, HJ; Ming, GL; Fon, E; Bellocchio, E; Edwards, RH; Poo, MM			Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging	NEURON			English	Article							NERVE-MUSCLE INTERACTIONS; XENOPUS CELL-CULTURE; CHOLINE-ACETYLTRANSFERASE; MONOAMINE TRANSPORTER; AMINE TRANSPORTER; NEUROMUSCULAR SYNAPSES; CAENORHABDITIS-ELEGANS; CHROMAFFIN GRANULES; SYNAPTIC VESICLES; GENE	A putative vesicular acetytcholine transporter (VAChT) was overexpressed in developing Xenopus spinal neurons by injection of rat VAChT cDNA or synthetic mRNA into Xenopus embryos. This resulted in a marked increase in the amplitude and frequency of miniature excitatory postsynaptic currents at neuromuscular synapses, reflecting an over 10-fold increase in the vesicular packaging of acetylcholine (ACh). The effect appeared in developing neurons even before synaptogenesis and was blocked by L-vesamicol, a specific blocker of ACh uptake into synaptic vesicles. Mutational studies showed that two highly conserved aspartate residues within putative transmembrane domains 4 and 10 are essential for the transport activity. These results provide direct evidence for the physiological function of a putative VAChT and demonstrate that quantal size can be regulated by changes in vesicular transporter activity.	UNIV CALIF SAN FRANCISCO, DEPT NEUROL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Song, HJ (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.		Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NIMH NIH HHS [MH 50712] Funding Source: Medline; NINDS NIH HHS [NS 22764] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDER J, 1995, J NEUROSCI, V15, P511; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; BERRARD S, 1995, J NEUROCHEM, V65, P939; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CERVINI R, 1995, J BIOL CHEM, V270, P24654, DOI 10.1074/jbc.270.42.24654; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DESNOS C, 1995, J BIOL CHEM, V270, P16030, DOI 10.1074/jbc.270.27.16030; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; EVERS J, 1989, J NEUROSCI, V9, P1523; Gilmor ML, 1996, J NEUROSCI, V16, P2179; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KIDOKORO Y, 1980, DEV BIOL, V78, P464, DOI 10.1016/0012-1606(80)90347-4; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; MARON R, 1983, J BIOL CHEM, V258, P1476; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; MISAWA H, 1995, NEUROREPORT, V6, P965, DOI 10.1097/00001756-199505090-00004; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; ORIDA N, 1978, NATURE, V275, P31, DOI 10.1038/275031a0; PARSONS SM, 1993, INT REV NEUROBIOL, V35, P279, DOI 10.1016/S0074-7742(08)60572-3; PRIOR C, 1992, GEN PHARMACOL, V23, P1017, DOI 10.1016/0306-3623(92)90280-W; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; SCHAFER MKH, 1994, J MOL NEUROSCI, V5, P1, DOI 10.1007/BF02736691; SCHULDINER S, 1993, J BIOL CHEM, V268, P29; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SteinerMordoch S, 1996, J BIOL CHEM, V271, P13048, DOI 10.1074/jbc.271.22.13048; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tabti N., 1991, CULTURING NERVE CELL, P137; VAROQUI H, 1994, FEBS LETT, V342, P97, DOI 10.1016/0014-5793(94)80592-X; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0	41	143	148	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1997	18	5					815	826		10.1016/S0896-6273(00)80320-7	http://dx.doi.org/10.1016/S0896-6273(00)80320-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182805	Bronze			2022-12-17	WOS:A1997XB72200014
J	Wu, LG; Betz, WJ				Wu, LG; Betz, WJ			Nerve activity but not intracellular calcium determines the time course of endocytosis at the frog neuromuscular junction	NEURON			English	Article							TRANSMITTER RELEASE; POSTTETANIC POTENTIATION; PRESYNAPTIC BOUTONS; SYNAPTIC VESICLES; EXOCYTOSIS; TERMINALS; MEMBRANE; CELLS; CA2+; DEPRESSION	We used FM1-43 imaging and intracellular recordings of synaptic potentials to measure the time course of endocytosis in frog motor nerve terminals following tetanic nerve stimulation, and we used fura-2 imaging of intraterminal Ca2+ concentration to compare endocytic rate and [Ca2+](i). Following a 30 Hz tetanus, endocytosis declined exponentially with a time constant that depended on the duration of stimulation. The level of [Ca2+](i) rose from a resting value of about 100 nM to more than 500 nM during 30 Hz stimulation, and rapidly declined to 200-250 nM after stimulation. [Ca2+](i) returned to resting level with a time course that, like endocytosis, depended on the duration of tetanic stimulation. However, the rate of [Ca2+](i) recovery was much slower than the rate of endocytosis, leading to the conclusion that endocytic rate is not determined solely by the instantaneous level of [Ca2+](i).	UNIV COLORADO,SCH MED,DEPT PHYSIOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NINDS NIH HHS [NS23466] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023466] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BURGOYNE RD, 1995, PFLUG ARCH EUR J PHY, V430, P213, DOI 10.1007/BF00374652; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; DELANEY KR, 1989, J NEUROSCI, V9, P3558; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1995, J NEUROSCI, V15, P8246; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; MELDOLESI J, 1981, PHILOS T ROY SOC B, V296, P55, DOI 10.1098/rstb.1981.0171; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Tank DW, 1995, J NEUROSCI, V15, P7940; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; ZENGEL JE, 1994, J PHYSIOL-LONDON, V477, P267, DOI 10.1113/jphysiol.1994.sp020189; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	34	143	148	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					769	779		10.1016/S0896-6273(00)80208-1	http://dx.doi.org/10.1016/S0896-6273(00)80208-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893033	Bronze			2022-12-17	WOS:A1996VP74300021
J	PIMENTA, AF; ZHUKAREVA, V; BARBE, MF; REINOSO, BS; GRIMLEY, C; HENZEL, W; FISCHER, I; LEVITT, P				PIMENTA, AF; ZHUKAREVA, V; BARBE, MF; REINOSO, BS; GRIMLEY, C; HENZEL, W; FISCHER, I; LEVITT, P			THE LIMBIC SYSTEM-ASSOCIATED MEMBRANE-PROTEIN IS AN IG SUPERFAMILY MEMBER THAT MEDIATES SELECTIVE NEURONAL GROWTH AND AXON TARGETING	NEURON			English	Article							CELL-ADHESION MOLECULE; MYELIN-ASSOCIATED GLYCOPROTEIN; IMMUNOGLOBULIN SUPERFAMILY; NEURAL DEVELOPMENT; OPIOID-BINDING; RAT-BRAIN; RECOGNITION; SEQUENCE; DOMAINS; DROSOPHILA	The formation of brain circuits requires molecular recognition between functionally related neurons. We report the cloning of a moleeule that participates in these interactions. The limbic system-associated membrane protein (LAMP) is an immunoglobulin (lg) superfamily member with 3 lg domains and a glycosyl-phosphatidylinositol anchor. In the developing forebrain, lamp is expressed mostly by neurons comprising limbic-associated cortical and subcortical regions that function in cognition, emotion, memory, and learning. The unique distribution of LAMP reflects its functional specificity. LAMP-transfected cells selectively facilitate neurite outgrowth of primary limbic neurons. Most striking, administration of anti-LAMP in vivo results in abnormal growth of the messy fiber projection from developing granule neurons in the dentate gyrus of the hippocampal formation, suggesting that LAMP is essential for proper targeting of this pathway. Rather than being a general guidance cue, LAMP likely serves as a recognition molecule for the formation of limbic connections.	TEMPLE UNIV,SCH ALLIED HLTH,DEPT PHYS THERAPY,PHILADELPHIA,PA 19140; GENENTECH INC,DEPT PROT CHEM,S SAN FRANCISCO,CA; MED COLL PENN,DEPT ANAT & NEUROBIOL,PHILADELPHIA,PA 19129	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Roche Holding; Genentech; Drexel University	PIMENTA, AF (corresponding author), UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT NEUROSCI & CELL BIOL,PISCATAWAY,NJ 08854, USA.		Fischer, Itzhak/D-1080-2012	Fischer, Itzhak/0000-0003-3187-8740; Henzel, William/0000-0003-2940-3797	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045507, R01MH045507] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45507] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARBE MF, 1995, J NEUROSCI, V15, P1819, DOI 10.1523/JNEUROSCI.15-03-01819.1995; BARBE MF, 1992, P NATL ACAD SCI USA, V89, P3706, DOI 10.1073/pnas.89.9.3706; BARBE MF, 1991, J NEUROSCI, V11, P519; BLISS TVP, 1974, J PHYSL, V239, P91; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHESSELET MF, 1991, NEUROSCIENCE, V40, P725, DOI 10.1016/0306-4522(91)90008-C; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FERRI RT, 1993, CEREB CORTEX, V3, P187, DOI 10.1093/cercor/3.3.187; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GAARSKJAER FB, 1985, J COMP NEUROL, V241, P154, DOI 10.1002/cne.902410204; GERBER LD, 1992, J BIOL CHEM, V267, P12168; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOODMAN CS, 1994, CELL, V78, P353, DOI 10.1016/0092-8674(94)90413-8; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAUG FMS, 1973, ADV ANAT EMBRYOL CEL, V47, P1; HEDGECOCK EM, 1990, NEURON, V2, P61; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HOOKFIELD S, 1994, MOL PROBES NERVOUS S; HORTON HL, 1988, J NEUROSCI, V8, P4653; HOUSER CR, 1990, J NEUROSCI, V10, P267; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KARLSTROM RO, 1993, DEVELOPMENT, V118, P509; KELLER F, 1989, NEURON, V3, P551, DOI 10.1016/0896-6273(89)90265-1; KELLER F, 1989, NEUROSCIENCE, V28, P455, DOI 10.1016/0306-4522(89)90192-9; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; LEVITT P, 1985, NEUROBIOLOGY DOWN SY, P195; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIPPMAN DA, 1992, GENE, V117, P249, DOI 10.1016/0378-1119(92)90734-7; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETER N, 1994, J NEUROSCI, V14, P1413, DOI 10.1523/JNEUROSCI.14-03-01413.1994; RIBAK CE, 1994, DEV BRAIN RES, V79, P47, DOI 10.1016/0165-3806(94)90048-5; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; SWEADNER KJ, 1983, J NEUROSCI, V3, P2504; TAKEUCHI M, 1991, Glycobiology, V1, P337, DOI 10.1093/glycob/1.4.337; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Warren Charles E., 1993, Current Opinion in Biotechnology, V4, P596, DOI 10.1016/0958-1669(93)90083-9; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; ZACCO A, 1990, J NEUROSCI, V10, P73; ZHUKAREVA V, 1995, DEVELOPMENT, V121, P1161	64	143	146	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1995	15	2					287	297		10.1016/0896-6273(95)90034-9	http://dx.doi.org/10.1016/0896-6273(95)90034-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR426	7646886	Bronze			2022-12-17	WOS:A1995RR42600007
J	MACCAFERRI, G; MCBAIN, CJ				MACCAFERRI, G; MCBAIN, CJ			PASSIVE PROPAGATION OF LTD TO STRATUM ORIENS-ALVEUS INHIBITORY NEURONS MODULATES THE TEMPOROAMMONIC INPUT TO THE HIPPOCAMPAL CA1 REGION	NEURON			English	Article							LONG-TERM POTENTIATION; LACUNOSUM-MOLECULARE INTERNEURONS; PYRAMIDAL CELLS; AREA CA1; RAT; DEPRESSION; SLICES; STIMULATION; RECORDINGS; CA1-REGION	Excitatory synaptic activity in horizontal stratum oriens-alveus interneurons (OAIs) is driven by the recurrent collaterals of CA1 pyramidal cells and is strongly influenced by protocols that elicit synaptic plasticity in these principal neurons. Induction of LTD in the Schaffer collateral-CA1 pyramidal neuron synapse causes a passive down-regulation of stratum radiatum-evoked excitatory synaptic responses onto OAIs. In addition, we show that the strength of the temporoammonic input to the CA1 pyramidal neuron distal dendrites is regulated by OAI activity. The passive propagation of LTD to OAIs consequently disinhibits the direct entorhinal cortex-CA1 input, resulting in an enhanced excitation of CA1 pyramidal neurons by a mechanism not requiring activation of the trisynaptic pathway.			MACCAFERRI, G (corresponding author), NICHHD, CELLULAR & MOLEC NEUROPHYSIOL LAB, CELLULAR & SUNAPT PHYSIOL UNIT, BETHESDA, MD 20892 USA.							ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BERNARD C, 1994, HIPPOCAMPUS, V4, P497, DOI 10.1002/hipo.450040502; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLASCOIBANEZ JM, 1995, IN PRESS EUR J NEURO; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1988, BRAIN RES, V455, P192, DOI 10.1016/0006-8993(88)90133-3; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; DESMOND NL, 1994, HIPPOCAMPUS, V4, P594, DOI 10.1002/hipo.450040509; DINGLEDINE R, 1980, BRAIN RES, V185, P277, DOI 10.1016/0006-8993(80)91068-9; DOLTER HJ, 1982, BRAIN RES, V237, P1; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Korn SJ., 1991, J NEUROSCI METH, V4, P264; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LACAILLE JC, 1989, HIPPOCAMPUS, P287; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NAUS CCG, 1988, DEV BRAIN RES, V40, P113, DOI 10.1016/0165-3806(88)90013-2; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SCHWARTZKROIN PA, 1990, PROG BRAIN RES, V83, P269; SEGAL M, 1972, EXP NEUROL, V35, P541, DOI 10.1016/0014-4886(72)90124-0; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; TAUBE JS, 1987, BRAIN RES, V419, P32, DOI 10.1016/0006-8993(87)90565-8; WILLIAMS S, 1992, SYNAPSE, V11, P249, DOI 10.1002/syn.890110309; WILLIAMS S, 1994, J NEUROPHYSIOL, V71, P2217, DOI 10.1152/jn.1994.71.6.2217; WITTER MP, 1988, NEUROSCI LETT, V85, P193, DOI 10.1016/0304-3940(88)90350-3; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	40	143	144	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1995	15	1					137	145		10.1016/0896-6273(95)90071-3	http://dx.doi.org/10.1016/0896-6273(95)90071-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL756	7619518	Bronze			2022-12-17	WOS:A1995RL75600016
J	OBERDICK, J; SCHILLING, K; SMEYNE, RJ; CORBIN, JG; BOCCHIARO, C; MORGAN, JI				OBERDICK, J; SCHILLING, K; SMEYNE, RJ; CORBIN, JG; BOCCHIARO, C; MORGAN, JI			CONTROL OF SEGMENT-LIKE PATTERNS OF GENE-EXPRESSION IN THE MOUSE CEREBELLUM	NEURON			English	Article							TRANSGENE EXPRESSION; OLIVOCEREBELLAR PROJECTION; PARASAGITTAL ORGANIZATION; VISUAL-CORTEX; PURKINJE; RAT; CAT; TRANSCRIPTION; COMPARTMENTS; PROMOTER	A Purkinje cell-specific transgene, L7-lacZ, is expressed in a series of parasagitally oriented stripes in the mouse cerebellum. This banding pattern can be perturbed by promoter mutation, showing that a combination of positive and negative control elements contributes to the temporal and spatial map of L7 gene expression. In addition to the parasagittal stripes, certain mutations reveal Purkinje cells organized into compartments oriented in the transverse plane of the cerebellum. Transcription factors of the POU or homeobox families appear to be involved in controlling L7 expression in the transverse orientation. Strikingly, some of the domains of gene expression revealed by the mutations appear to correspond to functional compartments of Purkinje cells, thereby suggesting an underlying genetic principle used to orchestrate functional organization in the nervous system.	OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University	OBERDICK, J (corresponding author), ROCHE INST MOLEC BIOL, DEPT NEUROSCI, ROCHE RES CTR, NUTLEY, NJ 07110 USA.		Morgan, James/N-8104-2018; Morgan, James/GRO-2905-2022	Morgan, James/0000-0002-8920-1065; Smeyne, Richard/0000-0002-8459-5472	PHS HHS [08-08601] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKAIKE T, 1992, J COMP NEUROL, V320, P398, DOI 10.1002/cne.903200311; ALLEN N D, 1987, P217; ARMSTRONG DM, 1974, J COMP NEUROL, V154, P287, DOI 10.1002/cne.901540305; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BUISSERETDELMAS C, 1988, NEUROSCI RES, V5, P494, DOI 10.1016/0168-0102(88)90039-9; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; EISENMAN LM, 1989, NEUROSCIENCE, V31, P231, DOI 10.1016/0306-4522(89)90045-6; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAVEL C, 1987, J COMP NEUROL, V265, P294, DOI 10.1002/cne.902650211; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; GROENEWEGEN HJ, 1977, J COMP NEUROL, V174, P417, DOI 10.1002/cne.901740304; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P255, DOI 10.1098/rstb.1984.0022; INMNIS MA, 1990, PCR PROTOCOLS GUIDE; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KAWAMURA K, 1979, NEUROSCIENCE, V4, P1615, DOI 10.1016/0306-4522(79)90024-1; LECLERC N, 1992, P NATL ACAD SCI USA, V89, P5006, DOI 10.1073/pnas.89.11.5006; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MARANI E, 1979, ACTA MORPHOL NEER SC, V17, P33; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; OSCARSSON O, 1979, TRENDS NEUROSCI, V2, P143, DOI 10.1016/0166-2236(79)90057-2; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROBERTSON LT, 1982, EXP BRAIN RES, V46, P281; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SOTELO C, 1991, PHILOS T R SOC B, V331, P307, DOI 10.1098/rstb.1991.0022; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Voogd J., 1980, INFERIOR OLIVARY NUC, P207; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	40	143	143	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1007	1018		10.1016/0896-6273(93)90050-2	http://dx.doi.org/10.1016/0896-6273(93)90050-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318226				2022-12-17	WOS:A1993LK37300002
J	COX, EC; MULLER, B; BONHOEFFER, F				COX, EC; MULLER, B; BONHOEFFER, F			AXONAL GUIDANCE IN THE CHICK VISUAL-SYSTEM - POSTERIOR TECTAL MEMBRANES INDUCE COLLAPSE OF GROWTH CONES FROM THE TEMPORAL RETINA	NEURON			English	Article									MAX PLANCK INST ENTWICKLUNGSBIOL,PHYS BIOL ABT,W-7400 TUBINGEN,GERMANY	Max Planck Society	COX, EC (corresponding author), PRINCETON UNIV,DEPT BIOL,PRINCETON,NJ 08544, USA.							BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; BONHOEFFER F, 1980, NATURE, V288, P162, DOI 10.1038/288162a0; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; BRAY D, 1979, J CELL SCI, V37, P391; BRAY D, 1980, EXP CELL RES, V130, P241, DOI 10.1016/0014-4827(80)90060-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; FRASER SE, 1980, DEV BIOL, V79, P453, DOI 10.1016/0012-1606(80)90130-X; Gaze RM, 1970, FORMATION NERVE CONN; GIERER A, 1987, DEVELOPMENT, V101, P479; JULIANO RL, 1971, BIOCHIM BIOPHYS ACTA, V249, P227, DOI 10.1016/0005-2736(71)90099-X; KAPFHAMMER JP, 1986, J NEUROSCI, V6, P2527; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; PATTERSON PH, 1988, NEURON, V1, P263, DOI 10.1016/0896-6273(88)90074-8; RAGER GH, 1980, ADV ANATOMY EMBRYOLO, V63; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; VARNUMFINNEY B, 1987, CELL MOTIL CYTOSKEL, V8, P7, DOI 10.1002/cm.970080103; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WALTER J, 1989, J PHYSL PARIS, V83, P1988; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	23	143	149	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1990	4	1					31	37		10.1016/0896-6273(90)90441-H	http://dx.doi.org/10.1016/0896-6273(90)90441-H			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM297	2310573				2022-12-17	WOS:A1990CM29700004
J	Foster, DJ; Conn, PJ				Foster, Daniel J.; Conn, P. Jeffrey			Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders	NEURON			English	Review							METABOTROPIC GLUTAMATE-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; LONG-TERM POTENTIATION; IN-VIVO VALIDATION; ANTIPSYCHOTIC-LIKE; PREFRONTAL CORTEX; WORKING-MEMORY; SIGNALING PATHWAYS; DOUBLE-BLIND; MOLECULAR-MECHANISMS	G-protein-coupled receptors (GPCRs) play critical roles in regulating brain function. Recent advances have greatly expanded our understanding of these receptors as complex signaling machines that can adopt numerous conformations and modulate multiple downstream signaling pathways. While agonists and antagonists have traditionally been pursued to target GPCRs, allosteric modulators provide several mechanistic advantages, including the ability to distinguish between closely related receptor subtypes. Recently, the discovery of allosteric ligands that confer bias and modulate some, but not all, of a given receptor's downstream signaling pathways can provide pharmacological modulation of brain circuitry with remarkable precision. In addition, allosteric modulators with unprecedented specificity have been developed that can differentiate between subpopulations of a given receptor subtype based on the receptor's dimerization state. These advances are not only providing insight into the biological roles of specific receptor populations, but hold great promise for treating numerous CNS disorders.	[Foster, Daniel J.; Conn, P. Jeffrey] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Foster, Daniel J.; Conn, P. Jeffrey] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Conn, PJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Conn, PJ (corresponding author), Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA.	jeff.conn@vanderbilt.edu	Foster, Dan/GYD-9809-2022	Foster, Daniel/0000-0002-5225-354X	NIH [R01MH062646, R01MH073676, R37NS031373]; Brain & Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062646, R01MH073676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain & Behavior Research Foundation(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Rachel Chandler for illustrating the figures in this manuscript. This work was supported by grants from the NIH (R01MH062646, R01MH073676, and R37NS031373) to P.J.C. and D.J.F. and Brain & Behavior Research Foundation to D.J.F.	Ade KK, 2016, BIOL PSYCHIAT, V80, P522, DOI 10.1016/j.biopsych.2016.04.023; Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; Alt A, 2016, J PHARMACOL EXP THER, V356, P293, DOI 10.1124/jpet.115.226910; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; [Anonymous], J MED CHEM, V59, P6313; Arnsten AFT, 2017, BIOL PSYCHIAT, V81, P67, DOI 10.1016/j.biopsych.2015.12.028; Attucci S, 2001, BRIT J PHARMACOL, V132, P799, DOI 10.1038/sj.bjp.0703904; Awad H, 2000, J NEUROSCI, V20, P7871; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Ayoub MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032849; Balu DT, 2016, NEUROPSYCHOPHARMACOL, V41, P2052, DOI 10.1038/npp.2016.2; Bariselli S, 2016, NAT NEUROSCI, V19, P926, DOI 10.1038/nn.4319; Barnes SA, 2015, MOL PSYCHIATR, V20, P1161, DOI 10.1038/mp.2015.113; Benquet P, 2002, J NEUROSCI, V22, P9679; Berman JA, 2007, INT REV NEUROBIOL, V78, P193, DOI 10.1016/S0074-7742(06)78007-2; Bhardwaj SK, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00072; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; Bridges TM, 2013, DRUG METAB DISPOS, V41, P1703, DOI 10.1124/dmd.113.052084; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; Brody SA, 2003, EUR J NEUROSCI, V18, P3361, DOI 10.1111/j.1460-9568.2003.03073.x; Bubser M, 2014, ACS CHEM NEUROSCI, V5, P920, DOI 10.1021/cn500128b; Bymaster FP, 2003, EUR J NEUROSCI, V17, P1403, DOI 10.1046/j.1460-9568.2003.02588.x; Byun NE, 2014, NEUROPSYCHOPHARMACOL, V39, P1578, DOI 10.1038/npp.2014.2; Caruana DA, 2011, J NEUROSCI, V31, P18464, DOI 10.1523/JNEUROSCI.4719-11.2011; Chaki S, 2004, NEUROPHARMACOLOGY, V46, P457, DOI 10.1016/j.neuropharm.2003.10.009; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; Cho HP, 2014, ACS CHEM BIOL, V9, P2334, DOI 10.1021/cb500560h; Choy KHC, 2016, J PHARMACOL EXP THER, V359, P354, DOI 10.1124/jpet.116.235788; Clifton NE, 2013, PSYCHOPHARMACOLOGY, V225, P579, DOI 10.1007/s00213-012-2845-3; Conde-Ceide S, 2015, ACS MED CHEM LETT, V6, P716, DOI 10.1021/acsmedchemlett.5b00181; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Darrah JM, 2008, BEHAV PHARMACOL, V19, P225, DOI 10.1097/FBP.0b013e3282feb0ac; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; Dean B, 2002, MOL PSYCHIATR, V7, P1083, DOI 10.1038/sj.mp.4001199; Dencker D, 2012, PSYCHOPHARMACOLOGY, V224, P277, DOI 10.1007/s00213-012-2751-8; Dencker D, 2011, J NEUROSCI, V31, P5905, DOI 10.1523/JNEUROSCI.0370-11.2011; Dhanya RP, 2014, J MED CHEM, V57, P4154, DOI 10.1021/jm5000563; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Digby GJ, 2010, CURR OPIN DRUG DISC, V13, P587; Doherty AJ, 2000, BRIT J PHARMACOL, V131, P239, DOI 10.1038/sj.bjp.0703574; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; Foster DJ, 2016, NEURON, V91, P1244, DOI 10.1016/j.neuron.2016.08.017; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Furness SGB, 2016, CELL, V167, P739, DOI 10.1016/j.cell.2016.09.021; Galici R, 2005, J PHARMACOL EXP THER, V315, P1181, DOI 10.1124/jpet.105.091074; Galici R, 2006, J PHARMACOL EXP THER, V318, P173, DOI 10.1124/jpet.106.102046; Gass JT, 2017, NEUROPHARMACOLOGY, V113, P198, DOI 10.1016/j.neuropharm.2016.10.005; Ghoshal A, 2016, NEUROPSYCHOPHARMACOL, V41, P598, DOI 10.1038/npp.2015.189; Gilmour G, 2013, NEUROPHARMACOLOGY, V64, P224, DOI 10.1016/j.neuropharm.2012.07.030; Gogliotti RG, 2016, HUM MOL GENET, V25, P1990, DOI 10.1093/hmg/ddw074; Gould RW, 2015, ACS CHEM NEUROSCI, V6, P1683, DOI 10.1021/acschemneuro.5b00123; Gould RW, 2016, NEUROPSYCHOPHARMACOL, V41, P1166, DOI 10.1038/npp.2015.265; Grannan MD, 2016, ACS CHEM NEUROSCI, V7, P1706, DOI 10.1021/acschemneuro.6b00230; Gregory KJ, 2015, MOL PHARMACOL, V88, P188, DOI 10.1124/mol.114.097220; Gregory Karen J, 2010, Curr Protoc Pharmacol, VChapter 1, DOI 10.1002/0471141755.ph0121s51; Griebel G, 2016, SCI REP-UK, V6, DOI 10.1038/srep35320; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Heidinger V, 2002, J NEUROSCI, V22, P5452; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Hopkins CR, 2013, ACS CHEM NEUROSCI, V4, P211, DOI 10.1021/cn400023y; Horio M, 2013, FUND CLIN PHARMACOL, V27, P483, DOI 10.1111/j.1472-8206.2012.01045.x; Hubner H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12298; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; Jin L. E., 2016, MOL PSYCHIAT; Jodo E, 2013, J PHYSIOL-PARIS, V107, P434, DOI 10.1016/j.jphysparis.2013.06.002; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Kalinichev M, 2014, J PHARMACOL EXP THER, V350, P495, DOI 10.1124/jpet.114.214437; Kammermeier PJ, 2012, MOL PHARMACOL, V82, P438, DOI 10.1124/mol.112.078501; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Kenakin T, 2004, MOL INTERV, V4, P222, DOI 10.1124/mi.4.4.6; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Kinon BJ, 2015, BIOL PSYCHIAT, V78, P754, DOI 10.1016/j.biopsych.2015.03.016; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Kiyonaka S, 2016, NAT CHEM, V8, P958, DOI [10.1038/NCHEM.2554, 10.1038/nchem.2554]; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Lane JR, 2014, NAT CHEM BIOL, V10, P745, DOI [10.1038/NCHEMBIO.1593, 10.1038/nchembio.1593]; Lange HS, 2015, J PHARMACOL EXP THER, V355, P442, DOI 10.1124/jpet.115.226712; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Levitz J, 2016, NEURON, V92, P143, DOI 10.1016/j.neuron.2016.08.036; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Lewis MA, 2015, J PHARMACOL EXP THER, V354, P340, DOI 10.1124/jpet.115.224071; Lin CW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00087; Litman RE, 2014, SCHIZOPHR RES, V153, pS176, DOI 10.1016/j.schres.2016.02.001; Liu F, 2008, J PHARMACOL EXP THER, V327, P827, DOI 10.1124/jpet.108.136580; Lovell KM, 2013, BIOORG MED CHEM LETT, V23, P3713, DOI 10.1016/j.bmcl.2013.05.020; Lum EN, 2014, NEUROPHARMACOLOGY, V79, P679, DOI 10.1016/j.neuropharm.2014.01.024; Lyon L, 2011, NEUROPSYCHOPHARMACOL, V36, P2616, DOI 10.1038/npp.2011.145; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Marino MJ, 2002, CNS NEUROL DISORD-DR, V1, P1, DOI 10.2174/1568007023339544; Marlo JE, 2009, MOL PHARMACOL, V75, P577, DOI 10.1124/mol.108.052886; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Millan MJ, 2016, NAT REV DRUG DISCOV, V15, P485, DOI 10.1038/nrd.2016.28; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Mistry SN, 2015, J MED CHEM, V58, P6819, DOI 10.1021/acs.jmedchem.5b00585; Mockett Bruce G., 2008, Journal of Integrative Neuroscience, V7, P315, DOI 10.1142/S0219635208001782; Moghaddam B, 2004, PSYCHOPHARMACOLOGY, V174, P39, DOI 10.1007/s00213-004-1792-z; Moreno JL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab0467; Muguruza C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00130; Nickols HH, 2016, J PHARMACOL EXP THER, V356, P123, DOI 10.1124/jpet.115.226597; Nickols HH, 2014, NEUROBIOL DIS, V61, P55, DOI 10.1016/j.nbd.2013.09.013; Nicoletti F, 2015, CURR OPIN PHARMACOL, V20, P89, DOI 10.1016/j.coph.2014.12.002; Niswender CM, 2016, ACS CHEM NEUROSCI, V7, P1201, DOI 10.1021/acschemneuro.6b00036; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Niswender CM, 2010, MOL PHARMACOL, V77, P459, DOI 10.1124/mol.109.058768; Noetzel MJ, 2013, MOL PHARMACOL, V83, P835, DOI 10.1124/mol.112.082891; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Pancani T, 2015, P NATL ACAD SCI USA, V112, P14078, DOI 10.1073/pnas.1512812112; Pancani T, 2014, ACS CHEM NEUROSCI, V5, P318, DOI 10.1021/cn500003z; Parmentier-Batteur S, 2014, NEUROPHARMACOLOGY, V82, P161, DOI 10.1016/j.neuropharm.2012.12.003; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Pittolo I, 2014, NAT CHEM BIOL, V10, P813, DOI [10.1038/NCHEMBIO.1612, 10.1038/nchembio.1612]; Power EM, 2016, J PHYSIOL-LONDON, V594, P4643, DOI 10.1113/JP271153; Puri V, 2015, BEHAV BRAIN RES, V287, P96, DOI 10.1016/j.bbr.2015.03.029; Raedler TJ, 2007, MOL PSYCHIATR, V12, P232, DOI 10.1038/sj.mp.4001924; Reilly JL, 2007, BIOL PSYCHIAT, V62, P818, DOI 10.1016/j.biopsych.2006.10.031; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rodriguez AL, 2005, MOL PHARMACOL, V68, P1793, DOI 10.1124/mol.105.016139; Rodriguez AL, 2010, MOL PHARMACOL, V78, P1105, DOI 10.1124/mol.110.067207; Rook JM, 2015, NEURON, V86, P1029, DOI 10.1016/j.neuron.2015.03.063; Rook JM, 2013, BIOL PSYCHIAT, V73, P501, DOI 10.1016/j.biopsych.2012.09.012; Rosell DR, 2015, NEUROPSYCHOPHARMACOL, V40, P446, DOI 10.1038/npp.2014.192; Rovira X, 2016, CELL CHEM BIOL, V23, P929, DOI 10.1016/j.chembiol.2016.06.013; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Salih H, 2015, J PSYCHOPHARMACOL, V29, P414, DOI 10.1177/0269881115573403; Sarihi A, 2008, J NEUROSCI, V28, P1224, DOI 10.1523/JNEUROSCI.4928-07.2008; Sawa A, 2003, MOL MED, V9, P3, DOI 10.1007/BF03402101; Scarr E, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.3; Sheffler DJ, 2008, NEUROPHARMACOLOGY, V55, P419, DOI 10.1016/j.neuropharm.2008.06.047; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shen WX, 2016, NEURON, V90, P1139, DOI 10.1016/j.neuron.2016.05.017; Shin JH, 2015, P NATL ACAD SCI USA, V112, P8124, DOI 10.1073/pnas.1508846112; Shirey JK, 2008, NAT CHEM BIOL, V4, P42, DOI 10.1038/nchembio.2007.55; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Slawinska A, 2013, BRIT J PHARMACOL, V169, P1824, DOI 10.1111/bph.12254; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Spooren WPJM, 2000, EUR J PHARMACOL, V397, pR1, DOI 10.1016/S0014-2999(00)00269-7; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Stefani MR, 2010, EUR J PHARMACOL, V639, P26, DOI 10.1016/j.ejphar.2010.01.028; Strube W, 2015, NEUROPSYCHOPHARMACOL, V40, P822, DOI 10.1038/npp.2014.275; Sun Y, 2016, ANN NEUROL, V80, P233, DOI 10.1002/ana.24708; Suratman S, 2011, BRIT J PHARMACOL, V162, P1659, DOI 10.1111/j.1476-5381.2010.01184.x; Svensson KA, 2017, J PHARMACOL EXP THER, V360, P117, DOI 10.1124/jpet.116.236372; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Ugolini A, 1999, NEUROPHARMACOLOGY, V38, P1569, DOI 10.1016/S0028-3908(99)00095-7; Uslaner JM, 2009, NEUROPHARMACOLOGY, V57, P531, DOI 10.1016/j.neuropharm.2009.07.022; Vardigan JD, 2015, PSYCHOPHARMACOLOGY, V232, P1859, DOI 10.1007/s00213-014-3813-x; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Vicidomini C., 2016, MOL PSYCHIAT; Walker AG, 2015, P NATL ACAD SCI USA, V112, P1196, DOI 10.1073/pnas.1416196112; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; WEINER DM, 1990, P NATL ACAD SCI USA, V87, P7050, DOI 10.1073/pnas.87.18.7050; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Woodward ND, 2013, J INT NEUROPSYCH SOC, V19, P782, DOI 10.1017/S1355617713000532; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Yin S, 2014, J NEUROSCI, V34, P79, DOI 10.1523/JNEUROSCI.1129-13.2014; Zhang YQ, 2005, J PHARMACOL EXP THER, V315, P1212, DOI 10.1124/jpet.105.090308	182	142	143	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 3	2017	94	3					431	446		10.1016/j.neuron.2017.03.016	http://dx.doi.org/10.1016/j.neuron.2017.03.016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET7HR	28472649	Green Accepted, Bronze			2022-12-17	WOS:000400466700006
J	Gandhi, AV; Mosser, EA; Oikonomou, G; Prober, DA				Gandhi, Avni V.; Mosser, Eric A.; Oikonomou, Grigorios; Prober, David A.			Melatonin Is Required for the Circadian Regulation of Sleep	NEURON			English	Article							ARYLALKYLAMINE-N-ACETYLTRANSFERASE; PINEAL-GLAND; ZEBRAFISH; TARGETS; NETWORK; RHYTHMS	Sleep is an evolutionarily conserved behavioral state whose regulation is poorly understood. A classical model posits that sleep is regulated by homeostatic and circadian mechanisms. Several factors have been implicated in mediating the homeostatic regulation of sleep, but molecules underlying the circadian mechanism are unknown. Here we use animals lacking melatonin due to mutation of arylalkylamine N-acetyltransferase 2 (aanat2) to show that melatonin is required for circadian regulation of sleep in zebrafish. Sleep is dramatically reduced at night in aanat2 mutants maintained in light/dark conditions, and the circadian regulation of sleep is abolished in free-running conditions. We find that melatonin promotes sleep downstream of the circadian clock as it is not required to initiate or maintain circadian rhythms. Additionally, we provide evidence that melatonin may induce sleep in part by promoting adenosine signaling, thus potentially linking circadian and homeostatic control of sleep.	[Gandhi, Avni V.; Mosser, Eric A.; Oikonomou, Grigorios; Prober, David A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Prober, DA (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	dprober@caltech.edu			Della Martin postdoctoral fellowship; NIH [F32NS082010, NS060996, NS070911, DA031367]; Mallinckrodt Foundation; Rita Allen Foundation; Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070911, F32NS082010, R00NS060996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031367] Funding Source: NIH RePORTER	Della Martin postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt Foundation; Rita Allen Foundation; Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Jason Rihel, Kathy Tamai, Michael Rosbash, Daniel Lee, Catherine Oikonomou, and Chanpreet Singh for critical reading of the manuscript and Melanie Pribisko Yen for assistance with melatonin isolation. This work was supported by a Della Martin postdoctoral fellowship (E.M.), NIH grants (G.O.: F32NS082010; D.A.P.: NS060996, NS070911 and DA031367), the Mallinckrodt Foundation, the Rita Allen Foundation, and the Brain and Behavior Research Foundation (D.A.P.).	Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borjigin J, 2012, MOL CELL ENDOCRINOL, V349, P13, DOI 10.1016/j.mce.2011.07.009; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buscemi N, 2006, BMJ-BRIT MED J, V332, P385, DOI 10.1136/bmj.38731.532766.F6; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Elbaz I, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00009; Fisher S.P., 2013, HDB EXP PHARM, V217, P157; GOLDSTEIN R, 1981, BRAIN RES BULL, V7, P723, DOI 10.1016/0361-9230(81)90126-X; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Hardeland R, 2012, SCI WORLD J, DOI 10.1100/2012/640389; Hu WP, 2007, SLEEP, V30, P247; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Mintz EM, 1998, NEUROSCI LETT, V258, P61, DOI 10.1016/S0304-3940(98)00849-0; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Roberts Reade B, 2006, J Circadian Rhythms, V4, P15, DOI 10.1186/1740-3391-4-15; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Scheer FA, 2005, SLEEP MED REV, V9, P5, DOI 10.1016/j.smrv.2004.11.004; Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Underwood Herbert, 2001, Handbook of Behavioral Neurobiology, V12, P111; van den Heuvel CJ, 2005, SLEEP MED REV, V9, P71, DOI 10.1016/j.smrv.2004.07.001; Woods IG, 2014, J NEUROSCI, V34, P3142, DOI 10.1523/JNEUROSCI.3529-13.2014; Zhdanova IV, 2005, SLEEP MED REV, V9, P51, DOI 10.1016/j.smrv.2004.04.003; Zhdanova IV, 2002, PHYSIOL BEHAV, V75, P523, DOI 10.1016/S0031-9384(02)00654-6	36	142	149	4	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 18	2015	85	6					1193	1199		10.1016/j.neuron.2015.02.016	http://dx.doi.org/10.1016/j.neuron.2015.02.016			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD8BA	25754820	Green Accepted, Bronze			2022-12-17	WOS:000351319000008
J	Nelson, DL; Orr, HT; Warren, ST				Nelson, David L.; Orr, Harry T.; Warren, Stephen T.			The Unstable Repeats-Three Evolving Faces of Neurological Disease	NEURON			English	Review							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; MYOTONIC-DYSTROPHY TYPE-1; POLYGLUTAMINE-INDUCED NEURODEGENERATION; POSTNATAL BRAIN-DEVELOPMENT; MESSENGER-RNA LOCALIZATION; UNINTERRUPTED CGG REPEATS; TRANSGENIC MOUSE MODEL; SPINOCEREBELLAR ATAXIA; TREMOR/ATAXIA SYNDROME	Disorders characterized by expansion of an unstable nucleotide repeat account for a number of inherited neurological diseases. Here, we review examples of unstable repeat disorders that nicely illustrate three of the major pathogenic mechanisms associated with these diseases: loss of function typically by disrupting transcription of the mutated gene, RNA toxic gain of function, and protein toxic gain of function. In addition to providing insight into the mechanisms underlying these devastating neurological disorders, the study of these unstable microsatellite repeat disorders has provided insight into very basic aspects of neuroscience.	[Nelson, David L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Emory University	Nelson, DL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	nelson@bcm.edu; orrxx002@umn.edu; swarren@emory.edu		Orr, Harry/0000-0001-6118-741X	N.I.H. [NS022920, NS045667, HD020521, HD024064, NS051630]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD020521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R01NS045667, R37NS022920] Funding Source: NIH RePORTER	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors' work in this area was supported by grants from the N.I.H. (NS022920 & NS045667, H.T.O.; HD020521 and HD024064, S.T.W.; NS051630 and HD024064, D.L.N.) Figures were drawn with assistance of J. Frisch.	Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Ash P.E., 2013, NEURON; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brouwer JR, 2008, PSYCHONEUROENDOCRINO, V33, P863, DOI 10.1016/j.psyneuen.2008.03.011; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P1984, DOI 10.1021/cb3001606; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Coffee B, 2008, AM J MED GENET A, V146A, P1358, DOI 10.1002/ajmg.a.32261; Collins SC, 2010, AM J MED GENET A, V152A, P2512, DOI 10.1002/ajmg.a.33626; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; Cvetanovic M, 2011, NAT MED, V17, P1445, DOI 10.1038/nm.2494; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; D'Hulst C, 2009, BRAIN RES, V1253, P176, DOI 10.1016/j.brainres.2008.11.075; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Disney MD, 2012, ACS CHEM BIOL, V7, P1711, DOI 10.1021/cb300135h; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fryer JD, 2011, SCIENCE, V334, P690, DOI 10.1126/science.1212673; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gantois I, 2006, NEUROBIOL DIS, V21, P346, DOI 10.1016/j.nbd.2005.07.017; Garcia-Lopez A, 2011, P NATL ACAD SCI USA, V108, P11866, DOI 10.1073/pnas.1018213108; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Gronskov K, 2011, EUR J HUM GENET, V19, P489, DOI 10.1038/ejhg.2010.223; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Hampson DR, 2011, BIOCHEM PHARMACOL, V81, P1078, DOI 10.1016/j.bcp.2011.02.005; HARPER PS, 1992, AM J HUM GENET, V51, P10; Hashem V, 2009, HUM MOL GENET, V18, P2443, DOI 10.1093/hmg/ddp182; Hearst SM, 2010, J NEUROCHEM, V114, P706, DOI 10.1111/j.1471-4159.2010.06791.x; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hokkanen S, 2012, HUM MOL GENET, V21, P473, DOI 10.1093/hmg/ddr476; Hong SG, 2003, BBA-MOL BASIS DIS, V1638, P35, DOI 10.1016/S0925-4439(03)00038-3; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; JACOBS PA, 1980, AM J MED GENET, V7, P471, DOI 10.1002/ajmg.1320070408; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jafar-Nejad P, 2011, P NATL ACAD SCI USA, V108, P2142, DOI 10.1073/pnas.1018748108; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kratter IH, 2010, NEURON, V67, P897, DOI 10.1016/j.neuron.2010.09.012; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lai SJ, 2011, J BIOL CHEM, V286, P34606, DOI 10.1074/jbc.M111.238527; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavedan C, 1998, GENOMICS, V50, P229, DOI 10.1006/geno.1998.5299; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Lorenzetti D, 2000, HUM MOL GENET, V9, P779, DOI 10.1093/hmg/9.5.779; LUBS HA, 1969, AM J HUM GENET, V21, P231; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mahadevan MS, 2012, CURR OPIN NEUROL, V25, P609, DOI 10.1097/WCO.0b013e328357b0d9; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; MEIJER H, 1994, HUM MOL GENET, V3, P615; Menon RP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00919; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Minamiyama M, 2012, NAT MED, V18, P1531, DOI 10.1038/nm.2932; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mori K., 2013, SCIENCE; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; Nolin SL, 2011, PRENATAL DIAG, V31, P925, DOI 10.1002/pd.2815; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Parkesh R, 2012, J AM CHEM SOC, V134, P4731, DOI 10.1021/ja210088v; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Qurashi A, 2012, HUM MOL GENET, V21, P2068, DOI 10.1093/hmg/dds024; Qurashi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002102; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Reyniers E, 1996, AM J MED GENET, V64, P408, DOI 10.1002/(SICI)1096-8628(19960809)64:2<408::AID-AJMG35>3.0.CO;2-H; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shelbourne Peggy, 1992, Human Mutation, V1, P183, DOI 10.1002/humu.1380010302; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; Takeyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P1209, DOI 10.1271/bbb.68.1209; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Tan HP, 2012, EXP NEUROL, V235, P469, DOI 10.1016/j.expneurol.2012.01.019; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Van Dam D, 2005, BEHAV BRAIN RES, V162, P233, DOI 10.1016/j.bbr.2005.03.007; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang YC, 1997, HUM MUTAT, V10, P393, DOI 10.1002/(SICI)1098-1004(1997)10:5<393::AID-HUMU10>3.3.CO;2-Q; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; YAKURA H, 1974, NEW ENGL J MED, V291, P154; Yrigollen CM, 2012, GENET MED, V14, P729, DOI 10.1038/gim.2012.34; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhong N, 1996, AM J MED GENET, V64, P261, DOI 10.1002/(SICI)1096-8628(19960809)64:2<261::AID-AJMG5>3.0.CO;2-X; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	234	142	151	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					825	843		10.1016/j.neuron.2013.02.022	http://dx.doi.org/10.1016/j.neuron.2013.02.022			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473314	Green Accepted, Bronze			2022-12-17	WOS:000316162600005
J	Hu, Y; Park, KK; Yang, L; Wei, X; Yang, Q; Cho, KS; Thielen, P; Lee, AH; Cartoni, R; Glimcher, LH; Chen, DF; He, ZG				Hu, Yang; Park, Kevin K.; Yang, Liu; Wei, Xin; Yang, Qiang; Cho, Kin-Sang; Thielen, Peter; Lee, Ann-Hwee; Cartoni, Romain; Glimcher, Laurie H.; Chen, Dong Feng; He, Zhigang			Differential Effects of Unfolded Protein Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells	NEURON			English	Article							OPEN-ANGLE GLAUCOMA; TRANSCRIPTION FACTOR XBP-1; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; RETINITIS-PIGMENTOSA; OCULAR HYPERTENSION; OXIDATIVE STRESS; MOUSE MODELS; OPTIC-NERVE	Loss of retinal ganglion cells (RGCs) accounts for visual function deficits after optic nerve injury, but how axonal insults lead to neuronal death remains elusive. By using an optic nerve crush model that results in the death of the majority of RGCs, we demonstrate that axotomy induces differential activation of distinct pathways of the unfolded protein response in axotomized RGCs. Optic nerve injury provokes a sustained CCAAT/enhancer binding homologous protein (CHOP) upregulation, and deletion of CHOP promotes RGC survival. In contrast, IRE/XBP-1 is only transiently activated, and forced XBP-1 activation dramatically protects RGCs from axon injury-induced death. Importantly, such differential activations of CHOP and XBP-1 and their distinct effects on neuronal cell death are also observed in RGCs with other types of axonal insults, such as vincristine treatment and intraocular pressure elevation, suggesting a new protective strategy for neurodegeneration associated with axonal damage.	[Hu, Yang; Park, Kevin K.; Yang, Liu; Cartoni, Romain; He, Zhigang] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Hu, Yang; Park, Kevin K.; Yang, Liu; Cartoni, Romain; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Wei, Xin; Yang, Qiang; Cho, Kin-Sang; Chen, Dong Feng] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02114 USA; [Thielen, Peter; Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Thielen, Peter; Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hu, Yang] Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19140 USA; [Park, Kevin K.] Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Chen, Dong Feng] Boston Healthcare Syst, Ctr Innovat Visual Rehabil, Vet Affairs, Boston, MA 02130 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Hu, Y (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	yanghu@temple.edu; dongfeng.chen@schepens.harvard.edu; zhigang.he@childrens.harvard.edu	Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Cho, Kin-Sang/0000-0003-4285-615X; Hu, Yang/0000-0002-7980-1649; Thielen, Peter/0000-0003-1807-2785	National Eye Institute; Miami Project to Cure Paralysis; Department of Veterans Affairs; National Institutes of Health (NIH) [AI32412]; NIH National Research Service; NATIONAL EYE INSTITUTE [R01EY021526, R01EY021342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Miami Project to Cure Paralysis; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Xu and L. Connolly for technical support. Our work was supported by grants from the National Eye Institute (Z.H.), Miami Project to Cure Paralysis (K.K.P.), Department of Veterans Affairs (D.F.C.), National Institutes of Health (NIH) grant AI32412, and a grant from an anonymous foundation (L.H.G.). Y.H. was supported by an NIH National Research Service Award Postdoctoral Fellowship. Y.H., K.K.P., L.Y., Q.Y., X.W., P.T., and A.H.L. performed the experiments and analyzed the data. Y.H., L.H.G., D.F.C., and Z.H. designed experiments and prepared the manuscript.	Aoki S, 2002, J NEUROSCI, V22, P10751; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H., 2010, INVEST OPHTH VIS SCI, V52, P36; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Doh SH, 2010, BRAIN RES, V1308, P158, DOI 10.1016/j.brainres.2009.10.025; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Levin L A, 1997, Curr Opin Ophthalmol, V8, P9, DOI 10.1097/00055735-199712000-00003; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin KRG, 2002, METHODS, V28, P267, DOI 10.1016/S1046-2023(02)00232-3; McKernan DP, 2007, J NEUROCHEM, V102, P922, DOI 10.1111/j.1471-4159.2007.04573.x; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Selles-Navarro I, 2001, EXP NEUROL, V167, P282, DOI 10.1006/exnr.2000.7573; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silva A, 2006, J PERIPHER NERV SYST, V11, P211, DOI 10.1111/j.1529-8027.2006.0090.x; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Urano F, 2000, J CELL SCI, V113, P3697; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	47	142	148	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					445	452		10.1016/j.neuron.2011.11.026	http://dx.doi.org/10.1016/j.neuron.2011.11.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325198	Bronze, Green Accepted			2022-12-17	WOS:000300140600007
J	Chang, LJ; Smith, A; Dufwenberg, M; Sanfey, AG				Chang, Luke J.; Smith, Alec; Dufwenberg, Martin; Sanfey, Alan G.			Triangulating the Neural, Psychological, and Economic Bases of Guilt Aversion	NEURON			English	Article							TRUST; FMRI; RECIPROCITY; CORTEX; REWARD; ACTIVATION; EXPERIENCE; MULTILEVEL; CIRCUITRY; GAMES	Why do people often choose to cooperate when they can better serve their interests by acting selfishly? One potential mechanism is that the anticipation of guilt can motivate cooperative behavior. We utilize a formal model of this process in conjunction with fMRI to identify brain regions that mediate cooperative behavior while participants decided whether or not to honor a partner's trust. We observed increased activation in the insula, supplementary motor area, dorsolateral prefrontal cortex (PEG), and temporal parietal junction when participants were behaving consistent with our model, and found increased activity in the ventromedial PFC, dorsomedial PEG, and nucleus accumbens when they chose to abuse trust and maximize their financial reward. This study demonstrates that a neural system previously implicated in expectation processing plays a critical role in assessing moral sentiments that in turn can sustain human cooperation in the face of temptation.	[Chang, Luke J.; Sanfey, Alan G.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Smith, Alec; Dufwenberg, Martin] Univ Arizona, Dept Econ, Tucson, AZ 85721 USA; [Sanfey, Alan G.] Radboud Univ Nijmegen, Donders Inst Brain Mind & Behav, NL-6525 EN Nijmegen, Netherlands; [Sanfey, Alan G.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525EN Nijmegen, Netherlands; [Smith, Alec] CALTECH, Pasadena, CA 91125 USA; [Dufwenberg, Martin] Univ Gothenburg, S-40530 Gothenburg, Sweden	University of Arizona; University of Arizona; Radboud University Nijmegen; Radboud University Nijmegen; California Institute of Technology; University of Gothenburg	Sanfey, AG (corresponding author), Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA.	asanfey@u.arizona.edu	Sanfey, Alan G/D-2350-2010	Smith, Alec/0000-0002-1938-4660; CHANG, LUKE/0000-0002-7177-4711; Chang, Luke/0000-0002-6621-8120; Sanfey, Alan/0000-0002-7421-8294	National Institute of Aging [R21AG030768]; National Institute of Mental Health [R03MH077058, F31MH085465]; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH077058, F31MH085465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030768] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Matt Kleinman for his help in collecting the data and Drs. Anouk Scheres, James Rilling, and Lynn Nadel for their helpful comments. We would like to acknowledge funding from the National Institute of Aging (R21AG030768) to A.G.S., the National Institute of Mental Health (R03MH077058) to A.G.S. and (F31MH085465) to L.J.C., and the National Science Foundation to M.D.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D., 2011, IME4 LINEAR MIXED EF; Battigalli P, 2007, AM ECON REV, V97, P170, DOI 10.1257/aer.97.2.170; Battigalli P, 2009, J ECON THEORY, V144, P1, DOI 10.1016/j.jet.2008.01.004; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Berns GS, 2010, NEUROIMAGE, V49, P2687, DOI 10.1016/j.neuroimage.2009.10.070; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Camerer C.F., 2003, BEHAV GAME THEORY; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreher JC, 2009, HANDBOOK OF REWARD AND DECISION MAKING, P1; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; Dufwenberg M, 2000, GAME ECON BEHAV, V30, P163, DOI 10.1006/game.1999.0715; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ellingsen T, 2010, GAME ECON BEHAV, V68, P95, DOI 10.1016/j.geb.2009.04.021; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Geanakoplos J., 1989, GAME ECON BEHAV, V1, P60, DOI [10.1016/0899-8256(89)90005-5, DOI 10.1016/0899-8256(89)90005-5]; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Haidt J, 2003, SER AFFECTIVE SCI, P852; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Ketelaar T, 2003, COGNITION EMOTION, V17, P429, DOI 10.1080/02699930143000662; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kliegl R, 2007, J EXP PSYCHOL HUMAN, V33, P1250, DOI 10.1037/0096-1523.33.5.1250; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P4404, DOI 10.1073/pnas.97.8.4404; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Newbould RD, 2007, MAGN RESON MED, V58, P70, DOI 10.1002/mrm.21255; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pinheiro J., 2006, MIXED EFFECT MODELS; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; RABIN M, 1993, AM ECON REV, V83, P1281; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reuben E, 2009, ECON LETT, V104, P89, DOI 10.1016/j.econlet.2009.04.007; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Shin LM, 2000, BIOL PSYCHIAT, V48, P43, DOI 10.1016/S0006-3223(00)00251-1; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Slovic P., 2002, HEURISTICS BIASES PS, P397, DOI DOI 10.1017/CBO9780511808098.025; Smith Adam, 1759, THEORY MORAL SENTIME; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stocker T, 2006, NEUROIMAGE, V30, P151, DOI 10.1016/j.neuroimage.2005.09.050; Team RC., 2022, R LANG ENV STAT COMP; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; van den Bos W, 2009, SOC COGN AFFECT NEUR, V4, P294, DOI 10.1093/scan/nsp009; Venables W., 2002, MODERN APPL STAT S, VFourth; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	71	142	145	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 12	2011	70	3					560	572		10.1016/j.neuron.2011.02.056	http://dx.doi.org/10.1016/j.neuron.2011.02.056			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	768HZ	21555080	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000290926100016
J	Zhang, G; Bai, H; Zhang, H; Dean, C; Wu, QA; Li, JX; Guariglia, S; Meng, QY; Cai, DS				Zhang, Guo; Bai, Hua; Zhang, Hai; Dean, Camin; Wu, Qiang; Li, Juxue; Guariglia, Sara; Meng, Qingyuan; Cai, Dongsheng			Neuropeptide Exocytosis Involving Synaptotagmin-4 and Oxytocin in Hypothalamic Programming of Body Weight and Energy Balance	NEURON			English	Article							FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; INSULIN-SECRETION; MICE LACKING; LEPTIN; RELEASE; NEURONS; IV; OBESITY; FOXO1	Hypothalamic neuropeptides play essential roles in regulating energy and body weight balance. Energy imbalance and obesity have been linked to hypothalamic signaling defects in regulating neuropeptide genes; however, it is unknown whether dysregulation of neuropeptide exocytosis could be critically involved. This study discovered that synaptotagmin-4, an atypical modulator of synaptic exocytosis, is expressed most abundantly in oxytocin neurons of the hypothalamus. Synaptotagmin-4 negatively regulates oxytocin exocytosis, and dietary obesity is associated with increased vesicle binding of synaptotagmin-4 and thus enhanced negative regulation of oxytocin release. Overexpressing synaptotagmin-4 in hypothalamic oxytocin neurons and centrally antagonizing oxytocin in mice are similarly obesogenic. Synaptotagmin-4 inhibition prevents against dietary obesity by normalizing oxytocin release and energy balance under chronic nutritional excess. In conclusion, the negative regulation of synaptotagmin-4 on oxytocin release represents a hypothalamic basis of neuropeptide exocytosis in controlling obesity and related diseases.	[Zhang, Guo; Zhang, Hai; Li, Juxue; Guariglia, Sara; Meng, Qingyuan; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhang, Guo; Zhang, Hai; Li, Juxue; Guariglia, Sara; Meng, Qingyuan; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Zhang, Guo; Bai, Hua; Zhang, Hai; Dean, Camin; Wu, Qiang; Li, Juxue; Cai, Dongsheng] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Zhang, Hai] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Zhang, Guo/Q-8513-2016	Zhang, Guo/0000-0003-0841-4710; Li, Juxue/0000-0003-0681-5713; Zhang, Guo/0000-0002-3880-6996; Bai, Hua/0000-0002-0448-4052	NIH [R01 DK078750, R01 AG031774]; American Diabetes Association [1-07-JF-09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Herschman for providing Syt4<SUP>-/-</SUP> mice, H. Gainer for mouse OXT promoter, G.Y. Wen for assistance in electron microscopy, M. Hendrickson for assistance in confocal microscopy, E. Chapman and M. Jackson for suggestions, and Cai lab members for general assistance. This study was supported by NIH R01 DK078750 and R01 AG031774, and by American Diabetes Association Junior Faculty Award 1-07-JF-09 (all to D.C.).	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Air EL, 2002, ENDOCRINOLOGY, V143, P2449, DOI 10.1210/en.143.6.2449; Amico JA, 2005, AM J PHYSIOL-REG I, V289, pR1798, DOI 10.1152/ajpregu.00558.2005; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Gao ZY, 2000, J BIOL CHEM, V275, P36079, DOI 10.1074/jbc.M004284200; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; Iezzi M, 2005, FEBS LETT, V579, P5241, DOI 10.1016/j.febslet.2005.08.047; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kutlu S, 2010, BRAIN RES, V1317, P87, DOI 10.1016/j.brainres.2009.12.044; Leng G, 2008, PROG BRAIN RES, V170, P137, DOI 10.1016/S0079-6123(08)00413-5; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Machado HB, 2004, J NEUROSCI RES, V76, P334, DOI 10.1002/jnr.20072; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mitra A, 2010, PEPTIDES, V31, P1346, DOI 10.1016/j.peptides.2010.04.005; Mobbs CV, 2007, CELL METAB, V5, P1, DOI 10.1016/j.cmet.2006.12.005; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Park AJ, 2005, CURR OPIN GASTROEN, V21, P228, DOI 10.1097/01.mog.0000153358.05901.3f; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Sladek CD, 2008, FRONT NEUROENDOCRIN, V29, P114, DOI 10.1016/j.yfrne.2007.08.005; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; Thomas DM, 1999, MOL BIOL CELL, V10, P2285, DOI 10.1091/mbc.10.7.2285; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zhang BJ, 2002, ENDOCRINOLOGY, V143, P1036, DOI 10.1210/en.143.3.1036; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252	63	142	145	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 10	2011	69	3					523	535		10.1016/j.neuron.2010.12.036	http://dx.doi.org/10.1016/j.neuron.2010.12.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	724XM	21315262	Green Accepted, Bronze			2022-12-17	WOS:000287609700013
J	Hippenmeyer, S; Youn, YH; Moon, HM; Miyamichi, K; Zong, H; Wynshaw-Boris, A; Luo, LQ				Hippenmeyer, Simon; Youn, Yong Ha; Moon, Hyang Mi; Miyamichi, Kazunari; Zong, Hui; Wynshaw-Boris, Anthony; Luo, Liqun			Genetic Mosaic Dissection of Lis1 and Ndel1 in Neuronal Migration	NEURON			English	Article							CELL-MIGRATION; DEFECTS; ORIGIN; NUDEL; CDK5; PROLIFERATION; HISTOGENESIS; LAMINATION; EXPRESSION; PROTEINS	Coordinated migration of newly born neurons to their prospective target laminae is a prerequisite for neural circuit assembly in the developing brain. The evolutionarily conserved LIS1/NDEL1 complex is essential for neuronal migration in the mammalian cerebral cortex. The cytoplasmic nature of LIS1 and NDEL1 proteins suggest that they regulate neuronal migration cell autonomously. Here, we extend mosaic analysis with double markers (MADM) to mouse chromosome 11 where Lis1, Ndel1, and 14-3-3 epsilon (encoding a LIS1/NDEL1 signaling partner) are located. Analyses of sparse and uniquely labeled mutant cells in mosaic animals reveal distinct cell-autonomous functions for these three genes. Lis1 regulates neuronal migration efficiency in a dose-dependent manner, while Ndel1 is essential for a specific, previously uncharacterized, late step of neuronal migration: entry into the target lamina. Comparisons with previous genetic perturbations of Lis1 and Ndel1 also suggest a surprising degree of cell-nonautonomous function for these proteins in regulating neuronal migration.	[Hippenmeyer, Simon; Miyamichi, Kazunari; Zong, Hui; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Hippenmeyer, Simon; Miyamichi, Kazunari; Zong, Hui; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Youn, Yong Ha; Moon, Hyang Mi; Wynshaw-Boris, Anthony] Univ Calif San Francisco, San Francisco Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Youn, Yong Ha; Moon, Hyang Mi; Wynshaw-Boris, Anthony] Univ Calif San Francisco, San Francisco Sch Med, Inst Human Genet, San Francisco, CA 94143 USA; [Moon, Hyang Mi] Univ Calif San Francisco, San Francisco Sch Med, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, San Francisco Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oregon	Hippenmeyer, S (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	simonh@stanford.edu; lluo@stanford.edu	Miyamichi, Kazunari/AAO-3705-2021	Hippenmeyer, Simon/0000-0003-2279-1061; Luo, Liqun/0000-0001-5467-9264	European Molecular Biology Organization [ALTF 851-2005]; Human Frontier Science Program [LT00805/2006-L, LT00300/2007-L]; Swiss National Science Foundation [PA00P3_124160]; JSPS; NIH [NS050835, NS041310, HD047380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835, R01NS041310] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Tasic and L. Li for generating and validating unpublished 3xMyctdT constructs, Y. Chen-Tsai and Stanford Transgenic Facility for help with generating knockin mice, R. Tsien for providing tdT, R. Kageyama for providing Nestin-CreER<SUP>+/-</SUP>, members of the Luo, Zong, and Wynshaw-Boris labs for discussion, and S. McConnell, T. Mosca, C. Potter, Y. Chou, C. Liu, L. Sweeney, W. Joo, and M. Spletter for comments on the manuscript. This work was supported by postdoctoral fellowships from the European Molecular Biology Organization ALTF 851-2005 (S.H.), Human Frontier Science Program LT00805/2006-L (S.H.) and LT00300/2007-L (K.M.), Swiss National Science Foundation PA00P3_124160 (S.H.), JSPS Postdoctoral Fellowships for Research Abroad (KM.), and NIH grants NS050835 to L.L. and NS041310 and HD047380 to A.W.-B. L.L. is an investigator of the Howard Hughes Medical Institute.	ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; Altman J., 1996, DEV CEREBELLAR SYSTE; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Takahashi Y, 2003, NEUROCHEM RES, V28, P1265, DOI 10.1023/A:1024296932670; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	47	142	148	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2010	68	4					695	709		10.1016/j.neuron.2010.09.027	http://dx.doi.org/10.1016/j.neuron.2010.09.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	691KU	21092859	Bronze, Green Accepted			2022-12-17	WOS:000285079500009
J	Bowers, MS; Chen, BT; Bonci, A				Bowers, M. Scott; Chen, Billy T.; Bonci, Antonello			AMPA Receptor Synaptic Plasticity Induced by Psychostimulants: The Past, Present, and Therapeutic Future	NEURON			English	Review							VENTRAL TEGMENTAL AREA; COCAINE-INDUCED REINSTATEMENT; MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS CORE; LONG-TERM DEPRESSION; MESOLIMBIC DOPAMINE SYSTEM; CUE-INDUCED REINSTATEMENT; SEEKING BEHAVIOR; DRUG-ADDICTION	Experience-dependent plasticity at excitatory synapses of the mesocorticolimbic system is a fundamental brain mechanism that enables adaptation to an ever-changing environment. These synaptic responses are critical for the planning and execution of adaptive behaviors that maximize survival. The mesocorticolimbic system mediates procurement of positive reinforcers such as food and sex; however, drugs of abuse resculpt this crucial circuitry to promote compulsive drug-seeking behavior. This review will discuss the long-term changes in glutamatergic neurotransmission that occur within the mesolimbic system following cocaine exposure. In addition, we will examine how these long-lasting neuroadaptations may drive the pathology of psychostimulant addiction. Finally, we review clinical trials that highlight antagonists at excitatory AMPA receptors as promising targets against cocaine abuse.	[Chen, Billy T.; Bonci, Antonello] UCSF Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Bowers, M. Scott] VCU Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Bowers, M. Scott] VCU Pharmacol, Inst Drug & Alcohol Studies, Richmond, VA 23284 USA; [Bonci, Antonello] Wheeler Ctr Neurobiol Addict, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Virginia Commonwealth University; Virginia Commonwealth University	Bonci, A (corresponding author), UCSF Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	antonello.bonci@ucsf.edu		Bowers, M Scott/0000-0003-0047-6765	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; National Institute on Drug Abuse [1R01DA15096]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096] Funding Source: NIH RePORTER	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funds provided by the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (A.B.), a National Institute on Drug Abuse grant, 1R01DA15096 (A.B.), and capital provided by the Virginia Commonwealth University School of Medicine and the Virginia Higher Education Equipment Trust Fund (M.S.B.). We would like to thank Micky Marinelli, Woody Hopf, Lisa Daitch, and Diana Dunkelberger for many helpful suggestions.	Adewale AS, 2006, J PHARMACOL EXP THER, V318, P922, DOI 10.1124/jpet.106.105387; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; [Anonymous], [No title captured]; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bachtell RK, 2008, EUR J NEUROSCI, V27, P2229, DOI 10.1111/j.1460-9568.2008.06199.x; Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bauzo RM, 2009, PHARMACOL BIOCHEM BE, V94, P204, DOI 10.1016/j.pbb.2009.08.011; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bowers MS, 2007, PSYCHOPHARMACOLOGY, V195, P397, DOI 10.1007/s00213-007-0904-y; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chen JS, 2000, J NEUROSCI, V20, P8965; Chimirri A, 1998, J MED CHEM, V41, P3409, DOI 10.1021/jm9800393; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Colby CR, 2003, J NEUROSCI, V23, P2488; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; DAVIS WM, 1976, PAVLOVIAN J BIOL SCI, V11, P222; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; El-Ghundi M, 2007, REV NEUROSCIENCE, V18, P37; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Famous KR, 2008, J NEUROSCI, V28, P11061, DOI 10.1523/JNEUROSCI.1221-08.2008; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Filip M, 2006, BRAIN RES, V1071, P218, DOI 10.1016/j.brainres.2005.11.099; Fuchs RA, 2006, J NEUROSCI, V26, P3584, DOI 10.1523/JNEUROSCI.5146-05.2006; Geisler S, 2008, NEUROPSYCHOPHARMACOL, V33, P2688, DOI 10.1038/sj.npp.1301650; Ghasemzadeh MB, 2009, BRAIN RES, V1267, P89, DOI 10.1016/j.brainres.2009.01.047; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gottwald MD, 2008, DRUG TODAY, V44, P531, DOI [10.1358/dot.2008.44.7.1122221, 10.1358/dot.2008.44.7.1217105]; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grimm JW, 2003, J NEUROSCI, V23, P742; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Haile CN, 2009, AM J DRUG ALCOHOL AB, V35, P161, DOI 10.1080/00952990902825447; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Hemby SE, 2005, J NEUROCHEM, V95, P1785, DOI 10.1111/j.1471-4159.2005.03517.x; Horger BA, 1999, J NEUROSCI, V19, P4110; HURD YL, 1993, SYNAPSE, V13, P357, DOI 10.1002/syn.890130408; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ito R, 2002, J NEUROSCI, V22, P6247; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Jin SH, 2005, NEUROSCIENCE, V133, P647, DOI 10.1016/j.neuroscience.2005.03.017; Johnson BA, 2007, PROG NEURO-PSYCHOPH, V31, P455, DOI 10.1016/j.pnpbp.2006.11.011; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Juo P, 2007, MOL BIOL CELL, V18, P3883, DOI 10.1091/mbc.E06-09-0818; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kalivas PW, 2006, TRENDS NEUROSCI, V29, P610, DOI 10.1016/j.tins.2006.08.008; Kalivas PW, 2008, NEUROTOX RES, V14, P185, DOI 10.1007/BF03033809; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kampman KM, 2004, DRUG ALCOHOL DEPEN, V75, P233, DOI 10.1016/j.drugalcdep.2004.03.008; Kast RE, 2007, MED HYPOTHESES, V69, P836, DOI 10.1016/j.mehy.2007.01.072; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Koob GF, 1998, J PSYCHOPHARMACOL, V12, P39, DOI 10.1177/026988119801200106; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kuzniecky R, 1998, NEUROLOGY, V51, P627, DOI 10.1212/WNL.51.2.627; Lauterborn JC, 2009, NEUROSCIENCE, V159, P283, DOI 10.1016/j.neuroscience.2008.12.018; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee CY, 2008, EPILEPSIA, V49, P888, DOI 10.1111/j.1528-1167.2007.01526.x; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Lu L, 2009, BIOL PSYCHIAT, V66, P137, DOI 10.1016/j.biopsych.2009.02.009; Lu W, 2002, EUR J NEUROSCI, V15, P2027, DOI 10.1046/j.1460-9568.2002.02036.x; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Martinez-Raga Jose, 2008, Curr Drug Abuse Rev, V1, P213; Mathon DS, 2003, EUR J PHARMACOL, V480, P97, DOI 10.1016/j.ejphar.2003.08.097; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; McGinty JF, 2008, J NEUROCHEM, V104, P1440, DOI 10.1111/j.1471-4159.2008.05240.x; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nikam SS, 2001, CURR MED CHEM, V8, P155, DOI 10.2174/0929867013373877; Nikam SS, 1999, J MED CHEM, V42, P2266, DOI 10.1021/jm980455n; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OBRIEN CP, 1992, RES P ARNMD, V70, P157; OBrien CP, 1996, J CONSULT CLIN PSYCH, V64, P677; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Pan WX, 2008, J NEUROSCI, V28, P9619, DOI 10.1523/JNEUROSCI.0255-08.2008; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pascuzzi RM, 2010, AMYOTROPH LATERAL SC, V11, P266, DOI 10.3109/17482960903307805; Peng XQ, 2010, EUR J PHARMACOL, V627, P156, DOI 10.1016/j.ejphar.2009.10.062; Peters J, 2006, PSYCHOPHARMACOLOGY, V186, P143, DOI 10.1007/s00213-006-0372-9; Petroff OAC, 1999, NEUROLOGY, V52, P473, DOI 10.1212/WNL.52.3.473; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Pierce RC, 1996, J NEUROSCI, V16, P1550; Ping AS, 2008, BRAIN RES, V1215, P173, DOI 10.1016/j.brainres.2008.03.088; Pu L, 2006, NAT NEUROSCI, V9, P605, DOI 10.1038/nn1687; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Robbe D, 2002, EUR J NEUROSCI, V16, P2231, DOI 10.1046/j.1460-9568.2002.02273.x; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Scheggi S, 2007, J NEUROCHEM, V103, P1168, DOI 10.1111/j.1471-4159.2007.04818.x; Schramm-Sapyta NL, 2006, NEUROPSYCHOPHARMACOL, V31, P1444, DOI 10.1038/sj.npp.1300918; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; SMITH GP, 2004, HDB BEHAV NEUROBIOLO; Solyom S, 2002, CURR PHARM DESIGN, V8, P913, DOI 10.2174/1381612024607081; Stoffel EC, 2008, DRUG ALCOHOL DEPEN, V92, P69, DOI 10.1016/j.drugalcdep.2007.06.012; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Tang WX, 2003, J NEUROCHEM, V85, P911, DOI 10.1046/j.1471-4159.2003.01740.x; Tatsuta T, 2007, PHARMACOL BIOCHEM BE, V87, P48, DOI 10.1016/j.pbb.2007.03.019; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Todtenkopf MS, 2006, J NEUROSCI, V26, P11665, DOI 10.1523/JNEUROSCI.3070-06.2006; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Uys JD, 2008, CNS NEUROL DISORD-DR, V7, P482, DOI 10.2174/187152708786927868; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Winstanley CA, 2009, PHARMACOL BIOCHEM BE, V93, P278, DOI 10.1016/j.pbb.2008.12.007; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Xi Zheng-Xiong, 2008, Curr Drug Abuse Rev, V1, P303; Yahyavi-Firouz-Abadi N, 2009, PHARMACOL THERAPEUT, V124, P235, DOI 10.1016/j.pharmthera.2009.06.014; Yu MF, 2005, J MOL NEUROSCI, V25, P171, DOI 10.1385/JMN:25:2:171; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	175	142	145	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					11	24		10.1016/j.neuron.2010.06.004	http://dx.doi.org/10.1016/j.neuron.2010.06.004			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624588	Green Accepted, Bronze			2022-12-17	WOS:000280221000005
J	Rieke, F; Rudd, ME				Rieke, Fred; Rudd, Michael E.			The Challenges Natural Images Pose for Visual Adaptation	NEURON			English	Review							RETINAL GANGLION-CELLS; CONTRAST GAIN-CONTROL; MONKEY MACACA-FASCICULARIS; LIGHT ADAPTATION; SENSITIVITY REGULATION; TEMPORAL CONTRAST; ROD VISION; CONE PHOTORECEPTORS; ABSOLUTE THRESHOLD; BACKGROUND LIGHT	Advances in our understanding of natural image statistics and of gain control within the retinal circuitry are leading to new insights into the classic problem of retinal light adaptation. Here we review what we know about how rapid adaptation occurs during active exploration of the visual scene. Adaptational mechanisms must balance the competing demands of adapting quickly, locally, and reliably, and this balance must be maintained as lighting conditions change. Multiple adaptational mechanisms in different locations within the retina act in concert to accomplish this task, with lighting conditions dictating which mechanisms dominate.	[Rieke, Fred; Rudd, Michael E.] Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.	rieke@u.washington.edu			HHM1; NIH [EY-11850]; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	HHM1; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Larry Brown, Felice Dunn, Martin Lankheet, Fred Soo, and Barry Wark for helping develop many of the ideas described here. We also thank Matteo Carandini and Valerio Mante for contributing Figure 4. Support was provided by HHM1 and NIH (EY-11850).	Aguilar M., 1954, OPT ACTA, V1, P59, DOI [10.1080/713818657, DOI 10.1080/713818657]; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Barlow H., 1961, SENSORY COMMUNICATIO, P217; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BARLOW HB, 1965, COLD SPRING HARB SYM, V30, P539, DOI 10.1101/SQB.1965.030.01.052; BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Borghuis BG, 2009, J NEUROSCI, V29, P3045, DOI 10.1523/JNEUROSCI.5071-08.2009; Brown LG, 1998, VISION RES, V38, P1925, DOI 10.1016/S0042-6989(97)00400-8; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; De Vries H, 1943, PHYSICA, V10, P553, DOI 10.1016/S0031-8914(43)90575-0; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; DONNER K, 1990, J GEN PHYSIOL, V95, P733, DOI 10.1085/jgp.95.4.733; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; DOWLING JE, 1967, SCIENCE, V155, P273, DOI 10.1126/science.155.3760.273; DOWLING JE, 1963, J GEN PHYSIOL, V46, P1287, DOI 10.1085/jgp.46.6.1287; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Dunn FA, 2008, NEURON, V57, P894, DOI 10.1016/j.neuron.2008.01.031; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P311, DOI 10.1113/jphysiol.1973.sp010309; Fechner G., 1860, ELEMENTS PSYCHOPHYSI; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; FINKELSTEIN MA, 1981, VISION RES, V21, P319, DOI 10.1016/0042-6989(81)90159-0; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; FRISHMAN LJ, 1995, VISION RES, V35, P435, DOI 10.1016/0042-6989(94)00165-I; Frishman LJ, 1996, J OPT SOC AM A, V13, P601, DOI 10.1364/JOSAA.13.000601; HAYHOE MM, 1987, VISION RES, V27, P1981, DOI 10.1016/0042-6989(87)90062-9; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Ives H. E., 1912, T ILLUM ENG SOC, V7, P62; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; LANKHEET MJM, 1993, VISION RES, V33, P1153, DOI 10.1016/0042-6989(93)90205-B; LANKHEET MJM, 1991, VISION RES, V31, P1129, DOI 10.1016/0042-6989(91)90039-8; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; MACLEOD DIA, 1989, VISION RES, V29, P965, DOI 10.1016/0042-6989(89)90111-9; MACLEOD DIA, 1992, VISION RES, V32, P347, DOI 10.1016/0042-6989(92)90144-8; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; PURPURA K, 1988, P NATL ACAD SCI USA, V85, P4534, DOI 10.1073/pnas.85.12.4534; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rodieck RW., 1998, 1 STEPS SEEING, V1; ROSE A, 1948, J OPT SOC AM, V38, P196, DOI 10.1364/JOSA.38.000196; Rose A., 1942, PROC I RADIO ENG NEW, V30, P293, DOI [10.1109/jrproc.1942.230998, DOI 10.1109/JRPROC.1942.230998]; Rosenblum Naomi, 1997, WORLD HIST PHOTOGRAP; Rudd ME, 1996, SPATIAL VISION, V10, P125, DOI 10.1163/156856896X00097; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; RUSHTON WAH, 1965, PROC R SOC SER B-BIO, V162, P20, DOI 10.1098/rspb.1965.0024; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SMIMAKIS SM, 1997, NATURE, V386, P69; Smith VC, 2001, J NEUROPHYSIOL, V85, P545, DOI 10.1152/jn.2001.85.2.545; Smith VC, 2008, VISION RES, V48, P2649, DOI 10.1016/j.visres.2008.05.002; Smithson H, 2004, J VISION, V4, P693, DOI 10.1167/4.9.3; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.3.3; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; von Helmholtz H., 1867, TREATISE PHYSL OPTIC; von Kries J., 1878, SOURCES COLOR SCI, P101; von Kries J., 1905, HDB PHYSL MENSCHEN, V3; VONGOETHE JW, 1810, THEORY COLORS; Walraven J, 1990, VISUAL PERCEPTION NE, P53; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Yarbus A. L., 1967, EYE MOVEMENTS VISION, P171; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	84	142	144	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 10	2009	64	5					605	616		10.1016/j.neuron.2009.11.028	http://dx.doi.org/10.1016/j.neuron.2009.11.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005818	Bronze			2022-12-17	WOS:000273123700007
J	Gogolla, N; Galimberti, I; Deguchi, Y; Caroni, P				Gogolla, Nadine; Galimberti, Ivan; Deguchi, Yuichi; Caroni, Pico			Wnt Signaling Mediates Experience-Related Regulation of Synapse Numbers and Mossy Fiber Connectivities in the Adult Hippocampus	NEURON			English	Article							PATTERN SEPARATION; DENTATE GYRUS; RAT HIPPOCAMPUS; PLASTICITY; CA3; TRANSMISSION; TERMINALS; STRESS; CELLS; RELEASE	We investigated how experience regulates the structure of a defined neuronal circuit in adult mice. Enriched environment (EE) produced a robust and reversible increase in hippocampal stratum lucidum synapse numbers, mossy fiber terminal (LMT) numbers, and spine plus synapse densities at LMTs, whereas a distinct mechanism depending on Rab3a promoted LMT volume growth. In parallel, EE increased postsynaptic CA3 pyramidal neuron Wnt7a/b levels. Inhibiting Writ signaling through locally applied sFRP-1 suppressed the effects of EE on synapse numbers and further reduced synapse numbers in control mice. Wnt7 applied to CA3 mimicked the effects of EE on synapse and LMT numbers. CA3 Wnt7a/b levels were enhanced by excitatory activity and reduced by sFRP-1. Synapse numbers and Wnt7a/b levels peaked in mice aged 6-12 months; a decline in aged mice was reversed by EE. Therefore, behavioral experience specifically regulates adult global stratum lucidum synapse numbers and hippocampal network structure through Writ signaling.	[Gogolla, Nadine; Galimberti, Ivan; Deguchi, Yuichi; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, CH-4058 Basel, Switzerland.	caroni@fmi.ch						Acsady L, 1998, J NEUROSCI, V18, P3386; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; Danzer SC, 2008, HIPPOCAMPUS, V18, P668, DOI 10.1002/hipo.20426; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kim BG, 2008, J COMP NEUROL, V508, P473, DOI 10.1002/cne.21686; Leranth C, 2003, J NEUROSCI, V23, P1588; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Magarinos AM, 2006, P NATL ACAD SCI USA, V103, P18775, DOI 10.1073/pnas.0608785103; McBain CJ, 2008, PROG BRAIN RES, V169, P225, DOI 10.1016/S0079-6123(07)00013-1; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pleskacheva MG, 2000, HIPPOCAMPUS, V10, P17, DOI 10.1002/(SICI)1098-1063(2000)10:1<17::AID-HIPO2>3.0.CO;2-O; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Sato K, 2007, BRAIN RES, V1150, P108, DOI 10.1016/j.brainres.2007.02.093; Stewart MG, 2005, NEUROSCIENCE, V131, P43, DOI 10.1016/j.neuroscience.2004.10.031; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598	54	142	148	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 28	2009	62	4					510	525		10.1016/j.neuron.2009.04.022	http://dx.doi.org/10.1016/j.neuron.2009.04.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	453OH	19477153	Bronze			2022-12-17	WOS:000266619700008
J	Elliott, J; Jolicoeur, C; Ramamurthy, V; Cayouette, M				Elliott, Jimmy; Jolicoeur, Christine; Ramamurthy, Vasanth; Cayouette, Michel			Ikaros Confers Early Temporal Competence to Mouse Retinal Progenitor Cells	NEURON			English	Article							DEVELOPING RAT RETINA; TRANSCRIPTION FACTOR; LYMPHOCYTE DEVELOPMENT; FATE DETERMINATION; GENE-EXPRESSION; DNA-BINDING; DROSOPHILA NEUROBLASTS; VERTEBRATE RETINA; ZEBRAFISH RETINA; NERVOUS-SYSTEM	In the developing mouse retina, multipotent retinal progenitor cells (RPCs) give rise to specific retinal cell types at different times, but the molecular mechanisms regulating how RPCs change over time remain unclear. In the Drosophila neuroblast lineage, the zinc finger transcription factor Hunchback (Hb) is both necessary and sufficient to specify early-born neuronal identity. We show here that Ikaros, a mouse ortholog of Hb, is expressed in all early embryonic RPCs, which then give rise to Ikaros-negative RPCs at later stages in the lineage. Remarkably, misexpression of Ikaros in late RPCs is sufficient to confer competence to generate early-born neurons. Conversely, Ikaros mutant mice have reduced numbers of early-born cell types, whereas late-born cell types are not affected. These results suggest a model in which Ikaros expression is both necessary and sufficient to confer early temporal competence to RPCs and raise the possibility that a similar strategy might be used to control the sequential order of cell birth in other parts of the nervous system.	[Elliott, Jimmy; Jolicoeur, Christine; Ramamurthy, Vasanth; Cayouette, Michel] Inst Rech Clin Montreal, Cellular Neurobiol Res Unit, Montreal, PQ H2W 1R7, Canada; [Cayouette, Michel] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Cayouette, Michel] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Cayouette, Michel] McGill Univ, Div Expt Med, Montreal, PQ H3A 2B2, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; McGill University	Cayouette, M (corresponding author), Inst Rech Clin Montreal, Cellular Neurobiol Res Unit, Montreal, PQ H2W 1R7, Canada.	michel.cayouette@ircm.qc.ca		Cayouette, Michel/0000-0003-4655-9048	Canadian Institutes of Health Research (CIHR); Foundation Fighting Blindness - Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness - Canada	We thank Katia Georgopoulos for the Ikaros knockout mice and the monoclonal Ikaros antibody, Stephen Smale for Ikaros antibodies, Nadean Brown for the Math5 probe, Connie Cepko for the Crx probe, Thomas Jessell for the Lim-1 antibodies, Jeremy Nathans for the cone opsin antibodies, Jacques Drouin for the NeuroD1 antibody, and Anne Galy for the Ikaros dominant-negative construct. We are grateful to Aude Daigneault for expert technical help with the mouse colony and to Martin Raff. Jacques Drouin, Frederic Charron, Artur Kania, and Jonah Chan for insightful comments on the manuscript. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Foundation Fighting Blindness - Canada. V.R. is supported by a studentship from the Foundation Fighting Blindness - Canada. M.C. is a CIHR New Investigator and a W.K. Stell Scholar of the Foundation Fighting Blindness - Canada.	Agoston DV, 2007, J NEUROCHEM, V102, P1805, DOI 10.1111/j.1471-4159.2007.04653.x; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Brown NL, 1998, DEVELOPMENT, V125, P4821; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Christopherson I, 2001, J LEUKOCYTE BIOL, V69, P675; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cobb BS, 2005, CURR TOP MICROBIOL, V290, P29; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Durand B, 2000, BIOESSAYS, V22, P64; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Ezzat S, 2006, P NATL ACAD SCI USA, V103, P2214, DOI 10.1073/pnas.0508565103; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Galy A, 2000, BLOOD, V95, P128; Gao FB, 1997, J CELL BIOL, V138, P1367, DOI 10.1083/jcb.138.6.1367; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2005, CURR BIOL, V15, P525, DOI 10.1016/j.cub.2005.01.043; Nelander S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-68; Novotny T, 2002, DEVELOPMENT, V129, P1027; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Perdomo J, 2000, J BIOL CHEM, V275, P38347, DOI 10.1074/jbc.M005457200; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Waid DK, 1998, DEVELOPMENT, V125, P1059; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; WATANABE T, 1992, DEVELOPMENT, V114, P899; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	53	142	144	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 9	2008	60	1					26	39		10.1016/j.neuron.2008.08.008	http://dx.doi.org/10.1016/j.neuron.2008.08.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	363AC	18940586	Bronze			2022-12-17	WOS:000260237300006
J	Higley, MJ; Sabatini, BL				Higley, Michael J.; Sabatini, Bernardo L.			Calcium signaling in dendrites and spines: Practical and functional considerations	NEURON			English	Review							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE NEURONS; LONG-TERM POTENTIATION; DEPENDENT SYNAPTIC PLASTICITY; PROPAGATING ACTION-POTENTIALS; EXCITATORY POSTSYNAPTIC POTENTIALS; BACKPROPAGATING ACTION-POTENTIALS; DISTAL APICAL DENDRITES; GATED CA2+ CHANNELS; HIPPOCAMPAL-NEURONS	Changes in intracellular calcium (Ca) concentration following synaptic and suprathreshold activity are mediated by a wide range of sources and contribute to the regulation of myriad neuronal functions. The development of Ca imaging techniques has dramatically increased our understanding of the complex interactions between different Ca sources and their ability to produce spatial and temporal specificity of signaling, even within small cellular compartments such as dendrites and dendritic spines. However, as the use of Ca imaging has become more prevalent, the need to exercise care in the experimental methodology and interpretation of data has also grown. In this review, we discuss the recent progress made using imaging methods in understanding dendritic Ca signaling and also describe a quantitative framework for using fluorescent indicators to experimentally measure and interpret changes in intracellular Ca.	[Higley, Michael J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, 220 Longwood Ave, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu			Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Sabatini Lab and J.A. Cardin for helpful comments during the preparation of this manuscript. M.J.H. is supported by a Postdoctoral Research Fellowship from the Parkinson's Disease Foundation.	AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Cormier RJ, 2001, J NEUROPHYSIOL, V85, P399, DOI 10.1152/jn.2001.85.1.399; COWAN WM, 2001, SYNAPSES; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Doering CJ, 2003, J BIOENERG BIOMEMBR, V35, P491, DOI 10.1023/B:JOBB.0000008022.50702.1a; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; Frick A, 2003, J NEUROSCI, V23, P3243; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Gasparini S, 2007, J PHYSIOL-LONDON, V580, P787, DOI 10.1113/jphysiol.2006.121343; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Henke W, 1996, CELL CALCIUM, V20, P287, DOI 10.1016/S0143-4160(96)90034-2; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; Hille B., 2001, ION CHANNELS EXCITAB; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Hong M, 2007, J PHYSIOL-LONDON, V584, P75, DOI 10.1113/jphysiol.2007.137661; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Isope P, 2005, J PHYSIOL-LONDON, V562, P257, DOI 10.1113/jphysiol.2004.074211; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JAHR CE, 1990, J NEUROSCI, V10, P1830; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; KAO JPY, 1988, BIOPHYS J, V53, P635, DOI 10.1016/S0006-3495(88)83142-4; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Milojkovic BA, 2007, J PHYSIOL-LONDON, V585, P447, DOI 10.1113/jphysiol.2007.142315; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oakley JC, 2001, J NEUROPHYSIOL, V86, P514, DOI 10.1152/jn.2001.86.1.514; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1992, J NEUROSCI, V12, P4202; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sarkisov DV, 2008, J NEUROSCI, V28, P133, DOI 10.1523/JNEUROSCI.1729-07.2008; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; SCHWARTZKROIN PA, 1977, BRAIN RES, V135, P157, DOI 10.1016/0006-8993(77)91060-5; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Watanabe S, 2006, J PHYSIOL-LONDON, V575, P455, DOI 10.1113/jphysiol.2006.114231; Waters J, 2003, J NEUROSCI, V23, P8558; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1999, J NEUROSCI, V19, P1976; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	139	142	146	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 25	2008	59	6					902	913		10.1016/j.neuron.2008.08.020	http://dx.doi.org/10.1016/j.neuron.2008.08.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356SK	18817730	Bronze			2022-12-17	WOS:000259797700008
J	Wang, H; Wu, LJ; Kim, SS; Lee, FJS; Gong, B; Toyoda, H; Ren, M; Shang, YZ; Xu, H; Liu, F; Zhao, MG; Zhuo, M				Wang, Hansen; Wu, Long-Jun; Kim, Susan S.; Lee, Frank J. S.; Gong, Bo; Toyoda, Hiroki; Ren, Ming; Shang, Yu-Ze; Xu, Hui; Liu, Fang; Zhao, Ming-Gao; Zhuo, Min			FMRP acts as a key messenger for dopamine modulation in the forebrain	NEURON			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; LONG-TERM-POTENTIATION; COUPLED-RECEPTOR KINASES; CONTEXTUAL FEAR MEMORY; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; WORKING-MEMORY	The fragile X mental retardation protein (FMRP) is an RNA-binding protein that controls translational efficiency and regulates synaptic plasticity. Here, we report that FMRP is involved in dopamine (DA) modulation of synaptic potentiation. AMPA glutamate receptor subtype 1 (GluR1) surface expression and phosphorylation in response to D1 receptor stimulation were reduced in cultured Fmr1(-/-) prefrontal cortex (PFC) neurons. Furthermore, D1 receptor signaling was impaired, accompanied by D1 receptor hyperphosphorylation at serine sites and subcellular redistribution of G protein-coupled receptor kinase 2 (GRK2) in both PFC and striatum of Fmr1(-/-) mice. FMRP interacted with GRK2, and pharmacological inhibition of GRK2 rescued D1 receptor signaling in Frnr1(-/-) neurons. Finally, D1 receptor agonist partially rescued hyperactivity and enhanced the motor function of Fmr1(-/-) mice. Our study has identified FMRP as a key messenger for DA modulation in the forebrain and may provide insights into the cellular and molecular mechanisms underlying fragile X syndrome.	[Wang, Hansen; Wu, Long-Jun; Kim, Susan S.; Gong, Bo; Toyoda, Hiroki; Ren, Ming; Shang, Yu-Ze; Xu, Hui; Zhao, Ming-Gao; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lee, Frank J. S.; Liu, Fang] Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON M5T 1R8, Canada; [Zhao, Ming-Gao] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Peoples R China	University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Air Force Military Medical University	Zhao, MG (corresponding author), Univ Toronto, Fac Med, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	minggao@fmmu.edu.cn; min.zhuo@utoronto.ca	Lee, Frank J.S./D-5899-2017; Wu, Long-Jun/AAK-7113-2020; Zhuo, Min/A-2072-2008; Gong, Bo/E-6820-2011; Wu, Long-Jun/E-2684-2012; wang, hansen/I-2510-2019	Lee, Frank J.S./0000-0002-5768-3776; Wu, Long-Jun/0000-0001-8019-3380; Zhuo, Min/0000-0001-9062-3241; Gong, Bo/0000-0001-6028-1818; wang, hansen/0000-0003-4414-3372; Zhao, Ming-gao/0000-0002-7539-3887; Toyoda, Hiroki/0000-0002-9907-7176	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health; CIHR [CIHR66975, CIHR84256]; Canada Research Chair; NeuroCanada; Fragile X Research Foundation of Canada	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NeuroCanada; Fragile X Research Foundation of Canada	This work was supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, CIHR operating grants CIHR66975 and CIHR84256, Canada Research Chair, and NeuroCanada to M.Z. and National Natural Science Foundation of China (30670684) to M-G.Z. H.W., L-J.W., and M.-G.Z. were supported by postdoctoral fellowships from the Fragile X Research Foundation of Canada. We thank W.T. Greenough for his generous gift of Fmr1 WT and KO breeding pairs and J.Darnell for kindly providing the FMRP constructs.	Arnsten AFT, 2006, NEUROPSYCHOPHARMACOL, V31, P2376, DOI 10.1038/sj.npp.1301164; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carlsson A, 2001, BIOSCIENCE REP, V21, P691, DOI 10.1023/A:1015556204669; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fraga S, 2004, AM J PHYSIOL-REG I, V287, pR772, DOI 10.1152/ajpregu.00208.2004; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heijtz RD, 2007, PHYSIOL BEHAV, V92, P155, DOI 10.1016/j.physbeh.2007.05.024; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Larson J, 2005, J NEUROSCI, V25, P9460, DOI 10.1523/JNEUROSCI.2638-05.2005; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moon J, 2006, BEHAV NEUROSCI, V120, P1367, DOI 10.1037/0735-7044.120.6.1367; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nicola SM, 1997, J NEUROSCI, V17, P5697; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Perez-Garcia GS, 2005, BEHAV BRAIN RES, V163, P136, DOI 10.1016/j.bbr.2005.04.014; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sullivan K, 2006, AM J MED GENET A, V140A, P2275, DOI 10.1002/ajmg.a.31388; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Surmeier DJ, 2007, J PHYSIOL-LONDON, V581, P885, DOI 10.1113/jphysiol.2007.134502; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Toyoda H, 2007, DEV NEUROBIOL, V67, P498, DOI 10.1002/dneu.20380; Ventura R, 2004, BEHAV PHARMACOL, V15, P433, DOI 10.1097/00008877-200409000-00018; Wang HS, 2008, J NEUROSCI, V28, P4385, DOI 10.1523/JNEUROSCI.0646-08.2008; Wang HS, 2007, J BIOL CHEM, V282, P1507, DOI 10.1074/jbc.M607291200; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Winstel R, 2005, BIOCHEM PHARMACOL, V70, P1001, DOI 10.1016/j.bcp.2005.06.015; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhuo M, 2002, DRUG DISCOV TODAY, V7, P259, DOI 10.1016/S1359-6446(01)02138-9; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003	65	142	143	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 28	2008	59	4					634	647		10.1016/j.neuron.2008.06.027	http://dx.doi.org/10.1016/j.neuron.2008.06.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	344RL	18760699	Bronze			2022-12-17	WOS:000258944900013
J	Xu, W; Schluter, OM; Steiner, P; Czervionke, BL; Sabatini, B; Malenka, RC				Xu, Weifeng; Schlueter, Oliver M.; Steiner, Pascal; Czervionke, Brian L.; Sabatini, Bernardo; Malenka, Robert C.			Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; DENSITY PROTEIN PSD-95; GLUTAMATE RECEPTORS; KINASE-A; PLASTICITY; MULTIMERIZATION; POTENTIATION; SYNAPSES; SUBUNITS	The postsynaptic density protein PSD-95 influences synaptic AMPA receptor (AMPAR) content and may play a critical role in LTD. Here we demonstrate that the effects of PSD-95 on AMPAR-mediated synaptic responses and LTD can be dissociated. Our findings suggest that N-terminal-domain-mediated dimerization is important for PSD-95's effect on basal synaptic AMPAR function, whereas the C-terminal SH3-GK domains are also necessary for localizing PSD-95 to synapses. We identify PSD-95 point mutants (Q15A, E17R) that maintain PSD-95's influence on basal AMPAR synaptic responses yet block LTD. These point mutants increase the proteolysis of PSD-95 within its N-terminal domain, resulting in a C-terminal fragment that functions as a dominant negative likely by scavenging critical signaling proteins required for LTD. Thus, the C-terminal portion of PSD-95 serves a dual function. It is required to localize PSD-95 at synapses and as a scaffold for signaling proteins that are required for LTD.	[Xu, Weifeng; Schlueter, Oliver M.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; [Schlueter, Oliver M.] Univ Gottingen, Sch Med, European Neurosci Inst, D-37077 Gottingen, Germany; [Schlueter, Oliver M.] Max Planck Soc, D-37077 Gottingen, Germany; [Steiner, Pascal; Czervionke, Brian L.; Sabatini, Bernardo] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02459 USA	Stanford University; University of Gottingen; Max Planck Society; Harvard University; Harvard Medical School	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH080310, R37MH063394, R01MH063394, F32MH075220, R00MH080310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052707] Funding Source: NIH RePORTER; NIMH NIH HHS [MH063394, MH075220, R01 MH118298, R00 MH080310, MH080310, R01 MH063394, F32 MH075220, R37 MH063394, K99 MH080310, K99 MH080310-01] Funding Source: Medline; NINDS NIH HHS [R01 NS052707-03, R01 NS052707] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AEL DE, 2002, CELL, V108, P849; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Stein V, 2003, J NEUROSCI, V23, P5503; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469	48	142	146	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 24	2008	57	2					248	262		10.1016/j.neuron.2007.11.027	http://dx.doi.org/10.1016/j.neuron.2007.11.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215622	Bronze, Green Accepted			2022-12-17	WOS:000252758400009
J	Crepel, V; Aronov, D; Jorquera, I; Represa, A; Ben-Ari, Y; Cossart, R				Crepel, Valerie; Aronov, Dmitriy; Jorquera, Isabel; Represa, Alfonso; Ben-Ari, Yehezkel; Cossart, Rosa			A parturition-associated nonsynaptic coherent activity pattern in the developing hippocampus	NEURON			English	Article							GIANT DEPOLARIZING POTENTIALS; DEVELOPING RAT HIPPOCAMPUS; ACTIVATED CATION CURRENT; MOUSE CORTICAL-NEURONS; IN-VITRO; DEVELOPING NEOCORTEX; CALCIUM-CHANNELS; GAP-JUNCTIONS; POSTNATAL-DEVELOPMENT; SUPRAOPTIC NUCLEUS	Correlated neuronal activity is instrumental in the formation of networks, but its emergence during maturation is poorly understood. We have used multibeam two-photon calcium microscopy combined with targeted electrophysiological recordings in order to determine the development of population coherence from embryonic to postnatal stages in the hippocampus. At embryonic stages (E16-E19), synchronized activity is absent, and neurons are intrinsically active and generate L-type channel-mediated calcium spikes. At birth, small cell assemblies coupled by gap junctions spontaneously generate synchronous nonsynaptic calcium plateaus associated to recurrent burst discharges. The emergence of coherent calcium plateaus at birth is controlled by oxytocin, a maternal hormone initiating labour, and progressively shut down a few days later by the synapse-driven giant depolarizing potentials (GDPs) that synchronize the entire network. Therefore, in the developing hippocampus, delivery is an important signal that triggers the first coherent activity pattern, which is silenced by the emergence of synaptic transmission.	Univ Mediterranee, INSERM, INMED, U29, F-13273 Marseille 09, France; MIT, Cambridge, MA 02139 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Massachusetts Institute of Technology (MIT)	Cossart, R (corresponding author), Univ Mediterranee, INSERM, INMED, U29, Parc Sci Luminy,BP 13, F-13273 Marseille 09, France.	cossart@inmed.univ-mrs.fr	Cossart, Rosa/AAT-7934-2020; Cossart, Rosa/E-7674-2014; Represa, Alfonso/M-7383-2016; Crépel, Valérie/E-1870-2016	Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638; Represa, Alfonso/0000-0002-5096-8939; Crépel, Valérie/0000-0003-0408-3766; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bender RA, 2005, EUR J NEUROSCI, V22, P2669, DOI 10.1111/j.1460-9568.2005.04407.x; Bittman K, 1997, J NEUROSCI, V17, P7037; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Brun ICL, 2004, J PHYSIOL-LONDON, V559, P129, DOI 10.1113/jphysiol.2004.065060; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; DI PE, 2001, EUR J NEUROSCI, V13, P1403; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hatton GI, 1996, J NEUROSCI, V16, P123; Jiang M, 2005, NEUROSCIENCE, V135, P839, DOI 10.1016/j.neuroscience.2005.06.073; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Kandler K, 1998, J NEUROSCI, V18, P1419; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Leinekugel X, 1998, J NEUROSCI, V18, P6349; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; Liljelund P, 2000, J NEUROSCI, V20, P7394; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.3109/14767059609025430; McCabe AK, 2006, J PHYSIOL-LONDON, V577, P155, DOI 10.1113/jphysiol.2006.117523; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nielsen T, 2001, J MICROSC-OXFORD, V201, P368, DOI 10.1046/j.1365-2818.2001.00852.x; Nita DA, 2003, J PHYSIOL-LONDON, V552, P325, DOI 10.1113/jphysiol.2003.050310; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Peinado A, 2000, J NEUROSCI, V20; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Theodosis DT, 2006, MOL CELL NEUROSCI, V31, P785, DOI 10.1016/j.mcn.2006.01.006; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	74	142	143	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					105	120		10.1016/j.neuron.2007.03.007	http://dx.doi.org/10.1016/j.neuron.2007.03.007			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408581	Bronze			2022-12-17	WOS:000245848400013
J	Murphy, GJ; Rieke, F				Murphy, Gabe J.; Rieke, Fred			Network variability limits stimulus-evoked spike timing precision in retinal ganglion cells	NEURON			English	Article							TIGER SALAMANDER RETINA; INNER PLEXIFORM LAYER; MAMMALIAN RETINA; FEEDFORWARD INHIBITION; BIPOLAR CELLS; SYNAPTIC CONDUCTANCE; CORTICAL-NEURONS; PYRAMIDAL CELLS; AUDITORY-CORTEX; VISUAL-CORTEX	Visual, auditory, somatosensory, and olfactory stimuli generate temporally precise patterns of action potentials (spikes). It is unclear, however, how the precision of spike generation relates to the pattern and variability of synaptic input elicited by physiological stimuli. We determined how synaptic conductances evoked by light stimuli that activate the rod bipolar pathway control spike generation in three identified types of mouse retinal ganglion cells (RGCs). The relative amplitude, timing, and impact of excitatory and inhibitory input differed dramatically between On and Off RGCs. Spikes evoked by repeated somatic injection of identical light-evoked synaptic conductances were more temporally precise than those evoked by light. However, the precision of spikes evoked by conductances that varied from trial to trial was similar to that of light-evoked spikes. Thus, the rod bipolar pathway modulates different RGCs via unique combinations of synaptic input, and RGC temporal variability reflects variability in the input this circuit provides.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murphy, GJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	gjmurphy@u.washington.edu		Murphy, Gabe/0000-0002-9321-8556	NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11850, R01 EY011850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Dhingra NK, 2004, J NEUROSCI, V24, P2914, DOI 10.1523/JNEUROSCI.5346-03.2004; DIAMOND JS, 1993, NEURON, V11, P725, DOI 10.1016/0896-6273(93)90082-3; DIAMOND JS, 1995, J PHYSIOL-LONDON, V487, P711, DOI 10.1113/jphysiol.1995.sp020912; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Grunert U, 2000, MICROSC RES TECHNIQ, V50, P130; HENSLEY SH, 1993, J NEUROPHYSIOL, V69, P2099, DOI 10.1152/jn.1993.69.6.2099; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Matsui K, 1998, J NEUROSCI, V18, P4500; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Owczarzak MT, 1999, ANAT RECORD, V255, P363; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Protti DA, 1997, J NEUROSCI, V17, P6075; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Roska B, 1998, J NEUROSCI, V18, P3451; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Shu YS, 2003, J NEUROSCI, V23, P10388; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Stuart G., 2000, DENDRITES; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Zaghloul KA, 2003, J NEUROSCI, V23, P2645; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	67	142	142	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					511	524		10.1016/j.neuron.2006.09.014	http://dx.doi.org/10.1016/j.neuron.2006.09.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088216	Green Accepted, Bronze			2022-12-17	WOS:000242269700013
J	Liu, TS; Pestilli, F; Carrasco, M				Liu, TS; Pestilli, F; Carrasco, M			Transient attention enhances perceptual performance and fMRI response in human visual cortex	NEURON			English	Article							SELECTIVE ATTENTION; CONTRAST SENSITIVITY; REFLEXIVE ATTENTION; NEURAL MECHANISMS; CORTICAL AREAS; BRAIN ACTIVITY; STRIATE; MODULATION; COMPONENTS; MT	When a visual stimulus suddenly appears, it captures attention, producing a transient improvement of performance on basic visual tasks. We investigate the effect of transient attention on stimulus representations in early visual areas using rapid event-related fMRI. Participants discriminated the orientation of one of two gratings preceded or followed by a non-predictive peripheral cue. Compared to control conditions, precueing the target location improved performance and produced a larger fMRI response in corresponding retinotopic areas. This enhancement progressively increased from striate to extrastriate areas. Control conditions indicated that the enhanced fMRI response was not due to sensory summation of cue and target signals. Thus, an uninformative precue increases both perceptual performance and the concomitant stimulus-evoked activity in early visual areas. These results provide evidence regarding the retinotopically specific neural correlate for the effects of transient attention on early vision.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	marisa.carrasco@nyu.edu	Pestilli, Franco/J-5236-2012; Liu, Taosheng/K-9148-2013	Pestilli, Franco/0000-0002-2469-0494; Liu, Taosheng/0000-0002-9768-0393	NEI NIH HHS [R01 EY016200] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2004, VISION RES, V44, P1351, DOI 10.1016/j.visres.2003.11.026; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GOBEL J, 2005, IN PRESS PSYCHOL SCI; Handy TC, 2003, NAT NEUROSCI, V6, P421, DOI 10.1038/nn1031; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1999, PERCEPT PSYCHOPHYS, V61, P1424, DOI 10.3758/BF03206191; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Mayfrank L., 1987, EYE MOVEMENTS PHYSL, P37, DOI DOI 10.1167/4.12.12; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; NACHMIAS J, 1967, J OPT SOC AM, V57, P421, DOI 10.1364/JOSA.57.000421; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Noesselt T, 2002, NEURON, V35, P575, DOI 10.1016/S0896-6273(02)00781-X; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PESTILLI F, 2005, IN PRESS VISION RES; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SERENCES JT, 2005, IN PRESS PSYCHOL SCI; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; WANDELL BA, 2005, IN PRESS PHILOS T B; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	60	142	144	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					469	477		10.1016/j.neuron.2004.12.039	http://dx.doi.org/10.1016/j.neuron.2004.12.039			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694332	Green Accepted, Bronze			2022-12-17	WOS:000226787700018
J	Davis, RL				Davis, RL			Olfactory learning	NEURON			English	Review							ANTERIOR PIRIFORM CORTEX; LONG-TERM-MEMORY; DROSOPHILA MUSHROOM BODIES; INDUCED OSCILLATORY RESPONSES; ENCODING NEURAL ASSEMBLIES; ANTENNAL LOBE; BASOLATERAL AMYGDALA; ORBITOFRONTAL CORTEX; ODOR REPRESENTATIONS; PERIRHINAL CORTEX	The olfactory nervous systems of insects and mammals exhibit many similarities, suggesting that the mechanisms for olfactory learning may be shared. Neural correlates of olfactory memory are distributed among many neurons within the olfactory nervous system. Perceptual olfactory learning may be mediated by alterations in the odorant receptive fields of second and/or third order olfactory neurons, and by increases in the coherency of activity among ensembles of second order neurons. Operant olfactory conditioning is associated with an increase in the coherent population activity of these neurons. Olfactory classical conditioning increases the odor responsiveness and synaptic activity of second and perhaps third order neurons. Operant and classical conditioning both produce an increased responsiveness to conditioned odors in neurons of the basolateral amygdala. Molecular genetic studies of olfactory learning in Drosophila have revealed numerous molecules that function within the third order olfactory neurons for normal olfactory learning.	Baylor Coll Med, Dept Mol & Cellular Biol, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	rdavis@bcm.tmc-edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NINDS NIH HHS [NS 19904] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Chiang AS, 2004, CURR BIOL, V14, P263, DOI 10.1016/j.cub.2004.02.003; Christensen TA, 2003, P NATL ACAD SCI USA, V100, P11076, DOI 10.1073/pnas.1934001100; Chu S, 2000, CHEM SENSES, V25, P111, DOI 10.1093/chemse/25.1.111; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, J NEUROBIOL, V54, P238, DOI 10.1002/neu.10170; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Faber T, 2001, NATURWISSENSCHAFTEN, V88, P472, DOI 10.1007/s001140100263; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fletcher ML, 2003, J NEUROSCI, V23, P6946; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holscher Christian, 2002, Neural Plast, V9, P41, DOI 10.1155/NP.2002.41; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Insausti R, 2002, BRAIN RES BULL, V57, P557, DOI 10.1016/S0361-9230(01)00684-0; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1998, LEARN MEMORY, V5, P124; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; Lessing D, 1999, CURR OPIN NEUROBIOL, V9, P766, DOI 10.1016/S0959-4388(99)00035-5; Litaudon P, 1997, EUR J NEUROSCI, V9, P1593, DOI 10.1111/j.1460-9568.1997.tb01517.x; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mcguire S.E., 2001, SCIENCE, V10, P1126; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mouly AM, 2002, LEARN MEMORY, V9, P66, DOI 10.1101/lm.45602; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Otto T, 2000, BEHAV BRAIN RES, V110, P119, DOI 10.1016/S0166-4328(99)00190-4; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; PERAZZONA B, 2004, IN PRESS J NEUROSCI; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Ravel N, 2003, EUR J NEUROSCI, V17, P350, DOI 10.1046/j.1460-9568.2003.02445.x; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Schettino LF, 2001, BEHAV NEUROSCI, V115, P1257, DOI 10.1037//0735-7044.115.6.1257; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Sun XJ, 1997, J COMP NEUROL, V379, P2, DOI 10.1002/(SICI)1096-9861(19970303)379:1<2::AID-CNE2>3.0.CO;2-8; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Vermetten E, 2003, J CLIN PSYCHIAT, V64, P202, DOI 10.4088/JCP.v64n0214; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson DA, 2000, J NEUROPHYSIOL, V83, P139, DOI 10.1152/jn.2000.83.1.139; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Wilson DA, 2001, LEARN MEMORY, V8, P279, DOI 10.1101/lm.42601; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	113	142	146	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					31	48		10.1016/j.neuron.2004.09.008	http://dx.doi.org/10.1016/j.neuron.2004.09.008			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450158	Bronze			2022-12-17	WOS:000224232600005
J	Lin, B; Wang, SW; Masland, RH				Lin, B; Wang, SW; Masland, RH			Retinal ganglion cell type, size, and spacing can be specified independent of homotypic dendritic contacts	NEURON			English	Article							DOMAIN FACTOR BRN-3B; MAMMALIAN RETINA; SENSORY NEURONS; MOUSE RETINA; CAT RETINA; SPATIAL-ORGANIZATION; RECEPTIVE-FIELDS; NERVOUS-SYSTEM; AXON OUTGROWTH; VISUAL-SYSTEM	In Brn3b(-/-) mice, where 80% of retinal ganglion cells degenerate early in development, the remaining 20% include most or all ganglion cell types. Cells of the same type cover the retinal surface evenly but tile it incompletely, indicating that a regular mosaic and normal dendritic field size can be maintained in the absence of contact among homotypic cells. In Math5(-/-) mice, where only similar to5% of ganglion cells are formed, the dendritic arbors of at least two types among the residual ganglion cells are indistinguishable from normal in shape and size, even though throughout development they are separated by millimeters from the nearest neighboring ganglion cell of the same type. It appears that the primary phenotype of retinal ganglion cells can develop without homotypic contact; dendritic repulsion may be an end-stage mechanism that fine-tunes the dendritic arbors for more efficient coverage of the retinal surface.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Masland, RH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	masland@helix.mgh.harvard.edu	Lin, Bin/E-9871-2010	Lin, Bin/0000-0003-1309-3480				AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; EYSEL UT, 1985, J COMP NEUROL, V242, P134, DOI 10.1002/cne.902420109; Farajian R, 2004, VISUAL NEUROSCI, V21, P13, DOI 10.1017/S0952523804041021; Galli-Resta L, 2000, EUR J NEUROSCI, V12, P3819, DOI 10.1046/j.1460-9568.2000.00280.x; Galli-Resta L, 1999, EUR J NEUROSCI, V11, P1461, DOI 10.1046/j.1460-9568.1999.00555.x; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HITCHCOCK PF, 1989, DEVELOPMENT, V106, P589; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KIRBY MA, 1986, J COMP NEUROL, V251, P532, DOI 10.1002/cne.902510408; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Lohmann C, 2001, J NEUROBIOL, V48, P150, DOI 10.1002/neu.1048; Masland RH, 2000, ANNU REV NEUROSCI, V23, P249, DOI 10.1146/annurev.neuro.23.1.249; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; NICHOLLS JG, 1968, J NEUROPHYSIOL, V31, P740, DOI 10.1152/jn.1968.31.5.740; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Raven MA, 2002, J COMP NEUROL, V454, P168, DOI 10.1002/cne.10444; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Rockhill RL, 2002, J NEUROSCI, V22, P3831; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; TAUCHI M, 1985, J NEUROSCI, V5, P2494; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; VANEY DI, 1994, J NEUROSCI, V14, P6301; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang SW, 2000, MOL CELL NEUROSCI, V16, P141, DOI 10.1006/mcne.2000.0860; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1983, PROG BRAIN RES, V58, P183, DOI 10.1016/S0079-6123(08)60019-9; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1983, VISION RES, V23, P1151, DOI 10.1016/0042-6989(83)90029-9; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	53	142	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					475	485		10.1016/j.neuron.2004.08.002	http://dx.doi.org/10.1016/j.neuron.2004.08.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312647	Bronze			2022-12-17	WOS:000223436400007
J	Estevez, R; Schroeder, BC; Accardi, A; Jentsch, TJ; Pusch, M				Estevez, R; Schroeder, BC; Accardi, A; Jentsch, TJ; Pusch, M			Conservation of chloride channel structure revealed by an inhibitor binding site in CIC-1	NEURON			English	Article							FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; HUMAN MYOTONIA; MUTATIONS; VOLTAGE; KIDNEY; ACID; CONDUCTANCE; DOMINANT; CLC-1	Crystal structures of bacterial CLC proteins were solved recently, but it is unclear to which level of detail they can be extrapolated to mammalian chloride channels. Exploiting the difference in inhibition by 9-anthracene carboxylic acid (9-AC) between CIC-0, -1, and -2, we identified a serine between helices 0 and P as crucial for 9-AC binding. Mutagenesis based on the crystal structure identified further residues affecting inhibitor binding. They surround a partially hydrophobic pocket close to the chloride binding site that is accessible from the cytoplasm, consistent with the observed intracellular block by 9-AC. Mutations in presumably Cl- -coordinating residues yield additional insights into the structure and function of CIC-1. Our work shows that the structure of bacterial CLCs can be extrapolated with fidelity to mammalian Cl- channels.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Ist Biofis, I-16149 Genoa, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Falkenried 94, D-20246 Hamburg, Germany.	jentsch@zmnh.uni-hamburg.de; pusch@icb.ge.cnr.it	Estevez, Raul/D-8610-2015	Estevez, Raul/0000-0003-1579-650X; Pusch, Michael/0000-0002-8644-8847; Jentsch, Thomas/0000-0002-3509-2553; Accardi, Alessio/0000-0002-6584-0102	Telethon [1079] Funding Source: Medline	Telethon(Fondazione Telethon)		Aromataris EC, 1999, BRIT J PHARMACOL, V126, P1375, DOI 10.1038/sj.bjp.0702459; Astill DS, 1996, BBA-BIOMEMBRANES, V1280, P178, DOI 10.1016/0005-2736(95)00281-2; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P367, DOI 10.1113/jphysiol.1971.sp009667; Clark S, 1998, J PHYSIOL-LONDON, V506, P665, DOI 10.1111/j.1469-7793.1998.665bv.x; Creighton T.E., 1993, PROTEINS; DELUCA A, 1992, J PHARMACOL EXP THER, V260, P364; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2002, CURR OPIN STRUC BIOL, V12, P531, DOI 10.1016/S0959-440X(02)00358-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hille B., 2001, ION CHANNELS EXCITAB; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; LANGER T, 1968, NEW ENGL J MED, V279, P856, DOI 10.1056/NEJM196810172791604; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; PALADE PT, 1977, J GEN PHYSIOL, V69, P879, DOI 10.1085/jgp.69.6.879; Pusch M, 2000, MOL PHARMACOL, V58, P498, DOI 10.1124/mol.58.3.498; PUSCH M, 1994, BIOPHYS J, V66, P149, DOI 10.1016/S0006-3495(94)80753-2; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Pusch M, 2001, J GEN PHYSIOL, V118, P45, DOI 10.1085/jgp.118.1.45; Pusch M, 1999, J PHYSIOL-LONDON, V515, P341, DOI 10.1111/j.1469-7793.1999.341ac.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Varela D, 2002, J PHYSIOL-LONDON, V544, P363, DOI 10.1113/jphysiol.2002.026096; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wollnik B, 1997, HUM MOL GENET, V6, P805, DOI 10.1093/hmg/6.5.805	54	142	146	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					47	59		10.1016/S0896-6273(03)00168-5	http://dx.doi.org/10.1016/S0896-6273(03)00168-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691663	Bronze			2022-12-17	WOS:000182202300008
J	Wolfe, JM; Cave, KR				Wolfe, JM; Cave, KR			The psychophysical evidence for a binding problem in human vision	NEURON			English	Article									Harvard Univ, Sch Med, Ctr Ophthalm Res, Boston, MA 02115 USA; Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England	Harvard University; Harvard Medical School; University of Southampton	Wolfe, JM (corresponding author), Harvard Univ, Sch Med, Ctr Ophthalm Res, Boston, MA 02115 USA.		Wolfe, Jeremy M/C-1621-2012; Wolfe, Jeremy M/A-9248-2016	Wolfe, Jeremy M/0000-0002-6475-1984; Wolfe, Jeremy M/0000-0002-6475-1984					0	142	144	2	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					11	17		10.1016/S0896-6273(00)80818-1	http://dx.doi.org/10.1016/S0896-6273(00)80818-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677023	Bronze			2022-12-17	WOS:000082893200005
J	Chou, WH; Hall, KJ; Wilson, DB; Wideman, CL; Townson, SM; Chadwell, LV; Britt, SG				Chou, WH; Hall, KJ; Wilson, DB; Wideman, CL; Townson, SM; Chadwell, LV; Britt, SG			Identification of a novel Drosophila opsin reveals specific patterning of the R7 and R8 photoreceptor cells	NEURON			English	Article							ELECTRO-PHYSIOLOGICAL ANALYSIS; TYROSINE KINASE DOMAIN; SCHIFF-BASE COUNTERION; HUMAN COLOR-VISION; MOLECULAR-GENETICS; VISUAL PIGMENT; SEVENLESS PROTEIN; BOVINE RHODOPSIN; COMPOUND EYE; EXTRACELLULAR DOMAIN	The function of the compound eye is dependent upon a developmental program that specifies different cell fates and directs the expression of spectrally distinct opsins in different photoreceptor cells. Rh5 is a novel Drosophila opsin gene that encodes a biologically active visual pigment that is expressed in a subset of R8 photoreceptor cells. Rh5 expression in the R8 cell of an individual ommatidium is strictly coordinated with the expression of Rh3, in the overlying R7 cell. In sevenless mutant flies, which lack R7 photoreceptor cells, the expression of the Rh5 protein in R8 cells is disrupted, providing evidence for a specific developmental signal between the R7 and R8 cells that is responsible for the paired expression of opsin genes.	UNIV TEXAS, HLTH SCI CTR, DEPT MOL MED, SAN ANTONIO, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Chou, WH (corresponding author), UNIV TEXAS, HLTH SCI CTR, INST BIOTECHNOL, SAN ANTONIO, TX 78245 USA.		Britt, Steven/GVT-1340-2022; Chou, Wen-Hai/H-1970-2016	Chou, Wen-Hai/0000-0002-7899-1129; Britt, Steven/0000-0001-7656-7984				ALTSCHUL SF, 1990, BASIC LOCAL ALIGNMEN, V216, P403; Ashburner M, 1989, DROSOPHILA LABORATOR, P44; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BASLER K, 1988, CELL, V54, P299; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRITT SG, 1993, NEURON, V11, P29, DOI 10.1016/0896-6273(93)90268-V; BURKHARDT D., 1962, SYMPOSIA SOC EXPTL BIOL, V16, P86; CARULLI JP, 1992, GENETICS, V132, P193; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; Dickson Barry, 1993, P1327; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Gelbart WM, 1996, NUCLEIC ACIDS RES, V24, P53, DOI 10.1093/nar/24.1.53; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; HARDIE RC, 1979, J COMP PHYSIOL, V133, P23, DOI 10.1007/BF00663107; HARDIE RC, 1983, CELL TISSUE RES, V233, P1, DOI 10.1007/BF00222228; HARDIE RC, 1983, BIOPHYS STRUCT MECH, V9, P171, DOI 10.1007/BF00537814; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HART AC, 1993, NATURE, V361, P732, DOI 10.1038/361732a0; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HEISENBERG M, 1984, VISION DROSOPHILA; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HU KG, 1978, J COMP PHYSIOL, V126, P15, DOI 10.1007/BF01342646; HUBER A, 1990, J BIOL CHEM, V265, P17906; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; Jacobs GH, 1981, COMP COLOR VISION; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V162, P421, DOI 10.1007/BF00612508; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lindsley D.L., 1992, GENOME DROSOPHILA ME; MEFFERT P, 1976, NATURE, V260, P342, DOI 10.1038/260342a0; MINKE B, 1979, J GEN PHYSIOL, V73, P517, DOI 10.1085/jgp.73.5.517; MONTELL C, 1987, J NEUROSCI, V7, P1558; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NATHANS J, 1992, ANNU REV GENET, V26, P403, DOI 10.1146/annurev.ge.26.120192.002155; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Ohguro H, 1996, J BIOL CHEM, V271, P5215; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; RANGANATHAN R, 1991, TRENDS NEUROSCI, V14, P486, DOI 10.1016/0166-2236(91)90060-8; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; ROBERTSON HM, 1989, GENETICS, V123, P815; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SMOLA U, 1979, J COMP PHYSIOL, V133, P41, DOI 10.1007/BF00663108; STARK WS, 1977, J COMP PHYSIOL, V115, P47, DOI 10.1007/BF00667784; STARK WS, 1977, J COMP PHYSIOL, V121, P289, DOI 10.1007/BF00613010; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Sved J, 1986, DROSOPH INF SERV, V63, P169; SWIMMER C, 1985, NUCLEIC ACIDS RES, V13, P8053, DOI 10.1093/nar/13.22.8053; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; VOGT K, 1984, Z NATURFORSCH C, V39, P196; Wolff Tanya, 1993, P1277; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	97	142	146	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1101	1115		10.1016/S0896-6273(00)80243-3	http://dx.doi.org/10.1016/S0896-6273(00)80243-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982159	Bronze			2022-12-17	WOS:A1996WA24800009
J	PENG, X; GREENE, LA; KAPLAN, DR; STEPHENS, RM				PENG, X; GREENE, LA; KAPLAN, DR; STEPHENS, RM			DELETION OF A CONSERVED JUXTAMEMBRANE SEQUENCE IN TRK ABOLISHES NGF-PROMOTED NEURITOGENESIS	NEURON			English	Article							NERVE GROWTH-FACTOR; PC12 PHEOCHROMOCYTOMA CELLS; FACTOR-INDUCED DIFFERENTIATION; TYROSINE KINASE-ACTIVITY; SIGNAL-TRANSDUCTION; NEURONAL DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; NEURITE OUTGROWTH; FACTOR RECEPTORS; HIGH-AFFINITY	Deletion of a conserved juxtamembrane sequence (KFG) in the Trk NGF receptor resulted in impaired neurite outgrowth, somatic hypertrophy, and induction of c-fos, c-jun, and TIS1 immediate-early genes. In contrast, these receptors retained the ability to mediate NGF-promoted survival and TIS8 and TIS11 immediate-early gene induction. The mutated receptor also mediated unimpaired autophosphorylation; SHC, PLC-gamma 1, and ERK tyrosine phosphorylation; and PI-3 kinase and ERK activation. However, SNT protein tyrosine phosphorylation, which wild-type receptors mediate via a ras-independent pathway, was undetectable. These findings indicate that the KFG sequence is indispensable for activating a ras-independent NGF signaling pathway involved in promoting neuronal differentiation and highlight potential roles of nontyrosine-containing receptor domains in growth factor signal transduction.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,EUKARYOT SIGNAL TRANSDUCT SECT,FREDERICK,MD 21702	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	PENG, X (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,630 W 168TH ST,NEW YORK,NY 10032, USA.				NCI NIH HHS [N01-CO-4600] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTIN JG, 1991, J BIOL CHEM, V266, P5401; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BATISTATOU A, 1992, MOL BIOL CELL, V3, P363, DOI 10.1091/mbc.3.3.363; BERND P, 1984, J BIOL CHEM, V259, P5509; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BURSTEIN DE, 1982, DEV BIOL, V94, P477, DOI 10.1016/0012-1606(82)90364-5; BURSTEIN DE, 1983, MOL APPROACHES NEURO, P159; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARTER AN, 1992, J BIOL CHEM, V267, P14563; CARTER AN, 1992, J BIOL CHEM, V267, P23434; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; DIKIC I, 1990, CURR BIOL, V4, P702; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1990, J NEUROSCI, V10, P1479; GREENE LA, 1991, CULTURING NERVE CELL, P207; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOEB DM, 1994, J BIOL CHEM, V269, P8901; LOEB DM, 1993, J NEUROSCI, V13, P2919; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MYLES GM, 1994, MOL CELL BIOL, V14, P4843, DOI 10.1128/MCB.14.7.4843; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; OHMICHI M, 1992, NEURON, V9, P769, DOI 10.1016/0896-6273(92)90039-G; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RAFFIONI S, 1992, P NATL ACAD SCI USA, V89, P9121, DOI 10.1073/pnas.89.19.9121; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; SEGATTO O, 1991, MOL CELL BIOL, V11, P3191, DOI 10.1128/MCB.11.6.3191; SIGMUND O, 1990, J BIOL CHEM, V265, P2257; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VALE RD, 1985, METHOD ENZYMOL, V109, P21; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016	62	142	142	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1995	15	2					395	406		10.1016/0896-6273(95)90043-8	http://dx.doi.org/10.1016/0896-6273(95)90043-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR426	7646892	Bronze			2022-12-17	WOS:A1995RR42600016
J	NICLAS, J; NAVONE, F; HOMBOOHER, N; VALE, RD				NICLAS, J; NAVONE, F; HOMBOOHER, N; VALE, RD			CLONING AND LOCALIZATION OF A CONVENTIONAL KINESIN MOTOR EXPRESSED EXCLUSIVELY IN NEURONS	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; BOVINE BRAIN KINESIN; PHENOL-CHLOROFORM EXTRACTION; SINGLE-STEP METHOD; HEAVY-CHAIN; NERVOUS-SYSTEM; AXONAL-TRANSPORT; SUBCELLULAR-LOCALIZATION; MONOCLONAL-ANTIBODY; DROSOPHILA KINESIN	Kinesin is a microtubule-based motor protein involved in organelle transport in neuronal and nonneuronal cells. Although a single kinesin motor has been thought to serve all cell types, we document here that neurons express a second conventional kinesin heavy chain (nKHC) that is 65% identical in amino acid sequence to the ubiquitously expressed kinesin heavy chain (uKHC). By preparing antibodies which distinguish between the two KHCs, we demonstrate that nKHC is a nucleotide-dependent microtubule-binding protein which partially cofractionates with membrane organelles. Immunolocalization experiments show that nKHC is distributed throughout the CNS but is highly enriched in subsets of neurons. in hippocampal neurons in culture, uKHC is distributed uniformly throughout the neuron, whereas nKHC is selectively concentrated in the cell body. These results demonstrate that mammalian neuronal tissue contains two conventional kinesin motors which may serve distinct functions in microtubule-based transport.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM, SAN FRANCISCO, CA 94143 USA; CNR, CTR CYTOPHARMACOL, DEPT MED PHARMACOL, MILAN, ITALY	University of California System; University of California San Francisco; Consiglio Nazionale delle Ricerche (CNR)	NICLAS, J (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA.				NIGMS NIH HHS [GM38499] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499, R37GM038499] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMARATUNGA A, 1993, J BIOL CHEM, V268, P17427; ANDREWS SB, 1993, P NATL ACAD SCI USA, V90, P6503, DOI 10.1073/pnas.90.14.6503; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1991, NEURON, V7, P521, DOI 10.1016/0896-6273(91)90365-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CYR JL, 1991, P NATL ACAD SCI USA, V88, P10114, DOI 10.1073/pnas.88.22.10114; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; ENDOW SA, 1991, P NATL ACAD SCI USA, V88, P4424, DOI 10.1073/pnas.88.10.4424; ENDOW SA, 1992, ANNU REV CELL BIOL, V8, P29; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; GHO M, 1992, SCIENCE, V258, P313, DOI 10.1126/science.1384131; Goldstein L S, 1991, Trends Cell Biol, V1, P93, DOI 10.1016/0962-8924(91)90036-9; GOLDSTEIN LSB, 1993, J CELL BIOL, V120, P1, DOI 10.1083/jcb.120.1.1; HACKNEY DD, 1991, BIOCHEM BIOPH RES CO, V174, P810, DOI 10.1016/0006-291X(91)91490-4; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; JUSTICE MJ, 1992, GENOMICS, V13, P1281, DOI 10.1016/0888-7543(92)90047-V; KATO K, 1990, EUR J NEUROSCI, V2, P704, DOI 10.1111/j.1460-9568.1990.tb00460.x; KOSIK KS, 1990, J BIOL CHEM, V265, P3278; KUZNETSOV SA, 1988, EMBO J, V7, P353, DOI 10.1002/j.1460-2075.1988.tb02820.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEOPOLD PL, 1992, CELL MOTIL CYTOSKEL, V23, P19, DOI 10.1002/cm.970230104; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; Skoufias DA, 1993, CURR OPIN CELL BIOL, V5, P95, DOI 10.1016/S0955-0674(05)80014-6; STEWART RJ, 1991, P NATL ACAD SCI USA, V88, P8470, DOI 10.1073/pnas.88.19.8470; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; WAGNER MC, 1989, CELL MOTIL CYTOSKEL, V12, P195, DOI 10.1002/cm.970120403; WRIGHT BD, 1991, J CELL BIOL, V113, P817, DOI 10.1083/jcb.113.4.817; YANG JT, 1988, P NATL ACAD SCI USA, V85, P1864, DOI 10.1073/pnas.85.6.1864; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332	56	142	147	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					1059	1072		10.1016/0896-6273(94)90314-X	http://dx.doi.org/10.1016/0896-6273(94)90314-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	7514426				2022-12-17	WOS:A1994NM83100010
J	Paton, JJ; Buonomano, DV				Paton, Joseph J.; Buonomano, Dean V.			The Neural Basis of Timing: Distributed Mechanisms for Diverse Functions	NEURON			English	Review							PRIMARY VISUAL-CORTEX; TERM SYNAPTIC PLASTICITY; CONDITIONED EYELID RESPONSES; CEREBELLAR PURKINJE-CELLS; PRIMARY AUDITORY-CORTEX; MEDIAL PREMOTOR CORTEX; TIME PERCEPTION; BASAL GANGLIA; PREFRONTAL CORTEX; NEURONAL-ACTIVITY	Timing is critical to most forms of learning, behavior, and sensory-motor processing. Converging evidence supports the notion that, precisely because of its importance across a wide range of brain functions, timing relies on intrinsic and general properties of neurons and neural circuits; that is, the brain uses its natural cellular and network dynamics to solve a diversity of temporal computations. Many circuits have been shown to encode elapsed time in dynamically changing patterns of neural activity-so-called population clocks. But temporal processing encompasses a wide range of different computations, and just as there are different circuits and mechanisms underlying computations about space, there are a multitude of circuits and mechanisms underlying the ability to tell time and generate temporal patterns.	[Paton, Joseph J.] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Neurobiol, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Psychol, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Los Angeles, CA 90024 USA	Fundacao Champalimaud; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Paton, JJ (corresponding author), Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal.; Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.; Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Psychol, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.; Buonomano, DV (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Los Angeles, CA 90024 USA.	joe.paton@neuro.fchampalimaud.org; dbuono@ucla.edu		Paton, Joseph/0000-0002-1663-6455	Champalimaud Foundation; Howard Hughes Medical Institute [55008745]; European Research Council [772239]; Bial Foundation [193/2016]; NIH [MH60163, NS100050]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100050] Funding Source: NIH RePORTER	Champalimaud Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); Bial Foundation(Bial Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Michale Fee and Patrick Simen for helpful discussions. J.J.P. would like to acknowledge the funding support of the Champalimaud Foundation, the Howard Hughes Medical Institute (International Research Scholar HHMI #55008745), the European Research Council (Consolidator Grant #772239), and the Bial Foundation (193/2016). D.V.B. would like to acknowledge the funding support of the NIH (MH60163, NS100050).	Abeles M., 1982, LOCAL CORTICAL CIRCU; ASCHOFF J, 1985, HUM NEUROBIOL, V4, P41; Aubie B, 2012, J NEUROSCI, V32, P6373, DOI 10.1523/JNEUROSCI.5624-11.2012; Aubie B, 2009, J NEUROSCI, V29, P9255, DOI 10.1523/JNEUROSCI.1085-09.2009; Baker CA, 2014, J NEUROSCI, V34, P14272, DOI 10.1523/JNEUROSCI.2299-14.2014; Bakhurin KI, 2017, J NEUROSCI, V37, P854, DOI 10.1523/JNEUROSCI.1789-16.2016; Balci F, 2016, CURR OPIN BEHAV SCI, V8, P94, DOI 10.1016/j.cobeha.2016.02.002; Balsam PD, 2009, TRENDS NEUROSCI, V32, P73, DOI 10.1016/j.tins.2008.10.004; Bittner KC, 2017, SCIENCE, V357, P1033, DOI 10.1126/science.aan3846; Braitenberg V, 1967, Prog Brain Res, V25, P334; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Bueti D., 2014, TIMING TIME PERCEPT, V2, P261, DOI [10.1163/22134468-00002023, DOI 10.1163/22134468-00002023]; Bueti D, 2012, NEURON, V75, P725, DOI 10.1016/j.neuron.2012.07.019; Buhusi CV, 2006, BEHAV PROCESS, V71, P107, DOI 10.1016/j.beproc.2005.11.017; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Buonomano DV, 2009, PHILOS T R SOC B, V364, P1865, DOI 10.1098/rstb.2009.0019; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Buzsaki G, 2017, SCIENCE, V358, P482, DOI 10.1126/science.aan8869; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Carnevale F, 2015, NEURON, V86, P1067, DOI 10.1016/j.neuron.2015.04.014; Chiba A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12283; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Cordes S, 2008, BRAIN RES, V1227, P120, DOI 10.1016/j.brainres.2008.06.043; Coslett HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010324; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Covey E, 1999, ANNU REV PHYSIOL, V61, P457, DOI 10.1146/annurev.physiol.61.1.457; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Crowe DA, 2014, J NEUROSCI, V34, P11972, DOI 10.1523/JNEUROSCI.2177-14.2014; Dale RC, 2004, BRAIN, V127, P21, DOI 10.1093/brain/awh008; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Duysens J, 1996, VISION RES, V36, P3243, DOI 10.1016/0042-6989(96)00040-5; Edwards CJ, 2007, J NEUROSCI, V27, P13384, DOI 10.1523/JNEUROSCI.2816-07.2007; Elliott TM, 2011, J NEUROPHYSIOL, V105, P1620, DOI 10.1152/jn.00261.2009; Emmons EB, 2017, J NEUROSCI, V37, P8718, DOI 10.1523/JNEUROSCI.1376-17.2017; FALK JL, 1954, J EXP PSYCHOL, V47, P279, DOI 10.1037/h0061946; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Fiala JC, 1996, J NEUROSCI, V16, P3760; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Freeman J S, 1996, Parkinsonism Relat Disord, V2, P81, DOI 10.1016/1353-8020(96)00009-0; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Fung BJ, 2017, J EXP PSYCHOL HUMAN, V43, P1925, DOI 10.1037/xhp0000418; Gable PA, 2012, PSYCHOL SCI, V23, P879, DOI 10.1177/0956797611435817; Gavornik JP, 2014, NAT NEUROSCI, V17, P732, DOI 10.1038/nn.3683; Gavornik JP, 2009, P NATL ACAD SCI USA, V106, P6826, DOI 10.1073/pnas.0901835106; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Goel A, 2016, NEURON, V91, P320, DOI 10.1016/j.neuron.2016.05.042; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Golombek DA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0465; Gouvea TS, 2015, ELIFE, V4, DOI 10.7554/eLife.11386; Gouvea TS, 2014, FRONT NEUROROBOTICS, V8, DOI 10.3389/fnbot.2014.00010; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Grube M, 2010, P NATL ACAD SCI USA, V107, P11597, DOI 10.1073/pnas.0910473107; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hardy N. F., 2017, BIORXIV, DOI [10.1101/159590, DOI 10.1101/159590]; Hardy NF, 2016, CURR OPIN BEHAV SCI, V8, P250, DOI 10.1016/j.cobeha.2016.01.012; Hass J, 2014, ADV EXP MED BIOL, V829, P49, DOI 10.1007/978-1-4939-1782-2_4; He JF, 1997, J NEUROSCI, V17, P2615; Hooper SL, 2002, NAT NEUROSCI, V5, P552, DOI 10.1038/nn838; Howard CD, 2017, NEURON, V93, P1436, DOI 10.1016/j.neuron.2017.02.029; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jazayeri M, 2015, CURR BIOL, V25, P2599, DOI 10.1016/j.cub.2015.08.038; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Johansson F, 2014, P NATL ACAD SCI USA, V111, P14930, DOI 10.1073/pnas.1415371111; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Kalmbach BE, 2010, J NEUROPHYSIOL, V103, P2039, DOI 10.1152/jn.00033.2010; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kennedy A, 2014, NAT NEUROSCI, V17, P416, DOI 10.1038/nn.3650; Kheifets A, 2012, P NATL ACAD SCI USA, V109, P8776, DOI 10.1073/pnas.1205131109; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; KILLEEN PR, 1988, PSYCHOL REV, V95, P274, DOI 10.1037/0033-295X.95.2.274; Kim J, 2013, J NEUROSCI, V33, P13834, DOI 10.1523/JNEUROSCI.1443-13.2013; Kim YC, 2017, CURR BIOL, V27, P39, DOI 10.1016/j.cub.2016.11.029; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Kopec C. D., 2018, BIORXIV, DOI [10.1101/245092, DOI 10.1101/245092]; Kostarakos K, 2012, J NEUROSCI, V32, P9601, DOI 10.1523/JNEUROSCI.1170-12.2012; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Lee TP, 2012, NEURAL COMPUT, V24, P2579, DOI 10.1162/NECO_a_00345; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2003, NEUROSCI LETT, V348, P131, DOI 10.1016/S0304-3940(03)00521-4; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Li Y, 2013, P NATL ACAD SCI USA, V110, P17154, DOI 10.1073/pnas.1310666110; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Luzardo A, 2017, J MATH PSYCHOL, V77, P111, DOI 10.1016/j.jmp.2016.10.002; Lynch GF, 2016, NEURON, V90, P877, DOI 10.1016/j.neuron.2016.04.021; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2004, J PHYSIOL-PARIS, V98, P315, DOI 10.1016/j.jphysparis.2005.09.020; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Machado A, 2003, BEHAV PROCESS, V62, P157, DOI 10.1016/S0376-6357(03)00023-8; Machado A, 2009, J EXP ANAL BEHAV, V92, P423, DOI 10.1901/jeab.2009.92-423; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2016, CURR OPIN BEHAV SCI, V8, pVI, DOI 10.1016/j.cobeha.2016.03.001; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mehner E. M., 1885, PHILOS STUD, V2, P546; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Mendoza G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03482-8; Merchant H, 2017, J NEUROSCI, V37, P4552, DOI 10.1523/JNEUROSCI.0367-17.2017; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Miller A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062716; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; Murray JM, 2017, ELIFE, V6, DOI 10.7554/eLife.26084; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Namboodiri VMK, 2015, NEURON, V86, P319, DOI 10.1016/j.neuron.2015.02.043; NARINS PM, 1980, BRAIN BEHAV EVOLUT, V17, P48, DOI 10.1159/000121790; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Nobre AC, 2018, NAT REV NEUROSCI, V19, P34, DOI 10.1038/nrn.2017.141; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Olin C. H., 1910, PHRENOLOGY TELL YOUR; OLTON DS, 1988, NEUROPSYCHOLOGIA, V26, P307, DOI 10.1016/0028-3932(88)90083-8; Pai S, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00074; Pang KCH, 2001, NEUROSCIENCE, V103, P615, DOI 10.1016/S0306-4522(01)00018-5; Papachristos EB, 2011, J BIOL RHYTHM, V26, P305, DOI 10.1177/0748730411410026; Pasquereau B, 2015, J NEUROPHYSIOL, V113, P1110, DOI 10.1152/jn.00401.2014; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Perez O, 2018, J NEUROSCI, V38, P4186, DOI 10.1523/JNEUROSCI.2651-17.2018; Perez-Gonzalez D, 2006, J NEUROPHYSIOL, V95, P823, DOI 10.1152/jn.00741.2005; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Pfeuty M, 2003, EXP BRAIN RES, V151, P372, DOI 10.1007/s00221-003-1505-6; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; RAMMSAYER TH, 1994, PERCEPT PSYCHOPHYS, V55, P454, DOI 10.3758/BF03205302; RAMMSAYER TH, 1992, NEUROPSYCHOBIOLOGY, V26, P71, DOI 10.1159/000118899; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01626; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Renoult L, 2006, EUR J NEUROSCI, V23, P3098, DOI 10.1111/j.1460-9568.2006.04824.x; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; Reyes A, 1999, J NEUROSCI, V19, P3827; Rose GJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00206; Sacks O, 1991, AWAKENINGS; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; SAITOH I, 1995, J NEUROPHYSIOL, V74, P1; Sardo P, 2000, EUR J NEUROSCI, V12, P1801, DOI 10.1046/j.1460-9568.2000.00068.x; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Soares S, 2016, SCIENCE, V354, P1273, DOI 10.1126/science.aah5234; Spencer RMC, 2009, PHILOS T R SOC B, V364, P1853, DOI 10.1098/rstb.2009.0024; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Stern DL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-38; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; SULLIVAN WE, 1982, J NEUROPHYSIOL, V48, P1033, DOI 10.1152/jn.1982.48.4.1033; Takahashi YK, 2016, NEURON, V91, P182, DOI 10.1016/j.neuron.2016.05.015; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Tiganj Z, 2017, CEREB CORTEX, V27, P5663, DOI 10.1093/cercor/bhw336; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; Vicario CM, 2010, BRAIN COGNITION, V73, P28, DOI 10.1016/j.bandc.2010.01.008; Wang J, 2018, NAT NEUROSCI, V21, P102, DOI 10.1038/s41593-017-0028-6; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Wright BA, 1997, J NEUROSCI, V17, P3956; Wright BA, 2010, J NEUROSCI, V30, P11635, DOI 10.1523/JNEUROSCI.1441-10.2010; Xu M, 2014, P NATL ACAD SCI USA, V111, P480, DOI 10.1073/pnas.1321314111; Yin B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0466; Yin P, 2008, J NEUROPHYSIOL, V100, P3009, DOI 10.1152/jn.00828.2007; Zhou XM, 2010, P NATL ACAD SCI USA, V107, P14839, DOI 10.1073/pnas.1009433107; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	213	141	143	9	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2018	98	4					687	705		10.1016/j.neuron.2018.03.045	http://dx.doi.org/10.1016/j.neuron.2018.03.045			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GG1UZ	29772201	Green Accepted, Bronze			2022-12-17	WOS:000432474200007
J	Vergnano, AM; Rebola, N; Savtchenko, LP; Pinheiro, PS; Casado, M; Kieffer, BL; Rusakov, DA; Mulle, C; Paoletti, P				Vergnano, Angela Maria; Rebola, Nelson; Savtchenko, Leonid P.; Pinheiro, Paulo S.; Casado, Mariano; Kieffer, Brigitte L.; Rusakov, Dmitri A.; Mulle, Christophe; Paoletti, Pierre			Zinc Dynamics and Action at Excitatory Synapses	NEURON			English	Article							MOSSY FIBER SYNAPSES; SYNAPTICALLY-RELEASED ZINC; LONG-TERM POTENTIATION; NMDA RECEPTOR SUBUNIT; CENTRAL-NERVOUS-SYSTEM; LIGAND-BINDING DOMAIN; HIPPOCAMPAL SLICES; NEUROTRANSMITTER RELEASE; ALLOSTERIC INTERACTION; SPREADING DEPRESSION	Decades after the discovery that ionic zinc is present at high levels in glutamatergic synaptic vesicles, where, when, and how much zinc is released during synaptic activity remains highly controversial. Here we provide a quantitative assessment of zinc dynamics in the synaptic cleft and clarify its role in the regulation of excitatory neurotransmission by combining synaptic recordings from mice deficient for zinc signaling with Monte Carlo simulations. Ambient extracellular zinc levels are too low for tonic occupation of the GluN2A-specific nanomolar zinc sites on NMDA receptors (NMDARs). However, following short trains of physiologically relevant synaptic stimuli, zinc transiently rises in the cleft and selectively inhibits postsynaptic GluN2A-NMDARs, causing changes in synaptic integration and plasticity. Our work establishes the rules of zinc action and reveals that zinc modulation extends beyond hippocampal mossy fibers to excitatory SC-CA1 synapses. By specifically moderating GluN2A-NMDAR signaling, zinc acts as a widespread activity-dependent regulator of neuronal circuits.	[Vergnano, Angela Maria; Casado, Mariano; Paoletti, Pierre] Ecole Normale Super, IBENS, F-75005 Paris, France; [Vergnano, Angela Maria; Casado, Mariano; Paoletti, Pierre] INSERM, U1024, F-75005 Paris, France; [Vergnano, Angela Maria; Casado, Mariano; Paoletti, Pierre] CNRS, UMR 8197, F-75005 Paris, France; [Rebola, Nelson; Pinheiro, Paulo S.; Mulle, Christophe] Univ Bordeaux, Inst Interdisciplinaire Neurosci, F-33000 Bordeaux, France; [Rebola, Nelson; Pinheiro, Paulo S.; Mulle, Christophe] CNRS, UMR 5297, F-33000 Bordeaux, France; [Savtchenko, Leonid P.; Rusakov, Dmitri A.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Kieffer, Brigitte L.] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mulle, C (corresponding author), Univ Bordeaux, Inst Interdisciplinaire Neurosci, F-33000 Bordeaux, France.	mulle@u-bordeaux2.fr; pierre.paoletti@ens.fr	Paoletti, Pierre/L-7358-2013; Pinheiro, Paulo/O-8765-2017; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021	Paoletti, Pierre/0000-0002-3681-4845; Pinheiro, Paulo/0000-0002-9024-1021; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Casado, Mariano/0000-0001-8049-8096; Mulle, Christophe/0000-0003-2709-6615	Agence Nationale de le Recherche (ANR); Fondation pour la Recherche Medicale ('Equipe FRM' grant) [DEQ2000326520]; Region Ile-de-France; Wellcome Trust; European Research Council; BBSRC; EU BM1001 Cost Action; French government under the program "Investissements d'Avenir" [ANR-10-LABX-54, ANR-11-IDEX-0001-02]; Biotechnology and Biological Sciences Research Council [BB/J001473/1] Funding Source: researchfish; Medical Research Council [G0900613] Funding Source: researchfish; BBSRC [BB/J001473/1] Funding Source: UKRI; MRC [G0900613] Funding Source: UKRI	Agence Nationale de le Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ('Equipe FRM' grant); Region Ile-de-France(Region Ile-de-France); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU BM1001 Cost Action; French government under the program "Investissements d'Avenir"(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Agence Nationale de le Recherche (ANR grants to C.M. and P.P.), Fondation pour la Recherche Medicale ('Equipe FRM' grant DEQ2000326520 to P.P.) and Region Ile-de-France (A.M.V.); Wellcome Trust Principal Fellowship, European Research Council Advanced Grant, BBSRC, and EU BM1001 Cost Action (D.A.R.). This work also received support from the French government under the program "Investissements d'Avenir" (ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University). We are grateful to Steven Traynelis for help with the NMDAR kinetic scheme and Kaiyu Zheng for help with computational cluster environment.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Carter RE, 2011, J CEREBR BLOOD F MET, V31, P1073, DOI 10.1038/jcbfm.2010.183; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Grauert A, 2014, J PHYSIOL-LONDON, V592, P67, DOI 10.1113/jphysiol.2013.261420; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Jing Q, 2006, J NEUROSCI, V26, P6089, DOI 10.1523/JNEUROSCI.0475-06.2006; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kay AR, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.119re3; Kay AR, 2003, J NEUROSCI, V23, P6847; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Komatsu K, 2005, J AM CHEM SOC, V127, P10197, DOI 10.1021/ja050301e; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lavoie N, 2011, J NEUROSCI, V31, P18251, DOI 10.1523/JNEUROSCI.4164-11.2011; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martel G, 2011, BEHAV BRAIN RES, V223, P233, DOI 10.1016/j.bbr.2011.04.020; Martel G, 2010, LEARN MEMORY, V17, P582, DOI 10.1101/lm.1962010; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Molnar P, 2001, BRAIN RES, V910, P205, DOI 10.1016/S0006-8993(01)02720-2; Mott DD, 2008, J NEUROSCI, V28, P1659, DOI 10.1523/JNEUROSCI.3567-07.2008; Nozaki C, 2011, NAT NEUROSCI, V14, P1017, DOI 10.1038/nn.2844; Nydegger I, 2010, ACS CHEM NEUROSCI, V1, P728, DOI 10.1021/cn100065s; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Perez-Rosello T, 2013, J NEUROSCI, V33, P9259, DOI 10.1523/JNEUROSCI.0237-13.2013; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Savtchenko LP, 2013, NAT NEUROSCI, V16, P10, DOI 10.1038/nn.3285; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Sylantyev S, 2008, SCIENCE, V319, P1845, DOI 10.1126/science.1154330; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; Tovar KR, 2012, J NEUROSCI, V32, P8065, DOI 10.1523/JNEUROSCI.0538-12.2012; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Veran J, 2012, NEURON, V76, P565, DOI 10.1016/j.neuron.2012.08.027; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	70	141	142	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 4	2014	82	5					1101	1114		10.1016/j.neuron.2014.04.034	http://dx.doi.org/10.1016/j.neuron.2014.04.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ0QH	24908489	Bronze			2022-12-17	WOS:000337359800016
J	Clause, A; Kim, G; Sonntag, M; Weisz, CJC; Vetter, DE; Rubsamen, R; Kandler, K				Clause, Amanda; Kim, Gunsoo; Sonntag, Mandy; Weisz, Catherine J. C.; Vetter, Douglas E.; Rubsamen, Rudolf; Kandler, Karl			The Precise Temporal Pattern of Prehearing Spontaneous Activity Is Necessary for Tonotopic Map Refinement	NEURON			English	Article							AUDITORY BRAIN-STEM; LATERAL SUPERIOR OLIVE; INNER HAIR-CELLS; CA(V)1.3 CALCIUM-CHANNELS; VENTRAL COCHLEAR NUCLEUS; VISUAL-CORTEX; ACTION-POTENTIALS; DEVELOPMENTAL REGULATION; ACETYLCHOLINE-RECEPTOR; POSTNATAL-DEVELOPMENT	Patterned spontaneous activity is a hallmark of developing sensory systems. In the auditory system, rhythmic bursts of spontaneous activity are generated in cochlear hair cells and propagated along central auditory pathways. The role of these activity patterns in the development of central auditory circuits has remained speculative. Here we demonstrate that blocking efferent cholinergic neurotransmission to developing hair cells in mice that lack the alpha 9 subunit of nicotinic acetylcholine receptors (alpha 9 KO mice) altered the temporal fine structure of spontaneous activity without changing activity levels. KO mice showed a severe impairment in the functional and structural sharpening of an inhibitory tonotopic map, as evidenced by deficits in synaptic strengthening and silencing of connections and an absence in axonal pruning. These results provide evidence that the precise temporal pattern of spontaneous activity before hearing onset is crucial for the establishment of precise tonotopy, the major organizing principle of central auditory pathways.	[Clause, Amanda; Weisz, Catherine J. C.; Kandler, Karl] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15261 USA; [Clause, Amanda; Kim, Gunsoo; Kandler, Karl] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Clause, Amanda; Kim, Gunsoo; Kandler, Karl] Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; [Sonntag, Mandy; Rubsamen, Rudolf] Univ Leipzig, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Vetter, Douglas E.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Leipzig University; University of Mississippi; University of Mississippi Medical Center	Kim, G (corresponding author), Univ Calif San Francisco, Dept Physiol, Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	gkim@phy.ucsf.edu; kkarl@pitt.edu	Vetter, Douglas E./O-8150-2019; Sonntag, Mandy/A-5925-2017	Kandler, Karl/0000-0002-6053-6400; Kim, Gunsoo/0000-0001-9318-8329; Clause, Amanda/0000-0002-2078-7280	US National Institute on Deafness and Other Communication Disorders [04199, 06258]; NIH [T32 NS007433]; National Science Foundation IGERT [DGE 0549352]; National Institute on Deafness and Other Communication Disorders Institutional Training grant [T32 DC011499]; Pennsylvania Lions Hearing Research Foundation; Deutsche Forschungsgemeinschaft [Ru 390/19-1, GK 1097]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC011499, R01DC004199] Funding Source: NIH RePORTER	US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation IGERT(National Science Foundation (NSF)); National Institute on Deafness and Other Communication Disorders Institutional Training grant; Pennsylvania Lions Hearing Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Richard Givens (Department of Chemistry, University of Kansas) for his generous gift of p-hydroxyphenacyl-glutamate, Jessica Garver and Xinyan Gu for technical support, and Dr. Tuan Nguyen for help with the noise-rearing experiments. The work was supported by US National Institute on Deafness and Other Communication Disorders grant 04199 (to K. K.) and 06258 (to D. E. V.), NIH Basic Neuroscience Predoctoral Training grant T32 NS007433 (to A. C.), National Science Foundation IGERT Training grant DGE 0549352 (to A. C.), National Institute on Deafness and Other Communication Disorders Institutional Training grant T32 DC011499 (to C.J.C.W.), a Pennsylvania Lions Hearing Research Foundation grant (to K. K.), Deutsche Forschungsgemeinschaft Ru 390/19-1 (to R. R.), and GK 1097 (to M.S.).	Allen Institute for Brain Science, 2012, ALL DEV MOUS BRAIN A; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Brown MC, 2009, JARO-J ASSOC RES OTO, V10, P64, DOI 10.1007/s10162-008-0144-9; BROWN MC, 1988, J COMP NEUROL, V278, P591, DOI 10.1002/cne.902780410; Cao XJ, 2008, J COMP NEUROL, V510, P297, DOI 10.1002/cne.21788; Case DT, 2011, J NEUROPHYSIOL, V106, P2570, DOI 10.1152/jn.00644.2010; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Couchman K, 2011, HEARING RES, V277, P163, DOI 10.1016/j.heares.2011.01.012; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Friauf E, 2004, SPR HDB AUD, V23, P49; FUCHS PA, 1992, J NEUROSCI, V12, P800; Fujino K, 2001, J NEUROSCI, V21, P7372, DOI 10.1523/JNEUROSCI.21-18-07372.2001; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Givens RS, 1997, J AM CHEM SOC, V119, P8369, DOI 10.1021/ja971331n; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HASHISAKI GT, 1989, J COMP NEUROL, V283, P465, DOI 10.1002/cne.902830402; Hirtz JJ, 2012, J NEUROSCI, V32, P14602, DOI 10.1523/JNEUROSCI.0765-12.2012; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Johnson SL, 2013, P NATL ACAD SCI USA, V110, P8720, DOI 10.1073/pnas.1219578110; Johnson SL, 2012, J NEUROSCI, V32, P10479, DOI 10.1523/JNEUROSCI.0803-12.2012; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kandler Karl, 2013, Cold Spring Harb Protoc, V2013, P118, DOI 10.1101/pdb.top072900; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kim G, 2010, NEUROSCIENCE, V171, P924, DOI 10.1016/j.neuroscience.2010.09.054; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; KITZES LM, 1995, J COMP NEUROL, V353, P341, DOI 10.1002/cne.903530303; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kotak VC, 1998, J NEUROSCI, V18, P4646; KOTAK VC, 1995, J NEUROPHYSIOL, V74, P1611, DOI 10.1152/jn.1995.74.4.1611; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; KUWABARA N, 1991, J COMP NEUROL, V314, P684, DOI 10.1002/cne.903140405; Leake PA, 2006, J COMP NEUROL, V497, P13, DOI 10.1002/cne.20968; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; Leao RN, 2004, J NEUROPHYSIOL, V91, P1006, DOI 10.1152/jn.00771.2003; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; Marcotti W, 2012, EXP PHYSIOL, V97, P438, DOI 10.1113/expphysiol.2011.059303; May BJ, 2002, HEARING RES, V171, P142, DOI 10.1016/S0378-5955(02)00495-1; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mikuni T, 2013, NEURON, V78, P1024, DOI 10.1016/j.neuron.2013.04.036; MOREST D K, 1968, Zeitschrift fuer Anatomie und Entwicklungsgeschichte, V127, P201, DOI 10.1007/BF00526129; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; SCHOFIELD BR, 1995, J COMP NEUROL, V360, P135, DOI 10.1002/cne.903600110; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Simmons DD, 1996, J COMP NEUROL, V370, P551, DOI 10.1002/(SICI)1096-9861(19960708)370:4<551::AID-CNE10>3.0.CO;2-M; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3031, DOI 10.1016/0306-4522(82)90228-7; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Walcher J, 2011, J NEUROPHYSIOL, V106, P1443, DOI 10.1152/jn.01087.2010; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1; WINTER IM, 1989, J COMP NEUROL, V280, P143, DOI 10.1002/cne.902800110; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Youssoufian M, 2005, J NEUROPHYSIOL, V94, P3168, DOI 10.1152/jn.00342.2005; Youssoufian M, 2008, J COMP NEUROL, V506, P442, DOI 10.1002/cne.21566; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zuo J, 1999, P NATL ACAD SCI USA, V96, P14100, DOI 10.1073/pnas.96.24.14100	78	141	141	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 21	2014	82	4					822	835		10.1016/j.neuron.2014.04.001	http://dx.doi.org/10.1016/j.neuron.2014.04.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH8IA	24853941	Green Accepted, Bronze			2022-12-17	WOS:000336379800013
J	Smittenaar, P; FitzGerald, THB; Romei, V; Wright, ND; Dolan, RJ				Smittenaar, Peter; FitzGerald, Thomas H. B.; Romei, Vincenzo; Wright, Nicholas D.; Dolan, Raymond J.			Disruption of Dorsolateral Prefrontal Cortex Decreases Model-Based in Favor of Model-free Control in Humans	NEURON			English	Article							THETA-BURST STIMULATION; WORKING-MEMORY; REINFORCEMENT; STRIATUM; HABITS; RATS; MECHANISMS; BEHAVIOR; SYSTEMS; CHOICE	Human choice behavior often reflects a competition between inflexible computationally efficient control on the one hand and a slower more flexible system of control on the other. This distinction is well captured by model-free and model-based reinforcement learning algorithms. Here, studying human subjects, we show it is possible to shift the balance of control between these systems by disruption of right dorsolateral prefrontal cortex, such that participants manifest a dominance of the less optimal model-free control. In contrast, disruption of left dorsolateral prefrontal cortex impaired model-based performance only in those participants with low working memory capacity.	[Smittenaar, Peter; FitzGerald, Thomas H. B.; Romei, Vincenzo; Wright, Nicholas D.; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London WC1N 3BG, England; [Romei, Vincenzo] Univ Essex, Dept Psychol, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England	University of London; University College London; University of Essex	Smittenaar, P (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, 12 Queen Sq, London WC1N 3BG, England.	petersmittenaar@gmail.com	Romei, Vincenzo/AAT-5755-2021	Romei, Vincenzo/0000-0003-1214-2316; FitzGerald, Thomas/0000-0002-3855-1591; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [098362/Z/12/Z, 092859/Z/10/Z, 091593/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. McNab and E. Feredoes for help with the experiment and P. Dayan and N. Daw for helpful discussions and comments. R.J.D. is supported by a Wellcome Trust Senior Investigator Award 098362/Z/12/Z. P.S. is supported by a 4-year Wellcome Trust PhD studentship 092859/Z/10/Z. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bates D.M., 2012, LME4 LINEAR MIXED EF; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; de Wit S, 2011, J COGNITIVE NEUROSCI, V23, P1218, DOI 10.1162/jocn.2010.21514; de Wit S, 2009, J NEUROSCI, V29, P11330, DOI 10.1523/JNEUROSCI.1639-09.2009; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feredoes E, 2011, P NATL ACAD SCI USA, V108, P17510, DOI 10.1073/pnas.1106439108; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Liljeholm M, 2012, TRENDS COGN SCI, V16, P467, DOI 10.1016/j.tics.2012.07.007; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; R Development Core Team, 2011, R LANG ENV STAT COMP; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; [No title captured]	35	141	143	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2013	80	4					914	919		10.1016/j.neuron.2013.08.009	http://dx.doi.org/10.1016/j.neuron.2013.08.009			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256AD	24206669	hybrid, Green Submitted, Green Published			2022-12-17	WOS:000327281200009
J	Singer, AC; Carr, MF; Karlsson, MP; Frank, LM				Singer, Annabelle C.; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.			Hippocampal SWR Activity Predicts Correct Decisions during the Initial Learning of an Alternation Task	NEURON			English	Article							SPATIAL MEMORY; AWAKE STATE; EXPERIENCE; REPLAY; REACTIVATION; RIPPLES; CONSOLIDATION; SEQUENCES	The hippocampus frequently replays memories of past experiences during sharp-wave ripple (SWR) events. These events can represent spatial trajectories extending from the animal's current location to distant locations, suggesting a role in the evaluation of upcoming choices. While SWRs have been linked to learning and memory, the specific role of awake replay remains unclear. Here we show that there is greater coordinated neural activity during SWRs preceding correct, as compared to incorrect, trials in a spatial alternation task. As a result, the proportion of cell pairs coactive during SWRs was predictive of subsequent correct or incorrect responses on a trial-by-trial basis. This effect was seen specifically during early learning, when the hippocampus is essential for task performance. SWR activity preceding correct trials represented multiple trajectories that included both correct and incorrect options. These results suggest that reactivation during awake SWRs contributes to the evaluation of possible choices during memory-guided decision making.	[Singer, Annabelle C.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Singer, Annabelle C.] MIT, MIT Media Lab, Cambridge, MA 02139 USA; [Singer, Annabelle C.; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Singer, Annabelle C.; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Carr, Margaret F.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Karlsson, Mattias P.] HHMI, Ashburn, VA 20147 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute	Frank, LM (corresponding author), Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu		/0000-0003-4111-1535; Singer, Annabelle C./0000-0001-6003-0488; Frank, Loren/0000-0002-1752-5677	John Merck Scholars Program; U.S. National Institutes of Health [RO1MH090188, F31093067]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283, R01MH090188] Funding Source: NIH RePORTER	John Merck Scholars Program; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Frank laboratory for comments on the manuscript. This work was supported by the John Merck Scholars Program and the U.S. National Institutes of Health research grants RO1MH090188 and F31093067.	Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	26	141	144	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1163	1173		10.1016/j.neuron.2013.01.027	http://dx.doi.org/10.1016/j.neuron.2013.01.027			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522050	Green Accepted, Bronze			2022-12-17	WOS:000316645000016
J	Fukunaga, I; Berning, M; Kollo, M; Schmaltz, A; Schaefer, AT				Fukunaga, Izumi; Berning, Manuel; Kollo, Mihaly; Schmaltz, Anja; Schaefer, Andreas T.			Two Distinct Channels of Olfactory Bulb Output	NEURON			English	Article							TUFTED CELLS; MITRAL CELLS; ODOR DISCRIMINATION; TEMPORAL STRUCTURE; AXONAL PROJECTION; IN-VIVO; RAT; INFORMATION; NEURONS; MOUSE	Rhythmic neural activity is a hallmark of brain function, used ubiquitously to structure neural information. In mammalian olfaction, repetitive sniffing sets the principal rhythm but little is known about its role in sensory coding. Here, we show that mitral and tufted cells, the two main classes of olfactory bulb projection neurons, tightly lock to this rhythm, but to opposing phases of the sniff cycle. This phase shift is established by local inhibition that selectively delays mitral cell activity. Furthermore, while tufted cell phase is unperturbed in response to purely excitatory odorants, mitral cell phase is advanced in a graded, stimulus-dependent manner. Thus, phase separation by inhibition forms the basis for two distinct channels of olfactory processing.	[Fukunaga, Izumi; Berning, Manuel; Kollo, Mihaly; Schmaltz, Anja; Schaefer, Andreas T.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Schaefer, Andreas T.] Heidelberg Univ, Inst Anat & Cell Biol, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Schaefer, AT (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	schaefer@mpimf-heidelberg.mpg.de	Kollo, Mihaly/M-5497-2019	Kollo, Mihaly/0000-0002-0147-6997; Fukunaga, Izumi/0000-0003-1860-5377; Schaefer, Andreas/0000-0002-4677-8788	Max-Planck-Society; DFG [SPP1392]; Bauer Stiftung; Alexander von Humboldt-foundation; MRC [MC_UP_1202/5] Funding Source: UKRI; Medical Research Council [MC_UP_1202/5] Funding Source: researchfish	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Bauer Stiftung; Alexander von Humboldt-foundation(Alexander von Humboldt Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Mar lies Kaiser, Ellen Stier and Sebastiano Bellanca for technical assistance, Jenny Davie, Matt Angle, Andreas Draguhn, Johann Bollman, Kevin Franks, and Moritz Helmstaedter for comments on the manuscript and Jan Herb, Matthew Phillips and Gordon Shepherd for discussion. This work was supported by the Max-Planck-Society, DFG SPP1392, Bauer Stiftung and the Alexander von Humboldt-foundation. A.T.S. is a member of the ExcellenzCluster CellNetworks. I.F. and A.T.S. designed and conceived all experiments; M.B., I.F. and A.T.S. designed the model and computational analyses; I.F. performed all experiments apart from awake recordings, which were carried out by M.K., and A.S.; I.F. and A.T.S. analyzed the data with help from M.B. and M.K.; M.B. implemented, analyzed and interpreted the model with advice from I.F. and A.T.S.; I.F. and A.T.S. wrote the article with contributions from all authors. The authors declare no competing financial interests.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/S0896-6273(04)00753-6; Angelo K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00050; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Cang J., 2003, J NEUROSCI, V23, P4108; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Fisher N.I., 1995, STAT ANAL CIRCULAR D, DOI DOI 10.1017/CBO9780511564345; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Ma J, 2010, NEUROSCIENCE, V169, P1715, DOI 10.1016/j.neuroscience.2010.06.033; MACRIDES F, 1982, J COMP NEUROL, V208, P419, DOI 10.1002/cne.902080410; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Schaefer AT, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00030; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030	45	141	142	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 26	2012	75	2					320	329		10.1016/j.neuron.2012.05.017	http://dx.doi.org/10.1016/j.neuron.2012.05.017			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	982HH	22841316	Bronze			2022-12-17	WOS:000307033200016
J	Feinberg, K; Eshed-Eisenbach, Y; Frechter, S; Amor, V; Salomon, D; Sabanay, H; Dupree, JL; Grumet, M; Brophy, PJ; Shrager, P; Peles, E				Feinberg, Konstantin; Eshed-Eisenbach, Yael; Frechter, Shahar; Amor, Veronique; Salomon, Daniela; Sabanay, Helena; Dupree, Jeffrey L.; Grumet, Martin; Brophy, Peter J.; Shrager, Peter; Peles, Elior			A Glial Signal Consisting of Gliomedin and NrCAM Clusters Axonal Na+ Channels during the Formation of Nodes of Ranvier	NEURON			English	Article							CELL-ADHESION MOLECULES; PERIPHERAL NERVOUS-SYSTEM; BETA-IV-SPECTRIN; MYELINATED AXONS; INITIAL SEGMENTS; SODIUM-CHANNELS; ANKYRIN-G; K+ CHANNELS; NR-CAM; NEUROFASCIN	Saltatory conduction requires high-density accumulation of Na+ channels at the nodes of Ranvier. Nodal Na+ channel clustering in the peripheral nervous system is regulated by myelinating Schwann cells through unknown mechanisms. During development, Na+ channels are first clustered at heminodes that border each myelin segment, and later in the mature nodes that are formed by the fusion of two heminodes. Here, we show that initial clustering of Na+ channels at heminodes requires glial NrCAM and gliomedin, as well as their axonal receptor neurofascin 186 (NF186). We further demonstrate that heminodal clustering coincides with a second, paranodal junction (PNJ)-dependent mechanism that allows Na+ channels to accumulate at mature nodes by restricting their distribution between two growing myelin internodes. We propose that Schwann cells assemble the nodes of Ranvier by capturing Na+ channels at heminodes and by constraining their distribution to the nodal gap. Together, these two cooperating mechanisms ensure fast and efficient conduction in myelinated nerves.	[Feinberg, Konstantin; Eshed-Eisenbach, Yael; Frechter, Shahar; Amor, Veronique; Salomon, Daniela; Sabanay, Helena; Peles, Elior] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Dupree, Jeffrey L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Grumet, Martin] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Brophy, Peter J.] Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland; [Shrager, Peter] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Weizmann Institute of Science; Virginia Commonwealth University; Rutgers State University New Brunswick; University of Edinburgh; University of Rochester	Peles, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.		grumet, martin/ABC-6462-2020	Peles, Elior/0000-0002-3325-0597	National Multiple Sclerosis Society [RG3594-A-4]; NIH; NINDS [NS50220, NS17965]; Sheldon G Adelson Medical Research Foundation; European Community's Seventh Framework Programme [FP7/2007-2013]; Shapell Family Biomedical Research Foundation [HEALTH-F2-2008-201535]; Medical Research Council [G0301172] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017965, R01NS050220] Funding Source: NIH RePORTER; MRC [G0301172] Funding Source: UKRI	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sheldon G Adelson Medical Research Foundation; European Community's Seventh Framework Programme; Shapell Family Biomedical Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Matt Rasband and Rock Levinson for their generous gift of antibodies and valuable comments This work was supported by grants from the National Multiple Sclerosis Society (RG3594-A-4), the NIH (NINDS grants NS50220 (E P) and NS17965 (P S), NYS CORE 19772-3784 (P S). the Dr Miriam and Sheldon G Adelson Medical Research Foundation, the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No HEALTH-F2-2008-201535, the Shapell Family Biomedical Research Foundation at the Weizmann Institute, the Moskowitz Center for Imaging, and the Wolgin Prize for Scientific Excellence E P is the Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience	Arroyo EJ, 2004, J COMP NEUROL, V479, P424, DOI 10.1002/cne.20321; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BERTHOLD CH, 1983, J NEUROCYTOL, V12, P475, DOI 10.1007/BF01159386; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Ching W, 1999, J NEUROCYTOL, V28, P295, DOI 10.1023/A:1007053411667; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Craner MJ, 2003, BRAIN, V126, P1552, DOI 10.1093/brain/awg153; Custer AW, 2003, J NEUROSCI, V23, P10032; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Grumet M, 1997, CELL TISSUE RES, V290, P423, DOI 10.1007/s004410050949; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Ishibashi T, 2002, J NEUROSCI, V22, P6507; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; Lambert S, 1997, J NEUROSCI, V17, P7025; Lasiecka ZM, 2009, INT REV CEL MOL BIO, V272, P303, DOI 10.1016/S1937-6448(08)01607-9; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Rios JC, 2003, J NEUROSCI, V23, P7001, DOI 10.1523/JNEUROSCI.23-18-07001.2003; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; ROSENBLUTH J, 1976, J NEUROCYTOL, V5, P731, DOI 10.1007/BF01181584; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TAOCHENG JH, 1983, DEV BRAIN RES, V9, P251, DOI 10.1016/0165-3806(83)90023-8; Vabnick I, 1996, J NEUROSCI, V16, P4914; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	60	141	145	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					490	502		10.1016/j.neuron.2010.02.004	http://dx.doi.org/10.1016/j.neuron.2010.02.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188654	Green Accepted, Bronze			2022-12-17	WOS:000275359800008
J	Krubitzer, L				Krubitzer, Leah			The magnificent compromise: Cortical field evolution in mammals	NEURON			English	Editorial Material							BLIND MOLE-RAT; FIBROBLAST-GROWTH-FACTOR; TAILED FRUIT BAT; CEREBRAL-CORTEX; SENSORY REPRESENTATION; SPALAX-EHRENBERGI; REGULATORY GENES; NEOCORTEX; ORGANIZATION; EXPRESSION	The neocortex of mammals is composed of cortical fields that have a unique organization associated with the animal's ecological niche and lifestyle. Each cortical field has a specific pattern of connections with other cortical fields and brain structures, and together they comprise a neocortical network that generates a variety of behaviors. These networks and the behaviors they generate are variable across mammals, and are particularly complex in some species such as humans. Here I discuss the mechanisms that contribute to neocortical organization in mammals, and how this organization has been altered to generate the variability that exists in different lineages.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Krubitzer, L (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA.	lakrubitzer@ucdavis.edu	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283	NINDS NIH HHS [R01 NS 035103-11] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035103] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; [Anonymous], 2006, EVOLUTION NERVOUS SY; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; ASANUMA A, 1983, J NEUROPHYSIOL, V50, P1182, DOI 10.1152/jn.1983.50.5.1182; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bresin A, 2001, Swed Dent J Suppl, P1; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; BULLOCK TH, 1984, SCIENCE, V225, P473, DOI 10.1126/science.6740319; CALFORD MB, 1985, NATURE, V313, P477, DOI 10.1038/313477a0; Changizi M. A., 2006, EVOLUTION NERVOUS SY, P181; Chen CH, 2005, EVOL DEV, V7, P130, DOI 10.1111/j.1525-142X.2005.05015.x; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; COOPER HM, 1993, J COMP NEUROL, V328, P313, DOI 10.1002/cne.903280302; Cretekos CJ, 2005, DEV DYNAM, V233, P721, DOI 10.1002/dvdy.20400; Davies JH, 2005, ARCH DIS CHILD, V90, P373, DOI 10.1136/adc.2004.053553; DORON N, 1994, NEUROREPORT, V5, P2697, DOI 10.1097/00001756-199412000-00072; EBBESSON SOE, 1980, CELL TISSUE RES, V213, P179; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; HAIGHT JR, 1979, J ANAT, V129, P673; Hall, 1994, FLEXIBILITY CONSTRAI, P15; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hanashima C, 2002, J NEUROSCI, V22, P6526; He Tailun, 2004, Swed Dent J Suppl, P1; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; HERRON P, 1978, J COMP NEUROL, V181, P717, DOI 10.1002/cne.901810403; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; JOHNSTON TD, 1990, J THEOR BIOL, V147, P471, DOI 10.1016/S0022-5193(05)80260-7; KAAS JH, 2006, EVOLUTION NERVOUS SY, P27; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Karlen SJ, 2007, PROG NEUROBIOL, V82, P122, DOI 10.1016/j.pneurobio.2007.03.003; Katsaros Christos, 2002, J Orofac Orthop, V63, P5, DOI 10.1007/s00056-002-9903-0; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kornack DR, 2000, BRAIN BEHAV EVOLUT, V55, P336, DOI 10.1159/000006668; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; KRUBITZER L, 1995, J COMP NEUROL, V351, P261, DOI 10.1002/cne.903510206; Krubitzer L, 2005, CURR OPIN NEUROBIOL, V15, P444, DOI 10.1016/j.conb.2005.07.003; Krubitzer L, 2003, PROG NEUROBIOL, V70, P33, DOI 10.1016/S0301-0082(03)00088-1; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; KRUBITZER L, 2006, EVOLUTION NERVOUS SY, P49; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kujirai K, 1983, Auris Nasus Larynx, V10, P9; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; NELSON RJ, 1980, J COMP NEUROL, V192, P611, DOI 10.1002/cne.901920402; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pettigrew JD, 1999, J EXP BIOL, V202, P1447; Raballo R, 2000, J NEUROSCI, V20, P5012; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Singh R, 2005, ACTA ASTRONAUT, V56, P357, DOI 10.1016/j.actaastro.2004.06.002; STEVENS CF, 2006, EVOLUTION NERVOUS SY, P272; SUGA N, 1975, J EXP BIOL, V63, P161; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tobler I, 1998, BEHAV BRAIN RES, V96, P173, DOI 10.1016/S0166-4328(98)00012-6; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; WELKER WI, 1959, J COMP NEUROL, V111, P469, DOI 10.1002/cne.901110306; WOOLSEY TA, 1967, JOHNS HOPKINS MED J, V121, P91; ZOOK JM, 2006, EVOLUTION NERVOUS SY, P49	70	141	142	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2007	56	2					201	208		10.1016/j.neuron.2007.10.002	http://dx.doi.org/10.1016/j.neuron.2007.10.002			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	228PA	17964240	Bronze			2022-12-17	WOS:000250740700001
J	Gottfried, JA; Winston, JS; Dolan, RJ				Gottfried, JA; Winston, JS; Dolan, RJ			Dissociable codes of odor quality and odorant structure in human piriform cortex	NEURON			English	Article							OLFACTORY DISCRIMINATION ABILITY; INFERIOR TEMPORAL CORTEX; CROSS-ADAPTATION; ORBITOFRONTAL CORTEX; NEURAL REPRESENTATIONS; RECOGNITION MEMORY; ALIPHATIC-ALCOHOLS; GLOMERULAR LAYER; SELF-ADAPTATION; PERCEPTION	The relationship between odorant structure and odor quality has been a focus of olfactory research for 100 years, although no systematic correlations are yet apparent. Animal studies suggest that topographical representations of odorant structure in olfactory bulb form the perceptual basis of odor quality. Whether central olfactory regions are similarly organized is unclear. Using an olfactory version of fMRI cross-adaptation, we measured neural responses in primary olfactory (piriform) cortex as subjects smelled pairs of odorants systematically differing in quality and molecular functional group (as one critical attribute of odorant structure). Our results indicate a double dissociation in piriform cortex, whereby posterior regions encode quality (but not structure) and anterior regions encode structure (but not quality). The presence of structure-based codes suggests fidelity of sensory information arising from olfactory bulb. In turn, quality-based codes are independent of any simple structural configuration, implying that synthetic mechanisms may underlie our experience of smell.	Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Dept Neurol, Chicago, IL 60611 USA; Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	Northwestern University; Feinberg School of Medicine; University of London; University College London	Gottfried, JA (corresponding author), Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Dept Neurol, 320 E Super St, Chicago, IL 60611 USA.	j-gottfried@northwestern.edu	Winston, Joel/F-6180-2010	Winston, Joel/0000-0002-3957-0612; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMOORE JE, 1972, MOL BASIS ODOR; [Anonymous], 1997, ATLAS HUMAN BRAIN; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Arctander S, 1994, PERFUME FLAVOR CHEM; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CAIN WS, 1992, CHEM SENSES, V17, P481, DOI 10.1093/chemse/17.5.481; CAIN WS, 1970, PERCEPT PSYCHOPHYS, V7, P271, DOI 10.3758/BF03210163; CATTARELLI M, 1988, BRAIN RES, V442, P180, DOI 10.1016/0006-8993(88)91449-7; Counet C, 2002, J AGR FOOD CHEM, V50, P2385, DOI 10.1021/jf0114177; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dravnieks A., 1985, ATLAS ODOR CHARACTER; ENGEN T, 1963, AM J PSYCHOL, V76, P96, DOI 10.2307/1420004; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Henning H., 1916, DER GERUCH; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Laska M, 2000, CHEM SENSES, V25, P189, DOI 10.1093/chemse/25.2.189; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; MacDonald MK, 1922, AM J PSYCHOL, V33, P535, DOI 10.2307/1413549; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Menager I, 2004, J AGR FOOD CHEM, V52, P1248, DOI 10.1021/jf0350919; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Moncrieff R.W., 1967, CHEM SENSES, V3rd; MONCRIEFF RW, 1956, J PHYSIOL-LONDON, V133, P301, DOI 10.1113/jphysiol.1956.sp005587; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; OCONNELL RJ, 1994, CHEM SENSES, V19, P197, DOI 10.1093/chemse/19.3.197; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Pierce JD, 1996, CHEM SENSES, V21, P223, DOI 10.1093/chemse/21.2.223; POLAK EH, 1973, J THEOR BIOL, V245, P175; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Stevenson RJ, 2001, LEARN MOTIV, V32, P154, DOI 10.1006/lmot.2000.1070; Sullivan R.M., 2003, HDB OLFACTION GESTAT, P181; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; TODRANK J, 1991, CHEM SENSES, V16, P467, DOI 10.1093/chemse/16.5.467; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Wise PM, 2000, CHEM SENSES, V25, P429, DOI 10.1093/chemse/25.4.429; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; Zwaardemaker H, 1895, PHYSL GERUCHS	61	141	146	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					467	479		10.1016/j.neuron.2006.01.007	http://dx.doi.org/10.1016/j.neuron.2006.01.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446149	Green Submitted, Bronze			2022-12-17	WOS:000235260900017
J	L'Etoile, ND; Coburn, CM; Eastham, J; Kistler, A; Gallegos, G; Bargmann, CI				L'Etoile, ND; Coburn, CM; Eastham, J; Kistler, A; Gallegos, G; Bargmann, CI			The cyclic GMP-dependent protein kinase EGL-4 regulates olfactory adaptation in C-elegans	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; NEMATODE CAENORHABDITIS-ELEGANS; ODOR ADAPTATION; CHEMOSENSORY RECEPTORS; CHEMORECEPTOR GENES; SIGNALING COMPLEX; NEURONS; EXPRESSION; DISCRIMINATION; IDENTIFICATION	Prolonged odor exposure causes a specific, reversible adaptation of olfactory responses. A genetic screen for negative regulators of olfaction uncovered mutations in the cGMP-dependent protein kinase EGL-4 that disrupt olfactory adaptation in C. elegans. G protein-coupled olfactory receptors within the AWC olfactory neuron signal through cGMP and a cGMP-gated channel. The cGMP-dependent kinase functions in AWC neurons during odor exposure to direct adaptation to AWC-sensed odors, suggesting that adaptation is a cell intrinsic process initiated by cGMP. A predicted phosphorylation site on the beta subunit of the cGMP-gated channel is required for adaptation after short odor exposure, suggesting that phosphorylation of signaling molecules generates adaptation at early time points. A predicted nuclear localization signal within EGL-4 is required for adaptation after longer odor exposure, suggesting that nuclear translocation of EGL-4 triggers late forms of adaptation.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Biochem & Mol Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bear MF, 2001, SYNAPSES, P455; Birnby DA, 2000, GENETICS, V155, P85; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BRENNER S, 1974, GENETICS, V77, P71; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; Daniels SA, 2000, GENETICS, V156, P123; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kramer RH, 2001, J EXP BIOL, V204, P2921; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Mello C, 1995, METHOD CELL BIOL, V48, P451; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Riddle DL, 1997, C ELEGANS, P739; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Saeki S, 2001, J EXP BIOL, V204, P1757; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Stansberry J, 2001, J NEUROCHEM, V76, P1177, DOI 10.1046/j.1471-4159.2001.00131.x; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Sulston J., 1988, METHODS NEMATODE CAE, P587; TRENT C, 1983, GENETICS, V104, P619; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TROEMEL ER, 1999, THESIS U CALIFORNIA; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 1997, J NEUROSCI, V17, P2703	50	141	160	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1079	1089		10.1016/S0896-6273(02)01066-8	http://dx.doi.org/10.1016/S0896-6273(02)01066-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495623	Bronze			2022-12-17	WOS:000180011600011
J	Elhamdani, A; Palfrey, HC; Artalejo, CR				Elhamdani, A; Palfrey, HC; Artalejo, CR			Quantal size is dependent on stimulation frequency and calcium entry in calf chromaffin cells	NEURON			English	Article							SYNAPTIC VESICLE MEMBRANE; DENSE-CORE VESICLES; RAPID ENDOCYTOSIS; TRANSMITTER RELEASE; FUSION PORE; EXOCYTOSIS; SECRETION; CATECHOLAMINES; KISS; GRANULES	To what extent the quantal hypothesis of transmitter release applies to dense-core vesicle (DCV) secretion is unknown. We determined the characteristics of individual secretory events in calf chromaffin cells using catecholamine amperometry combined with different patterns of stimulation. Raising the frequency of action potential trains from 0.25-10 Hz in 2 mM [Ca2+](o) or [Ca2+](o) from 0.25-7 mM at 7 Hz elevated the amount released per event (quantal size). With increased stimulation, quantal size rose continuously, not abruptly, suggesting that release efficiency from a single population of DCVs rather than recruitment of different-sized vesicles contributed to the effect. These results suggest that catecholamine secretion does not conform to the quantal model. Inhibition of rapid endocytosis damped secretion in successive episodes, implying an essential role for this process in the recycling of vesicles needed for continuous secretion.	Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Wayne State University; University of Chicago	Artalejo, CR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	cartalej@med.wayne.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH047181] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 58921] Funding Source: Medline; NIGMS NIH HHS [GM-56396] Funding Source: Medline; NIMH NIH HHS [MH47181] Funding Source: Medline; PHS HHS [IBN-9985874] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; Artalejo CR, 1998, CURR BIOL, V8, pR62, DOI 10.1016/S0960-9822(98)70036-3; Artalejo CR, 1997, EMBO J, V16, P1565, DOI 10.1093/emboj/16.7.1565; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Borges R, 1997, J BIOL CHEM, V272, P8325, DOI 10.1074/jbc.272.13.8325; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; COUPLAND RE, 1968, NATURE, V217, P384, DOI 10.1038/217384a0; De Camilli P, 2001, SYNAPSES, P217; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Elhamdani A, 2000, J NEUROSCI, V20, P2495; Elhamdani A, 1998, J NEUROSCI, V18, P6230; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Folkow B, 1997, NEWS PHYSIOL SCI, V12, P32; GRYNSZPANWINOGR.O, 1975, HDB PHYSIOLOGY     7, V6, P295; HARTMANN J, 1995, FEBS LETT, V363, P217, DOI 10.1016/0014-5793(95)00318-4; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JANKOWSKI JA, 1993, J BIOL CHEM, V268, P14694; Katz B, 1969, SHERRINGTON LECT, VX; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mansvelder HD, 1998, J NEUROSCI, V18, P81; Marszalek PE, 1997, BIOPHYS J, V73, P1169, DOI 10.1016/S0006-3495(97)78149-9; MARTIN AR, 1966, PHYSIOL REV, V46, P51, DOI 10.1152/physrev.1966.46.1.51; Monck JR, 1996, CURR OPIN CELL BIOL, V8, P524, DOI 10.1016/S0955-0674(96)80031-7; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Regehr WG, 2001, SYNAPSES, P135; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stjarne L, 2000, J AUTONOM NERV SYST, V81, P236, DOI 10.1016/S0165-1838(00)00119-3; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; Travis ER, 1998, ANNU REV BIOPH BIOM, V27, P77, DOI 10.1146/annurev.biophys.27.1.77; UVNAS B, 1985, ACTA PHYSIOL SCAND, V123, P249, DOI 10.1111/j.1748-1716.1985.tb07585.x; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; WIGHTMAN RM, 1995, BIOPHYS J, V68, P383, DOI 10.1016/S0006-3495(95)80199-2; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zimmerberg J, 2001, TRENDS CELL BIOL, V11, P233, DOI 10.1016/S0962-8924(01)02003-7	52	141	143	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					819	830		10.1016/S0896-6273(01)00418-4	http://dx.doi.org/10.1016/S0896-6273(01)00418-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567619	Bronze			2022-12-17	WOS:000171013300014
J	Sutton, MA; Masters, SE; Bagnall, MW; Carew, TJ				Sutton, MA; Masters, SE; Bagnall, MW; Carew, TJ			Molecular mechanisms underlying a unique intermediate phase of memory in Aplysia	NEURON			English	Article							LONG-TERM FACILITATION; SIPHON-WITHDRAWAL REFLEX; DEPENDENT PROTEIN-KINASE; PRE-SYNAPTIC FACILITATION; SENSORY NEURONS; GILL-WITHDRAWAL; PRESYNAPTIC FACILITATION; BEHAVIORAL SENSITIZATION; MACROMOLECULAR-SYNTHESIS; TRANSMITTER RELEASE	Short- and long-term synaptic facilitation induced by serotonin at Aplysia sensory-motor (SN-MN) synapses has been widely used as a cellular model of short- and long-term memory for sensitization. In recent years, a distinct intermediate phase of synaptic facilitation (ITF) has been described at SN-MN synapses. Here, we identify a novel intermediate phase of behavioral memory (ITM) for sensitization in Aplysia and demonstrate that it shares the temporal and mechanistic features of ITF in the intact CNS: (1) it declines completely prior to the onset of LTM, (2) its induction requires protein but not RNA synthesis, and (3) its expression requires the persistent activation of protein kinase A. Thus, in Aplysia, the same temporal and molecular characteristics that distinguish ITF from other phases of synaptic plasticity distinguish ITM from other phases of behavioral memory.	Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Yale Univ, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of California System; University of California Irvine; Yale University; Yale University	Carew, TJ (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92697 USA.		Sutton, Michael/C-6264-2011	Bagnall, Martha/0000-0003-2102-6165; Sutton, Michael/0000-0002-0692-6459	NIMH NIH HHS [R01 MH-14-1083] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Antonov I, 1999, J NEUROSCI, V19, P10438; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bao JX, 1998, J NEUROSCI, V18, P458; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BUONOMANO DV, 1990, SCIENCE, V249, P420, DOI 10.1126/science.2165631; CAREW TJ, 1983, SCIENCE, V219, P397, DOI 10.1126/science.6681571; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CLARK GA, 1993, P NATL ACAD SCI USA, V90, P11411, DOI 10.1073/pnas.90.23.11411; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; Crow T, 1999, J NEUROPHYSIOL, V82, P495, DOI 10.1152/jn.1999.82.1.495; CROW T, 1997, NEUROBIOL LEARN MEM, V68, P340; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FISCHER TM, 1993, J NEUROSCI, V13, P1302; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FRIEDER B, 1978, BEHAV BIOL, V22, P178, DOI 10.1016/S0091-6773(78)92200-9; FRIEDER B, 1982, PHYSIOL BEHAV, V29, P1071, DOI 10.1016/0031-9384(82)90300-6; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; FROST WN, 1995, J NEUROPHYSIOL, V73, P2413, DOI 10.1152/jn.1995.73.6.2413; Gerber B, 2000, LEARN MEMORY, V7, P151, DOI 10.1101/lm.7.3.151; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GIBBS ME, 1977, BIOBEHAV REV, V1, P113, DOI 10.1016/0147-7552(77)90017-1; GIBBS ME, 1979, NEUROSCI LETT, V13, P279, DOI 10.1016/0304-3940(79)91507-6; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1981, J NEUROPHYSIOL, V45, P304, DOI 10.1152/jn.1981.45.2.304; HICKIE C, 1995, J NEUROPHYSIOL, V74, P307, DOI 10.1152/jn.1995.74.1.307; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; KAMIN LJ, 1957, J COMP PHYSIOL PSYCH, V50, P457, DOI 10.1037/h0044226; KAMIN LJ, 1963, J COMP PHYSIOL PSYCH, V56, P719; Levenson J, 1999, J NEUROSCI, V19, P8094; Levenson J, 2000, P NATL ACAD SCI USA, V97, P12858, DOI 10.1073/pnas.220256497; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; MERCER AR, 1991, SCIENCE, V254, P1811, DOI 10.1126/science.1662413; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; RIEGE WH, 1971, SCIENCE, V172, P966, DOI 10.1126/science.172.3986.966; ROSENZWEIG MR, 1993, BEHAV BRAIN RES, V57, P193, DOI 10.1016/0166-4328(93)90135-D; SANDERS GD, 1971, NATURE, V232, P203, DOI 10.1038/232203a0; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Stopfer M, 1996, J NEUROSCI, V16, P4923; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; TALLARICO PT, 1973, J RES MUSIC EDUC, V21, P153, DOI 10.2307/3344591; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1990, COLD SH Q B, V55, P203; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WRIGHT WG, 1995, J NEUROSCI, V15, P790; Xia SZ, 1998, PHARMACOL BIOCHEM BE, V60, P809, DOI 10.1016/S0091-3057(98)00060-4; Yanow SK, 1998, J NEUROCHEM, V70, P572; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	68	141	142	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					143	154		10.1016/S0896-6273(01)00342-7	http://dx.doi.org/10.1016/S0896-6273(01)00342-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498057				2022-12-17	WOS:000170101100017
J	Leskov, IB; Klenchin, VA; Handy, JW; Whitlock, GG; Govardovskii, VI; Bownds, MD; Lamb, TD; Pugh, EN; Arshavsky, VY				Leskov, IB; Klenchin, VA; Handy, JW; Whitlock, GG; Govardovskii, VI; Bownds, MD; Lamb, TD; Pugh, EN; Arshavsky, VY			The gain of rod phototransduction: Reconciliation of biochemical and electrophysiological measurements	NEURON			English	Article							CGMP-BINDING-SITES; LIGHT-ACTIVATED PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; SINGLE-PHOTON RESPONSES; OUTER SEGMENTS; RETINAL RODS; PHOTORECEPTOR PHOSPHODIESTERASE; VISUAL TRANSDUCTION; NUCLEOTIDE CASCADE; DISK MEMBRANE	We have resolved a central and long-standing paradox in understanding the amplification of rod phototransduction by making direct measurements of the gains of the underlying enzymatic amplifiers. We find that under optimized conditions a single photoisomerized rhodopsin activates transducin molecules and phosphodiesterase (PDE) catalytic subunits at rates of 120-150/s, much lower than indirect estimates from lightscattering experiments. Further, we measure the Michaelis constant, K-m, of the rod PDE activated by transducin to be 10 mu M, at least 10-fold lower than published estimates. Thus, the gain of cGMP hydrolysis (determined by k(cat)/K-m) is at least 10-fold higher than reported in the literature. Accordingly, our results now provide a quantitative account of the overall gain of the rod cascade in terms of directly measured factors.	IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge; University of Pennsylvania	Arshavsky, VY (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.		Lamb, Trevor/C-9755-2009; Govardovskii, Victor I/K-2655-2018	Whitlock, Gary/0000-0003-3070-1281	NEI NIH HHS [EY-00463, EY-10336, EY-02660] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010336, R01EY002660] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; BARKDOLL AE, 1988, J NEUROCHEM, V50, P839, DOI 10.1111/j.1471-4159.1988.tb02989.x; BARKDOLL AE, 1989, J GEN PHYSIOL, V93, P1091, DOI 10.1085/jgp.93.6.1091; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BIERNBAUM MS, 1985, J GEN PHYSIOL, V85, P83, DOI 10.1085/jgp.85.1.83; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; BOWNDS MD, 1995, BEHAV BRAIN SCI, V18, P415, DOI 10.1017/S0140525X00039170; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; COTE RH, 1993, J BIOL CHEM, V268, P17190; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Crank J., 1956, MATH DIFFUSION; D'Amours MR, 1999, BIOCHEM J, V340, P863, DOI 10.1042/0264-6021:3400863; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; EDIDIN M, 1987, CURR TOP MEMBR TRANS, V29, P91; FERSHT A, 1977, ENZYME STRUCTURE MEH; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GRAYKELLER MP, 1990, J BIOL CHEM, V265, P15323; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; KAMPS KMP, 1985, FEBS LETT, V188, P15; KUHN H, 1981, CURR TOP MEMBR TRANS, V15, P171; LAMB TD, 1994, BIOPHYS J, V67, P1439, DOI 10.1016/S0006-3495(94)80617-4; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Pugh EN, 1999, NEURON, V23, P205, DOI 10.1016/S0896-6273(00)80772-2; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SHINITZKY M, 1983, BIOCHIM BIOPHYS ACTA, V738, P251, DOI 10.1016/0304-419X(83)90007-0; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WU CF, 1978, J GEN PHYSIOL, V71, P249, DOI 10.1085/jgp.71.3.249; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	47	141	149	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					525	537		10.1016/S0896-6273(00)00063-5	http://dx.doi.org/10.1016/S0896-6273(00)00063-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055435	Bronze			2022-12-17	WOS:000089601300016
J	Schwappach, B; Zerangue, N; Jan, YN; Jan, LY				Schwappach, B; Zerangue, N; Jan, YN; Jan, LY			Molecular basis for K-ATP assembly: Transmembrane interactions mediate association of a K+ channel with an ABC transporter	NEURON			English	Article							SENSITIVE POTASSIUM CHANNELS; PORE-FORMING SUBUNIT; SULFONYLUREA RECEPTOR; MULTIDRUG-RESISTANCE; N-TERMINUS; MEMBRANE TOPOLOGY; INHIBITION; PROTEIN; KIR6.2; DOMAINS	K-ATP channels are large heteromultimeric complexes containing four subunits from the inwardly rectifying K+ channel family (Kir6.2) and four regulatory sulphonylurea receptor subunits from the ATP-binding cassette (ABC) transporter family (SUR1 and SUR2A/B). The molecular basis for interactions between these two unrelated protein families is poorly understood. Using novel trafficking-based interaction assays, coimmunoprecipitation, and current measurements, we show that the first transmembrane segment (M1) and the N terminus of Kir6.2 are involved in K-ATP assembly and gating. Additionally, the transmembrane domains, but not the nucleotide-binding domains, of SUR1 are required for interaction with Kir6.2. The identification of specific transmembrane interactions involved in K-ATP assembly may provide a clue as to how ABC proteins that transport hydrophobic substrates evolved to regulate other membrane proteins.	Univ Calif San Francisco, Grad Program Neurosci, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498; Schwappach, Blanche/0000-0003-0225-6432; Jan, Yuh Nung/0000-0003-1367-6299	NINDS NIH HHS [NS-15963] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015963] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; ALLIKMETS R, 1993, GENE, V136, P231, DOI 10.1016/0378-1119(93)90470-N; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Ruknudin A, 1998, J BIOL CHEM, V273, P14165, DOI 10.1074/jbc.273.23.14165; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1996, J BIOL CHEM, V271, P5866, DOI 10.1074/jbc.271.10.5866; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Tucker SJ, 1999, J BIOL CHEM, V274, P33393, DOI 10.1074/jbc.274.47.33393; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Uhde I, 1999, J BIOL CHEM, V274, P28079, DOI 10.1074/jbc.274.40.28079; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	43	141	141	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					155	167		10.1016/S0896-6273(00)81146-0	http://dx.doi.org/10.1016/S0896-6273(00)81146-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798400	Bronze			2022-12-17	WOS:000086770500016
J	WIERASZKO, A; LI, G; KORNECKI, E; HOGAN, MV; EHRLICH, YH				WIERASZKO, A; LI, G; KORNECKI, E; HOGAN, MV; EHRLICH, YH			LONG-TERM POTENTIATION IN THE HIPPOCAMPUS INDUCED BY PLATELET-ACTIVATING-FACTOR	NEURON			English	Article							CENTRAL NEURONS; NMDA RECEPTORS; BINDING-SITES; INDUCTION; CHANNELS; BRAIN; BLOCK	Platelet-activating factor (PAF) is an ether phospholipid that serves as an autacoid in a wide range of biological processes. We found that when PAF was added to hippocampal slices, it induced a stable and concentration-dependent increase in excitatory postsynaptic potential and population spike recordings (long-term potentiation [LTP]). The PAF effect was blocked by the PAF receptor antagonists BN 52021 and WEB 2086 and the N-methyl-D-aspartate receptor antagonists MK 801 and 2-amino-5-phosphonovalerate. However, these PAF receptor antagonists did not block LTP induced by high frequency stimulation. The facilitation induced by PAF could not be reversed by PAF receptor antagonists. Induction of either PAF- or tetanus-triggered facilitation occluded the subsequent expression of the other, suggesting a common pathway. LTP is a type of synaptic plasticity associated with the formation of memory, and PAF may play an important modulatory role in this process.	NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314; SUNY,HLTH SCI CTR,DEPT ANAT & CELL BIOL,BROOKLYN,NY 11203	Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College	WIERASZKO, A (corresponding author), CUNY COLL STATEN ISL,CSI IBR CTR DEV NEUROSCI & DEV DISABIL,STATEN ISL,NY 10301, USA.				NINDS NIH HHS [R01 NS27866] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027866] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES PY, 1989, PLATELET ACTIVATING; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOUMANN WJ, 1991, LIPIDS, V26, P945; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; CLAY KL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P309, DOI 10.1016/0005-2760(90)90246-T; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; DOMINGO MT, 1988, BIOCHEM BIOPH RES CO, V151, P730, DOI 10.1016/S0006-291X(88)80341-3; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; KORNECKI E, 1991, LIPIDS, V26, P1243, DOI 10.1007/BF02536540; KORNECKI E, 1988, SCIENCE, V240, P1792, DOI 10.1126/science.3381103; KORNECKI E, 1984, SCIENCE, V226, P1454, DOI 10.1126/science.6150550; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; TEYLER TJ, 1984, BRAIN RES REV, V7, P15, DOI 10.1016/0165-0173(84)90027-4; WIERASZKO A, 1989, BRAIN RES, V491, P356, DOI 10.1016/0006-8993(89)90070-X	22	141	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					553	557		10.1016/0896-6273(93)90342-O	http://dx.doi.org/10.1016/0896-6273(93)90342-O			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461142				2022-12-17	WOS:A1993KU90100019
J	COLE, GJ; AKESON, R				COLE, GJ; AKESON, R			IDENTIFICATION OF A HEPARIN BINDING DOMAIN OF THE NEURAL CELL-ADHESION MOLECULE N-CAM USING SYNTHETIC PEPTIDES	NEURON			English	Article									CHILDRENS HOSP RES FDN,DIV BASIC RES,CINCINNATI,OH 45229	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	COLE, GJ (corresponding author), MED UNIV S CAROLINA,DEPT ANAT & CELL BIOL,CHARLESTON,SC 29425, USA.				NEI NIH HHS [EY 07130] Funding Source: Medline; NICHD NIH HHS [HD 21065] Funding Source: Medline; NIGMS NIH HHS [GM 38285] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021065] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY007130] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; BARANY G, 1981, PEPTIDES, V2, P1; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; CARDIN AD, 1989, IN PRESS ATHEROSCLER; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; CHARONIS AS, 1988, J CELL BIOL, V107, P1253, DOI 10.1083/jcb.107.3.1253; COLE GJ, 1986, J CELL BIOL, V103, P1739, DOI 10.1083/jcb.103.5.1739; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; COLE GJ, 1985, J CELL BIOL, V100, P1192, DOI 10.1083/jcb.100.4.1192; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAVIS GE, 1987, NEUROCHEM RES, V12, P909, DOI 10.1007/BF00966313; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; FAHRIG T, 1987, EMBO J, V6, P2875, DOI 10.1002/j.1460-2075.1987.tb02590.x; FRASER SE, 1984, P NATL ACAD SCI-BIOL, V81, P4222, DOI 10.1073/pnas.81.13.4222; FRELINGER AL, 1986, J CELL BIOL, V103, P1729, DOI 10.1083/jcb.103.5.1729; GENNARINI G, 1986, J NEUROSCI, V6, P1983; GRUMET M, 1982, NATURE, V295, P693, DOI 10.1038/295693a0; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P267, DOI 10.1073/pnas.81.1.267; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HIROSE N, 1987, BIOCHEMISTRY-US, V26, P5505, DOI 10.1021/bi00391a044; HOFFMAN S, 1987, P NATL ACAD SCI USA, V84, P2523, DOI 10.1073/pnas.84.8.2523; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HOFFMAN S, 1986, J CELL BIOL, V103, P145, DOI 10.1083/jcb.103.1.145; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; HOVINGH P, 1986, BIOCHEM J, V237, P573, DOI 10.1042/bj2370573; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; MURRAY BA, 1986, J CELL BIOL, V102, P189, DOI 10.1083/jcb.102.1.189; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; RATHJEN FG, 1984, EMBO J, V3, P1; RIEGER F, 1985, J CELL BIOL, V101, P285, DOI 10.1083/jcb.101.1.285; ROGERS SL, 1985, J NEUROSCI, V5, P369; ROUGON G, 1986, J BIOL CHEM, V261, P3396; RUTISHAUSER U, 1984, NATURE, V310, P549, DOI 10.1038/310549a0; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; SANDROCK AW, 1987, P NATL ACAD SCI USA, V84, P6934, DOI 10.1073/pnas.84.19.6934; SCHUBERT D, 1985, J CELL BIOL, V100, P56, DOI 10.1083/jcb.100.1.56; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SMALL SJ, 1987, J CELL BIOL, V105, P2335, DOI 10.1083/jcb.105.5.2335; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; THIERY JP, 1977, J BIOL CHEM, V252, P6841	50	141	145	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1989	2	2					1157	1165		10.1016/0896-6273(89)90182-7	http://dx.doi.org/10.1016/0896-6273(89)90182-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	U1845	2624745				2022-12-17	WOS:A1989U184500006
J	YAN, Q; SNIDER, WD; PINZONE, JJ; JOHNSON, EM				YAN, Q; SNIDER, WD; PINZONE, JJ; JOHNSON, EM			RETROGRADE TRANSPORT OF NERVE GROWTH-FACTOR (NGF) IN MOTONEURONS OF DEVELOPING RATS - ASSESSMENT OF POTENTIAL NEUROTROPHIC EFFECTS	NEURON			English	Article									WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110	Washington University (WUSTL)	YAN, Q (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110, USA.				NINDS NIH HHS [NS 18073] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERND P, 1984, J BIOL CHEM, V259, P5509; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; BRUNSOBECHTOLD JK, 1979, P NATL ACAD SCI USA, V76, P1494, DOI 10.1073/pnas.76.3.1494; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; DISTEFANO PS, 1988, J NEUROSCI, V8, P231; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; GREEN SH, 1986, J BIOL CHEM, V261, P5316; HEATON MB, 1987, J COMP NEUROL, V265, P362, DOI 10.1002/cne.902650305; HENDRY IA, 1974, BRAIN RES, V82, P117, DOI 10.1016/0006-8993(74)90897-X; JACOBOWITZ DM, 1975, BRAIN RES, V91, P165, DOI 10.1016/0006-8993(75)90478-3; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JOHNSON EM, 1978, BRAIN RES, V150, P319, DOI 10.1016/0006-8993(78)90283-4; KASHIHARA Y, 1987, J PHYSIOL-LONDON, V386, P135, DOI 10.1113/jphysiol.1987.sp016526; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; MIYATA Y, 1986, J NEUROSCI, V6, P2012; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; PEARSON J, 1983, DEV BIOL, V96, P32, DOI 10.1016/0012-1606(83)90308-1; RAIVICH G, 1987, J COMP NEUROL, V256, P229, DOI 10.1002/cne.902560204; RAIVICH G, 1985, EMBO J, V4, P637, DOI 10.1002/j.1460-2075.1985.tb03677.x; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; SCHRIER BK, 1967, J NEUROCHEM, V14, P977, DOI 10.1111/j.1471-4159.1967.tb09509.x; SNIDER WD, 1988, IN PRESS J NEUROSCI; SONNENFELD KH, 1982, J NEUROSCI RES, V8, P375, DOI 10.1002/jnr.490080226; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TANIUCHI M, 1985, J CELL BIOL, V101, P1100, DOI 10.1083/jcb.101.3.1100; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P1950, DOI 10.1073/pnas.83.6.1950; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; YAN Q, 1987, DEV BIOL, V121, P139, DOI 10.1016/0012-1606(87)90147-3; YAN Q, 1988, IN PRESS J NEUROSCI; YIP HK, 1984, J NEUROSCI, V4, P2986	35	141	141	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1988	1	4					335	343						9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	P0129	2483324				2022-12-17	WOS:A1988P012900009
J	Robbins, TW; Vaghi, MM; Banca, P				Robbins, Trevor W.; Vaghi, Matilde M.; Banca, Paula			Obsessive-Compulsive Disorder: Puzzles and Prospects	NEURON			English	Review							IMPAIRED COGNITIVE FLEXIBILITY; SEROTONIN REUPTAKE INHIBITORS; GENOME-WIDE ASSOCIATION; DEEP BRAIN-STIMULATION; ORBITOFRONTAL CORTEX; BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; DORSOLATERAL STRIATUM; ATTENTIONAL CONTROL; EXECUTIVE FUNCTION	Obsessive-compulsive disorder is a severe and disabling psychiatric disorder that presents several challenges for neuroscience. Recent advances in its genetic and developmental causation, as well as its neuropsychological basis, are reviewed. Hypotheses concerning an imbalance between goal-directed and habitual behavior together with neural correlates in cortico-striatal circuitry are evaluated and contrasted with meta-cognitive theories. Treatments for obsessive-compulsive disorder (OCD) tend to be of mixed efficacy but include psychological, pharmacological, and surgical approaches, the underlying mechanisms of which are still under debate. Overall, the prospects for new animal models and an integrated understanding of the pathophysiology of OCD are considered in the context of dimensional psychiatry.	[Robbins, Trevor W.; Vaghi, Matilde M.; Banca, Paula] Univ Cambridge, Behav & Clin Neurosci Inst, Dept Psychol, Cambridge CB2 3EB, England; [Vaghi, Matilde M.] Max Planck UCL Ctr Computat Psychiat & Ageing Res, 10-12 Russell Sq, London WC1B 5EH, England	University of Cambridge	Robbins, TW; Vaghi, MM; Banca, P (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Dept Psychol, Cambridge CB2 3EB, England.; Vaghi, MM (corresponding author), Max Planck UCL Ctr Computat Psychiat & Ageing Res, 10-12 Russell Sq, London WC1B 5EH, England.	twr2@cam.ac.uk; matilde.vaghi@gmail.com; paula.banca@gmail.com	Robbins, Trevor W/A-7551-2008; Banca, Paula/G-8330-2017; Vaghi, Matilde/GQH-9010-2022	Banca, Paula/0000-0001-7617-3635; Vaghi, Matilde/0000-0002-0999-9055	Wellcome Trust Senior Investigator Award [104631/Z/14/Z]; Angharad Dodds John Bursary in Mental Health and Neuropsychiatry; Sir Henry Wellcome Trust Postdoctoral Research Fellowship [RG86232]	Wellcome Trust Senior Investigator Award(Wellcome Trust); Angharad Dodds John Bursary in Mental Health and Neuropsychiatry; Sir Henry Wellcome Trust Postdoctoral Research Fellowship	This work was supported by a Wellcome Trust Senior Investigator Award (104631/Z/14/Z) to T.W.R., an Angharad Dodds John Bursary in Mental Health and Neuropsychiatry to M.M.V., and a Sir Henry Wellcome Trust Postdoctoral Research Fellowship (RG86232) to P.B. We would also like to acknowledge all our clinical and nonclinical collaborators for their contributions to our research on OCD.	Abramovitch A, 2013, CLIN PSYCHOL REV, V33, P1163, DOI 10.1016/j.cpr.2013.09.004; ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; Adams KH, 2005, INT J NEUROPSYCHOPH, V8, P391, DOI 10.1017/S1461145705005055; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anticevic A, 2014, BIOL PSYCHIAT, V75, P595, DOI 10.1016/j.biopsych.2013.10.021; Apergis-Schoute AM, 2017, P NATL ACAD SCI USA, V114, P3216, DOI 10.1073/pnas.1609194114; Arnold PD, 2018, MOL PSYCHIATR, V23, P1181, DOI 10.1038/mp.2017.154; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Attwells S, 2017, JAMA PSYCHIAT, V74, P833, DOI 10.1001/jamapsychiatry.2017.1567; AZRIN NH, 1973, BEHAV RES THER, V11, P619, DOI 10.1016/0005-7967(73)90119-8; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Banca P, 2015, NEUROPSYCHOPHARMACOL, V40, P1192, DOI 10.1038/npp.2014.303; Banca P, 2015, BRAIN, V138, P798, DOI 10.1093/brain/awu379; Barlow RL, 2015, NEUROPSYCHOPHARMACOL, V40, P1619, DOI 10.1038/npp.2014.335; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; Bloch MH, 2010, MOL PSYCHIATR, V15, P850, DOI 10.1038/mp.2009.50; Boileau Bernard, 2011, Dialogues Clin Neurosci, V13, P401; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Bradfield L., 2017, OBSESSIVE COMPULSIVE, P343; Brennan BP, 2013, BIOL PSYCHIAT, V73, P24, DOI 10.1016/j.biopsych.2012.06.023; Brunelin J, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020037; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Ceaser AE, 2008, BIOL PSYCHIAT, V64, P782, DOI 10.1016/j.biopsych.2008.05.009; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P335, DOI 10.1176/appi.ajp.164.2.335; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chou-Green JM, 2003, PHYSIOL BEHAV, V78, P641, DOI 10.1016/S0031-9384(03)00047-7; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clarke HF, 2011, J NEUROSCI, V31, P4290, DOI 10.1523/JNEUROSCI.5066-10.2011; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; d'Angelo LSC, 2014, CNS SPECTRUMS, V19, P28, DOI 10.1017/S1092852913000564; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; de Vries FE, 2014, BIOL PSYCHIAT, V76, P878, DOI 10.1016/j.biopsych.2013.11.021; de Wit S, 2018, J EXP PSYCHOL GEN, V147, P1043, DOI 10.1037/xge0000402; de Wit SJ, 2012, AM J PSYCHIAT, V169, P1100, DOI 10.1176/appi.ajp.2012.12010073; Denys D, 2013, EUR NEUROPSYCHOPHARM, V23, P1423, DOI 10.1016/j.euroneuro.2013.05.012; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; DOUGLASS HM, 1995, J AM ACAD CHILD PSY, V34, P1424, DOI 10.1097/00004583-199511000-00008; Eagle DM, 2014, BEHAV BRAIN RES, V264, P207, DOI 10.1016/j.bbr.2013.12.040; Eley TC, 2003, J CHILD PSYCHOL PSYC, V44, P945, DOI 10.1111/1469-7610.00179; ELMANSARI M, 1995, NEUROPSYCHOPHARMACOL, V13, P117, DOI 10.1016/0893-133X(95)00045-F; Evans DW, 1997, CHILD DEV, V68, P58, DOI 10.2307/1131925; Everitt BJ, 2016, ANNU REV PSYCHOL, V67, P23, DOI 10.1146/annurev-psych-122414-033457; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Fitzgerald KD, 2015, CNS SPECTRUMS, V20, P346, DOI 10.1017/S1092852915000036; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; Fouche JP, 2017, BRIT J PSYCHIAT, V210, P67, DOI 10.1192/bjp.bp.115.164020; Frick L, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8606057; Fullana MA, 2016, MOL PSYCHIATR, V21, P500, DOI 10.1038/mp.2015.88; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; Gillan CM, 2017, PSYCHOL MED, V47, P1528, DOI 10.1017/S0033291716002786; Gillan CM, 2016, EUR NEUROPSYCHOPHARM, V26, P828, DOI 10.1016/j.euroneuro.2015.12.033; Gillan CM, 2015, COGN AFFECT BEHAV NE, V15, P523, DOI 10.3758/s13415-015-0347-6; Gillan CM, 2015, AM J PSYCHIAT, V172, P284, DOI 10.1176/appi.ajp.2014.14040525; Gillan CM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0475; Gillan CM, 2014, BIOL PSYCHIAT, V75, P631, DOI 10.1016/j.biopsych.2013.02.002; Gillan CM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00204; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gottwald J, 2018, PSYCHOL MED, V48, P1900, DOI 10.1017/S0033291717003464; Graat I, 2017, OBSESSIVE COMPULSIVE, P271; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Greenberg BD, 2010, NEUROPSYCHOPHARMACOL, V35, P317, DOI 10.1038/npp.2009.128; Groman SM, 2013, BIOL PSYCHIAT, V73, P756, DOI 10.1016/j.biopsych.2012.12.002; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hanna GL, 2018, DEPRESS ANXIETY, V35, P752, DOI 10.1002/da.22767; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hauser TU, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06116-z; Hermans D, 2008, BEHAV RES THER, V46, P98, DOI 10.1016/j.brat.2007.11.001; Hybel KA, 2017, J ABNORM CHILD PSYCH, V45, P1195, DOI 10.1007/s10802-016-0229-6; Jalal B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33142-2; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Keeler JF, 2011, BIOCHEM PHARMACOL, V81, P1356, DOI 10.1016/j.bcp.2010.12.028; Krabbe G, 2017, P NATL ACAD SCI USA, V114, P5029, DOI 10.1073/pnas.1700477114; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lei H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10413; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; Mancebo MC, 2008, ACTA PSYCHIAT SCAND, V118, P149, DOI 10.1111/j.1600-0447.2008.01224.x; Manning EE, 2019, NEUROPSYCHOPHARMACOL, V44, P1494, DOI 10.1038/s41386-018-0307-2; Mataix-Cols D, 2008, J AM ACAD CHILD PSY, V47, P773, DOI 10.1097/CHI.0b013e31816b73c0; Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Meunier D, 2012, NEUROIMAGE, V59, P1461, DOI 10.1016/j.neuroimage.2011.08.003; Milad MR, 2013, JAMA PSYCHIAT, V70, P608, DOI 10.1001/jamapsychiatry.2013.914; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Morein-Zamir S, 2010, PSYCHOL MED, V40, P263, DOI 10.1017/S003329170999033X; Morein-Zamir S, 2018, Q J EXP PSYCHOL, V71, P2052, DOI 10.1177/1747021817737727; Morein-Zamir S, 2014, PSYCHIAT RES, V215, P659, DOI 10.1016/j.psychres.2013.12.026; Morelli E, 2011, J NEUROSCI, V31, P15742, DOI 10.1523/JNEUROSCI.2989-11.2011; Moresco RM, 2007, NEUROPSYCHOPHARMACOL, V32, P197, DOI 10.1038/sj.npp.1301199; Morgieve M, 2014, PSYCHOL MED, V44, P1461, DOI 10.1017/S0033291713002237; Myers SG, 2005, J ANXIETY DISORD, V19, P806, DOI 10.1016/j.janxdis.2004.09.004; Nagarajan N, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.180; Noh HJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00831-x; Palminteri S, 2012, BIOL PSYCHIAT, V72, P244, DOI 10.1016/j.biopsych.2011.12.028; Pauls David L, 2010, Dialogues Clin Neurosci, V12, P149; Perani D, 2008, NEUROIMAGE, V42, P306, DOI 10.1016/j.neuroimage.2008.04.233; Pinhal CM, 2018, BIOL PSYCHIAT, V84, P917, DOI 10.1016/j.biopsych.2018.05.011; Pittenger C., 2017, OBSESSIVE COMPULSIVE; Pittenger C., 2017, OBSESSIVE COMPULSIVE, P463; RACHMAN S, 1993, BEHAV RES THER, V31, P149, DOI 10.1016/0005-7967(93)90066-4; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; RAPOPORT JL, 1992, ARCH GEN PSYCHIAT, V49, P517; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; Rauch SL, 2002, NEUROPSYCHOPHARMACOL, V27, P782, DOI 10.1016/S0893-133X(02)00351-2; Rauch SL, 2001, BIOL PSYCHIAT, V50, P659, DOI 10.1016/S0006-3223(01)01188-X; Reghunandanan S., 2015, OBSESSIVE COMPULSIVE, V2nd; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Robbins TW, 2017, CURR BIOL, V27, pR1200, DOI 10.1016/j.cub.2017.09.060; Robbins TW, 2015, CURR OPIN NEUROBIOL, V30, P66, DOI 10.1016/j.conb.2014.09.005; Rodriguez-Romaguera J, 2016, BIOL PSYCHIAT, V80, P534, DOI 10.1016/j.biopsych.2016.02.012; Rogers RD, 1999, PSYCHOPHARMACOLOGY, V146, P482, DOI 10.1007/PL00005494; Rotge JY, 2010, NEUROSCIENCE, V165, P408, DOI 10.1016/j.neuroscience.2009.10.043; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Rotge Jean-Yves, 2010, Biol Psychiatry, V67, pe37, DOI 10.1016/j.biopsych.2009.10.007; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; SALKOVSKIS PM, 1985, BEHAV RES THER, V23, P571, DOI 10.1016/0005-7967(85)90105-6; Saxena S, 1999, NEUROPSYCHOPHARMACOL, V21, P683, DOI 10.1016/S0893-133X(99)00082-2; Schiller D, 2010, TRENDS COGN SCI, V14, P268, DOI 10.1016/j.tics.2010.04.002; Schrag A, 2009, NEUROLOGY, V73, P1256, DOI 10.1212/WNL.0b013e3181bd10fd; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Simon D, 2010, PSYCHOPHYSIOLOGY, V47, P728, DOI 10.1111/j.1469-8986.2010.00980.x; Simpson HB, 2011, BIOL PSYCHIAT, V70, P897, DOI 10.1016/j.biopsych.2011.06.023; Skapinakis P, 2016, LANCET PSYCHIAT, V3, P730, DOI 10.1016/S2215-0366(16)30069-4; Soomro GM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001765.pub3; Stein DJ, 2010, DEPRESS ANXIETY, V27, P495, DOI 10.1002/da.20699; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Subira M, 2016, J PSYCHIATR NEUROSCI, V41, P115, DOI 10.1503/jpn.150012; SWEDO SE, 1992, ARCH GEN PSYCHIAT, V49, P690; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P335; Szechtman H, 1998, BEHAV NEUROSCI, V112, P1475, DOI 10.1037/0735-7044.112.6.1475; Taylor S, 2011, CLIN PSYCHOL REV, V31, P1083, DOI 10.1016/j.cpr.2011.06.007; Thorsen AL, 2018, BIOL PSYCHIAT-COGN N, V3, P563, DOI 10.1016/j.bpsc.2018.01.009; Tolin DF, 2001, BEHAV RES THER, V39, P913, DOI 10.1016/S0005-7967(00)00064-4; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Tyagi H, 2019, BIOL PSYCHIAT, V85, P726, DOI 10.1016/j.biopsych.2019.01.017; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; Vaghi MM, 2019, BIOL PSYCHIAT-COGN N, V4, P200, DOI 10.1016/j.bpsc.2018.09.014; Vaghi MM, 2017, BIOL PSYCHIAT-COGN N, V2, P655, DOI 10.1016/j.bpsc.2017.05.005; Vaghi MM, 2017, NEURON, V96, P348, DOI 10.1016/j.neuron.2017.09.006; Vaghi MM, 2017, BIOL PSYCHIAT, V81, P708, DOI 10.1016/j.biopsych.2016.08.009; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; van den Heuvel OA, 2016, EUR NEUROPSYCHOPHARM, V26, P810, DOI 10.1016/j.euroneuro.2015.12.005; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; van Velzen LS, 2015, HUM BRAIN MAPP, V36, P4064, DOI 10.1002/hbm.22898; Voon V, 2017, BIOL PSYCHIAT, V82, P391, DOI 10.1016/j.biopsych.2017.04.006; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Wilhelm S, 2003, AM J PSYCHIAT, V160, P1175, DOI 10.1176/appi.ajp.160.6.1175; Williams KA, 2015, BRAIN RES, V1617, P144, DOI 10.1016/j.brainres.2014.09.071; Williams MT, 2011, DEPRESS ANXIETY, V28, P495, DOI 10.1002/da.20820; Worbe Y, 2016, MOL PSYCHIATR, V21, P624, DOI 10.1038/mp.2015.46; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zai G, 2014, PHARMACOGENOMICS, V15, P1147, DOI [10.2217/pgs.14.83, 10.2217/PGS.14.83]; Zald D. H., 2006, ORBITOFRONTAL CORTEX; Zald DH, 2014, CEREB CORTEX, V24, P232, DOI 10.1093/cercor/bhs308; Zhou DD, 2017, J AFFECT DISORDERS, V215, P187, DOI 10.1016/j.jad.2017.03.033; Zwosta K, 2018, NEUROIMAGE, V165, P125, DOI 10.1016/j.neuroimage.2017.09.062	176	140	151	17	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 3	2019	102	1					27	47		10.1016/j.neuron.2019.01.046	http://dx.doi.org/10.1016/j.neuron.2019.01.046			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HR7MH	30946823	Bronze, Green Accepted, Green Submitted			2022-12-17	WOS:000463337900009
J	Richards, BA; Frankland, PW				Richards, Blake A.; Frankland, Paul W.			The Persistence and Transience of Memory	NEURON			English	Review							LONG-TERM POTENTIATION; COMPLEMENTARY LEARNING-SYSTEMS; ADULT HIPPOCAMPAL NEUROGENESIS; RABBIT FOLLOWING STIMULATION; KINASE M-ZETA; SYNAPTIC-TRANSMISSION; CONNECTIONIST MODELS; LASTING POTENTIATION; EPISODIC MEMORY; NEURAL-NETWORKS	The predominant focus in the neurobiological study of memory has been on remembering (persistence). However, recent studies have considered the neurobiology of forgetting (transience). Here we draw parallels between neurobiological and computational mechanisms underlying transience. We propose that it is the interaction between persistence and transience that allows for intelligent decision-making in dynamic, noisy environments. Specifically, we argue that transience (1) enhances flexibility, by reducing the influence of outdated information on memory-guided decision-making, and (2) prevents overfitting to specific past events, thereby promoting generalization. According to this view, the goal of memory is not the transmission of information through time, per se. Rather, the goal of memory is to optimize decision-making. As such, transience is as important as persistence in mnemonic systems.	[Richards, Blake A.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Richards, Blake A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Richards, Blake A.] Canadian Inst Adv Res, Learning Machines & Brains Program, Toronto, ON M5G 1M1, Canada; [Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Frankland, Paul W.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Frankland, Paul W.] Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada	University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR)	Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Frankland, PW (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.; Frankland, PW (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.; Frankland, PW (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada.; Frankland, PW (corresponding author), Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada.	paul.frankland@sickkids.ca		Richards, Blake/0000-0001-9662-2151	Natural Sciences and Engineering Research Council grant (NSERC) [RGPIN-2014-04947]; Google Faculty Research Award [2016_665]; Canadian Institute of Health Research (CIHR) [FDN143227]	Natural Sciences and Engineering Research Council grant (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Google Faculty Research Award(Google Incorporated); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This review was supported by a Natural Sciences and Engineering Research Council grant (NSERC; RGPIN-2014-04947) and a 2016 Google Faculty Research Award (#2016_665) to B.A.R., and a Canadian Institute of Health Research (CIHR; FDN143227) grant to P.W.F. P.W.F. is a CIHR Canada Research Chair in Memory Research. We thank Dean Buonomano, Sheena Josselyn, and Adam Santoro for comments on earlier versions of this manuscript.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; AMARI S, 1989, NEURAL NETWORKS, V2, P451, DOI 10.1016/0893-6080(89)90043-9; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; Attardo A, 2015, NATURE, V523, P592, DOI 10.1038/nature14467; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bannerman DM, 2006, PSYCHOPHARMACOLOGY, V188, P552, DOI 10.1007/s00213-006-0403-6; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Benna MK, 2016, NAT NEUROSCI, V19, P1697, DOI 10.1038/nn.4401; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berry JA, 2015, CELL, V161, P1656, DOI 10.1016/j.cell.2015.05.027; Berry JA, 2014, PROG BRAIN RES, V208, P39, DOI 10.1016/B978-0-444-63350-7.00002-4; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brea J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003640; Buonomano, 2011, BRAIN BUGS BRAINS FL; BURGESS N, 1991, NETWORK-COMP NEURAL, V2, P399, DOI 10.1088/0954-898X/2/4/005; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CARPENTER GA, 1987, APPL OPTICS, V26, P4919, DOI 10.1364/AO.26.004919; Cervantes-Sandoval I, 2016, NEURON, V90, P1230, DOI 10.1016/j.neuron.2016.05.010; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dong T, 2016, P NATL ACAD SCI USA, V113, P7644, DOI 10.1073/pnas.1602152113; Dong ZF, 2015, J CLIN INVEST, V125, P234, DOI 10.1172/JCI77888; Dudai Y, 2005, NATURE, V434, P567, DOI 10.1038/434567a; Ebbinghaus H., 1913, MEMOTY CONTRIBUTION; Epp JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10838; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gershman SJ, 2017, ANNU REV PSYCHOL, V68, P101, DOI 10.1146/annurev-psych-122414-033625; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gould E, 1997, J NEUROSCI, V17, P2492; Graves A, 2016, NATURE, V538, P471, DOI 10.1038/nature20101; Hadziselimovic N, 2014, CELL, V156, P1153, DOI 10.1016/j.cell.2014.01.054; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hardt O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0141; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hinton G. E., 1993, P 6 ANN C COMP LEARN; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hsiang HL, 2014, J NEUROSCI, V34, P14115, DOI 10.1523/JNEUROSCI.3327-14.2014; Hunt KL, 2015, CURR BIOL, V25, P741, DOI 10.1016/j.cub.2015.01.023; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Ishikawa R, 2016, ELIFE, V5, DOI 10.7554/eLife.17464; Iuria A.R., 1968, MIND MNEMONIST LITTL; Jiang LZ, 2016, MOL NEUROBIOL, V53, P1247, DOI 10.1007/s12035-015-9093-6; Jones-Gotman M., 2012, EPILEPSY AND MEMORY, P19; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kirkpatricka J, 2017, P NATL ACAD SCI USA, V114, P3521, DOI 10.1073/pnas.1611835114; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Kumaran D, 2016, TRENDS COGN SCI, V20, P512, DOI 10.1016/j.tics.2016.05.004; LeCun Y., 1989, ADV NEURAL INF PROCE, P598; Lewandowsky Stephan, 1995, P329, DOI 10.1016/B978-012208930-5/50011-8; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Liu X, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0142; Liu YL, 2016, CURR BIOL, V26, P2351, DOI 10.1016/j.cub.2016.06.056; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Luu P, 2012, BEHAV NEUROSCI, V126, P381, DOI 10.1037/a0028252; MacKay D. J. C., 2003, INFORM THECRY INFERE; MACKAY DJC, 1992, FUND THEOR, V50, P39; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McAvoy KM, 2016, NEURON, V91, P1356, DOI 10.1016/j.neuron.2016.08.009; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCloskey M., 1989, PSYCHOL LEARNING MOT, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Migues PV, 2016, J NEUROSCI, V36, P3481, DOI 10.1523/JNEUROSCI.3333-15.2016; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Norby S, 2015, PERSPECT PSYCHOL SCI, V10, P551, DOI 10.1177/1745691615596787; O'Dell T J, 1994, Learn Mem, V1, P129; Ohkawa N, 2015, CELL REP, V11, P261, DOI 10.1016/j.celrep.2015.03.017; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Palm G, 2013, NEURAL NETWORKS, V37, P163, DOI 10.1016/j.neunet.2012.08.013; Park S, 2016, NEUROPSYCHOPHARMACOL, V41, P2987, DOI 10.1038/npp.2016.73; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Poo MM, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0261-6; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; RATCLIFF R, 1990, PSYCHOL REV, V97, P285, DOI 10.1037/0033-295X.97.2.285; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richards BA, 2014, NAT NEUROSCI, V17, P981, DOI 10.1038/nn.3736; Richards BA, 2013, HIPPOCAMPUS, V23, P207, DOI 10.1002/hipo.22089; Ritchey M, 2015, ELIFE, V4, DOI 10.7554/eLife.05025; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rogerson T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161655; Roxin A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003146; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Sachser RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22771; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Santoro A, 2016, PR MACH LEARN RES, V48; Santoro A, 2016, J NEUROSCI, V36, P12228, DOI 10.1523/JNEUROSCI.0763-16.2016; Schacter D.L., 2002, 7 SINS MEMORY MIND F; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Siegle GJ, 2002, PSYCHOL ASSESSMENT, V14, P263, DOI 10.1037//1040-3590.14.3.263; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Swan AA, 2014, HIPPOCAMPUS, V24, P1581, DOI 10.1002/hipo.22337; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tsokas P, 2016, ELIFE, V5, DOI 10.7554/eLife.14846; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wimber M, 2015, NAT NEUROSCI, V18, P582, DOI 10.1038/nn.3973; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880; Winocur G, 2012, BEHAV BRAIN RES, V227, P464, DOI 10.1016/j.bbr.2011.05.032; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	144	140	141	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2017	94	6					1071	1084		10.1016/j.neuron.2017.04.037	http://dx.doi.org/10.1016/j.neuron.2017.04.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EY2SH	28641107	Bronze			2022-12-17	WOS:000403820200007
J	Hanks, TD; Summerfield, C				Hanks, Timothy D.; Summerfield, Christopher			Perceptual Decision Making in Rodents, Monkeys, and Humans	NEURON			English	Review							LATERAL INTRAPARIETAL AREA; SPEED-ACCURACY TRADEOFF; PARIETAL CORTEX; EVIDENCE ACCUMULATION; PREFRONTAL CORTEX; CORTICAL ACTIVITY; PREMOTOR CORTEX; HUMAN BRAIN; FUNCTIONAL-SIGNIFICANCE; NEURAL COMPUTATIONS	Perceptual decision making is the process by which animals detect, discriminate, and categorize information from the senses. Over the past two decades, understanding how perceptual decisions are made has become a central theme in the neurosciences. Exceptional progress has been made by recording from single neurons in the cortex of the macaque monkey and using computational models from mathematical psychology to relate these neural data to behavior. More recently, however, the range of available techniques and paradigms has dramatically broadened, and researchers have begun to harness new approaches to explore how rodents and humans make perceptual decisions. The results have illustrated some striking convergences with findings from the monkey, but also raised new questions and provided new theoretical insights. In this review, we summarize key findings, and highlight open challenges, for understanding perceptual decision making in rodents, monkeys, and humans.	[Hanks, Timothy D.] Univ Calif Davis, Ctr Neurosci, 1554 Newton Court, Davis, CA 95618 USA; [Hanks, Timothy D.] Univ Calif Davis, Dept Neurol, 4860 Y St,Suite 3700, Sacramento, CA 95817 USA; [Summerfield, Christopher] Univ Oxford, Dept Expt Psychol, South Parks Rd, Oxford OX1 3UD, England	University of California System; University of California Davis; University of California System; University of California Davis; University of Oxford	Summerfield, C (corresponding author), Univ Oxford, Dept Expt Psychol, South Parks Rd, Oxford OX1 3UD, England.	christopher.summerfield@psy.ox.ac.uk						Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bell AH, 2016, CURR BIOL, V26, P2280, DOI 10.1016/j.cub.2016.07.007; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Boehm U, 2016, PSYCHON B REV, V23, P738, DOI 10.3758/s13423-015-0958-5; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Broadbent Donald Eric, 2013, PERCEPTION COMMUNICA; Brody CD, 2016, CURR OPIN NEUROBIOL, V37, P149, DOI 10.1016/j.conb.2016.01.003; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; Cassey P, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003700; Cheadle S, 2014, NEURON, V81, P1429, DOI 10.1016/j.neuron.2014.01.020; Chen MY, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00063; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland AK, 2016, CURR OPIN BEHAV SCI, V11, P74, DOI 10.1016/j.cobeha.2016.06.008; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; de Lange FP, 2013, J NEUROSCI, V33, P1400, DOI 10.1523/JNEUROSCI.1094-12.2013; de Lange FP, 2010, J NEUROSCI, V30, P731, DOI 10.1523/JNEUROSCI.4080-09.2010; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Deneve S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00075; Ding L, 2015, J NEUROPHYSIOL, V114, P1850, DOI 10.1152/jn.00395.2015; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Duan CA, 2015, NEURON, V86, P1491, DOI 10.1016/j.neuron.2015.05.042; Erlich JC, 2015, ELIFE, V4; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fetsch CR, 2014, COLD SH Q B, V79, P185, DOI 10.1101/sqb.2014.79.024893; Fitzgerald JK, 2013, NEURON, V77, P180, DOI 10.1016/j.neuron.2012.11.014; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Frazier PI, 2008, ADV NEURAL INFORM PR, P465; Fusi S, 2016, CURR OPIN NEUROBIOL, V37, P66, DOI 10.1016/j.conb.2016.01.010; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2008, J NEUROPHYSIOL, V100, P2653, DOI 10.1152/jn.90629.2008; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gorea A, 2014, J VISION, V14, DOI 10.1167/14.9.22; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hampton RR, 2001, P NATL ACAD SCI USA, V98, P5359, DOI 10.1073/pnas.071600998; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Hanks TD, 2014, ELIFE, V3, DOI 10.7554/eLife.02260; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Hawkins GE, 2015, J NEUROSCI, V35, P2476, DOI 10.1523/JNEUROSCI.2410-14.2015; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Heitz RP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0071; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Ho TC, 2009, J NEUROSCI, V29, P8675, DOI 10.1523/JNEUROSCI.5984-08.2009; Hubert-Wallander B, 2015, J VISION, V15, DOI 10.1167/15.4.5; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Huk AC, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00086; Hunt LT, 2014, TRENDS COGN SCI, V18, P222, DOI 10.1016/j.tics.2014.01.004; Insabato A, 2016, NEUROSCI BIOBEHAV R, V71, P167, DOI 10.1016/j.neubiorev.2016.08.030; Insabato A, 2010, J NEUROPHYSIOL, V104, P539, DOI 10.1152/jn.01068.2009; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kahneman D., 2011, THINKING; Katz LN, 2016, NATURE, V535, P285, DOI 10.1038/nature18617; Kelly SP, 2015, J PHYSIOL-PARIS, V109, P27, DOI 10.1016/j.jphysparis.2014.08.003; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2014, NEURON, V84, P1329, DOI 10.1016/j.neuron.2014.12.015; Kiani R, 2014, CURR BIOL, V24, P1542, DOI 10.1016/j.cub.2014.05.049; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; Kobak D, 2016, ELIFE, V5, DOI 10.7554/eLife.10989; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kok P, 2014, J COGNITIVE NEUROSCI, V26, P1546, DOI 10.1162/jocn_a_00562; Komura Y, 2013, NAT NEUROSCI, V16, P749, DOI 10.1038/nn.3393; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lak A, 2014, NEURON, V84, P190, DOI 10.1016/j.neuron.2014.08.039; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Licata A.M., 2016, BIORXIV; Liu TS, 2011, J NEUROPHYSIOL, V106, P2383, DOI 10.1152/jn.00413.2011; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2014, ANNU REV NEUROSCI, V37, P205, DOI 10.1146/annurev-neuro-071013-014017; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Meyniel F, 2015, NEURON, V88, P78, DOI 10.1016/j.neuron.2015.09.039; Moran R, 2015, PSYCHON B REV, V22, P38, DOI 10.3758/s13423-014-0669-3; Mulder MJ, 2014, NEUROSCIENCE, V277, P872, DOI 10.1016/j.neuroscience.2014.07.031; Mulder MJ, 2012, J NEUROSCI, V32, P2335, DOI 10.1523/JNEUROSCI.4156-11.2012; Murakami M, 2015, CURR OPIN NEUROBIOL, V33, P40, DOI 10.1016/j.conb.2015.01.005; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Philiastides MG, 2011, CURR BIOL, V21, P980, DOI 10.1016/j.cub.2011.04.034; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Poddar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083171; Pouget A, 2016, NAT NEUROSCI, V19, P366, DOI 10.1038/nn.4240; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rao V, 2012, J NEUROSCI, V32, P10063, DOI 10.1523/JNEUROSCI.5948-11.2012; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2016, TRENDS COGN SCI, V20, P260, DOI 10.1016/j.tics.2016.01.007; Renart A, 2014, CURR OPIN NEUROBIOL, V25, P211, DOI 10.1016/j.conb.2014.02.013; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Scott BB, 2015, ELIFE, V4, DOI 10.7554/eLife.11308; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shea N, 2014, TRENDS COGN SCI, V18, P186, DOI 10.1016/j.tics.2014.01.006; Siegel M, 2015, SCIENCE, V348, P1352, DOI 10.1126/science.aab0551; Simen P, 2009, J EXP PSYCHOL HUMAN, V35, P1865, DOI 10.1037/a0016926; Spitzer B, 2016, NEUROIMAGE, V129, P470, DOI 10.1016/j.neuroimage.2015.12.024; Summerfield C, 2015, TRENDS COGN SCI, V19, P27, DOI 10.1016/j.tics.2014.11.005; Summerfield C, 2014, NAT REV NEUROSCI, V15, P745, DOI 10.1038/nrn3838; Summerfield C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00070; Summerfield C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00208; Tegner J, 2002, BIOL CYBERN, V87, P471, DOI 10.1007/s00422-002-0363-9; Thura D, 2016, J NEUROSCI, V36, P938, DOI 10.1523/JNEUROSCI.2230-15.2016; Thura D, 2012, J NEUROPHYSIOL, V108, P2912, DOI 10.1152/jn.01071.2011; Tsetsos K, 2016, P NATL ACAD SCI USA, V113, P3102, DOI 10.1073/pnas.1519157113; Tsetsos K, 2012, P NATL ACAD SCI USA, V109, P9659, DOI 10.1073/pnas.1119569109; Twomey DM, 2015, EUR J NEUROSCI, V42, P1636, DOI 10.1111/ejn.12936; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; Vickers D., 1979, DECISION PROCESSES V; WALD A, 1949, P NATL ACAD SCI USA, V35, P99, DOI 10.1073/pnas.35.2.99; Wardak C, 2002, J NEUROSCI, V22, P9877; Wheeler ME, 2015, J COGNITIVE NEUROSCI, V27, P705, DOI 10.1162/jocn_a_00739; Wilke M, 2012, P NATL ACAD SCI USA, V109, P8274, DOI 10.1073/pnas.1204789109; Winkel J, 2014, PSYCHON B REV, V21, P777, DOI 10.3758/s13423-013-0551-8; Wyart V, 2016, CURR OPIN BEHAV SCI, V11, P109, DOI 10.1016/j.cobeha.2016.07.003; Wyart V, 2015, J NEUROSCI, V35, P3485, DOI 10.1523/JNEUROSCI.3276-14.2015; Wyart V, 2012, NEURON, V76, P847, DOI 10.1016/j.neuron.2012.09.015; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	152	140	141	4	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2017	93	1					15	31		10.1016/j.neuron.2016.12.003	http://dx.doi.org/10.1016/j.neuron.2016.12.003			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EO0ZR	28056343	Bronze			2022-12-17	WOS:000396427800006
J	Bichot, NP; Heard, MT; DeGennaro, EM; Desimone, R				Bichot, Narcisse P.; Heard, Matthew T.; DeGennaro, Ellen M.; Desimone, Robert			A Source for Feature-Based Attention in the Prefrontal Cortex	NEURON			English	Article							FRONTAL EYE FIELD; MACAQUE AREA V4; GUIDED VISUAL-SEARCH; NEURAL MECHANISMS; WORKING-MEMORY; NEURONAL RESPONSES; COGNITIVE CONTROL; SALIENCE MAP; MONKEY; TASK	In cluttered scenes, we can use feature-based attention to quickly locate a target object. To understand how feature attention is used to find and select objects for action, we focused on the ventral prearcuate (VPA) region of prefrontal cortex. In a visual search task, VPA cells responded selectively to search cues, maintained their feature selectivity throughout the delay and subsequent saccades, and discriminated the search target in their receptive fields with a time course earlier than in FEF or IT cortex. Inactivation of VPA impaired the animals' ability to find targets, and simultaneous recordings in FEF revealed that the effects of feature attention were eliminated while leaving the effects of spatial attention in FEF intact. Altogether, the results suggest that VPA neurons compute the locations of objects with the features sought and send this information to FEF to guide eye movements to those relevant stimuli.	[Bichot, Narcisse P.; Heard, Matthew T.; DeGennaro, Ellen M.; Desimone, Robert] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bichot, NP (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bichot@mit.edu	Desimone, Robert/G-1121-2018	DeGennaro, Ellen/0000-0001-5506-6451; Desimone, Robert/0000-0002-5938-4227	U.S. National Eye Institute [EY017921]; NSF [CCF 1317348]; NATIONAL EYE INSTITUTE [R01EY017921] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1317348] Funding Source: National Science Foundation	U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by U.S. National Eye Institute grant EY017921 and NSF grant CCF 1317348 (to R.D.).	Baldauf D, 2014, SCIENCE, V344, P424, DOI 10.1126/science.1247003; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Egner T, 2008, J NEUROSCI, V28, P6141, DOI 10.1523/JNEUROSCI.1262-08.2008; Everling S, 2006, EUR J NEUROSCI, V23, P2197, DOI 10.1111/j.1460-9568.2006.04736.x; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Gregoriou GG, 2014, NAT NEUROSCI, V17, P1003, DOI 10.1038/nn.3742; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; Ipata AE, 2012, P NATL ACAD SCI USA, V109, P16778, DOI 10.1073/pnas.1215402109; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kadohisa M, 2015, EUR J NEUROSCI, V41, P89, DOI 10.1111/ejn.12754; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McKee JL, 2014, J NEUROSCI, V34, P16065, DOI 10.1523/JNEUROSCI.1660-14.2014; Mendoza-Halliday D, 2014, NAT NEUROSCI, V17, P1255, DOI 10.1038/nn.3785; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; Monosov IE, 2010, P NATL ACAD SCI USA, V107, P13105, DOI 10.1073/pnas.1002870107; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Neubert FX, 2014, NEURON, V81, P700, DOI 10.1016/j.neuron.2013.11.012; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Pasternak T, 2015, J NEUROSCI, V35, P7095, DOI 10.1523/JNEUROSCI.5265-14.2015; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Siegel M, 2015, SCIENCE, V348, P1352, DOI 10.1126/science.aab0551; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wardak C, 2010, CEREB CORTEX, V20, P2464, DOI 10.1093/cercor/bhp315; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006; Zhou HH, 2011, NEURON, V70, P1205, DOI 10.1016/j.neuron.2011.04.032	62	140	142	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2015	88	4					832	844		10.1016/j.neuron.2015.10.001	http://dx.doi.org/10.1016/j.neuron.2015.10.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX5TR	26526392	Bronze, Green Accepted, Green Published			2022-12-17	WOS:000365765900021
J	Parvizi, J; Rangarajan, V; Shirer, WR; Desai, N; Greicius, MD				Parvizi, Josef; Rangarajan, Vinitha; Shirer, William R.; Desai, Nikita; Greicius, Michael D.			The Will to Persevere Induced by Electrical Stimulation of the Human Cingulate Gyrus	NEURON			English	Article							ALZHEIMERS-DISEASE; BRAIN NETWORKS; RHESUS-MONKEY; MR-IMAGES; CORTEX; REGISTRATION; SYSTEM; ROBUST; OPTIMIZATION; PAIN	Anterior cingulate cortex (ACC) is known to be involved in functions such as emotion, pain, and cognitive control. While studies in humans and nonhuman mammals have advanced our understanding of ACC function, the subjective correlates of ACC activity have remained largely unexplored. In the current study, we show that electrical charge delivery in the anterior midcingulate cortex (aMCC) elicits autonomic changes and the expectation of an imminent challenge coupled with a determined attitude to overcome it. Seed-based, resting-state connectivity analysis revealed that the site of stimulation in both patients was at the core of a large-scale distributed network linking aMCC to the frontoinsular and frontopolar as well as some subcortical regions. This report provides compelling, first-person accounts of electrical stimulation of this brain network and suggests its possible involvement in psychopathological conditions that are characterized by a reduced capacity to endure psychological or physical distress.	[Parvizi, Josef; Rangarajan, Vinitha; Desai, Nikita] Stanford Univ, LBCN, SHICEP, Stanford, CA 94305 USA; [Shirer, William R.; Greicius, Michael D.] Stanford Univ, Dept Neurol & Neurol Sci, Funct Imaging Neuropsychiat Disorders FIND Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Parvizi, J (corresponding author), Stanford Univ, LBCN, SHICEP, Stanford, CA 94305 USA.	jparvizi@stanford.edu			Stanford NeuroVentures Program [R01 NS078396-01, R01 N5073498]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073498, R01NS078396] Funding Source: NIH RePORTER	Stanford NeuroVentures Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients for their involvement in the study; Stanford Epilepsy Monitoring Unit staff for help with electrophysiological recordings; and Dr. Abbas Milani for his insightful comments about the ramifications of our findings. This research was funded by Stanford NeuroVentures Program, R01 NS078396-01 to J.P., and R01 N5073498 to M.D.G.	Andersson J.L.R., 2007, TR07A1 FMRIB; Andersson J.L.R., 2007, TR07JA2 FMRIB; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Critchley HD, 2000, J NEUROSCI, V20, P3033; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Richter EO, 2004, NEUROSURGERY, V54, P622, DOI 10.1227/01.NEU.0000108644.42992.95; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selimbeyoglu A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00046; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shakespeare W., 1992, TRAGEDY HAMLET PRINC; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sheth SA, 2013, J NEUROSURG, V118, P491, DOI 10.3171/2012.11.JNS12389; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; TALAIRAC.J, 1973, ELECTROEN CLIN NEURO, V34, P45, DOI 10.1016/0013-4694(73)90149-1; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; Van Hoesen GW, 1996, NEUROPSYCHIATRY, P113; Vogt B. A., 2004, RAT NERVOUS SYSTEM, P705; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	34	140	141	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2013	80	6					1359	1367		10.1016/j.neuron.2013.10.057	http://dx.doi.org/10.1016/j.neuron.2013.10.057			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	278VY	24316296	Bronze, Green Accepted			2022-12-17	WOS:000328919200006
J	Wang, Z; Chen, LM; Negyessy, L; Friedman, RM; Mishra, A; Gore, JC; Roe, AW				Wang, Zheng; Chen, Li Min; Negyessy, Laszlo; Friedman, Robert M.; Mishra, Arabinda; Gore, John C.; Roe, Anna W.			The Relationship of Anatomical and Functional Connectivity to Resting-State Connectivity in Primate Somatosensory Cortex	NEURON			English	Article							HUMAN BRAIN; STRUCTURAL CONNECTIVITY; MONKEYS; ORGANIZATION; RESPONSES; AREAS; V2; REPRESENTATION; ARCHITECTURE; SPECIFICITY	Studies of resting-state activity in the brain have provoked critical questions about the brain's functional organization, but the biological basis of this activity is not clear. Specifically, the relationships between interregional correlations in resting-state measures of activity, neuronal functional connectivity and anatomical connectivity are much debated. To investigate these relationships, we have examined both anatomical and steady-state functional connectivity within the hand representation of primary somatosensory cortex (areas 3b and 1) in anesthetized squirrel monkeys. The comparison of three data sets (fMRI, electrophysiological, and anatomical) indicate two primary axes of information flow within the SI: prominent interdigit interactions within area 3b and predominantly homotopic interactions between area 3b and area 1. These data support a strikingly close relationship between baseline functional connectivity and anatomical connections. This study extends findings derived from large-scale cortical networks to the realm of local millimeter-scale networks.	[Wang, Zheng; Friedman, Robert M.; Roe, Anna W.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37232 USA; [Chen, Li Min; Mishra, Arabinda; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA; [Negyessy, Laszlo] Hungarian Acad Sci, Wigner Res Ctr Phys, Dept Theory, H-1051 Budapest, Hungary; [Negyessy, Laszlo] Semmelweis Univ, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Chen, Li Min; Mishra, Arabinda; Gore, John C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Semmelweis University; Vanderbilt University	Gore, JC (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA.	john.gore@vanderbilt.edu; anna.roe@vanderbilt.edu	Wang, Zheng/GRE-7739-2022; Négyessy, László/G-6283-2019; Chen, Li Min/C-3554-2011	Négyessy, László/0000-0002-4369-0406; Roe, Anna Wang/0000-0003-4146-9705; Wang, Zheng/0000-0001-5943-344X; Wang, Zheng/0000-0001-7138-8581	FIRCA [NS059061]; NIH [NS044375, NS069909, NS078680]; Dana Foundation; Vanderbilt Core Grant [P30EY008126]; Hungarian Scientific Research Fund OTKA [NN79366]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS059061, R01NS044375, R01NS078680, R01NS069909, R56NS044375, R21NS081437] Funding Source: NIH RePORTER	FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Vanderbilt Core Grant; Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from FIRCA (NS059061 to A.W.R.) and NIH (NS044375 to A.W.R., NS069909 to L.M.C., and NS078680 to J.C.G.), and the Dana Foundation (to L.M.C.), a Vanderbilt Core Grant (P30EY008126), and the Hungarian Scientific Research Fund OTKA NN79366 (L.N.). The technical assistance of Chang Cu, Yan Yan Chu, and Alyssa Zuehl is highly appreciated. We thank Maria Ashaber, Emese Palfi, and Cory Palmer for help with anatomical data analyses, Hui-Xin Qi for assistance in some electrophysiology mapping experiments, and Baxter Rogers for guidance with fMRI analysis.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Brody CD, 1999, NEURAL COMPUT, V11, P1527, DOI 10.1162/089976699300016124; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friedman RM, 2004, P NATL ACAD SCI USA, V101, P12724, DOI 10.1073/pnas.0404884101; Friedman RM, 2008, J NEUROPHYSIOL, V100, P3185, DOI 10.1152/jn.90278.2008; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; Hung C. P., 2010, DYNAMIC BRAIN EXPLOR, P83; Hung CP, 2007, NAT NEUROSCI, V10, P1185, DOI 10.1038/nn1948; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kaskan PM, 2009, CEREB CORTEX, V19, P1394, DOI 10.1093/cercor/bhn178; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Lipton ML, 2010, J NEUROSCI, V30, P15895, DOI 10.1523/JNEUROSCI.4765-09.2010; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P2830; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Manger PR, 1997, J NEUROSCI, V17, P6338; Matsui T, 2011, CEREB CORTEX, V21, P2348, DOI 10.1093/cercor/bhr019; Negyessy L, 2013, J COMP NEUROL, V521, P2798, DOI 10.1002/cne.23317; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reed JL, 2008, P NATL ACAD SCI USA, V105, P10233, DOI 10.1073/pnas.0803800105; Roe AW, 1999, J NEUROPHYSIOL, V82, P2719, DOI 10.1152/jn.1999.82.5.2719; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; TSO DY, 1988, J NEUROSCI, V8, P1712; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758	47	140	142	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					1116	1126		10.1016/j.neuron.2013.04.023	http://dx.doi.org/10.1016/j.neuron.2013.04.023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791200	Bronze, Green Accepted			2022-12-17	WOS:000321026900016
J	Ince-Dunn, G; Okano, HJ; Jensen, KB; Park, WY; Zhong, R; Ule, J; Mele, A; Fak, JJ; Yang, CW; Zhang, CL; Yoo, J; Herre, M; Okano, H; Noebels, JL; Darnell, RB				Ince-Dunn, Gulayse; Okano, Hirotaka J.; Jensen, Kirk B.; Park, Woong-Yang; Zhong, Ru; Ule, Jernej; Mele, Aldo; Fak, John J.; Yang, ChingWen; Zhang, Chaolin; Yoo, Jong; Herre, Margaret; Okano, Hideyuki; Noebels, Jeffrey L.; Darnell, Robert B.			Neuronal Elav-like (Hu) Proteins Regulate RNA Splicing and Abundance to Control Glutamate Levels and Neuronal Excitability	NEURON			English	Article							PRE-MESSENGER-RNA; GENOME-WIDE IDENTIFICATION; BINDING PROTEINS; GENERATION; EXPRESSION; REVEALS; TARGETS; BRAIN; TRANSCRIPTOME; INCLUSION	The paraneoplastic neurologic disorders target several families of neuron-specific RNA binding proteins (RNABPs), revealing that there are unique aspects of gene expression regulation in the mammalian brain. Here, we used HITS-CLIP to determine robust binding sites targeted by the neuronal Elav-like (nElavl) RNABPs. Surprisingly, nElav protein binds preferentially to GU-rich sequences in vivo and in vitro, with secondary binding to AU-rich sequences. nElavl null mice were used to validate the consequence of these binding events in the brain, demonstrating that they bind intronic sequences in a position dependent manner to regulate alternative splicing and to 3'UTR sequences to regulate mRNA levels. These controls converge on the glutamate synthesis pathway in neurons; nElavl proteins are required to maintain neurotransmitter glutamate levels, and the lack of nElavl leads to spontaneous epileptic seizure activity. The genome-wide analysis of nElavl targets reveals that one function of neuron-specific RNABPs is to control excitation-inhibition balance in the brain.	[Ince-Dunn, Gulayse; Park, Woong-Yang; Zhong, Ru; Ule, Jernej; Mele, Aldo; Fak, John J.; Yang, ChingWen; Zhang, Chaolin; Herre, Margaret; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10021 USA; [Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Okano, Hirotaka J.; Okano, Hideyuki] Keio Univ, Sch Med, Tokyo 1058461, Japan; [Yoo, Jong; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Yoo, Jong; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Yoo, Jong; Noebels, Jeffrey L.] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Keio University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Darnell, RB (corresponding author), Rockefeller Univ, Lab Mol Neurooncol, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Okano, Hideyuki/I-7584-2019; Ule, Jernej/C-6315-2013; Darnell, Robert B/B-9022-2008; Jensen, Kirk/B-4756-2008; Jensen, Kirk/AAL-5883-2020	Ule, Jernej/0000-0002-2452-4277; Darnell, Robert B/0000-0002-5134-8088; Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; Park, Woong-Yang/0000-0003-4234-0380; Okano, Hirotaka James/0000-0003-4611-7098; Ince Dunn, Gulayse/0000-0003-1352-990X; Noebels, Jeffrey/0000-0002-2887-0839	GI-D (Rockefeller University, Women and Science Postdoctoral Fellowship); NINDS NS [29709]; IDDRC [HD24064]; Rockefeller University Hospital CTSA [UL1 RR024143];  [K99GM95713];  [NS34389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM095713, R00GM095713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R56NS034389, R01NS081706, R01NS029709] Funding Source: NIH RePORTER; Medical Research Council [MC_U105185858] Funding Source: researchfish; MRC [MC_U105185858] Funding Source: UKRI	GI-D (Rockefeller University, Women and Science Postdoctoral Fellowship); NINDS NS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); IDDRC; Rockefeller University Hospital CTSA; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Darnell laboratory for advice and suggestions throughout the course of this work, Melis Kayikci for ASPIRE2 Analysis and Norman Curthoys for the glutaminase antibody. We are grateful to sources of support to GI-D (Rockefeller University, Women and Science Postdoctoral Fellowship), J.L.N. (NINDS NS 29709 and IDDRC HD24064), C.Z. (K99GM95713), R.B.D. (NS34389) and the Rockefeller University Hospital CTSA (UL1 RR024143). R.B.D. is an HHMI Investigator.	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Calarco JA, 2011, RNA, V17, P775, DOI 10.1261/rna.2603911; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ibrahim H, 2008, KIDNEY INT, V73, P11, DOI 10.1038/sj.ki.5002581; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Koushika SP, 2000, MOL CELL BIOL, V20, P1836, DOI 10.1128/MCB.20.5.1836-1845.2000; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Okano HJ, 1997, J NEUROSCI, V17, P3024; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Soller M, 2005, MOL CELL BIOL, V25, P7580, DOI 10.1128/MCB.25.17.7580-7591.2005; Soller M, 2003, GENE DEV, V17, P2526, DOI 10.1101/gad.1106703; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HW, 2010, NUCLEIC ACIDS RES, V38, P3760, DOI 10.1093/nar/gkq028; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07	57	140	142	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2012	75	6					1067	1080		10.1016/j.neuron.2012.07.009	http://dx.doi.org/10.1016/j.neuron.2012.07.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011XF	22998874	Bronze, Green Accepted			2022-12-17	WOS:000309198900017
J	van Versendaal, D; Rajendran, R; Saiepour, MH; Klooster, J; Smit-Rigter, L; Sommeijer, JP; De Zeeuw, CI; Hofer, SB; Heimel, JA; Levelt, CN				van Versendaal, Danielle; Rajendran, Rajeev; Saiepour, M. Hadi; Klooster, Jan; Smit-Rigter, Laura; Sommeijer, Jean-Pierre; De Zeeuw, Chris I.; Hofer, Sonja B.; Heimel, J. Alexander; Levelt, Christiaan N.			Elimination of Inhibitory Synapses Is a Major Component of Adult Ocular Dominance Plasticity	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; GABA(A) RECEPTOR SUBTYPES; MONKEY STRIATE CORTEX; MOUSE VISUAL-CORTEX; DENDRITIC SPINES; IN-VIVO; GABAERGIC SYNAPSES; QUANTITATIVE DISTRIBUTION; INTRACORTICAL INHIBITION; CORTICAL-NEURONS	During development, cortical plasticity is associated with the rearrangement of excitatory connections. While these connections become more stable with age, plasticity can still be induced in the adult cortex. Here we provide evidence that structural plasticity of inhibitory synapses onto pyramidal neurons is a major component of plasticity in the adult neocortex. In vivo two-photon imaging was used to monitor the formation and elimination of fluorescently labeled inhibitory structures on pyramidal neurons. We find that ocular dominance plasticity in the adult visual cortex is associated with rapid inhibitory synapse loss, especially of those present on dendritic spines. This occurs not only with monocular deprivation but also with subsequent restoration of binocular vision. We propose that in the adult visual cortex the experience-induced loss of inhibition may effectively strengthen specific visual inputs with limited need for rearranging the excitatory circuitry.	[van Versendaal, Danielle; Rajendran, Rajeev; Saiepour, M. Hadi; Smit-Rigter, Laura; Sommeijer, Jean-Pierre; Heimel, J. Alexander; Levelt, Christiaan N.] Netherlands Inst Neurosci, Dept Mol Visual Plast, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [Klooster, Jan] Netherlands Inst Neurosci, Dept Retinal Signal Proc, NL-1105 BA Amsterdam, Netherlands; [De Zeeuw, Chris I.] Netherlands Inst Neurosci, Dept Cerebellar Coordinat & Cognit, NL-1105 BA Amsterdam, Netherlands; [De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; [Hofer, Sonja B.] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Max Planck Society	Levelt, CN (corresponding author), Netherlands Inst Neurosci, Dept Mol Visual Plast, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	c.levelt@nin.knaw.nl	Heimel, J.Alexander/F-5782-2012	Heimel, J.Alexander/0000-0002-5291-4184	AgentschapNL; Netherlands Organization for Scientific Research (NWO); European Community [223326]; Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); AgentschapNL (NeuroBasic PharmaPhenomics); Prinses Beatrix Fonds; EU	AgentschapNL; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); AgentschapNL (NeuroBasic PharmaPhenomics); Prinses Beatrix Fonds; EU(European Commission)	C.N.L. is funded by a grant from AgentschapNL to the NeuroBasic PharmaPhenomics consortium and by the Netherlands Organization for Scientific Research (NWO) and AgentschapNL. This research was made possible through funding from the European Community's Seventh Framework Programme (FP2007-2013) under grant agreement no 223326. J.A.H. is funded by a Vidi grant from NWO. C.I.D.Z. is funded by the Dutch Organization for Medical Sciences (ZonMw), Life Sciences (ALW), AgentschapNL (NeuroBasic PharmaPhenomics), Prinses Beatrix Fonds, and EU (CEREBNET, C7, and ERCadv). We thank Dr. Gunther Schwarz for providing the GFP-gephyrin P1 plasmid, Dr. Thomas Sudhof for the Syt2 antibody, and Elize Haasdijk, Emma Ruimschotel and Paul Feyen for technical assistance.	Antonini A, 1999, J NEUROSCI, V19, P4388; Antonini A, 1996, J COMP NEUROL, V369, P64; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; GRAY EG, 1959, J ANAT, V93, P420; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Harvey Alan R., 2009, V515, P63, DOI 10.1007/978-1-59745-559-6_5; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jones E G, 1998, Adv Neurol, V77, P49; JONES EG, 1969, J CELL SCI, V5, P509; Jones EG., 1998, ADV NEUROL, V77, P72; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Ovtscharoff W, 2006, BRAIN RES, V1116, P58, DOI 10.1016/j.brainres.2006.07.106; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sassoe-Pognetto M, 1999, ANN NY ACAD SCI, V868, P693, DOI 10.1111/j.1749-6632.1999.tb11348.x; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; van Rijnsoever C, 2005, EUR J NEUROSCI, V21, P327, DOI 10.1111/j.1460-9568.2005.03884.x; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	48	140	141	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 26	2012	74	2					374	383		10.1016/j.neuron.2012.03.015	http://dx.doi.org/10.1016/j.neuron.2012.03.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	933LA	22542189	Bronze			2022-12-17	WOS:000303361800017
J	Kawano, T; Po, MD; Gao, SB; Leung, G; Ryu, WS; Zhen, M				Kawano, Taizo; Po, Michelle D.; Gao, Shangbang; Leung, George; Ryu, William S.; Zhen, Mei			An Imbalancing Act: Gap Junctions Reduce the Backward Motor Circuit Activity to Bias C. elegans for Forward Locomotion	NEURON			English	Article							BEHAVING CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; EXCITABLE CELLS; NERVOUS-SYSTEM; NEURONS; INTERNEURONS; PROTEINS; CHANNEL; SYNAPSE; WALKING	A neural network can sustain and switch between different activity patterns to execute multiple behaviors. By monitoring the decision making for directional locomotion through motor circuit calcium imaging in behaving Caenorhabditis elegans (C. elegans), we reveal that C. elegans determines the directionality of movements by establishing an imbalanced output between the forward and backward motor circuits and that it alters directions by switching between these imbalanced states. We further demonstrate that premotor interneurons modulate endogenous motoneuron activity to establish the output imbalance. Specifically, the UNC-7 and UNC-9 innexin-dependent premotor interneuron-motoneuron coupling prevents a balanced output state that leads to movements without directionality. Moreover, they act as shunts to decrease the backward-circuit activity, establishing a persistent bias for the high forward-circuit output state that results in the inherent preference of C. elegans for forward locomotion. This study demonstrates that imbalanced motoneuron activity underlies directional movement and establishes gap junctions as critical modulators of the properties and outputs of neural circuits.	[Kawano, Taizo; Po, Michelle D.; Gao, Shangbang; Zhen, Mei] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Po, Michelle D.; Zhen, Mei] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Leung, George] Chinese Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Ryu, William S.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Ryu, William S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Chinese University of Hong Kong; University of Toronto; University of Toronto	Zhen, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	zhen@lunenfeld.ca	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Gao, Shangbang/0000-0001-5431-4628	Natural Sciences and Engineering Research Council of Canada; EJLB foundation; Canadian Institute of Health Research; Samuel Lunenfeld Research Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); EJLB foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Samuel Lunenfeld Research Institute	We thank H. Li and Y. Wang for technical support; A.V. Maricq for akls11, Z.W. Wang for UNC-9 antisera, C. Bergmann for tetanus toxin cDNA, S. Lockery for exchanging unpublished results, and M. Zhang and H. Suzuki for advice on calcium imaging. We are in debt to L. Avery, C. Bargmann, J.-L. Bessereau, J. Culotti, C.-Y. Ho, A. Kania, J. Richmond, Q. Wen, J. Woodgett, and anonymous reviewers for critical reading and comments on this manuscript. M. Po was a recipient of a Natural Sciences and Engineering Research Council of Canada scholarship. We thank the EJLB foundation, the Canadian Institute of Health Research and the Samuel Lunenfeld Research Institute for supporting this project.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Barnes TM, 1997, J NEUROCHEM, V69, P2251; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; GIAUME C, 1983, SCIENCE, V220, P84, DOI 10.1126/science.6298940; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kunkel MT, 2000, J NEUROSCI, V20, P7517; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Rela L, 2004, MOL NEUROBIOL, V30, P341, DOI 10.1385/MN:30:3:341; STARICH TA, 1993, GENETICS, V133, P527; Starich TA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-16; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wicks SR, 1996, J NEUROSCI, V16, P4017; Yeh E, 2009, J NEUROSCI, V29, P5207, DOI 10.1523/JNEUROSCI.0637-09.2009; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	34	140	143	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 17	2011	72	4					572	586		10.1016/j.neuron.2011.09.005	http://dx.doi.org/10.1016/j.neuron.2011.09.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	850FI	22099460	Bronze			2022-12-17	WOS:000297180100009
J	Giocomo, LM; Moser, MB; Moser, EI				Giocomo, Lisa M.; Moser, May-Britt; Moser, Edvard I.			Computational Models of Grid Cells	NEURON			English	Review							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL PLACE CELLS; MEMBRANE-POTENTIAL OSCILLATIONS; SPATIAL REPRESENTATION SYSTEM; PATH-INTEGRATION; HEAD-DIRECTION; STELLATE CELLS; LAYER-II; SUBTHRESHOLD OSCILLATIONS; AFTER-HYPERPOLARIZATION	Grid cells are space-modulated neurons with periodic firing fields. In moving animals, the multiple firing fields of an individual grid cell form a triangular pattern tiling the entire space available to the animal. Collectively, grid cells are thought to provide a context-independent metric representation of the local environment. Since the discovery of grid cells in 2005, a number of models have been proposed to explain the formation of spatially repetitive firing patterns as well as the conversion of these signals to place signals one synapse downstream in the hippocampus. The present article reviews the most recent developments in our understanding of how grid patterns are generated, maintained, and transformed, with particular emphasis on second-generation computational models that have emerged during the past 2-3 years in response to criticism and new data.	[Giocomo, Lisa M.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7030 Trondheim, Norway; [Giocomo, Lisa M.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, Med Tech Res Ctr, N-7030 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Giocomo, LM (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7030 Trondheim, Norway.	giocomo@gmail.com; edvard.moser@ntnu.no		Giocomo, Lisa/0000-0003-0416-2528	Marie Curie Fellowship; Kavli Foundation; Research Council of Norway	Marie Curie Fellowship(European Commission); Kavli Foundation; Research Council of Norway(Research Council of Norway)	We thank M.E. Hasselmo, E. Kropff, T. Solstad, and E.A. Zilli for helpful discussions. This work was supported by a Marie Curie Fellowship, the Kavli Foundation, and a Centre of Excellence grant from the Research Council of Norway.	ALONSO A, 1989, PHYS REV A, V342, P1007; AMIT DJ, 1987, PHYS REV A, V35, P2293, DOI 10.1103/PhysRevA.35.2293; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Blair HT, 2008, HIPPOCAMPUS, V18, P1239, DOI 10.1002/hipo.20509; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Boehlen A, 2010, J NEUROSCI, V30, P4585, DOI 10.1523/JNEUROSCI.4939-09.2010; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burak Y, 2006, J NEUROSCI, V26, P9352, DOI 10.1523/JNEUROSCI.2857-06.2006; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; de Almeida L, 2012, HIPPOCAMPUS, V22, P200, DOI 10.1002/hipo.20882; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Giocomo L.M., 2011, CELL IN PRESS, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Giocomo LM, 2008, HIPPOCAMPUS, V18, P1186, DOI 10.1002/hipo.20501; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; McNaughton BL, 1996, J EXP BIOL, V199, P173; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MHATRE H, 2010, HIPPOCAMPUS IN PRESS; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; MULLER RU, 1991, SPATIAL FIRING CORRE; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; RANCK JB, 1985, HEAD DIRECTION CELLS; RECHT M, 1988, 13 VERT PEST C; Redish AD, 1997, HIPPOCAMPUS, V7, P15; REDISH AD, 1999, BEYONG COGNITIVE MAP; Remme MWH, 2010, NEURON, V66, P429, DOI 10.1016/j.neuron.2010.04.027; Remme MWH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000493; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Russell JC, 2005, NATURE, V437, P1107, DOI 10.1038/4371107a; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Sharp PE, 1996, HIPPOCAMPUS, V6, P720, DOI 10.1002/(SICI)1098-1063(1996)6:6<720::AID-HIPO14>3.0.CO;2-2; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Skaggs W. E., 1995, ADV NEURAL INFORM PR, P130; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SPENCE KW, 1940, PSYCHOL BULL, V37, P429; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; SUN H, 1994, NEURAL NETWORKS, V6, P3883; TAMAMAKI N, 1995, J COMP NEUROL, V353, P379, DOI 10.1002/cne.903530306; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; Tolman E.C., 1930, PUBLICATIONS PSYCHOL, V4, P257; TOLMAN EC, 1946, J EXP PSYCHOL, V36, P221, DOI 10.1037/h0060262; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; TOLMAN EC, 1946, J EXP PSYCHOL, V36, P13, DOI 10.1037/h0053944; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; Van Cauter T, 2008, EUR J NEUROSCI, V27, P1933, DOI 10.1111/j.1460-9568.2008.06158.x; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; WITTER MP, 2004, IPPOCAMPAL FORMATION; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; YOGANARASIMHA D, 2010, HIPPOCAMPUS IN PRESS; YOSHIDA M, 2011, J NEUROSCI IN PRESS; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zhang K, 1996, J NEUROSCI, V16, P2112; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010; Zilli EA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000573	126	140	146	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					589	603		10.1016/j.neuron.2011.07.023	http://dx.doi.org/10.1016/j.neuron.2011.07.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867877	Bronze			2022-12-17	WOS:000294521600006
J	Marsh, JL; Thompson, LM				Marsh, J. Lawrence; Thompson, Leslie Michels			Drosophila in the study of neurodegenerative disease	NEURON			English	Review							BLOOD-BRAIN-BARRIER; AXONAL-TRANSPORT; DEPENDENT NEURODEGENERATION; MEDIATES NEURODEGENERATION; POLYGLUTAMINE AGGREGATION; MITOCHONDRIAL PATHOLOGY; PARKINSONS-DISEASE; REDUCES TOXICITY; GENE-EXPRESSION; NERVOUS-SYSTEM	As populations benefit from increasing lifespans, neurodegenerative diseases have emerged as a critical health concern. How can the fruit fly, Drosophila melanogaster, contribute to curing human diseases of the nervous system? A growing number of neurodegenerative diseases, as well as other human diseases, are being modeled in Drosophila and used as a platform to identify and validate cellular pathways that contribute to neurodegeneration and to identify promising therapeutic targets by using a variety of approaches from screens to target validation. The unique properties and tools available in the Drosophila system, coupled with the fact that testing in vivo has proven highly productive, have accelerated the progress of testing therapeutic strategies in mice and, ultimately, humans. This review highlights selected recent applications to illustrate the use of Drosophila in studying neurodegenerative diseases.	Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Gillespie 2121, Irvine, CA 92697 USA.	lmthomps@uci.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045283] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36081] Funding Source: Medline; NINDS NIH HHS [NS045283] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bhandari P, 2001, ONCOGENE, V20, P6871, DOI 10.1038/sj.onc.1204849; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Daneman R, 2005, CELL, V123, P9, DOI 10.1016/j.cell.2005.09.017; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Furutani T, 2005, J PHARMACOL EXP THER, V315, P545, DOI 10.1124/jpet.105.087643; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Grens A, 1995, DEVELOPMENT, V121, P4027; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Hidalgo A, 2006, BRAIN BEHAV EVOLUT, V68, P173, DOI 10.1159/000094086; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; LANE NJ, 1978, DEV BIOL, V62, P415, DOI 10.1016/0012-1606(78)90225-7; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Lush MJ, 1998, BIOCHEM J, V332, P1; MARSH JL, 1986, GENETICS, V112, P249; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; ROTHBACHER U, 1995, DEV BIOL, V170, P717, DOI 10.1006/dbio.1995.1249; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Seidner GA, 2006, CURR BIOL, V16, P1026, DOI 10.1016/j.cub.2006.04.004; Shulman JM, 2003, GENETICS, V165, P1233; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Thoreen CC, 2004, NAT GENET, V36, P553, DOI 10.1038/ng0604-553; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	85	140	145	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					169	178		10.1016/j.neuron.2006.09.025	http://dx.doi.org/10.1016/j.neuron.2006.09.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015234	Green Submitted, Bronze			2022-12-17	WOS:000241408100012
J	Kenchappa, RS; Zampieri, N; Chao, MV; Barker, PA; Teng, HK; Hempstead, BL; Carter, BD				Kenchappa, RS; Zampieri, N; Chao, MV; Barker, PA; Teng, HK; Hempstead, BL; Carter, BD			Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE CLEAVAGE; NECROSIS-FACTOR-ALPHA; ZINC-FINGER PROTEIN; CELL-DEATH; P75-MEDIATED DEATH; NOGO RECEPTOR; IN-VITRO	The p75 neurotrophin receptor regulates neuronal survival, promoting it in some contexts yet activating apoptosis in others. The mechanism by which the receptor elicits these differential effects is poorly understood. Here, we demonstrate that p75 is cleaved by gamma-secretase in sympathetic neurons, specifically in response to proapoptotic ligands. This cleavage resulted in ubiquitination and subsequent nuclear translocation of NRIF, a DNA binding protein essential for p75-mediated apoptosis. Inhibition of gamma-secretase or expression of a mutant p75 resistant to this protease prevented receptor proteolysis, blocked NRIF nuclear entry, and prevented apoptosis. In contrast, overexpression of the p75 ICD resulted in NRIF nuclear accumulation and apoptosis. The receptor proteolysis and NRIF nuclear localization were also observed in vivo during naturally occurring cell death in the superior cervical ganglia. These results indicate that p75-mediated apoptosis requires gamma-secretase dependent release of its ICD, which facilitates nuclear translocation of NRIF.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; McGill Univ, Inst Neurol, Montreal, PQ H3A 2B4, Canada; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Vanderbilt University; Vanderbilt University; New York University; New York University; McGill University; Cornell University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu		Zampieri, Niccolo/0000-0002-2228-9453; Chao, Moses/0000-0002-6969-3744	NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS38220, NS21072, NS30658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220, R01NS021072] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barde YA, 2004, P NATL ACAD SCI USA, V101, P5703, DOI 10.1073/pnas.0401374101; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Berezovska O, 2000, ANN NY ACAD SCI, V920, P223; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; DISTEFANO PS, 1990, BRAIN RES, V534, P340, DOI 10.1016/0006-8993(90)90154-4; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frade JM, 1996, NATURE, V383, P166; Frankowski H, 2002, NEUROMOL MED, V1, P153; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	68	140	143	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					219	232		10.1016/j.neuron.2006.03.011	http://dx.doi.org/10.1016/j.neuron.2006.03.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630834	Bronze			2022-12-17	WOS:000237176700010
J	Murakami, M; Kashiwadani, H; Kirino, Y; Mori, K				Murakami, M; Kashiwadani, H; Kirino, Y; Mori, K			State-dependent sensory gating in olfactory cortex	NEURON			English	Article							BASAL FOREBRAIN NEURONS; BRAIN-STEM; ODOR MAPS; THALAMOCORTICAL NEURONS; PIRIFORM CORTEX; SLEEP; STIMULATION; OSCILLATION; RESPONSES; THALAMUS	Sensory systems show behavioral state-dependent gating of information flow that largely depends on the thalamus. Here we examined whether the statedependent gating occurs in the central olfactory pathway that lacks a thalamic relay. In urethane-anesthetized rats, neocortical EEG showed a periodical alternation between two states: a slow-wave state (SWS) characterized by large and slow waves and a fast-wave state (FWS) characterized by faster waves. Single-unit recordings from olfactory cortex neurons showed robust spike responses to adequate odorants during FWS, whereas they showed only weak responses during SWS. The state-dependent change in odorant-evoked responses was observed in a majority of olfactory cortex neurons, but in only a small percentage of olfactory bulb neurons. These findings demonstrate a powerful state-dependent gating of odor information in the olfactory cortex that works in synchrony with the gating of other sensory systems. They suggest a state-dependent switchover of signal processing modes in the olfactory cortex.	Univ Tokyo, Dept Physiol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Mori, K (corresponding author), Univ Tokyo, Dept Physiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moriken@m.u-tokyo.ac.jp	Kashiwadani, Hideki/R-3404-2019; Murakami, Masayoshi/AAM-8778-2020	Mori, Kensaku/0000-0001-7853-9370; MURAKAMI, MASAYOSHI/0000-0001-5511-1144				Balatoni B, 2003, BRAIN RES, V959, P304, DOI 10.1016/S0006-8993(02)03768-X; Carskadon MA, 2004, SLEEP, V27, P402; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; Detari L, 1997, EUR J NEUROSCI, V9, P1153, DOI 10.1111/j.1460-9568.1997.tb01469.x; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; ELMANSARI M, 1989, EXP BRAIN RES, V76, P519, DOI 10.1007/BF00248908; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1222, DOI 10.1152/jn.1992.67.5.1222; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; Igarashi KM, 2005, J NEUROPHYSIOL, V93, P1007, DOI 10.1152/jn.00873.2004; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; KETCHUM KL, 1993, J NEUROPHYSIOL, V69, P248, DOI 10.1152/jn.1993.69.1.248; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Manns ID, 2000, J NEUROSCI, V20, P1505; MARIOTTI M, 1989, NEUROSCI LETT, V102, P70, DOI 10.1016/0304-3940(89)90309-1; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RASMUSSON DD, 1994, NEUROSCIENCE, V60, P665, DOI 10.1016/0306-4522(94)90495-2; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1997, THALAMUS, P536; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	47	140	142	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					285	296		10.1016/j.neuron.2005.02.025	http://dx.doi.org/10.1016/j.neuron.2005.02.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848806	Bronze			2022-12-17	WOS:000228674800014
J	Wang, J; Ma, XJ; Yang, JS; Zheng, XY; Zugates, CT; Lee, CHJ; Lee, T				Wang, J; Ma, XJ; Yang, JS; Zheng, XY; Zugates, CT; Lee, CHJ; Lee, T			Transmembrane/juxtamembrane domain-dependent Dscam distribution and function during mushroom body neuronal morphogenesis	NEURON			English	Article							REPRESSIBLE CELL MARKER; DROSOPHILA DSCAM; MOSAIC ANALYSIS; AXON GUIDANCE; BODIES; RECEPTOR; NEUROBLAST; EXPRESSION; CHANNELS; ROLES	Besides 19,008 possible ectodomains, Drosophila Dscam contains two alternative transmembrane/juxtamembrane segments, respectively, derived from exon 17.1 and exon 17.2. We wondered whether specific Dscam isoforms mediate formation and segregation of axonal branches in the Drosophila mushroom bodies (MBs). Removal of various subsets of the 12 exon 4s does not affect MB neuronal morphogenesis, while expression of a Dscam transgene only partially rescues Dscam mutant phenotypes. Interestingly, differential rescuing effects are observed between two Dscam transgenes that each possesses one of the two possible exon 17s. Axon bifurcation/segregation abnormalities are better rescued by the exon 17.2-containing transgene, but coexpression of both transgenes is required for rescuing mutant viability. Meanwhile, exon 17.1 targets ectopically expressed Dscam-GFP to dendrites while Dscam[exon 17.2]-GFP is enriched in axons; only Dscam[exon 17.2] affects MB axons. These results suggest that exon 17.1 is minimally involved in axonal morphogenesis and that morphogenesis of MB axons probably involves multiple distinct exon 17.2-containing Dscam isoforms.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Hematol Oncol Sect, Dept Internal Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.	tzumin@life.uiuc.edu	Yang, Shun-Jen/G-2968-2015; Zheng, Xiaoyan/AAG-1251-2020	Zheng, Xiaoyan/0000-0003-4983-5503; Zugates, Christopher/0000-0003-1882-3665				Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Celotto AM, 2001, GENETICS, V159, P599; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Noveen A, 2000, DEVELOPMENT, V127, P3475; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; YANG MY, 1995, NEURON, V15, P45; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	24	140	141	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					663	672		10.1016/j.neuron.2004.06.033	http://dx.doi.org/10.1016/j.neuron.2004.06.033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339648	Bronze			2022-12-17	WOS:000223691900012
J	Sopher, BL; Thomas, PS; LaFevre-Bernt, MA; Holm, IE; Wilke, SA; Ware, CB; Jin, LW; Libby, RT; Ellerby, LM; La Spada, AR				Sopher, BL; Thomas, PS; LaFevre-Bernt, MA; Holm, IE; Wilke, SA; Ware, CB; Jin, LW; Libby, RT; Ellerby, LM; La Spada, AR			Androgen receptor YAC Transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration	NEURON			English	Article							BULBAR MUSCULAR-ATROPHY; CREB-BINDING PROTEIN; MOUSE MODEL; CAG-REPEAT; TRINUCLEOTIDE REPEAT; HETEROZYGOUS FEMALES; HUNTINGTONS-DISEASE; STRUCTURAL BASIS; CELL-DEATH; LATE-ONSET	X-linked spinal and bulbar muscular atrophy (SBMA) is an inherited neuromuscular disorder characterized by lower motor neuron degeneration. SBMA is caused by polyglutamine repeat expansions in the androgen receptor (AR). To determine the basis of AR polyglutamine neurotoxicity, we introduced human AR yeast artificial chromosomes carrying either 20 or 100 CAGs into mouse embryonic stem cells. The AR100 transgenic mice developed a late-onset, gradually progressive neuromuscular phenotype accompanied by motor neuron degeneration, indicating striking recapitulation of the human disease. We then tested the hypothesis that polyglutamine-expanded AR interferes with CREB binding protein (CBP)-mediated transcription of vascular endothelial growth factor (VEGF) and observed altered CBP-AR binding and VEGF reduction in AR100 mice. We found that mutant AR-induced death of motor neuron-like cells could be rescued by VEGF. Our results suggest that SBMA motor neuronopathy involves altered expression of VEGF, consistent with a role for VEGF as a neurotrophic/survival factor in motor neuron disease.	Univ Washington, Ctr Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Neurol Neurogenet, Seattle, WA 98195 USA; Buck Inst Age Res, Novato, CA 94945 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Buck Institute for Research on Aging	La Spada, AR (corresponding author), Univ Washington, Ctr Med, Dept Lab Med, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041648, R01NS040251] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS41648, R01 NS40251] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gosztonyi G, 2001, MICROSC RES TECHNIQ, V55, P187, DOI 10.1002/jemt.1170; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Marbini A, 2002, BRAIN DEV-JPN, V24, P63, DOI 10.1016/S0387-7604(01)00394-1; Mariotti C, 2000, NEUROMUSCULAR DISORD, V10, P391, DOI 10.1016/S0960-8966(99)00132-7; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; RINGEL SP, 1978, MUSCLE NERVE, V1, P297, DOI 10.1002/mus.880010406; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SOBUE G, 1993, J NEUROL SCI, V117, P74, DOI 10.1016/0022-510X(93)90157-T; Sopher BL, 2000, GENE, V261, P383, DOI 10.1016/S0378-1119(00)00508-4; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor MD, 2001, J COMP NEUROL, V432, P244, DOI 10.1002/cne.1100; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	47	140	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					687	699		10.1016/S0896-6273(04)00082-0	http://dx.doi.org/10.1016/S0896-6273(04)00082-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003169	Green Published, Bronze			2022-12-17	WOS:000221458200005
J	Pedraza, L; Huang, JK; Colman, DR				Pedraza, L; Huang, JK; Colman, DR			Organizing principles of the axoglial apparatus	NEURON			English	Article							SODIUM-CHANNELS; DIFFUSION BARRIER; MYELINATED AXONS; PERIPHERAL-NERVE; PLASMA-MEMBRANE; CELL-ADHESION; RANVIER; JUNCTIONS; NODE; PROTEINS	On axonal surfaces that flank the node of Ranvier and in overlying glial paranodal loops, proteins are arranged within circumscribed microdomains that defy explanation by conventional biosynthetic mechanisms. We postulate that the constraint of proteins to these loci is accomplished in part by discriminative membrane-embedded molecular sieves and diffusion barriers, which serve to organize and redistribute proteins after delivery by vesicular transport to neural cell plasma membranes. One sieve likely comprises a moveable, macromolecular scaffold of axonal and glial cell-derived transmembrane adhesion molecules and their associated cytoplasmic binding partners, located at the ends of each elongating myelin internode; this sieve contributes to restricting the sodium channel complexes to the node. We also anticipate the existence of a passive paranodal diffusion barrier at the myelin/noncompact membrane border, which prohibits protein diffusion out of contiguous paranodal membranes.	CUNY Mt Sinai Sch Med, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, Dept Neurol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, Dept Biochem, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, Dept Mol Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, Fishberg Ctr Neurobiol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Colman, DR (corresponding author), CUNY Mt Sinai Sch Med, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, Dept Neurol, 1425 Madison Ave, New York, NY 10029 USA.	david.colman@mssm.edu	Huang, Jeffrey/J-5248-2017; Huang, Jeffrey K./AAH-2418-2021; Messier, Claude/A-2322-2008	Huang, Jeffrey/0000-0003-0996-9451; Huang, Jeffrey K./0000-0003-0996-9451; Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040560, R01NS020147] Funding Source: NIH RePORTER; NCI NIH HHS [CO16883] Funding Source: Medline; NINDS NIH HHS [NS20147, NS40560] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BOLKO T, 2001, NEURON, V30, P91; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; BRADY S, 1999, FUNDAMENTAL NEUROSCI, P71; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Colman DR, 1999, NEURON, V23, P649, DOI 10.1016/S0896-6273(01)80024-6; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dupree JL, 1998, J NEUROSCI, V18, P1642; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HIRANO A, 1967, J CELL BIOL, V34, P555, DOI 10.1083/jcb.34.2.555; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; ICHIMURA T, 1991, J NEUROCYTOL, V20, P667, DOI 10.1007/BF01187068; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; LAATSCH RH, 1966, NATURE, V210, P757, DOI 10.1038/210757a0; Lambert S, 1997, J NEUROSCI, V17, P7025; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Morell, 1984, MYELIN; Nakada C, 2001, BIOPHYS J, V80, p179A; Novakovic SD, 1996, J NEUROCYTOL, V25, P403, DOI 10.1007/BF02284811; Paley W., 1802, NATURAL THEOLOGY; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; PETERS A, 1991, FNE STRUCTURE NERVOU; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; ROSENBLUTH J, 1976, J NEUROCYTOL, V5, P731, DOI 10.1007/BF01181584; Rosenbluth Jack, 1995, P613; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; TETZLAFF W, 1978, CELL TISSUE RES, V189, P187; Trapp BD, 2000, J CELL BIOL, V150, pF97, DOI 10.1083/jcb.150.3.F97; VONMURALT A, 1959, EVOLUTION MAN, P211; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	49	140	140	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					335	344		10.1016/S0896-6273(01)00306-3	http://dx.doi.org/10.1016/S0896-6273(01)00306-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11394997	Bronze			2022-12-17	WOS:000168962000008
J	Sato, T; Murthy, A; Thompson, KG; Schall, JD				Sato, T; Murthy, A; Thompson, KG; Schall, JD			Search efficiency but not response interference affects visual selection in frontal eye field	NEURON			English	Article							SACCADE TARGET SELECTION; SUPERIOR COLLICULUS; NEURONAL-ACTIVITY; INTRACORTICAL MICROSTIMULATION; NEURAL MECHANISMS; PREFRONTAL CORTEX; SQUIRREL-MONKEYS; MENTAL PROCESSES; MACAQUE MONKEYS; CORTICAL AREAS	Two manipulations of a visual search task were used to test the hypothesis that the discrimination of a target from distracters by visually responsive neurons in the frontal eye field (FEF) marks the outcome and conclusion of visual processing instead of saccade preparation. First, search efficiency was reduced by increasing the similarity of the distracters to the target. Second, response interference was introduced by infrequently changing the location of the target in the array. Both manipulations increased reaction time, but only the change in search efficiency affected the time needed to select the target by visually responsive neurons. This result indicates that visually responsive neurons In FEF form an explicit representation of the location of the target in the image.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 111 21st Ave S,301 Wilson Hall, Nashville, TN 37240 USA.				NATIONAL EYE INSTITUTE [R01EY008890, ZIAEY000389, Z01EY000389, P30EY008126] Funding Source: NIH RePORTER; NEI NIH HHS [P30-EY08126, R01-EY08890] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Basso MA, 1998, J NEUROSCI, V18, P7519; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Carpenter RHS, 1991, EYE MOVEMENTS; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; COLES MGH, 1995, OX PSYCH S, P86; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Donders FC, 1868, ATTENTION PERFORM, V2, P92; Dorris MC, 1997, J NEUROSCI, V17, P8566; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GREEN DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Luce RD, 1986, RESPONSE TIMES; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; MILLER J, 1992, J EXP PSYCHOL GEN, V121, P195, DOI 10.1037/0096-3445.121.2.195; MILLER J, 1982, J EXP PSYCHOL HUMAN, V8, P273, DOI 10.1037/0096-1523.8.2.273; MILLER JO, 1983, J EXP PSYCHOL HUMAN, V11, P221; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Murthy A., 1999, Society for Neuroscience Abstracts, V25, P806; OSMAN A, 1992, J EXP PSYCHOL HUMAN, V18, P217, DOI 10.1037/0096-1523.18.1.217; PASHLER H, 1991, J EXP PSYCHOL HUMAN, V17, P1023, DOI 10.1037/0096-1523.17.4.1023; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; SANDERS AF, 1990, ACTA PSYCHOL, V74, P123, DOI 10.1016/0001-6918(90)90004-Y; SAYER RJ, 1990, J NEUROSCI, V10, P826; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1997, CEREBR CORT, V12, P527; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Thompson K. G., 1998, Society for Neuroscience Abstracts, V24, P1146; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P137; Viviani P, 1990, Rev Oculomot Res, V4, P353; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	59	140	140	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					583	591		10.1016/S0896-6273(01)00304-X	http://dx.doi.org/10.1016/S0896-6273(01)00304-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	436XW	11395016	Bronze			2022-12-17	WOS:000168962000027
J	Walker, MC; Ruiz, A; Kullmann, DM				Walker, MC; Ruiz, A; Kullmann, DM			Monosynaptic GABAergic signaling from dentate to CA3 with a pharmacological and physiological profile typical of mossy fiber synapses	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; EXCITATORY GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPUS; GUINEA-PIG; HETEROSYNAPTIC DEPRESSION; NEURONS; ACID; GABA	Mossy fibers are the sole excitatory projection from dentate gyrus granule cells to the hippocampus, where they release glutamate, dynorphin, and zinc. In addition, mossy fiber terminals show intense immunoreactivity for the inhibitory neurotransmitter GABA. Fast inhibitory transmission at mossy fiber synapses, however, has not previously been reported. Here, we show that electrical or chemical stimuli that recruit dentate granule cells elicit monosynaptic GABA, receptor-mediated synaptic signals in CA3 pyramidal neurons. These inhibitory signals satisfy the criteria that distinguish mossy fiber-CA3 synapses: high sensitivity to metabotropic glutamate receptor agonists, facilitation during repetitive stimulation, and NMDA receptor-independent long-term potentiation. GABAergic transmission from the dentate gyrus to CA3 has major implications not only for information flow into the hippocampus but also for developmental and pathological processes involving the hippocampus.	UCL, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Walker, Matthew C/C-1577-2008	Kullmann, Dimitri M/0000-0001-6696-3545; Walker, Matthew C/0000-0002-0812-0352				Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bresink I, 1996, NEUROPHARMACOLOGY, V35, P503, DOI 10.1016/0028-3908(95)00192-1; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; Makiura Y, 1999, EXP NEUROL, V159, P73, DOI 10.1006/exnr.1999.7138; MCGINTY JF, 1983, P NATL ACAD SCI-BIOL, V80, P589, DOI 10.1073/pnas.80.2.589; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sik A, 1997, EUR J NEUROSCI, V9, P573, DOI 10.1111/j.1460-9568.1997.tb01634.x; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Spiridon M, 1998, J PHYSIOL-LONDON, V506, P363, DOI 10.1111/j.1469-7793.1998.363bw.x; Spruston N, 1997, J COMP NEUROL, V385, P427; TAUPIN P, 1994, BRAIN RES, V644, P313, DOI 10.1016/0006-8993(94)91695-0; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Vida I, 2000, P NATL ACAD SCI USA, V97, P1275, DOI 10.1073/pnas.97.3.1275; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WILLIAMS SH, 1991, J NEUROPHYSIOL, V66, P1010, DOI 10.1152/jn.1991.66.3.1010; YAMAMOTO C, 1983, EXP BRAIN RES, V51, P128; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	52	140	147	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					703	715		10.1016/S0896-6273(01)00245-8	http://dx.doi.org/10.1016/S0896-6273(01)00245-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301029	Bronze			2022-12-17	WOS:000167868900019
J	Poeck, B; Fischer, S; Gunning, D; Zipursky, SL; Salecker, I				Poeck, B; Fischer, S; Gunning, D; Zipursky, SL; Salecker, I			Glial cells mediate target layer selection of retinal axons in the developing visual system of Drosophila	NEURON			English	Article							SH2/SH3 ADAPTER PROTEIN; OLFACTORY GLOMERULI; NERVOUS-SYSTEM; HOMEOBOX GENE; MELANOGASTER; NEURONS; CONNECTIONS; GUIDANCE; RECEPTOR; INSECT	In the fly visual system, each class of photoreceptor neurons (R cells) projects to a different synaptic layer in the brain. R1-R6 axons terminate in the lamina, while R7 and R8 axons pass through the lamina and stop in the medulla. As R cell axons enter the lamina, they encounter both glial cells and neurons. The cellular requirement for R1-R6 targeting was determined using loss-of-function mutations affecting different cell types in the lamina. nonstop (encoding a ubiquitin-specific protease) is required for glial cell development and hedgehog for neuronal development. Removal of glial cells but not neurons disrupts R1-R6 targeting. We propose that glial cells provide the initial stop signal promoting growth cone termination in the lamina. These findings uncover a novel function for neuron-glial interactions in regulating target specificity.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Regensburg, Inst Zool, Lehrstuhl Entwicklungsbiol, D-93053 Regensburg, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Regensburg	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.		Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763; Zipursky, Stephen/0000-0001-5630-7181				Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; Bailey MS, 1999, J COMP NEUROL, V415, P423; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Deak P, 1997, GENETICS, V147, P1697; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; FROHLICH A, 1982, J NEUROCYTOL, V11, P159, DOI 10.1007/BF01258010; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GHOSH A, 1993, DEVELOPMENT, V117, P1031; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; HALTER DA, 1995, DEVELOPMENT, V121, P317; HARRISON SD, 1995, GENETICS, V139, P1701; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; JONES B, 1993, DEVELOPMENT, V117, P793; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; MARDON G, 1994, DEVELOPMENT, V120, P3473; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; OLAND LA, 1988, J NEUROSCI, V8, P353; OLAND LA, 1988, J COMP NEUROL, V278, P377, DOI 10.1002/cne.902780307; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; POECK B, 1993, DEVELOPMENT, V117, P1017; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Rorth P, 2000, MOL CELL, V6, P23; Rossler W, 1999, J NEUROSCI, V19, P9865; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; SAVILLE KJ, 1993, P NATL ACAD SCI USA, V90, P8842, DOI 10.1073/pnas.90.19.8842; Senti KA, 2000, DEVELOPMENT, V127, P2291; Spradling AC, 1999, GENETICS, V153, P135; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Super H, 1998, J NEUROSCI, V18, P4616; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wilkinson KD, 1998, UBIQUITIN BIOL CELL, P99; WINBERG ML, 1992, DEVELOPMENT, V115, P903; XU T, 1993, DEVELOPMENT, V117, P1223	52	140	144	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2001	29	1					99	113		10.1016/S0896-6273(01)00183-0	http://dx.doi.org/10.1016/S0896-6273(01)00183-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182084	Bronze			2022-12-17	WOS:000166702700012
J	Schulte, D; Furukawa, T; Peters, MA; Kozak, CA; Cepko, CL				Schulte, D; Furukawa, T; Peters, MA; Kozak, CA; Cepko, CL			Misexpression of the Emx-related homeobox genes cVax and mVax2 ventralizes the retina and perturbs the retinotectal map	NEURON			English	Article							RECEPTOR TYROSINE KINASES; VISUAL-SYSTEM; CHICK-EMBRYO; TRANSCRIPTION FACTORS; COMMISSURAL AXONS; PROJECTION MAP; EPH RECEPTORS; EYE ANLAGE; IN-VITRO; T-BOX	The mechanisms that establish the dorsal-ventral (D-V) axis of the eye are poorly understood. We isolated two homeobox genes from mouse and chicken, mVax2 and cVax, whose expression during early eye development is restricted to the ventral retina. In chick, ectopic expression of either Var leads to ventralization of the early retina, as assayed by expression of the transcription factors Pax2 and Tbx5, and the Eph family members EphB2, EphB3, ephrinB1, and ephrinB2, all of which are normally dorsally or ventrally restricted. Moreover, the projections of dorsal but not ventral ganglion cell axons onto the optic tectum showed profound targeting errors following cVax mis-expression, mVax2/cVax thus specify positional identity along the D-V axis of the retina and influence retinotectal mapping.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			Schulte, Dorothea/0000-0002-7243-6319	NATIONAL EYE INSTITUTE [T32EY007110] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EYO 7110] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Boncinelli E, 1995, CIBA F SYMP, V193, P100; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Brennan C, 1997, DEVELOPMENT, V124, P655; Bruhn SL, 1996, J NEUROSCI, V16, P1430; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Drager UC, 1998, J NUTR, V128, p463S, DOI 10.1093/jn/128.2.463S; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; DUTTING D, 1995, DEV BIOL, V167, P263, DOI 10.1006/dbio.1995.1022; Dutting D, 1995, INT J DEV BIOL, V39, P921; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Godbout R, 1996, DEV DYNAM, V205, P319, DOI 10.1002/(SICI)1097-0177(199603)205:3<319::AID-AJA11>3.0.CO;2-#; GOLDBERG S, 1976, DEV BIOL, V53, P126, DOI 10.1016/0012-1606(76)90214-1; Green E., 1981, GENETICS PROBABILITY, DOI 10.1007/978-1-349-04904-2; Hallonet M, 1998, DEVELOPMENT, V125, P2599; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Huh SO, 1999, DEV BIOL, V211, P53, DOI 10.1006/dbio.1999.9303; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; Hyatt GA, 1996, DEVELOPMENT, V122, P195; Isaac A, 1998, DEVELOPMENT, V125, P1867; KASTURY K, 1994, GENOMICS, V22, P41, DOI 10.1006/geno.1994.1343; Logan M, 1998, DEVELOPMENT, V125, P2825; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; MATSUNO T, 1992, NEUROSCI RES, V15, P96, DOI 10.1016/0168-0102(92)90022-5; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; Muramatsu T, 1998, INT J MOL MED, V1, P55; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NOMES HO, 1990, DEVELOPMENT, V109, P797; Ohsaki K, 1999, GENES CELLS, V4, P267, DOI 10.1046/j.1365-2443.1999.00257.x; Ohuchi H, 1998, DEVELOPMENT, V125, P51; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shimamura K, 1995, DEVELOPMENT, V121, P3923; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	55	140	143	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					541	553		10.1016/S0896-6273(00)81111-3	http://dx.doi.org/10.1016/S0896-6273(00)81111-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595508	Bronze			2022-12-17	WOS:000083913000012
J	Tzounopoulos, T; Janz, R; Sudhof, TC; Nicoll, RA; Malenka, RC				Tzounopoulos, T; Janz, R; Sudhof, TC; Nicoll, RA; Malenka, RC			A role for cAMP in long-term depression at hippocampal mossy fiber synapses	NEURON			English	Article							SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; ADENYLATE-CYCLASE; GUINEA-PIG; 2 FORMS; POTENTIATION; PROTEIN; NEURONS; LTP	Mossy fiber synapses on hippocampal CA3 pyramidal cells, in addition to expressing an NMDA receptor-independent form of long-term potentiation (LTP), have recently been shown to express a novel presynaptic form of long-term depression (LTD). We have studied the mechanisms underlying mossy fiber LTD and present evidence that it is triggered, at least in part, by a metabotropic glutamate receptor-mediated decrease in adenylyl cyclase activity, which leads to a decrease in the activity of the cAMP-dependent protein kinase (PKA) and a reversal of the presynaptic processes responsible for mossy fiber LTP. The bidirectional control of synaptic strength at mossy fiber synapses by activity therefore appears to be due to modulation of the cAMP-PKA signaling pathway in mossy fiber boutons.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	malenka@itsa.ucsf.edu		Janz, Roger/0000-0002-9872-0596				ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 1996, J NEUROSCI, V16, P5942; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DIXON D, 1989, J NEUROSCI, V9, P4246; DUDEK SM, 1993, J NEUROSCI, V13, P2910; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1997, NEUROSCIENCE, V80, P89, DOI 10.1016/S0306-4522(97)00098-5; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lonart G, 1998, J NEUROSCI, V18, P634; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	37	140	141	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					837	845		10.1016/S0896-6273(00)80599-1	http://dx.doi.org/10.1016/S0896-6273(00)80599-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808469	Bronze			2022-12-17	WOS:000076697300026
J	Rosenblatt, KP; Sun, ZP; Heller, S; Hudspeth, AJ				Rosenblatt, KP; Sun, ZP; Heller, S; Hudspeth, AJ			Distribution of Ca2+-activated K+ channel isoforms along the tonotopic gradient of the chicken's cochlea	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; ION-DEPENDENT CONDUCTANCES; CALCIUM-BINDING PROTEIN; VERTEBRATE HAIR-CELLS; BASILAR PAPILLA; INNER-EAR; FREQUENCY-SELECTIVITY; SYNAPTIC TRANSMISSION; COMPLEMENTARY DNAS; RANA-CATESBEIANA	In some cochleae, the number and kinetic properties of Ca2+-activated K+ (K-Ca) channels partly determine the characteristic frequency of each hair cell and thus help establish a tonotopic map. In the chicken's basilar papilla, we found numerous isoforms of K-Ca channels generated by alternative mRNA splicing at seven sites in a single gene, cSlo. In situ polymerase chain reactions demonstrated cSlo expression in hair cells and revealed differential distributions of K-Ca channel isoforms along the basilar papilla. Analysis of single hair cells by the reverse transcription polymerase chain reaction confirmed the differential expression of channel variants. Heterologously expressed cSlo variants differed in their sensitivities to Ca2+ and voltage, suggesting that the distinct spatial distributions of cSlo variants help determine the tonotopic map.	ROCKEFELLER UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA; ROCKEFELLER UNIV, LAB SENSORY NEUROSCI, NEW YORK, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University					NIDCD NIH HHS [DC00317] Funding Source: Medline; NIGMS NIH HHS [GM08014] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ASHMORE JF, 1983, NATURE, V304, P536, DOI 10.1038/304536a0; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; BAGASRA O, 1997, INSITU PCR TECHNIQUE, P37; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHEN L, 1994, HEARING RES, V81, P130, DOI 10.1016/0378-5955(94)90160-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; FREEMAN DM, 1990, HEARING RES, V48, P1, DOI 10.1016/0378-5955(90)90195-U; FRISHKOPF LS, 1983, HEARING RES, V12, P393, DOI 10.1016/0378-5955(83)90008-4; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1992, PROG NEUROBIOL, V39, P493, DOI 10.1016/0301-0082(92)90003-W; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947; GRAY L, 1985, J ACOUST SOC AM, V77, P1162, DOI 10.1121/1.392180; GUMMER AW, 1987, HEARING RES, V29, P63, DOI 10.1016/0378-5955(87)90206-1; HINRICHSEN RD, 1993, CALCIUM DEPENDENT PO, P16; HIROKAWA N, 1978, J COMP NEUROL, V181, P361, DOI 10.1002/cne.901810208; HOLTON T, 1983, SCIENCE, V222, P508, DOI 10.1126/science.6623089; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; Jiang GJ, 1997, P ROY SOC B-BIOL SCI, V264, P731, DOI 10.1098/rspb.1997.0104; JONES SM, 1995, HEARING RES, V82, P149, DOI 10.1016/0378-5955(94)00173-N; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; Lewis RS., 1983, HEARING PHYSIOLOGICA, P17, DOI [10.1007/978-3-642-69257-4_3, DOI 10.1007/978-3-642-69257-4_3]; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MANLEY GA, 1989, J COMP PHYSIOL A, V164, P289, DOI 10.1007/BF00612989; MANLEY GA, 1987, SCIENCE, V237, P655, DOI 10.1126/science.3603046; Manley GA, 1996, AUDIT NEUROSCI, V3, P199; MANLEY GA, 1990, PERIPHERAL HEARING M, P206; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MURROW BW, 1994, J PHYSIOL-LONDON, V480, P247, DOI 10.1113/jphysiol.1994.sp020357; MURROW BW, 1990, P ROY SOC B-BIOL SCI, V242, P189, DOI 10.1098/rspb.1990.0123; NAVARATNAM DS, 1995, J BIOL CHEM, V270, P19238, DOI 10.1074/jbc.270.33.19238; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; NUOVO GJ, 1996, PCR INSITU HYBRIDIZA; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBERTS WM, 1986, AUDITORY FREQUENCY S, P89; RUBEL EW, 1984, ANNU REV PHYSIOL, V46, P213; RUBEL EW, 1984, ANN OTO RHINOL LARYN, V93, P609, DOI 10.1177/000348948409300614; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHEN NV, 1993, NEURON, V11, P67; SHUSTER MJ, 1991, J PHYSIOL-LONDON, V440, P601, DOI 10.1113/jphysiol.1991.sp018727; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; Subramony P, 1996, NEURON, V17, P115, DOI 10.1016/S0896-6273(00)80285-8; TAKEUCHI S, 1992, HEARING RES, V61, P86, DOI 10.1016/0378-5955(92)90039-P; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cellbio.8.1.257; TILNEY LG, 1986, DEV BIOL, V116, P110; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; von Bekesy G., 1960, EXPT HEARING; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; WILSON PW, 1985, NUCLEIC ACIDS RES, V13, P8867, DOI 10.1093/nar/13.24.8867; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Wu YC, 1996, BIOPHYS J, V70, P2557, DOI 10.1016/S0006-3495(96)79827-2; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	79	140	145	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1061	1075		10.1016/S0896-6273(00)80397-9	http://dx.doi.org/10.1016/S0896-6273(00)80397-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390519	Bronze			2022-12-17	WOS:A1997YH59400013
J	Cantrell, AR; Ma, JY; Scheuer, T; Catterall, WA				Cantrell, AR; Ma, JY; Scheuer, T; Catterall, WA			Muscarinic modulation of sodium current by activation of protein kinase C in rat hippocampal neurons	NEURON			English	Article							ACTIVE-CHEMICAL SYNAPSES; ACETYLCHOLINE-RECEPTOR GENES; FROG SYMPATHETIC NEURONS; CALCIUM CURRENT; NA+-CHANNEL; PHOSPHORYLATION; EXPRESSION; SUBTYPES; CLONING; CELLS	Phosphorylation of brain Na+ channels by protein kinase C (PKC) decreases peak Na+ current and slows macroscopic inactivation, but receptor-activated modulation of Na+ currents via the PKC pathway has not been demonstrated. We have examined modulation of Na+ channels by activation of muscarinic receptors in acutely-isolated hippocampal neurons using whole-cell voltage-clamp recording. Application of the muscarinic agonist carbachol reduced peak Na+ current and slowed macroscopic inactivation at all potentials, without changing the voltage-dependent properties of the channel. These effects were mediated by PKC, since they were eliminated when the specific PKC inhibitor (PKCI19-36) was included in the pipette solution and mimicked by the extracellular application of the PKC activator, GAG. Thus, activation of endogenous muscarinic receptors on hippocampal neurons strongly modulates Na+ channel activity by activation of PKC. Cholinergic input from basal forebrain neurons may have this effect in the hippocampus in vivo.			Cantrell, AR (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007278] Funding Source: NIH RePORTER; NIDA NIH HHS [T32DA07278] Funding Source: Medline; NINDS NIH HHS [NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGAS J, 1994, J NEUROSCI, V14, P6667; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOWLBY MR, 1995, J NEUROPHYSIOL, V73, P2221, DOI 10.1152/jn.1995.73.6.2221; BRANN MR, 1993, PROG BRAIN RES, V98, P121; BRUSSAARD AB, 1991, J PHYSIOL-LONDON, V441, P385, DOI 10.1113/jphysiol.1991.sp018757; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V451, P229, DOI 10.1113/jphysiol.1992.sp019162; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HOWE AR, 1995, J NEUROSCI, V15, P458; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; KRNJEVIC K, 1993, PROG BRAIN RES, V98, P285; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LIAO CF, 1989, J BIOL CHEM, V264, P7328; LINDEN DJ, 1989, J PHYSIOL-LONDON, V419, P95, DOI 10.1113/jphysiol.1989.sp017863; MCKINNEY M, 1984, ANNU REV PHARMACOL, V24, P121; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; NICOLL RA, 1985, TRENDS NEUROSCI, V8, P533, DOI 10.1016/0166-2236(85)90190-0; NUMANN R, 1994, J NEUROSCI, V14, P4226; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PRICE DL, 1993, PROG BRAIN RES, V98, P51; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RENGANATHAN M, 1995, J MEMBRANE BIOL, V144, P59; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; SURMEIER DJ, 1991, NEUROSCI LETT, V122, P41, DOI 10.1016/0304-3940(91)90188-Y; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TAYLOR CP, 1993, TRENDS NEUROSCI, V16, P455, DOI 10.1016/0166-2236(93)90077-Y; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TAYLOR CP, 1984, J NEUROPHYSIOL, V52, P143, DOI 10.1152/jn.1984.52.1.143; Tukey JW, 1977, EXPLORATORY DATA ANA, Vxvi; WAINER BH, 1993, PROG BRAIN RES, V98, P9; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B	49	140	143	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					1019	1026		10.1016/S0896-6273(00)80125-7	http://dx.doi.org/10.1016/S0896-6273(00)80125-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630240	Bronze			2022-12-17	WOS:A1996UN48000017
J	TOLEDOARAL, JJ; BREHM, P; HALEGOUA, S; MANDEL, G				TOLEDOARAL, JJ; BREHM, P; HALEGOUA, S; MANDEL, G			A SINGLE-PULSE OF NERVE GROWTH-FACTOR TRIGGERS LONG-TERM NEURONAL EXCITABILITY THROUGH SODIUM-CHANNEL GENE INDUCTION	NEURON			English	Article							PC12 CELLS; DIFFERENTIATION; PATHWAY; EXPRESSION; INHIBITION; RECEPTOR; KINASE; LINE	The continuous presence of nerve growth factor (NGF) is thought to be required for the elaboration of neuronal-like traits in PC12 cells. Surprisingly, we find that a 1 min exposure to NGF is sufficient to engage a longer-term genetic program leading to the acquisition of membrane excitability. Whereas continuous exposure to NGF causes the induction of a family of sodium channels, the effect of a brief exposure is to induce selectively expression of the peripheral nerve-type sodium channel gene PN1, through a distinct signaling pathway requiring immediate-early genes. A 1 min exposure of PC12 cells to interferon-gamma also causes PN1 gene induction, suggesting that the ''triggered'' NGF and interferon-gamma signaling pathways share common molecular intermediates.			TOLEDOARAL, JJ (corresponding author), SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA.		IBIS, TERAPIA CELULA/P-3297-2015; Toledo-Aral, Juan J/F-2613-2015	Toledo-Aral, Juan J/0000-0001-7512-7135				BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; COOPERMAN SS, 1987, P NATL ACAD SCI USA, V84, P8721, DOI 10.1073/pnas.84.23.8721; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; DARCANGELO G, 1993, J CELL BIOL, V122, P915, DOI 10.1083/jcb.122.4.915; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GINTY DD, 1992, J CELL BIOL, V116, P1465, DOI 10.1083/jcb.116.6.1465; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HAMILL OP, 1981, PFLUGERS ARCH, V391, P95; JONAKAIT GM, 1994, NEURON, V12, P1149; KENGAKU M, 1993, DEVELOPMENT, V119, P1067; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; ODOWD DK, 1983, NATURE, V303, P619, DOI 10.1038/303619a0; OLAGUE PH, 1985, J NEUROSCI RES, V13, P301, DOI 10.1002/jnr.490130120; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RIBERA AB, 1989, NEURON, V2, P1055, DOI 10.1016/0896-6273(89)90229-8; RUDY B, 1987, J NEUROSCI, V7, P1613; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; SISLER HD, 1967, ANTIBIOTICS, P238; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0	35	140	142	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1995	14	3					607	611		10.1016/0896-6273(95)90317-8	http://dx.doi.org/10.1016/0896-6273(95)90317-8			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695907	Bronze			2022-12-17	WOS:A1995QP23000014
J	MOCHIDA, S; KOBAYASHI, H; MATSUDA, Y; YUDA, Y; MURAMOTO, K; NONOMURA, Y				MOCHIDA, S; KOBAYASHI, H; MATSUDA, Y; YUDA, Y; MURAMOTO, K; NONOMURA, Y			MYOSIN-II IS INVOLVED IN TRANSMITTER RELEASE AT SYNAPSES FORMED BETWEEN RAT SYMPATHETIC NEURONS IN CULTURE	NEURON			English	Article							LIGHT CHAIN KINASE; SUPERIOR CERVICAL-GANGLION; ACTOMYOSIN-LIKE PROTEIN; CONTRACTILE PROTEINS; DIMETHYL-SULFOXIDE; SYNAPTIC VESICLES; CHROMAFFIN CELLS; NONMUSCLE MYOSIN; NERVOUS-SYSTEM; GROWTH CONES	The presynaptic function of myosin II was studied at cholinergic synapses formed between rat superior cervical ganglion neurons in culture. Immunofluorescent staining showed that myosin II was colocalized with synaptophysin at the presynaptic nerve terminals. Antimyosin II antibody introduced into presynaptic neurons inhibited synaptic transmission. Transmission was also inhibited in a dose-dependent manner by two inhibitors of myosin light chain kinase: a peptide, SM-1, and an organic inhibitor, wortmannin. The inhibition produced by these agents was dependent on presynaptic activity. Extracellularly applied wortmannin also blocked synaptic transmission, but its effects were slower in onset. Wortmannin also decreased postsynaptic potentials and post-tetanic potentiation in intact superior cervical ganglia. These results suggest a model in which myosin light chain kinase phosphorylates myosin, and the resultant change in actin-myosin interactions is involved in neurotransmitter release.	KYOWA HAKKO KOGYO CO LTD,TOKYO RES LABS,TOKYO 194,JAPAN; MEIJI SEIKA CO,PHARMACEUT RES CTR,YOKOHAMA,KANAGAWA 222,JAPAN; UNIV TOKYO,FAC MED,DEPT PHARMACOL,TOKYO 113,JAPAN	Kyowa Kirin Ltd; Meiji Holdings Co., Ltd.; University of Tokyo	MOCHIDA, S (corresponding author), TOKYO MED COLL,DEPT PHYSIOL,TOKYO 160,JAPAN.							ADELSTEIN RS, 1980, CALCIUM CELL FUNCTIO, V1, P167; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BEACH RL, 1981, BRAIN RES, V225, P75, DOI 10.1016/0006-8993(81)90319-X; BERL S, 1973, SCIENCE, V179, P441, DOI 10.1126/science.179.4072.441; BERL S, 1970, BIOCHEMISTRY-US, V9, P2058, DOI 10.1021/bi00812a005; BLITZ AL, 1974, P NATL ACAD SCI USA, V71, P4472, DOI 10.1073/pnas.71.11.4472; BRAY D, 1977, BIOCHIMIE, V59, P1, DOI 10.1016/S0300-9084(77)80079-5; BRAY D, 1973, NATURE, V244, P93, DOI 10.1038/244093a0; BURRIDGE K, 1975, J MOL BIOL, V99, P1, DOI 10.1016/S0022-2836(75)80154-9; DRENCKHAHN D, 1983, EUR J CELL BIOL, V31, P235; ECCLES RM, 1961, J PHYSIOL-LONDON, V157, P484, DOI 10.1113/jphysiol.1961.sp006738; ELFVIN LG, 1963, J ULTRA MOL STRUCT R, V8, P441, DOI 10.1016/S0022-5320(63)80049-0; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; GERMAIN M, 1965, BIOCHEM PHARMACOL, V14, P1815, DOI 10.1016/0006-2952(65)90271-6; GERON N, 1985, BIOCHIM BIOPHYS ACTA, V819, P258, DOI 10.1016/0005-2736(85)90181-6; GUTIERREZ LM, 1989, BIOCHEM J, V264, P589, DOI 10.1042/bj2640589; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P17078; HASLAM RJ, 1977, BIOCHEM BIOPH RES CO, V77, P714, DOI 10.1016/S0006-291X(77)80037-5; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSON M, 1976, NATURE, V262, P308, DOI 10.1038/262308a0; KASA P, 1991, CELL TISSUE RES, V265, P151, DOI 10.1007/BF00318149; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KITANI S, 1992, BIOCHEM BIOPH RES CO, V183, P48, DOI 10.1016/0006-291X(92)91607-R; KO CP, 1976, BRAIN RES, V117, P461, DOI 10.1016/0006-8993(76)90753-8; KUCZMARSKI ER, 1979, J CELL BIOL, V80, P356, DOI 10.1083/jcb.80.2.356; LASEK RJ, 1976, CELL MOTILITY, P1021; LETOURNEAU PC, 1981, DEV BIOL, V85, P113, DOI 10.1016/0012-1606(81)90240-2; LIBET B, 1964, J PHYSIOL-LONDON, V174, P1; LIBET B, 1988, BRAIN RES, V473, P271, DOI 10.1016/0006-8993(88)90856-6; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MATTHEWS MR, 1974, PERIPHERAL NERVOUS S, P111; MCLARNON JG, 1986, MOL PHARMACOL, V30, P631; MILLER M, 1992, NEURON, V8, P25, DOI 10.1016/0896-6273(92)90106-N; MOCHIDA S, 1986, NEUROSCI LETT, V72, P199, DOI 10.1016/0304-3940(86)90080-7; MOCHIDA S, 1986, NEUROSCI LETT, V72, P205, DOI 10.1016/0304-3940(86)90081-9; MORALES M, 1989, J COMP NEUROL, V279, P666, DOI 10.1002/cne.902790412; MURAKAMI N, 1992, CELL MOTIL CYTOSKEL, V22, P281, DOI 10.1002/cm.970220408; NAKAMURA S, 1984, J BIOCH, V96, P578; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NISHIKAWA M, 1980, NATURE, V287, P863, DOI 10.1038/287863a0; OHARAIMAIZUMI M, 1992, BIOCHEM BIOPH RES CO, V185, P1016, DOI 10.1016/0006-291X(92)91728-9; OLAGUE PH, 1978, DEV BIOL, V67, P424, DOI 10.1016/0012-1606(78)90210-5; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; PUSZKIN S, 1972, J NEUROCHEM, V19, P1319, DOI 10.1111/j.1471-4159.1972.tb01457.x; PUSZKIN S, 1968, SCIENCE, V161, P170, DOI 10.1126/science.161.3837.170; REES R, 1974, J COMP NEUROL, V157, P1, DOI 10.1002/cne.901570102; SAKURAI T, 1990, NEUROSCIENCE, V38, P743, DOI 10.1016/0306-4522(90)90067-E; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TOKIMASA T, 1993, NEUROSCI RES       S, V18, P23; TRIFARO JM, 1978, NEUROSCIENCE, V3, P1, DOI 10.1016/0306-4522(78)90150-1; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1426, DOI 10.1152/jn.1979.42.5.1426; Walsh M. P., 1985, CALCIUM CELL PHYSL, P170; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; YANO H, 1993, J BIOL CHEM, V268, P25846	60	140	140	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1131	1142		10.1016/0896-6273(94)90051-5	http://dx.doi.org/10.1016/0896-6273(94)90051-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946350				2022-12-17	WOS:A1994PU76300009
J	DEVREOTES, PN				DEVREOTES, PN			G-PROTEIN-LINKED SIGNALING PATHWAYS CONTROL THE DEVELOPMENTAL PROGRAM OF DICTYOSTELIUM	NEURON			English	Review							AGGREGATION-DEFICIENT MUTANTS; SURFACE CAMP RECEPTORS; BETA-GAMMA-SUBUNITS; ADENYLYL CYCLASE; DISCOIDEUM; KINASE; BINDING; PHOSPHORYLATION; GENES; OVEREXPRESSION				DEVREOTES, PN (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.							ANJARD C, 1992, DEVELOPMENT, V115, P785; BERLOT CH, 1985, CELL, V43, P307, DOI 10.1016/0092-8674(85)90036-4; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BOMINAAR AA, 1991, DEV GENET, V12, P19, DOI 10.1002/dvg.1020120106; COUKELL MB, 1983, DEV GENET, V3, P283; DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337; DEVREOTES PN, 1979, J CELL BIOL, V80, P300, DOI 10.1083/jcb.80.2.300; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DRAYER AL, 1992, J BIOL CHEM, V267, P18387; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FIRTEL RA, 1990, GENE DEV, V4, P18, DOI 10.1101/gad.4.1.18; FONTANA D, 1984, CELL SURFACE CANCER, P261; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUNDERSEN RE, 1990, SCIENCE, V248, P591, DOI 10.1126/science.2110382; HADWIGER JA, 1991, P NATL ACAD SCI USA, V88, P8213, DOI 10.1073/pnas.88.18.8213; HALL AL, 1989, DEV BIOL, V136, P517, DOI 10.1016/0012-1606(89)90277-7; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; HERELD D, 1994, IN PRESS J BIOL CHEM; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; KESBEKE F, 1988, J CELL BIOL, V107, P521, DOI 10.1083/jcb.107.2.521; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; LILLY P, 1993, GENE DEV, V7, P986, DOI 10.1101/gad.7.6.986; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; MILNE JL, 1991, J CELL BIOL, V112, P103, DOI 10.1083/jcb.112.1.103; MILNE JL, 1993, MOL BIOL CELL, V4, P283, DOI 10.1091/mbc.4.3.283; MUTZEL R, 1987, P NATL ACAD SCI USA, V84, P6, DOI 10.1073/pnas.84.1.6; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; PUPILLO M, 1992, MOL BIOL CELL, V3, P1229, DOI 10.1091/mbc.3.11.1229; ROSS FM, 1981, J GEN MICROBIOL, V127, P339; SAXE CL, 1993, GENE DEV, V7, P262, DOI 10.1101/gad.7.2.262; SCHAAP P, 1984, DEV BIOL, V105, P470, DOI 10.1016/0012-1606(84)90304-X; SNAARJAGALSKA BE, 1988, FEBS LETT, V232, P148, DOI 10.1016/0014-5793(88)80405-8; SUN TJ, 1991, GENE DEV, V5, P572, DOI 10.1101/gad.5.4.572; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; THEIBERT A, 1986, J BIOL CHEM, V261, P5121; VANHAASTERT PJM, 1983, J CELL BIOL, V96, P347, DOI 10.1083/jcb.96.2.347; VANHAASTERT PJM, 1992, MOL BIOL CELL, V3, P603, DOI 10.1091/mbc.3.6.603; VANHAASTERT PJM, 1993, SENSORY TRANSDUCTION, P329; VAUGHAN RA, 1988, J BIOL CHEM, V263, P14538; Williams JG, 1989, CURR OPIN CELL BIOL, V1, P1132, DOI 10.1016/S0955-0674(89)80062-6; WU LJ, 1991, BIOCHEM BIOPH RES CO, V179, P1141, DOI 10.1016/0006-291X(91)91690-E	47	140	140	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					235	241		10.1016/0896-6273(94)90267-4	http://dx.doi.org/10.1016/0896-6273(94)90267-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110455				2022-12-17	WOS:A1994MY50000001
J	GRAY, GE; SANES, JR				GRAY, GE; SANES, JR			MIGRATORY PATHS AND PHENOTYPIC CHOICES OF CLONALLY RELATED CELLS IN THE AVIAN OPTIC TECTUM	NEURON			English	Article							RECOMBINANT RETROVIRUS; CHICK-EMBRYO; NERVOUS-SYSTEM; LINEAGE ANALYSIS; CEREBRAL-CORTEX; RADIAL GLIA; NEURONS; MOUSE; DIFFERENTIATION; PATHWAYS	We used retrovirus-mediated gene transfer to study the migration of clonally related cells in the developing chicken optic tectum. Clonal cohorts initially form radial arrays in the ventricular zone (approximately E5), but eventually divide into three separate migratory streams. In the first migration, a minor population of cells migrates tangentially along axon fascicles in medio-laterally directed files (approximately E6-E7); these eventually differentiate into multipolar efferent cells. After E7, the majority of cells in each clone migrate radially along fascicles of radial glia to form the tectal plate, wherein they differentiate into neurons and astrocytes. Around E9, a set of small cells leaves the radial arrays in superficial layers to form a second tangential migration; at least some of these differentiate into astrocytes. Thus, as the tectum develops, cells derived from a single multipotential precursor migrate along three separate pathways, follow separate guidance cues, and adopt distinct phenotypes.			GRAY, GE (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.							ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BENNETT GS, 1984, BRAIN RES, V304, P291, DOI 10.1016/0006-8993(84)90333-0; BITNER C, 1987, DEV BRAIN RES, V37, P167, DOI 10.1016/0165-3806(87)90238-0; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; CAJAL SRY, 1960, ETUDES NEUROGENESIS; DOMESICK VB, 1977, NEUROSCIENCE, V2, P459, DOI 10.1016/0306-4522(77)90011-2; DRAGER UC, 1984, J NEUROSCI, V4, P2025; DUPOUEY P, 1985, DEV NEUROSCI-BASEL, V7, P81, DOI 10.1159/000112279; FUJITA S, 1964, J COMP NEUROL, V122, P311, DOI 10.1002/cne.901220303; GADISSEUX JF, 1985, DEV NEUROSCI-BASEL, V7, P12, DOI 10.1159/000112273; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMDI FA, 1954, Q J EXP PHYSIOL CMS, V39, P111, DOI 10.1113/expphysiol.1954.sp001053; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HYNES RO, 1986, J NEUROSCI, V6, P867; Jassik-Gerschenfeld D., 1984, P649; KROGER S, 1990, J NEUROSCI, V10, P3118; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LINSER PJ, 1985, J NEUROSCI, V5, P2388; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MOODY SA, 1983, J COMP NEUROL, V216, P20, DOI 10.1002/cne.902160104; ONO K, 1989, EXP BRAIN RES, V78, P290; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PUELLES L, 1978, NEUROSCIENCE, V3, P307, DOI 10.1016/0306-4522(78)90079-9; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAGER G, 1979, EXP BRAIN RES, V35, P213, DOI 10.1007/BF00236612; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rakic P, 1985, CELL CONTACT ADHESIO, P67; REINER A, 1982, J COMP NEUROL, V204, P165, DOI 10.1002/cne.902040206; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SANES JR, 1990, IN PRESS AVIAN MODEL; SENUT MC, 1987, DEV BRAIN RES, V32, P187, DOI 10.1016/0165-3806(87)90100-3; STENT GS, 1985, PHILOS T R SOC B, V312, P3, DOI 10.1098/rstb.1985.0174; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; WEIKERT T, 1990, J NEUROBIOL, V21, P482, DOI 10.1002/neu.480210309; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILSON DB, 1973, J EMBRYOL EXP MORPH, V29, P745	50	140	141	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					211	225		10.1016/0896-6273(91)90357-6	http://dx.doi.org/10.1016/0896-6273(91)90357-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1704243				2022-12-17	WOS:A1991EY70900004
J	Fiebelkorn, IC; Pinsk, MA; Kastner, S				Fiebelkorn, Ian C.; Pinsk, Mark A.; Kastner, Sabine			A Dynamic Interplay within the Frontoparietal Network Underlies Rhythmic Spatial Attention	NEURON			English	Article							FRONTAL EYE FIELDS; LATERAL INTRAPARIETAL AREA; GAMMA-BAND SYNCHRONIZATION; SACCADE-RELATED ACTIVITY; NEURONAL OSCILLATIONS; SUSTAINED ATTENTION; VISUAL-CORTEX; ALPHA-OSCILLATIONS; THETA-OSCILLATIONS; NEURAL MECHANISMS	Classic studies of spatial attention assumed that its neural and behavioral effects were continuous over time. Recent behavioral studies have instead revealed that spatial attention leads to alternating periods of heightened or diminished perceptual sensitivity. Yet, the neural basis of these rhythmic fluctuations has remained largely unknown. We show that a dynamic interplay within the macaque frontoparietal network accounts for the rhythmic properties of spatial attention. Neural oscillations characterize functional interactions between the frontal eye fields (FEF) and the lateral intraparietal area (LIP), with theta phase (3-8 Hz) coordinating two rhythmically alternating states. The first is defined by FEF-dominated beta-band activity, associated with suppressed attentional shifts, and LIP-dominated gamma-band activity, associated with enhanced visual processing and better behavioral performance. The second is defined by LIP-specific alpha-band activity, associated with attenuated visual processing and worse behavioral performance. Our findings reveal how network-level interactions organize environmental sampling into rhythmic cycles.	[Fiebelkorn, Ian C.; Pinsk, Mark A.; Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Fiebelkorn, IC (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	iancf@princeton.edu		Fiebelkorn, Ian/0000-0002-5617-2261	NEI [F32EY023465, RO1EY017699, R21EY023565]; NIMH [R01MH064063]; Silvio O. Conte Center [1P50MH109429-01A1]; NATIONAL EYE INSTITUTE [R21EY023565, F32EY023465, R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH109429, R01MH064043] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Silvio O. Conte Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C.E. Schroeder and T.J. Buschman for their insightful comments on the manuscript. This work was supported by a training fellowship from NEI to I.C.F. (F32EY023465) and by grants from NIMH (R01MH064063 to S.K.), Silvio O. Conte Center (1P50MH109429-01A1 to S.K.), and NEI (RO1EY017699 and R21EY023565 to S.K.).	Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Benedetto A, 2017, J NEUROSCI, V37, P3661, DOI 10.1523/JNEUROSCI.2390-16.2016; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chen CY, 2015, CURR BIOL, V25, P2065, DOI 10.1016/j.cub.2015.06.022; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; Dugue L, 2016, CURR BIOL, V26, P1595, DOI 10.1016/j.cub.2016.04.046; Dugue L, 2015, J COGNITIVE NEUROSCI, V27, P945, DOI 10.1162/jocn_a_00755; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Esghaei M, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00082; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Fiebelkorn IC, 2013, NEUROIMAGE, V69, P126, DOI 10.1016/j.neuroimage.2012.11.021; Fiebelkorn IC, 2013, CURR BIOL, V23, P2553, DOI 10.1016/j.cub.2013.10.063; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Helfrich RF, 2018, NEURON, V99, P854, DOI 10.1016/j.neuron.2018.07.032; Hogendoorn H, 2016, J COGNITIVE NEUROSCI, V28, P1625, DOI 10.1162/jocn_a_00986; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kienitz R, 2018, CURR BIOL, V28, P2377, DOI 10.1016/j.cub.2018.05.086; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Landau AN, 2015, CURR BIOL, V25, P2332, DOI 10.1016/j.cub.2015.07.048; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Moldakarimov S, 2005, J NEUROPHYSIOL, V94, P3388, DOI 10.1152/jn.00159.2005; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Pesaran B, 2010, CURR OPIN NEUROBIOL, V20, P166, DOI 10.1016/j.conb.2010.03.003; Phillips JM, 2014, CEREB CORTEX, V24, P1996, DOI 10.1093/cercor/bht050; Pigarev IN, 2009, J NEUROSCI METH, V181, P151, DOI 10.1016/j.jneumeth.2009.04.024; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Reveley C, 2017, CEREB CORTEX, V27, P4463, DOI 10.1093/cercor/bhw248; Rollenhagen JE, 2005, J NEUROPHYSIOL, V94, P3368, DOI 10.1152/jn.00158.2005; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Saleem KS, 2007, COMBINED MRI HISTOLO; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Sellers KK, 2016, CELL REP, V16, P2864, DOI 10.1016/j.celrep.2016.08.055; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song K, 2014, J NEUROSCI, V34, P4837, DOI 10.1523/JNEUROSCI.4856-13.2014; Spyropoulos G, 2018, P NATL ACAD SCI USA, V115, pE5614, DOI 10.1073/pnas.1719433115; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Szczepanski SM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001936; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; VanRullen R, 2016, TRENDS COGN SCI, V20, P723, DOI 10.1016/j.tics.2016.07.006; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Worden MS, 2000, J NEUROSCI, V20; Wutz A, 2016, CURR BIOL, V26, P1659, DOI 10.1016/j.cub.2016.04.070; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	93	139	142	9	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 22	2018	99	4					842	+		10.1016/j.neuron.2018.07.038	http://dx.doi.org/10.1016/j.neuron.2018.07.038			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GR1YF	30138590	Bronze, Green Accepted			2022-12-17	WOS:000442351600019
J	Huber, L; Handwerker, DA; Jangraw, DC; Chen, G; Hall, A; Stuber, C; Gonzalez-Castillo, J; Ivanov, D; Marrett, S; Guidi, M; Goense, J; Poser, BA; Bandettini, PA				Huber, Laurentius; Handwerker, Daniel A.; Jangraw, David C.; Chen, Gang; Hall, Andrew; Stuber, Carsten; Gonzalez-Castillo, Javier; Ivanov, Dimo; Marrett, Sean; Guidi, Maria; Goense, Jozien; Poser, Benedikt A.; Bandettini, Peter A.			High-Resolution CBV-fMRI Allows Mapping of Laminar Activity and Connectivity of Cortical Input and Output in Human M1	NEURON			English	Article							MOTOR CORTEX; FUNCTIONAL MRI; HUMAN-BRAIN; 7 T; VISUAL-CORTEX; SPIN-ECHO; BOLD; SIGNAL; ACTIVATION; RESPONSES	Layer-dependent fMRI allows measurements of information flow in cortical circuits, as afferent and efferent connections terminate in different cortical layers. However, it is unknown to what level human fMRI is specific and sensitive enough to reveal directional functional activity across layers. To answer this question, we developed acquisition and analysis methods for blood-oxygen-level-dependent (BOLD) and cerebral-blood-volume (CBV)-based laminar fMRI and used these to discriminate four different tasks in the human motor cortex (M1). In agreement with anatomical data from animal studies, we found evidence for somatosensory and premotor input in superficial layers of M1 and for cortico-spinal motor output in deep layers. Laminar resting-state fMRI showed directional functional connectivity of M1 with somatosensory and premotor areas. Our findings demonstrate that CBV-fMRI can be used to investigate cortical activity in humans with unprecedented detail, allowing investigations of information flow between brain regions and outperforming conventional BOLD results that are often buried under vascular biases.	[Huber, Laurentius; Handwerker, Daniel A.; Jangraw, David C.; Chen, Gang; Hall, Andrew; Gonzalez-Castillo, Javier; Marrett, Sean; Bandettini, Peter A.] NIMH, NIH, Bethesda, MD 20892 USA; [Stuber, Carsten] Weill Cornell Med Coll, Dept Radiol, New York, NY 10044 USA; [Stuber, Carsten] Yale Univ, Yale Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Ivanov, Dimo; Poser, Benedikt A.] Maastricht Univ, Maastricht Brain Imaging Ctr, NL-6229 Maastricht, Netherlands; [Guidi, Maria] Max Planck Inst Human Cognit & Brain Sci, NMR Grp, D-04103 Leipzig, Germany; [Goense, Jozien] Univ Glasgow, Sch Psychol, Glasgow G12 8QB, Lanark, Scotland; [Goense, Jozien] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QB, Lanark, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Cornell University; Yale University; Maastricht University; Max Planck Society; University of Glasgow; University of Glasgow	Huber, L (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	laurentius.huber@nih.gov	Guidi, Maria/AAC-3509-2022; Jangraw, David/HDO-0521-2022; Gonzalez-Castillo, Javier/B-6903-2012; Huber, Laurentius/AFL-2095-2022	Guidi, Maria/0000-0002-1740-5405; Huber, Laurentius/0000-0002-3291-2202; Gonzalez-Castillo, Javier/0000-0002-6520-5125; Ivanov, Dimo/0000-0001-9387-5823; Handwerker, Daniel/0000-0001-7261-4042; Marrett, Sean/0000-0001-8179-6511	Initial Training Network, HiMR - Marie Curie Actions of the European Commission [FP7-PEOPLE-2012-IT-316716]; NIMH Intramural Research Program [ZIA-MH002783]; MRC [MR/N003403/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002783] Funding Source: NIH RePORTER	Initial Training Network, HiMR - Marie Curie Actions of the European Commission; NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Ingo Marquardt, Daniel Glen, Rick Reynolds, Valentin Kemper, Hendrik Mandelkow, and Adam Thomas for discussions on best analysis practices and Chris Baker, Mark Hallett, and Alan Koretsky for comments on the manuscript. Early work on depth-dependent fMRI in the motor cortex was pioneered in authors' collaborations with Robert Turner and Robert Trampel. Markus Barth contributed to early versions of the MR sequence. M.G. was supported by Initial Training Network, HiMR, funded by the FP7 Marie Curie Actions of the European Commission (FP7-PEOPLE-2012-IT-316716). The research was conducted as part of the NIMH Intramural Research Program (#ZIA-MH002783).	[Anonymous], [No title captured]; Auerbach EJ, 2013, MAGN RESON MED, V69, P1261, DOI 10.1002/mrm.24719; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Buxton RB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00139; Cajal R. Y., 1906, PHYS MEDICA, V5, P221; Caulo M, 2007, AM J NEURORADIOL, V28, P1480, DOI 10.3174/ajnr.A0597; De Martino F, 2015, P NATL ACAD SCI USA, V112, P16036, DOI 10.1073/pnas.1507552112; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fracasso A, 2016, NEUROIMAGE, V139, P427, DOI 10.1016/j.neuroimage.2016.06.048; Gagnon L., 2013, P 21 M ISMRM SALT LA, P3244; Gagnon L, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0359; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goense JBM, 2006, MAGN RESON IMAGING, V24, P381, DOI 10.1016/j.mri.2005.12.032; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; HAACKE EM, 1991, J MAGN RESON, V92, P126, DOI 10.1016/0022-2364(91)90253-P; Hall A., 2017, ANN M ORG HUM BRAIN, P3540; Hallett M, 2014, BRAIN, V138, P229; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; Heinzle J, 2016, NEUROIMAGE, V125, P556, DOI 10.1016/j.neuroimage.2015.10.025; Hua J, 2014, MAGN RESON MED, V72, P1530, DOI 10.1002/mrm.25055; Huber L., 2017, P INT SOC MAGN RES M, P5272, DOI 10.7490/f1000research.1114417.1; Huber L., 2017, P INT SOC MAGN RESON, P586, DOI 10.7490/f1000research.1114430.1; Huber L., 2016, P INT SOC MAGN RES M, P633, DOI [10.7490/f1000research.1114359.1, DOI 10.7490/F1000RESEARCH.1114359.1]; Huber L., 2016, NEUROIMAGE; Huber L, 2015, NEUROIMAGE, V107, P23, DOI 10.1016/j.neuroimage.2014.11.046; Huber L, 2014, MAGN RESON MED, V72, P137, DOI 10.1002/mrm.24916; Kashyap S., 2017, NEUROIMAGE; Kemper V. G., 2017, NEUROIMAGE; Kemper VG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00163; Kennerley AJ, 2005, MAGN RESON MED, V54, P354, DOI 10.1002/mrm.20511; Kok P, 2016, CURR BIOL, V26, P371, DOI 10.1016/j.cub.2015.12.038; Koopmans PJ, 2010, HUM BRAIN MAPP, V31, P1297, DOI 10.1002/hbm.20936; LARKIN RP, 1979, BEHAV RES METH INSTR, V11, P467, DOI 10.3758/BF03205709; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2003, MAGNET RESON MED, V50, P263, DOI 10.1002/mrm.10519; Lu HZ, 2008, MAGN RESON MED, V60, P364, DOI 10.1002/mrm.21686; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Markuerkiaga I, 2016, NEUROIMAGE, V132, P491, DOI 10.1016/j.neuroimage.2016.02.073; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Muckli L, 2015, CURR BIOL, V25, P2690, DOI 10.1016/j.cub.2015.08.057; Nichols T. E., 2008, TR08TNI FMRIB; Olman CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032536; Papale A. E., 2017, NEUROSCIENCE; Polimeni J., 2010, P INT SOC MAG RESON, V18, P353; Polimeni J.R., 2015, P INT SOC MAGN RESON, V23, P592; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Rane S, 2014, MAGN RESON IMAGING, V32, P813, DOI 10.1016/j.mri.2014.04.001; Renvall V., 2014, P INT SOC MAG RES ME, P1488; Renvall V, 2016, NEUROIMAGE, V134, P338, DOI 10.1016/j.neuroimage.2016.04.004; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Terumitsu M, 2006, NEUROREPORT, V17, P1091, DOI 10.1097/01.wnr.0000224778.97399.c4; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; Turner R., 2013, MICROSTRUCTURAL PARC, P197; Uludag K., 2017, NEUROIMAGE; van der Zwaag W., 2016, P INT SOC MAGN RES M, V24, P71; Waehnert MD, 2014, NEUROIMAGE, V93, P210, DOI 10.1016/j.neuroimage.2013.03.078; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yu X, 2014, NAT METHODS, V11, P55, DOI [10.1038/NMETH.2730, 10.1038/nmeth.2730]; Zhao FQ, 2006, NEUROIMAGE, V30, P1149, DOI 10.1016/j.neuroimage.2005.11.013	66	139	139	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2017	96	6					1253	+		10.1016/j.neuron.2017.11.005	http://dx.doi.org/10.1016/j.neuron.2017.11.005			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR2MD	29224727	Green Accepted, Bronze, Green Published			2022-12-17	WOS:000418900200009
J	Gremel, CM; Chancey, JH; Atwood, BK; Luo, GX; Neve, R; Ramakrishnan, C; Deisseroth, K; Lovinger, DM; Costa, RM				Gremel, Christina M.; Chancey, Jessica H.; Atwood, Brady K.; Luo, Guoxiang; Neve, Rachael; Ramakrishnan, Charu; Deisseroth, Karl; Lovinger, David M.; Costa, Rui M.			Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation	NEURON			English	Article							GOAL-DIRECTED BEHAVIOR; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; CANNABINOID RECEPTORS; DORSOMEDIAL STRIATUM; SYNAPTIC MODULATION; DORSAL STRIATUM; ALCOHOL SEEKING; ORBITAL CORTEX; ADDICTION	Everyday function demands efficient and flexible decision-making that allows for habitual and goal-directed action control. An inability to shift has been implicated in disorders with impaired decision-making, including obsessive-compulsive disorder and addiction. Despite this, our understanding of the specific molecular mechanisms and circuitry involved in shifting action control remains limited. Here we identify an endogenous molecular mechanism in a specific cortical-striatal pathway that mediates the transition between goal-directed and habitual action strategies. Deletion of cannabinoid type 1 (CB1) receptors from cortical projections originating in the orbital frontal cortex (OFC) prevents mice from shifting from goal-directed to habitual instrumental lever pressing. Activity of OFC neurons projecting to dorsal striatum (OFC-DS) and, specifically, activity of OFC-DS terminals is necessary for goal-directed action control. Lastly, CB1 deletion from OFC-DS neurons prevents the shift from goal-directed to habitual action control. These data suggest that the emergence of habits depends on endocannabinoid-mediated attenuation of a competing circuit controlling goal-directed behaviors.	[Gremel, Christina M.; Chancey, Jessica H.; Atwood, Brady K.; Luo, Guoxiang; Lovinger, David M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Gremel, Christina M.] Univ Calif San Diego, Dept Psychol, Neurosci Grad Program, La Jolla, CA 92093 USA; [Neve, Rachael] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Costa, Rui M.] Champalimaud Inst Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Stanford University; Fundacao Champalimaud	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA.; Costa, RM (corresponding author), Champalimaud Inst Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal.	lovindav@mail.nih.gov; rui.costa@neuro.fchampalimaud.org	Atwood, Brady/AAJ-6852-2021; Atwood, Brady/AAA-4400-2021	Atwood, Brady/0000-0002-7441-2724; Costa, Rui M./0000-0003-0495-8374; Chancey, Jessica/0000-0002-8807-3938	NIAAA Division of Intramural Clinical and Biological Research, ERA-NET; European Research Council [COG 617142]; HHMI [IEC 55007415]; Pathway to Independence Award [R00 AA021780]; NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, R00AA021780] Funding Source: NIH RePORTER	NIAAA Division of Intramural Clinical and Biological Research, ERA-NET; European Research Council(European Research Council (ERC)European Commission); HHMI(Howard Hughes Medical Institute); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Matthew Pava for assistance in the electrophysiological experiments and Emily Baltz for assistance with intracranial surgeries. We thank Drs. Beat Lutz and Giovanni Marsicano for providing the Cnr1<SUP>loxP/loxP</SUP> mice. The DREADD virus was provided by the Gene Therapy and Vector Core at the University of North Carolina. This research was supported by the NIAAA Division of Intramural Clinical and Biological Research, ERA-NET; European Research Council (COG 617142) and HHMI (IEC 55007415) grants to R.M.C.; and Pathway to Independence Award R00 AA021780 and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation to C.M.G.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2013, CURR OPIN NEUROBIOL, V23, P564, DOI 10.1016/j.conb.2013.01.025; Bradfield LA, 2015, NEURON, V88, P1268, DOI 10.1016/j.neuron.2015.10.044; Burguiere E, 2015, CURR OPIN NEUROBIOL, V30, P59, DOI 10.1016/j.conb.2014.08.008; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; COLWILL RM, 1985, J EXP PSYCHOL ANIM B, V11, P120, DOI 10.1037/0097-7403.11.1.120; Corbit LH, 2012, BIOL PSYCHIAT, V72, P389, DOI 10.1016/j.biopsych.2012.02.024; Depoy L, 2013, P NATL ACAD SCI USA, V110, P14783, DOI 10.1073/pnas.1308198110; DeRusso AL, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00017; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dickinson A, 2002, Q J EXP PSYCHOL-B, V55, P331, DOI 10.1080/0272499024400016; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gourley SL, 2013, EUR J NEUROSCI, V38, P2382, DOI 10.1111/ejn.12239; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Gremel CM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3264; Griffiths KR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00101; Hilario M, 2012, EUR J NEUROSCI, V35, P1105, DOI 10.1111/j.1460-9568.2012.08073.x; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Hoover WB, 2011, J COMP NEUROL, V519, P3766, DOI 10.1002/cne.22733; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; Nazzaro C, 2012, NAT NEUROSCI, V15, P284, DOI 10.1038/nn.3022; Ostlund SB, 2007, ANN NY ACAD SCI, V1121, P174, DOI 10.1196/annals.1401.033; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rhodes SEV, 2013, J NEUROSCI, V33, P3380, DOI 10.1523/JNEUROSCI.4374-12.2013; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Rothermel M, 2013, J NEUROSCI, V33, P15195, DOI 10.1523/JNEUROSCI.1618-13.2013; Samson HH, 2004, ALCOHOL, V32, P203, DOI 10.1016/j.alcohol.2004.02.002; Schilman EA, 2008, NEUROSCI LETT, V432, P40, DOI 10.1016/j.neulet.2007.12.024; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Smith KS, 2013, NEURON, V79, P361, DOI 10.1016/j.neuron.2013.05.038; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Stalnaker TA, 2015, NAT NEUROSCI, V18, P620, DOI 10.1038/nn.3982; Stalnaker TA, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00012; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	56	139	139	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2016	90	6					1312	1324		10.1016/j.neuron.2016.04.043	http://dx.doi.org/10.1016/j.neuron.2016.04.043			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP5HT	27238866	Bronze, Green Accepted			2022-12-17	WOS:000378527600018
J	Jang, S; Nelson, JC; Bend, EG; Rodriguez-Laureano, L; Tueros, FG; Cartagenova, L; Underwood, K; Jorgensen, EM; Colon-Ramos, DA				Jang, SoRi; Nelson, Jessica C.; Bend, Eric G.; Rodriguez-Laureano, Lucelenie; Tueros, Felipe G.; Cartagenova, Luis; Underwood, Katherine; Jorgensen, Erik M.; Colon-Ramos, Daniel A.			Glycolytic Enzymes Localize to Synapses under Energy Stress to Support Synaptic Function	NEURON			English	Article							NERVOUS-SYSTEM; METABOLISM; PROTEIN; ATP; MITOCHONDRIA; VESICLES; DIFFERENTIATION; COLOCALIZATION; DEHYDROGENASE; ORGANIZATION	Changes in neuronal activity create local and transient changes in energy demands at synapses. Here we discover a metabolic compartment that forms in vivo near synapses to meet local energy demands and support synaptic function in Caenorhabditis elegans neurons. Under conditions of energy stress, glycolytic enzymes redistribute from a diffuse localization in the cytoplasm to a punctate localization adjacent to synapses. Glycolytic enzymes colocalize, suggesting the ad hoc formation of a glycolysis compartment, or a "glycolytic metabolon,'' that can maintain local levels of ATP. Local formation of the glycolytic metabolon is dependent on presynaptic scaffolding proteins, and disruption of the glycolytic metabolon blocks the synaptic vesicle cycle, impairs synaptic recovery, and affects locomotion. Our studies indicate that under energy stress conditions, energy demands in C. elegans synapses are met locally through the assembly of a glycolytic metabolon to sustain synaptic function and behavior.	[Jang, SoRi; Nelson, Jessica C.; Rodriguez-Laureano, Lucelenie; Cartagenova, Luis; Underwood, Katherine; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, POB 9812, New Haven, CT 06536 USA; [Jang, SoRi; Nelson, Jessica C.; Rodriguez-Laureano, Lucelenie; Cartagenova, Luis; Underwood, Katherine; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Neurosci, POB 9812, New Haven, CT 06536 USA; [Bend, Eric G.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA; [Tueros, Felipe G.] Univ Ricardo Palma, Fac Ciencias Biol, Lab Microbiol, POB 1801, Lima 33, Peru; [Jang, SoRi; Nelson, Jessica C.; Colon-Ramos, Daniel A.] Univ Puerto Rico, Inst Neurobiol, Recinto Ciencias Med, 201 Blvd Valle, San Juan, PR 00901 USA	Yale University; Yale University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Universidad Ricardo Palma; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Colon-Ramos, DA (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, POB 9812, New Haven, CT 06536 USA.; Colon-Ramos, DA (corresponding author), Yale Univ, Sch Med, Dept Neurosci, POB 9812, New Haven, CT 06536 USA.; Colon-Ramos, DA (corresponding author), Univ Puerto Rico, Inst Neurobiol, Recinto Ciencias Med, 201 Blvd Valle, San Juan, PR 00901 USA.	daniel.colon-ramos@yale.edu	Bend, Eric/AAT-6739-2020	Jang, SoRi/0000-0002-9156-552X; Tueros Farfan, Felipe Gonzalo/0000-0003-1649-9291; Nelson, Jessica/0000-0001-7528-4245	NIH [P40 OD010440, R01 NS034307]; Mitani lab (Tokyo Women's Medical University School of Medicine); Klingenstein Foundation [R01 NS076558]; Alfred P. Sloan Foundation; March of Dimes Research Grant; NSF [0920069]; Cellular, Biochemical, and Molecular Sciences Predoctoral Training Program [T32 GM007223]; Universidad Ricardo Palma, Peru and the Research Experience for Peruvian Undergraduates (REPU) program;  [5 T32 NS 41228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041228, R01NS034307, R01NS076558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitani lab (Tokyo Women's Medical University School of Medicine); Klingenstein Foundation(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); March of Dimes Research Grant(March of Dimes); NSF(National Science Foundation (NSF)); Cellular, Biochemical, and Molecular Sciences Predoctoral Training Program; Universidad Ricardo Palma, Peru and the Research Experience for Peruvian Undergraduates (REPU) program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Bai, M. Zhen, J. Dittman, A. Esquibies, M. Hammarlund, M. Koelle, P. Lusk, R. Rawson, S. Margolis, S. Han, and members of the D.A.C.-R. lab for strains, reagents, and advice on the project. We thank J. Kim and A. Gitler for sharing unpublished data and advice. We thank N. Cook, J. Belina, and M. Omar for technical assistance. Some strains were provided by the CGC, which is funded by NIH (P40 OD010440) and by the Mitani lab (Tokyo Women's Medical University School of Medicine). Yuji Kohara (National Institute of Genetics) provided the pfk-1.1 cDNA clone. This work was funded by the following grants: to D.A.C.-R., R01 NS076558, a fellowship from the Klingenstein Foundation and the Alfred P. Sloan Foundation, and a March of Dimes Research Grant, and to E.M.J., NIH R01 NS034307 and NSF 0920069. S.J. was supported by the Cellular, Biochemical, and Molecular Sciences Predoctoral Training Program (T32 GM007223). E.M.J. is an Investigator of the Howard Hughes Medical Institute. J.C.N. was supported by a training grant 5 T32 NS 41228. L.R.-L. was supported by a diversity supplement to R01 NS076558. F.G.T. was supported by a fellowship from Universidad Ricardo Palma, Peru and the Research Experience for Peruvian Undergraduates (REPU) program.	Altun Z.F., 2016, BMC DEV BIOL, V8, P38; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BOGUCKA K, 1966, BIOCHIM BIOPHYS ACTA, V122, P381, DOI 10.1016/0926-6593(66)90031-2; BRONSTEIN WW, 1981, CAN J BIOCHEM CELL B, V59, P494, DOI 10.1139/o81-069; BROOKS SPJ, 1991, FEBS LETT, V278, P135, DOI 10.1016/0014-5793(91)80101-8; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; CHAPPELL JB, 1961, NATURE, V190, P502, DOI 10.1038/190502a0; Chavan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125185; CHERUBINI E, 1989, J NEUROPHYSIOL, V62, P882, DOI 10.1152/jn.1989.62.4.882; CLARKE FM, 1975, BIOCHIM BIOPHYS ACTA, V381, P37, DOI 10.1016/0304-4165(75)90187-7; COHEN PJ, 1972, ANESTHESIOLOGY, V37, P148, DOI 10.1097/00000542-197208000-00007; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Gjedde A, 2001, J CEREBR BLOOD F MET, V21, P1384, DOI 10.1097/00004647-200112000-00002; GOLD AE, 1995, PSYCHOPHARMACOLOGY, V119, P325, DOI 10.1007/BF02246299; Haanstra J.R., 2015, BIOCH BIOPHYS ACTA; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hubley MJ, 1996, BBA-GEN SUBJECTS, V1291, P115, DOI 10.1016/0304-4165(96)00053-0; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Ishida A, 2009, NEUROCHEM RES, V34, P807, DOI 10.1007/s11064-008-9833-3; KNULL HR, 1980, J BIOL CHEM, V255, P6439; KNULL HR, 1985, COMP BIOCHEM PHYS B, V81, P349, DOI 10.1016/0305-0491(85)90324-4; KNULL HR, 1980, J NEUROCHEM, V34, P222, DOI 10.1111/j.1471-4159.1980.tb04646.x; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KURGANOV BI, 1985, J THEOR BIOL, V116, P509, DOI 10.1016/S0022-5193(85)80086-2; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lin MY, 2015, EXP CELL RES, V334, P35, DOI 10.1016/j.yexcr.2015.01.004; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Magistretti P. J., 2013, NEUROSCIENCE 21 CENT, DOI [10.1007/978-1-4614-1997-6_56, DOI 10.1007/978-1-4614-1997-6_56]; MASTERS C, 1991, MECH AGEING DEV, V61, P11, DOI 10.1016/0047-6374(91)90003-I; MASTERS C, 1984, J CELL BIOL, V99, pS222, DOI 10.1083/jcb.99.1.222s; Menard Lynda, 2014, Biology - Basel, V3, P623, DOI 10.3390/biology3030623; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; Nelson JC, 2013, J NEUROSCI, V33, P1366, DOI 10.1523/JNEUROSCI.3471-12.2012; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pitts KR, 2004, AM J PHYSIOL-HEART C, V287, pH1801, DOI 10.1152/ajpheart.00232.2004; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rawson RL, 2014, CURR BIOL, V24, P760, DOI 10.1016/j.cub.2014.02.025; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sullivan DT, 2003, J EXP BIOL, V206, P2031, DOI 10.1242/jeb.00367; Tanaka K, 2011, J CELL SCI, V124, P2457, DOI 10.1242/jcs.086470; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; URETA T, 1985, ARCH BIOL MED EXP, V18, P9; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Wagner OI, 2009, P NATL ACAD SCI USA, V106, P19605, DOI 10.1073/pnas.0902949106; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Waters J, 2003, PFLUG ARCH EUR J PHY, V447, P363, DOI 10.1007/s00424-003-1182-0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wojtas K, 1997, MOL BIOL CELL, V8, P1665, DOI 10.1091/mbc.8.9.1665; WOODWARD GE, 1954, CANCER RES, V14, P599; Wu K, 1997, P NATL ACAD SCI USA, V94, P13273, DOI 10.1073/pnas.94.24.13273; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zhou LF, 2005, AM J PHYSIOL-HEART C, V288, pH2400, DOI 10.1152/ajpheart.01030.2004	67	139	139	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2016	90	2					278	291		10.1016/j.neuron.2016.03.011	http://dx.doi.org/10.1016/j.neuron.2016.03.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ8ZV	27068791	Bronze, Green Accepted, Green Submitted			2022-12-17	WOS:000374504400010
J	Tran, H; Almeida, S; Moore, J; Gendron, TF; Chalasani, U; Lu, YB; Du, X; Nickerson, JA; Petrucelli, L; Weng, ZP; Gao, FB				Tran, Helene; Almeida, Sandra; Moore, Jill; Gendron, Tania F.; Chalasani, UmaDevi; Lu, Yubing; Du, Xing; Nickerson, Jeffrey A.; Petrucelli, Leonard; Weng, Zhiping; Gao, Fen-Biao			Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS	NEURON			English	Article							HEXANUCLEOTIDE REPEAT; FRONTOTEMPORAL DEMENTIA; ANTISENSE TRANSCRIPTS; GGGGCC REPEAT; TRANSLATION; EXPANSION; ALS; C9FTD/ALS; POLY(GA); LEAD	Dipeptide repeat (DPR) proteins are toxic in various models of FTD/ALS with GGGGCC (G(4)C(2)) repeat expansion. However, it is unclear whether nuclear G(4)C(2) RNA foci also induce neurotoxicity. Here, we describe a Drosophila model expressing 160 G(4)C(2) repeats (160R) flanked by human intronic and exonic sequences. Spliced intronic 160R formed nuclear G(4)C(2) sense RNA foci in glia and neurons about ten times more abundantly than in human neurons; however, they had little effect on global RNA processing and neuronal survival. In contrast, highly toxic 36R in the context of poly(A)(+) mRNA were exported to the cytoplasm, where DPR proteins were produced at >100-fold higher level than in 160R flies. Moreover, the modest toxicity of intronic 160R expressed at higher temperature correlated with increased DPR production, but not RNA foci. Thus, nuclear RNA foci are neutral intermediates or possibly neuroprotective through preventing G(4)C(2) RNA export and subsequent DPR production.	[Tran, Helene; Almeida, Sandra; Chalasani, UmaDevi; Lu, Yubing; Du, Xing; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Moore, Jill; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Gendron, Tania F.; Petrucelli, Leonard] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA; [Nickerson, Jeffrey A.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic; University of Massachusetts System; University of Massachusetts Worcester	Gao, FB (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	fen-biao.gao@umassmed.edu	Du, Xing/P-5179-2015; Lu, Yubing/G-2644-2011	Du, Xing/0000-0002-0599-4409; Lu, Yubing/0000-0002-7715-9867	ALS Association Milton Safenowitz Postdoctoral Fellowship; ALS Therapy Alliance; Mayo Clinic Foundation; Department of Defense [ALSRP AL130125]; ALS Association; National Institutes of Health [R01NS057553, R01NS079725, R21NS086318]; Packard Center for ALS Research and Target ALS;  [P50AG016574];  [R21NS084528];  [R01NS088689];  [R01NS063964];  [R01NS077402];  [P01NS084974];  [P01HD078253];  [R21NS089979]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS089979, P01NS084974, R01NS079725, R01NS088689, R21NS084528, R01NS063964, R01NS077402, R01NS057553, R21NS086318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574] Funding Source: NIH RePORTER	ALS Association Milton Safenowitz Postdoctoral Fellowship; ALS Therapy Alliance; Mayo Clinic Foundation; Department of Defense(United States Department of Defense); ALS Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Center for ALS Research and Target ALS; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Ladam, P.-H. Wu, E. Ricci, Z. Zhang, S. Ordway, and Gao lab members for comments; the Bloomington Drosophila Stock Center for 36R and other fly lines; and the UMMS Department of Cell and Developmental Biology Confocal Core for use of their microscopes. We also thank L. Ranum for anti-GR antibody, E. Baehrecke for anti-p62 antibody, and W. Seeley (Neurodegenerative Disease Brain Bank at the University of California, San Francisco) for brain tissues of C9ORF72 patients. This work was supported by an ALS Association Milton Safenowitz Postdoctoral Fellowship (H.T.); a grant from ALS Therapy Alliance (F.-B.G.); Mayo Clinic Foundation (L.P.); grants from the Department of Defense (ALSRP AL130125), the ALS Association, Packard Center for ALS Research and Target ALS (F.-B.G. and L.P.). This work was also supported by grants from the National Institutes of Health: R01NS057553, R01NS079725, and R21NS086318 (F.-B.G.); P50AG016574, R21NS084528, R01NS088689, and R01NS063964; R01NS077402 and P01NS084974 (L.P.); P01HD078253 (Z.W.); and R21NS089979 (T.F.G.).	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hesselberth JR, 2013, WIRES RNA, V4, P677, DOI 10.1002/wrna.1187; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mohan A, 2014, BRAIN RES, V1584, P3, DOI 10.1016/j.brainres.2014.03.039; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yang DJ, 2015, ACTA NEUROPATHOL, V130, P525, DOI 10.1007/s00401-015-1448-6; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	33	139	139	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 23	2015	87	6					1207	1214		10.1016/j.neuron.2015.09.015	http://dx.doi.org/10.1016/j.neuron.2015.09.015			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8HJ	26402604	Bronze, Green Accepted			2022-12-17	WOS:000363782200011
J	Rubin, DB; Van Hooser, SD; Miller, KD				Rubin, Daniel B.; Van Hooser, Stephen D.; Miller, Kenneth D.			The Stabilized Supralinear Network: A Unifying Circuit Motif Underlying Multi-Input Integration in Sensory Cortex	NEURON			English	Article							PRIMARY VISUAL-CORTEX; MACAQUE V1 NEURONS; RECEPTIVE-FIELD PROPERTIES; SURROUND SUPPRESSION; SPATIAL SUMMATION; CONTRAST-DEPENDENCE; BALANCED EXCITATION; AREA V4; IN-VIVO; INHIBITION	Neurons in sensory cortex integrate multiple influences to parse objects and support perception. Across multiple cortical areas, integration is characterized by two neuronal response properties: (1) surround suppression-modulatory contextual stimuli suppress responses to driving stimuli; and (2) "normalization''-responses to multiple driving stimuli add sublinearly. These depend on input strength: for weak driving stimuli, contextual influences facilitate or more weakly suppress and summation becomes linear or supralinear. Understanding the circuit operations underlying integration is critical to understanding cortical function and disease. We present a simple, general theory. A wealth of integrative properties, including the above, emerge robustly from four cortical circuit properties: (1) supralinear neuronal input/output functions; (2) sufficiently strong recurrent excitation; (3) feedback inhibition; and (4) simple spatial properties of intracortical connections. Integrative properties emerge dynamically as circuit properties, with excitatory and inhibitory neurons showing similar behaviors. In new recordings in visual cortex, we confirm key model predictions.	[Rubin, Daniel B.; Miller, Kenneth D.] Columbia Univ, Coll Phys & Surg, Doctoral Program Neurobiol & Behav, Ctr Theoret Neurosci, New York, NY 10032 USA; [Miller, Kenneth D.] Columbia Univ, Coll Phys & Surg, Swartz Program Theoret Neurosci, Dept Neurosci, New York, NY 10032 USA; [Van Hooser, Stephen D.] Brandeis Univ, Dept Biol, Swartz Ctr Theoret Biol, Waltham, MA 02454 USA	Columbia University; Columbia University; Brandeis University	Miller, KD (corresponding author), Columbia Univ, Coll Phys & Surg, Doctoral Program Neurobiol & Behav, Ctr Theoret Neurosci, New York, NY 10032 USA.	ken@neurotheory.columbia.edu		Rubin, Daniel/0000-0001-6982-9587	Gatsby Charitable Foundation; Medical Scientist Training Program [5 T32 GM007367-36]; NIH [P30NS069339]; Massachusetts Life Sciences Center; John Merck Foundation;  [R01-EY11001]; NATIONAL EYE INSTITUTE [R01EY022122, R01EY011001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069339] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Sciences Center; John Merck Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Larry Abbott, Yashar Ahmadian, Anne Churchland, David Ferster, Mark Goldman, Giancarlo LaCamera, Ashok Litwin-Kumar, Arianna Maffei, and Steve Siegelbaum for helpful comments; Liam Paninski for help with analysis of experimental data; and Jared Clemens for help with physiological recordings. Work supported by R01-EY11001 to K.D.M.; the Gatsby Charitable Foundation (K.D.M.); Medical Scientist Training Program grant 5 T32 GM007367-36 (D.B.R.); and a faculty startup grant from NIH P30NS069339 and grants from the Massachusetts Life Sciences Center and the John Merck Foundation (S.V.H.).	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; Ahmadian Y, 2013, NEURAL COMPUT, V25, P1994, DOI 10.1162/NECO_a_00472; Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanaugh J, 2012, J NEUROSCI, V32, P12284, DOI 10.1523/JNEUROSCI.0864-12.2012; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Ermentrout GB., 2010, MATH FDN NEUROSCIENC, Vvol 35; Falkner AL, 2010, J NEUROSCI, V30, P12787, DOI 10.1523/JNEUROSCI.2327-10.2010; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kaschube M, 2014, CURR OPIN NEUROBIOL, V24, P95, DOI 10.1016/j.conb.2013.08.017; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Pecka M, 2014, NEURON, V84, P457, DOI 10.1016/j.neuron.2014.09.010; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Qian N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00077; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sachdev RNS, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00043; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schwabe L, 2010, NEUROIMAGE, V52, P777, DOI 10.1016/j.neuroimage.2010.01.032; Sengpiel F, 2005, J NEUROSCI, V25, P6394, DOI 10.1523/JNEUROSCI.0862-05.2005; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Shao YR, 2013, NEURON, V80, P210, DOI 10.1016/j.neuron.2013.07.026; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Song XM, 2008, CEREB CORTEX, V18, P331, DOI 10.1093/cercor/bhm057; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Tanaka H, 2009, J NEUROPHYSIOL, V101, P1444, DOI 10.1152/jn.90749.2008; Teichert T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-38; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Tsui JMG, 2011, J NEUROPHYSIOL, V106, P1888, DOI 10.1152/jn.00165.2011; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Vanni MP, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00078; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Wang C, 2009, J VISION, V9, DOI 10.1167/9.1.20; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Zhou M, 2014, NAT NEUROSCI, V17, P841, DOI 10.1038/nn.3701	54	139	140	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 21	2015	85	2					402	417		10.1016/j.neuron.2014.12.026	http://dx.doi.org/10.1016/j.neuron.2014.12.026			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ5ZB	25611511	Green Accepted, Bronze			2022-12-17	WOS:000348296000017
J	Jeong, YT; Shim, J; Oh, SR; Yoon, HI; Kim, CH; Moon, SJ; Montell, C				Jeong, Yong Taek; Shim, Jaewon; Oh, So Ra; Yoon, Hong In; Kim, Chul Hoon; Moon, Seok Jun; Montell, Craig			An Odorant-Binding Protein Required for Suppression of Sweet Taste by Bitter Chemicals	NEURON			English	Article							PHEROMONE-BINDING; OLFACTORY RECEPTORS; MOLECULAR EVOLUTION; GUSTATORY RECEPTORS; CAFFEINE RESPONSE; DROSOPHILA; EXPRESSION; FAMILY; GENES; MUTANTS	Animals often must decide whether or not to consume a diet that contains competing attractive and aversive compounds. Here, using the fruit fly, Drosophila melanogaster, we describe a mechanism that influences this decision. Addition of bitter compounds to sucrose suppressed feeding behavior, and this inhibition depended on an odorant-binding protein (OBP) termed OBP49a. In wild-type flies, bitter compounds suppressed sucrose-induced action potentials, and the inhibition was impaired in Obp49a mutants. However, loss of OBP49a did not affect action potentials in sugar- or bitter-activated gustatory receptor neurons (GRNs) when the GRNs were presented with just one type of tastant. OBP49a was expressed in accessory cells and acted non-cell-autonomously to attenuate nerve firings in sugar-activated GRNs when bitter compounds were combined with sucrose. These findings demonstrate an unexpected role for an OBP in taste and identify a molecular player involved in the integration of opposing attractive and aversive gustatory inputs.	[Jeong, Yong Taek; Shim, Jaewon; Moon, Seok Jun] Yonsei Univ, Coll Dent, Dept Oral Biol, Project BK21, Seoul 120752, South Korea; [Oh, So Ra; Yoon, Hong In; Kim, Chul Hoon] Yonsei Univ, Coll Med, Dept Pharmacol, Project BK21, Seoul 120752, South Korea; [Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93110 USA; [Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93110 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Moon, SJ (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol, Project BK21, 250 Seongsanno, Seoul 120752, South Korea.	sjmoon@yuhs.ac; craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Jeong, Yong Taek/0000-0003-0067-6396; Moon, Seok Jun/0000-0001-7282-2888; Kim, Chul Hoon/0000-0002-7360-429X; Yoon, Hong In/0000-0002-2106-6856	NICHD; NIDCD [DC007864]; Converging Research Center Program; Ministry of Education, Science, and Technology [2012K001350, 2009-0075341, 2012R1A1A1012081]; Basic Science Research Program through National Research Foundation of Korea; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Converging Research Center Program; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank FlyBase, the Bloomington Stock Center and Drs. K. Scott, L. Vosshall, J.W. Posakony, and Y.D. Chung for fly stocks, and Dr. C.Y. Park and Mr. J. Song at the Surface Plasmon Resonance Facility, UNIST, for technical help. The tubulin monoclonal antibody developed by Drs. J. Frankel and E.M. Nelsen was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology, University of Iowa (Iowa City, IA). This work was supported by a grant to C.M. from the NIDCD (DC007864) and by grants to S.J.M. from the Converging Research Center Program funded by the Ministry of Education, Science, and Technology (2012K001350) and from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2009-0075341 and 2012R1A1A1012081).	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Formaker BK, 1997, BRAIN RES, V772, P239, DOI 10.1016/S0006-8993(97)00845-7; Galindo K, 2001, GENETICS, V159, P1059; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Glendinning JI, 2007, BIOL BULL-US, V213, P252, DOI 10.2307/25066643; Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Harada E, 2008, GENES GENET SYST, V83, P257, DOI 10.1266/ggs.83.257; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Koganezawa M, 2002, CHEM SENSES, V27, P319, DOI 10.1093/chemse/27.4.319; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Ogawa K, 1997, BRAIN RES, V769, P263, DOI 10.1016/S0006-8993(97)00729-4; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Vandenbeuch A, 2004, NEUROSCI LETT, V358, P137, DOI 10.1016/j.neulet.2004.01.013; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yasukawa J, 2010, GENE, V467, P25, DOI 10.1016/j.gene.2010.07.006; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	56	139	144	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					725	737		10.1016/j.neuron.2013.06.025	http://dx.doi.org/10.1016/j.neuron.2013.06.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972598	Bronze, Green Accepted			2022-12-17	WOS:000323587000012
J	Badre, D; Doll, BB; Long, NM; Frank, MJ				Badre, David; Doll, Bradley B.; Long, Nicole M.; Frank, Michael J.			Rostrolateral Prefrontal Cortex and Individual Differences in Uncertainty-Driven Exploration	NEURON			English	Article							DECISION-MAKING; FRONTOPOLAR CORTEX; COGNITIVE CONTROL; TRADE-OFF; EXPLOITATION; INFORMATION; INTEGRATION; MECHANISMS; HIERARCHY; DOPAMINE	How do individuals decide to act based on a rewarding status quo versus an unexplored choice that might yield a better outcome? Recent evidence suggests that individuals may strategically explore as a function of the relative uncertainty about the expected value of options. However, the neural mechanisms supporting uncertainty-driven exploration remain underspecified. The present fMRI study scanned a reinforcement learning task in which participants stop a rotating clock hand in order to win points. Reward schedules were such that expected value could increase, decrease, or remain constant with respect to time. We fit several mathematical models to subject behavior to generate trial-by-trial estimates of exploration as a function of relative uncertainty. These estimates were used to analyze our fMRI data. Results indicate that rostrolateral prefrontal cortex tracks trial-by-trial changes in relative uncertainty, and this pattern distinguished individuals who rely on relative uncertainty for their exploratory decisions versus those who do not.	[Badre, David; Doll, Bradley B.; Long, Nicole M.; Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Brown Inst Brain Sci, Providence, RI 02912 USA	Brown University	Badre, D (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Brown Inst Brain Sci, Providence, RI 02912 USA.	david_badre@brown.edu; michael_frank@brown.edu			National Institute of Neurological Disease and Stroke [R01 NS065046]; National Institute of Mental Health [R01 MH080066-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065046] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present work was supported by a National Institute of Neurological Disease and Stroke R01 NS065046 awarded to DB and a National Institute of Mental Health R01 MH080066-01 awarded to MJF.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Bunge SA, 2009, NEURON, V62, P609, DOI 10.1016/j.neuron.2009.05.020; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 1996, MACH LEARN, V25, P5, DOI 10.1023/A:1018357105171; Doll BB, 2009, HANDBOOK OF REWARD AND DECISION MAKING, P399, DOI 10.1016/B978-0-12-374620-7.00019-4; ELLSBERG, 1961, Q J ECON, V75, P643, DOI DOI 10.2307/1884324; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gittins J.C., 1974, STATISTICS, P241; Han S, 2009, J COGNITIVE NEUROSCI, V21, P922, DOI 10.1162/jocn.2009.21060; Jepma M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00170; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Krawczyk DC, 2011, CORTEX, V47, P588, DOI 10.1016/j.cortex.2010.04.008; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Speed A, 2010, COGN NEUROSCI-UK, V1, P126, DOI 10.1080/17588921003660728; Strauss GP, 2011, BIOL PSYCHIAT, V69, P424, DOI 10.1016/j.biopsych.2010.10.015; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Wallis JD, 2010, NAT NEUROSCI, V13, P7, DOI 10.1038/nn0110-7; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	40	139	141	2	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					595	607		10.1016/j.neuron.2011.12.025	http://dx.doi.org/10.1016/j.neuron.2011.12.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325209	Green Accepted, Bronze			2022-12-17	WOS:000300140600018
J	Lodato, S; Rouaux, C; Quast, KB; Jantrachotechatchawan, C; Studer, M; Hensch, TK; Arlotta, P				Lodato, Simona; Rouaux, Caroline; Quast, Kathleen B.; Jantrachotechatchawan, Chanati; Studer, Michele; Hensch, Takao K.; Arlotta, Paola			Excitatory Projection Neuron Subtypes Control the Distribution of Local Inhibitory Interneurons in the Cerebral Cortex	NEURON			English	Article							CORTICAL GABAERGIC INTERNEURONS; TANGENTIAL MIGRATION; IN-VIVO; IMMUNOREACTIVE NEURONS; GANGLIONIC EMINENCE; CELLULAR-PATTERNS; CORPUS-CALLOSUM; NERVOUS-SYSTEM; ADULT MICE; MOUSE	In the mammalian cerebral cortex, the developmental events governing the integration of excitatory projection neurons and inhibitory interneurons into balanced local circuitry are poorly understood. We report that different subtypes of projection neurons uniquely and differentially determine the laminar distribution of cortical interneurons. We find that in Fezf2(-/-) cortex, the exclusive absence of subcerebral projection neurons and their replacement by callosal projection neurons cause distinctly abnormal lamination of interneurons and altered GABAergic inhibition. In addition, experimental generation of either corticofugal neurons or callosal neurons below the cortex is sufficient to recruit cortical interneurons to these ectopic locations. Strikingly, the identity of the projection neurons generated, rather than strictly their birthdate, determines the specific types of interneurons recruited. These data demonstrate that in the neocortex individual populations of projection neurons cell-extrinsically control the laminar fate of interneurons and the assembly of local inhibitory circuitry.	[Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lodato, Simona; Rouaux, Caroline; Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Lodato, Simona; Rouaux, Caroline; Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Quast, Kathleen B.; Hensch, Takao K.] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Studer, Michele] INSERM, U636, F-06108 Nice, France; [Studer, Michele] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, F-06108 Nice, France; [Lodato, Simona; Studer, Michele] European Sch Mol Med SEMM, Naples, Italy	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	paola_arlotta@hms.harvard.edu	Rouaux, Caroline/O-1712-2017; Lodato, Simona/A-3525-2017; Studer, Michele/P-4580-2016	Rouaux, Caroline/0000-0002-5724-2903; Lodato, Simona/0000-0001-6498-2590; Studer, Michele/0000-0001-7105-2957	NIH [NS062849, 1DP1 OD 003699-01]; Harvard Stem Cell Institute; Ellison Medical Foundation; European School of Molecular Medicine; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); European School of Molecular Medicine; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Jeffrey Macklis and Bradley Molyneaux for reagents and insightful advice; Antonio Simeone, Antonio Baldini, and Tommaso Russo for serving on S.L.'s dissertation committee and for their comments; Oscar Mann for critical input during early stages of this study; Tracy Pearse-Young for sharing the APP shRNA construct and for help with electroporations in the rat; Roberto Rusconi for support with cell counting; Jeffrey Macklis, Verne Caviness, Eiman Azim, Giulio Srubek Tomassy, Feng Zhang, and Anne Goodwin for their careful reading of the manuscript and comments; Robert Hevner, Carlos Lois, John Rubenstein, Vassilis Pachnis, and Andre Goffinet for generous sharing of antibodies, cDNA clones, and expression vectors; Yuchio Yanagawa for sharing the GAD67::GFP mice; Alyssa Meleski, Amanda Merlino, and Zachary Trayes-Gibson for outstanding technical support; and Claudio Mare for schematic drawings. This work was partially supported by grants from the NIH (NS062849) and the Harvard Stem Cell Institute to P.A. and the NIH Director's Pioneer Award (1DP1 OD 003699-01) and Ellison Medical Foundation to T.K.H. S.L. was partially supported by a predoctoral fellowship from the European School of Molecular Medicine (S.E.M.M.) and C.R. was partially supported by a Milton-Safenowitz postdoctoral fellowship from the ALS Association.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Bayer S.A., 1991, NEOCORTICAL DEV; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Elias LAB, 2008, NEURON, V59, P679, DOI 10.1016/j.neuron.2008.08.017; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hammond V, 2006, J NEUROSCI, V26, P1646, DOI 10.1523/JNEUROSCI.3651-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Liapi A, 2008, DEV NEUROSCI-BASEL, V30, P117, DOI 10.1159/000109857; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; PEDUZZI JD, 1988, J NEUROSCI, V8, P920; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Polleux F, 2002, DEVELOPMENT, V129, P3147; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Tanaka DH, 2010, CEREB CORTEX, V20, P2810, DOI 10.1093/cercor/bhq027; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yabut O, 2007, BRAIN RES, V1140, P75, DOI 10.1016/j.brainres.2005.09.070; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	67	139	139	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					763	779		10.1016/j.neuron.2011.01.015	http://dx.doi.org/10.1016/j.neuron.2011.01.015			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338885	Green Accepted, Bronze			2022-12-17	WOS:000288413200017
J	Kawabe, H; Neeb, A; Dimova, K; Young, SM; Takeda, M; Katsurabayashi, S; Mitkovski, M; Malakhova, OA; Zhang, DE; Ulmilkawa, M; Kariya, K; Goebbels, S; Nave, KA; Rosenmund, C; Jahn, O; Rhee, J; Brose, N				Kawabe, Hiroshi; Neeb, Antje; Dimova, Kalina; Young, Samuel M., Jr.; Takeda, Michiko; Katsurabayashi, Shutaro; Mitkovski, Miso; Malakhova, Oxana A.; Zhang, Dong-Er; Ulmilkawa, Masato; Kariya, Ken-ichi; Goebbels, Sandra; Nave, Klaus-Armin; Rosenmund, Christian; Jahn, Olaf; Rhee, JeongSeop; Brose, Nils			Regulation of Rap2A by the Ubiquitin Ligase Nedd4-1 Controls Neurite Development	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SYNAPSE ELIMINATION; HIPPOCAMPAL-NEURONS; PUTATIVE EFFECTOR; PYRAMIDAL NEURONS; ANGELMAN SYNDROME; CORTICAL-NEURONS; PROTEIN-KINASE; WW DOMAINS; PHOSPHORYLATION	Nedd4-1 is a "neuronal precursor cell expressed and developmentally downregulated protein" and among the most abundant E3 ubiquitin ligases in mammalian neurons. In analyses of conventional and conditional Nedd4-1-deficient mice, we found that Nedd4-1 plays a critical role in dendrite formation. Nedd4-1, the serine/threonine kinase TNIK, and Rap2A form a complex that controls Nedd4-1-mediated ubiquitination of Rap2A. Ubiquitination by Nedd4-1 inhibits Rap2A function, which reduces the activity of Rap2 effector kinases of the TNIK family and promotes dendrite growth. We conclude that a Nedd4-1/Rap2A/TNIK signaling pathway regulates neurite growth and arborization in mammalian neurons.	[Kawabe, Hiroshi; Neeb, Antje; Dimova, Kalina; Takeda, Michiko; Rhee, JeongSeop; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Dimova, Kalina; Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany; [Dimova, Kalina; Jahn, Olaf] DFG CMPB, D-37075 Gottingen, Germany; [Young, Samuel M., Jr.; Katsurabayashi, Shutaro; Rosenmund, Christian; Rhee, JeongSeop] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Mitkovski, Miso] Max Planck Inst Expt Med, Imaging Facil, D-37075 Gottingen, Germany; [Malakhova, Oxana A.; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Ulmilkawa, Masato; Kariya, Ken-ichi] Univ Ryukyus, Div Cell Biol, Grad Sch Med, Nishihara, Okinawa 9030215, Japan; [Goebbels, Sandra; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of the Ryukyus; Max Planck Society	Kawabe, H (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	kawabe@em.mp.de; brose@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Jahn, Olaf/AAD-8212-2020	Rosenmund, Christian/0000-0002-3905-2444; Jahn, Olaf/0000-0002-3397-8924; Young, Samuel/0000-0002-7589-7612; Neeb, Antje/0000-0002-6516-2938; Mitkovski, Miso/0000-0001-9195-2434; Kawabe, Hiroshi/0000-0001-5650-8696	Deutsche Forschungsgemeinschaft [SFB271/B11]; Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad; Yamanouchi Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alexander von Humboldt Foundation; National Institutes of Health [NIH R01GM66955]; Max Planck Society; European Commission [LSHM-CT-2005-019055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamanouchi Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Hesse-Niessen, S. Wenger, S. Handt, F. Scheve, F. Benseler, I. Thanhauser, D. Schwerdtfeger, A. Zeuch, M. Dorre, A. Galinski, I. Herfort, and T. Wiles for excellent technical assistance, and the staff of the animal facility at the Max Planck Institute of Experimental Medicine for maintenance of the mouse colony. We are grateful to D.A. Gray, R. Nehring, A. Betz, T. Nagase, A. Kusumi, P. Osten, R.L. Huganir, M. Matsuda, R. Brandt, A. Wittinghofer, and N. Ziv for reagents and software, and to G. Meyer, S. Bungers, M. Kishimoto-Suga, V. Tarabylkin, K. Chowdhury, D. Sargin, M. Scheffner, S. Yamagishi, F. Nakamura, I. Vetter, A. Puschel, D. Rotin, S. Okabe, D. Yokomaku, and A.M. Craig for discussions and advice. This study was supported by the Deutsche Forschungsgemeinschaft (SFB271/B11; N.B.), the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (H.K.), the Yamanouchi Foundation for Research on Metabolic Disorders (H.K.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (H.K.), the Alexander von Humboldt Foundation (S.M.Y.), National Institutes of Health grants NIH R01GM66955 (D.E.Z.), the Max Planck Society (N.B.) and the European Commission (EU Synapse grant LSHM-CT-2005-019055; S.M.Y. and N.B.).	Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; LUNA RMD, 1995, NATURE, V378, P203; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; SHOLL DA, 1953, J ANAT, V87, P387; SNIDER WD, 1987, J NEUROSCI, V7, P1760; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052	61	139	151	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 11	2010	65	3					358	372		10.1016/j.neuron.2010.01.007	http://dx.doi.org/10.1016/j.neuron.2010.01.007			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159449	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000275185200009
J	Carter, BC; Bean, BP				Carter, Brett C.; Bean, Bruce P.			Sodium Entry during Action Potentials of Mammalian Neurons: Incomplete Inactivation and Reduced Metabolic Efficiency in Fast-Spiking Neurons	NEURON			English	Article							CEREBELLAR PURKINJE NEURONS; ELECTRO-PHYSIOLOGICAL PROPERTIES; PRIMARY VISUAL-CORTEX; MOSSY FIBER BOUTONS; RAT FRONTAL-CORTEX; K+ CHANNELS; POTASSIUM CONDUCTANCE; NEOCORTICAL NEURONS; NONPYRAMIDAL CELLS; IONIC CURRENTS	We measured the time course of sodium entry during action potentials of mouse central neurons at 37 degrees C to examine how efficiently sodium entry is coupled to depolarization. In cortical pyramidal neurons, sodium entry was nearly completely confined to the rising phase of the spike: only similar to 25% more sodium enters than the theoretical minimum necessary for spike depolarization. However, in fast-spiking GABAergic neurons (cerebellar Purkinje cells and cortical interneurons), twice as much sodium enters as the theoretical minimum. The extra entry occurs because sodium channel inactivation is incomplete during the failing phase of the spike. The efficiency of sodium entry in different cell types is primarily a function of action potential shape and not cell-type-specific differences in sodium channel kinetics. The narrow spikes of fast-spiking GABAergic neurons result in incomplete inactivation of sodium channels; this reduces metabolic efficiency but likely enhances the ability to fire spikes at high frequency.	[Carter, Brett C.; Bean, Bruce P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Carter, BC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	brett_carter@hms.harvard.edu		Carter, Brett/0000-0001-6474-6571	National Institutes of Health [R01-NS36855, F31-NS064630]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036855, F31NS064630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to Zayd Khaliq and Gary Yellen for helpful suggestions and to Gui-lan Yao for help with mouse breeding. Supported by the National Institutes of Health (R01-NS36855). B.C.C. was supported by an NIH predoctoral fellowship (F31-NS064630).	Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; ATWATER I, 1970, J PHYSIOL-LONDON, V211, P753, DOI 10.1113/jphysiol.1970.sp009302; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BEZANILLA F, 1970, J PHYSIOL-LONDON, V211, P729, DOI 10.1113/jphysiol.1970.sp009301; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Contreras D, 2003, J NEUROSCI, V23, P6936; DEHAAS V, 1989, EUR BIOPHYS J BIOPHY, V17, P49, DOI 10.1007/BF00257145; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; FRANKENHAEUSER B, 1964, J PHYSIOL-LONDON, V171, P302, DOI 10.1113/jphysiol.1964.sp007378; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HILLE B, 1966, NATURE, V210, P1220, DOI 10.1038/2101220a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KEYNES RD, 1951, J PHYSIOL-LONDON, V114, P151, DOI 10.1113/jphysiol.1951.sp004609; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; LATHAM A, 1971, J PHYSIOL-LONDON, V213, P135, DOI 10.1113/jphysiol.1971.sp009373; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Lien CC, 2003, J NEUROSCI, V23, P2058; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OTIS TS, 1990, P NATL ACAD SCI USA, V87, P2911, DOI 10.1073/pnas.87.8.2911; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Raman IM, 2000, J NEUROSCI, V20, P9004; Raman IM, 1999, J NEUROSCI, V19, P1663; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SHAW TI, 1966, J PHYSIOL-LONDON, V182, P209, DOI 10.1113/jphysiol.1966.sp007819; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x	48	139	139	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 24	2009	64	6					898	909		10.1016/j.neuron.2009.12.011	http://dx.doi.org/10.1016/j.neuron.2009.12.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064395	Green Accepted, Bronze			2022-12-17	WOS:000273425800015
J	Bozza, T; Vassalli, A; Fuss, S; Zhang, JJ; Weiland, B; Pacifico, R; Feinstein, P; Mombaerts, P				Bozza, Thomas; Vassalli, Anne; Fuss, Stefan; Zhang, Jing-Ji; Weiland, Brian; Pacifico, Rodrigo; Feinstein, Paul; Mombaerts, Peter			Mapping of Class I and Class II Odorant Receptors to Glomerular Domains by Two Distinct Types of Olfactory Sensory Neurons in the Mouse	NEURON			English	Article							MOLECULAR-FEATURES; XENOPUS-LAEVIS; AXON GUIDANCE; GENE CHOICE; BULB; EXPRESSION; SYSTEM; CONVERGENCE; PROJECTION; MAPS	The repertoire of similar to 1200 odorant receptors (ORs) is mapped onto the array of similar to 1800 glomeruli in the mouse olfactory bulb (OB). The spatial organization of this array is influenced by the ORs. Here we show that glomerular mapping to broad domains in the dorsal OB is determined by two types of olfactory sensory neurons (OSNs), which reside in the dorsal olfactory epithelium. The OSN types express either class I or class II OR genes. Axons from the two OSN types segregate already within the olfactory nerve and form distinct domains of glomeruli in the OB. These class-specific anatomical domains correlate with known functional odorant response domains. However, axonal segregation and domain formation are not determined by the class of the expressed OR protein. Thus, the two OSN types are determinants of axonal wiring, operate at a higher level than ORs, and contribute to the functional organization of the glomerular array.	[Bozza, Thomas; Vassalli, Anne; Fuss, Stefan; Feinstein, Paul; Mombaerts, Peter] Rockefeller Univ, New York, NY 10065 USA; [Bozza, Thomas; Zhang, Jing-Ji; Weiland, Brian; Pacifico, Rodrigo] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Rockefeller University; Northwestern University	Bozza, T (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	bozza@northwestern.edu	Pacifico, Rodrigo/L-6189-2017; Vassalli, Anne/M-7866-2016; Fuss, Stefan H/G-2065-2011	Pacifico, Rodrigo/0000-0003-2581-6818; Vassalli, Anne/0000-0002-5314-5620; Fuss, Stefan H/0000-0002-3076-1121	NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005973, R01DC003452, R01DC006291, R21DC007711] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants from NIDCD to T.B, A.V., S.F, P.F., and P.M. The authors thank Jessica Wu, Jinsong Li, and Wei Tang for performing blastocyst injections; Stephen Fischboek and Katherine Wofsey for help with ISH and IHC; Masayo Omura for ISH probes; Atsushi Miyawaki for providing Venus YFP; Matt Wachowiak and Guangzhe Huang for providing software and advice for odor delivery and optical imaging; and Hyung Woo Kim and the Northwestern University Biostatistics Collaboration Center for help with statistical analyses.	Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chehrehasa F, 2006, BRAIN RES, V1119, P58, DOI 10.1016/j.brainres.2006.08.060; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Gaudin A, 2005, J COMP NEUROL, V489, P403, DOI 10.1002/cne.20655; Gussing F, 2004, EUR J NEUROSCI, V19, P2511, DOI 10.1111/j.0953-816X.2004.03331.x; Hirota J, 2007, MOL CELL NEUROSCI, V34, P679, DOI 10.1016/j.mcn.2007.01.014; Hoppe R, 2006, GENOMICS, V87, P711, DOI 10.1016/j.ygeno.2006.02.005; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; MAINIC B, 1999, CELL, V96, P713; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Plas DT, 2005, J COMP NEUROL, V491, P305, DOI 10.1002/cne.20694; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	47	139	141	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 29	2009	61	2					220	233		10.1016/j.neuron.2008.11.010	http://dx.doi.org/10.1016/j.neuron.2008.11.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	407EY	19186165	Green Accepted, Bronze			2022-12-17	WOS:000263347600009
J	Ehninger, D; Li, WD; Fox, K; Stryker, MP; Silva, AJ				Ehninger, Dan; Li, Weidong; Fox, Kevin; Stryker, Michael P.; Silva, Alcino J.			Reversing Neurodevelopmental Disorders in Adults	NEURON			English	Review							RUBINSTEIN-TAYBI-SYNDROME; FRAGILE-X-SYNDROME; TUBEROUS SCLEROSIS COMPLEX; LONG-TERM POTENTIATION; EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; MENTAL-RETARDATION SYNDROME; CPG-BINDING PROTEIN-2; MOUSE MODEL; VISUAL-CORTEX	Abnormalities in brain development, thought to be irreversible in adults, have long been assumed to underlie the neurological and psychiatric symptoms associated with neurodevelopmental disorders. Surprisingly, a number of recent animal model studies of neurodevelopmental disorders demonstrate that reversing the underlying molecular deficits can result in substantial improvements in function even if treatments are started in adulthood. These findings mark a paradigmatic change in the way we understand and envision treating neurodevelopmental disorders.	[Ehninger, Dan; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Psychol & Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ehninger, Dan; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Psychol & Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; [Ehninger, Dan; Li, Weidong; Silva, Alcino J.] Univ Calif Los Angeles, Psychol & Brain Res Inst, Dept Biobehav Sci, Los Angeles, CA 90095 USA; [Fox, Kevin] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Stryker, Michael P.] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cardiff University; University of California System; University of California San Francisco	Silva, AJ (corresponding author), Univ Calif Los Angeles, Psychol & Brain Res Inst, Dept Neurobiol, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	silvaa@ucla.edu	Fox, Kevin/E-8836-2010; Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Fox, Kevin/0000-0002-2563-112X; Li, Weidong/0000-0001-5384-4838; Silva, Alcino/0000-0001-5525-0494; Stryker, Michael/0000-0003-1546-5831	NIH [R01-NS38480, P50-MH0779720];  [EH223/2-1]; MRC [G0200413] Funding Source: UKRI; Medical Research Council [G0200413] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Thomas Insel, Nora Volkow, Dan Geschwind, Rui Costa, Steve Kushner, Ype Elgersma, Carrie Shilyansky, Yijun Cui, and Yong-Seok Lee for discussions that shaped the ideas in the manuscript. This work was supported by the following grants: EH223/2-1 to D.E. and NIH R01-NS38480 and P50-MH0779720 to A.J.S.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; Consortium E.C.T.S., 1993, CELL, V75, P1305; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Davis J D, 2007, Minerva Endocrinol, V32, P49; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; de Vries P, 2005, EUR CHILD ADOLES PSY, V14, P183, DOI 10.1007/s00787-005-0443-1; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; FOX K, 1992, J NEUROSCI, V12, P1826; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; Hallam TM, 2006, CELL MOL LIFE SCI, V63, P1725, DOI 10.1007/s00018-005-5555-8; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Krab LC, 2008, JAMA-J AM MED ASSOC, V300, P287, DOI 10.1001/jama.300.3.287; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lenneberg Eric H, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; O'Callaghan FJK, 2004, ARCH DIS CHILD, V89, P530, DOI 10.1136/adc.2003.026815; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Raznahan A, 2007, PSYCHOL MED, V37, P1293, DOI 10.1017/S0033291707000177; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rett A, 1966, Wien Med Wochenschr, V116, P723; Rovet Joanne, 2003, Paediatr Drugs, V5, P141, DOI 10.2165/00128072-200305030-00001; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Rumpel S, 2004, J NEUROPHYSIOL, V91, P1097, DOI 10.1152/jn.00443.2003; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Spolidoro M, 2009, EXP BRAIN RES, V192, P335, DOI 10.1007/s00221-008-1509-3; Tailby C, 2005, P NATL ACAD SCI USA, V102, P4631, DOI 10.1073/pnas.0402747102; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weeber EJ, 2003, J NEUROSCI, V23, P2634; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x	88	139	140	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 26	2008	60	6					950	960		10.1016/j.neuron.2008.12.007	http://dx.doi.org/10.1016/j.neuron.2008.12.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	391BW	19109903	Green Accepted, Bronze			2022-12-17	WOS:000262208900004
J	Sachse, S; Rueckert, E; Keller, A; Okada, R; Tanaka, NK; Ito, K; Vosshall, LB				Sachse, Silke; Rueckert, Erroll; Keller, Andreas; Okada, Ryuichi; Tanaka, Nobuaki K.; Ito, Kei; Vosshall, Leslie B.			Activity-dependent plasticity in an olfactory circuit	NEURON			English	Article							DROSOPHILA ANTENNAL LOBE; GREEN FLUORESCENT PROTEIN; SENSORY MAP; IN-VIVO; ODOR REPRESENTATION; RECEPTOR REPERTOIRE; PROJECTION NEURONS; ADULT DROSOPHILA; MOLECULAR-BASIS; OUTPUT NEURONS	Olfactory sensory neurons (OSNs) form synapses with local interneurons and second-order projection neurons to form stereotyped olfactory glomeruli. This primary olfactory circuit is hard-wired through the action of genetic cues. We asked whether individual glomeruli have the capacity for stimulus-evoked plasticity by focusing on the carbon dioxide (CO2) circuit in Drosophila. Specialized OSNs detect this gas and relay the information to a dedicated circuit in the brain. Prolonged exposure to CO2 induced a reversible volume increase in the CO2-specific glomerulus. OSNs showed neither altered morphology nor function after chronic exposure, but one class of inhibitory local interneurons showed significantly increased responses to CO2. Two-photon imaging of the axon terminals of a single PN innervating the CO2 glomerulus showed significantly decreased functional output following CO2 exposure. Behavioral responses to CO2 were also reduced after such exposure. We suggest that activity-dependent functional plasticity may be a general feature of the Drosophila olfactory system.	[Sachse, Silke; Keller, Andreas; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Rueckert, Erroll] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Rueckert, Erroll] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Okada, Ryuichi; Tanaka, Nobuaki K.; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Rockefeller University; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of Tokyo	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu	Sachse, Silke/M-8484-2014	Sachse, Silke/0000-0002-9769-8067; Vosshall, Leslie/0000-0002-6060-8099; Keller, Andreas/0000-0001-5491-2214	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005036] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC05036] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Christensen TA, 1998, ANN NY ACAD SCI, V855, P475, DOI 10.1111/j.1749-6632.1998.tb10608.x; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pelz D, 2006, J NEUROBIOL, V66, P1544, DOI 10.1002/neu.20333; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	62	139	140	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					838	850		10.1016/j.neuron.2007.10.035	http://dx.doi.org/10.1016/j.neuron.2007.10.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054860	Bronze			2022-12-17	WOS:000251659300010
J	Serulle, Y; Zhang, S; Ninan, I; Puzzo, D; McCarthy, M; Khatri, L; Arancio, O; Ziff, EB				Serulle, Yafell; Zhang, Shuang; Ninan, Ipe; Puzzo, Daniela; McCarthy, Maria; Khatri, Latika; Arancio, Oftavio; Ziff, Edward B.			A GluR1-cGKII interaction regulates AMPA receptor trafficking	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; NITRIC-OXIDE; GLUR1 SUBUNIT; SYNAPTIC PLASTICITY; ACID RECEPTOR; INTERCELLULAR MESSENGER; PHOSPHORYLATION SITES; SURFACE EXPRESSION; GUANYLYL CYCLASE	Trafficking of AMPA receptors (AMPARs) is regulated by specific interactions of the subunit intracellular C-terminal domains (CTDs) with other proteins, but the mechanisms involved in this process are still unclear. We have found that the GIuR1 CTD binds to cGMP-dependent protein kinase II (cGKII) adjacent to the kinase catalytic site. Binding of GluR1 is increased when cGKII is activated by cGKP. cGKII and GluR1 form a complex in the brain, and cGKII in this complex phosphorylates GluR1 at S845, a site also phosphorylated by PKA. Activation of cGKII by cGMP increases the surface expression of AMPARs at extrasynaptic sites. Inhibition of cGKII activity blocks the surface increase of GIuR1 during chemLTP and reduces LTP in the hippocampal slice. This work identifies a pathway, downstream from the NMDA receptor (NMDAR) and nitric oxide (NO), which stimulates GluR1 accumulation in the plasma membrane and plays an important role in synaptic plasticity.	NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Taub Inst, New York, NY 10032 USA	New York University; New York University; Columbia University; Columbia University	Ziff, EB (corresponding author), NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA.	edward.ziff@med.nyu.edu	Puzzo, Daniela/AAF-5026-2019; arancio, ottavio/AAB-7959-2019	Puzzo, Daniela/0000-0002-9542-2251; arancio, ottavio/0000-0001-6335-164X; Ziff, Edward/0000-0001-7389-8649; Ninan, Ipe/0000-0001-9774-6455	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM 07308, T32 GM007308] Funding Source: Medline; NIMH NIH HHS [R01 MH067229-02, MH 067229, R01 MH067229-03, R01 MH067229, R01 MH067229-05, R01 MH067229-01, R01 MH067229-04] Funding Source: Medline; NINDS NIH HHS [R01 NS049442, NS 049442] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BON C, 1992, EUR J NEUROSCI, V4, P420, DOI 10.1111/j.1460-9568.1992.tb00891.x; Bon CLM, 2003, J NEUROSCI, V23, P1941; Bon CLM, 2001, EUR J NEUROSCI, V14, P585, DOI 10.1046/j.0953-816x.2001.01680.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BUTTS NK, 1994, J STRENGTH COND RES, V8, P265; Chien WL, 2003, MOL PHARMACOL, V63, P1322, DOI 10.1124/mol.63.6.1322; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; Hering H, 2003, J NEUROSCI, V23, P3262; Hofmann F, 2000, J CELL SCI, V113, P1671; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu YF, 1999, J NEUROSCI, V19, P10250; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MANDERS EMM, 1992, J CELL SCI, V103, P857; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Paxinos G, 1998, MOUSE BRAIN STEREOTA; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Shen L, 2000, J NEUROSCI, V20, P7932; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Son H, 1998, LEARN MEMORY, V5, P231; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang X, 1997, J NEUROCHEM, V68, P443; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	73	139	145	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2007	56	4					670	688		10.1016/j.neuron.2007.09.016	http://dx.doi.org/10.1016/j.neuron.2007.09.016			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031684	Green Accepted, Bronze			2022-12-17	WOS:000251306600010
J	Yakusheva, TA; Shaikh, AG; Green, AM; Blazquez, PM; Dickman, JD; Angelaki, DE				Yakusheva, Tatyana A.; Shaikh, Aasef G.; Green, Andrea M.; Blazquez, Pablo M.; Dickman, J. David; Angelaki, Dora E.			Purkinje cells in posterior cerebellar vermis encode motion in an inertial reference frame	NEURON			English	Article							QUALITATIVELY DIFFERENT MECHANISMS; INNERVATING OTOLITH ORGANS; CLIMBING FIBER AFFERENTS; VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VESTIBULAR SYSTEM; VESTIBULOCEREBELLAR NEURONS; OPTOKINETIC STIMULATION; PERCEPTUAL RESPONSES; SPATIAL ORIENTATION	The ability to orient and navigate through the terrestrial environment represents a computational challenge common to all vertebrates. It arises because motion sensors in the inner ear, the otolith organs, and the semicircular canals transduce self-motion in an egocentric reference frame. As a result, vestibular afferent information reaching the brain is inappropriate for coding our own motion and orientation relative to the outside world. Here we show that cerebellar cortical neuron activity in vermal lobules 9 and 10 reflects the critical computations of transforming head-centered vestibular afferent information into earth- referenced self-motion and spatial orientation signals. Unlike vestibular and deep cerebellar nuclei neurons, where a mixture of responses was observed, Purkinje cells represent a homogeneous population that encodes inertial motion. They carry the earth-horizontal component of a spatially transformed and temporally integrated rotation signal from the semicircular canals, which is critical for computing head attitude, thus isolating inertial linear accelerations during navigation.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu			NEI NIH HHS [R01 EY12814, R01 EY012814] Funding Source: Medline; NIDCD NIH HHS [F32 DC006540] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC006540] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANGAUT P., 1967, ARCH ITAL BIOL, V105, P441; ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729; ANGELAKI DE, 1994, J NEUROPHYSIOL, V71, P1222, DOI 10.1152/jn.1994.71.3.1222; Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; ANGELAKI DE, 1991, IEEE T BIO-MED ENG, V38, P1053, DOI 10.1109/10.99068; ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1716, DOI 10.1152/jn.1995.73.4.1716; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; ANGELAKI DE, 1995, J NEUROSCI, V15, P7201; Barmack NH, 2002, J NEUROPHYSIOL, V87, P962, DOI 10.1152/jn.00528.2001; Barmack NH, 1995, J NEUROPHYSIOL, V74, P2573, DOI 10.1152/jn.1995.74.6.2573; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; BERNARD JF, 1987, J COMP NEUROL, V263, P241, DOI 10.1002/cne.902630207; Chen-Huang C, 2006, EXP BRAIN RES, V168, P410, DOI 10.1007/s00221-005-0098-7; CLARK B, 1963, AM J PSYCHOL, V76, P18, DOI 10.2307/1419995; CLARK B, 1966, AM J PSYCHOL, V79, P377, DOI 10.2307/1420878; COHEN H, 1992, EXP BRAIN RES, V90, P526; Day BL, 2005, J PHYSIOL-LONDON, V567, P591, DOI 10.1113/jphysiol.2005.092544; Dean HL, 2006, J NEUROSCI, V26, P1117, DOI 10.1523/JNEUROSCI.2497-05.2006; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dickman JD, 2002, J NEUROPHYSIOL, V88, P3518, DOI 10.1152/jn.00518.2002; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P996, DOI 10.1152/jn.1976.39.5.996; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; Fushiki H, 1997, J NEUROPHYSIOL, V78, P3083, DOI 10.1152/jn.1997.78.6.3083; GLASAUER S, 1995, ACTA OTO-LARYNGOL, P37; GOLDBERG JM, 1975, ANNU REV PHYSIOL, V37, P129, DOI 10.1146/annurev.ph.37.030175.001021; GRAYBIEL A, 1952, AMA ARCH OPHTHALMOL, V48, P605; GRAYBIEL A, 1979, AVIAT SPACE ENVIR MD, V50, P382; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Green AM, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S02; GUEDRY FE, 1974, HDB SENSORY PHYSL, P1; Heinen S J, 1992, J Vestib Res, V2, P235; Howard IP, 2001, PERCEPTION, V30, P583, DOI 10.1068/p3106; Howard IP., 1986, HDB HUMAN PERCEPTION, P1; KANO M, 1991, NEUROSCI LETT, V128, P101, DOI 10.1016/0304-3940(91)90769-P; KANO M, 1990, EXP BRAIN RES, V80, P238; KANO MS, 1990, EXP BRAIN RES, V82, P499; Kaptein RG, 2006, J NEUROPHYSIOL, V95, P1936, DOI 10.1152/jn.00856.2005; MARINI G, 1975, BRAIN RES, V99, P367, DOI 10.1016/0006-8993(75)90038-4; MAYNE RA, 1974, HDB SENSORY PHYSL VE, P493; MCNEILAGE PR, 2007, IN PRESS EXP BRAIN R; Merfeld D.M., 1997, 3 DIMENSIONAL KINEMA, P387; MERFELD DM, 1995, EXP BRAIN RES, V106, P123; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P199, DOI 10.1152/jn.00905.2004; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Mergner T, 1999, ANN NY ACAD SCI, V871, P430, DOI 10.1111/j.1749-6632.1999.tb09211.x; Musallam S, 2002, J NEUROPHYSIOL, V88, P2104, DOI 10.1152/jn.2002.88.4.2104; NAITO Y, 1995, HEARING RES, V87, P141, DOI 10.1016/0378-5955(95)00085-I; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; Ono S, 2000, EXP BRAIN RES, V134, P1, DOI 10.1007/s002210000424; PRECHT W, 1976, NEUROSCIENCE, V1, P301, DOI 10.1016/0306-4522(76)90057-9; Seidman SH, 1998, EXP BRAIN RES, V119, P307, DOI 10.1007/s002210050346; Shaikh AG, 2005, CURR BIOL, V15, P1657, DOI 10.1016/j.cub.2005.08.009; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; SOLOMON D, 1994, EXP BRAIN RES, V102, P57; STOCKWELL CW, 1970, ACTA OTO-LARYNGOL, V70, P170, DOI 10.3109/00016487009181874; TORMES FR, 1975, AVIAT SPACE ENVIR MD, V46, P387; Van Pelt S, 2005, J NEUROPHYSIOL, V94, P1432, DOI 10.1152/jn.00018.2005; WALBERG F, 1962, J COMP NEUROL, V118, P49, DOI 10.1002/cne.901180105; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Wiest G, 1999, NEUROLOGY, V52, P417, DOI 10.1212/WNL.52.2.417; WYLIE DR, 1994, J COMP NEUROL, V349, P448, DOI 10.1002/cne.903490309; Xiong GX, 2000, EXP BRAIN RES, V133, P219, DOI 10.1007/s002210000372; Young L, 1984, HDB PHYSL NERVOUS SY, P1023; Zupan LH, 2003, J NEUROPHYSIOL, V89, P390, DOI 10.1152/jn.00513.2001; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	72	139	140	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					973	985		10.1016/j.neuron.2007.06.003	http://dx.doi.org/10.1016/j.neuron.2007.06.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582336	Bronze			2022-12-17	WOS:000247645600015
J	Nicholson, DA; Trana, R; Katz, Y; Kath, WL; Spruston, N; Geinisman, Y				Nicholson, Daniel A.; Trana, Rachel; Katz, Yael; Kath, William L.; Spruston, Nelson; Geinisman, Yuri			Distance-dependent differences in synapse number and AMPA receptor expression in hippocampal CA1 pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; NMDA RECEPTORS; POSTSYNAPTIC DENSITY; STRATUM-RADIATUM; RAT HIPPOCAMPUS; SPIKES; CELLS; LOCATION; RELEASE	The ability of synapses throughout the dendritic tree to influence neuronal output is crucial for information processing in the brain. Synaptic potentials attenuate dramatically, however, as they propagate along dendrites toward the soma. To examine whether excitatory axospinous synapses on CA1 pyramidal neurons compensate for their distance from the soma to counteract such dendritic filtering, we evaluated axospinous synapse number and receptor expression in three progressively distal regions: proximal and distal stratum radiatum (SR), and stratum lacunosum-moleculare (SLM). We found that the proportion of perforated synapses increases as a function of distance from the soma and that their AMPAR, but not NMDAR, expression is highest in distal SR and lowest in SLM. Computational models of pyramidal neurons derived from these results suggest that they arise from the compartment-specific use of conductance scaling in SR and dendritic spikes in SLM to minimize the influence of distance on synaptic efficacy.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Geinisman, Y (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	yurig@northwestern.edu	Kath, William/B-6771-2009	Kath, William/0000-0003-3867-4783; Nicholson, Dan/0000-0002-1963-0569; Spruston, Nelson/0000-0003-3118-1636	NIA NIH HHS [AG20506, AG17139] Funding Source: Medline; NINDS NIH HHS [NS35180, NS46064] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035180, R01NS046064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017139, R01AG017139, T32AG020506] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMARAL DG, 1995, RAT NERVOUS SYSTEM, P91; Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Desmond NL, 1998, NEUROREPORT, V9, P857, DOI 10.1097/00001756-199803300-00017; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Geinisman Y, 2004, NEUROBIOL AGING, V25, P407, DOI 10.1016/j.neurobiolaging.2003.12.001; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; JONES DG, 1995, REV NEUROSCIENCE, V6, P177; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mackinnon P, 2000, AUSTRALAS J AGEING, V19, P3; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; PETERS A, 1969, Z ZELLFORSCH MIK ANA, V100, P487, DOI 10.1007/BF00344370; Petralia RS, 1999, METH MOL B, V128, P73; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Racca C, 2000, J NEUROSCI, V20, P2512; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; RALL W, 1977, HDB PHYSL NERVOUS SY, P3; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; SMITH MA, 2003, J PHYSL, V528, P245; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3	59	139	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					431	442		10.1016/j.neuron.2006.03.022	http://dx.doi.org/10.1016/j.neuron.2006.03.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675397	Bronze			2022-12-17	WOS:000237726800012
J	Cheung, ZH; Fu, AKY; Ip, NY				Cheung, ZH; Fu, AKY; Ip, NY			Synaptic roles of Cdk5: Implications in higher cognitive functions and neurodegenerative diseases	NEURON			English	Review							DEPENDENT KINASE-5 PHOSPHORYLATES; NEUROMUSCULAR-JUNCTION; TYROSINE-HYDROXYLASE; MEMORY; TRANSCRIPTION; HIPPOCAMPUS; EXPRESSION; PLASTICITY; NEURONS; SIGNAL	Accumulating evidence indicates that cyclin dependent kinase 5 (Cdk5), through phosphorylating a plethora of pre- and postsynaptic proteins, functions as an essential modulator of synaptic transmission. Recent advances in the field of Cdk5 research have not only consolidated the in vivo importance of Cdk5 in neurotransmission but also suggest a pivotal role of Cdk5 in the regulation of higher cognitive functions and neurodegenerative diseases. In this review, we will discuss the recent findings on the emanating role of Cdk5 as a regulator of synaptic functions and plasticity.	Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Cheung, Zelda Hiu Yee/C-1402-2012	Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bibb JA, 2003, NEUROSIGNALS, V12, P191, DOI 10.1159/000074620; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Chergui K, 2004, P NATL ACAD SCI USA, V101, P2191, DOI 10.1073/pnas.0308652100; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2003, NEUROSIGNALS, V12, P200, DOI 10.1159/000074621; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li Z, 2004, J BIOL CHEM, V279, P54438, DOI 10.1074/jbc.M411002200; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; LIU Y, 2006, IN PRESS J BIOL CHEM; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Morgan JR, 2004, J CELL BIOL, V167, P43, DOI 10.1083/jcb.200406020; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Qi RZ, 2004, FEBS LETT, V561, P177, DOI 10.1016/S0014-5793(04)00174-7; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Xie F, 2004, J NEUROCHEM, V90, P1521, DOI 10.1111/j.1471-4159.2004.02685.x	37	139	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					13	18		10.1016/j.neuron.2006.02.024	http://dx.doi.org/10.1016/j.neuron.2006.02.024			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600851	Bronze			2022-12-17	WOS:000236811300006
J	John, J; Wu, MF; Boehmer, LN; Siegel, JM				John, J; Wu, MF; Boehmer, LN; Siegel, JM			Cataplexy-active neurons in the hypothalamus: Implications for the role of histamine in sleep and waking behavior	NEURON			English	Article							LOCUS-COERULEUS NEURONS; IN-VIVO MICRODIALYSIS; VENTROLATERAL PREOPTIC NUCLEUS; MUSCLE TONE SUPPRESSION; AMINO-ACID RELEASE; RAT HYPOTHALAMUS; HUMAN NARCOLEPSY; HYPOCRETIN NEURONS; OREXIN-2 RECEPTOR; REM-SLEEP	Noradrenergic, serotonergic, and histaminergic neurons are continuously active during waking, reduce discharge during NREM sleep, and cease discharge during REM sleep. Cataplexy, a symptom associated with narcolepsy, is a waking state in which muscle tone is lost, as it is in REM sleep, while environmental awareness continues, as in alert waking. In prior work, we reported that, during cataplexy, noradrenergic neurons cease discharge, and serotonergic neurons greatly reduce activity. We now report that, in contrast to these other monoaminergic "REM-off" cell groups, histamine neurons are active in cataplexy at a level similar to or greater than that in quiet waking. We hypothesize that the activity of histamine cells is linked to the maintenance of waking, in contrast to activity in noradrenergic and serotonergic neurons, which is more tightly coupled to the maintenance of muscle tone in waking and its loss in REM sleep and cataplexy.	Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Vet Adm Greater Los Angeles, Neurobiol Res 151A3, Healthcare Syst, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Siegel, JM (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.	jsiegel@ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041370, R37HL041370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014610, R01NS014610] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL041370, HL41370, R37 HL041370] Funding Source: Medline; NIMH NIH HHS [R01 MH064109, MH64109] Funding Source: Medline; NINDS NIH HHS [R37 NS014610, R01 NS014610, NS14610] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldrich MS, 1998, NEUROLOGY, V50, pS2, DOI 10.1212/WNL.50.2_Suppl_1.S2; ANDRE P, 1992, PFLUG ARCH EUR J PHY, V420, P376, DOI 10.1007/BF00374473; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BAUST W, 1972, PFLUG ARCH EUR J PHY, V331, P113, DOI 10.1007/BF00587254; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; Bender BG, 2003, J ALLERGY CLIN IMMUN, V111, P770, DOI 10.1067/mai.2003.1408; BOEHMER LN, 2004, IN PRESS EXPT NEUROL; Bourgin P, 2000, J NEUROSCI, V20, P7760; Chase M. H., 2000, PRINCIPLES PRACTICE, P155; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; D'Ascanio P., 1988, PROG BRAIN RES, P361; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; GUILLEMINAULT C, 1976, NARCOLEPSY, P125; Guilleminault C, 2000, PRINCIPLES PRACTICE, P676; Gulyani S, 2002, NEUROSCIENCE, V112, P355, DOI 10.1016/S0306-4522(02)00089-1; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Horvath TL, 1999, J COMP NEUROL, V415, P145; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Ishizuka T, 2002, NEUROSCI LETT, V323, P93, DOI 10.1016/S0304-3940(01)02552-6; Ivanov A, 2000, NEUROREPORT, V11, P1755, DOI 10.1097/00001756-200006050-00031; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; John J, 2003, J PHYSIOL-LONDON, V548, P557, DOI 10.1113/jphysiol.2002.038729; John J, 2000, Sleep Res Online, V3, P23; Kisanuki YY, 2001, SLEEP, V24, pA22; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Kohyama J, 1998, SLEEP, V21, P695, DOI 10.1093/sleep/21.7.695; KUSHIDA CA, 1985, ELECTROEN CLIN NEURO, V61, P61, DOI 10.1016/0013-4694(85)91073-9; LAI YY, 1991, J NEUROSCI, V11, P2931; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LANTOS TA, 1995, BRAIN RES REV, V20, P209, DOI 10.1016/0165-0173(94)00013-F; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; LIM RKS, 1960, STEROTAXIC ATALS DOG; LIN JS, 1994, EUR J NEUROSCI, V6, P618, DOI 10.1111/j.1460-9568.1994.tb00306.x; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mileykovskiy BY, 2000, J NEUROSCI, V20, P8551, DOI 10.1523/JNEUROSCI.20-22-08551.2000; NISHINO S, 1993, SLEEP, V16, P706, DOI 10.1093/sleep/16.8.706; Nishino S, 2001, NEUROSCI LETT, V313, P125, DOI 10.1016/S0304-3940(01)02270-4; Nishino SS, 2002, SLEEP, V25, pA476; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1990, NEUROSCIENCE, V34, P127, DOI 10.1016/0306-4522(90)90307-P; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PROSPEROGARCIA O, 1993, NEUROSCI LETT, V156, P158, DOI 10.1016/0304-3940(93)90462-T; REINER PB, 1987, NEUROSCI LETT, V73, P43, DOI 10.1016/0304-3940(87)90028-0; SAKAI K, 1990, DIENCEPHALON AND SLEEP, P171; Salin-Pascual R, 2001, NEUROPSYCHOPHARMACOL, V25, pS21, DOI 10.1016/S0893-133X(01)00318-9; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SIEGEL JM, 1983, BRAIN RES, V268, P344, DOI 10.1016/0006-8993(83)90501-2; SIEGEL JM, 1991, SCIENCE, V252, P1315, DOI 10.1126/science.1925546; SIEGEL JM, 1992, J NEUROSCI, V12, P1640; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; SIEGEL JM, 2000, PRINCIPLES PRACTICE, P112; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Thannickal T.C., 2000, SLEEP, V23, pA296; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; Vanni-Mercier G, 2003, BEHAV BRAIN RES, V144, P227, DOI 10.1016/S0166-4328(03)00091-3; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318	71	139	145	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					619	634		10.1016/S0896-6273(04)00247-8	http://dx.doi.org/10.1016/S0896-6273(04)00247-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157423	Green Accepted, Bronze			2022-12-17	WOS:000221708300012
J	McCoy, AN; Crowley, JC; Haghighian, G; Dean, HL; Platt, ML				McCoy, AN; Crowley, JC; Haghighian, G; Dean, HL; Platt, ML			Saccade reward signals in posterior cingulate cortex	NEURON			English	Article							MONKEY CAUDATE NEURONS; NIGRA PARS RETICULATA; FUNCTIONAL-PROPERTIES; ANTERIOR CINGULATE; ALZHEIMERS-DISEASE; CORTICAL ATROPHY; PARIETAL CORTEX; RHESUS-MONKEY; EXPECTATION; CONNECTIONS	Movement selection depends on the outcome of prior behavior. Posterior cingulate cortex (CGp) is strongly connected with both limbic and oculomotor circuitry, and CGp neurons respond following saccades, suggesting a role in signaling the motivational outcome of gaze shifts. To test this hypothesis, single CGp neurons were studied in monkeys while they shifted gaze to visual targets for liquid rewards that varied in size or were delivered probabilistically. CGp neurons responded following saccades as well as following reward delivery, and these responses were correlated with reward size. CGp neurons also responded following the omission of predicted rewards. The timing of CGp activation and its modulation by reward could provide signals useful for updating representations of expected saccade value.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Duke University; Carnegie Mellon University	Platt, ML (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	platt@neuro.duke.edu			NEI NIH HHS [EY-013496] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; ARNAULD A, 1562, ART THINKING PORT RO; BALEYDIER C, 1980, BRAIN, V103, P525, DOI 10.1093/brain/103.3.525; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; BERNOUILLI D, 1738, WORKS; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; DEVILLIERS PA, 1976, PSYCHOL BULL, V83, P1131, DOI DOI 10.1037/0033-2909.83.6.1131; FINCH DM, 1984, EXP NEUROL, V83, P468, DOI 10.1016/0014-4886(84)90116-X; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fletcher W A, 1994, Curr Opin Ophthalmol, V5, P38; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GABRIEL M, 1991, BEHAV BRAIN RES, V46, P175, DOI 10.1016/S0166-4328(05)80111-1; Gabriel M, 1996, BEHAV BRAIN RES, V82, P23, DOI 10.1016/S0166-4328(97)81105-9; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hof PR, 1997, VISION RES, V37, P3609, DOI 10.1016/S0042-6989(96)00240-4; HOF PR, 1993, ACTA NEUROPATHOL, V86, P215, DOI 10.1007/BF00304135; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PANDYA DN, 1982, J COMP NEUROL, V204, P196, DOI 10.1002/cne.902040208; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephens D.W., 1986, pi; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208	58	139	143	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1031	1040		10.1016/S0896-6273(03)00719-0	http://dx.doi.org/10.1016/S0896-6273(03)00719-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659101	Bronze			2022-12-17	WOS:000187042200019
J	Schwaerzel, M; Heisenberg, M; Zars, T				Schwaerzel, M; Heisenberg, M; Zars, T			Extinction antagonizes olfactory memory at the subcellular level	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; SHORT-TERM-MEMORY; MUSHROOM BODIES; ADENYLYL-CYCLASE; PREFERENTIAL EXPRESSION; DROSOPHILA-MELANOGASTER; SENSORY NEURONS; GENE; MUTANT; ACQUISITION	Memory loss occurs by diverse mechanisms, as different time constants of performance decrement and sensitivities to experimental manipulations suggest. While the phenomena of memory decay, interference, and extinction are well established behaviorally, little is known about them at the circuit or molecular level. In Drosophila, odorant memories lasting up to 3 hr can be localized to mushroom body Kenyon cells, a single neuronal level in the olfactory pathway. The plasticity underlying this memory trace can be induced without Kenyon cell synaptic output. Experimental extinction, i.e., presentation of the conditioned stimulus without the reinforcer, reduces memory performance and does so at the same circuit level as memory formation. Thus, unreinforced presentation of learned odorants antagonizes intracellularly the signaling cascade underlying memory formation.	Biozentrum, Lehrstuhl Genet & Neurobiol, Theodor Boveri Inst Biowissensch, D-97074 Wurzburg, Germany	University of Wurzburg	Zars, T (corresponding author), Univ Missouri, Div Biol, Columbia, MO 65211 USA.	zars@biozentrum.uni-wuerzburg.de		Zars, Troy/0000-0003-4114-9322				Antoni FA, 1998, J NEUROSCI, V18, P9650; BERGOLD PJ, 1992, NEURON, V8, P387, DOI 10.1016/0896-6273(92)90304-V; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BERNIER L, 1982, J NEUROSCI, V2, P1682; Bouton ME, 1999, PSYCHOL BULL, V125, P171, DOI 10.1037/0033-2909.125.2.171; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Byrne JH, 1996, J NEUROSCI, V16, P425; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COWAN TM, 1986, J NEUROGENET, V3, P187, DOI 10.3109/01677068609106849; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HEISENBERG M, 2002, NEUROFORUM, V8, P179; Iourgenko V, 1997, FEBS LETT, V413, P104, DOI 10.1016/S0014-5793(97)00891-0; Ito K, 1998, LEARN MEMORY, V5, P52; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lechner HA, 1998, NEURON, V20, P355, DOI 10.1016/S0896-6273(00)80977-0; Lee H, 1998, J NEUROSCI, V18, P8444; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; MADER M, 2001, THESIS J MAXIMILIANS; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Paterson JM, 2000, J NEUROCHEM, V75, P1358, DOI 10.1046/j.1471-4159.2000.0751358.x; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSFELD NJ, 1984, J INSECT PHYSIOL, V30, P73, DOI 10.1016/0022-1910(84)90109-4; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, CURR OPIN NEUROBIOL, V10, P790, DOI 10.1016/S0959-4388(00)00147-1; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	60	139	139	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					951	960		10.1016/S0896-6273(02)00832-2	http://dx.doi.org/10.1016/S0896-6273(02)00832-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372288	Bronze			2022-12-17	WOS:000177779800016
J	Ebinu, JO; Yankner, BA				Ebinu, JO; Yankner, BA			A RIP tide in neuronal signal transduction	NEURON			English	Review							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE CLEAVAGE; INTRAMEMBRANE CLEAVAGE; MECHANISMS; INHIBITORS; APP	The generation of nuclear signaling proteins by regulated intramembrane proteolysis (RIP) is a new paradigm of signal transduction. Mammalian proteins that are processed by RIP include SREBP-1, Notch-1, amyloid precursor protein (APP), and ErbB-4. Intramembranous gamma-secretase cleavage of APP plays a central role in Alzheimer's disease by generating the amyloid P protein. An intriguing possibility is that the cognate C-terminal fragment generated by T-secretase cleavage could also play a role through the regulation of nuclear signaling events. Thus, RIP may contribute to both brain development and degeneration and may provide unexpected diversity to the signaling repertoire of a cell.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.	bruce.yankner@tch.harvard.edu						Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	21	139	145	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					499	502		10.1016/S0896-6273(02)00704-3	http://dx.doi.org/10.1016/S0896-6273(02)00704-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062033	Bronze			2022-12-17	WOS:000175665700004
J	Magdaleno, S; Keshvara, L; Curran, T				Magdaleno, S; Keshvara, L; Curran, T			Rescue of ataxia and preplate splitting by ectopic expression of reelin in reeler mice	NEURON			English	Article							MOUSE-BRAIN DEVELOPMENT; APOE RECEPTOR 2; CORTICAL DEVELOPMENT; CEREBRAL-CORTEX; EXTRACELLULAR-MATRIX; NEURONAL MIGRATION; MUTANT MICE; TYROSINE PHOSPHORYLATION; LAMINAR ORGANIZATION; SIGNALING PATHWAY	The gene mutated in reeler (reelin) encodes a protein secreted by neurons in the developing brain that controls laminar positioning of migrating cells in the CNS by an unknown mechanism. To investigate Reelin function, we used the nestin promoter to express Reelin ectopically in the ventricular zone and other brain regions in transgenic mice. In the presence of the endogenous protein, ectopic Reelin did not alter cell migration in the neocortex or the cerebellum. However, in the reeler background, ectopic Reelin induced tyrosine phosphorylation of Dab-1 in the ventricular zone and rescued some, but not all, of the neuroanatomic and behavioral abnormalities characteristic of reeler. These results indicate that Reelin does not function simply as a positional signal. Rather, it appears to participate in multiple events critical for neuronal migration and cell positioning.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fos1@aol.com	Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/F-5234-2018; Curran, Tom/C-1164-2008	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551	NINDS NIH HHS [R01 NS36558] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; DERER P, 1979, NEUROSCI LETT, V13, P195, DOI 10.1016/0304-3940(79)90041-7; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Frotscher M, 1997, CELL TISSUE RES, V290, P315, DOI 10.1007/s004410050936; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howe S, 1999, STAND MAG, V1, P19; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MIKOSHIBA K, 1984, DEV NEUROSCI-BASEL, V6, P101; Miyata T, 1997, J NEUROSCI, V17, P3599; Miyata T, 1996, J COMP NEUROL, V372, P215; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PEARLMAN AL, 1986, PROG BRAIN RES, V108, P117; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Searle S.R., 1987, LINEAR MODELS UNBALA; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; TERASHIMA T, 1986, J COMP NEUROL, V252, P264, DOI 10.1002/cne.902520209; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	48	139	145	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					573	586		10.1016/S0896-6273(02)00582-2	http://dx.doi.org/10.1016/S0896-6273(02)00582-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856531	Bronze			2022-12-17	WOS:000173911100010
J	Hutson, LD; Chien, CB				Hutson, LD; Chien, CB			Pathfinding and error correction by retinal axons: The role of astray/robo2	NEURON			English	Article							GROWTH CONE MORPHOLOGY; TRANSIENT RETINOTECTAL PROJECTION; GANGLION-CELL AXONS; MOUSE OPTIC CHIASM; ZEBRAFISH EMBRYO; NITRIC-OXIDE; TIME-LAPSE; MULTIPLE ASPECTS; CNS MIDLINE; IN-VIVO	To address how the highly stereotyped retinotectal pathway develops in zebrafish, we used fixed-tissue and time-lapse imaging to analyze morphology and behavior of wild-type and mutant retinal growth cones. Wild-type growth cones increase in complexity and pause at the midline. Intriguingly, they make occasional ipsilateral projections and other path-finding errors, which are always eventually corrected. In the astray/robo2 mutant, growth cones are larger and more complex than wild-type. astray axons make midline errors not seen in wild-type, as well as errors both before and after the midline. astray errors are rarely corrected. The presumed Robo ligands Slit2 and Slit3 are expressed near the pathway in patterns consistent with their mediating pathfinding through Robo2. Thus, Robo2 does not control midline crossing of retinal axons, but rather shapes their pathway, by both preventing and correcting pathfinding errors.	Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Chien, CB (corresponding author), Univ Utah, Med Ctr, Dept Neurobiol & Anat, 20 North 1900 East, Salt Lake City, UT 84132 USA.	chi-bin.chien@hsc.utah.edu			NEI NIH HHS [R01-EY12873, F32-EY07017] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY007017, R01EY012873] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; Battye R, 1999, DEVELOPMENT, V126, P2475; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; Brand M, 1996, DEVELOPMENT, V123, P179; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURRILL J D, 1989, Investigative Ophthalmology and Visual Science, V30, P226; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; CAUDY M, 1986, J NEUROSCI, V6, P364; CAUDY M, 1987, DEV BIOL, V119, P454, DOI 10.1016/0012-1606(87)90049-2; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Ernst AF, 1998, PROG BRAIN RES, V118, P115; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; Erskine L, 2000, J NEUROSCI, V20, P4975; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Halloran MC, 1999, DEV DYNAM, V214, P13, DOI 10.1002/(SICI)1097-0177(199901)214:1<13::AID-DVDY2>3.0.CO;2-3; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HOLT CE, 1989, J NEUROSCI, V9, P3123; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Macdonald R, 1997, DEVELOPMENT, V124, P2397; Marcus RC, 2000, DEV BIOL, V221, P132, DOI 10.1006/dbio.2000.9660; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; Mason CA, 1997, J NEUROSCI, V17, P1086; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; MCLOON SC, 1982, EXP BRAIN RES, V45, P277; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Murray MJ, 1999, J NEUROSCI, V19, P7901; MYERS PZ, 1993, J NEUROSCI, V13, P127; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Walz A, 1997, DEVELOPMENT, V124, P2421; WILSON SW, 1991, DEVELOPMENT, V112, P723; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	71	139	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					205	217		10.1016/S0896-6273(01)00579-7	http://dx.doi.org/10.1016/S0896-6273(01)00579-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804569	Bronze			2022-12-17	WOS:000173387700009
J	Luo, M; Katz, LC				Luo, M; Katz, LC			Response correlation maps of neurons in the mammalian olfactory bulb	NEURON			English	Article							MITRAL TUFTED CELLS; CAT STRIATE CORTEX; ODOR STIMULATION; MITRAL/TUFTED CELLS; RECEPTIVE-FIELDS; GLOMERULAR LAYER; ORGANIZATION; SALAMANDER; REPRESENTATIONS; COMBINATORIAL	To define the relationship between glomerular activation patterns and neuronal olfactory responses in the main olfactory bulb, intracellular recordings were combined with optical imaging of intrinsic signals. Response correlation maps (RCMs) were constructed by correlating the fluctuations in membrane potential and firing rate during odorant presentations with patterns of glomerular activation. The RCMs indicated that mitral/tufted cells were excited by activation of a focal region surrounding their principal glomerulus and generally inhibited by activation of more distant regions. However, the structure of the RCMs and the relative contribution of excitatory and inhibitory glomerular input evolved and even changed sign during and after odorant application. These data suggest a dynamic center-surround organization of mitral/tufted cell receptive fields.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Luo, M (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Luo, Minmin/0000-0003-3535-6624				BAIER H, 1994, J NEUROSCI, V14, P219; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Buonviso N, 1996, J NEUROPHYSIOL, V76, P2393, DOI 10.1152/jn.1996.76.4.2393; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chalansonnet M, 1998, CHEM SENSES, V23, P1; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DEMONASTERIO FM, 1979, BRAIN RES, V166, P39, DOI 10.1016/0006-8993(79)90647-4; DOVING KB, 1966, J PHYSIOL-LONDON, V186, P97; EZEH PI, 1993, J NEUROPHYSIOL, V70, P263, DOI 10.1152/jn.1993.70.1.263; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; JIANG T, 1992, J NEUROPHYSIOL, V68, P726, DOI 10.1152/jn.1992.68.3.726; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; King JR, 2000, J NEUROSCI, V20, P2391; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1982, J NEUROSCI, V2, P497; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WILSON DA, 1987, BRAIN RES, V417, P175, DOI 10.1016/0006-8993(87)90196-X; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 2001, SCIENCE, V291, P835, DOI 10.1126/science.1058773	68	139	142	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1165	1179		10.1016/S0896-6273(01)00537-2	http://dx.doi.org/10.1016/S0896-6273(01)00537-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754845	Bronze			2022-12-17	WOS:000172886800020
J	Crump, JG; Zhen, M; Jin, Y; Bargmann, CI				Crump, JG; Zhen, M; Jin, Y; Bargmann, CI			The SAD-1 kinase regulates presynaptic vesicle clustering and axon termination	NEURON			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN-KINASE; NEUROMUSCULAR-JUNCTION; CHEMOSENSORY NEURONS; LARVAL DEVELOPMENT; SYNAPTIC VESICLES; CELL-ADHESION; SYNAPSIN-I; S-LAMININ	During synapse formation, presynaptic axon outgrowth is terminated, presynaptic clusters of vesicles are associated with active zone proteins, and active zones are aligned with postsynaptic neurotransmitter receptors. We report here the identification of a novel serine/threonine kinase, SAD-1,that regulates several aspects of presynaptic differentiation in C. elegans. In sad-1 mutant animals presynaptic vesicle clusters in sensory neurons and motor neurons are diffuse and disorganized. Sensory axons fail to terminate in sad-1 mutants, whereas overexpression of SAD-1 causes sensory axons to terminate prematurely. SAD-1 protein is expressed in the nervous system and localizes to synapse-rich regions of the axons. SAD-1 is related to PAR-1, a kinase that regulates cell polarity during asymmetric cell division. Overexpression of SAD-1 causes mislocalization of vesicle proteins to dendrites, suggesting that sad-1 affects axonal-dendritic polarity as well as synaptic development.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Dept Biol, Santa Cruz, CA 95064 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Crump, Gage/0000-0002-3209-0026; Jin, Yishi/0000-0002-9371-9860; Bargmann, Cornelia/0000-0002-8484-0618				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AVERY L, 1993, GENETICS, V134, P454; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; BRENNER S, 1974, GENETICS, V77, P71; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CARLING D, 1994, J BIOL CHEM, V269, P11442; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Jin YS, 1999, J NEUROSCI, V19, P539; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mello C, 1995, METHOD CELL BIOL, V48, P451; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PARSA I, 1988, CANCER RES, V48, P2265; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasakura Y, 1998, MECH DEVELOP, V76, P161, DOI 10.1016/S0925-4773(98)00100-2; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1995, METHOD CELL BIOL, V48, P31; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	60	139	161	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					115	129		10.1016/S0896-6273(01)00184-2	http://dx.doi.org/10.1016/S0896-6273(01)00184-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182085	Bronze			2022-12-17	WOS:000166702700013
J	Auger, C; Attwell, D				Auger, C; Attwell, D			Fast removal of synaptic glutamate by postsynaptic transporters	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; GATED CHLORIDE CHANNEL; AMINO-ACID TRANSPORTER; D-ASPARTATE RECEPTORS; BERGMANN GLIAL-CELLS; TIME-COURSE; CLIMBING FIBER; RAT-BRAIN; EXTRASYNAPTIC GLUTAMATE; PARALLEL FIBER	Glutamate transporters are believed to remove glutamate from the synaptic cleft only slowly because they cycle slowly. However, we show that when glutamate binds to postsynaptic transporters at the cerebellar climbing fiber synapse, it evokes a conformation change and inward current that reflect glutamate removal from the synaptic cleft within a few milliseconds, a time scale much faster than the overall cycle time. Contrary to present models, glutamate removal does not require binding of an extracellular proton, and the time course of transporter anion conductance activation differs from that of glutamate removal. The charge movement associated with glutamate removal is consistent with the majority of synaptically released glutamate being removed from the synaptic cleft by postsynaptic transporters.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020					Auger C, 1998, J NEUROSCI, V18, P4532; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Billups B, 1996, J NEUROSCI, V16, P6722; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; BILLUPS B, 1994, J PHYSIOL-LONDON, V476P, pP67; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Diamond JS, 1997, J NEUROSCI, V17, P4672; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ERECINSKA M, 1987, FEBS LETT, V213, P61, DOI 10.1016/0014-5793(87)81465-5; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1999, J NEUROSCI, V19, P9242; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RAMAN IM, 1994, J NEUROSCI, V14, P4998; RIVEROS N, 1986, BRAIN RES, V386, P405, DOI 10.1016/0006-8993(86)90181-2; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Shibata T, 1996, NEUROREPORT, V7, P705, DOI 10.1097/00001756-199602290-00006; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tzingounis AV, 1998, J BIOL CHEM, V273, P17315, DOI 10.1074/jbc.273.28.17315; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393	52	139	144	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					547	558		10.1016/S0896-6273(00)00132-X	http://dx.doi.org/10.1016/S0896-6273(00)00132-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144363	Green Published, Bronze			2022-12-17	WOS:000165493700028
J	Zitnan, D; Ross, LS; Zitnanova, I; Hermesman, JL; Gill, SS; Adams, ME				Zitnan, D; Ross, LS; Zitnanova, I; Hermesman, JL; Gill, SS; Adams, ME			Steroid induction of a peptide hormone gene leads to orchestration of a defined behavioral sequence	NEURON			English	Article							ECDYSIS-TRIGGERING HORMONE; PROGRAMMED CELL-DEATH; LARVAL MANDUCA-SEXTA; ECLOSION HORMONE; RECEPTOR ISOFORMS; TOBACCO HORNWORM; ENDOCRINE SYSTEM; MESSENGER-RNAS; DIRECT REPEATS; PRE-ECDYSIS	At the end of each molt, insects shed the old cuticle by performing preecdysis and ecdysis behaviors. Regulation of these centrally patterned movements involves peptide signaling between endocrine Inka cells and the CNS. In Inka cells, we have identified the cDNA and gene encoding preecdysis-triggering hormone (PETH) and ecdysis-triggering hormone (ETH), which activate these behaviors. Prior to behavioral onset, rising ecdysteroid levels induce expression of the ecdysone receptor (EcR) and ETH gene in Inka cells and evoke CNS sensitivity to PETH and ETH. Subsequent ecdysteroid decline is required for peptide release, which initiates three motor patterns in specific order: PETH triggers preecdysis I, while ETH activates preecdysis II and ecdysis. The Inka cell provides a model for linking steroid regulation of peptide hormone expression and release with activation of a defined behavioral sequence.	Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Neurosci, Riverside, CA 92521 USA; Slovak Acad Sci, Inst Zool, Bratislava 84206, Slovakia	University of California System; University of California Riverside; University of California System; University of California Riverside; Slovak Academy of Sciences	Zitnan, D (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.		Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113	NIAID NIH HHS [AI 40555] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040555, R01AI040555] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams ME, 1997, BIOCHEM BIOPH RES CO, V230, P188, DOI 10.1006/bbrc.1996.5915; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; ANTIN J, 1975, J COMP PHYSIOL PSYCH, V89, P784, DOI 10.1037/h0077040; Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Camhi JM, 1984, NEUROETHOLOGY; CARLSON JR, 1977, J COMP PHYSIOL, V115, P299, DOI 10.1007/BF00656847; DAVINO PP, 1995, MOL CELL ENDOCRINOL, V113, P1; Dellovade TL, 1999, J NEUROENDOCRINOL, V11, P1, DOI 10.1046/j.1365-2826.1999.00250.x; EWER J, 1994, J NEUROSCI, V14, P7704; Ewer J, 1996, J COMP NEUROL, V370, P330; Ewer J, 1997, J EXP BIOL, V200, P869; FLANAGAN LM, 1995, NEUROBIOLOGICAL EFFE, P142; FROHMAN MA, 1990, PCR PROTOCOLS GUIDE, P21; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Gammie SC, 1999, J EXP BIOL, V202, P343; Gammie SC, 1997, J NEUROSCI, V17, P4389; HARLAN RE, 1988, MOL NEUROBIOL, V2, P183, DOI 10.1007/BF02935345; Hegstrom CD, 1996, J NEUROBIOL, V29, P535; HEWES RS, 1994, J NEUROSCI, V14, P1812, DOI 10.1523/JNEUROSCI.14-03-01812.1994; Jindra M, 1996, DEV BIOL, V180, P258, DOI 10.1006/dbio.1996.0299; Kaczmarek LK, 1987, NEUROMODULATION BIOC; Kingan TG, 1997, J EXP BIOL, V200, P3245; KINGAN TG, 1989, ANAL BIOCHEM, V183, P283, DOI 10.1016/0003-2697(89)90481-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MCCARTHY MM, 1995, OXYTOCIN CELLULAR MO; MCEWEN BS, 1994, HORM BEHAV, V28, P396, DOI 10.1006/hbeh.1994.1036; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; MICEVYCH PE, 1988, EXP NEUROL, V100, P416, DOI 10.1016/0014-4886(88)90119-7; NOVICKI A, 1995, J COMP PHYSIOL A, V176, P45, DOI 10.1007/BF00197751; Novicki A, 1996, J EXP BIOL, V199, P1757; O'Brien MA, 1998, J EXP BIOL, V201, P193; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; RIDDIFORD LM, 1986, DEV BIOL, V118, P82, DOI 10.1016/0012-1606(86)90075-8; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; Ross LS, 1996, BIOTECHNIQUES, V21, P382; SCHELLER RH, 1983, CELL, V32, P7, DOI 10.1016/0092-8674(83)90492-0; Schulkin Jay, 1993, P13; SLAMA K, 1980, ACTA ENTOMOL BOHEMOS, V77, P145; Streichert LC, 1997, DEV BIOL, V183, P95, DOI 10.1006/dbio.1996.8467; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; TRUMAN JW, 1981, NATURE, V291, P70, DOI 10.1038/291070a0; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; VOLICER L, 1971, NEUROPHARMACOLOGY, V10, P631, DOI 10.1016/0028-3908(71)90029-3; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zitnan D, 1996, SCIENCE, V271, P88, DOI 10.1126/science.271.5245.88; ZITNAN D, 1993, DEV BIOL, V156, P117, DOI 10.1006/dbio.1993.1063	52	139	144	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					523	535		10.1016/S0896-6273(00)80805-3	http://dx.doi.org/10.1016/S0896-6273(00)80805-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433264	Bronze			2022-12-17	WOS:000081701000016
J	Krupp, JJ; Vissel, B; Heinemann, SF; Westbrook, GL				Krupp, JJ; Vissel, B; Heinemann, SF; Westbrook, GL			N-terminal domains in the NR2 subunit control desensitization of NMDA receptors	NEURON			English	Article							METHYL-D-ASPARTATE; GLYCINE-INSENSITIVE DESENSITIZATION; ACID-BINDING PROTEINS; GLUTAMATE RECEPTORS; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; MUTATIONAL ANALYSIS; AMPA RECEPTOR; CHANNELS; LIGAND	Recent molecular studies of glutamate channels have provided increasingly detailed models of the agonist-binding site and of the channel pore. However, little information is available on the domains involved in channel gating. We examined the molecular determinants for the NR2-subunit specificity of glycine-independent desensitization of NMDA channels using NR2C/NR2A chimeric subunits expressed in HEK 293 cells. We show that glycine-independent desensitization is controlled by N-terminal domains of the NR2 subunit that frank the putative agonist-binding domain: a four amino acid (aa) segment immediately preceding the first transmembrane domain (M1) and a region containing the leucine/isoleucine/valine-binding protein-like (LIVBP-like) domain. Our results provide evidence for a functional role of the region containing the LIVBP-like domain in glutamate receptor channels. We suggest that the pre-M1 segment, presumably situated near the entrance to the pore, serves as a dynamic link between ligand binding and channel gating.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Oregon Health & Science University; Salk Institute	Westbrook, GL (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.			Vissel, Bryce/0000-0001-8860-8050	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046613, R37MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46613] Funding Source: Medline; NINDS NIH HHS [NS28709] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; CHEN J, 1995, BIOPHYS J, V69, P849, DOI 10.1016/S0006-3495(95)79959-3; COLQUHOUN D, 1995, P NATL ACAD SCI USA, V92, P10327, DOI 10.1073/pnas.92.22.10327; Corringer PJ, 1998, J NEUROSCI, V18, P648; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; ISHII T, 1993, J BIOL CHEM, V268, P2836; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; OH BH, 1993, J BIOL CHEM, V268, P11348; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; OLAH GA, 1993, J BIOL CHEM, V268, P16241; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VAMUM MD, 1997, SCIENCE, V278, P110; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	50	139	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					317	327		10.1016/S0896-6273(00)80459-6	http://dx.doi.org/10.1016/S0896-6273(00)80459-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491992	Bronze			2022-12-17	WOS:000072154700016
J	Ono, K; Yasui, Y; Rutishauser, U; Miller, RH				Ono, K; Yasui, Y; Rutishauser, U; Miller, RH			Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve	NEURON			English	Article							MULTIPLE ADHESION MOLECULES; GRANULE CELL-MIGRATION; O-2A PROGENITOR CELLS; RAT SPINAL-CORD; POLYSIALIC ACID; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; NEURAL-TUBE; N-CADHERIN; EXPRESSION	During central nervous system (CNS) development, oligodendrocyte precursors originate in specific locations and subsequently migrate to all regions of the CNS. Here, we demonstrate that the chick optic nerve is populated by oligodendrocyte precursors, which initially appeared in a focal region at the ventral midline of the third ventricle at stage 26-27. Oligodendrocyte precursors migrated into the chiasmal end of the nerve by stage 29 and became uniformly distributed by stage 35. Migrating precursors were restricted to the anterior region of the nerve, closely apposed to axons, and had a bipolar morphology. In contrast to the polysialic acid (PSA)-dependent cooperative streaming migration of olfactory neuronal precursors, the migration of oligodendrocyte precursors along the optic nerve appeared axophilic and unaffected by removal of neural cell adhesion molecule (N-CAM)-associated PSA. These data indicate that during development, defined domains of the ventricular zone give rise to distinct cell types that utilize discrete mechanisms to navigate specific migrational pathways.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT GENET, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT NEUROSCI, CLEVELAND, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Ono, K (corresponding author), SHIMANE MED UNIV, DEPT ANAT, DIV 2, IZUMO, SHIMANE 693, JAPAN.				NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD18369] Funding Source: Medline; NINDS NIH HHS [NS30800] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030800] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASOU H, 1992, NEUROREPORT, V3, P481, DOI 10.1097/00001756-199206000-00006; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CHUONG CM, 1990, EXPERIENTIA, V46, P892, DOI 10.1007/BF01939381; FFRENCHCONSTANT C, 1988, J NEUROCYTOL, V17, P13, DOI 10.1007/BF01735374; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Kiernan BW, 1996, MOL CELL NEUROSCI, V7, P322, DOI 10.1006/mcne.1996.0024; KIERNAN BW, 1993, DEVELOPMENT, P219; LACHAPELLE F, 1984, DEV NEUORSCI, V10, P325; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MILNER R, 1994, DEVELOPMENT, V120, P3497; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOLL E, 1993, DEVELOPMENT, V118, P563; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; ONO K, 1995, DEVELOPMENT, V121, P1743; ONO K, 1989, EXP BRAIN RES, V79, P190; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; PAYNE HR, 1993, DEV BIOL, V159, P595, DOI 10.1006/dbio.1993.1267; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; Robinson S, 1996, MOL CELL NEUROSCI, V8, P38, DOI 10.1006/mcne.1996.0042; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; TIMSIT S, 1995, J NEUROSCI, V15, P1012; WANG C, 1994, J NEUROSCI, V14, P4446; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; WARF BC, 1991, J NEUROSCI, V11, P2477; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102	45	139	144	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					283	292		10.1016/S0896-6273(00)80939-3	http://dx.doi.org/10.1016/S0896-6273(00)80939-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292719	Bronze			2022-12-17	WOS:A1997XU14600008
J	MARTINEZSERRANO, A; FISCHER, W; BJORKLUND, A				MARTINEZSERRANO, A; FISCHER, W; BJORKLUND, A			REVERSAL OF AGE-DEPENDENT COGNITIVE IMPAIRMENTS AND CHOLINERGIC NEURON ATROPHY BY NGF-SECRETING NEURAL PROGENITORS GRAFTED TO THE BASAL FOREBRAIN	NEURON			English	Article							NERVE GROWTH-FACTOR; GENETICALLY MODIFIED CELLS; ACETYLTRANSFERASE ACTIVITY; DELAYED TREATMENT; SPATIAL MEMORY; GENE-THERAPY; ADULT-RAT; BRAIN; LINE; TRANSPLANTATION	A highly NGF-secreting cell line was generated by retroviral transduction of a conditionally immortalized CNS-derived neural progenitor cell line. After transplantation to the nucleus basalis magnocellularis (NBM), the cells continue to express the NGF transgene for at least 10 weeks, producing sufficient NGF to reverse cholinergic neuron atrophy in aged rats and induce cellular hypertrophy in young rats. In cognitively impaired aged rats, transplants of the NGF-secreting cells placed either in the NBM and septum or in only the NBM induced a near-complete reversal of the spatial learning impairment. This was accompanied by a normalization of the size of the cholinergic neurons in the grafted areas. The results demonstrate that locally increased supply of NGF to the basal forebrain cholinergic nuclei has a significant impact on cognitive function and support the usefulness of neural progenitor cells for long-term localized delivery of neurotrophins to the CNS.			MARTINEZSERRANO, A (corresponding author), LUND UNIV, DEPT MED CELL RES, BISKOPSGATAN 5, S-22362 LUND, SWEDEN.		Martínez-Serrano, Alberto/J-8146-2014; Björklund, Anders/ABA-1326-2020	Bjorklund, Anders/0000-0002-5676-6203; Martinez Serrano, Alberto/0000-0003-3927-6699				ANTON R, 1994, EXP NEUROL, V127, P207, DOI 10.1006/exnr.1994.1097; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CUNNINGHAM LA, 1991, BRAIN RES, V561, P192, DOI 10.1016/0006-8993(91)91595-R; DEKKER AJ, 1992, BRAIN RES, V584, P55, DOI 10.1016/0006-8993(92)90877-C; DEKKER AJ, 1992, NEUROSCIENCE, V48, P111, DOI 10.1016/0306-4522(92)90342-Y; DEKKER AJ, 1994, NEUROSCIENCE, V60, P299, DOI 10.1016/0306-4522(94)90244-5; DEKKER AJ, 1994, BRAIN RES, V639, P149, DOI 10.1016/0006-8993(94)91775-2; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; FISCHER W, 1989, EUR J NEUROSCI, V1, P34, DOI 10.1111/j.1460-9568.1989.tb00772.x; FISCHER W, 1991, J NEUROSCI, V11, P1889; FISCHER W, 1994, NEUROCHEM INT, V25, P47, DOI 10.1016/0197-0186(94)90052-3; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; FISHER LJ, 1991, NEURON, V6, P371, DOI 10.1016/0896-6273(91)90246-V; GAGE FH, 1984, J NEUROSCI, V4, P2856; GAGE FH, 1991, TRENDS NEUROSCI, V14, P328, DOI 10.1016/0166-2236(91)90156-O; GAGE FH, 1991, NEURON, V6, P1, DOI 10.1016/0896-6273(91)90116-H; GREENE LA, 1977, BRAIN RES, V133, P350, DOI 10.1016/0006-8993(77)90770-3; GREENE LA, 1989, NERVE GROWTH FACTORS; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HE YS, 1991, BRAIN RES, V552, P159, DOI 10.1016/0006-8993(91)90674-K; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; HOFFMAN D, 1993, EXP NEUROL, V122, P100, DOI 10.1006/exnr.1993.1111; JIAO S, 1992, BRAIN RES, V575, P143, DOI 10.1016/0006-8993(92)90434-B; JIAO SS, 1993, NATURE, V362, P450, DOI 10.1038/362450a0; KAWAJA MD, 1992, J NEUROSCI, V12, P2849; LAGAMMA EF, 1993, CELL TRANSPLANT, V2, P207, DOI 10.1177/096368979300200304; MANDEL RJ, 1989, EXP NEUROL, V104, P208, DOI 10.1016/0014-4886(89)90031-9; MARKOWSKA AL, 1994, J NEUROSCI, V14, P4815; MARTINEZSERRANO A, 1995, IN PRESS J NEUROSCI; MAYSINGER D, 1994, NEUROCHEM INT, V24, P495, DOI 10.1016/0197-0186(94)90097-3; MERVIS RF, 1991, ANN NY ACAD SCI, V640, P95; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORSE JK, 1993, J NEUROSCI, V13, P4146; MUCKE L, 1993, TRANSGENE, V1, P3; ONIFER SM, 1993, EXP NEUROL, V122, P130, DOI 10.1006/exnr.1993.1114; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; RYLETT RJ, 1993, J NEUROSCI, V13, P3956; Snyder Evan Y., 1994, Current Opinion in Neurobiology, V4, P742, DOI 10.1016/0959-4388(94)90018-3; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; STROMBERG I, 1990, J NEUROSCI RES, V25, P405, DOI 10.1002/jnr.490250318; WILLIAMS LR, 1991, NEUROBIOL AGING, V12, P39, DOI 10.1016/0197-4580(91)90037-K; WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076	45	139	141	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1995	15	2					473	484		10.1016/0896-6273(95)90051-9	http://dx.doi.org/10.1016/0896-6273(95)90051-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR426	7646899	Bronze			2022-12-17	WOS:A1995RR42600024
J	TAUSSIG, R; SANCHEZ, S; RIFO, M; GILMAN, AG; BELARDETTI, F				TAUSSIG, R; SANCHEZ, S; RIFO, M; GILMAN, AG; BELARDETTI, F			INHIBITION OF THE OMEGA-CONOTOXIN-SENSITIVE CALCIUM CURRENT BY DISTINCT G-PROTEINS	NEURON			English	Article							BINDING REGULATORY PROTEINS; GLIOMA HYBRID-CELLS; PERTUSSIS TOXIN; NG108-15 CELLS; ALPHA-SUBUNITS; ADENYLATE-CYCLASE; VERTEBRATE CELLS; ESCHERICHIA-COLI; WHOLE-CELL; CYCLIC-AMP	Leu-enkephalin (Leu-Enk), norepinephrine (NE), somatostatin (SS), and bradykinin (BK) decrease the voltage-dependent calcium current in NG108-15 cells. Here we have investigated whether distinct G proteins, or a G protein common to all of the pathways, mediates this inhibition. We found that pertussis toxin (PTX) reduced all of these transmitter actions, except that of BK. To examine which of the PTX-sensitive pathways is transduced by G(oA), we constructed an NG108-15 cell line that stably expresses a mutant, PTX-resistant alpha-subunit of G(oA). After treatment with PTX, the mutant G(oA-alpha) rescued the Leu-Enk and NE pathways but not the SS pathway. At least three different G proteins can transduce receptor-mediated inhibition of calcium currents in nerve cells. The effects of these G proteins appear to converge on the omega-conotoxin GVIA-sensitive calcium current.			TAUSSIG, R (corresponding author), UNIV TEXAS,MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034497, R01GM034497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS025186] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34497] Funding Source: Medline; NINDS NIH HHS [NS25186] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P167, DOI 10.1113/jphysiol.1988.sp016994; DOCHERTY RJ, 1988, J PHYSIOL-LONDON, V398, P33, DOI 10.1113/jphysiol.1988.sp017027; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRANDT R, 1986, FEBS LETT, V196, P279, DOI 10.1016/0014-5793(86)80263-0; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HARRIS BA, 1985, SCIENCE, V229, P1274, DOI 10.1126/science.3839937; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HIGASHIDA H, 1990, P ROY SOC B-BIOL SCI, V242, P68, DOI 10.1098/rspb.1990.0105; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HSIA JA, 1984, J BIOL CHEM, V259, P1086; HUS WH, 1990, J BIOL CHEM, V265, P11220; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; JONES DT, 1987, J BIOL CHEM, V262, P1421; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOCH BD, 1985, J BIOL CHEM, V260, P3138; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LOGOTHETIS DE, 1988, P NATL ACAD SCI USA, V85, P5814, DOI 10.1073/pnas.85.16.5814; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MULLANEY I, 1988, BIOCHEM J, V256, P649, DOI 10.1042/bj2560649; MUMBY S, 1988, J BIOL CHEM, V263, P2020; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; PANG IH, 1990, J BIOL CHEM, V265, P18707; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Sambrook J., 1989, MOL CLONING LAB MANU; SHEN SZ, 1991, PFLUGERS ARCH, V418, P614; SIEGELBAUM SA, 1983, TRENDS NEUROSCI, V6, P307, DOI 10.1016/0166-2236(83)90145-5; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; STRATHMANN M, 1989, P NATL ACAD SCI USA, V86, P7407, DOI 10.1073/pnas.86.19.7407; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAUSSIG R, 1985, J COMP NEUROL, V238, P53, DOI 10.1002/cne.902380105; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	61	139	139	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					799	809		10.1016/0896-6273(92)90100-R	http://dx.doi.org/10.1016/0896-6273(92)90100-R			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1348951				2022-12-17	WOS:A1992HQ18800018
J	HORTSCH, M; BIEBER, AJ; PATEL, NH; GOODMAN, CS				HORTSCH, M; BIEBER, AJ; PATEL, NH; GOODMAN, CS			DIFFERENTIAL SPLICING GENERATES A NERVOUS-SYSTEM - SPECIFIC FORM OF DROSOPHILA NEUROGLIAN	NEURON			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	HORTSCH, M (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.			Patel, Nipam/0000-0003-4328-654X; Hortsch, Michael/0000-0002-3750-737X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DANILOFF JK, 1986, J NEUROSCI, V6, P739; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHER G, 1986, J NEUROSCI, V6, P605; FRAIL DE, 1984, J BIOL CHEM, V259, P4857; FUSHIKI S, 1986, DEV BRAIN RES, V24, P153, DOI 10.1016/0165-3806(86)90183-5; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P7989, DOI 10.1073/pnas.81.24.7989; GRUMET M, 1984, J CELL BIOL, V98, P1746, DOI 10.1083/jcb.98.5.1746; GRUMET M, 1988, J CELL BIOL, V106, P487, DOI 10.1083/jcb.106.2.487; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HORTSCH M, 1985, J BIOL CHEM, V260, P9137; JACOBS JR, 1989, NEURON, V2, P1625; JACOBS JR, 1989, J NEUROSCI, V9, P2402; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MACKIE K, 1989, J NEUROSCI, V9, P1883; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MURRAY BA, 1986, J CELL BIOL, V102, P189, DOI 10.1083/jcb.102.1.189; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NATZLE JE, 1984, DEV BIOL, V104, P187, DOI 10.1016/0012-1606(84)90047-2; Oi V.T., 1980, SELECTED METHODS CEL, P351; OWENS GC, 1987, P NATL ACAD SCI USA, V84, P294, DOI 10.1073/pnas.84.1.294; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; PRINCE JT, 1989, J NEUROSCI, V9, P876; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; SALTON SRJ, 1983, J NEUROSCI, V3, P441; SALTON SRJ, 1983, J NEUROSCI, V3, P2420; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTONI MJ, 1989, EMBO J, V8, P385, DOI 10.1002/j.1460-2075.1989.tb03389.x; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SEILHEIMER B, 1989, J CELL BIOL, V108, P1909, DOI 10.1083/jcb.108.5.1909; SHIMOYAMA Y, 1989, J CELL BIOL, V109, P1787, DOI 10.1083/jcb.109.4.1787; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; SORKIN BC, 1984, SCIENCE, V225, P1476, DOI 10.1126/science.6474186; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; THOR G, 1987, EMBO J, V6, P2581, DOI 10.1002/j.1460-2075.1987.tb02548.x; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	62	139	141	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1990	4	5					697	709		10.1016/0896-6273(90)90196-M	http://dx.doi.org/10.1016/0896-6273(90)90196-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE975	1693086				2022-12-17	WOS:A1990DE97500005
J	KLARSFELD, A; LAUFER, R; FONTAINE, B; DEVILLERSTHIERY, A; DUBREUIL, C; CHANGEUX, JP				KLARSFELD, A; LAUFER, R; FONTAINE, B; DEVILLERSTHIERY, A; DUBREUIL, C; CHANGEUX, JP			REGULATION OF MUSCLE ACHR ALPHA-SUBUNIT GENE-EXPRESSION BY ELECTRICAL-ACTIVITY - INVOLVEMENT OF PROTEIN KINASE-C AND CA-2+	NEURON			English	Article											KLARSFELD, A (corresponding author), INST PASTEUR,DEPT BIOTECHNOL,CNRS,URA 0210,F-75724 PARIS 15,FRANCE.			Klarsfeld, Andre/0000-0001-9293-4887				BETZ H, 1979, NATURE, V278, P749, DOI 10.1038/278749a0; BETZ H, 1980, J PHYSIOL-LONDON, V302, P197; BIRNBAUM M, 1980, PFLUG ARCH EUR J PHY, V385, P37, DOI 10.1007/BF00583913; BROCKLEHURST KW, 1985, BIOCHEM J, V228, P35, DOI 10.1042/bj2280035; BURDEN S, 1977, DEV BIOL, V57, P317, DOI 10.1016/0012-1606(77)90218-4; BURSZTAJN S, 1988, BIOL CELL, V63, P57, DOI 10.1016/0248-4900(88)90108-6; CARLIN BE, 1986, J BIOL CHEM, V261, P5180; CHANGEUX JP, 1987, CELLULAR MOL BASES L, P31; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; CROOP J, 1982, DEV BIOL, V89, P460, DOI 10.1016/0012-1606(82)90334-7; DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801; EVANS S, 1987, J BIOL CHEM, V262, P4911; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FONTAINE B, 1989, IN PRESS J CELL BIOL; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; GOLDMAN D, 1985, J NEUROSCI, V5, P2553; HARRIS DA, 1988, P NATL ACAD SCI USA, V85, P1983, DOI 10.1073/pnas.85.6.1983; HO AK, 1988, J BIOL CHEM, V263, P9292; KLARSFELD A, 1985, P NATL ACAD SCI USA, V82, P4558, DOI 10.1073/pnas.82.13.4558; LAUFER R, 1989, IN PRESS MOL NEUROBI; LEYS EJ, 1984, J CELL BIOL, V99, P180, DOI 10.1083/jcb.99.1.180; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MCMANAMAN JL, 1982, BIOCHIM BIOPHYS ACTA, V720, P28, DOI 10.1016/0167-4889(82)90035-0; MERLIE JP, 1984, J CELL BIOL, V99, P332, DOI 10.1083/jcb.99.1.332; MOSS SJ, 1987, EMBO J, V6, P3917, DOI 10.1002/j.1460-2075.1987.tb02732.x; NARAYAN P, 1985, MOL CELL BIOL, V5, P2642, DOI 10.1128/MCB.5.10.2642; NIEDELJE, 1986, PHOSPHOINOSITIDES RE, V7, P47; PEZZEMENTI L, 1981, J BIOL CHEM, V256, P2651; RICHTER EA, 1987, FEBS LETT, V217, P232, DOI 10.1016/0014-5793(87)80669-5; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; SCHNEIDER M, 1984, J NEUROCHEM, V42, P1395, DOI 10.1111/j.1471-4159.1984.tb02800.x; SHAINBERG A, 1976, NATURE, V264, P368, DOI 10.1038/264368a0; SHAINBERG A, 1976, PFLUG ARCH EUR J PHY, V361, P255, DOI 10.1007/BF00587290; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHIEH BH, 1987, J CELL BIOL, V104, P1337, DOI 10.1083/jcb.104.5.1337; SHIEH BH, 1988, NEUROSCIENCE, V24, P175, DOI 10.1016/0306-4522(88)90321-1; SMILOWITZ H, 1988, J NEUROSCI RES, V19, P321, DOI 10.1002/jnr.490190307; VERGARA J, 1985, P NATL ACAD SCI USA, V82, P6352, DOI 10.1073/pnas.82.18.6352	41	139	139	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1989	2	3					1229	1236		10.1016/0896-6273(89)90307-3	http://dx.doi.org/10.1016/0896-6273(89)90307-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	T8021	2516449				2022-12-17	WOS:A1989T802100004
J	MACKINNON, R; REINHART, PH; WHITE, MM				MACKINNON, R; REINHART, PH; WHITE, MM			CHARYBDOTOXIN BLOCK OF SHAKER K+ CHANNELS SUGGESTS THAT DIFFERENT TYPES OF K+ CHANNELS SHARE COMMON STRUCTURAL FEATURES	NEURON			English	Article									UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104	University of Pennsylvania	MACKINNON, R (corresponding author), BRANDEIS UNIV,GRAD DEPT,WALTHAM,MA 02254, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR019826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017910, R01NS023885] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 19826] Funding Source: Medline; NINDS NIH HHS [NS 23885, NS 17910] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Benzanilla F, 1977, J GEN PHYSIOL, V70, P549; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; Hille B., 1984, IONIC CHANNELS EXCIT; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MILLER C, 1985, NATURE, V313, P315; MOCZYDLOWSKI E, 1988, J MEMBRANE BIOL, V105, P95, DOI 10.1007/BF02009164; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SALKOFF LB, 1983, J PHYSIOL-LONDON, V337, P687, DOI 10.1113/jphysiol.1983.sp014649; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SMITH C, 1986, J BIOL CHEM, V261, P4607; SOLC CK, 1987, SCIENCE, V236, P1094, DOI 10.1126/science.2437657; THORNHILL WB, 1987, BIOCHEMISTRY-US, V26, P4281; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WHITE MM, 1985, P NATL ACAD SCI USA, V82, P4852, DOI 10.1073/pnas.82.14.4852; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YELLEN G, 1987, ANNU REV BIOPHYS BIO, V16, P227	24	139	143	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1988	1	10					997	1001		10.1016/0896-6273(88)90156-0	http://dx.doi.org/10.1016/0896-6273(88)90156-0			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R4674	2483094				2022-12-17	WOS:A1988R467400010
J	Steadman, PE; Xia, F; Ahmed, M; Mocle, AJ; Penning, ARA; Geraghty, AC; Steenland, HW; Monje, M; Josselyn, SA; Frankland, PW				Steadman, Patrick E.; Xia, Frances; Ahmed, Moriam; Mocle, Andrew J.; Penning, Amber R. A.; Geraghty, Anna C.; Steenland, Hendrik W.; Monje, Michelle; Josselyn, Sheena A.; Frankland, Paul W.			Disruption of Oligodendrogenesis Impairs Memory Consolidation in Adult Mice	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; WHITE-MATTER; INDIVIDUAL OLIGODENDROCYTES; PREFRONTAL CORTEX; NERVOUS-SYSTEM; MYELINATION; PLASTICITY; SLEEP; GENERATE; SPINDLES	The generation of myelin-forming oligodendrocytes persists throughout life and is regulated by neural activity. Here we tested whether experience-driven changes in oligodendrogenesis are important for memory consolidation. We found that water maze learning promotes oligodendrogenesis and de novo myelination in the cortex and associated white matter tracts. Preventing these learning-induced increases in oligodendrogenesis without affecting existing oligodendrocytes impaired memory consolidation of water maze, as well as contextual fear, memories. These results suggest that de novo myelination tunes activated circuits, promoting coordinated activity that is important for memory consolidation. Consistent with this, contextual fear learning increased the coupling of hippocampal sharp wave ripples and cortical spindles, and these learning-induced increases in ripple-spindle coupling were blocked when oligodendrogenesis was suppressed. Our results identify a non-neuronal formof plasticity that remodels hippocampal-cortical networks following learning and is required for memory consolidation.	[Steadman, Patrick E.; Xia, Frances; Ahmed, Moriam; Mocle, Andrew J.; Penning, Amber R. A.; Steenland, Hendrik W.; Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Steadman, Patrick E.; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Xia, Frances; Mocle, Andrew J.; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Geraghty, Anna C.; Monje, Michelle] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Steenland, Hendrik W.] Max Planck Inst Microstruct Phys, D-06120 Halle, Germany; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Josselyn, Sheena A.] Canadian Inst Adv Res, Brain Mind & Consciousness Program, Toronto, ON M5G 1M1, Canada; [Frankland, Paul W.] Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Stanford University; Max Planck Society; University of Toronto; Canadian Institute for Advanced Research (CIFAR); Canadian Institute for Advanced Research (CIFAR)	Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Frankland, PW (corresponding author), Univ Toronto, Inst Med Sci, 100 Coll St, Toronto, ON M5S 1A8, Canada.; Frankland, PW (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada.; Frankland, PW (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.; Frankland, PW (corresponding author), Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada.	paul.frankland@sickkids.ca		Steadman, Patrick/0000-0002-5814-4977	Canadian Institutes of Health Research (CIHR) [FDN143227, PJT156164, MOP74650]; CIHR Vanier graduate scholarship; Arnie Aberman fellowship; McLaughlin MD/PhD studentship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Vanier graduate scholarship(Canadian Institutes of Health Research (CIHR)); Arnie Aberman fellowship; McLaughlin MD/PhD studentship	This work was supported by Canadian Institutes of Health Research (CIHR) grants FDN143227 and PJT156164 (to P.W.F. and MOP74650 (to S.A.J.). S.A.J. is a CIHR Canada Research Chair in Memory Function and Dysfunction. P.W.F. is a CIHR Canada Research Chair in Cognitive Neurobiology. P.E.S. was supported by a CIHR Vanier graduate scholarship, an Arnie Aberman fellowship, and a McLaughlin MD/PhD studentship. We thank Doug Holmyard and Ali Darbandi at the Nanoscale Biomedical Imaging Facility at The Hospital for Sick Children for assistance with electron microscopy. We also thank Lina Tran for development of the Python code for density plots of the water maze data.	Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Geraghty AC, 2019, NEURON, V103, P250, DOI 10.1016/j.neuron.2019.04.032; Gibson EM, 2018, DEV NEUROBIOL, V78, P123, DOI 10.1002/dneu.22541; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Hill RA, 2018, NAT NEUROSCI, V21, P683, DOI 10.1038/s41593-018-0120-6; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Li XB, 2004, BRAIN RES, V1008, P261, DOI 10.1016/j.brainres.2004.02.038; Maingret N, 2016, NAT NEUROSCI, V19, P959, DOI 10.1038/nn.4304; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; Mitew S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02719-2; Mount CW, 2017, NEURON, V95, P743, DOI 10.1016/j.neuron.2017.07.009; Ognjanovski N, 2018, CEREB CORTEX, V28, P3711, DOI 10.1093/cercor/bhy174; Ognjanovski N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15039; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Peyrache A, 2011, P NATL ACAD SCI USA, V108, P17207, DOI 10.1073/pnas.1103612108; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sampaio-Baptista C, 2017, NEURON, V96, P1239, DOI 10.1016/j.neuron.2017.11.026; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Stedehouder J, 2018, J NEUROSCI, V38, P3631, DOI 10.1523/JNEUROSCI.0074-18.2018; Takehara-Nishiuchi K, 2014, NEUROSCI RES, V84, P27, DOI 10.1016/j.neures.2014.02.012; Takeuchi T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0288; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tonegawa S, 2018, NAT REV NEUROSCI, V19, P485, DOI 10.1038/s41583-018-0031-2; Vetere G, 2017, NEURON, V94, P363, DOI 10.1016/j.neuron.2017.03.037; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Xia F, 2017, ELIFE, V6, DOI 10.7554/eLife.27868; Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	56	138	141	15	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2020	105	1					150	+		10.1016/j.neuron.2019.10.013	http://dx.doi.org/10.1016/j.neuron.2019.10.013			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KC7GI	31753579	Bronze, Green Accepted			2022-12-17	WOS:000507341300015
J	Kell, AJE; Yamins, DLK; Shook, EN; Norman-Haignere, SV; McDermott, JH				Kell, Alexander J. E.; Yamins, Daniel L. K.; Shook, Erica N.; Norman-Haignere, Sam V.; McDermott, Josh H.			A Task-Optimized Neural Network Replicates Human Auditory Behavior, Predicts Brain Responses, and Reveals a Cortical Processing Hierarchy	NEURON			English	Article							CORTEX EVIDENCE; COMPLEX SOUNDS; SPEECH; ORGANIZATION; REPRESENTATION; MODULATION; SUBDIVISIONS; STATISTICS; PERCEPTION; REGIONS	A core goal of auditory neuroscience is to build quantitative models that predict cortical responses to natural sounds. Reasoning that a complete model of auditory cortex must solve ecologically relevant tasks, we optimized hierarchical neural networks for speech and music recognition. The best-performing network contained separate music and speech pathways following early shared processing, potentially replicating human cortical organization. The network performed both tasks as well as humans and exhibited human-like errors despite not being optimized to do so, suggesting common constraints on network and human performance. The network predicted fMRI voxel responses substantially better than traditional spectrotemporal filter models throughout auditory cortex. It also provided a quantitative signature of cortical representational hierarchy-primary and non-primary responses were best predicted by intermediate and late network layers, respectively. The results suggest that task optimization provides a powerful set of tools for modeling sensory systems.	[Kell, Alexander J. E.; Shook, Erica N.; Norman-Haignere, Sam V.; McDermott, Josh H.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Kell, Alexander J. E.; Shook, Erica N.; McDermott, Josh H.] MIT, Ctr Brains Minds & Machines, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yamins, Daniel L. K.] Stanford Univ, Dept Psychol, Stanford, CA USA; [Yamins, Daniel L. K.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Yamins, Daniel L. K.] Stanford Neurosci Inst, Stanford, CA USA; [McDermott, Josh H.] Harvard Univ, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Harvard University	Kell, AJE; McDermott, JH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Kell, AJE; McDermott, JH (corresponding author), MIT, Ctr Brains Minds & Machines, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; McDermott, JH (corresponding author), Harvard Univ, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02138 USA.	alexkell@mit.edu; jhm@mit.edu		/0000-0002-3965-2503	NIH [NEI-R01 EY014970]; DOE Computational Science Graduate Fellowship [DE-FG02-97ER25308]; McDonnell Scholar Award; NSF [BCS-1634050]; NVIDIA Corporation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Computational Science Graduate Fellowship(United States Department of Energy (DOE)); McDonnell Scholar Award; NSF(National Science Foundation (NSF)); NVIDIA Corporation	The authors thank Nancy Kanwisher for sharing fMRI data, Steve Shannon for MR support, Kevin Woods for analysis of speakers for the representational similarity analysis, Ariel Herbert-Voss for help collecting behavioral data, Atsushi Takahashi for assistance with MR acquisition protocol design, and Satra Ghosh and the OpenMind team for computing resources. The authors also thank Michael Cohen, Elias Issa, Rebecca Saxe, Pedro Tsidivis, and members of the McDermott lab for comments on the manuscript. This work was supported by an NVIDIA Corporation hardware donation, NIH grant NEI-R01 EY014970 to J. DiCarlo (supporting D.L.K.Y.), a DOE Computational Science Graduate Fellowship (DE-FG02-97ER25308) to A.J.E.K., a McDonnell Scholar Award to J.H.M., and NSF grant BCS-1634050 to J.H.M.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Angulo-Perkins A, 2014, CORTEX, V59, P126, DOI 10.1016/j.cortex.2014.07.013; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Bertin-Mahieux T., 2011, P 12 INT SOC MUSIC I, P591, DOI DOI 10.7916/D8NZ8J07; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cadena Santiago A., 2017, BIORXIV, DOI [10.1101/201764, DOI 10.1101/201764]; Camalier CR, 2012, P NATL ACAD SCI USA, V109, P18168, DOI 10.1073/pnas.1206387109; Cammoun L, 2015, BRAIN STRUCT FUNCT, V220, P3537, DOI 10.1007/s00429-014-0872-z; Carlson NL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002594; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; de Heer WA, 2017, J NEUROSCI, V37, P6539, DOI 10.1523/JNEUROSCI.3267-16.2017; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Eickenberg M, 2017, NEUROIMAGE, V152, P184, DOI 10.1016/j.neuroimage.2016.10.001; Evans S, 2015, CEREB CORTEX, V25, P4772, DOI 10.1093/cercor/bhv136; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Garofolo J.S., 1993, TIMIT ACOUSTIC PHONE; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Hershey S, 2017, INT CONF ACOUST SPEE, P131, DOI 10.1109/ICASSP.2017.7952132; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Jones E., 2001, SCIPY OPEN SOURCE SC; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kawahara H, 2008, INT CONF ACOUST SPEE, P3933, DOI 10.1109/ICASSP.2008.4518514; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Klindt D., 2017, ARXIV171102653; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; McDermott JH, 2013, NAT NEUROSCI, V16, P493, DOI 10.1038/nn.3347; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Mlynarski W, 2018, NEURAL COMPUT, V30, P631, DOI 10.1162/neco_a_01048; Montufar GF., 2014, ADV NEURAL INFORM PR, V27, P2924, DOI DOI 10.5555/2969033.2969153; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mustafa K, 2006, IEEE T AUDIO SPEECH, V14, P435, DOI 10.1109/TSA.2005.855840; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Norman-Haignere S, 2013, J NEUROSCI, V33, P19451, DOI 10.1523/JNEUROSCI.2880-13.2013; Obleser J, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00232; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Oliphant TE., 2006, GUIDE NUMPY, DOI DOI 10.1016/J.JMOLDX.2015.02.001; Overath T, 2015, NAT NEUROSCI, V18, P903, DOI 10.1038/nn.4021; Patil K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002759; PAUL DB, 1992, SPEECH AND NATURAL LANGUAGE, P357; Peelle JE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00051; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Razavian AS, 2014, IEEE COMPUT SOC CONF, P512, DOI 10.1109/CVPRW.2014.131; Recanzone GH, 2010, BEHAV BRAIN RES, V206, P1, DOI 10.1016/j.bbr.2009.08.015; Santoro R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003412; Schonwiesner M, 2009, P NATL ACAD SCI USA, V106, P14611, DOI 10.1073/pnas.0907682106; Schoppe O, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00010; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Tierney A, 2013, CEREB CORTEX, V23, P249, DOI 10.1093/cercor/bhs003; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Woods KJP, 2017, ATTEN PERCEPT PSYCHO, V79, P2064, DOI 10.3758/s13414-017-1361-2; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907	77	138	139	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 2	2018	98	3					630	+		10.1016/j.neuron.2018.03.044	http://dx.doi.org/10.1016/j.neuron.2018.03.044			31	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1UU	29681533	Bronze			2022-12-17	WOS:000432473700018
J	Chen, G; Zhang, Y; Li, X; Zhao, XC; Ye, Q; Lin, YX; Tao, HZW; Rasch, MJ; Zhang, XH				Chen, Guang; Zhang, Yuan; Li, Xiang; Zhao, Xiaochen; Ye, Qian; Lin, Yingxi; Tao, Huizhong W.; Rasch, Malte J.; Zhang, Xiaohui			Distinct Inhibitory Circuits Orchestrate Cortical beta and gamma Band Oscillations	NEURON			English	Article							MOUSE VISUAL-CORTEX; IN-VIVO; CRITICAL PERIOD; GABAERGIC INTERNEURONS; MILLISECOND-TIMESCALE; THETA-OSCILLATIONS; TEMPORAL DYNAMICS; BEHAVIORAL STATE; NETWORK ACTIVITY; NEURAL ACTIVITY	Distinct subtypes of inhibitory interneuron are known to shape diverse rhythmic activities in the cortex, but how they interact to orchestrate specific band activity remains largely unknown. By recording optogenetically tagged interneurons of specific subtypes in the primary visual cortex of behaving mice, we show that spiking of somatostatin (SOM)- and parvalbumin (PV)-expressing interneurons preferentially correlates with cortical beta and gamma band oscillations, respectively. Suppression of SOM cell spiking reduces the spontaneous low-frequency band (<30-Hz) oscillations and selectively reduces visually induced enhancement of beta oscillation. In comparison, suppressing PV cell activity elevates the synchronization of spontaneous activity across a broad frequency range and further precludes visually induced changes in beta and gamma oscillations. Rhythmic activation of SOM and PV cells in the local circuit entrains resonant activity in the narrow 5- to 30-Hz band and the wide 20 -to 80-Hz band, respectively. Together, these findings reveal differential and cooperative roles of SOM and PV inhibitory neurons in orchestrating specific cortical oscillations.	[Chen, Guang; Zhang, Yuan; Li, Xiang; Zhao, Xiaochen; Ye, Qian; Rasch, Malte J.; Zhang, Xiaohui] Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Guang] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Lin, Yingxi] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA; [Tao, Huizhong W.] Univ Southern Calif, Zilkha Neurogenet Inst, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	Beijing Normal University; Chinese Academy of Sciences; Massachusetts Institute of Technology (MIT); University of Southern California	Rasch, MJ; Zhang, XH (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	malte.rasch@bnu.edu.cn; xhzhang@bnu.edu.cn	Zhang, Xiaohui/ABD-7056-2021; ZHANG, Yuan/AAO-3973-2021; Tao, Huizhong W/HDM-9767-2022	ZHANG, Yuan/0000-0002-5534-5415; Chen, Guang/0000-0003-1778-8730; /0000-0002-7002-1275	State Key Research Program of China [2011CBA00404, 2014CB846101]; Beijing Normal University; MIT Greater China for Innovation Fund; National Natural Science Foundation of China [31628007]; NIH [EY019049, EY025722]; NATIONAL EYE INSTITUTE [R01EY025722, R01EY019049] Funding Source: NIH RePORTER	State Key Research Program of China(State Key Development Program for Basic Research of China); Beijing Normal University; MIT Greater China for Innovation Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. J. Huang (CSHL) and H. Zeng (Allen Institute) for kindly providing Som-IRES-Cre mice as well as Ai35, Ai27, and Ai32 mice, respectively; Dr. Y. Liu for technical supports to the laser stimulation setup; and Dr. B. Li (CSHL) for critical reading on the manuscript. The work was supported by the grants from the State Key Research Program of China (2011CBA00404 to X. Zhang and 2014CB846101 to M.J.R.), the Interdisciplinary Research Funds of Beijing Normal University (to X. Zhang), and the MIT Greater China for Innovation Fund (to Y.L. and X. Zhang). H.W.T. was supported by a grant of the National Natural Science Foundation of China (31628007) and in part by NIH grants (EY019049 and EY025722).	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cammarota M, 2013, J PHYSIOL-LONDON, V591, P807, DOI 10.1113/jphysiol.2012.238154; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17847; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cottam JCH, 2013, J NEUROSCI, V33, P19567, DOI 10.1523/JNEUROSCI.2624-13.2013; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Esghaei M, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00082; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Fukunaga I, 2014, NAT NEUROSCI, V17, P1208, DOI 10.1038/nn.3760; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jurjut OF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016758; Karnani MM, 2016, NEURON, V90, P86, DOI 10.1016/j.neuron.2016.02.037; Kayser C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002717; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; Lazarus MS, 2011, J NEUROPHYSIOL, V106, P775, DOI 10.1152/jn.00729.2010; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miao QL, 2016, CELL REP, V16, P1677, DOI 10.1016/j.celrep.2016.07.013; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nase G, 2003, J NEUROPHYSIOL, V90, P1115, DOI 10.1152/jn.00480.2002; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perrenoud Q, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002383; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Roux L, 2014, CURR OPIN NEUROBIOL, V26, P88, DOI 10.1016/j.conb.2013.12.013; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Saleem AB, 2017, NEURON, V93, P315, DOI 10.1016/j.neuron.2016.12.028; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Siegle JH, 2014, NAT NEUROSCI, V17, P1371, DOI 10.1038/nn.3797; Snell F., 1972, PROGR THEORETICAL BI, P87, DOI [10.1016/b978-0-12-543102-6.50010-8, DOI 10.1016/B978-0-12-543102-6.50010-8]; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Veit J, 2017, NAT NEUROSCI, V20, P951, DOI 10.1038/nn.4562; Vierling-Claassen D, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00198; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Wang XJ, 1996, J NEUROSCI, V16, P6402; Welle C. G., 2010, THESIS; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Womelsdorf T, 2014, NAT NEUROSCI, V17, P1031, DOI 10.1038/nn.3764; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Zhang DK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00056; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064492	81	138	139	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2017	96	6					1403	+		10.1016/j.neuron.2017.11.033	http://dx.doi.org/10.1016/j.neuron.2017.11.033			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR2MD	29268099	Green Accepted, Bronze			2022-12-17	WOS:000418900200021
J	Burnett, CJ; Li, C; Webber, E; Tsaousidou, E; Xue, SY; Bruning, JC; Krashes, MJ				Burnett, C. Joseph; Li, Chia; Webber, Emily; Tsaousidou, Eva; Xue, Stephen Y.; Bruening, Jens C.; Krashes, Michael J.			Hunger-Driven Motivational State Competition	NEURON			English	Article							FEEDING-BEHAVIOR; NEURAL CIRCUITS; NEUROPEPTIDE-Y; CONSUMMATORY BEHAVIORS; LATERAL HYPOTHALAMUS; DOPAMINE NEURONS; MICE; NUCLEUS; AGRP; ACTIVATION	Behavioral choice is ubiquitous in the animal kingdom and is central to goal-oriented behavior. Hypothalamic Agouti-related peptide (AgRP) neurons are critical regulators of appetite. Hungry animals, bombarded by multiple sensory stimuli, are known to modify their behavior during times of caloric need, rapidly adapting to a consistently changing environment. Utilizing ARC AgRP neurons as an entry point, we analyzed the hierarchical position of hunger related to rival drive states. Employing a battery of behavioral assays, we found that hunger significantly increases its capacity to suppress competing motivational systems, such as thirst, anxiety-related behavior, innate fear, and social interactions, often only when food is accessible. Furthermore, real-time monitoring of ARC AgRP activity revealed time-locked responses to conspecific investigation in addition to food presentation, further establishing that, even at the level of ARC AgRP neurons, choices are remarkably flexible computations, integrating internal state, external factors, and anticipated yield.	[Burnett, C. Joseph; Li, Chia; Webber, Emily; Xue, Stephen Y.; Krashes, Michael J.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Burnett, C. Joseph; Li, Chia; Webber, Emily; Xue, Stephen Y.; Krashes, Michael J.] NIDA, NIH, Baltimore, MD 21224 USA; [Burnett, C. Joseph] Brown Univ, Grad Partnerships Program, Providence, RI 02912 USA; [Tsaousidou, Eva; Bruening, Jens C.] Max Plank Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany; [Tsaousidou, Eva; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Kerpener Str 26, D-50924 Cologne, Germany; [Tsaousidou, Eva; Bruening, Jens C.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Tsaousidou, Eva; Bruening, Jens C.] Univ Cologne, CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Tsaousidou, Eva; Bruening, Jens C.] Natl Ctr Diabet Res DZD, Ingolstadter Land Str 1, D-85764 Neuherberg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Brown University; University of Cologne; University of Cologne; University of Cologne	Krashes, MJ (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.; Krashes, MJ (corresponding author), NIDA, NIH, Baltimore, MD 21224 USA.	michael.krashes@nih.gov	Krashes, Michael/P-7677-2019; Tsaousidou, Eva/L-7602-2017	Tsaousidou, Eva/0000-0003-2751-1911; Webber, Emily/0000-0003-2893-7164; Burnett, Charles/0000-0002-3107-0146	Intramural Research Program of the NIH, National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK075087, DK075089]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075088, ZIADK075087] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Brad B. Lowell for providing Agrp-ires-Cre mice used in this study. We thank Alex Chesler, Lex Kravitz, and Nima Ghitani for photometry assistance and Alastair Garfield for comments on the manuscript. We thank the GENIE project for the development of GCaMP6. This work was supported by the Intramural Research Program of the NIH, The National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), DK075087 (M.J.K.), DK075089 (M.J.K.).	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; BOISSIER J R, 1962, Therapie, V17, P1225; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Chen YM, 2016, BIOESSAYS, V38, P316, DOI 10.1002/bies.201500167; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Falkner AL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00168; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Kawano H, 2010, NEUROSCIENCE, V169, P1227, DOI 10.1016/j.neuroscience.2010.05.065; Keys Ancel, 1946, JOUR AMER DIETETIC ASSOC, V22, P582; Kheifets A, 2012, P NATL ACAD SCI USA, V109, P8776, DOI 10.1073/pnas.1205131109; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; KUTSCHER CL, 1972, PHYSIOL BEHAV, V9, P753, DOI 10.1016/0031-9384(72)90046-7; Liu X, 2014, COLD SH Q B, V79, P59, DOI 10.1101/sqb.2014.79.024901; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; MONTGOMERY KC, 1955, J COMP PHYSIOL PSYCH, V48, P254, DOI 10.1037/h0043788; Navarro M, 2016, NEUROPSYCHOPHARMACOL, V41, P1505, DOI 10.1038/npp.2015.304; Nieh EH, 2016, NEURON, V90, P1286, DOI 10.1016/j.neuron.2016.04.035; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; NIESINK RJM, 1982, PHYSIOL BEHAV, V29, P819, DOI 10.1016/0031-9384(82)90331-6; Padilla SL, 2016, NAT NEUROSCI, V19, P734, DOI 10.1038/nn.4274; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Sherington C. A, 1906, INTEGRATIVE ACTIONS; SIEGEL PS, 1950, J COMP PHYSIOL PSYCH, V43, P62, DOI 10.1037/h0056669; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Silva BA, 2013, NAT NEUROSCI, V16, P1731, DOI 10.1038/nn.3573; Stamatakis AM, 2014, NEUROPHARMACOLOGY, V76, P320, DOI 10.1016/j.neuropharm.2013.05.046; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Stratford TR, 1997, J NEUROSCI, V17, P4434; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; VERPLANCK WS, 1953, J COMP PHYSIOL PSYCH, V46, P327, DOI 10.1037/h0055380; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Wu QL, 2014, ENDOCRINOLOGY, V155, P840, DOI 10.1210/en.2013-1831; Yang CF, 2014, NEURON, V82, P261, DOI 10.1016/j.neuron.2014.03.029; Yang HB, 2016, NAT NEUROSCI, V19, P283, DOI 10.1038/nn.4208; Yapici N, 2014, EMBO REP, V15, P1023, DOI 10.15252/embr.201438993	53	138	138	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2016	92	1					187	201		10.1016/j.neuron.2016.08.032	http://dx.doi.org/10.1016/j.neuron.2016.08.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA6TA	27693254	Green Accepted, Bronze			2022-12-17	WOS:000386760700020
J	Hutcherson, CA; Bushong, B; Rangel, A				Hutcherson, Cendri A.; Bushong, Benjamin; Rangel, Antonio			A Neurocomputational Model of Altruistic Choice and Its Implications	NEURON			English	Article							STIMULUS VALUE SIGNALS; DECISION-MAKING; TEMPOROPARIETAL JUNCTION; SOCIAL PREFERENCES; PARIETAL JUNCTION; PREFRONTAL CORTEX; NEURAL MECHANISMS; VALUATION SYSTEM; SUBJECTIVE VALUE; DICTATOR GAMES	We propose a neurocomputational model of altruistic choice and test it using behavioral and fMRI data from a task in which subjects make choices between real monetary prizes for themselves and another. We show that a multi-attribute drift-diffusion model, in which choice results from accumulation of a relative value signal that linearly weights payoffs for self and other, captures key patterns of choice, reaction time, and neural response in ventral striatum, temporoparietal junction, and ventromedial prefrontal cortex. The model generates several novel insights into the nature of altruism. It explains when and why generous choices are slower or faster than selfish choices, and why they produce greater response in TPJ and vmPFC, without invoking competition between automatic and deliberative processes or reward value for generosity. It also predicts that when one's own payoffs are valued more than others', some generous acts may reflect mistakes rather than genuinely pro-social preferences.	[Hutcherson, Cendri A.; Bushong, Benjamin; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Rangel, Antonio] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA; [Bushong, Benjamin] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Hutcherson, Cendri A.] Univ Toronto, Dept Psychol, Toronto, ON M1C 1A4, Canada	California Institute of Technology; California Institute of Technology; Harvard University; University of Toronto	Hutcherson, CA (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	chutcher@hss.caltech.edu	Hutcherson, Cendri/AAD-3820-2019	Hutcherson, Cendri/0000-0002-4441-4809	NSF-IGERT; NSF-Economics; NSF-DRMS; Gordon and Betty Moore Foundation; Lipper Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	NSF-IGERT(National Science Foundation (NSF)); NSF-Economics; NSF-DRMS(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Lipper Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Matthew Rabin was an earlier collaborator on this project, which benefited greatly from his insight. This research was supported by NSF-IGERT (B.B.), NSF-Economics (A.R.), NSF-DRMS (A.R.), the Gordon and Betty Moore Foundation (A.R., C.A.H.), and the Lipper Foundation (A.R.). We thank John Clithero and Anita Tusche for helpful comments.	ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Andreoni J, 2009, ECONOMETRICA, V77, P1607, DOI 10.3982/ECTA7384; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Batson C. D., 2011, ALTRUISM HUMANS, DOI DOI 10.1093/ACPROF:OSO/9780195341065.001.0001; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bernheim B. D., 2005, BEHAV PUBLIC EC WELF; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Boorman ED, 2013, NEURON, V80, P1558, DOI 10.1016/j.neuron.2013.10.024; Bruneau EG, 2012, NEUROPSYCHOLOGIA, V50, P219, DOI 10.1016/j.neuropsychologia.2011.11.008; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cisek P, 2009, J NEUROSCI, V29, P11560, DOI 10.1523/JNEUROSCI.1844-09.2009; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lim SL, 2013, J NEUROSCI, V33, P8729, DOI 10.1523/JNEUROSCI.4809-12.2013; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Piovesan M, 2009, ECON LETT, V105, P193, DOI 10.1016/j.econlet.2009.07.017; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; RANGEL A., 2014, NEUROECONOMICS, P125, DOI 10.1016/B978-0-12-416008-8.00008-5; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Rodriguez CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090138; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Scholz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004869; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Strombach T, 2015, P NATL ACAD SCI USA, V112, P1619, DOI 10.1073/pnas.1414715112; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; van den Bos W, 2013, J EXP ANAL BEHAV, V99, P58, DOI 10.1002/jeab.6; Waytz A, 2012, J NEUROSCI, V32, P7646, DOI 10.1523/JNEUROSCI.6193-11.2012; Zaki J, 2011, P NATL ACAD SCI USA, V108, P19761, DOI 10.1073/pnas.1112324108	63	138	141	14	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2015	87	2					451	462		10.1016/j.neuron.2015.06.031	http://dx.doi.org/10.1016/j.neuron.2015.06.031			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CR2GJ	26182424	Bronze, Green Accepted			2022-12-17	WOS:000361144200018
J	Swartz, JR; Knodt, AR; Radtke, SR; Hariri, AR				Swartz, Johnna R.; Knodt, Annchen R.; Radtke, Spenser R.; Hariri, Ahmad R.			A Neural Biomarker of Psychological Vulnerability to Future Life Stress	NEURON			English	Article							EMOTIONAL NEGLECT; NEGATIVE STIMULI; DSM-IV; AMYGDALA; DEPRESSION; ANXIETY; EVENTS; ONSET; MOOD; RISK	We all experience a host of common life stressors such as the death of a family member, medical illness, and financial uncertainty. While most of us are resilient to such stressors, continuing to function normally, for a subset of individuals, experiencing these stressors increases the likelihood of developing treatment-resistant, chronic psychological problems, including depression and anxiety. It is thus paramount to identify predictive markers of risk, particularly those reflecting fundamental biological processes that can be targets for intervention and prevention. Using data from a longitudinal study of 340 healthy young adults, we demonstrate that individual differences in threat-related amygdala reactivity predict psychological vulnerability to life stress occurring as much as 1 to 4 years later. These results highlight a readily assayed biomarker, threat-related amygdala reactivity, which predicts psychological vulnerability to commonly experienced stressors and represents a discrete target for intervention and prevention.	[Swartz, Johnna R.; Knodt, Annchen R.; Radtke, Spenser R.; Hariri, Ahmad R.] Duke Univ, Dept Psychol & Neurosci, Neurogenet Lab, Durham, NC 27708 USA; [Swartz, Johnna R.] Univ N Carolina, Ctr Dev Sci, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill	Swartz, JR (corresponding author), Duke Univ, Dept Psychol & Neurosci, Neurogenet Lab, Durham, NC 27708 USA.	johnna.swartz@duke.edu		Swartz, Johnna/0000-0002-6171-917X	Duke University; NIH [DA033369, DA031579, P30DA023026]; National Institute of Child Health and Human Development through the Center for Developmental Science grant [T32-HD07376]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA023026, R01DA031579, R01DA033369] Funding Source: NIH RePORTER	Duke University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development through the Center for Developmental Science grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Duke Neurogenetics Study is supported by Duke University and NIH grant DA033369. A.R.H. is supported by NIH grants DA033369 and DA031579. J.R.S. is supported by a Postdoctoral Fellowship provided by the National Institute of Child Health and Human Development through the Center for Developmental Science grant T32-HD07376 and by NIH grant P30DA023026.	Admon R, 2009, P NATL ACAD SCI USA, V106, P14120, DOI 10.1073/pnas.0903183106; Bogdan R, 2012, AM J PSYCHIAT, V169, P515, DOI 10.1176/appi.ajp.2011.11060855; Bredemeier K, 2010, PSYCHOL ASSESSMENT, V22, P702, DOI 10.1037/a0019915; Buckby JA, 2007, BRIT J CLIN PSYCHOL, V46, P235, DOI 10.1348/014466506X132912; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Clements K, 1996, PERS INDIV DIFFER, V20, P747, DOI 10.1016/0191-8869(96)00005-0; Espejo EP, 2012, J ABNORM CHILD PSYCH, V40, P303, DOI 10.1007/s10802-011-9552-0; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; FARAVELLI C, 1985, J AFFECT DISORDERS, V9, P103, DOI 10.1016/0165-0327(85)90016-3; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Groenewold NA, 2013, NEUROSCI BIOBEHAV R, V37, P152, DOI 10.1016/j.neubiorev.2012.11.015; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Joormann J, 2012, J ABNORM PSYCHOL, V121, P61, DOI 10.1037/a0025294; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; McLaughlin KA, 2014, DEPRESS ANXIETY, V31, P834, DOI 10.1002/da.22284; Monk CS, 2008, AM J PSYCHIAT, V165, P90, DOI 10.1176/appi.ajp.2007.06111917; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Nikolova YS, 2014, NAT NEUROSCI, V17, P1153, DOI 10.1038/nn.3778; Nikolova YS, 2012, BIOL PSYCHIAT, V72, P157, DOI 10.1016/j.biopsych.2012.03.014; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Prather AA, 2013, PSYCHOSOM MED, V75, P350, DOI 10.1097/PSY.0b013e31828ef15b; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Swartz J.R., 2014, AM J PSYCHIAT; WATSON D, 1995, J ABNORM PSYCHOL, V104, P15, DOI 10.1037/0021-843X.104.1.15; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x	29	138	143	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 4	2015	85	3					505	511		10.1016/j.neuron.2014.12.055	http://dx.doi.org/10.1016/j.neuron.2014.12.055			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB9NY	25654256	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-17	WOS:000349959700009
J	Orsborn, AL; Moorman, HG; Overduin, SA; Shanechi, MM; Dimitrov, DF; Carmena, JM				Orsborn, Amy L.; Moorman, Helene G.; Overduin, Simon A.; Shanechi, Maryam M.; Dimitrov, Dragan F.; Carmena, Jose M.			Closed-Loop Decoder Adaptation Shapes Neural Plasticity for Skillful Neuroprosthetic Control	NEURON			English	Article							BRAIN-COMPUTER INTERFACE; MACHINE INTERFACES; VOLITIONAL CONTROL; CORTICAL CONTROL; NETWORKS; DESIGN; ARM	Neuroplasticity may play a critical role in developing robust, naturally controlled neuroprostheses. This learning, however, is sensitive to system changes such as the neural activity used for control. The ultimate utility of neuroplasticity in real-world neuroprostheses is thus unclear. Adaptive decoding methods hold promise for improving neuroprosthetic performance in nonstationary systems. Here, we explore the use of decoder adaptation to shape neuroplasticity in two scenarios relevant for real-world neuroprostheses: nonstationary recordings of neural activity and changes in control context. Nonhuman primates learned to control a cursor to perform a reaching task using semistationary neural activity in two contexts: with and without simultaneous arm movements. Decoder adaptation was used to improve initial performance and compensate for changes in neural recordings. We show that beneficial neuroplasticity can occur alongside decoder adaptation, yielding performance improvements, skill retention, and resistance to interference from native motor networks. These results highlight the utility of neuroplasticity for real-world neuroprostheses.	[Orsborn, Amy L.; Carmena, Jose M.] Univ Calif Berkeley, UC Berkeley UCSF Joint Grad Program Bioengn, Berkeley, CA 94720 USA; [Moorman, Helene G.; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Overduin, Simon A.; Shanechi, Maryam M.; Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Dimitrov, Dragan F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Carmena, JM (corresponding author), Univ Calif Berkeley, UC Berkeley UCSF Joint Grad Program Bioengn, Berkeley, CA 94720 USA.	jcarmena@berkeley.edu		Orsborn, Amy/0000-0003-4131-5781	American Heart Association; National Science Foundation; Defense Advanced Research Projects Agency [N66001-10-C-2008]; National Science Foundation [CBET-0954243, EFRI-M3C 1137267]	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the American Heart Association predoctoral fellowship (to A.L.O.), the National Science Foundation Graduate Research Fellowship (to H.G.M.), the Defense Advanced Research Projects Agency contract N66001-10-C-2008 (to J.M.C.), and the National Science Foundation grants CBET-0954243 and EFRI-M3C 1137267 (to J.M.C.). We thank E. Rich for surgical assistance.	Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Carmena JM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001561; Chase SM, 2012, J NEUROPHYSIOL, V108, P624, DOI 10.1152/jn.00371.2011; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Dangi S, 2013, NEURAL COMPUT, V25, P1693, DOI 10.1162/NECO_a_00460; Danziger Z, 2009, IEEE T BIO-MED ENG, V56, P1502, DOI 10.1109/TBME.2009.2013822; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; Foldes ST, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-116; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Golub MD, 2012, IEEE ENG MED BIO, P1327, DOI 10.1109/EMBC.2012.6346182; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Hwang EJ, 2013, CURR BIOL, V23, P353, DOI 10.1016/j.cub.2013.01.027; Jackson A, 2011, IEEE T NEUR SYS REH, V19, P534, DOI 10.1109/TNSRE.2011.2158586; Jarosiewicz B, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046012; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Koralek AC, 2013, NEURON, V79, P865, DOI 10.1016/j.neuron.2013.06.047; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Li Z, 2011, NEURAL COMPUT, V23, P3162, DOI 10.1162/NECO_a_00207; Merel J. S., 2013, ADV NEURAL INFORM PR, V26, P2841; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Orsborn AL, 2012, IEEE T NEUR SYS REH, V20, P468, DOI 10.1109/TNSRE.2012.2185066; Shanechi MM, 2013, I IEEE EMBS C NEUR E, P653, DOI 10.1109/NER.2013.6696019; Suminski AJ, 2009, NEURAL NETWORKS, V22, P1224, DOI 10.1016/j.neunet.2009.05.006; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wander JD, 2013, P NATL ACAD SCI USA, V110, P10818, DOI 10.1073/pnas.1221127110; Wu W, 2003, ADV NEURAL INFORM PR, P133	32	138	139	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 18	2014	82	6					1380	1393		10.1016/j.neuron.2014.04.048	http://dx.doi.org/10.1016/j.neuron.2014.04.048			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ0QO	24945777	Bronze			2022-12-17	WOS:000337360700022
J	Jurado, S; Goswami, D; Zhang, YS; Molina, AJM; Sudhof, TC; Malenka, RC				Jurado, Sandra; Goswami, Debanjan; Zhang, Yingsha; Minano Molina, Alfredo J.; Suedhof, Thomas C.; Malenka, Robert C.			LTP Requires a Unique Postsynaptic SNARE Fusion Machinery	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR TRAFFICKING; SYNAPTIC VESICLE EXOCYTOSIS; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; DEPENDENT EXOCYTOSIS; EXCITATORY SYNAPSES; RECYCLING ENDOSOMES; HIPPOCAMPAL-NEURONS; COMPLEXIN CONTROLS	Membrane fusion during exocytosis is mediated by assemblies of SNARE (soluble NSF-attachment protein receptor) and SM (Sec1/Munc18-like) proteins. The SNARE/SM proteins involved in vesicle fusion during neurotransmitter release are well understood, whereas little is known about the protein machinery that mediates activity-dependent AMPA receptor (AMPAR) exocytosis during long-term potentiation (LTP). Using direct measurements of LTP in acute hippocampal slices and an in vitro LTP model of stimulated AMPAR exocytosis, we demonstrate that the Q-SNARE proteins syntaxin-3 and SNAP-47 are required for regulated AMPAR exocytosis during LTP but not for constitutive basal AMPAR exocytosis. In contrast, the R-SNARE protein synaptobrevin-2NAMP2 contributes to both regulated and constitutive AMPAR exocytosis. Both the central complexin-binding and the N-terminal Munc18-binding sites of syntaxin-3 are essential for its postsynaptic role in LTP. Thus, postsynaptic exocytosis of AMPARs during LTP is mediated by a unique fusion machinery that is distinct from that used during presynaptic neurotransmitter release.	[Jurado, Sandra; Goswami, Debanjan; Minano Molina, Alfredo J.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Zhang, Yingsha; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Minano Molina, Alfredo J.] Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain; [Minano Molina, Alfredo J.] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Minano Molina, Alfredo J.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Autonomous University of Barcelona; CIBERNED; Autonomous University of Barcelona; Autonomous University of Barcelona	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Jurado, Sandra/S-9936-2017; Miñano-Molina, Alfredo J/C-9863-2011	Jurado, Sandra/0000-0001-9864-9307; Miñano-Molina, Alfredo J/0000-0002-7761-5682	NIH [MH086403, MH063394]; Jose Castillejo Postdoctoral Fellowship from the Spanish Ministry of Education; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, P50MH086403, R37MH063394] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jose Castillejo Postdoctoral Fellowship from the Spanish Ministry of Education; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Malenka and Sudhof labs for comments and help during the course of the experiments. We thank Drs. P. Zhou and X. Yang for maintaining the synaptobrevin-2 knockout mouse colony. S.J. performed recordings from acute slices and stereotactic injections. D.G. performed all assays in hippocampal cultures. S.J. and D.G. constructed plasmids, generated lentivirus, and performed western blot analyses. D.G. and A.J.M.M. carried out transferrin recycling assays. Y.Z. designed shRNAs for Stx-3, Stx-4, Stx-1, SNAP-25, SNAP-23, and SNAP-47, generated all KD constructs, and identified effective shRNAs. S.J., D.G., T.C.S., and R.C.M. wrote the manuscript. All authors reviewed the paper and edited it. R.C.M. and T.C.S. directed and coordinated the project. This work was supported by NIH grants MH086403 (R.C.M., T.C.S.) and MH063394 (R.C.M.). A.J.M.M. was supported by a Jose Castillejo Postdoctoral Fellowship (I-D+i 2008-2011) from the Spanish Ministry of Education.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ahmad M, 2012, NEURON, V73, P260, DOI 10.1016/j.neuron.2011.11.020; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Clapp WC, 2012, BIOL PSYCHIAT, V71, P496, DOI 10.1016/j.biopsych.2011.08.021; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Ehlers MD, 2012, BIOL PSYCHIAT, V71, P484, DOI 10.1016/j.biopsych.2012.01.001; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tanaka H, 2012, CELL REPORTS, V1, P291, DOI 10.1016/j.celrep.2012.02.004; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang XF, 2010, NEURON, V68, P907, DOI 10.1016/j.neuron.2010.11.001; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	73	138	139	3	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 6	2013	77	3					542	558		10.1016/j.neuron.2012.11.029	http://dx.doi.org/10.1016/j.neuron.2012.11.029			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395379	Green Accepted, Bronze			2022-12-17	WOS:000317030800015
J	Sato, TK; Nauhaus, I; Carandini, M				Sato, Tatsuo K.; Nauhaus, Ian; Carandini, Matteo			Traveling Waves in Visual Cortex	NEURON			English	Review							RANGE LATERAL INTERACTIONS; RECEPTIVE-FIELD CENTER; PROPAGATING WAVES; MACAQUE V1; SPATIOTEMPORAL DYNAMICS; NETWORK MECHANISMS; SPATIAL SUMMATION; ONGOING ACTIVITY; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS	Electrode recordings and imaging studies have revealed that localized visual stimuli elicit waves of activity that travel across primary visual cortex. Traveling waves are present also during spontaneous activity, but they can be greatly reduced by widespread and intensive visual stimulation. In this Review, we summarize the evidence in favor of these traveling waves. We suggest that their substrate may lie in long-range horizontal connections and that their functional role may involve the integration of information over large regions of space.	[Sato, Tatsuo K.; Carandini, Matteo] UCL, London EC1V 9EL, England; [Nauhaus, Ian] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of London; University College London; Salk Institute	Carandini, M (corresponding author), UCL, London EC1V 9EL, England.	matteo@carandinilab.net	Carandini, Matteo/ABD-8296-2021; Sato, Tatsuo/AAC-2729-2019	Carandini, Matteo/0000-0003-4880-7682; Sato, Tatsuo/0000-0002-1279-5125	Medical Research Council [G0800791]; European Research Council; MRC [G0800791] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (grant G0800791) and by the European Research Council (project CORTEX). M.C. holds the GlaxoSmithKline / Fight for Sight Chair in Visual Neuroscience.	Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/NMETH.1479, 10.1038/nmeth.1479]; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P313; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; Chen CC, 2001, NEUROREPORT, V12, P655, DOI 10.1097/00001756-200103260-00008; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Compte A, 2006, CEREB CORTEX, V16, P761, DOI 10.1093/cercor/bhj021; COWEY A, 1964, J NEUROPHYSIOL, V27, P366, DOI 10.1152/jn.1964.27.3.366; CREUTZFELDT OD, 1977, EXP BRAIN RES, V27, P419; Derdikman D, 2003, J NEUROSCI, V23, P3100; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; EBERSOLE JS, 1981, BRAIN RES, V224, P160, DOI 10.1016/0006-8993(81)91126-4; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; FISKEN RA, 1975, PHILOS T ROY SOC B, V272, P487, DOI 10.1098/rstb.1975.0099; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; FUKUNISHI K, 1992, BIOL CYBERN, V67, P501, DOI 10.1007/BF00198757; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; Higo S, 2007, J COMP NEUROL, V503, P421, DOI 10.1002/cne.21395; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KITANO M, 1994, VISUAL NEUROSCI, V11, P953, DOI 10.1017/S0952523800003904; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lauritzen M, 2001, CEPHALALGIA, V21, P757, DOI 10.1046/j.1468-2982.2001.00244.x; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LONDON JA, 1989, J NEUROSCI, V9, P2182; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; MCDONALD CT, 1993, J NEUROSCI, V13, P768; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nauhaus I, 2012, J NEUROSCI, V32, P3088, DOI 10.1523/JNEUROSCI.5827-11.2012; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nenadic Z, 2003, J COMPUT NEUROSCI, V14, P161, DOI 10.1023/A:1021954701494; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; ORBACH HS, 1985, J NEUROSCI, V5, P1886; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Prechtl JC, 2000, P NATL ACAD SCI USA, V97, P877, DOI 10.1073/pnas.97.2.877; Ray S, 2011, J NEUROSCI, V31, P12674, DOI 10.1523/JNEUROSCI.1856-11.2011; Reimer A, 2011, CEREB CORTEX, V21, P166, DOI 10.1093/cercor/bhq073; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Series P, 2002, VISION RES, V42, P2781, DOI 10.1016/S0042-6989(02)00302-4; Sharon D, 2007, CEREB CORTEX, V17, P2866, DOI 10.1093/cercor/bhm019; Silver MA, 2008, NEURON, V60, P904, DOI 10.1016/j.neuron.2008.09.038; Sit YF, 2009, NEURON, V64, P943, DOI 10.1016/j.neuron.2009.08.041; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; Song WJ, 2006, CEREB CORTEX, V16, P718, DOI 10.1093/cercor/bhj018; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	99	138	138	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 26	2012	75	2					218	229		10.1016/j.neuron.2012.06.029	http://dx.doi.org/10.1016/j.neuron.2012.06.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	982HH	22841308	hybrid, Green Submitted			2022-12-17	WOS:000307033200008
J	Yang, Y; Shu, XG; Liu, D; Shang, Y; Wu, Y; Pei, L; Xu, X; Tian, Q; Zhang, J; Qian, K; Wang, YX; Petralia, RS; Tu, WH; Zhu, LQ; Wang, JZ; Lu, YM				Yang, Ying; Shu, Xiaogang; Liu, Dan; Shang, You; Wu, Yan; Pei, Lei; Xu, Xin; Tian, Qing; Zhang, Jian; Qian, Kun; Wang, Ya-Xian; Petralia, Ronald S.; Tu, Weihong; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming			EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; RAP1 ACTIVATION; GENE-EXPRESSION; EXCHANGE FACTOR; CELL-DEATH; MICRORNAS; MEMORY; PROTEINS; REVEALS	EPAC proteins are the guanine nucleotide exchange factors that act as the intracellular receptors for cyclic AMP. Two variants of EPAC genes including EPAC1 and EPAC2 are cloned and are widely expressed throughout the brain. But, their functions in the brain remain unknown. Here, we genetically delete EPAC1 (EPAC1(-/-)) EPAC2 (EPAC2(-/-)), or both EPAC1 and EPAC2 genes (EPAC(-/-)) in the fore-brain of mice. We show that EPAC null mutation impairs long-term potentiation (LTP) and that this impairment is paralleled with the severe deficits in spatial learning and social interactions and is mediated in a direct manner by miR-124 transcription and Zif268 translation. Knockdown of miR-124 restores Zif268 and hence reverses all aspects of the EPAC(-/-) phenotypes, whereas expression of miR-124 or knockdown of Zif268 reproduces the effects of EPAC null mutation. Thus, EPAC proteins control miR-124 transcription in the brain for processing spatial learning and social interactions.	[Yang, Ying; Liu, Dan; Pei, Lei; Tian, Qing; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ China, Key Lab Neurol Dis, Wuhan 430030, Peoples R China; [Yang, Ying; Liu, Dan; Pei, Lei; Tian, Qing; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming] Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Shu, Xiaogang; Shang, You; Wu, Yan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Shu, Xiaogang; Shang, You; Wu, Yan; Xu, Xin; Zhang, Jian; Qian, Kun; Tu, Weihong; Lu, Youming] Louisiana State Univ, Sch Med, Dept Neurol, New Orleans, LA 70112 USA; [Shu, Xiaogang; Shang, You; Wu, Yan; Xu, Xin; Zhang, Jian; Qian, Kun; Tu, Weihong; Lu, Youming] Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Wang, Ya-Xian; Petralia, Ronald S.] Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Huazhong University of Science & Technology; Ministry of Education, China; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Louisiana State University System; Louisiana State University System; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Zhu, LQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ China, Key Lab Neurol Dis, Wuhan 430030, Peoples R China.	zhulq@mail.hust.du.cn; wangjz@mail.hust.edu.cn; lym@mail.hust.edu.cn	Yang, Ying/J-3901-2016	shang, you/0000-0003-4097-6131; zhu, lingqiang/0000-0001-9964-9229	National Natural Science Foundation of China [81130079]; National Institute of Health (NIH/NINDS) [R01NS5051383]; NIH/NIA [R01AG033282]; New Century Excellent Talents in University (NCET [10-0421]; NIH/NIDCD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, ZICDC000081] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Century Excellent Talents in University (NCET(Program for New Century Excellent Talents in University (NCET)); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Natural Science Foundation of China (Grant 81130079 YL), National Institute of Health (NIH/NINDS, R01NS5051383Y.L and NIH/NIA R01AG033282Y.L), the New Century Excellent Talents in University (NCET-10-0421, L.-Q.Z.), and the NIH/NIDCD Intramural Program (R.S.P. and Y.-X.W.).	Arvanitis DN, 2010, MOL CELL BIOL, V30, P2508, DOI 10.1128/MCB.01620-09; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; FARNSWORTH CL, 1991, CELL, V64, P625, DOI 10.1016/0092-8674(91)90246-U; Fischbach SJ, 2009, NEURON, V63, P714, DOI 10.1016/j.neuron.2009.09.007; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	58	138	139	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					774	788		10.1016/j.neuron.2012.02.003	http://dx.doi.org/10.1016/j.neuron.2012.02.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365550	Bronze, Green Accepted			2022-12-17	WOS:000300815400015
J	Buchanan, KA; Petrovic, MM; Chamberlain, SEL; Marrion, NV; Mellor, JR				Buchanan, Katherine A.; Petrovic, Milos M.; Chamberlain, Sophie E. L.; Marrion, Neil V.; Mellor, Jack R.			Facilitation of Long-Term Potentiation by Muscarinic M-1 Receptors Is Mediated by Inhibition of SK Channels	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; PROTEIN-KINASE CK2; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; ACETYLCHOLINE-RECEPTORS; CHOLINERGIC INHIBITION; PROACTIVE-INTERFERENCE; PYRAMIDAL CELLS; NMDA RECEPTORS; CA1	Muscarinic receptor activation facilitates the induction of synaptic plasticity and enhances cognitive function. However, the specific muscarinic receptor subtype involved and the critical intracellular signaling pathways engaged have remained controversial. Here, we show that the recently discovered highly selective allosteric M-1 receptor agonist 77-LH-28-1 facilitates long-term potentiation (LTP) induced by theta burst stimulation at Schaffer collateral synapses in the hippocampus. Similarly, release of acetylcholine by stimulation of cholinergic fibers facilitates LTP via activation of M-1 receptors. N-methyl-D-aspartate receptor (NMDAR) opening during theta burst stimulation was enhanced by M-1 receptor activation, indicating this is the mechanism for LIP facilitation. M-1 receptors were found to enhance NMDAR activation by inhibiting SK channels that otherwise act to hyperpolarize postsynaptic spines and inhibit NMDAR opening. Thus, we describe a mechanism where M-1 receptor activation inhibits SK channels, allowing enhanced NMDAR activity and leading to a facilitation of LIP induction in the hippocampus.	[Buchanan, Katherine A.; Petrovic, Milos M.; Chamberlain, Sophie E. L.; Marrion, Neil V.; Mellor, Jack R.] Univ Bristol, Med Res Council Ctr Synapt Plast, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Buchanan, Katherine A.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of Bristol; University of London; University College London	Mellor, JR (corresponding author), Univ Bristol, Med Res Council Ctr Synapt Plast, Sch Physiol & Pharmacol, Univ Walk, Bristol BS8 1TD, Avon, England.	jack.mellor@bristol.ac.uk	MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105	GlaxoSmithKline; Marie Curie fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); Belgian Science Policy Interuniversity Attraction Poles (IAP) programme; Medical Research Council; Wellcome Trust; European Union Network of European Neuroscience Institutes (ENI-NET); MRC [G120/838] Funding Source: UKRI; Medical Research Council [G120/838] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Marie Curie fellowship(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Belgian Science Policy Interuniversity Attraction Poles (IAP) programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union Network of European Neuroscience Institutes (ENI-NET); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Hanley, A. Randall, and C. Davies for critical reading of earlier versions of the manuscript, and J. Hancock and M. Elbadawi for preliminary human embryonic kidney cell experiments. 77-LH-28-1 was a gift from GlaxoSmithKline. M<INF>1</INF>-/- mice were kindly provided by Dr. J. Wess. K.A.B. was supported by a GlaxoSmithKline studentship, M.P. is supported by a Marie Curie fellowship, S.E.L.C. is supported by Biotechnology and Biological Sciences Research Council (BBSRC), N.V.M. is supported by the Belgian Science Policy Interuniversity Attraction Poles (IAP) programme, J.R.M. is supported by Medical Research Council, BBSRC, Wellcome Trust, and the European Union Network of European Neuroscience Institutes (ENI-NET).	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Aramakis VB, 1999, SYNAPSE, V32, P262, DOI 10.1002/(SICI)1098-2396(19990615)32:4<262::AID-SYN3>3.3.CO;2-A; Atri A, 2004, BEHAV NEUROSCI, V118, P223, DOI 10.1037/0735-7044.118.1.223; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; BODDEKE EWGM, 1992, EUR J PHARMACOL, V222, P21, DOI 10.1016/0014-2999(92)90457-F; Brown DA, 1997, LIFE SCI, V60, P1137, DOI 10.1016/S0024-3205(97)00058-1; Buchanan KA, 2007, J PHYSIOL-LONDON, V585, P429, DOI 10.1113/jphysiol.2007.142984; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; De Rosa E, 2000, BEHAV NEUROSCI, V114, P32, DOI 10.1037/0735-7044.114.1.32; Dean B, 2003, CURR MOL MED, V3, P419, DOI 10.2174/1566524033479654; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; Faber ESL, 2010, J PHYSIOL-LONDON, V588, P1281, DOI 10.1113/jphysiol.2009.185645; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Fiorillo CD, 2000, J NEUROSCI, V20, P7855; Gu N, 2008, J NEUROPHYSIOL, V100, P2589, DOI 10.1152/jn.90433.2008; Gulledge AT, 2005, J NEUROSCI, V25, P10308, DOI 10.1523/JNEUROSCI.2697-05.2005; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Isaac JTR, 2009, J NEUROSCI, V29, P6840, DOI 10.1523/JNEUROSCI.0731-09.2009; Koch HJ, 2005, CURR MED CHEM, V12, P2915, DOI 10.2174/092986705774454742; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Langmead CJ, 2006, MOL PHARMACOL, V69, P236, DOI 10.1124/mol.105.017814; Leung LS, 2003, J NEUROSCI, V23, P9297; Lieberman DN, 1999, NAT NEUROSCI, V2, P125, DOI 10.1038/5680; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Maingret F, 2008, NEURON, V59, P439, DOI 10.1016/j.neuron.2008.05.026; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Seeger T, 2001, J PHYSIOL-LONDON, V535, P383, DOI 10.1111/j.1469-7793.2001.00383.x; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shimoshige Y, 1997, NEUROSCI RES, V27, P175, DOI 10.1016/S0168-0102(96)01147-9; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Stackman RW, 2002, J NEUROSCI, V22, P10163; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	57	138	139	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					948	963		10.1016/j.neuron.2010.11.018	http://dx.doi.org/10.1016/j.neuron.2010.11.018			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145007	hybrid, Green Published			2022-12-17	WOS:000285664900015
J	Wark, B; Fairhall, A; Rieke, F				Wark, Barry; Fairhall, Adrienne; Rieke, Fred			Timescales of Inference in Visual Adaptation	NEURON			English	Article							RETINAL GANGLION-CELLS; TEMPORAL CONTRAST ADAPTATION; VARIANCE ADAPTATION; GAIN-CONTROL; NEURAL CODE; TIME-COURSE; NEURONS; DYNAMICS; SIGNALS; INACTIVATION	Adaptation is a hallmark of sensory function. Adapting optimally requires matching the dynamics of adaptation to those of changes in the stimulus distribution. Here we show that the dynamics of adaptation in the responses of mouse retinal ganglion cells depend on stimulus history. We hypothesized that the accumulation of evidence for a change in the stimulus distribution controls the dynamics of adaptation, and developed a model for adaptation as an ongoing inference problem. Guided by predictions of this model, we found that the dynamics of adaptation depend on the discriminability of the change in stimulus distribution and that the retina exploits information contained in properties of the stimulus beyond the mean and variance to adapt more quickly when possible.	[Fairhall, Adrienne; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Wark, Barry] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	rieke@u.washington.edu		Wark, Barry/0000-0003-4265-3897	NEI [EY-07031]; HHMI; NIH [EY-11850]; Burroughs-Wellcome; McKnight Scholar Award; Sloan Research Fellowship; NATIONAL EYE INSTITUTE [F32EY007031, R01EY011850, T32EY007031] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome(Burroughs Wellcome Fund); McKnight Scholar Award; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Felice Dunn, Greg Horwitz, Brian Lundstrom, Gabe Murphy, Eric Shea-Brown, Abby Wark, and David Wark for their insightful, challenging, and constructive comments on this manuscript, and Paul Newman for excellent technical assistance. Support for this research was provided by NEI EY-07031 (B.W.); HHMI and NIH EY-11850 (F.R.); and a Burroughs-Wellcome Careers at the Scientific Interface grant, a McKnight Scholar Award, and a Sloan Research Fellowship (A.F.).	Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Cover TM., 1991, ELEMENTS INFORM THEO; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Dowling J.E., 1987, RETINA APPROACHABLE; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Dunn FA, 2006, CURR OPIN NEUROBIOL, V16, P363, DOI 10.1016/j.conb.2006.06.013; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gaudry KS, 2007, J NEUROSCI, V27, P8071, DOI 10.1523/JNEUROSCI.1093-07.2007; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Jones E., 2001, SCIPY OPEN SOURCE SC; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Schwartz G, 2007, NAT NEUROSCI, V10, P552, DOI 10.1038/nn1887; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; SMIMAKIS SM, 1997, NATURE, V386, P69; THORSON J, 1974, SCIENCE, V183, P161, DOI 10.1126/science.183.4121.161; Toib A, 1998, J NEUROSCI, V18, P1893; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	39	138	140	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 12	2009	61	5					750	761		10.1016/j.neuron.2009.01.019	http://dx.doi.org/10.1016/j.neuron.2009.01.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	421NZ	19285471	Green Accepted, Bronze			2022-12-17	WOS:000264366900014
J	Choi, SH; Veeraraghavalu, K; Lazarov, O; Marler, S; Ransohoff, RM; Ramirez, JM; Sisodia, SS				Choi, Se Hoon; Veeraraghavalu, Karthikeyan; Lazarov, Orly; Marler, Seoan; Ransohoff, Richard M.; Ramirez, Jan Marino; Sisodia, Sangrarn S.			Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation	NEURON			English	Article							NEURAL STEM-CELLS; PROMOTES NEURONAL DIFFERENTIATION; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; ADULT DENTATE GYRUS; ALZHEIMERS-DISEASE; IN-VIVO; ENVIRONMENTAL ENRICHMENT; STEM/PROGENITOR CELLS; TRANSGENIC MICE	Presenilin 1 (PS1) regulates environmental enrichment (EE)-mediated neural progenitor cell (NPC) proliferation and neurogenesis in the adult hippocampus. We now report that transgenic mice that ubiquitously express human PS1 variants linked to early-onset familial Alzheimer's disease (FAD) neither exhibit EE-induced proliferation, nor neuronal lineage commitment of NPCs. Remarkably, the proliferation and differentiation of cultured NPCs from standard-housed mice expressing wild-type PS1 or PS1 variants are indistinguishable. On the other hand, wild-type NPCs cocultured with primary microglia from mice expressing PS1 variants exhibit impaired proliferation and neuronal lineage commitment, phenotypes that are recapitulated with mutant microglia conditioned media in which we detect altered levels of selected soluble signaling factors. These findings lead us to conclude that factors secreted from microglia play a central role in modulating hippocampal neurogenesis, and argue for non-cell-autonomous mechanisms that govern FAD-linked PS1-mediated impairments in adult hippocampal neurogenesis.	[Choi, Se Hoon; Ramirez, Jan Marino; Sisodia, Sangrarn S.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Veeraraghavalu, Karthikeyan; Sisodia, Sangrarn S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Marler, Seoan; Ramirez, Jan Marino] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Lazarov, Orly] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA	University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cleveland Clinic Foundation	Sisodia, SS (corresponding author), Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu	Lazarov, Orly/F-9406-2015	Ramirez, Jan-Marino/0000-0002-5626-3999; Lazarov, Orly/0000-0002-5887-948X	National Institute of Health [AG021494, AG027854]; Edward H. Levi Fund; Alzheimer's Association New Investigator Research; Cure Alzheimer's Fund; Brain Research Foundation; Chicago Institute of Neurosurgery and Neuroresearch Foundation; Adler Foundation; NATIONAL INSTITUTE ON AGING [R01AG021494, R01AG040185, R01AG027854, R01AG033570] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward H. Levi Fund; Alzheimer's Association New Investigator Research(Alzheimer's Association); Cure Alzheimer's Fund; Brain Research Foundation; Chicago Institute of Neurosurgery and Neuroresearch Foundation; Adler Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank John Robinson and Yi Huang for excellent technical assistance, and Dr. Linda Van Eldik and Ling Guo (Northwestern University School of Medicine, Chicago, IL) for help with neonatal microglial cultures. The authors also thank Dr. Vytas Bindokas and Dr. Christine Labno for expert technical assistance with confocal microscopy. This work was supported by National Institute of Health grants AG021494 (S.S.S.) and AG027854 (S.S.S.), the Edward H. Levi Fund (S.H.C.), Alzheimer's Association New Investigator Research Grant (O.L.), Cure Alzheimer's Fund (S.S.S.), Brain Research Foundation, Chicago Institute of Neurosurgery and Neuroresearch Foundation (S.S.S.), and the Adler Foundation (K.V.). The corresponding author (S.S.S.) discloses that he is a paid Consultant of Neuropharma, Inc., Torrey Pines Therapeutics, and Eisai Research Labs Inc, but does not a shareholder in any company that is a maker or owner of a FDA-regulated drug or device.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Handler M, 2000, DEVELOPMENT, V127, P2593; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Kang DE, 1999, J NEUROSCI, V19, P4229; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin Y, 2003, CLIN CHEM LAB MED, V41, P139, DOI 10.1515/CCLM.2003.023; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; NAKASHIMA K, 2002, J NEUROSCI RES, V85, P1704; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Tropepe V, 1997, J NEUROSCI, V17, P7850; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wen PH, 2004, EXP NEUROL, V188, P224, DOI 10.1016/j.expneurol.2004.04.002; Wynes MW, 2003, J IMMUNOL, V171, P3550, DOI 10.4049/jimmunol.171.7.3550; Zhang J, 2007, J NEUROSCI RES, V85, P1618, DOI 10.1002/jnr.21289; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	58	138	146	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 28	2008	59	4					568	580		10.1016/j.neuron.2008.07.033	http://dx.doi.org/10.1016/j.neuron.2008.07.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	344RL	18760694	Bronze, Green Accepted			2022-12-17	WOS:000258944900008
J	Schreiner, CE; Winer, JA				Schreiner, Christoph E.; Winer, Jeffery A.			Auditory cortex mapmaking: Principles, projections, and rasticity	NEURON			English	Review							FUNCTIONAL-ORGANIZATION; TONOTOPIC ORGANIZATION; MODULAR ORGANIZATION; COMPUTATIONAL MAPS; PROCESSING STREAMS; RECEPTIVE-FIELDS; CORTICAL FIELDS; REPRESENTATION; CAT; PLASTICITY	Maps of sensory receptor epithelia and computed features of the sensory environment are common elements of auditory, visual, and somatic sensory representations from the periphery to the cerebral cortex. Maps enhance the understanding of normal neural organization and its modification by pathology and experience. They underlie the derivation of the computational principles that govern sensory processing and the generation of perception. Despite their intuitive explanatory power, the functions of and rules for organizing maps and their plasticity are not well understood. Some puzzles of auditory cortical map organization are that few complete receptor maps are available and that even fewer computational maps are known beyond primary cortical areas. Neuroanatomical evidence suggests equally organized connectional patterns throughout the cortical hierarchy that might underlie map stability. Here, we consider the implications of auditory cortical map organization and its plasticity and evaluate the complementary role of maps in representation and computation from an auditory perspective.	Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Coleman Mem Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Schreiner, CE (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Coleman Mem Lab, San Francisco, CA 94143 USA.	chris@phy.ucsf.edu; jaw@berkeley.edu		Schreiner, Christoph/0000-0002-4571-4328	NIDCD NIH HHS [R01 DC002319, R01 DC002260-13, R01 DC 2319, R01 DC002319-27, R01 DC 2260, R01 DC002260-12, R01 DC002260] Funding Source: Medline; NIMH NIH HHS [P50 MH077970-020007, P50 MH077970, MH 077970] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002319, R01DC002260] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALEKSANDROV YI, 2007, NEUROSCI BEHAV PHYSL, V36, P969; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Bregman A. S., 1990, AUDITORY SCENE ANAL; Brugge JF, 2005, AUDITORY CORTEX: SYNTHESIS OF HUMAN AND ANIMAL RESEARCH, P145; Calhoun BM, 1998, EUR J NEUROSCI, V10, P926, DOI 10.1046/j.1460-9568.1998.00102.x; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Cheung SW, 2001, J NEUROPHYSIOL, V85, P1732, DOI 10.1152/jn.2001.85.4.1732; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Cohen YE, 1999, TRENDS NEUROSCI, V22, P128, DOI 10.1016/S0166-2236(98)01295-8; DYKES RW, 1983, BRAIN RES REV, V6, P47, DOI 10.1016/0165-0173(83)90004-8; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; EVANS EF, 1964, J PHYSIOL-LONDON, V171, P476, DOI 10.1113/jphysiol.1964.sp007391; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; FROEMKE RC, 2007, IN PRESS NATURE; Godey B, 2005, J NEUROPHYSIOL, V94, P1299, DOI 10.1152/jn.00950.2004; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Heil P, 1997, J NEUROPHYSIOL, V77, P2642, DOI 10.1152/jn.1997.77.5.2642; Horridge G., 1968, INTERNEURONS THEIR O; Imaizumi K, 2005, AUDITORY CORTEX: SYNTHESIS OF HUMAN AND ANIMAL RESEARCH, P95; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; IMAZIUMI K, 2007, J NEUROPHYSIOL, DOI DOI 10.1152/JN.00511.2007; IMIG TJ, 1981, J COMP NEUROL, V203, P1, DOI 10.1002/cne.902030102; IMIG TJ, 1978, J COMP NEUROL, V182, P637, DOI 10.1002/cne.901820406; Ji WQ, 2007, J NEUROSCI, V27, P4910, DOI 10.1523/JNEUROSCI.5528-06.2007; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Keeling MD, 2008, EXP BRAIN RES, V184, P493, DOI 10.1007/s00221-007-1115-9; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kim H, 2008, J COMPUT NEUROSCI, V24, P277, DOI 10.1007/s10827-007-0055-5; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1984, DYNAMIC ASPECTS NEOC, P375; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2004, NEUROSCIENCE, V128, P871, DOI 10.1016/j.neuroscience.2004.06.062; Lee CC, 2004, CEREB CORTEX, V14, P441, DOI 10.1093/cercor/bhh006; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lomber SG, 2007, HEARING RES, V229, P31, DOI 10.1016/j.heares.2007.01.013; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; MIDDLEBROOKS JC, 1980, BRAIN RES, V181, P31, DOI 10.1016/0006-8993(80)91257-3; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Nelken I, 2002, SPR HDB AUD, V15, P358; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Nicolelis MAL, 1997, SEMIN NEUROSCI, V9, P24, DOI 10.1006/smns.1997.0103; ONEILL WE, 1989, J COMP NEUROL, V284, P60, DOI 10.1002/cne.902840106; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Philibert B, 2005, J COMP NEUROL, V487, P391, DOI 10.1002/cne.20581; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Puckett AC, 2007, J NEUROPHYSIOL, V98, P253, DOI 10.1152/jn.01309.2006; Raggio MW, 2003, J NEUROPHYSIOL, V89, P3190, DOI 10.1152/jn.00341.2002; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Razak KA, 2002, J NEUROPHYSIOL, V87, P72, DOI 10.1152/jn.00226.2001; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; RIQUIMAROUX H, 1991, SCIENCE, V251, P565, DOI 10.1126/science.1990432; SANDERSON KJ, 1971, J COMP NEUROL, V143, P101, DOI 10.1002/cne.901430107; Scheich H, 2007, HEARING RES, V229, P213, DOI 10.1016/j.heares.2007.01.025; SCHREINER CE, 1995, CURR OPIN NEUROBIOL, V5, P489, DOI 10.1016/0959-4388(95)80010-7; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SCHREINER CE, 1984, J NEUROPHYSIOL, V51, P1284, DOI 10.1152/jn.1984.51.6.1284; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; SUGA N, 1989, J EXP BIOL, V146, P277; SUGA N, 1984, TRENDS NEUROSCI, V7, P20, DOI 10.1016/S0166-2236(84)80183-6; Sussman E, 2006, BRAIN RES, V1075, P165, DOI 10.1016/j.brainres.2005.12.074; Tan AYY, 2007, NEUROSCIENCE, V146, P449, DOI 10.1016/j.neuroscience.2007.01.019; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; TUSA RJ, 1981, CORTICAL SENSORY ORG, V2, P1; Versnel H, 1998, J ACOUST SOC AM, V103, P2502, DOI 10.1121/1.422771; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; WHITSEL BL, 1978, J COMP NEUROL, V178, P385, DOI 10.1002/cne.901780302; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Winer JA, 2005, INFERIOR COLLICULUS, P1, DOI 10.1007/0-387-27083-3_1; WOOLSEY CN, 1981, MULTIPLE SOMATIC ARE, V1; WOOLSEY CN, 1981, MULTIPLE VISUAL AREA, V2; WOOLSEY CN, 1982, MULTIPLE AUDITORY AR, V3; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1384, DOI 10.1152/jn.1993.69.5.1384; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102	103	138	139	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2007	56	2					356	365		10.1016/j.neuron.2007.10.013	http://dx.doi.org/10.1016/j.neuron.2007.10.013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	228PA	17964251	Bronze, Green Accepted			2022-12-17	WOS:000250740700012
J	Wojcik, SM; Brose, N				Wojcik, Sonja M.; Brose, Nils			Regulation of membrane fusion in synaptic excitation-secretion coupling: Speed and accuracy matter	NEURON			English	Review							LONG-TERM POTENTIATION; ACTIVE ZONE PROTEINS; SNARE COMPLEX; SYNAPTOTAGMIN-I; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; T-SNARE; C2B DOMAIN; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL INTERACTION	Unlike most other secretory processes, neurotransmitter release at chemical synapses is extremely fast, tightly regulated, spatially restricted, and dynamically adjustable at the same time. In this review, we focus on recent discoveries of molecular and cell biological processes that determine how fusion competence of vesicles is achieved and controlled in order to suit the specific requirements of synaptic transmitter release with respect to speed and spatial selectivity.	Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany	Max Planck Society	Wojcik, SM (corresponding author), Max Planck Inst Expt Med, Abt Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	wojcik@em.mpg.de						AALTO MK, 1992, CELL, V68, P181, DOI 10.1016/0092-8674(92)90462-L; Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DIELL P, 2001, NEWS PHYSIOL SCI, V16, P239; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Fukuda M, 2005, METHOD ENZYMOL, V403, P469, DOI 10.1016/S0076-6879(05)03041-7; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Ghijsen WEJM, 2005, CELL MOL LIFE SCI, V62, P937, DOI 10.1007/s00018-004-4525-0; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Hagiwara A, 2005, J COMP NEUROL, V489, P195, DOI 10.1002/cne.20633; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; JAHN R, 1994, ANN NY ACAD SCI, V733, P245, DOI 10.1111/j.1749-6632.1994.tb17274.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kee Y, 1996, J NEUROSCI, V16, P1975; KLYONAKA S, 2007, NAT NEUROSCI, V10, P691; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Loewen CA, 2006, J COMP NEUROL, V496, P1, DOI 10.1002/cne.20868; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nonet ML, 1997, J NEUROSCI, V17, P8061; Oishi H, 1996, BIOCHEM BIOPH RES CO, V229, P498, DOI 10.1006/bbrc.1996.1833; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Reist NE, 1998, J NEUROSCI, V18, P7662; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Satzler K, 2002, J NEUROSCI, V22, P10567; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	158	138	143	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 5	2007	55	1					11	24		10.1016/j.neuron.2007.06.013	http://dx.doi.org/10.1016/j.neuron.2007.06.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610814	Bronze			2022-12-17	WOS:000248010700005
J	Karmarkar, UR; Dan, Y				Karmarkar, Uma R.; Dan, Yang			Experience-dependent plasticity in adult visual cortex	NEURON			English	Review							OCULAR DOMINANCE PLASTICITY; NR2A SUBUNIT EXPRESSION; LONG-TERM POTENTIATION; MONOCULAR DEPRIVATION; SYNAPTIC PLASTICITY; STRIATE CORTEX; TOPOGRAPHIC REORGANIZATION; HOMEOSTATIC PLASTICITY; CORTICAL EPIGENESIS; MAP REORGANIZATION	Experience-dependent plasticity is a prominent feature of the mammalian visual cortex. Although such neural changes are most evident during development, adult cortical circuits can be modified by a variety of manipulations, such as perceptual learning and visual deprivation. Elucidating the underlying mechanisms at the cellular and synaptic levels is an essential step in understanding neural plasticity in the mature animal. Although developmental and adult plasticity share many common features, notable differences may be attributed to developmental cortical changes at multiple levels. These range from shifts in the molecular profiles of cortical neurons to changes in the spatiotemporal dynamics of network activity. In this review, we will discuss recent progress and remaining challenges in understanding adult visual plasticity, focusing on the primary visual cortex.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY015180, F32EY016645] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY15180, F32EY016645] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bergan JF, 2005, J NEUROSCI, V25, P9816, DOI 10.1523/JNEUROSCI.2533-05.2005; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Calford MB, 2003, J NEUROSCI, V23, P6434; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHINO YM, 1995, J NEUROSCI, V15, P2417, DOI 10.1523/JNEUROSCI.15-03-02417.1995; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V66, P1785, DOI 10.1152/jn.1991.66.5.1785; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRINGENBERG HC, 2006, IN PRESS CEREB CORTE, DOI DOI 10.1093/CERCORBHK038; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fahle M, 2002, PERCEPTUAL LEARNING; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Flint AC, 1997, J NEUROSCI, V17, P2469; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hensch TK, 1998, J NEUROSCI, V18, P2108; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Karmarkar UR, 2006, EUR J NEUROSCI, V23, P1575, DOI 10.1111/j.1460-9568.2006.04692.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Maertens M, 2005, J COGNITIVE NEUROSCI, V17, P1553, DOI 10.1162/089892905774597209; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morales B, 2002, J NEUROSCI, V22, P8084; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Neary K, 2005, EXP BRAIN RES, V162, P23, DOI 10.1007/s00221-004-2117-5; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; SHULZ D, 1992, J NEUROSCI, V12, P1301; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Stettler DD, 2006, NEURON, V49, P877, DOI 10.1016/j.neuron.2006.02.018; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Teyler TJ, 2005, EUR J NEUROSCI, V21, P2045, DOI 10.1111/j.1460-9568.2005.04007.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	96	138	138	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					577	585		10.1016/j.neuron.2006.11.001	http://dx.doi.org/10.1016/j.neuron.2006.11.001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114043	Bronze			2022-12-17	WOS:000242413100006
J	Van Raay, TJ; Moore, KB; Iordanova, I; Steele, M; Jamrich, M; Harris, WA; Vetter, ML				Van Raay, TJ; Moore, KB; Iordanova, I; Steele, M; Jamrich, M; Harris, WA; Vetter, ML			Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; CELL-DIFFERENTIATION; STEM-CELLS; TRANSCRIPTION FACTORS; VERTEBRATE RETINA; EYE DEVELOPMENT; LENS INDUCTION; HOMEOBOX GENE; WNT-SIGNAL	Progenitors in the developing central nervous system acquire neural potential and proliferate to expand the pool of precursors competent to undergo neuronal differentiation. The formation and maintenance of neural-competent precursors are regulated by SoxB1 transcription factors, and evidence that their expression is regionally regulated suggests that specific signals regulate neural potential in subdomains of the developing nervous system. We show that the frizzled (Fz) transmembrane receptor Xfz5 selectively governs neural potential in the developing Xenopus retina by regulating the expression of Sox2. Blocking either Xfz5 or canonical Writ signaling within the developing retina inhibits Sox2 expression, reduces cell proliferation, inhibits the onset of proneural gene expression, and biases individual progenitors toward a nonneural fate, without altering the expression of multiple progenitor markers. Blocking Sox2 function mimics these effects. Rescue experiments indicate that Sox2 is downstream of Xfz5. Thus, Fz signaling can regulate the neural potential of progenitors in the developing nervous system.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Utah System of Higher Education; University of Utah; University of Cambridge; Baylor College of Medicine; Baylor College of Medicine	Vetter, ML (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	monica.vetter@neuro.utah.edu	Van Raay, Terry/AAA-7342-2021	Moore, Kathryn/0000-0002-6993-152X; Vetter, Monica/0000-0001-6262-8504; Van Raay, Terence/0000-0003-0196-1041	NEI NIH HHS [EY122074, R01 EY014954-03, R01 EY014954, EY14954] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014954] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BELECKYADAMS T, 1997, OPHTHALMOL VIS SCI, V38, P1298; Buescher M, 2002, DEVELOPMENT, V129, P4193; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Burns CJ, 2002, DEV DYNAM, V225, P536, DOI 10.1002/dvdy.10189; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fuhrmann S, 2003, GENE EXPR PATTERNS, V3, P659, DOI 10.1016/S1567-133X(03)00107-8; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Harris WA, 1998, INT J DEV BIOL, V42, P299; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HERMAN JP, 1993, DEV DYNAM, V197, P307, DOI 10.1002/aja.1001970408; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HUANG S, 1993, J NEUROSCI, V13, P3193; Hutcheson DA, 2002, METHODS, V28, P402, DOI 10.1016/S1046-2023(02)00259-1; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kishi M, 2000, DEVELOPMENT, V127, P791; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Levine EM, 2004, SEMIN CELL DEV BIOL, V15, P63, DOI 10.1016/j.semcdb.2003.09.001; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Overton PM, 2002, DEVELOPMENT, V129, P4219; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.3.CO;2-3; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sasai Y, 2001, INT J DEV BIOL, V45, P321; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; VANRAAY T, 2004, IN PRESS DEV NEUROSC, V5, P367; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vetter ML, 2001, DEV DYNAM, V221, P146, DOI 10.1002/dvdy.1145; Zhang L, 2003, DEVELOPMENT, V130, P4177, DOI 10.1242/dev.00626; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	76	138	145	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					23	36		10.1016/j.neuron.2005.02.023	http://dx.doi.org/10.1016/j.neuron.2005.02.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820691	Bronze			2022-12-17	WOS:000228228600006
J	Clandinin, TR; Zipursky, SL				Clandinin, TR; Zipursky, SL			Making connections in the fly visual system	NEURON			English	Review							PROTEIN-TYROSINE-PHOSPHATASE; PHOTORECEPTOR AXON GUIDANCE; CELL-ADHESION; N-CADHERIN; RETINAL AXONS; DROSOPHILA-MELANOGASTER; TARGET SPECIFICITY; SYNAPTIC ACTIVITY; GLIAL-CELLS; OPTIC LOBE	Understanding the molecular mechanisms that regulate formation of precise patterns of neuronal connections within the central nervous system remains a challenging problem in neurobiology. Genetic studies in worms and files and molecular studies in vertebrate systems have led to an increasingly sophisticated understanding of how growth cones navigate toward their targets and form topographic maps. Considerably less is known about how growth cones recognize their cellular targets and form synapses with them. Here, we review connection formation in the fly visual system, the methodological approaches used to study it, and recent progress in uncovering the molecular basis of connection specificity.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, 5-748 MRL,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Barth M, 1997, J NEUROSCI, V17, P1493; BASLER K, 1990, GENE DEV, V4, P728, DOI 10.1101/gad.4.5.728; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; CAJAL SRY, 1915, TRAB LAB INV BIOL, V13; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Heisenberg M, 1980, Basic Life Sci, V16, P373; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jin YS, 2002, CURR OPIN NEUROBIOL, V12, P71, DOI 10.1016/S0959-4388(02)00292-1; KAMINKER J, 2002, IN PRESS NAT NEUROSC; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KIRSHFELD K, 1967, EXP BRAIN RES, V3; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Meinertzhagen Ian A., 1993, P1363; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Ramon y Cajal S, 1937, RECOLLECTIONS MY LIF; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Senti KA, 2000, DEVELOPMENT, V127, P2291; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1991, J COMP NEUROL, V307, P393, DOI 10.1002/cne.903070305; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stowers RS, 1999, GENETICS, V152, P1631; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trujille-Cenoz O., 1966, P339; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Vigier P, 1909, CR HEBD ACAD SCI, V148, P1221; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	84	138	139	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					827	841		10.1016/S0896-6273(02)00876-0	http://dx.doi.org/10.1016/S0896-6273(02)00876-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372279	Bronze			2022-12-17	WOS:000177779800007
J	Flynn, GE; Zagotta, WN				Flynn, GE; Zagotta, WN			Conformational changes in S6 coupled to the opening of cyclic nucleotide-gated channels	NEURON			English	Review							ION CHANNELS; K+-CHANNEL; ACTIVATED CHANNELS; SUBUNIT STOICHIOMETRY; ROD PHOTORECEPTORS; CATION CHANNEL; RETINAL RODS; TOPOLOGY; PORE; MECHANISM	In cyclic nucleotide-gated channels (CNG), direct binding of cyclic nucleotides in the carboxy-terminal region is allosterically coupled to opening of the pore. A CNG1 channel pore was probed using site-directed cysteine substitution to elucidate conformational changes associated with channel opening. The effects of cysteine modification on permeation suggest a structural homology between CNG and KcsA pores. We found that intersubunit disulfide bonds form spontaneously between S399C residues in the helix bundle when channels are in the closed but not in the open state. While MTSET modification of pore-lining residues was state dependent, Ag+ modification of V391C, in the inner vestibule, occurred at the same diffusion-limited rate in both open and closed states. Our results suggest that the helix bundle undergoes a conformational change associated with gating but is not the activation Elate for CNG channels.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NEI NIH HHS [R01 EY010329-08, R01 EY010329, T32 EY07031] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329, T32EY007031] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Becchetti A, 1999, J GEN PHYSIOL, V114, P377, DOI 10.1085/jgp.114.3.377; Becchetti A, 2000, PFLUG ARCH EUR J PHY, V440, P556, DOI 10.1007/s004240050006; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; del Camino D, 2001, BIOPHYS J, V80, p16A; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fodor AA, 1997, J GEN PHYSIOL, V109, P3, DOI 10.1085/jgp.109.1.3; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; Hille B., 1992, IONIC CHANNELS EXCIT; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; SHABB JB, 1992, J BIOL CHEM, V267, P5723; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Stotz SC, 1996, BIOPHYS J, V71, P3136, DOI 10.1016/S0006-3495(96)79507-3; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WOHLFART P, 1992, J BIOL CHEM, V267, P644; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZAGOTTA WN, 1989, NEURON, V3, P773, DOI 10.1016/0896-6273(89)90246-8; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	45	138	142	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					689	698		10.1016/S0896-6273(01)00324-5	http://dx.doi.org/10.1016/S0896-6273(01)00324-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430803	Bronze			2022-12-17	WOS:000169508900010
J	Orban, GA; Sunaert, S; Todd, JT; Van Hecke, P; Marchal, G				Orban, GA; Sunaert, S; Todd, JT; Van Hecke, P; Marchal, G			Human cortical regions involved in extracting depth from motion	NEURON			English	Article							HUMAN VISUAL-CORTEX; HUMAN BRAIN; OPTIC FLOW; 3-DIMENSIONAL STRUCTURE; DISCRIMINATION TASKS; FUNCTIONAL-ANALYSIS; RIGID MOTION; PERCEPTION; AREAS; NEURONS	We used functional magnetic resonance imaging (fMRI) to investigate brain regions involved in extracting three-dimensional structure from motion. A factorial design included two-dimensional and three-dimensional structures undergoing rigid and nonrigid motions. As predicted from monkey data, the human homolog of MT/V5 was significantly more active when subjects viewed three-dimensional (as opposed to two-dimensional) displays, irrespective of their rigidity. Human MT/V5+ (hMT/V5+) is part of a network with right hemisphere dominance involved in extracting depth from motion, including a lateral occipital region, five sites along the intraparietal sulcus (IPS), and two ventral occipital regions. Control experiments confirmed that this pattern of activation is most strongly correlated with perceived three-dimensional structure, in as much as it arises from motion and cannot be attributed to numerous two-dimensional image properties or to saliency.	Katholieke Univ Leuven, Fac Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; Univ Ziekenhuis Gasthuisberg, B-3000 Louvain, Belgium; Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	KU Leuven; KU Leuven; University Hospital Leuven; University System of Ohio; Ohio State University	Orban, GA (corresponding author), Katholieke Univ Leuven, Fac Med, Neuro & Psychofysiol Lab, Campus Gasthuisberg, B-3000 Louvain, Belgium.		Sunaert, Stefan/E-8031-2011	Sunaert, Stefan/0000-0002-1177-4680; Orban, Guy/0000-0002-8179-9584				Braddick O. J., 1997, Investigative Ophthalmology and Visual Science, V38, pS919; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cornette L, 1998, J NEUROPHYSIOL, V79, P2749, DOI 10.1152/jn.1998.79.5.2749; CORNETTE L, 1999, NEUROIMAGE, V9, pS856; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dieterich M, 1998, BRAIN, V121, P1479, DOI 10.1093/brain/121.8.1479; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Duffy CJ, 1997, J NEUROSCI, V17, P2839; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Holmes AP., 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; KOENDERINK JJ, 1991, J OPT SOC AM A, V8, P377, DOI 10.1364/JOSAA.8.000377; KOENDERINK JJ, 1977, HOW AMBULANT OBSERVE, P224; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; Liter JC, 1998, J EXP PSYCHOL HUMAN, V24, P1257, DOI 10.1037/0096-1523.24.4.1257; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Orban GA, 1997, EUR J NEUROSCI, V9, P246, DOI 10.1111/j.1460-9568.1997.tb01395.x; Orban GA, 1998, EXP BRAIN RES, V122, P9, DOI 10.1007/s002210050486; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; Perotti VJ, 1996, PERCEPT PSYCHOPHYS, V58, P666, DOI 10.3758/BF03213099; Perotti VJ, 1998, PERCEPT PSYCHOPHYS, V60, P377, DOI 10.3758/BF03206861; Petit L, 1997, J NEUROPHYSIOL, V77, P3386, DOI 10.1152/jn.1997.77.6.3386; REGAN D, 1978, VISION RES, V18, P415, DOI 10.1016/0042-6989(78)90051-2; RIZZO M, 1995, BRAIN, V118, P1105, DOI 10.1093/brain/118.5.1105; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; SAITO H, 1986, J NEUROSCI, V6, P145; TODD JT, 1988, PERCEPT PSYCHOPHYS, V43, P179, DOI 10.3758/BF03214196; TODD JT, 1982, J EXP PSYCHOL HUMAN, V8, P238, DOI 10.1037/0096-1523.8.2.238; TODD JT, 1984, PERCEPT PSYCHOPHYS, V36, P97, DOI 10.3758/BF03202670; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Vaina L. M., 1996, Investigative Ophthalmology and Visual Science, V37, pS515; VAINA LM, 1990, VISUAL NEUROSCI, V5, P353, DOI 10.1017/S0952523800000444; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI S, 1991, J NEUROSCI, V11, P641	49	138	141	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					929	940		10.1016/S0896-6273(00)81040-5	http://dx.doi.org/10.1016/S0896-6273(00)81040-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624956	Bronze			2022-12-17	WOS:000084495300021
J	Schilling, G; Wood, JD; Kui, DA; Slunt, HH; Gonzales, V; Yamada, M; Cooper, JK; Margolis, RL; Jenkins, NA; Copeland, NG; Takahashi, H; Tsuji, S; Price, DL; Borchelt, DR; Ross, CA				Schilling, G; Wood, JD; Kui, DA; Slunt, HH; Gonzales, V; Yamada, M; Cooper, JK; Margolis, RL; Jenkins, NA; Copeland, NG; Takahashi, H; Tsuji, S; Price, DL; Borchelt, DR; Ross, CA			Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA	NEURON			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; NEURONAL INTRANUCLEAR INCLUSIONS; TRINUCLEOTIDE CAG REPEAT; HUNTINGTONS-DISEASE; TRIPLET-REPEAT; EXPANDED POLYGLUTAMINE; GENE-PRODUCT; SPINOCEREBELLAR ATAXIA; AGGREGATE FORMATION; HUMAN BRAIN	Dentatorubral and pallidoluysian atrophy (DRPLA) is a member of a family of progressive neurodegenerative diseases caused by polyglutamine repeat expansion. Transgenic mice expressing full-length human atrophin-1 with 65 consecutive glutamines exhibit ataxia, tremors, abnormal movements, seizures, and premature death. These mice accumulate atrophin-1 immunoreactivity and inclusion bodies in the nuclei of multiple populations of neurons. Subcellular fractionation revealed 120 kDa nuclear fragments of mutant atrophin-1, whose abundance increased with age and phenotypic severity. Brains of DRPLA patients contained apparently identical 120 kDa nuclear fragments. By contrast, mice overexpressing atrophin-1 with 26 glutamines were phenotypically normal and did not accumulate the 120 kDa fragments. We conclude that the evolution of neuropathology in DRPLA involves proteolytic processing of mutant atrophin-1 and nuclear accumulation of truncated fragments.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; NCI, Mammalian Genet Lab, Ctr Canc, Frederick, MD 21702 USA; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Niigata University; Niigata University	Borchelt, DR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	drbor@welchlink.welch.jhu.edu; caross@jhu.edu	Wood, Jonathan D/A-5060-2009		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, R01NS034172, P50NS016375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34172, NS16375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Becher MW, 1997, MOVEMENT DISORD, V12, P519, DOI 10.1002/mds.870120408; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gusella JF, 1996, ANNU REV MED, V47, P201; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hayashi Y, 1998, ACTA NEUROPATHOL, V96, P547, DOI 10.1007/s004010050933; HODGSON GJ, 1999, NEURON, V23, P1; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; ILZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288; Kahlem P, 1998, MOL CELL, V1, P595, DOI 10.1016/S1097-2765(00)80059-3; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Knight SP, 1997, J NEUROL SCI, V146, P19, DOI 10.1016/S0022-510X(96)00266-3; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margolis RL, 1996, MOL BRAIN RES, V36, P219, DOI 10.1016/0169-328X(95)00241-J; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Miyashita T, 1998, BIOCHEM BIOPH RES CO, V249, P96, DOI 10.1006/bbrc.1998.9096; Miyashita T, 1997, J BIOL CHEM, V272, P29238, DOI 10.1074/jbc.272.46.29238; Moulder KL, 1999, J NEUROSCI, V19, P705; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERUTZ MF, 1995, MOL MED, V1, P718, DOI 10.1007/BF03401886; PETERS MF, 1999, IN PRESS MOL CELL NE; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99	60	138	141	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					275	286		10.1016/S0896-6273(00)80839-9	http://dx.doi.org/10.1016/S0896-6273(00)80839-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677044	Bronze			2022-12-17	WOS:000082893200026
J	GORDON, SE; ZAGOTTA, WN				GORDON, SE; ZAGOTTA, WN			LOCALIZATION OF REGIONS AFFECTING AN ALLOSTERIC TRANSITION IN CYCLIC NUCLEOTIDE-ACTIVATED CHANNELS	NEURON			English	Article							RETINAL RODS; FUNCTIONAL EXPRESSION; PHOTORECEPTOR CELLS; GATED CHANNEL; CONDUCTANCE; GMP; CGMP; MEMBRANE	Sensory transduction in olfactory receptors and photoreceptors is mediated by cyclic nucleotide-activated ion channels. We have studied the gating mechanism in olfactory and rod channels expressed in Xenopus oocytes. We report that the differences in cyclic nucleotide affinity and efficacy between these channels resulted from sequence differences outside the cycle nucleotide-binding domain, especially in the amino-terminal domain, influencing the free energy of the closed to open allosteric conformational change. In addition, Ni2+ inhibited activation of the olfactory channel, decreasing both the maximum current and the apparent affinity for cyclic nucleotides. Ni2+ exerted its effect by binding preferentially to the closed configuration of the channel, thereby destabilizing the opening conformational change. We have localized this inhibition to a single histidine (H396) following the last transmembrane segment, suggesting a role for this region in channel gating.			GORDON, SE (corresponding author), UNIV WASHINGTON,SCH MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS SJ40,SEATTLE,WA 98195, USA.				NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [EY10329, R01 EY010329] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Firestein Stuart, 1994, Seminars in Cell Biology, V5, P39, DOI 10.1006/scel.1994.1006; FURMAN RE, 1989, BIOCHEMISTRY-US, V28, P2785, DOI 10.1021/bi00433a007; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, NEURON, V14, P177; GORDON SE, 1995, IN PRESS J PHYSL; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; ILDEFONSE M, 1991, J MEMBRANE BIOL, V123, P133, DOI 10.1007/BF01998084; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZIMMERMAN AL, 1988, BIOPHYS J, V54, P351, DOI 10.1016/S0006-3495(88)82966-7	21	138	139	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					857	864		10.1016/0896-6273(95)90229-5	http://dx.doi.org/10.1016/0896-6273(95)90229-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7536427	Bronze			2022-12-17	WOS:A1995QU82600019
J	PARTIN, KM; BOWIE, D; MAYER, ML				PARTIN, KM; BOWIE, D; MAYER, ML			STRUCTURAL DETERMINANTS OF ALLOSTERIC REGULATION IN ALTERNATIVELY SPLICED AMPA RECEPTORS	NEURON			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; PREGNENOLONE SULFATE; SYNAPTIC CURRENTS; DESENSITIZATION; MODULATION; CHANNELS; KAINATE	The flip and flop splice variants of AMPA receptors show strikingly different sensitivity to allosteric regulation by cyclothiazide; heteromers assembled from GluR-A and GluR-B also exhibit splice variant-dependent differences in efficacy for activation by glutamate and kainate. The sensitivity for attenuation of desensitization by cyclothiazide for homomeric GluR-A was solely dependent upon exchange of Ser-750 (flip) and Asn-750 (flop), and was unaffected by mutagenesis of other divergent residues. In contrast, substantial alteration of the relative efficacy of glutamate versus kainate required mutation of multiple residues in the flip/flop region. Modulation by cyclothiazide was abolished by mutation of Ser-750 to Gln, the residue found at the homologous site in kainate-preferring subunits, whereas introduction of Ser at this site in GluR6 imparted sensitivity to cyclothiazide.			PARTIN, KM (corresponding author), NICHHD,CELLULAR & MOLEC NEUROPHYSIOL LAB,BETHESDA,MD 20892, USA.		Partin, Kathryn/A-8706-2015; Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019; Partin, Kathryn/AAI-5412-2021	Partin, Kathryn/0000-0003-3801-3299; Mayer, Mark/0000-0003-4378-8451; Partin, Kathryn/0000-0003-3801-3299; Bowie, Derek/0000-0001-9491-8768				BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOWLBY MR, 1993, MOL PHARMACOL, V43, P813; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; GALLO V, 1992, J NEUROSCI, V12, P1010; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOHLER M, 1994, J BIOL CHEM, V269, P17367; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; LIVSEY CT, 1992, NEURON, V8, P745, DOI 10.1016/0896-6273(92)90095-U; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nicoletti F, 1992, Funct Neurol, V7, P413; OH BH, 1993, J BIOL CHEM, V268, P11348; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; PARTIN KM, 1993, A NEURON, V11, P1069; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; RAMAN IM, 1994, J NEUROSCI, V14, P4998; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TRUSSELL LO, 1994, SEMIN NEUROSCI, V6, P71; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; WONG LA, 1993, MOL PHARMACOL, V44, P504; WU FS, 1991, MOL PHARMACOL, V40, P333; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P385	44	138	141	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					833	843		10.1016/0896-6273(95)90227-9	http://dx.doi.org/10.1016/0896-6273(95)90227-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718245	Bronze			2022-12-17	WOS:A1995QU82600017
J	RAJENDRA, S; LYNCH, JW; PIERCE, KD; FRENCH, CR; BARRY, PH; SCHOFIELD, PR				RAJENDRA, S; LYNCH, JW; PIERCE, KD; FRENCH, CR; BARRY, PH; SCHOFIELD, PR			MUTATION OF AN ARGININE RESIDUE IN THE HUMAN GLYCINE RECEPTOR TRANSFORMS BETA-ALANINE AND TAURINE FROM AGONISTS INTO COMPETITIVE ANTAGONISTS	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; FUNCTIONAL EXPRESSION; ION CHANNEL; BINDING SITES; SUBUNIT; PHARMACOLOGY; CELLS; ACTIVATION; CONDUCTANCE; RESOLUTION	Agonist binding to the inhibitory glycine receptor (GlyR) initiates the opening of a chloride-selective channel that modulates the neuronal membrane potential. Point mutations of the GlyR, substituting Arg-271 with either Leu or Gin, have been shown to underlie the inherited neurological disorder startle disease (hyperekplexia). We show that these substitutions result in the redistribution of GlyR single-channel conductances to lower conductance levels. Additionally, the binding of the glycinergic agonists beta-alanine and taurine to mutated GryRs does not initiate a chloride current, but instead competitively antagonizes currents activated by glycine. These findings are consistent with mutations of Arg-271 resulting in the uncoupling of the agonist binding process from the channel activation mechanism of the receptor.	GARVAN INST MED RES,DARLINGHURST,NSW 2010,AUSTRALIA	Garvan Institute of Medical Research	RAJENDRA, S (corresponding author), UNIV NEW S WALES,SCH PHYSIOL & PHARMACOL,SYDNEY,NSW 2052,AUSTRALIA.		French, Chris/AHA-1801-2022; Pierce, Kerrie D/O-7300-2018; Lynch, Joseph/C-8636-2009; Schofield, Peter/C-9669-2011	Pierce, Kerrie D/0000-0003-0636-4836; French, Christopher/0000-0002-1445-8704; Schofield, Peter/0000-0003-2967-9662				AKAIKE N, 1987, J PHYSIOL-LONDON, V391, P219, DOI 10.1113/jphysiol.1987.sp016735; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; ANDERMANN F, 1988, BRAIN DEV-JPN, V10, P213, DOI 10.1016/S0387-7604(88)80001-9; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; CASCIO M, 1993, J BIOL CHEM, V268, P22135; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLQUHOUN D, 1993, NATURE, V366, P510, DOI 10.1038/366510b0; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KIRSTEIN L, 1958, ACTA PSYCH NEUROL, V33, P471, DOI 10.1111/j.1600-0447.1958.tb03533.x; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; LANGOSCH D, 1993, FEBS LETT, V336, P540, DOI 10.1016/0014-5793(93)80872-R; LANGOSCH D, 1991, BIOCHIM BIOPHYS ACTA, V1063, P36, DOI 10.1016/0005-2736(91)90350-H; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1992, BIOPHYS J, V62, P61, DOI 10.1016/S0006-3495(92)81779-4; LO DC, 1991, NEURON, V6, P31, DOI 10.1016/0896-6273(91)90119-K; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALENZUELA CF, 1994, BIOPHYS J, V66, P674, DOI 10.1016/S0006-3495(94)80841-0; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; VANDENBERG RJ, 1993, TODAYS LIFE SCI, V5, P20	40	138	142	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					169	175		10.1016/0896-6273(95)90251-1	http://dx.doi.org/10.1016/0896-6273(95)90251-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826634	Bronze			2022-12-17	WOS:A1995QC54800017
J	KAVANAUGH, MP; HURST, RS; YAKEL, J; VARNUM, MD; ADELMAN, JP; NORTH, RA				KAVANAUGH, MP; HURST, RS; YAKEL, J; VARNUM, MD; ADELMAN, JP; NORTH, RA			MULTIPLE SUBUNITS OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL CONTRIBUTE TO THE BINDING-SITE FOR TETRAETHYLAMMONIUM	NEURON			English	Article							SENSITIVE ION CHANNELS; XENOPUS OOCYTES	RNAs encoding a wild-type (RBK1) and a mutant (RBK1(Y379V,V381T);RBK1*) subunit of voltage-dependent potassium channels were injected into Xenopus oocytes. When expressed separately, they made homotetrameric channels that differed about 100-fold in sensitivity to tetraethylammonium (TEA). Mixtures of channels having one, two, or three low affinity subunits were expressed by injecting various proportions of RBK1 and RBK1* RNAs. The affinity for TEA of these three channel species was deduced by fitting concentration-response curves for the inhibition of potassium currents. DNAs were also concatenated to construct a sequence that encoded two connected subunits, and channels that contained four, two, or no TEA-sensitive subunits were expressed. The results suggest that bound TEA interacts simultaneously with all four subunits.			KAVANAUGH, MP (corresponding author), OREGON HLTH SCI UNIV,INST VOLLUM,PORTLAND,OR 97201, USA.		North, Richard/GQA-6156-2022	Yakel, Jerrel/0000-0001-5463-674X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003160, R37DA003160] Funding Source: NIH RePORTER; NIDA NIH HHS [DA03160] Funding Source: Medline; NINDS NIH HHS [NS28504] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HURST RS, 1991, MOL PHARMACOL, V40, P572; ISAACOFF EY, 1990, NATURE, V345, P530; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	19	138	139	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					493	497		10.1016/0896-6273(92)90277-K	http://dx.doi.org/10.1016/0896-6273(92)90277-K			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550674				2022-12-17	WOS:A1992HK67500009
J	MIYAWAKI, A; FURUICHI, T; MAEDA, N; MIKOSHIBA, K				MIYAWAKI, A; FURUICHI, T; MAEDA, N; MIKOSHIBA, K			EXPRESSED CEREBELLAR-TYPE INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR, P400, HAS CALCIUM RELEASE ACTIVITY IN A FIBROBLAST L-CELL LINE	NEURON			English	Article									OSAKA UNIV, INST PROT RES, DIV REGULAT MACROMOLEC FUNCT, SUITA, OSAKA 565, JAPAN	Osaka University	MIYAWAKI, A (corresponding author), NATL INST BASIC BIOL, DIV BEHAV & NEUROBIOL, 38 NISHIGONAKA, MYODAIJICHO, OKAZAKI, AICHI 444, JAPAN.		Mikoshiba, Katsuhiko/N-7943-2015; Miyawaki, Atsushi/K-3569-2014; Furuichi, Teiichi/B-5086-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Furuichi, Teiichi/0000-0002-9676-1888				BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLACKSTONE CD, 1989, P NATL ACAD SCI USA, V86, P4316, DOI 10.1073/pnas.86.11.4316; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CULLEN PJ, 1989, BIOCHEM J, V259, P931, DOI 10.1042/bj2590931; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X; FURUICHI T, 1989, NUCLEIC ACIDS RES, V17, P5385, DOI 10.1093/nar/17.13.5385; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; GILL DL, 1985, J BIOL CHEM, V260, P9289; HASHIMOTO T, 1985, BRIT J PHARMACOL, V86, P191, DOI 10.1111/j.1476-5381.1985.tb09449.x; HUANG FL, 1987, J BIOL CHEM, V262, P15714; JEAN T, 1986, J BIOL CHEM, V261, P6414; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; KINCAID RL, 1987, P NATL ACAD SCI USA, V84, P1118, DOI 10.1073/pnas.84.4.1118; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; MEIS LD, 1970, J BIOL CHEM, V245, P1883; MIKOSHIBA K, 1978, BRAIN RES, V142, P487, DOI 10.1016/0006-8993(78)90911-3; MIKOSHIBA K, 1979, DEV NEUROSCI-BASEL, V2, P254, DOI 10.1159/000112489; MIKOSHIBA K, 1985, DEV NEUROSCI-BASEL, V7, P179, DOI 10.1159/000112286; MULLANEY JM, 1988, P NATL ACAD SCI USA, V85, P2499, DOI 10.1073/pnas.85.8.2499; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; STAUDERMAN KA, 1988, BIOCHEM J, V255, P677; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; UEDA T, 1986, J BIOL CHEM, V261, P3184; WORLEY PF, 1987, J BIOL CHEM, V262, P12132	37	138	139	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1990	5	1					11	18		10.1016/0896-6273(90)90029-F	http://dx.doi.org/10.1016/0896-6273(90)90029-F			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU546	2164403				2022-12-17	WOS:A1990DU54600002
J	BIXBY, JL				BIXBY, JL			PROTEIN KINASE-C IS INVOLVED IN LAMININ STIMULATION OF NEURITE OUTGROWTH	NEURON			English	Article											BIXBY, JL (corresponding author), UNIV MIAMI,DEPT PHARMACOL,MIAMI,FL 33136, USA.			Bixby, John/0000-0003-1633-5318				AKERS RM, 1981, DEV BIOL, V86, P179, DOI 10.1016/0012-1606(81)90328-6; BANGA HS, 1986, P NATL ACAD SCI USA, V83, P9197, DOI 10.1073/pnas.83.23.9197; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BIXBY JL, 1985, J NEUROSCI, V5, P3070; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BORASIO GD, 1989, NEURON, V2, P1087; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; BOZYCZKO D, 1986, J NEUROSCI, V6, P1241; BURN P, 1988, P NATL ACAD SCI USA, V85, P497, DOI 10.1073/pnas.85.2.497; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CONN PJ, 1989, J NEUROSCI, V9, P473; DEGEORGE JJ, 1985, DEV BIOL, V111, P335, DOI 10.1016/0012-1606(85)90488-9; FORSCHER P, 1987, J NEUROSCI, V7, P3600; GAVER RC, 1966, J AM CHEM SOC, V88, P3643, DOI 10.1021/ja00967a032; GREENE LA, 1986, J CELL BIOL, V103, P1967, DOI 10.1083/jcb.103.5.1967; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL DE, 1987, J CELL BIOL, V104, P623, DOI 10.1083/jcb.104.3.623; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HASHIMOTO S, 1988, J CELL BIOL, V107, P1531, DOI 10.1083/jcb.107.4.1531; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HSU L, 1984, CANCER RES, V44, P4607; ISHII DN, 1978, CANCER RES, V38, P3886; KOIZUMI S, 1988, J NEUROSCI, V8, P715; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LANKFORD KL, 1988, P NATL ACAD SCI USA, V85, P2839, DOI 10.1073/pnas.85.8.2839; LETOURNEAU PC, 1974, J CELL BIOL, V61, P56, DOI 10.1083/jcb.61.1.56; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882; MATTSON MP, 1987, J NEUROSCI, V7, P4034; MATTSON MP, 1988, J NEUROSCI, V8, P1704; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; NIRENBERG M, 1983, COLD SPRING HARB SYM, V48, P707, DOI 10.1101/SQB.1983.048.01.074; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SCHUBERT D, 1978, NATURE, V273, P718, DOI 10.1038/273718a0; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; TRAYNOR AE, 1984, DEV BRAIN RES, V14, P197	45	138	143	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1989	3	3					287	297		10.1016/0896-6273(89)90253-5	http://dx.doi.org/10.1016/0896-6273(89)90253-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR527	2561968				2022-12-17	WOS:A1989AR52700003
J	Spitzer, SO; Sitnikov, S; Kamen, Y; Evans, KA; Kronenberg-Versteeg, D; Dietmann, S; de Faria, O; Agathou, S; Karadottir, RT				Spitzer, Sonia Olivia; Sitnikov, Sergey; Kamen, Yasmine; Evans, Kimberley Anne; Kronenberg-Versteeg, Deborah; Dietmann, Sabine; de Faria, Omar, Jr.; Agathou, Sylvia; Karadottir, Ragnhildur Thora			Oligodendrocyte Progenitor Cells Become Regionally Diverse and Heterogeneous with Age	NEURON			English	Article							NMDA RECEPTORS; NERVOUS-SYSTEM; WHITE; GLUTAMATE; BRAIN; EXPRESSION; REJUVENATION; MYELINATION; PLASTICITY; FOREBRAIN	Oligodendrocyte progenitor cells (OPCs), which differentiate into myelinating oligodendrocytes during CNS development, are the main proliferative cells in the adult brain. OPCs are conventionally considered a homogeneous population, particularly with respect to their electrophysiological properties, but this has been debated. We show, by using single-cell electrophysiological recordings, that OPCs start out as a homogeneous population but become functionally heterogeneous, varying both within and between brain regions and with age. These electrophysiological changes in OPCs correlate with the differentiation potential of OPCs; thus, they may underlie the differentiational differences in OPCs between regions and, likewise, differentiation failure with age.	[Spitzer, Sonia Olivia; Sitnikov, Sergey; Kamen, Yasmine; Evans, Kimberley Anne; Kronenberg-Versteeg, Deborah; Dietmann, Sabine; de Faria, Omar, Jr.; Agathou, Sylvia; Karadottir, Ragnhildur Thora] Univ Cambridge, Wellcome Med Res Council Cambridge Stem Cell Inst, Cambridge, England; [Spitzer, Sonia Olivia; Sitnikov, Sergey; Kamen, Yasmine; Evans, Kimberley Anne; Kronenberg-Versteeg, Deborah; Dietmann, Sabine; de Faria, Omar, Jr.; Agathou, Sylvia; Karadottir, Ragnhildur Thora] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Cambridge; University of Cambridge	Karadottir, RT (corresponding author), Univ Cambridge, Wellcome Med Res Council Cambridge Stem Cell Inst, Cambridge, England.; Karadottir, RT (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	rk385@cam.ac.uk	Kronenberg-Versteeg, Deborah/AAW-5442-2020	Kronenberg-Versteeg, Deborah/0000-0003-0965-9998; Kamen, Yasmine/0000-0003-1867-7397; Dietmann, Sabine./0000-0001-6672-8457; Evans, Kimberley/0000-0001-7037-8533; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program [771411]; Wellcome Trust [091543/Z/10/Z, 102160/Z/13/Z]; Paul G. Allen Frontiers Group Allen Distinguished Investigator Award [12076]; Medical Research Council studentship; Gates Cambridge Trust Gates scholarship; Biotechnology and Biological Sciences Research Council studentship; Homerton College Cambridge junior research fellowship; UK MS Society Cambridge Myelin Repair Centre grant [50]; Fonds de Recherche du Quebec - Sante scholarship; Cambridge Commonwealth, European and International Trust scholarship; Lister Institute research prize; MRC [MC_PC_15042, G0701476] Funding Source: UKRI	European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Paul G. Allen Frontiers Group Allen Distinguished Investigator Award; Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gates Cambridge Trust Gates scholarship; Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Homerton College Cambridge junior research fellowship; UK MS Society Cambridge Myelin Repair Centre grant; Fonds de Recherche du Quebec - Sante scholarship; Cambridge Commonwealth, European and International Trust scholarship; Lister Institute research prize; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Trotter (Johannes Gutenberg University, Mainz, Germany) for the NG2-EYFP mice, Dr. Moritz Matthey for help with minipump transplantation, Miss Mariann Kovacs with embryonic dissection, and Dr. Katrin Volbracht for critical comments on the work. We acknowledge the support of the Wellcome - MRC Cambridge Stem Cell Institute core facility managers, in particular for this work Dr. Maike Paramor and Miss Victoria Murray with RNA-seq, and all staff members of the University Biomedical Services (UBS). This project has received the following funding: funding from the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (grant agreement 771411 to R.T.K. and K.A.E.), a Wellcome Trust research career development fellowship (091543/Z/10/Z to R.T.K. and K.A.E.) and studentship (102160/Z/13/Z to Y.K.), Paul G. Allen Frontiers Group Allen Distinguished Investigator Award 12076 (to R.T.K., D.K.-V., and K.A.E.), a Medical Research Council studentship (to S.O.S.), a Gates Cambridge Trust Gates scholarship (to S.S.), a Biotechnology and Biological Sciences Research Council studentship (to S.A.), a Homerton College Cambridge junior research fellowship (to D.K.-V.), UK MS Society Cambridge Myelin Repair Centre grant 50 (to R.T.K. and O.d.F.), a Fonds de Recherche du Quebec - Sante scholarship (to Y.K.), a Cambridge Commonwealth, European and International Trust scholarship (to Y.K.), and a Lister Institute research prize (to R.T.K., K.A.E., and S.O.S.).	Basak O, 2014, EMBO J, V33, P2057, DOI 10.15252/embj.201488017; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; De Biase LM, 2011, J NEUROSCI, V31, P12650, DOI 10.1523/JNEUROSCI.2455-11.2011; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; de Faria O, 2018, DEV NEUROBIOL, V78, P93, DOI 10.1002/dneu.22539; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GALLO V, 1994, GLIA, V10, P149, DOI 10.1002/glia.440100209; Habes M, 2016, BRAIN, V139, P1164, DOI 10.1093/brain/aww008; Hamano K, 1998, DEV BRAIN RES, V108, P287, DOI 10.1016/S0165-3806(98)00063-7; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Karadottir R, 2006, NAT PROTOC, V1, P1977, DOI 10.1038/nprot.2006.261; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kougioumtzidou E, 2017, ELIFE, V6, DOI 10.7554/eLife.28080; Krasnow AM, 2018, NAT NEUROSCI, V21, P24, DOI 10.1038/s41593-017-0031-y; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Lambert G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7167; Lentferink DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19934-6; Liu J, 2016, CURR OPIN NEUROBIOL, V39, P133, DOI 10.1016/j.conb.2016.06.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marques S, 2018, DEV CELL, V46, P504, DOI 10.1016/j.devcel.2018.07.005; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mitew S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02719-2; Mort RL, 2014, CELL CYCLE, V13, P2681, DOI 10.4161/15384101.2015.945381; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Saab AS, 2016, NEURON, V91, P119, DOI 10.1016/j.neuron.2016.05.016; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Spitzer S, 2016, NEUROPHARMACOLOGY, V110, P574, DOI 10.1016/j.neuropharm.2016.06.014; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tripathi RB, 2017, CELL REP, V21, P316, DOI 10.1016/j.celrep.2017.09.050; Tripathi RB, 2011, J NEUROSCI, V31, P6809, DOI 10.1523/JNEUROSCI.6474-10.2011; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854; Zonouzi M, 2011, NAT NEUROSCI, V14, P1430, DOI 10.1038/nn.2942	52	137	137	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2019	101	3					459	+		10.1016/j.neuron.2018.12.020	http://dx.doi.org/10.1016/j.neuron.2018.12.020			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK3YY	30654924	Green Published, hybrid			2022-12-17	WOS:000457856700019
J	Cho, JR; Treweek, JB; Robinson, JE; Xiao, C; Bremner, LR; Greenbaum, A; Gradinaru, V				Cho, Jounhong Ryan; Treweek, Jennifer B.; Robinson, J. Elliott; Xiao, Cheng; Bremner, Lindsay R.; Greenbaum, Alon; Gradinaru, Viviana			Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient Stimuli	NEURON			English	Article							VENTRAL TEGMENTAL AREA; SLEEP-WAKING CYCLE; PERIAQUEDUCTAL GRAY; PARKINSONS-DISEASE; EXTENDED AMYGDALA; NOXIOUS STIMULI; REWARD; RAT; PROJECTION; AVERSION	Ventral midbrain dopamine (DA) is unambiguously involved in motivation and behavioral arousal, yet the contributions of other DA populations to these processes are poorly understood. Here, we demonstrate that the dorsal raphe nucleus DA neurons are critical modulators of behavioral arousal and sleep-wake patterning. Using simultaneous fiber photometry and polysomnography, we observed time-delineated dorsal raphe nucleus dopaminergic (DRNDA) activity upon exposure to arousal-evoking salient cues, irrespective of their hedonic valence. We also observed broader fluctuations of DRNDA activity across sleep-wake cycles with highest activity during wakefulness. Both endogenous DRNDA activity and optogenetically driven DRNDA activity were associated with waking from sleep, with DA signal strength predictive of wake duration. Conversely, chemogenetic inhibition opposed wakefulness and promoted NREM sleep, even in the face of salient stimuli. Therefore, the DRNDA population is a critical contributor to wake-promoting pathways and is capable of modulating sleep-wake states according to the outside environment, wherein the perception of salient stimuli prompts vigilance and arousal.	[Cho, Jounhong Ryan] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA; [Treweek, Jennifer B.; Robinson, J. Elliott; Xiao, Cheng; Bremner, Lindsay R.; Greenbaum, Alon; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	viviana@caltech.edu	Treweek, Jennifer/AAL-7647-2021; Core, Vector/CAF-4832-2022; Treweek, Jennifer/U-8768-2017; Xiao, Cheng/O-5696-2015	Robinson, J. Elliott/0000-0001-9417-3938; Xiao, Cheng/0000-0001-9649-7450	NIH [IDP20D017782-01]; NIH/NIA [1R01AG047664-01]; NIH/NIA (NIH BRAIN) [1U01NS090577]; Heritage Medical Research Institute [HMRI-15-09-01]; Pew Charitable Trust [00026171]; Michael J. Fox Foundation (RRIA); Caltech-GIST (CG); Sloan Foundation [FR2015-65471]; Children's Tumor Foundation [2016-01-006]; Michael J. Fox Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIA (NIH BRAIN); Heritage Medical Research Institute; Pew Charitable Trust; Michael J. Fox Foundation (RRIA); Caltech-GIST (CG); Sloan Foundation(Alfred P. Sloan Foundation); Children's Tumor Foundation; Michael J. Fox Foundation	We would like to acknowledge Drs. Karl Deisseroth and Tom Davidson for the fiber photometry setup. We appreciate the entire Gradinaru lab and Dr. David Anderson for helpful discussions. This work was supported by the NIH (Director's New Innovator grants IDP20D017782-01 and PECASE), the NIH/NIA (grants 1R01AG047664-01 and NIH BRAIN 1U01NS090577), the Heritage Medical Research Institute (HMRI-15-09-01), the Pew Charitable Trust (00026171), the Michael J. Fox Foundation (RRIA 2013), Caltech-GIST (CG2013), and the Sloan Foundation (FR2015-65471, to V.G.). J.B.T. is a Colvin postdoctoral fellow. J.E.R. is supported by the Children's Tumor Foundation (2016-01-006). C.X. was partly supported by the Michael J. Fox Foundation.	ASTONJONES G, 1981, J NEUROSCI, V1, P876; Benarroch EE, 2009, NEUROLOGY, V73, P106, DOI 10.1212/WNL.0b013e3181ad53e7; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Daberkow DP, 2013, J NEUROSCI, V33, P452, DOI 10.1523/JNEUROSCI.2136-12.2013; Dahan L, 2007, NEUROPSYCHOPHARMACOL, V32, P1232, DOI 10.1038/sj.npp.1301251; DESCARRIES L, 1986, J COMP NEUROL, V249, P511, DOI 10.1002/cne.902490407; Dougalis AG, 2012, EUR J NEUROSCI, V36, P3322, DOI 10.1111/j.1460-9568.2012.08255.x; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; Espana RA, 2012, VITAM HORM, V89, P185, DOI 10.1016/B978-0-12-394623-2.00010-X; Garey J, 2003, P NATL ACAD SCI USA, V100, P11019, DOI 10.1073/pnas.1633773100; George ED, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-123; Gjerstad MD, 2007, J NEUROL NEUROSUR PS, V78, P476, DOI 10.1136/jnnp.2006.100370; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hasue RH, 2002, J COMP NEUROL, V454, P15, DOI 10.1002/cne.10420; Hokfelt T., 1984, DISTRIBUTION MAPS TY; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Jouvet M, 1999, NEUROPSYCHOPHARMACOL, V21, pS24, DOI 10.1016/S0893-133X(99)00009-3; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Leger L, 2010, J CHEM NEUROANAT, V39, P262, DOI 10.1016/j.jchemneu.2010.03.001; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li C, 2016, NEUROPSYCHOPHARMACOL, V41, P2122, DOI 10.1038/npp.2016.12; Lima MMS, 2013, SLEEP MED REV, V17, P367, DOI 10.1016/j.smrv.2012.10.006; LIN JS, 1992, BRAIN RES, V591, P319, DOI 10.1016/0006-8993(92)91713-O; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; McCall JG, 2015, NEURON, V87, P605, DOI 10.1016/j.neuron.2015.07.002; McDevitt RA, 2014, CELL REP, V8, P1857, DOI 10.1016/j.celrep.2014.08.037; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; Minami M, 2015, CURR MOL MED, V15, P184, DOI 10.2174/1566524015666150303002336; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; NAGATSU I, 1979, ACTA HISTOCHEM CYTOC, V12, P20, DOI 10.1267/ahc.12.20; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Qiu MH, 2016, CEREB CORTEX, V26, P1430, DOI 10.1093/cercor/bhu241; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Rajasethupathy P., 2016, CELL, V765, P574; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sanford LD, 2015, CURR TOP BEHAV NEURO, V25, P379, DOI 10.1007/7854_2014_314; Sateia M J, 2000, Semin Clin Neuropsychiatry, V5, P227, DOI 10.1053/scnp.2000.9556; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schweimer JV, 2010, NEUROSCIENCE, V171, P1209, DOI 10.1016/j.neuroscience.2010.09.058; Steinberg EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094771; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; Taylor NE, 2016, P NATL ACAD SCI USA, V113, P12826, DOI 10.1073/pnas.1614340113; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Whitaker LR, 2013, NEURON, V77, P335, DOI 10.1016/j.neuron.2012.11.022; Winsky-Sommerer R, 2005, MOL NEUROBIOL, V32, P285, DOI 10.1385/MN:32:3:285; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Xu M, 2015, NAT NEUROSCI, V18, P1641, DOI 10.1038/nn.4143; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	69	137	142	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2017	94	6					1205	+		10.1016/j.neuron.2017.05.020	http://dx.doi.org/10.1016/j.neuron.2017.05.020			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY2SH	28602690	Bronze			2022-12-17	WOS:000403820200017
J	Ashrafi, G; Wu, ZH; Farrell, RJ; Ryan, TA				Ashrafi, Ghazaleh; Wu, Zhuhao; Farrell, Ryan J.; Ryan, Timothy A.			GLUT4 Mobilization Supports Energetic Demands of Active Synapses	NEURON			English	Article							SKELETAL-MUSCLE; PROTEIN-KINASE; GLUCOSE-TRANSPORT; SYNAPTIC FUNCTION; PLASMA-MEMBRANE; TRANSLOCATION; EXPRESSION; NEURONS; BRAIN; PHOSPHORYLATION	The brain is highly sensitive to proper fuel availability as evidenced by the rapid decline in neuronal function during ischemic attacks and acute severe hypoglycemia. We previously showed that sustained presynaptic function requires activity-driven glycolysis. Here, we provide strong evidence that during action potential (AP) firing, nerve terminals rely on the glucose transporter GLUT4 as a glycolytic regulatory system to meet the activity-driven increase in energy demands. Activity at synapses triggers insertion of GLUT4 into the axonal plasma membrane driven by activation of the metabolic sensor AMP kinase. Furthermore, we show that genetic ablation of GLUT4 leads to an arrest of synaptic vesicle recycling during sustained AP firing, similar to what is observed during acute glucose deprivation. The reliance on this biochemical regulatory system for ``exercising'' synapses is reminiscent of that occurring in exercising muscle to sustain cellular function and identifies nerve terminals as critical sites of proper metabolic control.	[Ashrafi, Ghazaleh; Farrell, Ryan J.; Ryan, Timothy A.] Weill Cornell Med, Dept Biochem, New York, NY 10021 USA; [Wu, Zhuhao; Farrell, Ryan J.] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA	Cornell University; Rockefeller University	Ryan, TA (corresponding author), Weill Cornell Med, Dept Biochem, New York, NY 10021 USA.	taryan@med.cornell.edu	Wu, Zhuhao/I-5852-2018; Ryan, Timothy/AAO-8286-2020	Wu, Zhuhao/0000-0002-2471-0555; Farrell, Ryan/0000-0003-4022-8707; Ryan, Timothy/0000-0003-2533-9548	NIH [NS036942]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the T.A.R. laboratory, Jeremy Dittman, and Tim McGraw for their valuable suggestions and input on this work. We thank David James (University of Sydney) for providing us with the GLUT4-pH construct, Gus Leinhard (Dartmouth University) for the TBC1D1 construct, and G. Bell (University of Chicago) for the GLUT3 construct. This work was supported by a grant to T.A.R. from the NIH (NS036942).	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Chauveau, 1887, CR HEBD ACAD SCI, V104, P1126; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Fernando RN, 2008, EUR J NEUROSCI, V28, P588, DOI 10.1111/j.1460-9568.2008.06347.x; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; GERHART DZ, 1992, P NATL ACAD SCI USA, V89, P733, DOI 10.1073/pnas.89.2.733; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; KNULL HR, 1985, COMP BIOCHEM PHYS B, V81, P349, DOI 10.1016/0305-0491(85)90324-4; Kobayashi M, 1996, NEUROSCI LETT, V213, P103, DOI 10.1016/0304-3940(96)12845-7; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lauritzen HPMM, 2010, DIABETES, V59, P2134, DOI 10.2337/db10-0233; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Roy D, 1996, BIOCHEM BIOPH RES CO, V223, P147, DOI 10.1006/bbrc.1996.0860; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sample V, 2015, MOL BIOL CELL, V26, P1935, DOI 10.1091/mbc.E14-02-0764; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Vichaiwong K, 2010, BIOCHEM J, V431, P311, DOI 10.1042/BJ20101100; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	41	137	139	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 8	2017	93	3					606	+		10.1016/j.neuron.2016.12.020	http://dx.doi.org/10.1016/j.neuron.2016.12.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO1AB	28111082	Bronze, Green Accepted			2022-12-17	WOS:000396428800016
J	Leong, YC; Radulescu, A; Daniel, R; DeWoskin, V; Niv, Y				Leong, Yuan Chang; Radulescu, Angela; Daniel, Reka; DeWoskin, Vivian; Niv, Yael			Dynamic Interaction between Reinforcement Learning and Attention in Multidimensional Environments	NEURON			English	Article							EYE-MOVEMENTS; PREFRONTAL CORTEX; VISUAL-ATTENTION; DECISION-MAKING; MECHANISMS; PREDICTION; STRIATUM; STIMULI; SIGNALS; CHOICE	Little is known about the relationship between attention and learning during decision making. Using eye tracking and multivariate pattern analysis of fMRI data, we measured participants' dimensional attention as they performed a trial-and-error learning task in which only one of three stimulus dimensions was relevant for reward at any given time. Analysis of participants' choices revealed that attention biased both value computation during choice and value update during learning. Value signals in the ventromedial prefrontal cortex and prediction errors in the striatum were similarly biased by attention. In turn, participants' focus of attention was dynamically modulated by ongoing learning. Attentional switches across dimensions correlated with activity in a frontoparietal attention network, which showed enhanced connectivity with the ventromedial prefrontal cortex between switches. Our results suggest a bidirectional interaction between attention and learning: attention constrains learning to relevant dimensions of the environment, while we learn what to attend to via trial and error.	[Leong, Yuan Chang] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Radulescu, Angela; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Daniel, Reka] Dstillery, New York, NY 10016 USA; [DeWoskin, Vivian] Trinity Partners, San Francisco, CA 94111 USA; [Niv, Yael] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Stanford University; Princeton University; Princeton University	Leong, YC (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.; Radulescu, A; Niv, Y (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Niv, Y (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	ycleong@stanford.edu; angelar@princeton.edu; yael@princeton.edu	Radulescu, Angela/AAA-4291-2022	Radulescu, Angela/0000-0003-2274-4265; Leong, Yuan Chang/0000-0003-2499-2393	Human Frontier Science Program Organization; National Institute for Mental Health [R01MH098861]; Army Research Office [W911NF-14-1-0101]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098861] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Army Research Office; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Jamil Zaki and Ian Ballard for scientific discussions and helpful comments on earlier versions of the manuscript and members of the Y.N. lab for their comments and support. This work was supported by the Human Frontier Science Program Organization, grant R01MH098861 from the National Institute for Mental Health, and grant W911NF-14-1-0101 from the Army Research Office. The views expressed do not necessarily reflect the opinion or policy of the federal government and no official endorsement should be inferred.	[Anonymous], 2020, REINFORCEMENT LEARNI; Bellman, 1957, DYNAMIC PROGRAMMING; Botvinick MM, 2012, CURR OPIN NEUROBIOL, V22, P956, DOI 10.1016/j.conb.2012.05.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Canas F., 2010, P 32 ANN C COGN SCI, P1258; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Esber GR, 2012, BIOL PSYCHIAT, V72, P1012, DOI 10.1016/j.biopsych.2012.05.023; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Gottlieb J, 2012, NEURON, V76, P281, DOI 10.1016/j.neuron.2012.09.034; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Holland PC, 2006, J NEUROSCI, V26, P3791, DOI 10.1523/JNEUROSCI.0390-06.2006; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Markovic D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004558; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Niv Y, 2015, J NEUROSCI, V35, P8145, DOI 10.1523/JNEUROSCI.2978-14.2015; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2012, EUR J NEUROSCI, V35, P987, DOI 10.1111/j.1460-9568.2012.08074.x; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pearce JM, 2010, ATTEN ASS LEARN BRAI, P11; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ponsen M, 2010, LECT NOTES ARTIF INT, V5924, P1, DOI 10.1007/978-3-642-11814-2_1; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Smith DT, 2004, CURR BIOL, V14, P792, DOI 10.1016/j.cub.2004.04.035; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Wilson RC, 2014, NEURON, V81, P267, DOI 10.1016/j.neuron.2013.11.005; Wilson RC, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00189	41	137	138	4	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2017	93	2					451	463		10.1016/j.neuron.2016.12.040	http://dx.doi.org/10.1016/j.neuron.2016.12.040			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EO0ZV	28103483	Bronze, Green Accepted			2022-12-17	WOS:000396428200021
J	Sellier, C; Buijsen, RAM; He, F; Natla, S; Jung, L; Tropel, P; Gaucherot, A; Jacobs, H; Meziane, H; Vincent, A; Champy, MF; Sorg, T; Pavlovic, G; Wattenhofer-Donze, M; Birling, MC; Oulad-Abdelghani, M; Eberling, P; Ruffenach, F; Joint, M; Anheim, M; Martinez-Cerdeno, V; Tassone, F; Willemsen, R; Hukema, RK; Viville, S; Martinat, C; Todd, PK; Charlet-Berguerand, N				Sellier, Chantal; Buijsen, Ronald A. M.; He, Fang; Natla, Sam; Jung, Laura; Tropel, Philippe; Gaucherot, Angeline; Jacobs, Hugues; Meziane, Hamid; Vincent, Alexandre; Champy, Marie-France; Sorg, Tania; Pavlovic, Guillaume; Wattenhofer-Donze, Marie; Birling, Marie-Christine; Oulad-Abdelghani, Mustapha; Eberling, Pascal; Ruffenach, Frank; Joint, Mathilde; Anheim, Mathieu; Martinez-Cerdeno, Veronica; Tassone, Flora; Willemsen, Rob; Hukema, Renate K.; Viville, Stephane; Martinat, Cecile; Todd, Peter K.; Charlet-Berguerand, Nicolas			Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome	NEURON			English	Article							FMR1 MESSENGER-RNA; TREMOR/ATAXIA-SYNDROME; NUCLEOCYTOPLASMIC TRANSPORT; MOUSE MODEL; MEDIATED NEURODEGENERATION; MITOCHONDRIAL DYSFUNCTION; HEXANUCLEOTIDE REPEAT; PREMUTATION CARRIERS; DROSOPHILA MODEL; RAN TRANSLATION	Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a limited expansion of CGG repeats in the 50 UTR of FMR1. Two mechanisms are proposed to cause FXTAS: RNA gain-of-function, where CGG RNA sequesters specific proteins, and translation of CGG repeats into a polyglycine-containing protein, FMRpolyG. Here we developed transgenic mice expressing CGG repeat RNA with or without FMRpolyG. Expression of FMRpolyG is pathogenic, while the sole expression of CGG RNA is not. FMRpolyG interacts with the nuclear lamina protein LAP2 beta and disorganizes the nuclear lamina architecture in neurons differentiated from FXTAS iPS cells. Finally, expression of LAP2 beta rescues neuronal death induced by FMRpolyG. Overall, these results suggest that translation of expanded CGG repeats into FMRpolyG alters nuclear lamina architecture and drives pathogenesis in FXTAS.	[Sellier, Chantal; Jung, Laura; Tropel, Philippe; Gaucherot, Angeline; Jacobs, Hugues; Meziane, Hamid; Vincent, Alexandre; Champy, Marie-France; Sorg, Tania; Pavlovic, Guillaume; Wattenhofer-Donze, Marie; Birling, Marie-Christine; Oulad-Abdelghani, Mustapha; Eberling, Pascal; Ruffenach, Frank; Joint, Mathilde; Viville, Stephane; Charlet-Berguerand, Nicolas] Univ Strasbourg, CNRS, Inst Genetique & Biol Moleculaire & Cellulaire IG, INSERM U964,UMR7104, F-67400 Illkirch Graffenstaden, France; [Buijsen, Ronald A. M.; Willemsen, Rob; Hukema, Renate K.] Erasmus MC, Dept Clin Genet, NL-3015 Rotterdam, Netherlands; [He, Fang; Natla, Sam; Todd, Peter K.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [He, Fang; Todd, Peter K.] Veteran Assoc Hlth Syst, Ann Arbor, MI 48105 USA; [He, Fang] Texas A&M Univ Kingsville, Dept Biol & Hlth Sci, Kingsville, TX 78363 USA; [Jacobs, Hugues; Meziane, Hamid; Champy, Marie-France; Sorg, Tania; Pavlovic, Guillaume; Wattenhofer-Donze, Marie; Birling, Marie-Christine; Charlet-Berguerand, Nicolas] Univ Strasbourg, CNRS, Inst Clin Souris ICS, PHENOMIN,INSERM U964,UMR7104, F-67400 Illkirch Graffenstaden, France; [Anheim, Mathieu] Univ Hosp Strasbourg, Hop Hautepierre, Dept Neurol, F-67200 Strasbourg, France; [Martinez-Cerdeno, Veronica] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica] Univ Calif Davis, Lab Med, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica] Inst Pediat Regenerat Med, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica] Shriners Hosp Children North Calif, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica; Tassone, Flora] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Viville, Stephane] Nouvel Hop Civil, UF3472 Infertilite, Lab Diagnost Genetique, 1 Place Hop Civil, F-67091 Strasbourg, France; [Viville, Stephane] IPPTS, 3 Koeberle, F-67000 Strasbourg, France; [Martinat, Cecile] INSERM UEVE, UMR 861, I STEM, AFM, F-91030 Evry, France; [Charlet-Berguerand, Nicolas] Univ Strasbourg, F-67000 Strasbourg, France; [Charlet-Berguerand, Nicolas] Centre Natl Rech Scientifique, UMR7104, F-67400 Illkirch Graffenstaden, France; [Charlet-Berguerand, Nicolas] Inst Natl Sante & Rech Med, U964, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; Texas A&M University System; Texas A&M University Kingsville; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sellier, C; Charlet-Berguerand, N (corresponding author), Univ Strasbourg, CNRS, Inst Genetique & Biol Moleculaire & Cellulaire IG, INSERM U964,UMR7104, F-67400 Illkirch Graffenstaden, France.; Charlet-Berguerand, N (corresponding author), Univ Strasbourg, F-67000 Strasbourg, France.; Charlet-Berguerand, N (corresponding author), Centre Natl Rech Scientifique, UMR7104, F-67400 Illkirch Graffenstaden, France.; Charlet-Berguerand, N (corresponding author), Inst Natl Sante & Rech Med, U964, F-67400 Illkirch Graffenstaden, France.	sellier@igbmc.fr; ncharlet@igbmc.fr	Todd, Peter/AAH-2463-2020; Martinat, Cécile S/F-6777-2010; abdelghani, mustapha oulad/A-5986-2017; Pavlovic, Guillaume/C-9907-2013; Charlet-Berguerand, Nicolas/I-6727-2016; Hukema, Renate K/E-1422-2013; Charlet-Berguerand, Nicolas/GZM-6636-2022; He, Fang/H-1545-2015	Todd, Peter/0000-0003-4781-6376; Martinat, Cécile S/0000-0002-5234-1064; abdelghani, mustapha oulad/0000-0002-8381-4397; Pavlovic, Guillaume/0000-0001-9122-4592; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Hukema, Renate K/0000-0002-1580-4154; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Buijsen, Ronald/0000-0002-9722-8110; He, Fang/0000-0002-0944-3364; Anheim, Mathieu/0000-0001-8121-0605; Viville, Stephane/0000-0002-5088-3003; Birling, Marie-Christine/0000-0002-3372-8108	Hersenstichting Nederland [F2012(1)-101, F2015(1)-02]; National Institutes of Health NINDS [RO1 NS079775]; NIH [R01NS08681001]; Department of Veterans Affairs BLRD [1I21BX001841];  [ANR-12-RARE-0001 E-RARE "CURE FXTAS"];  [ANR-14-RARE-0003 E-RARE "Drug_FXSPreMut"];  [ERC-2012-StG 310659 "RNA DISEASES"];  [ANR-14-CE10-0016-01 "MITO-FXTAS"];  [ANR-10-INBS-07 PHENOMIN];  [ANR-10-LABX-0030-INRT];  [ANR-10-IDEX-0002-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079775, R01NS086810] Funding Source: NIH RePORTER; Veterans Affairs [I21BX001841] Funding Source: NIH RePORTER	Hersenstichting Nederland; National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs BLRD; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Prof. P.J. Hagerman (Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis) for the kind gift of human samples. We thank all IGBMC and ICS common core facilities for assistance. This work was supported by ANR-12-RARE-0001 E-RARE "CURE FXTAS" (N.C.B. and R.K.H.), ANR-14-RARE-0003 E-RARE "Drug_FXSPreMut" (N.C.B., R.W., and C.M.), ERC-2012-StG 310659 "RNA DISEASES", ANR-14-CE10-0016-01 "MITO-FXTAS" (N.C.B.), ANR-10-INBS-07 PHENOMIN (I.C.S.), ANR-10-LABX-0030-INRT (IGBMC), ANR-10-IDEX-0002-02 (IGBMC), Hersenstichting Nederland F2012(1)-101 (R.W.), Hersenstichting Nederland F2015(1)-02 (R.K.H.), National Institutes of Health NINDS RO1 NS079775 (R.W.), NIH R01NS08681001 (P.K.T.), and the Department of Veterans Affairs BLRD 1I21BX001841 (P.K.T). P.K.T. serves as a consultant for Denali Therapeutics; this consultation role does not relate to the work described here.	Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Buijsen RAM, 2016, HUM REPROD, V31, P158, DOI 10.1093/humrep/dev280; Buijsen RAM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0162-2; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Entezam A, 2007, GENE, V395, P125, DOI 10.1016/j.gene.2007.02.026; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hashem V, 2009, HUM MOL GENET, V18, P2443, DOI 10.1093/hmg/ddp182; Hoem G, 2011, HUM MOL GENET, V20, P2161, DOI 10.1093/hmg/ddr101; Hukema RK, 2015, HUM MOL GENET, V24, P4948, DOI 10.1093/hmg/ddv216; Hukema RK, 2014, CELL CYCLE, V13, P2600, DOI 10.4161/15384101.2014.943112; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Oh SY, 2015, HUM MOL GENET, V24, P4317, DOI 10.1093/hmg/ddv165; Pretto DI, 2014, NEUROBIOL AGING, V35, P1189, DOI 10.1016/j.neurobiolaging.2013.11.009; Primerano B, 2002, RNA, V8, P1482, DOI 10.1017/s1355838202020642; Qin M, 2011, NEUROBIOL DIS, V42, P85, DOI 10.1016/j.nbd.2011.01.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shumaker DK, 2001, EMBO J, V20, P1754, DOI 10.1093/emboj/20.7.1754; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tassone F, 2000, AM J MED GENET, V94, P232, DOI 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H; Tassone F, 2007, RNA, V13, P555, DOI 10.1261/rna.280807; Tassone F, 2012, GENOME MED, V4, DOI 10.1186/gm401; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang Y.J., 2016, NAT NEUROSCI; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	57	137	137	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2017	93	2					331	347		10.1016/j.neuron.2016.12.016	http://dx.doi.org/10.1016/j.neuron.2016.12.016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO0ZV	28065649	hybrid, Green Published			2022-12-17	WOS:000396428200013
J	Tracy, TE; Sohn, PD; Minami, SS; Wang, C; Min, SW; Li, YQ; Zhou, YG; Le, D; Lo, I; Ponnusamy, R; Cong, X; Schilling, B; Ellerby, LM; Huganir, RL; Gan, L				Tracy, Tara E.; Sohn, Peter Dongmin; Minami, S. Sakura; Wang, Chao; Min, Sang-Won; Li, Yaqiao; Zhou, Yungui; Le, David; Lo, Iris; Ponnusamy, Ravikumar; Cong, Xin; Schilling, Birgit; Ellerby, Lisa M.; Huganir, Richard L.; Gan, Li			Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss	NEURON			English	Article							PROTEIN-KINASE-C; ALZHEIMERS-DISEASE; PATTERN SEPARATION; AMPA RECEPTORS; NEUROFIBRILLARY TANGLES; CASPASE-CLEAVAGE; DENDRITIC SPINES; TRANSGENIC MICE; MOUSE MODEL; WILD-TYPE	Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease (AD), but the mechanism by which tau alters synapse physiology and leads to cognitive decline is unclear. Here we report abnormal acetylation of K274 and K281 on tau, identified in AD brains, promotes memory loss and disrupts synaptic plasticity by reducing postsynaptic KIdney/BRAin (KIBRA) protein, a memory-associated protein. Transgenic mice expressing human tau with lysine-to-glutamine mutations to mimic K274 and K281 acetylation (tauKQ) exhibit AD-related memory deficits and impaired hippocampal long-term potentiation (LTP). TauKQ reduces synaptic KIBRA levels and disrupts activity-induced postsynaptic actin remodeling and AMPA receptor insertion. The LTP deficit was rescued by promoting actin polymerization or by KIBRA expression. In AD patients with dementia, we found enhanced tau acetylation is linked to loss of KIBRA. These findings suggest a novel mechanism by which pathogenic tau causes synaptic dysfunction and cognitive decline in AD pathogenesis.	[Tracy, Tara E.; Sohn, Peter Dongmin; Minami, S. Sakura; Wang, Chao; Min, Sang-Won; Li, Yaqiao; Zhou, Yungui; Le, David; Lo, Iris; Ponnusamy, Ravikumar; Cong, Xin; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA 91458 USA; [Tracy, Tara E.; Minami, S. Sakura; Wang, Chao; Min, Sang-Won; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 91458 USA; [Sohn, Peter Dongmin; Gan, Li] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 91458 USA; [Cong, Xin; Schilling, Birgit; Ellerby, Lisa M.] Buck Inst Res Aging, Novato, CA 94945 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Buck Institute for Research on Aging; Johns Hopkins University	Gan, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 91458 USA.; Gan, L (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 91458 USA.; Gan, L (corresponding author), Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 91458 USA.	lgan@gladstone.ucsf.edu		Gan, Li/0000-0003-4600-275X	NIH [1R01AG036884, R01AG030207, NS40251, NS062413, 5F32AG043301-02, P30NS065780]; Tau Consortium; Stephen D. Bechtel Jr. Foundation; National Center for Research Resources Grant [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251, P30NS065780, RL1NS062413, R01NS036715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG051390, R01AG036884, R01AG030207, F32AG043301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; Stephen D. Bechtel Jr. Foundation; National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Vahram Haroutunian (Mount Sinai) for human brain samples; Dr. David Borchelt (University of Florida) for the pPrp vector; Dr. Peter Davies (Albert Einstein) for the MC1 and PHF1 antibodies; Drs. Charles McCulloch, Isabel Elaine Allen, and Maria Glymour for statistical analyses; Dr. T. Michael Gill and Allyson Davis for advice on behavioral studies; Drs. Kurt Thorn and DeLaine Larsen for microscopy support at the University of California, San Francisco (UCSF) Nikon Imaging Center; Junli Zhang and the Gladstone Institutes Transgenic Gene-Targeting Core, Christopher Ma, Fengrong Yan, Yuan-Hung Lin, and Sainan Liu for technical support; Drs. Grant Kauwe, Jorge Palop, and Sumihiro Maeda for discussions; Gary Howard for editorial review; and Latrice Gross and Erica Nguyen for administrative assistance. This work was supported by the NIH (1R01AG036884 and R01AG030207 to L.G.; NS40251 and NS062413 to L.M.E.; and 5F32AG043301-02 to T.E.T.), the Tau Consortium (to L.G.), and the Stephen D. Bechtel Jr. Foundation. Behavioral data were obtained with the help of the Gladstone Institutes' Neurobehavioral Core (supported by NIH grant P30NS065780). The Gladstone Institutes received support from a National Center for Research Resources Grant RR18928.	Ally BA, 2013, HIPPOCAMPUS, V23, P1246, DOI 10.1002/hipo.22162; Burgess JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.004; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Cohen TJ, 2013, NAT STRUCT MOL BIOL, V20, P756, DOI 10.1038/nsmb.2555; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; CORREAS I, 1990, BIOCHEM J, V269, P61, DOI 10.1042/bj2690061; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; Decker JM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0193-3; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Frandemiche ML, 2014, J NEUROSCI, V34, P6084, DOI 10.1523/JNEUROSCI.4261-13.2014; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Grinberg LT, 2013, ACTA NEUROPATHOL, V125, P581, DOI 10.1007/s00401-013-1080-2; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046340; Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kremerskothen J, 2005, J NEUROCHEM, V92, P597, DOI 10.1111/j.1471-4159.2004.02888.x; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Vogt-Eisele A, 2014, J NEUROCHEM, V128, P686, DOI 10.1111/jnc.12480; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; Warmus BA, 2014, J NEUROSCI, V34, P16482, DOI 10.1523/JNEUROSCI.3418-14.2014; Wesnes KA, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt250; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004; Zhang L, 2014, CELL SIGNAL, V26, P1392, DOI 10.1016/j.cellsig.2014.02.023	60	137	141	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2016	90	2					245	260		10.1016/j.neuron.2016.03.005	http://dx.doi.org/10.1016/j.neuron.2016.03.005			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ8ZV	27041503	Green Accepted, Bronze			2022-12-17	WOS:000374504400008
J	Yang, WJ; Miller, JEK; Carrillo-Reid, L; Pnevmatikakis, E; Paninski, L; Yuste, R; Peterka, DS				Yang, Weijian; Miller, Jae-eun Kang; Carrillo-Reid, Luis; Pnevmatikakis, Eftychios; Paninski, Liam; Yuste, Rafael; Peterka, Darcy S.			Simultaneous Multi-plane Imaging of Neural Circuits	NEURON			English	Article							MULTIPHOTON MICROSCOPY; NEURONAL-ACTIVITY; EXTENDED DEPTH; FRAME RATE; 2-PHOTON; PHOTOSTIMULATION; DECONVOLUTION; INTERNEURONS; SELECTIVITY; INHIBITION	Recording the activity of large populations of neurons is an important step toward understanding the emergent function of neural circuits. Here we present a simple holographic method to simultaneously perform two-photon calcium imaging of neuronal populations across multiple areas and layers of mouse cortex in vivo. We use prior knowledge of neuronal locations, activity sparsity, and a constrained nonnegative matrix factorization algorithm to extract signals from neurons imaged simultaneously and located in different focal planes or fields of view. Our laser multiplexing approach is simple and fast, and could be used as a general method to image the activity of neural circuits in three dimensions across multiple areas in the brain.	[Yang, Weijian; Miller, Jae-eun Kang; Carrillo-Reid, Luis; Paninski, Liam; Yuste, Rafael; Peterka, Darcy S.] Columbia Univ, Dept Biol Sci, Neurotechnol Ctr, New York, NY 10027 USA; [Pnevmatikakis, Eftychios] Simons Fdn, Ctr Computat Biol, New York, NY 10010 USA; [Pnevmatikakis, Eftychios; Paninski, Liam] Columbia Univ, Dept Stat, Ctr Theoret Neurosci, New York, NY 10027 USA; [Pnevmatikakis, Eftychios; Paninski, Liam] Columbia Univ, Grossman Ctr Stat Mind, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Yang, WJ (corresponding author), Columbia Univ, Dept Biol Sci, Neurotechnol Ctr, New York, NY 10027 USA.	wy2221@columbia.edu		Peterka, Darcy/0000-0001-7351-5820; Pnevmatikakis, Eftychios/0000-0003-1509-6394; Carrillo-Reid, Luis/0000-0002-0511-2533	NEI [DP1EY024503, R01EY011787]; NIMH [R01MH101218, R41MH100895, R01MH100561]; DARPA [W91NF-14-1-0269, SIMPLEX N66001-15-C-4032]; U.S. Army Research Laboratory; U.S. Army Research Office (MURI) [W911NF-12-1-0594]; NATIONAL EYE INSTITUTE [R01EY011787, DP1EY024503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH100895, R01MH100561, R01MH101218] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office (MURI)(MURI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by the NEI (DP1EY024503, R01EY011787), NIMH (R01MH101218, R41MH100895, R01MH100561), and DARPA under contract numbers W91NF-14-1-0269 and SIMPLEX N66001-15-C-4032. This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911NF-12-1-0594 (MURI). The authors thank Yeonsook Shin for virus injection of the mice.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Andresen V, 2001, OPT LETT, V26, P75, DOI 10.1364/OL.26.000075; Anselmi F, 2011, P NATL ACAD SCI USA, V108, P19504, DOI 10.1073/pnas.1109111108; Bahlmann K, 2007, OPT EXPRESS, V15, P10991, DOI 10.1364/OE.15.010991; Beaurepaire E, 2002, APPL OPTICS, V41, P5376, DOI 10.1364/AO.41.005376; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Botcherby EJ, 2006, OPT COMMUN, V268, P253, DOI 10.1016/j.optcom.2006.07.026; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carriles R, 2008, OPT EXPRESS, V16, P10364, DOI 10.1364/OE.16.010364; Cha JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05153; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng A, 2011, NAT METHODS, V8, P139, DOI 10.1038/NMETH.1552; Cotton RJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00151; Dal Maschio M, 2010, OPT EXPRESS, V18, P18720, DOI 10.1364/OE.18.018720; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Ducros M, 2013, P NATL ACAD SCI USA, V110, P13138, DOI 10.1073/pnas.1307818110; Egner A, 2000, J OPT SOC AM A, V17, P1192, DOI 10.1364/JOSAA.17.001192; Fittinghoff DN, 2000, OPT EXPRESS, V7, P273, DOI 10.1364/OE.7.000273; Fricke M, 2005, APPL OPTICS, V44, P2984, DOI 10.1364/AO.44.002984; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmstaedter M, 2008, J NEUROSCI, V28, P8273, DOI 10.1523/JNEUROSCI.5701-07.2008; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Insel TR, 2013, SCIENCE, V340, P687, DOI 10.1126/science.1239276; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/nmeth.1851, 10.1038/NMETH.1851]; Kim KH, 2007, OPT EXPRESS, V15, P11658, DOI 10.1364/OE.15.011658; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/NMETH.3476, 10.1038/nmeth.3476]; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maruyama R, 2014, NEURAL NETWORKS, V55, P11, DOI 10.1016/j.neunet.2014.03.007; Matsumoto N, 2014, OPT EXPRESS, V22, P633, DOI 10.1364/OE.22.000633; Mazurek M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00092; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Otsu Y, 2008, J NEUROSCI METH, V173, P259, DOI 10.1016/j.jneumeth.2008.06.015; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Quirin S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00029; Quirin S, 2013, OPT EXPRESS, V21, P16007, DOI 10.1364/OE.21.016007; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Schmidt J. D., 2010, NUMERICAL SIMULATION; Shai AS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004090; Thalhammer G, 2013, OPT EXPRESS, V21, P1779, DOI 10.1364/OE.21.001779; Theriault G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00139; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Watson BO, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.006.2009; Williams RM, 2001, CURR OPIN CHEM BIOL, V5, P603, DOI 10.1016/S1367-5931(00)00241-6; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	64	137	142	6	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2016	89	2					269	284		10.1016/j.neuron.2015.12.012	http://dx.doi.org/10.1016/j.neuron.2015.12.012			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5TZ	26774159	Green Accepted, Bronze			2022-12-17	WOS:000373564700006
J	Haber, SN; Behrens, TEJ				Haber, Suzanne N.; Behrens, Timothy E. J.			The Neural Network Underlying Incentive-Based Learning: Implications for Interpreting Circuit Disruptions in Psychiatric Disorders	NEURON			English	Review							OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; HUMAN ORBITOFRONTAL CORTEX; DEEP BRAIN-STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; MAJOR DEPRESSIVE DISORDER; REWARD PREDICTION ERRORS; DECISION-MAKING; BASAL GANGLIA	Coupling stimuli and actions with positive or negative outcomes facilitates the selection of appropriate actions. Several brain regions are involved in the development of goal-directed behaviors and habit formation during incentive-based learning. This Review focuses on higher cognitive control of decision making and the cortical and subcortical structures and connections that attribute value to stimuli, associate that value with choices, and select an action plan. Delineating the connectivity between these areas is fundamental for understanding how brain regions work together to evaluate stimuli, develop actions plans, and modify behavior, as well as for elucidating the pathophysiology of psychiatric diseases.	[Haber, Suzanne N.] Univ Rochester, Sch Med, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Behrens, Timothy E. J.] Univ Oxford, FMRIB Ctr, Oxford OX3 9DU, England; [Behrens, Timothy E. J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	University of Rochester; University of Oxford; University of London; University College London	Haber, SN (corresponding author), Univ Rochester, Sch Med, Dept Pharmacol & Physiol, Rochester, NY 14642 USA.	suzanne_haber@urmc.rochester.edu		Behrens, Timothy/0000-0003-0048-1177	NIH [MH086400, MH73111, MH086404]; Wellcome Trust [WT088313AIa]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045573, P50MH086404, R01MH073111, P50MH086400] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to acknowledge funding from the NIH (MH086400, MH73111, and MH086404) and Wellcome Trust WT088313AIa. We would like to thank the James S. McDonnell foundation and the Brain and Behavior Research Foundation (BBRF).	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; [Anonymous], BIOL PSYCHIAT, V75, P631; APICELLA P, 1991, EXP BRAIN RES, V84, P672; Averbeck BB, 2014, J NEUROSCI, V34, P9497, DOI 10.1523/JNEUROSCI.5806-12.2014; Baliki MN, 2013, J NEUROSCI, V33, P16383, DOI 10.1523/JNEUROSCI.1731-13.2013; Barbas H, 2007, ANN NY ACAD SCI, V1121, P10, DOI 10.1196/annals.1401.015; Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Bonnici HM, 2012, J NEUROSCI, V32, P16982, DOI 10.1523/JNEUROSCI.2475-12.2012; Boorman ED, 2013, J NEUROSCI, V33, P2242, DOI 10.1523/JNEUROSCI.3022-12.2013; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Bouret S, 2010, J NEUROSCI, V30, P8591, DOI 10.1523/JNEUROSCI.0049-10.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Carlezon WA, 1996, J NEUROSCI, V16, P3112; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Chiavaras MM, 2000, J COMP NEUROL, V422, P35; Chikama M, 1997, J NEUROSCI, V17, P9686; Chowdhury R, 2013, NAT NEUROSCI, V16, P648, DOI 10.1038/nn.3364; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2012, CURR OPIN NEUROBIOL, V22, P927, DOI 10.1016/j.conb.2012.05.007; Clithero J. A., 2013, SOC COGN AFFECT NEUR; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Delgado MR, 2005, NEUROIMAGE, V24, P862, DOI 10.1016/j.neuroimage.2004.10.002; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feldman RP, 2001, J NEUROSURG, V95, P944, DOI 10.3171/jns.2001.95.6.0944; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frankle WG, 2006, NEUROPSYCHOPHARMACOL, V31, P1627, DOI 10.1038/sj.npp.1300990; Freedman LJ, 2000, J COMP NEUROL, V421, P172; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Fudge JL, 2002, NEUROSCIENCE, V110, P257, DOI 10.1016/S0306-4522(01)00546-2; Fudge JL, 2001, NEUROSCIENCE, V104, P807, DOI 10.1016/S0306-4522(01)00112-9; Gillan CM, 2014, BIOL PSYCHIAT, V75, P631, DOI 10.1016/j.biopsych.2013.02.002; GIMENEZAMAYA JM, 1995, J COMP NEUROL, V354, P127, DOI 10.1002/cne.903540109; Goldman-Rakic P.S., 1999, HDB CHEM NEUROANATOM, V15, P403; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greenberg BD, 2003, NEUROSURG CLIN N AM, V14, P199, DOI 10.1016/S1042-3680(03)00005-6; Greenberg BD, 2010, NEUROPSYCHOPHARMACOL, V35, P317, DOI 10.1038/npp.2009.128; Groenewold NA, 2013, NEUROSCI BIOBEHAV R, V37, P152, DOI 10.1016/j.neubiorev.2012.11.015; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; HABER S, 1987, P NATL ACAD SCI USA, V84, P1408, DOI 10.1073/pnas.84.5.1408; Haber SN, 2000, J NEUROSCI, V20, P2369; HABER SN, 1990, J COMP NEUROL, V293, P282, DOI 10.1002/cne.902930210; HABER SN, 1993, J COMP NEUROL, V329, P111, DOI 10.1002/cne.903290108; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Haynes WIA, 2013, J NEUROSCI, V33, P4804, DOI 10.1523/JNEUROSCI.4674-12.2013; Heimer L., 1978, LIMBIC MECHANISMS CO, P95; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hunt LT, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003225; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Jbabdi S, 2013, J NEUROSCI, V33, P3190, DOI 10.1523/JNEUROSCI.2457-12.2013; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kasanetz F, 2008, P NATL ACAD SCI USA, V105, P8124, DOI 10.1073/pnas.0711113105; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerly Donald, 2011, Am J Med Qual, V26, P43, DOI 10.1177/1062860610374645; Klein-Flugge MC, 2011, NEURON, V72, P654, DOI 10.1016/j.neuron.2011.08.024; Klein-Flugge MC, 2013, J NEUROSCI, V33, P3202, DOI 10.1523/JNEUROSCI.2532-12.2013; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kringelbach ML, 2003, NEUROIMAGE, V20, P1371, DOI 10.1016/S1053-8119(03)00393-8; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; LAVOIE B, 1994, J COMP NEUROL, V344, P232, DOI 10.1002/cne.903440205; Leckman JF, 1997, AM J PSYCHIAT, V154, P911; Lee SW, 2014, NEURON, V81, P687, DOI 10.1016/j.neuron.2013.11.028; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; Levy R, 1997, J NEUROSCI, V17, P3870; LEWIS DA, 1992, J NEURAL TRANSM-GEN, P179; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matthews SC, 2008, J AFFECT DISORDERS, V111, P13, DOI 10.1016/j.jad.2008.05.022; May PJ, 2009, EUR J NEUROSCI, V29, P575, DOI 10.1111/j.1460-9568.2008.06596.x; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MCENANEY KW, 1969, J COMP PHYSIOL PSYCH, V68, P558, DOI 10.1037/h0027639; Meredith GE, 1996, J COMP NEUROL, V365, P628, DOI 10.1002/(SICI)1096-9861(19960219)365:4<628::AID-CNE9>3.0.CO;2-6; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Morecraft RJ, 2012, BRAIN RES BULL, V87, P457, DOI 10.1016/j.brainresbull.2011.12.005; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; MORI S, 1987, ANAT EMBRYOL, V176, P13, DOI 10.1007/BF00309747; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Ongur D, 1998, J COMP NEUROL, V401, P480; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Passingham RE, 2010, TRENDS COGN SCI, V14, P16, DOI 10.1016/j.tics.2009.11.001; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; PERCHERON G, 1991, TRENDS NEUROSCI, V14, P55, DOI 10.1016/0166-2236(91)90020-U; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; PHILLIPS AG, 1978, CAN J PSYCHOL, V32, P58, DOI 10.1037/h0081676; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; RAY JP, 1993, J COMP NEUROL, V337, P1, DOI 10.1002/cne.903370102; Rempel-Clower NL, 1998, J COMP NEUROL, V398, P393, DOI 10.1002/(SICI)1096-9861(19980831)398:3<393::AID-CNE7>3.0.CO;2-V; Romero MJ, 2010, PSYCHIAT RES-NEUROIM, V181, P57, DOI 10.1016/j.pscychresns.2009.07.004; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Rudebeck PH, 2011, ANN NY ACAD SCI, V1239, P1, DOI 10.1111/j.1749-6632.2011.06267.x; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2012, CURR OPIN NEUROBIOL, V22, P946, DOI 10.1016/j.conb.2012.04.011; RUSSCHEN FT, 1985, BRAIN RES, V329, P241, DOI 10.1016/0006-8993(85)90530-X; Rutledge RB, 2010, J NEUROSCI, V30, P13525, DOI 10.1523/JNEUROSCI.1747-10.2010; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schlosser RGM, 2010, HUM BRAIN MAPP, V31, P1834, DOI 10.1002/hbm.20980; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SELEMON LD, 1985, J NEUROSCI, V5, P776; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Shadlen MN, 2008, NEUROBIOLOGY DECISIO; Shields DC, 2008, BIOL PSYCHIAT, V64, P449, DOI 10.1016/j.biopsych.2008.04.009; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Spooren WPJM, 1996, J COMP NEUROL, V370, P295, DOI 10.1002/(SICI)1096-9861(19960701)370:3<295::AID-CNE2>3.0.CO;2-#; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Togao O, 2010, PSYCHIAT RES-NEUROIM, V184, P29, DOI 10.1016/j.pscychresns.2010.06.011; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wallis JD, 2010, NAT NEUROSCI, V13, P7, DOI 10.1038/nn0110-7; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Watanabe K, 2003, J NEUROSCI, V23, P10052; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wunderlich K, 2011, J NEUROPHYSIOL, V106, P1558, DOI 10.1152/jn.01051.2010; ZABORSZKY L, 1992, BRAIN RES, V570, P92, DOI 10.1016/0006-8993(92)90568-T	177	137	138	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 3	2014	83	5					1019	1039		10.1016/j.neuron.2014.08.031	http://dx.doi.org/10.1016/j.neuron.2014.08.031			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5XB	25189208	Green Accepted, Bronze			2022-12-17	WOS:000341419000006
J	Cazorla, M; de Carvalho, FD; Chohan, MO; Shegda, M; Chuhma, N; Rayport, S; Ahmari, SE; Moore, H; Kellendonk, C				Cazorla, Maxime; de Carvalho, Fernanda Delmondes; Chohan, Muhammad O.; Shegda, Mariya; Chuhma, Nao; Rayport, Stephen; Ahmari, Susanne E.; Moore, Holly; Kellendonk, Christoph			Dopamine D2 Receptors Regulate the Anatomical and Functional Balance of Basal Ganglia Circuitry	NEURON			English	Article							MEDIUM SPINY NEURONS; SELECTIVE OVEREXPRESSION; OPTOGENETIC CONTROL; STRIATAL NEURONS; DISTINCT ROLES; D-2 RECEPTORS; TRANSIENT; SCHIZOPHRENIA; ORGANIZATION; REWARD	Structural plasticity in the adult brain is essential for adaptive behavior. We have found a remarkable anatomical plasticity in the basal ganglia of adult mice that is regulated by dopamine D2 receptors (D2Rs). By modulating neuronal excitability, striatal D2Rs bidirectionally control the density of direct pathway collaterals in the globus pallidus that bridge the direct pathway with the functionally opposing indirect pathway. An increase in bridging collaterals is associated with enhanced inhibition of pallidal neurons in vivo and disrupted locomotor activation after optogenetic stimulation of the direct pathway. Chronic blockade with haloperidol, an antipsychotic medication used to treat schizophrenia, decreases the extent of bridging collaterals and rescues the loconnotor imbalance. These findings identify a role for bridging collaterals in regulating the concerted balance of striatal output and may have important implications for understanding schizophrenia, a disease involving excessive activation of striatal D2Rs that is treated with D2R blockers.	[Cazorla, Maxime; de Carvalho, Fernanda Delmondes; Shegda, Mariya; Chuhma, Nao; Rayport, Stephen; Moore, Holly; Kellendonk, Christoph] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Cazorla, Maxime; de Carvalho, Fernanda Delmondes; Shegda, Mariya; Kellendonk, Christoph] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Cazorla, Maxime; de Carvalho, Fernanda Delmondes; Shegda, Mariya; Chuhma, Nao; Rayport, Stephen; Kellendonk, Christoph] New York State Psychiat Inst & Hosp, Dept Mol Therapeut, New York, NY 10032 USA; [Chohan, Muhammad O.; Moore, Holly] New York State Psychiat Inst & Hosp, Dept Integrat Neurosci, New York, NY 10032 USA; [Ahmari, Susanne E.] Univ Pittsburgh, Dept Psychiat, Translat Neurosci Program, Pittsburgh, PA 15213 USA	Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kellendonk, C (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	ck491@columbia.edu	Cazorla, Maxime/M-6425-2014; Ahmari, Susanne E./J-5812-2013; Kellendonk, Christoph/O-7229-2018; Core, Vector/CAF-4832-2022	Cazorla, Maxime/0000-0002-8260-1154; Ahmari, Susanne E./0000-0003-4576-076X; Kellendonk, Christoph/0000-0003-3302-2188; Carvalho Poyraz, Fernanda/0000-0003-2488-6849; Rayport, Stephen/0000-0001-9755-7486; Chohan, Muhammad/0000-0002-9359-3700; Chuhma, Nao/0000-0002-6846-3461	National Institute of Mental Health [MH086404, R01MH093672]; Rodent Neurobehavioral Analysis Core at the New York State Psychiatric Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086404, K08MH087718, R01MH093672] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Rodent Neurobehavioral Analysis Core at the New York State Psychiatric Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Bhavani Ramesh for excellent technical help and Pierre Trifilieff, Jonathan Javitch, Mark Ansorge, and members of the Kellendonk laboratory for thoughtful discussions of the manuscript. We would like to thank Karl Deisseroth for the ChR2 construct. This work was supported by the National Institute of Mental Health (MH086404 to C.K., M.O.C., N.C., and &R. and R01MH093672 to C.K. and MC.). Behavioral analyses were performed with support from the Rodent Neurobehavioral Analysis Core at the New York State Psychiatric Institute.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bach ME, 2008, P NATL ACAD SCI USA, V105, P16027, DOI 10.1073/pnas.0807746105; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; Cazorla M, 2012, J NEUROSCI, V32, P2398, DOI 10.1523/JNEUROSCI.6056-11.2012; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Simpson EH, 2012, SCHIZOPHRENIA BULL, V38, P1111, DOI 10.1093/schbul/sbs114; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Ward RD, 2012, NEUROPSYCHOPHARMACOL, V37, P1699, DOI 10.1038/npp.2012.15; Wu Y, 2000, NEUROSCI RES, V38, P49, DOI 10.1016/S0168-0102(00)00140-1; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	42	137	142	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2014	81	1					153	164		10.1016/j.neuron.2013.10.041	http://dx.doi.org/10.1016/j.neuron.2013.10.041			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287RD	24411738	Bronze, Green Accepted			2022-12-17	WOS:000329559000016
J	den Ouden, HEM; Daw, ND; Fernandez, G; Elshout, JA; Rijpkema, M; Hoogman, M; Franke, B; Cools, R				den Ouden, Hanneke E. M.; Daw, Nathaniel D.; Fernandez, Guillen; Elshout, Joris A.; Rijpkema, Mark; Hoogman, Martine; Franke, Barbara; Cools, Roshan			Dissociable Effects of Dopamine and Serotonin on Reversal Learning	NEURON			English	Article							NUCLEUS-ACCUMBENS; TRANSPORTER AVAILABILITY; COGNITIVE FLEXIBILITY; PARKINSONS-DISEASE; REINFORCEMENT; SYSTEMS; REWARD; MODULATION; INHIBITION; DEPLETION	Serotonin and dopamine are speculated to subserve motivationally opponent functions, but this hypothesis has not been directly tested. We studied the role of these neurotransmitters in probabilistic reversal learning in nearly 700 individuals as a function of two polymorphisms in the genes encoding the serotonin and dopamine transporters (SERT: 5HTTLPR plus rs25531; DAT1 3'UTR VNTR). A double dissociation was observed. The SERT polymorphism altered behavioral adaptation after losses, with increased lose-shift associated with L' homozygosity, while leaving unaffected perseveration after reversal. In contrast, the DAT1 genotype affected the influence of prior choices on perseveration, while leaving lose-shifting unaltered. A model of reinforcement learning captured the dose-dependent effect of DAT1 genotype, such that an increasing number of 9R-alleles resulted in a stronger reliance on previous experience and therefore reluctance to update learned associations. These data provide direct evidence for doubly dissociable effects of serotonin and dopamine systems.	[den Ouden, Hanneke E. M.; Fernandez, Guillen; Elshout, Joris A.; Rijpkema, Mark; Franke, Barbara; Cools, Roshan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 Nijmegen, Netherlands; [Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [den Ouden, Hanneke E. M.; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Fernandez, Guillen; Elshout, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6500 Nijmegen, Netherlands; [Hoogman, Martine; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 Nijmegen, Netherlands; [Franke, Barbara; Cools, Roshan] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6500 Nijmegen, Netherlands	Radboud University Nijmegen; New York University; New York University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	den Ouden, HEM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 Nijmegen, Netherlands.	h.denouden@gmail.com	Ouden, Hanneke den/D-3019-2009; Franke, Barbara/D-4836-2009; Fernandez, Guillen/B-3771-2009; Hoogman, Martine/G-8958-2015; Cools, Roshan/D-1905-2010; Rijpkema, Mark/D-1974-2010	Ouden, Hanneke den/0000-0001-7039-5130; Franke, Barbara/0000-0003-4375-6572; Fernandez, Guillen/0000-0002-5522-0604; Hoogman, Martine/0000-0002-1261-7628; Rijpkema, Mark/0000-0002-8495-4703; Cools, Roshan/0000-0001-8994-5534	Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organisation for Scientific Research; Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research; Human Frontiers Science Program grant	Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research; Human Frontiers Science Program grant	We thank Sabine Kooijman for logistic support; Angelien Heister, Remco Makkinje, and Marlies Naber for genotyping; and Bradley Doll, Sean Fallon, Michael Frank, Guillaume Sescousse, and Jennifer Cook for insightful discussions and feedback. This work makes use of the Brain Imaging Genetics (BIG) database, first established in Nijmegen, the Netherlands, in 2007. This resource is now part of Cognomics (http://www.cognomics.nl), a joint initiative by researchers of the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Centre and the Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative is supported by the participating departments and centres and by external grants: the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL), the Hersenstichting Nederland, and the Netherlands Organisation for Scientific Research. This study was also supported by a Research Vidi Grant to R.C. and a Research Veni Grant to H.d.O. from the Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research as well as a Human Frontiers Science Program grant to Kae Nakamura, N.D., and R.C., and a James McDonnell scholar award to both R.C. and N.D. We wish to thank all who kindly participated in this research.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bari A, 2010, NEUROPSYCHOPHARMACOL, V35, P1290, DOI 10.1038/npp.2009.233; Boulougouris V, 2008, NEUROPSYCHOPHARMACOL, V33, P2007, DOI 10.1038/sj.npp.1301584; Boulougouris V, 2010, J NEUROSCI, V30, P930, DOI 10.1523/JNEUROSCI.4312-09.2010; Boulougouris V, 2009, PSYCHOPHARMACOLOGY, V202, P611, DOI 10.1007/s00213-008-1341-2; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Collins AGE, 2012, EUR J NEUROSCI, V35, P1024, DOI 10.1111/j.1460-9568.2011.07980.x; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Cools R, 2006, NEUROPSYCHOLOGIA, V44, P1663, DOI 10.1016/j.neuropsychologia.2006.03.030; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Costa A, 2011, SYNAPSE, V65, P998, DOI 10.1002/syn.20927; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Daw N.D., 2011, DECISION MAKING AFFE, V23, P3, DOI [10.1093/acprof:oso/9780199600434.003.0001, DOI 10.1093/ACPROF:OSO/9780199600434.003.0001]; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040004; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; Dodds CM, 2008, J NEUROSCI, V28, P5976, DOI 10.1523/JNEUROSCI.1153-08.2008; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Houk JC, 1995, MODELS INFORM PROCES, P249; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Izquierdo A, 2007, P NATL ACAD SCI USA, V104, P14128, DOI 10.1073/pnas.0706583104; Jedema HP, 2010, MOL PSYCHIATR, V15, P512, DOI 10.1038/mp.2009.90; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lawrence AD, 1999, NEUROPSYCHOLOGIA, V37, P1359, DOI 10.1016/S0028-3932(99)00035-4; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy FC, 2003, PSYCHOL MED, V33, P455, DOI 10.1017/S0033291702007018; Palminteri S, 2012, BIOL PSYCHIAT, V72, P244, DOI 10.1016/j.biopsych.2011.12.028; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Praschak-Rieder N, 2007, BIOL PSYCHIAT, V62, P327, DOI 10.1016/j.biopsych.2006.09.022; Robinson OJ, 2010, PSYCHOPHARMACOLOGY, V211, P187, DOI 10.1007/s00213-010-1880-1; Roiser JP, 2009, J NEUROSCI, V29, P5985, DOI 10.1523/JNEUROSCI.0407-09.2009; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; Spencer TJ, 2013, BIOL PSYCHIAT, V74, P84, DOI 10.1016/j.biopsych.2012.11.010; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Thorndike EL, 1911, ANIMAL INTELLIGENCE; Vallender EJ, 2009, AM J MED GENET B, V150B, P467, DOI 10.1002/ajmg.b.30835; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van Dyck CH, 2005, J NUCL MED, V46, P745; Walker SC, 2009, CEREB CORTEX, V19, P889, DOI 10.1093/cercor/bhn136; Willeit M, 2010, NEUROIMAGE, V53, P878, DOI 10.1016/j.neuroimage.2010.04.030	66	137	137	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2013	80	4					1090	1100		10.1016/j.neuron.2013.08.030	http://dx.doi.org/10.1016/j.neuron.2013.08.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256AD	24267657	Green Published, Bronze			2022-12-17	WOS:000327281200023
J	Chen, LZ; Wang, ZP; Ghosh-Roy, A; Hubert, T; Yan, D; O'Rourke, S; Bowerman, B; Wu, ZL; Jin, YS; Chisholm, AD				Chen, Lizhen; Wang, Zhiping; Ghosh-Roy, Anindya; Hubert, Thomas; Yan, Dong; O'Rourke, Sean; Bowerman, Bruce; Wu, Zilu; Jin, Yishi; Chisholm, Andrew D.			Axon Regeneration Pathways Identified by Systematic Genetic Screening in C. elegans	NEURON			English	Article							CAENORHABDITIS-ELEGANS; MICROTUBULE GROWTH; MOLECULAR-MECHANISMS; MAP KINASE; NOGO-A; GUIDANCE; PROTEIN; EXPRESSION; SUBUNIT; FAMILY	The mechanisms underlying the ability of axons to regrow after injury remain poorly explored at the molecular genetic level. We used a laser injury model in Caenorhabditis elegans mechanosensory neurons to screen 654 conserved genes for regulators of axonal regrowth. We uncover several functional clusters of genes that promote or repress regrowth, including genes classically known to affect axon guidance, membrane excitability, neurotransmission, and synaptic vesicle endocytosis. The conserved Art Guanine nucleotide Exchange Factor (GEF), EFA-6, acts as an intrinsic inhibitor of regrowth. By combining genetics and in vivo imaging, we show that EFA-6 inhibits regrowth via microtubule dynamics, independent of its Art GEF activity. Among newly identified regrowth inhibitors, only loss of function in EFA-6 partially bypasses the requirement for DLK-1 kinase. Identification of these pathways significantly expands our understanding of the genetic basis of axonal injury responses and repair.	[Chen, Lizhen; Wang, Zhiping; Ghosh-Roy, Anindya; Hubert, Thomas; Yan, Dong; Wu, Zilu; Jin, Yishi; Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Yan, Dong; Wu, Zilu; Jin, Yishi] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [O'Rourke, Sean; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Jin, Yishi] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Oregon; University of Oregon; University of California System; University of California San Diego	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	yijin@ucsd.edu; chisholm@ucsd.edu	Yan, Dong/AAA-6559-2020; Chen, Lizhen/C-1800-2012	Yan, Dong/0000-0002-7542-1251; Ghosh-Roy, Anindya/0000-0002-3428-4588; Jin, Yishi/0000-0002-9371-9860; Chisholm, Andrew/0000-0001-5091-0537	NIH [R01 GM049859, GM058017, R01 NS035546, R01 NS057317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869, R01GM058017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057317, R01NS035546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Alison Hughes, Niousha Saghafi, Amanda Rajapaksa, Sunny Sun, Peg Scott, Caroline Yu, Laura Toy, and other members of our labs for strain construction. We thank Johann Gagnon-Bartsch and Terry Speed for advice on statistical analysis; Cori Bargmann, Gian Garriga, and Erik Jorgensen for reagents; Chris Fang-Yen for the bead immobilization protocol; and Emily Troemel for comments on the manuscript. We thank the C. elegans Gene Knockout Consortium and the Japanese National Bioresource Project for deletion mutations, and the Caenorhabditis Genetics Center for strains. L.C., A.D.C., and Y.J. designed the screen. Z. Wu performed axotomy, imaging, and technical development. L.C. constructed strains and analyzed efa-6; Z. Wang analyzed slt-1/sax-3 signaling. A.G.-R. designed and performed MT imaging and analysis. L.C., Z. Wang, T.H., A.G.-R. and D.Y. contributed to the screen and analyzed the results. S.O'R. and B.B. provided reagents and unpublished data for efa-6. L.C., Z. Wang, Y.J., and A.D.C. wrote the manuscript. Z. Wang is a Fellow of the Jane Coffin Childs Memorial Fund. Z. Wu is an Associate and Y.J. is an Investigator of the Howard Hughes Medical Institute. Supported by grants from the NIH to B.B. (R01 GM049859 and GM058017), Y.J. (R01 NS035546), and A.D.C. (R01 NS057317).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Ambron RT, 1996, J NEUROSCI, V16, P7469; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BRENNER S, 1974, GENETICS, V77, P71; Brushart TM, 2002, J NEUROSCI, V22, P6631; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Doi M, 2008, MOL CELL NEUROSCI, V38, P548, DOI 10.1016/j.mcn.2008.05.003; Enes J, 2010, CURR BIOL, V20, P1154, DOI 10.1016/j.cub.2010.05.055; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; Ghosh-Roy A, 2010, DEV DYNAM, V239, P1460, DOI 10.1002/dvdy.22253; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Itoh A, 2009, BIOCHEM BIOPH RES CO, V383, P258, DOI 10.1016/j.bbrc.2009.04.009; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Li HC, 2008, J NEUROSCI, V28, P3595, DOI 10.1523/JNEUROSCI.5536-07.2008; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; Manning Gerard, 2005, WormBook, P1; Massaro CM, 2009, J CELL BIOL, V187, P101, DOI 10.1083/jcb.200903166; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; O'Rourke SM, 2010, NAT CELL BIOL, V12, P1235, DOI 10.1038/ncb2128; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SCHWARZ V, 2009, AM J PHYSIOL-CELL PH, V287, pC468; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Shim S, 2010, EXP NEUROL, V223, P38, DOI 10.1016/j.expneurol.2009.10.001; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Song S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001056; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; Tuck Elizabeth, 2010, Commun Integr Biol, V3, P209; Wang ZP, 2011, CURR OPIN NEUROBIOL, V21, P189, DOI 10.1016/j.conb.2010.08.010; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Xie YM, 2001, J NEUROSCI, V21, P5130, DOI 10.1523/JNEUROSCI.21-14-05130.2001; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yang Y, 2006, BRAIN RES, V1075, P1, DOI 10.1016/j.brainres.2005.12.060; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	82	137	142	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1043	1057		10.1016/j.neuron.2011.07.009	http://dx.doi.org/10.1016/j.neuron.2011.07.009			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943602	Green Accepted, Bronze			2022-12-17	WOS:000295556500010
J	Peters, JH; McDougall, SJ; Fawley, JA; Smith, SM; Andresen, MC				Peters, James H.; McDougall, Stuart J.; Fawley, Jessica A.; Smith, Stephen M.; Andresen, Michael C.			Primary Afferent Activation of Thermosensitive TRPV1 Triggers Asynchronous Glutamate Release at Central Neurons	NEURON			English	Article							NUCLEUS-TRACTUS-SOLITARIUS; RAT AORTIC BARORECEPTORS; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; VISCERAL AFFERENTS; IN-VITRO; HIPPOCAMPAL SYNAPSES; VESICLE FUSION; BRAIN-STEM	TRPV1 receptors feature prominently in nociception of spinal primary afferents but are also expressed in unmyelinated cranial visceral primary afferents linked to homeostatic regulation. Cranial visceral afferents enter the brain at the solitary tract nucleus (NTS) to control the heart, lungs, and other vital organs. Here we identify a role for central TRPV1 in the activity-dependent facilitation of glutamatergic transmission from solitary tract (ST) afferents. Fast, synchronous ST-NTS transmission from capsaicin-sensitive (TRPV1+) and -insensitive (TRPV1-) afferents was similar. However, afferent activation triggered long-lasting asynchronous glutamate release only from TRPV1+ synapses. Asynchronous release was proportional to synchronous EPSC amplitude, activity, and calcium entry. TRPV1 antagonists and low temperature blocked asynchronous release, but not evoked EPSCs. At physiological afferent frequencies, asynchronous release strongly potentiated the duration of postsynaptic spiking. This activity-dependent TPRV1-mediated facilitation is a form of synaptic plasticity that brings a unique central integrative feature to the CNS and autonomic regulation.	[Peters, James H.; McDougall, Stuart J.; Fawley, Jessica A.; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Smith, Stephen M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Andresen, MC (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA.	andresen.ohsu@gmail.com	McDougall, Stuart/J-8310-2012	Andresen, Michael/0000-0003-0524-1172; Smith, Stephen/0000-0002-0331-7615; McDougall, Stuart/0000-0002-8778-675X; Fawley, Jessica/0000-0002-8723-6096	National Institutes of Health, U.S.A; National Health and Medical Research Council of Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083115, F32HL088894, R01HL105703, R01HL041119] Funding Source: NIH RePORTER	National Institutes of Health, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Craig Jahr for comments on an early version of the manuscript. J.H.P., J.A.F., S.M.S., and M.C.A. are funded by the National Institutes of Health, U.S.A. S.J.M. is funded by the National Health and Medical Research Council of Australia. The authors declare no competing financial interests.	Andresen MC, 2004, BRAZ J MED BIOL RES, V37, P549, DOI 10.1590/S0100-879X2004000400012; Andresen MC, 2008, AM J PHYSIOL-HEART C, V295, pH2032, DOI 10.1152/ajpheart.00568.2008; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bailey TW, 2006, J NEUROSCI, V26, P6131, DOI 10.1523/JNEUROSCI.5176-05.2006; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chen CF, 1999, J NEUROSCI, V19, P6257; COLERIDGE JCG, 1984, REV PHYSIOL BIOCH P, V99, P1, DOI 10.1007/BFb0027715; Cummings DD, 1996, J NEUROSCI, V16, P5312; Doyle MW, 2002, J NEUROSCI, V22, P8222; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Fan W, 1999, AM J PHYSIOL-REG I, V277, pR748, DOI 10.1152/ajpregu.1999.277.3.R748; Fan W, 1998, AM J PHYSIOL-HEART C, V275, pH632, DOI 10.1152/ajpheart.1998.275.2.H632; FORTIN G, 1993, BRAIN RES, V630, P125, DOI 10.1016/0006-8993(93)90650-C; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Kline DD, 2009, J NEUROPHYSIOL, V101, P2270, DOI 10.1152/jn.91304.2008; Kline DD, 2005, J NEUROSCI, V25, P3389, DOI 10.1523/JNEUROSCI.4556-04.2005; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Li BY, 2007, NEUROSCI LETT, V421, P62, DOI 10.1016/j.neulet.2007.05.036; Loewy AD., 1990, CENTRAL REGULATION A, P88; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; McDougall SJ, 2009, J NEUROSCI, V29, P12886, DOI 10.1523/JNEUROSCI.3491-09.2009; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; MENDELOWITZ D, 1995, J NEUROPHYSIOL, V73, P872, DOI 10.1152/jn.1995.73.2.872; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Paxinos GWC, 2007, RAT BRAIN STEREOTAXI; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith BN, 1998, J PHYSIOL-LONDON, V512, P149, DOI 10.1111/j.1469-7793.1998.149bf.x; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Swanson DM, 2005, J MED CHEM, V48, P1857, DOI 10.1021/jm0495071; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Yao J, 2009, BIOPHYS J, V96, P3611, DOI 10.1016/j.bpj.2009.02.016	51	137	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					657	669		10.1016/j.neuron.2010.02.017	http://dx.doi.org/10.1016/j.neuron.2010.02.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223201	Bronze, Green Accepted			2022-12-17	WOS:000275758000009
J	Busse, L; Wade, AR; Carandini, M				Busse, Laura; Wade, Alex R.; Carandini, Matteo			Representation of Concurrent Stimuli by Population Activity in Visual Cortex	NEURON			English	Article							CONTRAST-RESPONSE FUNCTION; AREA MT; STRIATE CORTEX; SIMPLE CELLS; HUMAN-VISION; ORIENTATION SELECTIVITY; ATTENTIONAL MODULATION; NEURONAL RESPONSES; SPATIAL SUMMATION; RECEPTIVE-FIELDS	How do neuronal populations represent concurrent stimuli? We measured population responses in cat primary visual cortex (V1) using electrode arrays. Population responses to two superimposed gratings were weighted sums of the individual grating responses. The weights depended strongly on the relative contrasts of the gratings. When the contrasts were similar, the population performed an approximately equal summation. When the contrasts differed markedly, however, the population performed approximately a winner-take-all competition. Stimuli that were intermediate to these extremes elicited intermediate responses. This entire range of behaviors was explained by a single model of contrast normalization. Normalization captured both the spike responses and the local field potential responses; it even predicted visually evoked currents source-localized to V1 in human subjects. Normalization has profound effects on V1 population responses and is likely to shape the interpretation of these responses by higher cortical areas.	[Busse, Laura; Carandini, Matteo] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Busse, Laura; Wade, Alex R.; Carandini, Matteo] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Wade, Alex R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94117 USA	University of London; University College London; The Smith-Kettlewell Eye Research Institute; University of California System; University of California San Francisco	Busse, L (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	laura.busse@cin.uni-tuebingen.de	Carandini, Matteo/ABD-8296-2021; Wade, Alex/B-5473-2010	Carandini, Matteo/0000-0003-4880-7682; Wade, Alexander Robert/0000-0003-4871-2747	National Institutes of Health [EY-17396, EY-18157]; UK charity Fight for Sight; European Research Council; German Academy of Sciences Leopoldina [BMBF-LPD9901/8-165]; NATIONAL EYE INSTITUTE [R01EY018157, R01EY017396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK charity Fight for Sight; European Research Council(European Research Council (ERC)European Commission); German Academy of Sciences Leopoldina; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to S. Katzner and A. Benucci for help with the experiments in cat, J. Rowland for help with the experiments in humans, and D. Fitzpatrick and S. MacEvoy for helpful discussions. This work was supported by National Institutes of Health (grants EY-17396 to M.C. and EY-18157 to A.R.W.), by a Project Grant from the UK charity Fight for Sight (to M.C.), by an Advanced Investigator Award to M.C. from the European Research Council, and by a postdoctoral fellowship of the German Academy of Sciences Leopoldina (BMBF-LPD9901/8-165 to L.B.). M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Appelbaum LG, 2006, J NEUROSCI, V26, P11695, DOI 10.1523/JNEUROSCI.2741-06.2006; Britten KH, 1999, J NEUROSCI, V19, P5074; BURR DC, 1987, J PHYSIOL-LONDON, V389, P1; Candy TR, 2001, J NEUROSCI, V21, P4530, DOI 10.1523/JNEUROSCI.21-12-04530.2001; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Carandini M, 2002, J NEUROSCI, V22, P10053; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heeger DJ., 1991, COMPUTATIONAL MODELS, P119; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; KUMBHANI RD, 2008, 2008 NEUR M PLANN WA; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; MCILWAIN JT, 1986, TRENDS NEUROSCI, V9, P354; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1986, NATURE, V321, P235, DOI 10.1038/321235a0; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Regan D., 1989, HUMAN BRAIN ELECTROP, P70; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2002, J NEUROSCI, V22, P5639; ROSS J, 1991, P ROY SOC B-BIOL SCI, V246, P61, DOI 10.1098/rspb.1991.0125; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Sheliga BM, 2006, VISION RES, V46, P2041, DOI 10.1016/j.visres.2005.11.033; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; STONE LS, 1990, VISION RES, V30, P1049, DOI 10.1016/0042-6989(90)90114-Z; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985	55	137	141	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 24	2009	64	6					931	942		10.1016/j.neuron.2009.11.004	http://dx.doi.org/10.1016/j.neuron.2009.11.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064398	Green Accepted, Bronze			2022-12-17	WOS:000273425800018
J	Saab, BJ; Georgiou, J; Nath, A; Lee, FJS; Wang, M; Michalon, A; Liu, F; Mansuy, IM; Roder, JC				Saab, Bechara J.; Georgiou, John; Nath, Arup; Lee, Frank J. S.; Wang, Min; Michalon, Aubin; Liu, Fang; Mansuy, Isabelle M.; Roder, John C.			NCS-1 in the Dentate Gyrus Promotes Exploration, Synaptic Plasticity, and Rapid Acquisition of Spatial Memory	NEURON			English	Article							LONG-TERM POTENTIATION; NEURONAL CALCIUM SENSOR-1; D2 DOPAMINE-RECEPTOR; PATTERN SEPARATION; PREFRONTAL CORTEX; BINDING-PROTEIN; NMDA RECEPTORS; HIPPOCAMPUS; RAT; CA3	The molecular underpinnings of exploration and its link to learning and memory remain poorly understood. Here we show that inducible, modest overexpression of neuronal calcium sensor 1 (Ncs1) selectively in the adult murine dentate gyrus (DG) promotes a specific form of exploratory behavior. The mice also display a selective facilitation of long-term potentiation (LTP) in the medial perforant path and a selective enhancement in rapid-acquisition spatial memory, phenotypes that are reversed by direct application of a cell-permeant peptide (DNIP) designed to interfere with NCS-1 binding to the dopamine type-2 receptor (D2R). Moreover, the DNIP and the D2R-selective antagonist L-741,626 attenuated exploratory behavior, DG LTP, and spatial memory in control mice. These data demonstrate a role for NCS-1 and D2R in DG plasticity and provide insight for understanding how the DG contributes to the origin of exploration and spatial memory acquisition.	[Saab, Bechara J.; Georgiou, John; Nath, Arup; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Saab, Bechara J.; Roder, John C.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Roder, John C.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lee, Frank J. S.; Wang, Min; Liu, Fang] Ctr Addict & Mental Hlth, Clarke Div, Dept Neurosci, Toronto, ON M5T 1R8, Canada; [Michalon, Aubin] Univ Bordeaux, Ctr Neurosci Integrat & Cognit, Bordeaux, France; [Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; UDICE-French Research Universities; Universite de Bordeaux; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Saab, BJ (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	saab@lunenfeld.ca	Georgiou, John/E-9873-2013; Roder, John/G-6468-2013; Lee, Frank J.S./D-5899-2017; Mansuy, Isabelle M/N-3042-2015; Georgiou, John/ABA-1687-2020	Georgiou, John/0000-0003-4503-6384; Lee, Frank J.S./0000-0002-5768-3776; Mansuy, Isabelle M/0000-0001-7785-5371; Georgiou, John/0000-0003-4503-6384; Michalon, Aubin/0000-0002-5246-4881; Saab, Bechara/0000-0003-1673-129X	CIHR [MOP-13239, CTP-79858]	CIHR(Canadian Institutes of Health Research (CIHR))	We are indebted to Shenna A. Josselyn, Roderick McInnes, Robert Gerlai and Karine Nader for excellent advice on the manuscript. This work was funded by a grant through the CIHR (MOP-13239 and CTP-79858). B.J.S. holds a CIHR doctoral research award. J.G. holds a NARSAD Young Investigator Award. A.N. holds a SLRI Summer Student Fellowship. J.C.R. holds a Tier One CRC Chair in Learning and Memory.	Abe K, 2008, NEUROPHARMACOLOGY, V55, P1419, DOI 10.1016/j.neuropharm.2008.09.005; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bramham CR, 1996, J NEUROSCI, V16, P8123; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cain SW, 2008, NEUROBIOL LEARN MEM, V89, P591, DOI 10.1016/j.nlm.2007.07.011; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Coukell B, 2004, DEV GROWTH DIFFER, V46, P449; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; HETHERINGTON PA, 1990, SEQUENTIAL LEARNING; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; JOYCE JN, 1993, NEUROSCI LETT, V154, P171, DOI 10.1016/0304-3940(93)90199-U; Kabbani N, 2006, NEUROREPORT, V17, P299, DOI 10.1097/01.wnr.0000199460.24412.04; Kabbani N, 2002, J NEUROSCI, V22, P8476; Kandel E.R., 2006, SEARCH MEMORY EMERGE; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; KOVACS GL, 1979, BRAIN RES, V175, P303, DOI 10.1016/0006-8993(79)91009-6; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Rick JT, 1996, HIPPOCAMPUS, V6, P118; Saab BJ, 2007, HYPOTHESIS, V5, P23; SANDNER G, 1987, PHYSIOL BEHAV, V39, P333, DOI 10.1016/0031-9384(87)90231-9; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Setlow B, 2000, LEARN MEMORY, V7, P187, DOI 10.1101/lm.7.3.187; Sigala S, 1997, EUR J PHARMACOL, V336, P107, DOI 10.1016/S0014-2999(97)01235-1; SILVEIRA MCL, 1992, BEHAV NEURAL BIOL, V57, P226, DOI 10.1016/0163-1047(92)90192-7; Souza Bruno R, 2006, Dialogues Clin Neurosci, V8, P95; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TIEDTKE PI, 1990, J NEURAL TRANSM-GEN, V81, P173, DOI 10.1007/BF01245040; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Valentinuzzi VS, 2008, NEUROBIOL LEARN MEM, V89, P604, DOI 10.1016/j.nlm.2007.08.002; Wang CY, 2001, NEURON, V32, P99, DOI 10.1016/S0896-6273(01)00434-2; Weinshenker D, 2008, NATURE, V455, P607, DOI 10.1038/455607a; Wilkerson A, 1999, NEUROSCIENCE, V89, P743, DOI 10.1016/S0306-4522(98)00346-7	67	137	145	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 10	2009	63	5					643	656		10.1016/j.neuron.2009.08.014	http://dx.doi.org/10.1016/j.neuron.2009.08.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755107	Bronze			2022-12-17	WOS:000269852300011
J	Samuels, IS; Saitta, SC; Landreth, GE				Samuels, Ivy S.; Saitta, Sulagna C.; Landreth, Gary E.			MAP'ing CNS Development and Cognition: An ERKsome Process	NEURON			English	Review							ACTIVATED PROTEIN-KINASE; 22Q11.2 DELETION SYNDROME; FIBROBLAST-GROWTH-FACTOR; HIPPOCAMPAL VOLUME REDUCTION; OF-FUNCTION MUTATIONS; NOONAN-SYNDROME; SIGNAL-TRANSDUCTION; DIGEORGE-SYNDROME; IN-VIVO; CORTICAL NEUROGENESIS	The ERK MAP kinase signaling cascade plays critical roles in brain development, learning, memory, and cognition. It has recently been appreciated that mutation or deletion of elements within this signaling pathway leads to developmental syndromes in humans that are associated with impaired cognitive function and autism. Here, we review recent studies that provide insight into the biological roles of the ERKs in the brain that may underlie the cognitive deficits seen in these syndromes.	[Samuels, Ivy S.; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Samuels, Ivy S.] Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44195 USA; [Samuels, Ivy S.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH 44106 USA; [Saitta, Sulagna C.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Landreth, GE (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	gel2@case.edu			NIMH NIH HHS [F31 MH074241] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH074241] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Antshel KM, 2005, CHILD NEUROPSYCHOL, V11, P5, DOI 10.1080/09297040590911185; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Christen B, 1999, DEVELOPMENT, V126, P119; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Debbane M, 2006, NEUROPSYCHOLOGIA, V44, P2360, DOI 10.1016/j.neuropsychologia.2006.05.006; DeBoer T, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-54; Delrue MA, 2003, AM J MED GENET A, V123A, P301, DOI 10.1002/ajmg.a.20330; Denayer E, 2008, J MED GENET, V45, P695, DOI 10.1136/jmg.2007.055772; Descheemaeker MJ, 2004, AM J MED GENET A, V131A, P325, DOI 10.1002/ajmg.a.30346; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; ENGEL SR, 2008, PSYCHIATRY IN PRESS, DOI DOI 10.1038/SJ.MP.4002135; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Ferguson SM, 2006, NEUROPSYCHOPHARMACOL, V31, P2660, DOI 10.1038/sj.npp.1301014; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; Frank DU, 2002, DEVELOPMENT, V129, P4591; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Inglis-Broadgate SL, 2005, DEV BIOL, V279, P73, DOI 10.1016/j.ydbio.2004.11.035; Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee DA, 2005, DEV MED CHILD NEUROL, V47, P35, DOI 10.1017/S00121622050006X; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; NEWBERN J, 2008, P NATL ACAD IN PRESS; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Paquin A, 2005, J NEUROSCI, V25, P10747, DOI 10.1523/JNEUROSCI.2662-05.2005; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Rauch A, 1999, AM J HUM GENET, V64, P659, DOI 10.1086/302235; Rauen KA, 2007, CLIN GENET, V71, P101, DOI 10.1111/j.1399-0004.2007.00743.x; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Saitta SC, 1999, AM J HUM GENET, V65, P562, DOI 10.1086/302514; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Schaer M, 2006, PSYCHIAT RES-NEUROIM, V146, P1, DOI 10.1016/j.pscychresns.2005.10.002; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Shalin SC, 2006, PROG BRAIN RES, V157, P25, DOI 10.1016/S0079-6123(06)57003-7; Shin DM, 2004, J NEUROSCI, V24, P2247, DOI 10.1523/JNEUROSCI.5285-03.2004; Shinya M, 2001, DEVELOPMENT, V128, P4153; Simon TJ, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-25; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomson RE, 2007, J NEUROCHEM, V100, P1565, DOI 10.1111/j.1471-4159.2006.04285.x; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto S, 2005, P NATL ACAD SCI USA, V102, P15983, DOI 10.1073/pnas.0507961102; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yntema HG, 1999, GENOMICS, V62, P332, DOI 10.1006/geno.1999.6004; Yoshida R, 2004, J CLIN ENDOCR METAB, V89, P3359, DOI 10.1210/jc.2003-032091; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	77	137	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 29	2009	61	2					160	167		10.1016/j.neuron.2009.01.001	http://dx.doi.org/10.1016/j.neuron.2009.01.001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	407EY	19186160	Bronze, Green Accepted			2022-12-17	WOS:000263347600004
J	Cang, JH; Kaneko, M; Yamada, J; Woods, G; Stryker, MP; Feldheim, DA				Cang, JH; Kaneko, M; Yamada, J; Woods, G; Stryker, MP; Feldheim, DA			Ephrin-As guide the formation of functional maps in the visual cortex	NEURON			English	Article							THALAMOCORTICAL PROJECTIONS; GENE-TRANSFER; MULTIPLE ROLES; CORTICAL AREAS; RECEPTORS; NEOCORTEX; SPECIFICATION; EMX2; MECHANISMS; GUIDANCE	Ephrin-As and their receptors, EphAs, are expressed in the developing cortex where they may act to organize thalamic inputs. Here, we map the visual cortex (V1) in mice deficient for ephrin-A2, -A3, and -A5 functionally, using intrinsic signal optical imaging and microelectrode recording, and structurally, by anatomical tracing of thalamocortical projections. V1 is shifted medially, rotated, and compressed and its internal organization is degraded. Expressing ephrin-A5 ectopically by in utero electroporation in the lateral cortex shifts the map of V1 medially, and expression within V1 disrupts its internal organization. These findings indicate that interactions between gradients of EphA/ephrin-A in the cortex guide map formation, but that factors other than redundant ephrin-As are responsible for the remnant map. Together with earlier work on the retinogeniculate map, the current findings show that the same molecular interactions may operate at successive stages of the visual pathway to organize maps.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu; feldheim@biology.ucsc.edu		Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [EY02874, R01 EY014689, R37 EY002874, R01 EY002874, EY014689, R37 EY002874-24S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874, R01EY014689, R01EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hashimoto M, 2004, J NEUROSCI, V24, P286, DOI 10.1523/JNEUROSCI.2529-03.2004; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Molnar Z, 1998, J NEUROSCI, V18, P5723; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Shimogori T, 2005, J NEUROSCI, V25, P6550, DOI 10.1523/JNEUROSCI.0453-05.2005; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Uziel D, 2002, J NEUROSCI, V22, P9352; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	49	137	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					577	589		10.1016/j.neuron.2005.10.026	http://dx.doi.org/10.1016/j.neuron.2005.10.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301175	Bronze, Green Accepted			2022-12-17	WOS:000233677300012
J	Haynes, JD; Driver, J; Rees, G				Haynes, JD; Driver, J; Rees, G			Visibility reflects dynamic changes of effective connectivity between V1 and fusiform cortex	NEURON			English	Article							PRIMARY VISUAL-CORTEX; HUMAN OCCIPITAL CORTEX; STRIATE CORTEX; HUMAN BRAIN; METACONTRAST MASKING; BACKWARD-MASKING; FEEDBACK CONNECTIONS; COGNITIVE-PROCESSES; DISTINCT MODES; MONKEY	Identifying the neural basis of visibility is central to understanding conscious visual perception. Visibility of basic features such as brightness is often thought to reflect activity in just early visual cortex. But here we show under metacontrast masking that fMRI activity in stimulus-driven areas of early visual cortex did not reflect parametric changes in the visibility of a brightness stimulus. The psychometric visibility function was instead correlated with activity in later visual regions plus parieto-frontal areas, and surprisingly, in representations of the unstimulated stimulus surround for primary visual cortex. Critically, decreased stimulus visibility was associated with a regionally-specific decoupling between early visual cortex and higher visual areas. This provides evidence that dynamic changes in effective connectivity can closely reflect visual perception.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; UCL, Neurol Inst, London WC1N 3BG, England; Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany	University of London; University College London; University of London; University College London; University of London; University College London; Otto von Guericke University	Haynes, JD (corresponding author), UCL, Inst Cognit Neurosci, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008; Driver, Jon/A-4779-2010	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007; 	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BRIDGEMAN B, 1975, VISION RES, V15, P91, DOI 10.1016/0042-6989(75)90065-6; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Francis G, 2000, PSYCHOL REV, V107, P768, DOI 10.1037/0033-295X.107.4.768; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Green MF, 2005, J COGNITIVE NEUROSCI, V17, P13, DOI 10.1162/0898929052880011; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2003, J NEUROPHYSIOL, V89, P2655, DOI 10.1152/jn.00820.2002; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Macknik SL, 1999, P NATL ACAD SCI USA, V96, P15208, DOI 10.1073/pnas.96.26.15208; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; RAMACHANDRAN VS, 1995, NATURE, V373, P66, DOI 10.1038/373066a0; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; ROCKLAND KS, 1994, VISUAL NEUROSCI, V11, P579, DOI 10.1017/S0952523800002480; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; VAUGHAN HG, 1968, SCIENCE, V160, P207, DOI 10.1126/science.160.3824.207; vonderHeydt R, 1997, INVEST OPHTH VIS SCI, V38, P2146; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	57	137	142	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 2	2005	46	5					811	821		10.1016/j.neuron.2005.05.012	http://dx.doi.org/10.1016/j.neuron.2005.05.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924866	Bronze			2022-12-17	WOS:000229689800014
J	Huang, Y; Man, HY; Sekine-Aizawa, Y; Han, YF; Juluri, K; Luo, HB; Cheah, J; Lowenstein, C; Huganir, RL; Snyder, SH				Huang, Y; Man, HY; Sekine-Aizawa, Y; Han, YF; Juluri, K; Luo, HB; Cheah, J; Lowenstein, C; Huganir, RL; Snyder, SH			S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors	NEURON			English	Article							LONG-TERM DEPRESSION; REFLECTION FLUORESCENCE MICROSCOPY; CULTURED HIPPOCAMPAL-NEURONS; NITRIC-OXIDE; SYNAPTIC PLASTICITY; ACTIVATION; NSF; GLUR2; TRAFFICKING; EXOCYTOSIS	Postsynaptic AMPA receptor (AMPAR) trafficking mediates some forms of synaptic plasticity that are modulated by NMDA receptor (NMDAR) activation and N-ethylmaleimide sensitive factor (NSF). We report that NSF is physiologically S-nitrosylated by endogenous, neuronally derived nitric oxide (NO). S-nitrosylation of NSF augments its binding to the AMPAR GluR2 subunit. Surface insertion of GluR2 in response to activation of synaptic NMDARs requires endogenous NO, acting selectively upon the binding of NSF to GluR2. Thus, AMPAR recycling elicited by NMDA neurotransmission is mediated by a cascade involving NMDA activation of neuronal NO synthase to form NO, leading to S-nitrosylation of NSF which is thereby activated, enabling it to bind to GluR2 and promote the receptor's surface expression.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@bs.jhmi.edu		Lowenstein, Charles/0000-0003-0485-7514	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00266, DA-00074] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2003, NEUROSCI RES, V47, P3, DOI 10.1016/S0168-0102(03)00160-3; Dingledine R, 1999, PHARMACOL REV, V51, P7; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Ishizuka Y, 2000, BRAIN RES, V862, P17, DOI 10.1016/S0006-8993(00)02061-8; Jaffrey SR, 2002, CHEM BIOL, V9, P1329, DOI 10.1016/S1074-5521(02)00293-4; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kim KA, 2002, J NEUROSCI RES, V69, P268, DOI 10.1002/jnr.10296; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Newman ME, 1998, J ECT, V14, P153; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Wilson M, 2003, NEURON, V37, P728, DOI 10.1016/S0896-6273(03)00121-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	42	137	140	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					533	540		10.1016/j.neuron.2005.03.028	http://dx.doi.org/10.1016/j.neuron.2005.03.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944123	Bronze			2022-12-17	WOS:000229294300006
J	Nair, KS; Hanson, SM; Mendez, A; Gurevich, EV; Kennedy, MJ; Shestopalov, VI; VlshnivetskLy, SA; Chen, J; Hurley, JB; Gurevich, VV; Slepak, VZ				Nair, KS; Hanson, SM; Mendez, A; Gurevich, EV; Kennedy, MJ; Shestopalov, VI; VlshnivetskLy, SA; Chen, J; Hurley, JB; Gurevich, VV; Slepak, VZ			Light-dependent redistribution of arrestin in vertebrate rods is an energy-independent process governed by protein-protein interactions	NEURON			English	Article							VISUAL ARRESTIN; RHODOPSIN PHOSPHORYLATION; MULTIPLE PHOSPHORYLATION; PHOTORECEPTOR CELLS; S-ANTIGEN; BINDING; TRANSLOCATION; SELECTIVITY; ADAPTATION; TRANSDUCIN	In rod photoreceptors, arrestin localizes to the outer segment (OS) in the light and to the inner segment (IS) in the dark. Here, we demonstrate that redistribution of arrestin between these compartments can proceed in ATP-depleted photoreceptors. Translocation of transducin from the IS to the OS also does not require energy, but depletion of ATP or GTP inhibits its reverse movement. A sustained presence of activated rhodopsin is required for sequestering arrestin in the OS, and the rate of arrestin relocalization to the OS is determined by the amount and the phosphorylation status of photolyzed rhodopsin. Interaction of arrestin with microtubules is increased in the dark. Mutations that enhance arrestin-microtubule binding attenuate arrestin translocation to the OS. These results indicate that the distribution of arrestin in rods is controlled by its dynamic interactions with rhodopsin in the OS and microtubules in the IS and that its movement occurs by simple diffusion.	Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Neurosci Program, Miami, FL 33136 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of Miami; University of Miami; Vanderbilt University; University of Southern California; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gurevich, VV (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	vsevolod.gurevich@vanderbilt.edu; v.slepak@miami.edu	Méndez, Ana/F-9729-2016; Gurevich, Vsevolod/A-3236-2008	Méndez, Ana/0000-0001-6393-1644; Gurevich, Vsevolod/0000-0002-3950-5351; Shestopalov, Valery/0000-0002-1568-6637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126, R01EY012982, F32EY006641, R01EY012703, R01EY006641, R01EY011500, R01EY012155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628, R01GM063097, R01GM060019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH062651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045117] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485, P30 CA068485] Funding Source: Medline; NEI NIH HHS [R01 EY011500, R01 EY006641, EY012703, F32 EY006641, R01 EY012982-04, R01 EY012703, EY 06641, EY11500, EY08126, EY012155, P30 EY008126, R01 EY012982, R01 EY012155] Funding Source: Medline; NICHD NIH HHS [HD15052, P30 HD015052] Funding Source: Medline; NIDDK NIH HHS [P60 DK020593, P30 DK058404, DK58404, P30 DK020593, DK20593] Funding Source: Medline; NIGMS NIH HHS [GM63097, GM 060019, R01 GM060019-03, T32 GM007628, GM07628, R01 GM060019-02S1, R01 GM060019-05, R01 GM063097, R01 GM060019, R01 GM060019-03S1] Funding Source: Medline; NIMH NIH HHS [MH62651] Funding Source: Medline; NINDS NIH HHS [NS45117, R01 NS045117] Funding Source: Medline; PHS HHS [NEI 012982] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARSHAVSKY VY, 2003, SCI STKE; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; EBREY TG, 1968, VISION RES, V8, P965, DOI 10.1016/0042-6989(68)90071-0; Eckmiller MS, 2000, VISUAL NEUROSCI, V17, P711, DOI 10.1017/S0952523800175054; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HAGINS WA, 1956, NATURE, V177, P989, DOI 10.1038/177989b0; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; HOFMANN KP, 1983, BIOCHIM BIOPHYS ACTA, V725, P60, DOI 10.1016/0005-2728(83)90224-4; HURLEY JB, 1977, NATURE, V270, P540, DOI 10.1038/270540a0; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; MANGINI NJ, 1994, VISUAL NEUROSCI, V11, P561, DOI 10.1017/S0952523800002467; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2003, J NEUROSCI, V23, P3124; Nair KS, 2004, J BIOL CHEM, V279, P41240, DOI 10.1074/jbc.M406768200; NIR I, 1993, EXP EYE RES, V57, P307, DOI 10.1006/exer.1993.1129; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; PUIG J, 1995, FEBS LETT, V362, P185, DOI 10.1016/0014-5793(95)00225-X; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang HB, 2003, MOL VIS, V9, P231	38	137	140	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					555	567		10.1016/j.neuron.2005.03.023	http://dx.doi.org/10.1016/j.neuron.2005.03.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944125	Bronze, Green Accepted			2022-12-17	WOS:000229294300008
J	Fyhn, M; Molden, S; Hollup, S; Moser, MB; Moser, EI				Fyhn, M; Molden, S; Hollup, S; Moser, MB; Moser, EI			Hippocampal neurons responding to first-time dislocation of a target object	NEURON			English	Article							SINGLE UNIT-ACTIVITY; FREELY-MOVING RAT; PLACE CELLS; PYRAMIDAL CELLS; ENSEMBLE CODE; GOAL LOCATION; TASK; SPACE; MEMORY; BACKPROPAGATION	To examine how hippocampal neurons respond to a mismatch between retrieved and actual experience, we trained rats to find a hidden platform at a particular location in an annular watermaze and then moved the platform. Several cells that were silent at the new platform location before the move fired vigorously when the rat found the goal. The new activity was paralleled by reduced discharge in a subset of simultaneously recorded interneurons. The pattern of activity returned toward its original configuration as the rat learned the new location. The activation of specific hippocampal neurons following dislocation of a target object may be essential for synaptic plasticity and adaptive modification of the animal's representation of the environment.	Norwegian Univ Sci & Technol, Neurosci Unit, NO-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Psychol, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Neurosci Unit, NO-7489 Trondheim, Norway.	edvard.moser@svt.ntnu.no						BREESE CR, 1989, J NEUROSCI, V9, P1097; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Deadwyler SA, 1996, J NEUROSCI, V16, P354; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; FRENCH AS, 1971, KYBERNETIK, V8, P165, DOI 10.1007/BF00291117; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Honey RC, 1998, J NEUROSCI, V18, P2226; Kay S. M., 1988, MODERN SPECTRAL ESTI; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MOSER EI, 1994, LEARN MEMORY, V1, P55; Moser EI, 1996, J NEUROSCI, V16, P1247; MULLER RU, 1994, J NEUROSCI, V14, P7235; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Thinus-Blanc C, 1991, Hippocampus, V1, P365, DOI 10.1002/hipo.450010404; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; VINOGRADOVA OS, 1971, SHORT TERM CHANGES N, P95; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Zinyuk L, 2000, P NATL ACAD SCI USA, V97, P3771, DOI 10.1073/pnas.050576397	40	137	138	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					555	566		10.1016/S0896-6273(02)00784-5	http://dx.doi.org/10.1016/S0896-6273(02)00784-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165476	Bronze			2022-12-17	WOS:000177331200015
J	Battelli, L; Cavanagh, P; Intriligator, J; Tramo, MJ; Henaff, MA; Michel, F; Barton, JJS				Battelli, L; Cavanagh, P; Intriligator, J; Tramo, MJ; Henaff, MA; Michel, F; Barton, JJS			Unilateral right parietal damage leads to bilateral deficit for high-level motion	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; FIRST-ORDER MOTION; BRAIN-DAMAGE; APPARENT MOTION; VISUAL EXTINCTION; SELECTIVE IMPAIRMENT; ATTENTIVE TRACKING; 2ND-ORDER MOTION; NEGLECT PATIENTS; SPATIAL NEGLECT	Patients with right parietal damage demonstrate a variety of attentional deficits in their left visual field contralateral to their lesion. We now report that patients with right lesions also show a severe loss in the perception of apparent motion in their "good" right visual field ipsilateral to their lesion. Three tests of attention were conducted, and losses were found only in the contralesional fields for a selective attention and a multiple object tracking task. Losses in apparent motion, however, were bilateral in all cases. The deficit in apparent motion in the parietal patients supports previous claims that this relatively effortless percept is mediated by attention. However, the bilateral deficit suggests that the disruption is due to a bilateral loss in the temporal resolution of attention to transient events that drive the apparent motion percept.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Beth Israel Deaconess Med Ctr, Dept Neurol & Opthalmol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; INSERM, U280, F-69008 Lyon, France	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	Battelli, L (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.		Barton, Jason JS/A-6362-2012		NATIONAL EYE INSTITUTE [R01EY009258] Funding Source: NIH RePORTER; NEI NIH HHS [EY09258] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; ARGUIN M, 1994, BRAIN COGNITION, V24, P44, DOI 10.1006/brcg.1994.1003; Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bellmann A, 2001, BRAIN, V124, P676, DOI 10.1093/brain/124.4.676; BLACK SE, 1990, J CLIN EXPT NEUROPSY, V12, P102; BOULTON JC, 1993, VISION RES, V33, P2013, DOI 10.1016/0042-6989(93)90024-Q; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CAVANAGH P, 1990, J EXP PSYCHOL HUMAN, V16, P479, DOI 10.1037/0096-1523.16.3.479; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Cusack R, 2000, J COGNITIVE NEUROSCI, V12, P1056, DOI 10.1162/089892900563867; DAMASIO H, 1995, HUMAN BRAIN ANATOMY; DICK M, 1991, VISION RES, V31, P2025, DOI 10.1016/0042-6989(91)90197-D; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; GREENLEE MW, 1995, J NEUROSCI, V15, P2287, DOI 10.1523/JNEUROSCI.15-03-02287.1995; Greenlee MW, 1997, J NEUROSCI, V17, P804; Harrington DL, 1998, J NEUROSCI, V18, P1085; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; James W, 1890, PRINCIPLES PSYCHOL, V1; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Lu ZL, 1996, CURR DIR PSYCHOL SCI, V5, P44, DOI 10.1111/1467-8721.ep10772720; MATHER G, 1994, VISUAL DETECTION MOT; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PASCUALLEONE A, 1994, NEUROLOGY, V44, P494, DOI 10.1212/WNL.44.3_Part_1.494; PLANT GT, 1993, BRAIN, V116, P1337, DOI 10.1093/brain/116.6.1337; POSNER MI, 1984, J NEUROSCI, V4, P1863; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; RAMACHANDRAN VS, 1983, VISION RES, V23, P1719, DOI 10.1016/0042-6989(83)90188-8; Reppas JB, 1997, NATURE, V388, P175, DOI 10.1038/40633; RIZZO M, 1995, BRAIN, V118, P1105, DOI 10.1093/brain/118.5.1105; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; ROBERTSON IH, 1999, ATTENTION SPACE ACTI, P297; Robertson L, 1997, J COGNITIVE NEUROSCI, V9, P295, DOI 10.1162/jocn.1997.9.3.295; Rorden C, 1997, NEUROPSYCHOLOGIA, V35, P421, DOI 10.1016/S0028-3932(96)00093-0; Seiffert AE, 1998, VISION RES, V38, P3569, DOI 10.1016/S0042-6989(98)00035-2; Seiffert AE, 1999, VISION RES, V39, P4172, DOI 10.1016/S0042-6989(99)00129-7; Shulman GL, 1999, J NEUROSCI, V19, P9480; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; SPINELLI D, 1992, NEUROPSYCHOLOGIA, V30, P393, DOI 10.1016/0028-3932(92)90112-Y; TERNUS J, 1938, SOURCE BOOK GESTALT; ULLMAN S, 1978, PERCEPTION, V7, P683, DOI 10.1068/p070683; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Vaina LM, 1998, VISUAL NEUROSCI, V15, P333, DOI 10.1017/S0952523898152082; VAINA LM, 1990, VISUAL NEUROSCI, V5, P353, DOI 10.1017/S0952523800000444; VALLAR G, 1994, J NEUROL NEUROSUR PS, V57, P464, DOI 10.1136/jnnp.57.4.464; Vallar G, 1993, UNILATERAL NEGLECT C, P27; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; Vuilleumier PO, 2000, BRAIN, V123, P1263, DOI 10.1093/brain/123.6.1263; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; YANTIS S, 1993, J EXP PSYCHOL HUMAN, V19, P676, DOI 10.1037/0096-1523.19.3.676; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	62	137	140	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					985	995		10.1016/S0896-6273(01)00536-0	http://dx.doi.org/10.1016/S0896-6273(01)00536-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	504ZT	11754832	Bronze			2022-12-17	WOS:000172886800007
J	Beneken, J; Tu, JC; Xiao, B; Nuriya, M; Yuan, JP; Worley, PF; Leahy, DJ				Beneken, J; Tu, JC; Xiao, B; Nuriya, M; Yuan, JP; Worley, PF; Leahy, DJ			Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition	NEURON			English	Article							WISKOTT-ALDRICH-SYNDROME; METABOTROPIC GLUTAMATE RECEPTORS; VASODILATOR-STIMULATED PHOSPHOPROTEIN; PLECKSTRIN-HOMOLOGY DOMAIN; ACTIN-BASED MOTILITY; POSTSYNAPTIC DENSITY PROTEINS; PROLINE-RICH PEPTIDES; LISTERIA-MONOCYTOGENES; CRYSTAL-STRUCTURES; TYROSINE KINASES	Homer EVH1 (Ena/VASP Homology 1) domains interact with proline-rich motifs in the cytoplasmic regions of group 1 metabotropic glutamate receptors (mGluRs), inositol-1,4,5-trisphosphate receptors (IP3Rs), and Shank proteins. We have determined the crystal structure of the Homer EVH1 domain complexed with a peptide from mGluR (TPPSPF). In contrast to other EVH1 domains, the bound mGluR ligand assumes an unusual conformation in which the side chains of the Ser-Pro tandem are oriented away from the Homer surface, and the Phe forms a unique contact. This unusual binding mode rationalizes conserved features of both Homer and Homer ligands that are not shared by other EVH1 domains. Site-directed mutagenesis confirms the importance of specific Homer residues for ligand binding. These results establish a molecular basis for understanding the biological properties of Homer-ligand complexes.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	leahy@groucho.med.jhmi.edu	Nuriya, Mutsuo/J-5928-2013	Nuriya, Mutsuo/0000-0002-5689-8222; Xiao, Bo/0000-0002-6161-9478				Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Cory GOC, 1996, J IMMUNOL, V157, P3791; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kirchhausen T, 1998, MOL MED TODAY, V4, P300, DOI 10.1016/S1357-4310(98)01268-4; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; KURTZ J, 1956, NATURE, V178, P1066, DOI 10.1038/1781066a0; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nonoyama S, 1998, CURR OPIN IMMUNOL, V10, P407, DOI 10.1016/S0952-7915(98)80113-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Purich DL, 1997, BIOCHEM BIOPH RES CO, V231, P686, DOI 10.1006/bbrc.1997.6158; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Ramesh N, 1999, TRENDS CELL BIOL, V9, P15, DOI 10.1016/S0962-8924(98)01411-1; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Schwarz K, 1996, IMMUNOL TODAY, V17, P496, DOI 10.1016/0167-5699(96)30061-3; She HY, 1997, MOL BIOL CELL, V8, P1709, DOI 10.1091/mbc.8.9.1709; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Stewart DM, 1999, J IMMUNOL, V162, P5019; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P777, DOI 10.1073/pnas.72.3.777; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	74	137	145	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					143	154		10.1016/S0896-6273(00)81145-9	http://dx.doi.org/10.1016/S0896-6273(00)81145-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798399	Bronze			2022-12-17	WOS:000086770500015
J	Reenan, RA; Hanrahan, CJ; Ganetzky, B				Reenan, RA; Hanrahan, CJ; Ganetzky, B			The mle(napts) RNA helicase mutation in Drosophila results in a splicing catastrophe of the para Na+ channel transcript in a region of RNA editing	NEURON			English	Article							MESSENGER-RNA; SECONDARY STRUCTURE; DOSAGE COMPENSATION; NERVE EXCITABILITY; RECEPTOR CHANNELS; MALELESS PROTEIN; X-CHROMOSOME; GENE; MUTANTS; DETERMINANTS	The mle(napts) mutation causes temperature-de pendent blockade of action potentials resulting from decreased abundance of para-encoded Na+ channels. Although maleless (mle) encodes a double-stranded RNA (dsRNA) helicase, exactly how mle(napts) affects para expression remained uncertain. Here, we show that para transcripts undergo adenosine-to-inosine (A-to-I) RNA editing via a mechanism that apparently requires dsRNA secondary structure formation encompassing the edited exon and the downstream intron. In an mle(napts) background, >80% of para transcripts are aberrant, owing to internal deletions that include the edited exon. We propose that the Mle helicase is required to resolve the dsRNA structure and that failure to do so in an mle(napts) background causes exon skipping because the normal splice donor is occluded. These results explain how mle(napts) affects Na+ channel expression and provide new insights into the mechanism of RNA editing.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Connecticut; University of Wisconsin System; University of Wisconsin Madison	Reenan, RA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015390] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43100] Funding Source: Medline; NINDS NIH HHS [NS15390] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Bass BL, 1997, RNA, V3, P947; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chabot B, 1997, MOL CELL BIOL, V17, P1776, DOI 10.1128/MCB.17.4.1776; ENG FJ, 1991, CELL, V65, P797, DOI 10.1016/0092-8674(91)90387-E; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; GANETZKY B, 1984, GENETICS, V108, P897; GANETZKY B, 1982, GENETICS, V100, P597; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P2552, DOI 10.1093/nar/22.13.2552; GOGUEL V, 1993, MOL CELL BIOL, V13, P6841, DOI 10.1128/MCB.13.11.6841; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HONG CS, 1994, J NEUROSCI, V14, P5160; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KERNAN MJ, 1991, CELL, V66, P949, DOI 10.1016/0092-8674(91)90440-A; KHARRAT A, 1995, EMBO J, V14, P3572, DOI 10.1002/j.1460-2075.1995.tb07363.x; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KRAWCZAK M, 1992, HUM GENET, V90, P41; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; LEE CG, 1993, J BIOL CHEM, V268, P16822; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lin J, 1996, RNA, V2, P835; LIU HX, 1995, EMBO J, V14, P377, DOI 10.1002/j.1460-2075.1995.tb07012.x; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Machesky LM, 1998, CURR BIOL, V8, P607, DOI 10.1016/S0960-9822(98)70233-7; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Parkansky N, 1995, SURF COAT TECH, V76, P197, DOI 10.1016/0257-8972(95)02588-X; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Powell J.R., 1997, PROGR PROSPECTS EVOL; Rueter S.M., 1998, MODIFICATION EDITING, P343; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SOLNICK D, 1987, MOL CELL BIOL, V7, P3194, DOI 10.1128/MCB.7.9.3194; STERN M, 1990, GENETICS, V124, P133; THACKERAY JR, 1994, J NEUROSCI, V14, P2569; WU CF, 1978, P NATL ACAD SCI USA, V75, P4047, DOI 10.1073/pnas.75.8.4047; Zaffran S, 1998, DEVELOPMENT, V125, P3571; ZHANG SS, 1995, J BIOL CHEM, V270, P16422, DOI 10.1074/jbc.270.27.16422	43	137	143	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					139	149		10.1016/S0896-6273(00)80878-8	http://dx.doi.org/10.1016/S0896-6273(00)80878-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707979	Bronze			2022-12-17	WOS:000085043200017
J	Schinder, AF; Berninger, B; Poo, MM				Schinder, AF; Berninger, B; Poo, MM			Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation	NEURON			English	Article							LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; CULTURED HIPPOCAMPAL-NEURONS; PAIRED-PULSE FACILITATION; SYNAPTIC TRANSMISSION; CA1 REGION; MONOCULAR DEPRIVATION; TRANSMITTER RELEASE; CORTICAL-NEURONS; DENDRITIC GROWTH	The role of the target cell in neurotrophin-induced modifications of glutamatergic synaptic transmission was examined in cultured hippocampal neurons. Brain-derived neurotrophic factor (BDNF) induced rapid and persistent potentiation of evoked glutamate release when the postsynaptic neuron was glutamatergic, or excitatory (E-->E), but not when it was GABAergic, or inhibitory (E-->I). This target-specific action of BDNF was also found at divergent outputs of a single presynaptic neuron innervating both glutamatergic and GABAergic neurons, suggesting that individual terminals can be independently modified. Surprisingly, BDNF increased the frequency of miniature postsynaptic currents at both E-->E and E-->I, although it had no effect on evoked currents at E-->I. Finally, potentiation by neurotrophin-3 (NT-3) was also target specific. The selective effect at E-->E suggests that retrograde signaling by the postsynaptic target cell endows a localized presynaptic action of neurotrophins.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Poo, MM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782; Schinder, Alejandro/0000-0003-4863-8348	NINDS NIH HHS [NS37831] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaneya Y, 1997, J NEUROSCI, V17, P6707; Baldelli P, 1999, EUR J NEUROSCI, V11, P1127, DOI 10.1046/j.1460-9568.1999.00523.x; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Berninger B, 1999, LEARN MEMORY, V6, P232; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Binder DK, 1999, J NEUROSCI, V19, P1424; Bloechl A., 1995, European Journal of Neuroscience, V7, P1220; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; Horch HW, 1999, NEURON, V23, P353; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Lessmann V, 1998, NEUROSCIENCE, V86, P399; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Ming GL, 1997, J NEUROSCI, V17, P7860; Morimoto T, 1998, NEUROSCIENCE, V82, P969; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Rocamora N, 1996, J NEUROSCI, V16, P3991; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; SAKMANN B, 1998, CENTRAL SYNAPSES QUA, P64; SCHINDER AF, 1993, FEBS LETT, V332, P44, DOI 10.1016/0014-5793(93)80480-I; SEELEY PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2789, DOI 10.1073/pnas.80.9.2789; Sherwood NT, 1999, J NEUROSCI, V19, P7025, DOI 10.1523/JNEUROSCI.19-16-07025.1999; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Tanaka T, 1997, J NEUROSCI, V17, P2959; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Wang X, 1998, WORLD J GASTROENTERO, V4, P18, DOI 10.3748/wjg.v4.i1.18; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	77	137	140	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	2000	25	1					151	163		10.1016/S0896-6273(00)80879-X	http://dx.doi.org/10.1016/S0896-6273(00)80879-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279KP	10707980	Bronze			2022-12-17	WOS:000085043200018
J	Burke, NV; Han, WP; Li, DQ; Takimoto, K; Watkins, SC; Levitan, ES				Burke, NV; Han, WP; Li, DQ; Takimoto, K; Watkins, SC; Levitan, ES			Neuronal peptide release is limited by secretory granule mobility	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; ATRIAL-NATRIURETIC-FACTOR; ADRENAL CHROMAFFIN CELLS; PC12 CELLS; SENSITIVITY; EXOCYTOSIS; EXPRESSION; ATP	Neuropeptides are slowly released from a limited pool of secretory granules. To visualize this process, GFP-tagged preproatrial natriuretic factor (ANF) was expressed in nerve growth factor-treated PC12 cells. Biochemical and microfluorimetric experiments demonstrate that proANF-EGFP is packaged in granules that accumulate at neurite endings and is released in a Ca2+-dependent manner by secretagogs. Confocal microscopy shows that secretion is associated with depletion of granules distributed throughout the terminal. Fluorescence recovery after photobleaching and time-lapse particle tracking reveal that only a subpopulation of cytoplasmic secretory granules, similar in size to the releasable pool, can move quickly enough (D = 6 x 10(-11) cm(2)/s) to support release. Therefore, sustained secretory responses are limited by the number of mobile granules and their slow rate of diffusion.	UNIV PITTSBURGH,DEPT PHARMACOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT CELL BIOL & PHYSIOL,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Oka, Yoshitaka/C-9670-2010; Watkins, Simon/ABG-2590-2021	Oka, Yoshitaka/0000-0002-3482-3051; Watkins, Simon/0000-0003-4092-1552	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32385] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANERJEE A, 1993, NEUROSCI LETT, V164, P93, DOI 10.1016/0304-3940(93)90865-I; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; FELDMAN EL, 1981, J NEUROBIOL, V12, P591, DOI 10.1002/neu.480120607; Gutierrez LM, 1997, J BIOL CHEM, V272, P2634, DOI 10.1074/jbc.272.5.2634; HUANG WQ, 1991, ENDOCRINOLOGY, V128, P2591, DOI 10.1210/endo-128-5-2591; LAETHER C, 1995, FEBS LETT, V369, P267; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; MAJID MA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P283, DOI 10.1016/0167-4889(92)90118-U; Patterson G. H., 1996, Biophysical Journal, V70, pA426; PEPPERS SC, 1986, J BIOL CHEM, V261, P4665; RIVAS RJ, 1989, J CELL BIOL, V109, P51, DOI 10.1083/jcb.109.1.51; SEI CA, 1992, MOL ENDOCRINOL, V6, P309, DOI 10.1210/me.6.3.309; SEIDMAN CE, 1984, SCIENCE, V225, P324, DOI 10.1126/science.6234658; SHIELDS PP, 1990, J BIOL CHEM, V265, P10905; SHIONO S, 1991, BIOCHEM BIOPH RES CO, V176, P1232, DOI 10.1016/0006-291X(91)90417-6; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; TERRY BR, 1995, BIOCHEM BIOPH RES CO, V217, P21, DOI 10.1006/bbrc.1995.2740; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	24	137	139	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1095	1102		10.1016/S0896-6273(00)80400-6	http://dx.doi.org/10.1016/S0896-6273(00)80400-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390522	Bronze			2022-12-17	WOS:A1997YH59400016
J	Williams, BP; Park, JK; Alberta, JA; Muhlebach, SG; Hwang, GY; Roberts, TM; Stiles, CD				Williams, BP; Park, JK; Alberta, JA; Muhlebach, SG; Hwang, GY; Roberts, TM; Stiles, CD			A PDGF-regulated immediate early gene response initiates neuronal differentiation in ventricular zone progenitor cells	NEURON			English	Article							RAT CEREBRAL-CORTEX; C-FOS GENE; GROWTH-FACTOR RECEPTOR; CENTRAL-NERVOUS-SYSTEM; ACHAETE-SCUTE HOMOLOG; PRECURSOR CELL; OPTIC-NERVE; STEM-CELLS; EXPRESSION; LINEAGE	When exposed to platelet-derived growth factor (PDGF), uncommitted neuroepithelial cells from the developing cortex of embryonic day 14 (E14) rats develop into neurons. Outward signs of the neuronal phenotype are not observed for 4 days following exposure to PDGF. However, only a brief (23 hr) period of PDGF receptor activation is required to initiate neuronal development. During the window of receptor activation, RNA synthesis is essential, but protein synthesis is not. These observations indicate that specification of neuronal fate is mediated by an immediate early gene response.	HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOL GENET,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH MED,DEPT PATHOL,CAMBRIDGE,MA 02138; DANA FARBER CANC INST,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT NEUROSURG,BOSTON,MA 02115; CHILDRENS HOSP,BOSTON,MA 02115	Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital				Williams, Brenda Patricia/0000-0003-4690-5932				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BANGALORE L, 1992, P NATL ACAD SCI USA, V89, P11637, DOI 10.1073/pnas.89.23.11637; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOSTROM H, 1996, CELL, V85, P1; BOWENPOPE DF, 1991, TRENDS GENET, V7, P413, DOI 10.1016/0168-9525(91)90222-C; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; EPSTEIN RJ, 1992, P NATL ACAD SCI USA, V89, P10435, DOI 10.1073/pnas.89.21.10435; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GROVE EA, 1993, DEVELOPMENT, V117, P553; HELDIN CH, 1993, GROWTH FACTORS, V8, P245, DOI 10.3109/08977199308991570; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; JAKOBOVITS EB, 1984, CELL, V38, P757, DOI 10.1016/0092-8674(84)90271-X; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mountcastle V., 1978, MINDFUL BRAIN; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; OGAWA M, 1993, BLOOD, V81, P2844; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAEDLER E, 1980, ANAT EMBRYOL, V158, P253, DOI 10.1007/BF00301816; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REDDY UR, 1992, J NEUROSCI RES, V31, P670, DOI 10.1002/jnr.490310411; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; SMART I, 1978, NEOSTRIATUM; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SONYANG Z, 1993, CELL, V72, P767; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; WOOD PM, 1984, ADV NEUROCHEM, P1; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221	62	137	144	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					553	562		10.1016/S0896-6273(00)80297-4	http://dx.doi.org/10.1016/S0896-6273(00)80297-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136765	Bronze			2022-12-17	WOS:A1997WW62600005
J	Naranjo, D; Miller, C				Naranjo, D; Miller, C			A strongly interacting pair of residues on the contact surface of charybdotoxin and a Shaker K+ channel	NEURON			English	Article							POTASSIUM CHANNELS; BINDING-SITE; BLOCKING PEPTIDE; TETRAETHYLAMMONIUM; PORE; INACTIVATION; INHIBITOR; MUTANTS; ION	Charybdotoxin, a peptide neurotoxin of known molecular structure, blocks Shaker K+ channels by binding to a receptor at the outer opening of the ion conduction pathway. Analysis of variants of CTX at position 29 and of Shaker at position 449 shows that these two residues interact closely in the channel-toxin complex. The CTX mutation M29I leads to a slight strengthening of block when tested on Shaker-449T; the same CTX mutation weakens block 1700-fold when tested on Shaker-449F. The known position of CTX-29 on the toxin's interaction surface thus locates Shaker-449 within 5 Angstrom of the pore axis of the closed channel. All four subunits must carry the 449F mutation to produce a highly toxin-insensitive channel.			Naranjo, D (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.			Naranjo, David/0000-0003-3482-5126	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031768, R01GM031768] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-31768] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; FERNANDEZ I, 1994, BIOCHEMISTRY-US, V33, P14256, DOI 10.1021/bi00251a038; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8185; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1016/S0022-2836(95)80064-6; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509	32	137	138	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					123	130		10.1016/S0896-6273(00)80029-X	http://dx.doi.org/10.1016/S0896-6273(00)80029-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562075	Bronze			2022-12-17	WOS:A1996TT30700015
J	KIOUSSI, C; GROSS, MK; GRUSS, P				KIOUSSI, C; GROSS, MK; GRUSS, P			PAX3 - A PAIRED DOMAIN GENE AS A REGULATOR IN PNS MYELINATION	NEURON			English	Article							FORMING SCHWANN-CELLS; DNA-BINDING PROTEIN; MOUSE NEURAL-TUBE; N-CAM; SCIATIC-NERVE; BASIC-PROTEIN; MUTANT MOUSE; EXPRESSION; RECEPTOR; DIFFERENTIATION	Pax3 RNA is expressed in neural crest when Schwann cell (SC) precursors migrate to the PNS. Pax3 RNA and SC markers were monitored in sciatic nerves of mice during development and nerve repair. An inverse correlation was observed between expression of Pax3 RNA and myelin basic protein (MBP). Inverse correlation was also observed in SC primary cultures. Treating cultures with forskolin, an adenylate cyclase agonist, repressed Pax3 RNA, GFAP, NGFR, N-CAM, and L1 and elevated MBP. Subsequent microinjection with Pax3 expression vector elevated Pax3 RNA, GFAP, NGFR, N-CAM, and L1 and repressed MBP. Thus, Pax3 is likely involved in the differentiation pathway to myelinating SCs. Pax3 repressed a 1.3 kb MBP promoter fragment in cotransfection assays, suggesting that it represses MBP transcription.			KIOUSSI, C (corresponding author), MAX PLANCK INST BIOPHYS CHEM,MOLEK ZELLBIOL ABT,D-37077 GOTTINGEN,GERMANY.			Kioussi, Chrissa/0000-0001-8226-9908				BHARUCHA VA, 1994, NEURON, V12, P627, DOI 10.1016/0896-6273(94)90218-6; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; EDELMAN GM, 1992, TRENDS BIOCHEM SCI, V17, P228, DOI 10.1016/0968-0004(92)90383-K; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FRANZ T, 1990, ACTA ANAT, V138, P246; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HERMAN MA, 1993, DEV BIOL, V161, P477; JESSEN KR, 1987, J NEUROCYTOL, V16, P681, DOI 10.1007/BF01637659; JESSEN KR, 1990, DEVELOPMENT, V109, P91; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; KIOUSSI C, 1992, NEUROSCIENCE, V50, P69, DOI 10.1016/0306-4522(92)90382-C; KIOUSSI C, 1994, J CELL BIOL, V125, P417, DOI 10.1083/jcb.125.2.417; KNIPPER M, 1993, FEBS LETT, V324, P145; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MATSUSHIMA H, 1993, MOL CELL BIOL, V13, P7447, DOI 10.1128/MCB.13.12.7447; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MIRSKY R, 1990, DEVELOPMENT, V109, P105; MIRSKY R, 1990, SEMINARS NEUROSCIENC, V2, P423; MIURA M, 1989, GENE, V75, P31; MOASE CE, 1990, TERATOLOGY, V42, P171, DOI 10.1002/tera.1420420208; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; OKANO H, 1988, EMBO J, V7, P77, DOI 10.1002/j.1460-2075.1988.tb02785.x; Ritchie J.M., 1984, PERIPHERAL NEUROPATH, P117; SCHERER SS, 1994, J NEUROSCI, V14, P1930; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; STUART ET, 1995, CLIN CANCER RES, V1, P207; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TANIUCHI M, 1988, J NEUROSCI, V8, P664; TRAPP BD, 1988, J NEUROSCI, V8, P3515; WEBSTER HD, 1984, PERIPHERAL NEUROPATH, P329	38	137	138	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1995	15	3					553	562		10.1016/0896-6273(95)90144-2	http://dx.doi.org/10.1016/0896-6273(95)90144-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RV945	7546735	Bronze, Green Published			2022-12-17	WOS:A1995RV94500009
J	MOORMAN, JR; KIRSCH, GE; VANDONGEN, AMJ; JOHO, RH; BROWN, AM				MOORMAN, JR; KIRSCH, GE; VANDONGEN, AMJ; JOHO, RH; BROWN, AM			FAST AND SLOW GATING OF SODIUM-CHANNELS ENCODED BY A SINGLE MESSENGER-RNA	NEURON			English	Article									BAYLOR UNIV,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor University	MOORMAN, JR (corresponding author), UNIV TEXAS,MED BRANCH,DEPT MED,GALVESTON,TX 77550, USA.		Moorman, J Randall/ABG-9946-2020	VanDongen, Antonius/0000-0002-9923-3407	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023877] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36930] Funding Source: Medline; NINDS NIH HHS [NS-23877] Funding Source: Medline; PHS HHS [KL-01858] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARRES BA, 1989, NEURON, V2, P1375, DOI 10.1016/0896-6273(89)90076-7; BAUD C, 1982, P NATL ACAD SCI-BIOL, V79, P3188, DOI 10.1073/pnas.79.10.3188; BROWN AM, 1981, J PHYSIOL-LONDON, V318, P455; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; GRANT AO, 1987, CIRC RES, V60, P897, DOI 10.1161/01.RES.60.6.897; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1988, CURR TOP MEMBR TRANS, V33, P289; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HORN R, 1984, BIOPHYS J, V45, P323, DOI 10.1016/S0006-3495(84)84158-2; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; JOHO RH, 1990, IN PRESS MOL BRAIN R; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KIRSCH GE, 1989, J GEN PHYSIOL, V93, P67, DOI 10.1085/jgp.93.1.67; KIRSCH GE, 1989, J GEN PHYSIOL, V93, P85, DOI 10.1085/jgp.93.1.85; KIYOSUE T, 1989, CIRC RES, V64, P389, DOI 10.1161/01.RES.64.2.389; KOHLHARDT M, 1987, PROC R SOC SER B-BIO, V232, P71, DOI 10.1098/rspb.1987.0062; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KUNZE DL, 1985, J GEN PHYSIOL, V86, P691, DOI 10.1085/jgp.86.5.691; LAPIN LL, 1983, PROBABILITY STATISTI, P455; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LUX HD, 1984, J GEN PHYSIOL, V83, P727, DOI 10.1085/jgp.83.5.727; MATTESON DR, 1982, J GEN PHYSIOL, V79, P739, DOI 10.1085/jgp.79.5.739; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MOORMAN JR, 1987, AM J PHYSIOL, V253, pH985, DOI 10.1152/ajpheart.1987.253.4.H985; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; PARKER I, 1987, PROC R SOC SER B-BIO, V232, P289, DOI 10.1098/rspb.1987.0075; PATLAK J, 1982, J GEN PHYSIOL, V79, P333, DOI 10.1085/jgp.79.3.333; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PATLAK JB, 1985, J GEN PHYSIOL, V86, P89, DOI 10.1085/jgp.86.1.89; QUANDT FN, 1987, J PHYSIOL-LONDON, V392, P563, DOI 10.1113/jphysiol.1987.sp016797; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625	42	137	138	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1990	4	2					243	252		10.1016/0896-6273(90)90099-2	http://dx.doi.org/10.1016/0896-6273(90)90099-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT254	2155011				2022-12-17	WOS:A1990CT25400007
J	MACHIDA, CM; RODLAND, KD; MATRISIAN, L; MAGUN, BE; CIMENT, G				MACHIDA, CM; RODLAND, KD; MATRISIAN, L; MAGUN, BE; CIMENT, G			NGF INDUCTION OF THE GENE ENCODING THE PROTEASE TRANSIN ACCOMPANIES NEURONAL DIFFERENTIATION IN PC12 CELLS	NEURON			English	Article									OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201; VANDERBILT UNIV,DEPT CELL BIOL,NASHVILLE,TN 37232	Oregon Health & Science University; Vanderbilt University	MACHIDA, CM (corresponding author), OREGON HLTH SCI UNIV,DEPT CELL BIOL & ANAT,PORTLAND,OR 97201, USA.		Rodland, Karin/R-6186-2019		NATIONAL CANCER INSTITUTE [R01CA047404, U01CA048643, R01CA039360] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47404, CA 39360, CA 48643] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALOE L, 1979, P NATL ACAD SCI USA, V76, P1246, DOI 10.1073/pnas.76.3.1246; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cb.04.110188.000355; BREATHNACH R, 1987, NUCLEIC ACIDS RES, V15, P1139, DOI 10.1093/nar/15.3.1139; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; CHIN JR, 1985, J BIOL CHEM, V260, P2367; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CLAUDE P, 1988, NEURON, V1, P783, DOI 10.1016/0896-6273(88)90126-2; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DICKSON JG, 1986, EMBO J, V5, P3449; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; FEDEROFF HJ, 1988, J BIOL CHEM, V263, P19290; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FRISCH SM, 1987, P NATL ACAD SCI USA, V84, P2600, DOI 10.1073/pnas.84.9.2600; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KRYSTOSEK A, 1981, P NATL ACAD SCI-BIOL, V78, P7810, DOI 10.1073/pnas.78.12.7810; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; LEE VMY, 1984, J NEUROSCI, V4, P1705; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; LETOURNEAU PC, 1987, TRENDS NEUROSCI, V10, P390, DOI 10.1016/0166-2236(87)90003-8; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; MACHIDA CM, 1988, MOL CELL BIOL, V8, P2479, DOI 10.1128/MCB.8.6.2479; MATRISIAN LM, 1982, ANAL BIOCHEM, V125, P339, DOI 10.1016/0003-2697(82)90015-X; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MEDCALF RL, 1988, J CELL BIOL, V106, P971, DOI 10.1083/jcb.106.3.971; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; MULLER D, 1988, BIOCHEM J, V253, P187, DOI 10.1042/bj2530187; PATTERSON PH, 1988, NEURON, V1, P263, DOI 10.1016/0896-6273(88)90074-8; PATTERSON PH, 1985, J PHYSIOLOGY PARIS, V80, P207; PATTERSON PH, 1988, J PHYSL, V1, P263; PITTMAN RN, 1985, DEV BIOL, V110, P91, DOI 10.1016/0012-1606(85)90067-3; PITTMAN RN, 1989, DEV NEUROSCI-BASEL, V11, P41, DOI 10.1159/000111884; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SAVAGE CR, 1972, J BIOL CHEM, V247, P7601; SEASHOLTZ AF, 1988, MOL ENDOCRINOL, V2, P1311, DOI 10.1210/mend-2-12-1311; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TOGARI A, 1985, J NEUROSCI, V5, P307; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; VISVADER J, 1988, P NATL ACAD SCI USA, V85, P9474, DOI 10.1073/pnas.85.24.9474; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913	57	137	138	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1989	2	6					1587	1596		10.1016/0896-6273(89)90047-0	http://dx.doi.org/10.1016/0896-6273(89)90047-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC665	2560648				2022-12-17	WOS:A1989AC66500008
J	Bai, B; Wang, XS; Li, YX; Chen, PC; Yu, KW; Dey, KK; Yarbro, JM; Han, X; Lutz, BM; Rao, SQ; Jiao, Y; Sifford, JM; Han, J; Wang, MH; Tan, HY; Shaw, TI; Cho, JH; Zhou, SP; Wang, H; Niu, MM; Mancieri, A; Messler, KA; Sun, XJ; Wu, ZP; Pagala, V; High, AA; Bi, WJ; Zhang, H; Chi, HB; Haroutunian, V; Zhang, B; Beach, TG; Yu, G; Peng, JM				Bai, Bing; Wang, Xusheng; Li, Yuxin; Chen, Ping-Chung; Yu, Kaiwen; Dey, Kaushik Kumar; Yarbro, Jay M.; Han, Xian; Lutz, Brianna M.; Rao, Shuquan; Jiao, Yun; Sifford, Jeffrey M.; Han, Jonghee; Wang, Minghui; Tan, Haiyan; Shaw, Timothy, I; Cho, Ji-Hoon; Zhou, Suiping; Wang, Hong; Niu, Mingming; Mancieri, Ariana; Messler, Kaitlynn A.; Sun, Xiaojun; Wu, Zhiping; Pagala, Vishwajeeth; High, Anthony A.; Bi, Wenjian; Zhang, Hui; Chi, Hongbo; Haroutunian, Vahram; Zhang, Bin; Beach, Thomas G.; Yu, Gang; Peng, Junmin			Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression	NEURON			English	Article							FALSE DISCOVERY RATE; AMYLOID-BETA; NEURODEGENERATIVE DISORDERS; SYSTEMATIC OPTIMIZATION; SIGNALING PATHWAYS; MASS-SPECTROMETRY; PROTEIN-ANALYSIS; TRANSGENIC MICE; RARE MUTATION; IN-VIVO	Alzheimer's disease (AD) displays a long asymptomatic stage before dementia. We characterize AD stage-associated molecular networks by profiling 14,513 proteins and 34,173 phosphosites in the human brain with mass spectrometry, highlighting 173 protein changes in 17 pathways. The altered proteins are validated in two independent cohorts, showing partial RNA dependency. Comparisons of brain tissue and cerebrospinal fluid proteomes reveal biomarker candidates. Combining with 5xFAD mouse analysis, we determine 15 A beta-correlated proteins (e.g., MDK, NTN1, SMOC1, SLIT2, and HTRA1). 5xFAD shows a proteomic signature similar to symptomatic AD but exhibits activation of autophagy and interferon response and lacks human-specific deleterious events, such as downregulation of neurotrophic factors and synaptic proteins. Multi-omics integration prioritizes AD-related molecules and pathways, including amyloid cascade, inflammation, complement, WNT signaling, TGF-beta and BMP signaling, lipid metabolism, iron homeostasis, and membrane transport. Some A beta-correlated proteins are colocalized with amyloid plaques. Thus, the multilayer omics approach identifies protein networks during AD progression.	[Bai, Bing; Li, Yuxin; Chen, Ping-Chung; Yu, Kaiwen; Dey, Kaushik Kumar; Yarbro, Jay M.; Han, Xian; Lutz, Brianna M.; Rao, Shuquan; Jiao, Yun; Sifford, Jeffrey M.; Wang, Hong; Niu, Mingming; Mancieri, Ariana; Messler, Kaitlynn A.; Sun, Xiaojun; Wu, Zhiping; Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Bai, Bing; Li, Yuxin; Chen, Ping-Chung; Yu, Kaiwen; Dey, Kaushik Kumar; Yarbro, Jay M.; Han, Xian; Lutz, Brianna M.; Rao, Shuquan; Jiao, Yun; Sifford, Jeffrey M.; Wang, Hong; Niu, Mingming; Mancieri, Ariana; Messler, Kaitlynn A.; Sun, Xiaojun; Wu, Zhiping; Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Xusheng; Li, Yuxin; Tan, Haiyan; Shaw, Timothy, I; Cho, Ji-Hoon; Zhou, Suiping; Pagala, Vishwajeeth; High, Anthony A.; Peng, Junmin] St Jude Childrens Res Hosp, Ctr Prote & Metabol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Shaw, Timothy, I] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Bi, Wenjian; Zhang, Hui] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yarbro, Jay M.; Han, Xian; Wang, Hong] Univ Tennessee, Integrated Biomed Sci Program, Hlth Sci Ctr, Memphis, TN 38163 USA; [Wang, Minghui; Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, Dept Psychiat, New York, NY 10029 USA; [Wang, Minghui; Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, Dept Neurosci, New York, NY 10029 USA; [Wang, Minghui; Haroutunian, Vahram] James J Peters VA Med Ctr, MIRECC, Bronx, NY 10468 USA; [Zhang, Bin] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, Mt Sinai Ctr Transformat Dis Modeling, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhang, Bin] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, Mt Sinai Ctr Transformat Dis Modeling, Dept Pharmacol Sci, New York, NY 10029 USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA; [Han, Jonghee; Yu, Gang] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Bai, Bing] Nanjing Univ, Ctr Precis Med, Dept Lab Med, Nanjing Drum Tower Hosp,Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xusheng] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Zhang, Hui] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Nanjing University; University of North Dakota Grand Forks; Northwestern University	Peng, JM (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Peng, JM (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Wang, XS; Peng, JM (corresponding author), St Jude Childrens Res Hosp, Ctr Prote & Metabol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Wang, XS (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.	xusheng.wang@und.edu; junmin.peng@stjude.org	Bai, Bing/AAV-9281-2021; Chi, Hongbo/M-9397-2018; Peng, Junmin/N-2614-2018; Li, yuxin/GSD-1668-2022; Wang, Minghui/P-8300-2017; Han, Xian/J-6957-2019; li, Yu/HCI-9086-2022; Wang, Hong/AAE-2340-2019	Chi, Hongbo/0000-0002-9997-2496; Peng, Junmin/0000-0003-0472-7648; Wang, Minghui/0000-0001-9171-4962; Han, Xian/0000-0002-3802-6420; Wang, Hong/0000-0002-6215-6348; Yu, Kaiwen/0000-0002-6050-8477	NIH [R01AG047928, R01AG053987, R01GM114260, R01AG064909, RF1AG057440, U01AG046170, R01AG057907, R01NS079796, U24NS072026, P30AG019610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; ALSAC (American Lebanese Syrian Associated Charities); NIH Cancer Center [P30CA021765]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Department of Health Services; Arizona Biomedical Research Commission; ALSAC (American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all other members in the lab and center for technical support and discussions. This work was partially supported by NIH grants R01AG047928 (to J.P.), R01AG053987 (to J.P.), R01GM114260 (to J.P.), R01AG064909 (to G.Y. and J.P.), RF1AG057440 (to B.Z. and V.H.), U01AG046170 (to V.H. and B.Z.), R01AG057907 (to V.H. and B.Z.), R01NS079796 (to G.Y.), U24NS072026 (to T.G.B.), and P30AG019610 (to T.G.B.); the Arizona Department of Health Services (contract 211002 to T.G.B.), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901, and 1001 to T.G.B.); RF1AG057440 (to V.H. and B.Z.); and ALSAC (American Lebanese Syrian Associated Charities). The MS analysis was performed in the Center of Proteomics and Metabolomics, and the microscopy analysis was performed in the Cell and Tissue Imaging Core at St. Jude Children's Research Hospital, partially supported by NIH Cancer Center support grant P30CA021765.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bai B, 2017, METHOD ENZYMOL, V585, P377, DOI 10.1016/bs.mie.2016.10.007; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Dayon L, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0397-4; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Dejanovic B, 2018, NEURON, V100, P1322, DOI 10.1016/j.neuron.2018.10.014; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Graham WV, 2017, ANNU REV MED, V68, P413, DOI 10.1146/annurev-med-042915-103753; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Han PC, 2014, NEUROBIOL AGING, V35, P2064, DOI 10.1016/j.neurobiolaging.2014.03.022; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto Y, 2016, J BIOL CHEM, V291, P12282, DOI 10.1074/jbc.M115.698092; Herradon G, 2014, BRIT J PHARMACOL, V171, P837, DOI 10.1111/bph.12312; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huttenrauch M, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0612-3; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Hynd MR, 2003, J NEUROCHEM, V85, P543, DOI 10.1046/j.1471-4159.2003.01747.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Katsouras I, 2015, SCI REP-UK, V5, DOI 10.1038/srep12094; Keshet Y, 2010, METHODS MOL BIOL, V661, P3, DOI 10.1007/978-1-60761-795-2_1; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Li YX, 2016, J PROTEOME RES, V15, P2309, DOI 10.1021/acs.jproteome.6b00344; Lin WJ, 2015, J NEUROSCI, V35, P10343, DOI 10.1523/JNEUROSCI.0584-15.2015; Liu CC, 2014, NEURON, V84, P63, DOI 10.1016/j.neuron.2014.08.048; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Llano DA, 2019, ALZ DIS ASSOC DIS, V33, P307, DOI 10.1097/WAD.0000000000000328; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Lutz BM, 2018, PROTEOMES, V6, DOI 10.3390/proteomes6040046; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Mischnik M, 2016, BIOINFORMATICS, V32, P424, DOI 10.1093/bioinformatics/btv699; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Niu MM, 2017, ANAL CHEM, V89, P2956, DOI 10.1021/acs.analchem.6b04415; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pagala VR, 2015, METHODS MOL BIOL, V1278, P281, DOI 10.1007/978-1-4939-2425-7_17; Pedersen WA, 2001, NEUROBIOL DIS, V8, P492, DOI 10.1006/nbdi.2001.0395; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schwartz M, 2016, TRENDS IMMUNOL, V37, P668, DOI 10.1016/j.it.2016.08.001; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Spilman PR, 2016, J ALZHEIMERS DIS, V52, P223, DOI 10.3233/JAD-151046; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Tan HY, 2015, PROTEOMICS, V15, P500, DOI 10.1002/pmic.201400171; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Wang H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11661-4; Wang H, 2015, J PROTEOME RES, V14, P829, DOI 10.1021/pr500882h; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang MH, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.185; Wang XS, 2014, MOL CELL PROTEOMICS, V13, P3663, DOI 10.1074/mcp.O114.039586; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; WILKS SS, 1948, B AM MATH SOC, V54, P6, DOI 10.1090/S0002-9904-1948-08936-4; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; Wingo AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09613-z; Xiao MF, 2017, ELIFE, V6, DOI 10.7554/eLife.23798; Xie Y, 2005, BIOINFORMATICS, V21, P4280, DOI 10.1093/bioinformatics/bti685; Xiong F, 2019, ALZHEIMERS DEMENT, V15, P429, DOI 10.1016/j.jalz.2018.10.006; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zheng HH, 2017, J NEUROSCI, V37, P1772, DOI 10.1523/JNEUROSCI.2459-16.2017	103	136	136	24	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 18	2020	105	6					975	+		10.1016/j.neuron.2019.12.015	http://dx.doi.org/10.1016/j.neuron.2019.12.015			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW0HR	31926610	Green Accepted, Green Submitted, Bronze			2022-12-17	WOS:000520854700007
J	Mateo, C; Knutsen, PM; Tsai, PS; Shih, AY; Kleinfeld, D				Mateo, Celine; Knutsen, Per M.; Tsai, Philbert S.; Shih, Andy Y.; Kleinfeld, David			Entrainment of Arteriole Vasomotor Fluctuations by Neural Activity Is a Basis of Blood-Oxygenation-Level-Dependent "Resting-State'' Connectivity	NEURON			English	Article							RAT SOMATOSENSORY CORTEX; LIGHT-INDUCED ACTIVATION; STIMULUS-INDUCED CHANGES; FUNCTIONAL CONNECTIVITY; IN-VIVO; TRANSGENIC MICE; SENSORY STIMULATION; BOLD SIGNAL; CEREBRAL HEMODYNAMICS; 2-PHOTON MICROSCOPY	Resting-state signals in blood-oxygenation-level-dependent (BOLD) imaging are used to parcellate brain regions and define "functional connections'' between regions. Yet a physiological link between fluctuations in blood oxygenation with those in neuronal signaling pathways is missing. We present evidence from studies on mouse cortex that modulation of vasomotion, i.e., intrinsic ultra-slow (0.1 Hz) fluctuations in arteriole diameter, provides this link. First, ultra-slow fluctuations in neuronal signaling, which occur as an envelope over g-band activity, entrains vasomotion. Second, optogenetic manipulations confirm that entrainment is unidirectional. Third, co-fluctuations in the diameter of pairs of arterioles within the same hemisphere diminish to chance for separations > 1.4 mm. Yet the diameters of arterioles in distant (> 5 mm), mirrored transhemispheric sites strongly co-fluctuate; these correlations are diminished in acallosal mice. Fourth, fluctuations in arteriole diameter coherently drive fluctuations in blood oxygenation. Thus, entrainment of vasomotion links neuronal pathways to functional connections.	[Mateo, Celine; Knutsen, Per M.; Tsai, Philbert S.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Shih, Andy Y.] Med Univ South Carolina, Dept Neurosci, Charleston, SC USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Medical University of South Carolina; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.; Kleinfeld, D (corresponding author), Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Mateo, Celine/V-4619-2019		United States National Institute of Mental Health [MH108503, MH111438]; United States National Institute of Neurological Disease and Stroke [NS082097, NS097265]; United States National Institute of Biomedical Imaging and Bioengineering [EB003832]; United States National Institute of General Medical Sciences [GM12345]; United States National Science Foundation [PHY-153264, OIA-1539034]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111438, R21MH108503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS096997, R01NS097775, R35NS097265, DP1NS082097, R21NS085402] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States National Institute of Neurological Disease and Stroke; United States National Institute of Biomedical Imaging and Bioengineering; United States National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jason Berwick, David Boas, Patrick Drew, Adrienne Fairhall, Elizabeth Hillman, Partha Mitra, Charles Schroeder, and Nelson Spruston for valuable discussions and Beth Friedman for critical comments on an early version of the manuscript. Our work was supported by the United States National Institute of Mental Health (grants MH108503 and MH111438), United States National Institute of Neurological Disease and Stroke (grants NS082097 and NS097265), the United States National Institute of Biomedical Imaging and Bioengineering (grant EB003832), an Institutional Development Award from the United States National Institute of General Medical Sciences (grant GM12345), and the United States National Science Foundation (grants PHY-153264 and OIA-1539034).	Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Chan AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8738; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Devor A, 2008, J NEUROSCI, V28, P14347, DOI 10.1523/JNEUROSCI.4307-08.2008; Drew PJ, 2008, NAT NEUROSCI, V11, P991, DOI 10.1038/nn0908-991; Drew PJ, 2011, P NATL ACAD SCI USA, V108, P8473, DOI 10.1073/pnas.1100428108; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Du CW, 2014, P NATL ACAD SCI USA, V111, pE4677, DOI 10.1073/pnas.1410800111; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Golanov EV, 1996, J PHYSIOL-LONDON, V495, P201, DOI 10.1113/jphysiol.1996.sp021585; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Intaglietta M., 1990, VASC MED REV, V1, P101, DOI [10.1177/1358836X9000100202, DOI 10.1177/1358836X9000100202]; Keller CJ, 2013, J NEUROSCI, V33, P6333, DOI 10.1523/JNEUROSCI.4837-12.2013; Kim KJ, 2016, J NEUROSCI, V36, P12624, DOI 10.1523/JNEUROSCI.1300-16.2016; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kleinfeld D., 2011, IMAGING LAB MANUAL, P1211; Kleinfeld David, 2014, Cold Spring Harb Protoc, V2014, P248, DOI 10.1101/pdb.top081075; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Knutsen PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0351; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Lacroix A, 2015, J NEUROSCI, V35, P11791, DOI 10.1523/JNEUROSCI.0651-15.2015; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewis LD, 2016, P NATL ACAD SCI USA, V113, pE6679, DOI 10.1073/pnas.1608117113; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Longden TA, 2017, NAT NEUROSCI, V20, P717, DOI 10.1038/nn.4533; Ma Y, 2016, P NATL ACAD SCI USA, V113, pE8463, DOI 10.1073/pnas.1525369113; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Magnuson ME, 2014, BRAIN CONNECT, V4, P15, DOI 10.1089/brain.2013.0167; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Mitra P., 2008, OBSERVED BRAIN DYNAM; Mitra PP, 1997, MAGNET RESON MED, V37, P511, DOI 10.1002/mrm.1910370407; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; O'Herron P, 2016, NATURE, V534, P378, DOI 10.1038/nature17965; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; OSOL G, 1988, AM J PHYSIOL, V254, pH28, DOI 10.1152/ajpheart.1988.254.1.H28; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Rungta RL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14191; Sakadzic S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6734; SEGAL SS, 1989, AM J PHYSIOL, V256, pH838, DOI 10.1152/ajpheart.1989.256.3.H838; Shih Andy Y, 2012, J Vis Exp, DOI 10.3791/3742; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Steinmetz N. A., 2017, BIORXIV; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Thompson GJ, 2013, NEUROIMAGE, V83, P826, DOI 10.1016/j.neuroimage.2013.07.036; Tsai PS, 2015, OPT EXPRESS, V23, P13833, DOI 10.1364/OE.23.013833; Tsai PS, 2009, FRONT NEUROSCI, P59; Vanni MP, 2017, J NEUROSCI, V37, P7513, DOI 10.1523/JNEUROSCI.3560-16.2017; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Wolf U, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3615249; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; YORKE CH, 1975, J COMP NEUROL, V164, P233, DOI 10.1002/cne.901640206; Yu X, 2016, NAT METHODS, V13, P337, DOI [10.1038/nmeth.3765, 10.1038/NMETH.3765]; Zong XP, 2012, NEUROIMAGE, V60, P2238, DOI 10.1016/j.neuroimage.2012.02.052	79	136	137	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 15	2017	96	4					936	+		10.1016/j.neuron.2017.10.012	http://dx.doi.org/10.1016/j.neuron.2017.10.012			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8CC	29107517	Green Accepted, Bronze			2022-12-17	WOS:000415310800022
J	Kim, YS; Anderson, M; Park, K; Zheng, Q; Agarwal, A; Gong, C; Saijilafu; Young, LA; He, SQ; LaVinka, PC; Zhou, FQ; Bergles, D; Hanani, M; Guan, Y; Spray, DC; Dong, XZ				Kim, Yu Shin; Anderson, Michael; Park, Kyoungsook; Zheng, Qin; Agarwal, Amit; Gong, Catherine; Saijilafu; Young, LeAnne; He, Shaoqiu; LaVinka, Pamela Colleen; Zhou, Fengquan; Bergles, Dwight; Hanani, Menachem; Guan, Yun; Spray, David C.; Dong, Xinzhong			Coupled Activation of Primary Sensory Neurons Contributes to Chronic Pain	NEURON			English	Article							SATELLITE GLIAL-CELLS; DORSAL-ROOT GANGLIA; CROSS-EXCITATION	Primary sensory neurons in the DRG play an essential role in initiating pain by detecting painful stimuli in the periphery. Tissue injury can sensitize DRG neurons, causing heightened pain sensitivity, often leading to chronic pain. Despite the functional importance, how DRG neurons function at a population level is unclear due to the lack of suitable tools. Here we developed an imaging technique that allowed us to simultaneously monitor the activities of >1,600 neurons/DRG in live mice and discovered a striking neuronal coupling phenomenon that adjacent neurons tend to activate together following tissue injury. This coupled activation occurs among various neurons and is mediated by an injury-induced upregulation of gap junctions in glial cells surrounding DRG neurons. Blocking gap junctions attenuated neuronal coupling and mechanical hyperalgesia. Therefore, neuronal coupling represents a new form of neuronal plasticity in the DRG and contributes to pain hypersensitivity by "hijacking'' neighboring neurons through gap junctions.	[Kim, Yu Shin; Anderson, Michael; Park, Kyoungsook; Zheng, Qin; Agarwal, Amit; Gong, Catherine; Young, LeAnne; LaVinka, Pamela Colleen; Bergles, Dwight; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Kim, Yu Shin; Anderson, Michael; Park, Kyoungsook; Zheng, Qin; Agarwal, Amit; Gong, Catherine; Young, LeAnne; LaVinka, Pamela Colleen; Bergles, Dwight; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ctr Sensory Biol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Kim, Yu Shin; Anderson, Michael; Park, Kyoungsook; Zheng, Qin; Agarwal, Amit; Gong, Catherine; Young, LeAnne; LaVinka, Pamela Colleen; Bergles, Dwight; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Dermatol, Ctr Sensory Biol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Kim, Yu Shin] Univ Texas Med Branch, Sch Med, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA; [Saijilafu; Zhou, Fengquan] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, 725 N Wolfe St, Baltimore, MD 21205 USA; [Saijilafu] Soochow Univ, Inst Orthopaed, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China; [Hanani, Menachem] Hadassah Hebrew Univ Med Ctr, IL-91240 Jerusalem, Israel; [He, Shaoqiu; Guan, Yun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Spray, David C.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Kim, Yu Shin; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Soochow University - China; Hebrew University of Jerusalem; Johns Hopkins University; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Johns Hopkins University	Kim, YS; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.; Kim, YS; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ctr Sensory Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.; Kim, YS; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Ctr Sensory Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.; Kim, YS (corresponding author), Univ Texas Med Branch, Sch Med, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	yukim@utmb.edu; xdong2@jhmi.edu	Saijilafu, Saijilafu/AAV-3704-2021; Zhou, Fengquan/X-5782-2019; Bergles, Dwight/U-8343-2019; Agarwal, Amit/B-7735-2008	Zhou, Fengquan/0000-0002-1525-9969; Bergles, Dwight/0000-0002-7133-7378; Agarwal, Amit/0000-0001-7948-4498; , Saijilafu/0000-0003-2290-9808; Hanani, Menachem/0000-0002-6716-1453; Anderson, Michael/0000-0001-8746-4681; Spray, David/0000-0001-8368-5073	National Institutes of Health [R01DE022750, R01GM087369]; Johns Hopkins University Brain Science Institute grant; HHMI; ISF [508/13]; BSF [201144]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026677, R01DE022750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085176, R01NS070814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Brain Science Institute grant; HHMI(Howard Hughes Medical Institute); ISF(Israel Science Foundation); BSF(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of X.D. laboratories for helpful comments and discussion. We also thank JHU pain research imaging core for its assistance. This work was supported by National Institutes of Health Grants (R01DE022750 and R01GM087369 to X.D.), Johns Hopkins University Brain Science Institute grant, and HHMI. M.H. was supported by ISF (508/13) and BSF (201144).	Amir R, 1996, J NEUROSCI, V16, P4733; Basbaum AI, 1999, CURR BIOL, V9, pR429, DOI 10.1016/S0960-9822(99)80273-5; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belzer V, 2010, NEURON GLIA BIOL, V6, P237, DOI 10.1017/S1740925X1100007X; Blum E, 2014, NEUROSCIENCE, V274, P209, DOI 10.1016/j.neuroscience.2014.05.029; Damodaram S, 2009, HEADACHE, V49, P5, DOI 10.1111/j.1526-4610.2008.01262.x; del Corsso C, 2006, NAT PROTOC, V1, P1799, DOI 10.1038/nprot.2006.266; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733, DOI 10.1152/jn.1990.64.6.1733; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dublin P, 2007, BRAIN BEHAV IMMUN, V21, P592, DOI 10.1016/j.bbi.2006.11.011; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2012, BRAIN RES, V1487, P183, DOI 10.1016/j.brainres.2012.03.070; Huang TY, 2010, EUR J PAIN, V14, P49, DOI 10.1016/j.ejpain.2009.02.005; Huang TY, 2005, BRAIN RES, V1036, P42, DOI 10.1016/j.brainres.2004.12.021; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; Ma C, 2010, J NEUROSCI METH, V191, P60, DOI 10.1016/j.jneumeth.2010.06.010; Ohara PT, 2008, J NEUROPHYSIOL, V100, P3064, DOI 10.1152/jn.90722.2008; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Rozanski GM, 2013, J PHYSIOL-LONDON, V591, P5575, DOI 10.1113/jphysiol.2013.260281; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; SCHMALBRUCH H, 1987, ANAT REC, V219, P315, DOI 10.1002/ar.1092190313; Sorensen B, 2003, J COMP NEUROL, V459, P242, DOI 10.1002/cne.10625; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; Zhang HJ, 2009, GLIA, V57, P1588, DOI 10.1002/glia.20872; Zuriel E, 2001, J PERIPHER NERV SYST, V6, P227, DOI 10.1046/j.1529-8027.2001.01024.x	27	136	141	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2016	91	5					1085	1096		10.1016/j.neuron.2016.07.044	http://dx.doi.org/10.1016/j.neuron.2016.07.044			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW2HH	27568517	Green Accepted, Bronze			2022-12-17	WOS:000383463000014
J	Suzuki, S; Harasawa, N; Ueno, K; Gardner, JL; Ichinohe, N; Haruno, M; Cheng, K; Nakahara, H				Suzuki, Shinsuke; Harasawa, Norihiro; Ueno, Kenichi; Gardner, Justin L.; Ichinohe, Noritaka; Haruno, Masahiko; Cheng, Kang; Nakahara, Hiroyuki			Learning to Simulate Others' Decisions	NEURON			English	Article							PREFRONTAL CORTEX; FRONTAL-CORTEX; NEURAL SIGNATURES; CINGULATE CORTEX; REWARD; SIGNALS; NEUROSCIENCE; PREDICTION; SYSTEMS; BRAIN	A fundamental challenge in social cognition is how humans learn another person's values to predict their decision-making behavior. This form of learning is often assumed to require simulation of the other by direct recruitment of one's own valuation process to model the other's process. However, the cognitive and neural mechanism of simulation learning is not known. Using behavior, modeling, and fMRI, we show that simulation involves two learning signals in a hierarchical arrangement. A simulated-other's reward prediction error processed in ventromedial prefrontal cortex mediated simulation by direct recruitment, being identical for valuation of the self and simulated-other. However, direct recruitment was insufficient for learning, and also required observation of the other's choices to generate a simulated-other's action prediction error encoded in dorsomedial/dorsolateral prefrontal cortex. These findings show that simulation uses a core prefrontal circuit for modeling the other's valuation to generate prediction and an adjunct circuit for tracking behavioral variation to refine prediction.	[Suzuki, Shinsuke; Harasawa, Norihiro; Nakahara, Hiroyuki] RIKEN, Brain Sci Inst, Lab Integrated Theoret Neurosci, Wako, Saitama 3510198, Japan; [Ueno, Kenichi; Cheng, Kang] RIKEN, Brain Sci Inst, Support Unit Funct Magnet Resonance Imaging, Wako, Saitama 3510198, Japan; [Gardner, Justin L.] RIKEN, Brain Sci Inst, Gardner Res Unit, Wako, Saitama 3510198, Japan; [Cheng, Kang] RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan; [Ichinohe, Noritaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan; [Haruno, Masahiko] NICT, Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan; [Nakahara, Hiroyuki] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268503, Japan	RIKEN; RIKEN; RIKEN; RIKEN; National Center for Neurology & Psychiatry - Japan; National Institute of Information & Communications Technology (NICT) - Japan; Tokyo Institute of Technology	Nakahara, H (corresponding author), RIKEN, Brain Sci Inst, Lab Integrated Theoret Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hiro@brain.riken.jp	Cheng, Kang/A-6448-2016; Nakahara, Hiroyuki/N-5411-2015; Ueno, Kenichi/A-9395-2014; Suzuki, Shinsuke/A-8254-2013	Nakahara, Hiroyuki/0000-0001-6891-1175; Gardner, Justin/0000-0003-2220-5050	KAKENHI [21300129, 20020034]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI grants 21300129 and 20020034 (H.N.). We thank S. Kaveri for discussion in the early stages of this work, Dr. X.H. Wan for assistance with data analysis, Drs. K. Tanaka and N. Sadato for helpful comments on the manuscript, and Drs. T. Asamizuya and C. Suzuki for technical assistance with the fMRI experiments.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bhatt MA, 2010, P NATL ACAD SCI USA, V107, P19720, DOI 10.1073/pnas.1009625107; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Cooper JC, 2012, J COGNITIVE NEUROSCI, V24, P106, DOI 10.1162/jocn_a_00114; Cooper JC, 2010, NEURON, V67, P511, DOI 10.1016/j.neuron.2010.06.030; Coricelli G, 2009, P NATL ACAD SCI USA, V106, P9163, DOI 10.1073/pnas.0807721106; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; de Bruijn ERA, 2009, J NEUROSCI, V29, P12183, DOI 10.1523/JNEUROSCI.1751-09.2009; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Haruno M, 2009, J NEUROSCI, V29, P4542, DOI 10.1523/JNEUROSCI.2707-08.2009; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Mackey S, 2010, EUR J NEUROSCI, V32, P1940, DOI 10.1111/j.1460-9568.2010.07465.x; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rushworth MFS, 2008, ANN NY ACAD SCI, V1124, P181, DOI 10.1196/annals.1440.014; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004; Yoshida W, 2010, J NEUROSCI, V30, P10744, DOI 10.1523/JNEUROSCI.5895-09.2010	58	136	140	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2012	74	6					1125	1137		10.1016/j.neuron.2012.04.030	http://dx.doi.org/10.1016/j.neuron.2012.04.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963YA	22726841	Bronze			2022-12-17	WOS:000305659700017
J	Marella, S; Mann, K; Scott, K				Marella, Sunanda; Mann, Kevin; Scott, Kristin			Dopaminergic Modulation of Sucrose Acceptance Behavior in Drosophila	NEURON			English	Article							TYROSINE-HYDROXYLASE; FEEDING-BEHAVIOR; NEUROPEPTIDE-Y; MOTOR CONTROL; FOOD-INTAKE; FLY BRAIN; TASTE; MELANOGASTER; NEURONS; GENE	For an animal to survive in a constantly changing environment, its behavior must be shaped by the complex milieu of sensory stimuli it detects, its previous experience, and its internal state. Although taste behaviors in the fly are relatively simple, with sugars eliciting acceptance behavior and bitter compounds avoidance, these behaviors are also plastic and are modified by intrinsic and extrinsic cues, such as hunger and sensory stimuli. Here, we show that dopamine modulates a simple taste behavior, proboscis extension to sucrose. Conditional silencing of dopaminergic neurons reduces proboscis extension probability, and increased activation of dopaminergic neurons increases extension to sucrose, but not to bitter compounds or water. One dopaminergic neuron with extensive branching in the primary taste relay, the subesophageal ganglion, triggers proboscis extension, and its activity is altered by satiety state. These studies demonstrate the marked specificity of dopamine signaling and provide a foundation to examine neural mechanisms of feeding modulation in the fly.	[Scott, Kristin] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Marella, Sunanda; Mann, Kevin; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Marella, Sunanda; Mann, Kevin; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	kscott@berkeley.edu			John Merck Fund; National Institute on Deafness and Other Communication Disorders [1R01DC009470]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252, R01DC009470] Funding Source: NIH RePORTER	John Merck Fund; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The Scott laboratory provided comments on the experiments and manuscript. Wendi Neckameyer generously provided anti-TH antisera. Michael Gordon provided images of E49 motor neurons and Gr5a sensory neurons. Pavel Masek provided assistance with laser activation experiments. This research was supported by a Scholars Award from the John Merck Fund and a grant from the National Institute on Deafness and Other Communication Disorders 1R01DC009470 to K.S. K.S. is an Early Career Scientist of the Howard Hughes Medical Institute. S.M. initiated the project and performed the majority of experiments. K.M. carried out electrophysiology as well as behavioral experiments with NaChBac. K.S. wrote the manuscript and generated most figures, with critical input from S.M. and K.M.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dethier VG, 1976, HUNGRY FLY; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; MCGUIRE SE, 2004, SCI STKE, pPL6; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Meunier N, 2003, CHEM SENSES, V28, P671, DOI 10.1093/chemse/bjg059; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	58	136	137	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 8	2012	73	5					941	950		10.1016/j.neuron.2011.12.032	http://dx.doi.org/10.1016/j.neuron.2011.12.032			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405204	Green Accepted, Bronze			2022-12-17	WOS:000301558600009
J	Lerner, TN; Kreitzer, AC				Lerner, Talia N.; Kreitzer, Anatol C.			RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits	NEURON			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; MEDIUM SPINY NEURONS; BASAL GANGLIA; SYNAPTIC PLASTICITY; CHOLINERGIC INTERNEURONS; POSTNATAL-DEVELOPMENT; CALCIUM-CHANNELS; PHOSPHOLIPASE-C; DORSAL STRIATUM	Plasticity of excitatory synapses onto striatal projection neurons (MSNs) has the potential to regulate motor function by setting the gain on signals driving both direct- and indirect-pathway basal ganglia circuits. Endocannabinoid-dependent long-term depression (eCB-LTD) is the best characterized form of striatal plasticity, but the mechanisms governing its normal regulation and pathological dysregulation are not well understood. We characterized two distinct signaling pathways mediating eCB production in striatal indirect-pathway MSNs and found that both pathways were modulated by dopamine D2 and adenosine A2A receptors, acting through cAMP/PKA. We identified regulator of G protein signaling 4 (RGS4) as a key link between D2/A2A signaling and eCB mobilization pathways. In contrast to wild-type mice, RGS4(-/-) mice exhibited normal eCB-LTD after dopamine depletion and were significantly less impaired in the 6-OHDA model of Parkinson's disease. Taken together, these results suggest that inhibition of RGS4 may be an effective nondopaminergic strategy for treating Parkinson's disease.	[Lerner, Talia N.; Kreitzer, Anatol C.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Lerner, Talia N.; Kreitzer, Anatol C.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	akreitzer@gladstone.ucsf.edu	Lerner, Talia/AGW-7812-2022; Lerner, Talia/AAB-5439-2020	Lerner, Talia/0000-0002-3875-0654; 	National Center for Research Resources [RR18928-01]; National Institutes of Health [R01 NS064984]; Pew Biomedical Scholars Program; W.M. Keck Foundation; McKnight Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984, P30NS065780] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Biomedical Scholars Program; W.M. Keck Foundation(W.M. Keck Foundation); McKnight Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Taussig, T. Golde, C. Ceballos, Y. Chen, B. Sabatini, S. Finkbeiner, E. LaDow, E. Korb, L. Shoenfeld, N. Hammack, A. Kravitz, G. Hang, and other members of the Kreitzer Lab for helpful advice on experiments, comments on the manuscript, technical assistance, and reagents. We also thank N. Devidze and B. Masatsugu of the Gladstone Institutes' Behavioral Core for help obtaining the behavioral data. The Gladstone Institutes received support from a National Center for Research Resources grant (RR18928-01). This work was supported by the National Institutes of Health (R01 NS064984), the Pew Biomedical Scholars Program, the W.M. Keck Foundation, and the McKnight Foundation.	Ade KK, 2007, J NEUROSCI, V27, P2403, DOI 10.1523/JNEUROSCI.2916-06.2007; Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Bence-Hanulec KK, 2000, NEURON, V27, P121, DOI 10.1016/S0896-6273(00)00014-3; Blazer LL, 2011, BIOCHEMISTRY-US, V50, P3181, DOI 10.1021/bi1019622; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; CALABRESI P, 1994, J NEUROSCI, V14, P4871; Calabresi P, 1997, J NEUROSCI, V17, P4536; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; FILION M, 1991, BRAIN RES, V547, P142; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Fuxe K, 2007, MOVEMENT DISORD, V22, P1990, DOI 10.1002/mds.21440; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gold SJ, 1997, J NEUROSCI, V17, P8024; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Henkels KM, 2010, MOL CELL BIOL, V30, P2251, DOI 10.1128/MCB.01239-09; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Lerner TN, 2011, CURR OPIN NEUROBIOL, V21, P322, DOI 10.1016/j.conb.2011.01.005; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Obeso JA, 2000, NEUROLOGY, V55, pS7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Peterson DA, 2010, NEUROBIOL DIS, V37, P558, DOI 10.1016/j.nbd.2009.12.003; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Saugstad JA, 1998, J NEUROSCI, V18, P905; Schwendt M, 2007, J PHARMACOL EXP THER, V323, P650, DOI 10.1124/jpet.107.128561; Schwendt M, 2007, NEUROREPORT, V18, P1261, DOI 10.1097/WNR.0b013e328240507a; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Taymans JM, 2004, EUR J NEUROSCI, V19, P2249, DOI 10.1111/j.0953-816X.2004.03336.x; Tozzi A, 2007, NEUROPHARMACOLOGY, V53, P783, DOI 10.1016/j.neuropharm.2007.08.006; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195	63	136	141	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 26	2012	73	2					347	359		10.1016/j.neuron.2011.11.015	http://dx.doi.org/10.1016/j.neuron.2011.11.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284188	Green Accepted, Bronze			2022-12-17	WOS:000299761600015
J	Raimondi, A; Ferguson, SM; Lou, XL; Armbruster, M; Paradise, S; Giovedi, S; Messa, M; Kono, N; Takasaki, J; Cappello, V; O'Toole, E; Ryan, TA; De Camilli, P				Raimondi, Andrea; Ferguson, Shawn M.; Lou, Xuelin; Armbruster, Moritz; Paradise, Summer; Giovedi, Silvia; Messa, Mirko; Kono, Nao; Takasaki, Junko; Cappello, Valentina; O'Toole, Eileen; Ryan, Timothy A.; De Camilli, Pietro			Overlapping Role of Dynamin Isoforms in Synaptic Vesicle Endocytosis	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; AMPA RECEPTOR TRAFFICKING; NERVE-TERMINALS; COATED VESICLES; HIPPOCAMPAL SYNAPSES; PRESYNAPTIC FUNCTION; SLOW ENDOCYTOSIS; CELL BIOLOGY; SYNDAPIN-I; PHOSPHORYLATION	The existence of neuron-specific endocytic protein isoforms raises questions about their importance for specialized neuronal functions. Dynamin, a GTPase implicated in the fission reaction of endocytosis, is encoded by three genes, two of which, dynamin 1 and 3, are highly expressed in neurons. We show that dynamin 3, thought to play a predominantly postsynaptic role, has a major presynaptic function. Although lack of dynamin 3 does not produce an overt phenotype in mice, it worsens the dynamin 1 KO phenotype, leading to perinatal lethality and a more severe defect in activity-dependent synaptic vesicle endocytosis. Thus, dynamin 1 and 3, which together account for the overwhelming majority of brain dynamin, cooperate in supporting optimal rates of synaptic vesicle endocytosis. Persistence of synaptic transmission in their absence indicates that if dynamin plays essential functions in neurons, such functions can be achieved by the very low levels of dynamin 2.	[Raimondi, Andrea; Ferguson, Shawn M.; Lou, Xuelin; Paradise, Summer; Giovedi, Silvia; Messa, Mirko; Kono, Nao; Takasaki, Junko; Cappello, Valentina; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Cell Biol,HHMI, New Haven, CT 06510 USA; [Raimondi, Andrea; Ferguson, Shawn M.; Lou, Xuelin; Paradise, Summer; Giovedi, Silvia; Messa, Mirko; Kono, Nao; Takasaki, Junko; Cappello, Valentina; De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Armbruster, Moritz; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Armbruster, Moritz] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10065 USA; [O'Toole, Eileen] Univ Colorado, MCDP Dept, Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Yale University; Yale University; Cornell University; Rockefeller University; University of Colorado System; University of Colorado Boulder	Ferguson, SM (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Cell Biol,HHMI, 333 Cedar St, New Haven, CT 06510 USA.	shawn.ferguson@yale.edu; pietro.decamilli@yale.edu	Cappello, Valentina/AAC-7867-2019; Raimondi, Andrea/AAN-2475-2020; Giovedì, Silvia/AAB-7614-2019; Takahashi, Junko/AAO-9861-2021; Ryan, Timothy/AAO-8286-2020	Cappello, Valentina/0000-0002-2385-8320; Takahashi, Junko/0000-0001-5792-0463; Armbruster, Moritz/0000-0003-2341-513X; Raimondi, Andrea/0000-0002-4563-386X; Lou, Xuelin/0000-0002-0576-8575; GIOVEDI', SILVIA/0000-0001-7949-4274; Ryan, Timothy/0000-0003-2533-9548	G. Harold and Leila Y. Mathers Charitable Foundation; National Institutes of Health [R37NS036251, DK45735, DA018343, NS36942]; W.M. Keck Foundation; NARSAD; Yale DERC; National Center for Research Resources of the National Institutes of Health [RR-000592]; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251, R01NS036942, R37NS036942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NARSAD(NARSAD); Yale DERC; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Frank Wilson, Lijuan Liu, Louise Lucast, Livia Tomasini, Kumi Mesaki, and Ricky Kwan for superb technical assistance. We appreciate the contributions of Tim Nottoli (Yale Cancer Center Animal Genomics Shared Resource) toward gene targeting and the support of the Yale Center for Genomics and Proteomics. This work was supported in part by the G. Harold and Leila Y. Mathers Charitable Foundation, National Institutes of Health grants (R37NS036251, DK45735, and DA018343), the W.M. Keck Foundation, and a NARSAD Distinguished Investigator Award to P.D.C., a pilot grant from the Yale DERC to XL., grant RR-000592 from the National Center for Research Resources of the National Institutes of Health to J.R. McIntosh, National Institutes of Health grant NS36942 to T.A.R., and a Canadian Institutes of Health Research fellowship to S.M.F.	AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boumil RM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001046; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; FISCHER V, 1990, P NATL ACAD SCI USA, V87, P1988; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Giovedi S, 2004, J BIOL CHEM, V279, P43769, DOI 10.1074/jbc.M404168200; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Guan R, 2010, STRUCTURE, V18, P1191, DOI 10.1016/j.str.2010.06.016; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lou XL, 2008, P NATL ACAD SCI USA, V105, P17555, DOI 10.1073/pnas.0809621105; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; STAMM S, 1992, NUCLEIC ACIDS RES, V20, P5097, DOI 10.1093/nar/20.19.5097; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vaid KS, 2007, J CELL PHYSIOL, V210, P644, DOI 10.1002/jcp.20855; WARNOCK DE, 1995, EMBO J, V14, P1322, DOI 10.1002/j.1460-2075.1995.tb07118.x; Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107	59	136	140	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1100	1114		10.1016/j.neuron.2011.04.031	http://dx.doi.org/10.1016/j.neuron.2011.04.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689597	Green Accepted, Bronze			2022-12-17	WOS:000292410700009
J	Lu, YJ; Ma, XY; Sabharwal, R; Snitsarev, V; Morgan, D; Rahmouni, K; Drummond, HA; Whiteis, CA; Costa, V; Price, M; Benson, C; Welsh, MJ; Chapleau, MW; Abboud, FM				Lu, Yongjun; Ma, Xiuying; Sabharwal, Rasna; Snitsarev, Vladislav; Morgan, Donald; Rahmouni, Kamal; Drummond, Heather A.; Whiteis, Carol A.; Costa, Vivian; Price, Margaret; Benson, Christopher; Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.			The Ion Channel ASIC2 Is Required for Baroreceptor and Autonomic Control of the Circulation	NEURON			English	Article							EPITHELIAL NA+ CHANNELS; HEART-RATE-VARIABILITY; NEURONS IN-VITRO; CAENORHABDITIS-ELEGANS; BAROREFLEX SENSITIVITY; SENSORY NEURONS; MECHANOSENSORY TRANSDUCTION; VASCULAR-RESISTANCE; ARTERIAL BAROREFLEX; MICE	Arterial baroreceptors; provide a neural sensory input that reflexly regulates the autonomic drive of circulation. Our goal was to test the hypothesis that a member of the acid-sensing ion channel (ASIC) subfamily of the DEG/ENaC superfamily is an important determinant of the arterial baroreceptor reflex. We found that aortic baroreceptor neurons in the nodose ganglia and their terminals express ASIC2. Conscious ASIC2 null mice developed hypertension, had exaggerated sympathetic and depressed parasympathetic control of the circulation, and a decreased gain of the baroreflex, all indicative of an impaired baroreceptor reflex. Multiple measures of baroreceptor activity each suggest that mechanosensitivity is diminished in ASIC2 null mice. The results define ASIC2 as an important determinant of autonomic circulatory control and of baroreceptor sensitivity. The genetic disruption of ASIC2 recapitulates the pathological dysautonomia seen in heart failure and hypertension and defines a molecular defect that may be relevant to its development.	[Lu, Yongjun; Ma, Xiuying; Sabharwal, Rasna; Snitsarev, Vladislav; Morgan, Donald; Rahmouni, Kamal; Drummond, Heather A.; Whiteis, Carol A.; Costa, Vivian; Price, Margaret; Benson, Christopher; Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Lu, Yongjun; Ma, Xiuying; Sabharwal, Rasna; Snitsarev, Vladislav; Morgan, Donald; Rahmouni, Kamal; Drummond, Heather A.; Whiteis, Carol A.; Costa, Vivian; Price, Margaret; Benson, Christopher; Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Univ Iowa, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Abboud, FM (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	francois-abboud@uiowa.edu	Snitsarev, Vladislav/AAP-5599-2020; Morgan, Donald A/L-6907-2013; Rahmouni, Kamal/Y-1788-2019	Morgan, Donald A/0000-0003-3167-1643; Chapleau, Mark/0000-0001-6961-931X; Rahmouni, Kamal/0000-0001-5136-6748; Welsh, Michael/0000-0002-1646-6206; Snitsarev, Vladislav/0000-0001-5518-5899; Abboud, Francois/0000-0002-7284-9148; Benson, Christopher/0000-0001-6600-8193; Sabharwal, Rasna/0000-0001-7256-5359	National Institutes of Health [HL14388-37]; Department of Veterans Affairs; HHMI; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, P01HL014388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); HHMI(Howard Hughes Medical Institute); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Sarah Porter and Courtney Cable for assistance with word processing and manuscript preparation, Shawn Roach for help creating and editing the figures, Rubens Fazan, Jr. for assistance in analyses of data on aortic baroreceptor nerve activity, and David Dellsperger for assisting Donald Morgan in studies of electrical stimulation of the aortic depressor nerve done in the lab of Kamal Rahmouni and Allyn Mark. We also thank the University of Iowa Core DNA Facility, the central microscopy facility and the animal care facility for assistance. Y.L. designed primers and performed molecular studies: X.M. performed neural recordings in vivo; R.S. did the telemetry and bilateral carotid occlusion studies; V.S. performed the EP work on isolated neurons; C.A.W. performed surgical procedures, prepared cultures, and analyzed data; D.M. did the studies on electrical stimulation of aortic depressor nerves in the laboratory of K.R.; H.A.D. contributed to the initial study design; M.P. contributed to concepts and technical approaches; V.C. developed the transgenic mouse; C.B. contributed to concepts and technical approaches; M.J.W. contributed to concepts and edited the manuscript; M.W.C. and F.M.A. designed the study, analyzed the data, and wrote the paper. This work was supported by grant HL14388-37 from the National Institutes of Health (F.M.A. and M.W.C.), the VA Merit Review Award from the Department of Veterans Affairs (M.W.C.), the HHMI (M.J.W.), and Heartland Affiliate Postdoctoral Fellowships from the American Heart Association (R.S.).	Awayda MS, 1998, J GEN PHYSIOL, V112, P97, DOI 10.1085/jgp.112.2.97; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BERTINIERI G, 1988, AM J PHYSIOL, V254, pH377, DOI 10.1152/ajpheart.1988.254.2.H377; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; CHALFIE M, 1993, NATURE, V361, P504, DOI 10.1038/361504a0; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Corey DP, 1996, SCIENCE, V273, P323, DOI 10.1126/science.273.5273.323; CUNNINGHAM JT, 1995, J NEUROPHYSIOL, V73, P2094, DOI 10.1152/jn.1995.73.5.2094; Cunningham JT, 1997, BRAIN RES, V757, P149, DOI 10.1016/S0006-8993(97)00153-4; Desai BN, 2005, PFLUG ARCH EUR J PHY, V451, P11, DOI 10.1007/s00424-005-1429-z; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; EPSTEIN SE, 1969, NEW ENGL J MED, V280, P971, DOI 10.1056/NEJM196905012801801; Filippone JD, 2007, CURR OPIN NEPHROL HY, V16, P403; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GUO GB, 1982, CIRC RES, V50, P554, DOI 10.1161/01.RES.50.4.554; GUO GB, 1984, AM J PHYSIOL, V246, pH720, DOI 10.1152/ajpheart.1984.246.5.H720; GUO GB, 1983, CIRC RES, V53, P223, DOI 10.1161/01.RES.53.2.223; HAJDUCZOK G, 1994, J CLIN INVEST, V94, P2392, DOI 10.1172/JCI117605; HEYMANS C, 1958, REFLEXOGENIC AREAS C, P1; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; ITURRIAGA R, 1988, ACTA PHYSIOL PHARM L, V38, P27; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; LANDGREN S, 1952, ACTA PHYSIOL SCAND, V26, P1; Laude D, 2008, AM J PHYSIOL-REG I, V294, pR142, DOI 10.1152/ajpregu.00319.2007; Lawrence IG, 1997, DIABETIC MED, V14, P82, DOI 10.1002/(SICI)1096-9136(199701)14:1<82::AID-DIA290>3.0.CO;2-3; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Li Z, 1997, J PHYSIOL-LONDON, V501, P275, DOI 10.1111/j.1469-7793.1997.275bn.x; Ma XY, 2002, AM J PHYSIOL-REG I, V283, pR1033, DOI 10.1152/ajpregu.00768.2001; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Mortara A, 1997, CIRCULATION, V96, P3450; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Robinson TG, 2003, STROKE, V34, P705, DOI 10.1161/01.STR.0000058493.94875.9F; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Snitsarev V, 2007, J PHYSIOL-LONDON, V582, P177, DOI 10.1113/jphysiol.2007.133330; Sullivan MJ, 1997, CIRC RES, V80, P861; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Zucker IH, 2007, HYPERTENSION, V50, P904, DOI 10.1161/HYPERTENSIONAHA.107.095216	56	136	145	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					885	897		10.1016/j.neuron.2009.11.007	http://dx.doi.org/10.1016/j.neuron.2009.11.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064394	Bronze, Green Accepted			2022-12-17	WOS:000273425800014
J	Jing, LL; Lefebvre, JL; Gordon, LR; Granato, M				Jing, Lili; Lefebvre, Julie L.; Gordon, Laura R.; Granato, Michael			Wnt Signals Organize Synaptic Prepattern and Axon Guidance through the Zebrafish unplugged/MuSK Receptor	NEURON			English	Article							NEUROMUSCULAR-JUNCTION; IN-VIVO; ACETYLCHOLINE-RECEPTORS; POSTSYNAPTIC MEMBRANE; GENE-EXPRESSION; CELL POLARITY; MUSCLE; MUSK; WINGLESS; AGRIN	Early during neuromuscular development, acetylcholine receptors (AChRs) accumulate at the center of muscle fibers, precisely where motor growth cones navigate and synapses eventually form. Here, we show that Wnt11r binds to the zebrafish unplugged/MuSK ectodomain to organize this central muscle zone. In the absence of such a zone, prepatterned AChRs fail to aggregate and, as visualized by live-cell imaging, growth cones stray from their central path. Using inducible unplugged/MuSK transgenes, we show that organization of the central muscle zone is dispensable for the formation of neural synapses, but essential for AChR prepattern and motor growth cone guidance. Finally, we show that blocking noncanonical dishevelled signaling in muscle fibers disrupts AChR prepatterning and growth cone guidance. We propose that Wnt ligands activate unplugged/MuSK signaling in muscle fibers to restrict growth cone guidance and AChR prepatterns to the muscle center through a mechanism reminiscent of the planar cell polarity pathway.	[Jing, Lili; Lefebvre, Julie L.; Gordon, Laura R.; Granato, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu			National Science Foundation; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank Drs. Ingham and Elworthy for sharing the smyhc1 promoter, Dr. Meyer for providing the Hb9 promotor and the Hb9:GFP line before publication, Andrea Stout from the CDB imaging core, members of the Bashaw laboratory for technical advice, and members of the Granato laboratory for comments. We would also like to thank Dr. Gilmour (EMBL) and members of his laboratory for help with live-cell imaging. This work was supported by grants from the National Science Foundation (M.G.) and the National Institutes of Health (M.G.).	ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Becker CG, 2003, J NEUROSCI, V23, P6232; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Burden SJ, 2003, NAT NEUROSCI, V6, P653, DOI 10.1038/nn0703-653; Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137; Cortes F, 2003, DEV CELL, V5, P865, DOI 10.1016/S1534-5807(03)00362-9; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Downes GB, 2002, GENESIS, V34, P196, DOI 10.1002/gene.10120; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Jones G, 1999, J NEUROSCI, V19, P3376; Kim CH, 2003, J BIOL CHEM, V278, P38522, DOI 10.1074/jbc.M305058200; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lefebvre JL, 2004, DEVELOPMENT, V131, P2605, DOI 10.1242/dev.01123; Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; LIU DWC, 1992, J NEUROSCI, V12, P1859; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Masuda T, 2004, MOL CELL NEUROSCI, V25, P217, DOI 10.1016/j.mcn.2003.10.005; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Vock VM, 2008, J NEUROSCI, V28, P3123, DOI 10.1523/JNEUROSCI.5080-07.2008; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350; Zhang J, 2000, DEVELOPMENT, V127, P2099; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	67	136	141	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 12	2009	61	5					721	733		10.1016/j.neuron.2008.12.025	http://dx.doi.org/10.1016/j.neuron.2008.12.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	421NZ	19285469	Green Accepted, Bronze			2022-12-17	WOS:000264366900012
J	Danziger, N; Faillenot, I; Peyron, R				Danziger, Nicolas; Faillenot, Isabelle; Peyron, Roland			Can We Share a Pain We Never Felt? Neural Correlates of Empathy in Patients with Congenital Insensitivity to Pain	NEURON			English	Article							EVENT-RELATED FMRI; SOCIAL COGNITION; FACIAL EXPRESSIONS; CINGULATE CORTEX; VISUAL ACTIVATION; PREFRONTAL CORTEX; MIND; PERCEPTION; OTHERS; SELF	Theories of empathy differ regarding the relative contributions of automatic resonance and perspective taking in understanding others' emotions. Patients with the rare syndrome of congenital insensitivity to pain cannot rely on "mirror matching" (i.e., resonance) mechanisms to understand the pain of others. Nevertheless, they showed normal fMRI responses to observed pain in anterior mid-cingulate cortex and anterior insula, two key regions of the so-called "shared circuits" for self and other pain. In these patients (but not in healthy controls), empathy trait predicted ventromedial prefrontal responses to somatosensory representations of others' pain and posterior cingulate responses to emotional representations of others' pain. These findings underline the major role of midline structures in emotional perspective taking and understanding someone else's feeling despite the lack of any previous personal experience of it-an empathic challenge frequently raised during human social interactions.	[Danziger, Nicolas] CHU Pitie Salpetriere, Dept Clin Neurophysiol, AP HP, F-75013 Paris, France; [Danziger, Nicolas] CHU Pitie Salpetriere, Pain Ctr, AP HP, F-75013 Paris, France; [Danziger, Nicolas] CHU Pitie Salpetriere, INSERM U713, AP HP, F-75013 Paris, France; [Faillenot, Isabelle; Peyron, Roland] CHU St Etienne, Pain Ctr, F-42100 St Etienne, France; [Peyron, Roland] CHU St Etienne, Dept Neurol, F-42100 St Etienne, France; [Faillenot, Isabelle; Peyron, Roland] UCB Lyon1 Univ, F-69003 Lyon, France; [Faillenot, Isabelle; Peyron, Roland] UJM St Etienne Unv, F-42000 St Etienne, France; [Peyron, Roland] CERMEP, F-69003 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de St Etienne; CHU de St Etienne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Danziger, N (corresponding author), CHU Pitie Salpetriere, Dept Clin Neurophysiol, AP HP, F-75013 Paris, France.	nicolas.danziger@psl.aphp.fr		Faillenot, Isabelle/0000-0003-2230-7874; Peyron, Roland/0000-0002-2706-0594	Institut UPSA do la Douleur	Institut UPSA do la Douleur	This work was supported by Institut UPSA do la Douleur. We thank R. Gaillard, L. Naccache, J.J. Benoliel, L. Garcia-Larrea, and L. Cohen for comments on an earlier version of the manuscript; K.M. Prkachin, who provided us with selected videotaped recordings of facial expressions; and Anne Renardet, who kindly edited this material.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; BEER JS, 2008, BRAIN RES, V1078, P98; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Danziger N, 2005, PAIN, V117, P478, DOI 10.1016/j.pain.2005.07.012; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ekman P, 2002, FACIAL ACTION CODING; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Gundel H, 2003, AM J PSYCHIAT, V160, P1946, DOI 10.1176/appi.ajp.160.11.1946; Hopfinger JB, 2000, NEUROIMAGE, V11, P326, DOI 10.1006/nimg.2000.0549; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Mitchell JP, 2006, BRAIN RES, V1079, P66, DOI 10.1016/j.brainres.2005.12.113; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Mourao-Miranda J, 2003, NEUROIMAGE, V20, P1955, DOI 10.1016/j.neuroimage.2003.08.011; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Panksepp J, 2003, SCIENCE, V302, P237, DOI 10.1126/science.1091062; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phan KL, 2004, NEUROREPORT, V15, P527, DOI 10.1097/00001756-200403010-00029; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; PICHOT P, 1984, REV PSYCHOL APPL, V34, P229; Preston AR, 2004, NEUROIMAGE, V21, P291, DOI 10.1016/j.neuroimage.2003.09.017; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	61	136	142	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 29	2009	61	2					203	212		10.1016/j.neuron.2008.11.023	http://dx.doi.org/10.1016/j.neuron.2008.11.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	407EY	19186163	Bronze			2022-12-17	WOS:000263347600007
J	Zylka, MJ; Sowa, NA; Taylor-Blake, B; Twomey, MA; Herrala, A; Voikar, V; Vihko, P				Zylka, Mark J.; Sowa, Nathaniel A.; Taylor-Blake, Bonnie; Twomey, Margaret A.; Herrala, Annakaisa; Voikar, Vootele; Vihko, Pirkko			Prostatic Acid Phosphatase Is an Ectonucleotidase and Suppresses Pain by Generating Adenosine	NEURON			English	Article							DORSAL-ROOT GANGLION; PRIMARY AFFERENT NEURONS; SPINAL-CORD; NEUROPATHIC PAIN; INTRATHECAL ADENOSINE; LYSOPHOSPHATIDIC ACID; SYNAPTIC-TRANSMISSION; SUBSTANTIA-GELATINOSA; NERVE INJURY; HORN NEURONS	Thiamine monophosphatase (TMPase, also known as fluoride-resistant acid phosphatase) is a classic histochemical marker of small-diameter dorsal root ganglia neurons. The molecular identity of TMPase is currently unknown. We found that TMPase is identical to the transmembrane isoform of prostatic acid phosphatase (PAP), an enzyme with unknown molecular and physiological functions. We then found that PAP knockout mice have normal acute pain sensitivity but enhanced sensitivity in chronic inflammatory and neuropathic pain models. In gain-of-function studies, intraspinal injection of PAP protein has potent antinociceptive, anti hyperalgesic, and antiallodynic effects that last longer than the opioid analgesic morphine. PAP suppresses pain by functioning as an ecto-5'-nucleotidase. Specifically, PAP dephosphorylates extracellular adenosine monophosphate (AMP) to adenosine and activates A(1)-adenosine receptors in dorsal spinal cord. Our studies reveal molecular and physiological functions for PAP in purine nucleotide metabolism and nociception and suggest a novel use for PAP in the treatment of chronic pain.	[Zylka, Mark J.; Sowa, Nathaniel A.; Taylor-Blake, Bonnie; Twomey, Margaret A.] Univ N Carolina, Ctr Neurosci, Dept Cellular & Mol Physiol, Chapel Hill, NC 27599 USA; [Herrala, Annakaisa; Vihko, Pirkko] Univ Helsinki, Dept Biol & Environm Sci, Div Biochem, FI-00014 Helsinki, Finland; [Voikar, Vootele] Univ Helsinki, Ctr Neurosci, FI-00014 Helsinki, Finland; [Vihko, Pirkko] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Vihko, Pirkko] Univ Oulu, Ctr Mol Endocrinol, FI-90014 Oulu, Finland	University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; University of Helsinki; University of Oulu; University of Oulu	Zylka, MJ (corresponding author), Univ N Carolina, Ctr Neurosci, Dept Cellular & Mol Physiol, CB 7545, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu; pirkko.vihko@helsinki.fi	Voikar, Vootele/V-4542-2019; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Voikar, Vootele/0000-0003-4201-8666; 	UNC; The Sloan Foundation; The Searle Scholars Program; The Klingenstein Foundation; The Whitehall Foundation; Rita Allen Foundation; NINDS [R01NS060725, F30NS063507]; The Sigrid Juselius Foundation; The Finnish Cancer Foundation; The Research Council for Medicine of the Academy of Finland; NICHD [P30NS045892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, P30NS045892, F30NS063507] Funding Source: NIH RePORTER	UNC; The Sloan Foundation(Alfred P. Sloan Foundation); The Searle Scholars Program; The Klingenstein Foundation(Klingenstein Philanthropies); The Whitehall Foundation; Rita Allen Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); The Finnish Cancer Foundation; The Research Council for Medicine of the Academy of Finland(Academy of Finland); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Edward Perl, Paul Farel, and Ben Philpot for comments on the manuscript; David J. Anderson for providing Mrgprd Delta<SUP>EGFPI</SUP> mice; Stephen L. Tilley for providing isogenic A<INF>1</INF>R<SUP>-/-</SUP> mice. Eduardo R. Lazarowski for measuring adenosine and adenine nucleotides by HPLC; Shannon Shields and Allan I. Basbaum for teaching us how to perform pain behavioral assays and SNI surgeries; and Yvette Chuang and Kunjumon Vadakkan for excellent technical assistance. This work was supported by UNC startup funds, grants to M.J.Z. from The Sloan Foundation. The Searle Scholars Program, The Klingenstein Foundation, The Whitehall Foundation. Rita Allen Foundation, and NINDS (R01NS060725), a grant to N.A.S. from NINDS (F30NS063507), and grants to P.V. from The Sigrid Juselius Foundation, The Finnish Cancer Foundation, and The Research Council for Medicine of the Academy of Finland. Confocal imaging was performed at the UNC-CH Confocal Imaging Facility, which is co-funded by NINDS and NICHD (P30NS045892). M.J.Z. is a Rita Allen Foundation Milton E. Cassel Scholar.; M.J.Z. empirically determined that PAP was TMPase, conceived the work, designed the experiments, supervised the project, and wrote the manuscript. N.A.S. performed in situ hybridizations, phosphatase assays, intrathecal injections, and behavioral assays. B.T-B. performed histological experiments. M.T. collected tissue for histology, performed intrathecal injections, SNI surgeries, and behavioral assays. A.H. and P.V. generated and provided PAP knockout mice and tissues. V.V. and P.V. conducted preliminary behavioral experiments with PAP knockout mice. M.J.Z and P.V. shared unpublished data to facilitate this study.	Belfrage M, 1999, ANESTH ANALG, V89, P136, DOI 10.1097/00000539-199907000-00023; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; CARR PA, 1990, NEUROSCIENCE, V36, P751, DOI 10.1016/0306-4522(90)90017-X; COLMANT H J, 1959, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V199, P60, DOI 10.1007/BF00361100; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; CSILLIK B, 1986, PROTEAN GATE STRUCTU; Cui JG, 1997, NEUROSCI LETT, V223, P173, DOI 10.1016/S0304-3940(97)13435-8; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; DALSGAARD CJ, 1984, NEUROSCI LETT, V51, P139, DOI 10.1016/0304-3940(84)90275-1; Davis-Taber RA, 2006, DRUG DEVELOP RES, V67, P308, DOI 10.1002/ddr.20096; DIRIG DM, 1995, PAIN, V62, P321, DOI 10.1016/0304-3959(95)00006-E; DODD J, 1983, COLD SPRING HARB SYM, V48, P685, DOI 10.1101/SQB.1983.048.01.072; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DZIEMBORGRYSZKIEWICZ E, 1978, B ACAD POL SCI BIOL, V26, P815; Eisenach JC, 2002, ANESTHESIOLOGY, V96, P29, DOI 10.1097/00000542-200201000-00011; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Fishman P, 2003, ANTICANCER RES, V23, P2077; Gomes JA, 1999, ANESTHESIOLOGY, V91, P1072, DOI 10.1097/00000542-199910000-00028; GRANT GJ, 1995, ANESTH ANALG, V81, P514, DOI 10.1097/00000539-199509000-00015; Gutman AB, 1938, J CLIN INVEST, V17, P473, DOI 10.1172/JCI100974; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashida Masakazu, 2005, J Anesth, V19, P225, DOI 10.1007/s00540-005-0310-8; Hua XY, 2007, AM J PHYSIOL-LUNG C, V293, pL25, DOI 10.1152/ajplung.00058.2007; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; Lao LJ, 2001, PAIN, V94, P315, DOI 10.1016/S0304-3959(01)00367-0; Lavand'homme PM, 1999, PAIN, V80, P31, DOI 10.1016/S0304-3959(98)00193-6; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lee YW, 1996, J PHARMACOL EXP THER, V277, P1642; LI HC, 1984, EUR J BIOCHEM, V138, P45, DOI 10.1111/j.1432-1033.1984.tb07879.x; LI J, 1994, J NEUROPHYSIOL, V72, P1611, DOI 10.1152/jn.1994.72.4.1611; LI J, 1995, J NEUROSCI, V15, P3357; LIN MF, 1992, CANCER RES, V52, P4600; Liu Xue Jun, 2005, Curr Opin Investig Drugs, V6, P65; Maione S, 2007, PAIN, V131, P281, DOI 10.1016/j.pain.2007.01.013; MCMAHON SB, 1988, J COMP NEUROL, V274, P1, DOI 10.1002/cne.902740102; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; NAGY JI, 1985, NEUROSCIENCE, V15, P799, DOI 10.1016/0306-4522(85)90079-X; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; Nishiyama T, 2000, ANESTH ANALG, V91, P423, DOI 10.1097/00000539-200008000-00036; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; Patel MK, 2001, BRAIN RES, V920, P19, DOI 10.1016/S0006-8993(01)02844-X; Patterson SL, 2001, J NEUROCHEM, V76, P234, DOI 10.1046/j.1471-4159.2001.00016.x; Poon A, 1998, PAIN, V74, P235, DOI 10.1016/S0304-3959(97)00186-3; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; POST C, 1984, NEUROSCI LETT, V51, P325, DOI 10.1016/0304-3940(84)90397-5; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; ROIKO K, 1990, GENE, V89, P223, DOI 10.1016/0378-1119(90)90009-G; SALTER MW, 1985, NEUROSCIENCE, V15, P815, DOI 10.1016/0306-4522(85)90080-6; SANYAL S, 1974, BRAIN RES, V76, P161, DOI 10.1016/0006-8993(74)90523-X; Sawynok J, 2007, Handb Exp Pharmacol, P309; Schulte G, 2003, NEUROSCIENCE, V121, P907, DOI 10.1016/S0306-4522(03)00480-9; SCOTT TG, 1967, J COMP NEUROL, V129, P97, DOI 10.1002/cne.901290108; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P219, DOI 10.3109/07367228809144628; SURAN AA, 1974, J HISTOCHEM CYTOCHEM, V22, P802, DOI 10.1177/22.8.802; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; TENSER RB, 1991, NEUROSCI LETT, V130, P85, DOI 10.1016/0304-3940(91)90233-J; TENSER RB, 1985, BRAIN RES, V332, P386, DOI 10.1016/0006-8993(85)90610-9; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; VIHKO P, 1978, CLIN CHEM, V24, P1783; VIHKO P, 1982, J UROLOGY, V128, P202, DOI 10.1016/S0022-5347(17)52818-9; VIHKO P, 1979, INVEST UROL, V16, P349; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Wu WP, 2005, PAIN, V113, P395, DOI 10.1016/j.pain.2004.11.020; Zhang Y, 2005, ANESTHESIOLOGY, V102, P416, DOI 10.1097/00000542-200502000-00027; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	78	136	143	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 9	2008	60	1					111	122		10.1016/j.neuron.2008.08.024	http://dx.doi.org/10.1016/j.neuron.2008.08.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	363AC	18940592	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000260237300012
J	Morgan, ML; DeAngelis, GC; Angelaki, DE				Morgan, Michael L.; DeAngelis, Gregory C.; Angelaki, Dora E.			Multisensory integration in macaque visual cortex depends on cue reliability	NEURON			English	Article							VENTRAL INTRAPARIETAL AREA; SUPERIOR COLLICULUS NEURONS; TEMPORAL SULCUS; SENSORY INPUTS; REPRESENTATION; INFORMATION; MONKEY; SUPERADDITIVITY; DETERMINANTS; ORGANIZATION	Responses of multisensory neurons to combinations of sensory cues are generally enhanced or depressed relative to single cues presented alone, but the rules that govern these interactions have remained unclear. We examined integration of visual and vestibular self-motion cues in macaque area MSTd in response to unimodal as well as congruent and conflicting bimodal stimuli in order to evaluate hypothetical combination rules employed by multisensory neurons. Bimodal responses were well fit by weighted linear sums of unimodal responses, with weights typically less than one (subadditive). Surprisingly, our results indicate that weights change with the relative reliabilities of the two cues: visual weights decrease and vestibular weights increase when visual stimuli are degraded. Moreover, both modulation depth and neuronal discrimination thresholds improve for matched bimodal compared to unimodal stimuli, which might allow for increased neural sensitivity during multisensory stimulation. These findings establish important new constraints for neural models of cue integration.	[Morgan, Michael L.; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [DeAngelis, Gregory C.] Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Washington University (WUSTL); University of Rochester	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273	NIH [EY017866, DC04260, EY016178]; NATIONAL EYE INSTITUTE [R01EY016178, R01EY017866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004260] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Amanda Turner and Erin White for excellent monkey care and training. We thank Alexandre Pouget for helpful comments on the manuscript. This work was supported by NIH EY017866 and DC04260 (to D.E.A.) and NIH EY016178 (to G.C.D.).	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Bell AH, 2003, EUR J NEUROSCI, V18, P2867, DOI 10.1111/j.1460-9568.2003.02976.x; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Frens MA, 1998, BRAIN RES BULL, V46, P211, DOI 10.1016/S0361-9230(98)00007-0; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; GU Y, 2008, NAT NEUROSC IN PRESS; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MEREDITH MA, 1986, BRAIN RES, V365, P350; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Perrault TJ, 2003, J NEUROPHYSIOL, V90, P4022, DOI 10.1152/jn.00494.2003; Populin LC, 2002, J NEUROSCI, V22, P2826, DOI 10.1523/JNEUROSCI.22-07-02826.2002; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Romanski LM, 2007, CEREB CORTEX, V17, pI61, DOI 10.1093/cercor/bhm099; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Skaliora I, 2004, J NEUROPHYSIOL, V92, P2933, DOI 10.1152/jn.00450.2004; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246	48	136	137	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 28	2008	59	4					662	673		10.1016/j.neuron.2008.06.024	http://dx.doi.org/10.1016/j.neuron.2008.06.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	344RL	18760701	Green Accepted, Bronze			2022-12-17	WOS:000258944900015
J	de Solages, C; Szapiro, G; Brunel, N; Hakim, V; Isope, P; Buisseret, P; Rousseau, C; Barbour, B; Lena, C				de Solages, Camille; Szapiro, German; Brunel, Nicolas; Hakim, Vincent; Isope, Philippe; Buisseret, Pierre; Rousseau, Charly; Barbour, Boris; Lena, Clement			High-frequency organization and synchrony of activity in the Purkinje cell layer of the cerebellum	NEURON			English	Article							SYNAPTIC CURRENTS; CANNABINOID RECEPTOR; OSCILLATIONS; CORTEX; INHIBITION; NEURONS; SYNAPSES; NETWORKS; PATTERN; COLLATERALS	The cerebellum controls complex, coordinated, and rapid movements, a function requiring precise timing abilities. However, the network mechanisms that underlie the temporal organization of activity in the cerebellum are largely unexplored, because in vivo recordings have usually targeted single units. Here, we use tetrode and multisite recordings to demonstrate that Purkinje cell activity is synchronized by a high-frequency (similar to 200 Hz) population oscillation. We combine pharmacological experiments and modeling to show how the recurrent inhibitory connections between Purkinje cells are sufficient to generate these oscillations. A key feature of these oscillations is a fixed population frequency that is independent of the firing rates of the individual cells. Convergence in the deep cerebellar nuclei of Purkinje cell activity, synchronized by these oscillations, likely organizes temporally the cerebellar output.	[de Solages, Camille; Szapiro, German; Isope, Philippe; Rousseau, Charly; Barbour, Boris; Lena, Clement] Ecole Normale Super, UMR 8544, Neurobiol Lab, F-75005 Paris, France; [Brunel, Nicolas] Univ Paris 05, UMR 8119, Lab Neurophys & Physiol, F-75006 Paris, France; [Hakim, Vincent] Ecole Normale Super, UMR 8550, Lab Phys Stat, F-75005 Paris, France; [Buisseret, Pierre] Museum Natl Hist Nat, Dept Regulat, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN)	Lena, C (corresponding author), Ecole Normale Super, UMR 8544, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	lena@biologie.ens.fr	Léna, Clément/ABE-4862-2021; Léna, Clément/P-6929-2019; Léna, Clément/T-8458-2018; , clement/ADN-8076-2022	Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Barbour, Boris/0000-0002-1911-0539; Isope, Philippe/0000-0002-0630-5935; hakim, vincent/0000-0001-7505-8192				[Anonymous], [No title captured]; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bearzatto B, 2006, FASEB J, V20, P380, DOI 10.1096/fj.05-3785fje; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; BISHOP GA, 1982, J COMP NEUROL, V210, P1, DOI 10.1002/cne.902100102; BROOKHART JM, 1960, HDB PHYSL NEUROPHYSI, P1245; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; Cheron G, 2004, J NEUROSCI, V24, P434, DOI 10.1523/JNEUROSCI.3197-03.2004; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Dean I, 2003, J NEUROSCI, V23, P4457; Delescluse M, 2006, J NEUROSCI METH, V150, P16, DOI 10.1016/j.jneumeth.2005.05.023; DeZeeuw CI, 1997, J NEUROPHYSIOL, V77, P1747, DOI 10.1152/jn.1997.77.4.1747; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dieudonne S, 2000, J NEUROSCI, V20, P1837; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; EBNER TJ, 1981, J NEUROPHYSIOL, V45, P948, DOI 10.1152/jn.1981.45.5.948; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gauck V, 2000, J NEUROSCI, V20, P3006; Gianola S, 2003, J NEUROSCI, V23, P4613; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; Heck DH, 2007, P NATL ACAD SCI USA, V104, P7658, DOI 10.1073/pnas.0609966104; Isope P, 2002, ANN NY ACAD SCI, V978, P164, DOI 10.1111/j.1749-6632.2002.tb07564.x; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Laine J, 1998, NEUROREPORT, V9, P2399, DOI 10.1097/00001756-199807130-00045; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Maex R, 2003, J NEUROSCI, V23, P10503; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Mathiesen C, 1998, EUR J PHARMACOL, V353, P159, DOI 10.1016/S0014-2999(98)00401-4; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; ODONOGHUE DL, 1989, J NEUROSCI, V9, P2141; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; Palay S.L., 1974, CEREBELLAR CORTEX CY; PELLET J, 1974, ARCH ITAL BIOL, V112, P163; Pouzat C, 1997, J NEUROSCI, V17, P9104; R Development Core Team, 2004, R LANG ENV STAT COMP; Ramon, 1911, HISTOLOGIE SYSTEME N, V2; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; Wang XJ, 1996, J NEUROSCI, V16, P6402; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	57	136	137	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					775	788		10.1016/j.neuron.2008.05.008	http://dx.doi.org/10.1016/j.neuron.2008.05.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549788	Bronze			2022-12-17	WOS:000256870800014
J	McGann, JP; Pirez, N; Gainey, MA; Muratore, C; Elias, AS; Wachowiak, M				McGann, JP; Pirez, N; Gainey, MA; Muratore, C; Elias, AS; Wachowiak, M			Odorant representations are modulated by intra- but not interglomerular presynaptic inhibition of olfactory sensory neurons	NEURON			English	Article							EXTERNAL TUFTED CELLS; BULB GLOMERULI; SYNAPTIC-TRANSMISSION; FUNCTIONAL-ORGANIZATION; RECIPROCAL SYNAPSES; NERVE-TERMINALS; INPUT; RAT; EXPRESSION; RELEASE	Input to the central nervous system from olfactory sensory neurons (OSNs) is modulated presynaptically. We investigated the functional organization of this inhibition and its role in odor coding by imaging neurotransmitter release from OSNs in slices and in vivo in mice expressing synaptopHluorin, an optical indicator of vesicle exocytosis. Release from OSNs was strongly suppressed by heterosynaptic, intraglomerular inhibition. In contrast, inhibitory connections between glomeruli mediated only weak lateral inhibition of OSN inputs in slices and did not do so in response to odorant stimulation in vivo. Blocking presynaptic inhibition in vivo increased the amplitude of odorant-evoked input to glomeruli but had little effect on spatial patterns of glomerular input. Thus, intraglomerular inhibition limits the strength of olfactory input to the CNS, whereas interglomerular inhibition plays little or no role. This organization allows for control of input sensitivity while maintaining the spatial maps of glomerular activity thought to encode odorant identity.	Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	McGann, JP (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	mcgann@bu.edu		Pirez, Nicolas/0000-0002-0463-0080; Gainey, Melanie/0000-0002-4782-9647	NIDCD NIH HHS [DC4938, F32 DC007258, DC6441, DC7258] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004938, R01DC006441, F32DC007258] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Cho JY, 1996, J COMP NEUROL, V369, P264; Duchamp-Viret P, 2000, NEUROSCIENCE, V97, P771, DOI 10.1016/S0306-4522(00)00055-5; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GETCHELL TV, 1975, J PHYSIOL-LONDON, V251, P523, DOI 10.1113/jphysiol.1975.sp011106; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Keller A, 1998, J NEUROSCI, V18, P2602; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ohliger-Frerking P, 2003, J NEUROSCI, V23, P4809; PINCHING AJ, 1971, J CELL SCI, V9, P379; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Toida K, 2000, NEUROSCIENCE, V101, P11, DOI 10.1016/S0306-4522(00)00356-0; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VUCINIC D, 2005, IN PRESS J NEUROPHYS, V30; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	40	136	138	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					1039	1053		10.1016/j.neuron.2005.10.031	http://dx.doi.org/10.1016/j.neuron.2005.10.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364906	Bronze			2022-12-17	WOS:000234301700018
J	Wardak, C; Olivier, E; Duhamel, JR				Wardak, C; Olivier, E; Duhamel, JR			A deficit in covert attention after parietal cortex inactivation in the monkey	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; VISUAL-SEARCH; REVERSIBLE INACTIVATION; NEURAL MECHANISMS; NEURONAL-ACTIVITY; SINGLE NEURONS; MACAQUE; REPRESENTATION; SELECTION	Although the parietal cortex has been repeatedly implicated in controlling attention, the nature and importance of this contribution remain unclear. Here we show that inactivating the lateral intraparietal area in monkeys delays the detection of a visual target located in the contralateral visual field. This effect was observed using different visual scene configurations, e.g., with distractors that differ in number or that differ from the target by a conjunction of shape and color or by a single feature. Since eye movements were not allowed during the searching tasks, these results argue for an unambiguous role of the parietal cortex in the top-down control of attentional deployment in space.	UCBL, CNRS, UMR 5015, Inst Cognit Sci, Bron, France; Catholic Univ Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain	Duhamel, JR (corresponding author), UCBL, CNRS, UMR 5015, Inst Cognit Sci, Bron, France.	duhamel@isc.cnrs.fr	Wardak, Claire/P-6222-2016; Duhamel, Jean-René/M-4723-2017	Wardak, Claire/0000-0001-8847-1859; Duhamel, Jean-René/0000-0003-0210-1027				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Bullier J, 1996, BEHAV BRAIN RES, V76, P89, DOI 10.1016/0166-4328(95)00182-4; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CRITCHLEYM, 1953, PARIETAL LOBES; Donner T, 2000, EUR J NEUROSCI, V12, P3407, DOI 10.1046/j.1460-9568.2000.00223.x; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eglin M, 1989, J Cogn Neurosci, V1, P372, DOI 10.1162/jocn.1989.1.4.372; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hays A., 1982, WESCON C P, V2, P1; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kodaka Y, 1997, NEUROSCI RES, V28, P291, DOI 10.1016/S0168-0102(97)00055-2; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Li CSR, 1999, J NEUROPHYSIOL, V81, P1827, DOI 10.1152/jn.1999.81.4.1827; Malpeli JG, 1999, J NEUROSCI METH, V86, P119, DOI 10.1016/S0165-0270(98)00161-7; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Nobre AC, 2003, NEUROIMAGE, V18, P91, DOI 10.1006/nimg.2002.1329; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vandenberghe R, 2000, CEREB CORTEX, V10, P706, DOI 10.1093/cercor/10.7.706; Wardak C, 2002, J NEUROSCI, V22, P9877; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	37	136	136	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					501	508		10.1016/S0896-6273(04)00185-0	http://dx.doi.org/10.1016/S0896-6273(04)00185-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134645	Bronze			2022-12-17	WOS:000221458700015
J	Thaler, JP; Koo, SJ; Kania, A; Lettieri, K; Andrews, S; Cox, C; Jessell, TM; Pfaff, SL				Thaler, JP; Koo, SJ; Kania, A; Lettieri, K; Andrews, S; Cox, C; Jessell, TM; Pfaff, SL			A postmitotic role for Isl-class LIM homeodomain proteins in the assignment of visceral spinal motor neuron identity	NEURON			English	Article							PROGENITOR-CELL IDENTITY; HOMEOBOX GENES; CHOLINE-ACETYLTRANSFERASE; TRANSCRIPTIONAL CODES; REPRESSOR ACTIVITY; SUBTYPE IDENTITY; EXPRESSION; FATE; SPECIFICATION; CORD	LIM homeobox genes have a prominent role in the regulation of neuronal subtype identity and distinguish motor neuron subclasses in the embryonic spinal cord. We have investigated the role of IsI-class LIM homeodomain proteins in motor neuron diversification using mouse genetic methods. All spinal motor neuron subtypes initially express both IsI1 and IsI2, but IsI2 is rapidly downregulated by visceral motor neurons, Mouse embryos lacking IsI2 function exhibit defects in the migration and axonal projections of thoracic level motor neurons that appear to reflect a cell-autonomous switch from visceral to somatic motor neuron character. Additional genetic mutations that reduce or eliminate both IsI1 and IsI2 activity result in more pronounced defects in visceral motor neuron generation and erode somatic motor neuron character. Thus, an early phase of high IsI expression and activity in newly generated motor neurons permits the diversification of visceral and somatic motor neuron subtypes in the developing spinal cord.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Salk Institute; Columbia University; Howard Hughes Medical Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	pfaff@salk.edu		Kania, Artur/0000-0002-5209-2520	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM07198] Funding Source: Medline; NINDS NIH HHS [R01NS37116] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Barber RP, 1998, J COMP NEUROL, V398, P568; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Desai AR, 2000, DEVELOPMENT, V127, P2863; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Koo SJ, 2002, NEURON, V35, P823, DOI 10.1016/S0896-6273(02)00870-X; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; LEVIMONTALCINI R, 1950, J MORPHOL, V86, P253, DOI 10.1002/jmor.1050860203; LICHTMAN JW, 1980, J PHYSIOL-LONDON, V298, P285, DOI 10.1113/jphysiol.1980.sp013081; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; MARKHAM JA, 1991, J NEUROBIOL, V22, P811, DOI 10.1002/neu.480220803; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PHELPS PE, 1988, J COMP NEUROL, V273, P459, DOI 10.1002/cne.902730403; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358	44	136	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					337	350		10.1016/S0896-6273(04)00011-X	http://dx.doi.org/10.1016/S0896-6273(04)00011-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766174	Bronze			2022-12-17	WOS:000221457900006
J	Dietrich, D; Kirschstein, T; Kukley, M; Pereverzev, A; von der Brelie, C; Schneider, T; Beck, H				Dietrich, D; Kirschstein, T; Kukley, M; Pereverzev, A; von der Brelie, C; Schneider, T; Beck, H			Functional specialization of presynaptic Ca(v)2.3 Ca2+ channels	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC TRANSMISSION; MOSSY FIBER SYNAPSES; METABOTROPIC GLUTAMATE-RECEPTOR; NEURONAL CALCIUM CHANNELS; RAT BRAIN-STEM; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; DEVELOPMENTAL-CHANGES; HIPPOCAMPAL CA3	Ca2+ influx into presynaptic terminals via voltage-dependent Call channels triggers fast neurotransmitter release as well as different forms of synaptic plasticity. Using electrophysiological and genetic techniques we demonstrate that presynaptic Call entry through Ca(v)2.3 subunits contributes to the induction of mossy fiber LTP and posttetanic potentiation by brief trains of presynaptic action potentials while they do not play a role in fast synaptic transmission, paired-pulse facilitation, or frequency facilitation. This functional specialization is most likely achieved by a localization remote from the release machinery and by a Cav2.3 channel-dependent facilitation of presynaptic Call influx. Thus, the presence of Ca(v)2.3 channels boosts the accumulation of presynaptic Ca2+ triggering presynaptic LTP and posttetanic potentiation without affecting the low release probability that is a prerequisite for the enormous plasticity displayed by mossy fiber synapses.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany; Univ Cologne, Dept Neurophysiol, D-50931 Cologne, Germany	University of Bonn; University of Bonn; University of Cologne	Dietrich, D (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.		Kukley, Maria/I-4064-2017	Kukley, Maria/0000-0002-4567-1241				Atluri PP, 1996, J NEUROSCI, V16, P5661; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELIOT LS, 1993, NATURE, V361, P634, DOI 10.1038/361634a0; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Jackson MB, 2003, J NEUROSCI, V23, P1612; Kamiya H, 1999, J PHYSIOL-LONDON, V518, P497, DOI 10.1111/j.1469-7793.1999.0497p.x; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Katz B., 1969, RELEASE NEURAL TRANS; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; Maeda T, 1997, NEUROSCI LETT, V224, P103, DOI 10.1016/S0304-3940(97)13474-7; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; NACHSHEN DA, 1984, J GEN PHYSIOL, V83, P941, DOI 10.1085/jgp.83.6.941; Naraghi M, 1997, J NEUROSCI, V17, P6961; Pereverzev A, 2002, MOL ENDOCRINOL, V16, P884, DOI 10.1210/me.16.4.884; Qian J, 2001, J NEUROSCI, V21, P3721, DOI 10.1523/JNEUROSCI.21-11-03721.2001; REGEHR WG, 1991, NEURON, V7, P451, DOI 10.1016/0896-6273(91)90297-D; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Vogt KE, 2001, J NEUROSCI, V21, P75, DOI 10.1523/JNEUROSCI.21-01-00075.2001; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wheeler DB, 1996, J NEUROSCI, V16, P2226; WU LG, 1994, J NEUROSCI, V14, P645; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; WU LG, 1995, J NEUROPHYSIOL, V73, P1965, DOI 10.1152/jn.1995.73.5.1965; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	136	137	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 31	2003	39	3					483	496		10.1016/S0896-6273(03)00430-6	http://dx.doi.org/10.1016/S0896-6273(03)00430-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895422	Bronze			2022-12-17	WOS:000184625800011
J	Casado, M; Isope, P; Ascher, P				Casado, M; Isope, P; Ascher, P			Involvement of presynaptic N-methyl-D-aspartate receptors in cerebellar long-term depression	NEURON			English	Article							PURKINJE-CELL SYNAPSE; RAT HIPPOCAMPUS; DENDRITIC SPINES; CALCIUM-RELEASE; NMDA RECEPTORS; ACID RECEPTOR; AREA CA1; GLUTAMATE; POTENTIATION; STIMULATION	At the cerebellar synapses between parallel fibers (PFs) and Purkinje cells (PCs), long-term depression (LTD) of the excitatory synaptic current has been assumed to be Independent of the N-methyl-D-aspartate (NMDA) receptor activation because PCs lack NMDA receptors. However, we now report that LTD is suppressed by NMDA receptor antagonists that act on presynaptic NMDA receptors of the PFs. This effect is still observed when the input Is restricted to a single fiber. Therefore, LTD does not require the spatial integration of multiple inputs. In contrast, it involves a temporal integration, since reliable LTD induction requires the PFs to fire two action potentials in close succession. This implies that LTD will selectively depress the response to a burst of presynaptic action potentials.	Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Casado, M (corresponding author), Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.			Isope, Philippe/0000-0002-0630-5935; Casado, Mariano/0000-0001-8049-8096				Atluri PP, 1996, J NEUROSCI, V16, P5661; Barbour B, 2000, J NEUROSCI METH, V103, P199, DOI 10.1016/S0165-0270(00)00318-6; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boxall AR, 1996, EUR J NEUROSCI, V8, P2209, DOI 10.1111/j.1460-9568.1996.tb00743.x; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Dzubay JA, 1996, J NEUROSCI, V16, P4129; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hamann M, 1996, EUR J NEUROSCI, V8, P1510, DOI 10.1111/j.1460-9568.1996.tb01613.x; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pananceau M, 1997, BRAIN RES, V752, P255, DOI 10.1016/S0006-8993(96)01471-0; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SALT TE, 1986, NATURE, V322, P263, DOI 10.1038/322263a0; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	41	136	139	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					123	130		10.1016/S0896-6273(01)00568-2	http://dx.doi.org/10.1016/S0896-6273(01)00568-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779485	Bronze			2022-12-17	WOS:000173106200015
J	Montgomery, JM; Pavlidis, P; Madison, DV				Montgomery, JM; Pavlidis, P; Madison, DV			Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation	NEURON			English	Article							EXTRASYNAPTIC GLUTAMATE SPILLOVER; HIPPOCAMPAL SLICE CULTURES; CA3 PYRAMIDAL CELLS; RAT HIPPOCAMPUS; TRANSPORTER CURRENTS; AMPA RECEPTORS; SYNAPSES; LTP; RELEASE; NEURONS	The activation of silent synapses is a proposed mechanism to account for rapid increases in synaptic efficacy such as long-term potentiation (LTP). Using simultaneous recordings from individual pre- and postsynaptic neurons in organotypic hippocampal slices, we show that two CA3 neurons can be connected entirely by silent synapses. Increasing release probability or application of cyclothiazide does not produce responses from these silent synapses. Direct measurement of NMDAR-mediated postsynaptic responses in all-silent synaptic connections before and after LTP induction show no change in failure rate, amplitude. or area. These data do not support hypotheses that synapse silent results from presynaptic factors or that LTP results from increases in presynaptic glutamate release. LTP is also associated with an increase in postsynaptic responsiveness to exogenous AMPA. We conclude that synapse silence, activation, and expression of LTP are postsynaptic.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Madison, DV (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	madison@stanford.edu	Pavlidis, Paul/H-8406-2013; Madison, Daniel/F-9341-2017	Pavlidis, Paul/0000-0002-0426-5028; Madison, Daniel/0000-0002-0718-5373	NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FABER DS, 1991, ANN NY ACAD SCI, V627, P151; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Hardingham NR, 1998, J PHYSIOL-LONDON, V507, P249, DOI 10.1111/j.1469-7793.1998.249bu.x; Isaac JTR, 1999, CAN J PHYSIOL PHARM, V77, P735, DOI 10.1139/cjpp-77-9-735; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCALLISTER KA, 2000, PNAS, V97, P6173; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; YAMADA KA, 1993, J NEUROSCI, V13, P3904; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	43	136	140	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					691	701		10.1016/S0896-6273(01)00244-6	http://dx.doi.org/10.1016/S0896-6273(01)00244-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301028	Bronze			2022-12-17	WOS:000167868900018
J	Cossart, R; Tyzio, R; Dinocourt, C; Esclapez, M; Hirsch, JC; Ben-Ari, Y; Bernard, C				Cossart, R; Tyzio, R; Dinocourt, C; Esclapez, M; Hirsch, JC; Ben-Ari, Y; Bernard, C			Presynaptic kainate receptors that enhance the release of GABA on CA1 hippocampal interneurons	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; SYNAPTIC ACTIVATION; IN-VITRO; GABAERGIC INTERNEURONS; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; AMPA RECEPTORS; INHIBITION; MECHANISMS	We report that kainate receptors are present on presynaptic GABAergic terminals contacting interneurons and that their activation increases GABA release. Application of kainate increased the frequency of miniature inhibitory postsynaptic currents recorded in CA1 interneurons. Local applications of glutamate but not of AMPA or NMDA also increased GABA quantal release. Application of kainate as well as synaptically released glutamate reduced the number of failures of GABAergic neurotransmission between interneurons. Thus, activation of presynaptic kainate receptors increases the probability of GABA release at interneuron-interneuron synapses. Glutamate may selectively control the communication between interneurons by increasing their mutual inhibition.	INSERM, INMED, U29, F-13273 Marseille, France; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Baylor College of Medicine	Ben-Ari, Y (corresponding author), INSERM, INMED, U29, Parc Sci Luminy,BP 13, F-13273 Marseille, France.		Esclapez, Monique/O-6509-2016; bernard, christophe/A-4929-2012; Cossart, Rosa/E-7674-2014; bernard, christophe/S-5937-2016; Cossart, Rosa/AAT-7934-2020	Esclapez, Monique/0000-0002-8558-1363; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				BAHN S, 1994, J NEUROSCI, V14, P5525; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Bureau I, 1999, J NEUROSCI, V19, P653; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cunha RA, 2000, FEBS LETT, V469, P159; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukuda T, 2000, J NEUROSCI, V20, P1519; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Glitsch M, 1999, J NEUROSCI, V19, P511; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Jiang L, 2000, J PHYSIOL-LONDON, V523, P425, DOI 10.1111/j.1469-7793.2000.t01-1-00425.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Liu QS, 1999, J NEUROPHYSIOL, V82, P1059, DOI 10.1152/jn.1999.82.2.1059; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Prince DA, 1998, EPILEPSY RES, V32, P83, DOI 10.1016/S0920-1211(98)00042-4; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; SIEGEL SJ, 1995, J NEUROSCI, V15, P2707; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Vida I, 2000, P NATL ACAD SCI USA, V97, P1275, DOI 10.1073/pnas.97.3.1275; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WISDEN W, 1993, J NEUROSCI, V13, P3582; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	48	136	140	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					497	508		10.1016/S0896-6273(01)00221-5	http://dx.doi.org/10.1016/S0896-6273(01)00221-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239438	Bronze			2022-12-17	WOS:000167141700021
J	Kuromi, H; Kidokoro, Y				Kuromi, H; Kidokoro, Y			Tetanic stimulation recruits vesicles from reserve pool via a cAMP-mediated process in Drosophila synapses	NEURON			English	Article							NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLES; CALCIUM CALMODULIN; ADENYLATE-CYCLASE; PROTEIN-KINASE; DISTINCT POOLS; CELLS; MELANOGASTER; MOBILIZATION; RUTABAGA	At Drosophila neuromuscular junctions, there are two synaptic vesicle pools, namely the exo/endo cycling pool (ECP) and the reserve pool (RP). We studied the recruitment process from RP using a fluorescent dye, FM1-43. During high-frequency nerve stimulation, vesicles in RP were recruited for release, and endocytosed vesicles were incorporated into both pools, whereas with low-frequency stimulation, vesicles were incorporated into and released from ECP. Release of vesicles from RP was detected electrophysiologically after emptying vesicles in the ECP of transmitter by a H+ pump inhibitor. Recruitment from RP was depressed by inhibitors of steps in the cAMP/PKA cascade and enhanced by their activators. In rutabaga (rut) with low cAMP levels, mobilization of vesicles from RP during tetanic stimulation was depressed, while it was enhanced in dunce (dnc) with high cAMP levels.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.							AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Cousin MA, 1997, J NEUROCHEM, V69, P1927; DIXON D, 1989, J NEUROSCI, V9, P4246; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 1997, NEUROSCI RES, V27, P101, DOI 10.1016/S0168-0102(96)01132-7; Kuromi H, 1999, J NEUROSCI, V19, P1557; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P5656, DOI 10.1073/pnas.86.14.5656; PARKERBOTELHO LH, 1988, METHOD ENZYMOL, V159, P159; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; PRADO MAM, 1992, J NEUROCHEM, V59, P544, DOI 10.1111/j.1471-4159.1992.tb09404.x; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Zhang DW, 1999, NEUROPHARMACOLOGY, V38, P645, DOI 10.1016/S0028-3908(98)00232-9; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	29	136	137	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	2000	27	1					133	143		10.1016/S0896-6273(00)00015-5	http://dx.doi.org/10.1016/S0896-6273(00)00015-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939337	Bronze			2022-12-17	WOS:000088503800016
J	Born, RT; Groh, JM; Zhao, R; Lukasewycz, SJ				Born, RT; Groh, JM; Zhao, R; Lukasewycz, SJ			Segregation of object and background motion in visual area MT: Effects of microstimulation on eye movements	NEURON			English	Article							MOVING TEXTURED BACKGROUNDS; SUPERIOR TEMPORAL SULCUS; MACAQUE MONKEY; FUNCTIONAL-PROPERTIES; PURSUIT; NEURONS; DIRECTION; SACCADES; CORTEX; HUMANS	To track a moving object, its motion must first be distinguished from that of the background. The center-surround properties of neurons in the middle temporal visual area (MT) may be important for signaling the relative motion between object and background. To test this, we microstimulated within MT and measured the effects on monkeys' eye movements to moving targets. We found that stimulation at "local motion" sites, where receptive fields possessed antagonistic surrounds, shifted pursuit in the preferred direction of the neurons, whereas stimulation at "wide-field motion" sites shifted pursuit in the opposite, or null, direction. We propose that activating wide-field sites simulated background motion, thus inducing a target motion signal in the opposite direction. Our results support the hypothesis that neuronal center-surround mechanisms contribute to the behavioral segregation of objects from the background.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Dept Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Dartmouth College; Dartmouth College; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University	Born, RT (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X; Groh, Jennifer/0000-0002-6435-3935	NEI NIH HHS [EY12196, EY11379] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012196, R01EY011379] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1989, VISUAL NEUROSCI, V2, P177, DOI 10.1017/S0952523800012037; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; COLLETT T, 1971, NATURE, V232, P127, DOI 10.1038/232127a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; EGELHAAF M, 1988, TRENDS NEUROSCI, V11, P351, DOI 10.1016/0166-2236(88)90057-4; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; GATTASS R, 1981, J NEUROPHYSIOL, V46, P621, DOI 10.1152/jn.1981.46.3.621; GELLMAN RS, 1991, EXP BRAIN RES, V84, P660; Groh JM, 1997, J NEUROSCI, V17, P4312; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KELLER E, 1990, EXP BRAIN RES, V80, P525; Keller EL, 1996, J NEUROPHYSIOL, V76, P3573, DOI 10.1152/jn.1996.76.5.3573; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LAGAE L, 1989, BRAIN RES, V496, P361, DOI 10.1016/0006-8993(89)91089-5; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; MASSON G, 1995, VISION RES, V35, P837, DOI 10.1016/0042-6989(94)00185-O; Maunsell JH, 1986, MATTERS INTELLIGENCE, P59; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; MILES FA, 1991, REPRESENTATIONS VISI, P185; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Niemann T, 1997, EXP BRAIN RES, V115, P531, DOI 10.1007/PL00005723; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RON S, 1989, VISION RES, V29, P1103, DOI 10.1016/0042-6989(89)90059-X; Rubin E., 1915, SYNSOPLEVEDE FIGURER; Schwarz U, 1999, NEUROREPORT, V10, P2477, DOI 10.1097/00001756-199908200-00008; STERLING P, 1969, J NEUROPHYSIOL, V32, P1, DOI 10.1152/jn.1969.32.1.1; TANAKA K, 1986, J NEUROSCI, V6, P134; TOOTELL R B H, 1990, Investigative Ophthalmology and Visual Science, V31, P238; Upton G. J. G., 1989, SPATIAL DATA ANAL EX, V2; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; VONGRUNAU M, 1983, EXP BRAIN RES, V49, P84, DOI 10.1007/BF00235544; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Zar J. H., 1996, BIOSTATISTICAL ANAL	49	136	137	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					725	734		10.1016/S0896-6273(00)81208-8	http://dx.doi.org/10.1016/S0896-6273(00)81208-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896167	Bronze			2022-12-17	WOS:000087991600022
J	Dityatev, A; Dityateva, G; Schachner, M				Dityatev, A; Dityateva, G; Schachner, M			Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM	NEURON			English	Article							LONG-TERM POTENTIATION; N-CAM; HIPPOCAMPAL-FORMATION; GENETIC DISSECTION; ENTORHINAL CORTEX; IN-VITRO; L1; NEURONS; PLASTICITY; GROWTH	To evaluate the contributions of the pre- versus postsynaptic expression of NCAM in regulation of synaptic efficacy, we cultured dissociated hippocampal cells from NCAM-deficient and wild-type mice in homo- and heterogenotypic combinations. Double recordings from synaptically coupled neurons maintained in heterogenotypic cocultures showed that synaptic strength of excitatory but not inhibitory synapses depended on expression of NCAM post- but not presynaptically. This correlated with higher levels of potentiation and synaptic coverage of NCAM-expressing neurons compared to NCAM-deficient neurons in heterogenotypic cocultures. Synaptic density was the same in homogenotypic cultures of NCAM-deficient and wild-type neurons as well as in heterogenotypic cocultures in which glutamate receptors were blocked. These observations indicate that the relative levels of postsynaptic NCAM expression control synaptic strength in an activity-dependent manner by regulating the number of synapses.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553				Arami S, 1996, BEHAV BRAIN RES, V81, P81, DOI 10.1016/S0166-4328(96)00046-0; Aubert I, 1998, J COMP NEUROL, V399, P1; Bahr BA, 1997, J NEUROSCI, V17, P1320; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DITYATEV A, 1999, CELL BIOL INT, V23, P129; Endo A, 1998, NEUROSCI LETT, V246, P37, DOI 10.1016/S0304-3940(98)00204-3; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; JUCKER M, 1995, MOL BRAIN RES, V28, P149, DOI 10.1016/0169-328X(94)00206-T; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Malhotra JD, 1998, J BIOL CHEM, V273, P33354, DOI 10.1074/jbc.273.50.33354; Mayford M, 1997, CURR BIOL, V7, pR580, DOI 10.1016/S0960-9822(06)00287-9; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; MILLER PD, 1993, J COMP NEUROL, V327, P341, DOI 10.1002/cne.903270303; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; RIVAS RJ, 1995, J NEUROSCI, V15, P981; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; SCHMIDT CE, 1995, J NEUROSCI, V15, P3400; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Seki T, 1998, J NEUROSCI, V18, P3757; SHINE HD, 1984, J CELL BIOL, V98, P1291, DOI 10.1083/jcb.98.4.1291; Staple JK, 1997, EUR J NEUROSCI, V9, P721, DOI 10.1111/j.1460-9568.1997.tb01420.x; Staubli U, 1998, J NEUROSCI, V18, P3460; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; UEDA S, 1994, BRAIN RES, V633, P284, DOI 10.1016/0006-8993(94)91550-4; WANG S, 1992, J NEUROSCI RES, V33, P626, DOI 10.1002/jnr.490330415; ZHU H, 1995, J NEUROSCI, V15, P4173	46	136	139	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2000	26	1					207	217		10.1016/S0896-6273(00)81151-4	http://dx.doi.org/10.1016/S0896-6273(00)81151-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798405	Bronze			2022-12-17	WOS:000086770500021
J	Yoshihara, Y; Mizuno, T; Nakahira, M; Kawasaki, M; Watanabe, Y; Kagamiyama, H; Jishage, K; Ueda, O; Suzuki, H; Tabuchi, K; Sawamoto, K; Okano, H; Noda, T; Mori, K				Yoshihara, Y; Mizuno, T; Nakahira, M; Kawasaki, M; Watanabe, Y; Kagamiyama, H; Jishage, K; Ueda, O; Suzuki, H; Tabuchi, K; Sawamoto, K; Okano, H; Noda, T; Mori, K			A genetic approach to visualization of multisynaptic neural pathways using plant lectin transgene	NEURON			English	Article							WHEAT-GERM-AGGLUTININ; OLFACTORY MARKER PROTEIN; WGA-HRP; NEURONAL TRANSPORT; DROSOPHILA EYE; EXPRESSION; PURKINJE; MICE; RAT; PROMOTER	The wiring patterns among various types of neurons via specific synaptic connections are the basis of functional logic employed by the brain for information processing. This study introduces a powerful method of analyzing the neuronal connectivity patterns by delivering a tracer selectively to specific types of neurons while simultaneously transsynaptically labeling their target neurons. We developed a novel genetic approach introducing cDNA for a plant lectin, wheat germ agglutinin (WGA), as a transgene under the control of specific promoter elements. Using this method, we demonstrate three examples of visualization of specific transsynaptic neural pathways: the mouse cerebellar efferent pathways, the mouse olfactory pathways, and the Drosophila visual pathways. This strategy should greatly facilitate studies on the anatomical and functional organization of the developing and mature nervous system.	RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Neuronal Recognit Mol, Wako, Saitama 3510198, Japan; Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; Osaka Biosci Inst, Dept Neurosci, Osaka 5650874, Japan; Chugai Pharmaceut Co Ltd, Shizuoka 4120038, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Dept Neuroanat, Osaka 5650871, Japan; Inst Canc, Dept Cell Biol, Tokyo 1700012, Japan	RIKEN; RIKEN; Osaka Medical College; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Osaka University	Yoshihara, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan.		Okano, Hideyuki/I-7584-2019; Yoshihara, Yoshihiro/N-6481-2015; Noda, Tetsuo/B-1667-2016	Yoshihara, Yoshihiro/0000-0002-0319-7166; Mori, Kensaku/0000-0001-7853-9370; Sawamoto, Kazunobu/0000-0003-1984-5129				Altman J., 1996, RELATION ITS EVOLUTI; BAKER H, 1986, EXP BRAIN RES, V63, P461, DOI 10.1007/BF00237470; BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADWELL RD, 1985, J COMP NEUROL, V242, P632, DOI 10.1002/cne.902420410; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; FABIAN RH, 1985, BRAIN RES, V344, P41, DOI 10.1016/0006-8993(85)91187-4; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Holtmaat AJGD, 1995, J NEUROSCI, V15, P7953; ITAYA SK, 1987, BRAIN RES, V409, P205, DOI 10.1016/0006-8993(87)90703-7; ITAYA SK, 1982, BRAIN RES, V236, P199, DOI 10.1016/0006-8993(82)90046-4; Ito K, 1997, DEVELOPMENT, V124, P761; Ito M, 1984, CEREBELLUM NEURAL CO; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; MANSFIELD MA, 1988, PLANTA, V173, P482, DOI 10.1007/BF00958961; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MARGOLIS FL, 1993, CYTOTECHNOLOGY, V11, P17, DOI 10.1007/BF00749053; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; MEINERTZHAGEN MA, 1993, DEV DROSOPHILA MELAG, P1363; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MISMER D, 1987, GENETICS, V116, P565; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; OBERDICK J, 1993, NEURON, V10, P1007, DOI 10.1016/0896-6273(93)90050-2; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; RUDA M, 1982, NEUROSCI LETT, V28, P237; SAWAMOTO K, 1994, DEV BIOL, V164, P267, DOI 10.1006/dbio.1994.1197; Shipley Michael T., 1995, P899; SHIPLEY MT, 1985, BRAIN RES BULL, V15, P129, DOI 10.1016/0361-9230(85)90129-7; SMITH JJ, 1989, PLANT MOL BIOL, V13, P601, DOI 10.1007/BF00027321; TROJANOWSKI JQ, 1983, J NEUROSCI METH, V9, P185, DOI 10.1016/0165-0270(83)90082-1; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Walters E, 1996, J NEUROSCI RES, V43, P146; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	38	136	139	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					33	41		10.1016/S0896-6273(00)80676-5	http://dx.doi.org/10.1016/S0896-6273(00)80676-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027287	Bronze			2022-12-17	WOS:000078410300010
J	Grunewald, M; Bendahan, A; Kanner, BI				Grunewald, M; Bendahan, A; Kanner, BI			Biotinylation of single cysteine mutants of the glutamate transporter GLT-1 from rat brain reveals its unusual topology	NEURON			English	Article							AMINO-ACID TRANSPORTER; MEMBRANE TOPOLOGY; HIGH-AFFINITY; FUNCTIONAL-CHARACTERIZATION; ASPARTATE TRANSPORTER; ESCHERICHIA-COLI; K+ CHANNEL; EXPRESSION; CLONING; GLAST-1	In the central nervous system, (Na+ + K+)-coupled glutamate transporters restrict the neurotoxicity of this transmitter and limit the duration of synaptic excitation at some synapses. The Various isotransporters exhibit a particularly high homology in an extended hydrophobic domain of ill-defined topology that contains several determinants involved in ion and transmitter binding. Here, we describe the determination of the membrane topology of the cloned astroglial glutamate transporter GLT-1. A series of functional transporters containing single cysteines was engineered. Their topological disposition was determined by using a biotinylated sulfhydryl reagent. The glutamate transporter has eight transmembrane domains long enough to span the membrane as cu helices. Strikingly, between the seventh and eighth domains, a structure reminiscent of a pore loop and an outward-facing hydrophobic linker are positioned.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel.							ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CONRADT M, 1995, J BIOL CHEM, V270, P25207, DOI 10.1074/jbc.270.42.25207; CONRADT M, 1995, EUR J BIOCHEM, V229, P682, DOI 10.1111/j.1432-1033.1995.tb20514.x; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; Diamond JS, 1997, J NEUROSCI, V17, P4672; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TOLNER B, 1995, J BACTERIOL, V177, P2863, DOI 10.1128/jb.177.10.2863-2869.1995; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	48	136	138	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					623	632		10.1016/S0896-6273(00)80572-3	http://dx.doi.org/10.1016/S0896-6273(00)80572-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768848	Bronze			2022-12-17	WOS:000076196400018
J	Broadie, K; Rushton, E; Skoulakis, EMC; Davis, RL				Broadie, K; Rushton, E; Skoulakis, EMC; Davis, RL			Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; LONG-TERM POTENTIATION; SYNAPTIC TRANSMISSION; CYCLIC-AMP; KINASE-C; NEUROMUSCULAR SYNAPSE; IN-VITRO; 14-3-3-PROTEINS; MUTANTS; PLASTICITY	The leonardo gene encodes a conserved member of the 14-3-3 protein family, which plays a role in Drosophila teaming. Immunological localization of the protein shows that it is expressed at synaptic connections and enriched in presynaptic boutons of the neuromuscular junction (NMJ). Null leonardo mutants die as mature embryos. Electrophysiological assays of the mutant NMJ demonstrate that basal synaptic transmission is reduced by 30% and that transmission amplitude, fidelity, and fatigue resistance properties are reduced at elevated stimulation frequencies and in low external [Ca2+]. Moreover, transmission augmentation and post-tetanic potentiation (PTP) are disrupted in the mutant. These results suggest that Leonardo plays a role in the regulation of synaptic vesicle dynamics, a function which may underlie synaptic modulation properties enabling learning.	BAYLOR COLL MED, DEPT CELL BIOL & NEUROL, HOUSTON, TX 77030 USA	Baylor College of Medicine	Broadie, K (corresponding author), UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM15406] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN A, 1995, MOL CELL BIOCHEM, V149, P41, DOI 10.1007/BF01076562; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROADIE KS, 1994, J PHYSIOLOGY-PARIS, V88, P123, DOI 10.1016/0928-4257(94)90023-X; Broadie KS, 1996, BIOCHEM SOC T, V24, P639, DOI 10.1042/bst0240639; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Byrne JH, 1996, J NEUROSCI, V16, P425; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; ICHIMURA T, 1995, J BIOL CHEM, V270, P28515, DOI 10.1074/jbc.270.48.28515; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; MARAIS R, 1995, STRUCTURE, V3, P751, DOI 10.1016/S0969-2126(01)00209-X; MARTIN H, 1994, J NEUROCHEM, V63, P2259; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; PATEL Y, 1994, BBA-MOL CELL RES, V1222, P405, DOI 10.1016/0167-4889(94)90048-5; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; ROTH D, 1995, FEBS LETT, V374, P77, DOI 10.1016/0014-5793(95)01080-X; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0; ZHONG Y, 1993, J NEUROGENET, V9, P15, DOI 10.3109/01677069309167273; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZUPAN LA, 1992, J BIOL CHEM, V267, P8707	50	136	138	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					391	402		10.1016/S0896-6273(00)80948-4	http://dx.doi.org/10.1016/S0896-6273(00)80948-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292728	Bronze			2022-12-17	WOS:A1997XU14600017
J	Ning, QA				Ning, QA			Binocular disparity and the perception of depth	NEURON			English	Review							TRANSPARENT MOTION PERCEPTION; CAT VISUAL-CORTEX; STEREO DISPARITY; SPATIAL-FREQUENCY; CORTICAL-NEURONS; INTEGRATION; CELLS; MECHANISMS; MACAQUE; SIGNALS				Ning, QA (corresponding author), COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH054125, R01MH054125] Funding Source: NIH RePORTER; NIMH NIH HHS [MH54125] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; BISHOP PO, 1986, VISION RES, V26, P1587, DOI 10.1016/0042-6989(86)90177-X; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; BURR DC, 1979, VISION RES, V19, P523, DOI 10.1016/0042-6989(79)90137-8; CARNEY T, 1989, VISION RES, V29, P155, DOI 10.1016/0042-6989(89)90121-1; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; DOW BM, 1981, EXP BRAIN RES, V44, P213; FALK DS, 1980, PERCEPT PSYCHOPHYS, V28, P19, DOI 10.3758/BF03204311; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; HESS RF, 1994, VISION RES, V34, P2431, DOI 10.1016/0042-6989(94)90287-9; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JULESZ B, 1971, F CYCLOPEAN PERCEPTI; LEHKY SR, 1990, J NEUROSCI, V10, P2281; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; LIU L, 1994, NATURE, V367, P66, DOI 10.1038/367066a0; MAIT D, 1976, SCIENCE, V194, P283; MANSFIELD RJW, 1978, VISION RES, V18, P1247, DOI 10.1016/0042-6989(78)90111-6; Marr D., 1982, VISION COMPUTATIONAL; MARSHALL JA, 1996, IN PRESS NETWORK COM; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MORGAN MJ, 1975, PERCEPTION, V4, P3, DOI 10.1068/p040003; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Ohzawa I, 1996, J NEUROPHYSIOL, V75, P1779, DOI 10.1152/jn.1996.75.5.1779; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; PRAZDNY K, 1985, BIOL CYBERN, V52, P93, DOI 10.1007/BF00363999; QIAN N, 1994, J NEUROSCI, V14, P7357; QIAN N, 1994, NEURAL COMPUT, V6, P390, DOI 10.1162/neco.1994.6.3.390; QIAN N, 1994, J NEUROSCI, V14, P7381; QIAN N, 1989, 1988 P CONN MOD SUMM, P435; QIAN N, 1997, IN PRESS VISION RES; RAMACHANDRAN VS, 1973, NATURE, V242, P412, DOI 10.1038/242412a0; REGAN D, 1973, NATURE, V181, P877; ROY JP, 1990, NATURE, V348, P160, DOI 10.1038/348160a0; SANGER TD, 1988, BIOL CYBERN, V59, P405, DOI 10.1007/BF00336114; SATO T, 1993, INVEST OPHTH VIS SCI, V34, P1438; SCHOR CM, 1983, VISION RES, V23, P1649, DOI 10.1016/0042-6989(83)90179-7; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SMALLMAN HS, 1994, J OPT SOC AM A, V11, P2169, DOI 10.1364/JOSAA.11.002169; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Spillmann L, 1996, TRENDS NEUROSCI, V19, P428; TYLER CW, 1974, NATURE, V250, P781, DOI 10.1038/250781a0; WAGNER H, 1993, NATURE, V364, P796, DOI 10.1038/364796a0; WESTHEIMER G, 1986, J PHYSIOL-LONDON, V370, P619, DOI 10.1113/jphysiol.1986.sp015954; WESTHEIMER G, 1990, OPTOMETRY VISION SCI, V67, P527; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; ZHU Y, 1996, NEURAL COMPUT, V8, P1647	54	136	141	3	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1997	18	3					359	368		10.1016/S0896-6273(00)81238-6	http://dx.doi.org/10.1016/S0896-6273(00)81238-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115731	hybrid			2022-12-17	WOS:A1997WQ07400005
J	Lin, ZX; Haus, S; Edgerton, J; Lipscombe, D				Lin, ZX; Haus, S; Edgerton, J; Lipscombe, D			Identification of functionally distinct isoforms of the N-type Ca2+ channel in rat sympathetic ganglia and brain	NEURON			English	Article							MESSENGER-RNA DEGRADATION; HIPPOCAMPAL CA3 NEURONS; GATED CALCIUM CHANNELS; CHICK SENSORY NEURONS; BETA-SUBUNIT; SYNAPTIC TRANSMISSION; XENOPUS-OOCYTES; VOLTAGE-DEPENDENCE; MOLECULAR-CLONING; VERTEBRATE CELLS	The N channel is critical for regulating release of neurotransmitter at many synapses, and even subtle differences in its activity would be expected to influence the efficacy of synaptic transmission. Although several splice variants of the N channel are expressed in the mammalian nervous system, their biological importance is presently unclear. Here, we show that variants of the alpha(1B) subunit of the N channel are expressed in sympathetic ganglia and that alternative splicing within IllS3-S4 and IVS3-S4 generate kinetically distinct channels. We further show a striking difference between the expression pattern of the S3-S4 variants in brain and peripheral ganglia and conclude that the brain-dominant form of the N channel gates 2- to 4-fold more rapidly than that predominant in ganglia.			Lin, ZX (corresponding author), BROWN UNIV,DEPT NEUROSCI,PROVIDENCE,RI 02912, USA.		Schorge, Stephanie/C-8515-2009; Tuluc, Petronel/C-2527-2011	Schorge, Stephanie/0000-0003-1541-5148; 	NIGMS NIH HHS [GM07601] Funding Source: Medline; NINDS NIH HHS [NS29967] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029967, R01NS029967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams BA, 1996, BIOPHYS J, V71, P156, DOI 10.1016/S0006-3495(96)79212-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CHARNET P, 1994, FEBS LETT, V344, P87, DOI 10.1016/0014-5793(94)00357-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COPPOLA T, 1994, FEBS LETT, V338, P1, DOI 10.1016/0014-5793(94)80105-3; COX DH, 1994, J GEN PHYSIOL, V104, P311, DOI 10.1085/jgp.104.2.311; DeKoninck P, 1995, J NEUROSCI, V15, P7966; DELCOUR AH, 1993, J NEUROSCI, V13, P181; Dolphin AC, 1996, TRENDS NEUROSCI, V19, P35, DOI 10.1016/0166-2236(96)81865-0; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; EIMSLIE KS, 1990, NEURON, V5, P75; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ELLIOTT EM, 1995, J NEUROSCI, V15, P6433; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P279; GREENBERG ME, 1990, ENZYME, V44, P181, DOI 10.1159/000468756; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hille B., 1992, IONIC CHANNELS EXCIT; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KONGSAMUT S, 1989, ANN NY ACAD SCI, V560, P312, DOI 10.1111/j.1749-6632.1989.tb24112.x; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; LIN Z, 1996, J MOL NEUROSCI, V7, P23; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MANDELZYS A, 1994, J NEUROSCI, V14, P2357; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MYNLIEFF M, 1992, J NEUROPHYSIOL, V68, P85, DOI 10.1152/jn.1992.68.1.85; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RITTENHOUSE AR, 1994, J PHYSIOL-LONDON, V474, P87, DOI 10.1113/jphysiol.1994.sp020005; ROCHE JP, 1995, FEBS LETT, V371, P43, DOI 10.1016/0014-5793(95)00860-C; RUANO D, 1995, NEURON, V14, P1009, DOI 10.1016/0896-6273(95)90339-9; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STEA A, 1993, NEUROPHARMACOLOGY, V32, P1103, DOI 10.1016/0028-3908(93)90005-N; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	64	136	153	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					153	166		10.1016/S0896-6273(01)80054-4	http://dx.doi.org/10.1016/S0896-6273(01)80054-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010213	Bronze			2022-12-17	WOS:A1997WE71800016
J	Tucker, T; Fettiplace, R				Tucker, T; Fettiplace, R			Confocal imaging of calcium microdomains and calcium extrusion in turtle hair cells	NEURON			English	Article							K+ CHANNELS; DEPENDENT CONDUCTANCES; FREQUENCY-SELECTIVITY; TRANSMITTER RELEASE; COCHLEA; CHICK; ION; CURRENTS; TRANSDUCTION; ADAPTATION	We have studied spatial Ca2+ distribution in hair cells filled with the low affinity fluorescent indicator Calcium Green 5N using real-time confocal microscopy and whole-cell recording. During depolarizations lasting several hundred milliseconds, Ca2+ fluorescence increased at a number of hotspots around the base of the cell but changed little near the hair bundle. The hotspots required influx of Ca2+ through voltage-dependent channels, and they expanded during the pulse from an initial diameter of <1 mu m. Strong Ca2+ buffers like BAPTA slowed their growth rate. On repolarization, the fluorescence decayed with two time constants: similar to 0.1 s, which may represent Ca2+ diffusion away from the entry sites, and 10 s, probably reflecting Ca2+ extrusion. Extrusion occurs mainly via a CaAT-Pase that can be blocked by vanadate. We suggest the hotspots are microdomains of Ca2+ attaining a concentration of at least 85 mu M near assemblies of synaptic release sites.			Tucker, T (corresponding author), UNIV WISCONSIN,SCH MED,DEPT NEUROPHYSIOL,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706, USA.				NIDCD NIH HHS [5 R01 DC 01362] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ART JJ, 1993, J PHYSIOL-LONDON, V470, P109, DOI 10.1113/jphysiol.1993.sp019850; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ASHMORE JF, 1990, J PHYSIOL-LONDON, V428, P109, DOI 10.1113/jphysiol.1990.sp018203; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLAUSTEI.MP, 1969, J PHYSIOL-LONDON, V200, P497, DOI 10.1113/jphysiol.1969.sp008704; BLAUSTEIN MP, 1991, ANN NY ACAD SCI, V639, P254, DOI 10.1111/j.1749-6632.1991.tb17315.x; CHABBERT C, 1994, PFLUGERS ARCH, V420, P493; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; EATOCK RA, 1987, J NEUROSCI, V7, P2821; ESCOBAR AL, 1994, NATURE, V367, P739, DOI 10.1038/367739a0; FETTIPLACE R, 1992, SOC GEN PHY, V47, P343; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1992, J NEUROSCI, V12, P800; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; IKEDA K, 1992, PFLUG ARCH EUR J PHY, V420, P493, DOI 10.1007/BF00374624; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; KASS GEN, 1989, J BIOL CHEM, V264, P15192; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; Lenzi David, 1994, Current Opinion in Neurobiology, V4, P496, DOI 10.1016/0959-4388(94)90049-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Mountcastle V., 1984, HDB PHYSL NERVOUS SY, VIII, P639; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; OHMORI H, 1984, J PHYSIOL-LONDON, V350, P561, DOI 10.1113/jphysiol.1984.sp015218; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Pawley James, 1995, P19; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAITO K, 1983, CELL TISSUE RES, V229, P467; SCHATZMANN HJ, 1989, ANNU REV PHYSIOL, V51, P473, DOI 10.1146/annurev.ph.51.030189.002353; SCHULTE BA, 1993, HEARING RES, V65, P262, DOI 10.1016/0378-5955(93)90219-Q; SHIGEMOTO T, 1991, J PHYSIOL-LONDON, V442, P669, DOI 10.1113/jphysiol.1991.sp018814; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SNEARY MG, 1988, J COMP NEUROL, V276, P588, DOI 10.1002/cne.902760411; TSIEN RY, 1980, BIOCHIM BIOPHYS ACTA, V599, P623, DOI 10.1016/0005-2736(80)90205-9; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; YAO Y, 1994, J PHYSIOL-LONDON, V476, P17	46	136	137	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1323	1335		10.1016/0896-6273(95)90011-X	http://dx.doi.org/10.1016/0896-6273(95)90011-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845156	Bronze			2022-12-17	WOS:A1995TL67800011
J	LO, LC; ANDERSON, DJ				LO, LC; ANDERSON, DJ			POSTMIGRATORY NEURAL CREST CELLS EXPRESSING C-RET DISPLAY RESTRICTED DEVELOPMENTAL AND PROLIFERATIVE CAPACITIES	NEURON			English	Article							HEMATOPOIETIC STEM-CELLS; INVITRO CLONAL ANALYSIS; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; LINEAGE DIVERSIFICATION; RECOMBINANT RETROVIRUS; PRECURSOR CELLS; DORSAL-ROOT; NEURONS; DIFFERENTIATION	c-RET is an orphan receptor tyrosine kinase essential for enteric neurogenesis in mice and is involved in several human genetic disorders. RET is also one of the earliest surface markers expressed by postmigratory neural crest cells in the gut. We generated anti-RET monoclonal antibodies to isolate such cells. We find that RET(+) cells are antigenically and functionally distinct from neural crest stem cells (NCSCs) characterized previously. Unlike NCSCs, which are RET(-) and MASH1(-), most RET(+) cells express MASH1. Moreover, unlike NCSCs, which are multipotent and have high proliferative capacity, many RET(+) cells generate only neurons following a limited number of divisions. This behavior is observed even in the presence of glial growth factor, a polypeptide that suppresses neuronal and promotes glial differentiation by NCSCs. These data provide direct evidence for the existence of committed neuronal progenitor cells and support a model of neural crest lineage diversification by progressive restriction of developmental potential.			LO, LC (corresponding author), CALTECH,HOWARD HUGHES MED INST,DIV BIO 21676,PASADENA,CA 91125, USA.							ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Anderson D J, 1993, Curr Opin Neurobiol, V3, P8, DOI 10.1016/0959-4388(93)90028-W; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; ARTINGER KB, 1992, DEV BIOL, V149, P149, DOI 10.1016/0012-1606(92)90271-H; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BRIEGEL K, 1993, GENE DEV, V7, P1097, DOI 10.1101/gad.7.6.1097; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; CARNAHAN JF, 1991, DEV BIOL, V148, P552, DOI 10.1016/0012-1606(91)90273-6; CHALAZONITIS A, 1994, J NEUROSCI, V14, P6571; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEVAUX B, 1991, EUR J IMMUNOL, V21, P2111, DOI 10.1002/eji.1830210920; DEVILLE FSSC, 1992, DEV BRAIN RES, V66, P1, DOI 10.1016/0165-3806(92)90134-I; DEVILLE FSSC, 1994, DEV BIOL, V163, P141, DOI 10.1006/dbio.1994.1130; DUFF RS, 1991, DEV BIOL, V147, P451, DOI 10.1016/0012-1606(91)90303-K; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; FRANK E, 1991, DEVELOPMENT, V111, P895; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1992, CELL, V75, P463; HALL AK, 1991, NEURON, V6, P741, DOI 10.1016/0896-6273(91)90171-U; ITO K, 1993, DEV BIOL, V157, P517, DOI 10.1006/dbio.1993.1154; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN N, 1991, GLIA, V4, P175; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LELIEVRE CS, 1980, DEV BIOL, V77, P362, DOI 10.1016/0012-1606(80)90481-9; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; LO LC, 1994, PERSPECT DEV NEUROBI, V2, P191; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MCONNELL SK, 1991, ANN REV NEUROSCI, V14, P269; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; OGAWA M, 1993, BLOOD, V81, P2844; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; POMERANZ HD, 1993, DEV BIOL, V156, P341, DOI 10.1006/dbio.1993.1082; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sieber-Blum M., 1990, Comments on Developmental Neurobiology, V1, P225; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STEMPLE DL, 1993, DEV BIOL, V159, P12, DOI 10.1006/dbio.1993.1218; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; WREN D, 1992, J CELL BIOL, V116, P167, DOI 10.1083/jcb.116.1.167	59	136	143	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1995	15	3					527	539		10.1016/0896-6273(95)90142-6	http://dx.doi.org/10.1016/0896-6273(95)90142-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RV945	7546733	Bronze			2022-12-17	WOS:A1995RV94500007
J	LAMANTIA, AS; COLBERT, MC; LINNEY, E				LAMANTIA, AS; COLBERT, MC; LINNEY, E			RETINOIC ACID INDUCTION AND REGIONAL DIFFERENTIATION PREFIGURE OLFACTORY PATHWAY FORMATION IN THE MAMMALIAN FOREBRAIN	NEURON			English	Article							NERVOUS-SYSTEM; MOUSE EMBRYOS; NEURAL-TUBE; FLOOR PLATE; POLARIZING ACTIVITY; BINDING-PROTEINS; EXPRESSION; PATTERN; MORPHOGENESIS; HINDBRAIN	We have used an in vitro assay to identify sources of retinoic acid (RA) and transgenic mice to identify target domains in the developing forebrain. RA participates in a sequence of events that leads to the establishment of the olfactory pathway. First, the lateral cranial mesoderm activates an RA-inducible transgene in neuroepithelial cells in the olfactory placode and the ventrolateral forebrain. Then, neurons and neurites begin to differentiate in these two regions. Finally, olfactory axons grow specifically into the ventrolateral forebrain and subsequently are limited to the olfactory bulb rudiment. The coordination of these events, perhaps by common signals, implies that retinoid induction and retinoid-activated region-specific transcriptional regulation may help to define a forebrain subdivision and the peripheral neurons that provide its primary innervation.	DUKE UNIV, MED CTR, DEPT MICROBIOL, DURHAM, NC 27710 USA	Duke University	LAMANTIA, AS (corresponding author), DUKE UNIV, MED CTR, DEPT CHEM & NUCL ENGN, DURHAM, NC 27710 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007637, R29HD029178, R01HD029178] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039066] Funding Source: NIH RePORTER; NCI NIH HHS [CA39066] Funding Source: Medline; NICHD NIH HHS [HD07637, HD29178-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTABA ARI, 1991, DEVELOPMENT, V112, P945; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Bartelmez G. W., 1962, CONTRIB EMBRYOL CARN, V37, P13; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; BRYANT SV, 1992, DEV BIOL, V152, P1, DOI 10.1016/0012-1606(92)90152-7; BULFONE A, 1993, IN PRESS J NEUROSCI; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; COLBERT MC, 1993, P NATL ACAD SCI US; CONLON RA, 1992, DEVELOPMENT, V116, P357; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOLLE P, 1990, DEVELOPMENT, V110, P1133; EASTER SS, 1993, J NEUROSCI, V13, P285; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESPESETH AS, 1989, GENE DEV, V3, P1647, DOI 10.1101/gad.3.11.1647; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GURDON JB, 1987, DEVELOPMENT, V99, P285; GUSTAFSON AL, 1993, DEVELOPMENT, V117, P451; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; KAPRONBRAS CM, 1985, TERATOLOGY, V32, P87, DOI 10.1002/tera.1420320112; KESSEL M, 1993, NEURON, V10, P379, DOI 10.1016/0896-6273(93)90328-O; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LINNEY E, 1992, CURR TOP DEV BIOL, V27, P309, DOI 10.1016/S0070-2153(08)60538-4; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MADEN M, 1991, DEVELOPMENT, P87; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MORRISSKAY GM, 1991, EMBO J, V10, P2985, DOI 10.1002/j.1460-2075.1991.tb07849.x; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; POPPERL H, 1993, MOL CELL BIOL, V13, P257; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; REYNOLDS K, 1991, MECH DEVELOP, V36, P15, DOI 10.1016/0925-4773(91)90068-H; RICHMAN JM, 1992, DEV BIOL, V154, P299, DOI 10.1016/0012-1606(92)90069-S; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; ROSS LS, 1992, J NEUROSCI, V12, P467; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUBERTE E, 1991, DEVELOPMENT, V111, P45; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SHARPE CR, 1991, NEURON, V7, P239, DOI 10.1016/0896-6273(91)90262-X; SHENEFELT RE, 1972, TERATOLOGY, V5, P103, DOI 10.1002/tera.1420050115; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SNYDER DC, 1991, J NEUROBIOL, V22, P897, DOI 10.1002/neu.480220903; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; SULIK KK, 1988, DEVELOPMENT, V103, P213; USMANN M, 1989, DEV BIOL, V136, P194; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WAGNER M, 1992, DEVELOPMENT, V116, P55; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILSON SW, 1990, DEVELOPMENT, V108, P121; Windle WF., 1970, EXP NEUROL S, V28, P44; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; ZIMMER A, 1992, DEVELOPMENT, V116, P977	67	136	139	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1035	1048		10.1016/0896-6273(93)90052-S	http://dx.doi.org/10.1016/0896-6273(93)90052-S			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318228				2022-12-17	WOS:A1993LK37300004
J	MEAKIN, SO; SHOOTER, EM				MEAKIN, SO; SHOOTER, EM			MOLECULAR INVESTIGATIONS ON THE HIGH-AFFINITY NERVE GROWTH-FACTOR RECEPTOR	NEURON			English	Article							PC12 PHEOCHROMOCYTOMA CELLS; HUMAN NGF RECEPTOR; MONOCLONAL-ANTIBODIES; SCHWANN-CELLS; GENE-TRANSFER; TYROSINE PHOSPHORYLATION; SURFACE RECEPTORS; V-SRC; EXPRESSION; DIFFERENTIATION	Nerve growth factor (NGF) receptors have been investigated by means of affinity labeling with I-125-NGF and chemical cross-linking. Two distinct NGF-receptor complexes are detected on PC12 cells; these correspond to 100 kd and 158 kd for the low-affinity (LNGFR) and the high-affinity (HNGFR) receptors, respectively. Interestingly, three different antibodies directed against distinct epitopes on the LNGFR immunoprecipitate the low- but not the high-affinity NGF-receptor complex. Although the identities of the signaling molecules in the HNGFR are unknown, antibodies to the src, ras, raf-1, and yes products fail to immunoprecipitate either receptor complex, suggesting that these molecules are not a part of, or tightly coupled to, either receptor type. Phosphotyrosine residues are found exclusively on the HNGFR complex, suggesting that tyrosine phosphorylation may be one of the initiating events in the NGF-induced signal transduction cascade.			MEAKIN, SO (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305, USA.		Meakin, Susan/K-8823-2013	Meakin, Susan/0000-0003-2469-6615				ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BERND P, 1984, J BIOL CHEM, V259, P5509; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BRUCK C, 1986, METHOD ENZYMOL, V121, P587; BUXSER S, 1985, J BIOL CHEM, V260, P1917; CARTERSU C, 1989, J BIOL CHEM, V264, P18654; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; DARLING TL, 1984, METHODS SERUM FREE C, P79; DISTEFANO PS, 1988, J NEUROSCI, V8, P231; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; EVELETH DD, 1988, NEURON, V1, P929, DOI 10.1016/0896-6273(88)90150-X; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GROB PM, 1985, J BIOL CHEM, V260, P8044; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALEGOUA S, 1990, IN PRESS CURRENT TOP; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARADA N, 1990, P NATL ACAD SCI USA, V87, P857, DOI 10.1073/pnas.87.3.857; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; HOSANG M, 1985, J BIOL CHEM, V260, P655; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; KAMPS MP, 1988, ONCOGENE, V2, P305; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KUMAR S, 1990, IN PRESS J NEUROSCI, V7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; MASSAGUE J, 1981, J BIOL CHEM, V256, P9419; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PFEIFFER SE, 1972, P NATL ACAD SCI USA, V69, P2885, DOI 10.1073/pnas.69.10.2885; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SARAGOVI H, 1990, P NATL ACAD SCI USA, V87, P11, DOI 10.1073/pnas.87.1.11; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHATTEMAN GC, 1988, J NEUROSCI, V8, P860; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SHARON M, 1990, P NATL ACAD SCI USA, V87, P4869, DOI 10.1073/pnas.87.12.4869; SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPRANG SR, 1990, TRENDS BIOCHEM SCI, V15, P366, DOI 10.1016/0968-0004(90)90228-4; SUTTER A, 1979, J BIOL CHEM, V254, P5972; SUTTER A, 1979, TRANSMEMBRANE SIGNAL, P659; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VALE RD, 1985, METHOD ENZYMOL, V109, P21; VALE RD, 1985, J NEUROSCI, V5, P2762; WELCHER AA, 1990, IN PRESS P NATL ACAD; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YAN Q, 1988, J NEUROSCI, V8, P3481; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZIMMERMANN A, 1978, J SUPRAMOL STR CELL, V9, P351, DOI 10.1002/jss.400090306	78	136	140	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					153	163		10.1016/0896-6273(91)90130-R	http://dx.doi.org/10.1016/0896-6273(91)90130-R			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1702649				2022-12-17	WOS:A1991EU27800015
J	Meyniel, F; Sigman, M; Mainen, ZF				Meyniel, Florent; Sigman, Mariano; Mainen, Zachary F.			Confidence as Bayesian Probability: From Neural Origins to Behavior	NEURON			English	Review							DECISION-MAKING; COMPUTATIONAL FRAMEWORK; POPULATION CODES; UNCERTAINTY; BRAIN; INFERENCE; ACCURACY; MODEL; METACOGNITION; INFORMATION	Research on confidence spreads across several sub-fields of psychology and neuroscience. Here, we explore how a definition of confidence as Bayesian probability can unify these viewpoints. This computational view entails that there are distinct forms in which confidence is represented and used in the brain, including distributional confidence, pertaining to neural representations of probability distributions, and summary confidence, pertaining to scalar summaries of those distributions. Summary confidence is, normatively, derived or "read out'' from distributional confidence. Neural implementations of readout will trade off optimality versus flexibility of routing across brain systems, allowing confidence to serve diverse cognitive functions.	[Meyniel, Florent] Univ Paris 11, Univ Paris Saclay, Cognit Neuroimaging Unit, CEA DSV I2BM,INSERM,NeuroSpin Ctr, F-91191 Gif Sur Yvette, France; [Sigman, Mariano] UBA, FCEN, Dept Fis, Buenos Aires, DF, Argentina; [Sigman, Mariano] Univ Torcuato Tella, IFIBA, Buenos Aires, DF, Argentina; [Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Buenos Aires; Universidad Torcuato Di Tella; Fundacao Champalimaud	Meyniel, F (corresponding author), Univ Paris 11, Univ Paris Saclay, Cognit Neuroimaging Unit, CEA DSV I2BM,INSERM,NeuroSpin Ctr, F-91191 Gif Sur Yvette, France.	florent.meyniel@gmail.com		Meyniel, Florent/0000-0002-6992-678X; Mainen, Zachary/0000-0001-7913-9109	European Union [604102]; Simons Foundation [325057]	European Union(European Commission); Simons Foundation	This work received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604102 (Human Brain Project). It was also supported in part by a grant from the Simons Foundation (325057) to Z.F.M.	Acerbi L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003661; Atas A, 2014, PSYCHOL SCI, V25, P113, DOI 10.1177/0956797613499591; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bang D, 2014, CONSCIOUS COGN, V26, P13, DOI 10.1016/j.concog.2014.02.002; BARANSKI JV, 1994, PERCEPT PSYCHOPHYS, V55, P412, DOI 10.3758/BF03205299; Barthelme S, 2010, P NATL ACAD SCI USA, V107, P20834, DOI 10.1073/pnas.1007704107; Barthelme S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000504; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bejjanki VR, 2011, NAT NEUROSCI, V14, P642, DOI 10.1038/nn.2796; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Bland AR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00085; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Costello F, 2014, PSYCHOL REV, V121, P463, DOI 10.1037/a0037010; Courville AC, 2004, ADV NEUR IN, V16, P977; d'Acremont M, 2013, J NEUROSCI, V33, P10887, DOI 10.1523/JNEUROSCI.5829-12.2013; Daunizeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015554; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 1996, NEURAL NETWORKS, V9, P1385, DOI 10.1016/S0893-6080(96)00009-3; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Dehaene S., 2014, CONSCIOUSNESS BRAIN; Dehaene S, 2014, CURR OPIN NEUROBIOL, V25, P76, DOI 10.1016/j.conb.2013.12.005; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Denison S, 2013, COGNITION, V126, P285, DOI 10.1016/j.cognition.2012.10.010; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Fetsch CR, 2014, NEURON, V83, P797, DOI 10.1016/j.neuron.2014.07.011; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fleming SM, 2015, PSYCHOL SCI, V26, P89, DOI 10.1177/0956797614557697; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fleming SM, 2012, PHILOS T R SOC B, V367, P1280, DOI 10.1098/rstb.2012.0021; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Fleming SM, 2010, CONSCIOUS COGN, V19, P352, DOI 10.1016/j.concog.2009.11.002; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Graziano M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004909; GRIFFIN D, 1992, COGNITIVE PSYCHOL, V24, P411, DOI 10.1016/0010-0285(92)90013-R; Griffiths TL, 2012, PSYCHOL BULL, V138, P415, DOI 10.1037/a0026884; Grimaldi P, 2015, NEUROSCI BIOBEHAV R, V55, P88, DOI 10.1016/j.neubiorev.2015.04.006; Hampton RR, 2001, P NATL ACAD SCI USA, V98, P5359, DOI 10.1073/pnas.071600998; Hart W, 2015, COGNITION, V137, P1, DOI 10.1016/j.cognition.2014.12.003; Hebart M.N., 2014, CEREB CORTEX; Hoyer PO, 2003, ADV NEURAL INFORM PR, V15, P277; Jarvstad A, 2013, P NATL ACAD SCI USA, V110, P16271, DOI 10.1073/pnas.1300239110; Jaynes E, 2003, PROBABILITY THEORY L; Juslin P, 2007, PSYCHOL REV, V114, P678, DOI 10.1037/0033-295X.114.3.678; KAHNEMAN D, 1982, COGNITION, V11, P143, DOI 10.1016/0010-0277(82)90023-3; Kahneman D., 2013, THINKING FAST SLOW; Karelitz TM, 2004, J EXP PSYCHOL-APPL, V10, P25, DOI 10.1037/1076-898X.10.1.25; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2014, NEURON, V84, P1329, DOI 10.1016/j.neuron.2014.12.015; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kim B, 2010, J NEUROSCI, V30, P2340, DOI 10.1523/JNEUROSCI.1730-09.2010; King JR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0204; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Komura Y, 2013, NAT NEUROSCI, V16, P749, DOI 10.1038/nn.3393; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Koriat A, 2012, PSYCHOL REV, V119, P80, DOI 10.1037/a0025648; Lak A, 2014, NEURON, V84, P190, DOI 10.1016/j.neuron.2014.08.039; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Legenstein R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003859; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2014, ANNU REV NEUROSCI, V37, P205, DOI 10.1146/annurev-neuro-071013-014017; Maloney LT, 2010, VISION RES, V50, P2362, DOI 10.1016/j.visres.2010.09.031; Mathys C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00039; Meyniel F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004305; Middlebrooks PG, 2012, NEURON, V75, P517, DOI 10.1016/j.neuron.2012.05.028; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; O'Reilly JX, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001662; Patel D, 2012, P ROY SOC B-BIOL SCI, V279, P4853, DOI 10.1098/rspb.2012.1847; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Pearl J, 1997, PROBABILISTIC REASON; Peirce C. S., 1884, MEMOIRS NATL ACAD SC, V3, P75, DOI DOI 10.5860/CHOICE.35SUP-462; Perez-Escudero A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002282; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Phillips L.D., 1977, DECISION MAKING CHAN, P507; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; RATCLIFF R, 1988, PSYCHOL REV, V95, P238, DOI 10.1037/0033-295X.95.2.238; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Rich D, 2015, J COMPUT NEUROSCI, V38, P315, DOI 10.1007/s10827-014-0545-1; Rose M, 2005, J COGNITIVE NEUROSCI, V17, P918, DOI 10.1162/0898929054021193; Schlaghecken F, 2000, MEM COGNITION, V28, P821, DOI 10.3758/BF03198417; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shea N, 2014, TRENDS COGN SCI, V18, P186, DOI 10.1016/j.tics.2014.01.006; Smith JD, 2003, BEHAV BRAIN SCI, V26, P317; Soltani A, 2010, NAT NEUROSCI, V13, P112, DOI 10.1038/nn.2450; Solway A, 2012, PSYCHOL REV, V119, P120, DOI 10.1037/a0026435; Summerfield C, 2014, NAT REV NEUROSCI, V15, P745, DOI 10.1038/nrn3838; Timmermans B, 2012, PHILOS T R SOC B, V367, P1412, DOI 10.1098/rstb.2011.0421; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van Zuijen TL, 2006, J COGNITIVE NEUROSCI, V18, P1292, DOI 10.1162/jocn.2006.18.8.1292; VICKERS D, 1985, ACTA PSYCHOL, V59, P129, DOI 10.1016/0001-6918(85)90017-4; Vilares I, 2012, CURR BIOL, V22, P1641, DOI 10.1016/j.cub.2012.07.010; Vul E., 2009, P 31 ANN C COGN SCI, P66; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; WALD A, 1945, ANN MATH STAT, V16, P117, DOI 10.1214/aoms/1177731118; WALLSTEN TS, 1995, KNOWL ENG REV, V10, P43, DOI 10.1017/S0269888900007256; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wu SW, 2009, P NATL ACAD SCI USA, V106, P6088, DOI 10.1073/pnas.0900102106; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416; Yokoyama O, 2010, NEUROSCI RES, V68, P199, DOI 10.1016/j.neures.2010.07.2041; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zylberberg A, 2014, CONSCIOUS COGN, V27, P246, DOI 10.1016/j.concog.2014.05.012; Zylberberg A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00079; Zylberberg A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000765	122	135	137	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2015	88	1					78	92		10.1016/j.neuron.2015.09.039	http://dx.doi.org/10.1016/j.neuron.2015.09.039			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8HM	26447574	Green Published, Bronze			2022-12-17	WOS:000363782500007
J	Peng, HC; Hawrylycz, M; Roskams, J; Hill, S; Spruston, N; Meijering, E; Ascoli, GA				Peng, Hanchuan; Hawrylycz, Michael; Roskams, Jane; Hill, Sean; Spruston, Nelson; Meijering, Erik; Ascoli, Giorgio A.			BigNeuron: Large-Scale 3D Neuron Reconstruction from Optical Microscopy Images	NEURON			English	Editorial Material							DIGITAL RECONSTRUCTIONS; VISUALIZATION	Understanding the structure of single neurons is critical for understanding how they function within neural circuits. BigNeuron is a new community effort that combines modern bioimaging informatics, recent leaps in labeling and microscopy, and the widely recognized need for openness and standardization to provide a community resource for automated reconstruction of dendritic and axonal morphology of single neurons.	[Peng, Hanchuan; Hawrylycz, Michael; Roskams, Jane] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Hill, Sean] Ctr Brain Simulat, CH-1202 Geneva, Switzerland; [Spruston, Nelson] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Meijering, Erik] Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Ascoli, Giorgio A.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; Erasmus University Rotterdam; Erasmus MC; George Mason University	Peng, HC (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	hanchuanp@alleninstitute.org; mikeh@alleninstitute.org; ascoli@gmu.edu	Meijering, Erik/AAL-8143-2020	Spruston, Nelson/0000-0003-3118-1636	NINDS NIH HHS [R01 NS039600, R01 NS086082] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086082, R01NS039600] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Gillette TA, 2011, NEUROINFORMATICS, V9, P303, DOI 10.1007/s12021-011-9104-3; Halavi M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00049; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Koch Christof, 1999, P1; Marr D., 1976, AI MEMOS; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Parekh R, 2013, NEURON, V77, P1017, DOI 10.1016/j.neuron.2013.03.008; Peng HC, 2015, NEUROINFORMATICS, V13, P259, DOI 10.1007/s12021-015-9270-9; Peng HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5342; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; Wang Y, 2011, NEUROINFORMATICS, V9, P193, DOI 10.1007/s12021-011-9110-5	18	135	135	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2015	87	2					252	256		10.1016/j.neuron.2015.06.036	http://dx.doi.org/10.1016/j.neuron.2015.06.036			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR2GJ	26182412	Green Published, Green Accepted, Bronze			2022-12-17	WOS:000361144200004
J	Trimmer, JS				Trimmer, James S.			Subcellular Localization of K+ Channels in Mammalian Brain Neurons: Remarkable Precision in the Midst of Extraordinary Complexity	NEURON			English	Review							AXON INITIAL SEGMENT; VOLTAGE-DEPENDENT POTASSIUM; ACTION-POTENTIAL INITIATION; GATED ION CHANNELS; A-TYPE; SURFACE EXPRESSION; PYRAMIDAL NEURONS; ALPHA-SUBUNIT; ULTRASTRUCTURAL-LOCALIZATION; PRESYNAPTIC LOCALIZATION	Potassium channels (KChs) are the most diverse ion channels, in part due to extensive combinatorial assembly of a large number of principal and auxiliary subunits into an assortment of KCh complexes. Their structural and functional diversity allows KChs to play diverse roles in neuronal function. Localization of KChs within specialized neuronal compartments defines their physiological role and also fundamentally impacts their activity, due to localized exposure to diverse cellular determinants of channel function. Recent studies in mammalian brain reveal an exquisite refinement of KCh subcellular localization. This includes axonal KChs at the initial segment, and near/within nodes of Ranvier and presynaptic terminals, dendritic KChs found at sites reflecting specific synaptic input, and KChs defining novel neuronal compartments. Painting the remarkable diversity of KChs onto the complex architecture of mammalian neurons creates an elegant picture of electrical signal processing underlying the sophisticated function of individual neuronal compartments, and ultimately neurotransmission and behavior.	[Trimmer, James S.] Univ Calif Davis, Dept Neurobiol, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu			NIH [R01NS034383, R01NS042225, U24NS050606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606, R01NS034383, R01NS042225] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work by J.S.T. was supported by NIH grants R01NS034383, R01NS042225, and U24NS050606. I thank current and former members of the Trimmer laboratory for their contributions, and especially Colleen Manning, for providing numerous unpublished images used here, as well as JoAnne Engebrecht, Colleen Manning, and Hannah Bishop for careful readings of the manuscript. I acknowledge authors cited and uncited who contributed to the work reviewed here, and apologize for any omissions or errors.	Alle H, 2011, J NEUROSCI, V31, P8001, DOI 10.1523/JNEUROSCI.0972-11.2011; Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Battefeld A, 2014, J NEUROSCI, V34, P3719, DOI 10.1523/JNEUROSCI.4206-13.2014; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bobik M, 2004, BRAIN RES, V1026, P168, DOI 10.1016/j.brainres.2004.07.088; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Brette R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003338; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Buttermore ED, 2013, J NEUROSCI RES, V91, P603, DOI 10.1002/jnr.23197; Caminos E, 2007, J COMP NEUROL, V505, P363, DOI 10.1002/cne.21497; Carta M, 2014, NEURON, V81, P787, DOI 10.1016/j.neuron.2013.12.028; Chang KJ, 2013, CURR TOP MEMBR, V72, P159, DOI 10.1016/B978-0-12-417027-8.00005-2; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chen XX, 2006, PFLUG ARCH EUR J PHY, V453, P397, DOI 10.1007/s00424-006-0097-y; Child ND, 2014, NEUROLOGY, V82, P989, DOI 10.1212/WNL.0000000000000228; Choo AMT, 2009, J NEUROSCI METH, V181, P6, DOI 10.1016/j.jneumeth.2009.04.007; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; Cooper EC, 1998, J NEUROSCI, V18, P965; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Devaux J, 2003, J NEUROSCI, V23, P4509; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dodson PD, 2003, J PHYSIOL-LONDON, V550, P27, DOI 10.1113/jphysiol.2003.046250; Dodson PD, 2002, J NEUROSCI, V22, P6953; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Elezgarai I, 2003, NEUROSCIENCE, V118, P889, DOI 10.1016/S0306-4522(03)00068-X; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Evanko D, 2009, NAT METHODS, V6, P19, DOI 10.1038/NMETH.F.235; Faivre-Sarrailh C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00196; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Fernandez-Alacid L, 2011, EUR J NEUROSCI, V34, P1724, DOI 10.1111/j.1460-9568.2011.07886.x; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Fukaya M, 2000, J COMP NEUROL, V426, P572; Gazula VR, 2010, J COMP NEUROL, V518, P3205, DOI 10.1002/cne.22393; Geffers L, 2012, MAMM GENOME, V23, P525, DOI 10.1007/s00335-012-9413-3; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Golan N, 2013, J NEUROSCI, V33, P10950, DOI 10.1523/JNEUROSCI.0571-13.2013; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gong B, 1999, J COMP NEUROL, V412, P342; Gonzalez C, 2014, SEMIN CELL DEV BIOL, V27, P23, DOI 10.1016/j.semcdb.2013.12.004; Goodman AD, 2013, NEUROTHERAPEUTICS, V10, P106, DOI 10.1007/s13311-012-0156-3; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Grunnet M, 2014, EUR J PHARMACOL, V726, P133, DOI 10.1016/j.ejphar.2014.01.017; Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hinman JD, 2006, J COMP NEUROL, V495, P351, DOI 10.1002/cne.20886; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 2013, NEURON, V79, P403, DOI 10.1016/j.neuron.2013.07.017; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang H, 2011, NAT NEUROSCI, V14, P840, DOI 10.1038/nn.2830; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Jan LY, 2012, J PHYSIOL-LONDON, V590, P2591, DOI 10.1113/jphysiol.2011.224212; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Jensen CS, 2014, J BIOL CHEM, V289, P10566, DOI 10.1074/jbc.M113.534495; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; JONES RSG, 1992, EPILEPSY RES, P173; Judge Susan I V, 2007, Recent Pat CNS Drug Discov, V2, P200, DOI 10.2174/157488907782411765; Judy Jennifer Toolan, 2013, Frontiers in Genetics, V4, P87, DOI 10.3389/fgene.2013.00087; Kerti K, 2012, EUR J NEUROSCI, V35, P66, DOI 10.1111/j.1460-9568.2011.07907.x; Kihira Y, 2010, J BIOL CHEM, V285, P15048, DOI 10.1074/jbc.M109.074260; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim E, 2012, J NEUROSCI, V32, P14427, DOI 10.1523/JNEUROSCI.2373-12.2012; King AN, 2014, J COMP NEUROL, V522, P2594, DOI 10.1002/cne.23551; Kirizs T, 2014, EUR J NEUROSCI, V39, P1771, DOI 10.1111/ejn.12526; Klinger F, 2011, NEUROIMAGE, V58, P761, DOI 10.1016/j.neuroimage.2011.07.003; Knaus HG, 1996, J NEUROSCI, V16, P955; Korber C, 2014, EUR J NEUROSCI, V40, P2867, DOI 10.1111/ejn.12661; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kullmann DM, 2010, J PHYSIOL-LONDON, V588, P1823, DOI 10.1113/jphysiol.2010.190652; Laube G, 1996, MOL BRAIN RES, V42, P51, DOI 10.1016/S0169-328X(96)00120-9; Leao RM, 2005, J NEUROSCI, V25, P3724, DOI 10.1523/JNEUROSCI.3983-04.2005; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Liao YJ, 1996, J NEUROSCI, V16, P7137; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lujan R, 2010, J CHEM NEUROANAT, V40, P1, DOI 10.1016/j.jchemneu.2010.03.003; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Mandikian D, 2014, J COMP NEUROL, V522, P3555, DOI 10.1002/cne.23641; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012; McNamara NMC, 1996, EUR J NEUROSCI, V8, P688, DOI 10.1111/j.1460-9568.1996.tb01254.x; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Miyashita T, 1997, BRAIN RES, V750, P251, DOI 10.1016/S0006-8993(96)01365-0; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nusser Z, 2012, CURR OPIN NEUROBIOL, V22, P366, DOI 10.1016/j.conb.2011.10.006; O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; Ogawa Y, 2008, J NEUROSCI, V28, P5731, DOI 10.1523/JNEUROSCI.4431-07.2008; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Otalora LFP, 2008, BRAIN RES, V1200, P116, DOI 10.1016/j.brainres.2008.01.017; Otalora LFP, 2011, BRAIN RES, V1368, P308, DOI 10.1016/j.brainres.2010.10.047; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poolos NP, 2012, EPILEPSIA, V53, P32, DOI 10.1111/epi.12033; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 2011, SEMIN CELL DEV BIOL, V22, P178, DOI 10.1016/j.semcdb.2010.09.010; Rasband MN, 2004, J NEUROSCI RES, V76, P749, DOI 10.1002/jnr.20073; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; Rasband MN, 2002, J CELL BIOL, V159, P663, DOI 10.1083/jcb.200206024; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; Rhodes KJ, 2008, J GEN PHYSIOL, V131, P407, DOI 10.1085/jgp.200709926; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Riazanski V, 2001, J PHYSIOL-LONDON, V537, P391, DOI 10.1111/j.1469-7793.2001.00391.x; Roeper J, 1997, J NEUROSCI, V17, P3379; Rollenhagen Astrid, 2010, Front Synaptic Neurosci, V2, P2, DOI 10.3389/fnsyn.2010.00002; Rowan MJM, 2014, J NEUROSCI, V34, P6611, DOI 10.1523/JNEUROSCI.4208-13.2014; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Sailer CA, 2006, EUR J NEUROSCI, V24, P442, DOI 10.1111/j.1460-9568.2006.04936.x; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Schaefer AT, 2007, J PHYSIOL-LONDON, V579, P737, DOI 10.1113/jphysiol.2006.122564; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Schulte U, 2011, SEMIN CELL DEV BIOL, V22, P132, DOI 10.1016/j.semcdb.2010.09.015; Scott R, 2008, J NEUROSCI, V28, P13139, DOI 10.1523/JNEUROSCI.2932-08.2008; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Simmons ML, 1996, MOL PHARMACOL, V50, P80; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Stafstrom CE, 2011, NAT REV DRUG DISCOV, V10, P729, DOI 10.1038/nrd3561; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Susuki K, 2013, ASN NEURO, V5, DOI 10.1042/AN20130025; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; Taussig MJ, 2013, PROTEOM CLIN APPL, V7, P756, DOI 10.1002/prca.201300060; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Trimmer J.S., 2014, HDB ION CHANNELS; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Turner RW, 2014, PFLUG ARCH EUR J PHY, V466, P661, DOI 10.1007/s00424-013-1434-6; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Vabnick I, 1999, J NEUROSCI, V19, P747; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vacher H, 2012, EPILEPSIA, V53, P21, DOI 10.1111/epi.12032; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Varga AW, 2000, LEARN MEMORY, V7, P321, DOI 10.1101/lm.35300; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watts RJ, 2013, CURR OPIN CHEM BIOL, V17, P393, DOI 10.1016/j.cbpa.2013.03.023; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yuste R, 2013, ANNU REV NEUROSCI, V36, P429, DOI 10.1146/annurev-neuro-062111-150455; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang CL, 1999, J NEUROSCI, V19, P2852	200	135	136	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 21	2015	85	2					238	256		10.1016/j.neuron.2014.12.042	http://dx.doi.org/10.1016/j.neuron.2014.12.042			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ5ZB	25611506	Green Accepted, Bronze			2022-12-17	WOS:000348296000005
J	Reig, R; Silberberg, G				Reig, Ramon; Silberberg, Gilad			Multisensory Integration in the Mouse Striatum	NEURON			English	Article							RECEPTIVE-FIELD PROPERTIES; BASAL GANGLIA; PROJECTION NEURONS; CORTICOTECTAL PROJECTIONS; BILATERAL PROJECTIONS; SYNAPTIC-TRANSMISSION; MEMBRANE-PROPERTIES; INDIRECT PATHWAYS; GLOBUS-PALLIDUS; CAUDATE NEURONS	The basal ganglia are involved in sensorimotor functions and action selection, both of which require the integration of sensory information. In order to determine how such sensory inputs are integrated, we obtained whole-cell recordings in mouse dorsal striatum during presentation of tactile and visual stimuli. All recorded neurons responded to bilateral whisker stimulation, and a subpopulation also responded to visual stimulation. Neurons responding to both visual and tactile stimuli were located in dorsomedial striatum, whereas those responding only to whisker deflections were located dorsolaterally. Responses were mediated by overlapping excitation and inhibition, with excitation onset preceding that of inhibition by several milliseconds. Responses differed according to the type of neuron, with direct pathway MSNs having larger responses and longer latencies between ipsilateral and contralateral responses than indirect pathway MSNs. Our results suggest that striatum acts as a sensory ``hub'' with specialized functional roles for the different neuron types.	[Reig, Ramon; Silberberg, Gilad] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet	Reig, R (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	ramon.reig@ki.se; gilad.silberberg@ki.se	Silberberg, Gilad/A-1048-2012; Reig, Ramon/A-6925-2017	Silberberg, Gilad/0000-0001-9964-505X; Reig, Ramon/0000-0002-6475-4181	ERC starting grant; Knut and Alice Wallenberg Academy Fellowship; Karolinska Institutet Strategic Research program in Neuroscience (StratNeuro); Swedish Medical Research Council	ERC starting grant(European Research Council (ERC)); Knut and Alice Wallenberg Academy Fellowship; Karolinska Institutet Strategic Research program in Neuroscience (StratNeuro); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	We thank Abdel El Manira, Ilan Lampl, Henrik Jorntell, and Maya Ketzef for comments on early versions of the manuscript. This work was supported by the following grants to G.S.: an ERC starting grant, the Knut and Alice Wallenberg Academy Fellowship, the Karolinska Institutet Strategic Research program in Neuroscience (StratNeuro), and the Swedish Medical Research Council.	Adler A, 2012, J NEUROSCI, V32, P2473, DOI 10.1523/JNEUROSCI.4830-11.2012; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Alloway KD, 1999, J NEUROSCI, V19, P10908, DOI 10.1523/JNEUROSCI.19-24-10908.1999; Alloway KD, 2006, J COMP NEUROL, V499, P33, DOI 10.1002/cne.21039; Alloway KD, 2009, J COMP NEUROL, V515, P548, DOI 10.1002/cne.22073; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BORDI F, 1992, J NEUROSCI, V12, P2493; Brown LL, 1996, NEUROSCIENCE, V75, P717, DOI 10.1016/0306-4522(96)00310-7; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; CARMAN JB, 1965, J NEUROL NEUROSUR PS, V28, P71, DOI 10.1136/jnnp.28.1.71; CHUDLER EH, 1995, BRAIN RES, V674, P33, DOI 10.1016/0006-8993(94)01427-J; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; FAULL RLM, 1986, NEUROSCIENCE, V19, P1119, DOI 10.1016/0306-4522(86)90128-4; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; FLAHERTY AW, 1991, J NEUROPHYSIOL, V66, P1249; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Goldberg JA, 2003, J NEUROSCI, V23, P10058; Haber S, 2008, BIOL PSYCHIAT, V64, P173, DOI 10.1016/j.biopsych.2008.05.033; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hoover JE, 2003, J NEUROPHYSIOL, V89, P1576, DOI 10.1152/jn.01009.2002; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; Kincaid AE, 1996, J COMP NEUROL, V374, P578; KITA T, 1984, BRAIN RES, V300, P129, DOI 10.1016/0006-8993(84)91347-7; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; KUNZLE H, 1975, BRAIN RES, V88, P195, DOI 10.1016/0006-8993(75)90384-4; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P15, DOI 10.1016/0306-4522(91)90248-M; MCGEORGE AJ, 1987, BRAIN RES, V423, P318, DOI 10.1016/0006-8993(87)90855-9; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mowery TM, 2011, J NEUROPHYSIOL, V105, P2225, DOI 10.1152/jn.01018.2010; Nagy A, 2005, EUR J NEUROSCI, V22, P419, DOI 10.1111/j.1460-9568.2005.04211.x; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; NORITA M, 1991, NEUROSCI RES, V10, P149, DOI 10.1016/0168-0102(91)90037-Y; Novejarque A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00054; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Olcese U, 2013, NEURON, V79, P579, DOI 10.1016/j.neuron.2013.06.010; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Pidoux M, 2011, J PHYSIOL-LONDON, V589, P263, DOI 10.1113/jphysiol.2010.199646; Planert H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057054; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Reig R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000670; Reiner A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00142; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; Schulz JM, 2009, J NEUROSCI, V29, P6336, DOI 10.1523/JNEUROSCI.4815-08.2009; SERIZAWA M, 1994, ARCH HISTOL CYTOL, V57, P493, DOI 10.1679/aohc.57.493; Smith Y, 1998, NEUROSCIENCE, V86, P353; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Tunstall MJ, 2002, J NEUROPHYSIOL, V88, P1263, DOI 10.1152/jn.2002.88.3.1263; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON JS, 1983, BRAIN RES, V270, P197, DOI 10.1016/0006-8993(83)90593-0; Wright AK, 2001, NEUROSCIENCE, V103, P87, DOI 10.1016/S0306-4522(00)00564-9	81	135	135	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 3	2014	83	5					1200	1212		10.1016/j.neuron.2014.07.033	http://dx.doi.org/10.1016/j.neuron.2014.07.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5XB	25155959	hybrid, Green Published			2022-12-17	WOS:000341419000020
J	Yau, KW; van Beuningen, SFB; Cunha-Ferreira, I; Cloin, BMC; van Battum, EY; Will, L; Schatzle, P; Tas, RP; van Krugten, J; Katrukha, EA; Jiang, K; Wulf, PS; Mikhaylova, M; Harterink, M; Pasterkamp, RJ; Akhmanova, A; Kapitein, LC; Hoogenraad, CC				Yau, Kah Wai; van Beuningen, Sam F. B.; Cunha-Ferreira, Ines; Cloin, Bas M. C.; van Battum, Eljo Y.; Will, Lena; Schatzle, Philipp; Tas, Roderick P.; van Krugten, Jaap; Katrukha, Eugene A.; Jiang, Kai; Wulf, Phebe S.; Mikhaylova, Marina; Harterink, Martin; Pasterkamp, R. Jeroen; Akhmanova, Anna; Kapitein, Lukas C.; Hoogenraad, Casper C.			Microtubule Minus-End Binding Protein CAMSAP2 Controls Axon Specification and Dendrite Development	NEURON			English	Article							NONCENTROSOMAL MICROTUBULES; NEURONAL POLARIZATION; HIPPOCAMPAL-NEURONS; POLARITY; NUCLEATION; STABILIZATION; ORGANIZATION; CENTROSOME; MECHANISMS; MORPHOLOGY	In neurons, most microtubules are not associated with a central microtubule-organizing center (MTOC), and therefore, both the minus and plus-ends of these noncentrosomal microtubules are found throughout the cell. Microtubule plus-ends are well established as dynamic regulatory sites in numerous processes, but the role of microtubule minus-ends has remained poorly understood. Using live-cell imaging, high-resolution microscopy, and laser-based microsurgery techniques, we show that the CAMSAP/Nezha/Patronin family protein CAMSAP2 specifically localizes to noncentrosomal microtubule minus-ends and is required for proper microtubule organization in neurons. CAMSAP2 stabilizes noncentrosomal microtubules and is required for neuronal polarity, axon specification, and dendritic branch formation in vitro and in vivo. Furthermore, we found that noncentrosomal microtubules in dendrites are largely generated by gamma-Tubulin-dependent nucleation. We propose a two-step model in which gamma-Tubulin initiates the formation of noncentrosomal microtubules and CAMSAP2 stabilizes the free microtubule minus-ends in order to control neuronal polarity and development.	[Yau, Kah Wai; van Beuningen, Sam F. B.; Cunha-Ferreira, Ines; Cloin, Bas M. C.; Will, Lena; Schatzle, Philipp; Tas, Roderick P.; van Krugten, Jaap; Katrukha, Eugene A.; Jiang, Kai; Wulf, Phebe S.; Mikhaylova, Marina; Harterink, Martin; Akhmanova, Anna; Kapitein, Lukas C.; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Yau, Kah Wai; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; [van Battum, Eljo Y.; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, NL-3584 CG Utrecht, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Kapitein, LC (corresponding author), Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands.	l.kapitein@uu.nl; c.hoogenraad@uu.nl	Mikhaylova, Marina/AAM-4368-2020; Harterink, Martin/M-2244-2019; Kapitein, Lukas C/J-4776-2016; Hoogenraad, Casper/B-8866-2011	Mikhaylova, Marina/0000-0001-7646-1346; Kapitein, Lukas C/0000-0001-9418-6739; Hoogenraad, Casper/0000-0002-2666-0758; Tas, Roderick/0000-0003-3111-8784; Harterink, Martin/0000-0002-8256-6651; van Krugten, Jaap/0000-0001-8790-2573; van Beuningen, Sam F. B./0000-0001-6166-196X; Pasterkamp, Jeroen/0000-0003-1631-6440	Netherlands Organization for Scientific Research (NWO-ALW-VICI); Netherlands Organization for Scientific Research (NWO-ALW-VIDI); Netherlands Organization for Scientific Research (NWO-ALW-VENI); Foundation for Fundamental Research on Matter (FOM), part of the NWO; Netherlands Organization for Health Research and Development (ZonMW-TOP); European Science Foundation (ESF-EURYI); Swiss National Science Foundation (SNSF); European Molecular Biology Organization - Young Investigators Program (EMBO-YIP)	Netherlands Organization for Scientific Research (NWO-ALW-VICI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO-ALW-VIDI); Netherlands Organization for Scientific Research (NWO-ALW-VENI)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM), part of the NWO; Netherlands Organization for Health Research and Development (ZonMW-TOP)(Netherlands Organization for Health Research and Development); European Science Foundation (ESF-EURYI)(European Science Foundation (ESF)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization - Young Investigators Program (EMBO-YIP)	We thank Dr. Rasband for sharing beta IV-Spectrin antibodies; N.T. Keijzer for cloning shRNA-constructs; Dr. F. Polleux and Dr. J. Courchet for sharing the cortical migration excel macro; and A.M.A. Chiotto for assisting with imaging and analyzing EB3 antibody stainings. This work was supported by the Netherlands Organization for Scientific Research (NWO-ALW-VICI to C.C.H. and A.A.; NWO-ALW-VIDI to L.C.K.; NWO-ALW-VENI to M.H.); the Foundation for Fundamental Research on Matter (FOM to C.C.H., L.C.K., and A.A.), which is part of the NWO; the Netherlands Organization for Health Research and Development (ZonMW-TOP to C.C.H.); the European Science Foundation (ESF-EURYI to C.C.H.); Swiss National Science Foundation (SNSF to P.S.); and European Molecular Biology Organization - Young Investigators Program (EMBO-YIP to C.C.H.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baas PW, 2011, DEV NEUROBIOL, V71, P403, DOI 10.1002/dneu.20818; BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Goodwin SS, 2010, CELL, V143, P263, DOI 10.1016/j.cell.2010.09.022; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kuijpers M, 2011, MOL CELL NEUROSCI, V48, P349, DOI 10.1016/j.mcn.2011.05.004; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Nguyen MM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-38; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Tanaka N, 2012, P NATL ACAD SCI USA, V109, P20029, DOI 10.1073/pnas.1218017109; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878	35	135	136	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 4	2014	82	5					1058	1073		10.1016/j.neuron.2014.04.019	http://dx.doi.org/10.1016/j.neuron.2014.04.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ0QH	24908486	Bronze			2022-12-17	WOS:000337359800013
J	Boudreau, RL; Jiang, P; Gilmore, BL; Spengler, RM; Tirabassi, R; Nelson, JA; Ross, CA; Xing, Y; Davidson, BL				Boudreau, Ryan L.; Jiang, Peng; Gilmore, Brian L.; Spengler, Ryan M.; Tirabassi, Rebecca; Nelson, Jay A.; Ross, Christopher A.; Xing, Yi; Davidson, Beverly L.			Transcriptome-wide Discovery of microRNA Binding Sites in Human Brain	NEURON			English	Article							ALPHA-SYNUCLEIN; TARGET SITES; MAMMALIAN MICRORNAS; HUMAN GENES; DISEASE; IDENTIFICATION; DATABASE; ASSOCIATION; EXPRESSION; DECAY	The orchestration of brain function requires complex gene regulatory networks that are modulated, in part, by microRNAs (miRNAs). These noncoding RNAs associate with argonaute (Ago) proteins in order to direct posttranscriptional gene suppression via base pairing with target transcripts. In order to better understand how miRNAs contribute to human-specialized brain processes and neurological phenotypes, identifying their targets is of paramount importance. Here, we address the latter by profiling Ago2:RNA interactions using HITS-CLIP to generate a transcriptome-wide map of miRNA binding sites in human brain. We uncovered similar to 7,000 stringent Ago2 binding sites that are highly enriched for conserved sequences corresponding to abundant brain miRNAs. This interactome points to functional miRNA:target pairs across > 3,000 genes and represents a valuable resource for accelerating our understanding of miRNA functions in brain. We demonstrate the utility of this map for exploring clinically relevant miRNA binding sites that may facilitate the translation of genetic studies of complex neuropsychiatric diseases into therapeutics.	[Boudreau, Ryan L.; Jiang, Peng; Gilmore, Brian L.; Xing, Yi; Davidson, Beverly L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Davidson, Beverly L.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Davidson, Beverly L.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Spengler, Ryan M.; Davidson, Beverly L.] Univ Iowa, Program Mol & Cellular Biol, Iowa City, IA 52242 USA; [Tirabassi, Rebecca; Nelson, Jay A.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Xing, Yi] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles	Xing, Y (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	yxing@ucla.edu; beverly-davidson@uiowa.edu	Spengler, Ryan/J-1412-2018	Spengler, Ryan/0000-0003-0181-5589; Boudreau, Ryan/0000-0002-9800-5349; Davidson, Beverly/0000-0002-3715-6290	Roy J. Carver Trust (University of Iowa); National Institutes of Health [NS50210, DA025132, HL07121, GM088342]; Alfred Sloan Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS050210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025132] Funding Source: NIH RePORTER	Roy J. Carver Trust (University of Iowa); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred Sloan Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the B.L.D. laboratory for insightful discussion, Clayton Oakley for assistance with molecular cloning, Kevin Knudtson and his staff of the University of Iowa DNA Facility and Alvaro Hernandez and his staff at the Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign, for sequencing-related services, Lan Lin for performing library quantitation, Edgardo Rodriguez for manuscript review, and Juan C. Troncoso and Olga Pletnikova and the Brain Resource Center, Division of Neuropathology, Department of Pathology, Johns Hopkins University School of Medicine for providing brain samples. This work was funded by the Roy J. Carver Trust (University of Iowa) and the National Institutes of Health (NS50210, DA025132, HL07121, and GM088342). Y.X. is supported by an Alfred Sloan Research Fellowship.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Coksaygan T, 2006, EXP NEUROL, V197, P475, DOI 10.1016/j.expneurol.2005.10.030; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gerrish A, 2012, J ALZHEIMERS DIS, V28, P377, DOI 10.3233/JAD-2011-110824; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Item CB, 2001, AM J HUM GENET, V69, P1127, DOI 10.1086/323765; Iwama H, 2013, ADV EXP MED BIOL, V774, P169, DOI 10.1007/978-94-007-5590-1_10; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Niino M, 2003, J NEUROIMMUNOL, V136, P125, DOI 10.1016/S0165-5728(03)00004-3; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schug J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-264; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sohn YB, 2012, CLIN GENET, V81, P185, DOI 10.1111/j.1399-0004.2011.01641.x; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Sotiriou S, 2009, NEUROSCI LETT, V461, P196, DOI 10.1016/j.neulet.2009.06.034; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Tian GL, 2010, HUM MOL GENET, V19, P3599, DOI 10.1093/hmg/ddq276; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; Whalley HC, 2012, NEUROPSYCHOPHARMACOL, V37, P2720, DOI 10.1038/npp.2012.137; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	64	135	136	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2014	81	2					294	305		10.1016/j.neuron.2013.10.062	http://dx.doi.org/10.1016/j.neuron.2013.10.062			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299UH	24389009	Bronze, Green Published, Green Accepted			2022-12-17	WOS:000330420700008
J	Suh, J; Choi, SH; Romano, DM; Gannon, MA; Lesinski, AN; Kim, DY; Tanzi, RE				Suh, Jaehong; Choi, Se Hoon; Romano, Donna M.; Gannon, Moira A.; Lesinski, Andrea N.; Kim, Doo Yeon; Tanzi, Rudolph E.			ADAM10 Missense Mutations Potentiate beta-Amyloid Accumulation by Impairing Prodomain Chaperone Function	NEURON			English	Article							ALPHA-SECRETASE ADAM10; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; DISINTEGRIN; BRAIN; APP; PROLIFERATION; DOMAIN; DEFICIENT; PATHOLOGY	The generation of A beta, the main component of senile plaques in Alzheimer's disease (AD), is precluded by alpha-secretase cleavage within the A beta domain of the amyloid precursor protein (APP). We identified two rare mutations (Q170H and R181G) in the prodomain of the metalloprotease, ADAM10, that cosegregate with late-onset AD (LOAD). Here, we addressed the pathogenicity of these mutations in transgenic mice expressing human ADAM10 in brain. In Tg2576 AD mice, both mutations attenuated alpha-secretase activity of ADAM10 and shifted APP processing toward beta-secretase-mediated cleavage, while enhancing A beta plaque load and reactive gliosis. We also demonstrated ADAM10 expression potentiates adult hippocampal neurogenesis, which is reduced by the LOAD mutations. Mechanistically, both LOAD mutations impaired the molecular chaperone activity of ADAM10 prodomain. Collectively, these findings suggest that diminished alpha-secretase activity, owing to LOAD ADAM10 prodomain mutations, leads to AD-related pathology, strongly supporting ADAM10 as a promising therapeutic target for this devastating disease.	[Suh, Jaehong; Choi, Se Hoon; Romano, Donna M.; Gannon, Moira A.; Lesinski, Andrea N.; Kim, Doo Yeon; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Boston, MA 02129 USA; [Suh, Jaehong; Choi, Se Hoon; Romano, Donna M.; Gannon, Moira A.; Lesinski, Andrea N.; Kim, Doo Yeon; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Boston, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	Cure Alzheimer's Fund; NIA, NIMH; American Health Assistance Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG041856] Funding Source: NIH RePORTER	Cure Alzheimer's Fund; NIA, NIMH; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Lin Wu for her scientific expertise and technical assistance in generating ADAM10 transgenic mice. We also thank Dr. Jorg Bartsch for providing ADAM10 prodomain antibody; Dr. Sam Sisodia for providing MoPrP.Xhol plasmid; Dr. Matthew Frosch for providing Tg2576 mice; Dr. Basavaraj Hooli and Dr. Can Zhang for helpful discussions; and William Wisdom for mouse tail genotyping. This study was supported by the Cure Alzheimer's Fund, grants from the NIA, NIMH (R.E.T.), and the American Health Assistance Foundation (J.S.).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao J, 2000, J BIOL CHEM, V275, P29648, DOI 10.1074/jbc.M001920200; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gaultier A, 2002, J BIOL CHEM, V277, P23336, DOI 10.1074/jbc.M201792200; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kang TB, 2002, J BIOL CHEM, V277, P48514, DOI 10.1074/jbc.M208961200; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Parkin E, 2009, J NEUROCHEM, V108, P1464, DOI 10.1111/j.1471-4159.2009.05907.x; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	44	135	140	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					385	401		10.1016/j.neuron.2013.08.035	http://dx.doi.org/10.1016/j.neuron.2013.08.035			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241VI	24055016	Bronze, Green Accepted			2022-12-17	WOS:000326196400020
J	Payzan-LeNestour, E; Dunne, S; Bossaerts, P; O'Doherty, JP				Payzan-LeNestour, Elise; Dunne, Simon; Bossaerts, Peter; O'Doherty, John P.			The Neural Representation of Unexpected Uncertainty during Value-Based Decision Making	NEURON			English	Article							LOCUS-COERULEUS; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; SELECTIVE ATTENTION; REWARD; PREDICTION; RISK; ACTIVATION; RESPONSES	Uncertainty is an inherent property of the environment and a central feature of models of decision-making and learning. Theoretical propositions suggest that one form, unexpected uncertainty, may be used to rapidly adapt to changes in the environment, while being influenced by two other forms: risk and estimation uncertainty. While previous studies have reported neural representations of estimation uncertainty and risk, relatively little is known about unexpected uncertainty. Here, participants performed a decision-making task while undergoing functional magnetic resonance imaging (fMRI), which, in combination with a Bayesian model-based analysis, enabled us to separately examine each form of uncertainty examined. We found representations of unexpected uncertainty in multiple cortical areas, as well as the noradrenergic brainstem nucleus locus coeruleus. Other unique cortical regions were found to encode risk, estimation uncertainty, and learning rate. Collectively, these findings support theoretical models in which several formally separable uncertainty computations determine the speed of learning.	[Payzan-LeNestour, Elise] Univ New S Wales, Sch Banking & Finance, Australian Sch Business, Sydney, NSW 2052, Australia; [Payzan-LeNestour, Elise; Dunne, Simon; Bossaerts, Peter; O'Doherty, John P.] CALTECH, Pasadena, CA 91125 USA; [O'Doherty, John P.] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland	University of New South Wales Sydney; California Institute of Technology; Trinity College Dublin	Payzan-LeNestour, E (corresponding author), Univ New S Wales, Sch Banking & Finance, Australian Sch Business, Sydney, NSW 2052, Australia.	elise@elisepayzan.com; sdunne@caltech.edu	Bossaerts, Peter/AAZ-9851-2020; O'Doherty, John P/F-1204-2013; Bossaerts, Peter/O-9964-2015	Bossaerts, Peter/0000-0003-2308-2603; Payzan-LeNestour, Elise/0000-0001-8658-3208; Dunne, Simon/0000-0003-4875-7953	Science Foundation Ireland [08/IN.1/B1844]; European Research Council; Swiss Finance Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swiss Finance Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Science Foundation Ireland grant 08/IN.1/B1844 and a European Research Council grant (to J.O.D). P.B. and E.P.L.N. acknowledge the support of the Swiss Finance Institute to the Ecole Polytechnique Federale Lausanne.	ARNSTEN AFT, 1984, BRAIN RES, V306, P9, DOI 10.1016/0006-8993(84)90351-2; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Aston-Jones G., 2002, SOC NEUR ABSTR, V2002, P86; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bach DR, 2011, J NEUROSCI, V31, P4811, DOI 10.1523/JNEUROSCI.1452-10.2011; Badre D, 2012, NEURON, V73, P595, DOI 10.1016/j.neuron.2011.12.025; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bland AR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00085; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; Bruguier AJ, 2010, J FINANC, V65, P1703, DOI 10.1111/j.1540-6261.2010.01591.x; Callan AM, 2009, HUM BRAIN MAPP, V30, P2804, DOI 10.1002/hbm.20710; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cavanagh JF, 2012, CEREB CORTEX, V22, P2575, DOI 10.1093/cercor/bhr332; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Chumbley JR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002346; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; d'Acremont M, 2009, NEUROIMAGE, V47, P1929, DOI 10.1016/j.neuroimage.2009.04.096; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; McGaughy J, 2008, NEUROSCIENCE, V153, P63, DOI 10.1016/j.neuroscience.2008.01.064; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Payzan-Lenestour Elise, 2012, Front Neurosci, V6, P150, DOI 10.3389/fnins.2012.00150; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Prevost C, 2011, EUR J NEUROSCI, V34, P134, DOI 10.1111/j.1460-9568.2011.07686.x; Rajkowski J., 1992, SOC NEUR ABSTR, V18, P538; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Schlund MW, 2010, NEUROSCIENCE, V165, P151, DOI 10.1016/j.neuroscience.2009.10.014; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Talsma D, 2010, J COGNITIVE NEUROSCI, V22, P761, DOI 10.1162/jocn.2009.21223; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Vercauteren T., 2007, DIFFEOMORPHIC DEMONS; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Yu AJ, 2012, NAT NEUROSCI, V15, P933, DOI 10.1038/nn.3150	70	135	136	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					191	201		10.1016/j.neuron.2013.04.037	http://dx.doi.org/10.1016/j.neuron.2013.04.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849203	Green Accepted, Bronze			2022-12-17	WOS:000321802000019
J	Yamahachi, H; Marik, SA; McManus, JNJ; Denk, W; Gilbert, CD				Yamahachi, Homare; Marik, Sally A.; McManus, Justin N. J.; Denk, Winfried; Gilbert, Charles D.			Rapid Axonal Sprouting and Pruning Accompany Functional Reorganization in Primary Visual Cortex	NEURON			English	Article							TOPOGRAPHIC MAP REORGANIZATION; HORIZONTAL CONNECTIONS; ADULT CAT; CORTICAL REORGANIZATION; DENDRITIC SPINES; STRIATE CORTEX; AREA 17; PLASTICITY; DYNAMICS; LESIONS	The functional architecture of adult cerebral cortex retains a capacity for experience-dependent change. This is seen following focal binocular lesions, which induce rapid changes in receptive field size and position. To follow the dynamics of the circuitry underlying these changes, we imaged the intrinsic long-range horizontal connections within the lesion projection zone (LPZ) in adult macaque primary visual cortex. To image the same axons over time, we combined viral vector-mediated EGFP transfer and two-photon microscopy. The lesion triggered, within the first week, an similar to 2-fold outgrowth of axons toward the center of the LPZ. Over the subsequent month, axonal density declined due to a parallel process of pruning and sprouting but maintained a net increase relative to prelesion levels. The rate of turnover of axonal boutons also increased. The axonal restructuring recapitulates the pattern of exuberance and pruning seen in early development and correlates well with the functional changes following retinal lesions.	[Yamahachi, Homare; Marik, Sally A.; McManus, Justin N. J.; Gilbert, Charles D.] Rockefeller Univ, New York, NY 10065 USA; [Denk, Winfried] Max Planck Inst Med Res, Heidelberg, Germany	Rockefeller University; Max Planck Society	Gilbert, CD (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	gilbert@rockefeller.edu	denk, winfried/I-6627-2012	Marik, Sally/0000-0002-1247-6001	NIH [EY018119]; NATIONAL EYE INSTITUTE [R01EY018119] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY018119. The authors would like to thank Matthew Isakson for technical assistance.	ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; Chen JB, 2010, CEREB CORTEX, V20, P650, DOI 10.1093/cercor/bhp131; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; CHINO YM, 1995, J NEUROSCI, V15, P2417, DOI 10.1523/JNEUROSCI.15-03-02417.1995; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Efron B, 1993, INTRO BOOTSTRAP, DOI DOI 10.1007/978-1-4899-4541-9; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hu TT, 2009, CEREB CORTEX, V19, P2982, DOI 10.1093/cercor/bhp069; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kasthuri N, 2004, CURR OPIN NEUROBIOL, V14, P105, DOI 10.1016/j.conb.2004.01.013; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kossut M, 1999, NEUROSCIENCE, V92, P807, DOI 10.1016/S0306-4522(98)00722-2; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LEVAY S, 1979, SOC NEUROSCI S, V4; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Low LK, 2005, CURR OPIN NEUROBIOL, V15, P549, DOI 10.1016/j.conb.2005.08.007; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Massie A, 2003, BRAIN RES, V976, P100, DOI 10.1016/S0006-8993(03)02717-3; Massie A, 2003, J NEUROCHEM, V84, P1387, DOI 10.1046/j.1471-4159.2003.01636.x; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; McManus JNJ, 2008, J NEUROPHYSIOL, V99, P2086, DOI 10.1152/jn.00871.2007; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; ROSE JE, 1960, J COMP NEUROL, V115, P243, DOI 10.1002/cne.901150303; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Stettler DD, 2006, NEURON, V49, P877, DOI 10.1016/j.neuron.2006.02.018; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E	57	135	139	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					719	729		10.1016/j.neuron.2009.11.026	http://dx.doi.org/10.1016/j.neuron.2009.11.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005827	Bronze, Green Accepted			2022-12-17	WOS:000273123700016
J	Terashima, A; Pelkey, KA; Rah, JC; Suh, YH; Roche, KW; Collingridge, GL; McBain, CJ; Isaac, JTR				Terashima, Akira; Pelkey, Kenneth A.; Rah, Jong-Cheol; Suh, Young Ho; Roche, Katherine W.; Collingridge, Graham L.; McBain, Chris J.; Isaac, John T. R.			An essential role for PICK1 in NMDA receptor-dependent bidirectional synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; DOMAIN-CONTAINING PROTEIN; KINASE-C-ALPHA; BINDING-PROTEIN; PKC PHOSPHORYLATION; SUBUNIT COMPOSITION; PDZ DOMAINS; CA1 REGION; AREA CA1	PICK1 is a calcium-sensing, PDZ domain-containing protein that interacts with GluR2 and GluR3 AMPA receptor (AMPAR) subunits and regulates their trafficking. Although PICK1 has been principally implicated in long-term depression (LTD), PICK1 overexpression in CA1 pyramidal neurons causes a CaMK- and PKC-dependent potentiation of AMPAR-mediated transmission and an increase in synaptic GluR2-lacking AMPARs, mechanisms associated with NMDA receptor (NMDAR)-dependent long-term potentiation (LTP). Here, we directly tested whether PICK1 participates in both hippocampal NMDAR-dependent LTP and LTD. We show that the PICK1 potentiation of AMPAR-mediated transmission is NMDAR dependent and fully occludes LTP. Conversely, blockade of PICK1 PDZ interactions or lack of PICK1 prevents LTP. These observations demonstrate an important role for PICK1 in LTP. In addition, deletion of PICK1 or blockade of PICK1 PDZ binding prevented NMDAR-dependent LTD. Thus, PICK1 plays a critical role in bidirectional NMDAR-dependent long-term synaptic plasticity in the hippocampus.	[Terashima, Akira; Rah, Jong-Cheol; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA; [Terashima, Akira; Collingridge, Graham L.; Isaac, John T. R.] Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synspt Plat, Bristol BS8 1TD, Avon, England; [Pelkey, Kenneth A.; McBain, Chris J.] NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Receptor Biol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bristol; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, 35 Convent Dr, Bethesda, MD 20892 USA.	isaacj@ninds.nih.gov	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Roche, Katherine/W-9893-2019	Collingridge, Graham L/0000-0002-9572-5359; Roche, Katherine/0000-0001-7282-6539; Rah, Jong-Cheol/0000-0003-3780-0522	Intramural NIH HHS [Z01 NS003011-03] Funding Source: Medline; Medical Research Council [G0601813] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0601813] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003011, ZIANS003035, ZIANS002994] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hjelmstad GO, 1997, NEURON, V19, P1309, DOI 10.1016/S0896-6273(00)80421-3; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Musleh W, 1997, P NATL ACAD SCI USA, V94, P9451, DOI 10.1073/pnas.94.17.9451; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sossa KG, 2006, MOL CELL NEUROSCI, V31, P574, DOI 10.1016/j.mcn.2005.11.011; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	73	135	138	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					872	882		10.1016/j.neuron.2008.01.028	http://dx.doi.org/10.1016/j.neuron.2008.01.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367088	Green Accepted, Bronze			2022-12-17	WOS:000254500000011
J	Durand, JB; Nelissen, K; Joly, O; Wardak, C; Todd, JT; Norman, JF; Janssen, P; Vanduffel, W; Orban, GA				Durand, Jean-Baptiste; Nelissen, Koen; Joly, Olivier; Wardak, Claire; Todd, James T.; Norman, J. Farley; Janssen, Peter; Vanduffel, Wim; Orban, Guy A.			Anterior regions of monkey parietal cortex process visual 3D shape	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; SURFACE-ORIENTATION; CORTICAL CONNECTIONS; NEURAL MECHANISMS; BINOCULAR VISION; MACAQUE MONKEYS; PRIMATE DORSAL; CONTRAST AGENT; EXTRACTING 3D; HAND ACTION	The intraparietal cortex is involved in the control of visually guided actions, like reach-to-grasp movements, which require extracting the 3D shape and position of objects from 2D retinal images. Using fMRI in behaving monkeys, we investigated the role of the intraparietal cortex in processing stereoscopic information for recovering the depth structure and the position in depth of objects. We found that while several areas (CIP, LIP, and AIP on the lateral bank; PIP and MIP on the medial bank) are activated by stereoscopic stimuli, AIP and an adjoining portion of LIP are sensitive only to depth structure. Furthermore, only these two regions are sensitive to both the depth structure and the 2D shape of small objects. These results indicate that extracting 3D spatial information from stereo involves several intraparietal areas, among which AIP and anterior LIP are more specifically engaged in extracting the 3D shape of objects.	Catholic Univ Louvain, Neuro & Psychofysiol Lab, Sch Med, B-3000 Louvain, Belgium; Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; Western Kentucky Univ, Dept Psychol, Bowling Green, KY 42101 USA; Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Universite Catholique Louvain; University System of Ohio; Ohio State University; Western Kentucky University	Orban, GA (corresponding author), Catholic Univ Louvain, Neuro & Psychofysiol Lab, Sch Med, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	guy.orban@med.kuleuven.be	Wardak, Claire/P-6222-2016; DURAND, Jean-Baptiste/E-9252-2011; Durand, Jean-Baptiste/ABE-9090-2020; Norman, Farley/A-7169-2012	Wardak, Claire/0000-0001-8847-1859; DURAND, Jean-Baptiste/0000-0003-4780-8691; Norman, Farley/0000-0001-5877-1914; Orban, Guy/0000-0002-8179-9584; Joly, Olivier/0000-0002-5818-6552	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB000790-06A2, R01 EB000790] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BOLTZ RL, 1979, EXP BRAIN RES, V37, P87, DOI 10.1007/BF01474256; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; CHEFDHOTEL C, 2002, P IEEE INT S BIOMEDI, V7, P753; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fize D, 2003, J NEUROSCI, V23, P7395; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hermosillo G, 2002, INT J COMPUT VISION, V50, P329, DOI 10.1023/A:1020830525823; Howard I, 2002, DEPTH PERCEPTION, V2; HOWARD IP, 2002, BASIC MECH, V1; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JEANNEROD M, 1986, BEHAV BRAIN RES, V19, P99, DOI 10.1016/0166-4328(86)90008-2; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M., 1981, ATTENTION PERFORM, P153; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; Melmoth DR, 2006, EXP BRAIN RES, V171, P371, DOI 10.1007/s00221-005-0273-x; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; Napier J, 1980, HANDS; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; ROGERS B, 1989, NATURE, V339, P135, DOI 10.1038/339135a0; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sakata H, 2005, NEUROPSYCHOLOGIA, V43, P151, DOI 10.1016/j.neuropsychologia.2004.11.003; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Snyder LH, 2000, J NEUROPHYSIOL, V83, P1099, DOI 10.1152/jn.2000.83.2.1099; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2005, NEUROSCI RES, V51, P221, DOI 10.1016/j.neures.2004.11.006; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Watt SJ, 2003, J EXP PSYCHOL HUMAN, V29, P404, DOI 10.1037/0096-1523.29.2.404; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Wheatstone C, 1838, PHILOS T SOC LOND B, V128, P371, DOI DOI 10.1098/RSTL.1838.0019; Zhao FQ, 2006, NEUROIMAGE, V30, P1149, DOI 10.1016/j.neuroimage.2005.11.013	77	135	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					493	505		10.1016/j.neuron.2007.06.040	http://dx.doi.org/10.1016/j.neuron.2007.06.040			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678860	Green Accepted, Bronze			2022-12-17	WOS:000248711000015
J	Stegmuller, J; Konishi, Y; Huynh, MA; Yuan, ZQ; DiBacco, S; Bonni, A				Stegmuller, Judith; Konishi, Yoshiyuki; Huynh, Mai Anh; Yuan, Zengqiang; DiBacco, Sara; Bonni, Azad			Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN	NEURON			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANSFORMING-GROWTH-FACTOR; SKI ONCOPROTEIN; SMAD PROTEINS; CO-REPRESSOR; GUIDANCE; RECEPTOR; DESTRUCTION; DEGRADATION; TRANSPORT	Axonal growth is fundamental to the establishment of neuronal connectivity in the brain. However, the cell-intrinsic mechanisms that govern axonal morphogenesis remain to be elucidated. The ubiquitin ligase Cdh1-anaphase-promoting complex (Cdh1-APC) suppresses the growth of axons in postmitotic neurons. Here, we report that Cdh1-APC operates in the nucleus to inhibit axonal growth. We also identify the transcriptional corepressor SnoN as a key target of neuronal Cdh1-APC that promotes axonal growth. Cdh1 forms a physical complex with SnoN and stimulates the ubiquitin-dependent proteasomal degradation of SnoN in neurons. Knockdown of SnoN in neurons significantly reduces axonal growth and suppresses Cdh1 RNAi enhancement of axonal growth. In addition, SnoN knockdown in vivo suggests an essential function for SnoN in the development of granule neuron parallel fibers in the cerebellar cortex. These findings define Cdh1-APC and SnoN as components of a cell-intrinsic pathway that orchestrates axonal morphogenesis in a transcription-dependent manner in the mammalian brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02116 USA	Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02116 USA.	azad_bonni@hms.harvard.edu	Yuan, Zengqiang/G-5245-2017	Yuan, Zengqiang/0000-0001-5739-2867	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bayer, 1997, RELATION ITS EVOLUTI; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Reed JA, 2001, CANCER RES, V61, P8074; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Shalizi A, 2003, J NEUROSCI, V23, P7326; Stegmuller J, 2005, TRENDS NEUROSCI, V28, P596, DOI 10.1016/j.tins.2005.09.003; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang SW, 2002, DEVELOPMENT, V129, P467; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhang F, 2003, CANCER RES, V63, P5005	43	135	146	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					389	400		10.1016/j.neuron.2006.03.034	http://dx.doi.org/10.1016/j.neuron.2006.03.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675394	Bronze			2022-12-17	WOS:000237726800009
J	Strasser, GA; Rahim, NA; VanderWaal, KE; Gertler, FB; Lanier, LM				Strasser, GA; Rahim, NA; VanderWaal, KE; Gertler, FB; Lanier, LM			Arp2/3 is a negative regulator of growth cone translocation	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN DEPOLYMERIZING FACTOR; AXON GUIDANCE; N-WASP; LISTERIA-MONOCYTOGENES; ENA/VASP PROTEINS; CULTURED NEURONS; IN-VITRO; F-ACTIN; REQUIRES INTERACTIONS	Arp2/3 is an actin binding complex that is enriched in the peripheral lamellipodia of fibroblasts, where it forms a network of short, branched actin filaments, generating the protrusive force that extends lamellipodia and drives fibroblast motility. Although it has been assumed that Arp2/3 would play a similar role in growth cones, our studies indicate that Arp2/3 is enriched in the central, not the peripheral, region of growth cones and that the growth cone periphery contains few branched actin filaments. Arp2/3 inhibition in fibroblasts severely disrupts actin organization and membrane protrusion. In contrast, Arp2/3 inhibition in growth cones minimally affects actin organization and does not inhibit lamellipodia protrusion or de novo filopodia formation. Surprisingly, Arp2/3 inhibition significantly enhances axon elongation and causes defects in growth cone guidance. These results indicate that Arp2/3 is a negative regulator of growth cone translocation.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT)	Lanier, LM (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	lanie002@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049178] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049178-01, R01 NS049178-02] Funding Source: Medline; PHS HHS [6895154] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; ARCE CA, 1978, J NEUROCHEM, V31, P205, DOI 10.1111/j.1471-4159.1978.tb12449.x; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 2003, J HISTOCHEM CYTOCHEM, V51, P407, DOI 10.1177/002215540305100401; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Buck KB, 2002, J NEUROSCI, V22, P9358; CALDWELL JE, 1989, J BIOL CHEM, V264, P12648; Challacombe JF, 1997, J NEUROSCI, V17, P3085; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DENT EW, 2004, IN PRESS J NEUROSCI; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Goslin K., 1998, CULTURING NERVE CELL, P339; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hufner K, 2002, FEBS LETT, V514, P168, DOI 10.1016/S0014-5793(02)02358-X; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; Kim MD, 2002, J NEUROSCI, V22, P1794, DOI 10.1523/JNEUROSCI.22-05-01794.2002; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koleske Anthony J, 2003, Sci STKE, V2003, ppe20; Kuhn TB, 1998, J NEUROSCI, V18, P184; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LETOURNEAU PC, 1983, J CELL BIOL, V97, P963, DOI 10.1083/jcb.97.4.963; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Machesky LM, 1997, BIOCHEM J, V328, P105; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2002, NAT CELL BIOL, V4, pE191, DOI 10.1038/ncb0802-e191a; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; TANAKA E, 1995, J CELL BIOL, V128, P127, DOI 10.1083/jcb.128.1.127; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	91	135	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					81	94		10.1016/j.neuron.2004.05.015	http://dx.doi.org/10.1016/j.neuron.2004.05.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233919	Green Published, Bronze			2022-12-17	WOS:000222549800009
J	Carr, DB; Day, M; Cantrell, AR; Held, J; Scheuer, T; Catterall, WA; Surmeier, DJ				Carr, DB; Day, M; Cantrell, AR; Held, J; Scheuer, T; Catterall, WA; Surmeier, DJ			Transmitter modulation of slow, activity-dependent alterations in sodium channel availability endows neurons with a novel form of cellular plasticity	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; PROTEIN-KINASE-C; RAT HIPPOCAMPAL-NEURONS; GATED NA+ CHANNELS; ACTION-POTENTIALS; NEOCORTICAL NEURONS; STRUCTURAL REARRANGEMENT; PREFRONTAL CORTEX; INACTIVATION; ACTIVATION	Voltage-gated Na+ channels are major targets of G protein-coupled receptor (GPCR)-initiated signaling cascades. These cascades act principally through protein kinase-mediated phosphorylation of the channel alpha subunit. Phosphorylation reduces Na+ channel availability in most instances without producing major alterations of fast channel gating. The nature of this change in availability is poorly understood. The results described here show that both GPCR- and protein kinase-dependent reductions in Na+ channel availability are mediated by a slow, voltage-dependent process with striking similarity to slow inactivation, an intrinsic gating mechanism of Na+ channels. This process is strictly associated with neuronal activity and develops over seconds, endowing neurons with a novel form of cellular plasticity shaping synaptic integration, dendritic electrogenesis, and repetitive discharge.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Washington; University of Washington Seattle	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062070, K01MH001669, F32MH064322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R01NS015751, R37NS034696] Funding Source: NIH RePORTER; NIMH NIH HHS [MH01669, MH62070, MH64322] Funding Source: Medline; NINDS NIH HHS [NS15751, NS34696] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; Cantrell AR, 1999, J NEUROSCI, V19, P5301; Cantrell AR, 1997, J NEUROSCI, V17, P7330; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Carr DB, 2002, J NEUROSCI, V22, P6846; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Goldman-Rakic PS, 1999, ANN NY ACAD SCI, V868, P13, DOI 10.1111/j.1749-6632.1999.tb11270.x; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; HIBER K, 2002, J BIOL CHEM, V277, P37105; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Jung HY, 1997, J NEUROSCI, V17, P6639; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Mickus T, 1999, ANN NY ACAD SCI, V868, P97, DOI 10.1111/j.1749-6632.1999.tb11280.x; Mitrovic N, 2000, J GEN PHYSIOL, V115, P707, DOI 10.1085/jgp.115.6.707; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PEROZO E, 1989, J GEN PHYSIOL, V93, P1195, DOI 10.1085/jgp.93.6.1195; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; Stuart G., 1999, DENDRITES; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Toib A, 1998, J NEUROSCI, V18, P1893; Townsend C, 1997, J GEN PHYSIOL, V110, P23, DOI 10.1085/jgp.110.1.23; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 1996, J NEUROPHYSIOL, V75, P963, DOI 10.1152/jn.1996.75.2.963; Vedantham V, 1998, J GEN PHYSIOL, V111, P83, DOI 10.1085/jgp.111.1.83; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	50	135	136	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 28	2003	39	5					793	806		10.1016/S0896-6273(03)00531-2	http://dx.doi.org/10.1016/S0896-6273(03)00531-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948446	Bronze			2022-12-17	WOS:000185079300009
J	Felmy, F; Neher, E; Schneggenburger, R				Felmy, F; Neher, E; Schneggenburger, R			Probing the intracellular calcium sensitivity of transmitter release during synaptic facilitation	NEURON			English	Article							SQUID GIANT SYNAPSE; RAT BRAIN-STEM; PRESYNAPTIC CALCIUM; RESIDUAL CALCIUM; NERVE-TERMINALS; NEUROTRANSMITTER RELEASE; TIME-COURSE; CA2+; CALYX; CURRENTS	In nerve terminals, residual Ca2+ remaining from previous activity can cause facilitation of transmitter release by a mechanism that is still under debate. Here we show that the intracellular Ca2+ sensitivity of transmitter release at the calyx of Held is largely unchanged during facilitation, which leaves an increased microdomain Ca2+ signal as a possible mechanism for facilitation. We measured the Ca2+ dependencies of facilitation, as well as of transmitter release, to estimate the required increment in microdomain Ca2+. These measurements show that linear summation of residual and microdomain Ca2+ accounts for only 30% of the observed facilitation. However, a small degree of supra-linearity in the summation of intracellular Ca2+ signals, which might be caused by saturation of cytosolic Ca2+ buffer(s), is sufficient to explain facilitation at this CNS synapse.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Synapt Dynam & Modulat, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Neher, Erwin/A-2109-2013					ADLER EM, 1991, J NEUROSCI, V11, P1496; AHARON S, 1994, B MATH BIOL, V56, P1095, DOI 10.1016/S0092-8240(05)80333-7; Atluri PP, 1996, J NEUROSCI, V16, P5661; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Chuhma N, 2001, J PHYSIOL-LONDON, V530, P93, DOI 10.1111/j.1469-7793.2001.0093m.x; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; STANLEY EF, 1986, J NEUROSCI, V6, P782; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; WU LG, 1994, J NEUROSCI, V14, P645; Wu LG, 1999, J NEUROSCI, V19, P726; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1992, CELL CALCIUM, V13, P29, DOI 10.1016/0143-4160(92)90027-P; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	53	135	137	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 6	2003	37	5					801	811		10.1016/S0896-6273(03)00085-0	http://dx.doi.org/10.1016/S0896-6273(03)00085-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628170	Bronze, Green Published			2022-12-17	WOS:000181452800009
J	Groh, JM; Trause, AS; Underhill, AM; Clark, KR; Inati, S				Groh, JM; Trause, AS; Underhill, AM; Clark, KR; Inati, S			Eye position influences auditory responses in primate inferior colliculus	NEURON			English	Article							POSTERIOR PARIETAL NEURONS; SUPERIOR COLLICULUS; SOUND-LOCALIZATION; NEURAL REPRESENTATION; EXTERNAL NUCLEUS; RECEPTIVE-FIELDS; BARN OWLS; VISUAL CALIBRATION; STIMULUS AZIMUTH; CORTEX NEURONS	We examined the frame of reference of auditory responses in the inferior colliculus in monkeys fixating visual stimuli at different locations. Eye position modulated the level of auditory responses in 33% of the neurons we encountered, but it did not appear to shift their spatial tuning. The effect of eye position on auditory responses was substantial-comparable in magnitude to that of sound location. The eye position signal appeared to interact with the auditory responses in at least a partly multiplicative fashion. We conclude that the representation of sound location in primate IC is distributed and that the frame of reference is intermediate between head- and eye-centered coordinates. The information contained in these neurons appears to be sufficient for later neural stages to calculate the positions of sounds with respect to the eyes.	Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Groh, JM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, 6207 Moore Hall, Hanover, NH 03755 USA.		Clark, Kimberly/Z-6228-2019	Groh, Jennifer/0000-0002-6435-3935; Inati, Souheil/0000-0001-5596-9554				AITKIN L, 1990, HEARING RES, V50, P97, DOI 10.1016/0378-5955(90)90036-O; AITKIN LM, 1978, J NEUROPHYSIOL, V41, P837, DOI 10.1152/jn.1978.41.4.837; AITKIN LM, 1981, J COMP NEUROL, V196, P25, DOI 10.1002/cne.901960104; AITKIN LM, 1987, J NEUROPHYSIOL, V57, P1185, DOI 10.1152/jn.1987.57.4.1185; AITKIN LM, 1985, J NEUROPHYSIOL, V53, P43, DOI 10.1152/jn.1985.53.1.43; AITKIN LM, 1984, J NEUROPHYSIOL, V52, P1; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; BINNS KE, 1992, BRAIN RES, V589, P231, DOI 10.1016/0006-8993(92)91282-J; BOCK GR, 1974, EXP BRAIN RES, V21, P387; BRAINARD MS, 1995, J NEUROPHYSIOL, V73, P595, DOI 10.1152/jn.1995.73.2.595; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; BRAINARD MS, 1993, BIOMED RES-TOKYO, V14, P35; Bremmer F, 1997, J NEUROPHYSIOL, V77, P962, DOI 10.1152/jn.1997.77.2.962; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1999, NEUROREPORT, V10, P873, DOI 10.1097/00001756-199903170-00037; CALFORD MB, 1986, J NEUROPHYSIOL, V55, P587, DOI 10.1152/jn.1986.55.3.587; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; EHRET G, 1997, CENTRAL AUDITORY SYS; Feldman DE, 1996, SCIENCE, V271, P525, DOI 10.1126/science.271.5248.525; GROH JM, 1992, BIOL CYBERN, V67, P291, DOI 10.1007/BF02414885; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; HARTLINE PH, 1995, EXP BRAIN RES, V104, P402; ITAYA SK, 1982, BRAIN RES, V233, P45, DOI 10.1016/0006-8993(82)90928-3; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KELLY JB, 1994, J NEUROPHYSIOL, V71, P1078, DOI 10.1152/jn.1994.71.3.1078; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; MASCETTI GG, 1988, BRAIN RES, V442, P387, DOI 10.1016/0006-8993(88)91531-4; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; PALOFF AM, 1992, J HIRNFORSCH, V33, P597; PECK CK, 1995, EXP BRAIN RES, V103, P227; Populin LC, 1998, J NEUROSCI, V18, P4233; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; RYAN A, 1978, EXP BRAIN RES, V32, P389; RYAN A, 1977, J NEUROPHYSIOL, V40, P943, DOI 10.1152/jn.1977.40.4.943; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; SCHROEDER DM, 1976, BRAIN BEHAV EVOLUT, V13, P125, DOI 10.1159/000123805; SEMPLE MN, 1983, HEARING RES, V10, P203, DOI 10.1016/0378-5955(83)90054-0; SEMPLE MN, 1979, J NEUROPHYSIOL, V42, P1626, DOI 10.1152/jn.1979.42.6.1626; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; VOLMAN SF, 1989, J NEUROSCI, V9, P3083; WAGNER H, 1987, J NEUROSCI, V7, P3105; WAGNER H, 1993, J NEUROSCI, V13, P371; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; Zrull MC, 1997, EXP NEUROL, V145, P16, DOI 10.1006/exnr.1997.6439	55	135	135	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					509	518		10.1016/S0896-6273(01)00222-7	http://dx.doi.org/10.1016/S0896-6273(01)00222-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239439	Bronze			2022-12-17	WOS:000167141700022
J	Bellingham, MC; Walmsley, B				Bellingham, MC; Walmsley, B			A novel presynaptic inhibitory mechanism underlies paired pulse depression at a fast central synapse	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ANTEROVENTRAL COCHLEAR NUCLEUS; READILY RELEASABLE POOL; TRANSMITTER RELEASE; TIME-COURSE; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; RECEPTOR DESENSITIZATION; GLUTAMATE RECEPTORS; CLIMBING FIBER	Several distinct mechanisms may cause synaptic depression, a common form of short-term synaptic plasticity. These include postsynaptic receptor desensitization, presynaptic depletion of releasable vesicles, or other presynaptic mechanisms depressing vesicle release. At the endbulb of Held, a fast central calyceal synapse in the auditory pathway, cyclothiazide (CTZ) abolished marked paired pulse depression (PPD) by acting presynaptically to enhance transmitter release, rather than by blocking postsynaptic receptor desensitization. PPD and its response to CTZ were not altered by prior depletion of the releasable vesicle pool but were blocked by lowering external calcium concentration, while raising external calcium enhanced PPD. We conclude that a major component of PPD at the endbulb is due to a novel, transient depression of release, which is dependent on the level of presynaptic calcium entry and is CTZ sensitive.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Synapt Struct & Funct Grp, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Bellingham, MC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Synapt Struct & Funct Grp, Canberra, ACT 0200, Australia.	mark.bellingham@anu.edu.au	Bellingham, Mark/G-1697-2011; Oka, Yoshitaka/C-9670-2010	Bellingham, Mark/0000-0001-9189-4430; Oka, Yoshitaka/0000-0002-3482-3051				AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOYT KR, 1995, J NEUROCHEM, V64, P2049; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Katz B., 1969, RELEASE NEURAL TRANS; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; ODonovan MJ, 1997, TRENDS NEUROSCI, V20, P431, DOI 10.1016/S0166-2236(97)01124-7; Oertel D, 1997, NEURON, V19, P959, DOI 10.1016/S0896-6273(00)80388-8; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Reist NE, 1998, J NEUROSCI, V18, P7662; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Varela JA, 1997, J NEUROSCI, V17, P7926; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; Wu MN, 1997, CURR OPIN NEUROBIOL, V7, P624, DOI 10.1016/S0959-4388(97)80081-5; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	64	135	135	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1999	23	1					159	170		10.1016/S0896-6273(00)80762-X	http://dx.doi.org/10.1016/S0896-6273(00)80762-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402202	Bronze			2022-12-17	WOS:000080681200019
J	Saito, N; Okada, Y; Noda, Y; Kinoshita, Y; Kondo, S; Hirokawa, N				Saito, N; Okada, Y; Noda, Y; Kinoshita, Y; Kondo, S; Hirokawa, N			KIFC2 is a novel neuron-specific C-terminal type kinesin superfamily motor for dendritic transport of multivesicular body-like organelles	NEURON			English	Article							ANTEROGRADE AXONAL-TRANSPORT; END-DIRECTED MOTOR; MEMBRANOUS ORGANELLES; MICROTUBULE MOTOR; RECOMBINANT ADENOVIRUS; MONOCLONAL-ANTIBODIES; HIPPOCAMPAL-NEURONS; PROTEIN SEQUENCES; MAMMALIAN-CELLS; MONOMERIC MOTOR	We have cloned two novel C-terminal motor domain-type kinesin superfamily motor proteins (KIFCs) from mouse brain by utilizing a KIFC-specific consensus sequence. The first protein was the murine homologue of CHO2 antigen, a member of the kar3-type mitotic motor subfamily, and we designated this protein KIFC1. The other protein, KIFC2 (792 amino acids), is novel, with no significant similarity to known kinesin superfamily proteins (KIFs). KIFC2 was specifically expressed in adult neurons, and was immunofluorescently localized to punctate structures in cell bodies and dendrites, but was not detected in axons. Electron microscopic analysis of the immunoisolated KIFC2-bound organelles revealed that KIFC2 associates with multivesicular body (mvb)-like organelles, suggesting that KIFC2 functions as the motor for the transport of mvb-like organelles in dendrites.			Saito, N (corresponding author), UNIV TOKYO, FAC MED, DEPT ANAT & CELL BIOL, TOKYO 113, JAPAN.		Okada, Yasushi/N-5067-2015; Kondo, Satoru/Y-1060-2019	Okada, Yasushi/0000-0003-2601-3689; 				AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Barton NR, 1996, P NATL ACAD SCI USA, V93, P1735, DOI 10.1073/pnas.93.5.1735; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CHANDRA R, 1993, J BIOL CHEM, V268, P9005; CHANDRA R, 1993, J CELL SCI, V104, P899; CHEN JW, 1986, BIOCHEM SOC SYMP, P97; DAVIS L, 1990, J NEUROSCI, V10, P3056; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; ENDOW SA, 1991, TRENDS BIOCHEM SCI, V16, P221, DOI 10.1016/0968-0004(91)90089-E; FORMAN DS, 1987, BRAIN RES, V412, P96, DOI 10.1016/0006-8993(87)91443-0; FREY T, 1995, CYTOMETRY, V21, P265, DOI 10.1002/cyto.990210307; GOLDSTEIN LSB, 1993, ANNU REV GENET, V27, P319; GOODSON HV, 1994, J CELL SCI, V107, P1875; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; GUGERLI P, 1984, J VIROL METHODS, V9, P249, DOI 10.1016/0166-0934(84)90031-4; HACKNEY DD, 1991, BIOCHEM BIOPH RES CO, V174, P810, DOI 10.1016/0006-291X(91)91490-4; Higgins D G, 1994, Methods Mol Biol, V25, P307; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1986, CELL MOTIL CYTOSKEL, V6, P458, DOI 10.1002/cm.970060504; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; HOLLENBECK PJ, 1993, J CELL BIOL, V121, P305, DOI 10.1083/jcb.121.2.305; HOYT MA, 1993, GENETICS, V135, P35; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; KANAI Y, 1995, NEURON, V14, P421, DOI 10.1016/0896-6273(95)90298-8; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; KURIYAMA R, 1995, J CELL BIOL, V129, P1049, DOI 10.1083/jcb.129.4.1049; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MIDDLETON K, 1994, P NATL ACAD SCI USA, V91, P7212, DOI 10.1073/pnas.91.15.7212; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; NAKATA T, 1993, BIOPHYS J, V65, P2504, DOI 10.1016/S0006-3495(93)81304-3; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; NODA Y, 1993, NEUROSCIENCE, V55, P113, DOI 10.1016/0306-4522(93)90459-S; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; OBATA K, 1986, BRAIN RES, V375, P37, DOI 10.1016/0006-8993(86)90956-X; OKADA Y, 1995, J NEUROSCI, V15, P3053; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; SAITO I, 1985, J VIROL, V54, P711, DOI 10.1128/JVI.54.3.711-719.1985; Scholey JM, 1996, J CELL BIOL, V133, P1, DOI 10.1083/jcb.133.1.1; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Terada S, 1996, SCIENCE, V273, P784, DOI 10.1126/science.273.5276.784; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387	65	135	143	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1997	18	3					425	438		10.1016/S0896-6273(00)81243-X	http://dx.doi.org/10.1016/S0896-6273(00)81243-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115736	Bronze			2022-12-17	WOS:A1997WQ07400010
J	TEMPLE, S; QIAN, XM				TEMPLE, S; QIAN, XM			BFGF, NEUROTROPHINS, AND THE CONTROL OF CORTICAL NEUROGENESIS	NEURON			English	Review							GROWTH-FACTOR; CELLS; PROLIFERATION; RAT; DIFFERENTIATION				TEMPLE, S (corresponding author), ALBANY MED COLL,DEPT PHARMACOL & NEUROSCI,ALBANY,NY 12208, USA.							AVERBUCHHELLER L, 1994, P NATL ACAD SCI USA, V91, P3247, DOI 10.1073/pnas.91.8.3247; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; BIFFO S, 1995, DEVELOPMENT, V121, P2461; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; KILPATRICK TJ, 1995, MOL CELL NEUROSCI, V6, P2, DOI 10.1006/mcne.1995.1002; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; McConnell S K, 1992, Curr Opin Neurobiol, V2, P23, DOI 10.1016/0959-4388(92)90156-F; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; TEMPLE S, 1994, DEVELOPMENT, V120, P999; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; WEISE B, 1993, J NEUROSCI RES, V34, P442, DOI 10.1002/jnr.490340409; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1	23	135	137	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1995	15	2					249	252		10.1016/0896-6273(95)90030-6	http://dx.doi.org/10.1016/0896-6273(95)90030-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR426	7646883	Bronze			2022-12-17	WOS:A1995RR42600003
J	FAKLER, B; BRANDLE, U; GLOWATZKI, E; ZENNER, HP; RUPPERSBERG, JP				FAKLER, B; BRANDLE, U; GLOWATZKI, E; ZENNER, HP; RUPPERSBERG, JP			K(IR)2.1 INWARD RECTIFIER K+ CHANNELS ARE REGULATED INDEPENDENTLY BY PROTEIN-KINASES AND ATP HYDROLYSIS	NEURON			English	Article							POTASSIUM CHANNEL; FUNCTIONAL EXPRESSION; CELLS; CONDUCTANCE; MODULATION; RECEPTORS; ACTIVATE; HEART	Second messenger regulation of IRK1 (K(ir)2.1) inward rectifier K+ channels was investigated in giant inside-out patches from Xenopus oocytes. K(ir)2.1-mediated currents that run down completely within minutes upon excision of the patches could be partly restored by application of Mg-ATP together with >10 mu M free Mg2+ to the cytoplasmic side of the patch. As restoration could not be induced by the ATP analogs AMP-PNP or ATP gamma S, this suggests an ATPase-like mechanism. In addition to ATP, the catalytic subunit of cAMP-dependent protein kinase (PKA) induced an increase in current amplitude, which could, however, only be observed if channels were previously or subsequently stimulated by Mg-ATP and free Mg2+. This indicates that functional activity of K(ir)2.1 channels requires both phosphorylation by PKA and ATP hydrolysis. Moreover, currents could be down-regulated by N-heptyl-5-chloro-1-naphthalenesulfonamide, a specific stimulator of protein kinase C (PKC), suggesting that PKA and PKC mediate inverse effects on K(ir)2.1 channels. Regulation of K(ir)2.1 channels described here may be an important mechanism for regulation of excitability.			FAKLER, B (corresponding author), UNIV TUBINGEN,ENT HOSP,DEPT SENSORY BIOPHYS,RONTGENWEG 11,D-72076 TUBINGEN,GERMANY.			Glowatzki, Elisabeth/0000-0003-3135-658X				ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BUSCH AE, 1992, J PHYSIOL-LONDON, V450, P491, DOI 10.1113/jphysiol.1992.sp019138; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CODERRE TJ, 1992, NEUROSCI LETT, V140, P181, DOI 10.1016/0304-3940(92)90097-Q; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.biochem.54.1.367; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FINDLAY I, 1986, PFLUG ARCH EUR J PHY, V407, P238, DOI 10.1007/BF00580683; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Hille B, 1992, IONIC CHANNELS EXCIT, P127; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HONORE E, 1993, PFLUG ARCH EUR J PHY, V424, P113, DOI 10.1007/BF00374601; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MATSUDA H, 1991, J PHYSIOL-LONDON, V435, P83, DOI 10.1113/jphysiol.1991.sp018499; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MING L, 1993, SCIENCE, V261, P1439; NILIUS B, 1993, J PHYSIOL-LONDON, V472, P359, DOI 10.1113/jphysiol.1993.sp019951; NORTH RA, 1989, J PHYSIOL-LONDON, V417, P1; OLESEN SP, 1993, CIRC RES, V73, P492, DOI 10.1161/01.RES.73.3.492; PAYET MD, 1992, J BIOL CHEM, V267, P18270; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; YAZAWA K, 1990, J PHYSIOL-LONDON, V421, P135, DOI 10.1113/jphysiol.1990.sp017937; YOUNT RG, 1971, BIOCHEMISTRY-US, V10, P2490, DOI 10.1021/bi00789a010	33	135	138	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1413	1420		10.1016/0896-6273(94)90426-X	http://dx.doi.org/10.1016/0896-6273(94)90426-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993632				2022-12-17	WOS:A1994PZ68900015
J	SRETAVAN, DW; FENG, L; PURE, E; REICHARDT, LF				SRETAVAN, DW; FENG, L; PURE, E; REICHARDT, LF			EMBRYONIC NEURONS OF THE DEVELOPING OPTIC CHIASM EXPRESS L1 AND CD44, CELL-SURFACE MOLECULES WITH OPPOSING EFFECTS ON RETINAL AXON GROWTH	NEURON			English	Article							LYMPHOCYTE HOMING RECEPTOR; POSTERIOR TECTAL MEMBRANES; HYALURONIC-ACID BINDING; CENTRAL-NERVOUS-SYSTEM; ADHESION MOLECULES; NEURAL DEVELOPMENT; NEURITE OUTGROWTH; CONE GUIDANCE; POSTTRANSLATIONAL MODIFICATION; BIOCHEMICAL-CHARACTERIZATION	The first retinal ganglion cell axons arriving at the embryonic mouse ventral diencephalon encounter an inverted V-shaped neuronal array defining the midline and posterior boundaries of the future optic chiasm. These neurons express L1, an immunoglobulin superfamily molecule known to promote retinal axon outgrowth, and CD44, a cell surface molecule that we find inhibits embryonic retinal axon growth in vitro. Incoming retinal axons do not penetrate this L1/CD44 neuron array, but turn to establish the characteristic X-shaped optic chiasm along the anterior border of this array. These results suggest that L1/CD44 neurons may serve as an anatomical template for retinal axon pathways at the embryonic mouse ventral diencephalon.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; ROCKEFELLER UNIV,NEUROBIOL LAB,NEW YORK,NY 10021; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Rockefeller University; The Wistar Institute	SRETAVAN, DW (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT OPHTHALMOL,K107,10 KIRKHAM ST,SAN FRANCISCO,CA 94143, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-17A10014] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CAMP RL, 1991, J CELL BIOL, V115, P1283, DOI 10.1083/jcb.115.5.1283; CARTER WG, 1988, J BIOL CHEM, V263, P4193; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; COLELLO RJ, 1992, J COMP NEUROL, V317, P357, DOI 10.1002/cne.903170404; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; DALCHAU R, 1980, EUR J IMMUNOL, V10, P745, DOI 10.1002/eji.1830101004; DENNING SM, 1990, J IMMUNOL, V144, P7; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; EASTER SS, 1993, J NEUROSCI, V13, P285; FISCHER G, 1986, J NEUROSCI, V6, P605; GALLATIN WM, 1989, P NATL ACAD SCI USA, V86, P4654, DOI 10.1073/pnas.86.12.4654; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GITLER MS, 1988, BRAIN RES, V447, P205, DOI 10.1016/0006-8993(88)91121-3; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; GRAYBIEL AM, 1978, BRAIN RES, V145, P365, DOI 10.1016/0006-8993(78)90870-3; GUILLERY RW, 1987, J COMP NEUROL, V265, P203, DOI 10.1002/cne.902650205; GUILLERY RW, 1982, CONTRIB SENS PHYSIOL, V7, P39; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; JALKANEN S, 1988, J IMMUNOL, V141, P1615; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; JALKANEN ST, 1986, EUR J IMMUNOL, V16, P1195, DOI 10.1002/eji.1830161003; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; MIYAKE K, 1990, J EXP MED, V171, P477, DOI 10.1084/jem.171.2.477; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; NORRIS CR, 1991, J NEUROSCI, V11, P3481; NOTTENBURG C, 1989, P NATL ACAD SCI USA, V86, P8521, DOI 10.1073/pnas.86.21.8521; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; RAPER JA, 1990, NEURON, V2, P21; RATHJEN FG, 1984, EMBO J, V3, P1; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; SILVER J, 1983, SCIENCE, V220, P1067, DOI 10.1126/science.6844928; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SILVER J, 1984, J COMP NEUROL, V223, P238, DOI 10.1002/cne.902230207; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; STERN CD, 1987, DEVELOPMENT, V99, P261; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOSNEY KW, 1988, DEV BIOL, V127, P266, DOI 10.1016/0012-1606(88)90314-4; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; VOGEL H, 1992, J NEUROCYTOL, V21, P363, DOI 10.1007/BF01191704; WALTER J, 1987, DEVELOPMENT, V101, P909; WATANABE K, 1979, BRAIN RES, V168, P1, DOI 10.1016/0006-8993(79)90123-9; WISENMANN A, 1993, DEVELOPMENT, V117, P725	77	135	136	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					957	975		10.1016/0896-6273(94)90307-7	http://dx.doi.org/10.1016/0896-6273(94)90307-7			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	7514428	Green Accepted			2022-12-17	WOS:A1994NM83100003
J	COHENCORY, S; FRASER, SE				COHENCORY, S; FRASER, SE			BDNF IN THE DEVELOPMENT OF THE VISUAL-SYSTEM OF XENOPUS	NEURON			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; TYROSINE PROTEIN-KINASE; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; NGF RECEPTOR; MAP FORMATION; MOLECULAR-CLONING; RETINOTECTAL MAP; FACTOR FAMILY	To explore the role of BDNF during Xenopus visual system development, the expression of BDNF and TrkB, as well as the effect of BDNF during retinal ganglion cell (RGC) development in culture, was examined. BDNF mRNA was found to be expressed in both the developing eye and tectum, peaking at stage 45/46. The expression of BDNF coincided with RGC expression of full-length trkB transcripts, suggesting a functional role for BDNF. In culture, BDNF significantly increased the number of RGCs. The ability of BDNF to rescue differentiated RGCs that had projected to the tectum, the time course of the effect, and the lack of mitogenic response indicate that this neurotrophin promotes survival. The expression of BDNF and TrkB and the responsiveness of RGCs to BDNF coincide with retinal axon terminal arborization and patterning. Our results indicate that BDNF is a relevant neurotrophin for Xenopus RGC development and suggest that it plays a role during visual system patterning.			COHENCORY, S (corresponding author), CALTECH,BECKMAN INST,DIV BIOL,PASADENA,CA 91125, USA.		Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223	NIMH NIH HHS [NIMH MH49176] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH049176] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CARMIGNOTO G, 1991, EXP NEUROL, V111, P302, DOI 10.1016/0014-4886(91)90097-V; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHENCORY S, 1991, J NEUROSCI, V11, P462; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; EASTER SS, 1984, J NEUROSCI, V4, P1052; EBENDAL T, 1988, DEVELOPMENT, V102, P101; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ESCANDON E, 1993, J NEUROSCI RES, V34, P601, DOI 10.1002/jnr.490340602; ESCANDON E, 1994, IN PRESS J NEUROSCI; FRASER SE, 1983, DEV BIOL, V95, P505, DOI 10.1016/0012-1606(83)90053-2; FRASER SE, 1990, J NEUROBIOL, V21, P51, DOI 10.1002/neu.480210105; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; GAZE RM, 1992, J COMP NEUROL, V315, P264, DOI 10.1002/cne.903150303; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GRANT P, 1989, DEV BIOL, V133, P502, DOI 10.1016/0012-1606(89)90053-5; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUMPHREY MF, 1988, J NEUROCYTOL, V17, P293, DOI 10.1007/BF01187852; ISACKSON PJ, 1991, FEBS LETT, V285, P260, DOI 10.1016/0014-5793(91)80812-H; JACOBSON M, 1968, DEV BIOL, V17, P219, DOI 10.1016/0012-1606(68)90062-6; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KELLER R, 1991, XENOPUS LAEVIS PRACT, P102; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; MACLEISH PR, 1984, J PHYSIOL-LONDON, V348, P645, DOI 10.1113/jphysiol.1984.sp015131; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REH TA, 1984, J NEUROSCI, V4, P442; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STAHLE U, 1994, TRENDS GENET, V10, P75; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; TURNER JE, 1979, BRAIN RES, V171, P197, DOI 10.1016/0006-8993(79)90327-5; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VONBARTHELD CS, 1991, J COMP NEUROL, V310, P103, DOI 10.1002/cne.903100110; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; YIP HK, 1982, BRAIN RES, V238, P329, DOI 10.1016/0006-8993(82)90108-1	71	135	137	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					747	761		10.1016/0896-6273(94)90328-X	http://dx.doi.org/10.1016/0896-6273(94)90328-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8068082				2022-12-17	WOS:A1994NH25300004
J	GILLESPIE, PG; WAGNER, MC; HUDSPETH, AJ				GILLESPIE, PG; WAGNER, MC; HUDSPETH, AJ			IDENTIFICATION OF A 120 KD HAIR-BUNDLE MYOSIN LOCATED NEAR STEREOCILIARY TIPS	NEURON			English	Article							VANADATE-DEPENDENT MODIFICATION; SUBFRAGMENT-1 HEAVY-CHAIN; MUSCLE-CONTRACTION; ACTIN-FILAMENTS; SMOOTH-MUSCLE; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; ADENOSINE-TRIPHOSPHATASE; CROSS-LINKS; CELLS	By adapting to sustained stimuli, hair cells of the internal ear maintain their optimal sensitivity to minute displacements. Biophysical experiments have suggested that adaptation is mediated by a molecular motor, most likely a member of the myosin family. To provide direct evidence for the presence of myosin isozymes in hair bundles, we used photoaffinity labeling with vanadate-trapped uridine and adenine nucleotides to identify proteins of 120, 160, and 230 kd in a preparation of hair bundles purified from the bullfrog's sacculus. The photoaffinity labeling properties of these proteins, particularly the 120 kd protein, resembled those of other well-characterized myosins. A 120 kd hair-bundle protein was also recognized by a monoclonal antibody directed against a vertebrate myosin I isozyme. Immunofluorescence microscopy localized this protein near the beveled top edge of the hair bundle, the site of mechanoelectrical transduction and adaptation.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,CTR BASIC NEUROSCI RES,DEPT PHARMACOL,DALLAS,TX 75235	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Barr-Gillespie, Peter/0000-0002-9787-5860	NIDCD NIH HHS [DC00241] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; CARBONI JM, 1988, J CELL BIOL, V107, P1749, DOI 10.1083/jcb.107.5.1749; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; CORWIN JT, 1985, P NATL ACAD SCI USA, V82, P3911, DOI 10.1073/pnas.82.11.3911; COUDRIER E, 1983, EMBO J, V2, P469, DOI 10.1002/j.1460-2075.1983.tb01446.x; CREMO CR, 1988, BIOCHEMISTRY-US, V27, P8415, DOI 10.1021/bi00422a018; DANTZIG JA, 1985, J GEN PHYSIOL, V86, P305, DOI 10.1085/jgp.86.3.305; DRENCKHAHN D, 1982, NATURE, V300, P531, DOI 10.1038/300531a0; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; DRENCKHAHN D, 1985, AUDITORY BIOCH, P312; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; FUKAI Y, 1989, NATURE, V341, P328; FULLER SA, 1988, CURRENT PROTOCOLS MO, V2; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GARABEDIAN TE, 1990, J BIOL CHEM, V265, P22547; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1991, P NATL ACAD SCI USA, V88, P2563, DOI 10.1073/pnas.88.6.2563; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; GLENNEY JR, 1980, J BIOL CHEM, V255, P551; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; GOODY R S, 1980, Journal of Muscle Research and Cell Motility, V1, P101, DOI 10.1007/BF00711928; GRAMMER JC, 1988, BIOCHEMISTRY-US, V27, P8408, DOI 10.1021/bi00422a017; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HIBBERD MG, 1986, ANNU REV BIOPHYS BIO, V15, P119; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1987, SENSORY TRANSDUCTION, P138; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JACKSON AP, 1988, BIOCHEM J, V251, P515, DOI 10.1042/bj2510515; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KIEHART DP, 1984, J CELL BIOL, V99, P1002, DOI 10.1083/jcb.99.3.1002; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; LEWIS ER, 1973, J MORPHOL, V39, P351; MACARTNEY JC, 1980, NATURE, V288, P491, DOI 10.1038/288491a0; MARUTA H, 1981, J BIOL CHEM, V256, P499; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; NAKAMAYE KL, 1985, BIOCHEMISTRY-US, V24, P5226, DOI 10.1021/bi00340a041; PATE E, 1991, BIOPHYS J, V59, P598, DOI 10.1016/S0006-3495(91)82275-5; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.physiol.53.1.653; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; SANS A, 1989, HEARING RES, V40, P117, DOI 10.1016/0378-5955(89)90105-6; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; SLEPECKY N, 1985, HEARING RES, V20, P245, DOI 10.1016/0378-5955(85)90029-2; SLEPECKY NB, 1992, HEARING RES, V57, P201, DOI 10.1016/0378-5955(92)90152-D; SWANLJUNGCOLLINS H, 1991, J BIOL CHEM, V266, P1312; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cellbio.8.1.257; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020	72	135	138	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					581	594		10.1016/0896-6273(93)90071-X	http://dx.doi.org/10.1016/0896-6273(93)90071-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398149				2022-12-17	WOS:A1993MD06800004
J	OROURKE, NA; FRASER, SE				OROURKE, NA; FRASER, SE			DYNAMIC CHANGES IN OPTIC FIBER TERMINAL ARBORS LEAD TO RETINOTOPIC MAP FORMATION - AN INVIVO CONFOCAL MICROSCOPIC STUDY	NEURON			English	Article									UNIV CALIF IRVINE, DEPT PHYSIOL & BIOPHYS, IRVINE, CA 92717 USA	University of California System; University of California Irvine			Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223	NINDS NIH HHS [NS2521] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; Cowan WM, 1985, MOL BASES NEURAL DEV, P481; EASTER SS, 1984, J NEUROSCI, V4, P1052; FINE A, 1988, TRENDS NEUROSCI, V11, P346, DOI 10.1016/0166-2236(88)90056-2; FRASER SE, 1983, DEV BIOL, V95, P505, DOI 10.1016/0012-1606(83)90053-2; FRASER SE, 1986, J EMBRYOL EXP MORPH, V94, P149; FUJISAWA H, 1987, J COMP NEUROL, V260, P127, DOI 10.1002/cne.902600110; FUJISAWA H, 1982, DEV BIOL, V90, P43, DOI 10.1016/0012-1606(82)90210-X; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; GAZE RM, 1974, P ROY SOC LOND B BIO, V185, P303; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HUMPHREY MF, 1982, BRAIN RES, V239, P595, DOI 10.1016/0006-8993(82)90534-0; LEHMANN EL, 1975, NONPARAMETRICS; MEYER RL, 1980, J COMP NEUROL, V189, P273, DOI 10.1002/cne.901890205; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Nieukoop P. D., 1956, NORMAL TABLE XENOPUS; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; OROURKE NA, 1988, CELL INTERACTIONS VI, P47; RANKIN ECC, 1986, EXP BRAIN RES, V63, P409; RAYMOND PA, 1983, J NEUROSCI, V3, P1077; REH TA, 1984, J NEUROSCI, V4, P442; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHMIDT JT, 1988, J COMP NEUROL, V269, P565, DOI 10.1002/cne.902690408; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; SCHMIDT JT, 1985, MOL BASES NEURAL DEV, P453; SHOLL DA, 1953, J ANAT, V87, P387; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; STRAZNICKY K, 1972, J EMBRYOL EXP MORPH, V28, P87; STUERMER CAO, 1984, J COMP NEUROL, V223, P57, DOI 10.1002/cne.902230106; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41	40	135	136	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1990	5	2					159	171		10.1016/0896-6273(90)90306-Z	http://dx.doi.org/10.1016/0896-6273(90)90306-Z			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU559	2383399				2022-12-17	WOS:A1990DU55900006
J	Ecker, JR; Geschwind, DH; Kriegstein, AR; Ngai, J; Osten, P; Polioudakis, D; Regev, A; Sestan, N; Wickersham, IR; Zeng, HK				Ecker, Joseph R.; Geschwind, Daniel H.; Kriegstein, Arnold R.; Ngai, John; Osten, Pavel; Polioudakis, Damon; Regev, Aviv; Sestan, Nenad; Wickersham, Ian R.; Zeng, Hongkui			The BRAIN Initiative Cell Census Consortium: Lessons Learned toward Generating a Comprehensive Brain Cell Atlas	NEURON			English	Review							GENE-EXPRESSION ATLAS; MESSENGER-RNA-SEQ; SINGLE-CELL; NERVOUS-SYSTEM; CHROMATIN ACCESSIBILITY; NEURONAL DIVERSITY; TRANSCRIPTIONAL REGULATION; TEMPORAL DYNAMICS; GABAERGIC NEURONS; NEURAL CIRCUITS	A comprehensive characterization of neuronal cell types, their distributions, and patterns of connectivity is critical for understanding the properties of neural circuits and how they generate behaviors. Here we review the experiences of the BRAIN Initiative Cell Census Consortium, ten pilot projects funded by the U.S. BRAIN Initiative, in developing, validating, and scaling up emerging genomic and anatomical mapping technologies for creating a complete inventory of neuronal cell types and their connections in multiple species and during development. These projects lay the foundation for a larger and longer-term effort to generate whole-brain cell atlases in species including mice and humans.	[Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Geschwind, Daniel H.; Polioudakis, Damon] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.; Polioudakis, Damon] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Human Genet, Los Angeles, CA 90095 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, San Francisco, CA 94143 USA; [Ngai, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Funct Genom Lab QB3, Berkeley, CA 94720 USA; [Osten, Pavel] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Regev, Aviv] MIT, Klarman Cell Observ, Broad Inst MIT & Harvard, Dept Biol,Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, Program Cellular Neurosci Neurodegenerat & Repair, Yale Child Study Ctr,Dept Neurosci, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, Program Cellular Neurosci Neurodegenerat & Repair, Yale Child Study Ctr,Dept Genet, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, Program Cellular Neurosci Neurodegenerat & Repair, Yale Child Study Ctr,Dept Psychiat, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, Program Cellular Neurosci Neurodegenerat & Repair, Yale Child Study Ctr,Dept Comparat Med, New Haven, CT 06510 USA; [Wickersham, Ian R.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98109 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Cold Spring Harbor Laboratory; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; Yale University; Massachusetts Institute of Technology (MIT); Allen Institute for Brain Science	Ngai, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Funct Genom Lab QB3, Berkeley, CA 94720 USA.	jngai@berkeley.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	NIH BRAIN Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105989, U01MH105985, U01MH105972, U01MH105991, U19MH114830, U01MH105960, U01MH105979, U01MH105982, U01MH105971] Funding Source: NIH RePORTER	NIH BRAIN Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all of our BICCC colleagues for stimulating discussions over the course of the project; Andrea Beckel-Mitchener and Michelle Freund for their tireless efforts in organizing and encouraging the consortium's activities; Cathy Ng and Bishen Singh for facilitating the BICCC's numerous meetings and conference calls; and Bishen Singh for his assistance in compiling the data shown in Table S1. We gratefully acknowledge the generous and enabling support of the NIH BRAIN Initiative as noted for the authors in Table 1. A.R.K. is a founder, shareholder, and board member of Neurona Therapeutics. A.R. is a Scientific Advisory Board member of Syros Pharmaceuticals, Thermo Fisher Scientific, and the Driver Group, and A.R. has filed disclosures on intellectual property relating to some of the single-cell technologies described in this article.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bandler RC, 2017, CURR OPIN NEUROBIOL, V42, P17, DOI 10.1016/j.conb.2016.10.003; Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; Bardy C, 2016, MOL PSYCHIATR, V21, P1573, DOI 10.1038/mp.2016.158; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bota M, 2007, BRAIN RES REV, V56, P79, DOI 10.1016/j.brainresrev.2007.05.005; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cadwell CR, 2016, NAT BIOTECHNOL, V34, P199, DOI 10.1038/nbt.3445; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chen RC, 2017, CELL REP, V18, P3227, DOI 10.1016/j.celrep.2017.03.004; Chevee M., 2017, BIORXIV; Ciabatti E, 2017, CELL, V170, P382, DOI 10.1016/j.cell.2017.06.014; Clark SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0944-x; Close JL, 2017, NEURON, V93, P1035, DOI [10.1016/j.neuron.2017.02.014, 10.1016/j.neuron.2017.10.024]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Crow M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0964-6; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dickel DE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12923; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Druckmann S, 2013, CEREB CORTEX, V23, P2994, DOI 10.1093/cercor/bhs290; Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060; Economon MN, 2016, ELIFE, V5, DOI 10.7554/eLife.10566; Fahrbach FO, 2013, OPT EXPRESS, V21, P11425, DOI 10.1364/OE.21.011425; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Fletcher RB, 2017, CELL STEM CELL, V20, P817, DOI 10.1016/j.stem.2017.04.003; Fuzik J, 2016, NAT BIOTECHNOL, V34, P175, DOI 10.1038/nbt.3443; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Gokce O, 2016, CELL REP, V16, P1126, DOI 10.1016/j.celrep.2016.06.059; Golgi C, 1873, GAZZ MED ITAL LOMBAR, V33, P244; Gong H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12142; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray LT, 2017, ELIFE, V6, DOI 10.7554/eLife.21883; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Harris Julie A, 2012, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0120s59; Harris K., 2017, BIORXIV; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; He M, 2016, NEURON, V91, P1228, DOI 10.1016/j.neuron.2016.08.021; He YP, 2017, P NATL ACAD SCI USA, V114, pE1633, DOI 10.1073/pnas.1618353114; He YP, 2015, ANNU REV GENOM HUM G, V16, P55, DOI 10.1146/annurev-genom-090413-025437; Hu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31851; Huang ZJ, 2013, ANNU REV NEUROSCI, V36, P183, DOI 10.1146/annurev-neuro-062012-170307; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Kee N, 2017, CELL STEM CELL, V20, P29, DOI 10.1016/j.stem.2016.10.003; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Kim EJ, 2016, CELL REP, V15, P692, DOI 10.1016/j.celrep.2016.03.067; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kim Y, 2017, CELL, V171, P456, DOI 10.1016/j.cell.2017.09.020; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kocabas A, 2015, NEURON, V88, P1149, DOI 10.1016/j.neuron.2015.10.048; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Konopka G, 2010, NEURON, V68, P231, DOI 10.1016/j.neuron.2010.10.012; Kozlenkov A, 2016, NUCLEIC ACIDS RES, V44, P2593, DOI 10.1093/nar/gkv1304; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Kuan L, 2015, METHODS, V73, P4, DOI 10.1016/j.ymeth.2014.12.013; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu K, 2017, NATURE, V548, P582, DOI 10.1038/nature23663; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351; Macaulay IC, 2017, TRENDS GENET, V33, P155, DOI 10.1016/j.tig.2016.12.003; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Miller CT, 2016, NEURON, V90, P219, DOI 10.1016/j.neuron.2016.03.018; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Ng L, 2007, IEEE ACM T COMPUT BI, V4, P382, DOI 10.1109/TCBB.2007.1035; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Peng HC, 2017, NAT METHODS, V14, P332, DOI 10.1038/nmeth.4233; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Preissl S., 2017, BIORXIV; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/NMETH.1854, 10.1038/nmeth.1854]; Ramon, 1899, HISTOLOGY NERVOUS SY; Ramon, 1904, TEXTURA SISTEMA NERV, VII; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Regev A, 2017, BIORXIV, DOI 10.1101/121202; Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Schwartzman O, 2015, NAT REV GENET, V16, P716, DOI 10.1038/nrg3980; Seiriki K, 2017, NEURON, V94, P1085, DOI 10.1016/j.neuron.2017.05.017; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shibata M, 2015, TRENDS GENET, V31, P77, DOI 10.1016/j.tig.2014.12.004; Shima Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13503; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Silberberg SN, 2016, NEURON, V92, P59, DOI 10.1016/j.neuron.2016.09.027; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Spaethling JM, 2017, CELL REP, V18, P791, DOI 10.1016/j.celrep.2016.12.066; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sumbul U, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00139; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Treutlein B, 2016, NATURE, V534, P391, DOI 10.1038/nature18323; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Vettenburg T, 2014, NAT METHODS, V11, P541, DOI [10.1038/nmeth.2922, 10.1038/NMETH.2922]; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zeng WB, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0179-7; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng T, 2013, OPT EXPRESS, V21, P9839, DOI 10.1364/OE.21.009839; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045	172	134	136	4	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 1	2017	96	3					542	557		10.1016/j.neuron.2017.10.007	http://dx.doi.org/10.1016/j.neuron.2017.10.007			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL4MG	29096072	Green Accepted, Green Submitted, Bronze			2022-12-17	WOS:000414203400003
J	de Juan-Sanz, J; Holt, GT; Schreiter, ER; de Juan, F; Kim, DS; Ryan, TA				de Juan-Sanz, Jaime; Holt, Graham T.; Schreiter, Eric R.; de Juan, Fernando; Kim, Douglas S.; Ryan, Timothy A.			Axonal Endoplasmic Reticulum Ca2+ Content Controls Release Probability in CNS Nerve Terminals	NEURON			English	Article							FLUORESCENT PROTEINS; RYANODINE RECEPTORS; CALCIUM-CHANNELS; STORE; ENTRY; STIM1; MITOCHONDRIA; ACTIVATION; NEURONS; SENSOR	Although the endoplasmic reticulum (ER) extends throughout axons and axonal ER dysfunction is implicated in numerous neurological diseases, its role at nerve terminals is poorly understood. We developed novel genetically encoded ER-targeted low-affinity Ca2+ indicators optimized for examining axonal ER Ca2+. Our experiments revealed that presynaptic function is tightly controlled by ER Ca2+ content. We found that neuronal activity drives net Ca2+ uptake into presynaptic ER although this activity does not contribute significantly to shaping cytosolic Ca2+ except during prolonged repetitive firing. In contrast, we found that axonal ER acts as an actuator of plasma membrane (PM) function: [Ca2+] ER controls STIM1 activation in presynaptic terminals, which results in the local modulation of presynaptic function, impacting activity-driven Ca2+ entry and release probability. These experiments reveal a critical role of presynaptic ER in the control of neurotransmitter release and will help frame future investigations into the molecular basis of ER-driven neuronal disease states.	[de Juan-Sanz, Jaime; Ryan, Timothy A.] Weill Cornell Med, Dept Biochem, New York, NY 10065 USA; [Holt, Graham T.; Schreiter, Eric R.; Kim, Douglas S.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [de Juan, Fernando] Univ Oxford, Dept Phys, Oxford OX1 3NP, England	Cornell University; Howard Hughes Medical Institute; University of Oxford	Ryan, TA (corresponding author), Weill Cornell Med, Dept Biochem, New York, NY 10065 USA.	taryan@med.cornell.edu	de Juan, Fernando/B-9392-2008; Ryan, Timothy/AAO-8286-2020; de Juan-Sanz, Jaime/L-7990-2017	Ryan, Timothy/0000-0003-2533-9548; Schreiter, Eric/0000-0002-2864-7469; Kim, Douglas/0000-0001-9029-314X; de Juan-Sanz, Jaime/0000-0002-1212-5623	NIH [NS036942, MH0855783]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036942, R01NS036942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the NIH (NS036942, MH0855783) to T.A.R. We thank Loren L. Looger and Jeremy Dittman for comments and Julia Marrs and Lucia A. Saidenberg for technical assistance. We thank the members of the Ryan lab for helpful discussion, especially Nimra Asi for her additional contribution to the statistical analysis and Geraldine Gouzer for generating the synaptophysin-GCaMP6f construct.	Alonso MT, 1998, CELL CALCIUM, V24, P87, DOI 10.1016/S0143-4160(98)90076-8; Ariel Pablo, 2012, Front Synaptic Neurosci, V4, P9, DOI 10.3389/fnsyn.2012.00009; Armbruster M, 2011, NAT NEUROSCI, V14, P824, DOI 10.1038/nn.2828; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Calloway N, 2015, ELIFE, V4, DOI 10.7554/eLife.07728; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; de Juan-Sanz J, 2014, J BIOL CHEM, V289, P34308, DOI 10.1074/jbc.M114.586966; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Garcia-Alvarez G, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00180; Harraz OF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00043; Hartmann J, 2014, NEURON, V82, P635, DOI 10.1016/j.neuron.2014.03.027; Heine M, 2016, CHANNELS, V10, P267, DOI 10.1080/19336950.2016.1153210; Henderson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139273; HENKART MP, 1978, SCIENCE, V202, P1300, DOI 10.1126/science.725607; Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110; Hooper R, 2013, PFLUG ARCH EUR J PHY, V465, P1383, DOI 10.1007/s00424-013-1270-8; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Keil JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013465; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kim SH, 2013, J NEUROSCI, V33, P8937, DOI 10.1523/JNEUROSCI.4288-12.2013; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/NMETH.2690, 10.1038/nmeth.2690]; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Majewski L, 2015, BBA-MOL CELL RES, V1853, P1940, DOI 10.1016/j.bbamcr.2015.01.019; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moccia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00153; Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560; Moreno C, 2011, IUBMB LIFE, V63, P856, DOI 10.1002/iub.547; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nizami S, 2010, BIOCHEM SOC T, V38, P529, DOI 10.1042/BST0380529; Noreau A, 2014, EXP CELL RES, V325, P18, DOI 10.1016/j.yexcr.2014.02.021; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Putney JW, 2003, CELL CALCIUM, V34, P339, DOI 10.1016/S0143-4160(03)00143-X; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneider R, 2015, NEURON, V86, P672, DOI 10.1016/j.neuron.2015.03.050; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wu B, 2013, P NATL ACAD SCI USA, V110, P15091, DOI 10.1073/pnas.1304171110; Wu JH, 2014, BIOCHEM J, V464, P13, DOI 10.1042/BJ20140931; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yarotskyy V, 2012, BIOPHYS J, V103, P202, DOI 10.1016/j.bpj.2012.06.001; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108	73	134	134	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 22	2017	93	4					867	+		10.1016/j.neuron.2017.01.010	http://dx.doi.org/10.1016/j.neuron.2017.01.010			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO1AE	28162809	Green Accepted, Bronze			2022-12-17	WOS:000396429100016
J	Senzai, Y; Buzsaki, G				Senzai, Yuta; Buzsaki, Gyorgy			Physiological Properties and Behavioral Correlates of Hippocampal Granule Cells and Mossy Cells	NEURON			English	Article							RAT DENTATE GYRUS; CA3 PYRAMIDAL CELLS; HEAD DIRECTION CELLS; PATTERN SEPARATION; IN-VIVO; PLACE CELLS; MILLISECOND-TIMESCALE; ENTORHINAL CORTEX; FIELD POTENTIALS; MOLECULAR LAYER	The hippocampal dentate gyrus is often viewed as a segregator of upstream information. Physiological support for such function has been hampered by a lack of well-defined characteristics that can identify granule cells and mossy cells. We developed an electrophysiology-based classification of dentate granule cells and mossy cells in mice that we validated by optogenetic tagging of mossy cells. Granule cells exhibited sparse firing, had a single place field, and showed only modest changes when the mouse was tested in different mazes in the same room. In contrast, mossy cells were more active, had multiple place fields and showed stronger remapping of place fields under the same conditions. Although the granule cell-mossy cell synapse was strong and facilitating, mossy cells rarely ``inherited'' place fields from single granule cells. Our findings suggest that the granule cells and mossy cells could be modulated separately and their joint action may be critical for pattern separation.	[Senzai, Yuta; Buzsaki, Gyorgy] NYU, Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA; [Buzsaki, Gyorgy] NYU, Langone Med Ctr, Dept Neurol, New York, NY 10016 USA; [Buzsaki, Gyorgy] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University	Buzsaki, G (corresponding author), NYU, Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA.; Buzsaki, G (corresponding author), NYU, Langone Med Ctr, Dept Neurol, New York, NY 10016 USA.; Buzsaki, G (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	gyorgy.buzsaki@nyumc.org	Core, Vector/CAF-4832-2022; Senzai, Yuta/W-8083-2018	Senzai, Yuta/0000-0002-2990-9889; Buzsaki, Gyorgy/0000-0002-3100-4800	Nakajima Foundation; NSF PIRE grant; Simons Foundation;  [NIHMH54671];  [MH107396];  [NS 090583]	Nakajima Foundation; NSF PIRE grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Simons Foundation; ; ; 	We thank Lisa Roux and Eran Stark for technical support and extensive discussion. We also thank Nathan Danielson, Antonio Fernandez-Ruiz, Jennifer Gelinas, Dion Khodagholy, James Knierim, Attila Losonczy, Sam Mckenzie, and Ivan Soltesz for insightful comments on the manuscript; Anna Conti for help maintaining transgenic animals; and Helen Scharfman and Edward Ziff for providing DRD2-Cre mice. This work was supported by the Nakajima Foundation, NIHMH54671, MH107396, NS 090583, NSF PIRE grant, and the Simons Foundation.	Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; BLAND BH, 1980, EXP BRAIN RES, V38, P205; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1981, EXP BRAIN RES, V43, P429; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Diamantaki M, 2016, ELIFE, V5, DOI 10.7554/eLife.20252; Diba K, 2014, J NEUROSCI, V34, P14984, DOI 10.1523/JNEUROSCI.1091-14.2014; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; GoodSmith D, 2017, NEURON, V93, P677, DOI 10.1016/j.neuron.2016.12.026; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hasselmo ME, 1997, BEHAV BRAIN RES, V89, P1, DOI 10.1016/S0166-4328(97)00048-X; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Henze DA, 2007, PROG BRAIN RES, V163, P199, DOI 10.1016/S0079-6123(07)63012-X; Hosp JA, 2014, HIPPOCAMPUS, V24, P189, DOI 10.1002/hipo.22214; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kim J, 2011, HIPPOCAMPUS, V21, P609, DOI 10.1002/hipo.20784; Knierim JJ, 2016, NEUROBIOL LEARN MEM, V129, P38, DOI 10.1016/j.nlm.2015.10.008; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; LANGDON RB, 1993, J PHYSIOL-LONDON, V472, P157, DOI 10.1113/jphysiol.1993.sp019941; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lysetskiy M, 2005, HIPPOCAMPUS, V15, P691, DOI 10.1002/hipo.20096; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; MIZUMORI SJY, 1989, J NEUROPHYSIOL, V61, P15, DOI 10.1152/jn.1989.61.1.15; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; MULLER RU, 1987, J NEUROSCI, V7, P1951; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Puighermanal E, 2015, HIPPOCAMPUS, V25, P858, DOI 10.1002/hipo.22408; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; ROSE G, 1983, BRAIN RES, V266, P29, DOI 10.1016/0006-8993(83)91306-9; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Sik A, 1997, EUR J NEUROSCI, V9, P573, DOI 10.1111/j.1460-9568.1997.tb01634.x; SOLTESZ I, 1993, NEUROSCIENCE, V57, P555, DOI 10.1016/0306-4522(93)90005-Z; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Stark E, 2009, J NEUROSCI METH, V179, P90, DOI 10.1016/j.jneumeth.2008.12.029; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Ujfalussy B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000500; Vyleta NP, 2016, ELIFE, V5, DOI 10.7554/eLife.17977; Williams PA, 2007, J NEUROSCI, V27, P13756, DOI 10.1523/JNEUROSCI.4053-07.2007; Winter SS, 2015, SCIENCE, V347, P870, DOI 10.1126/science.1259591; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yoganarasimha D, 2005, EXP BRAIN RES, V160, P344, DOI 10.1007/s00221-004-2016-9	82	134	135	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 8	2017	93	3					691	+		10.1016/j.neuron.2016.12.011	http://dx.doi.org/10.1016/j.neuron.2016.12.011			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO1AB	28132824	Green Accepted, Bronze			2022-12-17	WOS:000396428800022
J	Lewitus, GM; Konefal, SC; Greenhalgh, AD; Pribiag, H; Augereau, K; Stellwagen, D				Lewitus, Gil M.; Konefal, Sarah C.; Greenhalgh, Andrew D.; Pribiag, Horia; Augereau, Keanan; Stellwagen, David			Microglial TNF-alpha Suppresses Cocaine-Induced Plasticity and Behavioral Sensitization	NEURON			English	Article							RECEPTOR STIMULATION INCREASES; EVOKED SYNAPTIC PLASTICITY; MONOPHOSPHORYL-LIPID-A; NUCLEUS-ACCUMBENS; AMPA RECEPTOR; DOPAMINE; WITHDRAWAL; PHOSPHORYLATION; TRANSMISSION; ACTIVATION	Repeated administration of cocaine results in the development of behavioral sensitization, accompanied by a decrease in excitatory synaptic strength in the nucleus accumbens (NAc) through an unknown mechanism. Furthermore, glial cells in the NAc are activated by drugs of abuse, but the contribution of glia to the development of addictive behaviors is unknown. Tumor necrosis factor alpha (TNF-alpha), an inflammatory cytokine released by activated glia, can drive the internalization of synaptic AMPA receptors on striatal medium spiny neurons. Here we show that repeated administration of cocaine activates striatal microglia and induces TNF-alpha production, which in turn depresses glutamatergic synaptic strength in the NAc core and limits the development of behavioral sensitization. Critically, following a period of abstinence, a weak TLR4 agonist can reactivate microglia, increase TNF-alpha production, depress striatal synaptic strength, and suppress cocaine-induced sensitization. Thus, cytokine signaling from microglia can regulate both the induction and expression of drug-induced behaviors.	[Lewitus, Gil M.; Konefal, Sarah C.; Greenhalgh, Andrew D.; Pribiag, Horia; Augereau, Keanan; Stellwagen, David] McGill Univ, Ctr Hlth, Res Inst, Dept Neurol & Neurosurg,Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University	Stellwagen, D (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Neurol & Neurosurg,Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada.	david.stellwagen@mcgill.ca	Pribiag, Horia/T-4722-2019; Pribiag, Horia/G-4524-2014	Pribiag, Horia/0000-0001-8455-1966	NIDA; CIHR; NSERC; ALS Canada; Neuro-inflammation Training Program; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026053] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); ALS Canada; Neuro-inflammation Training Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Alexandre Trottier, J.P. Clement, Kevin Jepson, and Joseph Lee for expert technical assistance and David Szymkowski (Xencor) for the donation of XENP1595. This work was supported by NIDA, CIHR, and NSERC (D.S.), the Ronald Peter Griggs Fellowship from ALS Canada (G.M.L.), and the Neuroinflammation Training Program (S.C.K.).	Bell K, 1996, PSYCHOPHARMACOLOGY, V127, P377, DOI 10.1007/BF02806018; Bell K, 2000, NEUROPSYCHOPHARMACOL, V23, P335, DOI 10.1016/S0893-133X(00)00100-7; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bowers MS, 2003, EUR J NEUROSCI, V17, P1273, DOI 10.1046/j.1460-9568.2003.02537.x; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; HOOKS MS, 1992, BRAIN RES, V587, P306; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kim J, 2011, BIOL PSYCHIAT, V69, P1026, DOI 10.1016/j.biopsych.2011.01.013; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Lewitus GM, 2014, J NEUROSCI, V34, P6146, DOI 10.1523/JNEUROSCI.3481-13.2014; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Miguel-Hidalgo Jose Javier, 2009, Curr Drug Abuse Rev, V2, P76; Nakajima A, 2004, J NEUROSCI, V24, P2212, DOI 10.1523/JNEUROSCI.4847-03.2004; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Northcutt AL, 2015, MOL PSYCHIATR, V20, P1525, DOI 10.1038/mp.2014.177; Ortinski PI, 2012, NEUROPSYCHOPHARMACOL, V37, P1671, DOI 10.1038/npp.2012.12; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Pierce RC, 1996, J NEUROSCI, V16, P1550; Schramm-Sapyta NL, 2006, NEUROPSYCHOPHARMACOL, V31, P1444, DOI 10.1038/sj.npp.1300918; Schumann J, 2009, J NEUROSCI, V29, P6955, DOI 10.1523/JNEUROSCI.1329-09.2009; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Wisor JP, 2011, BRAIN BEHAV IMMUN, V25, P767, DOI 10.1016/j.bbi.2011.02.002	35	134	137	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2016	90	3					483	491		10.1016/j.neuron.2016.03.030	http://dx.doi.org/10.1016/j.neuron.2016.03.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM3NZ	27112496	Green Accepted, Bronze			2022-12-17	WOS:000376254500009
J	Okaty, BW; Freret, ME; Rood, BD; Brust, RD; Hennessy, ML; Debairos, D; Kim, JC; Cook, MN; Dymecki, SM				Okaty, Benjamin W.; Freret, Morgan E.; Rood, Benjamin D.; Brust, Rachael D.; Hennessy, Morgan L.; debairos, Danielle; Kim, Jun Chul; Cook, Melloni N.; Dymecki, Susan M.			Multi-Scale Molecular Deconstruction of the Serotonin Neuron System	NEURON			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SINGLE-CELL TRANSCRIPTOMICS; AUTISM SPECTRUM DISORDER; INFANT-DEATH-SYNDROME; RECEPTOR GENE OXTR; IN-VIVO; DORSAL RAPHE; BRAIN-STEM; ASSOCIATION; MET	Serotonergic (5HT) neurons modulate diverse behaviors and physiology and are implicated in distinct clinical disorders. Corresponding diversity in 5HT neuronal phenotypes is becoming apparent and is likely rooted in molecular differences, yet a comprehensive approach characterizing molecular variation across the 5HT system is lacking, as is concomitant linkage to cellular phenotypes. Here we combine intersectional fate mapping, neuron sorting, and genome-wide RNA-seq to deconstruct the mouse 5HT system at multiple levels of granularity-from anatomy, to genetic sublineages, to single neurons. Our unbiased analyses reveal principles underlying system organization, 5HT neuron subtypes, constellations of differentially expressed genes distinguishing subtypes, and predictions of subtype-specific functions. Using electrophysiology, subtype-specific neuron silencing, and conditional gene knockout, we show that these molecularly defined 5HT neuron subtypes are functionally distinct. Collectively, this resource classifies molecular diversity across the 5HT system and discovers sertonergic subtypes, markers, organizing principles, and subtype-specific functions with potential disease relevance.	[Okaty, Benjamin W.; Freret, Morgan E.; Rood, Benjamin D.; Brust, Rachael D.; Hennessy, Morgan L.; debairos, Danielle; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kim, Jun Chul] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Cook, Melloni N.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA	Harvard University; Harvard Medical School; University of Toronto; University of Memphis	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu		Brust, Rachael/0000-0001-5375-6731; Freret, Morgan/0000-0001-5189-716X	NIH [P01 HD036379, R01 DA034022]; Harvard Stem Cell Institute Seed Grant; NARSAD Distinguished Investigator Grant from the Brain and Behavior Foundation; Blavatnik Biomedical Accelerator at Harvard University Pilot Award; American SIDS Institute research grant; NIGMS [T32GM007753];  [R21 MH083613];  [R21 DA023643]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643, R01DA034022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute Seed Grant; NARSAD Distinguished Investigator Grant from the Brain and Behavior Foundation; Blavatnik Biomedical Accelerator at Harvard University Pilot Award; American SIDS Institute research grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Biopolymers Facility at HMS for assistance in next generation sequencing, especially K. Waraska. Thank you to the Harvard NeuroDiscovery Center NBL Core and CHB IDDRC (P30 HD18655), including B. Caldarone, N. Andrews, and G. Gunner, for help with behavior assays. Thank you to M. Heiman for microscope use, T. Huycke for smFISH support, P. Tschopp for discussions on this manuscript, P. Kharchenko for advice on single-cell RNA-seq analysis, K. Sugino for advice on RNA-seq workflows, R. Kirchner for advice on RNA-seq analysis, A. Karger for computing support, and J.J. Mai for reagents and animal husbandry. Grants supporting this work include NIH P01 HD036379 (S.M.D., B.W.O., and R.D.B.), NIH R01 DA034022 (S.M.D.), Harvard Stem Cell Institute Seed Grant (S.M.D. and B.W.O.), NARSAD Distinguished Investigator Grant from the Brain and Behavior Foundation (S.M.D. and B.W.O.), the Blavatnik Biomedical Accelerator at Harvard University Pilot Award (S.M.D., B.W.O., and B.D.R.), R21 MH083613 (S.M.D. and J.C.K.), R21 DA023643 (S.M.D. and M.E.F.), American SIDS Institute research grant (B.W.O.), and NIGMS T32GM007753 (M.L.H.). Authors declare no conflicts of interest.	Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Brust RD, 2014, CELL REP, V9, P2152, DOI 10.1016/j.celrep.2014.11.027; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2011, J NEURODEV DISORD, V3, P101, DOI 10.1007/s11689-010-9071-2; Crawford LK, 2010, J NEUROPHYSIOL, V103, P2652, DOI 10.1152/jn.01132.2009; Dougherty JD, 2013, J NEUROSCI, V33, P2732, DOI 10.1523/JNEUROSCI.4762-12.2013; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Gaspar P, 2012, PHILOS T R SOC B, V367, P2382, DOI 10.1098/rstb.2011.0378; Hale MW, 2011, PSYCHOPHARMACOLOGY, V213, P243, DOI 10.1007/s00213-010-2089-z; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hendricks T, 1999, J NEUROSCI, V19, P10348; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kimmel RA, 2000, GENE DEV, V14, P1377; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Lambert N, 2014, AUTISM RES, V7, P617, DOI 10.1002/aur.1396; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Maloney SE, 2013, INT REV NEUROBIOL, V113, P61, DOI 10.1016/B978-0-12-418700-9.00003-4; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Paxinos G., 2007, MOUSE BRAIN STEREOTA, DOI 10.1016/B978-0-12-374247-6.50004-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudie JD, 2012, NEURON, V75, P904, DOI 10.1016/j.neuron.2012.07.010; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Spaethling JM, 2014, FASEB J, V28, P771, DOI 10.1096/fj.13-240267; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wu HH, 2013, DEV NEUROSCI-BASEL, V35, P1, DOI 10.1159/000346367; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zheng H., 2013, GENERATION TAC1 CRE	48	134	134	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2015	88	4					774	791		10.1016/j.neuron.2015.10.007	http://dx.doi.org/10.1016/j.neuron.2015.10.007			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX5TR	26549332	Green Accepted, Bronze			2022-12-17	WOS:000365765900017
J	Araki, Y; Zeng, ML; Zhang, MJ; Huganir, RL				Araki, Yoichi; Zeng, Menglong; Zhang, Mingjie; Huganir, Richard L.			Rapid Dispersion of SynGAP from Synaptic Spines Triggers AMPA Receptor Insertion and Spine Enlargement during LTP	NEURON			English	Article							GTPASE-ACTIVATING PROTEIN; NMDA RECEPTORS; RHO-GTPASES; RAS; PLASTICITY; TIAM1; TRAFFICKING; MATURATION; MUTATIONS; MEMBRANE	SynGAP is a Ras-GTPase activating protein highly enriched at excitatory synapses in the brain. Previous studies have shown that CaMKII and the RASERK pathway are critical for several forms of synaptic plasticity including LTP. NMDA receptor-dependent calcium influx has been shown to regulate the RASERK pathway and downstream events that result in AMPA receptor synaptic accumulation, spine enlargement, and synaptic strengthening during LTP. However, the cellular mechanisms whereby calcium influx and CaMKII control Ras activity remain elusive. Using live-imaging techniques, we have found that SynGAP is rapidly dispersed from spines upon LTP induction in hippocampal neurons, and this dispersion depends on phosphorylation of SynGAP by CaMKII. Moreover, the degree of acute dispersion predicts the maintenance of spine enlargement. Thus, the synaptic dispersion of SynGAP by CaMKII phosphorylation during LTP represents a key signaling component that transduces CaMKII activity to small G protein-mediated spine enlargement, AMPA receptor synaptic incorporation, and synaptic potentiation.	[Araki, Yoichi; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Araki, Yoichi; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Zeng, Menglong; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Hong Kong University of Science & Technology	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Zhang, Mingjie/0000-0001-9404-0190	National Institute of Health [MH64856, NS036715]; JSPS; Research Grant Council of Hong Kong [AoE/M09/12]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Huganir lab for discussion and support throughout this work-especially Drs. Graham Diering, Ingie Hong, Lenora Volk, Olof Lagerlof, and Natasha Hussain for critical reading of the manuscript. Dominant-negative forms of Ras (Ras<SUP>DN</SUP>; S17N) and Rac1 (Rac1<SUP>DN</SUP>; T17N) were generous gift from Dr. Takanari Inoue (Johns Hopkins University). Raichu-Ras was generous gift from Dr. Michiyuki Matsuda (Kyoto University). This work was supported by grants from National Institute of Health (MH64856, NS036715 to R.L.H.), JSPS (Y.A.), the Research Grant Council of Hong Kong (AoE/M09/12 to M.Z.), and the Howard Hughes Medical Institute (R.L.H.).	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Clement JP, 2013, J NEUROSCI, V33, P10447, DOI 10.1523/JNEUROSCI.0765-13.2013; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Colgan LA, 2013, ANN REV PHYSL; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Li WD, 2001, J BIOL CHEM, V276, P21417, DOI 10.1074/jbc.M010744200; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu XL, 2012, GENOME RES, V22, P611, DOI 10.1101/gr.127324.111; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Ozkan ED, 2014, NEURON, V82, P1317, DOI 10.1016/j.neuron.2014.05.015; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Penzes P, 2009, NEURON, V61, P3, DOI 10.1016/j.neuron.2008.12.018; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	55	134	137	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 7	2015	85	1					173	189		10.1016/j.neuron.2014.12.023	http://dx.doi.org/10.1016/j.neuron.2014.12.023			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ5YS	25569349	Green Accepted, Bronze			2022-12-17	WOS:000348295100017
J	Cabungcal, JH; Counotte, DS; Lewis, EM; Tejeda, HA; Piantadosi, P; Pollock, C; Calhoon, GG; Sullivan, EM; Presgraves, E; Kil, J; Hong, LE; Cuenod, M; Do, KQ; O'Donnell, P				Cabungcal, Jan-Harry; Counotte, Danielle S.; Lewis, Eastman M.; Tejeda, Hugo A.; Piantadosi, Patrick; Pollock, Cameron; Calhoon, Gwendolyn G.; Sullivan, Elyse M.; Presgraves, Echo; Kil, Jonathan; Hong, L. Elliot; Cuenod, Michel; Do, Kim Q.; O'Donnell, Patricio			Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia	NEURON			English	Article							VENTRAL HIPPOCAMPAL LESION; N-ACETYL-CYSTEINE; FAST-SPIKING INTERNEURONS; OXIDATIVE STRESS; GLUTATHIONE DEFICIT; PREFRONTAL CORTEX; NITRIC-OXIDE; PARVALBUMIN INTERNEURONS; CORTICAL DISINHIBITION; COGNITIVE DEFICITS	Abnormal development can lead to deficits in adult brain function, a trajectory likely underlying adolescent- onset psychiatric conditions such as schizophrenia. Developmental manipulations yielding adult deficits in rodents provide an opportunity to explore mechanisms involved in a delayed emergence of anomalies driven by developmental alterations. Here we assessed whether oxidative stress during presymptomatic stages causes adult anomalies in rats with a neonatal ventral hippocampal lesion, a developmental rodent model useful for schizophrenia research. Juvenile and adolescent treatment with the antioxidant N-acetyl cysteine prevented the reduction of prefrontal parvalbumin interneuron activity observed in this model, as well as electrophysiological and behavioral deficits relevant to schizophrenia. Adolescent treatment with the glutathione peroxidase mimic ebselen also reversed behavioral deficits in this animal model. These findings suggest that presymptomatic oxidative stress yields abnormal adult brain function in a developmentally compromised brain, and highlight redox modulation as a potential target for early intervention.	[Cabungcal, Jan-Harry; Cuenod, Michel; Do, Kim Q.] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Lewis, Eastman M.; Tejeda, Hugo A.; Calhoon, Gwendolyn G.; Sullivan, Elyse M.; Hong, L. Elliot; O'Donnell, Patricio] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Counotte, Danielle S.; Lewis, Eastman M.; Tejeda, Hugo A.; Piantadosi, Patrick; Pollock, Cameron; Calhoon, Gwendolyn G.; Sullivan, Elyse M.; Presgraves, Echo; O'Donnell, Patricio] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Kil, Jonathan] Sound Pharmaceut Inc, Res & Dev, Seattle, WA USA; [Hong, L. Elliot; O'Donnell, Patricio] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Hong, L. Elliot] Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Do, KQ (corresponding author), Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland.	kim.do@chuv.ch; patricio.odonnell@pfizer.com	Tejeda, Hugo/AAX-2529-2021; Do, Kim Q./G-6694-2016	Do, Kim Q./0000-0003-1968-1646; Piantadosi, Patrick/0000-0001-7003-0676; Lewis, Eastman/0000-0003-0647-0719	NARSAD Distinguished Investigator Award; NIH [R01 MH057683]; Swiss National Science Foundation [310030_135736/1]; National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases'' [51AU40_125759]; Avina Foundation; Damm-Etienne Foundation; Alamaya Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057683] Funding Source: NIH RePORTER	NARSAD Distinguished Investigator Award(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases''(Swiss National Science Foundation (SNSF)); Avina Foundation; Damm-Etienne Foundation; Alamaya Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank Alex Hernandez, Meredyth Wegener, Christopher Schiefer, Kimberly Konka, Adeline Cottier, and Rudolf Kraftsik for excellent technical assistance. Supported by a NARSAD Distinguished Investigator Award (P.O'D.); NIH grant R01 MH057683 (P.O'D.); Swiss National Science Foundation (# 310030_135736/1 to K.Q.D.); National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases'' no 51AU40_125759); and the Avina, Damm-Etienne, and Alamaya Foundations (K.Q.D.). P.O'D. is employee and stockholder at Pfizer, inc. J.K. is employee at Sound Pharmaceuticals, Ltd. All other authors have nothing to disclose.	Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Cabungcal JH, 2006, NEUROBIOL DIS, V22, P624, DOI 10.1016/j.nbd.2006.01.003; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Cabungcal JH, 2013, BIOL PSYCHIAT, V73, P574, DOI 10.1016/j.biopsych.2012.09.020; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chambers RA, 2011, NEUROMETHODS, V59, P1, DOI 10.1007/978-1-61779-157-4_1; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Duarte JMD, 2012, BIOL PSYCHIAT, V71, P1006, DOI 10.1016/j.biopsych.2011.07.035; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; HARTIG W, 1994, BRAIN RES, V635, P307, DOI 10.1016/0006-8993(94)91452-4; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; JAVITT DC, 1993, BIOL PSYCHIAT, V33, P513, DOI 10.1016/0006-3223(93)90005-X; Johnson AW, 2013, P NATL ACAD SCI USA, V110, P12462, DOI 10.1073/pnas.1307925110; Jones DP, 2010, DIABETES OBES METAB, V12, P116, DOI 10.1111/j.1463-1326.2010.01266.x; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Lipska BK, 1995, PSYCHOPHARMACOLOGY, V122, P35, DOI 10.1007/BF02246439; Lipska BK, 2002, J NEUROSCI, V22, P2835, DOI 10.1523/JNEUROSCI.22-07-02835.2002; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; MULLER A, 1984, BIOCHEM PHARMACOL, V33, P3235, DOI 10.1016/0006-2952(84)90083-2; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Nwokocha CR, 2013, CARDIOVASC TOXICOL, V13, P357, DOI 10.1007/s12012-013-9216-0; O'Donnell P, 2002, CEREB CORTEX, V12, P975, DOI 10.1093/cercor/12.9.975; O'Donnell P, 2013, SCHIZOPHRENIA EVOLUT, P205; O'Donnell P, 2012, EUR J NEUROSCI, V35, P1866, DOI 10.1111/j.1460-9568.2012.08130.x; O'Donnell P, 2012, PHARMACOL THERAPEUT, V133, P19, DOI 10.1016/j.pharmthera.2011.07.005; O'Donnell P, 2011, SCHIZOPHRENIA BULL, V37, P484, DOI 10.1093/schbul/sbr028; Otte DM, 2011, NEUROPSYCHOPHARMACOL, V36, P2233, DOI 10.1038/npp.2011.109; Pawlas N, 2007, PHARMACOL REP, V59, P708; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; Tosic M, 2006, AM J HUM GENET, V79, P586, DOI 10.1086/507566; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Tseng KY, 2009, BEHAV BRAIN RES, V204, P295, DOI 10.1016/j.bbr.2008.11.039; Tseng KY, 2008, J NEUROSCI, V28, P12691, DOI 10.1523/JNEUROSCI.4166-08.2008; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Yao JK, 2004, SCHIZOPHRENIA BULL, V30, P923, DOI 10.1093/oxfordjournals.schbul.a007142	55	134	138	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 3	2014	83	5					1073	1084		10.1016/j.neuron.2014.07.028	http://dx.doi.org/10.1016/j.neuron.2014.07.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5XB	25132466	Green Accepted, Green Published, Bronze			2022-12-17	WOS:000341419000011
J	Bartolini, G; Ciceri, G; Marin, O				Bartolini, Giorgia; Ciceri, Gabriele; Marin, Oscar			Integration of GABAergic Interneurons into Cortical Cell Assemblies: Lessons from Embryos and Adults	NEURON			English	Review							MOUSE OLFACTORY-BULB; MEDIAL GANGLIONIC EMINENCE; POSTNATAL SUBVENTRICULAR ZONE; NEOCORTICAL NETWORK ACTIVITY; DEVELOPING CEREBRAL-CORTEX; GENERATED GRANULE CELLS; CENTRAL-NERVOUS-SYSTEM; FATE MAPPING REVEALS; NEURONAL MIGRATION; INHIBITORY INTERNEURONS	In the forebrain, cortical structures consist of networks of excitatory and inhibitory neurons born in distant locations. Understanding how these two major classes of neurons integrate into unique functional cell assemblies may shed light on the organization of cortical circuits. In this review, we provide an overview of the mechanisms used by GABAergic interneurons to reach their final position, with an emphasis on the final steps of this process. To this end, we analyze similarities and differences between the integration of GABAergic interneurons in the developing cerebral cortex and in the postnatal brain, using the neocortex and the olfactory bulb as model systems.	[Bartolini, Giorgia; Ciceri, Gabriele; Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Bartolini, Giorgia; Ciceri, Gabriele; Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Marin, O (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027; Ciceri, Gabriele/0000-0002-8481-9771	Spanish Ministry of Economy and Competiveness (MINECO) [SAF2011-28845, CONSOLIDER CSD2007-00023]; "Formacion de Personal Investigador" (FPI) fellowship from MINECO	Spanish Ministry of Economy and Competiveness (MINECO); "Formacion de Personal Investigador" (FPI) fellowship from MINECO	We are grateful to members of the Mann and Rico laboratories for stimulating discussions and ideas. Our research on this topic is supported by grants from the Spanish Ministry of Economy and Competiveness (MINECO; SAF2011-28845 and CONSOLIDER CSD2007-00023) and the European Research Council (ERC-2011-AdG 293683). G.C. is a recipient of a "Formacion de Personal Investigador" (FPI) fellowship from MINECO.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Armstrong C, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00023; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bardy C, 2010, J NEUROSCI, V30, P17023, DOI 10.1523/JNEUROSCI.4543-10.2010; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Belvindrah R, 2009, REV NEUROSCIENCE, V20, P331, DOI 10.1515/REVNEURO.2009.20.5-6.331; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chen WR, 2005, J NEUROCYTOL, V34, P353, DOI 10.1007/s11068-005-8362-0; Chittajallu R, 2013, NAT NEUROSCI, V16, P13, DOI 10.1038/nn.3284; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cuzon VC, 2006, CEREB CORTEX, V16, P1377, DOI 10.1093/cercor/bhj084; Daniel D, 2005, GENE EXPR PATTERNS, V5, P317, DOI 10.1016/j.modgep.2004.10.007; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; de Lima AD, 2009, DEV NEUROBIOL, V69, P105, DOI 10.1002/dneu.20696; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; DEVOR M, 1975, J COMP NEUROL, V164, P471, DOI 10.1002/cne.901640406; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Franco SJ, 2011, DEV NEUROBIOL, V71, P889, DOI 10.1002/dneu.20946; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hellwig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050646; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Huang LW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00032; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; Inamura N, 2012, J NEUROSCI, V32, P6032, DOI 10.1523/JNEUROSCI.3446-11.2012; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jankovski A, 1996, J COMP NEUROL, V371, P376; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Katagiri Hiroyuki, 2011, Neural Syst Circuits, V1, P6, DOI 10.1186/2042-1001-1-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kelsch W, 2009, J NEUROSCI, V29, P11852, DOI 10.1523/JNEUROSCI.2406-09.2009; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kosaka T, 2005, CHEM SENSES, V30, pI107, DOI 10.1093/chemse/bjh137; Kosaka T, 2008, NEUROSCI RES, V60, P56, DOI 10.1016/j.neures.2007.09.008; Krosnowski K, 2012, NEUROSCIENCE, V213, P161, DOI 10.1016/j.neuroscience.2012.04.024; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Le Magueresse C, 2011, J NEUROSCI, V31, P16731, DOI 10.1523/JNEUROSCI.4273-11.2011; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li XS, 2011, J NEUROSCI, V31, P8450, DOI 10.1523/JNEUROSCI.0939-11.2011; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lodato S, 2011, NEURON, V69, P763, DOI 10.1016/j.neuron.2011.01.015; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Lourenco MR, 2012, NEUROSCIENCE, V201, P357, DOI 10.1016/j.neuroscience.2011.10.041; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Meechan DW, 2012, P NATL ACAD SCI USA, V109, P18601, DOI 10.1073/pnas.1211507109; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; MILLER MW, 1995, J COMP NEUROL, V355, P6, DOI 10.1002/cne.903550104; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Mizuguchi R, 2012, J NEUROSCI, V32, P8831, DOI 10.1523/JNEUROSCI.5746-11.2012; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Packer AM, 2013, CEREB CORTEX, V23, P2790, DOI 10.1093/cercor/bhs210; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Panzanelli P, 2009, J NEUROSCI, V29, P15039, DOI 10.1523/JNEUROSCI.3034-09.2009; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; PRICE JL, 1970, J CELL SCI, V7, P125; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Riccio O, 2012, CEREB CORTEX, V22, P86, DOI 10.1093/cercor/bhr086; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Rymar VV, 2007, J COMP NEUROL, V501, P369, DOI 10.1002/cne.21250; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; Sessa A, 2010, GENE DEV, V24, P1816, DOI 10.1101/gad.575410; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Stenman J, 2003, J NEUROSCI, V23, P167; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tanaka DH, 2010, CEREB CORTEX, V20, P2810, DOI 10.1093/cercor/bhq027; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; Thomas LB, 1996, GLIA, V17, P1; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tremblay R., 2010, 2010 NUER M PLANN SA; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Waclaw RR, 2009, NEURON, V63, P451, DOI 10.1016/j.neuron.2009.07.015; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Willaime-Morawek S, 2006, J CELL BIOL, V175, P159, DOI 10.1083/jcb.200604123; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Woodworth MB, 2012, CELL, V151, P918, DOI 10.1016/j.cell.2012.10.004; Wu SX, 2011, DEVELOPMENT, V138, P2499, DOI 10.1242/dev.063032; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhu YL, 2010, GLIA, V58, P716, DOI 10.1002/glia.20957; Zou DJ, 2009, NAT REV NEUROSCI, V10, P611, DOI 10.1038/nrn2666	155	134	135	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					849	864		10.1016/j.neuron.2013.08.014	http://dx.doi.org/10.1016/j.neuron.2013.08.014			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012001	Bronze			2022-12-17	WOS:000330269100005
J	Vickery, TJ; Chun, MM; Lee, D				Vickery, Timothy J.; Chun, Marvin M.; Lee, Daeyeol			Ubiquity and Specificity of Reinforcement Signals throughout the Human Brain	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; MIXED-STRATEGY GAME; DORSOLATERAL PREFRONTAL CORTEX; HUMAN ORBITOFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; DECISION-MAKING; PARIETAL CORTEX; PREDICTION ERRORS; REWARD SIGNALS; VISUAL-CORTEX	Reinforcements and punishments facilitate adaptive behavior in diverse domains ranging from perception to social interactions. A conventional approach to understanding the corresponding neural substrates focuses on the basal ganglia and its dopaminergic projections. Here, we show that reinforcement and punishment signals are surprisingly ubiquitous in the gray matter of nearly every subdivision of the human brain. Humans played either matching-pennies or rock-paper-scissors games against computerized opponents while being scanned using fMRI. Multivoxel pattern analysis was used to decode previous choices and their outcomes, and to predict upcoming choices. Whereas choices were decodable from a confined set of brain structures, their outcomes were decodable from nearly all cortical and subcortical structures. In addition, signals related to both reinforcements and punishments were recovered reliably in many areas and displayed patterns not consistent with salience-based explanations. Thus, reinforcement and punishment might play global modulatory roles in the entire brain.	[Vickery, Timothy J.; Chun, Marvin M.; Lee, Daeyeol] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Chun, Marvin M.; Lee, Daeyeol] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Vickery, TJ (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	tim.vickery@gmail.com	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X; Chun, Marvin/0000-0003-1070-7993	Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine	Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine	This study was supported by the Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine. We thank Matt Kleinman, Zhihao Zhang, and Sam Cartmell for assistance with data collection, and Brice Kuhl for useful discussions.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kim S, 2009, NEURAL NETWORKS, V22, P294, DOI 10.1016/j.neunet.2009.03.010; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Thorndike EL, 1911, ANIMAL INTELLIGENCE; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Vickery TJ, 2009, CEREB CORTEX, V19, P916, DOI 10.1093/cercor/bhn140; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001	61	134	138	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					166	177		10.1016/j.neuron.2011.08.011	http://dx.doi.org/10.1016/j.neuron.2011.08.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	833BH	21982377	Bronze			2022-12-17	WOS:000295856300016
J	Pan, EH; Zhang, XA; Huang, Z; Krezel, A; Zhao, M; Tinberg, CE; Lippard, SJ; McNamara, JO				Pan, Enhui; Zhang, Xiao-an; Huang, Zhen; Krezel, Artur; Zhao, Min; Tinberg, Christine E.; Lippard, Stephen J.; McNamara, James O.			Vesicular Zinc Promotes Presynaptic and Inhibits Postsynaptic Long-Term Potentiation of Mossy Fiber-CA3 Synapse	NEURON			English	Article							NMDA RECEPTORS; HIPPOCAMPAL; RELEASE; MEMORY; NEUROTROPHINS; DISRUPTION; COMPONENTS; TERMINALS; VESICLES; BRAIN	The presence of zinc in glutamatergic synaptic vesicles of excitatory neurons of mammalian cerebral cortex suggests that zinc might regulate plasticity of synapses formed by these neurons. Long-term potentiation (LTP) is a form of synaptic plasticity that may underlie learning and memory. We tested the hypothesis that zinc within vesicles of mossy fibers (mf) contributes to mf-LTP, a classical form of presynaptic LTP. We synthesized an extracellular zinc chelator with selectivity and kinetic properties suitable for study of the large transient of zinc in the synaptic cleft induced by mf stimulation. We found that vesicular zinc is required for presynaptic mf-LTP. Unexpectedly, vesicular zinc also inhibits a form of postsynaptic mf-LTP. Because the mf-CA3 synapse provides a major source of excitatory input to the hippocampus, regulating its efficacy by these dual actions, vesicular zinc is critical to proper function of hippocampal circuitry in health and disease.	[Zhang, Xiao-an; Huang, Zhen; Zhao, Min; Tinberg, Christine E.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Pan, Enhui; McNamara, James O.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA; [Krezel, Artur] Univ Wroclaw, Lab Prot Engn, PL-50137 Wroclaw, Poland	Massachusetts Institute of Technology (MIT); Duke University; Duke University; Duke University; University of Wroclaw	Lippard, SJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lippard@mit.edu; jmc@neuro.duke.edu	Krezel, Artur/AAG-8729-2021; Huang, Zhen/N-1894-2013; Krezel, Artur/E-7047-2011; Zhang, Xiao-an/E-4458-2016	Krezel, Artur/0000-0001-9252-5784; Zhang, Xiao-an/0000-0001-9417-4228	National Institute of General Medical Sciences [GM065519]; National Institute of Neurological Disease and Stroke [NS56217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institute of General Medical Sciences (GM065519 to S.J.L.) and from the National Institute of Neurological Disease and Stroke (NS56217 to J.O.M.). The authors thank Drs. Daniela Buccella, Nicole Calakos, Danny Jones, and Richard Mooney for valuable discussions and Wei-Hua Qian for support of mouse husbandry and genotyping.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Alder J, 2005, J NEUROSCI, V25, P3080, DOI 10.1523/JNEUROSCI.2970-04.2005; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Breustedt J, 2003, P NATL ACAD SCI USA, V100, P12450, DOI 10.1073/pnas.2035117100; Budde T, 1997, NEUROSCIENCE, V79, P347, DOI 10.1016/S0306-4522(96)00695-1; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chang C. J., 2006, METAL IONS LIFE SCI, V1, P321; Chang CJ, 2004, CHEM BIOL, V11, P203, DOI 10.1016/j.chembiol.2004.01.017; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2001, BRAIN RES, V891, P253, DOI 10.1016/S0006-8993(00)03220-0; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; HAUG FMS, 1967, HISTOCHEMISTRY, V8, P355, DOI 10.1007/BF00401978; He XP, 2010, J NEUROSCI, V30, P6188, DOI 10.1523/JNEUROSCI.5821-09.2010; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kamiya H, 2002, J NEUROSCI, V22, P10524; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; Li Y, 2010, J NEUROPHYSIOL, V103, P2846, DOI 10.1152/jn.01140.2009; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MASKE H, 1955, NATURWISSENSCHAFTEN, V42, P424, DOI 10.1007/BF00601955; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nolan EM, 2005, J AM CHEM SOC, V127, P16812, DOI 10.1021/ja052184t; Paoletti P, 1997, J NEUROSCI, V17, P5711; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Quinta-Ferreira ME, 2004, BRAIN RES, V1004, P52, DOI 10.1016/j.brainres.2004.01.013; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Regehr WG, 2001, SYNAPSES, P135; Reid CA, 2004, J NEUROSCI, V24, P3618, DOI 10.1523/JNEUROSCI.3567-03.2004; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Stoltenberg M, 2004, J MOL HISTOL, V35, P141; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang XA, 2007, P NATL ACAD SCI USA, V104, P10780, DOI 10.1073/pnas.0702393104	46	134	135	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1116	1126		10.1016/j.neuron.2011.07.019	http://dx.doi.org/10.1016/j.neuron.2011.07.019			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943607	Green Accepted, Green Published, Bronze			2022-12-17	WOS:000295556500015
J	Ding, JB; Takasaki, KT; Sabatini, BL				Ding, Jun B.; Takasaki, Kevin T.; Sabatini, Bernardo L.			Supraresolution Imaging in Brain Slices using Stimulated-Emission Depletion Two-Photon Laser Scanning Microscopy	NEURON			English	Article							SINGLE DENDRITIC SPINES; FLUORESCENCE MICROSCOPY; SYNAPTIC PLASTICITY; STED MICROSCOPY; STRUCTURED-ILLUMINATION; IN-VIVO; RESOLUTION; COMPARTMENTALIZATION; DIFFUSION; PROTEIN	Two-photon laser scanning microscopy (2PLSM) has allowed unprecedented fluorescence imaging of neuronal structure and function within neural tissue. However, the resolution of this approach is poor compared to that of conventional confocal microscopy. Here, we demonstrate supraresolution 2PLSM within brain slices. Imaging beyond the diffraction limit is accomplished by using near-infrared (NIR) lasers for both pulsed two-photon excitation and continuous wave stimulated emission depletion (STED). Furthermore, we demonstrate that Alexa Fluor 594, a bright fluorophore commonly used for both live cell and fixed tissue fluorescence imaging, is suitable for STED 2PLSM. STED 2PLSM supraresolution microscopy achieves approximately 3-fold improvement in resolution in the radial direction over conventional 2PLSM, revealing greater detail in the structure of dendritic spines located similar to 100 microns below the surface of brain slices. Further improvements in resolution are theoretically achievable, suggesting that STED 2PLSM will permit nanoscale imaging of neuronal structures located in relatively intact brain tissue.	[Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Takasaki, Kevin T.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312	NINDS NIH HHS [R01 NS046579, R01 NS046579-06A1, T32 NS007484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R01NS046579] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI [10.1007/BF02956173, DOI 10.1007/BF02956173]; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2004, CURR OPIN NEUROBIOL, V14, P599, DOI 10.1016/j.conb.2004.08.015; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TSAI S, 2002, PRINCIPLES DESIGN CO; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Yan Y, 2007, J PHYS CHEM B, V111, P6374, DOI 10.1021/jp0706331; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	34	134	141	4	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 27	2009	63	4					429	437		10.1016/j.neuron.2009.07.011	http://dx.doi.org/10.1016/j.neuron.2009.07.011			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491HV	19709626	Bronze, Green Accepted			2022-12-17	WOS:000269570400004
J	Espinosa, JS; Wheeler, DG; Tsien, RW; Luo, LQ				Espinosa, J. Sebastian; Wheeler, Damian G.; Tsien, Richard W.; Luo, Liqun			Uncoupling Dendrite Growth and Patterning: Single-Cell Knockout Analysis of NMDA Receptor 2B	NEURON			English	Article							RAT SOMATOSENSORY CORTEX; D-ASPARTATE RECEPTOR; IN-VIVO; BARREL CORTEX; DENTATE GYRUS; GRANULE CELLS; TARGETED DISRUPTION; ARBOR DEVELOPMENT; MOSAIC ANALYSIS; DOUBLE MARKERS	N-methyl-D-aspartate receptors (NMDARs) play important functions in neural development. NR2B is the predominant NR2 subunit of NMDAR in the developing brain. Here we use mosaic analysis with double markers (MADM) to knock out NR2B in isolated single cells and analyze its cell-autonomous function in dendrite development. NR2B mutant dentate gyrus granule cells (dGCs) and barrel cortex layer 4 spiny stellate cells (bSCs) have similar dendritic growth rates, total length, and branch number as control cells. However, mutant dGCs maintain supernumerary primary dendrites resulting from a pruning defect. Furthermore, while control bSCs restrict dendritic growth to a single barrel, mutant bSCs maintain dendritic growth in multiple barrels. Thus, NR2B functions cell autonomously to regulate dendrite patterning to ensure that sensory information is properly represented in the cortex. Our study also indicates that molecular mechanisms that regulate activity dependent dendrite patterning can be separated from those that control general dendrite growth and branching.	[Espinosa, J. Sebastian; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Espinosa, J. Sebastian; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wheeler, Damian G.; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Espinosa, J. Sebastian; Tsien, Richard W.; Luo, Liqun] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264	National Institutes of Health (NIH) [GM58234, NS050835]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS053270, R01NS050835] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Westbrook for NR2B knockout mice, R. Kageyama for nestin-CreER mice, and W. Zhong for nestin-Cre mice. We thank many colleagues for helpful advice and discussion, in particular B. Barres, S. McConnell, M. Schnitzer, and members of the Luo laboratory. We thank K. Svoboda, B. Tasic, K. Miyamichi, S. Hippenmeyer, Y. Chou, and J. Leong for comments on the manuscript; and J. Zhong and C. Manalac for technical assistance. J.S.E. is a predoctoral Ruth L. Kirschstein National Research Service Award fellow. L.L. is a Howard Hughes Medical Institute (HHMI) investigator. This work was supported by National Institutes of Health (NIH) grants GM58234 (R.W.T) and NS050835 (L.L.).	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CLAIBORNE BJ, 1990, J COMP NEUROL, V302, P206, DOI 10.1002/cne.903020203; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; CLINE HT, 1990, J NEUROSCI, V10, P1197; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FRICKE R, 1977, J COMP NEUROL, V173, P231, DOI 10.1002/cne.901730203; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; GREEN EJ, 1985, EXP BRAIN RES, V59, P582; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hickmott PW, 1999, J COMP NEUROL, V409, P385; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kadotani H, 1996, J NEUROSCI, V16, P7859; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rajan I, 1998, J NEUROSCI, V18, P7836; RUTHAZER ES, 2003, NATURE, V373, P151; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Senft SL, 1991, CEREB CORTEX, V1, P308, DOI 10.1093/cercor/1.4.308; SHOLL DA, 1953, J ANAT, V87, P387; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tovar KR, 1999, J NEUROSCI, V19, P4180; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	73	134	136	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 30	2009	62	2					205	217		10.1016/j.neuron.2009.03.006	http://dx.doi.org/10.1016/j.neuron.2009.03.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	441MU	19409266	Bronze, Green Accepted			2022-12-17	WOS:000265774100009
J	Hayden, BY; Nair, AC; Mccoy, AN; Platt, ML				Hayden, Benjamin Y.; Nair, Amrita C.; Mccoy, Allison N.; Platt, Michael L.			Posterior Cingulate Cortex Mediates Outcome-Contingent Allocation of Behavior	NEURON			English	Article							MIXED-STRATEGY GAME; PREFRONTAL CORTEX; DECISION-MAKING; PSYCHOPHYSICS TOOLBOX; REWARD SIGNALS; MACAQUE; NEURONS	Adaptive decision making requires selecting an action and then monitoring its consequences to improve future decisions. The neuronal mechanisms supporting action evaluation and subsequent behavioral modification, however, remain poorly understood. To investigate the contribution of posterior cingulate cortex (CGp) to these processes, we recorded activity of single neurons in monkeys performing a gambling task in which the reward outcome of each choice strongly influenced subsequent choices. We found that CGp neurons signaled reward outcomes in a nonlinear fashion and that outcome-contingent modulations in firing rate persisted into subsequent trials. Moreover, firing rate on any one trial predicted switching to the alternative option on the next trial. Finally, microstimulation in CGp following risky choices promoted a preference reversal for the safe option on the following trial. Collectively, these results demonstrate that CGp directly contributes to the evaluative processes that support dynamic changes in decision making in volatile environments.	[Hayden, Benjamin Y.; Nair, Amrita C.; Mccoy, Allison N.; Platt, Michael L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27706 USA; [Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27710 USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hayden, BY (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27706 USA.	hayden@neuro.duke.edu	Nair, Amrita/AAM-3611-2021; Hayden, Benjamin/J-7994-2013	Nair, Amrita/0000-0002-6563-7112; Hayden, Benjamin/0000-0002-7678-4281	NIH [EY013496]; Kirschstein NRSA [DA023338]; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA023338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Vinod Venkatraman for help in developing Psychtoolbox for our rig. We thank Sarah Heilbronner for comments on the manuscript. This work was supported by the NIH EY013496 (M.L.P.) and a Kirschstein NRSA DA023338 (B.Y.H.).	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; GABRIEL M, 1990, PROG BRAIN RES, V85, P467; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	24	134	139	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 9	2008	60	1					19	25		10.1016/j.neuron.2008.09.012	http://dx.doi.org/10.1016/j.neuron.2008.09.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	363AC	18940585	Green Accepted, Bronze			2022-12-17	WOS:000260237300005
J	Zhou, FM; Liang, Y; Salas, R; Zhang, LF; De Biasi, M; Dani, JA				Zhou, FM; Liang, Y; Salas, R; Zhang, LF; De Biasi, M; Dani, JA			Corelease of dopamine and serotonin from striatal dopamine terminals	NEURON			English	Article							IN-VIVO MICRODIALYSIS; TRANSPORTER; RAT; RELEASE; MONOAMINE; NUCLEUS; MECHANISMS; FLUOXETINE; BEHAVIOR; NEURONS	The striatum receives rich dopaminergic and more moderate serotonergic innervation. After vesicular release, dopamine and serotonin (5-hydroxytryptamine, 5-HT) signaling is controlled by transporter-mediated reuptake. Dopamine is taken up by dopamine transporters (DATs), which are expressed at the highest density in the striatum. Although DATs also display a low affinity for 5-HT, that neurotransmitter is normally efficiently taken up by the 5-HT transporters. We found that when extracellular 5-HT is elevated by exogenous application or by using antidepressants (e.g., fluoxetine) to inhibit the 5-HT transporters, the extremely dense striatal DATs uptake 5-HT into dopamine terminals. Immunohistochemical results and measurements using fast cyclic voltammetry showed that elevated 5-HT is taken up by DATs into striatal dopamine terminals that subsequently release 5-HT and dopamine together. These results suggest that antidepressants that block serotonin transporters or other factors that elevate extracellular 5-HT alter the temporal and spatial relationship between dopamine and 5-HT signaling in the striatum.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	jdani@bcm.tmc.edu	Salas, Ramiro/A-9602-2015; De Biasi, Mariella/M-7646-2017	De Biasi, Mariella/0000-0002-0687-8872	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R23NS021229, R01NS021229, R01NS048505, R37NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017173, R01DA009411] Funding Source: NIH RePORTER; NIDA NIH HHS [DA017173, DA09411] Funding Source: Medline; NIMH NIH HHS [MH67119] Funding Source: Medline; NINDS NIH HHS [R01 NS021229, NS048505, NS21229] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bjorklund A, 1984, HDB CHEM NEUROANAT 1, V2, P55; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Bunin MA, 1998, J NEUROSCI, V18, P4854; Bymaster FP, 2002, PSYCHOPHARMACOLOGY, V160, P353, DOI 10.1007/s00213-001-0986-x; Cases O, 1998, J NEUROSCI, V18, P6914; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7; Descarries L, 2000, PROG BRAIN RES, V125, P27; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; FEUERSTEIN TJ, 1986, BRIT J PHARMACOL, V88, P677, DOI 10.1111/j.1476-5381.1986.tb10250.x; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Iravani MM, 1997, SYNAPSE, V25, P93; JACKSON BP, 1995, BRAIN RES, V674, P163, DOI 10.1016/0006-8993(95)00019-M; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Knobelman DA, 2000, J PHARMACOL EXP THER, V292, P1111; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Laasonen-Balk T, 1999, PSYCHOPHARMACOLOGY, V144, P282, DOI 10.1007/s002130051005; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McMahon LR, 2001, J NEUROSCI, V21, P7781, DOI 10.1523/JNEUROSCI.21-19-07781.2001; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Pickel VM, 1999, J NEUROSCI, V19, P7356, DOI 10.1523/JNEUROSCI.19-17-07356.1999; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; PRISTUPA ZB, 1994, MOL PHARMACOL, V45, P125; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Sesack SR, 1998, J NEUROSCI, V18, P2697; Sesack SR, 2002, HANDB EXP PHARM 1, P63; SHASKAN EG, 1970, J PHARMACOL EXP THER, V175, P404; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Smith TD, 2000, SYNAPSE, V38, P460, DOI 10.1002/1098-2396(20001215)38:4<460::AID-SYN11>3.0.CO;2-D; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; VANBOCKSTAELE EJ, 1993, J COMP NEUROL, V334, P603, DOI 10.1002/cne.903340408; WILLNER P, 2002, HANDB EXP PHARM 2, V154, P387; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Yelin Rodrigo, 2002, P313; Yuan J, 2002, J NEUROCHEM, V80, P960, DOI 10.1046/j.0022-3042.2002.00758.x; Zangen A, 2001, PSYCHOPHARMACOLOGY, V155, P434, DOI 10.1007/s002130100746; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	53	134	138	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					65	74		10.1016/j.neuron.2005.02.010	http://dx.doi.org/10.1016/j.neuron.2005.02.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820694	Bronze			2022-12-17	WOS:000228228600009
J	Hirono, M; Denis, CS; Richardson, GP; Gillespie, PG				Hirono, M; Denis, CS; Richardson, GP; Gillespie, PG			Hair cells require phosphatidylinositol 4,5-bisphosphate for mechanical transduction and adaptation	NEURON			English	Article							MYOSIN-I-BETA; BULLFROGS SACCULUS; MEMBRANE-PROTEINS; BINDING; PHOSPHOINOSITIDES; STEREOCILIA; MOTOR; PHOSPHATASE; CALMODULIN; DOMAINS	After opening in response to mechanical stimuli, hair cell transduction channels adapt with fast and slow mechanisms that each depend on Call. We demonstrate here that transduction and adaptation require phosphatidylinositol 4,5-bisphosphate (PIP2) for normal kinetics. PlP(2) has a striking distribution in hair cells, being excluded from the basal region of hair bundles and apical surfaces of frog saccular hair cells. Localization of a phosphatidylinositol lipid phosphatase, Ptprq, to these PlP(2)-free domains suggests that Ptprq maintains low PIP2 levels there. Depletion of PIP2 by inhibition of phosphatidylinositol 4-kinase or sequestration by aminoglycosides reduces the rates of fast and slow adaptation. PIP2 and other anionic phospholipids bind directly to the 10 domains of myosin-1c, the motor that mediates slow adaptation, permitting a strong interaction with membranes and likely regulating the motor's activity. PlP2 depletion also causes a loss in transduction current. PlP2 therefore plays an essential role in hair cell adaptation and transduction.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	Oregon Health & Science University; Oregon Health & Science University; University of Sussex	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gillespp@ohsu.edu		Barr-Gillespie, Peter/0000-0002-9787-5860; Hirono, Moritoshi/0000-0001-6068-1045	NIDCD NIH HHS [R01 DC004571, R01 DC002387, P30 DC005983] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC004571] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; AUGERT G, 1989, J BIOL CHEM, V264, P2574; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; CHOQUETTE D, 1984, BIOCHEM BIOPH RES CO, V125, P908, DOI 10.1016/0006-291X(84)91369-X; COCHET C, 1986, BIOCHEM J, V237, P25, DOI 10.1042/bj2370025; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gillespie PG, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-31; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; HILGEMANN DW, 2001, SCI STKE; Hinners I, 1999, ANAL BIOCHEM, V276, P1, DOI 10.1006/abio.1999.4325; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.bb.18.060189.000553; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; SCHAEFER T, 1994, ANN NY ACAD SCI, V710, P356, DOI 10.1111/j.1749-6632.1994.tb26642.x; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; TACHIBANA M, 1984, HISTOCHEMISTRY, V81, P157, DOI 10.1007/BF00490110; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Thomas CL, 1999, BIOCHEM SOC T, V27, P648, DOI 10.1042/bst0270648; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; WANG BM, 1984, BIOCHEM PHARMACOL, V33, P3257, DOI 10.1016/0006-2952(84)90087-X; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	54	134	138	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					309	320		10.1016/j.neuron.2004.09.020	http://dx.doi.org/10.1016/j.neuron.2004.09.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473969	Bronze			2022-12-17	WOS:000224635800013
J	Bentley, P; Husain, M; Dolan, RJ				Bentley, P; Husain, M; Dolan, RJ			Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory	NEURON			English	Article							ACETYLCHOLINE-RELEASE; SUSTAINED ATTENTION; CORTICAL ACETYLCHOLINE; ALZHEIMERS-DISEASE; TOP-DOWN; CORTEX; PERFORMANCE; SCOPOLAMINE; MODULATION; NICOTINE	We compared behavioral and neural effects of cholinergic enhancement between spatial attention, spatial working memory (WM), and visual control tasks, using fMRI and the anticholinesterase physostigmine. Physostigmine speeded responses nonselectively but increased accuracy selectively for attention. Physostigmine also decreased activations to visual stimulation across all tasks within primary visual cortex, increased extrastriate occipital cortex activation selectively during maintained attention and WM encoding, and decreased parietal activation selectively during maintained attention. Finally, lateralization of occipital activation as a function of the visual hemifield toward which attention or memory was directed was decreased under physostigmine. In the case of attention, this effect correlated strongly with a decrease in a behavioral measure of selective spatial processing. Our results suggest that, while cholinergic enhancement facilitates visual attention by increasing activity in extrastriate cortex generally, it accomplishes this in a manner that reduces expectation-driven selective biasing of extrastriate cortex.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Charing Cross Hosp, Dept Neurol, London W6 8RF, England; Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; Imperial College London; University of London; University College London	Bentley, P (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	p.bentley@fil.ion.ucl.ac.uk	Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Dolan, Ray/0000-0001-9356-761X; Bentley, Paul/0000-0001-8036-7010				Acquas E, 1996, J NEUROSCI, V16, P3089; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Baxter MG, 1996, NEUROREPORT, V7, P1417, DOI 10.1097/00001756-199605310-00019; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Berntson GG, 1998, BEHAV BRAIN RES, V94, P225, DOI 10.1016/S0166-4328(98)00041-2; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Chappell J, 1998, NEUROPHARMACOLOGY, V37, P481, DOI 10.1016/S0028-3908(98)00032-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; Davidson MC, 2000, J NEUROPHYSIOL, V83, P1536, DOI 10.1152/jn.2000.83.3.1536; Ernst M, 2001, NEUROPSYCHOPHARMACOL, V25, P313, DOI 10.1016/S0893-133X(01)00257-3; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Furey ML, 2000, PHARMACOL BIOCHEM BE, V66, P475, DOI 10.1016/S0091-3057(00)00186-6; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Glaser DE, 2001, NEUROIMAGE, V13, pS127; GRASBY PM, 1995, EXP BRAIN RES, V104, P337; Hasselmo ME, 1996, BEHAV BRAIN RES, V79, P153, DOI 10.1016/0166-4328(96)00010-1; Heishman SJ, 1994, EXP CLIN PSYCHOPHARM, V2, P345, DOI 10.1037/1064-1297.2.4.345; Herremans AHJ, 1996, BRAIN RES, V711, P102, DOI 10.1016/0006-8993(95)01404-7; Himmelheber AM, 2000, COGNITIVE BRAIN RES, V9, P313, DOI 10.1016/S0926-6410(00)00012-4; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MASH DC, 1988, J COMP NEUROL, V278, P265, DOI 10.1002/cne.902780209; McGaughy J, 1998, BEHAV NEUROSCI, V112, P1519, DOI 10.1037/0735-7044.112.6.1519; Mentis MJ, 2001, NEUROPSYCHOPHARMACOL, V25, P555, DOI 10.1016/S0893-133X(01)00264-0; MURPHY PC, 1991, NEUROSCIENCE, V40, P13, DOI 10.1016/0306-4522(91)90170-S; Park S, 2000, NEUROPSYCHOPHARMACOL, V22, P200, DOI 10.1016/S0893-133X(99)00098-6; Phillips JM, 2000, PSYCHOPHARMACOLOGY, V150, P112, DOI 10.1007/s002130000437; PHILLIS JW, 1965, NATURE, V207, P1253, DOI 10.1038/2071253a0; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Prusky G T, 1988, Brain Res, V467, P161; Robbins TW, 1998, ATTENTIVE BRAIN, P189; Robbins TW, 1997, PSYCHOPHARMACOLOGY, V134, P95, DOI 10.1007/s002130050430; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; RUSTED JM, 1988, PSYCHOPHARMACOLOGY, V96, P145; SAHAKIAN BJ, 1993, PSYCHOPHARMACOLOGY, V110, P395, DOI 10.1007/BF02244644; Sarter M, 2003, NEUROBIOL LEARN MEM, V80, P245, DOI 10.1016/S1074-7427(03)00070-4; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Stewart C, 2001, PSYCHOPHARMACOLOGY, V155, P210, DOI 10.1007/s002130100692; Thiel CM, 2002, EUR J NEUROSCI, V16, P2199, DOI 10.1046/j.1460-9568.2002.02272.x; Thiel CM, 2001, J NEUROSCI, V21, P6846, DOI 10.1523/JNEUROSCI.21-17-06846.2001; VOYTKO ML, 1994, J NEUROSCI, V14, P167; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	54	134	136	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 25	2004	41	6					969	982		10.1016/S0896-6273(04)00145-X	http://dx.doi.org/10.1016/S0896-6273(04)00145-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046728	Green Published, Bronze			2022-12-17	WOS:000221458300015
J	Kim, J; Ghosh, S; Nunziato, DA; Pitt, GS				Kim, J; Ghosh, S; Nunziato, DA; Pitt, GS			Identification of the components controlling inactivation of voltage-gated Ca2+ channels	NEURON			English	Article							EF-HAND MOTIF; CALCIUM-CHANNELS; CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; DEPENDENT INACTIVATION; CALMODULIN-BINDING; ALPHA(1C) SUBUNIT; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; DETERMINANTS	Ca2+-dependent inactivation (CDI) of L-type voltage-gated Ca2+ channels limits Ca2+ entry into neurons, thereby regulating numerous cellular events. Here we present the isolation and purification of the Ca2+-sensor complex, consisting of calmodulin (CaM) and part of the channel's pore-forming otic subunit, and demonstrate the Ca2+-dependent conformational shift that underlies inactivation. Dominant-negative CaM mutants that prevent CDI block the sensor's Ca2+-dependent conformational change. We show how IIe1654 in the CaM binding IQ motif of alpha(1c) forms the link between the Ca2+ sensor and the downstream inactivation machinery, using the alpha(1c) EF hand motif as a signal transducer to activate the putative pore-occluder, the alpha(1c) I-II intracellular linker.	Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, Div Cardiol, New York, NY 10032 USA	Columbia University; Columbia University	Pitt, GS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St,PH 7W 318, New York, NY 10032 USA.	gp2004@columbia.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	NHLBI NIH HHS [R01 HL071165-01, R01 HL071165-02, R01 HL071165-03, R01 HL71165, R01 HL071165] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071165] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams B, 1997, J GEN PHYSIOL, V110, P379, DOI 10.1085/jgp.110.4.379; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Ghosh S, 1996, GENE, V176, P249, DOI 10.1016/0378-1119(96)00260-0; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liddington RC, 2002, NATURE, V415, P373, DOI 10.1038/415373a; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	33	134	137	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					745	754		10.1016/S0896-6273(04)00081-9	http://dx.doi.org/10.1016/S0896-6273(04)00081-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003174	Bronze			2022-12-17	WOS:000221458200010
J	Myat, A; Henry, P; McCabe, V; Flintoft, L; Rotin, D; Tear, G				Myat, A; Henry, P; McCabe, V; Flintoft, L; Rotin, D; Tear, G			Drosophila Nedd4, a ubiquitin ligase, is recruited by commissureless to control cell surface levels of the roundabout receptor	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; AXON GUIDANCE; CNS MIDLINE; PROTEASOME PATHWAY; GENETIC-ANALYSIS; SYNAPTIC GROWTH; PROTEIN LIGASES; FLOOR PLATE; WW DOMAIN	Crossing the midline produces changes in axons such that they are no longer attracted to the midline. In Drosophila, Roundabout reaches high levels on axons once they have crossed the midline, and this prohibits recrossing. Roundabout protein levels are regulated by Commissureless. We show that Commissureless binds to and is regulated by the ubiquitin ligase DNedd4. We further show that the ability of Commissureless to regulate Roundabout protein levels requires an intact DNedd4 binding site and ubiquitin acceptor sites within the Commissureless protein. The ability of Commissureless to regulate Robo in the embryo also requires a Commissureless/DNedd4 interaction. Our results show that changes in axonal sensitivity to external cues during pathfinding across the midline makes use of ubiquitin-dependent mechanisms to regulate transmembrane protein levels.	Kings Coll London, MRC, Ctr Dev Neurobiol, Mol Neurobiol Grp, London SE1 1UL, England; Kings Coll London, MRC, Ctr Dev Neurobiol, Dept Dev Neurobiol, London SE1 1UL, England; Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of London; King's College London; University of London; King's College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tear, G (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Mol Neurobiol Grp, New Hunts House,Guys Campus, London SE1 1UL, England.	guy.tear@kcl.ac.uk	Tear, Guy/C-5444-2009	Tear, Guy/0000-0002-3114-7537				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Cornell M, 1999, GENETICS, V152, P567; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; OH CE, 1994, J NEUROSCI, V14, P3166; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Siegel S., 1988, NONPARAMETRIC STAT B, V2nd; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Tear G, 1999, CELL MOL LIFE SCI, V55, P1365, DOI 10.1007/s000180050377; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wolf B, 1998, DEVELOPMENT, V125, P3853; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	51	134	138	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					447	459		10.1016/S0896-6273(02)00795-X	http://dx.doi.org/10.1016/S0896-6273(02)00795-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165468	Bronze			2022-12-17	WOS:000177331200007
J	Chang, KT; Berg, DK				Chang, KT; Berg, DK			Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; TYROSINE-HYDROXYLASE; ALPHA-BUNGAROTOXIN; CALCIUM CHANNELS; OKADAIC ACID; C-FOS; PROTEIN; CA2+; TRANSCRIPTION; CIRCUITS	Synaptic activation of the transcription factor CREB and downstream gene expression usually depend on calcium influx aided by voltage-gated calcium channels. We find that nicotinic signaling, in contrast, activates CREB and gene expression in ciliary ganglion neurons both in culture and in situ only if voltage-gated channels are silent. The nicotinic response requires calcium influx and release from internal stores and acts through CaMK and MAPK pathways to sustain activated CREB. Voltage-gated channels mobilize CaMK to activate CREB initially, but they also enable calcineurin and PP1 to terminate the activation before transcription is affected. L-type voltage-gated channels dominate the outcome and block the effects of nicotinic signaling on transcription. This demonstrates a novel aspect of activity-dependent gene regulation.	Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, R01NS035469] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35469, NS12601] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberini CM, 1999, J EXP BIOL, V202, P2887; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Bansal A, 2000, J NEUROSCI, V20, P7672; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Blumenthal EM, 1999, J NEUROPHYSIOL, V81, P111, DOI 10.1152/jn.1999.81.1.111; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; CHALAZONITIS A, 1980, J PHYSIOL-LONDON, V300, P525, DOI 10.1113/jphysiol.1980.sp013177; Chang KT, 1999, J NEUROSCI, V19, P3701; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; FAUCONBIGUET N, 1989, NEUROSCI LETT, V104, P189; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greenberg ME, 2001, SYNAPSES, P357; Gueorguiev VD, 2000, J NEUROCHEM, V75, P1997, DOI 10.1046/j.1471-4159.2000.0751997.x; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Lein ES, 2000, J NEUROSCI, V20, P1470; Lena C, 1997, CURR OPIN NEUROBIOL, V7, P674, DOI 10.1016/S0959-4388(97)80088-8; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu YW, 1999, J GASTROINTEST SURG, V3, P82, DOI 10.1016/S1091-255X(99)80013-4; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Milner LD, 1999, J NEUROSCI, V19, P3007; Nagao M, 1995, MUTAT RES-FUND MOL M, V333, P173, DOI 10.1016/0027-5107(95)00143-3; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PELTOHUIKKO M, 1995, J NEUROSCI, V15, P1854, DOI 10.1523/JNEUROSCI.15-03-01854.1995; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Salminen O, 1999, J NEUROSCI, V19, P8145; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	51	134	136	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					855	865		10.1016/S0896-6273(01)00516-5	http://dx.doi.org/10.1016/S0896-6273(01)00516-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738031	Bronze			2022-12-17	WOS:000172700700012
J	Marsh-Armstrong, N; Huang, HC; Remo, BF; Liu, TT; Brown, DD				Marsh-Armstrong, N; Huang, HC; Remo, BF; Liu, TT; Brown, DD			Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase	NEURON			English	Article							IPSILATERAL RETINOTHALAMIC PROJECTION; GANGLION-CELLS; CLAWED FROG; THYROXINE; EXPRESSION; HORMONE; GENE; PROLIFERATION; RESORPTION; TADPOLE	During the metamorphosis of the Xenopus laevis retina, thyroid hormone (TH) preferentially induces ventral ciliary marginal zone (CMZ) cells to both increase their proliferation and give rise to ipsilaterally projecting ganglion cells. Here we show that dorsal CMZ cells express type ill deiodinase (D3), an enzyme that inactivates TH. The dorsal CMZ cells can be induced to proliferate if deiodinase activity is inhibited. D3 or dominant-negative thyroid hormone receptor transgenes inhibit both TH-induced proliferation of the ventral CMZ cells and the formation of the ipsilateral projection. Thus, the localized expression of D3 in the dorsal CMZ cells accounts for the asymmetric growth of the frog retina.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Marsh-Armstrong, N (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.							BEACH DH, 1979, J COMP NEUROL, V183, P615, DOI 10.1002/cne.901830309; BEACH DH, 1979, J COMP NEUROL, V183, P625, DOI 10.1002/cne.901830310; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; GALTON V, 1989, ENDOCRINOLOGY, V127, P1977; GALTON VA, 1989, ENDOCRINOLOGY, V124, P2427, DOI 10.1210/endo-124-5-2427; HOSKINS SG, 1985, J NEUROSCI, V5, P930; HOSKINS SG, 1985, J NEUROSCI, V5, P911; HOSKINS SG, 1985, J NEUROSCI, V5, P920; HOSKINS SG, 1990, J NEUROBIOL, V21, P970, DOI 10.1002/neu.480210704; HOSKINS SG, 1984, NATURE, V307, P730, DOI 10.1038/307730a0; HOSKINS SG, 1986, J NEUROBIOL, V17, P203, DOI 10.1002/neu.480170306; Huang HC, 1999, P NATL ACAD SCI USA, V96, P962, DOI 10.1073/pnas.96.3.962; KENNARD C, 1981, J EMBRYOL EXP MORPH, V65, P199; Kroll KL, 1996, DEVELOPMENT, V122, P3173; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; SCHUTTE M, 1993, J COMP NEUROL, V331, P482, DOI 10.1002/cne.903310405; STEEDMAN JG, 1979, J EMBRYOL EXP MORPH, V50, P199; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P11282; TAY D, 1982, ANAT EMBRYOL, V164, P75, DOI 10.1007/BF00301880; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; WANG Z, 1991, P NATL ACAD SCI USA, V88, P11505, DOI 10.1073/pnas.88.24.11505; WANG Z, 1993, J BIOL CHEM, V268, P16270	28	134	136	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					871	878		10.1016/S0896-6273(00)81034-X	http://dx.doi.org/10.1016/S0896-6273(00)81034-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624950	Bronze			2022-12-17	WOS:000084495300015
J	Eden, GF; Zeffiro, TA				Eden, GF; Zeffiro, TA			Neural systems affected in developmental dyslexia revealed by functional neuroimaging	NEURON			English	Review							BRAIN; PET		Georgetown Univ, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA	Georgetown University	Eden, GF (corresponding author), Georgetown Univ, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA.		Zeffiro, Thomas/AAE-3441-2019	Zeffiro, Thomas/0000-0002-0846-4577				BOWERS PG, 1993, READ WRIT, V5, P69, DOI 10.1007/BF01026919; DEMB J, 1998, IN PRESS J NEUROSCI; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Heilman KM, 1996, ANN NEUROL, V39, P407, DOI 10.1002/ana.410390323; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; HULME C, 1995, J CHILD PSYCHOL PSYC, V36, P373, DOI 10.1111/j.1469-7610.1995.tb01297.x; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; LOVEGROVE W, 1993, ANN NY ACAD SCI, V682, P57, DOI 10.1111/j.1749-6632.1993.tb22959.x; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Poeppel D, 1996, BRAIN LANG, V55, P317, DOI 10.1006/brln.1996.0108; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WOLFF PH, 1984, NEUROPSYCHOLOGIA, V22, P587, DOI 10.1016/0028-3932(84)90023-X; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	17	134	134	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					279	282		10.1016/S0896-6273(00)80537-1	http://dx.doi.org/10.1016/S0896-6273(00)80537-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728909	hybrid			2022-12-17	WOS:000075598300005
J	Cochilla, AJ; Alford, S				Cochilla, AJ; Alford, S			Metabotropic glutamate receptor-mediated control of neurotransmitter release	NEURON			English	Article							PRESYNAPTIC NERVE-TERMINALS; SYNAPTIC TRANSMISSION; CALCIUM CHANNELS; NEURONS; LAMPREY; CELLS; HIPPOCAMPUS; ACTIVATION; INHIBITION; COMPONENT	Presynaptic metabotropic glutamate receptors (mGluRs) modulate the release of transmitter from most central synapses. However, difficulties in recording from presynaptic structures has lead to an incomplete understanding of the mechanisms underlying these fundamental processes. By recording directly from presynaptic reticulospinal axons and postsynaptic motoneurons of the lamprey spinal cord, we have obtained electrophysiological and optical evidence that vertebrate presynaptic metabotropic glutamate receptors modulate neurotransmitter release at this synapse through two distinct mechanisms: (1) mGluR activation in the presynaptic terminal depresses transmitter release by activating a presynaptic K+ current, and (2) mGluR activation enhances transmitter release by amplifying the action potential-evoked presynaptic Ca2+ signal by rapidly releasing Ca2+ from intracellular stores in a Ca2+-dependent manner. Furthermore, this effect is mediated by physiological release of glutamate from the presynaptic terminals. These autoreceptor-mediated processes are likely to generate complex effects on transmitter release evoked by repetitive stimulation.	Northwestern Univ, Sch Med, Dept Physiol, Inst Neurosci, Chicago, IL 60611 USA	Northwestern University	Alford, S (corresponding author), Northwestern Univ, Sch Med, Dept Physiol, Inst Neurosci, Chicago, IL 60611 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Alford, Simon/0000-0002-0454-4246				ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; Annoura H, 1996, BIOORG MED CHEM LETT, V6, P763, DOI 10.1016/0960-894X(96)00104-7; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; CHAVIS P, 1995, J NEUROSCI, V15, P135; Cochilla AJ, 1997, J PHYSIOL-LONDON, V499, P443, DOI 10.1113/jphysiol.1997.sp021940; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; HERRERO I, 1992, NATURE, V360, P163, DOI 10.1038/360163a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Krieger P, 1996, J NEUROPHYSIOL, V76, P3834, DOI 10.1152/jn.1996.76.6.3834; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; Liou HC, 1996, NEUROSCIENCE, V75, P325, DOI 10.1016/0306-4522(96)00280-1; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Morishige K, 1996, BIOCHEM BIOPH RES CO, V220, P300, DOI 10.1006/bbrc.1996.0400; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Peng YY, 1996, J NEUROSCI, V16, P6703; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; RINGHAM GL, 1975, J PHYSIOL-LONDON, V251, P395, DOI 10.1113/jphysiol.1975.sp011100; Saugstad JA, 1996, J NEUROSCI, V16, P5979; SAYER RJ, 1992, J NEUROPHYSIOL, V68, P833, DOI 10.1152/jn.1992.68.3.833; SCANZIANI M, 1995, NEUROPHARMACOLOGY, V34, P1549, DOI 10.1016/0028-3908(95)00119-Q; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; WICKELGREN WO, 1977, J PHYSIOL-LONDON, V270, P89, DOI 10.1113/jphysiol.1977.sp011940; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	35	134	138	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1998	20	5					1007	1016		10.1016/S0896-6273(00)80481-X	http://dx.doi.org/10.1016/S0896-6273(00)80481-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620704	Bronze			2022-12-17	WOS:000073864700019
J	Maina, F; Hilton, MC; Andres, R; Wyatt, S; Klein, R; Davies, AM				Maina, F; Hilton, MC; Andres, R; Wyatt, S; Klein, R; Davies, AM			Multiple roles for hepatocyte growth factor in sympathetic neuron development	NEURON			English	Article							FACTOR-SCATTER FACTOR; CENTRAL-NERVOUS-SYSTEM; C-MET; PRECURSOR CELLS; SENSORY NEURONS; RECEPTOR GENE; IN-VIVO; SURVIVAL; DIFFERENTIATION; NEUROTROPHIN-3	We have studied the role of hepatocyte growth factor (HGF)/Met signaling in the development of sympathetic neuroblasts and neurons. Anti-HGF antibodies reduced the number of sympathetic neuroblasts that differentiated into neurons, but neither anti-HGF antibodies nor HGF affected neuroblast proliferation. Anti-HGF antibodies also reduced the survival of neuroblasts but not sympathetic neurons. HGF greatly enhanced the neurite outgrowth of NGF-dependent sympathetic neurons throughout development. These in vitro effects of anti-HGF antibodies and HGF were abolished by a disabling mutation of Met, the HGF receptor tyrosine kinase. The Met mutation also increased sympathetic neuroblast apoptosis in vivo. Because Met and HGF are expressed in sympathetic ganglia throughout development, it is possible that the multiple effects of HGF/Met signaling on sympathetic neuroblasts and neurons occur in part by an autocrine mechanism.	Univ St Andrews, Sch Biol & Med Sci, St Andrews KY16 9TS, Fife, Scotland; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of St Andrews; European Molecular Biology Laboratory (EMBL)	Davies, AM (corresponding author), Univ St Andrews, Sch Biol & Med Sci, St Andrews KY16 9TS, Fife, Scotland.		Davies, Alun M/A-4334-2010; Andres, Rosa/A-7236-2012; Maina, Flavio/J-9962-2019; Klein, Ruediger/C-6147-2008; Wyatt, Sean/A-5266-2010	Davies, Alun M/0000-0001-5841-8176; Maina, Flavio/0000-0001-6100-4695; Klein, Ruediger/0000-0002-3109-0163; Wyatt, Sean/0000-0002-0572-234X; Andres, Rosa/0000-0002-6818-5203	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Andermarcher E, 1996, DEV GENET, V18, P254, DOI 10.1002/(SICI)1520-6408(1996)18:3<254::AID-DVG6>3.0.CO;2-8; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BRINKMANN V, 1995, J CELL BIOL, V131, P1573, DOI 10.1083/jcb.131.6.1573; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHEN AM, 1974, WENN CTR INT S SER D; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Davies AM, 1997, CURR OPIN NEUROBIOL, V7, P110, DOI 10.1016/S0959-4388(97)80128-6; DAVIES AM, 1989, NATURE, V337, P553, DOI 10.1038/337553a0; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; Fagan AM, 1996, J NEUROSCI, V16, P6208; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227; Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H; Hilton M, 1997, CURR BIOL, V7, P798, DOI 10.1016/S0960-9822(06)00339-3; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; Pinon LGP, 1996, DEVELOPMENT, V122, P3255; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROTHMAN TP, 1980, P NATL ACAD SCI-BIOL, V77, P6221, DOI 10.1073/pnas.77.10.6221; ROTHMAN TP, 1978, DEV BIOL, V65, P322, DOI 10.1016/0012-1606(78)90030-1; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wong VV, 1997, J BIOL CHEM, V272, P5187, DOI 10.1074/jbc.272.8.5187; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Yamamoto Y, 1997, DEVELOPMENT, V124, P2903; ZHOU XF, 1995, J NEUROSCI, V15, P6521	44	134	139	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					835	846		10.1016/S0896-6273(00)80466-3	http://dx.doi.org/10.1016/S0896-6273(00)80466-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620689	Bronze			2022-12-17	WOS:000073864700004
J	Kaech, S; Ludin, B; Matus, A				Kaech, S; Ludin, B; Matus, A			Cytoskeletal plasticity in cells expressing neuronal microtubule-associated proteins	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; REAL-TIME OBSERVATIONS; DYNAMIC INSTABILITY; LIVING CELLS; TAU-PROTEIN; POSTTRANSLATIONAL MODIFICATION; NONNEURONAL CELLS; CORTICAL-NEURONS; BINDING MOTIF; GROWTH CONES	MAP2 and tau are the two most prominent neuron-specific microtubule-associated proteins. They have been implicated in the stabilization of microtubules and consequently of neurite morphology. To investigate their influence on microtubule dynamics, we have tagged both proteins with green fluorescent protein and expressed them in non-neuronal cells. Time-lapse recordings of living cells showed that MAP2 and tau did not significantly affect the rates of microtubule growth and shrinkage. Longer recordings revealed the growth and disappearance of MAP-induced microtubule bundles coinciding with changes in cell shape. This supports the idea that microtubule dynamics are influenced by the cortical cytoskeleton. The dynamics-preserving stabilization of microtubules by MAP2 and tau thus provides a molecular basis for the morphological plasticity reported to exist in established neurites.			Kaech, S (corresponding author), FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND.			Kaech Petrie, Stefanie/0000-0002-6246-6434				AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; BURTON PR, 1987, BRAIN RES, V409, P71, DOI 10.1016/0006-8993(87)90742-6; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CUMMING R, 1984, J CELL BIOL, V98, P347, DOI 10.1083/jcb.98.1.347; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOLL T, 1993, J CELL SCI, V106, P633; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DYE RB, 1993, J BIOL CHEM, V268, P6847; EDSON K, 1993, DEVELOPMENT, V117, P689; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; HARRISON RG, 1910, J EXP ZOOL, V17, P521; HEIDEMANN SR, 1990, CELL MOTIL CYTOSKEL, V17, P6, DOI 10.1002/cm.970170103; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279, DOI 10.1247/csf.19.279; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; LEE G, 1992, J CELL SCI, V102, P227; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; LUBYPHELPS K, 1988, CELL MOTIL CYTOSKEL, V10, P28, DOI 10.1002/cm.970100107; Ludin B, 1996, GENE, V173, P107, DOI 10.1016/0378-1119(95)00899-3; Ludin B, 1996, J CELL SCI, V109, P91; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; PRYER NK, 1992, J CELL SCI, V103, P965; Ramon y Cajal S, 1960, STUDIES VERTEBRATE N; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SAMMAK PJ, 1988, CELL MOTIL CYTOSKEL, V10, P237, DOI 10.1002/cm.970100128; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SHARMA N, 1994, CELL MOTIL CYTOSKEL, V27, P234, DOI 10.1002/cm.970270305; Sharp DJ, 1996, J NEUROSCI, V16, P4370; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; TAKEMURA R, 1992, J CELL SCI, V103, P953; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; WEEKS PRG, 1991, BIOESSAYS, V13, P235; WEEKS PRG, 1989, DEV BRAIN RES, V49, P305; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WEISSHAAR B, 1992, DEVELOPMENT, V116, P1151; Wordeman Linda, 1994, V13, P287	66	134	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1189	1199		10.1016/S0896-6273(00)80249-4	http://dx.doi.org/10.1016/S0896-6273(00)80249-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982165	Bronze			2022-12-17	WOS:A1996WA24800015
J	RACE, RE; PRIOLA, SA; BESSEN, RA; ERNST, D; DOCKTER, J; RALL, GF; MUCKE, L; CHESEBRO, B; OLDSTONE, MBA				RACE, RE; PRIOLA, SA; BESSEN, RA; ERNST, D; DOCKTER, J; RALL, GF; MUCKE, L; CHESEBRO, B; OLDSTONE, MBA			NEURON-SPECIFIC EXPRESSION OF A HAMSTER PRION PROTEIN MINIGENE IN TRANSGENIC MICE INDUCES SUSCEPTIBILITY TO HAMSTER SCRAPIE AGENT	NEURON			English	Article							CREUTZFELDT-JAKOB-DISEASE; GERSTMANN-STRAUSSLER SYNDROME; INCUBATION PERIOD; ABNORMAL ISOFORM; CULTURED-CELLS; MESSENGER-RNA; PRP GENE; LINKAGE; INFECTIVITY; MUTATION	To study the effect of cell type-restricted hamster PrP expression on susceptibility to the hamster scrapie agent, we generated transgenic mice using al kb hamster cDNA clone containing the 0.76 kb HPrP open reading frame under control of the neuron-specific enolase promoter. In these mice, expression of HPrP was detected only in brain tissue, with highest levels found in neurons of the cerebellum, hippocampus, thalamus, and cerebral cortex. These transgenic mice were susceptible to infection by the 263K strain of hamster scrapie with an average incubation period of 93 days, compared to 72 days in normal hamsters. In contrast, nontransgenic mice were not susceptible to this agent. These results indicate that neuron-specific expression of the 1 kb HPrP minigene including the HPrP open-reading frame is sufficient to mediate susceptibility to hamster scrapie, and that HPrP expression in nonneuronal brain cells is not necessary to overcome the TSE species barrier.	SCRIPPS RES INST, LA JOLLA, CA 92037 USA	Scripps Research Institute	RACE, RE (corresponding author), NIAID, ROCKY MT LABS, PERSISTENT VIRAL DIS LAB, HAMILTON, MT 59840 USA.			Mucke, Lennart/0000-0001-6256-9559; Rall, Glenn/0000-0003-2717-3238				ALPER T, 1978, J GEN VIROL, V41, P503, DOI 10.1099/0022-1317-41-3-503; BELLINGERKAWAHARA C, 1987, VIROLOGY, V160, P271, DOI 10.1016/0042-6822(87)90072-9; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; BROWN HR, 1990, ACTA NEUROPATHOL, V80, P1, DOI 10.1007/BF00294214; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CARP RI, 1986, INTERVIROLOGY, V26, P85, DOI 10.1159/000149685; CAUGHEY B, 1988, J GEN VIROL, V69, P711, DOI 10.1099/0022-1317-69-3-711; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; DEARMOND SJ, 1992, E H S NEURO, P483; DEES C, 1985, J GEN VIROL, V66, P845, DOI 10.1099/0022-1317-66-4-845; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GOLDFARB LG, 1990, LANCET, V336, P174, DOI 10.1016/0140-6736(90)91693-5; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; HUNTER GD, 1979, SLOW TRANSMISSIBLE D, V2, P365; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; HUNTER N, 1989, VET REC, V124, P364, DOI 10.1136/vr.124.14.364; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; MANSON J, 1992, DEVELOPMENT, V115, P117; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MARSH RF, 1975, J INFECT DIS, V131, P104, DOI 10.1093/infdis/131.2.104; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; MURAMOTO T, 1993, J VIROL, V67, P6808, DOI 10.1128/JVI.67.11.6808-6810.1993; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; RACE RE, 1992, J GEN VIROL, V73, P3319, DOI 10.1099/0022-1317-73-12-3319; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1990, J GEN VIROL, V71, P493, DOI 10.1099/0022-1317-71-2-493; RALL GF, 1994, J NEUROIMMUNOL, V52, P61, DOI 10.1016/0165-5728(94)90163-5; RALL GF, 1995, IN PRESS J EXP MED; ROBAKIS NK, 1986, P NATL ACAD SCI USA, V83, P6377, DOI 10.1073/pnas.83.17.6377; ROBAKIS NK, 1986, BIOCHEM BIOPH RES CO, V140, P758, DOI 10.1016/0006-291X(86)90796-5; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; WESTAWAY D, 1991, NEURON, V7, P59, DOI 10.1016/0896-6273(91)90074-A; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Winterwerp v The Netherlands, 1979, BAILLI ECHR 1979 2 E	61	134	135	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV	1995	15	5					1183	1191		10.1016/0896-6273(95)90105-1	http://dx.doi.org/10.1016/0896-6273(95)90105-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TF887	7576660	Green Published, Bronze			2022-12-17	WOS:A1995TF88700022
J	SULLIVAN, SL; BOHM, S; RESSLER, KJ; HOROWITZ, LF; BUCK, LB				SULLIVAN, SL; BOHM, S; RESSLER, KJ; HOROWITZ, LF; BUCK, LB			TARGET-INDEPENDENT PATTERN SPECIFICATION IN THE OLFACTORY EPITHELIUM	NEURON			English	Article							EARLY NEURON DIFFERENTIATION; ODORANT RECEPTOR EXPRESSION; MARKER PROTEIN; ELECTRON-MICROSCOPY; SIGNAL TRANSDUCTION; SYNAPSE FORMATION; LIGHT-MICROSCOPY; SENSORY NEURONS; BULB; MOUSE	In mammals, odors are detected by similar to 1000 different types of odorant receptors (ORs), each expressed by a fraction of neurons in the olfactory epithelium. Neurons expressing a given OR are confined to one of four spatial zones but are distributed randomly throughout that zone. In the olfactory bulb, the axons of neurons expressing different ORs synapse at different sites, giving rise to a highly organized and stereotyped information map. An important issue is whether the epithelial and bulbar maps evolve independently or are linked, for example, by retrograde influences of the bulb on the epithelium. Here we examined the onset of expression and patterning of genes encoding ORs and sensory transduction molecules during mouse embryogenesis and in mice lacking olfactory bulbs. Our results argue for an independent development of epithelial and bulbar maps and an early functional development that may be pertinent to pattern development in the olfactory bulb.			SULLIVAN, SL (corresponding author), HARVARD UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT NEUROBIOL, BOSTON, MA 02115 USA.		Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001662, F32DC000188] Funding Source: NIH RePORTER; NIDCD NIH HHS [1-RO1-DC01662, 5-F32-DC00188-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], [No title captured]; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BRUNJES PC, 1986, BRAIN RES REV, V11, P1, DOI 10.1016/0165-0173(86)90008-1; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1992, CURR OPIN GENET DEV, V2, P467, DOI 10.1016/S0959-437X(05)80159-5; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CLARK WL, 1957, PROC R SOC SER B-BIO, V146, P299, DOI 10.1098/rspb.1957.0013; COSTANZO RM, 1978, BRAIN RES, V139, P327, DOI 10.1016/0006-8993(78)90932-0; CUSCHIERI A, 1975, J ANAT, V119, P277; CUSCHIERI A, 1975, J ANAT, V119, P471; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Farbman Albert I., 1994, Seminars in Cell Biology, V5, P3; FRANZ T, 1994, ACTA ANAT, V150, P38; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRAZIADEI GAM, 1983, BRAIN RES, V262, P303; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GRAZIADEI PPC, 1986, NEUROSCIENCE, V19, P1025, DOI 10.1016/0306-4522(86)90119-3; GREER CA, 1981, BRAIN RES, V217, P279, DOI 10.1016/0006-8993(81)90004-4; HEPPER PG, 1988, ANIM BEHAV, V36, P935, DOI 10.1016/S0003-3472(88)80177-5; HINDS JW, 1972, J COMP NEUROL, V146, P253, DOI 10.1002/cne.901460208; HINDS JW, 1972, J COMP NEUROL, V146, P233, DOI 10.1002/cne.901460207; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kauer J.S., 1987, P205; Kaufman M.H., 1992, ATLAS MOUSE DEV; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; LAND LJ, 1973, BRAIN RES, V63, P153, DOI 10.1016/0006-8993(73)90084-X; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LEWIN B, 1994, CELL, V79, P935, DOI 10.1016/0092-8674(94)90025-6; MARGALIT T, 1993, DEV BRAIN RES, V73, P7, DOI 10.1016/0165-3806(93)90040-H; MENCO BPM, 1994, J NEUROCYTOL, V23, P708, DOI 10.1007/BF01181645; MONTIGRAZIADEI GA, 1980, NEUROSCIENCE, V5, P1239; MORI K, 1993, MICROSC RES TECHNIQ, V24, P131, DOI 10.1002/jemt.1070240205; MOULTON DG, 1974, ANN NY ACAD SCI, V237, P52, DOI 10.1111/j.1749-6632.1974.tb49843.x; NARUSE I, 1990, DEV BRAIN RES, V51, P253, DOI 10.1016/0165-3806(90)90283-5; NARUSE I, 1993, DEV BRAIN RES, V71, P69, DOI 10.1016/0165-3806(93)90106-K; NARUSE I, 1994, DEV BRAIN RES, V81, P178, DOI 10.1016/0165-3806(94)90304-2; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; POMEROY SL, 1990, J NEUROSCI, V10, P1952; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; Reed Randall R., 1994, Seminars in Cell Biology, V5, P33, DOI 10.1006/scel.1994.1005; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SAUCIER D, 1986, BRAIN RES BULL, V16, P455, DOI 10.1016/0361-9230(86)90173-5; SCHAAL B, 1992, Q J EXP PSYCHOL-B, V44B, P245; SCHIMMANG T, 1994, MAMM GENOME, V5, P384, DOI 10.1007/BF00356560; SCHOENFELD TA, 1994, BRAIN RES BULL, V34, P183, DOI 10.1016/0361-9230(94)90059-0; SCHWANZELFUKUDA M, 1992, J COMP NEUROL, V321, P1, DOI 10.1002/cne.903210102; SCHWARTING GA, 1991, BRAIN RES, V547, P239, DOI 10.1016/0006-8993(91)90967-Z; Schwob J, 1992, SCI OLFACTION, P80; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; SCHWOB JE, 1986, J NEUROSCI, V6, P3393; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Shepherd G. M., 1990, SYNAPTIC ORG BRAIN, P133; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; STEWART WB, 1987, BRAIN RES, V411, P248, DOI 10.1016/0006-8993(87)91076-6; STICKROD G, 1982, PHYSIOL BEHAV, V28, P5, DOI 10.1016/0031-9384(82)90093-2; STROTMANN J, 1995, EUR J NEUROSCI, V7, P492, DOI 10.1111/j.1460-9568.1995.tb00345.x; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; THEILER K, 1989, HOUSE MOUSE; VALVERDE F, 1993, DEV BRAIN RES, V71, P209, DOI 10.1016/0165-3806(93)90173-8; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M	78	134	135	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1995	15	4					779	789		10.1016/0896-6273(95)90170-1	http://dx.doi.org/10.1016/0896-6273(95)90170-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TC640	7576628	Bronze			2022-12-17	WOS:A1995TC64000008
J	HUA, SY; TOKIMASA, T; TAKASAWA, S; FURUYA, Y; NOHMI, M; OKAMOTO, H; KUBA, K				HUA, SY; TOKIMASA, T; TAKASAWA, S; FURUYA, Y; NOHMI, M; OKAMOTO, H; KUBA, K			CYCLIC ADP-RIBOSE MODULATES CA2+ RELEASE CHANNELS FOR ACTIVATION BY PHYSIOLOGICAL CA2+ ENTRY IN BULLFROG SYMPATHETIC NEURONS	NEURON			English	Article							FREE CALCIUM-CONCENTRATION; ROOT GANGLION NEURONS; CELLS; CAFFEINE; OSCILLATION; AFTERHYPERPOLARIZATION; CONDUCTANCE; GENERATION; HYDROLYSIS; DYNAMICS	Although Ca2+-induced Ca2+ release (CICR) via ryanodine receptors has been found to occur in intact neurons, little is known about the physiological processes that regulate it. We studied the effects of cyclic ADP-ribose (cADPR) on CICR in cultured bullfrog sympathetic neurons by fura-2 fluorescence recording and patch-clamp techniques. cADPR applied through a patch pipette augmented action potential- or depolarizing pulse-induced rises in intracellular Ca2+ without a change in Ca2+ entry initiating the responses, but not in the presence of ryanodine. Likewise, cADPR enhanced a single or oscillatory rise(s) in intracellular Ca2+ induced by caffeine. These results strongly suggest that cADPR tan be an endogenous modulator of ryanodine receptors in neurons.	SAGA MED SCH,CENT LABS MSRE,SAGA 849,JAPAN; KURUME UNIV,SCH MED,DEPT PHYSIOL,KURUME,FUKUOKA 830,JAPAN; TOHOKU UNIV,SCH MED,DEPT BIOCHEM,SENDAI,MIYAGI 98077,JAPAN	Saga University; Kurume University; Tohoku University	HUA, SY (corresponding author), SAGA MED SCH,DEPT PHYSIOL,SAGA 849,JAPAN.							BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; CURRIE KPM, 1992, MOL BIOL CELL, V3, P1415, DOI 10.1091/mbc.3.12.1415; ENDO M, 1970, NATURE, V249, P469; FORD LE, 1970, SCIENCE, V167, P58, DOI 10.1126/science.167.3914.58; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUA SY, 1993, J PHYSIOL-LONDON, V464, P245, DOI 10.1113/jphysiol.1993.sp019633; JASSAR BS, 1991, PFLUG ARCH EUR J PHY, V419, P478, DOI 10.1007/BF00370792; KOSHIYAMA H, 1991, J BIOL CHEM, V266, P16985; KUBA K, 1992, CAN J PHYSIOL PHARM, V70, pS64, DOI 10.1139/y92-245; KUBA K, 1983, PFLUG ARCH EUR J PHY, V399, P194, DOI 10.1007/BF00656714; KUBA K, 1981, J THEOR BIOL, V93, P1009, DOI 10.1016/0022-5193(81)90352-0; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; KUBA K, 1976, J NEUROPHYSIOL, V39, P547, DOI 10.1152/jn.1976.39.3.547; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1993, J BIOL CHEM, V268, P293; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LOPEZ HS, 1992, NEURON, V8, P725, DOI 10.1016/0896-6273(92)90093-S; MARION MNV, 1992, J PHYSL, V445, P515; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; MORITA K, 1980, NATURE, V283, P204, DOI 10.1038/283204a0; NOHMI M, 1992, J PHYSIOL-LONDON, V450, P513, DOI 10.1113/jphysiol.1992.sp019140; NOHMI M, 1992, J PHYSIOL-LONDON, V458, P171, DOI 10.1113/jphysiol.1992.sp019412; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; THAYER SA, 1988, MOL PHARMACOL, V34, P664; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; WALSETH TF, 1993, J BIOL CHEM, V268, P26686; WHITE AM, 1993, FEBS LETT, V318, P259, DOI 10.1016/0014-5793(93)80524-X	36	134	135	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1073	1079		10.1016/0896-6273(94)90315-8	http://dx.doi.org/10.1016/0896-6273(94)90315-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185944				2022-12-17	WOS:A1994NM83100011
J	KSIEZAKREDING, H; YEN, SH				KSIEZAKREDING, H; YEN, SH			STRUCTURAL STABILITY OF PAIRED HELICAL FILAMENTS REQUIRES MICROTUBULE-BINDING DOMAINS OF TAU - A MODEL FOR SELF-ASSOCIATION	NEURON			English	Article							ALZHEIMERS-DISEASE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; ABNORMAL PHOSPHORYLATION; ANTIGENIC DETERMINANTS; NERVOUS-SYSTEM; EPITOPES; LOCALIZATION; SOLUBILITY; COMPONENT	Highly purified and SDS-soluble paired helical filaments (PHFs) were immunogold labeled and immunoblotted with antibodies to tau: Tau 14 (N-terminal half), AH-1 (microtubule-binding domain), and Tau 46 (C-terminal end). The main component of PHFs was modified tau of 68, 64, and 60 kd, also called A68 or PHF-tau. Trypsin digestion reduced the maximum width of PHFs by 10%-20%, increased aggregation of filaments, and abolished the binding of Tau 14, but had no effect on the binding of AH-1. The smallest tau-reactive tryptic fragments were 13 and 7-8 kd, positive with AH-1, and negative with Tau 46. Our results and the model of Crowther and Wischik suggest that by self-association and anti-parallel arrangement of the microtubule-binding domains, PHF-tau forms the backbone of PHFs.			KSIEZAKREDING, H (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10461, USA.				NATIONAL INSTITUTE ON AGING [P01AG006803, R01AG004145, R37AG001136, R01AG001136] Funding Source: NIH RePORTER; NIA NIH HHS [AG4145, AG1136, AG06803] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BONDAREFF W, 1990, AM J PATHOL, V137, P711; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; CROWTHER RA, 1985, EMBO J, V4, P3661, DOI 10.1002/j.1460-2075.1985.tb04132.x; CROWTHER T, 1989, ANN MED, V21, P127, DOI 10.3109/07853898909149199; DEGARCINI EM, 1987, J BIOCHEM-TOKYO, V102, P1415, DOI 10.1093/oxfordjournals.jbchem.a122187; DICKSON DW, 1987, ALTERATIONS NEURONAL, P165; FLAMENT S, 1989, CR ACAD SCI III-VIE, V308, P77; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; IQBAL K, 1984, ACTA NEUROPATHOL, V62, P167, DOI 10.1007/BF00691849; IQBAL K, 1986, LIFE SCI, V38, P1695, DOI 10.1016/0024-3205(86)90414-5; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P420, DOI 10.1002/jnr.490250320; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P412, DOI 10.1002/jnr.490250319; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7943; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTENBERG B, 1988, NATURE, V334, P359, DOI 10.1038/334359a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NIETO A, 1988, BIOCHEM BIOPH RES CO, V154, P660, DOI 10.1016/0006-291X(88)90190-8; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; RUBENSTEIN R, 1986, BRAIN RES, V372, P80, DOI 10.1016/0006-8993(86)91460-5; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; VOGELSANG GD, 1990, J NEUROCHEM, V54, P148, DOI 10.1111/j.1471-4159.1990.tb13295.x; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WISNIEWSKI HM, 1987, NEUROCHEM RES, V12, P93, DOI 10.1007/BF00971370; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YEN SH, 1987, AM J PATHOL, V126, P81; YEN SH, 1991, IN PRESS NIIGATA INT; YEN SH, 1983, BANBURY REPORT, V15, P155	45	134	140	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					717	728		10.1016/0896-6273(91)90169-Z	http://dx.doi.org/10.1016/0896-6273(91)90169-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1709023				2022-12-17	WOS:A1991FM52200005
J	ABELE, AE; SCHOLZ, KP; SCHOLZ, WK; MILLER, RJ				ABELE, AE; SCHOLZ, KP; SCHOLZ, WK; MILLER, RJ			EXCITOTOXICITY INDUCED BY ENHANCED EXCITATORY NEUROTRANSMISSION IN CULTURED HIPPOCAMPAL PYRAMIDAL NEURONS	NEURON			English	Article											ABELE, AE (corresponding author), UNIV CHICAGO, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA.		Abele, Andrea E./AFL-3996-2022	Abele, Andrea E./0000-0002-0237-8774	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040165, R37MH040165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002575, R01DA002121] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-02121, DA-02575] Funding Source: Medline; NIMH NIH HHS [MH-40165] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P357; COLMERS WF, 1988, J NEUROSCI, V8, P3827; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; FREDHOLM BB, 1989, EUR J PHARM-MOLEC PH, V172, P249, DOI 10.1016/0922-4106(89)90055-2; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1988, NEUROSCI LETT, V85, P105, DOI 10.1016/0304-3940(88)90437-5; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1990, IN PRESS TRENDS PHAR; MURPHY SN, 1989, J PHARMACOL EXP THER, V249, P184; MURPHY SN, 1987, J NEUROSCI, V7, P4145; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; NICHOLLS DG, 1989, J NEUROCHEM, V52, P331, DOI 10.1111/j.1471-4159.1989.tb09126.x; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; Olney J W, 1986, Adv Exp Med Biol, V203, P631; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SANCHEZPRIETO J, 1988, J NEUROCHEM, V50, P1322, DOI 10.1111/j.1471-4159.1988.tb10611.x; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SIESJO BK, 1988, ANN NY ACAD SCI, V522, P638; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; THAYER SA, 1988, PFLUG ARCH EUR J PHY, V412, P216, DOI 10.1007/BF00583753; THAYER SA, 1990, IN PRESS J PHYSL	35	134	135	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1990	4	3					413	419		10.1016/0896-6273(90)90053-I	http://dx.doi.org/10.1016/0896-6273(90)90053-I			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690567				2022-12-17	WOS:A1990CX03200009
J	BOBKER, DH; WILLIAMS, JT				BOBKER, DH; WILLIAMS, JT			SEROTONIN AUGMENTS THE CATIONIC CURRENT IH IN CENTRAL NEURONS	NEURON			English	Article											BOBKER, DH (corresponding author), OREGON REG PRIMATE RES CTR,VOLLUM INST,BEAVERTON,OR 97006, USA.				NHLBI NIH HHS [HL 07596] Funding Source: Medline; NIDA NIH HHS [DA 04523] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004523] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; BADER CR, 1984, J PHYSIOL-LONDON, V347, P611, DOI 10.1113/jphysiol.1984.sp015086; BENHAM CD, 1987, J PHYSIOL-LONDON, V383, P461; BOUHELAL R, 1988, EUR J PHARMACOL, V151, P189, DOI 10.1016/0014-2999(88)90799-6; BROWN H, 1980, J PHYSIOL-LONDON, V308, P331, DOI 10.1113/jphysiol.1980.sp013474; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; COLINO A, 1987, NATURE, V328, P73, DOI 10.1038/328073a0; DAVIES M, 1988, BRIT J PHARMACOL, V94, P483, DOI 10.1111/j.1476-5381.1988.tb11551.x; DAVIES MF, 1987, BRAIN RES, V423, P347, DOI 10.1016/0006-8993(87)90861-4; DEVIVO M, 1986, J PHARMACOL EXP THER, V238, P248; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P477, DOI 10.1113/jphysiol.1988.sp017343; GALLIGAN JJ, 1988, AM J PHYSIOL, V255, pG603, DOI 10.1152/ajpgi.1988.255.5.G603; GOZLAN H, 1983, NATURE, V305, P140, DOI 10.1038/305140a0; HAGIWARA S, 1974, J MEMBRANE BIOL, V18, P61, DOI 10.1007/BF01870103; HAMON M, 1984, EUR J PHARMACOL, V100, P263, DOI 10.1016/0014-2999(84)90002-5; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; HIGASHI H, 1982, J PHYSIOL-LONDON, V323, P543, DOI 10.1113/jphysiol.1982.sp014091; MARKSTEIN R, 1986, N-S ARCH PHARMACOL, V333, P335, DOI 10.1007/BF00500006; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; NEILD TO, 1981, GEN PHARMACOL-VASC S, V12, P281, DOI 10.1016/0306-3623(81)90059-8; NOBLE D, 1985, TRENDS NEUROSCI, V8, P499, DOI 10.1016/0166-2236(85)90177-8; PAXINOS G, 1982, RAT BRAIN STEREOTAXI, P55; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SILLS MA, 1984, J PHARMACOL EXP THER, V231, P480; SPAIN WJ, 1987, J NEUROPHYSIOL, V57, P1555, DOI 10.1152/jn.1987.57.5.1555; WILLIAMS JT, 1988, J NEUROSCI, V8, P4299; WILLIAMS JT, 1988, J NEUROSCI, V8, P3499; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YANAGIHARA K, 1980, PFLUG ARCH EUR J PHY, V385, P11, DOI 10.1007/BF00583909	29	134	134	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1989	2	6					1535	1540		10.1016/0896-6273(89)90041-X	http://dx.doi.org/10.1016/0896-6273(89)90041-X			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC665	2483327				2022-12-17	WOS:A1989AC66500002
J	Chen, X; Wanggou, S; Bodalia, A; Zhu, M; Dong, WF; Fan, JJ; Yin, WC; Min, HK; Hu, M; Draghici, D; Dou, WK; Li, F; Coutinho, FJ; Whetstone, H; Kushida, MM; Dirks, PB; Song, YQ; Hui, CC; Sun, Y; Wang, LY; Li, XJ; Huang, X				Chen, Xin; Wanggou, Siyi; Bodalia, Ankur; Zhu, Min; Dong, Weifan; Fan, Jerry J.; Yin, Wen Chi; Min, Hyun-Kee; Hu, Malini; Draghici, Diana; Dou, Wenkun; Li, Feng; Coutinho, Fiona J.; Whetstone, Heather; Kushida, Michelle M.; Dirks, Peter B.; Song, Yuanquan; Hui, Chi-Chung; Sun, Yu; Wang, Lu-Yang; Li, Xuejun; Huang, Xi			A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression	NEURON			English	Article							CELL-MIGRATION; GLIOBLASTOMA; MECHANOTRANSDUCTION; STRETCH; GROWTH; ARCHITECTURE; PRESSURE; HYDROGEL; FUSIONS; TENSION	Alteration of tissue mechanical properties is a physical hallmark of solid tumors including gliomas. How tumor cells sense and regulate tissue mechanics is largely unknown. Here, we show that mechanosensitive ion channel Piezo regulates mitosis and tissue stiffness of Drosophila gliomas, but not non-transformed brains. PIEZO1 is overexpressed in aggressive human gliomas and its expression inversely correlates with patient survival. Deleting PIEZO1 suppresses the growth of glioblastoma stem cells, inhibits tumor development, and prolongs mouse survival. Focal mechanical force activates prominent PIEZO1-dependent currents from glioma cell processes, but not soma. PIEZO1 localizes at focal adhesions to activate integrin-FAK signaling, regulate extracellular matrix, and reinforce tissue stiffening. In turn, a stiffer mechanical microenvironment elevates PIEZO1 expression to promote glioma aggression. Therefore, glioma cells are mechanosensory in a PIEZO1-dependent manner, and targeting PIEZO1 represents a strategy to break the reciprocal, disease-aggravating feedforward circuit between tumor cell mechanotransduction and the aberrant tissue mechanics.	[Chen, Xin; Zhu, Min; Dong, Weifan; Fan, Jerry J.; Yin, Wen Chi; Min, Hyun-Kee; Hu, Malini; Draghici, Diana; Coutinho, Fiona J.; Whetstone, Heather; Kushida, Michelle M.; Dirks, Peter B.; Hui, Chi-Chung; Huang, Xi] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Chen, Xin; Dong, Weifan; Fan, Jerry J.; Min, Hyun-Kee; Coutinho, Fiona J.; Whetstone, Heather; Kushida, Michelle M.; Dirks, Peter B.; Huang, Xi] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Wanggou, Siyi; Li, Xuejun] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China; [Bodalia, Ankur; Wang, Lu-Yang] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Bodalia, Ankur; Wang, Lu-Yang] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Zhu, Min; Dou, Wenkun; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada; [Dong, Weifan; Fan, Jerry J.; Yin, Wen Chi; Min, Hyun-Kee; Dirks, Peter B.; Hui, Chi-Chung; Huang, Xi] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Li, Feng; Song, Yuanquan] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Li, Feng; Song, Yuanquan] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Central South University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Huang, X (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.; Huang, X (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada.; Huang, X (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada.	xi.huang@sickkids.ca	Huang, Xi/C-2409-2017	Huang, Xi/0000-0002-7177-7525; Fan, Jerry/0000-0002-2381-5427; Sun, Yu/0000-0001-7895-0741; Li, Xuejun/0000-0001-6406-4423; Chen, Xin/0000-0001-7620-5975	SickKids Foundation; Arthur and Sonia Labatt Brain Tumour Research Centre; Garron Family Cancer Centre; b.r.a.i.n. child; Meagan's Walk; Natural Sciences and Engineering Research Council (NSERC); Ontario Institute for Cancer Research (OICR) Translational Research Initiative (BC-TRI-FR-HSK); Canadian Institutes of Health Research (CIHR) [PJT 156439]	SickKids Foundation; Arthur and Sonia Labatt Brain Tumour Research Centre; Garron Family Cancer Centre; b.r.a.i.n. child; Meagan's Walk; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Institute for Cancer Research (OICR) Translational Research Initiative (BC-TRI-FR-HSK); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work is supported by SickKids Foundation, Arthur and Sonia Labatt Brain Tumour Research Centre, Garron Family Cancer Centre, b.r.a.i.n. child, Meagan's Walk, Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, and Ontario Institute for Cancer Research (OICR) Translational Research Initiative (BC-TRI-FR-HSK) to X.H., and Canadian Institutes of Health Research (CIHR) Project Grants to X.H., L.-Y.W. (PJT 156439), and C.-c.H. We thank Krzysztof Jagla, Marta Llimargas, and Dorothea Godt for fly stocks. We thank Michael Taylor for constructive suggestions on the project and his lab for technical support. We thank Samantha Stehbens for technical advice on studying focal adhesions. We are grateful for Paul Paroutis and Kimberly Lau at the SickKids Imaging Facility for their help on confocal imaging and image analysis. We thank Shan Meltzer and all Huang lab members for critical reading of the manuscript, and Zexin Chen for helping with drawing the schematic in Figure 1C.X.H. thanks the love and support from Lucas Huang and Liam Huang. X.H. is a Catalyst Scholar at The Hospital for Sick Children and Canada Research Chair in Cancer Biophysics.	Agnihotri S, 2013, ARCH IMMUNOL THER EX, V61, P25, DOI 10.1007/s00005-012-0203-0; Aguilar-Cuenca R, 2014, CELL MOL LIFE SCI, V71, P479, DOI 10.1007/s00018-013-1439-5; Bataille L, 2010, DEV CELL, V19, P317, DOI 10.1016/j.devcel.2010.07.008; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Frattini V, 2018, NATURE, V553, P222, DOI 10.1038/nature25171; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; He L, 2018, NATURE, V555, P103, DOI 10.1038/nature25744; Huse JT, 2013, ANNU REV MED, V64, P59, DOI 10.1146/annurev-med-100711-143028; Jia ZF, 2016, J BIOL CHEM, V291, P9087, DOI 10.1074/jbc.M115.692384; Kai F, 2016, TRENDS CELL BIOL, V26, P486, DOI 10.1016/j.tcb.2016.03.007; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Marco D. E., 2015, Journal of Scientific Research and Reports, V5, P1, DOI 10.9734/JSRR/2015/14076; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; Martins JR, 2016, PFLUG ARCH EUR J PHY, V468, P1197, DOI 10.1007/s00424-016-1811-z; Miroshnikova YA, 2016, NAT CELL BIOL, V18, P1336, DOI 10.1038/ncb3429; Moussian B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004939; Murthy SE, 2017, NAT REV MOL CELL BIO, V18, P771, DOI 10.1038/nrm.2017.92; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Northey JJ, 2017, CANCER DISCOV, V7, P1224, DOI 10.1158/2159-8290.CD-16-0733; Oudin MJ, 2016, COLD SH Q B, V81, P189, DOI 10.1101/sqb.2016.81.030817; Pajic Marina, 2015, Small GTPases, V6, P123, DOI 10.4161/21541248.2014.973749; Pardo-Pastor C, 2018, P NATL ACAD SCI USA, V115, P1925, DOI 10.1073/pnas.1718177115; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Penman CL, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00054; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Przybyla L, 2016, ANNU REV CELL DEV BI, V32, P527, DOI 10.1146/annurev-cellbio-111315-125150; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Rape AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9129; Rape AD, 2014, BIOMATERIALS, V35, P8846, DOI 10.1016/j.biomaterials.2014.07.003; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Rode B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00429-3; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Seo BR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010467; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tsai PI, 2012, P NATL ACAD SCI USA, V109, P17699, DOI 10.1073/pnas.1206416109; Tung JC, 2015, FREE RADICAL BIO MED, V79, P269, DOI 10.1016/j.freeradbiomed.2014.11.020; Umesh V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101771; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wang YF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03570-9; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Wu J, 2017, TRENDS BIOCHEM SCI, V42, P57, DOI 10.1016/j.tibs.2016.09.004; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743	58	133	135	9	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2018	100	4					799	+		10.1016/j.neuron.2018.09.046	http://dx.doi.org/10.1016/j.neuron.2018.09.046			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB0VN	30344046	Bronze			2022-12-17	WOS:000450736600009
J	Yu, XZ; Taylor, AMW; Nagai, J; Golshani, P; Evans, CJ; Coppola, G; Khakh, BS				Yu, Xinzhu; Taylor, Anna M. W.; Nagai, Jun; Golshani, Peyman; Evans, Christopher J.; Coppola, Giovanni; Khakh, Baljit S.			Reducing Astrocyte Calcium Signaling In Vivo Alters Striatal Microcircuits and Causes Repetitive Behavior	NEURON			English	Article							CA2+; HUNTINGTONS; RNA; DYSFUNCTION; INCREASES; NEURONS	Astrocytes tile the central nervous system, but their functions in neural microcircuits in vivo and their roles in mammalian behavior remain incompletely defined. We used two-photon laser scanning microscopy, electrophysiology, MINIscopes, RNA-seq, and a genetic approach to explore the effects of reduced striatal astrocyte Ca2+ signaling in vivo. In wild-type mice, reducing striatal astrocyte Ca2+-dependent signaling increased repetitive self-grooming behaviors by altering medium spiny neuron (MSN) activity. The mechanism involved astrocyte-mediated neuromodulation facilitated by ambient GABA and was corrected by blocking astrocyte GABA transporter 3 (GAT-3). Furthermore, in a mouse model of Huntington's disease, dysregulation of GABA and astrocyte Ca2+ signaling accompanied excessive self-grooming, which was relieved by blocking GAT-3. Assessments with RNA-seq revealed astrocyte genes and pathways regulated by Ca2+ signaling in a cell-autonomous and non-cell-autonomous manner, including Rab11a, a regulator of GAT-3 functional expression. Thus, striatal astrocytes contribute to neuromodulation controlling mouse obsessive-compulsive-like behavior.	[Yu, Xinzhu; Nagai, Jun; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Taylor, Anna M. W.; Evans, Christopher J.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Hatos Ctr Neuropharmacol, Los Angeles, CA 90095 USA; [Golshani, Peyman; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Golshani, Peyman; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Golshani, Peyman; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Intellectual & Dev Disabil Res Ctr, Los Angeles, CA 90095 USA; [Golshani, Peyman] West Los Angeles VA Med Ctr, Los Angeles, CA 90073 USA; [Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.; Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	Nagai, Jun/AAA-3666-2022	Nagai, Jun/0000-0003-1752-2852	NIH [NS060677, MH104069]; Shirley and Stefan Hatos Foundation; NINDS Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; Genetics, Genomics, and Informatics Core of the Semel Institute of Neuroscience at UCLA; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD087101-01]; American Heart Association [16POST27260256]; JSPS Overseas Research Fellowship [H28-729];  [U01NS094286];  [K99DA004016];  [DA005010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH104069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060677, P30NS062691, U01NS094286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shirley and Stefan Hatos Foundation; NINDS Informatics Center for Neurogenetics and Neurogenomics; Genetics, Genomics, and Informatics Core of the Semel Institute of Neuroscience at UCLA; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); JSPS Overseas Research Fellowship; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH grants NS060677 and MH104069 (B.S.K.). MINIscopes supported by U01NS094286 (B.S.K. and P.G.). A.M.W.T. and C.J.E. supported by K99DA004016 (A.M.W.T.), DA005010 (C.J.E.), and the Shirley and Stefan Hatos Foundation. We acknowledge the NINDS Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691 to G.C.) and the Genetics, Genomics, and Informatics Core of the Semel Institute of Neuroscience at UCLA (supported by grant U54HD087101-01 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development). X.Y. was supported by the American Heart Association (16POST27260256). J.N. supported by a JSPS Overseas Research Fellowship (H28-729). Thanks to Daniel Aharoni for help with MINIscopes, to Blanca Diaz-Castro for help with qPCR, Fuying Gao for help with RNA-seq data processing, and the UCLA Neuroscience Genomics Core for sequencing data. J. Christopher Octeau and Blanca Diaz-Castro helped with AAV2/5 Rpl22HA testing. Thanks to Michael V. Sofroniew and Wendy Walwyn for equipment and Nicholas Brecha for GAT-3 antibody. Thanks to Jonathan Flint, Vahri Beaumont, Ignacio Munoz-Sanjuan, Michael V. Sofroniew, and Daniel Geschwind for comments. Thanks to Emanuel E. Strehler for sharing tips. Thanks to Brandon Brown for R scripts.	Adermark L, 2006, NEUROPHARMACOLOGY, V51, P1099, DOI 10.1016/j.neuropharm.2006.05.035; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Aida T, 2015, NEUROPSYCHOPHARMACOL, V40, P1569, DOI 10.1038/npp.2015.26; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bakhurin KI, 2016, J NEUROPHYSIOL, V115, P1521, DOI 10.1152/jn.01037.2015; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Beenhakker MP, 2010, J NEUROSCI, V30, P15262, DOI 10.1523/JNEUROSCI.3243-10.2010; Beglinger LJ, 2008, J CLIN PSYCHIAT, V69, P1758, DOI 10.4088/JCP.v69n1111; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Cromwell HC, 1996, J NEUROSCI, V16, P3444; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graybiel AM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021691; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Jiang RT, 2016, J NEUROSCI, V36, P3453, DOI 10.1523/JNEUROSCI.3693-15.2016; Jiang R, 2014, JOVE-J VIS EXP, DOI 10.3791/51972; Kalueff AV, 2007, NAT PROTOC, V2, P2538, DOI 10.1038/nprot.2007.367; Kalueff AV, 2016, NAT REV NEUROSCI, V17, P45, DOI 10.1038/nrn.2015.8; Khakh BS, 2017, TRENDS NEUROSCI, V40, P422, DOI 10.1016/j.tins.2017.05.002; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khakh BS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020404; Kirmse K, 2009, SYNAPSE, V63, P921, DOI 10.1002/syn.20675; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lippiat Jonathan D., 2008, V491, P141, DOI 10.1007/978-1-59745-526-8_11; Martin R, 2015, SCIENCE, V349, P730, DOI 10.1126/science.aaa7945; Muthukumar AK, 2014, NAT NEUROSCI, V17, P1340, DOI 10.1038/nn.3791; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Octeau JC, 2018, NEURON, V98, P49, DOI 10.1016/j.neuron.2018.03.003; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenegger DG, 2015, J NEUROSCI, V35, P13463, DOI 10.1523/JNEUROSCI.1780-15.2015; Rungta RL, 2016, GLIA, V64, P2093, DOI 10.1002/glia.23042; Sanz E, 2015, J NEUROSCI, V35, P5549, DOI 10.1523/JNEUROSCI.3614-14.2015; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Shepherd G.M., 2010, HDB BRAIN MICROCIRCU, pxvii; Sherman-Gold R., 2006, AXON CNS GUIDE ELECT; Shigetomi E, 2016, TRENDS CELL BIOL, V26, P300, DOI 10.1016/j.tcb.2016.01.003; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Sloan SA, 2014, NEURON, V84, P1112, DOI 10.1016/j.neuron.2014.12.003; Smith NA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aal2039; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Stobart JL, 2018, CEREB CORTEX, V28, P184, DOI 10.1093/cercor/bhw366; Strehler EE, 2015, BIOCHEM BIOPH RES CO, V460, P26, DOI 10.1016/j.bbrc.2015.01.121; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wojtowicz AM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00188; Wu Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5159; Xie Y, 2010, NEUROSCIENCE, V170, P992, DOI 10.1016/j.neuroscience.2010.08.034; Zhang YV, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0340-16.2017; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	62	133	134	7	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 19	2018	99	6					1170	+		10.1016/j.neuron.2018.08.015	http://dx.doi.org/10.1016/j.neuron.2018.08.015			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU1HG	30174118	Green Accepted, Bronze			2022-12-17	WOS:000445009100011
J	Aldiri, I; Xu, BS; Wang, L; Chen, X; Hiler, D; Griffiths, L; Valentine, M; Shirinifard, A; Thiagarajan, S; Sablauer, A; Barabas, ME; Zhang, JK; Johnson, D; Frase, S; Zhou, X; Easton, J; Zhang, JH; Mardis, ER; Wilson, RK; Downing, JR; Dyer, MA				Aldiri, Issam; Xu, Beisi; Wang, Lu; Chen, Xiang; Hiler, Daniel; Griffiths, Lyra; Valentine, Marc; Shirinifard, Abbas; Thiagarajan, Suresh; Sablauer, Andras; Barabas, Marie-Elizabeth; Zhang, Jiakun; Johnson, Dianna; Frase, Sharon; Zhou, Xin; Easton, John; Zhang, Jinghui; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Dyer, Michael A.		St Jude Childrens Res Hosp; Washington Univ Pediatric Canc Gen	The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis	NEURON			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; SUPER-ENHANCERS; CELL IDENTITY; SEQ REVEALS; CHROMATIN; DIFFERENTIATION; RETINOBLASTOMA; CANCER; DNA	In the developing retina, multipotent neural progenitors undergo unidirectional differentiation in a precise spatiotemporal order. Here we profile the epigenetic and transcriptional changes that occur during retinogenesis in mice and humans. Although some progenitor genes and cell cycle genes were epigenetically silenced during retinogenesis, the most dramatic change was derepression of cell-type-specific differentiation programs. We identified developmental-stage-specific super-enhancers and showed that most epigenetic changes are conserved in humans and mice. To determine how the epigenome changes during tumorigenesis and reprogramming, we performed integrated epigenetic analysis of murine and human retinoblastomas and induced pluripotent stem cells (iPSCs) derived from murine rod photoreceptors. The retinoblastoma epigenome mapped to the developmental stage when retinal progenitors switch from neurogenic to terminal patterns of cell division. The epigenome of retinoblastomas was more similar to that of the normal retina than that of retina-derived iPSCs, and we identified retina-specific epigenetic memory.	[Aldiri, Issam; Wang, Lu; Hiler, Daniel; Griffiths, Lyra; Barabas, Marie-Elizabeth; Zhang, Jiakun; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Xu, Beisi; Chen, Xiang; Zhou, Xin; Easton, John; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Valentine, Marc] St Jude Childrens Res Hosp, Cytogenet Shared Resource, Memphis, TN 38105 USA; [Shirinifard, Abbas; Thiagarajan, Suresh; Sablauer, Andras] St Jude Childrens Res Hosp, Dept Diagnost Imaging, Memphis, TN 38105 USA; [Johnson, Dianna; Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Frase, Sharon] St Jude Childrens Res Hosp, Cell & Tissue Imaging Shared Resource, Memphis, TN 38105 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, Dept Genet, St Louis, MO 63108 USA; [Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, Dept Med, St Louis, MO 63108 USA; [Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, Siteman Canc Ctr, St Louis, MO 63108 USA; [Downing, James R.; Washington Univ Pediatric Canc Gen] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); St Jude Children's Research Hospital; Howard Hughes Medical Institute	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA.; Dyer, MA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA.; Dyer, MA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	michael.dyer@stjude.org	Zhang, Jing/GWZ-7332-2022; Wang, Lu/I-8245-2018; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Chen, Xiang/N-2524-2018; Downing, James R./N-8102-2018; Dyer, Michael/N-8134-2018; Xu, Beisi/C-8560-2009; Barabas, Marie-Elizabeth/AAG-8822-2021	Wang, Lu/0000-0002-8896-0115; Wilson, Richard K./0000-0002-1992-1358; Chen, Xiang/0000-0002-2499-8261; Xu, Beisi/0000-0003-0099-858X; Barabas, Marie-Elizabeth/0000-0002-4240-6979; Al Diri, Issam/0000-0002-0813-2943; Easton, John/0000-0003-4503-6608	Cancer Center Support from the NCI [CA21765]; NIH [EY014867, EY018599, CA168875]; ALSAC; Alex's Lemonade Stand Foundation for Childhood Cancer; Tully Family Foundation; Peterson Foundation; HHMI; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA168875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014867, R01EY023619, R01EY018599] Funding Source: NIH RePORTER	Cancer Center Support from the NCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); Alex's Lemonade Stand Foundation for Childhood Cancer; Tully Family Foundation; Peterson Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Angela McArthur for editing the manuscript. This work was supported, in part, by Cancer Center Support (CA21765) from the NCI, grants to M.A.D. from the NIH (EY014867, EY018599, and CA168875), and ALSAC. M.A.D. was also supported by grants from Alex's Lemonade Stand Foundation for Childhood Cancer, the Tully Family Foundation, and the Peterson Foundation. Most of this research was supported by HHMI. The human retina and retinoblastoma RNA-seq and WGBS were performed as part of the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project. The murine retina, retinoblastoma, and iPSC sequencing were performed with assistance from the Hartwell Center at St. Jude. The 3D EM was performed with assistance from the Cell and Tissue Imaging Shared Resource at St. Jude, and the FISH analysis was performed with assistance from the Cytogenetics Shared Resource at St. Jude.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Blackshaw S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r17; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko C, 2014, NAT REV NEUROSCI, V15, P615, DOI 10.1038/nrn3767; Chen X, 2015, ONCOGENE, V34, P5207, DOI 10.1038/onc.2014.474; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Dyer MA, 2016, CELL STEM CELL, V18, P425, DOI 10.1016/j.stem.2016.03.017; Dyer MA, 2009, P NATL ACAD SCI USA, V106, P8963, DOI 10.1073/pnas.0901484106; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hiler D, 2015, CELL STEM CELL, V17, P101, DOI 10.1016/j.stem.2015.05.015; Hiler DJ, 2016, NAT PROTOC, V11, P1955, DOI 10.1038/nprot.2016.109; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Johnson DA, 2007, CANCER RES, V67, P2701, DOI 10.1158/0008-5472.CAN-06-3754; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kashi VP, 2015, NAT REV CANCER, V15, P426, DOI 10.1038/nrc3961; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kunst S, 2015, MOL VIS, V21, P173; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MacPherson D, 2007, CANCER RES, V67, P7547, DOI 10.1158/0008-5472.CAN-07-0276; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Mo A, 2016, ELIFE, V5, DOI 10.7554/eLife.11613; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2011, R LANG ENV STAT COMP; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez- Galindo C, 2015, HEMATOL ONCOL, P1747; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Roesch Karin, 2012, Mol Vis, V18, P1197; Rohleder N, 2006, EUR J NEUROSCI, V23, P105, DOI 10.1111/j.1460-9568.2005.04528.x; Saint-Andre V, 2016, GENOME RES, V26, P385, DOI 10.1101/gr.197590.115; Samuel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089110; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stewart E, 2016, DEV BIOL, V411, P287, DOI 10.1016/j.ydbio.2015.03.001; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Ziller MJ, 2015, NATURE, V518, P355, DOI 10.1038/nature13990; Zwang Y, 2012, CANCER RES, V72, P1051, DOI 10.1158/0008-5472.CAN-11-3382	87	133	133	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 3	2017	94	3					550	+		10.1016/j.neuron.2017.04.022	http://dx.doi.org/10.1016/j.neuron.2017.04.022			29	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET7HR	28472656	Green Accepted, Bronze			2022-12-17	WOS:000400466700013
J	Espuny-Camacho, I; Arranz, AM; Fiers, M; Snellinx, A; Ando, K; Munck, S; Bonnefont, J; Lambot, L; Corthout, N; Omodho, L; Eynden, EV; Radaelli, E; Tesseur, I; Wray, S; Ebneth, A; Hardy, J; Leroy, K; Brion, JP; Vanderhaeghen, P; De Strooper, B				Espuny-Camacho, Ira; Arranz, Amaia M.; Fiers, Mark; Snellinx, An; Ando, Kunie; Munck, Sebastian; Bonnefont, Jerome; Lambot, Laurie; Corthout, Nikky; Omodho, Lorna; Eynden, Elke Vanden; Radaelli, Enrico; Tesseur, Ina; Wray, Selina; Ebneth, Andreas; Hardy, John; Leroy, Karelle; Brion, Jean-Pierre; Vanderhaeghen, Pierre; De Strooper, Bart			Hallmarks of Alzheimer's Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain	NEURON			English	Article							IN-VITRO; TAU; MICE; EXPRESSION; MODEL; NEURODEGENERATION; PATHOLOGY; DISORDERS; MECHANISM; PRECURSOR	Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific aspects of human disorders such as Alzheimer's disease (AD). However, in vitro culture of neurons deprives them of their natural environment. Here we transplanted human PSC-derived cortical neuronal precursors into the brain of a murine AD model. Human neurons differentiate and integrate into the brain, express 3R/4R Tau splice forms, show abnormal phosphorylation and conformational Tau changes, and undergo neurodegeneration. Remarkably, cell death was dissociated from tangle formation in this natural 3D model of AD. Using genome-wide expression analysis, we observed upregulation of genes involved in myelination and downregulation of genes related to memory and cognition, synaptic transmission, and neuron projection. This novel chimeric model for AD displays human-specific pathological features and allows the analysis of different genetic backgrounds and mutations during the course of the disease.	[Espuny-Camacho, Ira; Arranz, Amaia M.; Fiers, Mark; Snellinx, An; Munck, Sebastian; Corthout, Nikky; Omodho, Lorna; Eynden, Elke Vanden; Radaelli, Enrico; Tesseur, Ina; Vanderhaeghen, Pierre; De Strooper, Bart] VIB Leuven, VIB Ctr Brain & Dis Res, B-3000 Leuven, Belgium; [Espuny-Camacho, Ira; Arranz, Amaia M.; Fiers, Mark; Snellinx, An; Munck, Sebastian; Corthout, Nikky; Omodho, Lorna; Eynden, Elke Vanden; Radaelli, Enrico; Tesseur, Ina; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Univ Ziekenhuizen, B-3000 Leuven, Belgium; [Espuny-Camacho, Ira; Arranz, Amaia M.; Fiers, Mark; Snellinx, An; Munck, Sebastian; Corthout, Nikky; Omodho, Lorna; Eynden, Elke Vanden; Radaelli, Enrico; Tesseur, Ina; De Strooper, Bart] Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium; [Munck, Sebastian; Corthout, Nikky] Katholieke Univ Leuven, VIB Bio Imaging Core, Herestr 49, B-3000 Leuven, Belgium; [Bonnefont, Jerome; Vanderhaeghen, Pierre] Univ Libre Bruxelles, Inst Interdisciplinary Res IRIBHM, B-1070 Brussels, Belgium; [Ando, Kunie; Bonnefont, Jerome; Leroy, Karelle; Brion, Jean-Pierre; Vanderhaeghen, Pierre] Univ Libre Bruxelles, ULB Inst Neurosci UNI, B-1070 Brussels, Belgium; [Vanderhaeghen, Pierre] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium; [Ando, Kunie; Leroy, Karelle; Brion, Jean-Pierre] Univ Libre Bruxelles, Lab Histol Neuroanat & Neuropathol, B-1070 Brussels, Belgium; [Lambot, Laurie] Neurophysiol Lab, 808 Route Lennik, B-1070 Brussels, Belgium; [Lambot, Laurie] ULB Neurosci Inst UNI, 808 Route Lennik, B-1070 Brussels, Belgium; [Wray, Selina; Hardy, John; De Strooper, Bart] UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England; [Wray, Selina; Hardy, John; De Strooper, Bart] UCL, Dementia Res Inst, Queen Sq, London WC1N 3BG, England; [Ebneth, Andreas] Janssen Pharmaceut, Johnson & Johnson Pharmaceut Res & Dev, Dept Neurosci, Turnhoutseweg 30, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO; Universite Libre de Bruxelles; University of London; University College London; University of London; University College London; Johnson & Johnson; Janssen Pharmaceuticals	Arranz, AM; Vanderhaeghen, P; De Strooper, B (corresponding author), VIB Leuven, VIB Ctr Brain & Dis Res, B-3000 Leuven, Belgium.; Arranz, AM; De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Univ Ziekenhuizen, B-3000 Leuven, Belgium.; Arranz, AM; De Strooper, B (corresponding author), Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium.; Vanderhaeghen, P (corresponding author), Univ Libre Bruxelles, Inst Interdisciplinary Res IRIBHM, B-1070 Brussels, Belgium.; Vanderhaeghen, P (corresponding author), Univ Libre Bruxelles, ULB Inst Neurosci UNI, B-1070 Brussels, Belgium.; Vanderhaeghen, P (corresponding author), Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium.; De Strooper, B (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.; De Strooper, B (corresponding author), UCL, Dementia Res Inst, Queen Sq, London WC1N 3BG, England.	amaia.arranz@kuleuven.vib.be; pvdhaegh@ulb.ac.be; bart.destrooper@vib.be	Fiers, Mark WEJ/E-6755-2010; Arranz, Amaia/ACV-3437-2022; Wray, Selina/C-3682-2009; Bonnefont, Jerome/J-6767-2012; de+Strooper, Bart/Z-1638-2019; Wyss-Coray, Tony/AAF-3380-2019; Hardy, John/C-2451-2009; Arranz, Amaia M/C-3776-2017; Brion, Jean-Pierre/C-6467-2009; Espuny, Ira/AAM-1991-2021	Fiers, Mark WEJ/0000-0001-5694-2409; Wray, Selina/0000-0003-3062-7050; Bonnefont, Jerome/0000-0003-1996-8452; Wyss-Coray, Tony/0000-0001-5893-0831; Hardy, John/0000-0002-3122-0423; Arranz, Amaia M/0000-0002-8314-7870; Brion, Jean-Pierre/0000-0002-1917-775X; Espuny, Ira/0000-0002-2356-2159; Vanderhaeghen, Pierre/0000-0001-7899-5720; Corthout, Nikky/0000-0003-1176-7277; Munck, Sebastian/0000-0002-5182-5358; Bonnefont, Jerome/0000-0001-5283-8428; Leroy, Karelle/0000-0002-8661-5262; Ando, Kunie/0000-0003-3822-175X	European Research Council [ERC-2010-AG_268675]; Fonds voor Wetenschappelijk Onderzoek (FWO); KU Leuven; VIB; KU Leuven/Flemish Government; Bax-Vanluffelen Chair for Alzheimer's Disease and "Opening the Future" of the Leuven Universiteit Fonds (LUF); Vlaams Initiatief voor Netwerken voor Dementie Onderzoek (VIND) [135043]; Belgian Queen Elizabeth Medical Foundation; WELBIO Program of the Walloon Region; Fondation de SPOELBERCH; AXA Research Fund; Fondation ULB; Belgian Fonds de la Recherche Scientifique Medicale [T.0023.15]; Fund Aline (King Baudoin Foundation); Foundation for Alzheimer Research [FRA/SAO] [14001]; Fund Genicot [ULB - 2015]; IAP program of the Belgian Federal Science Policy Office [P7/16, P7/20]; NIHR Queen Square Dementia Biomedical Research Unit; Janssen Pharmaceutics;  [ERC-2013 ERC-2013-AG_340020];  [1.B.007.15]; Medical Research Council [MC_PC_17116] Funding Source: researchfish; MRC [MR/K01417X/1, MC_PC_17116, G0901254, G1001253, G0701075, MR/J004758/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); KU Leuven(KU Leuven); VIB; KU Leuven/Flemish Government(KU Leuven); Bax-Vanluffelen Chair for Alzheimer's Disease and "Opening the Future" of the Leuven Universiteit Fonds (LUF); Vlaams Initiatief voor Netwerken voor Dementie Onderzoek (VIND); Belgian Queen Elizabeth Medical Foundation; WELBIO Program of the Walloon Region(WELBIO); Fondation de SPOELBERCH; AXA Research Fund(AXA Research Fund); Fondation ULB; Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fund Aline (King Baudoin Foundation); Foundation for Alzheimer Research [FRA/SAO]; Fund Genicot; IAP program of the Belgian Federal Science Policy Office; NIHR Queen Square Dementia Biomedical Research Unit; Janssen Pharmaceutics; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council ERC-2010-AG_268675 to B.D.S., the Fonds voor Wetenschappelijk Onderzoek (FWO), the KU Leuven and VIB, and a Methusalem grant from the KU Leuven/Flemish Government to B.D.S. B.D.S. is supported by the Bax-Vanluffelen Chair for Alzheimer's Disease and "Opening the Future" of the Leuven Universiteit Fonds (LUF). This work is supported by Vlaams Initiatief voor Netwerken voor Dementie Onderzoek (VIND, Strategic Basic Research Grant 135043). P.V. is supported by the Belgian Queen Elizabeth Medical Foundation, the WELBIO Program of the Walloon Region, the Fondation de SPOELBERCH, the AXA Research Fund, the Fondation ULB, and ERC-2013 ERC-2013-AG_340020. Confocal microscope equipment was acquired through a Hercules Type 1 AKUL/09/037 to W. Annaert. Confocal and electron microscopy were performed in the VIB Bio Imaging Core (LiMoNe and EMoNe facilities). Mouse experiments were supported by Inframouse (KU Leuven and VIB). J.-P.B. was supported by grants from the Belgian Fonds de la Recherche Scientifique Medicale (T.0023.15), the Fund Aline (King Baudoin Foundation and Foundation for Alzheimer Research [FRA/SAO] [S#14001]), and the Fund Genicot (ULB - 2015). K.A. is a research fellow of the Belgian Fonds National de la Recherche Scientifique (F.N.R.S.) (and supported by grant 1.B.007.15). This work was supported by the IAP program (P7/16 and P7/20) of the Belgian Federal Science Policy Office. S.W. and J.H. received funding from the NIHR Queen Square Dementia Biomedical Research Unit. B.D.S. is a consultant for Janssen Pharmaceutics and Remynd NV. He receives research funding from Janssen Pharmaceutics.	Alzheimer A., 1906, NEUROL CBL, V25, P1134; Arranz AM, 2015, J CELL SCI, V128, P541, DOI 10.1242/jcs.158196; Arranz AM, 2010, NEUROBIOL DIS, V37, P156, DOI 10.1016/j.nbd.2009.09.019; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennand KJ, 2015, STEM CELL REP, V5, P933, DOI 10.1016/j.stemcr.2015.10.011; BRION JP, 1991, BRAIN RES, V539, P143, DOI 10.1016/0006-8993(91)90697-T; Burattini S, 2013, Methods Mol Biol, V1004, P77, DOI 10.1007/978-1-62703-383-1_7; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Erikson GA, 2016, CELL, V165, P1002, DOI 10.1016/j.cell.2016.03.022; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Ettle B, 2016, MOL NEUROBIOL, V53, P3046, DOI 10.1007/s12035-015-9205-3; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; LaFerla F. M., 2012, COLD SPRING HARB PER, V2, P2; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leroy K, 2012, AM J PATHOL, V181, P1928, DOI 10.1016/j.ajpath.2012.08.012; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; McGeer P L, 1988, Ann N Y Acad Sci, V540, P319, DOI 10.1111/j.1749-6632.1988.tb27086.x; Michelsen KA, 2015, NEURON, V85, P982, DOI 10.1016/j.neuron.2015.02.001; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Naganska E, 2001, FOLIA NEUROPATHOL, V39, P129; Pasca SP, 2014, ANNU REV NEUROSCI, V37, P479, DOI 10.1146/annurev-neuro-062012-170328; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Suzuki IK, 2015, DEVELOPMENT, V142, P3138, DOI 10.1242/dev.120568; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; van den Ameele J, 2014, TRENDS NEUROSCI, V37, P334, DOI 10.1016/j.tins.2014.03.005; Vera E, 2015, DEVELOPMENT, V142, P3085, DOI 10.1242/dev.120667; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	60	133	135	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2017	93	5					1066	+		10.1016/j.neuron.2017.02.001	http://dx.doi.org/10.1016/j.neuron.2017.02.001			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO1AL	28238547	Bronze, Green Submitted, Green Published			2022-12-17	WOS:000396429800011
J	Sittig, LJ; Carbonetto, P; Engel, KA; Krauss, KS; Barrios-Camacho, CM; Palmer, AA				Sittig, Laura J.; Carbonetto, Peter; Engel, Kyle A.; Krauss, Kathleen S.; Barrios-Camacho, Camila M.; Palmer, Abraham A.			Genetic Background Limits Generalizability of Genotype-Phenotype Relationships	NEURON			English	Article							GENOME-WIDE ASSOCIATION; MOUSE; IDENTIFICATION; RISK; MICE; TCF7L2; ARCHITECTURE; ENVIRONMENT; DROSOPHILA; REGULATOR	Genome-wide association studies (GWASs) have identified numerous loci that influence risk for psychiatric diseases. Genetically engineered mice are often used to characterize genes implicated by GWASs. These studies are based on the assumption that observed genotype-phenotype relationships will generalize to humans, implying that the results would at least generalize to other inbred mouse strains. Given current concerns about reproducibility, we sought to directly test this assumption. We produced F-1 crosses between male C57BL/6J mice heterozygous for null alleles of Cacna1c and Tcf7l2 and wild-type females from 30 inbred laboratory strains. We found extremely strong interactions with genetic background that sometimes supported diametrically opposing conclusions. These results do not negate the invaluable contributions of mouse genetics to biomedical science, but they do show that genotype-phenotype relationships cannot be reliably inferred by studying a single genetic background, and thus constitute a major challenge to the status quo.	[Sittig, Laura J.; Carbonetto, Peter; Engel, Kyle A.; Krauss, Kathleen S.; Barrios-Camacho, Camila M.; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, 920 East 58th St, Chicago, IL 60637 USA; [Sittig, Laura J.; Palmer, Abraham A.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of Chicago; University of California System; University of California San Diego	Palmer, AA (corresponding author), Univ Chicago, Dept Human Genet, 920 East 58th St, Chicago, IL 60637 USA.; Palmer, AA (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	aap@ucsd.edu		Krauss, Kathleen/0000-0001-9432-6623; Barrios-Camacho, Camila/0000-0003-1014-9207; Sittig, Laura/0000-0001-5912-9528	NIH [MH102931, MH102728]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020065, F32MH102931, R21MH102728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank Dr. Bruce Hamilton for providing comments on a draft of the manuscript. The studies were supported by NIH grants MH102931 and MH102728.	Alkelai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029228; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; BRANDON EP, 1995, CURR BIOL, V5, P625, DOI 10.1016/S0960-9822(95)00127-8; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Castle WE, 1919, P NATL ACAD SCI USA, V5, P126, DOI 10.1073/pnas.5.4.126; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dexter JS, 1914, AM NAT, V48, P712, DOI 10.1086/279446; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Dorman A, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0349-6; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Hamilton BA, 2012, PLOS GENET, V8, P326, DOI 10.1371/journal.pgen.1002644; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; Hide T, 2002, DEVELOPMENT, V129, P4347; Karp NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002151; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Little TJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002525; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Park SY, 2014, GENETICS, V196, P539, DOI 10.1534/genetics.113.157602; Phillips TJ, 1999, PSYCHOPHARMACOLOGY, V147, P5, DOI 10.1007/s002130051128; Pinto RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003930; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Sanford LP, 2000, METH MOL B, V158, P217; Savic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026897; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Winham SJ, 2014, MOL PSYCHIATR, V19, P1010, DOI 10.1038/mp.2013.159	47	133	139	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2016	91	6					1253	1259		10.1016/j.neuron.2016.08.013	http://dx.doi.org/10.1016/j.neuron.2016.08.013			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA6SW	27618673	Bronze, Green Accepted			2022-12-17	WOS:000386760300011
J	Reardon, TR; Murray, AJ; Turi, GF; Wirblich, C; Croce, KR; Schnell, MJ; Jessell, TM; Losonczy, A				Reardon, Thomas R.; Murray, Andrew J.; Turi, Gergely F.; Wirblich, Christoph; Croce, Katherine R.; Schnell, Matthias J.; Jessell, Thomas M.; Losonczy, Attila			Rabies Virus CVS-N2c(Delta G) Strain Enhances Retrograde Synaptic Transfer and Neuronal Viability	NEURON			English	Article							TRANSNEURONAL TRACER; GENE-EXPRESSION; OPTICAL CONTROL; CIRCUIT; GLYCOPROTEIN; CONNECTIVITY; VARIANTS; DYNAMICS; SINGLE; INPUTS	Virally based transsynaptic tracing technologies are powerful experimental tools for neuronal circuit mapping. The glycoprotein-deletion variant of the SAD-B19 vaccine strain rabies virus (RABV) has been the reagent of choice in monosynaptic tracing, since it permits the mapping of synaptic inputs to genetically marked neurons. Since its introduction, new helper viruses and reagents that facilitate complementation have enhanced the efficiency of SAD-B19(Delta G) transsynaptic transfer, but there has been little focus on improvements to the core RABV strain. Here we generate a new deletion mutant strain, CVS-N2c(Delta G), and examine its neuronal toxicity and efficiency in directing retrograde transsynaptic transfer. We find that by comparison with SAD-B19(Delta G) , the CVS-N2c(Delta G) strain exhibits a reduction in neuronal toxicity and a marked enhancement in transsynaptic neuronal transfer. We conclude that the CVS-N2c(Delta G) strain provides a more effective means of mapping neuronal circuitry and of monitoring and manipulating neuronal activity in vivo in the mammalian CNS.	[Reardon, Thomas R.; Murray, Andrew J.; Croce, Katherine R.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [Reardon, Thomas R.; Murray, Andrew J.; Croce, Katherine R.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Turi, Gergely F.; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Jessell, Thomas M.; Losonczy, Attila] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Wirblich, Christoph; Schnell, Matthias J.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Murray, Andrew J.] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London W1T 4JG, England	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Jefferson University; University of London; University College London	Murray, AJ; Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA.; Murray, AJ; Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.; Jessell, TM (corresponding author), Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA.; Murray, AJ (corresponding author), UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London W1T 4JG, England.	a.murray@ucl.ac.uk; tmj1@columbia.edu	Turi, Gergely/E-7631-2013; Turi, Gergely/G-5054-2019	Turi, Gergely/0000-0001-5651-9459; Schnell, Matthias/0000-0001-9040-9405	Rabies Core Center [5P40OD010996-10]; McKnight Memory and Cognitive Disorders Award, Human Frontiers Science Program, Brain and Behavior Research Foundation (NARSAD); NIH [NS0332245]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080932, R37NS033245, R01NS033245] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010996] Funding Source: NIH RePORTER	Rabies Core Center; McKnight Memory and Cognitive Disorders Award, Human Frontiers Science Program, Brain and Behavior Research Foundation (NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank E. Callaway (Salk Institute) and I. Wickersham (MIT) for early discussions and the SAD-B19 complementation vector (Addgene 11680). KK Conzelmann (LMU) for SAD-B19 rescue plasmids. A. Sisti for RABV-Cre injections and imaging. S. Fageiry, N. Balaskas, A. Miri, and F. Polleux for comments on the manuscript. N. Balaskas and D. Ng for analysis of overlap of motor neuron dendrites. A. Kaufman for technical assistance. I. Schieren for assistance with FACS and imaging. M.S. was supported by the Rabies Core Center grant 5P40OD010996-10. A.L. was supported by McKnight Memory and Cognitive Disorders Award, Human Frontiers Science Program, Brain and Behavior Research Foundation (NARSAD). T.M.J. was supported by NIH grant NS0332245 and Project A.L.S. T.M.J. is a HHMI investigator.	Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Cetin A, 2014, J NEUROPHYSIOL, V111, P2150, DOI 10.1152/jn.00495.2013; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; COULON P, 1989, J VIROL, V63, P3550, DOI 10.1128/JVI.63.8.3550-3554.1989; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Dorocic IP, 2014, NEURON, V83, P663, DOI 10.1016/j.neuron.2014.07.002; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Finke S, 2003, J GEN VIROL, V84, P1613, DOI 10.1099/vir.0.19128-0; FRANK E, 1983, J PHYSIOL-LONDON, V343, P593, DOI 10.1113/jphysiol.1983.sp014912; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; Geue L, 2008, VACCINE, V26, P3227, DOI 10.1016/j.vaccine.2008.04.007; Ghanem A., 2015, VIRUS RES; Ghanem A, 2012, EUR J CELL BIOL, V91, P10, DOI 10.1016/j.ejcb.2011.01.008; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hagendorf N., 2011, COLD SPRING HARB PRO; HONGO T, 1984, PROC R SOC SER B-BIO, V221, P261, DOI 10.1098/rspb.1984.0034; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Mendelsohn AI, 2015, NEURON, V87, P111, DOI 10.1016/j.neuron.2015.05.045; Mori T, 2014, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00047; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morimoto K, 1998, P NATL ACAD SCI USA, V95, P3152, DOI 10.1073/pnas.95.6.3152; Morimoto K, 2000, J NEUROVIROL, V6, P373, DOI 10.3109/13550280009018301; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Nassi JJ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00080; Ogawa SK, 2014, CELL REP, V8, P1105, DOI 10.1016/j.celrep.2014.06.042; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Palusa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033561; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Roy A, 2008, J NEUROVIROL, V14, P401, DOI 10.1080/13550280802235924; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Scott CA, 2008, J VIROL, V82, P513, DOI 10.1128/JVI.01677-07; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Sun YJ, 2014, CELL REP, V7, P269, DOI 10.1016/j.celrep.2014.02.030; Turi GF, 2015, NEUROPHARMACOLOGY, V88, P55, DOI 10.1016/j.neuropharm.2014.10.005; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wirblich C, 2011, J VIROL, V85, P697, DOI 10.1128/JVI.01309-10; Zampieri N, 2014, NEURON, V81, P766, DOI 10.1016/j.neuron.2013.12.033; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	61	133	138	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2016	89	4					711	724		10.1016/j.neuron.2016.01.004	http://dx.doi.org/10.1016/j.neuron.2016.01.004			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5UE	26804990	Green Accepted, Bronze			2022-12-17	WOS:000373565200007
J	Liu, CC; Tsai, CW; Deak, F; Rogers, J; Penuliar, M; Sung, YM; Maher, JN; Fu, Y; Li, X; Xu, HX; Estus, S; Hoe, HS; Fryer, JD; Kanekiyo, T; Bu, GJ				Liu, Chia-Chen; Tsai, Chih-Wei; Deak, Ferenc; Rogers, Justin; Penuliar, Michael; Sung, You Me; Maher, James N.; Fu, Yuan; Li, Xia; Xu, Huaxi; Estus, Steven; Hoe, Hyang-Sook; Fryer, John D.; Kanekiyo, Takahisa; Bu, Guojun			Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease	NEURON			English	Article							COMMON GENETIC-VARIATION; BETA-CATENIN; LRP6; RECEPTOR; PROTEIN; LOW-DENSITY-LIPOPROTEIN-RECEPTOR-RELATED-PROTEIN-6; DEGENERATION; TRANSMISSION; DYSFUNCTION; GENERATION	Alzheimer's disease (AD) is an age-related neurological disorder characterized by synaptic loss and dementia. The low-density lipoprotein receptor-related protein 6 (LRP6) is an essential coreceptor for Wnt signaling, and its genetic variants have been linked to AD risk. Here we report that neuronal LRP6-mediated Wnt signaling is critical for synaptic function and cognition. Conditional deletion of Lrp6 gene in mouse forebrain neurons leads to age-dependent deficits in synaptic integrity and memory. Neuronal LRP6 deficiency in an amyloid mouse model also leads to exacerbated amyloid pathology due to increased APP processing to amyloid-beta. In humans, LRP6 and Wnt signaling are significantly downregulated in AD brains, likely by a mechanism that depends on amyloid-b. Our results define a critical pathway in which decreased LRP6-mediated Wnt signaling, synaptic dysfunction, and elevated Ab synergistically accelerate AD progression and suggest that restoring LRP6-mediated Wnt signaling can be explored as a viable strategy for AD therapy.	[Liu, Chia-Chen; Tsai, Chih-Wei; Deak, Ferenc; Rogers, Justin; Penuliar, Michael; Fu, Yuan; Li, Xia; Fryer, John D.; Kanekiyo, Takahisa; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Estus, Steven] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Estus, Steven] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; [Fryer, John D.; Bu, Guojun] Mayo Clin, Coll Med, Neurobiol Dis Grad Program, Jacksonville, FL 32224 USA; [Liu, Chia-Chen; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Inst Neurosci, Xiamen, Fujian, Peoples R China; [Sung, You Me; Maher, James N.; Hoe, Hyang-Sook] Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA; [Deak, Ferenc] Univ Oklahoma HSC, Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA; [Hoe, Hyang-Sook] KBRI, Convergence Brain Res Dept, Taegu, South Korea	Mayo Clinic; University of Kentucky; University of Kentucky; Mayo Clinic; Xiamen University; Georgetown University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Korea Brain Research Institute (KBRI)	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Fu, Yuan/AAO-6040-2020; Deak, Ferenc/AAE-4324-2019; Xu, Huaxi/AAV-7177-2021; Deak, Ferenc/G-2620-2011	Fu, Yuan/0000-0003-2293-814X; Deak, Ferenc/0000-0003-1677-2518	NIH [R01AG027924, R01AG035355, R01AG046205, P01AG030128, P01NS074969]; Alzheimer's Association; Cure Alzheimer's Fund; Mayo Clinic CRM Career Development Award; NIRG from the Alzheimer's Association; GHR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG027924, R01AG031784, RF1AG046205, R01AG044420, R01AG021173, R01AG046205, R01AG035355, P30AG028383, P50AG016574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; Mayo Clinic CRM Career Development Award; NIRG from the Alzheimer's Association; GHR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R01AG027924, R01AG035355, R01AG046205, P01AG030128, and P01NS074969, grants from the Alzheimer's Association, and Cure Alzheimer's Fund (to G. B.); from Mayo Clinic CRM Career Development Award and NIRG from the Alzheimer's Association (to T. K.); and from the GHR Foundation (to F. D). We thank Dr. Bart Williams (Van Andel Research Institute) for providing Lrp6<SUP>flox/flox</SUP> mice; Dr. Joy Snider, Dr. Mingjie Li, and Nada Husic from the Viral Vectors Core (Washington University) for producing the lentiviruses; Lester Manly for assistance of dendritic spine counting; Dr. Jaekwang Kim for providing LDLR siRNA; and Dr. Bob Weinberg (Whitehead Institute, Cambridge) for providing beta-catenin deltaN90 plasmid. We are grateful to Dr. Dennis Dickson, Monica Castanedes Casey, Linda Rousseau, and Virginia Phillips for histology and immunohistochemical analyses; Dr. Terrone Rosenberry and Dr. William Tay for advice and assistance with Ab oligomer preparation; and Dr. Melissa Murray for developing algorithms in ImageScope software to quantify immunohistochemical staining. We also thank Caroline Stetler, Melissa Wren, and Caroline Casey for careful reading of this manuscript.	Alarcon MA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.11.004; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Castelo-Branco G, 2010, DEV DYNAM, V239, P211, DOI 10.1002/dvdy.22094; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Inestrosa N.C., 2013, TRENDS CELL SIGNALIN; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Megill A, 2013, J NEUROSCI, V33, P9306, DOI 10.1523/JNEUROSCI.1615-12.2013; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Pachet AK, 2003, PSYCHOPHARMACOLOGY, V170, P225, DOI 10.1007/s00213-003-1592-x; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; Purro SA, 2012, J NEUROSCI, V32, P3492, DOI 10.1523/JNEUROSCI.4562-11.2012; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130; Tarawneh R, 2010, NEUROPHARMACOLOGY, V59, P310, DOI 10.1016/j.neuropharm.2010.04.006; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Wan WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/301575; Wang XH, 2004, AM J PHYSIOL-HEART C, V287, pH2376, DOI 10.1152/ajpheart.01173.2003; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011	64	133	140	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 1	2014	84	1					63	77		10.1016/j.neuron.2014.08.048	http://dx.doi.org/10.1016/j.neuron.2014.08.048			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ0WG	25242217	Bronze, Green Accepted			2022-12-17	WOS:000342502800011
J	Stork, T; Sheehan, A; Tasdemir-Yilmaz, OE; Freeman, MR				Stork, Tobias; Sheehan, Amy; Tasdemir-Yilmaz, Ozge E.; Freeman, Marc R.			Neuron-Glia Interactions through the Heartless FGF Receptor Signaling Pathway Mediate Morphogenesis of Drosophila Astrocytes	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; GENE-EXPRESSION; GABA TRANSPORTER; RAT ASTROBLASTS; BRAIN; CELLS; MELANOGASTER; CNS; DIFFERENTIATION	Astrocytes are critically important for neuronal circuit assembly and function. Mammalian protoplasmic astrocytes develop a dense ramified meshwork of cellular processes to form intimate contacts with neuronal cell bodies, neurites, and synapses. This close neuron-glia morphological relationship is essential for astrocyte function, but it remains unclear how astrocytes establish their intricate morphology, organize spatial domains, and associate with neurons and synapses in vivo. Here we characterize a Drosophila glial subtype that shows striking morphological and functional similarities to mammalian astrocytes. We demonstrate that the Fibroblast growth factor (FGF) receptor Heartless autonomously controls astrocyte membrane growth, and the FGFs Pyramus and Thisbe direct astrocyte processes to ramify specifically in CNS synaptic regions. We further show that the shape and size of individual astrocytes are dynamically sculpted through inhibitory or competitive astrocyte-astrocyte interactions and Heartless FGF signaling. Our data identify FGF signaling through Heartless as a key regulator of astrocyte morphological elaboration in vivo.	[Stork, Tobias; Sheehan, Amy; Tasdemir-Yilmaz, Ozge E.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Worcester, MA 01605 USA.	marc.freeman@umassmed.edu		Freeman, Marc/0000-0003-3481-3715	NICHD; National Center For Research Resources [S10RR027897]; Deutsche Forschungsgemeinschaft (DFG); NINDS [R01NS053538]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Christian Klambt, Angelike Stathopoulos, Arno Muller, Ingolf Reim, Matthias Landgraf, Hermann Aberle, Marion Silies, Melissa Rolls, Tzumin Lee, Motojiro Yoshihara, Joachim Schulz, Gerd Vorbruggen, Roger Jacobs as well as the Vienna Drosophila RNAi Center, the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947), and the Bloomington Stock Center for generously providing fly stocks. The monoclonal antibodies mAb 1D4, mAb 8D12, mab MR1A, and mAb nc82 developed by C. Goodman, C. Q. Doe, and E. Buchner, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences. Plasmids containing QF, codon-optimized Gal4, and iGluSnFR were obtained from Addgene. Roger Tsien generously provided a plasmid containing mCherry sequence and Tzumin Lee a plasmid containing LexA::GAD. We thank Looren Looger for generously sharing a GCaMP5a construct prior to publication. We further thank Michael Brodsky and the University of Massachusetts Medical School Mutagenesis Core for assistance with TALEN-mediated mutagenesis, the University of Massachusetts Medical School Electron Microscopy core facility for assistance with TEM experiments (supported by award number S10RR027897 from the National Center For Research Resources), Harleen Saini for help with laser injuries of astrocytes, and Johnna Doherty for generating a ths cDNA. T. S. was supported by a postdoctoral fellowship by the Deutsche Forschungsgemeinschaft (DFG). This work was supported by NINDS grant R01NS053538 (to M. R. F.). M. R. F. is an Investigator with the Howard Hughes Medical Institute.	Allerstorfer S, 2008, ONCOGENE, V27, P4180, DOI 10.1038/onc.2008.61; Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Avet-Rochex A, 2012, DEVELOPMENT, V139, P2763, DOI 10.1242/dev.074179; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Beckervordersandforth RM, 2008, MECH DEVELOP, V125, P542, DOI 10.1016/j.mod.2007.12.004; Broadus J, 1995, DEVELOPMENT, V121, P3989; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Condron B, 1999, DEVELOPMENT, V126, P4635; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Gao XJ, 1999, INSECT BIOCHEM MOLEC, V29, P609, DOI 10.1016/S0965-1748(99)00039-9; Gibson NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033828; Hartline DK, 2011, GLIA, V59, P1215, DOI 10.1002/glia.21149; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Imam F, 1999, GENETICS, V152, P307; Irmady K, 2011, GLIA, V59, P708, DOI 10.1002/glia.21141; JACOBS JR, 1989, NEURON, V2, P1625; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; Kang K, 2010, BIOCHEM BIOPH RES CO, V395, P324, DOI 10.1016/j.bbrc.2010.03.174; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Klingseisen A, 2009, DEVELOPMENT, V136, P2393, DOI 10.1242/dev.035451; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Leal SM, 2004, J NEUROBIOL, V61, P189, DOI 10.1002/neu.20061; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin XH, 1999, DEVELOPMENT, V126, P3715; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; MBUNGU D, 1995, ARCH BIOCHEM BIOPHYS, V318, P489, DOI 10.1006/abbi.1995.1258; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Mohanan V, 2013, CLIN EXP METASTAS, V30, P507, DOI 10.1007/s10585-012-9555-4; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Neckameyer W. S., 1998, Invertebrate Neuroscience, V3, P279, DOI 10.1007/BF02577688; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ng FS, 2011, CURR BIOL, V21, P625, DOI 10.1016/j.cub.2011.03.027; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Ohkubo Y, 2004, J NEUROSCI, V24, P6057, DOI 10.1523/JNEUROSCI.1140-04.2004; Ou YM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-16; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Parton R.M., 2010, COLD SPRING HARB PRO, V2010, pt5403; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; PERRAUD F, 1988, GLIA, V1, P124, DOI 10.1002/glia.440010204; PERRAUD F, 1988, J NEUROSCI RES, V20, P1, DOI 10.1002/jnr.490200102; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Reilly JF, 1996, EXP NEUROL, V140, P139, DOI 10.1006/exnr.1996.0124; Reuss B, 2003, J NEUROSCI, V23, P6404; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schousboe A, 2004, NEUROCHEM INT, V45, P521, DOI 10.1016/j.neuint.2003.11.001; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shishido E, 1997, DEVELOPMENT, V124, P2119; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Smith KM, 2012, BRAIN RES, V1460, P12, DOI 10.1016/j.brainres.2012.04.002; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Stacey SM, 2010, J NEUROSCI, V30, P14446, DOI 10.1523/JNEUROSCI.1021-10.2010; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; Thimgan MS, 2006, J EXP BIOL, V209, P3383, DOI 10.1242/jeb.02328; Thomas GB, 2007, DEVELOPMENT, V134, P591, DOI 10.1242/dev.02754; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Yamada SM, 2002, NEUROL RES, V24, P244, DOI 10.1179/016164102101199864	71	133	134	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2014	83	2					388	403		10.1016/j.neuron.2014.06.026	http://dx.doi.org/10.1016/j.neuron.2014.06.026			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN3HU	25033182	Bronze, Green Accepted			2022-12-17	WOS:000340478700014
J	Wu, H; Luo, JJ; Yu, HM; Rattner, A; Mo, A; Wang, YS; Smallwood, PM; Erlanger, B; Wheelan, SJ; Nathans, J				Wu, Hao; Luo, Junjie; Yu, Huimin; Rattner, Amir; Mo, Alisa; Wang, Yanshu; Smallwood, Philip M.; Erlanger, Bracha; Wheelan, Sarah J.; Nathans, Jeremy			Cellular Resolution Maps of X Chromosome Inactivation: Implications for Neural Development, Function, and Disease	NEURON			English	Article							RETINAL VASCULAR DEVELOPMENT; NORRIE-DISEASE; COLOR-VISION; MOUSE; EXPRESSION; ORIGIN; MICE; TRANSGENE; DISPERSION; MUTATIONS	Female eutherian mammals use X chromosome inactivation (XCI) to epigenetically regulate gene expression from similar to 4% of the genome. To quantitatively map the topography of XCI for defined cell types at single cell resolution, we have generated female mice that carry X-linked, Cre-activated, and nuclear-localized fluorescent reporters-GFP on one X chromosome and tdTomato on the other. Using these reporters in combination with different Cre drivers, we have defined the topographies of XCI mosaicism for multiple CNS cell types and of retinal vascular dysfunction in a model of Norrie disease. Depending on cell type, fluctuations in the XCI mosaic are observed over a wide range of spatial scales, from neighboring cells to left versus right sides of the body. These data imply a major role for XCI in generating female-specific, genetically directed, stochastic diversity in eutherian mammals on spatial scales that would be predicted to affect CNS function within and between individuals.	[Wu, Hao; Yu, Huimin; Rattner, Amir; Wang, Yanshu; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Luo, Junjie] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Mo, Alisa; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Erlanger, Bracha; Wheelan, Sarah J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wheelan, Sarah J.] Johns Hopkins Univ, Sch Med, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Wu, Hao; Wang, Yanshu; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu	Mo, Alisa/AAP-9083-2020; Luo, Junjie/L-3285-2019	Mo, Alisa/0000-0002-6435-1227; Rattner, Amir/0000-0001-9542-6212; Nathans, Jeremy/0000-0001-8106-5460	National Institutes of Health [P30 CA006973]; Human Frontier Science Program; Howard Hughes Medical Institute; Brain Sciences Institute of the Johns Hopkins University; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007143, R01EY018637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Brain Sciences Institute of the Johns Hopkins University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Elizabeth Simpson for the gift of Hprt mutant ES cells, Dominic Ciavatta for the Hprt targeting vector, Dwight Bergles, Karl Deisseroth, Alex Kolodkin, and Se-Jin Lee for Cre lines, Terry Shelley for custom manufacturing support, the members of the Johns Hopkins Transgenic, Flow Cytometry, and NextGen Sequencing core facilities for blastocyst injection, FACS sorting, and RNA-seq library construction, John Williams for assistance with genotyping, and Rudolf Jaenisch, Lucas Hua, Barbara Migeon, and Max Tischfield for helpful discussions and/or comments on the manuscript. Supported by National Institutes of Health P30 CA006973 (S.J.W.), the Human Frontier Science Program (H.W.), the Howard Hughes Medical Institute, and the Brain Sciences Institute of the Johns Hopkins University.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chonchaiya W, 2010, CLIN GENET, V78, P38, DOI 10.1111/j.1399-0004.2010.01448.x; Chung IM, 1998, AM J PATHOL, V152, P913; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; COHN SA, 1989, VISION RES, V29, P255, DOI 10.1016/0042-6989(89)90129-6; Coussa RG, 2012, OPHTHALMIC GENET, V33, P57, DOI 10.3109/13816810.2011.620056; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 1998, VISION RES, V38, P3307, DOI 10.1016/S0042-6989(97)00405-7; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jan TA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-3; Jangouk P, 2012, MOL GENET METAB, V105, P180, DOI 10.1016/j.ymgme.2011.11.001; Jinnah H, 2001, METABOLIC MOL BASES, P2537; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Li SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031751; Lin P, 2010, J AAPOS, V14, P93, DOI 10.1016/j.jaapos.2009.11.012; Liu XZ, 2013, INT J AUDIOL, V52, P23, DOI 10.3109/14992027.2012.736032; Liu XZ, 2010, AM J HUM GENET, V86, P65, DOI 10.1016/j.ajhg.2009.11.015; LYON MF, 1962, AM J HUM GENET, V14, P135; Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Ramirez A, 2001, GENETICS, V158, P341; Reese BE, 1999, EUR J NEUROSCI, V11, P2965, DOI 10.1046/j.1460-9568.1999.00712.x; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Sims KB, 1997, ARCH OPHTHALMOL-CHIC, V115, P517, DOI 10.1001/archopht.1997.01100150519012; SPERRY R, 1982, SCIENCE, V217, P1223, DOI 10.1126/science.7112125; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Sugimoto M, 2000, INT J DEV BIOL, V44, P177; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Tassone F, 2012, GENES BRAIN BEHAV, V11, P577, DOI 10.1111/j.1601-183X.2012.00779.x; Thorvaldsen JL, 2012, GENETICS, V192, P1095, DOI 10.1534/genetics.112.144477; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; WILLARD HF, 2001, METABOLIC MOL BASES, P1191; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang GS, 2009, GENOMICS, V93, P196, DOI 10.1016/j.ygeno.2008.09.014; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003	52	133	133	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2014	81	1					103	119		10.1016/j.neuron.2013.10.051	http://dx.doi.org/10.1016/j.neuron.2013.10.051			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287RD	24411735	Green Accepted, Bronze			2022-12-17	WOS:000329559000012
J	Sohn, JW; Xu, Y; Jones, JE; Wickman, K; Williams, KW; Elmquist, JK				Sohn, Jong-Woo; Xu, Yong; Jones, Juli E.; Wickman, Kevin; Williams, Kevin W.; Elmquist, Joel K.			Serotonin 2C Receptor Activates a Distinct Population of Arcuate Pro-opiomelanocortin Neurons via TRPC Channels	NEURON			English	Article							ENERGY HOMEOSTASIS REGULATION; GATED POTASSIUM CHANNELS; RECTIFYING K+ CHANNELS; MELANOCORTIN PATHWAYS; AGRP NEURONS; GLUCOSE-HOMEOSTASIS; D-FENFLURAMINE; POMC NEURONS; FOOD-INTAKE; I-KACH	Serotonin 2C receptors (5-HT(2C)Rs) expressed by pro-opiomelanocortin (POMC) neurons of hypothalamic arcuate nucleus regulate food intake, energy homeostasis and glucose metabolism. However, the cellular mechanisms underlying the effects of 5-HT to regulate POMC neuronal activity via 5-HT(2C)Rs have not yet been identified. In the present study, we found the putative transient receptor potential C (TRPC) channels mediate the activation of a subpopulation of POMC neurons by mCPP (a 5-HT(2C)R agonist). Interestingly, mCPP-activated POMC neurons were found to be a distinct population from those activated by leptin. Together, our data suggest that 5-HT(2C)R and leptin receptors are expressed by distinct subpopulations of arcuate POMC neurons and that both 5-HT and leptin exert their actions in POMC neurons via TRPC channels.	[Sohn, Jong-Woo; Xu, Yong; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Xu, Yong] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Jones, Juli E.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities	Williams, KW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	kevin.williams@utsouthwestern.edu; joel.elmquist@utsouthwestern.edu	Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021; Sohn, Jong Woo/D-6700-2014	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Wickman, Kevin/0000-0002-5179-9540; Xu, Yong/0000-0002-4908-1572	American Diabetes Association; Naman Family Fund for Basic Research; Curtis Hankamer Basic Research Fund;  [R00DK085330];  [P30DK079638-03];  [R01MH061933];  [P50DA011806];  [K01DK087780];  [R01DK53301];  [R01DK088423];  [RL1DK081185];  [PL1 DK081182];  [UL1RR024923]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053301, RL1DK081185, PL1DK081182, P30DK079638, K01DK087780, R01DK053301, R01DK088423, R00DK085330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933, R01MH061583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Naman Family Fund for Basic Research; Curtis Hankamer Basic Research Fund; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Jefferey Friedman (Rockefeller University) for kindly providing us with the LepR-cre mice. This work was supported by grants to J.-W.S. (American Diabetes Association), Y.X. (R00DK085330, P30DK079638-03, American Diabetes Association, and the Naman Family Fund for Basic Research and the Curtis Hankamer Basic Research Fund), K.W. (R01MH061933, P50DA011806), K.W.W. (K01DK087780), and J.K.E. (R01DK53301, R01DK088423, and RL1DK081185). This work was also supported by PL1 DK081182 and UL1RR024923.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Astrup A, 2010, NEW ENGL J MED, V363, P288, DOI 10.1056/NEJMe1004076; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Davila V, 2003, J NEUROSCI, V23, P5693; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Giorgetti M, 2004, EUR J PHARMACOL, V488, P1, DOI 10.1016/j.ejphar.2004.01.036; Halford JCG, 2010, NAT REV ENDOCRINOL, V6, P255, DOI 10.1038/nrendo.2010.19; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Kennedy ME, 1996, NEUROPHARMACOLOGY, V35, P831, DOI 10.1016/0028-3908(96)00132-3; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Perry CA, 2008, P NATL ACAD SCI USA, V105, P8148, DOI 10.1073/pnas.0803261105; Pollack A, 2010, NY TIMES        0627, pA1; POLLACK A, 2010, NY TIMES        1023, pA27; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033	50	133	138	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 11	2011	71	3					488	497		10.1016/j.neuron.2011.06.012	http://dx.doi.org/10.1016/j.neuron.2011.06.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835345	Green Accepted, Bronze			2022-12-17	WOS:000293991700012
J	Hallermann, S; Fejtova, A; Schmidt, H; Weyhersmuller, A; Silver, RA; Gundelfinger, ED; Eilers, J				Hallermann, Stefan; Fejtova, Anna; Schmidt, Hartmut; Weyhersmueller, Annika; Silver, R. Angus; Gundelfinger, Eckart D.; Eilers, Jens			Bassoon Speeds Vesicle Reloading at a Central Excitatory Synapse	NEURON			English	Article							CEREBELLAR MOSSY FIBER; PROBABILITY FLUCTUATION ANALYSIS; PRESYNAPTIC ACTIVE ZONE; NEUROTRANSMITTER RELEASE; GLUTAMATERGIC SYNAPSE; CALCIUM-DEPENDENCE; PROTEIN BASSOON; CLIMBING FIBER; CELL SYNAPSES; HELD SYNAPSE	Sustained rate-coded signals encode many types of sensory modalities. Some sensory synapses possess specialized ribbon structures, which tether vesicles, to enable high-frequency signaling. However, central synapses lack these structures, yet some can maintain signaling over a wide bandwidth. To analyze the underlying molecular mechanisms, we investigated the function of the active zone core component Bassoon in cerebellar mossy fiber to granule cell synapses. We show that short-term synaptic depression is enhanced in Bassoon knockout mice during sustained high-frequency trains but basal synaptic transmission is unaffected. Fluctuation and quantal analysis as well as quantification with constrained short-term plasticity models revealed that the vesicle reloading rate was halved in the absence of Bassoon. Thus, our data show that the cytomatrix protein Bassoon speeds the reloading of vesicles to release sites at a central excitatory synapse.	[Hallermann, Stefan; Schmidt, Hartmut; Weyhersmueller, Annika; Eilers, Jens] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, D-04103 Leipzig, Germany; [Fejtova, Anna; Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Silver, R. Angus] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Leipzig University; Leibniz Institut fur Neurobiologie (LIN); University of London; University College London	Hallermann, S (corresponding author), Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Liebigstr 27, D-04103 Leipzig, Germany.	hallermann@medizin.uni-leipzig.de	Schmidt, Hartmut/F-7058-2010; Fejtova, Anna/E-6343-2015; Eilers, Jens/E-6251-2012; Fejtova, Anna/AAZ-1024-2020	Eilers, Jens/0000-0003-0497-5625; Hallermann, Stefan/0000-0001-9376-7048; Fejtova, Anna/0000-0002-1815-4409; Silver, Robin/0000-0002-5480-6638	Medical Faculty of the University of Leipzig; DFG [SFB 779/B9, EI 342/4-1]; Wellcome Trust; European Commission	Medical Faculty of the University of Leipzig; DFG(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre)	We would like to thank Dr. Erwin Neher for helpful discussions and for critically reading the manuscript, and Gudrun Bethge and Bettina Kracht for expert technical assistance. This work was supported by a formel.1 grant from the Medical Faculty of the University of Leipzig to S.H. and from the DFG to E.D.G. (SFB 779/B9), J.E., and H.S. (EI 342/4-1). R.A.S. is in receipt of a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science. R.A.S. and E.D.G. are supported by the European Commission (Marie Curie Training Network "BrainTrain").	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Bagnall MW, 2008, NEURON, V60, P343, DOI 10.1016/j.neuron.2008.10.002; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hallermann S, 2010, HFSP J, V4, P72, DOI 10.2976/1.3338710; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim JH, 2009, NEURON, V63, P143, DOI 10.1016/j.neuron.2009.07.006; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Neher E, 2006, PFLUG ARCH EUR J PHY, V453, P261, DOI 10.1007/s00424-006-0143-9; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	55	133	135	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 18	2010	68	4					710	723		10.1016/j.neuron.2010.10.026	http://dx.doi.org/10.1016/j.neuron.2010.10.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	691KU	21092860	Green Published, hybrid			2022-12-17	WOS:000285079500010
J	Carr, VA; Rissman, J; Wagner, AD				Carr, Valerie A.; Rissman, Jesse; Wagner, Anthony D.			Imaging the Human Medial Temporal Lobe with High-Resolution fMRI	NEURON			English	Review							COMPLEMENTARY-LEARNING-SYSTEMS; LONG-TERM-MEMORY; VOXEL PATTERN-ANALYSIS; VISUAL WORKING-MEMORY; MATCH-TO-SAMPLE; RECOGNITION MEMORY; PERIRHINAL CORTEX; HIPPOCAMPAL FUNCTION; EPISODIC MEMORY; FUNCTIONAL MRI	High-resolution functional MRI (hr-fMRI) affords unique leverage on the functional properties of human medial temporal lobe (MTL) substructures. We review initial hr-fMRI efforts to delineate (1) encoding and retrieval processes within the hippocampal circuit, (2) hippocampal subfield contributions to pattern separation and pattern completion, and (3) the representational capabilities of distinct MTL subregions. Extant data reveal functional heterogeneity within human MTL and highlight the promise of hr-fMRI for bridging human, animal, and computational approaches to understanding MTL function.	[Carr, Valerie A.; Rissman, Jesse; Wagner, Anthony D.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Wagner, Anthony D.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Carr, VA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	valerie.carr@stanford.edu	Rissman, Jesse/ABH-2217-2021	Rissman, Jesse/0000-0001-8889-5539; Carr, Valerie/0000-0002-2969-2181	National Institute of Mental Health [5R01-MH076932, F32-NS059195]; National Alliance for Research on Schizophrenia and Depression; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS059195] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. van der Kouwe for helpful discussions regarding susceptibility artifacts in the MTL. We thank N. Suthana, S. Bookheimer, R. Olsen, A. Preston, C. Stark, and R. Diana for providing us with original artwork from their respective publications. This work is supported by the National Institute of Mental Health (5R01-MH076932, F32-NS059195), the National Alliance for Research on Schizophrenia and Depression. and the Alfred P. Sloan Foundation.	Angenstein F, 2009, J NEUROSCI, V29, P2428, DOI 10.1523/JNEUROSCI.5015-08.2009; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buffalo EA, 2006, LEARN MEMORY, V13, P638, DOI 10.1101/lm.251906; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Carr VA, 2010, J COGNITIVE NEUROSCI, V22, P2652, DOI 10.1162/jocn.2009.21381; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Deadwyler SA, 2004, NEURON, V42, P465, DOI 10.1016/S0896-6273(04)00195-3; Diana RA, 2008, HIPPOCAMPUS, V18, P536, DOI 10.1002/hipo.20433; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dudukovic NM, 2007, NEUROPSYCHOLOGIA, V45, P2608, DOI 10.1016/j.neuropsychologia.2007.02.025; Duncan K, 2009, J NEUROSCI, V29, P131, DOI 10.1523/JNEUROSCI.2998-08.2009; Duvernoy H.M., 2005, HUMAN HIPPOCAMPUS FU, V3rd, DOI DOI 10.1007/978-3-642-33603-4; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H., 2004, CONDITIONING CONSCIO; Ekstrom A, 2008, J NEUROSURG, V108, P812, DOI 10.3171/JNS/2008/108/4/0812; Ekstrom A, 2009, J NEUROPHYSIOL, V101, P2668, DOI 10.1152/jn.91252.2008; Ekstrom AD, 2009, NEUROIMAGE, V47, P42, DOI 10.1016/j.neuroimage.2009.03.017; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; Gaisler-Salomon I, 2009, SCHIZOPHRENIA BULL, V35, P1037, DOI 10.1093/schbul/sbp114; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haskins AL, 2008, NEURON, V59, P554, DOI 10.1016/j.neuron.2008.07.035; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Insausti R., 2004, HUMAN NERVOUS SYSTEM, P871, DOI [10.1016/B978-012547626-3/50024-7, DOI 10.1016/B978-012547626-3/50024-7]; Johnson JD, 2008, HIPPOCAMPUS, V18, P975, DOI 10.1002/hipo.20456; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Krasnow B, 2003, NEUROIMAGE, V18, P813, DOI 10.1016/S1053-8119(03)00002-8; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Kumaran D, 2009, TRENDS COGN SCI, V13, P47, DOI 10.1016/j.tics.2008.11.004; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Litman L, 2009, HIPPOCAMPUS, V19, P308, DOI 10.1002/hipo.20515; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Meunier M, 1996, J NEUROPHYSIOL, V75, P1190, DOI 10.1152/jn.1996.75.3.1190; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Mara S, 2006, BEHAV BRAIN RES, V174, P304, DOI 10.1016/j.bbr.2006.08.018; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Olman CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008160; Olsen RK, 2009, J NEUROSCI, V29, P11880, DOI 10.1523/JNEUROSCI.2245-09.2009; Olson IR, 2006, J COGNITIVE NEUROSCI, V18, P1087, DOI 10.1162/jocn.2006.18.7.1087; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Preston AR, 2010, J COGNITIVE NEUROSCI, V22, P156, DOI 10.1162/jocn.2009.21195; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Schobel SA, 2009, ARCH GEN PSYCHIAT, V66, P938, DOI 10.1001/archgenpsychiatry.2009.115; Schon K, 2004, J NEUROSCI, V24, P11088, DOI 10.1523/JNEUROSCI.3807-04.2004; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Small SA, 2000, MICROSC RES TECHNIQ, V51, P101, DOI 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H; Small SA, 2000, NEURON, V28, P653, DOI 10.1016/S0896-6273(00)00144-6; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; SUTHANA NA, 2009, NEUROIMAGE IN PRESS, DOI DOI 10.1016/J.NEUROIMAGE.2009.12.014; Suthana NA, 2009, J NEUROSCI, V29, P10512, DOI 10.1523/JNEUROSCI.0621-09.2009; SUZUKI WA, 1993, J NEUROSCI, V13, P2430, DOI 10.1523/JNEUROSCI.13-06-02430.1993; Tendolkar I, 2007, BRAIN RES, V1142, P159, DOI 10.1016/j.brainres.2007.01.040; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Van Cauter T, 2008, NEUROBIOL LEARN MEM, V90, P192, DOI 10.1016/j.nlm.2008.03.001; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Viskontas IV, 2009, HIPPOCAMPUS, V19, P265, DOI 10.1002/hipo.20503; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775; Zeineh MM, 2000, NEUROIMAGE, V11, P668, DOI 10.1006/nimg.2000.0561	114	133	135	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 11	2010	65	3					298	308		10.1016/j.neuron.2009.12.022	http://dx.doi.org/10.1016/j.neuron.2009.12.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159444	Bronze, Green Accepted			2022-12-17	WOS:000275185200004
J	Yong, VW; Rivest, S				Yong, V. Wee; Rivest, Serge			Taking Advantage of the Systemic Immune System to Cure Brain Diseases	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MARROW-DERIVED MICROGLIA; ALZHEIMERS-DISEASE; MOUSE MODEL; INNATE; CELLS; MONOCYTES; CNS; REGENERATION; ACTIVATION	The systemic immune system has the ability to modulate multiple brain functions, including autonomic responses, glial reactivity following neural injuries, and neuronal excitability. Immune stimuli also influence microglia subpopulations originating from blood progenitors, and neuroprotective and reparative capacities of blood-derived microglia, were recently described in mouse models of spinal cord injury and brain disorders. Furthermore, reparative roles for various immune subsets have been recognized, such as in inducing myelin repair. Nonetheless, uncontrolled and excessive activation of immune responses can be detrimental. The development of strategies to stimulate the systemic immune system safely to protect or repair brain disorders remains a major challenge ahead, but important inroads have been made. We discuss here some of the mechanisms underlying the neuroprotective and reparative effects of the systemic immune system and the most promising immunotherapies tested in mouse models of injuries and diseases, such as Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis.	[Yong, V. Wee] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Yong, V. Wee] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Yong, V. Wee] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Rivest, Serge] Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada; [Rivest, Serge] Univ Laval, CHUL Res Ctr, Lab Endocrinol & Genom, Quebec City, PQ G1V 4G2, Canada	University of Calgary; University of Calgary; University of Calgary; Laval University; Laval University	Yong, VW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	vyong@ucalgary.ca; serge.rivest@crchul.ulaval.ca		Rivest, Serge/0000-0002-6082-770X; Yong, V. Wee/0000-0002-2600-3563	Canadian Institutes of Health Research (CIHR); NeuroScience Canada; MS Society of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NeuroScience Canada; MS Society of Canada	The Canadian Institutes of Health Research (CIHR), NeuroScience Canada (Brain repair program), and the MS Society of Canada support this research. V.W.Y. and S.R. are both holders of the Canada Research Chair in Neuroimmunology.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Burt RK, 2009, LANCET NEUROL, V8, P244, DOI 10.1016/S1474-4422(09)70017-1; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Frenkel D, 2005, J CLIN INVEST, V115, P2423, DOI 10.1172/JCI23241; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; SKIHAR V, 2009, P NATL ACAD IN PRESS; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006	28	133	142	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 15	2009	64	1					55	60		10.1016/j.neuron.2009.09.035	http://dx.doi.org/10.1016/j.neuron.2009.09.035			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840549	Bronze			2022-12-17	WOS:000271454400011
J	Steinert, JR; Kopp-Scheinpflug, C; Baker, C; Challiss, RAJ; Mistry, R; Haustein, MD; Griffin, SJ; Tong, HX; Graham, BP; Forsythe, ID				Steinert, Joern R.; Kopp-Scheinpflug, Cornelia; Baker, Claire; Challiss, R. A. John; Mistry, Raj; Haustein, Martin D.; Griffin, Sarah J.; Tong, Huaxia; Graham, Bruce P.; Forsythe, Ian D.			Nitric Oxide Is a Volume Transmitter Regulating Postsynaptic Excitability at a Glutamatergic Synapse	NEURON			English	Article							LONG-TERM POTENTIATION; KV3.1 POTASSIUM CHANNEL; DENSITY PROTEIN PSD-95; AUDITORY BRAIN-STEM; RAT MEDIAL NUCLEUS; TRAPEZOID BODY; RELAXING FACTOR; AMPA RECEPTORS; TRANSMISSION; NEURONS	Neuronal nitric oxide synthase (nNOS) is broadly expressed in the brain and associated with synaptic plasticity through NMDAR-mediated calcium influx. However, its physiological activation and the mechanisms by which nitric oxide (NO) influences synaptic transmission have proved elusive. Here, we exploit the unique input-specificity of the calyx of Held to characterize NO modulation at this glutamatergic synapse in the auditory pathway. NO is generated in an activity-dependent manner by MNTB principal neurons receiving a calyceal synaptic input. It acts in the target neuron and adjacent inactive neurons to modulate excitability and synaptic efficacy, inhibiting postsynaptic Kv3 potassium currents (via phosphorylation), reducing EPSCs and so increasing action potential duration and reducing transmission fidelity. We conclude that NO serves as a volume transmitter and slow dynamic modulator, integrating spontaneous and evoked neuronal firing, thereby providing an index of global activity and regulating information transmission across a population of active and inactive neurons.	[Steinert, Joern R.; Baker, Claire; Haustein, Martin D.; Griffin, Sarah J.; Tong, Huaxia; Forsythe, Ian D.] Univ Leicester, Toxicol Unit, MRC, Leicester LE1 9HN, Leics, England; [Kopp-Scheinpflug, Cornelia] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biol 2, D-04103 Leipzig, Germany; [Challiss, R. A. John; Mistry, Raj] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Graham, Bruce P.] Univ Stirling, Dept Comp Sci & Math, Stirling FK9 4LA, Scotland	University of Leicester; Leipzig University; University of Leicester; University of Stirling	Forsythe, ID (corresponding author), Univ Leicester, Toxicol Unit, MRC, Hodgkin Bldg, Leicester LE1 9HN, Leics, England.	idf@le.ac.uk	Steinert, Joern/ABB-4561-2020; Steinert, Joern/A-6678-2008; Steinert, Joern R/AAI-2742-2020	Steinert, Joern/0000-0003-1640-0845; Steinert, Joern R/0000-0003-1640-0845; Kopp-Scheinpflug, Conny/0000-0002-8083-6232; Forsythe, Ian/0000-0001-8216-0419; Challiss, John/0000-0001-5506-2848	Medical Research Council; Deutsche Forschungsgemeinschaft [Ru 390/18-1]; Biotechnology and Biological Sciences Research Council; Deafness Research UK; MRC [MC_U132681855] Funding Source: UKRI; Medical Research Council [MC_U132681855] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deafness Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Thanks to Volko Straub for comments on a draft manuscript. We are grateful to Paul L. Huang for the generous provision of KN2 transgenic mice. This work was supported by the following organizations: Medical Research Council, Deutsche Forschungsgemeinschaft (Ru 390/18-1), Biotechnology and Biological Sciences Research Council, and Deafness Research UK.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; Billups B, 2005, J PHYSIOL-LONDON, V565, P885, DOI 10.1113/jphysiol.2005.086736; Billups B, 2005, NEUROSCI LETT, V382, P66, DOI 10.1016/j.neulet.2005.02.071; Billups B, 2002, PFLUG ARCH EUR J PHY, V444, P663, DOI 10.1007/s00424-002-0861-6; BINNS KE, 1995, VISUAL NEUROSCI, V12, P563, DOI 10.1017/S0952523800008452; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bollmann JH, 1998, J NEUROSCI, V18, P10409; Bon CLM, 2003, J NEUROSCI, V23, P1941; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brew HM, 2005, HEARING RES, V206, P116, DOI 10.1016/j.heares.2004.12.012; Bullock TH, 2005, SCIENCE, V310, P791, DOI 10.1126/science.1114394; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; CARNEVALE NT, 1987, J NEUROSCI METH, V19, P69, DOI 10.1016/0165-0270(87)90022-7; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dodson PD, 2002, J NEUROSCI, V22, P6953; Elezgarai I, 2003, NEUROSCIENCE, V118, P889, DOI 10.1016/S0306-4522(03)00068-X; Fessenden JD, 1999, J COMP NEUROL, V404, P52; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gyurko R, 2002, ENDOCRINOLOGY, V143, P2767, DOI 10.1210/en.143.7.2767; Hall CN, 2006, J PHYSIOL-LONDON, V577, P549, DOI 10.1113/jphysiol.2006.118380; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Hurt KJ, 2006, P NATL ACAD SCI USA, V103, P3440, DOI 10.1073/pnas.0511326103; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Joshi I, 2004, J NEUROSCI, V24, P183, DOI 10.1523/JNEUROSCI.1074-03.2004; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Lei SB, 2000, NAT NEUROSCI, V3, P559, DOI 10.1038/75729; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIBERMAN MC, 1984, J COMP NEUROL, V223, P163, DOI 10.1002/cne.902230203; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Moreschi OM, 2001, ICTP LECT NOTES, V3, P345; Mottola A, 2005, FASEB J, V19, P2075, DOI 10.1096/fj.05-4110fje; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3083, DOI 10.1152/jn.00126.2002; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; SOUTHAM E, 1993, NEUROPHARMACOLOGY, V32, P1267, DOI 10.1016/0028-3908(93)90021-T; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Tansey EP, 2002, HIPPOCAMPUS, V12, P137, DOI 10.1002/hipo.1104; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wong AYC, 2006, J NEUROPHYSIOL, V95, P3336, DOI 10.1152/jn.00694.2005	63	133	133	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 26	2008	60	4					642	656		10.1016/j.neuron.2008.08.025	http://dx.doi.org/10.1016/j.neuron.2008.08.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	382JX	19038221	Green Submitted, Bronze			2022-12-17	WOS:000261603200014
J	Jinushi-Nakao, S; Arvind, R; Amikura, R; Kinameri, E; Liu, AW; Moore, AW				Jinushi-Nakao, Shiho; Arvind, Ramanathan; Amikura, Reiko; Kinameri, Emi; Liu, Andrew Winston; Moore, Adrian Walton			Knot/Collier and cut control different aspects of dendrite cytoskeleton and synergize to define final arbor shape	NEURON			English	Article							HEREDITARY SPASTIC PARAPLEGIA; TRANSCRIPTION FACTORS; SENSORY NEURONS; DROSOPHILA; PROTEIN; MICROTUBULE; MECHANISMS; GROWTH; GENE; EXPRESSION	In a complex nervous system, neuronal functional diversity is reflected in the wide variety of dendritic arbor shapes. Different neuronal classes are defined by class-specific transcription factor combinatorial codes. We show that the combination of the transcription factors Knot and Cut is particular to Drosophila class IV dendritic arborization (da) neurons. Knot and Cut control different aspects of the dendrite cytoskeleton, promoting microtubule- and actin-based dendritic arbors, respectively. Knot delineates class IV arbor morphology by simultaneously synergizing with Cut to promote complexity and repressing Cut-mediated promotion of dendritic filopodia/spikes. Knot increases dendritic arbor outgrowth through promoting the expression of Spastin, a microtubule-severing protein disrupted in autosomal dominant hereditary spastic paraplegia (AD-HSP). Knot and Cut may modulate cellular mechanisms that are conserved between Drosophila and vertebrates. Hence, this study gives significant general insight into how multiple transcription factors combine to control class-specific dendritic arbor morphology through controlling different aspects of the cytoskeleton.	[Jinushi-Nakao, Shiho; Arvind, Ramanathan; Amikura, Reiko; Kinameri, Emi; Liu, Andrew Winston; Moore, Adrian Walton] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Moore, AW (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan.	adrianm@brain.riken.jp	Moore, Adrian Walton/AAN-5656-2021; Moore, Adrian W/A-3339-2013	Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Grabham PW, 2003, J CELL SCI, V116, P3739, DOI 10.1242/jcs.00686; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Iulianella A, 2003, GENE EXPR PATTERNS, V3, P571, DOI 10.1016/S1567-133X(03)00123-6; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; McMonagle P, 2004, NEUROLOGY, V62, P407, DOI 10.1212/01.WNL.0000108629.04434.05; Nestoras K, 1997, GENETICS, V147, P1203; Orgogozo V, 2004, MECH DEVELOP, V121, P427, DOI 10.1016/j.mod.2004.04.001; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	41	133	134	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					963	978		10.1016/j.neuron.2007.10.031	http://dx.doi.org/10.1016/j.neuron.2007.10.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093520	Bronze			2022-12-17	WOS:000252138000007
J	Lee, S; Zhou, ZJ				Lee, Seunghoon; Zhou, Z. Jimmy			The synaptic mechanism of direction selectivity in distal processes of starburst amacrine cells	NEURON			English	Article							RETINAL GANGLION-CELLS; TRANSMITTER RELEASE; CHOLINERGIC NEURONS; RABBIT RETINA; IMAGE MOTION; INHIBITION; COMPUTATION; RECEPTORS; DENDRITES; NETWORK	Patch-clamp recordings revealed that distal processes of starburst amacrine cells (SACs) received largely excitatory synaptic input from the receptive field center and nearly purely inhibitory inputs from the surround during both stationary and moving light stimulations. The direct surround inhibition was mediated mainly by reciprocal GABA(A) synapses between opposing SACs, which provided leading and prolonged inhibition during centripetal stimulus motion. Simultaneous Ca2+ imaging and current-clamp recording during apparent-motion stimulation further demonstrated the contributions of both centrifugal excitation and GABA(A/C)-receptor-mediated centripetal inhibition to the direction-selective Ca2+ responses in SAC distal processes. Thus, by placing GABA release sites in electrotonically semi-isolated distal processes and endowing these sites with reciprocal GABAA synapses, SACs use a radial-symmetric center-surround receptive field structure to build a polarasymmetric circuitry. This circuitry may integrate at least three levels of interactions-center excitation, surround inhibition, and reciprocal inhibitions that amplify the center-surround antagonism-to generate robust direction selectivity in the distal processes.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NEI NIH HHS [EY10894, EY017353, R01 EY017353, R01 EY010894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017353, R01EY010894] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; HUGHES A, 1972, VISION RES, V12, P123, DOI 10.1016/0042-6989(72)90143-5; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Munch TA, 2006, J NEUROPHYSIOL, V96, P471, DOI 10.1152/jn.00628.2005; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shields CR, 2000, J NEUROSCI, V20, P2673; TAUCHI M, 1985, J NEUROSCI, V5, P2494; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	38	133	133	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					787	799		10.1016/j.neuron.2006.08.007	http://dx.doi.org/10.1016/j.neuron.2006.08.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982423	Green Accepted, Bronze			2022-12-17	WOS:000240997900016
J	de la Prida, LM; Huberfeld, G; Cohen, I; Miles, R				de la Prida, LM; Huberfeld, G; Cohen, I; Miles, R			Threshold behavior in the initiation of hippocampal population bursts	NEURON			English	Article							RECURRENT COLLATERAL SYNAPSES; SPONTANEOUS NETWORK ACTIVITY; EPILEPTIFORM BURSTS; IN-VITRO; FIRING PATTERNS; HIGH POTASSIUM; SPINAL-CORD/; RAT; NEURONS; SYNCHRONIZATION	Hippocampal population discharges such as sharp waves, epileptiform firing, and GDPs recur at long and variable intervals. The mechanisms for their precise timing are not well understood. Here, we show that population bursts in the disinhibited CA3 region are initiated at a threshold level of population firing after recovery from a previous event. Each population discharge follows an active buildup period when synaptic traffic and cell firing increase to threshold levels. Single-cell firing can advance burst onset by increasing population firing to suprathreshold values. Population synchrony is suppressed when threshold frequencies cannot be reached due to reduced cellular excitability or synaptic efficacy. Reducing synaptic strength reveals partially synchronous population bursts that are curtailed by GABA(B)-mediated conductances. Excitatory glutamatergic transmission and delayed GABA(B)-mediated signals have opposing feedback effects on CA3 cell firing and so determine threshold behavior for population synchrony.	Univ Paris 06, INSERM, U739, CHU Pitie Salpetriere, F-75013 Paris, France; Hosp Ramon y Cajal, E-28034 Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario Ramon y Cajal	de la Prida, LM (corresponding author), Univ Paris 06, INSERM, U739, CHU Pitie Salpetriere, F-75013 Paris, France.	liset.m.prida@hrc.es	de la Prida, Liset M/O-1342-2013	de la Prida, Liset M/0000-0002-0160-6472; Cohen, Ivan/0000-0001-6046-5289; Miles, Richard/0000-0001-7303-0233	NIMH NIH HHS [MH54671] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agmon A, 2003, J NEUROSCI, V23, P3658; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; Ankri N, 1999, J NEUROSCI METH, V91, P83, DOI 10.1016/S0165-0270(99)00078-3; Aradi I, 2004, J NEUROSCI, V24, P9681, DOI 10.1523/JNEUROSCI.2800-04.2004; AYALA GF, 1973, BRAIN RES, V52, P1, DOI 10.1016/0006-8993(73)90647-1; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; CALVIN WH, 1972, BRAIN RES, V39, P71, DOI 10.1016/0006-8993(72)90786-X; CHAMBERLIN NL, 1990, J NEUROPHYSIOL, V64, P1000, DOI 10.1152/jn.1990.64.3.1000; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; COLOM LV, 1994, J NEUROPHYSIOL, V71, P1574, DOI 10.1152/jn.1994.71.4.1574; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 1999, J NEUROPHYSIOL, V82, P202, DOI 10.1152/jn.1999.82.1.202; de la Prida LM, 2000, NEUROSCIENCE, V97, P227, DOI 10.1016/S0306-4522(00)00029-4; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Grzywacz NM, 2000, VISUAL NEUROSCI, V17, P229, DOI 10.1017/S0952523800172050; HABLITZ JJ, 1984, J NEUROPHYSIOL, V51, P1011, DOI 10.1152/jn.1984.51.5.1011; IVES AE, 1990, NEUROSCI LETT, V112, P239, DOI 10.1016/0304-3940(90)90210-Z; Jack J, 1983, ELECT CURRENT FLOW E; JEFFERYS JGR, 1994, CURR OPIN NEUROL, V7, P113, DOI 10.1097/00019052-199404000-00007; KNOWLES WD, 1987, NEUROSCIENCE, V21, P441, DOI 10.1016/0306-4522(87)90134-5; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; LEUNG LWS, 1992, HIPPOCAMPUS, V2, P93, DOI 10.1002/hipo.450020202; Levy R, 2000, J NEUROSCI, V20, P7766; MASUKAWA LM, 1982, BRAIN RES, V242, P341, DOI 10.1016/0006-8993(82)90320-1; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Staley KJ, 2001, J NEUROPHYSIOL, V86, P2736, DOI 10.1152/jn.2001.86.6.2736; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Szucs A, 1998, J NEUROSCI METH, V81, P159, DOI 10.1016/S0165-0270(98)00033-8; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; TRAUB RD, 1990, J NEUROPHYSIOL, V64, P1009, DOI 10.1152/jn.1990.64.3.1009; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TRAUB RD, 1991, NEUROONAL NETWORKS H; Wenner P, 2001, J NEUROPHYSIOL, V86, P1481, DOI 10.1152/jn.2001.86.3.1481	51	133	135	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					131	142		10.1016/j.neuron.2005.10.034	http://dx.doi.org/10.1016/j.neuron.2005.10.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387645	Bronze, Green Submitted			2022-12-17	WOS:000236699300015
J	Bayley, PJ; Gold, JJ; Hopkins, RO; Squire, LR				Bayley, PJ; Gold, JJ; Hopkins, RO; Squire, LR			The neuroanatomy of remote memory	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; RETROGRADE-AMNESIA; AUTOBIOGRAPHICAL MEMORY; SEMANTIC DEMENTIA; EPISODIC MEMORY; VISUAL-IMAGERY; DAMAGE; PATIENT; IMPAIRMENT; CONSOLIDATION	In humans and experimental animals, damage to the hippocampus or related medial temporal lobe structures severely impairs the formation of new memory but typically spares very remote memory. Questions remain about the importance of these structures for the storage and retrieval of remote autobiographical memory. We carried out a detailed volumetric analysis of structural brain images from eight memory-impaired patients. Five of the patients had damage limited mainly to the medial temporal lobe. These patients performed normally on tests of remote autobiographical memory. Three patients had medial temporal lobe damage plus significant additional damage to neocortex, and these patients were severely impaired. These findings account for previously reported differences in the recollective ability of memory-impaired patients and demonstrate that the ability to recollect remote autobiographical events depends not on the medial temporal lobe but on widely distributed neocortical areas, especially the frontal, lateral temporal, and occipital lobes.	Univ Calif San Diego, La Jolla, CA 92093 USA; Brigham Young Univ, Provo, UT 84602 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Vet Adm Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; Brigham Young University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	lsquire@ucsd.edu			NIMH NIH HHS [R01 MH024600, MH 24600] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024600, R37MH024600] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bayley PJ, 2003, NEURON, V38, P135, DOI 10.1016/S0896-6273(03)00156-9; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Corkin S, 1997, J NEUROSCI, V17, P3964; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CROVITZ HF, 1974, B PSYCHONOMIC SOC, V4, P517; DUVERNOY H, 1991, HUMAN BRAIN; Eslinger PJ, 1998, NEUROCASE, V4, P481, DOI 10.1093/neucas/4.6.481; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; FUJII T, 2000, HDB NEUROPSYCHOLOGY, P223; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; Goodglass H, 1983, BOSTON NAMING TEST; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; HAYMAN CAG, 1993, J COGNITIVE NEUROSCI, V5, P375, DOI 10.1162/jocn.1993.5.4.375; Heaps CM, 2001, J EXP PSYCHOL LEARN, V27, P920, DOI 10.1037//0278-7393.27.4.920; Hermann BP, 1999, NEUROPSYCHOLOGY, V13, P3, DOI 10.1037/0894-4105.13.1.3; Hirano M, 2002, J CLIN EXP NEUROPSYC, V24, P548, DOI 10.1076/jcen.24.4.548.1041; Hirano M, 1998, PERCEPT MOTOR SKILL, V87, P99, DOI 10.2466/pms.1998.87.1.99; Insausti R, 1998, MICROSC RES TECHNIQ, V43, P8, DOI 10.1002/(SICI)1097-0029(19981001)43:1<8::AID-JEMT2>3.0.CO;2-4; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Kapur N, 1999, PSYCHOL BULL, V125, P800, DOI 10.1037/0033-2909.125.6.800; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; KARTSOUNIS LD, 1995, J NEUROL NEUROSUR PS, V59, P95, DOI 10.1136/jnnp.59.1.95; Kitchener EG, 1998, BRAIN, V121, P1313, DOI 10.1093/brain/121.7.1313; Kopelman MD, 2003, HIPPOCAMPUS, V13, P879, DOI 10.1002/hipo.10140; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Levy DA, 2004, P NATL ACAD SCI USA, V101, P6710, DOI 10.1073/pnas.0401679101; MACKINNON DF, 1989, PSYCHOBIOLOGY, V17, P247, DOI 10.1007/BF03337776; Mattis S, 1976, GERIATRIC PSYCHIAT, P77; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.0.CO;2-D; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; OGDEN JA, 1993, NEUROPSYCHOLOGIA, V31, P571, DOI 10.1016/0028-3932(93)90053-3; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Reed JM, 1998, J NEUROSCI, V18, P3943; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rosenbaum RS, 2004, NEUROPSYCHOLOGIA, V42, P1619, DOI 10.1016/j.neuropsychologia.2004.04.010; Rubin DC, 1998, P NATL ACAD SCI USA, V95, P5413, DOI 10.1073/pnas.95.9.5413; SAGAR HJ, 1985, ANN NY ACAD SCI, V444, P533, DOI 10.1111/j.1749-6632.1985.tb37637.x; Squire LR, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P691; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; Stark CEL, 2003, HIPPOCAMPUS, V13, P281, DOI 10.1002/hipo.10085; Stefanacci L, 2000, J NEUROSCI, V20, P7024, DOI 10.1523/JNEUROSCI.20-18-07024.2000; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P1581, DOI 10.1016/S0028-3932(00)00073-7; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Wechsler D., 1987, WECHSLER MEMORY SCAL; WECHSLER D, 1981, WECHSLER AUDLT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL; Westmacott R, 2001, NEUROCASE, V7, P37, DOI 10.1093/neucas/7.1.37; WITTGEN BJ, 2004, NEURON, V44, P101; ZOLAMORGAN S, 1983, NEUROPSYCHOLOGIA, V21, P487, DOI 10.1016/0028-3932(83)90005-2; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	66	133	138	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					799	810		10.1016/j.neuron.2005.04.034	http://dx.doi.org/10.1016/j.neuron.2005.04.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924865	Green Accepted, Bronze			2022-12-17	WOS:000229689800013
J	Sauman, I; Briscoe, AD; Zhu, HS; Shi, DD; Froy, O; Stalleicken, J; Yuan, Q; Casselman, A; Reppert, SM				Sauman, I; Briscoe, AD; Zhu, HS; Shi, DD; Froy, O; Stalleicken, J; Yuan, Q; Casselman, A; Reppert, SM			Connecting the navigational clock to sun compass input in monarch butterfly brain	NEURON			English	Article							CIRCADIAN CLOCK; POLARIZATION; CRYPTOCHROME; ORIENTATION; ULTRAVIOLET; MECHANISMS; SEQUENCE; OPSINS; PHOTORECEPTOR; LOCALIZATION	Migratory monarch butterflies (Danaus plexippus) use a time-compensated sun compass to navigate to their overwintering grounds in Mexico. Although polarized light: is one of the celestial cues used for orientation, the spectral content (color) of that light has not been fully explored. We cloned the cDNAs of three visual pigment-encoding opsins (ultraviolet [UV], blue, and long wavelength) and found that all three are expressed uniformly in main retina. The photoreceptors of the polarization-specialized dorsal rim area, on the other hand, are monochromatic for the UV opsin. Behavioral studies support the importance of polarized UV light for flight orientation. Next, we used clock protein expression patterns to identify the location of a ci-cadian clock in the dorsolateral protocerebrum of butterfly brain. To provide a link between the clock and the sun compass, we identified a CRYPTOCHROME-staining neural pathway that likely connects the circadian clock to polarized light input entering brain.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Comparat & Evolutionary Physiol Grp, Irvine, CA 92697 USA; Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, VW Nachwuchsgrp Anim Invest, D-26111 Oldenburg, Germany	University of Massachusetts System; University of Massachusetts Worcester; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of California System; University of California Irvine; Carl von Ossietzky Universitat Oldenburg	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	Steven.Reppert@umassmed.edu	Briscoe, Adriana/E-8963-2010; Sauman, Ivo/H-2071-2014; Froy, Oren/C-3550-2009	Briscoe, Adriana/0000-0001-8514-4983; Sauman, Ivo/0000-0002-3576-3222	NINDS NIH HHS [R01 NS047141] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barta A, 2004, J THEOR BIOL, V226, P429, DOI 10.1016/j.jtbi.2003.09.017; Batschelet E., 1981, CIRCULAR STAT BIOL; BRINES ML, 1979, SCIENCE, V206, P571, DOI 10.1126/science.206.4418.571; Briscoe A, 1999, AM ZOOL, V39, p134A; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2003, J COMP NEUROL, V458, P334, DOI 10.1002/cne.10582; Briscoe AD, 2001, MOL BIOL EVOL, V18, P2270, DOI 10.1093/oxfordjournals.molbev.a003773; Brower LP, 1996, J EXP BIOL, V199, P93; EDRICH W, 1979, J COMP PHYSIOL, V134, P151, DOI 10.1007/BF00610473; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; Frisch K., 1967, DANCE LANGUAGE ORIEN; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; HYATT MB, 1993, THESIS U PITTSBURGH; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; Kumar S, 2001, GENETICS, V158, P1321; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; LAMPEL J, 2005, IN PRESS CELL TISSUE; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Qi-Miao S, 2003, EUR J ENTOMOL, V100, P283, DOI 10.14411/eje.2003.044; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sauman Ivo, 1999, Entomological Science, V2, P589; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Waterman T.H., 1981, HDB SENSORY PHYSL, P281; Wehner R, 1997, EXS, V84, P145; Wehner R, 2001, J EXP BIOL, V204, P2589; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Wise S, 2002, J COMP NEUROL, V447, P366, DOI 10.1002/cne.10242; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711	49	133	137	5	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					457	467		10.1016/j.neuron.2005.03.014	http://dx.doi.org/10.1016/j.neuron.2005.03.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882645	Bronze			2022-12-17	WOS:000229011400017
J	Grishanin, RN; Kowalchyk, JA; Klenchin, VA; Kyougsook, A; Earles, CA; Chapman, ER; Gerona, RRL; Martin, TFJ				Grishanin, RN; Kowalchyk, JA; Klenchin, VA; Kyougsook, A; Earles, CA; Chapman, ER; Gerona, RRL; Martin, TFJ			CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein	NEURON			English	Article							CA2+-DEPENDENT ACTIVATOR PROTEIN; CHROMAFFIN CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; REGULATED EXOCYTOSIS; SECRETORY GRANULES; PLASMA-MEMBRANE; C2 DOMAINS; CALCIUM; RELEASE; SYNAPTOTAGMIN	CAPS-1 is required for Ca2+-triggered fusion of dense-core vesicles with the plasma membrane, but its site of action and mechanism are unknown. We analyzed the kinetics of Ca2+-triggered exocytosis reconstituted in permeable PC12 cells. CAPS-1 increased the initial rate of Ca2+-triggered vesicle exocytosis by acting at a rate-limiting, Ca2+-dependent prefusion step. CAPS-1 activity depended upon prior ATP-dependent priming during which PIP2 synthesis occurs. CAPS-1 activity and binding to the plasma membrane depended upon PIP2- Call Was ineffective in triggering vesicle fusion in the absence of CAPS-1 but instead promoted desensitization to CAPS-1 resulting from decreased plasma membrane PIP2. We conclude that CAPS-1 functions following ATP-dependent priming as a PIP2 binding protein to enhance Ca2+-dependent DCV exocytosis. Essential prefusion steps in dense-core vesicle exocytosis involve sequential ATP-dependent synthesis of PIP2 and the subsequent PIP2-dependent action of CAPS-1. Regulation of PIP2 levels and CAPS-1 activity would control the secretion of neuropeptides and monoaminergic transmitters.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@facstaff.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40428] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; AVERY L, 1993, GENETICS, V134, P454; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Barg S, 2001, J CELL SCI, V114, P2145; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Earles C, 1998, ANAL BIOCHEM, V264, P191, DOI 10.1006/abio.1998.2850; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Elhamdani A, 2000, J NEUROSCI, V20, P2495; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES PM, 1992, BIOCHEM J, V285, P973, DOI 10.1042/bj2850973; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; Krause M, 1995, METHOD CELL BIOL, V48, P513; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Ng YK, 2002, J NEUROSCI, V22, P3890, DOI 10.1523/JNEUROSCI.22-10-03890.2002; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SEWARD EP, 1995, J NEUROSCI, V15, P3390; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VANDERMERWE PA, 1990, BIOCHEM J, V268, P493, DOI 10.1042/bj2680493; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	64	133	137	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					551	562		10.1016/j.neuron.2004.07.028	http://dx.doi.org/10.1016/j.neuron.2004.07.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312653	Bronze			2022-12-17	WOS:000223436400013
J	Cui, ZZ; Wang, HM; Tan, YS; Zaia, KA; Zhang, SQ; Tsien, JZ				Cui, ZZ; Wang, HM; Tan, YS; Zaia, KA; Zhang, SQ; Tsien, JZ			Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain	NEURON			English	Article							FEAR-POTENTIATED STARTLE; PERIRHINAL CORTEX; RETROGRADE-AMNESIA; RECOGNITION MEMORY; CONDITIONED FEAR; CONTEXTUAL FEAR; CONSOLIDATION; HIPPOCAMPUS; LESIONS; EXPRESSION	Long-term storage of information is a hallmark feature of the brain, yet routine turnover of synaptic receptors appears to be intrinsically paradoxical to this capability. To investigate how the brain preserves its delicate synaptic efficacies, we generated inducible and reversible knockout mice in which the NMDA receptor can be temporarily switched off in the forebrain specifically during the storage stage. Retention of 9-month contextual and cued fear memories is severely disrupted by prolonged, but not transient, loss of the NMDA receptor that occurs 6 months after initial training and at least 2 months prior to memory retrieval. Normal learning and memory function in subsequent tasks following the 9-month retention tests suggest that the observed retention deficits did not result from recall or performance impairment. Thus, our study reveals a hitherto unrecognized role of the NMDA receptor in dynamically maintaining the long-term synaptic stability of memory storage circuits in the brain.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Tsien, JZ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jtsien@princeton.edu						Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bucci DJ, 2000, BEHAV NEUROSCI, V114, P882, DOI 10.1037//0735-7044.114.5.882; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; DAVIS M, 1987, ANXIETY AMYGDALA PHA; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FALLS WA, 1992, J NEUROSCI, V12, P854; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frey J U, 2001, Results Probl Cell Differ, V34, P27; Hedou G, 2003, PHILOS T R SOC B, V358, P797, DOI 10.1098/rstb.2002.1245; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lechner HA, 1999, LEARN MEMORY, V6, P77; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maren S, 1996, BEHAV NEUROSCI, V110, P718, DOI 10.1037/0735-7044.110.4.718; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pilzecker, 1900, Z PSYCHOL, V1, P1; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROSEN JB, 1992, J NEUROSCI, V12, P4624; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Squire L.R., 1987, MEMORY BRAIN; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Suzuki WA, 1996, CURR OPIN NEUROBIOL, V6, P179, DOI 10.1016/S0959-4388(96)80071-7; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 2000, SCI AM, V282, P62, DOI 10.1038/scientificamerican0400-62; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V123, P519, DOI 10.1111/j.1748-1716.1985.tb07621.x; Wittenberg GM, 2002, HIPPOCAMPUS, V12, P637, DOI 10.1002/hipo.10102; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Zola SM, 2001, HIPPOCAMPUS, V11, P92, DOI 10.1002/hipo.1027; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	60	133	142	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					781	793		10.1016/S0896-6273(04)00072-8	http://dx.doi.org/10.1016/S0896-6273(04)00072-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003177	Bronze			2022-12-17	WOS:000221458200013
J	Reddy, LV; Koirala, S; Sugiura, Y; Herrera, AA; Ko, CP				Reddy, LV; Koirala, S; Sugiura, Y; Herrera, AA; Ko, CP			Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo	NEURON			English	Article							PERISYNAPTIC SCHWANN-CELLS; PERIPHERAL-NERVE REGENERATION; RAT SOLEUS MUSCLE; EXTRACELLULAR-MATRIX; END-PLATE; ACETYLCHOLINE-RECEPTORS; NEUROTROPHIC FACTORS; TRANSMITTER RELEASE; FROG; TERMINALS	To investigate the in vivo role of glial cells in synaptic function, maintenance, and development, we have developed an approach to selectively ablate perisynaptic Schwann cells (PSCs), the glial cells at the neuromuscular junction (NMJ), en masse from live frog muscles. In adults, following acute PSC ablation, synaptic structure and function were not altered. However, 1 week after PSC ablation, presynaptic function decreased by approximately half, while postsynaptic function was unchanged. Retraction of nerve terminals increased over 10-fold at PSC-ablated NMJs. Furthermore, nerve-evoked muscle twitch tension was reduced. In tadpoles, repeated in vivo observations revealed that PSC processes lead nerve terminal growth. In the absence of PSCs, growth and addition of synapses was dramatically reduced, and existing synapses underwent widespread retraction. Our findings provide in vivo evidence that glial cells maintain presynaptic structure and function at adult synapses and are vital for the growth and stability of developing synapses.	Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Ko, CP (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	cko@usc.edu	Ko, Chien-Ping/AAN-2314-2020		NINDS NIH HHS [NS017954] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017954] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Astrow SH, 1998, J NEUROCYTOL, V27, P667, DOI 10.1023/A:1006916232627; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BIRKS R, 1960, J PHYSIOL-LONDON, V150, P145, DOI 10.1113/jphysiol.1960.sp006379; CARATSCH CG, 1994, NEUROSCI LETT, V166, P97, DOI 10.1016/0304-3940(94)90849-4; Castonguay A, 2001, Prog Brain Res, V132, P227; Castonguay A, 2001, J NEUROSCI, V21, P1911, DOI 10.1523/JNEUROSCI.21-06-01911.2001; CHEN LL, 1991, J NEUROSCI, V11, P2920; CHEN LL, 1994, J NEUROSCI, V14, P796; FALLON JR, 1985, J NEUROSCI, V5, P3169; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Fu Q, 1998, J NEUROCHEM, V71, P549; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; GRIM M, 1992, ANAT EMBRYOL, V186, P311; GRINNELL AD, 1980, J PHYSIOL-LONDON, V307, P301, DOI 10.1113/jphysiol.1980.sp013436; GRINNELL AD, 1991, RES NEUROL, V5, P151; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Herrera AA, 2000, J NEUROBIOL, V45, P237, DOI 10.1002/1097-4695(200012)45:4<237::AID-NEU5>3.0.CO;2-J; Hirata K, 1997, J NEUROCYTOL, V26, P799, DOI 10.1023/A:1018570500052; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; KELLY AM, 1969, J CELL BIOL, V42, P154, DOI 10.1083/jcb.42.1.154; KO CP, 1987, J NEUROCYTOL, V16, P567, DOI 10.1007/BF01668509; Ko CP, 1996, J NEUROSCI, V16, P1780; Koirala S, 2000, J NEUROBIOL, V44, P343, DOI 10.1002/1097-4695(20000905)44:3<343::AID-NEU5>3.0.CO;2-O; KOIRALA S, 2003, IN PRESS J NEUROCYTO; KRAUSE M, 1985, J NEUROCYTOL, V14, P765, DOI 10.1007/BF01170827; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Love FM, 1998, J NEUROSCI, V18, P9376; Lubischer JL, 1999, J NEUROSCI, V19, P8931, DOI 10.1523/JNEUROSCI.19-20-08931.1999; Macleod GT, 2001, J NEUROSCI, V21, P2380, DOI 10.1523/JNEUROSCI.21-07-02380.2001; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYER MM, 1961, EXPERIMENTAL IMMUNOC, P148; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Neethling FA, 1999, J IMMUNOL METHODS, V222, P31, DOI 10.1016/S0022-1759(98)00175-6; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Peng HB, 2003, J NEUROSCI, V23, P5050; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; RANDALL D, 2001, ANIMAL PHYSL, P379; REIST NE, 1992, P NATL ACAD SCI USA, V89, P7625, DOI 10.1073/pnas.89.16.7625; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; ROBITAILLE R, 2002, TRIPARTITE SYNAPSE, P224; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sendtner M, 1998, CYTOKINE GROWTH F R, V9, P1, DOI 10.1016/S1359-6101(97)00033-6; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SLATER CR, 1982, DEV BIOL, V94, P23, DOI 10.1016/0012-1606(82)90064-1; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Volterra A., 2002, TRIPARTITE SYNAPSE; WALPORT M, 1998, IMMUNOLOGY, P43; Werle MJ, 1996, J NEUROBIOL, V30, P293, DOI 10.1002/(SICI)1097-4695(199606)30:2<293::AID-NEU10>3.0.CO;2-L; Yang JF, 2001, J NEUROSCI, V21, P9572, DOI 10.1523/JNEUROSCI.21-24-09572.2001; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	65	133	137	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					563	580		10.1016/S0896-6273(03)00682-2	http://dx.doi.org/10.1016/S0896-6273(03)00682-2			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642280	Bronze			2022-12-17	WOS:000186379000015
J	Fan, XP; Labrador, JP; Hing, H; Bashaw, GJ				Fan, XP; Labrador, JP; Hing, H; Bashaw, GJ			Slit stimulation recruits Dock and Pak to the roundabout receptor and increases Rac activity to regulate axon repulsion at the CNS midline	NEURON			English	Article							ADAPTER PROTEIN; GUIDANCE RECEPTORS; DROSOPHILA CNS; ACTIN CYTOSKELETON; RHO GTPASES; C-ELEGANS; GROWTH; KINASE; ACTIVATION; CDC42	Drosophila Roundabout (Robo) is the founding member of a conserved family of repulsive axon guidance receptors that respond to secreted Slit proteins. Here we present evidence that the SH3-SH2 adaptor protein Dreadlocks (Dock), the p21-activated serine-threonine kinase (Pak), and the Rac1/Rac2/Mtl small GTPases can function during Robo repulsion. Loss-of-function and genetic interaction experiments suggest that limiting the function of Dock, Pak, or Rac partially disrupts Robo repulsion. In addition, Dock can directly bind to Robo's cytoplasmic domain, and the association of Dock and Robo is enhanced by stimulation with Slit. Furthermore, Slit stimulation can recruit a complex of Dock and Pak to the Robo receptor and trigger an increase in Rac1 activity. These results provide a direct physical link between the Robo receptor and an important cytoskeletal regulatory protein complex and suggest that Rac can function in both attractive and repulsive axon guidance.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 421 Curie Blvd, Philadelphia, PA 19104 USA.		Labrador, Juan Pablo/C-3018-2014	Labrador, Juan Pablo/0000-0003-3671-848X; Fan, Xueping/0000-0002-3715-6864	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046333] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS046333] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 1999, DEVELOPMENT, V126, P2475; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Desai CJ, 1999, DEVELOPMENT, V126, P1527; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Eby JJ, 1998, CURR BIOL, V8, P967, DOI 10.1016/S0960-9822(98)00398-4; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harden N, 1996, MOL CELL BIOL, V16, P1896; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kochhar KS, 1996, CANCER LETT, V104, P163, DOI 10.1016/0304-3835(96)04244-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Magie CR, 1999, DEVELOPMENT, V126, P5353; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	41	133	136	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					113	127		10.1016/S0896-6273(03)00591-9	http://dx.doi.org/10.1016/S0896-6273(03)00591-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527437	Bronze			2022-12-17	WOS:000185614700013
J	Wang, Q; Bardgett, ME; Wong, M; Wozniak, DF; Lou, JY; McNeil, BD; Chen, C; Nardi, A; Reid, DC; Yamada, K; Ornitz, DM				Wang, Q; Bardgett, ME; Wong, M; Wozniak, DF; Lou, JY; McNeil, BD; Chen, C; Nardi, A; Reid, DC; Yamada, K; Ornitz, DM			Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14	NEURON			English	Article							FACTOR HOMOLOGOUS FACTORS; BEHAVIORAL-RESPONSES; DOPAMINE-RECEPTORS; GENE-EXPRESSION; ANIMAL-MODELS; SYNAPSIN I; COCAINE; STRIATUM; AMPHETAMINE; DYSTONIA	Fibroblast growth factor 14 (FGF14) belongs to a distinct subclass of FGFs that is expressed in the developing and adult CNS. We disrupted the Fgf14 gene and introduced an Fgf(14N-beta-Gal) allele that abolished Fgf14 expression and generated a fusion protein (FGF14N-beta-gal) containing the first exon of FGF14 and P-galactosidase. Fgf14-deficient mice were viable, fertile, and anatomically normal, but developed ataxia and a paroxysmal hyperkinetic movement disorder. Neuropharmacological studies showed that Fgf14-deficient mice have reduced responses to dopamine agonists. The paroxysmal hyperkinetic movement disorder phenocopies a form of dystonia, a disease often associated with dysfunction of the putamen. Strikingly, the FGF14N-beta-gal chimeric protein was efficiently transported into neuronal processes in the basal ganglia and cerebellum. Together, these studies identify a novel function for FGF14 in neuronal signaling and implicate FGF14 in axonal trafficking and synaptosomal function.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ornitz, DM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	dornitz@pcg.wustl.edu	Nardi, Antonio E/A-7335-2014	Nardi, Antonio E/0000-0002-2152-4669; Chen, Chen/0000-0001-9159-4489; Ornitz, David/0000-0003-1592-7629; Bardgett, Mark/0000-0001-7028-2603; McNeil, Benjamin/0000-0001-7545-3598	NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011355] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIMOTO K, 1990, BRAIN RES, V507, P344, DOI 10.1016/0006-8993(90)90295-M; Alonso R, 1999, EUR J NEUROSCI, V11, P967, DOI 10.1046/j.1460-9568.1999.00506.x; Bahn S, 1997, P NATL ACAD SCI USA, V94, P9417, DOI 10.1073/pnas.94.17.9417; Bardgett ME, 1997, PSYCHOPHARMACOLOGY, V133, P142, DOI 10.1007/s002130050384; Bhatia KP, 1999, J NEUROL, V246, P149, DOI 10.1007/s004150050325; BrosnanWatters G, 1996, PHARMACOL BIOCHEM BE, V53, P701, DOI 10.1016/0091-3057(95)02073-X; BUTCHER SP, 1988, J NEUROCHEM, V50, P346, DOI 10.1111/j.1471-4159.1988.tb02919.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JF, 2000, NEUROSCIENCE, V97, P195, DOI 10.1016/S0306-4522(99)00604-1; CLARK M, 1992, BRAIN RES, V582, P101, DOI 10.1016/0006-8993(92)90322-Z; Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; FERGUSON IA, 1991, J COMP NEUROL, V313, P693, DOI 10.1002/cne.903130412; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Frantz KJ, 1999, PHARMACOL BIOCHEM BE, V64, P821, DOI 10.1016/S0091-3057(99)00162-8; Gernert M, 2000, J NEUROSCI, V20, P7052, DOI 10.1523/JNEUROSCI.20-18-07052.2000; GERSHANIK O, 1983, NEUROLOGY, V33, P1489, DOI 10.1212/WNL.33.11.1489; GeterDouglass B, 1997, J PHARMACOL EXP THER, V283, P7; Goldfarb M., 2001, SCI STKE, V106, ppe37; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jarman PR, 1998, J MED GENET, V35, P314, DOI 10.1136/jmg.35.4.314; Jones A, 1997, J NEUROSCI, V17, P1350; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; LeMoine C, 1997, J NEUROSCI, V17, P8038; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LOSCHER W, 1989, MOVEMENT DISORD, V4, P219, DOI 10.1002/mds.870040304; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nobrega JN, 1996, NEUROSCIENCE, V71, P927, DOI 10.1016/0306-4522(95)00511-0; Nobrega JN, 1999, NEUROSCIENCE, V92, P211, DOI 10.1016/S0306-4522(98)00753-2; Obeso JA, 2000, ANN NEUROL, V47, pS22; Ornitz DM, 2001, GENOME BIOL, V2; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Rehders JH, 2000, NEUROSCIENCE, V97, P267, DOI 10.1016/S0306-4522(00)00073-7; Richter A, 1998, PROG NEUROBIOL, V54, P633, DOI 10.1016/S0301-0082(97)00089-0; ROBERTSON GS, 1995, NEUROSCIENCE, V64, P1019, DOI 10.1016/0306-4522(94)00426-6; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Sheehan D.C., 1980, THEORY PRACTICE HIST, VSecond; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Smith Y, 2000, TRENDS NEUROSCI, V23, pS28, DOI 10.1016/S1471-1931(00)00023-9; Surmeier D J, 1998, Adv Pharmacol, V42, P1020; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; Todd RD, 1998, MOL NEUROBIOL, V16, P135, DOI 10.1007/BF02740641; USHIJIMA I, 1995, PHARMACOL BIOCHEM BE, V52, P737, DOI 10.1016/0091-3057(95)00167-U; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vidailhet Marie, 2000, Current Opinion in Neurology, V13, P457, DOI 10.1097/00019052-200008000-00015; Vitek JL, 2000, ANN NEUROL, V47, pS131; Waddington J.L., 1993, D1 D2 DOPAMINE RECEP; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wozniak DF, 1996, BRAIN RES, V707, P165, DOI 10.1016/0006-8993(95)01230-3; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; Yamamoto S, 1998, BBA-GENE STRUCT EXPR, V1398, P38, DOI 10.1016/S0167-4781(98)00050-5; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	67	133	137	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					25	38		10.1016/S0896-6273(02)00744-4	http://dx.doi.org/10.1016/S0896-6273(02)00744-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123606	Bronze			2022-12-17	WOS:000176601800008
J	Sereno, ME; Trinath, T; Augath, M; Logothetis, NK				Sereno, ME; Trinath, T; Augath, M; Logothetis, NK			Three-dimensional shape representation in monkey cortex	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; STRUCTURE-FROM-MOTION; VISUAL AREA MT; CORTICAL CONNECTIONS; RHESUS-MONKEY; INFEROTEMPORAL CORTEX; SURFACE ORIENTATION; POLYSENSORY AREA; MACAQUE; NEURONS	Using fMRI in anesthetized monkeys, this study investigates how the primate visual system constructs representations of three-dimensional (3D) shape from a variety of cues. Computer-generated 3D objects defined by shading, random dots, texture elements, or silhouettes were presented either statically or dynamically (rotating). Results suggest that 3D shape representations are highly localized, although widely distributed, in occipital, temporal, parietal, and frontal cortices and may involve common brain regions regardless of shape cue. This distributed network of areas cuts across both "what" and "where" processing streams, reflecting multiple uses for 3D shape representation in perception, recognition, and action.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	University of Oregon; Max Planck Society	Sereno, ME (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.	margaret.sereno@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019					ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURKE DS, 1986, ARBOVIRUSES EPIDEMIO, V3, P63; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gibson J.J., 1950, PERCEPTION VISUAL WO; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Lyon DC, 2001, J NEUROSCI, V21, P249, DOI 10.1523/JNEUROSCI.21-01-00249.2001; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Moore C, 2001, NEURON, V29, P277, DOI 10.1016/S0896-6273(01)00197-0; MOREL A, 1990, VISUAL NEUROSCI, V4, P555, DOI 10.1017/S0952523800005769; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Ringach DL, 1996, VISION RES, V36, P1479, DOI 10.1016/0042-6989(95)00285-5; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Saleem KS, 2000, J NEUROSCI, V20, P5083; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SELEMON LD, 1988, J NEUROSCI, V8, P4049; SELTZER B, 1989, J COMP NEUROL, V290, P451, DOI 10.1002/cne.902900402; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; SELTZER B, 1989, J COMP NEUROL, V281, P97, DOI 10.1002/cne.902810108; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno M. E., 1993, NEURAL COMPUTATION P; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	65	133	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					635	652		10.1016/S0896-6273(02)00598-6	http://dx.doi.org/10.1016/S0896-6273(02)00598-6			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856536	Bronze			2022-12-17	WOS:000173911100015
J	Krishnan, KS; Rikhy, R; Rao, S; Shivalkar, M; Mosko, M; Narayanan, R; Etter, P; Estes, PS; Ramaswami, M				Krishnan, KS; Rikhy, R; Rao, S; Shivalkar, M; Mosko, M; Narayanan, R; Etter, P; Estes, PS; Ramaswami, M			Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling	NEURON			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; DROSOPHILA-MELANOGASTER; TUMOR-METASTASIS; NEUROMUSCULAR-JUNCTIONS; TRANSMITTER RELEASE; LETHAL INTERACTION; ENZYMATIC-ACTIVITY; TYROSINE-KINASE; NERVE-TERMINALS; MELANOMA-CELLS	Nucleoside diphosphate kinase (NDK), an enzyme encoded by the Drosophila abnormal wing discs (awd) or human nm23 tumor suppressor genes, generates nucleoside triphosphates from respective diphosphates. We demonstrate that NDK regulates synaptic vesicle internalization at the stage where function of the dynamin GTPase is required, awd mutations lower the temperature at which behavioral paralysis, synaptic failure, and blocked membrane internalization occur at dynamin-deficient, shi(ts), mutant nerve terminals. Hypomorphic awd alleles display shi(ts)-like defects. NDK is present at synapses and its enzymatic activity is essential for normal presynaptic function. We suggest a model in which dynamin activity in nerve terminals is highly dependent on NDK-mediated supply of GTP. This connection between NDK and membrane internalization further strengthens an emerging hypothesis that endocytosis, probably of activated growth factor receptors, is an important tumor suppressor activity in vivo.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL, Div Neurobiol, Tucson, AZ 85721 USA; Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	University of Arizona; University of Arizona; Tata Institute of Fundamental Research (TIFR)	Ramaswami, M (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.		Rikhy, Richa/J-4481-2012	Rikhy, Richa/0000-0002-4262-0238; Ramaswami, Mani/0000-0001-7631-0468	NINDS NIH HHS [KO2-NS02001, NS34889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS002001, R01NS034889] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALAWI AA, 1971, SCIENCE, V172, P1055, DOI 10.1126/science.172.3987.1055; BABA H, 1995, CANCER RES, V55, P1977; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DEAROLF CR, 1988, DEV BIOL, V129, P159, DOI 10.1016/0012-1606(88)90170-4; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; ENGEL M, 1995, EUR J BIOCHEM, V234, P200, DOI 10.1111/j.1432-1033.1995.200_c.x; Engel M, 1998, J BIOL CHEM, V273, P20058, DOI 10.1074/jbc.273.32.20058; Estes PS, 1996, J NEUROSCI, V16, P5443; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Floyd S, 1998, TRENDS CELL BIOL, V8, P299, DOI 10.1016/S0962-8924(98)01316-6; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Fukuda M, 1996, INT J CANCER, V65, P531, DOI 10.1002/(SICI)1097-0215(19960208)65:4<531::AID-IJC23>3.0.CO;2-B; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grant D, 1998, GENETICS, V149, P1019; JONGEWARD GD, 1995, GENETICS, V139, P1553; KANTOR JD, 1993, CANCER RES, V53, P1971; KELLY LE, 1974, P NATL ACAD SCI USA, V71, P4906, DOI 10.1073/pnas.71.12.4906; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; Krishnan KS, 1996, J NEUROGENET, V10, P221, DOI 10.3109/01677069609083464; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEONE A, 1993, ONCOGENE, V8, P2325; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MacDonald NJ, 1996, J BIOL CHEM, V271, P25107, DOI 10.1074/jbc.271.41.25107; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; PALLANCK L, 1995, NATURE, V376, P25, DOI 10.1038/376025a0; PARHAR RS, 1995, INT J CANCER, V60, P204; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; POODRY CA, 1990, DEV BIOL, V138, P464, DOI 10.1016/0012-1606(90)90212-2; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; RANDAZZO PA, 1992, SCIENCE, V257, P862, DOI 10.1126/science.1323875; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STEEG PS, 1988, CANCER RES, V48, P6550; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Stimson DT, 1998, J NEUROSCI, V18, P9638; STURTEVANT AH, 1956, GENETICS, V41, P118; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TENG DHF, 1991, NATURE, V353, P437, DOI 10.1038/353437a0; TIMMONS L, 1995, J BIOL CHEM, V270, P23021, DOI 10.1074/jbc.270.39.23021; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Whistler JL, 1999, J BIOL CHEM, V274, P24575, DOI 10.1074/jbc.274.35.24575; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; Xu J, 1996, DEV BIOL, V177, P544, DOI 10.1006/dbio.1996.0184; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zhu JH, 1999, P NATL ACAD SCI USA, V96, P14911, DOI 10.1073/pnas.96.26.14911; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	83	133	134	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					197	210		10.1016/S0896-6273(01)00273-2	http://dx.doi.org/10.1016/S0896-6273(01)00273-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343655	Bronze			2022-12-17	WOS:000168412900021
J	Rohr, KB; Barth, KA; Varga, ZM; Wilson, SW				Rohr, KB; Barth, KA; Varga, ZM; Wilson, SW			The nodal pathway acts upstream of hedgehog signaling to specify ventral telencephalic identity	NEURON			English	Article							ONE-EYED-PINHEAD; PROSENCEPHALIC NEURAL PLATE; SONIC-HEDGEHOG; NEURONAL DIFFERENTIATION; MAMMALIAN TELENCEPHALON; EMBRYONIC ZEBRAFISH; NERVOUS-SYSTEM; GENE-FUNCTION; FLOOR PLATE; EXPRESSION	The Nodal and Hedgehog signaling pathways influence dorsoventral patterning at all axial levels of the CNS, but it remains largely unclear how these pathways interact to mediate patterning. Here we show that, in zebrafish, Nodal signaling is required for induction of the homeobox genes nk2. 1a in the ventral diencephalon and nk2.1b in the ventral telencephalon. Hedgehog signaling is also required for telencephalic nk2. 1b expression but may not be essential to establish diencephalic nk2. la expression. Furthermore, Shh does not restore ventral diencephalic development in embryos lacking Nodal activity. In contrast, Shh does restore telencephalic nk2.1b expression in the absence of Nodal activity, suggesting that Hedgehog signaling acts downstream of Nodal activity to pattern the ventral telencephalon. Thus, the Nodal pathway regulates ventral forebrain patterning through both Hedgehog signaling-dependent and -independent mechanisms.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Freiburg, Inst Biol Zool 1, Dept Dev Biol, D-79104 Freiburg, Germany	University of London; University College London; University of Freiburg	Wilson, SW (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	s.wilson@ucl.ac.uk	Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008	Wilson, Stephen W/0000-0002-8557-5940				Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Barth KA, 1999, DEVELOPMENT, V126, P4977; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Concordet JP, 1996, DEVELOPMENT, V122, P2835; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Fishell G, 1997, CURR OPIN NEUROBIOL, V7, P62, DOI 10.1016/S0959-4388(97)80121-3; Force A, 1999, GENETICS, V151, P1531; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; HATTA K, 1994, P NATL ACAD SCI USA, V91, P2061, DOI 10.1073/pnas.91.6.2061; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Huh SO, 1999, DEV BIOL, V211, P53, DOI 10.1006/dbio.1999.9303; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mione M, 2001, MECH DEVELOP, V100, P93, DOI 10.1016/S0925-4773(00)00501-3; Muller F, 2000, DEVELOPMENT, V127, P3889; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; Pera EM, 1997, DEVELOPMENT, V124, P4153; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Rohr KB, 2000, MECH DEVELOP, V95, P267, DOI 10.1016/S0925-4773(00)00345-2; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1996, DEVELOPMENT, V123, P165; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Sirotkin HI, 2000, CURR BIOL, V10, P1051, DOI 10.1016/S0960-9822(00)00679-5; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Strahle U, 1997, Genes Funct, V1, P131; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Sussel L, 1999, DEVELOPMENT, V126, P3359; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Thisse C, 1999, DEVELOPMENT, V126, P229; Toresson H, 1998, DEV GENES EVOL, V208, P431, DOI 10.1007/s004270050200; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Varlet I, 1997, DEVELOPMENT, V124, P1033; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	71	133	134	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					341	351		10.1016/S0896-6273(01)00210-0	http://dx.doi.org/10.1016/S0896-6273(01)00210-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239427	Bronze			2022-12-17	WOS:000167141700010
J	Erkman, L; Yates, PA; McLaughlin, T; McEvilly, RJ; Whisenhunt, T; O'Connell, SM; Krones, AI; Kirby, MA; Rapaport, DH; Bermingham, JR; O'Leary, DDM; Rosenfeld, MG				Erkman, L; Yates, PA; McLaughlin, T; McEvilly, RJ; Whisenhunt, T; O'Connell, SM; Krones, AI; Kirby, MA; Rapaport, DH; Bermingham, JR; O'Leary, DDM; Rosenfeld, MG			A POU domain transcription factor-dependent program regulates axon pathfinding in the vertebrate visual system	NEURON			English	Article							GANGLION-CELL DIFFERENTIATION; MOUSE OPTIC CHIASM; MESSENGER-RNA; LIM DOMAINS; TOPOGRAPHIC ORDER; ACTIN-BINDING; FACTOR BRN-3B; GUIDANCE; GENE; EXPRESSION	Axon pathfinding relies on the ability of the growth cone to detect and interpret guidance cues and to modulate cytoskeletal changes in response to these signals. We report that the murine POU domain transcription factor Brn-3.2 regulates pathfinding in retinal ganglion cell (RGC) axons at multiple points along their pathways and the establishment of topographic order in the superior colliculus. Using representational difference analysis, we identified Brn-3.2 gene targets likely to act on axon guidance at the levels of transcription, cell-cell interaction, and signal transduction, including the actin-binding LIM domain protein abLIM. We present evidence that abLIM plays a crucial role in RGC axon pathfinding, sharing functional similarity with its C. elegans homolog, UNC-115. Our findings provide insights into a Brn-3.2-directed hierarchical program linking signaling events to cytoskeletal changes required for axon pathfinding.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Loma Linda Univ, Dept Pediat & Anat, Loma Linda, CA 92350 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Loma Linda University	Erkman, L (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	lerkman@ucsd.edu; doleary@salk.edu; mrosenfeld@ucsd.edu		Kirby, Ph.D., Michael/0000-0002-0859-374X	NEI NIH HHS [EY07025, EY11875] Funding Source: Medline; NINDS NIH HHS [NS34934] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Certel SJ, 2000, DEVELOPMENT, V127, P2395; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Duggan A, 1998, DEVELOPMENT, V125, P4107; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erskine L, 2000, J NEUROSCI, V20, P4975; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; HOLT CE, 1989, J NEUROSCI, V9, P3123; Homburger SA, 1996, DEV DYNAM, V206, P112, DOI 10.1002/(SICI)1097-0177(199605)206:1<112::AID-AJA10>3.0.CO;2-7; Huang EJ, 1999, DEVELOPMENT, V126, P2869; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Kikuchi Y, 1997, NEURON, V18, P369, DOI 10.1016/S0896-6273(00)81239-8; KIRBY MA, 1988, DEV BRAIN RES, V44, P37, DOI 10.1016/0165-3806(88)90116-2; LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Marcus RC, 1999, J COMP NEUROL, V403, P346; MARCUS RC, 1995, J NEUROSCI, V15, P6389; McEvilly RJ, 2000, PROG NUCLEIC ACID RE, V63, P223, DOI 10.1016/S0079-6603(08)60724-2; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MCLOON SC, 1982, EXP BRAIN RES, V45, P277; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Niclou SP, 2000, J NEUROSCI, V20, P4962; Niwa H, 1997, ENDOCRINOLOGY, V138, P1419, DOI 10.1210/en.138.4.1419; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Seeger MA, 1999, CELL, V97, P821, DOI 10.1016/S0092-8674(00)80793-X; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Sretavan DW, 1998, J NEUROSCI, V18, P10502; Sze JY, 1997, DEVELOPMENT, V124, P1159; Tear G, 1999, TRENDS GENET, V15, P113, DOI 10.1016/S0168-9525(98)01686-2; THANOS S, 1984, J COMP NEUROL, V224, P407, DOI 10.1002/cne.902240308; Torres MA, 1996, DEVELOPMENT, V122, P3381; Tuttle R, 1998, DEVELOPMENT, V125, P791; Wang SS, 1997, J NEUROSCI, V17, P4149; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS RW, 1986, J COMP NEUROL, V246, P32, DOI 10.1002/cne.902460104; Williams RW, 1996, J NEUROSCI, V16, P7193; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; Zhu QZ, 1999, EXP NEUROL, V155, P228, DOI 10.1006/exnr.1998.6989	68	133	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					779	792		10.1016/S0896-6273(00)00153-7	http://dx.doi.org/10.1016/S0896-6273(00)00153-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163266	Bronze			2022-12-17	WOS:000166057500016
J	Fernandez, PA; Tang, DG; Cheng, LL; Prochiantz, A; Mudge, AW; Raff, MC				Fernandez, PA; Tang, DG; Cheng, LL; Prochiantz, A; Mudge, AW; Raff, MC			Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve	NEURON			English	Article							NEU DIFFERENTIATION FACTOR; NEURONAL SURVIVAL; PROGENITOR CELLS; GLIAL-CELLS; RECEPTORS; PROLIFERATION; BRAIN; EXPRESSION; ISOFORMS; LINEAGE	It was previously shown that newly formed oligodendrocytes depend on axons for their survival, but the nature of the axon-derived survival signal(s) remained unknown. We show here that neuregulin (NRG) supports the survival of purified oligodendrocytes and aged oligodendrocyte precursor cells (OPCs) but not of young OPCs. We demonstrate that axons promote the survival of purified oligodendrocytes and that this effect is inhibited if NRG is neutralized. In the developing rat optic nerve, we provide evidence that delivery of NRG decreases both normal oligodendrocyte death and the extra oligodendrocyte death induced by nerve transection, whereas neutralization of endogenous NRG increases the normal death. These results suggest that NRG is an axon-associated survival signal for developing oligodendrocytes.	UCL, MRC, Dev Neurobiol Programme, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Ecole Normale Super, CNRS, UMR 8542, F-75230 Paris 05, France	University of London; University College London; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Raff, MC (corresponding author), UCL, MRC, Dev Neurobiol Programme, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	dmcbmar@ucl.ac.uk	Messier, Claude/A-2322-2008; Tang, Dean/AAI-3457-2020	Messier, Claude/0000-0002-4791-1763; Tang, Dean/0000-0001-5029-1174				BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; BOYES BE, 1986, NEUROSCIENCE, V17, P857, DOI 10.1016/0306-4522(86)90050-3; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; BROCKES JP, 1980, J BIOL CHEM, V255, P8374; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Burne JF, 1996, J NEUROSCI, V16, P2064; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L; Canoll PD, 1999, MOL CELL NEUROSCI, V13, P79, DOI 10.1006/mcne.1998.0733; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; Cheng LL, 1998, MOL CELL NEUROSCI, V12, P141, DOI 10.1006/mcne.1998.0706; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; FULTON BP, 1992, J NEUROSCI, V12, P4816; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; HART IK, 1989, DEVELOPMENT, V105, P595; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Pollock GS, 1999, EUR J NEUROSCI, V11, P769, DOI 10.1046/j.1460-9568.1999.00484.x; Raabe TD, 1998, NEUROCHEM RES, V23, P311, DOI 10.1023/A:1022449231651; Raabe TD, 1997, J NEUROSCI RES, V50, P755; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; RAFF MC, 1978, CELL, V15, P720; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Shi JY, 1998, J NEUROSCI, V18, P4627; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; WOOD JN, 1981, BIOSCIENCE REP, V1, P263, DOI 10.1007/BF01114913	46	133	138	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	2000	28	1					81	90		10.1016/S0896-6273(00)00087-8	http://dx.doi.org/10.1016/S0896-6273(00)00087-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370VN	11086985	Bronze			2022-12-17	WOS:000165143500012
J	Messer, CJ; Eisch, AJ; Carlezon, WA; Whisler, K; Shen, L; Wolf, DH; Westphal, H; Collins, F; Russell, DS; Nestler, EJ				Messer, CJ; Eisch, AJ; Carlezon, WA; Whisler, K; Shen, L; Wolf, DH; Westphal, H; Collins, F; Russell, DS; Nestler, EJ			Role for GDNF in biochemical and behavioral adaptations to drugs of abuse	NEURON			English	Article							MESOLIMBIC DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; MICE LACKING GDNF; CHOLERA-TOXIN INFUSION; MESSENGER-RNA LEVELS; C-RET PROTOONCOGENE; NERVE GROWTH-FACTOR; CYCLIC-AMP SYSTEM; NEUROTROPHIC FACTOR; NUCLEUS-ACCUMBENS	The present study examined a role for GDNF in adaptations to drugs of abuse. Infusion of GDNF into the ventral tegmental area (VTA), a dopaminergic brain region important for addiction, blocks certain biochemical adaptations to chronic cocaine or morphine as well as the rewarding effects of cocaine. Conversely, responses to cocaine are enhanced in rats by intra-VTA infusion of an anti-GDNF antibody and in mice heterozygous for a null mutation in the GDNF gene. Chronic morphine or cocaine exposure decreases levels of phosphoRet, the protein kinase that mediates GDNF signaling, in the VTA. Together, these results suggest a feedback loop, whereby drugs of abuse decrease signaling through endogenous GDNF pathways in the VTA, which then increases the behavioral sensitivity to subsequent drug exposure.	Yale Univ, Sch Med, Lab Mol Psychiat, New Haven, CT 06508 USA; Yale Univ, Sch Med, Yale Ctr Genes & Behav, New Haven, CT 06508 USA; Connecticut Mental Hlth Ctr, New Haven, CT 06508 USA; NIH, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; Amgen	Nestler, EJ (corresponding author), Yale Univ, Sch Med, Lab Mol Psychiat, New Haven, CT 06508 USA.		; Wolf, Daniel/H-2581-2013	/0000-0002-4162-3947; Wolf, Daniel/0000-0002-9731-8781; Eisch, Amelia/0000-0001-6476-5385	NIDA NIH HHS [K08 DA000302-05] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA000302] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akerud P, 1999, J NEUROCHEM, V73, P70, DOI 10.1046/j.1471-4159.1999.0730070.x; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165; BEITNERJOHNSON D, 1991, J NEUROCHEM, V57, P344, DOI 10.1111/j.1471-4159.1991.tb02133.x; BEITNERJOHNSON D, 1993, J NEUROCHEM, V61, P1766, DOI 10.1111/j.1471-4159.1993.tb09814.x; Berhow MT, 1996, J NEUROSCI, V16, P4707; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Boundy VA, 1998, J NEUROSCI, V18, P9989; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; CHEAH TB, 1973, J NEUROBIOL, V4, P443, DOI 10.1002/neu.480040505; CUNNINGHAM ST, 1993, J NEUROSCI, V13, P2342, DOI 10.1523/JNEUROSCI.13-06-02342.1993; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Gash D M, 1998, Adv Pharmacol, V42, P911; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; GRAFSTEIN B, 1975, EXP NEUROL, V48, P32, DOI 10.1016/0014-4886(75)90170-3; Griesbeck O, 1996, COLD SPRING HARB SYM, V61, P77; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Horger BA, 1999, J NEUROSCI, V19, P4110; HURD YL, 1992, BRAIN RES, V578, P317, DOI 10.1016/0006-8993(92)90264-A; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kelley AE, 1997, SYNAPSE, V26, P46, DOI 10.1002/(SICI)1098-2396(199705)26:1<46::AID-SYN5>3.0.CO;2-E; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KOKAIA Z, 1993, MOL BRAIN RES, V19, P277, DOI 10.1016/0169-328X(93)90126-A; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lu X, 1997, J COMP NEUROL, V388, P484; MISERENDINO MJD, 1995, BRAIN RES, V674, P299, DOI 10.1016/0006-8993(95)00030-T; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Numan S, 1998, J NEUROSCI, V18, P10700; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Nye HE, 1996, MOL PHARMACOL, V49, P636; ORTIZ J, 1995, SYNAPSE, V21, P289, DOI 10.1002/syn.890210403; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pich EM, 1997, SCIENCE, V275, P83; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pilotte NS, 1997, CURR OPIN NEUROL, V10, P534, DOI 10.1097/00019052-199712000-00017; Robinson TE, 1997, J NEUROSCI, V17, P8491; Robinson TE, 1999, SYNAPSE, V33, P160; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Self DW, 1998, J NEUROSCI, V18, P1848; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; SORG BA, 1993, J PHARMACOL EXP THER, V266, P424; TAKAHASHI M, 1991, ONCOGENE, V6, P297; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; Vaidya VA, 1999, NEUROSCIENCE, V89, P157, DOI 10.1016/S0306-4522(98)00289-9; VRANA SL, 1993, J NEUROCHEM, V61, P2262, DOI 10.1111/j.1471-4159.1993.tb07468.x; Winkler C, 1996, J NEUROSCI, V16, P7206; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Xu RY, 1998, J NEUROCHEM, V70, P1383, DOI 10.1046/j.1471-4159.1998.70041383.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	64	133	163	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2000	26	1					247	257		10.1016/S0896-6273(00)81154-X	http://dx.doi.org/10.1016/S0896-6273(00)81154-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309MA	10798408	Green Accepted, Bronze			2022-12-17	WOS:000086770500024
J	Fayyazuddin, A; Villarroel, A; Le Goff, A; Lerma, J; Neyton, J				Fayyazuddin, A; Villarroel, A; Le Goff, A; Lerma, J; Neyton, J			Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors	NEURON			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; ZINC INHIBITION; AMINO-ACID; PROTEIN STRUCTURES; METAL SITES; CHANNEL; NEURONS; MODULATION; COMPLEX	NMDA receptors are allosterically inhibited by Zn2+ ions in a voltage-independent manner. The apparent affinity for Zn2+ of the heteromeric NMDA receptors is determined by the subtype of NR2 subunit expressed, with NR2A-containing receptors being the most sensitive (IC50, similar to 20 nM) and NR2C-containing receptors being the least sensitive (IC50, similar to 30 mu M). Using chimeras constructed from these two NR2 subtypes, we show that the N-terminal LIVBP-like domain of the NR2A subunit controls the high-affinity Zn2+ inhibition. Mutations at four residues in this domain markedly reduce Zn2+ affinity (by up to >500-fold) without affecting either receptor activation by glutamate and glycine or inhibition by extracellular protons and Ni2+ ions, indicating that these residues most likely participate in high-affinity Zn2+ binding.	CNRS, Ecole Normale Super, Neurobiol Lab, UMR 8544, F-75005 Paris, France; CSIC, Inst Cajal, E-28002 Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Neyton, J (corresponding author), CNRS, Ecole Normale Super, Neurobiol Lab, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.		Villarroel, Alvaro/H-5580-2015; Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199				Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; Buy C, 1996, BIOCHEMISTRY-US, V35, P9880, DOI 10.1021/bi960532l; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dingledine R, 1999, PHARMACOL REV, V51, P7; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; Horenstein J, 1998, MOL PHARMACOL, V53, P870; ISHII T, 1993, J BIOL CHEM, V268, P2836; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kashiwagi K, 1997, MOL PHARMACOL, V52, P701, DOI 10.1124/mol.52.4.701; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LIPPARD SJ, 1997, PRINCIPLES BIOCH MIN, V505, P641; Martell A. E., 1989, CRITICAL STABILITY C, V1; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; Paoletti P, 1997, J NEUROSCI, V17, P5711; PARK IS, 1995, SCIENCE, V267, P1156, DOI 10.1126/science.7855593; PARKER DR, 1995, CHEM EQUILIBRIUM REA; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Soloviev MM, 1996, J BIOL CHEM, V271, P32572, DOI 10.1074/jbc.271.51.32572; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; VIELES P, 1972, J CHIM PHYS PCB, V69, P869, DOI 10.1051/jcp/1972690869; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Volbeda A, 1996, CURR OPIN STRUC BIOL, V6, P804, DOI 10.1016/S0959-440X(96)80011-X; Weber WM, 1999, J MEMBRANE BIOL, V170, P1, DOI 10.1007/s002329900532; Williams K, 1995, MOL PHARMACOL, V48, P1087; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Zheng X, 1999, NEUROSCIENCE, V93, P125, DOI 10.1016/S0306-4522(99)00154-2	49	133	136	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2000	25	3					683	694		10.1016/S0896-6273(00)81070-3	http://dx.doi.org/10.1016/S0896-6273(00)81070-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774735	Green Submitted, Bronze			2022-12-17	WOS:000086291700020
J	Clyne, PJ; Certel, SJ; de Bruyne, M; Zaslavsky, L; Johnson, WA; Carlson, JR				Clyne, PJ; Certel, SJ; de Bruyne, M; Zaslavsky, L; Johnson, WA; Carlson, JR			The odor specificities of a subset of olfactory receptor neurons are governed by Acj6, a POU-domain transcription factor	NEURON			English	Article							RETINAL GANGLION-CELLS; DROSOPHILA-MELANOGASTER; C-ELEGANS; CHEMOSENSORY NEURONS; GENE-EXPRESSION; MAXILLARY PALP; SENSE-ORGANS; BRN-3 FAMILY; I-POU; PROTEIN	Little is known about how the odor specificities of olfactory neurons are generated, a process essential to olfactory coding. We have found that neuronal identity relies on the abnormal chemosensory jump 6 (acj6) gene, originally identified by a defect in olfactory behavior. Physiological analysis of individual olfactory neurons shows that in acj6 mutants, a subset of neurons acquires a different odorant response profile. Certain other neurons do not respond to any tested odors in acj6. Molecular analysis of acj6 shows that it encodes a POU-domain transcription factor expressed in olfactory neurons. Our data suggest that the odor response spectrum of an olfactory neuron, and perhaps the choice of receptor genes, is determined through a process requiring the action of Acj6.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Iowa, Coll Med, Genet Program, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Yale University; University of Iowa; University of Iowa	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.			Johnson, Wayne/0000-0002-6961-5498	NIDCD NIH HHS [DC-02174] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; ARORA K, 1987, NATURE, V330, P62, DOI 10.1038/330062a0; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; BILLIN AN, 1991, MECH DEVELOP, V34, P75, DOI 10.1016/0925-4773(91)90045-8; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DECICCO DV, 1984, CELL, V38, P45, DOI 10.1016/0092-8674(84)90525-7; DICK T, 1991, P NATL ACAD SCI USA, V88, P7645, DOI 10.1073/pnas.88.17.7645; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Getz WM, 1997, J COMP PHYSIOL A, V180, P701, DOI 10.1007/s003590050084; GUILLET JC, 1972, J INSECT PHYSIOL, V18, P2155, DOI 10.1016/0022-1910(72)90246-6; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; LIENHARD MC, 1991, DEVELOPMENT, V112, P1063; LLOYD A, 1991, MECH DEVELOP, V36, P87, DOI 10.1016/0925-4773(91)90075-H; Maniatis T., 1982, MOL CLONING LAB MANU; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; POOLE SJ, 1995, MECH DEVELOP, V49, P107, DOI 10.1016/0925-4773(94)00307-9; RAHA D, 1994, J NEUROBIOL, V25, P169, DOI 10.1002/neu.480250208; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; SINGH RN, 1985, INT J INSECT MORPHOL, V14, P291; THEIL T, 1993, NUCLEIC ACIDS RES, V21, P5921, DOI 10.1093/nar/21.25.5921; TREACY MN, 1992, CELL, V68, P491, DOI 10.1016/0092-8674(92)90186-G; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309; Wang SS, 1997, J NEUROSCI, V17, P4149; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/0307-4412(91), DOI 10.1016/0307-4412(91)]; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P596, DOI 10.1073/pnas.93.2.596; YANG XH, 1993, GENE DEV, V7, P504, DOI 10.1101/gad.7.3.504	51	133	140	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					339	347		10.1016/S0896-6273(00)81094-6	http://dx.doi.org/10.1016/S0896-6273(00)81094-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069339	Bronze			2022-12-17	WOS:000078875200018
J	Broillet, MC; Firestein, S				Broillet, MC; Firestein, S			Direct activation of the olfactory cyclic nucleotide-gated channel through modification of sulfhydryl groups by NO compounds	NEURON			English	Article							NITRIC-OXIDE; RECEPTOR NEURONS; FUNCTIONAL EXPRESSION; NITROGEN-DIOXIDE; CELLS	The activation of a cyclic nucleotide-gated channel is the final step in sensory transduction in olfaction. Normally, this channel is opened by the intracellular cyclic nucleotide second messenger cAMP or cGMP. However, in single channel recordings we found that donors of nitric oxide, a putative intercellular messenger, could directly activate the native olfactory neuron channel. Its action was independent of the presence of the normal ligand and did not involve the cyclic nucleotide binding site, suggesting an alternate site on the molecule that is critical in channel gating. The biochemical pathway appears to utilize nitric oxide in one of its alternate redox states, the nitrosonium ion, transnitrosylating a free sulfhydryl group belonging to a cysteine residue tentatively identified as being in the region linking the S6 transmembrane domain to the ligand binding domain.			Broillet, MC (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.			Broillet, Marie-Christine/0000-0002-0487-6638				BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; BUTLER AR, 1995, TRENDS PHARMACOL SCI, V16, P18, DOI 10.1016/S0165-6147(00)88968-3; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DONNER K, 1990, EXP EYE RES, V51, P97, DOI 10.1016/0014-4835(90)90176-U; DRYER SE, 1991, NATURE, V353, P756, DOI 10.1038/353756a0; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Firestein Stuart, 1994, Seminars in Cell Biology, V5, P39, DOI 10.1006/scel.1994.1006; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; JOCELYN PC, 1987, SULFUR SULFUR AMINO, P246; JOCELYN PC, 1987, SULFUR SULFUR AMINO, P44; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KENYON GL, 1977, ENZYME STRUCTURE, P407; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LEINDERSZUFALL T, 1995, NEUROREPORT, V6, P45; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LISCHKA FW, 1993, NEUROREPORT, V4, P582, DOI 10.1097/00001756-199305000-00031; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; PRYOR WA, 1981, SCIENCE, V214, P435, DOI 10.1126/science.214.4519.435; PRYOR WA, 1982, J ORG CHEM, V47, P156, DOI 10.1021/jo00340a038; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; ROSKAMS AJ, 1994, NEURON, V13, P289; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE FHJ, 1972, ENZYME STRUCTURE, P481; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481; ZHAO HQ, 1994, NEUROREPORT, V6, P149, DOI 10.1097/00001756-199412300-00038; ZUFALL F, 1991, J NEUROSCI, V11, P3573; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	42	133	137	3	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					377	385		10.1016/S0896-6273(00)80055-0	http://dx.doi.org/10.1016/S0896-6273(00)80055-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789952	hybrid			2022-12-17	WOS:A1996TW95700017
J	Grabner, M; Wang, ZY; Hering, S; Striessnig, J; Glossmann, H				Grabner, M; Wang, ZY; Hering, S; Striessnig, J; Glossmann, H			Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels	NEURON			English	Article							SKELETAL-MUSCLE; BETA-SUBUNIT; DIHYDROPYRIDINE RECEPTOR; SMOOTH-MUSCLE; CA2+ CHANNELS; FUNCTIONAL EXPRESSION; DEPENDENT MODULATION; ALPHA-1 SUBUNIT; MESSENGER-RNAS; ACTIVATION	L-type Ca2+ channels are characterized by their unique sensitivity to organic Ca2+ channel modulators like the 1,4-dihydropyridines (DHPs). To identify molecular motifs mediating DHP sensitivity, we transferred this sensitivity from L-type Ca2+ channels to the DHP-insensitive class A brain Ca2+ channel, BI-2. Expression of chimeras revealed minimum sequence stretches conferring DHP sensitivity including segments IIIS5, lllS6, and the connecting linker, as well as the IVS5-IVS6 linker plus segment IVS6. DHP agonist and antagonist effects are determined by different regions within the repeat IV motif. Sequence regions responsible for DHP sensitivity comprise only 9.4% of the overall primary structure of a DHP-sensitive alpha(1A)/alpha(1S) construct. This chimera fully exhibits the DHP sensitivity of channels formed by L-type alpha(1) subunits. In addition, it displays the electrophysiological properties of alpha(1A) as well as its sensitivity toward the peptide toxins omega-agatoxin IVA and omega-conotoxin MVIIC.			Grabner, M (corresponding author), UNIV INNSBRUCK, INST BIOCHEM PHARMAKOL, PETER MAYRSTR 1, A-6020 INNSBRUCK, AUSTRIA.		Striessnig, Joerg/S-9334-2017; Glossmann, Hartmut/AAL-9790-2020	Striessnig, Joerg/0000-0002-9406-7120; glossmann, hartmut h./0000-0002-7392-3266				BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BECHEM M, 1993, PFLUG ARCH EUR J PHY, V424, P343, DOI 10.1007/BF00384362; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; GINAP T, 1993, NEUROSCI LETT, V156, P35, DOI 10.1016/0304-3940(93)90433-L; Glossmann H., 1990, REV PHYSL BIOCH PHAR, V114, P1; GRABNER M, 1994, J BIOL CHEM, V269, P23668; GRABNER M, 1991, P NATL ACAD SCI USA, V88, P727, DOI 10.1073/pnas.88.3.727; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HERING S, 1989, CIRC RES, V64, P928, DOI 10.1161/01.RES.64.5.928; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P83; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUGHES AD, 1990, BRIT J PHARMACOL, V101, P3, DOI 10.1111/j.1476-5381.1990.tb12076.x; KAMP TJ, 1989, CIRC RES, V64, P338, DOI 10.1161/01.RES.64.2.338; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; LACERDA AE, 1989, J GEN PHYSIOL, V93, P1243, DOI 10.1085/jgp.93.6.1243; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MARKS TN, 1992, J GEN PHYSIOL, V99, P367, DOI 10.1085/jgp.99.3.367; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITTERDORFER J, 1995, BIOCHEMISTRY-US, V34, P9350, DOI 10.1021/bi00029a010; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; RANDALL A, 1995, J NEUROSCI, V15, P2995; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; STRUBING C, 1993, BRIT J PHARMACOL, V108, P884, DOI 10.1111/j.1476-5381.1993.tb13482.x; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1991, NATURE, V352, P800, DOI 10.1038/352800a0; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; TRIGGLE DJ, 1991, ANN NY ACAD SCI, V635, P123, DOI 10.1111/j.1749-6632.1991.tb36487.x; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WANG Z, 1995, J PHYSL, P131; WEI XY, 1991, J BIOL CHEM, V266, P21943; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	57	133	133	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					207	218		10.1016/S0896-6273(00)80037-9	http://dx.doi.org/10.1016/S0896-6273(00)80037-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562085	Bronze			2022-12-17	WOS:A1996TT30700023
J	BOUZAT, C; BREN, N; SINE, SM				BOUZAT, C; BREN, N; SINE, SM			STRUCTURAL BASIS OF THE DIFFERENT GATING KINETICS OF FETAL AND ADULT ACETYLCHOLINE-RECEPTORS	NEURON			English	Article							GLUTAMATE-OPERATED CHANNELS; MAMMALIAN BC3H-1 CELLS; EPSILON-SUBUNIT; NEUROMUSCULAR-JUNCTION; AGONIST; MUSCLE; FIBROBLASTS; ACTIVATION; EXPRESSION; FORMS	Structure-function studies have identified key functional motifs in the acetylcholine receptor, including residues that contribute to the ion channel and to the ligand-binding sites. Little is known, however, about determinants of channel gating kinetics. To identify structural correlates of gating, we examined the structual basis of the fetal-to-adult decrease in channel open time conferred by the presence of the epsilon subunit in place of the gamma subunit. By constructing chimeras composed of segments of the epsilon and gamma subunits, we shaw that the main determinant of this kinetic change is a 30 residue segment of a predicted amphipathic helix located between transmembrane domains M3 and M4. Further subdividing the amphipathic helix revealed that either multiple residues or its overall conformation confers this regulation of channel kinetics. We also show that L440 and M442, conserved residues within M4 of the gamma subunit, contribute to long duration openings characteristic of the fetal receptor.			BOUZAT, C (corresponding author), MAYO CLIN & MAYO FDN,DEPT PHYSIOL & BIOPHYS,RECEPTOR BIOL LAB,ROCHESTER,MN 55905, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31744] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CAMACHO P, 1993, J NEUROSCI, V13, P605; COCKCROFT VB, 1992, MOL NEUROBIOL, V4, P129; ENGEL AG, 1993, ANN NY ACAD SCI, V681, P496, DOI 10.1111/j.1749-6632.1993.tb22933.x; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; GARDNER PD, 1990, NUCLEIC ACIDS RES, V18, P6714, DOI 10.1093/nar/18.22.6714; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JACKSON MB, 1988, J PHYSIOL-LONDON, V397, P555, DOI 10.1113/jphysiol.1988.sp017019; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1991, J BIOL CHEM, V266, P13679; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; TAKAI T, 1985, NATURE, V315, P761, DOI 10.1038/315761a0	23	133	134	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1395	1402		10.1016/0896-6273(94)90424-3	http://dx.doi.org/10.1016/0896-6273(94)90424-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993630				2022-12-17	WOS:A1994PZ68900013
J	PUIA, G; COSTA, E; VICINI, S				PUIA, G; COSTA, E; VICINI, S			FUNCTIONAL DIVERSITY OF GABA-ACTIVATED CL- CURRENTS IN PURKINJE VERSUS GRANULE NEURONS IN RAT CEREBELLAR SLICES	NEURON			English	Article							INHIBITORY SYNAPTIC CURRENTS; SUBUNIT MESSENGER-RNAS; CENTRAL-NERVOUS-SYSTEM; RECEPTOR SUBUNIT; HIPPOCAMPAL-NEURONS; PATCH-CLAMP; BENZODIAZEPINE RECEPTORS; POSTSYNAPTIC CURRENTS; MOLECULAR-BIOLOGY; ALPHA-6 SUBUNIT	In rat cerebellar slices, we compared whole-cell recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) with Cl- currents resulting from pulses of GABA (1 mM, <2 ms) to outside-out patches from Purkinje and granule neurons. sIPSCs in Purkinje cells decayed with a single fast exponential, as previously reported, whereas in granule cells sIPSC decay was best described by the sum of a fast and a slow exponential curve, with a variable contribution of the slow component to the peak current. GABA pulses to nucleated patches from granule cells elicited Cl- currents with decays similar to sIPSC decays, whereas in patches from Purkinje neurons GABA pulses produced Cl- currents decaying largely with a fast component, but often followed by a slower exponential. GABA concentration steps produced rapidly desensitizing currents in patches from both cerebellar neurons. In distinct cerebellar neurons, specific functional properties of GABA(A) receptors may relate to the presence of distinct receptor subtypes.			PUIA, G (corresponding author), GEORGETOWN UNIV,SCH MED,GEORGETOWN INST NEUROSCI,FIDIA,WASHINGTON,DC 20007, USA.		Puja, Giulia/C-3540-2015	Puja, Giulia/0000-0001-8385-6020; Ribeiro, Jessyca/0000-0003-0068-0061; Vicini, Stefano/0000-0001-8671-5194	NIMH NIH HHS [NIMH R01 MH49486-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049486] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAUDE A, 1992, NEUROSCIENCE, V51, P739, DOI 10.1016/0306-4522(92)90513-2; BOVOLIN P, 1992, P NATL ACAD SCI USA, V89, P9344, DOI 10.1073/pnas.89.19.9344; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CACECI MS, 1984, BYTE, V9, P340; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; COSTA E, 1989, NEUROPSYCHOPHARMACOL, V2, P167, DOI 10.1016/0893-133X(89)90020-1; COSTA E, 1975, MECHANISM ACTION BEN, P113; CULLCANDY SG, 1987, BRAIN RES, V402, P182, DOI 10.1016/0006-8993(87)91065-1; DOBLE A, 1992, TRENDS PHARMACOL SCI, V13, P76, DOI 10.1016/0165-6147(92)90027-4; DUCIC I, 1993, EUR J PHARM-MOLEC PH, V244, P29, DOI 10.1016/0922-4106(93)90056-F; Eccles JC, 1967, CEREBELLUM NEURONAL; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; FROSCH MP, 1992, J NEUROSCI, V12, P3042, DOI 10.1523/JNEUROSCI.12-08-03042.1992; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMORI J, 1989, EXP BRAIN RES, V74, P471; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ito M, 1984, CEREBELLUM NEURAL CO; KLEINGOOR C, 1991, NEUROSCI LETT, V130, P169, DOI 10.1016/0304-3940(91)90389-B; KLEINGOOR C, 1993, NEUROREPORT, V4, P187, DOI 10.1097/00001756-199302000-00018; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MIERLAK D, 1988, J NEUROSCI, V8, P814; OH DJ, 1992, NEUROSCIENCE, V49, P571, DOI 10.1016/0306-4522(92)90227-S; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; Palay S.L., 1974, CEREBELLAR CORTEX CY; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; PUIA G, 1991, MOL PHARMACOL, V39, P691; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCHNEGGENBURGER R, 1992, J PHYSIOL-LONDON, V445, P261, DOI 10.1113/jphysiol.1992.sp018923; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469, DOI 10.1152/jn.1984.52.3.469; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; THOMPSON CL, 1992, NEUROSCI LETT, V144, P53, DOI 10.1016/0304-3940(92)90714-I; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VICINI S, 1985, J NEUROSCI, V5, P2212; VICINI S, 1986, P NATL ACAD SCI USA, V83, P9269, DOI 10.1073/pnas.83.23.9269; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; WISDEN W, 1992, J NEUROSCI, V12, P1040; YMER S, 1989, FEBS LETT, V258, P119, DOI 10.1016/0014-5793(89)81630-8	58	133	133	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					117	126		10.1016/0896-6273(94)90157-0	http://dx.doi.org/10.1016/0896-6273(94)90157-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292357				2022-12-17	WOS:A1994MU49300011
J	YAN, YM; LAGENAUR, C; NARAYANAN, V				YAN, YM; LAGENAUR, C; NARAYANAN, V			MOLECULAR-CLONING OF M6 - IDENTIFICATION OF A PLP/DM20 GENE FAMILY	NEURON			English	Article							MYELIN PROTEOLIPID PROTEIN; CENTRAL NERVOUS-SYSTEM; WHITE MATTER; CELL-DEATH; BRAIN; HYBRIDIZATION; MUTATION; SEQUENCE; NEURONS; MOUSE	M6 is a membrane glycoprotein that is expressed on central neurons and certain polarized epithelia from early developmental stage. Antibodies against M6 interfere with cerebellar neurite outgrowth in vitro. Two closely related cDNAs were obtained by expression cloning, both of which showed high homology with the major CNS myelin protein PLP/DM20. Although M6 and PLP/DM20 share many molecular characteristics, in situ hybridization revealed nonoverlapping distributions of their mRNAs in mouse CNS. The identification of a gene family including neuron-specific M6 and glia-specific PLP/DM20 in CNS suggests a broader functional role for these molecules than myelination.	CHILDRENS HOSP, DEPT PEDIAT, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	YAN, YM (corresponding author), UNIV PITTSBURGH, SCH MED, DEPT NEUROBIOL, PITTSBURGH, PA 15261 USA.			Narayanan, Vinodh/0000-0002-0658-3847	NINDS NIH HHS [CIDA-NS 01282] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001282] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P8; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; HENIKOFF S, 1984, GENE, V28, P357; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; Lees M.B., 1984, PROTEINS MYELIN, P197; LEES MB, 1983, ARCH BIOCHEM BIOPHYS, V226, P643, DOI 10.1016/0003-9861(83)90334-X; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; LUND RD, 1986, J COMP NEUROL, V247, P439, DOI 10.1002/cne.902470404; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; WAEHNELDT TV, 1987, COMP BIOCHEM PHYS B, V88, P1209, DOI 10.1016/0305-0491(87)90025-3; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x	37	133	138	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP	1993	11	3					423	431		10.1016/0896-6273(93)90147-J	http://dx.doi.org/10.1016/0896-6273(93)90147-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398137				2022-12-17	WOS:A1993LY49800003
J	KUWAJIMA, G; FUTATSUGI, A; NIINOBE, M; NAKANISHI, S; MIKOSHIBA, K				KUWAJIMA, G; FUTATSUGI, A; NIINOBE, M; NAKANISHI, S; MIKOSHIBA, K			2 TYPES OF RYANODINE RECEPTORS IN MOUSE-BRAIN - SKELETAL-MUSCLE TYPE EXCLUSIVELY IN PURKINJE-CELLS AND CARDIAC-MUSCLE TYPE IN VARIOUS NEURONS	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; HIPPOCAMPAL PYRAMIDAL NEURONS; SENSITIVE CALCIUM CHANNELS; SARCOPLASMIC-RETICULUM; FUNCTIONAL EXPRESSION; MICROSOMAL-MEMBRANES; CHICKEN CEREBELLUM; COMPLEMENTARY-DNA; P400 PROTEIN; LOCALIZATION	Two types of ryanodine receptors, channels for Ca2+ release from intracellular stores, are known. We detected the skeletal muscle type only in cerebellum by immunoblot analysis of microsomes and partially purified proteins. The cardiac muscle type was found in all parts of the mouse brain. Immunohistochemical study showed that the cardiac muscle type was localized mainly at the somata of most neurons. Analysis of mutant cerebella suggested that the skeletal muscle type was present exclusively in Purkinje cells. These results suggest that Ca2+-induced Ca2+ release, probably mediated by the cardiac muscle receptor, functions generally in various neurons, whereas depolarization-induced Ca2+ release, probably mediated by the skeletal muscle receptor, functions specifically in Purkinje cells.	OSAKA UNIV,INST PROT RES,DIV REGULAT MACROMOLEC FUNCT,SUITA,OSAKA 565,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO 108,JAPAN; JAPAN TOBACCO INC,PHARMACEUT BASIC RES LABS,KANAZAWA KU,YOKOHAMA 236,JAPAN	Osaka University; University of Tokyo; Japan Tobacco Inc.	KUWAJIMA, G (corresponding author), SHIONOGI INST MED SCI,2-5-1 MISHIMA,SETTSU,OSAKA 566,JAPAN.		Mikoshiba, Katsuhiko/N-7943-2015					AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AIREY JA, 1990, J BIOL CHEM, V265, P14187; ASHLEY RH, 1989, J MEMBRANE BIOL, V111, P179, DOI 10.1007/BF01871781; BENNETT J, 1986, BRIT MED BULL, V42, P385, DOI 10.1093/oxfordjournals.bmb.a072156; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; HERRUP K, 1983, DEV BRAIN RES, V11, P267, DOI 10.1016/0165-3806(83)90225-0; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; IMAGAWA T, 1989, J BIOCHEM-TOKYO, V106, P342, DOI 10.1093/oxfordjournals.jbchem.a122855; KAPRIELIAN Z, 1989, MOL BRAIN RES, V6, P55, DOI 10.1016/0169-328X(89)90028-4; KAWAI T, 1971, BRAIN RES, V540, P331; KITAGAWA T, 1982, METHODS IMMUNOLOGICA, V11, P3529; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MARTINEZSERRANO A, 1989, BIOCHEM BIOPH RES CO, V161, P965, DOI 10.1016/0006-291X(89)91337-5; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MICHELANGELI F, 1991, BIOCHEM J, V275, P555, DOI 10.1042/bj2750555; MIKOSHIBA K, 1986, TRH SPINOCEREBELLAR, V1, P125; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; NAKANISHI S, 1992, IN PRESS NEUROSCI RE; OSU K, 1990, J BIOL CHEM, V265, P13472; PADUA RA, 1991, BRAIN RES, V542, P135, DOI 10.1016/0006-8993(91)91007-N; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VOLPE P, 1990, NEURON, V5, P713, DOI 10.1016/0896-6273(90)90225-5; VOLPE P, 1991, EMBO J, V10, P3183, DOI 10.1002/j.1460-2075.1991.tb04880.x; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; ZIMANYI I, 1991, BRAIN RES, V561, P181, DOI 10.1016/0006-8993(91)91594-Q; ZUCKER RS, 1986, SCIENCE, V231, P574, DOI 10.1126/science.2868525	44	133	135	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1133	1142		10.1016/0896-6273(92)90071-K	http://dx.doi.org/10.1016/0896-6273(92)90071-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334420				2022-12-17	WOS:A1992KD71600011
J	UKOMADU, C; ZHOU, JY; SIGWORTH, FJ; AGNEW, WS				UKOMADU, C; ZHOU, JY; SIGWORTH, FJ; AGNEW, WS			MU-I NA+ CHANNELS EXPRESSED TRANSIENTLY IN HUMAN EMBRYONIC KIDNEY-CELLS - BIOCHEMICAL AND BIOPHYSICAL PROPERTIES	NEURON			English	Article								We describe the transient expression of the rat skeletal muscle mu-l Na+ channel in human embryonic kidney(HEK 293) cells. Functional channels appear at a density of approximately 30 in a 10-mu-m2 patch, comparable to those of native excitable cells. Unlike mu-l currents in oocytes, inactivation gating is predominantly (approximately 97%) fast, although clear evidence is provided for noninactivating gating modes, which have been linked to anomalous behavior in the inherited disorder hyperkalemic periodic paralysis. Sequence-specific antibodies detect a approximately 230 kd glycopeptide. The majority of molecules acquire only neutral oligosaccharides and are retained within the cell. Electrophoretic mobility on SDS gels suggests the molecules may acquire covalently attached lipid. The channel is readily phosphorylated by activation of the protein kinase A and protein kinase C second messenger pathways.			UKOMADU, C (corresponding author), YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA.				NHLBI NIH HHS [HL 38156] Funding Source: Medline; NINDS NIH HHS [NS 17928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEW WS, 1984, ANNU REV PHYSIOL, V46, P517; AGNEW WS, 1978, P NATL ACAD SCI USA, V75, P2606, DOI 10.1073/pnas.75.6.2606; AGNEW WS, 1980, BIOCHEM BIOPH RES CO, V92, P860, DOI 10.1016/0006-291X(80)90782-2; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1983, J NEUROCHEM, V40, P1377, DOI 10.1111/j.1471-4159.1983.tb13580.x; CALDWELL JH, 1988, J PHYSIOL-LONDON, V401, P145, DOI 10.1113/jphysiol.1988.sp017155; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CASADEI JM, 1986, J BIOL CHEM, V261, P4318; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAIMOVICH B, 1987, J NEUROSCI, V7, P2957; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LEVINSON SR, 1986, ANN NY ACAD SCI, V479, P162, DOI 10.1111/j.1749-6632.1986.tb15568.x; Maniatis T., 1982, MOL CLONING; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEPHAN M, 1991, Current Opinion in Cell Biology, V3, P676, DOI 10.1016/0955-0674(91)90041-V; THORNHILL WB, 1987, BIOCHEMISTRY-US, V26, P4381, DOI 10.1021/bi00388a029; TRIMMER JS, 1989, ANNU REV PHYSIOL, V51, P401, DOI 10.1146/annurev.physiol.51.1.401; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; YANG J, 1990, J NEUROCHEM, V54, P954, DOI 10.1111/j.1471-4159.1990.tb02343.x; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	42	133	135	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					663	676		10.1016/0896-6273(92)90088-U	http://dx.doi.org/10.1016/0896-6273(92)90088-U			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314619				2022-12-17	WOS:A1992HQ18800006
J	LOGOTHETIS, DE; MOVAHEDI, S; SATLER, C; LINDPAINTNER, K; NADALGINARD, B				LOGOTHETIS, DE; MOVAHEDI, S; SATLER, C; LINDPAINTNER, K; NADALGINARD, B			INCREMENTAL REDUCTIONS OF POSITIVE CHARGE WITHIN THE S4 REGION OF A VOLTAGE-GATED K+ CHANNEL RESULT IN CORRESPONDING DECREASES IN GATING CHARGE	NEURON			English	Article							POTASSIUM-CHANNEL; SODIUM-CHANNEL; FUNCTIONAL EXPRESSION; RAT-BRAIN; GENE FAMILY; CLONING; CDNA; DROSOPHILA; EXISTENCE; DIVERSITY	The S4 region of voltage-dependent ion channels is involved in the voltage-sensing mechanism of channel activation. Previous studies in fast inactivating channels have used non-steady-state measurements and thus have not allowed the quantitative assessment of activation parameters. Using site-directed mutagenesis and voltage-clamp recordings in a noninactivating channel (RCK1), we demonstrate that stepwise reductions of positive charge within the S4 region correlate with a progressive decrease in the channel's overall gating valence. In addition to testing for electrostatic behavior of individual charged residues, our study was designed to probe non-electrostatic influences on charge movement. We provide evidence that individual charged residues behave differentially in response to the electric field, so that purely electrostatic influences cannot fully account for the gating movement of certain charges.	HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LOGOTHETIS, DE (corresponding author), CHILDRENS HOSP MED CTR,DEPT QUANTUM CHEM,HOWARD HUGHES MED INST,BOSTON,MA 02115, USA.							Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; DOUGLASS J, 1990, J IMMUNOL, V144, P4841; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Hille B., 1984, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; KEYNES RD, 1974, J PHYSIOL-LONDON, V239, P393, DOI 10.1113/jphysiol.1974.sp010575; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STEVENS CF, 1987, PROTEINS EXCITABLE M, P99; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P9	37	133	134	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					531	540		10.1016/0896-6273(92)90281-H	http://dx.doi.org/10.1016/0896-6273(92)90281-H			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550676				2022-12-17	WOS:A1992HK67500013
J	NG, SC; DELAMONTE, SM; CONBOY, GL; KARNS, LR; FISHMAN, MC				NG, SC; DELAMONTE, SM; CONBOY, GL; KARNS, LR; FISHMAN, MC			CLONING OF HUMAN GAP-43 - GROWTH ASSOCIATION AND ISCHEMIC RESURGENCE	NEURON			English	Article									MASSACHUSETTS GEN HOSP,MED SERV,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,PATHOL SERV,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,NEUROL SERV,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	NG, SC (corresponding author), MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02114, USA.		de la monte, suzanne/L-7670-2019	de la monte, suzanne/0000-0001-5886-2306				AKERS RF, 1985, BRAIN RES, V334, P147, DOI 10.1016/0006-8993(85)90576-1; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ALOYO VJ, 1983, J NEUROCHEM, V41, P649, DOI 10.1111/j.1471-4159.1983.tb04790.x; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BELARDETTI F, 1986, P NATL ACAD SCI USA, V83, P7094, DOI 10.1073/pnas.83.18.7094; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BENOWITZ LI, 1983, J NEUROSCI, V3, P2153; Brierly J, 1984, GREENFIELDS NEUROPAT, P125; Cajal S. Ramon, 1928, DEGENERATION REGENER; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CIMLER BM, 1985, J BIOL CHEM, V260, P784; CIMLER BM, 1987, J BIOL CHEM, V262, P12158; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; KATER S, 1985, BIOL NERVE GROWTH CO; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NELSON RB, 1985, EXP NEUROL, V89, P213, DOI 10.1016/0014-4886(85)90277-8; NEVE RL, 1987, MOL BRAIN RES, V2, P177, DOI 10.1016/0169-328X(87)90012-X; Olney J.W., 1980, EXPT CLIN NEUROTOXIC, P272; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; REEVES R, 1986, P NATL ACAD SCI USA, V83, P3228, DOI 10.1073/pnas.83.10.3228; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1984, CELL, V37, P697; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	36	133	135	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1988	1	2					133	139		10.1016/0896-6273(88)90197-3	http://dx.doi.org/10.1016/0896-6273(88)90197-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	N3327	3272163				2022-12-17	WOS:A1988N332700005
J	Hudry, E; Vandenberghe, LH				Hudry, Eloise; Vandenberghe, Luk H.			Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality	NEURON			English	Review							RECOMBINANT ADENOASSOCIATED VIRUS; AMYOTROPHIC-LATERAL-SCLEROSIS; CONVECTION-ENHANCED DELIVERY; AMINO-ACID DECARBOXYLASE; BLOOD-BRAIN-BARRIER; SITE-SPECIFIC INTEGRATION; MPTP-LESIONED PRIMATES; LONG-TERM CORRECTION; NONHUMAN-PRIMATES; SPINAL-CORD	Gene transfer has long been a compelling yet elusive therapeutic modality. First mainly considered for rare inherited disorders, gene therapy may open treatment opportunities for more challenging and complex diseases such as Alzheimer's or Parkinson's disease. Today, examples of striking clinical proof of concept, the first gene therapy drugs coming onto the market, and the emergence of powerful new molecular tools have broadened the number of avenues to target neurological disorders but have also highlighted safety concerns and technology gaps. The vector of choice for many nervous system targets currently is the adeno-associated viral (AAV) vector due to its desirable safety profile and strong neuronal tropism. In aggregate, the clinical success, the preclinical potential, and the technological innovation have made therapeutic AAV drug development a reality, particularly for nervous system disorders. Here, we discuss the rationale, opportunities, limitations, and progress in clinical AAV gene therapy.	[Hudry, Eloise] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Hudry, Eloise] Harvard Med Sch, NeuroDiscovery Ctr, Boston, MA 02115 USA; [Vandenberghe, Luk H.] Schepens Eye Res Inst, Grousbeck Gene Therapy Ctr, Boston, MA 02114 USA; [Vandenberghe, Luk H.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Vandenberghe, Luk H.] Harvard Med Sch, Dept Ophthalmol, Ocular Genom Inst, Boston, MA 02115 USA; [Vandenberghe, Luk H.] Harvard Univ, Harvard Program Therapeut Sci, Cambridge, MA 02138 USA; [Vandenberghe, Luk H.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Vandenberghe, Luk H.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Schepens Eye Research Institute; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hudry, E (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.; Hudry, E (corresponding author), Harvard Med Sch, NeuroDiscovery Ctr, Boston, MA 02115 USA.; Vandenberghe, LH (corresponding author), Schepens Eye Res Inst, Grousbeck Gene Therapy Ctr, Boston, MA 02114 USA.; Vandenberghe, LH (corresponding author), Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.; Vandenberghe, LH (corresponding author), Harvard Med Sch, Dept Ophthalmol, Ocular Genom Inst, Boston, MA 02115 USA.; Vandenberghe, LH (corresponding author), Harvard Univ, Harvard Program Therapeut Sci, Cambridge, MA 02138 USA.; Vandenberghe, LH (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Vandenberghe, LH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	ehudry@mgh.harvard.edu; luk_vandenberghe@meei.harvard.edu	Vandenberghe, Luk H./J-6395-2014; VANDENBERGHE, LUC H./ABH-1765-2020	Vandenberghe, Luk H./0000-0002-3508-4924; VANDENBERGHE, LUC H./0000-0002-3508-4924	Foundation Fighting Blindness; Research to Prevent Blindness; Lonza Houston; Oxford Biomedica; Butler Family Foundation; Candyce Henwood Fund; Ush2a Consortium; National Institutes of Health NIA [1R56AG057454-01, 1R00AG047336-01A1]; NATIONAL INSTITUTE ON AGING [R00AG047336, P30AG062421] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Lonza Houston; Oxford Biomedica; Butler Family Foundation; Candyce Henwood Fund; Ush2a Consortium; National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Anna Maurer and Eric Zinn for the AAV capsid renderings in Figure 1 and Casey Maguire for valuable additional input about the biology of AAVs and their clinical application. This work was supported by grants from the Foundation Fighting Blindness, Research to Prevent Blindness, Lonza Houston, Oxford Biomedica, gifts from Giving/Grousbeck, the Butler Family Foundation, the Candyce Henwood Fund, the Ush2a Consortium (L.H.V.), and funding from the National Institutes of Health NIA (1R56AG057454-01 and 1R00AG047336-01A1) (E.H.).	Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Appu AP, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00161; Armbruster N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.60; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Bartus RT, 2011, MOVEMENT DISORD, V26, P27, DOI 10.1002/mds.23442; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bell P, 2005, MOL THER, V12, P299, DOI 10.1016/j.ymthe.2005.03.020; Belur LR, 2017, HUM GENE THER, V28, P576, DOI 10.1089/hum.2017.187; Benkhelifa-Ziyyat S, 2013, MOL THER, V21, P282, DOI 10.1038/mt.2012.261; Benraiss A, 2013, CELL STEM CELL, V12, P787, DOI 10.1016/j.stem.2013.04.014; Bey K, 2017, GENE THER, V24, P325, DOI 10.1038/gt.2017.18; Biferi MG, 2017, MOL THER, V25, P2038, DOI 10.1016/j.ymthe.2017.05.017; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Borel F, 2014, MOL THER, V22, P692, DOI 10.1038/mt.2013.285; Botta S, 2016, ELIFE, V5, DOI [10.7554/eLife/12242, 10.7554/eLife.12242]; Boulis NM, 2003, NEUROBIOL DIS, V14, P535, DOI 10.1016/j.nbd.2003.08.025; Broekman MLD, 2007, MOL THER, V15, P30, DOI 10.1038/sj.mt.6300004; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BURNS A, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B158; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Castle MJ, 2016, METHODS MOL BIOL, V1382, P133, DOI 10.1007/978-1-4939-3271-9_10; Castle MJ, 2014, HUM GENE THER, V25, P705, DOI 10.1089/hum.2013.189; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chakrabarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067680; Challis RC, 2019, NAT PROTOC, V14, P379, DOI 10.1038/s41596-018-0097-3; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Charlesworth CT, 2018, BIORXIV, DOI [10.1101/243345, DOI 10.1101/243345]; CHAUHAN AN, 1979, NEUROPATH APPL NEURO, V5, P303, DOI 10.1111/j.1365-2990.1979.tb00629.x; Chien YH, 2017, LANCET CHILD ADOLESC, V1, P265, DOI 10.1016/S2352-4642(17)30125-6; Choudhury SR, 2017, NEUROPHARMACOLOGY, V120, P63, DOI 10.1016/j.neuropharm.2016.02.013; Choudhury SR, 2016, MOL THER, V24, P1247, DOI 10.1038/mt.2016.84; Choudhury SR, 2016, MOL THER, V24, P726, DOI 10.1038/mt.2015.231; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Ciron C, 2009, HUM GENE THER, V20, P350, DOI 10.1089/hum.2008.155; Colle MA, 2010, HUM MOL GENET, V19, P147, DOI 10.1093/hmg/ddp475; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cukras C, 2018, MOL THER, V26, P2282, DOI 10.1016/j.ymthe.2018.05.025; Cummings Jeffrey, 2018, Alzheimers Dement (N Y), V4, P195, DOI 10.1016/j.trci.2018.03.009; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Dashkoff J, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.81; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Deverman BE, 2018, NAT REV DRUG DISCOV, V17, P641, DOI 10.1038/nrd.2018.110; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; DiCarlo JE, 2018, J CLIN INVEST, V128, P2177, DOI 10.1172/JCI120429; Dirren E, 2015, ANN CLIN TRANSL NEUR, V2, P167, DOI 10.1002/acn3.162; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Donsante A, 2018, EXPERT OPIN BIOL TH, V18, P755, DOI 10.1080/14712598.2018.1492544; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Dufour BD, 2014, MOL THER, V22, P797, DOI 10.1038/mt.2013.289; Dulon D, 2018, J CLIN INVEST, V128, P3382, DOI 10.1172/JCI94351; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Eichler F, 2017, NEW ENGL J MED, V377, P1630, DOI 10.1056/NEJMoa1700554; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Fiandaca MS, 2009, NEUROIMAGE, V47, pT27, DOI 10.1016/j.neuroimage.2008.11.012; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fisher KJ, 1996, J VIROL, V70, P520, DOI 10.1128/JVI.70.1.520-532.1996; Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; FRIEDMANN T, 1992, NAT GENET, V2, P93, DOI 10.1038/ng1092-93; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Garanto A, 2016, HUM MOL GENET, V25, P2552, DOI 10.1093/hmg/ddw118; Gasmi M, 2007, NEUROBIOL DIS, V27, P67, DOI 10.1016/j.nbd.2007.04.003; Geleoc GSG, 2014, SCIENCE, V344, P596, DOI 10.1126/science.1241062; Georgiou E, 2017, BRAIN, V140, P599, DOI 10.1093/brain/aww351; Gil-Farina I, 2016, MOL THER, V24, P1100, DOI 10.1038/mt.2016.52; Ginn SL, 2018, J GENE MED, V20, DOI 10.1002/jgm.3015; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Grimm D, 2017, HUM GENE THER, V28, P1075, DOI 10.1089/hum.2017.172; Grimm D, 2015, MOL THER, V23, P1819, DOI 10.1038/mt.2015.173; Guedon JMG, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0018-1; Gurda BL, 2016, MOL THER, V24, P206, DOI 10.1038/mt.2015.189; Gyorgy B, 2019, MOL THER-METH CLIN D, V13, P1, DOI 10.1016/j.omtm.2018.11.003; Gyorgy B, 2017, MOL THER, V25, P379, DOI 10.1016/j.ymthe.2016.12.010; Hadaczek P, 2006, HUM GENE THER, V17, P291, DOI 10.1089/hum.2006.17.291; Hadaczek P, 2010, MOL THER, V18, P1458, DOI 10.1038/mt.2010.106; Hampel H, 2018, BRAIN, V141, P1917, DOI 10.1093/brain/awy132; Han CL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1139-z; Hardcastle N, 2018, EXPERT OPIN BIOL TH, V18, P293, DOI 10.1080/14712598.2018.1416089; Harmatz P, 2018, MOL GENET METAB, V123, pS59, DOI 10.1016/j.ymgme.2017.12.143; Hastie E, 2015, HUM GENE THER, V26, P257, DOI 10.1089/hum.2015.025; Haurigot V, 2013, J CLIN INVEST, V123, P3254, DOI 10.1172/JCI66778; Herzog CD, 2007, MOVEMENT DISORD, V22, P1124, DOI 10.1002/mds.21503; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Hinderer C, 2018, HUM GENE THER, V29, P15, DOI 10.1089/hum.2017.026; Hinderer C, 2016, HUM GENE THER, V27, P906, DOI 10.1089/hum.2016.101; Hironaka K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13104; Hocquemiller M, 2016, HUM GENE THER, V27, P478, DOI 10.1089/hum.2016.087; Hollis ER, 2008, MOL THER, V16, P296, DOI 10.1038/sj.mt.6300367; Holt JR, 2012, MOL THER, V20, P1836, DOI 10.1038/mt.2012.196; Hordeaux J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0464-2; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; Hoshino H, 2014, PEDIATR INT, V56, P477, DOI 10.1111/ped.12422; Hudry E, 2016, GENE THER, V23, P380, DOI 10.1038/gt.2016.11; Hudry E, 2018, MOL THER-METH CLIN D, V10, P197, DOI 10.1016/j.omtm.2018.07.006; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Hwu WL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003640; Isgrig K, 2017, MOL THER, V25, P780, DOI 10.1016/j.ymthe.2017.01.007; Iwata N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01472; Jackson KL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00116; Janson C, 2002, HUM GENE THER, V13, P1391, DOI 10.1089/104303402760128612; Janson CG, 2006, NEUROPEDIATRICS, V37, P209, DOI 10.1055/s-2006-924734; Jergova S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00406; Johnston LC, 2009, HUM GENE THER, V20, P497, DOI 10.1089/hum.2008.137; Kanaan NM, 2017, MOL THER-NUCL ACIDS, V8, P184, DOI 10.1016/j.omtn.2017.06.011; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Karumuthil-Melethil S, 2016, J NEUROSCI RES, V94, P1138, DOI 10.1002/jnr.23882; KEELER CE, 1947, J HERED, V38, P294; Kennedy LH, 2017, JOVE-J VIS EXP, DOI 10.3791/56237; Keppeler D, 2018, EMBO J, V37, DOI 10.15252/embj.201899649; Khabou H, 2018, HUM GENE THER, V29, P1235, DOI 10.1089/hum.2018.144; Knipe DM, 2013, FIELDS VIROLOGY; Koh W, 2017, EXP NEUROBIOL, V26, P350, DOI 10.5607/en.2017.26.6.350; Kordower JH, 2006, ANN NEUROL, V60, P706, DOI 10.1002/ana.21032; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Landegger LD, 2017, NAT BIOTECHNOL, V35, P280, DOI 10.1038/nbt.3781; Laoharawee K, 2018, MOL THER, V26, P1127, DOI 10.1016/j.ymthe.2018.03.002; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; Leone P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003454; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Li DX, 2017, NEUROSCIENCE, V365, P192, DOI 10.1016/j.neuroscience.2017.10.001; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Liu GM, 2005, J NEUROSCI, V25, P9321, DOI 10.1523/JNEUROSCI.2936-05.2005; Low K, 2013, HUM GENE THER, V24, P613, DOI 10.1089/hum.2012.174; Logan GJ, 2017, NAT GENET, V49, P1267, DOI 10.1038/ng.3893; Lukason M, 2011, MOL THER, V19, P260, DOI 10.1038/mt.2010.230; Ma XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22404; MacLachlan TK, 2011, MOL THER, V19, P326, DOI 10.1038/mt.2010.258; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; Mastakov MY, 2002, MOL THER, V5, P371, DOI 10.1006/mthe.2002.0564; Matalon R, 2003, MOL THER, V7, P580, DOI 10.1016/S1525-0016(03)00066-2; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; McCarty DM, 2009, GENE THER, V16, P1340, DOI 10.1038/gt.2009.85; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; McCurdy VJ, 2015, GENE THER, V22, P181, DOI 10.1038/gt.2014.108; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; McPhee SWJ, 2005, MOL BRAIN RES, V135, P112, DOI 10.1016/j.molbrainres.2004.12.007; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Meyer K, 2015, MOL THER, V23, P477, DOI 10.1038/mt.2014.210; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; Miller JW, 2018, MOL THER, V26, P2081, DOI 10.1016/j.ymthe.2018.08.003; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135; Murrey DA, 2014, HUM GENE THER CL DEV, V25, P72, DOI 10.1089/humc.2013.208; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nault JC, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1095271; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Pan B, 2017, NAT BIOTECHNOL, V35, P264, DOI 10.1038/nbt.3801; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Peden MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017140; Pillay S, 2017, CURR OPIN VIROL, V24, P124, DOI 10.1016/j.coviro.2017.06.003; Platt FM, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0025-4; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pleger ST, 2011, SCI TRANSL MED, V92, P64; Rafii MS, 2018, JAMA NEUROL, V75, P834, DOI 10.1001/jamaneurol.2018.0233; Rafii MS, 2014, ALZHEIMERS DEMENT, V10, P571, DOI 10.1016/j.jalz.2013.09.004; Reichel FF, 2017, MOL THER, V25, P2648, DOI 10.1016/j.ymthe.2017.08.018; Rigotti DJ, 2011, AM J NEURORADIOL, V32, P1011, DOI 10.3174/ajnr.A2452; Rockwell HE, 2015, ASN NEURO, V7, DOI 10.1177/1759091415569908; Rosario AM, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.26; Rosenberg JB, 2018, HUM GENE THER CL DEV, V29, P24, DOI 10.1089/humc.2017.231; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; Sanchez-Pernaute R, 2001, MOL THER, V4, P324, DOI 10.1006/mthe.2001.0466; Saraiva J, 2016, J CONTROL RELEASE, V241, P94, DOI 10.1016/j.jconrel.2016.09.011; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Shibata SB, 2016, AM J HUM GENET, V98, P1101, DOI 10.1016/j.ajhg.2016.03.028; Sondhi D, 2012, HUM GENE THER METHOD, V23, P324, DOI 10.1089/hgtb.2012.120; Srivastava A, 2017, HUM GENE THER, V28, P323, DOI 10.1089/hum.2016.147; Stein-Streilein J, 2013, INT REV IMMUNOL, V32, P42, DOI 10.3109/08830185.2012.740535; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Takahashi K, 2017, MOL THER, V25, P296, DOI 10.1016/j.ymthe.2016.10.008; TALLAN HH, 1957, J BIOL CHEM, V224, P41; Tao Y, 2018, HUM GENE THER, V29, P492, DOI 10.1089/hum.2017.120; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Taschenberger G, 2017, MOL THER-NUCL ACIDS, V8, P13, DOI 10.1016/j.omtn.2017.03.009; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Trapani I, 2018, TRENDS MOL MED, V24, P669, DOI 10.1016/j.molmed.2018.06.006; Tse LV, 2017, P NATL ACAD SCI USA, V114, pE4812, DOI 10.1073/pnas.1704766114; Vandamme C, 2017, HUM GENE THER, V28, P1061, DOI 10.1089/hum.2017.150; Vandenberghe LH, 2012, GENE THER, V19, P162, DOI 10.1038/gt.2011.151; Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170; Vandenberghe LH, 2007, CURR GENE THER, V7, P325, DOI 10.2174/156652307782151416; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Walia JS, 2015, MOL THER, V23, P414, DOI 10.1038/mt.2014.240; Wang DB, 2010, MOL THER, V18, P2064, DOI 10.1038/mt.2010.191; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Wang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182473; Wang LJ, 2002, J NEUROSCI, V22, P6920; Wang PR, 2012, P NATL ACAD SCI USA, V109, P11264, DOI 10.1073/pnas.1117032109; Wassmer SJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45329; Watakabe A, 2015, NEUROSCI RES, V93, P144, DOI 10.1016/j.neures.2014.09.002; Weismann CM, 2015, HUM MOL GENET, V24, P4353, DOI 10.1093/hmg/ddv168; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Williams CL, 2017, MOL THER, V25, P904, DOI 10.1016/j.ymthe.2017.02.006; Wolf DA, 2012, MOL GENET METAB, V106, P131, DOI 10.1016/j.ymgme.2012.02.006; Wolf DA, 2011, NEUROBIOL DIS, V43, P123, DOI 10.1016/j.nbd.2011.02.015; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wrobel C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0540; Wu P, 1998, J VIROL, V72, P5919, DOI 10.1128/JVI.72.7.5919-5926.1998; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yamashita T, 2013, EMBO MOL MED, V5, P1710, DOI 10.1002/emmm.201302935; Yang B, 2014, MOL THER, V22, P1299, DOI 10.1038/mt.2014.68; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yoshimura H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21233-z; Zerah M, 2015, HUM GENE THER CL DEV, V26, P113, DOI 10.1089/humc.2014.139; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zhong L, 2013, HUM GENE THER, V24, P520, DOI 10.1089/hum.2012.112; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019	240	132	142	8	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2019	101	5					839	862		10.1016/j.neuron.2019.02.017	http://dx.doi.org/10.1016/j.neuron.2019.02.017			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN7UQ	30844402	Bronze			2022-12-17	WOS:000460398100011
J	Beckervordersandforth, R; Ebert, B; Schaffner, I; Moss, J; Fiebig, C; Shin, J; Moore, DL; Ghosh, L; Trinchero, MF; Stockburger, C; Friedland, K; Steib, K; von Wittgenstein, J; Keiner, S; Redecker, C; Holter, SM; Xiang, W; Wurst, W; Jagasia, R; Schinder, AF; Ming, GL; Toni, N; Jessberger, S; Song, HJ; Lie, DCC				Beckervordersandforth, Ruth; Ebert, Birgit; Schaeffner, Iris; Moss, Jonathan; Fiebig, Christian; Shin, Jaehoon; Moore, Darcie L.; Ghosh, Laboni; Trinchero, Mariela F.; Stockburger, Carola; Friedland, Kristina; Steib, Kathrin; von Wittgenstein, Julia; Keiner, Silke; Redecker, Christoph; Hoelter, Sabine M.; Xiang, Wei; Wurst, Wolfgang; Jagasia, Ravi; Schinder, Alejandro F.; Ming, Guo-li; Toni, Nicolas; Jessberger, Sebastian; Song, Hongjun; Lie, D. Chichung			Role of Mitochondrial Metabolism in the Control of Early Lineage Progression and Aging Phenotypes in Adult Hippocampal Neurogenesis	NEURON			English	Article							NEURAL STEM-CELLS; OXIDATIVE-PHOSPHORYLATION; PROGENITOR PROLIFERATION; ENHANCER PIRACETAM; ENERGY-METABOLISM; TRANSGENIC MICE; DENTATE GYRUS; BRAIN; DYSFUNCTION; DYNAMICS	Precise regulation of cellular metabolism is hypothesized to constitute a vital component of the developmental sequence underlying the life-long generation of hippocampal neurons from quiescent neural stem cells (NSCs). The identity of stage-specific metabolic programs and their impact on adult neurogenesis are largely unknown. We show that the adult hippocampal neurogenic lineage is critically dependent on the mitochondrial electron transport chain and oxidative phosphorylation machinery at the stage of the fast proliferating intermediate progenitor cell. Perturbation of mitochondrial complex function by ablation of the mitochondrial transcription factor A (Tfam) reproduces multiple hallmarks of aging in hippocampal neurogenesis, whereas pharmacological enhancement of mitochondrial function ameliorates age-associated neurogenesis defects. Together with the finding of age-associated alterations in mitochondrial function and morphology in NSCs, these data link mitochondrial complex function to efficient lineage progression of adult NSCs and identify mitochondrial function as a potential target to ameliorate neurogenesis-defects in the aging hippocampus.	[Beckervordersandforth, Ruth; Ebert, Birgit; Schaeffner, Iris; Fiebig, Christian; von Wittgenstein, Julia; Xiang, Wei; Lie, D. Chichung] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, D-91054 Erlangen, Germany; [Ebert, Birgit; Steib, Kathrin; von Wittgenstein, Julia; Hoelter, Sabine M.; Wurst, Wolfgang; Jagasia, Ravi] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Dev Genet, D-85764 Munich, Germany; [Moss, Jonathan; Toni, Nicolas] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Shin, Jaehoon; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol,Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Moore, Darcie L.; Ghosh, Laboni; Jessberger, Sebastian] Univ Zurich, Fac Med Sci, Inst Brain Res, CH-8057 Zurich, Switzerland; [Trinchero, Mariela F.; Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn, Lab Neuronal Plast, Leloir Inst, IIBBA, C1405BWE, Buenos Aires, DF, Argentina; [Stockburger, Carola; Friedland, Kristina] Friedrich Alexander Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany; [Keiner, Silke; Redecker, Christoph] Jena Univ Hosp, Hans Berger Dept Neurol, D-07747 Jena, Germany; [Jagasia, Ravi] F Hoffmann La Roche Ltd, CNS Discovery Pharma Res & Early Dev, CH-4070 Basel, Switzerland	University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Lausanne; Johns Hopkins University; University of Zurich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Erlangen Nuremberg; Friedrich Schiller University of Jena; Roche Holding	Beckervordersandforth, R; Lie, DCC (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, D-91054 Erlangen, Germany.	ruth.beckervordersandforth@fau.de; chi.lie@fau.de	Jessberger, Sebastian/AAJ-4032-2020; Lie, Dieter Chichung/AAS-8604-2020; Keiner, Silke/A-5405-2018; Lie, Dieter Chichung/S-7914-2017; Toni, Nicolas/M-2057-2014; Xiang, Wei/Y-3171-2019; Friedland, Kristina/G-4651-2015; Holter-Koch, Sabine/N-5868-2014	Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; Toni, Nicolas/0000-0001-5585-268X; Jessberger, Sebastian/0000-0002-0056-8275; Friedland, Kristina/0000-0001-8603-5957; Moore, Darcie/0000-0002-0854-7655; Holter-Koch, Sabine/0000-0003-4878-5241; Ming, Guo-li/0000-0002-2517-6075; Wurst, Wolfgang/0000-0003-4422-7410	Schering foundation; German Research Foundation (DFG) [BE 5136/1-1, LI 858/6-3, LI 858/9-1, INST 410/45-1 FUGG]; Bavarian Research Network "ForIPS"; Helmholtz Alliance for Mental Health in an Ageing Society; University Hospital Erlangen (IZKF) [E12, E16, E21, E11]; NIH [R37NS047344, P01 NS097206, R35NS097370, R01MH105128]; Swiss National Science Foundation [SNSF 31003A-156943, PPOOA-119026/1]	Schering foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Research Network "ForIPS"; Helmholtz Alliance for Mental Health in an Ageing Society; University Hospital Erlangen (IZKF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank M. Gotz (LMU Munich) and N. Larsson (Max Planck Institute for Biology of Ageing, Cologne) for providing the GLAST::CreERT2 and the Tfam-loxP/loxP mice, respectively. K.S. was supported by a fellowship of the Schering foundation. This work was supported by grants from the German Research Foundation (DFG; BE 5136/1-1 to R.B., LI 858/6-3 and 9-1 to D.C.L., INST 410/45-1 FUGG), the Bavarian Research Network "ForIPS," the Helmholtz Alliance for Mental Health in an Ageing Society, the University Hospital Erlangen (IZKF grants E12, E16, and E21 to D.C.L., E11 to W.X.), the NIH (R37NS047344 and P01 NS097206 to H.S, and R35NS097370 and R01MH105128 to G.M.), and the Swiss National Science Foundation (SNSF 31003A-156943 to S.J. and PPOOA-119026/1 to N.T.). C.F. and R.B. are members of the research training group 2162 "Neurodevelopment and Vulnerability of the Central Nervous System" of the Deutsche Forschungsgemeinschaft (DFG GRK2162/1).	Abrous D. N., 2015, COLD SPRING HARB PER, V7, P7; Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Beckervordersandforth Ruth, 2015, [Frontiers in Biology, 生物学前沿], V10, P107; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Costa RAP, 2013, EUR J PHARMACOL, V701, P82, DOI 10.1016/j.ejphar.2013.01.001; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Homem CCF, 2014, CELL, V158, P874, DOI 10.1016/j.cell.2014.06.024; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; HYDEN H, 1962, J CELL BIOL, V13, P233, DOI 10.1083/jcb.13.2.233; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Keil U, 2006, BRIT J PHARMACOL, V147, P199, DOI 10.1038/sj.bjp.0706459; Kempermann G, 1998, J NEUROSCI, V18, P3206; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Knobloch Marlen, 2015, [Frontiers in Biology, 生物学前沿], V10, P100; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kurz C, 2010, BRIT J PHARMACOL, V160, P246, DOI 10.1111/j.1476-5381.2010.00656.x; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leuner K, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00044; Lie DC, 2002, J NEUROSCI, V22, P6639; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Martynoga B, 2013, GENE DEV, V27, P1769, DOI 10.1101/gad.216804.113; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Moss J, 2016, P NATL ACAD SCI USA, V113, pE2536, DOI 10.1073/pnas.1514652113; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nolte C, 2001, GLIA, V33, P72; Oruganty-Das A, 2012, CELL METAB, V16, P789, DOI 10.1016/j.cmet.2012.11.002; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Rolando C, 2014, CURR TOP DEV BIOL, V107, P183, DOI 10.1016/B978-0-12-416022-4.00007-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Shook BA, 2012, J NEUROSCI, V32, P6947, DOI 10.1523/JNEUROSCI.5987-11.2012; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Stockburger C, 2013, BIOCHEM SOC T, V41, P1331, DOI 10.1042/BST20130054; Stoll EA, 2015, STEM CELLS, V33, P2306, DOI 10.1002/stem.2042; Stoll EA, 2011, J BIOL CHEM, V286, P38592, DOI 10.1074/jbc.M111.252171; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Waegemans T, 2002, DEMENT GERIATR COGN, V13, P217, DOI 10.1159/000057700; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Zhang XL, 2010, NEUROSCI LETT, V473, P224, DOI 10.1016/j.neulet.2010.02.054; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	67	132	134	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 8	2017	93	3					560	+		10.1016/j.neuron.2016.12.017	http://dx.doi.org/10.1016/j.neuron.2016.12.017			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO1AB	28111078	Green Published, Green Accepted, Bronze			2022-12-17	WOS:000396428800013
J	Lee, JA; Damianov, A; Lin, CH; Fontes, M; Parikshak, NN; Anderson, ES; Geschwind, DH; Black, DL; Martin, KC				Lee, Ji-Ann; Damianov, Andrey; Lin, Chia-Ho; Fontes, Mariana; Parikshak, Neelroop N.; Anderson, Erik S.; Geschwind, Daniel H.; Black, Douglas L.; Martin, Kelsey C.			Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes	NEURON			English	Article							RNA-BINDING PROTEINS; HITS-CLIP; SPLICING FACTORS; MOLECULAR-BASIS; WIDE ANALYSIS; 3' UTRS; REVEALS; BRAIN; TISSUE; FOX-1	Human genetic studies have identified the neuronal RNA binding protein, Rbfox1, as a candidate gene for autism spectrum disorders. While Rbfox1 functions as a splicing regulator in the nucleus, it is also alternatively spliced to produce cytoplasmic isoforms. To investigate the function of cytoplasmic Rbfox1, we knocked down Rbfox proteins in mouse neurons and rescued with cytoplasmic or nuclear Rbfox1. Transcriptome profiling showed that nuclear Rbfox1 rescued splicing changes, whereas cytoplasmic Rbfox1 rescued changes in mRNA levels. iCLIP-seq of subcellular fractions revealed that Rbfox1 bound predominantly to introns in nascent RNA, while cytoplasmic Rbox1 bound to 3' UTRs. Cytoplasmic Rbfox1 binding increased target mRNA stability and translation, and Rbfox1 and miRNA binding sites overlapped significantly. Cytoplasmic Rbfox1 target mRNAs were enriched in genes involved in cortical development and autism. Our results uncover a new Rbfox1 regulatory network and highlight the importance of cytoplasmic RNA metabolism to cortical development and disease.	[Lee, Ji-Ann; Fontes, Mariana; Martin, Kelsey C.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Damianov, Andrey; Lin, Chia-Ho; Anderson, Erik S.; Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Parikshak, Neelroop N.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurobehav Genet, Semel Inst, Los Angeles, CA 90095 USA; [Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu		Parikshak, Neel/0000-0003-2027-1871; Anderson, Erik/0000-0001-5014-8706; Lee, Ji-Ann/0000-0002-9069-2113	NARSAD Young Investigator Award; HHMI; NIH [R01 GM084317, 4F30AG033993]; UCLA Medical Scientist Training Program; NRSA [F30MH099886]; Fundacao para a Ciencia e a Tecnologia through the Graduate Program in Areas of Basic and Applied Biology;  [R21 MH101684];  [P50-HD-055784]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH099886, R21MH101684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG033993] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Medical Scientist Training Program; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia through the Graduate Program in Areas of Basic and Applied Biology; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Konig and J. Ule (UCL Institute of Neurology) for the iCLIP protocol; L. Zipursky (UCLA) and members of the K.C.M. and D.L.B. labs for helpful discussions; and V. Ho, L. Zipursky and K. Otis (UCLA) for comments on the manuscript. This work was supported by R21 MH101684 to K.C.M., P50-HD-055784 pilot grant to K.C.M., and a NARSAD Young Investigator Award to J.-A.L. Work in the D.L.B. lab was supported by HHMI, and by NIH grant R01 GM084317. E.S.A. was supported by the UCLA Medical Scientist Training Program, and by NIH Graduate Fellowship 4F30AG033993. D.L.B. is an Investigator of HHMI. N.N.P. was supported by NRSA Fellowship F30MH099886. M.F. was supported by Fundacao para a Ciencia e a Tecnologia through the Graduate Program in Areas of Basic and Applied Biology.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Boudreau RL, 2014, NEURON, V81, P294, DOI 10.1016/j.neuron.2013.10.062; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Hamada N, 2013, J NEUROSCI RES, V91, P1303, DOI 10.1002/jnr.23266; Heraud-Farlow JE, 2014, TRENDS NEUROSCI, V37, P470, DOI 10.1016/j.tins.2014.05.009; Ho VM, 2014, MOL CELL NEUROSCI, V61, P1, DOI 10.1016/j.mcn.2014.04.006; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; Khodor YL, 2012, RNA, V18, P2174, DOI 10.1261/rna.034090.112; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073323; Lal D, 2013, EPILEPSIA, V54, P265, DOI 10.1111/epi.12084; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; MACKALL J, 1979, ANAL BIOCHEM, V95, P270, DOI 10.1016/0003-2697(79)90216-1; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pandya-Jones A, 2013, RNA, V19, P811, DOI 10.1261/rna.039081.113; Papin C, 2008, FEBS J, V275, P490, DOI 10.1111/j.1742-4658.2007.06216.x; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rossbach O, 2014, RNA BIOL, V11, P146, DOI 10.4161/rna.27991; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Smith CL, 2012, MAMM GENOME, V23, P653, DOI 10.1007/s00335-012-9421-3; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Talkowski ME, 2014, HARVARD REV PSYCHIAT, V22, P65, DOI 10.1097/HRP.0000000000000002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner M, 2012, ADV IMMUNOL, V115, P161, DOI 10.1016/B978-0-12-394299-9.00006-0; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Vanharanta S, 2014, ELIFE, V3, DOI 10.7554/eLife.02734; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Wu J, 2011, BIOINFORMATICS, V27, P3010, DOI 10.1093/bioinformatics/btr508; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yokoshi M, 2014, MOL CELL, V55, P186, DOI 10.1016/j.molcel.2014.05.022; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	58	132	135	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2016	89	1					113	128		10.1016/j.neuron.2015.11.025	http://dx.doi.org/10.1016/j.neuron.2015.11.025			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5TV	26687839	Bronze, Green Accepted			2022-12-17	WOS:000373564300012
J	Zuchero, YJY; Chen, X; Bien-Ly, N; Bumbaca, D; Tong, RK; Gao, X; Zhang, S; Hoyte, K; Luk, W; Huntley, MA; Phu, L; Tan, C; Kallop, D; Weimer, RM; Lu, Y; Kirkpatrick, DS; Ernst, JA; Chih, B; Dennis, MS; Watts, RJ				Zuchero, Y. Joy Yu; Chen, Xiaocheng; Bien-Ly, Nga; Bumbaca, Daniela; Tong, Raymond K.; Gao, Xiaoying; Zhang, Shuo; Hoyte, Kwame; Luk, Wilman; Huntley, Melanie A.; Phu, Lilian; Tan, Christine; Kallop, Dara; Weimer, Robby M.; Lu, Yanmei; Kirkpatrick, Donald S.; Ernst, James A.; Chih, Ben; Dennis, Mark S.; Watts, Ryan J.			Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies	NEURON			English	Article							HUMAN INSULIN-RECEPTOR; AMINO-ACID TRANSPORTER; TRANSFERRIN RECEPTOR; MONOCLONAL-ANTIBODY; HEAVY-CHAIN; IN-VIVO; PRIMATE; LOCALIZATION; PERMEABILITY; TRANSCYTOSIS	The blood-brain barrier (BBB) poses a major challenge for developing effective antibody therapies for neurological diseases. Using transcriptomic and proteomic profiling, we searched for proteins in mouse brain endothelial cells (BECs) that could potentially be exploited to transport antibodies across the BBB. Due to their limited protein abundance, neither antibodies against literature-identified targets nor BBB-enriched proteins identified by microarray facilitated significant antibody brain uptake. Using proteomic analysis of isolated mouse BECs, we identified multiple highly expressed proteins, including basigin, Glut1, and CD98hc. Antibodies to each of these targets were significantly enriched in the brain after administration in vivo. In particular, antibodies against CD98hc showed robust accumulation in brain after systemic dosing, and a significant pharmacodynamic response as measured by brain Ab reduction. The discovery of CD98hc as a robust receptor-mediated transcytosis pathway for antibody delivery to the brain expands the current approaches available for enhancing brain uptake of therapeutic antibodies.	[Zuchero, Y. Joy Yu; Bien-Ly, Nga; Watts, Ryan J.] Genentech Inc, Dept Neurosci, 1 DNA Way, South San Francisco, CA 94080 USA; [Chen, Xiaocheng; Dennis, Mark S.] Genentech Inc, Antibody Engn, 1 DNA Way, South San Francisco, CA 94080 USA; Genentech Inc, Dev Sci, 1 DNA Way, South San Francisco, CA 94080 USA; [Tong, Raymond K.; Kirkpatrick, Donald S.; Ernst, James A.] Genentech Inc, Prot Chem, 1 DNA Way, South San Francisco, CA 94080 USA; [Gao, Xiaoying; Hoyte, Kwame; Luk, Wilman; Lu, Yanmei; Chih, Ben] Genentech Inc, Biochem & Cellular Pharmacol, 1 DNA Way, South San Francisco, CA 94080 USA; [Huntley, Melanie A.] Genentech Inc, Bioinformat & Computat Biol, 1 DNA Way, South San Francisco, CA 94080 USA; [Kallop, Dara; Weimer, Robby M.] Genentech Inc, Biomed Imaging, 1 DNA Way, South San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Zuchero, YJY (corresponding author), Genentech Inc, Dept Neurosci, 1 DNA Way, South San Francisco, CA 94080 USA.	joy.yu929@gmail.com		Kirkpatrick, Donald/0000-0003-3091-2804				Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; BAILER AJ, 1988, J PHARMACOKINET BIOP, V16, P303, DOI 10.1007/BF01062139; Bertrand Y, 2011, BRIT J CANCER, V105, P1697, DOI 10.1038/bjc.2011.427; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Boado RJ, 2007, BIOTECHNOL BIOENG, V96, P381, DOI 10.1002/bit.21120; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; CHIZZONITE R, 1991, J IMMUNOL, V147, P1548; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FISHMAN JB, 1987, J NEUROSCI RES, V18, P299, DOI 10.1002/jnr.490180206; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; Kissel K, 1998, HISTOCHEM CELL BIOL, V110, P63, DOI 10.1007/s004180050266; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lee HJ, 2000, J PHARMACOL EXP THER, V292, P1048; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; PARMACEK MS, 1989, NUCLEIC ACIDS RES, V17, P1915, DOI 10.1093/nar/17.5.1915; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; ROBERTS RL, 1993, J CELL SCI, V104, P521; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Walus LR, 1996, J PHARMACOL EXP THER, V277, P1067; Watts RJ, 2013, CURR OPIN CHEM BIOL, V17, P393, DOI 10.1016/j.cbpa.2013.03.023; Wu DF, 1997, J CLIN INVEST, V100, P1804, DOI 10.1172/JCI119708; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	35	132	142	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2016	89	1					70	82		10.1016/j.neuron.2015.11.024	http://dx.doi.org/10.1016/j.neuron.2015.11.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5TV	26687840	Bronze			2022-12-17	WOS:000373564300009
J	Pernia-Andrade, AJ; Jonas, P				Pernia-Andrade, Alejandro Javier; Jonas, Peter			Theta-Gamma-Modulated Synaptic Currents in Hippocampal Granule Cells In Vivo Define a Mechanism for Network Oscillations	NEURON			English	Article							DENTATE GYRUS; RECORDINGS; SYNAPSES; NEURONS; INTERNEURONS; FREQUENCY; AWAKE; INFORMATION; PLASTICITY; RESOLUTION	Theta-gamma network oscillations are thought to represent key reference signals for information processing in neuronal ensembles, but the underlying synaptic mechanisms remain unclear. To address this question, we performed whole-cell (WC) patchclamp recordings from mature hippocampal granule cells (GCs) in vivo in the dentate gyrus of anesthetized and awake rats. GCs in vivo fired action potentials at low frequency, consistent with sparse coding in the dentate gyrus. GCs were exposed to barrages of fast AMPAR-mediated excitatory postsynaptic currents (EPSCs), primarily relayed from the entorhinal cortex, and inhibitory postsynaptic currents (IPSCs), presumably generated by local interneurons. EPSCs exhibited coherence with the field potential predominantly in the theta frequency band, whereas IPSCs showed coherence primarily in the gamma range. Action potentials in GCs were phase locked to network oscillations. Thus, theta-gamma-modulated synaptic currents may provide a framework for sparse temporal coding of information in the dentate gyrus.	[Pernia-Andrade, Alejandro Javier; Jonas, Peter] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Pernia-Andrade, AJ (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	alejandro.pernia-andrade@ist.ac.at; peter.jonas@ist.ac.at		Jonas, Peter/0000-0001-5001-4804	Fond zur Forderung der Wissenschaftlichen Forschung [P24909-B24]; European Union (European Research Council) [268548]	Fond zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); European Union (European Research Council)(European Research Council (ERC)European Commission)	We thank Jozsef Csicsvari, Jose Guzman, and John Lisman for critically reading prior versions of the manuscript. We also thank Michael Brecht and Albert Lee for generous introduction into in vivo patch-clamp techniques, T. Asenov for engineering mechanical devices, A. Schlogl for programming, F. Marr for technical assistance, and E. Kramberger for manuscript editing. This work was supported by the Fond zur Forderung der Wissenschaftlichen Forschung (P24909-B24) and the European Union (European Research Council Advanced Grant 268548 to P.J.).	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Carnevale NT, 1997, J NEUROPHYSIOL, V78, P703, DOI 10.1152/jn.1997.78.2.703; Castaneda-Castellanos DR, 2006, NAT PROTOC, V1, P532, DOI 10.1038/nprot.2006.75; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; FROTSCHER M, 1986, J COMP NEUROL, V243, P58, DOI 10.1002/cne.902430106; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MUNOZ MD, 1990, BRAIN RES, V509, P91, DOI 10.1016/0006-8993(90)90313-Z; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Pernia-Andrade AJ, 2012, BIOPHYS J, V103, P1429, DOI 10.1016/j.bpj.2012.08.039; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Whishaw IQ, 2005, BEHAV LAB RAT; Wiebe SP, 1999, J NEUROSCI, V19, P10562; Zar JH., 2010, BIOSTAT ANAL	52	132	135	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2014	81	1					140	152		10.1016/j.neuron.2013.09.046	http://dx.doi.org/10.1016/j.neuron.2013.09.046			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287RD	24333053	Green Published, hybrid			2022-12-17	WOS:000329559000015
J	Song, YY; Kirkpatrick, LL; Schilling, AB; Helseth, DL; Chabot, N; Keillor, JW; Johnson, GVW; Brady, ST				Song, Yuyu; Kirkpatrick, Laura L.; Schilling, Alexander B.; Helseth, Donald L.; Chabot, Nicolas; Keillor, Jeffrey W.; Johnson, Gail V. W.; Brady, Scott T.			Transglutaminase and Polyamination of Tubulin: Posttranslational Modification for Stabilizing Axonal Microtubules	NEURON			English	Article							TISSUE TRANSGLUTAMINASE; NEURODEGENERATIVE DISEASES; ALPHA-TUBULIN; ORNITHINE DECARBOXYLASE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; CULTURED-CELLS; CROSS-LINKING; BRAIN; PROTEINS	Neuronal microtubules support intracellular transport, facilitate axon growth, and form a basis for neuronal morphology. While microtubules in non-neuronal cells are depolymerized by cold, Ca2+, or antimitotic drugs, neuronal microtubules are unusually stable. Such stability is important for normal axon growth and maintenance, while hyperstability may compromise neuronal function in aging and degeneration. Though mechanisms for stability are unclear, studies suggest that stable microtubules contain biochemically distinct tubulins that are more basic than conventional tubulins. Transglutaminase-catalyzed posttranslational incorporation of polyamines is one of the few modifications of intracellular proteins that add positive charges. Here we show that neuronal tubulin can be polyaminated by transglutaminase. Endogenous brain transglutaminase-catalyzed polyaminated tubulins have the biochemical characteristics of neuronal stable microtubules. Inhibiting polyamine synthesis or transglutaminase activity significantly decreases microtubule stability in vitro and in vivo. Together, these findings suggest that transglutaminase-catalyzed polyamination of tubulins stabilizes microtubules essential for unique neuronal structures and functions.	[Song, Yuyu; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Kirkpatrick, Laura L.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Schilling, Alexander B.; Helseth, Donald L.] Univ Illinois, CBC RRC Prote & Informat Serv Facil, Chicago, IL 60612 USA; [Chabot, Nicolas; Keillor, Jeffrey W.] Univ Ottawa, Dept Chem, Ottawa, ON K1N 6N5, Canada; [Johnson, Gail V. W.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Lexicon Pharmaceuticals; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Ottawa; University of Rochester	Brady, ST (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	stbrady@uic.edu	Song, Yuyu/J-8939-2019	Song, Yuyu/0000-0002-9196-1610	NINDS [NS23868, NS23320]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R01NS023320, R56NS023868] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Brady and Johnson Laboratories for their general support; Dr. Hua Xu for help with MassMatrix data analysis; Dr. Robert Graham for generating the TG2 KO mouse; Gerardo Morfini, Gustavo Pigino, Hanwu Liu, Bin Wang, and Bao-shiang Lee for advice and encouragement; and Nicholas Kanaan for assistance with electron microscopy. The work was funded in part by grants from NINDS (NS23868, NS23320) to S.T.B.	AMBRON RT, 1982, P NATL ACAD SCI-BIOL, V79, P3442, DOI 10.1073/pnas.79.11.3442; Bailey CDC, 2005, PROG EXP TUMOR RES, V38, P139; Bailey CDC, 2004, J NEUROCHEM, V91, P1369, DOI 10.1111/j.1471-4159.2004.02825.x; Basso M, 2012, J NEUROSCI, V32, P6561, DOI 10.1523/JNEUROSCI.3353-11.2012; Brady Scott T., 1993, P7; BRADY ST, 1982, METHOD CELL BIOL, V25, P365, DOI 10.1016/S0091-679X(08)61434-X; BRADY ST, 1986, ANN NY ACAD SCI, V466, P199, DOI 10.1111/j.1749-6632.1986.tb38395.x; BRADY ST, 1984, J CELL BIOL, V99, P1716, DOI 10.1083/jcb.99.5.1716; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; CACERES A, 1984, J NEUROSCI, V4, P394; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chabot N, 2010, CHEM BIOL, V17, P1143, DOI 10.1016/j.chembiol.2010.06.019; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Cooper AJL, 2002, NEUROCHEM INT, V40, P1, DOI 10.1016/S0197-0186(01)00055-9; Dai Y, 2008, J PHARMACOL EXP THER, V326, P153, DOI 10.1124/jpet.107.135046; DANZIN C, 1979, LIFE SCI, V24, P519, DOI 10.1016/0024-3205(79)90173-5; De Vivo G, 2009, CURR MED CHEM, V16, P4767, DOI 10.2174/092986709789909594; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Facchiano F, 2010, AMINO ACIDS, V39, P257, DOI 10.1007/s00726-009-0436-3; FALCONER MM, 1994, NEUROTOXICOLOGY, V15, P109; FOLK JE, 1980, J BIOL CHEM, V255, P3695; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; HAND D, 1993, INT J DEV NEUROSCI, V11, P709, DOI 10.1016/0736-5748(93)90060-Q; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Kirkpatrick LL, 2001, J NEUROSCI, V21, P2288, DOI 10.1523/JNEUROSCI.21-07-02288.2001; KIRKPATRICK LL, 1994, J NEUROSCI, V14, P7440; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Lesort M, 2000, PROG NEUROBIOL, V61, P439, DOI 10.1016/S0301-0082(99)00052-0; LORAND L, 1971, ANAL BIOCHEM, V44, P221, DOI 10.1016/0003-2697(71)90363-0; Luduena RF, 1998, INT REV CYTOL, V178, P207; MACCIONI RB, 1986, MOL CELL BIOCHEM, V69, P161; Mahoney SA, 2000, NEUROSCIENCE, V101, P141, DOI 10.1016/S0306-4522(00)00324-9; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Mehta K, 2006, FRONT BIOSCI-LANDMRK, V11, P173, DOI 10.2741/1789; MELINO G, 1988, EXP CELL RES, V179, P429, DOI 10.1016/0014-4827(88)90281-9; MILLER CCJ, 1986, J NEUROCHEM, V46, P1912; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PEGG AE, 1988, ISI ATLAS-BIOCHEM, V1, P11; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; POHJANPELTO P, 1981, NATURE, V293, P475, DOI 10.1038/293475a0; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; SAHENK Z, 1987, CELL MOTIL CYTOSKEL, V8, P155, DOI 10.1002/cm.970080207; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; SHAW GG, 1973, J NEUROCHEM, V20, P1225, DOI 10.1111/j.1471-4159.1973.tb00091.x; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113	55	132	134	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 10	2013	78	1					109	123		10.1016/j.neuron.2013.01.036	http://dx.doi.org/10.1016/j.neuron.2013.01.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583110	Bronze, Green Accepted			2022-12-17	WOS:000317556000011
J	Flynn, KC; Hellal, F; Neukirchen, D; Jacob, S; Tahirovic, S; Dupraz, S; Stem, S; Garvalov, BK; Gurniak, C; Shaw, AE; Meyn, L; Wedlich-Soeldner, R; Bamburg, JR; Small, JV; Witke, W; Bradke, F				Flynn, Kevin C.; Hellal, Farida; Neukirchen, Dorothee; Jacob, Sonja; Tahirovic, Sabina; Dupraz, Sebastian; Stem, Sina; Garvalov, Boyan K.; Gurniak, Christine; Shaw, Alisa E.; Meyn, Liane; Wedlich-Soeldner, Roland; Bamburg, James R.; Small, J. Victor; Witke, Walter; Bradke, Frank			ADF/Cofilin-Mediated Actin Retrograde Flow Directs Neurite Formation in the Developing Brain	NEURON			English	Article							GROWTH CONE MOTILITY; NEURONAL POLARITY; DEPOLYMERIZING FACTOR; FILAMENT TURNOVER; IN-VIVO; COFILIN; DYNAMICS; CELLS; NEURITOGENESIS; ESTABLISHMENT	Neurites are the characteristic structural element of neurons that will initiate brain connectivity and elaborate information. Early in development, neurons are spherical cells but this symmetry is broken through the initial formation of neurites. This fundamental step is thought to rely on actin and microtubule dynamics. However, it is unclear which aspects of the complex actin behavior control neuritogenesis and which molecular mechanisms are involved. Here, we demonstrate that augmented actin retrograde flow and protrusion dynamics facilitate neurite formation. Our data indicate that a single family of actin regulatory proteins, ADF/Cofilin, provides the required control of actin retrograde flow and dynamics to form neurites. In particular, the F-actin severing activity of ADF/Cofilin organizes space for the protrusion and bundling of microtubules, the backbone of neurites. Our data reveal how ADF/Cofilin organizes the cytoskeleton to drive actin retrograde flow and thus break the spherical shape of neurons.	[Flynn, Kevin C.; Neukirchen, Dorothee; Tahirovic, Sabina; Garvalov, Boyan K.; Meyn, Liane; Bradke, Frank] Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, D-82152 Martinsried, Germany; [Flynn, Kevin C.; Hellal, Farida; Dupraz, Sebastian; Stem, Sina; Meyn, Liane; Bradke, Frank] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Jacob, Sonja; Small, J. Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Tahirovic, Sabina] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Garvalov, Boyan K.] Univ Giessen, Inst Neuropathol, D-35392 Giessen, Germany; [Gurniak, Christine; Witke, Walter] Univ Bonn, Inst Genet, D-53115 Bonn, Germany; [Shaw, Alisa E.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Wedlich-Soeldner, Roland] Max Planck Inst Biochem, Cellular Dynam & Cell Patterning Grp, D-82152 Martinsried, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Justus Liebig University Giessen; University of Bonn; Colorado State University; Max Planck Society	Bradke, F (corresponding author), Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, Klopferspitz 18, D-82152 Martinsried, Germany.	frank.bradke@dzne.de	Hellal, Farida/D-1834-2015; Garvalov, Boyan K./AAF-6414-2020; Hellal, Farida/E-8533-2013; Hellal, Farida/AHC-2588-2022	Hellal, Farida/0000-0002-9344-1846; Garvalov, Boyan K./0000-0003-0013-9064; Hellal, Farida/0000-0002-9344-1846; Bradke, Frank/0000-0002-0345-3772	Marie Curie Actions; Max Planck Society; Deutsche Forschungsgemeinschaft; Austrian Science Fund (FWF); Austrian Science Fund (FWF) [I 516, P 21292] Funding Source: researchfish	Marie Curie Actions(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are very grateful for the technical assistance of Ralf Zenke, Ireen Konig, and Hans Fried. Frank Gertler, Franck Polleux, and Gerard Marriott receive our appreciation for reagents supplied in this study. We thank Barbara Bernstein, Mark Hubener, Artur Kania, Claudia Laskowski, Klemens Rattner, Michael Sixt, and Michael Stiess for helpful comments and suggestions on the manuscript. Xiao-bing Yuan (Shanghai Institute for Biological Sciences) is gratefully acknowledged for instruction in utero electroporation techniques. We gratefully acknowledge support from the Marie Curie Actions (K.C.F.), the Max Planck Society (F.B), the Deutsche Forschungsgemeinschaft (F.B. and W.W.), and Austrian Science Fund (FWF to J.V.S.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EDSON K, 1993, DEVELOPMENT, V117, P689; Endo M, 2003, J NEUROSCI, V23, P2527; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; Korets-Smith E, 2004, GENESIS, V40, P131, DOI 10.1002/gene.20074; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; LUBYPHELPS K, 1988, CELL MOTIL CYTOSKEL, V10, P28, DOI 10.1002/cm.970100107; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Petchprayoon C, 2005, BIOCONJUGATE CHEM, V16, P1382, DOI 10.1021/bc050006j; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roland J, 2008, BIOPHYS J, V94, P2082, DOI 10.1529/biophysj.107.121988; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042	50	132	133	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 20	2012	76	6					1091	1107		10.1016/j.neuron.2012.09.038	http://dx.doi.org/10.1016/j.neuron.2012.09.038			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	065NI	23259946	Bronze			2022-12-17	WOS:000313154800008
J	Wallace, ML; Burette, AC; Weinberg, RJ; Philpot, BD				Wallace, Michael L.; Burette, Alain C.; Weinberg, Richard J.; Philpot, Benjamin D.			Maternal Loss of Ube3a Produces an Excitatory/Inhibitory Imbalance through Neuron Type-Specific Synaptic Defects	NEURON			English	Article							PRIMARY VISUAL-CORTEX; ANGELMAN-SYNDROME; GABAERGIC TRANSMISSION; CRITICAL PERIOD; DEPENDENT MATURATION; UBIQUITIN LIGASE; MOUSE MODEL; EXPERIENCE; INTERNEURONS; INHIBITION	Angelman syndrome (AS) is a neurodevelopmental disorder caused by loss of the maternally inherited allele of UBE3A. AS model mice, which carry a maternal Ube3a null mutation (Ube3a(m-/p+)), recapitulate major features of AS in humans, including enhanced seizure susceptibility. Excitatory neuro-transmission onto neocortical pyramidal neurons is diminished in Ube3a(m-/p+) mice, seemingly at odds with enhanced seizure susceptibility. We show here that inhibitory drive onto neocortical pyramidal neurons is more severely decreased in Ube3a(m-/p+) mice. This inhibitory deficit follows the loss of excitatory inputs and appears to arise from defective presynaptic vesicle cycling in multiple interneuron populations. In contrast, excitatory and inhibitory synaptic inputs onto inhibitory interneurons are largely normal. Our results indicate that there are neuron type-specific synaptic deficits in Ube3a(m-/p+) mice despite the presence of Ube3a in all neurons. These deficits result in excitatory/inhibitory imbalance at cellular and circuit levels and may contribute to seizure susceptibility in AS.	[Wallace, Michael L.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [Burette, Alain C.; Weinberg, Richard J.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Weinberg, Richard J.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA.	bphilpot@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Weinberg, Richard/AAC-1898-2020	Wallace, Michael/0000-0002-7270-8521; Weinberg, Richard/0000-0001-9689-7278	NICHD Center [P30 HD03110, P30 NS045892]; NINDS [5T32NS007431, 1F31NS077847, 5R01NS035527]; Angelman Syndrome Foundation; Simons Foundation; National Eye Institute [R01EY018323]; National Institute of Mental Health [1R01MH093372]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035527, P30NS045892, T32NS007431, F31NS077847] Funding Source: NIH RePORTER	NICHD Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Angelman Syndrome Foundation; Simons Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rylan Larsen and Matt Judson for critical readings of the manuscript, Paul Mania for experimental advice, Yong-hui Jiang for his generous donation of C57BL/6J Ube3a-deficient mutant mice and Kristen Phend for histological support. Imaging was supported by the Confocal and Multiphoton Imaging Core of NINDS Center Grant P30 NS045892 and NICHD Center Grant P30 HD03110. M.L.W was supported by a Neurobiology Research Training Grant from NINDS (5T32NS007431) and a National Research Service Award from NINDS (1F31NS077847). R.J.W. was supported by NINDS (5R01NS035527). B.D.P was supported by the Angelman Syndrome Foundation, the Simons Foundation, the National Eye Institute (R01EY018323), and the National Institute of Mental Health (1R01MH093372).	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dan B, 2003, NEUROPEDIATRICS, V34, P169; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Morales B, 2002, J NEUROSCI, V22, P8084; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thibert RL, 2009, EPILEPSIA, V50, P2369, DOI 10.1111/j.1528-1167.2009.02108.x; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	35	132	134	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2012	74	5					793	800		10.1016/j.neuron.2012.03.036	http://dx.doi.org/10.1016/j.neuron.2012.03.036			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957YQ	22681684	Green Published, Bronze, Green Accepted			2022-12-17	WOS:000305203400006
J	Brockmann, MD; Poschel, B; Cichon, N; Hanganu-Opatz, IL				Brockmann, Marco D.; Poeschel, Beatrice; Cichon, Nicole; Hanganu-Opatz, Ileana L.			Coupled Oscillations Mediate Directed Interactions between Prefrontal Cortex and Hippocampus of the Neonatal Rat	NEURON			English	Article							THETA-RHYTHM; SPINDLE BURSTS; VISUAL-CORTEX; RETINAL WAVES; IN-VIVO; SLEEP; MODEL; SCHIZOPHRENIA; SYNCHRONY; NETWORKS	The coactivation of prefrontal and hippocampal networks in oscillatory rhythms is critical for precise information flow in mnemonic and executive tasks, yet the mechanisms governing its development are still unknown. Here, we demonstrate that already in neonatal rats, patterns of discontinuous oscillatory activity precisely entrain the firing of prefrontal neurons and have distinct spatial and temporal organization over cingulate and prelimbic cortices. Moreover, we show that hippocampal theta bursts drive the generation of neonatal prefrontal oscillations by phase-locking the neuronal firing via axonal pathways. Consequently, functional impairment of the hippocampus reduces the prefrontal activity. With ongoing maturation continuous theta-gamma oscillations emerge and mutually entrain the prejuvenile prefrontal-hippocampal networks. Thus, theta-modulated communication within developing prefrontal-hippocampal networks may be relevant for circuitry refinement and maturation of functional units underlying information storage at adulthood.	[Brockmann, Marco D.; Poeschel, Beatrice; Cichon, Nicole; Hanganu-Opatz, Ileana L.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hanganu-Opatz, IL (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20251 Hamburg, Germany.	hangop@zmnh.uni-hamburg.de			German Research Foundation [Ha4466/3-1]; German Federal Ministry of Education and Research [01GQ0809]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank Drs. M. Denker, T. Siapas, A. Sirota, and M. Ding for valuable discussions, Drs. A. Draguhn, S. Grun, and W. Kilb for helpful suggestions and comments on the manuscript, and Dr. G. Schneider and G. Meckenhauser for assistance on statistics. I.L.H.-O. acknowledges support by the Emmy Noether-Program of German Research Foundation (Ha4466/3-1) and the German Federal Ministry of Education and Research (01GQ0809).	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; ANGEVINE JB, 1975, HIPPOCAMPUS, V1, P61; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bertrand JB, 2010, HIPPOCAMPUS, V20, P264, DOI 10.1002/hipo.20628; BOLLES RC, 1964, ANIM BEHAV, V12, P427, DOI 10.1016/0003-3472(64)90062-4; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G., 2006, RHYTHMS BRAIN; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Deller T, 1996, CELL TISSUE RES, V286, P293, DOI 10.1007/s004410050699; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; DREYFUS-BRISAC C, 1962, World Neurol, V3, P5; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Flechsig P, 1901, LANCET, V158, P1027, DOI [10.1016/S0140-6736(01)01429-5, DOI 10.1016/S0140-6736(01)01429-5]; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Hanganu-Opatz IL, 2010, BRAIN RES REV, V64, P160, DOI 10.1016/j.brainresrev.2010.03.005; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lahtinen H, 2002, J NEUROPHYSIOL, V88, P1469, DOI 10.1152/jn.2002.88.3.1469; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Loveland KA, 2008, NEUROPSYCHOLOGIA, V46, P49, DOI 10.1016/j.neuropsychologia.2007.08.017; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; Mohns EJ, 2008, J NEUROSCI, V28, P10134, DOI 10.1523/JNEUROSCI.1967-08.2008; Mohns EJ, 2010, J NEUROSCI, V30, P3438, DOI 10.1523/JNEUROSCI.4832-09.2010; Moran RJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00200; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; PANG KC, 2010, HIPPOCAMPUS, V17; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Soteropoulos DS, 2006, J NEUROPHYSIOL, V95, P1194, DOI 10.1152/jn.00935.2005; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Traub RD, 2000, J NEUROSCI, V20, P2086; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Van Quyen ML, 2008, J NEUROSCI, V28, P6104, DOI 10.1523/JNEUROSCI.0437-08.2008; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008; Vecchierini MF, 2007, NEUROPHYSIOL CLIN, V37, P311, DOI 10.1016/j.neucli.2007.10.008; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	61	132	132	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					332	347		10.1016/j.neuron.2011.05.041	http://dx.doi.org/10.1016/j.neuron.2011.05.041			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791291	Bronze			2022-12-17	WOS:000293433900016
J	Wang, BS; Sarnaik, R; Cang, JH				Wang, Bor-Shuen; Sarnaik, Rashmi; Cang, Jianhua			Critical Period Plasticity Matches Binocular Orientation Preference in the Visual Cortex	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; RECEPTIVE-FIELDS; STRIATE CORTEX; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; CORTICAL PLASTICITY; INTRINSIC SIGNAL; AUDITORY SPACE; SIMPLE CELLS	Changes of ocular dominance in the visual cortex can be induced by visual manipulations during a critical period in early life. However, the role of critical period plasticity in normal development is unknown. Here we show that at the onset of this time window, the preferred orientations of individual cortical cells in the mouse are mismatched through the two eyes and the mismatch decreases and reaches adult levels by the end of the period. Deprivation of visual experience during this period irreversibly blocks the binocular matching of orientation preference, but has no effect in adulthood. The critical period of binocular matching can be delayed by long-term visual deprivation from birth, like that of ocular dominance plasticity. These results demonstrate that activity-dependent changes induced by normal visual experience during the well-studied critical period serve to match eye-specific inputs in the cortex, thus revealing a physiological role for critical period plasticity during normal development.	[Wang, Bor-Shuen; Sarnaik, Rashmi; Cang, Jianhua] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Wang, Bor-Shuen; Sarnaik, Rashmi] Northwestern Univ, Interdepartmental Neurosci Program, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Cang, JH (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	cang@northwestern.edu	sarnaik, Rashmi/O-3755-2016; Sarnaik, Rashmi/S-2218-2019; Wang, Bor-Shuen/I-1567-2013	Sarnaik, Rashmi/0000-0003-1977-2740; 	US National Institutes of Health (NIH) [EY018621]; Sloan Research Fellowship; Klingenstein Fellowship; Brain Research Foundation; NATIONAL EYE INSTITUTE [R01EY018621] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Fellowship(Alfred P. Sloan Foundation); Klingenstein Fellowship(Klingenstein Philanthropies); Brain Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Cris Niell for help with visual stimulation and data analyses, and Martha Vitaterna for providing space for dark-rearing mice. We also thank Xiaorong Liu, Tom Bozza, David Ferster, Indira Raman, Garth Fowler, and members of the Cang laboratory for discussions and comments on the manuscript. This work was supported by a US National Institutes of Health (NIH) grant (EY018621), a Sloan Research Fellowship, a Klingenstein Fellowship Award in Neurosciences, and a Brain Research Foundation Seed Grant to J.C.	Adorjan P, 1999, VISUAL NEUROSCI, V16, P303, DOI 10.1017/S0952523899162114; BenYishai R, 1997, J COMPUT NEUROSCI, V4, P57, DOI 10.1023/A:1008816611284; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BOOTHE R G, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P206; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brainard MS, 1998, J NEUROSCI, V18, P3929; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Gandhi SP, 2005, NAT NEUROSCI, V8, P9, DOI 10.1038/nn0105-9; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Iwai Y, 2003, J NEUROSCI, V23, P6695; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; Morales B, 2002, J NEUROSCI, V22, P8084; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; MOVSHON JA, 1981, ANNU REV PSYCHOL, V32, P477, DOI 10.1146/annurev.ps.32.020181.002401; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; SOMERS DC, 1995, J NEUROSCI, V15, P5448; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	63	132	133	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 28	2010	65	2					246	256		10.1016/j.neuron.2010.01.002	http://dx.doi.org/10.1016/j.neuron.2010.01.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	550OA	20152130	Green Accepted, Bronze			2022-12-17	WOS:000274136100011
J	Enomoto, A; Asai, N; Namba, T; Wang, Y; Kato, T; Tanaka, M; Tatsumi, H; Taya, S; Tsuboi, D; Kuroda, K; Kaneko, N; Sawamoto, K; Miyamoto, R; Jijiwa, M; Murakumo, Y; Sokabe, M; Seki, T; Kaibuchi, K; Takahashi, M				Enomoto, Atsushi; Asai, Naoya; Namba, Takashi; Wang, Yun; Kato, Takuya; Tanaka, Motoki; Tatsumi, Hitoshi; Taya, Shinichiro; Tsuboi, Daisuke; Kuroda, Keisuke; Kaneko, Naoko; Sawamoto, Kazunobu; Miyamoto, Rieko; Jijiwa, Mayumi; Murakumo, Yoshiki; Sokabe, Masahiro; Seki, Tatsunori; Kaibuchi, Kozo; Takahashi, Masahide			Roles of Disrupted-In-Schizophrenia 1-Interacting Protein Girdin in Postnatal Development of the Dentate Gyrus	NEURON			English	Article							NEURONAL POLARITY; DISC1; ADULT; DISRUPTED-IN-SCHIZOPHRENIA-1; NEUROGENESIS; MECHANISMS; EXPRESSION; MIGRATION; TRANSPORT; MOTILITY	Disrupted-in-Schizophrenia 1 (DISC1), a susceptibility gene for major psychiatric disorders, regulates neuronal migration and differentiation during mammalian brain development. Although roles for DISC1 in postnatal neurogenesis in the dentate gyrus (DG) have recently emerged, it is not known how DISC1 and its interacting proteins govern the migration, positioning, and differentiation of dentate granule cells (DGCs). Here, we report that DISC1 interacts with the actin-binding protein girdin to regulate axonal development. DGCs in girdin-deficient neonatal mice exhibit deficits in axonal sprouting in the cornu ammonis 3 region of the hippocampus.' Girdin deficiency, RNA interference-mediated knockdown, and inhibition of the DISC1/girdin interaction lead to overextended migration and mispositioning of the DGCs resulting in profound cytoarchitectural disorganization of the DG. These findings identify girdin as an intrinsic factor in postnatal development of the DG and provide insights into the critical role of the DISC1/girdin interaction in postnatal neurogenesis in the DG.	[Enomoto, Atsushi; Asai, Naoya; Wang, Yun; Kato, Takuya; Miyamoto, Rieko; Jijiwa, Mayumi; Murakumo, Yoshiki; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Tatsumi, Hitoshi; Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Taya, Shinichiro; Tsuboi, Daisuke; Kuroda, Keisuke; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Namba, Takashi] Natl Inst Neurosci, Dept Neurochem, Kodaira, Tokyo 1878502, Japan; [Namba, Takashi; Seki, Tatsunori] Juntendo Univ, Sch Med, Dept Anat, Bunkyo Ku, Tokyo 1138421, Japan; [Tanaka, Motoki; Sokabe, Masahiro] Japan Sci & Technol Agcy, Int Cooperat Res Project Solut Oriented Res Sci &, Cell Mechanosensing, Nagoya, Aichi 4668550, Japan; [Taya, Shinichiro; Tsuboi, Daisuke; Kuroda, Keisuke; Kaibuchi, Kozo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kaneko, Naoko; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Inst Mol Med, Dept Dev & Regenerat Biol,Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Enomoto, Atsushi; Seki, Tatsunori] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Dev Neurosci,Aoba Ku, Sendai, Miyagi 9808575, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; National Center for Neurology & Psychiatry - Japan; Juntendo University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Nagoya City University; Tohoku University	Enomoto, A (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	enomoto@iar.nagoya-u.ac.jp; mtakaha@med.nagoya-u.ac.jp	Namba, Takashi/AAE-4439-2022; Kuroda, Keisuke/K-5255-2013; ASAI, Naoya/I-7377-2014; Kaneko, Naoko/P-2054-2019; Enomoto, Atsushi/I-7272-2014; Takahashi, Masahide/AAN-4770-2020; Namba, Takashi/ABF-4571-2020; Sokabe, Masahiro/I-1565-2012; TANAKA, Motoki/I-7299-2014; TAKAHASHI, Masahide/I-7244-2014	Kuroda, Keisuke/0000-0002-6715-5125; Enomoto, Atsushi/0000-0002-9206-6116; Takahashi, Masahide/0000-0002-2803-2683; Namba, Takashi/0000-0003-4875-666X; Kaneko, Naoko/0000-0003-3121-7117; Sawamoto, Kazunobu/0000-0003-1984-5129	Special Coordination Funds for Promoting Science and Technology (SCF)	Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We gratefully acknowledge A. Sawa (Johns Hopkins University School of Medicine) for providing cDNA for mouse DISC1 and T. Akiyama (Tokyo University, Japan) for providing anti-DISC1 antibody. We thank M. Sugiyama and T. Yoshimura (Nagoya University) for assistance with culturing of hippocampal neurons, and T. Miyata (Nagoya University), T. Shinoda (Aichi Human Service Center), and T. Hikita (Nagoya City University) for helpful discussions. This work was supported by Grants-in-Aid for Global Center of Excellence (GCOE) Research, Scientific Research (A), and Scientific Research on Priority Area 'Cancer' (to M.T.); the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF) (to A.E.) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and the Uehara Memorial Foundation (to A.E.).	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Brandon NJ, 2007, BIOCHEM SOC T, V35, P1283, DOI 10.1042/BST0351283; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Dranovsky A, 2007, CELL, V130, P981, DOI 10.1016/j.cell.2007.09.004; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	41	132	140	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					774	787		10.1016/j.neuron.2009.08.015	http://dx.doi.org/10.1016/j.neuron.2009.08.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778507	Bronze			2022-12-17	WOS:000270569700011
J	Santoro, B; Piskorowski, RA; Pian, P; Hu, L; Liu, HY; Siegelbaum, SA				Santoro, Bina; Piskorowski, Rebecca A.; Pian, Phillip; Hu, Lei; Liu, Haiying; Siegelbaum, Steven A.			TRIP8b Splice Variants Form a Family of Auxiliary Subunits that Regulate Gating and Trafficking of HCN Channels in the Brain	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; I-H; DENDRITIC INTEGRATION; HIPPOCAMPAL-NEURONS; PACEMAKER CHANNELS; DISTAL DENDRITES; ION CHANNELS; CYCLIC-AMP; PROTEIN; EXPRESSION	Hyperpolarization-activated cyclic nucleotide-regulated (HCN) channels, which generate the I-h current, mediate a number of important brain functions. The HCN1 isoform regulates dendritic integration in cortical pyramidal neurons and provides an inhibitory constraint on both working memory in prefrontal cortex and spatial learning and memory in the hippocampus. Altered expression of HCN1 following seizures may contribute to the development of temporal lobe epilepsy. Yet the regulatory networks and pathways governing HCN channel expression and function in the brain are largely unknown. Here, we report the presence of nine alternative N-terminal splice forms of the brain-specific cytoplasmic protein TRIP8b and demonstrate the differential effects of six isoforms to downregulate or upregulate HCN1 surface expression. Furthermore, we find that all TRIP8b isoforms inhibit channel opening by shifting activation to more negative potentials. TRIP8b thus functions as an auxiliary subunit that provides a mechanism for the dynamic regulation of HCN1 channel expression and function.	[Santoro, Bina; Piskorowski, Rebecca A.; Pian, Phillip; Hu, Lei; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Liu, Haiying; Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu	Piskorowski, Rebecca Ann/G-6610-2017; Hu, Lei/B-1455-2009	Piskorowski, Rebecca Ann/0000-0003-0120-2360; Santoro, Bina/0000-0002-4277-1992	NIH [NS36658, MH80745]; Italian Academy for Advanced Studies in America; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS036658, R01NS036658] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Academy for Advanced Studies in America; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by grants NS36658 and MH80745 from NIH to S.A.S., by a Fellowship from the Italian Academy for Advanced Studies in America (B.S.) and a Research Grant from the Epilepsy Foundation (B.S.). We thank Nikolaj Klocker, Bernd Fakler, and colleagues for sharing with us their unpublished data that first suggested that TRIP8b inhibits the facilitatory action of cAMP on HCN2 channels. We are grateful to Catherine Smith, Alexander Kushnir, and Jayeeta Basu for their valuable contributions during the course of this study, and to John Riley for his excellent technical assistance. We thank Pavel Osten for his kind gift of plasmid pFCK(0.4)GW, and Frank Muller for generously providing the HCN1-7C3 monoclonal antibody.	Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Gasparini S, 1999, EUR J NEUROSCI, V11, P3093, DOI 10.1046/j.1460-9568.1999.00728.x; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Popova NV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P644, DOI 10.1134/S0006297908060035; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Stuart G, 1998, J NEUROSCI, V18, P3501; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	39	132	135	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 25	2009	62	6					802	813		10.1016/j.neuron.2009.05.009	http://dx.doi.org/10.1016/j.neuron.2009.05.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	464TH	19555649	Green Accepted, Bronze			2022-12-17	WOS:000267529300009
J	Dudman, JT; Tsay, D; Siegelbaum, SA				Dudman, Joshua T.; Tsay, David; Siegelbaum, Steven A.			A role for synaptic inputs at distal dendrites: Instructive signals for hippocampal long-term plasticity	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; DIRECT CORTICAL INPUT; ENTORHINAL CORTEX; AREA CA1; SPATIAL SEGREGATION; ACTION-POTENTIALS; DIFFERENT FORMS; CALCIUM STORES; CA2+; LTP	Synaptic potentials originating at distal dendritic locations are severely attenuated when they reach the soma and, thus, are poor at driving somatic spikes. Nonetheless, distal inputs convey essential information, suggesting that such inputs may be important for compartmentalized dendritic signaling. Here we report a new plasticity rule in which stimulation of distal perforant path inputs to hippocampal CA1 pyramidal neurons induces long-term potentiation at the CA1 proximal Schaffer collateral synapses when the two inputs are paired at a precise interval. This subthreshold form of heterosynaptic plasticity occurs in the absence of somatic spiking but requires activation of both NMDA receptors and IP3 receptor-dependent release of Ca2+ from internal stores. Our results suggest that direct sensory information arriving at distal CA1 synapses through the perforant path provide compartmentalized, instructive signals that assess the saliency of mnemonic information propagated through the hippocampal circuit to proximal synapses.	[Dudman, Joshua T.; Tsay, David; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	sas8@columbia.edu		Dudman, Joshua/0000-0002-4436-1057	NIMH NIH HHS [T32 MH015174, T32 MH015174-30] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CAJAL SRY, 1911, HIST SYSTEME NERVEUX; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Frerking M, 2005, J NEUROPHYSIOL, V94, P1528, DOI 10.1152/jn.00108.2005; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Judge SJ, 2004, J NEUROPHYSIOL, V92, P1615, DOI 10.1152/jn.00848.2003; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2003, J NEUROPHYSIOL, V89, P1910, DOI 10.1152/jn.00842.2002; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Okubo Y, 2004, J NEUROSCI, V24, P9513, DOI 10.1523/JNEUROSCI.1829-04.2004; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Otmakhova NA, 2000, ANN NY ACAD SCI, V911, P462; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; STEWARD O, 1990, BRAIN RES, V516, P292, DOI 10.1016/0006-8993(90)90930-A; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Wohrl R, 2007, EUR J NEUROSCI, V25, P251, DOI 10.1111/j.1460-9568.2006.05274.x; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	73	132	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					866	879		10.1016/j.neuron.2007.10.020	http://dx.doi.org/10.1016/j.neuron.2007.10.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054862	Green Accepted, Bronze			2022-12-17	WOS:000251659300012
J	Cho, CH; St-Gelais, F; Zhang, W; Tomita, S; Howe, JR				Cho, Chang-Hoon; St-Gelais, Fannie; Zhang, Wei; Tomita, Susumu; Howe, James R.			Two families of TARP isoforms that have distinct effects on the kinetic properties of AMPA receptors and synaptic currents	NEURON			English	Article							ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS; RAT HIPPOCAMPAL SLICES; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; INWARD RECTIFICATION; EXCITATORY SYNAPSES; NMDA RECEPTORS; ION-CHANNEL; DESENSITIZATION; STARGAZIN	Transmembrane AMPA receptor regulatory proteins (TARPs) are auxiliary AMPA receptor subunits that regulate both the trafficking and gating properties of AMPA receptors, and different TARP isoforms display distinct expression patterns in brain. Here, we compared the effects of four TARP isoforms on the kinetics of AMPA receptor currents. Each isoform slowed the deactivation of GluRl currents, but the slowing was greatest with gamma-4 and gamma-8. Isoform-specific differences in desensitization were also observed that correlated with effects on deactivation. TARP isoforms also differentially modulated responses to trains of glutamate applications designed to mimic high-frequency presynaptic firing. Importantly, whereas both stargazin and gamma-4 rescued excitatory synaptic transmission in cerebellar granule cells from stargazer mice, the decay of miniature EPSCs was 2-fold slower in neurons expressing gamma-4. The results show that heterogeneity in the composition of AMPA receptor/TARP complexes contributes to synapse-specific differences in EPSC decays and frequency-dependent modulation of neurotransmission.	Yale Univ, Dept Pharm, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Howe, JR (corresponding author), Yale Univ, Dept Pharm, 333 Cedar St, New Haven, CT 06520 USA.	james.howe@yale.edu	zhang, wei/V-6712-2018; Zhang, Wei/AAV-4253-2020	zhang, wei/0000-0001-9825-0371; Zhang, Wei/0000-0001-9825-0371	NINDS NIH HHS [NS-047712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047712] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Korber C, 2007, J NEUROSCI, V27, P8442, DOI 10.1523/JNEUROSCI.0424-07.2007; Korber C, 2007, J BIOL CHEM, V282, P18758, DOI 10.1074/jbc.M611182200; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; LIVSEY CT, 1993, J NEUROSCI, V13, P5324, DOI 10.1523/JNEUROSCI.13-12-05324.1993; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; Robert A, 2003, J NEUROSCI, V23, P847; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Wall MJ, 2002, EUR J NEUROSCI, V15, P785, DOI 10.1046/j.1460-9568.2002.01910.x; Washburn MS, 1997, J NEUROSCI, V17, P9393; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Zhang W, 2006, BIOPHYS J, V91, P1336, DOI 10.1529/biophysj.106.084426; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	50	132	138	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					890	904		10.1016/j.neuron.2007.08.024	http://dx.doi.org/10.1016/j.neuron.2007.08.024			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880893	Bronze			2022-12-17	WOS:000250078500007
J	Lerchner, W; Xiao, C; Nashmi, R; Slimko, EM; van Trigt, L; Lester, HA; Anderson, DJ				Lerchner, Walter; Xiao, Cheng; Nashmi, Raad; Slimko, Eric M.; van Trigt, Laurent; Lester, Henry A.; Anderson, David J.			Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel	NEURON			English	Article							MAMMALIAN NEURONS; IN-VIVO; STRIATAL NEURONS; EXPRESSION; RAT; SYSTEM; DROSOPHILA; RECEPTOR; INACTIVATION; SUPPRESSION	Several genetic strategies for inhibiting neuronal function in mice have been described, but no system that directly suppresses membrane excitability and is triggered by a systemically administered drug, has been validated in awake behaving animals. We expressed unilaterally in mouse striatum a modified heteromeric ivermectin (IVM)-gated chloride channel from C. elegans (GluCl alpha beta), systemically administered IVM, and then assessed amphetamine-induced rotational behavior. Rotation was observed as early as 4 hr after a single intraperitoneal IVM injection (10 mg/kg), reached maximal levels by 12 hr, and was almost fully reversed by 4 days. Multiple cycles of silencing and recovery could be performed in a single animal. In striatal slice preparations from GluCl alpha beta-expressing animals, IVM rapidly suppressed spiking. The two-subunit GluCl/IVM system permits "intersectional" strategies designed to increase the cellular specificity of silencing in transgenic animals.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Xiao, Cheng/O-5696-2015	Xiao, Cheng/0000-0001-9649-7450; Nashmi, Raad/0000-0001-6596-2620; Lerchner, Walter/0000-0003-0842-4409	NIMH NIH HHS [MH-67867] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067867] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Burdett EC, 1997, CONTEMP TOP LAB ANIM, V36, P73; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014; Conole J, 2003, CONTEMP TOP LAB ANIM, V42, P42; Davis JA, 1999, LAB ANIM SCI, V49, P288; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; Johns DC, 1999, J NEUROSCI, V19, P1691; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; OBERLANDER C, 1983, J PHARMACOL-PARIS, V14, P401; Olds ME, 2006, SYNAPSE, V59, P532, DOI 10.1002/syn.20270; Roder Joseph D., 1998, Veterinary and Human Toxicology, V40, P369; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHWARCZ R, 1979, BRAIN RES, V170, P485, DOI 10.1016/0006-8993(79)90966-1; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Willis GL, 2004, REV NEUROSCIENCE, V15, P75; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455	42	132	137	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					35	49		10.1016/j.neuron.2007.02.030	http://dx.doi.org/10.1016/j.neuron.2007.02.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408576	Bronze			2022-12-17	WOS:000245848400008
J	Howard, RJ; Clark, KA; Holton, JM; Minor, DL				Howard, Rebecca J.; Clark, Kimberly A.; Holton, James M.; Minor, Daniel L., Jr.			Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy	NEURON			English	Article							LONG-QT SYNDROME; POTASSIUM CHANNEL; K+ CHANNEL; GENOMIC ORGANIZATION; SURFACE EXPRESSION; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; COILED COILS; MUTATIONS; SUBUNIT	Kv7.x (KCNQ) voltage-gated potassium channels form the cardiac and auditory l(Ks) current and the neuronal M-current. The five Kv7 subtypes have distinct assembly preferences encoded by a C-terminal cytoplasmic assembly domain, the A-domain Tail. Here, we present the high-resolution structure of the Kv7.4 Adomain Tail together with biochemical experiments that show that the domain is a selfassembling, parallel, four-stranded coiled coil. Structural analysis and biochemical studies indicate conservation of the coiled coil in all Kv7 subtypes and that a limited set of interactions encode assembly specificity determinants. Kv7 mutations have prominent roles in arrhythmias, deafness, and epilepsy. The structure together with biochemical data indicate that A-domain Tail arrhythmia mutations cluster on the solvent-accessible surface of the subunit interface at a likely site of action for modulatory proteins. Together, the data provide a framework for understanding Kv7 assembly specificity and the molecular basis of a distinct set of Kv7 channelopathies.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	daniel.minor@ucsf.edu		Howard, Rebecca/0000-0003-2049-3378	NIDCD NIH HHS [R01 DC007664-03, R01 DC007664] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chen S, 2003, CLIN GENET, V63, P273, DOI 10.1034/j.1399-0004.2003.00048.x; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; DeLano W. L, 2002, PYMOL MOL GENETICS G; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Friedrich T, 2002, BIOPHYS J, V82, p577A; Grunnet M, 2005, HEART RHYTHM, V2, P1238, DOI 10.1016/j.hrthm.2005.07.025; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HARBURY PB, 1995, P NATL ACAD SCI USA, V92, P8408, DOI 10.1073/pnas.92.18.8408; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Hille B., 2001, ION CHANNELS EXCITAB; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; Itoh T, 1998, HUM GENET, V103, P290, DOI 10.1007/s004390050819; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liu J, 2006, J MOL BIOL, V361, P168, DOI 10.1016/j.jmb.2006.05.063; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Neyroud N, 1999, CIRC RES, V84, P290, DOI 10.1161/01.RES.84.3.290; Novotny T, 2006, Vnitr Lek, V52, P116; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yamashita F, 2001, J MOL CELL CARDIOL, V33, P197, DOI 10.1006/jmcc.2000.1300; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100	69	132	138	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					663	675		10.1016/j.neuron.2007.02.010	http://dx.doi.org/10.1016/j.neuron.2007.02.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329207	Bronze, Green Accepted			2022-12-17	WOS:000245127100008
J	Oka, Y; Katada, S; Omura, M; Suwa, M; Yoshihara, Y; Touhara, K				Oka, Yuki; Katada, Sayako; Omura, Masayo; Suwa, Makiko; Yoshihara, Yoshihiro; Touhara, Kazushige			Odorant receptor map in the mouse olfactory bulb: In vivo sensitivity and specificity of receptor-defined glomeruli	NEURON			English	Article							NEURON INPUT; MICE DEFICIENT; FUNCTIONAL MRI; EXPRESSION; REPRESENTATIONS; DISCRIMINATION; LIGANDS; SYSTEM; IDENTIFICATION; RECONSTITUTION	Odorant identity is represented in the olfactory bulb (OB) by the glomerular activity pattern, which reflects a combination of activated odorant receptors (ORs) in the olfactory epithelium. To elucidate this neuronal circuit at the molecular level, we established a functional OR identification strategy based on glomerular activity by combining in vivo Ca2+, imaging, retrograde dye labeling, and single-cell RT-PCR. Spatial and functional mapping of OR-defined glomeruli revealed that the glomerular positional relationship varied considerably between individual animals, resulting in different OR maps in the OB. Notably, OR-defined glomeruli exhibited different ligand spectra and far higher sensitivity compared to the in vitro pharmacological properties of corresponding ORs. Moreover, we found that the olfactory mucus was an important factor in the regulation of in vivo odorant responsiveness. Our results provide a methodology to examine in vivo glomerular responses at the receptor level and further help address the long-standing issues of olfactory sensitivity and specificity under physiological conditions.	Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; Natl Inst Adv Ind Sci & Technol AIST, CBRC, Tokyo 1350064, Japan; RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Osaka 5600082, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; Japan Science & Technology Agency (JST)	Touhara, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan.	touhara@k.u-tokyo.ac.jp	Oka, Yoshitaka/G-4952-2014; Yoshihara, Yoshihiro/N-6481-2015; Suwa, Makiko/M-5056-2018	Oka, Yoshitaka/0000-0002-3482-3051; Yoshihara, Yoshihiro/0000-0002-0319-7166; Katada, Sayako/0000-0002-0466-0466; Suwa, Makiko/0000-0001-8812-1023; Oka, Yuki/0000-0003-2686-0677				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Bozza TC, 1998, J NEUROSCI, V18, P4560; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mizrahi A, 2004, NEUROPHARMACOLOGY, V47, P661, DOI 10.1016/j.neuropharm.2004.07.020; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Oka Y, 2004, CHEM SENSES, V29, P815, DOI 10.1093/chemse/bjh247; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Weiler E, 2006, CHEM SENSES, V31, P641, DOI 10.1093/chemse/bjl004; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	48	132	133	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					857	869		10.1016/j.neuron.2006.10.019	http://dx.doi.org/10.1016/j.neuron.2006.10.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145506	Bronze			2022-12-17	WOS:000242856400013
J	Brincat, SL; Connor, CE				Brincat, SL; Connor, CE			Dynamic shape synthesis in posterior inferotemporal cortex	NEURON			English	Article							VISUAL-CORTEX; AREA MT; MACAQUE; NEURONS; REPRESENTATION; RESPONSES; FEATURES; FACE; RECOGNITION; SELECTIVITY	How does the brain synthesize low-level neural signals for simple shape parts into coherent representations of complete objects? Here, we present evidence for a dynamic process of object part integration in macaque posterior inferotemporal cortex (IT). Immediately after stimulus onset, neural responses carried information about individual object parts (simple contour fragments) only. Subsequently, information about specific multipart configurations emerged, building gradually over the course of similar to 60 ms, producing a sparser and more explicit representation of object shape. We show that this gradual transformation can be explained by a recurrent network process that effectively compares parts signals across neurons to generate inferences about multipart shape configurations.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	connor@jhu.edu						Arguin M, 2000, VISION RES, V40, P3099, DOI 10.1016/S0042-6989(00)00155-3; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Bullier J, 2001, PROG BRAIN RES, V134, P193; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Dayan P., 2001, THEORETICAL NEUROSCI; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Movshon A, 1985, PATTERN RECOGN, V54, P117; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pugh MC, 2000, J COMPUT NEUROSCI, V8, P143, DOI 10.1023/A:1008921231855; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	38	132	132	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					17	24		10.1016/j.neuron.2005.11.026	http://dx.doi.org/10.1016/j.neuron.2005.11.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387636	Bronze			2022-12-17	WOS:000236699300006
J	Dulla, CG; Dobelis, P; Pearson, T; Frenguelli, BG; Staley, KJ; Masino, SA				Dulla, CG; Dobelis, P; Pearson, T; Frenguelli, BG; Staley, KJ; Masino, SA			Adenosine and ATP link P-CO2 to cortical excitability via pH	NEURON			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICE; CENTRAL-NERVOUS-SYSTEM; CA3 NETWORK ACTIVITY; METHYL-D-ASPARTATE; SYNAPTIC-TRANSMISSION; P2X RECEPTORS; EPILEPTIFORM ACTIVITY; SEROTONERGIC NEURONS; CARBON-DIOXIDE	In addition to affecting respiration and vascular tone, deviations from normal CO2 alter pH, consciousness, and seizure propensity. Outside the brainstem, however, the mechanisms by which CO2 levels modify neuronal function are unknown. In the hippocampal slice preparation, increasing CO2, and thus decreasing pH, increased the extracellular concentration of the endogenous neuromodulator adenosine and inhibited excitatory synaptic transmission. These effects involve adenosine A(1) and ATP receptors and depend on decreased extracellular pH. In contrast, decreasing CO2 levels reduced extracellular adenosine concentration and increased neuronal excitability via adenosine A, receptors, ATP receptors, and ecto-ATPase. Based on these studies, we propose that CO2-induced changes in neuronal function arise from a pH-dependent modulation of adenosine and ATP levels. These findings demonstrate a mechanism for the bidirectional effects Of CO2 on neuronal excitability in the forebrain.	Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Dundee, Div Pathol & Neurosci, Inst Neurosci, Ninewells Hosp, Dundee DD1 9SY, Scotland; Trinity Coll, Program Neurosci, Hartford, CT 06106 USA; Trinity Coll, Dept Psychol, Hartford, CT 06106 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Dundee; Trinity College; Trinity College	Staley, KJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Program Neurosci, 4200 E 9th Ave, Denver, CO 80262 USA.	kevin.staley@uchsc.edu	Frenguelli, Bruno/C-5007-2015	Frenguelli, Bruno/0000-0001-7214-3172; Dulla, Chris/0000-0002-6560-6535	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029173] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029173-09A1, R01 NS029173-11, R01 NS029173-10, R01 NS029173-12, R01 NS029173, R01 NS029173-13] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ACHENBACHNG J, 1994, J CLIN NEUROPHYSIOL, V11, P220, DOI 10.1097/00004691-199403000-00007; ADAMS DJ, 1981, NEUROLOGY, V31, P1175, DOI 10.1212/WNL.31.9.1175; Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; Almeida T, 2003, NEUROSCIENCE, V122, P111, DOI 10.1016/S0306-4522(03)00523-2; ARAM JA, 1987, NEUROSCI LETT, V83, P345, DOI 10.1016/0304-3940(87)90112-1; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; BALESTRINO M, 1988, J PHYSIOL-LONDON, V396, P247, DOI 10.1113/jphysiol.1988.sp016961; Bao Yinghui, 2000, Chin J Traumatol, V3, P210; Boison D, 2002, EPILEPSIA, V43, P788, DOI 10.1046/j.1528-1157.2002.33001.x; Bradley SR, 2002, NAT NEUROSCI, V5, P401, DOI 10.1038/nn848; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Capps R T, 1968, Clin Anesth, V3, P122; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cunha RA, 1998, J NEUROSCI, V18, P1987; Dale N, 1998, J PHYSIOL-LONDON, V511, P265, DOI 10.1111/j.1469-7793.1998.265bi.x; Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Datto C, 2002, J ECT, V18, P118, DOI 10.1097/00124509-200209000-00002; Drakulich DA, 2004, EUR J PHARMACOL, V485, P137, DOI 10.1016/j.ejphar.2003.11.056; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FUJIWARA N, 1992, BRAIN RES, V572, P335, DOI 10.1016/0006-8993(92)90496-V; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; GU JG, 1995, J NEUROCHEM, V64, P2105; Guaranha MSB, 2005, EPILEPSIA, V46, P69, DOI 10.1111/j.0013-9580.2005.11104.x; Huguenard J R, 1999, Adv Neurol, V79, P991; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Khakh BS, 2003, J NEUROSCI, V23, P7426; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Lee J, 1996, BRAIN RES, V706, P210, DOI 10.1016/0006-8993(95)01214-1; MACVICAR BA, 1982, BRAIN RES, V242, P341; Malva JO, 2003, NEUROCHEM RES, V28, P1501, DOI 10.1023/A:1025618324593; Masino SA, 1999, J NEUROSCI, V19, P1932; Mendoza-Fernandez V, 2000, J PHARMACOL EXP THER, V293, P172; MILEY CE, 1977, ARCH NEUROL-CHICAGO, V34, P371, DOI 10.1001/archneur.1977.00500180065014; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; NAGY AK, 1986, J NEUROCHEM, V47, P976; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Pankratov Y, 1999, PROG BRAIN RES, V120, P237; Pankratov YV, 2002, J NEUROSCI, V22, P8363; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pearson T, 2001, J NEUROSCI, V21, P2298, DOI 10.1523/JNEUROSCI.21-07-02298.2001; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; Thummler S, 2000, J NEUROPHYSIOL, V83, P1787, DOI 10.1152/jn.2000.83.4.1787; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wirrell EC, 1996, EPILEPSIA, V37, P459, DOI 10.1111/j.1528-1157.1996.tb00592.x; Yoshioka K, 2002, FEBS LETT, V531, P299, DOI 10.1016/S0014-5793(02)03540-8; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; ZIGANSHIN AU, 1994, DRUG DEVELOP RES, V32, P134, DOI 10.1002/ddr.430320303; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	67	132	136	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1011	1023		10.1016/j.neuron.2005.11.009	http://dx.doi.org/10.1016/j.neuron.2005.11.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364904	Bronze, Green Accepted			2022-12-17	WOS:000234301700016
J	Lou, H; Kim, SK; Zaitsev, E; Snell, CR; Lu, B; Loh, YP				Lou, H; Kim, SK; Zaitsev, E; Snell, CR; Lu, B; Loh, YP			Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase E	NEURON			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; SYNAPTIC MODULATION; PATHWAY; CELLS; PROOPIOMELANOCORTIN; IDENTIFICATION	Activity-dependent secretion of BDNF is important in mediating synaptic plasticity, but how it is achieved is unclear. Here we uncover a sorting motif receptor-mediated mechanism for regulated secretion of BDNF. X-ray crystal structure analysis revealed a putative sorting Motif, l(16)E(18)l(105)D(106), in BDNF, which when mutated at the acidic residues resulted in missorting of proBDNF to the constitutive pathway in AtT-20 cells. A V20E mutation to complete a similar motif in NGF redirected a significant proportion of it from the constitutive to the regulated pathway. Modeling and binding studies showed interaction of the acidic residues in the BDNF motif with two basic residues in the sorting receptor, carboxypeptidase E (CPE). S-35 labeling experiments demonstrated that activity dependent secretion of BDNF from cortical neurons was obliterated in CPE knockout mice. Thus, we have identified a mechanism whereby a specific Motif l(16)E(18)l(105)D(106) interacts with CPIE to sort proBDNF into regulated pathway vesicles for activity-dependent secretion.	NICHHD, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; NICHHD, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Medivir UK Ltd, Saffron Walden CB10 1XL, Essex, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Medivir	Loh, YP (corresponding author), NICHHD, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	lohp@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714, Z01HD000056] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BALSCHMIDT P, 1991, ACTA CRYSTALLOGR B, V47, P975, DOI 10.1107/S010876819100842X; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; CAWLEY NX, 2004, BEHAV DEICITS ENDOCR, V145, P5807; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cool DR, 1998, MOL CELL ENDOCRINOL, V139, P7, DOI 10.1016/S0303-7207(98)00081-1; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dhanvantari S, 2003, MOL ENDOCRINOL, V17, P1856, DOI 10.1210/me.2002-0380; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Haubensak W, 1998, J CELL SCI, V111, P1483; Heymach JV, 1996, J BIOL CHEM, V271, P25430, DOI 10.1074/jbc.271.41.25430; Hibbert AP, 2003, J BIOL CHEM, V278, P48129, DOI 10.1074/jbc.M300961200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Loh YP, 2004, J MOL NEUROSCI, V22, P63, DOI 10.1385/JMN:22:1-2:63; LOH YP, 1988, FEBS LETT, V238, P142, DOI 10.1016/0014-5793(88)80244-8; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Luo XG, 2001, NEUROSCI RES, V39, P377, DOI 10.1016/S0168-0102(00)00238-8; MCDONALD NQ, 1991, J MOL BIOL, V219, P595, DOI 10.1016/0022-2836(91)90655-P; Michael GJ, 1997, J NEUROSCI, V17, P8476; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moller JC, 1998, J NEUROSCI RES, V51, P463, DOI 10.1002/(SICI)1097-4547(19980215)51:4<463::AID-JNR6>3.0.CO;2-A; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shen FS, 1999, NEUROPEPTIDES, V33, P276, DOI 10.1054/npep.1999.0045; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Wang LC, 2004, J NEUROENDOCRINOL, V16, P19, DOI 10.1111/j.1365-2826.2004.01110.x; Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048; Zhang CF, 1999, MOL ENDOCRINOL, V13, P527, DOI 10.1210/me.13.4.527; Zhang CF, 2003, BIOCHEM J, V369, P453, DOI 10.1042/BJ20020827	52	132	140	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					245	255		10.1016/j.neuron.2004.12.037	http://dx.doi.org/10.1016/j.neuron.2004.12.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664176	Bronze			2022-12-17	WOS:000226451500011
J	Drouot', X; Oshino, S; Jarraya, B; Besret, L; Kishima, H; Remy, P; Dauguet, J; Lefaucheur, JP; Dolle, F; Conde, F; Bottlaender, M; Peschanski, M; Keravel, Y; Hantraye, P; Palfi, S				Drouot', X; Oshino, S; Jarraya, B; Besret, L; Kishima, H; Remy, P; Dauguet, J; Lefaucheur, JP; Dolle, F; Conde, F; Bottlaender, M; Peschanski, M; Keravel, Y; Hantraye, P; Palfi, S			Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation	NEURON			English	Article							HIGH-FREQUENCY STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS; GLOBUS-PALLIDUS; BASAL GANGLIA; NEURONAL-ACTIVITY; DOPAMINE; OSCILLATIONS; INHIBITION	A concept in Parkinson's disease postulates that motor cortex may pattern abnormal rhythmic activities in the basal ganglia, underlying the genesis of observed motor symptoms. We conducted a preclinical study of electrical interference in the primary motor cortex using a chronic MPTP primate model in which dopamine depletion was progressive and regularly documented using F-18-DOPA positron tomography. High-frequency motor cortex stimulation significantly reduced akinesia and bradykinesia. This behavioral benefit was associated with an increased metabolic activity in the supplementary motor area as assessed with 18-F-deoxyglucose PET, a normalization of mean firing rate in the internal globus pallidus (GPi) and the subthalamic nucleus (STN), and a reduction of synchronized oscillatory neuronal activities in these two structures. Motor cortex stimulation is a simple and safe procedure to modulate subthalamo-pallido-cortical loop and alleviate parkinsonian symptoms without requiring deep brain stereotactic surgery.	Serv Hosp Frederic Joliot, CEA, CNRS, URA 2210, F-91401 Orsay, France; Serv Hosp Frederic Joliot, Isotop Imaging Biochem & Pharmacol Unit, F-91401 Orsay, France; Serv Hosp Frederic Joliot, Imagene Program, F-91401 Orsay, France; Univ Paris 12, UPVM U 421, INSERM, F-94010 Creteil, France; Univ Paris 12, Serv Physiol, F-94010 Creteil, France; Univ Paris 12, Serv Neurol, F-94010 Creteil, France; Univ Paris 12, Serv Neurochirurg, Hop Henri Mondor, AP HP, F-94010 Creteil, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Palfi, S (corresponding author), Serv Hosp Frederic Joliot, CEA, CNRS, URA 2210, F-91401 Orsay, France.	stephane.palfi@hmn.ap-hop-paris.fr	Peschanski, Marc/N-5769-2017; Oshino, Satoru/AAS-1647-2020; Jarraya, Bechir/R-6023-2019; Dollé, Frédéric/R-5756-2017	Jarraya, Bechir/0000-0003-0878-763X; Oshino, Satoru/0000-0002-4248-2322; Remy, Philippe/0000-0003-2150-2563; Drouot, Xavier/0000-0002-3940-4825				Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bezard Erwan, 2001, FASEB Journal, V15, P1092; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Escola L, 2003, BRAIN, V126, P95, DOI 10.1093/brain/awg004; Fukuda M, 2001, ANN NEUROL, V49, P155, DOI 10.1002/1531-8249(20010201)49:2<155::AID-ANA35>3.0.CO;2-9; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; GRAFTON ST, 1995, ANN NEUROL, V37, P776, DOI 10.1002/ana.410370611; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Hashimoto T, 2002, J NEUROSCI METH, V113, P181, DOI 10.1016/S0165-0270(01)00491-5; Heimer G, 2002, J NEUROSCI, V22, P7850; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Krack P, 1998, BRAIN, V121, P451, DOI 10.1093/brain/121.3.451; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Magill PJ, 2001, NEUROSCIENCE, V106, P313, DOI 10.1016/S0306-4522(01)00281-0; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Ribeiro MJ, 2002, ARCH NEUROL-CHICAGO, V59, P580, DOI 10.1001/archneur.59.4.580; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89; Wichmann T, 1999, NATURE, V400, P621, DOI 10.1038/23148	34	132	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					769	778		10.1016/j.neuron.2004.11.023	http://dx.doi.org/10.1016/j.neuron.2004.11.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572109	Bronze			2022-12-17	WOS:000225548400006
J	Sacchetti, B; Scelfo, B; Tempia, F; Strata, P				Sacchetti, B; Scelfo, B; Tempia, F; Strata, P			Long-term synaptic changes induced in the cerebellar cortex by fear conditioning	NEURON			English	Article							PURKINJE-CELLS; GLUTAMATE-RECEPTOR; EYELID RESPONSES; NITRIC-OXIDE; HEART-RATE; IN-VITRO; RAT; CONSOLIDATION; POTENTIATION; DEPRESSION	To better understand learning mechanisms, one needs to study synaptic plasticity induced by behavioral training. Recently, it has been demonstrated that the cerebellum is involved in the consolidation of fear memory. Nevertheless, how the cerebellum contributes to emotional behavior is far from known. In cerebellar slices at 10 min and 24 hr following fear conditioning, we found a long-lasting potentiation of the synapse between parallel fibers and Purkinje cells in vermal lobules V-VI, but not in the climbing fiber synapses. The mechanism is postsynaptic, due to an increased AMPA response. In addition, in hotfoot mice with a primary deficiency of the parallel fiber to Purkinje cell synapse, cued (but not contextual) fear conditioning is affected. We propose that this synapse plays an important role in the learned fear and that its long-term potentiation may represent a contribution to the neural substrate of fear memory.	Univ Turin, Rita Levi Montalcini Ctr Brain Repair, Dept Neurosci, I-10125 Turin, Italy; Univ Perugia, Sect Human Physiol, Dept Internal Med, I-06126 Perugia, Italy; Rehabil Hosp & Res Inst, Santa Lucia Fdn, I-00179 Rome, Italy	University of Turin; University of Perugia; IRCCS Santa Lucia	Strata, P (corresponding author), Univ Turin, Rita Levi Montalcini Ctr Brain Repair, Dept Neurosci, Corso Raffaello 30, I-10125 Turin, Italy.	piergiorgio.strata@unito.it	Tempia, Filippo/A-5883-2012; Sacchetti, Benedetto/AFK-4141-2022; Sacchetti, Benedetto/AAG-2916-2022; Scelfo, Bibiana/B-5997-2017	Tempia, Filippo/0000-0003-2778-0943; Scelfo, Bibiana/0000-0002-2261-8683; Sacchetti, Benedetto/0000-0002-8695-8310				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bures J, 1998, CONDITIONED TASTE AV; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Cesa R, 2003, J NEUROSCI, V23, P2363; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Heath R G, 1981, Curr Psychiatr Ther, V20, P329; HOLLMANN H, 1994, ANNU REV NEUROSCI, V17, P31; HUANG CM, 1982, BRAIN RES, V244, P1, DOI 10.1016/0006-8993(82)90897-6; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kleim JA, 1997, J NEUROSCI, V17, P717; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Mediavilla C, 1999, NEUROBIOL LEARN MEM, V72, P13, DOI 10.1006/nlme.1998.3899; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MOYE TB, 1987, DEV PSYCHOBIOL, V20, P405, DOI 10.1002/dev.420200405; Moyer JR, 1996, J NEUROSCI, V16, P5536; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Saab CY, 2003, BRAIN RES REV, V42, P85, DOI 10.1016/S0165-0173(03)00151-6; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P86, DOI 10.1152/jn.1997.77.1.86; SEBASTIANI L, 1992, EXP BRAIN RES, V88, P193, DOI 10.1007/BF02259141; Snider RS, 1944, J NEUROPHYSIOL, V7, P331, DOI 10.1152/jn.1944.7.6.331; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Strata Piergiorgio, 2002, Cerebellum, V1, P230, DOI 10.1080/147342202320883533; SUPPLE WF, 1990, BEHAV NEUROSCI, V104, P934; SUPPLE WF, 1988, PHYSIOL BEHAV, V42, P145, DOI 10.1016/0031-9384(88)90290-9; SUPPLE WF, 1987, PHYSIOL BEHAV, V39, P579, DOI 10.1016/0031-9384(87)90156-9; SUPPLE WF, 1993, J NEUROSCI, V13, P3705; Tempia F, 1996, J NEUROSCI, V16, P456; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1	61	132	133	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					973	982		10.1016/j.neuron.2004.05.012	http://dx.doi.org/10.1016/j.neuron.2004.05.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207241	Bronze			2022-12-17	WOS:000222329300012
J	Gelfand, JR; Bookheimer, SY				Gelfand, JR; Bookheimer, SY			Dissociating neural mechanisms of temporal sequencing and processing phonemes	NEURON			English	Article							SHORT-TERM-MEMORY; INFERIOR PREFRONTAL CORTEX; HUMAN AUDITORY-CORTEX; EVENT-RELATED FMRI; WORKING-MEMORY; HEMISPHERIC LATERALIZATION; SENTENCE COMPREHENSION; PITCH DISCRIMINATION; RECOGNITION MEMORY; TASK-DIFFICULTY	Using fMRI, we sought to determine whether the posterior, superior portion of Broca's area performs operations on phoneme segments specifically or implements processes general to sequencing discrete units. Twelve healthy volunteers performed two sequence manipulation tasks and one matching task, using strings of syllables and hummed notes. The posterior portion of Broca's area responded specifically to the sequence manipulation tasks, independent of whether the stimuli were composed of phonemes or hummed notes. In contrast, the left supramarginal gyrus was somewhat more specific to sequencing phoneme segments. These results suggest a functional dissociation of the canonical left hemisphere language regions encompassing the "phonological loop," with the left posterior inferior frontal gyrus responding not to the sound structure of language but rather to sequential operations that may underlie the ability to form words out of dissociable elements.	Univ Calif Los Angeles, David Geffen Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bookheimer, SY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA.			Bookheimer, Susan/0000-0002-3417-5891				ALBERT ML, 1972, NEUROPSYCHOLOGIA, V10, P245, DOI 10.1016/0028-3932(72)90067-X; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; AUZOU P, 1995, NEUROPSYCHOLOGIA, V33, P25, DOI 10.1016/0028-3932(94)00100-4; Baddeley Alan, 1986, WORKING MEMORY; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Benson RR, 2001, BRAIN LANG, V78, P364, DOI 10.1006/brln.2001.2484; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BISIACCHI PS, 1989, Q J EXP PSYCHOL-A, V41, P293, DOI 10.1080/14640748908402367; BOGEN JE, 1971, NATURE, V230, P524, DOI 10.1038/230524a0; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; BUB D, 1987, COGNITIVE NEUROPSYCH, P79; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; CANTER GJ, 1985, BRAIN LANG, V24, P204, DOI 10.1016/0093-934X(85)90131-2; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; Caplan D, 2000, HUM BRAIN MAPP, V9, P65; Carmon A, 1971, Cortex, V7, P411; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DEMONET JF, 1994, BRAIN, V117, P671, DOI 10.1093/brain/117.4.671; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GATES A, 1977, BRAIN LANG, V4, P403, DOI 10.1016/0093-934X(77)90035-9; GORDON HW, 1974, J NEUROL NEUROSUR PS, V37, P727, DOI 10.1136/jnnp.37.6.727; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hanten G, 2001, BRAIN COGNITION, V45, P164, DOI 10.1006/brcg.2000.1236; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kang AM, 1999, NEUROIMAGE, V10, P555, DOI 10.1006/nimg.1999.0493; Kim JJ, 2002, NEUROIMAGE, V15, P879, DOI 10.1006/nimg.2001.1025; Kim JJ, 1999, BRAIN, V122, P1069, DOI 10.1093/brain/122.6.1069; KIM Y, 1980, CORTEX, V16, P135, DOI 10.1016/S0010-9452(80)80028-1; KIM YC, 1976, BRAIN LANG, V3, P507, DOI 10.1016/0093-934X(76)90045-6; KIMURA D, 1974, BRAIN, V97, P337, DOI 10.1093/brain/97.1.337; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; LOMAS J, 1976, NEUROPSYCHOLOGIA, V14, P23, DOI 10.1016/0028-3932(76)90004-X; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Martin R C, 1982, Brain Cogn, V1, P50, DOI 10.1016/0278-2626(82)90006-9; MONOI H, 1983, BRAIN LANG, V20, P175, DOI 10.1016/0093-934X(83)90041-X; Oakhill J, 2000, J EXP CHILD PSYCHOL, V75, P152, DOI 10.1006/jecp.1999.2529; OJEMANN G, 1979, SCIENCE, V205, P1401, DOI 10.1126/science.472757; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Perry DW, 1999, NEUROREPORT, V10, P3979, DOI 10.1097/00001756-199912160-00046; Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; PRICE CJ, 1997, HUMAN BRAIN FUNCTION, P301; Rao SM, 1997, J NEUROSCI, V17, P5528; Raye CL, 2002, NEUROIMAGE, V15, P447, DOI 10.1006/nimg.2001.0983; Riecker A, 2000, NEUROREPORT, V11, P1997, DOI 10.1097/00001756-200006260-00038; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; SHAPIRO BE, 1981, NEUROPSYCHOLOGIA, V19, P161, DOI 10.1016/0028-3932(81)90101-9; STUART M, 1990, Q J EXP PSYCHOL-A, V42, P305, DOI 10.1080/14640749008401224; Stuss DT., 1986, FRONTAL LOBES; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanji K, 2001, CORTEX, V37, P671, DOI 10.1016/S0010-9452(08)70613-0; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Thierry G, 1999, NEUROREPORT, V10, P2599, DOI 10.1097/00001756-199908200-00029; TZORTZIS C, 1974, NEUROPSYCHOLOGIA, V12, P355, DOI 10.1016/0028-3932(74)90051-7; von Zerssen GC, 2001, EUR J NEUROSCI, V13, P2148, DOI 10.1046/j.0953-816x.2001.01589.x; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Weschler D., 1974, MANUAL WESCHLER INTE; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	86	132	134	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					831	842		10.1016/S0896-6273(03)00285-X	http://dx.doi.org/10.1016/S0896-6273(03)00285-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	687DU	12797966	Bronze			2022-12-17	WOS:000183361400017
J	Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N				Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N			G alpha(i) controls the gating of the G protein-activated K+ channel, GIRK	NEURON			English	Article							BETA-GAMMA-SUBUNITS; MUSCARINIC POTASSIUM CHANNEL; XENOPUS-OOCYTES; ATRIAL MYOCYTES; I-KACH; RECEPTORS; BINDING; CELLS; G(BETA-GAMMA); SPECIFICITY	GIRK (Kir3) channels are activated by neurotransmitters; coupled to G proteins, via a direct binding of Gbetagamma. The role of Galpha subunits in GIRK gating is elusive. Here we demonstrate that Galpha(i) is not only a donor of Gbetagamma but also regulates GIRK gating. When overexpressed in Xenopus oocytes, GIRK channels show excessive basal activity and poor activation by agonist or Gbetagamma. Coexpression of Galpha(i3) or Galpha(i1), restores the correct gating parameters. Galpha(i) acts neither as a pure Gbetagamma scavenger nor as an allosteric cofactor for Gbetagamma. It inhibits only the basal activity without interfering with Gbetagamma-induced response. Thus, GIRK is regulated, in distinct ways, by both arms of the G protein. Gal probably acts in its GDP bound form, alone or as a part of Galphabetagamma heterotrimer.	Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; Univ Texas, Houston Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.		Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280	NIGMS NIH HHS [R01 GM060419-02, R01 GM060419, GM 56260-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419, R01GM056260] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bender K, 1998, FEBS LETT, V439, P115, DOI 10.1016/S0014-5793(98)01350-7; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Kim D, 1997, AM J PHYSIOL-HEART C, V272, pH195, DOI 10.1152/ajpheart.1997.272.1.H195; Kozasa T, 1996, NEUROSCI RES, V26, P289, DOI 10.1016/S0168-0102(96)01111-X; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Logothetis DE, 1999, J PHYSIOL-LONDON, V520, P630, DOI 10.1111/j.1469-7793.1999.00630.x; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; ROSS EM, 1995, RECENT PROG HORM RES, V50, P207; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Singer-Lahat D, 2000, PFLUG ARCH EUR J PHY, V440, P627, DOI 10.1007/s004240000341; Sorota S, 1999, J PHYSIOL-LONDON, V514, P413, DOI 10.1111/j.1469-7793.1999.413ae.x; Sowell MO, 1997, P NATL ACAD SCI USA, V94, P7921, DOI 10.1073/pnas.94.15.7921; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; Yamada M, 1998, PHARMACOL REV, V50, P723; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	43	132	135	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					87	99		10.1016/S0896-6273(01)00567-0	http://dx.doi.org/10.1016/S0896-6273(01)00567-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779482	Bronze			2022-12-17	WOS:000173106200012
J	Butler, MH; Hayashi, A; Ohkoshi, N; Villmann, C; Becker, CM; Feng, GP; De Camilli, P; Solimena, M				Butler, MH; Hayashi, A; Ohkoshi, N; Villmann, C; Becker, CM; Feng, GP; De Camilli, P; Solimena, M			Autoimmunity to gephyrin in Stiff-Man syndrome	NEURON			English	Article							GLUTAMIC-ACID DECARBOXYLASE; PARANEOPLASTIC CEREBELLAR DEGENERATION; BREAST-CANCER; NEUROLOGICAL SYNDROMES; DIABETES-MELLITUS; PERSON SYNDROME; AMPHIPHYSIN; PROTEIN; AUTOANTIBODIES; HYPEREKPLEXIA	Stiff-Man syndrome (SMS) is a rare disease of the central nervous system (CNS) characterized by chronic rigidity, spasms, and autoimmunity directed against synaptic antigens, most often the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD). In a sub-set of cases, SMS has an autoimmune paraneoplastic origin. We report here the identification of high-titer autoantibodies directed against gephyrin in a patient with clinical features of SMS and mediastinal cancer. Gephyrin is a cytosolic protein selectively concentrated at the postsynaptic membrane of inhibitory synapses, where it is associated with GABA(A) and glycine receptors. Our findings provide new evidence for a close link between autoimmunity directed against components of inhibitory synapses and neurological conditions characterized by chronic rigidity and spasms.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 3058575, Japan	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Washington University (WUSTL); University of Erlangen Nuremberg; University of Tsukuba	Solimena, M (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.		Feng, Guoping/Y-2827-2019; Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011		NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, P01DK053015] Funding Source: NIH RePORTER; NCI NIH HHS [CA-46128] Funding Source: Medline; NIDDK NIH HHS [DK-53015, DK-45735] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; ANDERSON NE, 1987, CRIT REV NEUROBIOL, V3, P245; Andrew M, 1997, BRIT J PSYCHIAT, V170, P106, DOI 10.1192/bjp.170.2.106; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Betz H, 1998, NAT NEUROSCI, V1, P541, DOI 10.1038/2777; BLUM P, 1991, MOVEMENT DISORD, V6, P12, DOI 10.1002/mds.870060104; Dalmau JO, 1999, ARCH NEUROL-CHICAGO, V56, P405, DOI 10.1001/archneur.56.4.405; Darnell RB, 1999, NEW ENGL J MED, V340, P1831, DOI 10.1056/NEJM199906103402311; DAVID C, 1994, FEBS LETT, V351, P73, DOI 10.1016/0014-5793(94)00826-4; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DECAMILLI P, 1993, J EXP MED, V178, P2219, DOI 10.1084/jem.178.6.2219; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DIRKX R, 1995, J BIOL CHEM, V270, P2241, DOI 10.1074/jbc.270.5.2241; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Floeter MK, 1998, NEUROLOGY, V51, P85, DOI 10.1212/WNL.51.1.85; Floyd S, 1998, MOL MED, V4, P29, DOI 10.1007/BF03401727; FOLLI F, 1993, NEW ENGL J MED, V328, P546, DOI 10.1056/NEJM199302253280805; FURNEAUX HM, 1990, NEW ENGL J MED, V322, P1844, DOI 10.1056/NEJM199006283222604; Harada H, 1999, Rinsho Shinkeigaku, V39, P1025; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KOK O, 1962, LANCET, V1, P1359; LENNON VA, 1995, NEW ENGL J MED, V332, P1467, DOI 10.1056/NEJM199506013322203; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; LORISH TR, 1989, MAYO CLIN PROC, V64, P629, DOI 10.1016/S0025-6196(12)65339-7; MEINCK HM, 1984, J NEUROL NEUROSUR PS, V47, P280, DOI 10.1136/jnnp.47.3.280; MITSUMOTO H, 1991, J NEUROL, V238, P91, DOI 10.1007/BF00315688; MOERSCH FP, 1956, P STAFF M MAYO CLIN, V31, P421; Newsom-Davis J, 1999, J ROY COLL PHYS LOND, V33, P225; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; SANDER JE, 1980, ANN NEUROL, V8, P195, DOI 10.1002/ana.410080212; Saul B, 1999, J NEUROSCI, V19, P869; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1991, TRENDS NEUROSCI, V14, P452, DOI 10.1016/0166-2236(91)90044-U; SOLIMENA M, 1995, GABA 95, P31; SOLIMENA M, 1990, NEW ENGL J MED, V322, P155; Stayer C, 1998, Neurologia, V13, P83; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Vincent A, 1999, J NEUROIMMUNOL, V100, P169, DOI 10.1016/S0165-5728(99)00210-6; Whitney KD, 1999, ANNU REV NEUROSCI, V22, P175, DOI 10.1146/annurev.neuro.22.1.175; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	49	132	137	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2000	26	2					307	312		10.1016/S0896-6273(00)81165-4	http://dx.doi.org/10.1016/S0896-6273(00)81165-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839351	Bronze			2022-12-17	WOS:000087296500009
J	Hsu, SF; Augustine, GJ; Jackson, MB				Hsu, SF; Augustine, GJ; Jackson, MB			Adaptation of Ca2+-triggered exocytosis in presynaptic terminals	NEURON			English	Article							SQUID GIANT SYNAPSE; BOVINE CHROMAFFIN CELLS; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; CA2+ RELEASE; NEUROTRANSMITTER RELEASE; INTRACELLULAR CALCIUM; FLUORESCENT INDICATOR; PHOTOLABILE CHELATOR; FLASH-PHOTOLYSIS	Rapid increases in Ca2+ concentration, produced by photolysis of caged Ca2+, triggered exocytosis in squid nerve terminals. This exocytosis was transient in nature, decaying with a time constant of approximately 30 ms. The decay could not be explained by a decline in presynaptic Ca2+ concentration, depletion of synaptic vesicles, or desensitization of postsynaptic receptors. Experiments in which Ca2+ was increased either in a series of steps or continuously at different rates suggested that the decay is caused by adaptation of the exocytotic Ca2+ receptor to higher levels of Ca2+. This adjustable sensitivity to Ca2+ represents a novel property of the triggering mechanism that can be used to evaluate molecular models of exocytosis. Adaptation can limit the amount of transmitter released by a nerve terminal and permit the speed of a presynaptic Ca2+ rise to serve as a critical determinant of synaptic efficacy.	DUKE UNIV, SCH MED, DEPT NEUROBIOL, DURHAM, NC 27710 USA; MARINE BIOL LAB, WOODS HOLE, MA 02543 USA	Duke University; Marine Biological Laboratory - Woods Hole	Hsu, SF (corresponding author), UNIV WISCONSIN, SCH MED, DEPT PHYSIOL, MADISON, WI 53706 USA.		Augustine, George James/J-9228-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R01NS021624, R37NS030016] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30016, NS21624] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P143, DOI 10.1113/jphysiol.1985.sp015818; AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BOWNDS MD, 1995, BEHAV BRAIN SCI, V18, P415, DOI 10.1017/S0140525X00039170; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CHENG HP, 1995, SCIENCE, V267, P2009, DOI 10.1126/science.7701326; CORRIE JET, 1993, J PHYSIOL-LONDON, V465, P1; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; EATOCK RA, 1987, J NEUROSCI, V7, P2821; EllisDavies GCR, 1996, BIOPHYS J, V70, P1006, DOI 10.1016/S0006-3495(96)79644-3; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GYORKE S, 1993, SCIENCE, V260, P807, DOI 10.1126/science.8387229; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERRINGTON J, 1994, PULSE CONTROL VERSIO; Hodgkin AL., 1964, CONDUCTION NERVOUS I; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Katz B., 1969, RELEASE NEURAL TRANS; KELLY JS, 1969, J NEUROBIOL, V2, P209; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNOX BE, 1986, P NATL ACAD SCI USA, V83, P2345, DOI 10.1073/pnas.83.8.2345; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1975, P NATL ACAD SCI USA, V72, P187, DOI 10.1073/pnas.72.1.187; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MOORE WJ, 1972, PHYSICAL CHEM; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PARNAS H, 1989, BIOPHYS J, V55, P859, DOI 10.1016/S0006-3495(89)82885-1; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; SCHELLER RH, 1995, NEURON, V14, P893; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; STUENKEL EL, 1993, J PHYSIOL-LONDON, V468, P335, DOI 10.1113/jphysiol.1993.sp019775; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	57	132	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					501	512		10.1016/S0896-6273(00)80182-8	http://dx.doi.org/10.1016/S0896-6273(00)80182-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816713	Bronze			2022-12-17	WOS:A1996VJ44000016
J	McFarlane, S; Cornel, E; Amaya, E; Holt, CE				McFarlane, S; Cornel, E; Amaya, E; Holt, CE			Inhibition of FGF receptor activity in retinal ganglion cell axons causes errors in target recognition	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; NEURITE OUTGROWTH; XENOPUS-LAEVIS; VISUAL-SYSTEM; DEVELOPMENTAL EXPRESSION; CONE GUIDANCE; IN-VIVO; NEURONS; DIFFERENTIATION; IDENTIFICATION	Native fibroblast growth factor receptor (FGFR) function was inhibited in developing Xenopus retinal ganglion cells (RGCs) by in vivo transfection of a dominant negative FGFR. Axons expressing the dominant negative protein advanced at 60% of the normal speed, but nevertheless navigated appropriately in the embryonic optic pathway. When they neared the optic tectum, however, many axons made erroneous turns, causing them to bypass rather than enter their target. By contrast, RGC axons expressing nonfunctional FGFR mutants entered the tectum correctly. These findings demonstrate a role for FGFR signaling in the extension and targeting of RGC axons and suggest that receptor tyrosine kinase/growth factor interactions play a critical function in establishing initial connectivity in the vertebrate visual system.	UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	McFarlane, S (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23780] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Elshamy WM, 1996, DEVELOPMENT, V122, P491; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FRIESEL R, 1991, MOL CELL BIOL, V11, P2481, DOI 10.1128/MCB.11.5.2481; FRIESEL R, 1992, DEVELOPMENT, V116, P1051; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; ISAACS HV, 1995, INT J DEV BIOL, V39, P575; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Launay C, 1996, DEVELOPMENT, V122, P869; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; MUSOI TJ, 1990, P NATL ACAD SCI USA, V87, P8365; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ROU JF, 1996, BIOCHEM BIOPH RES CO, V218, P198; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SHIOZAKI C, 1995, GENE, V152, P215, DOI 10.1016/0378-1119(94)00694-N; TANNAHILL D, 1992, DEVELOPMENT, V115, P695; TCHENG M, 1994, EXP EYE RES, V58, P351, DOI 10.1006/exer.1994.1025; UENO H, 1992, J BIOL CHEM, V267, P1470; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WALLICKE PC, 1986, P NATL ACAD SCI USA, V83, P3012; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1995, J CELL SCI, V108, P3523; Worley T, 1996, J NEUROSCI, V16, P2294; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; ZHANG L, 1994, J NEUROSCI, V14, P5187	51	132	133	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					245	254		10.1016/S0896-6273(00)80156-7	http://dx.doi.org/10.1016/S0896-6273(00)80156-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780648	Bronze			2022-12-17	WOS:A1996VE84000007
J	Brandes, C; Plautz, JD; Stanewsky, R; Jamison, CF; Straume, M; Wood, KV; Kay, SA; Hall, JC				Brandes, C; Plautz, JD; Stanewsky, R; Jamison, CF; Straume, M; Wood, KV; Kay, SA; Hall, JC			Novel features of Drosophila period transcription revealed by real-time luciferase reporting	NEURON			English	Article							MESSENGER-RNA LEVELS; CIRCADIAN CLOCK; GENE; MELANOGASTER; EXPRESSION; MUTATIONS	The rapid turnover of luciferase and the sensitive, noninvasive nature of its assay make this reporter gene uniquely situated for temporal gene expression studies. To determine the in vivo regulatory pattern of the Drosophila clock gene period (per), we generated transgenic strains carrying a luciferase cDNA fused to the promoter region of the per gene. This has allowed us to monitor circadian rhythms of bioluminescence from pacemaker cells within the head for several days in individual living adults. These high time-resolution experiments permitted neuronal per transcription to be accurately measured in single animals. This new technology has revealed a novel feature of per transcription and opens the door to vastly simplified experiments in general chronobiology and studies of temporally regulated transcription in a wide range of experimental systems.	UNIV VIRGINIA,DEPT BIOL,CHARLOTTESVILLE,VA 22903; UNIV VIRGINIA,NATL SCI FDN CTR BIOL TIMING,CHARLOTTESVILLE,VA 22903; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BRANDEIS UNIV,NATL SCI FDN CTR BIOL TIMING,WALTHAM,MA 02254; PROMEGA CORP,MADISON,WI 53711	University of Virginia; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; Brandeis University; Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; Promega Corporation			Stanewsky, Ralf/ABB-9193-2021; Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Stanewsky, Ralf/0000-0001-8238-6864	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33205] Funding Source: Medline; NIMH NIH HHS [MH-51573] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CARPENTER JM, 1950, DROSOPHILA INFORMATI, V24, P96; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; HALL JC, 1995, TRENDS NEUROSCI, V18, P218; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; Kay S A, 1993, Semin Cell Biol, V4, P81, DOI 10.1006/scel.1993.1010; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; LOCKETT TJ, 1992, GENE, V114, P187, DOI 10.1016/0378-1119(92)90573-8; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MONSMA SA, 1988, J EXP ZOOL, V247, P279, DOI 10.1002/jez.1402470312; PLAUTZ JD, 1996, IN PRESS GENE; PRESS WH, 1989, NUMERICAL RECIPES FO; ROBERTSON HM, 1988, GENETICS, V118, P461; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Straume M, 1991, TOPICS FLUORESCENCE, P177, DOI DOI 10.1007/B112907; THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317; WASHBURN T, 1992, GENETICS, V130, P585; Wood Keith V., 1995, Current Opinion in Biotechnology, V6, P50, DOI 10.1016/0958-1669(95)80009-3; WRIGHT NJD, 1995, J NEUROSCI, V15, P1025; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; ZWIEBEL LJ, 1991, P NATL ACAD SCI USA, V88, P3882, DOI 10.1073/pnas.88.9.3882	33	132	133	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					687	692		10.1016/S0896-6273(00)80088-4	http://dx.doi.org/10.1016/S0896-6273(00)80088-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607986	Bronze			2022-12-17	WOS:A1996UG61100001
J	CAMMACK, JN; RAKHILIN, SV; SCHWARTZ, EA				CAMMACK, JN; RAKHILIN, SV; SCHWARTZ, EA			A GABA TRANSPORTER OPERATES ASYMMETRICALLY AND WITH VARIABLE STOICHIOMETRY	NEURON			English	Article							ELECTROGENIC GLUTAMATE UPTAKE; NA+ GLUCOSE COTRANSPORTER; GLIAL-CELLS; MONOVALENT CATIONS; CA EXCHANGE; ION-CHANNEL; RELEASE; RETINA; CLAMP; NEUROTRANSMITTER	Membrane currents produced by the expression of a rat GABA transporter (GAT-1) stably transfected into HEK293 cells were characterized with a whole-cell voltage clamp. Three modes of function were identified: ex-gated currents produced by extracellular GABA, ingated currents produced by intracellular GABA, and uncoupled currents produced in the absence of GABA. The ex-gated current was not the reversal of the in-gated current; moreover, the stoichiometry between GABA and co-ions was not always fixed. Each mode of function required a different set of ions on the two sides of the membrane. We made rapid solution changes and observed an allosteric effect of Na+ that only occurred at the extracellular surface. Thus, the GAT-1 transporter does not behave like a recirculating carrier but may be described as a pore with ion gates at either end that are controlled in part by allosteric sites.			CAMMACK, JN (corresponding author), UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,947 E 58TH ST,CHICAGO,IL 60637, USA.				NEI NIH HHS [EY-02440, F32-EY-0644] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002440, R37EY002440] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALI FE, 1985, J MED CHEM, V28, P653, DOI 10.1021/jm50001a020; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; BEAUGE L, 1991, ANN NY ACAD SCI, V639, P147, DOI 10.1111/j.1749-6632.1991.tb17298.x; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CAMMACK JN, 1993, J PHYSIOL-LONDON, V472, P81, DOI 10.1113/jphysiol.1993.sp019938; GADSBY DC, 1991, ANN NY ACAD SCI, V639, P140, DOI 10.1111/j.1749-6632.1991.tb17297.x; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JAUCH P, 1986, J MEMBRANE BIOL, V94, P117, DOI 10.1007/BF01871192; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; NEAL MJ, 1972, NATURE-NEW BIOL, V235, P217, DOI 10.1038/newbio235217a0; NEHER E, 1992, METHOD ENZYMOL, V207, P123; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; PATWARDHAN S, 1991, ONCOGENE, V6, P917; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Sambrook J., 1989, MOL CLONING LAB MANU; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SCHWARTZ EA, 1982, J PHYSIOL-LONDON, V323, P211, DOI 10.1113/jphysiol.1982.sp014069; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0	24	132	135	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					949	960		10.1016/0896-6273(94)90260-7	http://dx.doi.org/10.1016/0896-6273(94)90260-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7524562				2022-12-17	WOS:A1994PP53300017
J	WENDLAND, B; MILLER, KG; SCHILLING, J; SCHELLER, RH				WENDLAND, B; MILLER, KG; SCHILLING, J; SCHELLER, RH			DIFFERENTIAL EXPRESSION OF THE P65 GENE FAMILY	NEURON			English	Article							INTEGRAL MEMBRANE-PROTEIN; SYNAPTIC VESICLE PROTEIN; ENDOCRINE-CELLS; RAT-BRAIN; CHANNEL PROTEIN; NERVOUS-SYSTEM; SYNAPSIN-I; KINASE-C; SYNAPTOPHYSIN; IDENTIFICATION	The genome of the marine ray Discopyge ommata contains at least three p65-related genes. o-p65-A is 84% identical, o-p65-B is 78% identical, and o-p65-C is only 41% identical to a previously characterized rat p65. The cytoplasmic domain, particularly the two regions that are similar to the regulatory domain of protein kinase C, are most highly conserved. The three genes are expressed in different but overlapping patterns in the central nervous system. o-p65-A immunoreactivity is found predominantly in forebrain, cerebellum, and neuroendocrine cells, while o-p65-B immunoreactivity is predominantly localized to the spinal cord, brainstem, and midbrain. Many synaptic vesicle proteins are members of small gene families that are differentially expressed, resulting in several unique combinations of these molecules in specific brain regions.	STANFORD UNIV,BECKMAN CTR,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305; STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University; Stanford University	WENDLAND, B (corresponding author), STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305, USA.				NINDS NIH HHS [F32 NS009565] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009565] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BUCKLEY KM, 1987, J CELL BIOL, V105, P2447, DOI 10.1083/jcb.105.6.2447; CARLSON SS, 1978, BIOCHEMISTRY-US, V17, P1188, DOI 10.1021/bi00600a009; COWAN D, 1989, BRAIN RES, V509, P1; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FLOOR E, 1989, J NEUROCHEM, V52, P1433, DOI 10.1111/j.1471-4159.1989.tb09190.x; Gros E., 1967, METHOD ENZYMOL, V11, P238; Hoar W. S., 1969, FISH PHYSL, V2; JOHNSTON PA, 1990, J BIOL CHEM, V265, P8869; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KNAUS P, 1990, NEURON, V5, P453, DOI 10.1016/0896-6273(90)90084-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LINIAL M, 1989, NEURON, V2, P1265, DOI 10.1016/0896-6273(89)90311-5; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; Maniatis T., 1982, MOL CLONING; MATTEOLI M, 1989, CELL BIOL INT REP, V13, P981, DOI 10.1016/0309-1651(89)90014-3; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NGSEE JK, 1991, J BIOL CHEM, V266, P2675; NGSEE JK, 1990, J NEUROSCI, V10, P317; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; REICHARDT LF, 1983, ANNU REV BIOCHEM, V52, P871, DOI 10.1146/annurev.bi.52.070183.004255; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5643; SNYDER M, 1987, METHOD ENZYMOL, V154, P107; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 1989, CURR OPIN CELL BIOL, V1, P655, DOI 10.1016/0955-0674(89)90030-6; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; Thomas TB, 1940, ANAT REC, V76, P1, DOI 10.1002/ar.1090760102; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.biochem.56.1.365; ZIMMERMANN H, 1977, NEUROSCIENCE, V2, P715, DOI 10.1016/0306-4522(77)90025-2	47	132	135	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					993	1007		10.1016/0896-6273(91)90239-V	http://dx.doi.org/10.1016/0896-6273(91)90239-V			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	2054189	Green Accepted			2022-12-17	WOS:A1991FT94900014
J	Valle, G; Mazzoni, A; Iberite, F; D'Anna, E; Strauss, I; Granata, G; Controzzi, M; Clemente, F; Rognini, G; Cipriani, C; Stieglitz, T; Petrini, FM; Rossini, PM; Micera, S				Valle, Giacomo; Mazzoni, Alberto; Iberite, Francesco; D'Anna, Edoardo; Strauss, Ivo; Granata, Giuseppe; Controzzi, Marco; Clemente, Francesco; Rognini, Giulio; Cipriani, Christian; Stieglitz, Thomas; Petrini, Francesco Maria; Rossini, Paolo Maria; Micera, Silvestro			Biomimetic Intraneural Sensory Feedback Enhances Sensation Naturalness, Tactile Sensitivity, and Manual Dexterity in a Bidirectional Prosthesis	NEURON			English	Article							SOMATOSENSORY FEEDBACK; POPULATION RESPONSE; PERIPHERAL-NERVE; RUBBER HAND; AMPUTEES; TOUCH; PHANTOM; RESTORATION; STIMULATION; EMBODIMENT	Peripheral intraneural stimulation can provide tactile information to amputees. However, efforts are still necessary to identify encoding strategy eliciting percepts that are felt as both natural and effective for prosthesis control. Here we compared the naturalness and efficacy of different encoding strategies to deliver neural stimulation to trans-radial amputees implanted with intraneural electrodes. Biomimetic frequency modulation was perceived as more natural, while amplitude modulation enabled better performance in tasks requiring fine identification of the applied force. Notably, the optimal combination of naturalness and sensitivity of the tactile feedback can be achieved with "hybrid" encoding strategies based on simultaneous biomimetic frequency and amplitude neuromodulation. These strategies improved the gross manual dexterity of the subjects during functional task while maintaining high levels of manual accuracy. They also improved prosthesis embodiment, reducing abnormal phantom limb perceptions ("telescoping effect"). Hybrid strategies are able to provide highly sensitive and natural percepts and should be preferred.	[Valle, Giacomo; D'Anna, Edoardo; Strauss, Ivo; Rognini, Giulio; Petrini, Francesco Maria; Micera, Silvestro] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Sch Engn, Bertarelli Fdn Chair Translat Neuroengn, CH-1202 Lausanne, Switzerland; [Valle, Giacomo; D'Anna, Edoardo; Strauss, Ivo; Rognini, Giulio; Petrini, Francesco Maria; Micera, Silvestro] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, CH-1202 Lausanne, Switzerland; [Valle, Giacomo; Mazzoni, Alberto; Iberite, Francesco; Strauss, Ivo; Controzzi, Marco; Clemente, Francesco; Cipriani, Christian; Micera, Silvestro] Scuola Super Sant Anna, BioRobot Inst, I-56025 Pisa, Italy; [Granata, Giuseppe; Rossini, Paolo Maria] Univ Cattolica Sacro Cuore, IRCCS Policlin A Gemelli Fdn, Inst Neurol, I-00168 Rome, Italy; [Rognini, Giulio] Ecole Polytech Fed Lausanne, Lab Cognit Neurosci, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Stieglitz, Thomas] Univ Freiburg, Bernstein Ctr, Dept Microsyst Engn IMTEK, BrainLinks BrainTools Cluster Excellence,Lab Biom, D-79110 Freiburg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Scuola Superiore Sant'Anna; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Freiburg	Micera, S (corresponding author), Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Sch Engn, Bertarelli Fdn Chair Translat Neuroengn, CH-1202 Lausanne, Switzerland.; Micera, S (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, CH-1202 Lausanne, Switzerland.; Micera, S (corresponding author), Scuola Super Sant Anna, BioRobot Inst, I-56025 Pisa, Italy.	silvestro.micera@epfl.ch	Granata, Giuseppe/Z-5871-2019; Micera, Silvestro/AAD-6630-2021; Mazzoni, Alberto/AGO-5998-2022; Iberite, Francesco/AAN-2096-2020; Valle, Giacomo/AAE-6490-2019; Strauss, Ivo/AAZ-1214-2021; Mazzoni, Alberto/N-6960-2016; Granata, Giuseppe/ABE-2015-2021; Stieglitz, Thomas/C-7916-2013; D'Anna, Edoardo/D-5062-2018; Rossini, Paolo Maria/D-4994-2013	Mazzoni, Alberto/0000-0002-9632-1831; Iberite, Francesco/0000-0002-4365-5328; Valle, Giacomo/0000-0002-2637-8007; Strauss, Ivo/0000-0003-0971-8783; Mazzoni, Alberto/0000-0002-9632-1831; Granata, Giuseppe/0000-0002-8939-7467; Stieglitz, Thomas/0000-0002-7349-4254; D'Anna, Edoardo/0000-0003-1299-4957; Rossini, Paolo Maria/0000-0003-2665-534X; controzzi, marco/0000-0003-2135-0707	EU [FET 611687 NEBIAS]; National Competence Center in Research (NCCR) in Robotics - Swiss National Science Foundation; Bertarelli Foundation	EU(European Commission); National Competence Center in Research (NCCR) in Robotics - Swiss National Science Foundation; Bertarelli Foundation	The authors are deeply grateful to the subjects who freely donated weeks of their life for the advancement of knowledge and for a better future of people with hand amputation. The authors wish to thank Prof. Sliman Bensmaia for his valuable suggestions during the development and test of the encoding strategies. We also thank Prof. Olaf Blanke for sharing with us the equipment for measuring the telescoping effect and Prof. Stanisa Raspopovic for the valuable discussions during the early phase of the experiments. This work was partly funded by the EU Grant FET 611687 NEBIAS Project (neurocontrolled bidirectional artificial upper limb and hand prosthesis), the National Competence Center in Research (NCCR) in Robotics funded by the Swiss National Science Foundation, and by the Bertarelli Foundation.	Boretius T, 2010, BIOSENS BIOELECTRON, V26, P62, DOI 10.1016/j.bios.2010.05.010; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bourbeau DJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056009; Chortos A, 2016, NAT MATER, V15, P937, DOI 10.1038/NMAT4671; Clemente F, 2016, IEEE T NEUR SYS REH, V24, P1314, DOI 10.1109/TNSRE.2015.2500586; D'Alonzo M, 2015, IEEE T NEUR SYS REH, V23, P450, DOI 10.1109/TNSRE.2014.2337952; De'Sperati C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15619-8; Delgado-Martinez I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00286; Delhaye B, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00037; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Giummarra MJ, 2010, BRIT J PSYCHOL, V101, P791, DOI 10.1348/000712610X492558; Graczyk EL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5187; Horch K, 2011, IEEE T NEUR SYS REH, V19, P483, DOI 10.1109/TNSRE.2011.2162635; Horch W., 1983, J NEUROSCI, V3, P14; Jabaley M E, 1980, J Hand Surg Am, V5, P1; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHNSON KO, 1974, J NEUROPHYSIOL, V37, P48, DOI 10.1152/jn.1974.37.1.48; King H. Hawkeye, 2010, 2010 IEEE Haptics Symposium (Formerly known as Symposium on Haptic Interfaces for Virtual Environment and Teleoperator Systems), P95, DOI 10.1109/HAPTIC.2010.5444670; LENZ FA, 1993, J NEUROPHYSIOL, V70, P200, DOI 10.1152/jn.1993.70.1.200; Manfredi LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031203; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; Oddo CM, 2016, ELIFE, V5, DOI 10.7554/eLife.09148; Ortiz-Catalan M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008933; Osborn LE, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat3818; Pasluosta C, 2018, CLIN NEUROPHYSIOL, V129, P851, DOI 10.1016/j.clinph.2017.12.027; Prochazka A, 2015, J ANAT, V227, P167, DOI 10.1111/joa.12311; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Raspopovic S, 2017, P IEEE, V105, P34, DOI 10.1109/JPROC.2016.2600560; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Rognini G, 2019, J NEUROL NEUROSUR PS, V90, P833, DOI 10.1136/jnnp-2018-318570; Saal HP, 2017, P NATL ACAD SCI USA, V114, pE5693, DOI 10.1073/pnas.1704856114; Saal HP, 2015, NEUROPSYCHOLOGIA, V79, P344, DOI 10.1016/j.neuropsychologia.2015.06.010; Schiefer M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016001; Tan DW, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026002; Tan DW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008669; Tuckett P., 1983, J NEUROSCI, V3, P8; Tyler DJ, 2015, CURR OPIN NEUROL, V28, P574, DOI 10.1097/WCO.0000000000000266; Urban FM, 1910, PSYCHOL REV, V17, P229, DOI 10.1037/h0074515; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; Wendelken S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0320-4; Wijk U, 2015, J HAND THER, V28, P269, DOI 10.1016/j.jht.2015.01.013	45	131	133	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 10	2018	100	1					37	+		10.1016/j.neuron.2018.08.033	http://dx.doi.org/10.1016/j.neuron.2018.08.033			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW4DV	30244887	Bronze, Green Submitted			2022-12-17	WOS:000446862000009
J	Gauthier, JL; Tank, DW				Gauthier, Jeffrey L.; Tank, David W.			A Dedicated Population for Reward Coding in the Hippocampus	NEURON			English	Article							SPATIAL FIRING PATTERNS; SINGLE UNIT-ACTIVITY; PLACE CELLS; CELLULAR-RESOLUTION; VENTRAL STRIATUM; MEMORY; REPRESENTATION; DYNAMICS; NAVIGATION; NEURONS	The hippocampus plays a critical role in goal-directed navigation. Across different environments, however, hippocampal maps are randomized, making it unclear how goal locations could be encoded consistently. To address this question, we developed a virtual reality task with shifting reward contingencies to distinguish place versus reward encoding. In mice performing the task, large-scale recordings in CA1 and subiculum revealed a small, specialized cell population that was only active near reward yet whose activity could not be explained by sensory cues or stereotyped reward anticipation behavior. Across different virtual environments, most cells remapped randomly, but reward encoding consistently arose from a single pool of cells, suggesting that they formed a dedicated channel for reward. These observations represent a significant departure from the current understanding of CA1 as a relatively homogeneous ensemble without fixed coding properties and provide a new candidate for the cellular basis of goal memory in the hippocampus.	[Gauthier, Jeffrey L.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University	Gauthier, JL; Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	jeff.l.gauthier@gmail.com; dwtank@princeton.edu			NIH NRSA [1F32NS077840-01A1]; NIH NIMH [R01 2R01MH083686-06]; NIH [R37NS081242-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS081242] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NRSA 1F32NS077840-01A1 (J.L.G.), NIH NIMH R01 2R01MH083686-06 (J.L.G. and D.W.T.), and NIH R37NS081242-06 (J.L.G. and D.W.T.). Transgenic mice were made by the Genetically-Encoded Neuronal Indicator and Effector (GENIE) Project at the HHMI's Janelia Research Campus. We thank D. Aronov, M. Harnett, A. Charles, and T. Boyd-Meredith for comments on the manuscript.	Ambrose RE, 2016, NEURON, V91, P1124, DOI 10.1016/j.neuron.2016.07.047; Andersen P., 2007, HIPPOCAMPUS BOOK; Anderson MI, 2003, J NEUROSCI, V23, P8827; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Atallah HE, 2014, NEURON, V82, P1145, DOI 10.1016/j.neuron.2014.04.021; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Danielson NB, 2016, NEURON, V91, P652, DOI 10.1016/j.neuron.2016.06.020; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; Deadwyler SA, 2004, NEURON, V42, P465, DOI 10.1016/S0896-6273(04)00195-3; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Gothard KM, 1996, J NEUROSCI, V16, P823; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kelemen E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000403; Kim SM, 2012, J NEUROSCI, V32, P11539, DOI 10.1523/JNEUROSCI.5942-11.2012; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lin LN, 2007, P NATL ACAD SCI USA, V104, P6066, DOI 10.1073/pnas.0701106104; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Malvache A, 2016, SCIENCE, V353, P1280, DOI 10.1126/science.aaf3319; McKenzie S, 2016, NEUROBIOL LEARN MEM, V134, P178, DOI 10.1016/j.nlm.2015.12.008; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; McKenzie S, 2013, J NEUROSCI, V33, P10243, DOI 10.1523/JNEUROSCI.0879-13.2013; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Poucet B, 2017, CURR OPIN BEHAV SCI, V17, P51, DOI 10.1016/j.cobeha.2017.06.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rodriguez F, 2002, BRAIN RES BULL, V57, P499, DOI 10.1016/S0361-9230(01)00682-7; Rosenzweig ES, 2003, NAT NEUROSCI, V6, P609, DOI 10.1038/nn1053; Rubin A, 2015, ELIFE, V4, DOI 10.7554/eLife.12247; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Sato M., 2018, DYNAMIC EMBEDDING SA, DOI 10.1101/266767; Sato M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0369-16.2017; Schoenbaum G, 2011, ANN NY ACAD SCI, V1239, P87, DOI 10.1111/j.1749-6632.2011.06210.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Stachenfeld KL, 2017, NAT NEUROSCI, V20, P1643, DOI 10.1038/nn.4650; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Zaremba JD, 2017, NAT NEUROSCI, V20, P1612, DOI 10.1038/nn.4634	65	131	132	9	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 11	2018	99	1					179	+		10.1016/j.neuron.2018.06.008	http://dx.doi.org/10.1016/j.neuron.2018.06.008			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM7OG	30008297	Green Accepted, Bronze			2022-12-17	WOS:000438378100017
J	Tyssowski, KM; DeStefino, NR; Cho, JH; Dunn, CJ; Poston, RG; Carty, CE; Jones, RD; Chang, SM; Romeo, P; Wurzelmann, MK; Ward, JM; Andermann, ML; Saha, RN; Dudek, SM; Gray, JM				Tyssowski, Kelsey M.; DeStefino, Nicholas R.; Cho, Jin-Hyung; Dunn, Carissa J.; Poston, Robert G.; Carty, Crista E.; Jones, Richard D.; Chang, Sarah M.; Romeo, Palmyra; Wurzelmann, Mary K.; Ward, James M.; Andermann, Mark L.; Saha, Ramendra N.; Dudek, Serena M.; Gray, Jesse M.			Different Neuronal Activity Patterns Induce Different Gene Expression Programs	NEURON			English	Article							PRIMARY RESPONSE GENES; REGULATED KINASE ACTIVATION; RNA-POLYMERASE-II; MAP KINASE; SYNAPTIC PLASTICITY; GROWTH-FACTOR; ENHANCER TRANSCRIPTION; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NMDA RECEPTORS	A vast number of different neuronal activity patterns could each induce a different set of activity-regulated genes. Mapping this coupling between activity pattern and gene induction would allow inference of a neuron's activity-pattern history from its gene expression and improve our understanding of activity-pattern-dependent synaptic plasticity. In genome-scale experiments comparing brief and sustained activity patterns, we reveal that activity-duration history can be inferred from gene expression profiles. Brief activity selectively induces a small subset of the activity-regulated gene program that corresponds to the first of three temporal waves of genes induced by sustained activity. Induction of these first-wave genes is mechanistically distinct from that of the later waves because it requires MAPK/ERK signaling but does not require de novo translation. Thus, the same mechanisms that establish the multi-wave temporal structure of gene induction also enable different gene sets to be induced by different activity durations.	[Tyssowski, Kelsey M.; DeStefino, Nicholas R.; Cho, Jin-Hyung; Jones, Richard D.; Chang, Sarah M.; Gray, Jesse M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Dunn, Carissa J.; Poston, Robert G.; Saha, Ramendra N.] Univ Calif Merced, Mol Cell Biol Unit, Merced, CA 95343 USA; [Carty, Crista E.; Andermann, Mark L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Romeo, Palmyra; Wurzelmann, Mary K.; Saha, Ramendra N.; Dudek, Serena M.] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Ward, James M.] NIEHS, Integrat Bioinformat, NIH, Res Triangle Pk, NC 27709 USA	Harvard University; Harvard Medical School; University of California System; University of California Merced; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Gray, JM (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Saha, RN (corresponding author), Univ Calif Merced, Mol Cell Biol Unit, Merced, CA 95343 USA.; Saha, RN; Dudek, SM (corresponding author), NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA.	rsaha3@ucmerced.edu; dudek@niehs.nih.gov; gray@genetics.med.harvard.edu	Dudek, Serena/C-6561-2009	Dudek, Serena/0000-0003-4094-8368; Tyssowski, Kelsey/0000-0002-5324-4872; Ward, James/0000-0002-9510-2848	BCH IDDRC [1U54HD090255]; Armenise-Harvard [R01 MH101528-01, R01 MH116223-01]; Kaneb family; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health [Z01 ES100221]; NSF Graduate Research Fellowship Program [DGE1144152, DEG1745303]; National Institute of Health NRSA [R00 MH096941]; Canadian Institute of Health Research; NIH New Innovator Award [DP2 DK105570, R01 DK109930]; McKnight Scholar Award; Harvard Brain Science Initiative Bipolar Disorder Seed Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109930, DP2DK105570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100221, ZIAES100221, ZICES102445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH116223, R01MH101528, R00MH096941] Funding Source: NIH RePORTER	BCH IDDRC; Armenise-Harvard; Kaneb family; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institute of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; Harvard Brain Science Initiative Bipolar Disorder Seed Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank: Anastasia Nizhnik (technical assistance); Karen Adelman, Charles Danko, Sandeep R. Datta, Steven Flavell, Harrison Gabel, Michael Greenberg, Elizabeth Hong, Kelly Biette, Heather Landry, Colin Waters, Emily Low, Ian Hill, and Patricia Rohs (critical reading); Gray laboratory members (helpful discussion throughout the course of the project); Joseph Ling and Matthew Friese (early work on this project). BCH IDDRC, 1U54HD090255 (Fluidigm qPCR) Kevin Gerrish, NIEHS Molecular Genomics Core. Funding: R01 MH101528-01, R01 MH116223-01, Armenise-Harvard, and the Kaneb family (J.M.G. lab); the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health Z01 ES100221 (S.M.D. lab); the NSF Graduate Research Fellowship Program DGE1144152, DEG1745303 (K.M.T.); National Institute of Health NRSA (N.R.D), R00 MH096941 (R.N.S), Canadian Institute of Health Research (J.-H.C.), NIH New Innovator Award DP2 DK105570, R01 DK109930, McKnight Scholar Award, Harvard Brain Science Initiative Bipolar Disorder Seed Grant, supported by Kent and Liz Dauten (M.L.A. lab).	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cho JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31753; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dale RK, 2014, NUCLEIC ACIDS RES, V42, P9158, DOI 10.1093/nar/gku644; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DOUGLAS RM, 1988, MOL BRAIN RES, V4, P259, DOI 10.1016/0169-328X(88)90033-2; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Eshete F, 2001, J NEUROSCI, V21, P6694, DOI 10.1523/JNEUROSCI.21-17-06694.2001; Evans MD, 2013, J NEUROSCI, V33, P6950, DOI 10.1523/JNEUROSCI.0277-13.2013; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fields RD, 1997, J NEUROSCI, V17, P7252; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; Gaidatzis D, 2015, NAT BIOTECHNOL, V33, P722, DOI 10.1038/nbt.3269; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hengen KB, 2016, CELL, V165, P180, DOI 10.1016/j.cell.2016.01.046; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Hu P, 2017, MOL CELL, V68, P1006, DOI 10.1016/j.molcel.2017.11.017; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee PR, 2017, SCI REP-UK, V7, DOI 10.1038/srep43765; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ma H, 2011, NEUROSCI RES, V70, P2, DOI 10.1016/j.neures.2011.02.004; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Mohammed AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep20986; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nguyen TA, 2016, GENOME RES, V26, P1023, DOI 10.1101/gr.204834.116; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sgambato V, 1998, J NEUROSCI, V18, P214; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; SHENG HZ, 1993, J NEUROSCI RES, V35, P459, DOI 10.1002/jnr.490350502; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Telese F, 2015, NEURON, V86, P696, DOI 10.1016/j.neuron.2015.03.033; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Xia ZG, 1996, J NEUROSCI, V16, P5425; Ye C., 2017, BIORXIV, DOI [10.1101/225177, DOI 10.1101/225177]; Yu Y, 2017, CELL CALCIUM, V65, P14, DOI 10.1016/j.ceca.2017.03.003; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622; Zheng F, 2009, J NEUROSCI RES, V87, P380, DOI 10.1002/jnr.21863; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	96	131	131	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 2	2018	98	3					530	+		10.1016/j.neuron.2018.04.001	http://dx.doi.org/10.1016/j.neuron.2018.04.001			28	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1UU	29681534	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-17	WOS:000432473700011
J	Gallo, V; Deneen, B				Gallo, Vittorio; Deneen, Benjamin			Glial Development: The Crossroads of Regeneration and Repair in the CNS	NEURON			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PRECURSOR CELLS; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; ISCHEMIC BRAIN-INJURY; BONE MORPHOGENETIC PROTEINS; FIBRILLARY ACIDIC PROTEIN; EPIGENETIC REGULATORY MECHANISMS; CUPRIZONE-INDUCED DEMYELINATION	Given the complexities of the mammalian CNS, its regeneration is viewed as the holy grail of regenerative medicine. Extraordinary efforts have been made to understand developmental neurogenesis, with the hopes of clinically applying this knowledge. CNS regeneration also involves glia, which comprises at least 50% of the cellular constituency of the brain and is involved in all forms of injury and disease response, recovery, and regeneration. Recent developmental studies have given us unprecedented insight into the processes that regulate the generation of CNS glia. Because restorative processes often parallel those found in development, we will peer through the lens of developmental gliogenesis to gain a clearer understanding of the processes that underlie glial regeneration under pathological conditions. Specifically, this review will focus on key signaling pathways that regulate astrocyte and oligodendrocyte development and describe how these mechanisms are reutilized in these populations during regeneration and repair after CNS injury.	[Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA; [Deneen, Benjamin] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Deneen, Benjamin] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Children's National Health System; Baylor College of Medicine; Baylor College of Medicine	Gallo, V (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmc.org; deneen@bcm.edu		Deneen, Benjmain/0000-0002-6335-1081	NIH [R01NS045702, R01NS056427, P01NS062686, R01NS071153]; National Multiple Sclerosis Society [RG4706, RG4623]; Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers [P30HD40677, P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686, R01NS071153, R01NS045702, R01NS056427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH (R01NS045702, R01NS056427, and P01NS062686 to V. G. and R01NS071153 to B. D.) and the National Multiple Sclerosis Society RG4706 (V. G.) and RG4623 (B. D.). This work was also supported by Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers P30HD40677 (Children's National Medical Center) and P30HD024064 (Baylor College of Medicine). We thank Jonathan Ritter for figures and Li-Jin Chew for comments on the manuscript.	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Albrecht PJ, 2003, NEUROBIOL DIS, V13, P89, DOI 10.1016/S0969-9961(03)00019-6; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Ara J, 2008, J NEUROSCI RES, V86, P125, DOI 10.1002/jnr.21462; Armstrong RC, 2002, J NEUROSCI, V22, P8574; ARMSTRONG RC, 1995, GLIA, V14, P303, DOI 10.1002/glia.440140407; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Azoulay S, 1909, HISTOLOGIE SYSTEME N, V1; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2014, GLIA; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Badaracco ME, 2008, J NEUROSCI RES, V86, P2663, DOI 10.1002/jnr.21709; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Bansal R, 2002, DEV NEUROSCI-BASEL, V24, P35, DOI 10.1159/000064944; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Belachew S, 2002, J NEUROSCI, V22, P8553; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Berninger B, 2010, NEUROPHARMACOLOGY, V58, P894, DOI 10.1016/j.neuropharm.2009.11.004; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Cammer W, 1999, J NEUROIMMUNOL, V97, P37, DOI 10.1016/S0165-5728(99)00045-4; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Carbonell WS, 2003, J NEUROTRAUM, V20, P327, DOI 10.1089/089771503765172282; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Casaccia-Bonnefil P, 2000, GLIA, V29, P124, DOI 10.1002/(SICI)1098-1136(20000115)29:2<124::AID-GLIA5>3.0.CO;2-O; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Cate HS, 2010, J NEUROCHEM, V115, P11, DOI 10.1111/j.1471-4159.2010.06660.x; Cayre M, 2013, DEVELOPMENT, V140, P3107, DOI 10.1242/dev.092999; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Chaboub LS, 2012, DEV NEUROSCI-BASEL, V34, P379, DOI 10.1159/000343723; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Chen J, 2005, EUR J NEUROSCI, V22, P1895, DOI 10.1111/j.1460-9568.2005.04348.x; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Cohen RI, 1996, J NEUROSCI, V16, P6433; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Covey MV, 2007, NEUROSCIENCE, V148, P501, DOI 10.1016/j.neuroscience.2007.06.015; Crocker SJ, 2006, AM J PATHOL, V169, P2104, DOI 10.2353/ajpath.2006.060626; Crockett DP, 2005, GLIA, V49, P301, DOI 10.1002/glia.20111; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2010, CURR OPIN NEUROBIOL, V20, P601, DOI 10.1016/j.conb.2010.05.005; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2012, ANN NEUROL, V72, P224, DOI 10.1002/ana.23590; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feigenson K, 2011, ASN NEURO, V3, DOI 10.1042/AN20110004; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Ferreira AA, 2004, J NEUROCYTOL, V33, P225, DOI 10.1023/B:NEUR.0000030697.78488.63; Fischer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023905; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fortin D, 2005, J NEUROSCI, V25, P7470, DOI 10.1523/JNEUROSCI.2120-05.2005; Franco PG, 2008, EXP NEUROL, V212, P458, DOI 10.1016/j.expneurol.2008.04.039; Franklin R.J., 2014, GLIA; FRANKLIN RJM, 1991, J NEUROCYTOL, V20, P420, DOI 10.1007/BF01355538; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fu H, 2009, J NEUROSCI, V29, P11399, DOI 10.1523/JNEUROSCI.0160-09.2009; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Ganat Y, 2002, NEUROSCIENCE, V112, P977, DOI 10.1016/S0306-4522(02)00060-X; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; GERSTL B, 1970, J NEUROCHEM, V17, P677, DOI 10.1111/j.1471-4159.1970.tb00547.x; Ghiani CA, 1999, DEVELOPMENT, V126, P1077; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Goncalves MBC, 2005, DEV BIOL, V278, P60, DOI 10.1016/j.ydbio.2004.10.015; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Grinspan JB, 2000, J NEUROBIOL, V43, P1; Clausi MG, 2012, GLIA, V60, P1540, DOI 10.1002/glia.22374; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hirayama A, 2003, DEV BRAIN RES, V140, P85, DOI 10.1016/S0165-3806(02)00585-0; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ibarrola N, 1997, BRAIN RES, V752, P285, DOI 10.1016/S0006-8993(96)01480-1; Ichiyama T, 2006, J NEUROIMMUNOL, V172, P182, DOI 10.1016/j.jneuroim.2005.10.010; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Jadasz JJ, 2012, DEVELOPMENT, V139, P3306, DOI 10.1242/dev.074518; Jean I, 2003, BRAIN RES, V972, P110, DOI 10.1016/S0006-8993(03)02510-1; Jiang P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3196; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Jones SA, 2003, MOL CELL ENDOCRINOL, V199, P49, DOI 10.1016/S0303-7207(02)00296-4; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim JHY, 1997, DEV BRAIN RES, V102, P77, DOI 10.1016/S0165-3806(97)00080-1; Kremer D, 2009, P NATL ACAD SCI USA, V106, P9087, DOI 10.1073/pnas.0900204106; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kumral A, 2013, EARLY HUM DEV, V89, P165, DOI 10.1016/j.earlhumdev.2012.09.016; Kumral A, 2009, MED HYPOTHESES, V72, P692, DOI 10.1016/j.mehy.2008.10.032; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lin SY, 2005, BRAIN RES, V1063, P15, DOI 10.1016/j.brainres.2005.09.042; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; Marta CB, 1998, J NEUROSCI RES, V53, P251, DOI 10.1002/(SICI)1097-4547(19980715)53:2<251::AID-JNR14>3.0.CO;2-9; Martinez G, 2001, BRAIN RES, V894, P1, DOI 10.1016/S0006-8993(00)03140-1; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; MATTHIEU JM, 1992, J NEUROIMMUNOL, V40, P231, DOI 10.1016/0165-5728(92)90138-B; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Mela A, 2013, J NEUROSCI, V33, P7952, DOI 10.1523/JNEUROSCI.5836-12.2013; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Messersmith DJ, 2000, J NEUROSCI RES, V62, P241, DOI 10.1002/1097-4547(20001015)62:2<241::AID-JNR9>3.0.CO;2-D; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2011, NAT MED, V17, P816, DOI 10.1038/nm.2373; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Min J, 2012, GLIA, V60, P1684, DOI 10.1002/glia.22387; Ming XT, 2013, J NEUROSCI, V33, P12528, DOI 10.1523/JNEUROSCI.0536-13.2013; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mitew S, 2013, NEUROSCIENCE; Moll NM, 2013, GLIA, V61, P1659, DOI 10.1002/glia.22547; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moore CS, 2011, J NEUROSCI, V31, P6247, DOI 10.1523/JNEUROSCI.5474-10.2011; Morga E, 2009, GLIA, V57, P1741, DOI 10.1002/glia.20887; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Nakatani H, 2013, J NEUROSCI, V33, P9752, DOI 10.1523/JNEUROSCI.0805-13.2013; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Ness JK, 2002, DEV NEUROSCI-BASEL, V24, P437, DOI 10.1159/000069050; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Nygardas PT, 2002, CLIN EXP IMMUNOL, V128, P245, DOI 10.1046/j.1365-2249.2002.01855.x; O'Leary MT, 2002, MOL CELL NEUROSCI, V19, P32, DOI 10.1006/mcne.2001.1062; Ohya W, 2007, BRAIN RES, V1147, P51, DOI 10.1016/j.brainres.2007.02.045; Okada A, 2007, BIOCHEM BIOPH RES CO, V352, P158, DOI 10.1016/j.bbrc.2006.10.176; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Pacey LKK, 2007, GLIA, V55, P1601, DOI 10.1002/glia.20573; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Patel JR, 2012, ACTA NEUROPATHOL, V124, P847, DOI 10.1007/s00401-012-1034-0; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Planas AM, 1998, GLIA, V23, P120, DOI 10.1002/(SICI)1098-1136(199806)23:2<120::AID-GLIA3>3.0.CO;2-A; Plane JM, 2004, NEUROBIOL DIS, V16, P585, DOI 10.1016/j.nbd.2004.04.003; Raine CS, 1998, REV NEUROL-FRANCE, V154, P577; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rempe DA, 2010, NEUROTHERAPEUTICS, V7, P335, DOI 10.1016/j.nurt.2010.08.003; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sabo JK, 2011, J NEUROSCI, V31, P4504, DOI 10.1523/JNEUROSCI.5859-10.2011; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Samanta J, 2007, J NEUROSCI, V27, P7397, DOI 10.1523/JNEUROSCI.1434-07.2007; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Scafidi J, 2009, INT J DEV NEUROSCI, V27, P863, DOI 10.1016/j.ijdevneu.2009.05.009; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schweizer S, 2013, J CEREBR BLOOD F MET, V33, P1335, DOI 10.1038/jcbfm.2013.93; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; See J, 2004, MOL CELL NEUROSCI, V26, P481, DOI 10.1016/j.mcn.2004.04.004; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Singh N, 2012, CELL MOL NEUROBIOL, V32, P491, DOI 10.1007/s10571-012-9803-9; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Soula C, 2001, DEVELOPMENT, V128, P1369; Spassky N, 2002, J NEUROSCI, V22, P5992; Spassky N, 2001, DEVELOPMENT, V128, P4993; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stankoff B, 2002, J NEUROSCI, V22, P9221; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; TCHELINGERIAN JL, 1995, J NEUROCHEM, V65, P2377; Tien AC, 2012, DEVELOPMENT, V139, P2477, DOI 10.1242/dev.077214; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tsai HW, 2009, EPIGENETICS-US, V4, P47, DOI 10.4161/epi.4.1.7288; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Vaccarino FM, 2004, ARCH DIS CHILD-FETAL, V89, pF190, DOI 10.1136/adc.2003.043661; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Wijngaarden P, 2013, DEVELOPMENT, V140, P2562, DOI 10.1242/dev.092262; Vana AC, 2007, GLIA, V55, P687, DOI 10.1002/glia.20492; VonDran MW, 2011, J NEUROSCI, V31, P14182, DOI 10.1523/JNEUROSCI.6595-10.2011; Vondran MW, 2010, GLIA, V58, P848, DOI 10.1002/glia.20969; Vose LR, 2013, J NEUROSCI, V33, P17232, DOI 10.1523/JNEUROSCI.2713-13.2013; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Werther GA, 1998, HORM RES, V49, P37, DOI 10.1159/000053066; Wolswijk G, 1998, J NEUROSCI, V18, P601; Xia XG, 2002, MOL CELL NEUROSCI, V21, P379, DOI 10.1006/mcne.2002.1180; Xiang X, 2012, NEUROSCI LETT, V530, P127, DOI 10.1016/j.neulet.2012.09.058; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; YAO DL, 1995, P NATL ACAD SCI USA, V92, P6190, DOI 10.1073/pnas.92.13.6190; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Ye P, 1999, ENDOCRINOLOGY, V140, P3063, DOI 10.1210/en.140.7.3063; Ye P, 2002, J NEUROSCI, V22, P6041; Younes-Rapozo V, 2006, INT J DEV NEUROSCI, V24, P445, DOI 10.1016/j.ijdevneu.2006.08.004; Yu K, 2013, DEVELOPMENT, V140, P1594, DOI 10.1242/dev.090845; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zaidi AU, 2004, GLIA, V46, P380, DOI 10.1002/glia.20013; Zeger M, 2007, GLIA, V55, P400, DOI 10.1002/glia.20469; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106; Zhong J, 2009, NEUROL RES, V31, P483, DOI 10.1179/174313208X338133; Zuo H, 2013, NEUROSCI BULL, V29, P165, DOI 10.1007/s12264-013-1320-4	293	131	133	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2014	83	2					283	308		10.1016/j.neuron.2014.06.010	http://dx.doi.org/10.1016/j.neuron.2014.06.010			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN3HU	25033178	Green Accepted, Bronze			2022-12-17	WOS:000340478700007
J	Plotkin, JL; Day, M; Peterson, JD; Xie, Z; Kress, GJ; Rafalovich, I; Kondapalli, J; Gertler, TS; Flajolet, M; Greengard, P; Stavarache, M; Kaplitt, MG; Rosinski, J; Chan, CS; Surmeier, DJ				Plotkin, Joshua L.; Day, Michelle; Peterson, Jayms D.; Xie, Zhong; Kress, Geraldine J.; Rafalovich, Igor; Kondapalli, Jyothisri; Gertler, Tracy S.; Flajolet, Marc; Greengard, Paul; Stavarache, Mihaela; Kaplitt, Michael G.; Rosinski, Jim; Chan, C. Savio; Surmeier, D. James			Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington's Disease	NEURON			English	Article							P75 NEUROTROPHIN RECEPTOR; LONG-TERM POTENTIATION; MUTANT-HUNTINGTIN; MOUSE MODELS; STRIATUM; NEURONS; PHOSPHORYLATION; ACTIVATION; EXPRESSION; PLASTICITY	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. The debilitating choreic movements that plague HD patients have been attributed to striatal degeneration induced by the loss of cortically supplied brain-derived neurotrophic factor (BDNF). Here, we show that in mouse models of early symptomatic HD, BDNF delivery to the striatum and its activation of tyrosine-related kinase B (TrkB) receptors were normal. However, in striatal neurons responsible for movement suppression, TrkB receptors failed to properly engage postsynaptic signaling mechanisms controlling the induction of potentiation at corticostriatal synapses. Plasticity was rescued by inhibiting p75 neurotrophin receptor (p75NTR) signaling or its downstream target phosphatase-and-tensin-homolog-deleted-on-chromosome-10 (PTEN). Thus, corticostriatal synaptic dysfunction early in HD is attributable to a correctable defect in the response to BDNF, not its delivery.	[Plotkin, Joshua L.; Day, Michelle; Peterson, Jayms D.; Xie, Zhong; Kress, Geraldine J.; Rafalovich, Igor; Kondapalli, Jyothisri; Gertler, Tracy S.; Chan, C. Savio; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Stavarache, Mihaela; Kaplitt, Michael G.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY 10028 USA; [Rosinski, Jim] CHDI Management CHDI Fdn, Princeton, NJ 08540 USA	Northwestern University; Feinberg School of Medicine; Rockefeller University; Cornell University	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Plotkin, Joshua/AAJ-5043-2021; Xie, Zhong/B-6829-2011	Xie, Zhong/0000-0002-8348-4455; Chan, C. Savio/0000-0002-3474-1718; Plotkin, Joshua/0000-0001-6232-7613; Greengard, Paul/0000-0002-4437-0893; Kress, Geraldine/0000-0001-9442-8734	Cure Huntington's Disease Initiative Foundation; JPB Foundation; Fisher Center for Alzheimer's Research Foundation; NIH [NS034696, MH074866, NS067414]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696, R01NS067414] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative Foundation; JPB Foundation; Fisher Center for Alzheimer's Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Cure Huntington's Disease Initiative Foundation (D.J.S.), the JPB Foundation (M. G. K., D.J.S., P. G.), the Fisher Center for Alzheimer's Research Foundation (P. G.), and the NIH (NS034696 and MH074866 to D.J.S.; NS067414 to M. G. K.) supported this work. We thank Dr. D. Wokosin, Dr. E. Ilijic, S. Ulrich, and K. Saporito for technical assistance.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Besusso D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3031; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brito V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.116; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gines S, 2010, J BIOL CHEM, V285, P21537, DOI 10.1074/jbc.M109.084202; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Harrison LM, 2013, NEUROSCIENCE, V236, P21, DOI 10.1016/j.neuroscience.2012.12.062; Harrison LM, 2013, EXP CELL RES, V319, P2310, DOI 10.1016/j.yexcr.2013.03.033; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Ilag LL, 1999, BIOCHEM BIOPH RES CO, V255, P104, DOI 10.1006/bbrc.1999.0101; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kung VWS, 2007, NEUROSCIENCE, V146, P1571, DOI 10.1016/j.neuroscience.2007.03.036; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Morgenstern PF, 2011, METHODS MOL BIOL, V793, P443, DOI 10.1007/978-1-61779-328-8_29; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfister Christina, 2011, BMC Res Notes, V4, P275, DOI 10.1186/1756-0500-4-275; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; TOOYAMA I, 1993, BRAIN RES, V610, P1, DOI 10.1016/0006-8993(93)91209-B; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yang S, 2012, BIOMATERIALS, V33, P2902, DOI 10.1016/j.biomaterials.2011.12.051; Zhang YH, 2008, J PHYSIOL-LONDON, V586, P3113, DOI 10.1113/jphysiol.2008.152439; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	63	131	133	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 2	2014	83	1					178	188		10.1016/j.neuron.2014.05.032	http://dx.doi.org/10.1016/j.neuron.2014.05.032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN3HJ	24991961	Bronze, Green Accepted			2022-12-17	WOS:000340476800016
J	Matta, JA; Ashby, MC; Sanz-Clemente, A; Roche, KW; Isaac, JTR				Matta, Jose A.; Ashby, Michael C.; Sanz-Clemente, Antonio; Roche, Katherine W.; Isaac, John T. R.			mGluR5 and NMDA Receptors Drive the Experience- and Activity-Dependent NMDA Receptor NR2B to NR2A Subunit Switch	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC-TRANSMISSION; MICE LACKING; FUNCTIONAL-PROPERTIES; HIPPOCAMPAL LTP; EXPRESSION; TRAFFICKING; PLASTICITY; ENHANCEMENT; INDUCTION	In cerebral cortex there is a developmental switch from NR2B- to NR2A-containing NMDA receptors (NMDARs) driven by activity and sensory experience. This subunit switch alters NMDAR function, influences synaptic plasticity, and its dysregulation is associated with neurological disorders. However, the mechanisms driving the subunit switch are not known. Here, we show in hippocampal CA1 pyramidal neurons that the NR2B to NR2A switch driven acutely by activity requires activation of NMDARs and mGluR5, involves PLC, Ca2+ release from IP3R-dependent stores, and PKC activity. In mGluR5 knockout mice the developmental NR2B-NR2A switch in CA1 is deficient. Moreover, in visual cortex of mGluR5 knockout mice, the NR2B-NR2A switch evoked in vivo by visual experience is absent. Thus, we establish that mGluR5 and NMDARs are required for the activity-dependent NR2B-NR2A switch and play a critical role in experience-dependent regulation of NMDAR subunit composition in vivo.	[Matta, Jose A.; Ashby, Michael C.; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA; [Sanz-Clemente, Antonio; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Matta, JA (corresponding author), Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA.	mattaja@mail.nih.gov; isaacjo@lilly.com	Roche, Katherine/W-9893-2019; Sanz-Clemente, Antonio/AAF-7124-2019	Sanz-Clemente, Antonio/0000-0002-1256-4722; Ashby, Michael/0000-0002-8593-8473; Roche, Katherine/0000-0001-7282-6539	National Institute of Neurological Disorders and Stroke; NIGMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003036, ZIANS002994] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Program. J.A.M. is supported on a Pharmacology Research Associate fellowship from NIGMS. We are grateful to Chris McBain and members cif the McBain and Isaac labs for discussions on this study. We thank Hey Kyoung Lee and Emily Petrus for advice on the visual cortex experiments.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Cosford NDP, 2003, J MED CHEM, V46, P204, DOI 10.1021/jm025570j; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Flint AC, 1997, J NEUROSCI, V17, P2469; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Itoh S, 2001, BRAIN RES, V901, P237, DOI 10.1016/S0006-8993(01)02373-3; Jia ZP, 1998, LEARN MEMORY, V5, P331; Kingston AE, 1999, ANN NY ACAD SCI, V890, P438, DOI 10.1111/j.1749-6632.1999.tb08022.x; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Ross WN, 2005, CELL MOL NEUROBIOL, V25, P283, DOI 10.1007/s10571-005-3060-0; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans NA, 2000, DEV BRAIN RES, V123, P41, DOI 10.1016/S0165-3806(00)00082-1; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Taufiq AM, 2005, LEARN MEMORY, V12, P594, DOI 10.1101/lm.17405; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	68	131	137	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					339	351		10.1016/j.neuron.2011.02.045	http://dx.doi.org/10.1016/j.neuron.2011.02.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521618	Green Accepted, Bronze, Green Submitted			2022-12-17	WOS:000291073700014
J	Buchman, JJ; Tseng, HC; Zhou, Y; Frank, CL; Xie, ZG; Tsai, LH				Buchman, Joshua J.; Tseng, Huan-Chung; Zhou, Ying; Frank, Christopher L.; Xie, Zhigang; Tsai, Li-Huei			Cdk5rap2 Interacts with Pericentrin to Maintain the Neural Progenitor Pool in the Developing Neocortex	NEURON			English	Article							GAMMA-TUBULIN COMPLEXES; RECESSIVE MICROCEPHALY MAPS; MICROTUBULE ORGANIZATION; SPINDLE ORGANIZATION; PRIMORDIAL DWARFISM; CENTROSOMAL PROTEIN; NEURONAL MIGRATION; RNA INTERFERENCE; BRAIN SIZE; CELL-CYCLE	Primary autosomal-recessive microcephaly (MCPH) and Majewski osteodysplastic primordial dwarfism type II (MOPDII) are both genetic diseases that result in decreased brain size at birth. MCPH is thought to arise from alterations in the size of the neural progenitor pool, but the cause of this defect has not been thoroughly explored. We find that one of the genes associated with MCPH, Cdk5rap2, is highly expressed in the neural progenitor pool and that its loss results in a depletion of apical progenitors and increased cell-cycle exit leading to premature neuronal differentiation. We link Cdk5rap2 function to the pericentriolar material protein pericentrin, loss of function of which is associated with MOPDII. Depletion of pericentrin in neural progenitors phenocopies effects of Cdk5rap2 knockdown and results in decreased recruitment of Cdk5rap2 to the centrosome. Our findings uncover a common mechanism, involving aberrations in the neurogenesis program, that may underlie the development of microcephaly in multiple diseases.	[Buchman, Joshua J.; Tseng, Huan-Chung; Zhou, Ying; Frank, Christopher L.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Buchman, Joshua J.; Zhou, Ying; Frank, Christopher L.; Tsai, Li-Huei] Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Buchman, Joshua J.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Neurosurg, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave,Bldg 46,Room 4235A, Cambridge, MA 02139 USA.	lhtsai@mit.edu		Xie, Zhigang/0000-0002-5794-2977	National Institutes of Health [NS37007]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Y. Mao, K. Singh, and D. Kim for helpful comments and criticism of the manuscript. Thanks to X. Ge for preparing and contributing perfused embryonic brains. Thanks to Dr. Stephen Doxsey for providing human Kendrin cDNA. The Pax6 antibody developed by A. Kawakami was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. This work was supported by grant NS37007 from the National Institutes of Health. L.-H.T. is an investigator of the Howard Hughes Medical Institute and the director of the neurobiology program at the Stanley Center for Psychiatric Research.	Aicardi J, 1998, DIS NERVOUS SYSTEM C; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Endoh-Yamagami S, 2010, DEV BIOL, V340, P41, DOI 10.1016/j.ydbio.2010.01.017; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hassan MJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-58; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	56	131	134	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					386	402		10.1016/j.neuron.2010.03.036	http://dx.doi.org/10.1016/j.neuron.2010.03.036			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471352	Green Published, Bronze			2022-12-17	WOS:000277825200008
J	Montague, PR; Lohrenz, T				Montague, P. Read; Lohrenz, Terry			To detect and correct: Norm violations and their enforcement	NEURON			English	Editorial Material							NEURAL BASIS; ALTRUISTIC PUNISHMENT; DECISION-MAKING; INSULA; REWARD; RISK; ACTIVATION; ADDICTION; TRUST; BRAIN	Compliance with social norms requires neural signals related both to the norm and to deviations from it. Recent work using economic games between two interacting subjects has uncovered brain responses related to norm compliance and to an individual's strategic outlook during the exchange. These brain responses possess a provocative relationship to those associated with negative emotional outcomes, and hint at computational depictions of emotion processing.	Baylor Coll Med, Dept Neurosci, Computat Psychiat Unit, Houston, TX 77030 USA	Baylor College of Medicine	Montague, PR (corresponding author), Baylor Coll Med, Dept Neurosci, Computat Psychiat Unit, 1 Bayor Plaza, Houston, TX 77030 USA.	read@bcm.tmc.edu						Axelrod Robert., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Camerer C.F., 2003, BEHAV GAME THEORY; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dani JA, 2007, NAT NEUROSCI, V10, P403, DOI 10.1038/nn0407-403; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Roth A.E., 1995, HDB EXPT EC, P253; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318	27	131	132	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					14	18		10.1016/j.neuron.2007.09.020	http://dx.doi.org/10.1016/j.neuron.2007.09.020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920011	Bronze			2022-12-17	WOS:000250289800006
J	Yu, FW; Kuo, CT; Jan, YN				Yu, Fengwei; Kuo, Chay T.; Jan, Yuh Nung			Drosophila neuroblast asymmetric cell division: Recent advances and implications for stem cell biology	NEURON			English	Review							REGULATES SPINDLE ORIENTATION; G-ALPHA-I; G-PROTEIN; MITOTIC SPINDLE; CORTICAL LOCALIZATION; PLANAR POLARITY; SELF-RENEWAL; BRAIN-TUMOR; COMPLEX; PINS	Asymmetric cell division is an evolutionarily conserved mechanism widely used to generate cellular diversity during development. Drosophila neuroblasts have been a useful model system for studying the molecular mechanisms of asymmetric cell division. In this minireview, we focus on recent progress in understanding the role of heterotrimeric G proteins and their regulators in asymmetric spindle geometry, as well as the role of an Inscuteable-independent microtubule pathway in asymmetric localization of proteins in neuroblasts. We also discuss issues of progenitor proliferation and differentiation associated with asymmetric cell division and their broader implications for stem cell biology.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol Biochem & Biophys, San Francisco, CA 94143 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National University of Singapore; National University of Singapore	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Rock Hall,1550 4th St, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299				Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Katoh M, 2003, INT J MOL MED, V11, P111; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schneider M, 2006, INT J ONCOL, V28, P883; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Somers WG, 2005, DEV CELL, V9, P312, DOI 10.1016/j.devcel.2005.08.007; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; van Diepen MT, 2005, MOL CELL NEUROSCI, V29, P74, DOI 10.1016/j.mcn.2005.01.005; Wang H, 2003, CURR OPIN CELL BIOL, V15, P82, DOI 10.1016/S0955-0674(02)00006-6; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	59	131	133	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					13	20		10.1016/j.neuron.2006.06.016	http://dx.doi.org/10.1016/j.neuron.2006.06.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815328	Bronze			2022-12-17	WOS:000239037700006
J	Daniels, RW; Collins, CA; Chen, K; Gelfand, MV; Featherstone, DE; DiAntonio, A				Daniels, RW; Collins, CA; Chen, K; Gelfand, MV; Featherstone, DE; DiAntonio, A			A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle	NEURON			English	Article							QUANTAL SIZE; NEUROMUSCULAR-JUNCTION; RELEASE; EXPRESSION; LOCALIZATION; RECEPTORS; SYNAPSES; VGLUT1; SITES	Quantal size is the postsynaptic response to the release of a single synaptic vesicle and is determined in part by the amount of transmitter within that vesicle. At glutamatergic synapses, the vesicular glutamate transporter (VGLUT) fills vesicles with glutamate. While elevated VGLUT expression increases quantal size, the minimum number of transporters required to fill a vesicle is unknown. In Drosophila DVGLUT mutants, reduced transporter levels lead to a dose-dependent reduction in the frequency of spontaneous quantal release with no change in quantal size. Quantal frequency is not limited by vesicle number or impaired exocytosis. This suggests that a single functional unit of transporter is both necessary and sufficient to fill a vesicle to completion and that vesicles without DVGLUT are empty. Consistent with the presence of empty vesicles, at dvglut mutant synapses synaptic vesicles are smaller, suggesting that vesicle filling and/or transporter level is an important determinant of vesicle size.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	diantonio@wustl.edu		DiAntonio, Aaron/0000-0002-7262-0968; Collins, Catherine/0000-0002-1608-6692	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453, R01NS043171, R01NS045628] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM08151, T32 GM008151] Funding Source: Medline; NINDS NIH HHS [R01 NS045628-03, R01 NS043171, R01 NS051453, R01 NS045628, R01 NS045628-04, NS043171, NS045628, NS041543, R01 NS045628-01, R01 NS045628-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Franks KM, 2003, J NEUROSCI, V23, P3186; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gong LW, 2003, J NEUROSCI, V23, P7917; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pothos EN, 2000, J NEUROSCI, V20, P7297; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	18	131	143	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					11	16		10.1016/j.neuron.2005.11.032	http://dx.doi.org/10.1016/j.neuron.2005.11.032			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387635	Green Accepted, Bronze			2022-12-17	WOS:000236699300005
J	Reisert, J; Lai, J; Yau, KW; Bradley, J				Reisert, J; Lai, J; Yau, KW; Bradley, J			Mechanism of the excitatory Cl- response in mouse olfactory receptor neurons	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; CHLORIDE CURRENT; SENSORY NEURONS; NA-K-2CL COTRANSPORTER; FUNCTIONAL EXPRESSION; INDUCED CURRENTS; TRANSGENIC MICE; CELLS; TRANSDUCTION; CILIA	In vertebrate olfactory receptor neurons (ORNs), the odorant-triggered receptor current flows through two distinct ion channels on the sensory cilia: Ca2+ influx through a cyclic nucleotide-gated (CNG) channel followed by CI- efflux through a Ca2+-activated anion channel. The excitatory CI- current amplifies the small CNG current and crucially depends on a high intracellular CI- concentration. We show here that a Na+-K+-2CI(-) cotransporter, NKCC1, is required for this CI- current, in that ORNs deficient in NKCC1 or incubated with an NKCC blocker (bumetanide) lack the CI- current. Surprisingly, immunocytochemistry indicates that NKCC1 is located on the somata and dendrites of ORNs rather than the cilia, where transduction occurs. This topography is remarkably similar to the situation in secretory epithelial cells, where basolateral CI- uptake and apical CI- efflux facilitate transepithelial fluid movement. Thus, a single functional architecture serves two entirely different purposes, probably underscoring the epithelial origin of the ORNs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Reisert, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	jreisert@jhmi.edu; jbradley@jhu.edu		Bradley, Jonathan/0000-0002-6933-1153	NATIONAL EYE INSTITUTE [R01EY006837, R01EY014596, R37EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-15, R01 EY006837, R01 EY006837-18, R01 EY014596, R01 EY014596-02, R01 EY006837-16A1, R37 EY006837, R01 EY006837-17, R01 EY014596-01, R37 EY006837-15S1, R01 EY014596-03] Funding Source: Medline; NIDCD NIH HHS [DC 06904, R01 DC006904-01, R01 DC006904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Bradley J, 1997, J NEUROSCI, V17, P1993; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHIU D, 1988, CHEM SENSES, V13, P677; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; Evans RL, 2000, J BIOL CHEM, V275, P26720; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kaneko H, 2001, AM J PHYSIOL-CELL PH, V280, pC1387, DOI 10.1152/ajpcell.2001.280.6.C1387; Kaplan MR, 1996, J CLIN INVEST, V98, P723, DOI 10.1172/JCI118844; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; KURAHASHI T, 1994, CURR BIOL, V4, P256, DOI 10.1016/S0960-9822(00)00058-0; Laird JMA, 2004, NEUROSCI LETT, V361, P200, DOI 10.1016/j.neulet.2003.12.015; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; MATTHEWS HR, 1990, J PHYSL, V425, P20; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakamura T, 1997, NEUROSCI LETT, V237, P5, DOI 10.1016/S0304-3940(97)00794-5; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V534, P179, DOI 10.1111/j.1469-7793.2001.t01-1-00179.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Reuter D, 1998, J NEUROSCI, V18, P6623; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Sung KW, 2000, J NEUROSCI, V20, P7531; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; ZHAINAZAROV AB, 1995, J NEUROPHYSIOL, V74, P479, DOI 10.1152/jn.1995.74.1.479; Zhao H, 2001, CHEM SENSES, V26, P1110; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zhuo XL, 2001, ARCH BIOCHEM BIOPHYS, V391, P127, DOI 10.1006/abbi.2001.2410; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	48	131	139	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					553	561		10.1016/j.neuron.2005.01.012	http://dx.doi.org/10.1016/j.neuron.2005.01.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721241	Bronze, Green Accepted			2022-12-17	WOS:000227099700011
J	Zheng, J; Zagotta, WN				Zheng, J; Zagotta, WN			Stoichiometry and assembly of olfactory cyclic nucleotide-gated channels	NEURON			English	Article							SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; POTASSIUM CHANNELS; ACTIVATED CHANNEL; STRUCTURAL BASIS; CATION CHANNEL; MODULATION; CA2+-CALMODULIN; RECEPTOR; PROTEIN	Native ion channels are precisely tuned to their physiological role in neuronal signaling. This tuning frequently involves the controlled assembly of heteromeric channels comprising multiple types of subunits. Cyclic nucleotide-gated (CNG) channels of olfactory neurons are tetramers and require three types of subunits, CNGA2, CNGA4, and CNGB1b, to exhibit properties necessary for olfactory transduction. Using fluorescently tagged subunits and fluorescence resonance energy transfer (FRET), we find the subunit composition of heteromeric olfactory channels in the surface membrane is fixed, with 2:11:11 CNGA2: CNGA4:CNGB1b. Furthermore, when expressed individually with CNGA2, CNGA4 and CNGB1b subunits were still present in only a single copy and, when expressed alone, did not self-assemble. These results suggest that the precise assembly of heteromeric olfactory channels results from a mechanism where CNGA4 and CNGB1b subunits have a high affinity for CNGA2 but not for self-assembly, precluding more than one CNGA4 or CNGB1b subunit in the channel complex.	Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, POB 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu			NEI NIH HHS [R01 EY010329, R01 EY010329-11, EY 10329] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BROWN RL, 1995, BIOCHEMISTRY-US, V34, P8365, DOI 10.1021/bi00026a018; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Finn JT, 1998, BIOPHYS J, V74, P1333, DOI 10.1016/S0006-3495(98)77846-4; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Shapiro MS, 2000, BIOPHYS J, V78, P2307, DOI 10.1016/S0006-3495(00)76777-4; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2003, J NEUROSCI, V23, P8167; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; ZHENG J, 2003, SCI STKE, pPL7; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100; Zhou L, 2002, BIOPHYS J, V82, p183A; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	50	131	143	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					411	421		10.1016/S0896-6273(04)00253-3	http://dx.doi.org/10.1016/S0896-6273(04)00253-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134638	Bronze			2022-12-17	WOS:000221458700008
J	Cayouette, M; Barres, BA; Raff, M				Cayouette, M; Barres, BA; Raff, M			Importance of intrinsic mechanisms in cell fate decisions in the developing rat retina	NEURON			English	Article							ROD PHOTORECEPTOR DEVELOPMENT; PROGENITOR CELLS; AMACRINE CELLS; DROSOPHILA NEUROBLASTS; DEVELOPMENT INVITRO; MAMMALIAN RETINA; TADPOLE RETINA; XENOPUS RETINA; BIPOLAR CELLS; FROG RETINA	Cell diversification in the developing nervous system is thought to involve both cell-intrinsic mechanisms and extracellular signals, but their relative importance in particular cell fate decisions remains uncertain. In the mammalian retina, different cell types develop on a predictable schedule from multipotent retinal neuroepithelial cells (RNECs). A current view is that RNECs pass through a series of competence states, progressively changing their responsiveness to instructive extracellular cues, which also change over time. We show here, however, that embryonic day 16-17 (E16-17) rat RNECs develop similarly in serum-free clonal-density cultures and in serum-containing retinal explants-in the number of times they divide, the cell types they generate, and the order in which they generate these cell types. These surprising results suggest that extracellular signals may be less important than currently believed in determining when RNECs stop dividing and what cell types they generate when they withdraw from the cell cycle, at least from E16-17 onward.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	University of London; University College London; University of London; University College London; Stanford University	Cayouette, M (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,299 Campus Dr,D231, Stanford, CA 94305 USA.	m.cayouefte@stanford.edu		Cayouette, Michel/0000-0003-4655-9048	NEI NIH HHS [R01 EY113110] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAGAWA K, 1986, BRAIN RES, V383, P110, DOI 10.1016/0006-8993(86)90012-0; AKAGAWA K, 1987, BRAIN RES, V437, P298, DOI 10.1016/0006-8993(87)91644-1; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; FURST A, 1985, DEV BIOL, V112, P467, DOI 10.1016/0012-1606(85)90419-1; GalliResta L, 1997, J NEUROSCI, V17, P7831; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUANG S, 1995, J COMP NEUROL, V360, P442, DOI 10.1002/cne.903600306; Huang S, 1997, J COMP NEUROL, V387, P42; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jensen AM, 1997, DEV BIOL, V188, P267, DOI 10.1006/dbio.1997.8645; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LUER K, 1992, DEVELOPMENT, V116, P377; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Moody SA, 2000, J NEUROSCI, V20, P3244, DOI 10.1523/JNEUROSCI.20-09-03244.2000; Morrow EM, 1998, J NEUROSCI, V18, P3738; NEGISHI K, 1982, SCIENCE, V216, P747, DOI 10.1126/science.7079736; Neophytou C, 1997, DEVELOPMENT, V124, P2345; ONODA N, 1987, BRAIN RES, V416, P359, DOI 10.1016/0006-8993(87)90919-X; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rapaport DH, 1996, PERSPECT DEV NEUROBI, V3, P147; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; Sheedlo HJ, 1996, J NEUROSCI RES, V44, P519; Shen Q, 2002, DEVELOPMENT, V129, P4843; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Waid DK, 1998, DEVELOPMENT, V125, P1059; WATANABE T, 1992, DEVELOPMENT, V114, P899; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS RW, 1992, TRENDS NEUROSCI, V15, P368, DOI 10.1016/0166-2236(92)90181-7; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	46	131	133	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					897	904		10.1016/S0896-6273(03)00756-6	http://dx.doi.org/10.1016/S0896-6273(03)00756-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659089	Bronze			2022-12-17	WOS:000187042200007
J	Schnitzer, MJ; Meister, M				Schnitzer, MJ; Meister, M			Multineuronal firing patterns in the signal from eye to brain	NEURON			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; INFORMATION; DISCHARGE; NEURONS; IDENTIFICATION; ADAPTATION; RESPONSES; GOLDFISH	Population codes in the brain have generally been characterized by recording responses from one neuron at a time. This approach will miss codes that rely on concerted patterns of action potentials from many cells. Here we analyze visual signaling in populations of ganglion cells recorded from the isolated salamander retina. These neurons tend to fire synchronously far more frequently than expected by chance. We present an efficient algorithm to identify what groups of cells cooperate in this way. Such groups can include up to seven or more neurons and may account for more than 50% of all the spikes recorded from the retina. These firing patterns represent specific messages about the visual stimulus that differ significantly from what one would derive by single-cell analysis.	Lucent Technol, Bell Labs, Biol Computat & Theoret Phys Res Dept, Murray Hill, NJ 07974 USA; Harvard Univ, Mol & Cellular Biol Dept, Cambridge, MA 02138 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Harvard University	Meister, M (corresponding author), Lucent Technol, Bell Labs, Biol Computat & Theoret Phys Res Dept, Murray Hill, NJ 07974 USA.			Meister, Markus/0000-0003-2136-6506	NEI NIH HHS [EY10020] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010020] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARNETT D, 1981, J PHYSIOL-LONDON, V317, P29, DOI 10.1113/jphysiol.1981.sp013812; ARNETT DW, 1978, EXP BRAIN RES, V32, P49; Balasubramanian V, 2001, NEURAL COMPUT, V13, P799, DOI 10.1162/089976601300014358; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; BUZSAKI G, 1989, J NEUROSCI METH, V28, P209, DOI 10.1016/0165-0270(89)90038-1; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1976, J PHYSIOL-LONDON, V255, P299, DOI 10.1113/jphysiol.1976.sp011281; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DellaSantina CC, 1997, J NEUROSCI METH, V72, P71, DOI 10.1016/S0165-0270(96)00159-8; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; FROSTIG RD, 1990, BIOL CYBERN, V62, P487, DOI 10.1007/BF00205110; GERSTEIN GL, 1978, BRAIN RES, V140, P43, DOI 10.1016/0006-8993(78)90237-8; GERSTEIN GL, 1985, J NEUROPHYSIOL, V54, P1513, DOI 10.1152/jn.1985.54.6.1513; GHOSE GM, 1994, J NEUROPHYSIOL, V71, P330, DOI 10.1152/jn.1994.71.1.330; HUNTER IW, 1986, BIOL CYBERN, V55, P135; JOHNSEN JA, 1983, J PHYSIOL-LONDON, V345, P439, DOI 10.1113/jphysiol.1983.sp014987; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KOVACS GTA, 1994, IEEE T BIO-MED ENG, V41, P567, DOI 10.1109/10.293244; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nordhausen CT, 1996, BRAIN RES, V726, P129; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; REDLICH AN, 1993, NEURAL COMPUT, V5, P289, DOI 10.1162/neco.1993.5.2.289; Shannon E.R., 1963, MATH THEORY COMMUNIC; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Storer J.A., 1988, DATA COMPRESSION MET; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Wandell B.A., 1995, FDN VISION; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	40	131	161	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					499	511		10.1016/S0896-6273(03)00004-7	http://dx.doi.org/10.1016/S0896-6273(03)00004-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575956	Bronze			2022-12-17	WOS:000181081600014
J	Weitz, D; Ficek, N; Kremmer, E; Bauer, PJ; Kaupp, UB				Weitz, D; Ficek, N; Kremmer, E; Bauer, PJ; Kaupp, UB			Subunit stoichiometry of the CNG channel of rod photoreceptors	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; ACID-RICH PROTEINS; ION CHANNELS; BETA-SUBUNIT; CATION CHANNEL; INTERSUBUNIT INTERACTION; FUNCTIONAL EXPRESSION; CALCIUM-CALMODULIN; POTASSIUM CHANNEL; OLFACTORY NEURONS	Cyclic nucleotide-gated (CNG) channels play a central role in the conversion of sensory stimuli into electrical signals. CNG channels form heterooligomeric complexes built of A and B subunits. Here, we study the subunit stoichiometry of the native rod CNG channel by chemical crosslinking. The apparent molecular weight (M-w) of each crosslink product was determined by SDS-PAGE, and its composition was analyzed by Western blotting using antibodies specific for the A1 or B1 subunit. The number of crosslink products and their M-w as well as the immunological identification of A1 and B1 subunits in the crosslink products led us to conclude that the native rod CNG channel is a tetramer composed of three A1 and one B1 subunit. This is an example of violation of symmetry in tetrameric channels.	Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany; GSF, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kaupp, UB (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany.	a.eckert@fz-juelich.de						Bonigk W, 1999, J NEUROSCI, V19, P5332; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Gerstner A, 2000, J NEUROSCI, V20, P1324; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HSU YT, 1994, J BIOL CHEM, V269, P29765; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; HU DH, 1989, BIOMED RES-TOKYO, V10, P165, DOI 10.2220/biomedres.10.165; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mallouk N, 2002, J MEMBRANE BIOL, V185, P129, DOI 10.1007/s00232-001-0119-9; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Molday RS, 1998, VISION RES, V38, P1315, DOI 10.1016/S0042-6989(97)00409-4; Molokanova E, 1997, J NEUROSCI, V17, P9068; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SCHNETKAMP PPM, 1982, METHOD ENZYMOL, V81, P110; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Schwarzer A, 2000, J BIOL CHEM, V275, P13448, DOI 10.1074/jbc.275.18.13448; Seifert R, 1999, EMBO J, V18, P119, DOI 10.1093/emboj/18.1.119; SERRE V, 1995, J MEMBRANE BIOL, V146, P145; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Sukharev SI, 1999, J MEMBRANE BIOL, V171, P183, DOI 10.1007/s002329900570; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; WOHLFART P, 1992, J BIOL CHEM, V267, P644; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3	55	131	135	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					881	889		10.1016/S0896-6273(02)01098-X	http://dx.doi.org/10.1016/S0896-6273(02)01098-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467591	Bronze			2022-12-17	WOS:000179667800012
J	Hassan, BA; Bermingham, NA; He, YC; Sun, Y; Jan, YN; Zoghbi, HY; Bellen, HJ				Hassan, BA; Bermingham, NA; He, YC; Sun, Y; Jan, YN; Zoghbi, HY; Bellen, HJ			Atonal regulates neurite arborization but does not act as a proneural gene in the Drosophila brain	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; SENSE ORGAN; TRANSCRIPTION FACTOR; MUSHROOM BODIES; EXPRESSION; NEUROGENESIS; LOCALIZATION; NOTCH; PHOTORECEPTORS; PROGENITORS	Drosophila atonal (ato) is the proneural gene of the chordotonal organs (CHOs) in the peripheral nervous system (PNS) and the larval and adult photoreceptor organs. Here, we show that ato is expressed at multiple stages during the development of a lineage of central brain neurons that innervate the optic lobes and are required for eclosion. A novel fate mapping approach shows that ato is expressed in the embryonic precursors of these neurons and that its expression is reactivated in third instar larvae (L3). In contrast to its function in the PNS, ato does not act as a proneural gene in the embryonic brain. Instead, ato performs a novel function, regulating arborization during larval and pupal development by interacting with Notch.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Physiol & Biochem, San Francisco, CA 94143 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	bhassan@bcm.tmc.edu; hbellen@bcm.tmc.edu	Hassan, Bassem A/D-5221-2012	Hassan, Bassem A/0000-0001-9533-4908; Bellen, Hugo/0000-0001-5992-5989; Zoghbi, Huda/0000-0002-0700-3349; Jan, Yuh Nung/0000-0003-1367-6299				Ahmad I, 1998, J MOL NEUROSCI, V11, P165, DOI 10.1385/JMN:11:2:165; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bauer H., 1943, Zeitschrift fuer Induktive Abstammungs- und Vererbungslehre, V81, P374, DOI 10.1007/BF01847454; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NL, 1998, DEVELOPMENT, V125, P4821; Cau E, 1997, DEVELOPMENT, V124, P1611; Clark IE, 1997, DEVELOPMENT, V124, P461; Daniel A, 1999, DEVELOPMENT, V126, P2945; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DRELLER C, 1993, J COMP PHYSIOL A, V173, P275, DOI 10.1007/BF00212691; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; FISCHBACH KF, 1981, NEUROSCI LETT S, V7, pS288; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; GINIGER E, 1993, DEVELOPMENT, V117, P431; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kunes S, 1999, NEURON, V22, P639, DOI 10.1016/S0896-6273(00)80719-9; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MARDON G, 1994, DEVELOPMENT, V120, P3473; McIver S.B., 1985, P71; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; MOULINS M, 1976, ULTRASTRUCTURE CHORD; Nieto MA, 1996, NEURON, V17, P1039, DOI 10.1016/S0896-6273(00)80237-8; Okabe M, 1997, DEVELOPMENT, V124, P1045; PFLUGFELDER GO, 1992, P NATL ACAD SCI USA, V89, P1199, DOI 10.1073/pnas.89.4.1199; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; SHELLENBARGER DL, 1971, GENETICS, V68, pS61; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun Y, 1998, DEVELOPMENT, V125, P3731; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsuda H, 1998, J BIOL CHEM, V273, P6327, DOI 10.1074/jbc.273.11.6327; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; YANG MY, 1995, NEURON, V15, P45; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475; ZHAO C, 1995, NATURE, V373, P74, DOI 10.1038/373074a0; zur Lage P, 1999, DEVELOPMENT, V126, P3149; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	57	131	135	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					549	561		10.1016/S0896-6273(00)81059-4	http://dx.doi.org/10.1016/S0896-6273(00)81059-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774724	Bronze			2022-12-17	WOS:000086291700009
J	Gad, H; Low, P; Zotova, E; Brodin, L; Shupliakov, O				Gad, H; Low, P; Zotova, E; Brodin, L; Shupliakov, O			Dissociation between Ca2+-triggered synaptic vesicle exocytosis and clathrin-mediated endocytosis at a central synapse	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; ADRENAL CHROMAFFIN CELLS; TRANSMITTER RELEASE; NERVE-TERMINALS; GLUTAMATERGIC TRANSMISSION; RETICULOSPINAL AXONS; PRESYNAPTIC BOUTONS; MEMBRANE RETRIEVAL; COATED VESICLES; DYNAMIN-I	We have tested whether action potential-evoked Ca2+ influx is required to initiate clathrin-mediated synaptic vesicle endocytosis in the lamprey reticulospinal synapse. Exo- and endocytosis were temporally separated by a procedure involving tonic action potential stimulation and subsequent removal of extracellular Ca2+ (Ca-e(2+)). A low concentration of Ca2+ ([Ca2+](e) of 11 mu M) was found to be required for the induction of early stages of endocytosis. However, the entire endocytic process, from the formation of clathrin-coated membrane invaginations to the generation of synaptic vesicles, proceeded in the absence of action potential-mediated Ca2+ entry. Our results indicate that the membrane of synaptic vesicles newly incorporated in the plasma membrane is a sufficient trigger of clathrin-mediated synaptic Vesicle endocytosis.	Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Brodin, L (corresponding author), Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden.		Gad, Helge/J-2238-2014; Shupliakov, Oleg/R-9148-2016	Shupliakov, Oleg/0000-0001-5352-6848; Gad, Helge/0000-0001-6530-1443				ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; ARTALEJO CR, 1996, NEURON, V16, P1; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Brodin L, 1997, EUR J NEUROSCI, V9, P2503, DOI 10.1111/j.1460-9568.1997.tb01679.x; BRODIN L, 1994, ADV SEC MESS PHOSPH, V29, P205; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HENKEL AW, 1995, NEUROPHARMACOLOGY, V34, P1397, DOI 10.1016/0028-3908(95)00126-Q; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HURLBUT WP, 1994, J MEMBRANE BIOL, V138, P91, DOI 10.1007/BF00211072; Huttner WB, 1995, COLD SPRING HARB SYM, V60, P315, DOI 10.1101/SQB.1995.060.01.036; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KASICKI S, 1989, BRAIN RES, V484, P203, DOI 10.1016/0006-8993(89)90363-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; MALLABIABARRENA A, 1995, CELL, V83, P667, DOI 10.1016/0092-8674(95)90177-9; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Nucifora PGP, 1998, J PHYSIOL-LONDON, V508, P483, DOI 10.1111/j.1469-7793.1998.483bq.x; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P1035, DOI 10.1016/S0896-6273(00)80236-6; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WHITNEY JA, 1995, CELL, V83, P703; WICKELGREN WO, 1985, J NEUROSCI, V5, P1188; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	56	131	135	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					607	616		10.1016/S0896-6273(00)80570-X	http://dx.doi.org/10.1016/S0896-6273(00)80570-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768846	Bronze			2022-12-17	WOS:000076196400016
